PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Islam, R; Kim, JG; Park, Y; Cho, JY; Cap, KC; Kho, AR; Chung, WS; Suh, SW; Park, JB				Islam, Rokibul; Kim, Jae-Gyu; Park, Yohan; Cho, Jung-Yoon; Cap, Kim-Cuong; Kho, A-Ra; Chung, Won-Suk; Suh, Sang-Won; Park, Jae-Bong			Insulin induces phosphorylation of pyruvate dehydrogenase through RhoA activation pathway in HepG2 cells	FASEB JOURNAL			English	Article						GTPase; GSK-3 beta; hepatocellular carcinoma	GLYCOGEN-SYNTHASE KINASE-3; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; COMPLEX ACTIVITY; PROMOTES; LIVER; TRANSLOCATION; MUSCLE; GSK-3; BETA	Insulin is a critical signaling molecule in reducing blood glucose levels, and pyruvate dehydrogenase (PDH) is an essential enzyme in regulating glucose metabolism. However, the insulin effect on PDH function has not been well established. We observed that insulin attenuated the phosphorylation (p) of Ser264 (p-Ser264) in the PDH E1 subunit (PDHA1) in normal rat hepatocyte. In contrast, insulin induced an increase of p-Ser264 PDHA1 levels in hepatocellular carcinoma HepG2 and Huh7 cells. Insulin activated RhoA and Rho-dependent coiled coil kinase, an effector protein of active RhoA, which regulated p-Ser264 PDHA1 levels, along with both p-Ser9 and p-Tyr216 forms of glycogen synthase kinase-3 (GSK-3) in HepG2 cells. Only p-Tyr216 GSK-3, the active form was involved in an increase of p-Ser264 PDHA1. Akt was also engaged in p-Ser9 of GSK-3, but neither in p-Tyr216 of GSK-3 nor p-Ser264 of PDHA1 upon insulin. Reconstituted dephospho-mimic forms PDHA1 S264A and GSK-3 Y216F impaired, but wild-types PDHA1 and GSK-3 and phospho-mimic forms PDHA1 S264D and GSK-3 Y216E increased cell proliferation upon insulin through expression of c-Myc and cyclin D1. Therefore, we propose that insulin-mediated p-PDHA1 is involved in the regulation of HepG2 cell proliferation through RhoA signaling pathway.Islam, R., Kim, J.-G., Park, Y., Cho, J.-Y., Cap, K.-C., Kho, A.-R., Chung, W.-S., Suh, S.-W., Park, J.-B. Insulin induces phosphorylation of pyruvate dehydrogenase through RhoA activation pathway in HepG2 cells.	[Islam, Rokibul; Kim, Jae-Gyu; Park, Yohan; Cho, Jung-Yoon; Cap, Kim-Cuong; Park, Jae-Bong] Hallym Univ, Coll Med, Dept Biochem, Chunchon 24252, Kangwon Do, South Korea; [Islam, Rokibul; Kim, Jae-Gyu; Cho, Jung-Yoon; Park, Jae-Bong] Hallym Univ, Coll Med, Inst Cell Differentiat & Aging, Chunchon, South Korea; [Kho, A-Ra; Suh, Sang-Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Suh, Sang-Won; Park, Jae-Bong] Hallym Univ, Hallym Clin & Translat Res Inst, Chunchon, South Korea; [Islam, Rokibul] Islamic Univ, Fac Appl Sci & Technol, Dept Biotechnol & Genet Engn, Kushtia, Bangladesh; [Chung, Won-Suk] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Hallym University; Hallym University; Hallym University; Hallym University; Islamic University; Korea Advanced Institute of Science & Technology (KAIST)	Park, JB (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon 24252, Kangwon Do, South Korea.	jbpark@hallym.ac.kr	Chung, Won-Suk/B-9011-2016	Chung, Won-Suk/0000-0003-1060-9007	National Research Foundation (NRF) of Korea - Ministry of Science and Information and Communications Technology (ICT) of the Korean government [NRF-2018R1A4A1020922]; Hallym University [HRF-201802-017]	National Research Foundation (NRF) of Korea - Ministry of Science and Information and Communications Technology (ICT) of the Korean government; Hallym University	This work was supported by a grant from the National Research Foundation (NRF) of Korea, funded by the Ministry of Science and Information and Communications Technology (ICT) of the Korean government (NRF-2018R1A4A1020922), and Hallym University (HRF-201802-017). The authors declare no conflicts of interest.	Baumann CA, 2001, BIOESSAYS, V23, P215, DOI 10.1002/1521-1878(200103)23:3<215::AID-BIES1031>3.0.CO;2-S; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Boucher J, 2014, COLD SPRING HARB PER, V6; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Caruso M, 2001, J BIOL CHEM, V276, P45088, DOI 10.1074/jbc.M105451200; Chettouh H, 2015, LIVER INT, V35, P2203, DOI 10.1111/liv.12903; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Choi E. K., 2017, SMALL GTPASES; CLOT JP, 1988, METABOLISM, V37, P1101, DOI 10.1016/0026-0495(88)90075-3; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Dyberg C, 2017, P NATL ACAD SCI USA, V114, pE6603, DOI 10.1073/pnas.1706011114; Fan J, 2014, J BIOL CHEM, V289, P26533, DOI 10.1074/jbc.M114.593970; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Goc A, 2014, ONCOTARGET, V5, P775, DOI 10.18632/oncotarget.1770; Hartigan JA, 2001, BIOCHEM BIOPH RES CO, V284, P485, DOI 10.1006/bbrc.2001.4986; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; Jeoung NH, 2015, DIABETES METAB J, V39, P188, DOI 10.4093/dmj.2015.39.3.188; Julian Linda, 2014, Small GTPases, V5, pe29846, DOI 10.4161/sgtp.29846; Kim HJ, 2014, J BIOL CHEM, V289, P1429, DOI 10.1074/jbc.M113.520130; Kim JG, 2018, J CELL PHYSIOL, V233, P6381, DOI 10.1002/jcp.26487; Kim JG, 2017, FREE RADICAL BIO MED, V112, P69, DOI 10.1016/j.freeradbiomed.2017.07.013; Kim JG, 2017, FREE RADICAL BIO MED, V103, P57, DOI 10.1016/j.freeradbiomed.2016.12.013; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; MURAT JC, 1974, CLIN CHEM, V20, P1576; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Noel A, 2011, J NEUROSCI RES, V89, P755, DOI 10.1002/jnr.22587; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Poloz Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.381; Ren XD, 2000, METHOD ENZYMOL, V325, P264; SALE GJ, 1981, EUR J BIOCHEM, V120, P535, DOI 10.1111/j.1432-1033.1981.tb05733.x; Satoh Takaya, 2014, Small GTPases, V5, pe28102, DOI 10.4161/sgtp.28102; Sayas CL, 2006, MOL BIOL CELL, V17, P1834, DOI 10.1091/mbc.E05-07-0688; Sayas CL, 2002, J NEUROSCI, V22, P6863; Shan CL, 2014, J BIOL CHEM, V289, P21413, DOI 10.1074/jbc.M114.581124; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; TEAGUE WM, 1979, BIOCHEM BIOPH RES CO, V87, P244, DOI 10.1016/0006-291X(79)91672-3; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xie P, 2003, CLIN EXP PHARMACOL P, V30, P643, DOI 10.1046/j.1440-1681.2003.03899.x	47	5	5	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2072	2083		10.1096/fj.201800917R	http://dx.doi.org/10.1096/fj.201800917R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30226812				2022-12-28	WOS:000457296600044
J	Cunningham, KE; Novak, EA; Vincent, G; Siow, VS; Griffith, BD; Ranganathan, S; Rosengart, MR; Piganelli, JD; Mollen, KP				Cunningham, Kellie E.; Novak, Elizabeth A.; Vincent, Garret; Siow, Vei Shaun; Griffith, Brian D.; Ranganathan, Sarangarajan; Rosengart, Matthew R.; Piganelli, Jon D.; Mollen, Kevin P.			Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation	FASEB JOURNAL			English	Article						inflammatory bowel disease; CREB; intracellular calcium signaling; intestinal epithelial barrier	ENDOPLASMIC-RETICULUM STRESS; INFLAMMATORY-BOWEL-DISEASE; ELEMENT-BINDING PROTEIN; DEXTRAN SULFATE SODIUM; CYCLE ARREST; OCCLUDING JUNCTIONS; TIGHT JUNCTIONS; CROHNS-DISEASE; STEM-CELLS; ER STRESS	The incidence and prevalence of inflammatory bowel disease (IBD) are increasing worldwide. IBD is known to be multifactorial, but inflammatory signaling within the intestinal epithelium and a subsequent failure of the intestinal epithelial barrier have been shown to play essential roles in disease pathogenesis. CaMKIV is a multifunctional protein kinase associated with inflammation and cell cycle regulation. CaMKIV has been extensively studied in autoimmune diseases, but a role in idiopathic intestinal inflammation has not been described. In this study, active CaMKIV was highly expressed within the intestinal epithelium of humans with ulcerative colitis and wild-type (WT) mice with experimental induced colitis. Clinical disease severity directly correlates with CaMKIV activation, as does expression of proinflammatory cytokines and histologic features of colitis. In WT mice, CaMKIV activation is associated with increases in expression of 2 cell cycle proarrest signals: p53 and p21. Cell cycle arrest inhibits proliferation of the intestinal epithelium and ultimately results in compromised intestinal epithelial barrier integrity, further perpetuating intestinal inflammation during experimental colitis. Using a CaMKIV null mutant mouse, we demonstrate that a loss of CaMKIV protects against murine DSS colitis. Small molecules targeting CaMKIV activation may provide therapeutic benefit for patients with IBD.Cunningham, K. E., Novak, E. A., Vincent, G., Siow, V. S., Griffith, B. D., Ranganathan, S., Rosengart, M. R., Piganelli, J. D., Mollen, K. P. Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation.	[Cunningham, Kellie E.; Novak, Elizabeth A.; Vincent, Garret; Siow, Vei Shaun; Griffith, Brian D.; Rosengart, Matthew R.; Piganelli, Jon D.; Mollen, Kevin P.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Novak, Elizabeth A.; Vincent, Garret; Mollen, Kevin P.] UPMC, Childrens Hosp Pittsburgh, Div Pediat Surg, Pittsburgh, PA USA; [Ranganathan, Sarangarajan] UPMC, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mollen, KP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Sch Med, 4401 Penn Ave,Fac Pavil,Suite 7000, Pittsburgh, PA 15224 USA.	kevin.mollen@chp.edu		Griffith, Brian/0000-0001-6580-7217; Ranganathan, Sarangarajan/0000-0001-6214-9167	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants [K08DK101753, R03DK114464]; NIH National Institute of General Medical Sciences [R01GM082852]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101753, R03DK114464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082852] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants K08DK101753 and R03DK114464 (to K.P.M.) and NIH National Institute of General Medical Sciences Grant R01GM082852 (to M.R.R.). The authors declare no conflicts of interest.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; Al-Sadi R, 2013, AM J PATHOL, V183, P1871, DOI 10.1016/j.ajpath.2013.09.001; Al-Sadi R, 2012, J INTERF CYTOK RES, V32, P474, DOI 10.1089/jir.2012.0031; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; Araki Y, 2006, ONCOL REP, V16, P1357; Araki Y, 2012, ONCOL REP, V28, P1597, DOI 10.3892/or.2012.1969; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Basaranoglu M., 2016, J GASTROINTEST DIG S, V6, P467; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Beigel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099293; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281; Blough E, 1999, BIOTECHNIQUES, V26, P202, DOI 10.2144/99262bm05; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cabral M, 2013, INT J BIOCHEM CELL B, V45, P1620, DOI 10.1016/j.biocel.2013.05.009; Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; CCFA, 2014, FACTS INFLAMMATORY B; CEREIJIDO M, 1981, AM J PHYSIOL, V240, pC96, DOI 10.1152/ajpcell.1981.240.3.C96; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cintolo Marcello, 2016, World J Gastrointest Pathophysiol, V7, P1, DOI 10.4291/wjgp.v7.i1.1; Clem BF, 2005, ENDOCRINOLOGY, V146, P1348, DOI 10.1210/en.2004-0761; Cunningham KE, 2016, J BIOL CHEM, V291, P10184, DOI 10.1074/jbc.M115.688812; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Duronio Robert J, 2013, Cold Spring Harb Perspect Biol, V5, pa008904, DOI 10.1101/cshperspect.a008904; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; Evankovich J, 2012, AM J PHYSIOL-GASTR L, V303, pG189, DOI 10.1152/ajpgi.00051.2012; Ferrer R, 2010, BIOCHEM PHARMACOL, V80, P431, DOI 10.1016/j.bcp.2010.04.033; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; GALLI P, 1976, EXP CELL RES, V99, P178, DOI 10.1016/0014-4827(76)90694-7; Gersemann M, 2011, WORLD J GASTROENTERO, V17, P3198, DOI 10.3748/wjg.v17.i27.3198; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Greco CA, 2011, VOX SANG, V100, P336, DOI 10.1111/j.1423-0410.2010.01419.x; Groenendyk J, 2013, ANNU REV PHYSIOL, V75, P49, DOI 10.1146/annurev-physiol-030212-183707; Hamabata T, 2018, J LIPID RES, V59, P586, DOI 10.1194/jlr.M079095; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; HAYS RM, 1965, J CELL BIOL, V25, P195, DOI 10.1083/jcb.25.3.195; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hetz C, 2013, NAT REV MOL CELL BIO, V14, DOI 10.1038/nrm3606; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Holmberg FEO, 2018, J TISSUE ENG REGEN M, V12, P923, DOI 10.1002/term.2506; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krebs J, 1997, BIOCHEM BIOPH RES CO, V241, P383, DOI 10.1006/bbrc.1997.7823; Landy J, 2016, WORLD J GASTROENTERO, V22, P3117, DOI 10.3748/wjg.v22.i11.3117; Larmonier CB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504638; Luo QY, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020066; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mao HZ, 2014, J BIOL CHEM, V289, P24417, DOI 10.1074/jbc.M114.588764; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; MELDOLESI J, 1978, J CELL BIOL, V79, P156, DOI 10.1083/jcb.79.1.156; Nagy Z, 2007, BBA-MOL BASIS DIS, V1772, P402, DOI 10.1016/j.bbadis.2006.11.001; Naz H, 2016, PROG BIOPHYS MOL BIO, V121, P54, DOI 10.1016/j.pbiomolbio.2015.12.016; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Novak EA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00062; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Okamoto R, 2016, J GASTROENTEROL, V51, P11, DOI 10.1007/s00535-015-1098-4; Orlando A, 2013, DIGEST LIVER DIS, V45, P986, DOI 10.1016/j.dld.2013.07.005; PALANT CE, 1983, AM J PHYSIOL, V245, pC203, DOI 10.1152/ajpcell.1983.245.3.C203; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Rigoli L, 2014, WORLD J GASTROENTERO, V20, P10262, DOI 10.3748/wjg.v20.i30.10262; Roda G, 2010, WORLD J GASTROENTERO, V16, P4264, DOI 10.3748/wjg.v16.i34.4264; Rolhion N, 2010, GUT, V59, P1355, DOI 10.1136/gut.2010.207456; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schuh RA, 2005, J NEUROCHEM, V92, P388, DOI 10.1111/j.1471-4159.2004.02873.x; SEDAR AW, 1964, J CELL BIOL, V22, P173, DOI 10.1083/jcb.22.1.173; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Shiomi R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13262; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Teshima CW, 2012, ANN NY ACAD SCI, V1258, P159, DOI 10.1111/j.1749-6632.2012.06612.x; Tsuru A, 2013, P NATL ACAD SCI USA, V110, P2864, DOI 10.1073/pnas.1212484110; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vaughn Byron P, 2014, Curr Treat Options Gastroenterol, V12, P103, DOI 10.1007/s11938-013-0008-1; Viazis N, 2010, INFLAMM BOWEL DIS, V16, P507, DOI 10.1002/ibd.21077; Wang H, 1997, BBA-GENE STRUCT EXPR, V1352, P325, DOI 10.1016/S0167-4781(97)00035-3; Zhang XH, 2017, FASEB J, V31, P4382, DOI 10.1096/fj.201601096RRR; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhou XY, 2014, IMMUNOLOGY, V143, P287, DOI 10.1111/imm.12309	102	7	8	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1330	1346		10.1096/fj.201800535R	http://dx.doi.org/10.1096/fj.201800535R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113881	Green Published			2022-12-28	WOS:000457401500105
J	Hahn, J; Schauer, C; Czegley, C; Kling, L; Petru, L; Schmid, B; Weidner, D; Reinwald, C; Biermann, MHC; Blunder, S; Ernst, J; Lesner, A; Bauerle, T; Palmisano, R; Christiansen, S; Herrmann, M; Bozec, A; Gruber, R; Schett, G; Hoffmann, MH				Hahn, Jonas; Schauer, Christine; Czegley, Christine; Kling, Lasse; Petru, Lenka; Schmid, Benjamin; Weidner, Daniela; Reinwald, Christiane; Biermann, Mona H. C.; Blunder, Stefan; Ernst, Juergen; Lesner, Adam; Baeuerle, Tobias; Palmisano, Ralf; Christiansen, Silke; Herrmann, Martin; Bozec, Aline; Gruber, Robert; Schett, Georg; Hoffmann, Markus H.			Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases	FASEB JOURNAL			English	Article						neutrophil serine proteases; periodontal inflammation; eosinophils; immune regulation	PAPILLON-LEFEVRE-SYNDROME; NADPH OXIDASE; CELL-DEATH; RESOLUTION; PROTEASES; ELASTASE; LEADS; MYELOPEROXIDASE; REQUIREMENTS; DEFICIENCY	Papillon-Lefevre syndrome (PLS) is characterized by nonfunctional neutrophil serine proteases (NSPs) and fulminant periodontal inflammation of unknown cause. Here we investigated neutrophil extracellular trap (NET)-associated aggregation and cytokine/chemokine-release/degradation by normal and NSP-deficient human and mouse granulocytes. Stimulated with solid or soluble NET inducers, normal neutrophils formed aggregates and both released and degraded cytokines/chemokines. With increasing cell density, proteolytic degradation outweighed release. Maximum output of cytokines/chemokines occurred mostly at densities between 2 x 10(7) and 4 x 10(7) neutrophils/cm(3). Assessment of neutrophil density in vivo showed that these concentrations are surpassed during inflammation. Association with aggregated NETs conferred protection of neutrophil elastase against 1-antitrypsin. In contrast, eosinophils did not influence cytokine/chemokine concentrations. The proteolytic degradation of inflammatory mediators seen in NETs was abrogated in Papillon-Lefevre syndrome (PLS) neutrophils. In summary, neutrophil-driven proteolysis of inflammatory mediators works as a built-in safeguard for inflammation. The absence of this negative feedback mechanism might be responsible for the nonresolving periodontitis seen in PLS.Hahn, J., Schauer, C., Czegley, C., Kling, L., Petru, L., Schmid, B., Weidner, D., Reinwald, C., Biermann, M. H. C., Blunder, S., Ernst, J., Lesner, A., Bauerle, T., Palmisano, R., Christiansen, S., Herrmann, M., Bozec, A., Gruber, R., Schett, G., Hoffmann, M. H. Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases.	[Hahn, Jonas; Schauer, Christine; Czegley, Christine; Petru, Lenka; Weidner, Daniela; Reinwald, Christiane; Biermann, Mona H. C.; Herrmann, Martin; Bozec, Aline; Schett, Georg; Hoffmann, Markus H.] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Med 3, Erlangen, Germany; [Baeuerle, Tobias] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Inst Radiol, Erlangen, Germany; [Kling, Lasse; Christiansen, Silke] Max Planck Inst Sci Light, Erlangen, Germany; [Petru, Lenka] Charles Univ Prague, Inst Rheumatol, Dept Rheumatol, Fac Med 1, Prague, Czech Republic; [Schmid, Benjamin; Palmisano, Ralf] Friedrich Alexander Univ Erlangen Nurnberg FAU, OICE, Erlangen, Germany; [Blunder, Stefan; Gruber, Robert] Med Univ Innsbruck, Dept Dermatol Venereol & Allergol, Innsbruck, Austria; [Ernst, Juergen] Fraunhofer Inst Integrated Circuits IIS, Erlangen, Germany; [Lesner, Adam] Univ Gdansk, Fac Chem, Gdansk, Poland; [Christiansen, Silke] Helmholtz Zentrum Berlin Mat & Energie, Berlin, Germany; [Christiansen, Silke] Free Univ Berlin, Phys Dept, Berlin, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Max Planck Society; Charles University Prague; Institute of Rheumatology; University of Erlangen Nuremberg; Medical University of Innsbruck; Fraunhofer Gesellschaft; Fahrenheit Universities; University of Gdansk; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Free University of Berlin	Hoffmann, MH (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Univ Str 25a, D-91054 Erlangen, Germany.	markus.hoffmann@uk-erlangen.de	herrmann, martin/AAT-9836-2020; christiansen, silke/R-1567-2019; Schmid, Benjamin/ABD-2017-2020; Herrmann, Martin/A-9597-2013; Hasikova, Lenka/ABI-4867-2020	christiansen, silke/0000-0002-4908-4087; Schmid, Benjamin/0000-0002-9327-2296; Herrmann, Martin/0000-0002-0258-2484; Hasikova, Lenka/0000-0002-4794-2252; Hahn, Jonas/0000-0003-3944-2108; Bauerle, Tobias/0000-0002-0206-6199; Hoffmann, Markus/0000-0001-9698-9922; Lesner, Adam/0000-0001-8335-3431; Kling, Lasse/0000-0003-1246-8228	German Research Council [DFG CRC1181, SCHA 2040/1-1]; Stadtler-Stiftung Nurnberg; European Union Project Research and Innovation Staff Exchange-Reactive Oxygen Species as Elixirs Against Chronic Disease: Oxidative Regulatory Mechanisms in T cells and Neutrophils (RISE-REDOXIT) (H2020-MSCA-RISE-2014) [644035]; Interdisziplinare Zentrum fur Klinische Forschung (IZKF) Anschubfinanzierung (ELAN) Fonds of the Faculty of Medicine of the Friedrich-Alexander University Erlangen-Nurnberg; Articulum Fellowship	German Research Council(German Research Foundation (DFG)); Stadtler-Stiftung Nurnberg; European Union Project Research and Innovation Staff Exchange-Reactive Oxygen Species as Elixirs Against Chronic Disease: Oxidative Regulatory Mechanisms in T cells and Neutrophils (RISE-REDOXIT) (H2020-MSCA-RISE-2014); Interdisziplinare Zentrum fur Klinische Forschung (IZKF) Anschubfinanzierung (ELAN) Fonds of the Faculty of Medicine of the Friedrich-Alexander University Erlangen-Nurnberg; Articulum Fellowship	The authors thank P. Tripal (Optical Imaging Centre Erlangen) for trouble-shooting with multiphoton imaging of aggNETs, D. Andreev for help with quantitative PCR, D. Kienhofer for biotinylation of proteins, and Z. E. Kilgus (all from Friedrich Alexander University of Erlangen-Nurnberg, Universitatsklinikum Erlangen) for help with the experiments showing temporal distribution of inflammatory mediators in neutrophil cultures. The authors also thank the PLS patients and control subjects enrolled in this study. This work was supported by the German Research Council (DFG CRC1181, Projects C03 and Z02, and SCHA 2040/1-1), the Stadtler-Stiftung Nurnberg, the European Union Project Research and Innovation Staff Exchange-Reactive Oxygen Species as Elixirs Against Chronic Disease: Oxidative Regulatory Mechanisms in T cells and Neutrophils (RISE-REDOXIT) (H2020-MSCA-RISE-2014, Project 644035), and the Interdisziplinare Zentrum fur Klinische Forschung (IZKF) Anschubfinanzierung (ELAN) Fonds of the Faculty of Medicine of the Friedrich-Alexander University Erlangen-Nurnberg (to C.S.). L.P. was a recipient of the Articulum Fellowship. The authors declare no conflicts of interest.	Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; Chen Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11596; Clancy DM, 2018, CELL REP, V22, P2937, DOI 10.1016/j.celrep.2018.02.062; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Doring G, 1999, PEDIATR PULM, V28, P363, DOI 10.1002/(SICI)1099-0496(199911)28:5<363::AID-PPUL9>3.0.CO;2-#; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gordon RA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92926; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/eLife.24437, 10.7554/elife.24437]; Kienhofer D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92920; Kienle K, 2016, IMMUNOL REV, V273, P76, DOI 10.1111/imr.12458; Konig MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00461; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Maueroder C, 2015, J MOL MED, V93, P727, DOI 10.1007/s00109-015-1295-x; Munoz LE, 2017, IMMUNOL REV, V280, P26, DOI 10.1111/imr.12569; NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811; Nauseef WM, 2014, J CLIN INVEST, V124, P4237, DOI 10.1172/JCI77985; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pieterse E, 2017, ARTERIOSCL THROM VAS, V37, P1371, DOI 10.1161/ATVBAHA.117.309002; Popow-Stellmaszyk J, 2013, ANAL BIOCHEM, V442, P75, DOI 10.1016/j.ab.2013.07.028; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Reategui E, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0094; Reinwald C, 2016, NAT MED, V22, P1384, DOI 10.1038/nm.4217; Roberts H, 2016, J LEUKOCYTE BIOL, V100, P433, DOI 10.1189/jlb.5A1015-489R; Sareila O, 2013, J LEUKOCYTE BIOL, V93, P427, DOI 10.1189/jlb.1211588; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shah K, 2007, J EMERG MED, V32, P23, DOI 10.1016/j.jemermed.2006.07.019; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Toyama S, 2017, ALLERGOL INT, V66, P463, DOI 10.1016/j.alit.2017.01.001; Treffers LW, 2016, IMMUNOL REV, V273, P312, DOI 10.1111/imr.12444; Ueki S, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0634-5; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	49	64	67	0	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1401	1414		10.1096/fj.201800752R	http://dx.doi.org/10.1096/fj.201800752R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130433	Bronze, Green Published			2022-12-28	WOS:000457401500110
J	Zhao, W; Zhang, LN; Wang, XL; Zhang, J; Yu, HX				Zhao, Wei; Zhang, Le-Ning; Wang, Xiao-Long; Zhang, Ji; Yu, Hai-Xiang			Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1	FASEB JOURNAL			English	Article						TAZ; YAP1; proliferation; apoptosis	E-CADHERIN; POOR-PROGNOSIS; DOWN-REGULATION; PROGRESSION; EXPRESSION; CONTRIBUTES; PROMOTES; METASTASIS; OVEREXPRESSION; PROLIFERATION	Metastatic growth is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC). Metastasis is believed to be initiated by an increase in cell motility mediated by the loss of cell-cell adhesion because of the suppression of E-cadherin [encoded by cadherin 1 (CDH1)]. However, very little is known about the molecular mechanism of CDH1 regulation. Therefore, we hypothesized that non-small cell lung cancerassociated transcript-1 (NSCLCAT1) suppresses functional CDH1 and mediates the Hippo signaling pathway, resulting in increased cell migration and invasion, and reduced apoptosis. Initially, microarray profiling and target prediction programs were employed to identify whether NSCLCAT1 targets CDH1. Next, quantitative PCR was used to determine the expression pattern of NSCLCAT1 in 114 specimens. The biologic functions of NSCLCAT1 in NSCLC were assessed through the up-regulation and down-regulation of the levels of endogenous NSCLCAT1 with the use of NSCLCAT1 vector or small interfering RNA against NSCLCAT1 in NSCLC cells. Furthermore, the Hippo signaling pathway in NSCLC cells was blocked by applying the verteporfin treatment to have a better understanding on the pivotal role of the Hippo signaling pathway in NSCLC. Microarray expression profiles of long noncoding RNAs, GSE19804 and GSE27262), revealed that NSCLCAT1 was up-regulated in NSCLC. Among patients with NSCLC, we determined that the NSCLCAT1 was robustly induced, whereas CDH1 was suppressed. The luciferase activity determination identified CDH1 as a NSCLCAT1 target. NSCLCAT1 was found to increase cell viability, migration, and invasion and to reduce apoptosis in NSCLC cells. The results from the quantitative PCR and Western blot analysis revealed that NSCLCAT1 modulated the Hippo signaling pathway. Furthermore, the inhibition of the Hippo signaling pathway by verteporfin treatment led to the loss of the effect of NSCLCAT1 on NSCLC cells. In summary, our findings suggested that NSCLCAT1 potentially has a role in NSCLC and NSCLCAT1-mediated regulation of the Hippo signaling pathway through the transcriptional repression of CDH1; therefore, the functional suppression or inhibition of NSCLCAT1 could be used as a novel therapeutic pathway in the control of aggressive and metastatic NSCLC.Zhao, W., Zhang, L.-N., Wang, X.-L., Zhang, J., Yu, H.-X. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1.	[Zhao, Wei; Zhang, Le-Ning; Wang, Xiao-Long; Zhang, Ji; Yu, Hai-Xiang] Jilin Univ, Dept Thorac Surg, China Japan Union Hosp, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China	Jilin University	Yu, HX (corresponding author), Jilin Univ, Dept Thorac Surg, China Japan Union Hosp, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China.	yu_haixiang1980@yeah.net						Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Cai Q, 2017, ONCOTARGET, V8, P47957, DOI 10.18632/oncotarget.18204; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Cui JD, 2015, INT J CLIN EXP PATHO, V8, P12400; Cui Y, 2017, ONCOTARGET, V8, P17785, DOI 10.18632/oncotarget.14854; Ding X, 2017, CLIN TRANSL ONCOL, V19, P546, DOI 10.1007/s12094-016-1562-5; Fujita A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-469; He R, 2017, BIOMED PHARMACOTHER, V95, P331, DOI 10.1016/j.biopha.2017.08.057; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Li XL, 2013, MED RES REV, V33, P517, DOI 10.1002/med.21254; Lin XY, 2014, TUMOR BIOL, V35, P6435, DOI 10.1007/s13277-014-1826-z; Ling ZQ, 2011, INT J MOL MED, V27, P625, DOI 10.3892/ijmm.2011.640; Liu XF, 2013, FEBS LETT, V587, P3995, DOI 10.1016/j.febslet.2013.10.036; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Nie W, 2016, CANCER LETT, V371, P99, DOI 10.1016/j.canlet.2015.11.024; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pilli T, 2017, THYROID, V27, P1053, DOI 10.1089/thy.2017.0035; Reardon SN, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.098871; Redis RS, 2013, ONCOTARGET, V4, P1748, DOI 10.18632/oncotarget.1292; Shi Q, 2017, CANCER BIOMARK, V20, P539, DOI 10.3233/CBM-170350; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Song YM, 2015, EXP THER MED, V9, P1292, DOI 10.3892/etm.2015.2232; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xia ZX, 2016, EXP MOL PATHOL, V100, P353, DOI 10.1016/j.yexmp.2015.10.004; Xiao L, 2016, ONCOTARGET, V7, P40038, DOI 10.18632/oncotarget.9480; Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b; Xu CM, 2013, CANCER GENE THER, V20, P453, DOI 10.1038/cgt.2013.40; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Xu WR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/278917; Yeung B, 2016, INT J CANCER, V138, P533, DOI 10.1002/ijc.29457; Yu QW, 2015, DRUG DES DEV THER, V9, P2171, DOI 10.2147/DDDT.S78537; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zang CS, 2016, ONCOTARGET, V7, P11696, DOI 10.18632/oncotarget.7077; Zhang HM, 2015, TUMOR BIOL, V36, P2947, DOI 10.1007/s13277-014-2925-6; Zhang M, 2016, BIOMED PHARMACOTHER, V80, P73, DOI 10.1016/j.biopha.2016.02.036; Zheng SY, 2012, ASIAN PAC J CANCER P, V13, P1557, DOI 10.7314/APJCP.2012.13.4.1557; Zheng XY, 2017, ONCOTARGET, V8, P78734, DOI 10.18632/oncotarget.20223; Zhou FZ, 2017, ONCOL REP, V38, P1857, DOI 10.3892/or.2017.5835; Zhou S, 2017, TUMOR BIOL, V39	43	17	17	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1151	1166		10.1096/fj.201800408R	http://dx.doi.org/10.1096/fj.201800408R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148675				2022-12-28	WOS:000457401500091
J	Wang, HB; Li, T; Ma, DZ; Zhi, H				Wang, Hong-Bin; Li, Tao; Ma, Dong-Zhou; Zhi, Hua			ER36 gene silencing promotes tau protein phosphorylation, inhibits cell proliferation, and induces apoptosis in human neuroblastoma SH-SY5Y cells	FASEB JOURNAL			English	Article						estrogen stimulation; Caveolin-1; GSK-3; PP2A; MAPK pathway	ESTROGEN-RECEPTOR-ALPHA; PHOSPHATASE 2A PP2A; BREAST-CANCER; TUMOR-SUPPRESSOR; EXPRESSION; VARIANT; RECEPTOR-ALPHA-36; DIFFERENTIATION; IDENTIFICATION; ER-ALPHA-36	Neuroblastoma is the most common cancer in infants and the third most common cancer in children after leukemia and brain cancer. The purpose of our study was to investigate the effects of estrogen receptor (ER)-36 gene silencing on tau protein phosphorylation, cell proliferation, and cell apoptosis in human neuroblastoma SH-SY5Y cells. SH-SY5Y cells were treated with estrogen or left untreated, to investigate the effects of estrogen stimulation on ER36 and the ERK/protein B kinase (AKT) signaling pathway. ER36 mRNA expressions were detected by quantitative RT-PCR. A phosphatase kit was used to test protein phosphatase (PP)-2A activity before and after treatment. Western blot analysis was conducted to detect protein expression of ER36; tau protein; phosphorylated- tau (p-tau) at site Thr231 [p-tau (Thr231)]; glycogen synthase kinase (GSK)3 and its specificity sites (Tyr216 and Ser9); Cyclin Dl; proliferating cell nuclear antigen (PCNA); B-cell lymphoma (Bcl)-2; and Bcl-2-associated X protein (Bax). A cell-counting kit (CCK)-8 assay was used to determine cell viability. Cell apoptosis and rate of tumor growth and volume were determined by Annexin V-FITC/PI staining and a xenotransplanted tumor model in nude mice. Results show that without estrogen stimulation, ER36 was inactivated. When stimulated by estrogen, expression of ER36, PP2A, p-GSK3 (Ser9)/total protein (t)-GSK3, Cyclin Dl, PCNA, and Bcl-2 were up-regulated, and p-GSK3 (Tyr216)/t-GSK3 expression was down-regulated, as was p-tau (Thr231) and Bax expression. The expression of p-ERK/ERK, p-AKT/AKT, p-methyl ethyl ketone (MEK)/MEK, and p-mammalian target of rapamycin (mTOR)/mTOR expression was up-regulated, suggesting that the ERK/AKT signaling pathway is activated. Cell proliferation was also accelerated, whereas apoptosis was inhibited with stimulation by estrogen. However, we found that the effects of silencing ER36 on the expression of related intracellular factors had no association with estrogen. Our study demonstrates that ER36 gene silencing can inhibit the activation of the ERK/AKT signaling pathway, increase tau protein phosphorylation, decrease cell vitality and tumorigenicity, and promote apoptosis of human neuroblastoma SH-SY5Y cells.Wang, H.-B., Li, T., Ma, D.-Z., Zhi, H. ER36 gene silencing promotes tau protein phosphorylation, inhibits cell proliferation, and induces apoptosis in human neuroblastoma SH-SY5Y cells.	[Wang, Hong-Bin; Li, Tao; Ma, Dong-Zhou] Hebei Univ Engn, Affiliated Hosp, Dept Neurosurg, Handan, Peoples R China; [Zhi, Hua] Hebei Univ Engn, Affiliated Hosp, Dept Cardiol, 81 Congtai Rd, Handan 056002, Hebei, Peoples R China	Hebei University of Engineering; Hebei University of Engineering	Zhi, H (corresponding author), Hebei Univ Engn, Affiliated Hosp, Dept Cardiol, 81 Congtai Rd, Handan 056002, Hebei, Peoples R China.	zhihuazh0310@163.com						Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Anwar Sumadi Lukman, 2015, Asian Pac J Cancer Prev, V16, P6803; Cao P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1495-3; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Christensen A, 2012, ENDOCRINOLOGY, V153, P3872, DOI 10.1210/en.2012-1312; Ciana P, 2003, J BIOL CHEM, V278, P31737, DOI 10.1074/jbc.M301525200; Nguyen CT, 2015, J GINSENG RES, V39, P69, DOI 10.1016/j.jgr.2014.06.005; D'Aguanno S, 2011, J PROTEOME RES, V10, P416, DOI 10.1021/pr100457n; Davidoff AM, 2012, SEMIN PEDIATR SURG, V21, P2, DOI 10.1053/j.sempedsurg.2011.10.009; Gleissman H, 2011, INT J CANCER, V128, P1703, DOI 10.1002/ijc.25473; Gu Y, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-16; Hassan MH, 2010, FERTIL STERIL, V93, P239, DOI 10.1016/j.fertnstert.2008.09.086; Jeyabalan J, 2014, J AGR FOOD CHEM, V62, P3963, DOI 10.1021/jf403734j; Jiang HP, 2008, J STEROID BIOCHEM, V112, P20, DOI 10.1016/j.jsbmb.2008.07.004; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kaur A, 2016, BIOCHEM SOC T, V44, P1683, DOI 10.1042/BST20160161; Kayhan H, 2016, CELL BIOCHEM BIOPHYS, V74, P99, DOI 10.1007/s12013-016-0734-9; Keen JC, 2004, CANCER BIOL THER, V3, P1304, DOI 10.4161/cbt.3.12.1458; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; London WB, 2011, J CLIN ONCOL, V29, P3286, DOI 10.1200/JCO.2010.34.3392; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Mookherjee P, 2001, BRAIN RES, V921, P31, DOI 10.1016/S0006-8993(01)03074-8; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Ojala JO, 2008, J NEUROIMMUNOL, V205, P86, DOI 10.1016/j.jneuroim.2008.09.012; Ootsuka S, 2007, BIOL PHARM BULL, V30, P2294, DOI 10.1248/bpb.30.2294; Petroni D, 2012, ENVIRON TOXICOL, V27, P549, DOI 10.1002/tox.20672; Rao J, 2011, J STEROID BIOCHEM, V127, P231, DOI 10.1016/j.jsbmb.2011.08.004; SHIN RW, 1991, LAB INVEST, V64, P693; Song YX, 2016, CHIN J INTEGR MED, V22, P430, DOI 10.1007/s11655-015-2116-3; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Tu BB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.015; Volpicelli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109671; Wang DD, 2012, MOL MED REP, V6, P591, DOI 10.3892/mmr.2012.945; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Xiong YS, 2015, AGING CELL, V14, P867, DOI 10.1111/acel.12366; Yang Q, 2015, ANN NEUROL, V77, P618, DOI 10.1002/ana.24358; Yu UY, 2014, KOREAN J PHYSIOL PHA, V18, P155, DOI 10.4196/kjpp.2014.18.2.155; Zage PE, 2008, PEDIATR BLOOD CANCER, V51, P747, DOI 10.1002/pbc.21713	44	9	10	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6456	6468		10.1096/fj.201701386	http://dx.doi.org/10.1096/fj.201701386			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29932870				2022-12-28	WOS:000449359700009
J	Zhang, JJ; Chen, HX; Leung, RKK; Choy, KW; Lam, TP; Ng, BKW; Qiu, Y; Feng, JQ; Cheng, JCY; Lee, WYW				Zhang, Jiajun; Chen, Huanxiong; Leung, Ross K. K.; Choy, Kwong Wai; Lam, Tsz-Ping; Ng, Bobby K. W.; Qiu, Yong; Feng, Jian Q.; Cheng, Jack C. Y.; Lee, Wayne Y. W.			Aberrant miR-145-5p/-catenin signal impairs osteocyte function in adolescent idiopathic scoliosis	FASEB JOURNAL			English	Article						bone biopsy; primary osteoblasts; circulating microRNA; serum bone markers	BONE-MINERAL DENSITY; OSTEOBLASTIC CELLS; ILIAC CREST; DIFFERENTIATION; ASSOCIATION; DISEASE; MASS; HOMEOSTASIS; MIR-145; CULTURE	Recently, noncoding RNAs have been thought to play important roles in the sporadic occurrence of spinal deformity of adolescent idiopathic scoliosis (AIS). As a prognostic factor for curve progression, low bone mass has been hypothesized to crosstalk with AIS pathogenesis. Abnormal osteoblasts activities are reported in AIS without a clear mechanism. In this study, bone biopsies from patients with AIS and control subjects and the primary osteoblasts derived from those samples were used to identify the potential microRNA (miRNA) candidates that interfere with osteoblasts and osteocytes function. Microarray analysis identified miRNA-145-5p (miR-145) as a potential upstream regulator. miR-145 and -catenin mRNA (CTNNB1) were overexpressed in AIS bone tissues and primary osteoblasts, and their expression correlated positively in AIS. Knockdown of miR-145 restored impaired osteocyte activity through the down-regulation of active -catenin expression and its transcriptional activity. Significant negative correlations between circulating miR-145 and serum sclerostin, osteopontin, and osteoprotegerin were noted in patients with AIS, which was in line with our cellular findings. This is the first study to demonstrate the effect of aberrant miRNA expression and its effect on osteocyte function in AIS, which may contribute to the low bone mass. Our findings also provide insight into the development of circulating microRNAs as a bone quality biomarker or even a prognostic biomarker for AIS.Zhang, J., Chen, H., Leung, R. K. K., Choy, K. W., Lam, T.-P., Ng, B. K. W., Qiu,Y., Feng, J. Q., Cheng, J. C. Y., Lee, W. Y. W. Aberrant miR-145-5p/-catenin signal impairs osteocyte function in adolescent idiopathic scoliosis.	[Zhang, Jiajun; Chen, Huanxiong; Lam, Tsz-Ping; Ng, Bobby K. W.; Cheng, Jack C. Y.; Lee, Wayne Y. W.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, SH Ho Scoliosis Res Lab, Shatin, Hong Kong, Peoples R China; [Choy, Kwong Wai] Chinese Univ Hong Kong, Dept Obstet & Gynecol, Shatin, Hong Kong, Peoples R China; [Zhang, Jiajun; Chen, Huanxiong; Lam, Tsz-Ping; Ng, Bobby K. W.; Qiu, Yong; Cheng, Jack C. Y.; Lee, Wayne Y. W.] Chinese Univ Hong Kong, Joint Scoliosis Res Ctr, Shatin, Hong Kong, Peoples R China; [Zhang, Jiajun; Chen, Huanxiong; Lam, Tsz-Ping; Ng, Bobby K. W.; Qiu, Yong; Cheng, Jack C. Y.; Lee, Wayne Y. W.] Nanjing Univ, Shatin, Hong Kong, Peoples R China; [Zhang, Jiajun; Chen, Huanxiong; Lam, Tsz-Ping; Ng, Bobby K. W.; Qiu, Yong; Cheng, Jack C. Y.; Lee, Wayne Y. W.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Chen, Huanxiong] Hainan Med Univ, Dept Orthopaed Surg, Affiliated Hosp 1, Haikou, Hainan, Peoples R China; [Leung, Ross K. K.] Guangzhou Med Univ, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Qiu, Yong] Nanjing Univ, Nanjing Drum Tower Hosp, Spine Surg, Nanjing, Jiangsu, Peoples R China; [Feng, Jian Q.] Texas A&M Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Nanjing University; Chinese University of Hong Kong; Hainan Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Nanjing University	Feng, JQ (corresponding author), Texas A&M Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA.; Lee, WYW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Room 904,9-F Li Ka Shing Med Sci Bldg, Shatin, Hong Kong, Peoples R China.	jfeng@tamhsc.edu; waynelee@ort.cuhk.edu.hk	Lam, Tsz Ping/P-9963-2016; Cheng, Jack/J-3878-2018; Choy, Richard/AAW-8230-2020; Lee, Wayne YW/H-8298-2013	Lam, Tsz Ping/0000-0002-2427-2719; Cheng, Jack/0000-0001-8153-364X; Choy, Richard/0000-0002-3616-6200; Lee, Wayne YW/0000-0002-0486-360X	Research Grants Council of the Hong Kong S.A.R., China [14116415, 14135016]; Health and Medical Research Fund [04152176]; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) collaborative grant [N_CUHK416/16]; National Institutes of Health, National Institute of Dental and Craniofacial Research Grant [DE025659]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025659] Funding Source: NIH RePORTER	Research Grants Council of the Hong Kong S.A.R., China(Hong Kong Research Grants Council); Health and Medical Research Fund; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) collaborative grant; National Institutes of Health, National Institute of Dental and Craniofacial Research Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was partially supported by the Research Grants Council of the Hong Kong S.A.R., China (Project Nos.14116415 and 14135016 to J.C.Y.C.), the Health and Medical Research Fund (04152176 to J.C.Y.C.), a National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) collaborative grant (N_CUHK416/16) (to J.C.Y.C), and National Institutes of Health, National Institute of Dental and Craniofacial Research Grant DE025659 (to J.Q.F.) The authors declare no conflicts of interest.	Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]; Buckley Katherine A, 2005, Methods Mol Med, V107, P55; Burwell RG, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-26; Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024; Chen Peifen, 2015, Nan Fang Yi Ke Da Xue Xue Bao, V35, P1073; Cheng J C, 2001, Spine (Phila Pa 1976), V26, pE19; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; CHENG JC, 2015, NAT REV DIS PRIMERS, V1, DOI DOI 10.1038/NRDP.2015.30; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Chiru Mariana, 2011, Maedica (Bucur), V6, P17; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; DEACON P, 1984, J BONE JOINT SURG BR, V66, P509, DOI 10.1302/0301-620X.66B4.6746683; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Ell Brian, 2014, Bonekey Rep, V3, P549, DOI 10.1038/bonekey.2014.44; Fendri K, 2013, EUR SPINE J, V22, P1300, DOI 10.1007/s00586-013-2728-2; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Han HS, 2014, ONCOL LETT, V8, P1889, DOI 10.3892/ol.2014.2404; Hayes M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5777; Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782; Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Iwasaki S, 2005, J PINEAL RES, V39, P261, DOI 10.1111/j.1600-079X.2005.00244.x; Jia J, 2013, FEBS LETT, V587, P3027, DOI 10.1016/j.febslet.2013.07.030; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kondo N, 2011, SPINE, V36, pE513, DOI 10.1097/BRS.0b013e3181f52cb5; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee WTK, 2005, OSTEOPOROSIS INT, V16, P1024, DOI 10.1007/s00198-004-1792-1; Li W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047040; Garcia-Gimenez JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21146-x; Man GCW, 2011, J PINEAL RES, V50, P395, DOI 10.1111/j.1600-079X.2011.00857.x; Mayorga ME, 2012, J CELL MOL MED, V16, P1106, DOI 10.1111/j.1582-4934.2011.01385.x; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; Ogura Y, 2017, HUM MOL GENET, V26, P4086, DOI 10.1093/hmg/ddx291; Oliazadeh N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44260; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Ren Y, 2014, CONNECT TISSUE RES, V55, P129, DOI 10.3109/03008207.2014.923879; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sadat-Ali M, 2008, EUR SPINE J, V17, P944, DOI 10.1007/s00586-008-0671-4; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Suh KT, 2007, EUR SPINE J, V16, P1563, DOI 10.1007/s00586-007-0390-2; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Tanabe H, 2017, EUR SPINE J, V26, P1600, DOI 10.1007/s00586-017-4974-1; Tate MLK, 2004, INT J BIOCHEM CELL B, V36, P1, DOI 10.1016/S1357-2725(03)00241-3; Themistocleous GS, 2004, IN VIVO, V18, P687; Thomsen JS, 2002, BONE, V30, P267, DOI 10.1016/S8756-3282(01)00666-4; Uchihashi K, 2013, BONE, V52, P102, DOI 10.1016/j.bone.2012.09.001; van Rhijn LW, 2001, ACTA ORTHOP SCAND, V72, P621, DOI 10.1080/000164701317269058; Wajchenberg M., 2014, SCOLIOSIS S1, V9, pO12; Wajchenberg M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000598; Wang ZW, 2017, SCI REP-UK, V7, DOI 10.1038/srep40265; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yamada N, 2013, CANCER LETT, V335, P332, DOI 10.1016/j.canlet.2013.02.060; Yu WS, 2014, BONE, V61, P109, DOI 10.1016/j.bone.2013.12.033; Zhang LY, 2015, MOL MED REP, V11, P4365, DOI 10.3892/mmr.2015.3273; Zhu ZZ, 2017, HUM MOL GENET, V26, P1577, DOI 10.1093/hmg/ddx045; Zhu ZZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9355	60	20	22	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6537	6549		10.1096/fj.201800281	http://dx.doi.org/10.1096/fj.201800281			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906249	Bronze			2022-12-28	WOS:000449359700015
J	Lu, J; Lin, YX; Li, FY; Ye, H; Zhou, RX; Jin, YW; Li, B; Xiong, XZ; Cheng, NS				Lu, Jiong; Lin, Yixin; Li, Fuyu; Ye, Hui; Zhou, Rongxing; Jin, Yanwen; Li, Bei; Xiong, Xianze; Cheng, Nansheng			MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma	FASEB JOURNAL			English	Article						microRNA; EMT; SEMA4C; HCC	CELL-PROLIFERATION; CANCER CELLS; DOWN-REGULATION; BREAST-CANCER; METASTASIS; EXPRESSION; MICRORNA-205; PROGRESSION; PATHWAY; ZEB1	Growing evidence indicates that microRNAs are involved in tumorigenesis and progression of hepatocellular carcinoma (HCC). However, the functional mechanisms of miR-205 in HCC remain largely unknown. Here, we demonstrate that miR-205 expression was significantly down-regulated in HCC tissues and cell lines and was correlated with metastatic pathologic features and shorter disease-free and overall survival. Overexpression of miR-205 dramatically inhibited HCC cell proliferation, apoptosis, migration, invasion, epithelial-mesenchymal transition (EMT) in vitro, and tumor growth in vivo. We subsequently identified semaphorin 4C (SEMA4C) as a novel target of miR-205. Furthermore, high expression levels of SEMA4C were frequently found in HCC tissues and were associated with poor prognosis. Ectopic expression of SEMA4C restored the suppressive effect of overexpressed miR-205 on migration, invasion, and EMT. Taken together, our findings provide new insight into the critical role of miR-205 in regulating tumor growth, invasion, and EMT of HCC, suggesting miR-205 may serve as a promising therapeutic target and novel prognostic indicator for patients with HCC.Lu, J., Lin, Y., Li, F., Ye, H., Zhou, R., Jin, Y., Li, B., Xiong, X., Cheng, N. MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma.	[Lu, Jiong; Lin, Yixin; Li, Fuyu; Ye, Hui; Zhou, Rongxing; Jin, Yanwen; Li, Bei; Xiong, Xianze; Cheng, Nansheng] Sichuan Univ, West China Hosp, Dept Bile Duct Surg, 37 Guo Xue Xiang Rd, Chengdu 610041, Sichuan, Peoples R China	Sichuan University	Xiong, XZ; Cheng, NS (corresponding author), Sichuan Univ, West China Hosp, Dept Bile Duct Surg, 37 Guo Xue Xiang Rd, Chengdu 610041, Sichuan, Peoples R China.	xiongxze@163.com; nanshengcheng@163.com		Zhou, Rong-Xing/0000-0003-2468-8535	Science and Technology Supportive Plan of Sichuan Province [2015SZ0070]	Science and Technology Supportive Plan of Sichuan Province	This work was supported by grants from the Science and Technology Supportive Plan of Sichuan Province (Grant 2015SZ0070). The authors declare no conflicts of interest.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chaudhary AK, 2017, CANCER LETT, V402, P1, DOI 10.1016/j.canlet.2017.05.007; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dou CW, 2016, CANCER LETT, V381, P380, DOI 10.1016/j.canlet.2016.08.011; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fang F, 2015, J HEPATOL, V63, P874, DOI 10.1016/j.jhep.2015.05.008; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fu X, 2017, CANCER SCI, V108, P620, DOI 10.1111/cas.13177; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; He JL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0427-9; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Kabir TD, 2018, HEPATOLOGY, V67, P216, DOI 10.1002/hep.29478; Kodama T, 2016, P NATL ACAD SCI USA, V113, pE3384, DOI 10.1073/pnas.1606876113; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JY, 2014, ONCOGENE, V33, P1325, DOI 10.1038/onc.2013.53; Li JF, 2015, J CELL MOL MED, V19, P2793, DOI 10.1111/jcmm.12666; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Qin AY, 2013, EUR J CELL BIOL, V92, P54, DOI 10.1016/j.ejcb.2012.11.002; Rebouissou S, 2017, CLIN CANCER RES, V23, P4364, DOI 10.1158/1078-0432.CCR-16-3118; Song J, 2017, CANCER SCI, V108, P23, DOI 10.1111/cas.13104; Song SM, 2013, NAT REV GASTRO HEPAT, V10, P109, DOI 10.1038/nrgastro.2012.210; Su N, 2013, ONCOL REP, V29, P2297, DOI 10.3892/or.2013.2400; Su YH, 2014, CANCER LETT, V344, P147, DOI 10.1016/j.canlet.2013.10.024; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Wang XW, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.412; Wei JC, 2017, CLIN CANCER RES, V23, P214, DOI 10.1158/1078-0432.CCR-16-0741; Wu H, 2017, HEPATOLOGY, V66, P1952, DOI 10.1002/hep.29374; Xiao S, 2016, HEPATOLOGY, V63, P1256, DOI 10.1002/hep.28417; Xie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046990; Yang QL, 2015, ONCOTARGET, V6, P3268, DOI 10.18632/oncotarget.3065; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941; Ye LY, 2016, CANCER RES, V76, P818, DOI 10.1158/0008-5472.CAN-15-0977; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang PJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6671; Zhao J, 2015, NEOPLASMA, V62, P567, DOI 10.4149/neo_2015_068; Zhao JK, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0629-4; Zhao XD, 2013, CURR CANCER DRUG TAR, V13, P935, DOI 10.2174/15680096113136660099	38	21	21	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6123	6134		10.1096/fj.201800113R	http://dx.doi.org/10.1096/fj.201800113R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29799789	hybrid			2022-12-28	WOS:000447172000030
J	Hu, F; Zhu, Q; Sun, BR; Cui, CP; Li, CL; Zhang, LQ				Hu, Fan; Zhu, Qiong; Sun, Banruo; Cui, Chunping; Li, Chunlin; Zhang, Lingqiang			Smad ubiquitylation regulatory factor 1 promotes LIM-homeobox gene 9 degradation and represses testosterone production in Leydig cells	FASEB JOURNAL			English	Article						steroidogenesis; NR5A1; gene knockout; mouse	INHIBITS OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; PROTEIN; STEROIDOGENESIS; LHX9; UBIQUITINATION; TRANSCRIPTION; EXPRESSION; PATHWAY; TARGETS	Testosterone is essential for spermatogenesis and the maintenance of secondary sexual characteristics in males. An important transcription factor, LIM-homeobox gene 9 (Lhx9) is indispensable for testis development and testosterone production; however, post-translational modifications of Lhx9 are largely unknown. Here, for the first time to our knowledge, we demonstrate that the level of Lhx9 protein increases in human chorionic gonadotropin-exposed Leydig cells and can be polyubiquitylated. We found that Smad ubiquitylation regulatory factor 1 (Smurf1), an E3 ubiquitin ligase, targets Lhx9 for ubiquitin-mediated proteasome degradation, thereby negatively modulating its function. Increasing Smurf1 decreases the level of Lhx9 and inhibits the Lhx9 transactivation capacity of steroidogenic factor 1 [nuclear receptor subfamily 5, group A, member 1 (NR5A1)]. In contrast, the depletion of Smurf1 leads to increased expression of Lhx9 protein and enhances testosterone biosynthesis-related gene transcripts [NR5A1, steroidogenic acute regulatory protein, CYP17A1, hydroxy--5-steroid dehydrogenase, hydroxy--5-steroid dehydrogenase isomerase 6, and hydroxysteroid (17-) dehydrogenase 3] and testosterone production in Leydig cells. Furthermore, we found that Smurf1 knockout mice exhibit higher levels of Lhx9 protein and steroidogenesis, which leads to increased serum testosterone concentration. These findings reveal that Smurf1 promotes Lhx9 ubiquitylation and is involved in testosterone production in Leydig cells directly. Our results provide new insights into the molecular events that play a role in the homeostasis of testosterone levels and may provide a new target for testosterone regulation.Hu, F., Zhu, Q., Sun, B., Cui, C., Li, C., Zhang, L. Smad ubiquitylation regulatory factor 1 promotes LIM-homeobox gene 9 degradation and represses testosterone production in Leydig cells.	[Hu, Fan; Sun, Banruo; Li, Chunlin] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Endocrinol, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China; [Hu, Fan; Zhu, Qiong; Cui, Chunping; Zhang, Lingqiang] Beijing Inst Life, Beijing Proteome Res Ctr, Natl Ctr Prot Sci, State Key Lab Prote, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Li, CL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Zhang, LQ (corresponding author), Beijing Inst Life, 27 Taiping Rd, Beijing 100850, Peoples R China.	lichunlin301@163.com; zhanglq@nic.bmi.ac.cn			National Key Research and Development Program of China [2017YFA0505602]; Chinese National Natural Science Foundation [81774119, 81521064]	National Key Research and Development Program of China; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Ping Wang (Tongji University School of Medicine, Shanghai, China) for kindly providing Smurf1<SUP>-/-</SUP> mice. This work was supported by the National Key Research and Development Program of China (2017YFA0505602) and the Chinese National Natural Science Foundation Projects 81774119 and 81521064. The authors declare no conflicts of interest.	Abdou HS, 2014, MOL CELL BIOL, V34, P4257, DOI 10.1128/MCB.00734-14; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bieser KL, 2013, J EXP ZOOL PART B, V320B, P238, DOI 10.1002/jez.b.22497; Cao Y, 2013, CELL MOL LIFE SCI, V70, P2305, DOI 10.1007/s00018-012-1170-7; Chen WY, 2007, MOL CELL BIOL, V27, P7284, DOI 10.1128/MCB.00476-07; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; Guo X, 2011, J BIOL CHEM, V286, P18037, DOI 10.1074/jbc.M111.225615; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; LALA DS, 1995, STEROIDS, V60, P10, DOI 10.1016/0039-128X(94)00002-T; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Liu J, 2015, DEVELOPMENT, V142, P1113, DOI 10.1242/dev.117424; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Mazaud S., 2002, Gene Expression Patterns, V2, P373, DOI 10.1016/S1567-133X(02)00050-9; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Nie J, 2010, FEBS LETT, V584, P3021, DOI 10.1016/j.febslet.2010.05.034; Nie J, 2010, FEBS LETT, V584, P3005, DOI 10.1016/j.febslet.2010.05.033; O'Shaughnessy PJ, 2014, SEMIN CELL DEV BIOL, V29, P55, DOI 10.1016/j.semcdb.2014.02.010; Oreal E, 2002, DEV DYNAM, V225, P221, DOI 10.1002/dvdy.10153; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peukert D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001218; Qamar I, 2010, J BIOL CHEM, V285, P22360, DOI 10.1074/jbc.M109.059949; Scott HM, 2007, ENDOCRINOLOGY, V148, P2027, DOI 10.1210/en.2006-1622; Selvage DJ, 2006, ENDOCRINOLOGY, V147, P3070, DOI 10.1210/en.2005-1358; Shang T, 2011, ENDOCRINOLOGY, V152, P2827, DOI 10.1210/en.2011-0031; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Shimazu J, 2016, CELL REP, V15, P27, DOI 10.1016/j.celrep.2016.03.003; Smagulova FO, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-67; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Tremblay JJ, 2015, STEROIDS, V103, P3, DOI 10.1016/j.steroids.2015.08.001; Vasta V, 2006, P NATL ACAD SCI USA, V103, P19925, DOI 10.1073/pnas.0609483103; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yamazaki F, 2015, BRAIN STRUCT FUNCT, V220, P1497, DOI 10.1007/s00429-014-0740-x; Yang YS, 2015, GENE EXPR PATTERNS, V19, P45, DOI 10.1016/j.gep.2015.07.002; Yazawa T, 2015, ZOOL SCI, V32, P323, DOI 10.2108/zs140237; Yuan L, 2015, NAT CELL BIOL, V17, P1169, DOI 10.1038/ncb3218; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899; Zhang L, 2014, CELL RES, V24, P742, DOI 10.1038/cr.2014.53; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891; Zhang YC, 2016, INT J INTERDISCIP TE, V8, P1, DOI 10.4018/IJITN.2016040101; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	57	7	7	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4627	4640		10.1096/fj.201701480R	http://dx.doi.org/10.1096/fj.201701480R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29565736				2022-12-28	WOS:000443817700002
J	Wong, JCY; Smyllie, NJ; Banks, GT; Pothecary, CA; Barnard, AR; Maywood, ES; Jagannath, A; Hughes, S; van der Horst, GTJ; MacLaren, RE; Hankins, MW; Hastings, MH; Nolan, PM; Foster, RG; Peirson, SN				Wong, Jovi C. Y.; Smyllie, Nicola J.; Banks, Gareth T.; Pothecary, Carina A.; Barnard, Alun R.; Maywood, Elizabeth S.; Jagannath, Aarti; Hughes, Steven; van der Horst, Gijsbertus T. J.; MacLaren, Robert E.; Hankins, Mark W.; Hastings, Michael H.; Nolan, Patrick M.; Foster, Russell G.; Peirson, Stuart N.			Differential roles for cryptochromes in the mammalian retinal clock	FASEB JOURNAL			English	Article						circadian rhythms; retina; electroretinogram; pupillary light response; contrast sensitivity	CIRCADIAN CLOCK; GANGLION-CELLS; MOUSE RETINA; SUPRACHIASMATIC NUCLEUS; LIGHT; MICE; MELANOPSIN; DOPAMINE; PHOTORECEPTION; RESPONSES	Cryptochromes 1 and 2 (CRY1/2) are key components of the negative limb of the mammalian circadian clock. Like many peripheral tissues, Cry1 and -2 are expressed in the retina, where they are thought to play a role in regulating rhythmic physiology. However, studies differ in consensus as to their localization and function, and CRY1 immunostaining has not been convincingly demonstrated in the retina. Here we describe the expression and function of CRY1 and -2 in the mouse retina in both sexes. Unexpectedly, we show that CRY1 is expressed throughout all retinal layers, whereas CRY2 is restricted to the photoreceptor layer. Retinal period 2::luciferase recordings from CRY1-deficient mice show reduced clock robustness and stability, while those from CRY2-deficient mice show normal, albeit long-period, rhythms. In functional studies, we then investigated well-defined rhythms in retinal physiology. Rhythms in the photopic electroretinogram, contrast sensitivity, and pupillary light response were all severely attenuated or abolished in CRY1-deficient mice. In contrast, these physiological rhythms are largely unaffected in mice lacking CRY2, and only photopic electroretinogram rhythms are affected. Together, our data suggest that CRY1 is an essential component of the mammalian retinal clock, whereas CRY2 has a more limited role.Wong, J. C. Y., Smyllie, N. J., Banks, G. T., Pothecary, C. A., Barnard, A. R., Maywood, E. S., Jagannath, A., Hughes, S., van der Horst, G. T. J., MacLaren, R. E., Hankins, M. W., Hastings, M. H., Nolan, P. M., Foster, R. G., Peirson, S. N. Differential roles for cryptochromes in the mammalian retinal clock.	[Wong, Jovi C. Y.; Pothecary, Carina A.; Jagannath, Aarti; Hughes, Steven; Hankins, Mark W.; Foster, Russell G.; Peirson, Stuart N.] Univ Oxford, Sleep & Circadian Neurosci Inst, Oxford, England; [Barnard, Alun R.; MacLaren, Robert E.] Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford, England; [Smyllie, Nicola J.; Maywood, Elizabeth S.; Hastings, Michael H.] MRC, Mol Biol Lab, Cambridge, England; [Banks, Gareth T.; Nolan, Patrick M.] MRC Harwell, Harwell Sci & Innovat Campus, Harwell, Berks, England; [van der Horst, Gijsbertus T. J.] Erasmus Univ, Dept Mol Genet, Med Ctr, Rotterdam, Netherlands	University of Oxford; University of Oxford; MRC Laboratory Molecular Biology; MRC Harwell; Erasmus University Rotterdam; Erasmus MC	Foster, RG; Peirson, SN (corresponding author), OMPI, Dunn Sch Pathol, Nuffield Dept Clin Neurosci, Sleep & Circadian Neurosci Inst, South Parks Rd, Oxford OX1 3RE, England.	russell.foster@eye.ox.ac.uk; stuart.peirson@eye.ox.ac.uk	van der Horst, Gijsbertus TJ/E-3661-2015; Jagannath, Aarti/GQA-7297-2022; Nolan, Patrick/W-3918-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Nolan, Patrick/0000-0001-5550-0334; Smyllie, Nicola/0000-0002-6324-1421; Wong, Jovi/0000-0001-7980-9352; Jagannath, Aarti/0000-0003-2132-8200; Banks, Gareth/0000-0002-8647-667X; MacLaren, Robert/0000-0002-3096-4682; FOSTER, RUSSELL/0000-0001-6055-2067	Electric and Magnetic Fields Biological Research Trust; Wellcome Trust [098461/Z/12/Z, 106174/Z/14/Z]; Biotechnology and Biological Sciences Research Council [BB/I021086/1]; MRC [MC_U142684173, MC_U105170643]; BBSRC [BB/N01992X/1, BB/I021086/1, BB/M009998/1] Funding Source: UKRI	Electric and Magnetic Fields Biological Research Trust(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank S. di Pretoro (Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford) for transgenic colony oversight. J.C.Y.W. and N.J.S. were both funded by grants from the Electric and Magnetic Fields Biological Research Trust awarded to S.N.P. and M.H.H. S.N.P. and R.G.F. are also funded by the Wellcome Trust (098461/Z/12/Z and 106174/Z/14/Z) and the Biotechnology and Biological Sciences Research Council (BB/I021086/1). P.M.N. and M.H.H. are funded by the MRC (MC_U142684173 and MC_U105170643). The authors declare no conflicts of interest.	Anand SN, 2013, J NEUROSCI, V33, P7145, DOI 10.1523/JNEUROSCI.4950-12.2013; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; Dkhissi-Benyahya O, 2013, CELL MOL LIFE SCI, V70, P3435, DOI 10.1007/s00018-013-1338-9; Hakkari OAH, 2016, FASEB J, V30, P3690, DOI 10.1096/fj.201600414R; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2014, J NEUROENDOCRINOL, V26, P2, DOI 10.1111/jne.12125; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hughes S, 2015, CELL MOL LIFE SCI, V72, P165, DOI 10.1007/s00018-014-1664-6; Hughes S, 2013, CURR BIOL, V23, P1696, DOI 10.1016/j.cub.2013.07.010; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; Jackson CR, 2014, J NEUROSCI, V34, P4627, DOI 10.1523/JNEUROSCI.4887-13.2014; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Jaeger C, 2015, FASEB J, V29, P1493, DOI 10.1096/fj.14-261214; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lipinski DM, 2011, INVEST OPHTH VIS SCI, V52, P6617, DOI 10.1167/iovs.11-7932; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; Malik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139655; Maywood ES, 2011, J NEUROSCI, V31, P1539, DOI 10.1523/JNEUROSCI.4107-10.2011; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Ouk K, 2016, HUM MOL GENET, V25, P5418, DOI 10.1093/hmg/ddw359; Owens L, 2012, INVEST OPHTH VIS SCI, V53, P454, DOI 10.1167/iovs.11-8717; Papp SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04883; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Smyllie NJ, 2016, P NATL ACAD SCI USA, V113, P3657, DOI 10.1073/pnas.1511351113; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Witkovsky P, 2003, J NEUROSCI, V23, P7670; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042647	53	15	15	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4302	4314		10.1096/fj.201701165RR	http://dx.doi.org/10.1096/fj.201701165RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29561690	Green Published			2022-12-28	WOS:000439325400021
J	Halade, GV; Kain, V; Serhan, CN				Halade, Ganesh V.; Kain, Vasundhara; Serhan, Charles N.			Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure	FASEB JOURNAL			English	Article						leukocytes; inflammation resolution; neutrophil clearance; miRNA storm	ACUTE KIDNEY INJURY; ACUTE-INFLAMMATION; MACROPHAGE ACTIVATION; LIPID MEDIATORS; RESOLUTION; MICRORNAS; MICE; DYSFUNCTION; MECHANISMS; PATHOLOGY	Resolvins are innate, immune responsive, bioactive mediators generated after myocardial infarction (MI) to resolve inflammation. The MI-induced bidirectional interaction between progressive left ventricle (LV) remodeling and kidney dysfunction is known to advance cardiorenal syndrome (CRS). Whether resolvins limit MI-induced cardiorenal inflammation is unclear. Thus, to define the role of exogenous resolvin D (RvD)-1 in post-MI CRS, we subjected 8- to 12-wk-old male C57BL/6 mice to coronary artery ligation. RvD1 was injected 3 h after MI. MI mice with no treatment served as MI controls (d 1 and 5). Mice with no surgery served as naive controls. In the injected mice, RvD1 promoted neutrophil (CD11b(+)/Ly6G(+)) egress from the infarcted LV, compared with the MI control group at d 5, indicative of neutrophil clearance and thereby resolved inflammation. Further, RvD1-injected mice showed higher reparative macrophages (F4/80(+)/Ly6C(low)/CD206(+)) in the infarcted LV than did MI control mice at d 5 after MI. RvD1 suppressed the miRNA storm at d 1 and limited the MI-induced edematous milieu in a remote area of the LV compared with the MI control at d 5 after MI. Also, RvD1 preserved the nephrin expression that was diffuse in the glomerular membrane at d 5 and 28 in MI controls, indicating renal injury. RvD1 attenuated MI-induced renal inflammation, decreasing neutrophil gelatinase-associated lipocalin and proinflammatory cytokines and chemokines in the kidney compared with the MI control. In summary, RvD1 clears MI-induced inflammation by increasing resolving leukocytes and facilitates renoprotective mechanisms to limit CRS in acute and chronic heart failure.Halade, G. V., Kain, V., Serhan, C. N. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.	[Halade, Ganesh V.; Kain, Vasundhara] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St South,MC 7755, Birmingham, AL 35294 USA; [Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA USA; [Serhan, Charles N.] Harvard Med Sch, Boston, MA USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Halade, GV (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St South,MC 7755, Birmingham, AL 35294 USA.	ganeshhalade@uabmc.edu	Kain, Vasundhara/AAL-7371-2021		U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health Grant [AT006704]; NIH National Heart, Lung and Blood Institute [HL132989]; University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association Postdoctoral Fellowship [POST31000008]; NIH National Institute of General Medical Sciences [P01-GM095467, GM038765-32]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K99AT006704] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R00AT006704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765, R37GM038765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health Grant; NIH National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association Postdoctoral Fellowship(American Heart Association); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health Grant AT006704; NIH National Heart, Lung and Blood Institute Grant HL132989; The University of Alabama at Birmingham (UAB) Pittman Scholar Award (to G.V.H.); American Heart Association Postdoctoral Fellowship Grant POST31000008 (to V.K.); and NIH National Institute of General Medical Sciences Grants P01-GM095467 and GM038765-32 (to C.N.S.) The authors declare no conflicts of interest.	Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chistiakov DA, 2016, J MOL CELL CARDIOL, V94, P107, DOI 10.1016/j.yjmcc.2016.03.015; Coletta AP, 2002, EUR J HEART FAIL, V4, P559, DOI 10.1016/S1388-9842(02)00121-6; Damman K, 2015, EUR HEART J, V36, P1437, DOI 10.1093/eurheartj/ehv010; Fox CS, 2012, CIRCULATION, V125, P497, DOI 10.1161/CIRCULATIONAHA.111.039909; Halade GV, 2018, AM J PHYSIOL-HEART C, V314, pH255, DOI 10.1152/ajpheart.00528.2017; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Halade GV, 2013, AM J PHYSIOL-HEART C, V305, pH1830, DOI 10.1152/ajpheart.00224.2013; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Ingle KA, 2015, AM J PHYSIOL-HEART C, V309, pH1827, DOI 10.1152/ajpheart.00608.2015; Kain V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10441-8; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Knier B, 2011, J HYPERTENS, V29, P1602, DOI 10.1097/HJH.0b013e32834840e8; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kyne L, 2000, AM HEART J, V139, P94, DOI 10.1016/S0002-8703(00)90314-4; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Lopez EF, 2015, AM J PHYSIOL-HEART C, V308, pH269, DOI 10.1152/ajpheart.00604.2014; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Maisel AS, 2011, NEPHROL DIAL TRANSPL, V26, P62, DOI 10.1093/ndt/gfq647; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mohamed JS, 2015, J BIOL CHEM, V290, P24986, DOI 10.1074/jbc.M115.659375; Muller WA, 2015, CARDIOVASC RES, V107, P310, DOI 10.1093/cvr/cvv145; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roy AK, 2013, CARDIORENAL MED, V3, P26, DOI 10.1159/000347037; SEKULIC M., 2013, PATHOL RES INT, V2013; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tourki B, 2017, FASEB J, V31, P4226, DOI 10.1096/fj.201700109R; Wei YY, 2013, CIRCULATION, V127, P1609, DOI 10.1161/CIRCULATIONAHA.112.000736; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	42	40	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3717	3729		10.1096/fj.201701173RR	http://dx.doi.org/10.1096/fj.201701173RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29455574	Green Published			2022-12-28	WOS:000435104500020
J	Wang, SY; Yu, JS; Jones, JW; Pierzchalski, K; Kane, MA; Trainor, PA; Xavier-Neto, J; Moise, AR				Wang, Suya; Yu, Jianshi; Jones, Jace W.; Pierzchalski, Keely; Kane, Maureen A.; Trainor, Paul A.; Xavier-Neto, Jose; Moise, Alexander R.			Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells	FASEB JOURNAL			English	Article						cardiac development; RhoA; cytoskeletal remodeling; retinoic acid; vitamin A	ZEBRAFISH HEART REGENERATION; SMOOTH-MUSCLE DIFFERENTIATION; RHO-KINASE-ACTIVITY; IN-VITRO; MESENCHYMAL TRANSITION; CARDIAC DEVELOPMENT; MOUSE DEVELOPMENT; AVIAN HEART; RNA-SEQ; EXPRESSION	All-trans-retinoic acid (RA), a vitamin A metabolite, is an important signaling molecule required for the proper development of the heart. The epicardium is the main source of RA in the embryonic heart, yet the cardiogenic functions of epicardial-produced RA are not fully understood. Here, we investigated the roles of RA signaling in the embryonic epicardium using in vivo and in vitro models of excess or deficiency of RA. Our results suggested that RA signaling facilitates the cytoskeletal rearrangement required for the epicardial-to-mesenchymal transition of epicardial cells. In vivo treatment with an inhibitor of RA synthesis delayed the migration of epicardial-derived precursor cells (EPDCs) into the myocardium; the opposite was seen in the case of dehydrogenase/reductase superfamily (DHRS)3-deficient embryos, a mouse model of RA excess. Analysis of the behavior of epicardial cells exposed to RA receptor agonists or inhibitors of RA synthesis in vitro revealed that appropriate levels of RA are important in orchestrating the platelet-derived growth factor-induced loss of epithelial character, cytoskeletal remodeling, and migration, necessary for the infiltration of the myocardium by EPDCs. To understand the molecular mechanisms by which RA regulates epicardial cytoskeletal rearrangement, we used a whole transcriptome profiling approach, which in combination with pull-down and inhibition assays, demonstrated that the Ras homolog gene family, member A (RhoA) pathway is required for the morphologic changes induced by RA in epicardial cells. Collectively, these data demonstrate that RA regulates the cytoskeletal rearrangement of epicardial cells via a signaling cascade that involves the RhoA pathway.Wang, S., Yu, J., Jones, J. W., Pierzchalski, K., Kane, M. A., Trainor, P. A., Xavier-Neto, J., Moise, A. R. Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells.	[Wang, Suya; Moise, Alexander R.] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Yu, Jianshi; Jones, Jace W.; Pierzchalski, Keely; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Xavier-Neto, Jose] Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Sao Paulo, Brazil; [Moise, Alexander R.] Laurentian Univ, Northern Ontario Sch Med, Dept Chem & Biochem, Sudbury, ON, Canada	University of Kansas; University System of Maryland; University of Maryland Baltimore; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Laurentian University; Northern Ontario School of Medicine	Moise, AR (corresponding author), Northern Ontario Sch Med, Med Sci Div, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada.	amoise@nosm.ca	AR, Moise/P-2474-2019; Moise, Alexander R/C-9498-2009; Wang, Suya/AAW-5584-2020	AR, Moise/0000-0003-2307-6035; Moise, Alexander R/0000-0003-2307-6035; Jones, Jace/0000-0003-0460-0380; Trainor, Paul/0000-0003-2774-3624	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [R01HD077260]; Fulbright U.S. Scholar Award - Bureau of Educational and Cultural Affairs (U.S. Department of State); Commission for Educational Exchange between the United States of America and Brazil; Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES); University of Maryland School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; Northern Ontario School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD077260] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; Fulbright U.S. Scholar Award - Bureau of Educational and Cultural Affairs (U.S. Department of State); Commission for Educational Exchange between the United States of America and Brazil; Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Maryland School of Pharmacy Mass Spectrometry Center; Northern Ontario School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Henry Sucov (University of Southern California-Los Angeles, Los Angeles, CA, USA) for his kind gift of the MEC1 cell line and for helpful advice. The authors thank the University of Kansas Microscopy and Analytical Imaging Laboratory for help in image analysis and the James Martin Laboratory (Baylor College of Medicine, Houston, TX, USA) for helpful advice. The authors thank Nancy Muma (University of Kansas) for the kind gift of the antibody against RhoA. This work was supported, in part, by U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01HD077260 (to A.R.M., M.A.K., and P.A.T.), and by a Fulbright U.S. Scholar Award (to A.R.M.), funded by the Bureau of Educational and Cultural Affairs (U.S. Department of State); the Commission for Educational Exchange between the United States of America and Brazil; and the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES). Additional support to M.A.K. was provided by the University of Maryland School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014), and by start-up funds to A.R.M. from the Northern Ontario School of Medicine. A.R.M. is a member of the Biomolecular Sciences Program (Laurentian University). The authors declare no conflicts of interest.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnold SLM, 2015, BIOCHEM PHARMACOL, V95, P177, DOI 10.1016/j.bcp.2015.03.001; Artamonov MV, 2015, J BIOL CHEM, V290, P10353, DOI 10.1074/jbc.M114.613190; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Azambuja AP, 2010, CIRC RES, V107, P204, DOI 10.1161/CIRCRESAHA.109.214650; Bax NAM, 2010, DEV DYNAM, V239, P2307, DOI 10.1002/dvdy.22363; BEARD RL, 1995, J MED CHEM, V38, P2820, DOI 10.1021/jm00015a004; Bilbija D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044740; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Braitsch CM, 2012, DEV BIOL, V368, P345, DOI 10.1016/j.ydbio.2012.06.002; Chen F, 2014, J CLIN INVEST, V124, P801, DOI 10.1172/JCI70291; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; COUCHMAN JR, 1979, J CELL SCI, V39, P149; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Dolle Pascal, 2009, Nucl Recept Signal, V7, pe006, DOI 10.1621/nrs.07006; Fang M, 2016, J MOL CELL CARDIOL, V91, P23, DOI 10.1016/j.yjmcc.2015.12.019; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Fischer AH, 2008, CSH PROTOC, P655; Garcia-Mariscal Alberto, 2018, Small GTPases, V9, P433, DOI 10.1080/21541248.2016.1248272; Hanato T, 2011, BIRTH DEFECTS RES B, V92, P10, DOI 10.1002/bdrb.20279; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Jones JW, 2015, ANAL CHEM, V87, P3222, DOI 10.1021/ac504597q; Kam RKT, 2013, J BIOL CHEM, V288, P31477, DOI 10.1074/jbc.M113.514984; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kennedy-Lydon T, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2147; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; KILBURN KH, 1982, TERATOLOGY, V26, P155, DOI 10.1002/tera.1420260207; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Lu J, 2001, DEV BIOL, V240, P404, DOI 10.1006/dbio.2001.0403; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marin-Juez R, 2016, P NATL ACAD SCI USA, V113, P11237, DOI 10.1073/pnas.1605431113; Matt N, 2005, DEV DYNAM, V233, P167, DOI 10.1002/dvdy.20313; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Metzler MA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120812; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nishijima S, 2000, TERATOLOGY, V62, P115, DOI 10.1002/1096-9926(200008)62:2<115::AID-TERA8>3.3.CO;2-R; OSTER G, 1974, AM J OBSTET GYNECOL, V119, P583, DOI 10.1016/0002-9378(74)90117-3; Paik J, 2014, J BIOL CHEM, V289, P15104, DOI 10.1074/jbc.M113.540211; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rudat C, 2013, CARDIOVASC RES, V100, P411, DOI 10.1093/cvr/cvt210; Ruiz-Villalba A, 2012, CURR OPIN PEDIATR, V24, P569, DOI 10.1097/MOP.0b013e328357a532; Shannon SR, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.264; Singh A, 2016, CELL REP, V15, P1384, DOI 10.1016/j.celrep.2016.04.027; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Stefanovic S, 2017, MECH DEVELOP, V143, P9, DOI 10.1016/j.mod.2016.12.002; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Volz KS, 2015, ELIFE, V4, DOI 10.7554/eLife.10036; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Xavier-Neto J, 2000, DEV BIOL, V219, P129, DOI 10.1006/dbio.1999.9588; Xavier-Neto J, 2015, BBA-GENE REGUL MECH, V1849, P94, DOI 10.1016/j.bbagrm.2014.08.003; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	71	21	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3765	3781		10.1096/fj.201701038R	http://dx.doi.org/10.1096/fj.201701038R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29447006	Green Published			2022-12-28	WOS:000435104500024
J	Xu, JM; Yi, J; Zhang, HJ; Feng, F; Gu, SL; Weng, LH; Zhang, J; Chen, YZ; An, N; Liu, Z; An, QX; Yin, W; Hu, XB				Xu, Jinmei; Yi, Jing; Zhang, Huijie; Feng, Fan; Gu, Shunli; Weng, Lihong; Zhang, Jing; Chen, Yaozhen; An, Ning; Liu, Zheng; An, Qunxing; Yin, Wen; Hu, Xingbin			Platelets directly regulate DNA damage and division of Staphylococcus aureus	FASEB JOURNAL			English	Article						immunity; infection; inflammation; DNA damage	GROWTH-FACTOR-BETA; HOST-DEFENSE; IN-VITRO; LIPOPOLYSACCHARIDE; THROMBOCYTOPENIA; ACTIVATION; SECRETION; PATHOGENS; RECEPTOR; BLOOD	Platelets (PLTs) are classically used in the clinical setting to maintain hemostasis. Recent evidence supports important roles for PLTs in host inflammatory and immune responses, and PLT-rich plasma has been demonstrated to inhibit the growth of bacteria in vitro and in vivo; however, few studies have examined whether PLTs can inhibit bacterial growth directly, and related mechanisms have not been elucidated further. Accordingly, in this study, we evaluated the effects of PLTs on bacterial growth. We washed and purified PLTs from peripheral blood, then confirmed that PLTs significantly inhibited the growth of Staphylococcus aureus when cocultured in vitro. Moreover, PLTs damaged DNA and blocked cell division in S. aureus. During coculture, PLT-derived TGF-1 was dramatically down-regulated compared with that in PLT culture alone, and the addition of TGF-1 to the coculture system promoted the inhibition of PLTs on S. aureus. Analysis of a murine S. aureus infection model demonstrated that the depletion of PLTs exacerbated the severity of infection, whereas the transfusion of PLTs alleviated this infection. Our observations demonstrate that PLTs could directly inhibit the growth of S. aureus by damaging DNA and blockage cell division, and that PLT-derived TGF-1 may play an important role in this machinery.Xu, J., Yi, J., Zhang, H., Feng, F., Gu, S., Weng, L., Zhang, J., Chen, Y., An, N., Liu, Z., An, Q., Yin, W., Hu, X. Platelets directly regulate DNA damage and division of Staphylococcus aureus.	[Xu, Jinmei; Yi, Jing; Zhang, Huijie; Gu, Shunli; Zhang, Jing; Chen, Yaozhen; An, Ning; An, Qunxing; Yin, Wen; Hu, Xingbin] Fourth Mil Med Univ, Xijing Hosp, Dept Transfus Med, Changle Rd, Xian 710032, Shaanxi, Peoples R China; [Feng, Fan] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Surg, Xian, Shaanxi, Peoples R China; [Zhang, Huijie] Chongqing Med Univ, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing, Peoples R China; [Weng, Lihong] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Beckman Res Inst, Duarte, CA USA; [Liu, Zheng] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	Air Force Military Medical University; Air Force Military Medical University; Chongqing Medical University; City of Hope; Beckman Research Institute of City of Hope; Columbia University	Yin, W; Hu, XB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Transfus Med, Changle Rd, Xian 710032, Shaanxi, Peoples R China.	yinwen@fmmu.edu.cn; hxbyqh@fmmu.edu.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022; Hu, XB/U-8501-2019	Hu, Xingbin/0000-0002-3952-3373	Natural Science Foundation of Shaanxi Province [2016JQ8033]; Xijing Hospital Foundation [XJZT15M12]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Xijing Hospital Foundation	This work was supported by the Natural Science Foundation of Shaanxi Province (2016JQ8033) and the Xijing Hospital Foundation (XJZT15M12). The authors declare no conflicts of interest.	Aktan I, 2013, VET IMMUNOL IMMUNOP, V152, P209, DOI 10.1016/j.vetimm.2012.12.007; Ali RA, 2017, J IMMUNOL, V198, P344, DOI 10.4049/jimmunol.1601178; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brecher ME, 2013, TRANSFUSION, V53, P221, DOI 10.1111/j.1537-2995.2012.03708.x; Chabert A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06024-2; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Czapiga M, 2005, EXP HEMATOL, V33, P73, DOI 10.1016/j.exphem.2004.09.010; Dai G., 1999, Tubercle and Lung Disease, V79, P207, DOI 10.1054/tuld.1998.0198; Despotovic D, 2017, FEBS J, V284, P2194, DOI 10.1111/febs.14113; Francois B, 1997, AM J MED, V103, P114, DOI 10.1016/S0002-9343(97)00136-8; Grundler K, 2014, CRIT CARE, V18, DOI 10.1186/cc13724; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Harvey AR, 2015, TRANSFUSION, V55, P709, DOI 10.1111/trf.12918; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Lin XR, 2015, CLIN EXP HYPERTENS, V37, P82, DOI 10.3109/10641963.2014.913600; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; MARCUS AJ, 1982, BIOCHEM BIOPH RES CO, V109, P130, DOI 10.1016/0006-291X(82)91575-3; Mariani E, 2014, CYTOTHERAPY, V16, P1294, DOI 10.1016/j.jcyt.2014.06.003; Marriott AS, 2015, DNA REPAIR, V33, P90, DOI 10.1016/j.dnarep.2015.06.008; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Patrignani P, 2006, BLOOD, V107, P3572, DOI 10.1182/blood-2005-12-4811; Puebla-Osorio N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.115; Schleicher RI, 2015, BLOOD, V126, P1483, DOI 10.1182/blood-2013-12-544445; SLOAND EM, 1992, EUR J HAEMATOL, V48, P168; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Tsegaye TS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-48; Unsal E, 2016, EUR J OBSTET GYN R B, V197, P125, DOI 10.1016/j.ejogrb.2015.12.016; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhang S, 2015, CIRCULATION, V131, P1160, DOI 10.1161/CIRCULATIONAHA.114.013743	40	3	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3707	3716		10.1096/fj.201701190R	http://dx.doi.org/10.1096/fj.201701190R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29430991				2022-12-28	WOS:000435104500019
J	Senchenkova, EY; Russell, J; Vital, SA; Yildirim, A; Orr, AW; Granger, DN; Gavins, FNE				Senchenkova, Elena Y.; Russell, Janice; Vital, Shantel A.; Yildirim, Alper; Orr, A. Wayne; Granger, D. Neil; Gavins, Felicity N. E.			A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation	FASEB JOURNAL			English	Article						sCD40L thrombosis; leukocytes; platelets; endothelium; hypertension	ALPHA-5-BETA-1 INTEGRIN; MICROVASCULAR RESPONSES; GLYCOPROTEIN IIB/IIIA; SOLUBLE CD40L; LIGAND; LEUKOCYTE; PLATELETS; TRIGGERS; BINDING; HYPERTENSION	Angiotensin II (Ang-II)-induced hypertension is associated with accelerated thrombus formation in arterioles and leukocyte recruitment in venules. The mechanisms that underlie the prothrombotic and proinflammatory responses to chronic Ang-II administration remain poorly understood. We evaluated the role of CD40/CD40 ligand (CD40L) signaling in Ang-Il-mediated microvascular responses and assessed whether and how soluble CD40L (sCD40L) contributes to this response. Intravital video microscopy was performed to analyze leukocyte recruitment and dihydrorhodamine-123 oxidation in postcapillary venules. Thrombus formation in cremaster muscle arterioles was induced by using the light/dye endothelial cell injury model. Wild-type (WT), CD40, and CD40L(-/-) mice received Ang-II for 14 d via osmotic minipumps. Some mice were treated with either recombinant sCD40L or the VLA5 (very late antigen 5; alpha 5 beta 1) antagonist, ATN-161. Our results demonstrate that CD40(-/-), CD40L(-/-), and WT mice that were treated with ATN-161 were protected against the thrombotic and inflammatory effects of Ang-II infusion. Infusion of sCD40L into CD40(-/-) or CD40L(-/-) mice restored the prothrombotic effect of Ang-II infusion. Mice that were treated with ATN-161 and infused with sCD40L were protected against accelerated thrombosis. Collectively, these novel findings suggest that the mechanisms that underlie Ang-Il-dependent thrombotic and inflammatory responses link to the signaling of CD40L via both CD40 and VLA5.	[Senchenkova, Elena Y.; Russell, Janice; Vital, Shantel A.; Yildirim, Alper; Granger, D. Neil; Gavins, Felicity N. E.] Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr Shreveport, 1501 Kings Highway, Shreveport, LA 71103 USA; [Orr, A. Wayne] Louisiana State Univ, Dept Pathol & Translat Pathobiol, Hlth Sci Ctr Shreveport, Shreveport, LA 71103 USA; [Gavins, Felicity N. E.] Louisiana State Univ, Dept Neurol, Hlth Sci Ctr Shreveport, Shreveport, LA 71103 USA; [Senchenkova, Elena Y.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Yildirim, Alper] Marmara Univ, Dept Physiol, Sch Med, Istanbul, Turkey	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Marmara University	Gavins, FNE (corresponding author), Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr Shreveport, 1501 Kings Highway, Shreveport, LA 71103 USA.	fgavin@lsuhsc.edu	Yildirim, Alper/I-2330-2014; Gavins, Felicity N. E./AAU-6010-2020; Orr, Anthony/P-8927-2015	Yildirim, Alper/0000-0002-3328-1692; Gavins, Felicity N. E./0000-0001-7008-5423; Orr, Anthony/0000-0002-2377-213X				Alexander RW, 2006, ARTERIOSCL THROM VAS, V26, P240, DOI 10.1161/01.ATV.0000199680.42737.ca; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bachsais M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158987; Celi A, 2010, EXPERT REV CARDIOVAS, V8, P1723, DOI 10.1586/ERC.10.161; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; Ferroni Patrizia, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P194, DOI 10.2174/187152908785849125; Freedman JE, 2003, CIRC RES, V92, P944, DOI 10.1161/01.RES.0000074030.98009.FF; Fullard JF, 2004, CURR PHARM DESIGN, V10, P1567, DOI 10.2174/1381612043384682; Gavins FNE, 2011, J THROMB HAEMOST, V9, P574, DOI 10.1111/j.1538-7836.2010.04176.x; Granger DN, 2010, MICROCIRCULATION, V17, P192, DOI 10.1111/j.1549-8719.2009.00015.x; HALL J E, 1991, Comprehensive Therapy, V17, P8; Hausding M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0386-5; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Kuijpers MJE, 2015, ARTERIOSCL THROM VAS, V35, P1374, DOI 10.1161/ATVBAHA.114.305127; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Li HM, 2007, J BIOL CHEM, V282, P5991, DOI 10.1074/jbc.M608482200; Matthies KMG, 2006, CELL IMMUNOL, V241, P47, DOI 10.1016/j.cellimm.2006.08.001; May AE, 2002, CIRCULATION, V106, P2111, DOI 10.1161/01.CIR.0000033597.45947.0F; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; Safar ME, 2008, J HUM HYPERTENS, V22, P590, DOI 10.1038/jhh.2008.43; Senchenkova EY, 2014, MICROCIRCULATION, V21, P401, DOI 10.1111/micc.12120; Senchenkova EY, 2011, HYPERTENSION, V58, P959, DOI 10.1161/HYPERTENSIONAHA.111.173856; Senchenkova EY, 2010, HYPERTENSION, V56, P1089, DOI 10.1161/HYPERTENSIONAHA.110.158220; Souza HP, 2009, CLIN SCI, V116, P423, DOI 10.1042/CS20080155; Stokes KY, 2009, AM J PHYSIOL-HEART C, V296, pH689, DOI 10.1152/ajpheart.00962.2008; Touyz RM, 2001, J HYPERTENS, V19, P1245, DOI 10.1097/00004872-200107000-00009; Ueland T, 2005, EUR HEART J, V26, P1101, DOI 10.1093/eurheartj/ehi132; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Vital SA, 2010, MICROCIRCULATION, V17, P641, DOI 10.1111/j.1549-8719.2010.00060.x; Vowinkel T, 2007, GASTROENTEROLOGY, V132, P955, DOI 10.1053/j.gastro.2006.12.027; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Yan JC, 2005, CLIN CHIM ACTA, V355, P191, DOI 10.1016/j.cccn.2005.01.009; Yildirim A, 2012, HYPERTENSION, V60, P1503, DOI 10.1161/HYPERTENSIONAHA.112.198465	35	13	14	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3448	3456		10.1096/fj.201701068R	http://dx.doi.org/10.1096/fj.201701068R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29452567	Green Published			2022-12-28	WOS:000432546000044
J	Cui, R; Choi, SE; Kim, TH; Lee, HJ; Lee, SJ; Kang, Y; Jeon, JY; Kim, HJ; Lee, KW				Cui, Rihua; Choi, Sung-E; Kim, Tae Ho; Lee, Hwa Joung; Lee, Soo Jin; Kang, Yup; Jeon, Ja Young; Kim, Hae Jin; Lee, Kwan-Woo			Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells	FASEB JOURNAL			English	Article						free fatty acids; iron disturbances; calcium; iron-responsive element-binding proteins 2	CALCIUM-DEPENDENT INACTIVATION; HYPOXIA; GLUCOSE; MICE; CA2+; LIPOTOXICITY; PATHOGENESIS; INVOLVEMENT; SENSITIVITY; HOMEOSTASIS	Free fatty acid is considered to be one of the major pathogenic factors of inducing insulin resistance. The association between iron disturbances and insulin resistance has recently begun to receive a lot of attention. Although skeletal muscles are a major tissue for iron utilization and storage, the role of iron in palmitate (PA)-induced insulin resistance is unknown. We investigated the molecular mechanism underlying iron dysregulation in PA-induced insulin resistance. Interestingly, we found that PA simultaneously increased intracellular iron and induced insulin resistance. The iron chelator deferoxamine dramatically inhibited PA-induced insulin resistance, and iron donors impaired insulin sensitivity by activating JNK. PA up-regulated transferrin receptor 1 (tfR1), an iron uptake protein, which was modulated by iron-responsive element-binding proteins 2. Knockdown of tfR1 and iron-responsive element-binding proteins 2 prevented PA-induced iron uptake and insulin resistance. PA also translocated the tfR1 by stimulating calcium influx, but the calcium chelator, BAPTA-AM, dramatically reduced iron overload by inhibiting tfR1 translocation and ultimately increased insulin sensitivity. Iron overload may play a critical role in PA-induced insulin resistance. Blocking iron overload may thus be a useful strategy for preventing insulin resistance and diabetes.Cui, R., Choi, S.-E., Kim, T. H., Lee, H. J., Lee, S. J., Kang, Y., Jeon, J. Y., Kim, H. J., Lee, K.-W. Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells.	[Cui, Rihua; Lee, Hwa Joung; Jeon, Ja Young; Kim, Hae Jin; Lee, Kwan-Woo] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon, South Korea; [Choi, Sung-E; Lee, Soo Jin; Kang, Yup] Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Kim, Tae Ho] Seoul Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Ajou University; Ajou University; Seoul Medical Center	Lee, KW (corresponding author), Ajou Univ, Sch Med, Dept Endocrinol & Metab, 206 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea.	lkw65@ajou.ac.kr		Kim, Tae Ho/0000-0002-3720-8011; Jeon, Ja Young/0000-0002-3877-0479	National Research Foundation of Korea [NRF-2016-R1D1A1B03930214]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF-2016-R1D1A1B03930214 to K.-W.L.). The authors declare no conflicts of interest.	Adam J, 2017, CELL REP, V20, P3135, DOI 10.1016/j.celrep.2017.08.093; Adams BD, 2005, J INVEST DERMATOL, V125, P1200, DOI 10.1111/j.0022-202X.2005.23949.x; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Brons C, 2009, J PHYSIOL-LONDON, V587, P3977, DOI 10.1113/jphysiol.2009.177758; Chen MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109214; Chen Min, 2009, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V26, P1088; Ci WM, 2003, CELL CALCIUM, V33, P257, DOI 10.1016/S0143-4160(02)00240-3; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Corna G, 2016, J IMMUNOL, V197, P1914, DOI 10.4049/jimmunol.1501417; DeRuisseau KC, 2013, EXP GERONTOL, V48, P1294, DOI 10.1016/j.exger.2013.08.011; Dongiovanni P., 2015, PLOS ONE; Dongiovanni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116855; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gammella E, 2017, METALLOMICS, V9, P1367, DOI 10.1039/c7mt00143f; Gera S, 1999, J GEN PHYSIOL, V114, P535, DOI 10.1085/jgp.114.4.535; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; HAACK JA, 1994, BIOPHYS J, V66, P1051, DOI 10.1016/S0006-3495(94)80886-0; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; Jung IR, 2015, MOL CELL ENDOCRINOL, V407, P74, DOI 10.1016/j.mce.2015.03.007; Kerins MJ, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00079-17; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019; Lee MS, 2012, METABOLISM, V61, P1142, DOI 10.1016/j.metabol.2012.01.012; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li XP, 2012, NEUROSIGNALS, V20, P223, DOI 10.1159/000332954; Ly LD, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.157; Moreno-Navarrete JM, 2014, DIABETOLOGIA, V57, P1957, DOI 10.1007/s00125-014-3298-5; Marsella M, 2014, HEMATOL ONCOL CLIN N, V28, P703, DOI 10.1016/j.hoc.2014.04.004; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Meli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066570; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Norouzirad R, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5350267; Owens J, 2013, IN VITRO CELL DEV-AN, V49, P695, DOI 10.1007/s11626-013-9655-8; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Ragheb R, 2009, BIOCHEM BIOPH RES CO, V389, P211, DOI 10.1016/j.bbrc.2009.08.106; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Smith AG, 2005, INT J BIOCHEM CELL B, V37, P2047, DOI 10.1016/j.biocel.2005.03.002; Choi E, 2007, MOL CELL ENDOCRINOL, V272, P50, DOI 10.1016/j.mce.2007.04.004; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Tenopoulou M, 2007, BIOCHEM J, V403, P261, DOI 10.1042/BJ20061840; Widera A, 2003, ADV DRUG DELIVER REV, V55, P1439, DOI 10.1016/j.addr.2003.07.004; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65	59	11	12	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1771	1786		10.1096/fj.201800448R	http://dx.doi.org/10.1096/fj.201800448R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207798				2022-12-28	WOS:000457296600021
J	Matthiesen, J; Lender, C; Haferkorn, A; Fehling, H; Meyer, M; Matthies, T; Tannich, E; Roeder, T; Lotter, H; Bruchhaus, I				Matthiesen, Jenny; Lender, Corinna; Haferkorn, Anne; Fehling, Helena; Meyer, Martin; Matthies, Thorben; Tannich, Egbert; Roeder, Thomas; Lotter, Hannelore; Bruchhaus, Iris			Trigger-induced RNAi gene silencing to identify pathogenicity factors of Entamoeba histolytica	FASEB JOURNAL			English	Article						amoebic liver abscess; cysteine peptidase; eukaryotic transfection	AMEBIC LIVER-ABSCESS; CYSTEINE PROTEINASES; EXPRESSION; TRANSFECTION; VIRULENCE; IDENTIFICATION; PROTEASE-1; STRAINS	Recently, Entamoeba histolytica clones derived from isolate HM-1:IMSS that differ in their pathogenicity were identified. Whereas some clones induce amoebic liver abscesses (ALAs) in animal models of amoebiasis, others provoke only minimal liver lesions. Based on transcriptome studies of pathogenic and nonpathogenic clones, differentially expressed genes associated with reduced or increased liver pathology can be identified. Here, to analyze the influence of these genes on ALA formation in more detail, an RNA interference-trigger mediated silencing approach was used. Using newly identified trigger sequences, the expression of 15 genes was silenced. The respective transfectants were analyzed for their ability to induce liver destruction in the murine model for the disease. Silencing of EHI_180390 (encoding an AIG1 protein) increased liver pathology induced by a nonpathogenic parent clone, whereas silencing of EHI_127670 (encoding a hypothetical protein) decreased the pathogenicity of an initially pathogenic parent clone. Additional phenotypical in vitro analyses of EHI_127670 silencing as well as overexpression transfectants indicated that this molecule has an influence on size, growth, and cysteine peptidase activity of E. histolytica. This work describes an example of how the sole operational method for effective gene silencing in E. histolytica can be used for comprehensive analyses of putative pathogenicity factors.Matthiesen, J., Lender, C., Haferkorn, A., Fehling, H., Meyer, M., Matthies, T., Tannich, E., Roeder, T., Lotter, H., Bruchhaus, I. Trigger-induced RNAi gene silencing to identify pathogenicity factors of Entamoeba histolytica.	[Matthiesen, Jenny; Lender, Corinna; Haferkorn, Anne; Fehling, Helena; Meyer, Martin; Matthies, Thorben; Tannich, Egbert; Lotter, Hannelore; Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Roeder, Thomas] Christian Albrechts Univ Kiel, Dept Mol Physiol, Inst Zool, Kiel, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Kiel	Lotter, H; Bruchhaus, I (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	lotter@bnitm.de; bruchhaus@bnitm.de	Roeder, Thomas/B-9016-2011	Roeder, Thomas/0000-0002-3489-3834; Fehling, Helena/0000-0003-1112-7608	Deutsche Forschungsgemeinschaft (DFG) [Br1744/11-2]; Jurgen Manchot Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Jurgen Manchot Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, Br1744/11-2) and Jurgen Manchot Stiftung. The authors declare no conflicts of interest.	Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Baumel-Alterzon S, 2013, CELL MICROBIOL, V15, P130, DOI 10.1111/cmi.12036; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Biller L, 2009, PROTEOMICS, V9, P4107, DOI 10.1002/pmic.200900022; Blessmann J, 2003, J CLIN MICROBIOL, V41, P4745, DOI 10.1128/JCM.41.10.4745-4750.2003; Bracha R, 2003, EUKARYOT CELL, V2, P295, DOI 10.1128/EC.2.2.295-305.2003; Bracha Rivka, 2006, PLoS Pathog, V2, pe48, DOI 10.1371/journal.ppat.0020048; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Ehrenkaufer GM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-216; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; Hellberg A, 2000, MOL BIOCHEM PARASIT, V105, P305, DOI 10.1016/S0166-6851(99)00194-2; Hon CC, 2013, NUCLEIC ACIDS RES, V41, P1936, DOI 10.1093/nar/gks1271; Irmer H, 2009, MOL MICROBIOL, V72, P658, DOI 10.1111/j.1365-2958.2009.06672.x; Khalil MI, 2016, INT J PARASITOL, V46, P205, DOI 10.1016/j.ijpara.2015.11.004; Leippe M, 1995, PARASITOLOGY, V111, P569, DOI 10.1017/S0031182000077040; Lotter H, 2006, INFECT IMMUN, V74, P118, DOI 10.1128/IAI.74.1.118-124.2006; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Matthiesen J, 2013, MBIO, V4, DOI 10.1128/mBio.00072-13; Meyer M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005853; Mirelman D, 2008, IUBMB LIFE, V60, P598, DOI 10.1002/iub.96; Morf L, 2013, NUCLEIC ACIDS RES, V41, P9424, DOI 10.1093/nar/gkt717; NICKEL R, 1994, P NATL ACAD SCI USA, V91, P7095, DOI 10.1073/pnas.91.15.7095; Pearson RJ, 2013, J BIOL CHEM, V288, P4462, DOI 10.1074/jbc.M112.423467; Penuliar GM, 2012, J ANTIMICROB CHEMOTH, V67, P375, DOI 10.1093/jac/dkr484; Pompey JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106477; Rastew E, 2015, EXP PARASITOL, V154, P33, DOI 10.1016/j.exppara.2015.04.004; STANLEY SL, 1995, INFECT IMMUN, V63, P1587, DOI 10.1128/IAI.63.4.1587-1590.1995; Teixeira JE, 2012, INFECT IMMUN, V80, P2165, DOI 10.1128/IAI.06389-11; Tillack M, 2006, MOL BIOCHEM PARASIT, V149, P58, DOI 10.1016/j.molbiopara.2006.04.009; Weber C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35852; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	35	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1658	1668		10.1096/fj.201801313R	http://dx.doi.org/10.1096/fj.201801313R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30169111	Bronze			2022-12-28	WOS:000457296600013
J	Pfeiler, S; Thakur, M; Grunauer, P; Megens, RTA; Joshi, U; Coletti, R; Samara, V; Muller-Stoy, G; Ishikawa-Ankerhold, H; Stark, K; Klingl, A; Frohlich, T; Arnold, GJ; Wormann, S; Bruns, CJ; Algul, H; Weber, C; Massberg, S; Engelmann, B				Pfeiler, Susanne; Thakur, Manovriti; Gruenauer, Petra; Megens, Remco T. A.; Joshi, Urjita; Coletti, Raffaele; Samara, Verena; Mueller-Stoy, Geraldine; Ishikawa-Ankerhold, Hellen; Stark, Konstantin; Klingl, Andreas; Froehlich, Thomas; Arnold, Georg J.; Woermann, Sonja; Bruns, Christiane J.; Alguel, Hana; Weber, Christian; Massberg, Steffen; Engelmann, Bernd			CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis	FASEB JOURNAL			English	Article						super-resolution microscopy; microvesicle extravasation; Ly6C(-)macrophages	EXTRACELLULAR VESICLES; CANCER; MACROPHAGES; MICROPARTICLES; COMMUNICATION; MELANOMA; BIOLOGY	Tumor microvesicles are a peculiar type of extracellular vesicles that circulate in the blood of patients with metastatic cancer. The itineraries and immune cell interactions of tumor microvesicles during the intravascular and extravascular stages of metastasis are largely unknown. We found that the lipid receptor CD36 is a major mediator of the engulfment of pancreatic tumor microvesicles by myeloid immune cells in vitro and critically samples circulating tumor microvesicles by resident liver macrophages in mice in vivo. Direct nanoscopic imaging of individual tumor microvesicles shows that the microvesicles rapidly decay during engulfment whereby their cargo is targeted concomitantly to the plasma membrane and the cytoplasm excluding lysosomal compartments. CD36 also promotes internalization of blood cell (nontumor) microvesicles, which involves endolysosomal pathways. A portion of tumor microvesicles circulating in the liver microcirculation traverses the vessel wall in a CD36-dependent way. Extravasated microvesicles colonize distinct perivascular Ly6C(-) macrophages for at least 2 wk. Thus, the microvesicles are increasingly integrated into CD36-induced premetastatic cell clusters and enhance development of liver metastasis. Hence, promotion of metastasis by pancreatic tumor microvesicles is associated with CD36-regulated immune cell invasion and extravasation of microvesicles and persistent infiltration of specific tissue macrophages by microvesicle cargo.Pfeiler, S., Thakur, M., Grunauer, P., Megens, R. T. A., Joshi, U., Coletti, R., Samara, V., Muller-Stoy, G., Ishikawa-Ankerhold, H., Stark, K., Klingl, A., Frohlich, T., Arnold, G. J., Wormann, S., Bruns, C. J., Algul, H., Weber, C., Massberg, S., Engelmann, B. CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis.	[Pfeiler, Susanne; Thakur, Manovriti; Gruenauer, Petra; Joshi, Urjita; Samara, Verena; Mueller-Stoy, Geraldine; Engelmann, Bernd] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Lab Med, Munich, Germany; [Megens, Remco T. A.; Weber, Christian] Ludwig Maximilians Univ Munchen, Prophylaxe Kreislaufkrankheiten, Munich, Germany; [Coletti, Raffaele; Ishikawa-Ankerhold, Hellen; Stark, Konstantin; Massberg, Steffen] Ludwig Maximilians Univ Munchen, Med Klin 1, Munich, Germany; [Klingl, Andreas] Ludwig Maximilians Univ Munchen, Biol Bot 1, Munich, Germany; [Froehlich, Thomas; Arnold, Georg J.] Ludwig Maximilians Univ Munchen, Genzentrum, Munich, Germany; [Megens, Remco T. A.; Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Woermann, Sonja; Alguel, Hana] Tech Univ Munich, Klin & Poliklin Innere Med 2, Munich, Germany; [Bruns, Christiane J.] Univ Cologne, Chirurg Klin, Cologne, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; Maastricht University; Technical University of Munich; University of Cologne	Engelmann, B (corresponding author), Ludwig Maximilians Univ Munchen, Inst Lab Med, Marchioninistr 15, D-81377 Munich, Germany.	Bernd.Engelmann@med.uni-muenchen.de	Fröhlich, Thomas/C-6735-2011; Klingl, Andreas/K-6675-2014; Weber, Christian/AAW-2153-2020; Massberg, Steffen/AAN-6054-2021; Stark, Konstantin/AAJ-2815-2020	Fröhlich, Thomas/0000-0002-4709-3211; Weber, Christian/0000-0003-4610-8714; Stark, Konstantin/0000-0002-5369-8399; Pfeiler, Susanne/0000-0002-8591-6186; megens, remco/0000-0001-9871-6696; Klingl, Andreas/0000-0001-8414-8317; Thakur, Manovriti/0000-0003-3825-4121	Deutsche Forschungsgemeinschaft [SFB1123, INST 409/150-1 FUGG]; Deutsche Krebshilfe; Wilhelm-Sander-Stiftung;  [SFB1321];  [SFB 914]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Sander-Stiftung; ; 	The authors thank Katja Reges (Institut fur Laboratoriumsmedizin, Klinikum der Universitat Munchen) for preparation of CFP-TF construct, and Kathrin Gartner (Helmholtz Zentrum Munchen) for help with nanoparticle tracking analysis. The work was supported by SFB1123 from Deutsche Forschungsgemeinschaft (Projects B06 to S.M. and B.E., A01 to C.W., and Z01 to R.T.A.M.; INST 409/150-1 FUGG to C.W., S.M., and R.T.A.M.), by SFB1321 (Project P10 to B.E. and S.M.), as well as by grants from Deutsche Krebshilfe and Wilhelm-Sander-Stiftung (to B.E.) and SFB 914 (Project Z01 to R.C., H.I.-A., and S.M.). S.P. and M.T. shared first authorship. The authors declare no conflicts of interest.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Desrochers LM, 2016, DEV CELL, V37, P301, DOI 10.1016/j.devcel.2016.04.019; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gopal SK, 2017, BIOCHEM J, V474, P21, DOI 10.1042/BCJ20160006; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Kosaka N, 2016, J CLIN INVEST, V126, P1163, DOI 10.1172/JCI81130; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Lewis CE, 2016, CANCER CELL, V30, P18, DOI 10.1016/j.ccell.2016.05.017; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Marcovecchio PM, 2017, ARTERIOSCL THROM VAS, V37, P2043, DOI 10.1161/ATVBAHA.117.309123; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Menck K, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1340745; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Prada I, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081296; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; Sansone P, 2017, CANCER RES, V77, P1927, DOI 10.1158/0008-5472.CAN-16-2129; Soung YH, 2017, CANCERS, V9, DOI 10.3390/cancers9010008; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111	31	19	19	5	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1860	1872		10.1096/fj.201800985R	http://dx.doi.org/10.1096/fj.201800985R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207797				2022-12-28	WOS:000457296600028
J	Deng, B; Shen, WJ; Dong, DC; Azhar, S; Kraemer, FB				Deng, Bing; Shen, Wen-Jun; Dong, Dachuan; Azhar, Salman; Kraemer, Fredric B.			Plasma membrane cholesterol trafficking in steroidogenesis	FASEB JOURNAL			English	Article						adrenal gland; mitochondria; SNARE proteins	ENDOPLASMIC-RETICULUM; ACTH REGULATION; PROTEIN; CELLS; TRANSPORT; STEROL; ACCUMULATION; SUBSTRATE; IMPORT; LIPIDS	Cholesterol is an important component of plasma membranes (PMs) and the precursor of all steroid hormones. In steroidogenic tissues, upon hormone stimulation, there is a rapid transfer of cholesterol to the mitochondria, which is the site of the initial step in steroidogenesis. In the current study, we examined PM cholesterol trafficking for steroidogenesis. In a mitochondrial reconstitution assay, adrenal PMs supported steroidogenesis in the absence of additional transport proteins. Depletion of cholesterol in PMs by 50% eliminated the membranes' ability to support steroidogenesis in vitro and reduced steroid production in intact Y1 adrenocortical cells. Syntaxin (STX)-5 and -soluble N-ethylmaleimide-sensitive factor attachment protein (-SNAP) are enriched in adrenal PMs, and adrenocorticotropic hormone treatment of rats recruited STX5 and -SNAP to adrenal PMs and mitochondria. Immunodepletion of STX5 and -SNAP from PMs decreased steroidogenesis supported by PMs in vitro. Protease digestion of PMs decreased, whereas recombinant STX5 or -SNAP restored, the PMs' ability to support steroidogenesis. Knockdown of either STX5 or -SNAP in Y1 cells decreased stimulated steroidogenesis. These results indicate that STX5 and -SNAP facilitate cholesterol trafficking from PMs to mitochondria for adrenal steroid synthesis and underscore the importance of vesicular trafficking of PM cholesterol for steroidogenesis.Deng, B., Shen, W.-J., Dong, D., Azhar, S., Kraemer, F. B. Plasma membrane cholesterol trafficking in steroidogenesis.	[Deng, Bing; Shen, Wen-Jun; Dong, Dachuan; Azhar, Salman; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol Gerontol & Metab, Palo Alto, CA 94304 USA; [Deng, Bing; Shen, Wen-Jun; Dong, Dachuan; Azhar, Salman; Kraemer, Fredric B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Deng, Bing] Wuhan Acad Agr Sci, Wuhan, Hubei, Peoples R China	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kraemer, FB (corresponding author), Stanford Univ, Med Ctr, Div Endocrinol Gerontol & Metab, S025, Stanford, CA 94305 USA.	fbk@stanford.edu	Kraemer, Fredric/AAC-3633-2019	Deng, Bing/0000-0002-7391-7018; Kraemer, Fredric/0000-0003-2468-7807; Dong, Dachuan/0000-0002-5443-5304	Merit Review Awards from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program [I01BX001923, I01BX000398]; U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program [IK6B004200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK116074] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398, I01BX001923] Funding Source: NIH RePORTER	Merit Review Awards from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program; U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Awards I01BX001923 (to S.A.) and I01BX000398 (to F.B.K.); and Senior Research Career Scientist Award IK6B004200 (to S.A.) from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program. The authors declare no conflicts of interest.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; CARR BR, 1981, ENDOCR REV, V2, P306, DOI 10.1210/edrv-2-3-306; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Enrich C, 2015, J CELL SCI, V128, P1071, DOI 10.1242/jcs.164459; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREEMAN DA, 1989, ENDOCRINOLOGY, V124, P2527, DOI 10.1210/endo-124-5-2527; GOCZE PM, 1993, EXP CELL RES, V209, P21, DOI 10.1006/excr.1993.1279; Grant NJ, 1999, J NEUROCHEM, V72, P363, DOI 10.1046/j.1471-4159.1999.0720363.x; Grosse J, 2000, BIOL REPROD, V63, P643, DOI 10.1095/biolreprod63.2.643; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Lange Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098482; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lin Y, 2016, MOL ENDOCRINOL, V30, P234, DOI 10.1210/me.2015-1281; Lindzey Jonathan, 1997, P47; Martin LA, 2016, J BIOENERG BIOMEMBR, V48, P137, DOI 10.1007/s10863-014-9592-6; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Ostrom Rennolds S., 2007, V400, P459; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PON LA, 1988, ENDOCRINOLOGY, V123, P1942, DOI 10.1210/endo-123-4-1942; PON LA, 1986, J BIOL CHEM, V261, P3309; Purdy PH, 2004, BIOL REPROD, V71, P522, DOI 10.1095/biolreprod.103.025577; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; ROTHMAN JE, 1984, J CELL BIOL, V99, P248, DOI 10.1083/jcb.99.1.248; Shen WJ, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00042; Steegmaier M, 2000, MOL BIOL CELL, V11, P2719, DOI 10.1091/mbc.11.8.2719; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Venugopal S, 2016, J BIOL CHEM, V291, P26109, DOI 10.1074/jbc.M116.740928; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x	38	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1389	1400		10.1096/fj.201800697RRR	http://dx.doi.org/10.1096/fj.201800697RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30133326	Green Published			2022-12-28	WOS:000457401500109
J	Fonte, C; Kaminski, S; Vanet, A; Lanfumey, L; Cohen-Salmon, C; Ghislin, S; Frippiat, JP				Fonte, Coralie; Kaminski, Sandra; Vanet, Anne; Lanfumey, Laurence; Cohen-Salmon, Charles; Ghislin, Stephanie; Frippiat, Jean-Pol			Socioenvironmental stressors encountered during spaceflight partially affect the murine TCR- repertoire and increase its self-reactivity	FASEB JOURNAL			English	Article						lymphopoiesis; immunity; T cell; lymphocytes; antigen receptor	CHRONIC ULTRAMILD STRESS; BONE-MARROW; LYMPHOID ORGANS; CELL; RECEPTOR; EXPOSURE; TRANSCRIPTION; RECOMBINASE; MODEL; USAGE	Spaceflights are known to affect the immune system. In a previous study, we demonstrated that hypergravity exposure during murine development modified 85% of the T-cell receptor (TCR)- repertoire. In this study, we investigated whether socioenvironmental stressors encountered during space missions affect T lymphopoiesis and the TCR- repertoire. To address this question, pregnant mice were subjected throughout gestation to chronic unpredictable mild stressors (CUMS), a model used to mimic socioenvironmental stresses encountered during space missions. Then, newborn T lymphopoiesis and the TCR- repertoire were studied by flow cytometry and high-throughput sequencing, respectively. No change in thymocyte maturation or TCR expression were noted. TCR- repertoire analysis revealed that 75% of neonate TCR- sequences resulted from the expression of 3 variable (V) segments and that this core repertoire was not affected by CUMS. However, the minor repertoire, representing 25% of the global repertoire, was sensitive to CUMS exposure. We also showed that the variable (diversity) joining [V(D)J] recombination process was unlikely to be affected. Finally, we noted that the CUMS neonatal minor repertoire was more self-reactive than the one of control pups. These findings show that socioenvironmental stressors such as those encountered during space missions affect a fraction (25%) of the TCR- repertoire and that these stressors could increase self-reactivity.Fonte, C., Kaminski, S., Vanet, A., Lanfumey, L., Cohen-Salmon, C., Ghislin, S., Frippiat, J.-P. Socioenvironmental stressors encountered during spaceflight partially affect the murine TCR- repertoire and increase its self-reactivity.	[Fonte, Coralie; Kaminski, Sandra; Ghislin, Stephanie; Frippiat, Jean-Pol] Univ Lorraine, EA7300, Fac Med, Stress Immun Pathogens Lab, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France; [Vanet, Anne] Univ Sorbonne Paris Cite, Paris Diderot Univ, Inst Jacques Monod, CNRS,Unite Mixte Rech 7592,Epole Genoinformat, Paris, France; [Lanfumey, Laurence] INSERM, Unit Mixte Rech 894, Ctr Psychiat & Neurosci, Paris, France; [Cohen-Salmon, Charles] Univ Paris Diderot, Sorbonne Paris Cite, Hop Robert Debre, INSERM,Unite 1141, Paris, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Frippiat, JP (corresponding author), Univ Lorraine, EA7300, Fac Med, Stress Immun Pathogens Lab, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	jean-pol.frippiat@univ-lorraine.fr	Kaminski, Sandra/AAM-6134-2021; Lanfumey, Laurence/P-3037-2017	Vanet, Anne/0000-0002-6018-3158	French Space Agency [DAR 4800000894, 4800000950]; French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine; INSERM; Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir) [ANR 15-004]; ImagoSeine Core Facility of the Institut Jacques Monod; France BioImaging [ANR-10.INBS-04]; La Ligue Contre le Cancer [R03/75-79]	French Space Agency(Centre National D'etudes Spatiales); French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine(Region Grand-Est); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir)(French National Research Agency (ANR)); ImagoSeine Core Facility of the Institut Jacques Monod; France BioImaging(French National Research Agency (ANR)); La Ligue Contre le Cancer(Ligue nationale contre le cancer)	The authors thank T. Marday, N. Boggetto, and G. Wentzinger for efficient technical support and assistance. This work was supported by the French Space Agency (Grants DAR 4800000894 and 4800000950), the French Ministry of Higher Education and Research, the Universite de Lorraine, the Region Lorraine, and INSERM; the Stress Immunity Pathogens Laboratory received support from the Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir; ANR 15-004). The study was supported by the ImagoSeine Core Facility of the Institut Jacques Monod, a member of France BioImaging (ANR-10.INBS-04), and La Ligue Contre le Cancer (R03/75-79). The authors declare no conflicts of interest.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Bale TL, 2015, NAT REV NEUROSCI, V16, P332, DOI 10.1038/nrn3818; Bevington S, 2013, EMBO J, V32, P1381, DOI 10.1038/emboj.2013.42; CANDEIAS S, 1991, J EXP MED, V174, P989, DOI 10.1084/jem.174.5.989; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69; Dong MQ, 2017, J IMMUNOL, V199, P965, DOI 10.4049/jimmunol.1602137; Fonte C, 2015, DEV COMP IMMUNOL, V53, P371, DOI 10.1016/j.dci.2015.08.006; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Gaignier F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00514; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Hunter MC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00613; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Kimzey SL, 1977, BIOMEDICAL RESULTS S, P248; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Madi A, 2017, ELIFE, V6, DOI 10.7554/eLife.22057; Madi A, 2014, GENOME RES, V24, P1603, DOI 10.1101/gr.170753.113; Massart R, 2016, DEV PSYCHOPATHOL, V28, P1259, DOI 10.1017/S0954579416000833; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Misdrahi D, 2005, PSYCHIAT RES, V137, P123, DOI 10.1016/j.psychres.2005.07.020; MORAHAN G, 1987, EMBO J, V6, P3679, DOI 10.1002/j.1460-2075.1987.tb02701.x; Murray JM, 2012, J IMMUNOL, V189, P2356, DOI 10.4049/jimmunol.1200382; Ndifon W, 2012, P NATL ACAD SCI USA, V109, P15865, DOI 10.1073/pnas.1203916109; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Pardon MC, 2000, BIOL PSYCHIAT, V47, P858, DOI 10.1016/S0006-3223(99)00253-X; Rangon CM, 2007, J NEUROSCI, V27, P7532, DOI 10.1523/JNEUROSCI.5330-06.2007; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Sethna Z, 2017, P NATL ACAD SCI USA, V114, P2253, DOI 10.1073/pnas.1700241114; Subrahmanyam R, 2012, NAT IMMUNOL, V13, P1205, DOI 10.1038/ni.2447; Taves MD, 2017, HORM BEHAV, V88, P4, DOI 10.1016/j.yhbeh.2016.10.022; VACEK A, 1991, FOLIA BIOL-PRAGUE, V37, P35; Ward C, 2018, LIFE SCI SPACE RES, V16, P63, DOI 10.1016/j.lssr.2017.11.003; Woods CC, 2003, FASEB J, V17, P1526, DOI 10.1096/fj.02-0749fje; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488	39	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					896	908		10.1096/fj.201800969R	http://dx.doi.org/10.1096/fj.201800969R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052484	Green Submitted			2022-12-28	WOS:000457401500070
J	Kolbe, I; Carrasco-Benso, MP; Lopez-Minguez, J; Lujan, J; Scheer, FAJL; Oster, H; Garaulet, M				Kolbe, Isa; Paz Carrasco-Benso, Maria; Lopez-Minguez, Jesus; Lujan, Juan; Scheer, Frank A. J. L.; Oster, Henrik; Garaulet, Marta			Circadian period of luciferase expression shortens with age in human mature adipocytes from obese patients	FASEB JOURNAL			English	Article						peripheral clocks; adipose tissue; BMAL1 reporter; lenti virus; primary cells	CLOCK; RHYTHMS; SLEEP; PHASE	Daily rhythms in physiology and behavior change with age. An unresolved question is to what extent such age-related alterations in circadian organization are driven by the central clock in the suprachiasmatic nucleus (SCN), modifying timing signals to contributing peripheral tissue oscillators, and are mediated by underlying changes in the local cellular oscillators themselves. Using a bioluminescence reporter approach, we sought to determine whether circadian clock function in human adipocytes from subcutaneous (SAT) and visceral (VAT) adipose tissues changes with age. SAT and VAT biopsies were obtained from obese individuals during gastric bypass surgeries [n = 16; body mass index: 44.8 +/- 11.4 kg/m(2); age: 44 +/- 9 yr (range: 30-58)]. Cells were isolated and transduced with a lentiviral circadian reporter construct [brain and muscle aryl hydrocarbon receptor nuclear translocator-like:luciferase (BMAL:LUC)], and bioluminescence was recorded over a period of 3 d. Human BMAL1:LUC adipocytes displayed a robust luminescence rhythm with comparable within-individual periods in mature and preadipocytes (P > 0.05). With increasing age, the circadian period decreased in mature adipocytes (P = 0.005) ( = 4 min/yr; P < 0.05). Our ex vivo approach indicated that ageing changes the organization of endogenous circadian oscillators in human adipocytes, independent of SCN signaling.Kolbe, I., Carrasco-Benso, M. P., Lopez-Minguez, J., Lujan, J., Scheer, F. A. J. L., Oster, H., Garaulet, M. Circadian period of luciferase expression shortens with age in human mature adipocytes from obese patients.	[Kolbe, Isa; Oster, Henrik] Univ Lubeck, Inst Neurobiol, Lubeck, Germany; [Paz Carrasco-Benso, Maria; Lopez-Minguez, Jesus; Garaulet, Marta] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Paz Carrasco-Benso, Maria; Lopez-Minguez, Jesus; Garaulet, Marta] Biomed Res Inst Arrixaca, Murcia, Spain; [Lujan, Juan] Univ Hosp Virgen de la Arrixaca, Gen Surg Serv, Murcia, Spain; [Scheer, Frank A. J. L.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Scheer, Frank A. J. L.] Harvard Med Sch, Div Sleep Med, Boston, MA USA	University of Lubeck; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Oster, H (corresponding author), Univ Lubeck, Inst Neurobiol, Lubeck, Germany.; Garaulet, M (corresponding author), Univ Murcia, Virgen de la Arrixaca Univ Hosp, Campus Espinardo, Murcia, Spain.	henrik.oster@uni-luebeck.de; garaulet@um.es	Oster, Henrik/O-4426-2019; Scheer, Frank A.J.L./C-2795-2012; Oster, Henrik/D-2335-2013; Garaulet, Marta/K-6625-2014	Oster, Henrik/0000-0002-1414-7068; Scheer, Frank A.J.L./0000-0002-2014-7582; Oster, Henrik/0000-0002-1414-7068; Garaulet, Marta/0000-0002-4066-3509; Maria Paz, Carrasco-Benso/0000-0001-5611-4929; Lujan Mompean, Juan Antonio/0000-0003-4987-7578	Spanish Department of Investigation, Development, and Innovation [SAF2017-84135-R]; Spanish Federation of Rare Diseases (FEDER); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK105072]; German Research Foundation [GRK-1957, SFB-134]; NIH NIDDK [R01 DK099512]; NIH National Heart, Lung and Blood Institute [R01 HL118601, R01 HL140574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140574, R01HL118601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105072, R01DK099512] Funding Source: NIH RePORTER	Spanish Department of Investigation, Development, and Innovation; Spanish Federation of Rare Diseases (FEDER); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Research Foundation(German Research Foundation (DFG)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work as supported in part by The Spanish Department of Investigation, Development, and Innovation (SAF2017-84135-R) including cofunding from the Spanish Federation of Rare Diseases (FEDER), and U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant R01DK105072 (to M.G.); German Research Foundation grants GRK-1957 and SFB-134 (to H.O.); and NIH NIDDK Grant R01 DK099512 and NIH National Heart, Lung and Blood Institute grants R01 HL118601 and R01 HL140574 (to F.A.J.L.S). H.O. is a Lichtenberg fellow of the Volkswagen Foundation. F.A.J.L.S. has received speaker fees from Bayer Healthcare (Montville, NJ, USA), Sentara Healthcare (Norfolk, VA, USA), Kellogg Company (Battle Creek, MI, USA), and Philips (Eindhoven, The Netherlands). The other authors declare no conflicts of interest.	Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Davis FC, 1998, AM J PHYSIOL-REG I, V275, pR960; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; Duffy JF, 1999, NEUROSCI LETT, V271, P77, DOI 10.1016/S0304-3940(99)00519-4; Froy O, 2018, ENDOCR REV, V39, P261, DOI 10.1210/er.2017-00193; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Abellan PG, 2011, NUTR HOSP, V26, P1394, DOI [10.3305/nh.2011.26.6.5305, 10.1590/S0212-16112011000600029]; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Gomez-Abellan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050435; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Hamada T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11705; Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001; Juda M, 2013, J BIOL RHYTHM, V28, P130, DOI 10.1177/0748730412475041; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Maronde E, 2003, CHRONOBIOL INT, V20, P671, DOI 10.1081/CBI-120022413; Moore SR, 2014, DIS MODEL MECH, V7, P1123, DOI 10.1242/dmm.014399; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; PITTENDRIGH CS, 1974, SCIENCE, V186, P548, DOI 10.1126/science.186.4163.548; Pulimeno P, 2013, DIABETOLOGIA, V56, P497, DOI 10.1007/s00125-012-2779-7; Ramanathan C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004244; RENFREW JW, 1987, PHYSIOL BEHAV, V41, P627, DOI 10.1016/0031-9384(87)90321-0; ROSENBERG RS, 1991, AM J PHYSIOL, V261, pR491, DOI 10.1152/ajpregu.1991.261.2.R491; Schmidt Christina, 2012, Front Neurol, V3, P118, DOI 10.3389/fneur.2012.00118; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; Weinert D, 2001, CHRONOBIOL INT, V18, P921, DOI 10.1081/CBI-100107968; WITTING W, 1994, CHRONOBIOL INT, V11, P103, DOI 10.3109/07420529409055896; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yoshino J, 2013, DIABETES, V62, P2175, DOI 10.2337/db13-0457	31	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					175	180		10.1096/fj.201800441R	http://dx.doi.org/10.1096/fj.201800441R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29965796	Green Published			2022-12-28	WOS:000457401500014
J	Wang, C; Fung, G; Deng, HY; Jagdeo, J; Mohamud, Y; Xue, YC; Jan, E; Hirota, JA; Luo, HL				Wang, Chen; Fung, Gabriel; Deng, Haoyu; Jagdeo, Julienne; Mohamud, Yasir; Xue, Yuan Chao; Jan, Eric; Hirota, Jeremy A.; Luo, Honglin			NLRP3 deficiency exacerbates enterovirus infection in mice	FASEB JOURNAL			English	Article						inflammasome; coxsackievirus; innate immune response; RIP1; RIP3	NONCANONICAL INFLAMMASOME ACTIVATION; COXSACKIEVIRUS B3 INFECTION; PROTEIN; CLEAVAGE; MAVS; INTERLEUKIN-18; INNATE	The role for the NOD-like receptor (NLR) P3 inflammasome in enterovirus infection remains controversial. Available data suggest that the NLRP3 inflammasome is protective against enterovirus A71 but detrimental to the host during coxsackievirus B3 (CVB3) infection. CVB3 is a common etiologic agent associated with myocarditis and pancreatitis. Previous findings on the role of NLRP3 in CVB3 were based primarily on indirect evidence. Here, we utilized NLRP3 knockout mice as well as immune and cardiac cells to investigate the direct interplay between CVB3 infection and NLRP3 activation. We demonstrated that NLRP3 knockout mice exhibited more severe disease phenotype after CVB3 infection (significantly higher virus titers), increased myocardial, and pancreatic damage, as well as markedly impaired cardiac function compared to nontransgenic control mice. We further showed that NLRP3 activity was enhanced during early stage of CVB3 infection, as evidenced by increased gene expression and/or secretion of IL-1 and caspase-1. Finally, we demonstrated that CVB3 inactivates the NLRP3 inflammasome by degrading NLRP3 and its upstream serine/threonine-protein kinase receptor-interacting protein 1/3 via the proteolytic activity of virus-encoded proteinases. Taken together, our results reveal the functional significance of NLRP3 in host antiviral immunity against CVB3 infection and the mechanisms by which CVB3 has evolved to counteract the host defense response.Wang, C., Fung, G., Deng, H., Jagdeo, J., Mohamud, Y., Xue, Y. C., Jan, E., Hirota, J. A., Luo, H. NLRP3 deficiency exacerbates enterovirus infection in mice.	[Wang, Chen; Fung, Gabriel; Deng, Haoyu; Mohamud, Yasir; Xue, Yuan Chao; Luo, Honglin] Univ British Columbia, St Pauls Hosp, Dept Pathol & Lab Med, James Hogg Res Ctr,Providence Heart & Lung Inst, Vancouver, BC, Canada; [Jagdeo, Julienne; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Wang, Chen] China Acad Chinese Med Sci, Inst Basic Theory Tradit Chinese Med, Beijing, Peoples R China; [Deng, Haoyu] Shanghai Jiao Tong Univ, RenJi Hosp, Dept Vasc Surg, Sch Med, Shanghai, Peoples R China; [Hirota, Jeremy A.] McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; China Academy of Chinese Medical Sciences; Institute of Basic Theory for Chinese Medicine, CACMS; Shanghai Jiao Tong University; McMaster University	Luo, HL (corresponding author), Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	honglin.luo@hli.ubc.ca		Mohamud, Yasir/0000-0002-3950-2070	Heart & Stroke Foundation of Canada [G-16-00013800, G18-0022051]; Natural Sciences and Engineering Research Council [RGPIN-2016-03811]	Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank J. Wang (Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China) for the generous gift of the Flag-NLRP3 plasmid, and L. Bohunek (James Hogg Research Center Animal Facility) for his assistance with the measurement of mouse heart function. The authors also thank Dr. William Claycomb for generously providing the HL-1 mouse atrial cardiomyocytes, and Dr. Carolyn Coyne (University of Pittsburgh, Pittsburgh, PA, USA) for providing the CVB3-3C<SUP>wt</SUP>, CVB3-3C<SUP>mut</SUP> (C147A), and GFP-RIP3 constructs. This work was supported by the Heart & Stroke Foundation of Canada (G-16-00013800 and G18-0022051 to H.L.) and the Natural Sciences and Engineering Research Council (RGPIN-2016-03811 to H.L.). The authors declare no conflicts of interest.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Belmonte SL, 2013, AM J PHYSIOL-HEART C, V305, pH875, DOI 10.1152/ajpheart.00342.2013; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; Deng HY, 2015, FASEB J, V29, P4523, DOI 10.1096/fj.15-274829; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Fung G, 2015, CELL DEATH DIFFER, V22, P2087, DOI 10.1038/cdd.2015.58; Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573; Gao G, 2008, AM J PHYSIOL-HEART C, V295, pH401, DOI 10.1152/ajpheart.00292.2008; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Haque S, 2016, AM J PATHOL, V186, P347, DOI 10.1016/j.ajpath.2015.10.002; Harris KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141383; Harris KG, 2015, CELL HOST MICROBE, V18, P221, DOI 10.1016/j.chom.2015.07.007; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Jagdeo JM, 2015, J VIROL, V89, P7064, DOI 10.1128/JVI.02977-14; Kanda T, 2000, J MOL CELL CARDIOL, V32, P2163, DOI 10.1006/jmcc.2000.1242; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kemball CC, 2010, FUTURE MICROBIOL, V5, P1329, DOI 10.2217/FMB.10.101; Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12; Lei X., J VIROL; Li Z, 2017, CYTOKINE, V96, P132, DOI 10.1016/j.cyto.2017.04.002; Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McRae S, 2016, J BIOL CHEM, V291, P3254, DOI 10.1074/jbc.M115.694059; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039; Ramsingh AI, 2008, CURR TOP MICROBIOL, V323, P241; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shrivastava S, 2013, J VIROL, V87, P12284, DOI 10.1128/JVI.01962-13; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tate MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27912; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tschope C., CIRC HEART FAIL; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Wang C, 2015, CELL MICROBIOL, V17, P1423, DOI 10.1111/cmi.12473; Wang HB, 2015, CELL REP, V12, P42, DOI 10.1016/j.celrep.2015.05.047; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang Y, 2014, AM J PHYSIOL-HEART C, V307, pH1438, DOI 10.1152/ajpheart.00441.2014; Wong J, 2012, CELL RES, V22, P360, DOI 10.1038/cr.2011.114; WOODRUFF JF, 1970, J INFECT DIS, V121, P164, DOI 10.1093/infdis/121.2.164; Yogarajah T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05589-2; Yu JY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01420	49	17	17	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					942	952		10.1096/fj.201800301RRR	http://dx.doi.org/10.1096/fj.201800301RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30080445	Bronze			2022-12-28	WOS:000457401500074
J	Liu, XJ; Wu, XY; Wang, H; Wang, SX; Kong, W; Zhang, L; Liu, G; Huang, W				Liu, Xue-Jing; Wu, Xiao-Yue; Wang, Huan; Wang, Su-Xia; Kong, Wei; Zhang, Ling; Liu, George; Huang, Wei			Renal injury in Seipin-deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue-kidney crosstalk	FASEB JOURNAL			English	Article						fatty acid oxidation; glucolipotoxicity; glycosuria; Glut2	FATTY-ACID OXIDATION; CONGENITAL GENERALIZED LIPODYSTROPHY; INSULIN-RESISTANCE; MOUSE MODEL; GLUCOSE-TOLERANCE; IMMUNE-RESPONSE; GLYCOSURIA; BSCL2/SEIPIN; NEPHROPATHY; ADIPONECTIN	Seipin deficiency is responsible for type 2 congenital generalized lipodystrophy with severe loss of adipose tissue (AT) and could lead to renal failure in humans. However, the effect of Seipin on renal function is poorly understood. Here we report that Seipin knockout (SKO) mice exhibited impaired renal function, enlarged glomerular and mesangial surface areas, renal depositions of lipid, and advanced glycation end products. Elevated glycosuria and increased electrolyte excretion were also detected. Relative renal gene expression in fatty acid oxidation and reabsorption pathways were impaired in SKO mice. Elevated glycosuria might be associated with reduced renal glucose transporter 2 levels. To improve renal function, AT transplantation or leptin administration alone was performed. Both treatments effectively ameliorated renal injury by improving all of the parameters that were measured in the kidney. The treatments also rescued insulin resistance and low plasma leptin levels in SKO mice. Our findings demonstrate for the first time that Seipin deficiency induces renal injury, which is closely related to glucolipotoxicity and impaired renal reabsorption in SKO mice, and is primarily caused by the loss of AT and especially the lack of leptin. AT transplantation and leptin administration are two effective treatments for renal injury in Seipin-deficient mice.Liu, X.-J., Wu, X.-Y., Wang, H., Wang, S.-X., Kong, W., Zhang, L., Liu, G., Huang, W. Renal injury in Seipin-deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue-kidney crosstalk.	[Liu, Xue-Jing; Wu, Xiao-Yue; Wang, Huan; Zhang, Ling; Liu, George; Huang, Wei] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China; [Liu, Xue-Jing; Wu, Xiao-Yue; Wang, Huan; Kong, Wei; Zhang, Ling; Liu, George; Huang, Wei] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; [Wang, Su-Xia] Peking Univ, Hosp 1, Dept Med, Renal Div, Beijing, Peoples R China; [Wang, Su-Xia] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Wang, Su-Xia] Peking Univ, Inst Nephrol, Sch Basic Med Sci, Beijing, Peoples R China; [Kong, Wei] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Huang, W (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China.; Huang, W (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China.	huangwei@bjmu.edu.cn		Liu, Xuejing/0000-0002-3931-0191	National Science Foundation of China [81470553, 81770448]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (81470553 and 81770448). The authors are grateful to Prof. H. Liu (Peking University) for assistance in describing the pathologic changes. The authors declare no conflicts of interest.	Antuna-Puente B, 2010, J CLIN ENDOCR METAB, V95, P1463, DOI 10.1210/jc.2009-1824; Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; Capeau J, 2010, ENDOCR DEV, V19, P1, DOI 10.1159/000316893; Chhabra KH, 2017, MOL METAB, V6, P1274, DOI 10.1016/j.molmet.2017.07.005; Chhabra KH, 2016, DIABETES, V65, P660, DOI 10.2337/db15-0804; Chong AY, 2010, DIABETOLOGIA, V53, P27, DOI 10.1007/s00125-009-1502-9; Colombo C, 2002, DIABETES, V51, P2727, DOI 10.2337/diabetes.51.9.2727; Cortes VA, 2014, J LIPID RES, V55, P276, DOI 10.1194/jlr.M045799; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Faria CA, 2009, EUROPACE, V11, P763, DOI 10.1093/europace/eup095; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Friedman JM, 2010, NAT MED, V16, P1100, DOI 10.1038/nm1010-1100; Garfield AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045790; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gomes KB, 2005, J INHERIT METAB DIS, V28, P1123, DOI 10.1007/s10545-005-0038-5; Goto K, 2016, INT IMMUNOL, V28, P197, DOI 10.1093/intimm/dxv067; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Huang W, 2001, P NATL ACAD SCI USA, V98, P13330, DOI 10.1073/pnas.231476798; Javor ED, 2004, J CLIN ENDOCR METAB, V89, P3199, DOI 10.1210/jc.2003-032140; Joubert M, 2017, DIABETES, V66, P1030, DOI 10.2337/db16-0733; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Liu L, 2014, DIABETES, V63, P2320, DOI 10.2337/db13-0729; Momken I, 2017, BIOCHEM J, V474, P149, DOI 10.1042/BCJ20160804; MOORHEAD JF, 1982, LANCET, V2, P1309; Musso C, 2006, CLIN J AM SOC NEPHRO, V1, P616, DOI 10.2215/CJN.01271005; Nasrallah MP, 2013, SEMIN NEPHROL, V33, P54, DOI 10.1016/j.semnephrol.2012.12.005; O'Neill HM, 2014, DIABETOLOGIA, V57, P1693, DOI 10.1007/s00125-014-3273-1; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Prie D, 2014, DIABETES METAB, V40, pS12, DOI 10.1016/S1262-3636(14)72690-4; Rahmouni K, 2003, J NEUROSCI, V23, P5998, DOI 10.1523/JNEUROSCI.23-14-05998.2003; Routh RE, 2002, KIDNEY INT, V61, P1365, DOI 10.1046/j.1523-1755.2002.00277.x; Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170; Scerbo D, 2017, J LIPID RES, V58, P1132, DOI 10.1194/jlr.M074427; Shi S, 2015, KIDNEY INT, V88, P479, DOI 10.1038/ki.2015.103; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Steinbrekera B, 2016, J ENDOCRINOL, V231, pR47, DOI 10.1530/JOE-16-0273; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Suganami T, 2004, FASEB J, V18, P127, DOI 10.1096/fj.04-2183fje; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Wang Y, 2017, METHODS MOL BIOL, V1614, P69, DOI 10.1007/978-1-4939-7030-8_6; Xu PF, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0054-x; Yang WL, 2014, HUM MOL GENET, V23, P502, DOI 10.1093/hmg/ddt444	49	15	15	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5550	5562		10.1096/fj.201701427R	http://dx.doi.org/10.1096/fj.201701427R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29738274				2022-12-28	WOS:000447972500029
J	Lu, QC; Shan, S; Li, YY; Zhu, DY; Jin, WJ; Ren, T				Lu, Qingchun; Shan, Shan; Li, Yanyan; Zhu, Dongyi; Jin, Wenjing; Ren, Tao			Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p	FASEB JOURNAL			English	Article						competing endogenous RNA; NSCLC; long noncoding RNAs; SNHG1	LNCRNA SNHG1; HEPATOCELLULAR-CARCINOMA; TARGETING METADHERIN; SIGNALING PATHWAY; PROSTATE-CANCER; BREAST-CANCER; METASTASIS; EXPRESSION; INVASION; PROLIFERATION	Long noncoding RNAs participate in the progression and initiation of non-small cell lung cancer (NSCLC), although the mechanism remains unknown. The lncRNA identified as small nucleolar RNA host gene 1 (SNHG1) is a novel lncRNA that is increased in multiple human cancers; however, the regulatory mechanism requires further investigation. In this study, we discovered that SNHG1 was markedly up-regulated in NSCLC tissues and cells and that SNHG1 silencing decreased tumor volumes. Moreover, we explored its regulatory mechanism and found that SNHG1 directly bound to microRNA (miRNA)-145-5p, isolating miR-145-5p from its target gene MTDH. Inhibition of SNHG1 suppressed NSCLC cell viability, proliferation, migration, and invasion in vitro, but its effect was rescued by miR-145-5p inhibition. These results demonstrate that SNHG1 contributes to NSCLC progression by modulating the miR-145-5p/MTDH axis, and it could potentially be a therapeutic target as well as a diagnostic marker.Lu, Q., Shan, S., Li, Y., Zhu, D., Jin, W., Ren, T. Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDHvia sponging miR-145-5p.	[Lu, Qingchun; Zhu, Dongyi] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Resp Med, Shanghai, Peoples R China; [Shan, Shan; Ren, Tao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Resp Med, Shanghai, Peoples R China; [Li, Yanyan] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China; [Jin, Wenjing] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Jin, Wenjing] Fudan Univ, Pudong Med Ctr, Shanghai Pudong Hosp, Intens Care Unit, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University; Fudan University; Fudan University; Fudan University	Ren, T (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Resp Med, Xuhui Area, 600 Yishan Rd, Shanghai 200233, Peoples R China.	rentaosh@126.com	Lu, Qingchun/K-8250-2019		National Natural Science Foundation of China [81673014, 81372347, 81602075]; Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee [16XD1403100]; National Key Research and Development Plan [2017YFA0104600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee; National Key Research and Development Plan	This work was supported by the National Natural Science Foundation of China (Grants 81673014, 81372347, and 81602075), the Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee (Grant 16XD1403100), and the National Key Research and Development Plan (Grant 2017YFA0104600). The authors declare no conflicts of interest.	Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cui Y, 2017, ONCOTARGET, V8, P17785, DOI 10.18632/oncotarget.14854; Dong RF, 2014, ONCOTARGET, V5, P10816, DOI 10.18632/oncotarget.2522; Du Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10982; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Emdad L, 2016, ADV CANCER RES, V131, P97, DOI 10.1016/bs.acr.2016.05.002; Hou JP, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00193; Hu HB, 2016, LUNG CANCER, V97, P87, DOI 10.1016/j.lungcan.2016.04.017; Jen JY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0674-z; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kartha RV, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00008; Li J, 2017, HORMONE METABOLISM AND SIGNALING IN PLANTS, P1; Liang YJ, 2015, CANCER RES, V75, P3672, DOI 10.1158/0008-5472.CAN-15-0930; Ma MZ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.541; Mataki H, 2016, ONCOTARGET, V7, P72084, DOI 10.18632/oncotarget.12290; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Shen Y, 2017, EMBO REP, V18, P536, DOI 10.15252/embr.201643139; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Subramanian M, 2015, METHODS MOL BIOL, V1206, P29, DOI 10.1007/978-1-4939-1369-5_3; Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036; Sun SJ, 2017, EUR REV MED PHARMACO, V21, P504; Wang MZ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0344-6; Wang Q, 2017, BIOMED PHARMACOTHER, V91, P906, DOI 10.1016/j.biopha.2017.05.014; Wang YH, 2015, CANCER BIOL THER, V16, P1308, DOI 10.1080/15384047.2015.1056413; Wu T, 2015, J CANCER RES THER, V11, pC7, DOI 10.4103/0973-1482.163831; Xie Y, 2016, EXCLI J, V15, P745, DOI 10.17179/excli2016-694; Yan Y, 2017, ONCOTARGET, V8, P35750, DOI 10.18632/oncotarget.16189; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; You J, 2014, INDIAN J CANCER, V51, P99, DOI 10.4103/0019-509X.154092; Yu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129190; Yu J, 2016, ONCOTARGET, V7, P38612, DOI 10.18632/oncotarget.9572; Zhang HY, 2017, BIOMED PHARMACOTHER, V90, P650, DOI 10.1016/j.biopha.2017.03.104; Zhang M, 2017, ONCOL REP, V37, P1772, DOI 10.3892/or.2017.5401; Zhang X, 2017, ONCOTARGET, V8, P51058, DOI 10.18632/oncotarget.16918; Zhu GC, 2017, ONCOL REP, V38, P2893, DOI 10.3892/or.2017.5949	38	112	116	0	50	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3957	3967		10.1096/fj.201701237RR	http://dx.doi.org/10.1096/fj.201701237RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29466052	Bronze			2022-12-28	WOS:000435104500040
J	Zhang, XP; Li, KR; Yu, Q; Yao, MD; Ge, HM; Li, XM; Jiang, Q; Yao, J; Cao, C				Zhang, Xiao-Pei; Li, Ke-Ran; Yu, Qing; Yao, Mu-Di; Ge, Hui-Min; Li, Xiu-Miao; Jiang, Qin; Yao, Jin; Cao, Cong			Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization	FASEB JOURNAL			English	Article						VEGF; Gab1; inflammation; traditional Chinese medicine	NF-KAPPA-B; LONG NONCODING RNAS; ACTIVATION; EXPRESSION; VEGF; GAB1; CELLS; PROLIFERATION; ANGIOGENESIS; MIGRATION	VEGF-induced neovascularization plays a pivotal role in corneal neovascularization (CoNV). The current study investigated the potential effect of ginsenoside Rh2 (GRh2) on neovascularization. In HUVECs, pretreatment with GRh2 largely attenuated VEGF-induced cell proliferation, migration, and vessel-like tube formation in vitro. At the molecular level, GRh2 disrupted VEGF-induced VEGF receptor 2 (VEGFR2)-Grb-2-associated binder 1 (Gab1) association in HUVECs, causing inactivation of downstream AKT and ERK signaling. Gab1 knockdown (by targeted short hairpin RNA) similarly inhibited HUVEC proliferation and migration. Notably, GRh2 was ineffective against VEGF in Gab1-silenced HUVECs. In a mouse cornea alkali burn model, GRh2 eyedrops inhibited alkali-induced neovascularization and inflammatory cell infiltrations in the cornea. Furthermore, alkali-induced corneal expression of mRNAs/long noncoding RNAs in cornea were largely attenuated by GRh2. Overall, GRh2 inhibits VEGF-induced angiogenic effect via inhibiting VEGFR2-Gab1 signaling in vitro. It also alleviates angiogenic and inflammatory responses in alkali burn-treated mouse corneas.Zhang, X.-P., Li, K.-R., Yu, Q., Yao, M.-D., Ge, H.-M., Li, X.-M., Jiang, Q., Yao, J., Cao, C. Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization.	[Zhang, Xiao-Pei; Li, Ke-Ran; Yu, Qing; Yao, Mu-Di; Ge, Hui-Min; Li, Xiu-Miao; Jiang, Qin; Yao, Jin; Cao, Cong] Nanjing Med Univ, Affiliated Eye Hosp, Sch Clin Med 4, Nanjing, Jiangsu, Peoples R China; [Cao, Cong] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis Res, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Cao, Cong] Soochow Univ, Inst Neurosci, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Cao, Cong] Municipal Hosp Suzhou, Suzhou, Peoples R China	Nanjing Medical University; Soochow University - China; Soochow University - China	Cao, C (corresponding author), Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis Res, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Cao, C (corresponding author), Soochow Univ, Inst Neurosci, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Jiang, Q (corresponding author), Nanjing Med Univ, Affiliated Eye Hosp, 138 Han Zhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	jqin710@vip.sina.com; caocong@suda.edu.cn			National Natural Science Foundation of China [81302195, 31371139, 81571282, 81771457, 81700859, 81371055, 81570859, 81670878]; Medical Science and Technology Development Project Fund of Nanjing [YKK16271, YKK15241, YKK16270]; Jiangsu Province Six-Talent Peaks; Natural Science Foundation [BK2016022104, BK20170060, BK20171065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Development Project Fund of Nanjing; Jiangsu Province Six-Talent Peaks; Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was generously supported by the National Natural Science Foundation of China (Grants 81302195, 31371139, 81571282, 81771457, 81700859, 81371055, 81570859, 81670878), the Medical Science and Technology Development Project Fund of Nanjing (Grants YKK16271, YKK15241, YKK16270), grants from Jiangsu Province Six-Talent Peaks (to C.C.) and Natural Science Foundation (BK2016022104, BK20170060, BK20171065). The authors declare no conflicts of interest.	Abdelfattah NS, 2015, INT J OPHTHALMOL-CHI, V8, P182, DOI 10.3980/j.issn.2222-3959.2015.01.32; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Bi WY, 2012, INFLAMMATION, V35, P1659, DOI 10.1007/s10753-012-9482-1; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Choi K, 2007, NEUROSCI LETT, V421, P37, DOI 10.1016/j.neulet.2007.05.017; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.10; Ferrari G, 2015, EYE CONTACT LENS, V41, P72, DOI 10.1097/ICL.0000000000000071; Gong YQ, 2016, ONCOTARGET, V7, P60123, DOI 10.18632/oncotarget.11164; Guo XX, 2014, PROTEIN CELL, V5, P224, DOI 10.1007/s13238-014-0027-2; He L, 2012, BONE, V50, P1207, DOI 10.1016/j.bone.2012.03.022; Huang J, 2015, CORNEA, V34, P580, DOI 10.1097/ICO.0000000000000389; Huang JJ, 2016, ACTA BIOCH BIOPH SIN, V48, P750, DOI 10.1093/abbs/gmw049; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Li KR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25525; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Lian LH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/646728; Lu Y, 2011, P NATL ACAD SCI USA, V108, P2957, DOI 10.1073/pnas.1009395108; Lv Y, 2017, ONCOTARGET, V8, P52699, DOI 10.18632/oncotarget.17084; Nakata H, 1998, JPN J CANCER RES, V89, P733, DOI 10.1111/j.1349-7006.1998.tb03278.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park EK, 2004, BIOL PHARM BULL, V27, P433, DOI 10.1248/bpb.27.433; Park EK, 2003, BIOL PHARM BULL, V26, P1581, DOI 10.1248/bpb.26.1581; Park JA, 1997, CANCER LETT, V121, P73, DOI 10.1016/S0304-3835(97)00333-9; Poon MW, 2015, INVEST OPHTH VIS SCI, V56, P711, DOI 10.1167/iovs.14-15268; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Shakiba Y, 2009, RECENT PATENTS INFLA, V3, P221, DOI 10.2174/187221309789257450; Wang M, 2017, ONCOL LETT, V13, P681, DOI 10.3892/ol.2016.5490; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Wu CH, 2012, NANO LETT, V12, P5475, DOI 10.1021/nl301865c; Yan B, 2014, INVEST OPHTH VIS SCI, V55, P941, DOI 10.1167/iovs.13-13221; Yang ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19383; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhang Y, 2015, INT REV SPAT PLAN SU, V3, P1, DOI 10.14246/irspsd.3.2_1	42	18	19	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3782	3791		10.1096/fj.201701074RR	http://dx.doi.org/10.1096/fj.201701074RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465315				2022-12-28	WOS:000435104500025
J	Gu, YT; Cai, RP; Zhang, C; Xue, YX; Pan, YL; Wang, JH; Zhang, Z				Gu, Yanting; Cai, Ruiping; Zhang, Cai; Xue, Yixue; Pan, Yali; Wang, Jiahong; Zhang, Zhou			miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway	FASEB JOURNAL			English	Article						BTB; caveolin-1; permeability; miRNA	BARRIER PERMEABILITY; CEREBRAL-ISCHEMIA; UP-REGULATION; BRAIN; MICRORNA-132; PHOSPHORYLATION; EXPRESSION; SRC; PROLIFERATION; POLARIZATION	Blood-brain tumor barrier (BTB) impedes the transportation of antitumor therapeutic drugs into brain tumors. Its mechanism is still unknown, but learning how to improve the BTB permeability is critical for drug intervention. Recently, microRNAs (miRNAs) have appeared as regulation factors of numerous biologic processes and therapeutic targets of diverse diseases. In this study, we have identified that miR-132-3p is an essential miRNA by increasing the transcellular transport through the BTB. We found that miR-132-3p expression was significantly up-regulated in glioma endothelial cells (GECs). Furthermore we showed that miR132-3p(+) greatly induced the endocytosis of cholera toxin subunit B and FITC-bovine serum albumin and up-regulated the expression of p-PKB, p-Src and Tyr14 phosphorylation of caveolin-1 (p-Cav-1), while phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression was markedly down-regulated in GECs. Our results identify PTEN as a direct and functional downstream target of miR-132-3p, which is involved in the regulation of p-PKB, p-Src, and p-Cav-1. The inhibitors for PI3K and Src significantly reversed the increase of p-Cav-1 induced by miR-132-3p. Moreover, overexpression of PTEN greatly reduced the endocytosis of cholera toxin subunit B and the up-regulation of p-Cav-1 induced by agomiR132-3p, suggesting that miR132-3p(+) increases the endothelial permeability by inhibition of PTEN expression. In addition, miR132-3p(+) significantly increased the delivery of doxorubicin across the BTB in vitro and contributed to the accumulation of doxorubicin within the brain tumor tissue. Our results show that miR-132-3p contributes to the increased permeability of BTB by targeting PTEN/PI3K/PKB/Src/Cav-1, thereby revealing a novel drug target for the treatment of brain gliomas.Gu, Y., Cai, R., Zhang, C., Xue, Y., Pan, Y., Wang, J., Zhang, Z. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.	[Gu, Yanting; Cai, Ruiping; Zhang, Cai; Pan, Yali; Wang, Jiahong; Zhang, Zhou] Shenyang Pharmaceut Univ, Life Sci & Biopharmaceut Inst, Dept Physiol, Shenyang 110016, Liaoning, Peoples R China; [Xue, Yixue] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning, Peoples R China	Shenyang Pharmaceutical University; China Medical University	Zhang, Z (corresponding author), Shenyang Pharmaceut Univ, Life Sci & Biopharmaceut Inst, Dept Physiol, Shenyang 110016, Liaoning, Peoples R China.	zzhouzhang@163.com			National Science Foundation for China [81201989, 81773289]; Special and Scientific Research Foundation of Shenyang Pharmaceutical University for Middle and Young Teachers' Career Development [ZCJJ2014407]; National Science Foundation for Liaoning Province [2015020564]; Innovative Entrepreneurship Training Plan of Shenyang Pharmaceutical University	National Science Foundation for China; Special and Scientific Research Foundation of Shenyang Pharmaceutical University for Middle and Young Teachers' Career Development; National Science Foundation for Liaoning Province; Innovative Entrepreneurship Training Plan of Shenyang Pharmaceutical University	The authors thank Dr. P.-O. Couraud (Institute Cochin, Paris, France) for providing the hCMECs. This work was supported by National Science Foundation for China (Grants 81201989 and 81773289), Special and Scientific Research Foundation of Shenyang Pharmaceutical University for Middle and Young Teachers' Career Development (Grant ZCJJ2014407), National Science Foundation for Liaoning Province (Grant 2015020564), and the Innovative Entrepreneurship Training Plan of Shenyang Pharmaceutical University. The authors declare no conflicts of interest.	Akers JC, 2017, ONCOTARGET, V8, P68769, DOI 10.18632/oncotarget.18332; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Belhadj Z, 2017, ONCOTARGET, V8, P66889, DOI 10.18632/oncotarget.17976; Biemans EALM, 2017, J NEUROSCI RES, V95, P1513, DOI 10.1002/jnr.23964; Chen S, 2016, BIOMED PHARMACOTHER, V83, P898, DOI 10.1016/j.biopha.2016.08.004; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Devalliere J, 2014, FASEB J, V28, P908, DOI 10.1096/fj.13-238527; Gao FY, 2015, MOL MED REP, V12, P7005, DOI 10.3892/mmr.2015.4253; Geng F, 2016, J NEURO-ONCOL, V129, P211, DOI 10.1007/s11060-016-2173-2; Gross S, 2017, J CEREBR BLOOD F MET, V37, P2471, DOI 10.1177/0271678X16669365; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; HE J, 2017, BIOMED RES INT, V2017, DOI DOI 10.1155/2017/3681707; Kilic U, 2017, REDOX BIOL, V12, P657, DOI 10.1016/j.redox.2017.04.006; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20486; Li JY, 2017, ACTA PHARMACOL SIN, V38, P182, DOI 10.1038/aps.2016.109; Li YJ, 2016, BIOMED PHARMACOTHER, V78, P177, DOI 10.1016/j.biopha.2016.01.022; Liao YW, 2017, J CELL BIOCHEM, V118, P1889, DOI 10.1002/jcb.25910; Liu F, 2015, EXP LUNG RES, V41, P261, DOI 10.3109/01902148.2015.1004206; Liu Q, 2014, TUMOR BIOL, V35, P12299, DOI 10.1007/s13277-014-2541-5; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Ma J, 2014, J CEREBR BLOOD F MET, V34, P1826, DOI 10.1038/jcbfm.2014.152; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Pan LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099526; Poirier C, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0856-5; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rathor N, 2014, AM J PHYSIOL-GASTR L, V306, pG650, DOI 10.1152/ajpgi.00003.2014; Shang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32180; Shao Y, 2016, ONCOTARGET, V7, P34011, DOI [10.18632/oncotarget.8514, 10.18632/oncotarget.12708]; Srinivasan VM, 2017, NEUROTHERAPEUTICS, V14, P345, DOI 10.1007/s13311-017-0522-2; Wang HZ, 2015, ONCOTARGETS THER, V8, P3211, DOI 10.2147/OTT.S79282; Wang Y, 2018, FASEB J, V32, P935, DOI 10.1096/fj.201700139RRR; Watson LJ, 2016, CELL SIGNAL, V28, P1580, DOI 10.1016/j.cellsig.2016.05.006; Wu F, 2017, ONCOTARGET, V8, P53110, DOI 10.18632/oncotarget.18162; Wu H, 2015, NEUROBIOL AGING, V36, P1439, DOI 10.1016/j.neurobiolaging.2014.12.029; Yang F, 2016, MED SCI MONITOR, V22, P3562, DOI 10.12659/MSM.897773; Zhang LW, 2014, CARDIOVASC DRUG THER, V28, P303, DOI 10.1007/s10557-014-6533-x; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhao Y, 2018, BIOFACTORS, V44, P609, DOI 10.1002/biof.1411; Zhou YF, 2018, FASEB J, V32, P2181, DOI 10.1096/fj.201700786RR	41	26	28	4	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					441	454		10.1096/fj.201800095RR	http://dx.doi.org/10.1096/fj.201800095RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024792	Bronze			2022-12-28	WOS:000457401500035
J	Jeon, HY; Lee, YJ; Kim, YS; Kim, SY; Han, ET; Park, WS; Hong, SH; Kim, YM; Ha, KS				Jeon, Hye-Yoon; Lee, Yeon-Ju; Kim, You-Sun; Kim, Soo-Youl; Han, Eun-Taek; Park, Won Sun; Hong, Seok-Ho; Kim, Young-Myeong; Ha, Kwon-Soo			Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice	FASEB JOURNAL			English	Article						transglutaminase 2; VEGF; adherens junction	TISSUE TRANSGLUTAMINASE; MESENCHYMAL TRANSITION; ENDOTHELIAL APOPTOSIS; PERMEABILITY; REPLACEMENT; ACTIVATION; THERAPY	C-peptide has a beneficial effect against diabetic complications, but its role in hyperglycemia-induced metastasis is unknown. We investigated hyperglycemia-mediated pulmonary vascular leakage and metastasis and C-peptide inhibition of these molecular events using human pulmonary microvascular endothelial cells (HPMVECs) and streptozotocin-induced diabetic mice. VEGF, which is elevated in the lungs of diabetic mice, activated transglutaminase 2 (TGase2) in HPMVECs by sequential elevation of intracellular Ca2+ and reactive oxygen species (ROS) levels. VEGF also induced vascular endothelial (VE)-cadherin disruption and increased the permeability of endothelial cells, both of which were prevented by the TGase inhibitors monodansylcadaverine and cystamine or TGM2-specific small interfering RNA. C-peptide prevented VEGF-induced VE-cadherin disruption and endothelial cell permeability through inhibiting ROS-mediated activation of TGase2. C-peptide supplementation inhibited hyperglycemia-induced ROS generation and TGase2 activation and prevented vascular leakage and metastasis in the lungs of diabetic mice. The role of TGase2 in hyperglycemia-induced pulmonary vascular leakage and metastasis was further demonstrated in diabetic Tgm2(-/-) mice. These findings demonstrate that hyperglycemia induces metastasis, and C-peptide prevents the hyperglycemia-induced metastasis in the lungs of diabetic mice by inhibiting VEGF-induced TGase2 activation and subsequent vascular leakage.Jeon, H.-Y., Lee, Y.-J., Kim, Y.-S., Kim, S.-Y., Han, E.-T., Park, W. S., Hong, S.-H., Kim, Y.-M., Ha, K.-S. Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice.	[Jeon, Hye-Yoon; Lee, Yeon-Ju; Kim, Young-Myeong; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea; [Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, South Korea; [Park, Won Sun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea; [Hong, Seok-Ho] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea; [Kim, You-Sun] Ajou Univ, Sch Med, Dept Biochem, Suwon, South Korea; [Kim, Soo-Youl] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Goyang, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Ajou University; National Cancer Center - Korea (NCC)	Ha, KS (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea.	ksha@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea [2015R1A4A1038666, 2016R1A2A1A05004975]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea grants 2015R1A4A1038666 and 2016R1A2A1A05004975 (to K.-S.H.). The authors declare no conflicts of interest.	Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Ayinde O, 2017, ONCOTARGET, V8, P20025, DOI 10.18632/oncotarget.15370; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bhatt MP, 2016, J ENDOCRINOL, V231, P97, DOI 10.1530/JOE-16-0349; Bhatt MP, 2014, CARDIOVASC RES, V104, P234, DOI 10.1093/cvr/cvu211; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Di Giacomo G, 2009, AMINO ACIDS, V36, P717, DOI 10.1007/s00726-008-0119-5; Di Sabatino A, 2012, AUTOIMMUN REV, V11, P746, DOI 10.1016/j.autrev.2012.01.007; Hanbali A, 2007, ARCH INTERN MED, V167, P513, DOI 10.1001/archinte.167.5.513-a; Hills CE, 2010, AM J NEPHROL, V31, P389, DOI 10.1159/000289864; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Kronig M, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1117-4; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lee K, 2013, J BIOTECHNOL, V168, P324, DOI 10.1016/j.jbiotec.2013.10.007; Lee YJ, 2017, J ENDOCRINOL, V235, P39, DOI 10.1530/JOE-17-0109; Lee YJ, 2016, DIABETES, V65, P2414, DOI 10.2337/db15-1594; Li W, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5190314; Lim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145004; Lim YC, 2015, J INVEST DERMATOL, V135, P269, DOI 10.1038/jid.2014.285; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Meadows KL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006577; Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ozer Kutan, 2016, Asian Pac J Cancer Prev, V17, P105; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Park MK, 2013, EUR J CANCER, V49, P1692, DOI 10.1016/j.ejca.2012.11.036; Phoomak C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43842; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; Sane DC, 2007, FRONT BIOSCI-LANDMRK, V12, P2530, DOI 10.2741/2253; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Takatani-Nakase T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090136; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Vasconcelos-dos-Santos A, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.2; Wahren J, 2016, DIABETES CARE, V39, P596, DOI 10.2337/dc15-2068; Wahren J, 2012, DIABETES, V61, P761, DOI 10.2337/db11-1423; Wu FTH, 2015, EMBO MOL MED, V7, P770, DOI 10.15252/emmm.201404193; Ye WL, 2016, DEV CELL, V37, P114, DOI 10.1016/j.devcel.2016.03.015	41	15	15	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					750	762		10.1096/fj.201800723R	http://dx.doi.org/10.1096/fj.201800723R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020832				2022-12-28	WOS:000457401500058
J	Pomar, CA; Kuda, O; Kopecky, J; Rombaldova, M; Castro, H; Pico, C; Sanchez, J; Palou, A				Pomar, Catalina A.; Kuda, Ondrej; Kopecky, Jan; Rombaldova, Martina; Castro, Heriberto; Pico, Catalina; Sanchez, Juana; Palou, Andreu			Alterations in plasma acylcarnitine and amino acid profiles may indicate poor nutrition during the suckling period due to maternal intake of an unbalanced diet and may predict later metabolic dysfunction	FASEB JOURNAL			English	Article						perinatal nutrition; early biomarkers; cafeteria diet; postcafeteria	FATTY-ACID; INSULIN-RESISTANCE; LIPID MEDIATORS; CAFETERIA DIET; OBESITY; MECHANISMS; CARNITINE; RISK; CONSUMPTION; LACTATION	Plasma profiles of acylcarnitines (ACs) and amino acids (AAs) may have interest as potential biomarkers. Here we analyzed plasma AC and AA profiles in 2 rat models with different metabolic programming outcomes: offspring of dams fed a cafeteria diet during lactation (O-CAF, with a thin-outside-fat-inside phenotype) and the offspring of dams with diet-induced obesity subjected to dietary normalization before gestation [offspring of postcafeteria dams (O-PCaf), nonaltered phenotype]. The purpose was to identify early variables that might indicate a propensity for a dysmetabolic state. O-CAF rats presented higher circulating levels of most of the lipid-derived ACs and higher hepatic expression of genes related to fatty acid oxidation (Ppara and Cpt1a) than controls [offspring of control dams (O-C)]. They also exhibited an altered plasma AA profile. These differences were not observed in O-PCaf animals. A partial least squares-discriminant analysis score plot of the metabolomics data showed a clear separation between O-CAF and O-C animals. The long-chain ACs (C18, C18:1, C18:2, C16:1, and C16DC) and the AAs glycine, alanine, isoleucine, serine, and proline are the variables mainly influencing this separation. In summary, we have identified a cluster of ACs and AAs whose alterations may indicate poor nutrition during lactation due to maternal unbalanced diet intake and predict the later dysmetabolic phenotype observed in the offspring.Pomar, C. A., Kuda, O., Kopecky, J., Rombaldova, M., Castro, H., Pico, C., Sanchez, J., Palou, A. Alterations in plasma acylcarnitine and amino acid profiles may indicate poor nutrition during the suckling period due to maternal intake of an unbalanced diet and may predict later metabolic dysfunction.	[Pomar, Catalina A.; Castro, Heriberto; Pico, Catalina; Sanchez, Juana; Palou, Andreu] Lab Mol Biol Nutr & Biotechnol Nutrigen & Obes, Palma De Mallorca, Spain; [Pomar, Catalina A.; Pico, Catalina; Sanchez, Juana; Palou, Andreu] Univ Balearic Isl, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Palma De Mallorca, Spain; [Kuda, Ondrej; Kopecky, Jan; Rombaldova, Martina] Czech Acad Sci, Inst Physiol, Dept Adipose Tissue Biol, Prague, Czech Republic; [Castro, Heriberto] Univ Autonoma Nuevo Leon, Fac Salud Publ & Nutr, Nuevo Leon, Mexico; [Pico, Catalina; Sanchez, Juana; Palou, Andreu] Inst Invest Sanitaria Illes Balears, Palma De Mallorca, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de les Illes Balears; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Universidad Autonoma de Nuevo Leon; Institut Investigacio Sanitaria Illes Balears (IdISBa)	Sanchez, J (corresponding author), Univ Illes Balears, Lab Biol Mol Nutr & Biotecnol Nutrigen, Edif Mateu Orfila,Carretera Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.	joana.sanchez@uib.es	Pico, Catalina/H-7115-2015; Kopecky, Jan/B-8244-2012; Pomar, Catalina Amadora/AAF-1411-2021; Kuda, Ondrej/B-7990-2012; Sanchez, Juana/K-9675-2014; Castro García, Heriberto/GMW-8564-2022; Palou, Andreu/K-9881-2014	Pico, Catalina/0000-0001-6759-5844; Kopecky, Jan/0000-0001-8072-2035; Pomar, Catalina Amadora/0000-0002-8113-761X; Kuda, Ondrej/0000-0001-7034-4536; Sanchez, Juana/0000-0002-9176-8060; Castro García, Heriberto/0000-0003-4186-9004; Palou, Andreu/0000-0002-0295-4452	Ministerio de Economia y Empresa/Fondos Europeos de Desarrollo Regional; European Union (MINECO/FEDER; EU) [AGL2012-33692, AGL2015-67019-P]; Czech Science Foundation [GB14-36804G]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion (CIBEROBN); EU [FP6506360]	Ministerio de Economia y Empresa/Fondos Europeos de Desarrollo Regional; European Union (MINECO/FEDER; EU); Czech Science Foundation(Grant Agency of the Czech Republic); Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion (CIBEROBN); EU(European Commission)	This research was supported by the Ministerio de Economia y Empresa/Fondos Europeos de Desarrollo Regional; European Union (MINECO/FEDER; EU) Grants AGL2012-33692 and AGL2015-67019-P, and by Czech Science Foundation Grant GB14-36804G. The research group Nutrigenomics and Obesity (NUO) receives financial support from Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), and is a member of the European Research Network of Excellence European Nutrigenomics Organization (NuGO; EU Contract FP6506360). The authors declare no conflicts of interest.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Baker PR, 2015, OBESITY, V23, P981, DOI 10.1002/oby.21046; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Castro H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600513; Costa CCG, 1999, PEDIATR RES, V46, P440, DOI 10.1203/00006450-199910000-00013; Fraser M, 2016, ENDOCRINE, V53, P839, DOI 10.1007/s12020-016-0918-5; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; HOPPEL CL, 1980, AM J PHYSIOL, V238, pE409, DOI 10.1152/ajpendo.1980.238.5.E409; Horakova O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155776; Horakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kien CL, 2011, OBESITY, V19, P305, DOI 10.1038/oby.2010.135; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Muoio D.M., 2007, NOVART FDN SYMP, V286, P24; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Palou M, 2012, J NUTR BIOCHEM, V23, P1627, DOI 10.1016/j.jnutbio.2011.11.005; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Pico C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00436; Pomar CA, 2017, INT J OBESITY, V41, P1279, DOI 10.1038/ijo.2017.42; Popkin BM, 2006, OBES REV, V7, P271, DOI 10.1111/j.1467-789X.2006.00230.x; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Reynolds CM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00245; Rombaldova M, 2017, BIOCHEM BIOPH RES CO, V490, P1080, DOI 10.1016/j.bbrc.2017.06.170; Schooneman MG, 2014, BBA-MOL CELL BIOL L, V1841, P987, DOI 10.1016/j.bbalip.2014.04.001; Soeters MR, 2009, CLIN SCI, V116, P585, DOI 10.1042/CS20080433; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Vickers MH, 2007, CURR DRUG TARGETS, V8, P923; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wright TM, 2011, INT J DEV NEUROSCI, V29, P785, DOI 10.1016/j.ijdevneu.2011.09.007; Wurtz P, 2012, DIABETES CARE, V35, P1749, DOI 10.2337/dc11-1838; Yamakado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11918; Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011; Zhao X, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8160545	44	4	4	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					796	807		10.1096/fj.201800327RR	http://dx.doi.org/10.1096/fj.201800327RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30080446	Bronze			2022-12-28	WOS:000457401500062
J	Wang, LJ; Lo, HF; Lin, CF; Ng, PS; Wu, YH; Lee, YS; Cheong, ML; Chen, HW				Wang, Liang-Jie; Lo, Hsiao-Fan; Lin, Cheng-Fu; Ng, Pui-Sze; Wu, Yi-Hung; Lee, Yun-Shien; Cheong, Mei-Leng; Chen, Hungwen			SFRP3 negatively regulates placental extravillous trophoblast cell migration mediated by the GCM1-WNT10B-FZD7 axis	FASEB JOURNAL			English	Article						trophoblast-decidual cell interaction; pregnancy; gene expression; cytoskeletal remodeling	CATENIN SIGNALING PATHWAY; PROTEIN; ACTIVATION; BMP2; WNT4; GCMA	Migration of placental extravillous trophoblast (EVT) cells into uterine decidua facilitates the establishment of blood circulation between mother and fetus and is modulated by EVT-decidual cell interaction. Poor or excessive EVT migration is associated with pregnancy complications such as preeclampsia or placenta accreta. Glial cells missing 1 (GCM1) transcription factor is essential for placental development, and decreased GCM1 activity is detected in preeclampsia. To study whether GCM1 regulates trophoblast cell migration, here we showed that GCM1 promotes BeWo and JAR trophoblast cell migration through a novel target gene, WNT10B. Moreover, WNT10B signaling stimulated cytoskeletal remodeling via Rac1 and frizzled 7 (FZD7) was identified as the cognate receptor for WNT10B to up-regulate cell migration. We further showed that secreted frizzled-related protein 3 (SFRP3) is expressed in uterine decidual cells by immunohistochemistry and that SFRP3 expression in telomerase-transformed human endometrial stromal cells (T-HESCs) is elevated under decidualization stimuli and further enhanced by bone morphogenetic protein 2 via SMAD1. SFRP3 blocked the interaction between FZD7 and WNT10B to decrease BeWo cell migration, which corroborated the elevated BeWo cell migration when cocultured with decidualized and SFRP3-knockdown T-HESC monolayer. Our results suggest that GCM1 up-regulates EVT cell migration through WNT10B and FZD7, which is negatively modulated by decidual SFRP3.Wang, L.-J., Lo, H.-F., Lin, C.-F., Ng, P.-S., Wu, Y.-H., Lee, Y.-S., Cheong, M.-L., Chen, H. SFRP3 negatively regulates placental extravillous trophoblast cell migration mediated by the GCM1-WNT10B-FZD7 axis.	[Wang, Liang-Jie; Lo, Hsiao-Fan; Ng, Pui-Sze; Wu, Yi-Hung; Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lin, Cheng-Fu] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Cheong, Mei-Leng] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Cheong, Mei-Leng] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Ming Chuan University; Cathay General Hospital; Taipei Medical University	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	hwchen@gate.sinica.edu.tw	Chen, Hungwen/AAC-1394-2022		Ministry of Science and Technology [106-2311-B-001-013-MY3]; Academia Sinica	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the Ministry of Science and Technology (Grant 106-2311-B-001-013-MY3) and Academia Sinica (to H.C.). The authors declare no conflicts of interest.	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Aprelikova O, 2013, ONCOGENE, V32, P3246, DOI 10.1038/onc.2012.351; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chen YY, 2014, J BIOL CHEM, V289, P22958, DOI 10.1074/jbc.M114.576744; Chiang MH, 2009, J BIOL CHEM, V284, P17411, DOI 10.1074/jbc.M109.016170; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollheimer J, 2006, AM J PATHOL, V168, P1134, DOI 10.2353/ajpath.2006.050686; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Wei SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028797; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	32	4	4	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					314	326		10.1096/fj.201800124R	http://dx.doi.org/10.1096/fj.201800124R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979633				2022-12-28	WOS:000457401500026
J	Zhan, LX; Lu, ZW; Zhu, XY; Xu, WS; Li, LX; Li, XY; Chen, SY; Sun, WW; Xu, E				Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En			Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKII inactivation in adult rats	FASEB JOURNAL			English	Article						apoptosis; dynamin-related protein 1; necroptosis; ischemic tolerance	DEPENDENT PROTEIN-KINASE; PROGRAMMED CELL-DEATH; MIXED LINEAGE KINASE; MITOCHONDRIAL FISSION; CHEMICAL INHIBITOR; NEUROPROTECTION; DRP1; PHOSPHORYLATION; FRAGMENTATION; CONTRIBUTES	Hypoxic preconditioning (HPC) alleviates the selective and delayed neuronal death in the hippocampal CA1 region induced by transient global cerebral ischemia (tGCI). This type of cell death may include different programmed cell death mechanisms, namely, apoptosis and necroptosis. Although apoptotic signaling is well defined, the mechanisms that underlie neuronal necroptosis are yet to be fully elucidated. In this study, we investigated whether HPC protects neurons from cerebral ischemia-induced necroptosis. We observed that tGCI up-regulated the expression of receptor-interacting protein (RIP) 3 and increased the interaction of RIP1-RIP3 in CA1 at the early stage of reperfusion. The pretreatment with HPC or necrostatin-1 decreased the expression of RIP3 and the formation of RIP1-RIP3 after tGCI. We also found that HPC decreased the expression and the activity of caspase-8 in CA1 after tGCI, and notably, the pretreatment with Z-VAD-FMK, a pan-caspase inhibitor, did not trigger necroptosis but attenuated the tGCI-induced neuronal damage. Furthermore, we demonstrated that HPC decreased the activation of calcium-calmodulin kinase (CaMK) II and the interaction of RIP1 and CaMKII induced by tGCI. Intriguingly, the pretreatment with a CaMKs inhibitor KN-93 before tGCI resulted in significantly reduced RIP1-3 interaction and tGCI-induced neuronal damage. Finally, we ascertained that HPC prevented the dephosphorylation of dynamin-related protein 1 (Drp1)-Ser637 (serine 637) and inhibited the translocation of Drp1 to mitochondria induced by tGCI. Importantly, the treatment with a Drp1 inhibitor Mdivi-1 or necrostatin-1 before tGCI also abolished Drp1 dephosphorylation at Ser637 and mitochondrial translocation. Taken together, our results highlight that HPC attenuates necroptotic neuronal death induced by tGCI via Drp1-dependent mitochondrial signaling pathways mediated by CaMKII inactivation.Zhan, L., Lu, Z., Zhu, X., Xu, W., Li, L., Li, X., Chen, S., Sun, W., Xu, E. Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKII inactivation in adult rats.	[Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En] Minist Educ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En] Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China; [Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Lu, Zhiwei] Guangzhou Med Univ, Guangzhou Huai Hosp, Affiliated Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Xu, E (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China.				National Natural Science Foundation of China [81571140]; Natural Science Foundation of Guangdong, China [2015A030313461]; Project of Science and Technology Program of Guangzhou Bureau of Education, China [1201630280]; Science and Technology Program of Guangzhou, China [201510010118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Project of Science and Technology Program of Guangzhou Bureau of Education, China; Science and Technology Program of Guangzhou, China	The authors thank Peifeng Du (Guangzhou International Bio-Island Investment and Development Co., Guangzhou, China) for editing this paper. This work was supported by the National Natural Science Foundation of China (Grant 81571140), the Natural Science Foundation of Guangdong, China (Grant 2015A030313461), the Project of Science and Technology Program of Guangzhou Bureau of Education, China (Grant 1201630280), and the Science and Technology Program of Guangzhou, China (Grant 201510010118). The authors declare no conflicts of interest.	Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen WW, 2012, J NEUROCHEM, V120, P70, DOI 10.1111/j.1471-4159.2011.07526.x; Cho Bongki, 2013, Exp Neurobiol, V22, P149, DOI 10.5607/en.2013.22.3.149; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang HC, 2015, P NATL ACAD SCI USA, V112, P8768, DOI 10.1073/pnas.1501831112; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Li YL, 2008, NEUROSCI LETT, V447, P120, DOI 10.1016/j.neulet.2008.08.037; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lu JV, 2014, SEMIN CELL DEV BIOL, V35, P33, DOI 10.1016/j.semcdb.2014.07.003; Martinon F, 2000, FEBS LETT, V468, P134, DOI 10.1016/S0014-5793(00)01212-6; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Nomura M, 2014, CANCER RES, V74, P1056, DOI 10.1158/0008-5472.CAN-13-1283; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Szobi A, 2014, MOL CELL BIOCHEM, V388, P269, DOI 10.1007/s11010-013-1918-x; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Thornton C, 2015, CLIN CHIM ACTA, V451, P35, DOI 10.1016/j.cca.2015.01.026; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Vieira M, 2014, NEUROBIOL DIS, V68, P26, DOI 10.1016/j.nbd.2014.04.002; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wang Y, 2014, NEUROSCIENCE, V266, P91, DOI 10.1016/j.neuroscience.2014.02.007; Wang Y, 2011, NEUROCHEM RES, V36, P2381, DOI 10.1007/s11064-011-0564-5; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Zhan LX, 2017, BRAIN PATHOL, V27, P822, DOI 10.1111/bpa.12472; Zhan LX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.330; Zhan LX, 2012, NEUROPHARMACOLOGY, V63, P873, DOI 10.1016/j.neuropharm.2012.06.035; Zhan LX, 2011, NEUROCHEM INT, V59, P65, DOI 10.1016/j.neuint.2011.04.016; Zhan LX, 2010, J NEUROCHEM, V114, P897, DOI 10.1111/j.1471-4159.2010.06816.x; Zhang YF, 2014, TOXICOL LETT, V225, P445, DOI 10.1016/j.toxlet.2014.01.005; Zhu PP, 2014, MOL NEUROBIOL, V49, P1338, DOI 10.1007/s12035-013-8611-7; Zhu TN, 2014, J NEUROPATH EXP NEUR, V73, P975, DOI 10.1097/NEN.0000000000000118	55	23	25	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1313	1329		10.1096/fj.201800111RR	http://dx.doi.org/10.1096/fj.201800111RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148677	Bronze			2022-12-28	WOS:000457401500104
J	Chen, J; Wang, Q; Zhou, W; Zhou, Z; Tang, PY; Xu, T; Liu, W; Li, LW; Cheng, L; Zhou, ZM; Fan, J; Yin, GY				Chen, Jian; Wang, Qian; Zhou, Wei; Zhou, Zheng; Tang, Peng-Yu; Xu, Tao; Liu, Wei; Li, Lin-Wei; Cheng, Lin; Zhou, Zhi-Min; Fan, Jin; Yin, Guo-Yong			GPCR kinase 2-interacting protein-1 protects against ischemia-reperfusion injury of the spinal cord by modulating ASK1/JNK/p38 signaling	FASEB JOURNAL			English	Article						GIT1; spinal cord injury; apoptosis; neuron	EPIDERMAL-GROWTH-FACTOR; PHOSPHOLIPASE-C-GAMMA; INTERACTING PROTEIN-1; CELL-DEATH; SYNAPSE FORMATION; FOCAL ADHESIONS; CHONDROCYTE PROLIFERATION; REGULATING KINASE-1; GLUCOSE-DEPRIVATION; NEURONAL APOPTOSIS	GPCR kinase 2-interacting protein-1 (GIT1) is a scaffold protein that plays an important role in cell adaptation, proliferation, migration, and differentiation; however, the role of GIT1 in the regulation of neuronal death after spinal cord injury remains obscure. Here, we demonstrate that GIT1 deficiency remarkably increased neuronal apoptosis and enhanced JNK/p38 signaling, which resulted in stronger motor deficits by ischemia-reperfusion in vivo, consistent with the finding of oxygen-glucose deprivation/reoxygenation-induced neuronal injury in vitro. After treatment with JNK and p38 inhibitors, abnormally necroptotic cell death caused by GIT1 knockdown could be partially rescued, with the recovery of neuronal viability, which was still poorer than that in control neurons. Meanwhile, overactivation of JNK/p38 after GIT1 depletion was concomitant with excessive activity of apoptosis signal-regulating kinase-1 (ASK1) that could be abolished by ASK1 silencing in HEK293T cells. Finally, GIT1 could disrupt the oligomerization of ASK1 via interaction between the synaptic localization domain that contains the coiled-coil (CC)-2 domain of GIT1 and the C-terminal CC domain of ASK1. It suppressed the autophosphorylation of ASK1 and led to decreasing activity of the ASK1/JNK/p38 pathway. These data reveal a protective role for GIT1 in neuronal damage by modulating ASK1/JNK/p38 signaling.Chen, J., Wang, Q., Zhou, W., Zhou, Z., Tang, P.-Y., Xu, T., Liu, W., Li, L.-W., Cheng, L., Zhou, Z.-M., Fan, J., Yin, G.-Y. GPCR kinase 2-interacting protein-1 protects against ischemia-reperfusion injury of the spinal cord by modulating ASK1/JNK/p38 signaling.	[Chen, Jian; Wang, Qian; Zhou, Wei; Zhou, Zheng; Tang, Peng-Yu; Xu, Tao; Liu, Wei; Li, Lin-Wei; Cheng, Lin; Zhou, Zhi-Min; Fan, Jin; Yin, Guo-Yong] Nanjing Med Univ, Dept Orthoped, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Fan, J; Yin, GY (corresponding author), Nanjing Med Univ, Dept Orthoped, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	fanjin@njmu.edu.cn; guoyong_yin@sina.com		Yin, Guoyong/0000-0002-7268-5374	National Natural Science Foundation of China [81772351, 81520108018, 81472080, 81772352, 81401800]; Jiangsu Committee of Science and Technology-Social Development Plan [BE2017755]; Jiangsu Six Talents Peak [WSN-011]; Nanjing Committee of Science and Technology [201505005]; Research Innovation Program for Academic Degree College Graduates of Jiangsu [KYLX16_1105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Committee of Science and Technology-Social Development Plan; Jiangsu Six Talents Peak; Nanjing Committee of Science and Technology; Research Innovation Program for Academic Degree College Graduates of Jiangsu	The authors thank all colleagues who assisted in this study. This study was supported by grants from the National Natural Science Foundation of China (81772351, 81520108018, 81472080, 81772352, and 81401800), the Jiangsu Committee of Science and Technology-Social Development Plan (BE2017755), the Jiangsu Six Talents Peak (WSN-011), the Nanjing Committee of Science and Technology (201505005), and the Research Innovation Program for Academic Degree College Graduates of Jiangsu (KYLX16_1105). The authors declare no conflicts of interest.	Abdel-Azim H, 2008, BLOOD, V111, P4064, DOI 10.1182/blood-2007-08-107466; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cho JH, 2012, CELL DEATH DIFFER, V19, P859, DOI 10.1038/cdd.2011.168; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Cockrell LM, 2010, ONCOGENE, V29, P822, DOI 10.1038/onc.2009.382; Eaton GJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.480; Fan J, 2016, CELL PHYSIOL BIOCHEM, V38, P1063, DOI 10.1159/000443057; Fan J, 2010, NEUROSCI LETT, V473, P196, DOI 10.1016/j.neulet.2010.02.045; Fiuza M, 2013, P NATL ACAD SCI USA, V110, P20807, DOI 10.1073/pnas.1312211110; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hong ST, 2015, EXP NEUROBIOL, V24, P8, DOI 10.5607/en.2015.24.1.8; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Lang-Lazdunski L, 2000, STROKE, V31, P208, DOI 10.1161/01.STR.31.1.208; Li YS, 2016, NEURAL REGEN RES, V11, P427, DOI 10.4103/1673-5374.179054; Liu DF, 2016, ADV HEALTHC MATER, V5, P1513, DOI 10.1002/adhm.201600055; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Menon P, 2010, J CELL PHYSIOL, V225, P777, DOI 10.1002/jcp.22282; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Muraoka-Cook RS, 2006, MOL CELL BIOL, V26, P6412, DOI 10.1128/MCB.01950-05; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Pang JJ, 2013, ARTERIOSCL THROM VAS, V33, P999, DOI 10.1161/ATVBAHA.112.300966; Pang JJ, 2009, CIRCULATION, V119, P1524, DOI 10.1161/CIRCULATIONAHA.108.823997; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Qiu JX, 2001, J NEUROTRAUM, V18, P1267, DOI 10.1089/089771501317095304; Ren YX, 2012, MOL CELL BIOCHEM, V365, P109, DOI 10.1007/s11010-012-1249-3; Rui Z, 2012, INT J MOL MED, V30, P819, DOI 10.3892/ijmm.2012.1058; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schmalzigaug R, 2009, NEUROSCI LETT, V458, P79, DOI 10.1016/j.neulet.2009.04.037; Smithson LJ, 2016, GENE DEV, V30, P1383, DOI 10.1101/gad.279661.116; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Wang P, 2007, NEUROSCI LETT, V415, P248, DOI 10.1016/j.neulet.2007.01.050; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Weijman JF, 2017, P NATL ACAD SCI USA, V114, pE2096, DOI 10.1073/pnas.1620813114; Won H, 2011, NAT MED, V17, P566, DOI 10.1038/nm.2330; Xing JJ, 2016, NAT IMMUNOL, V17, P1373, DOI 10.1038/ni.3580; Yang CW, 2008, NEUROSCI LETT, V441, P267, DOI 10.1016/j.neulet.2008.06.037; Yin GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089127; Yin GY, 2005, J BIOL CHEM, V280, P27705, DOI 10.1074/jbc.M502271200; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Yin XH, 2013, NEUROSCIENCE, V248, P290, DOI 10.1016/j.neuroscience.2013.06.012; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang LQ, 2015, INT J MOL MED, V35, P1074, DOI 10.3892/ijmm.2015.2114; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang N, 2010, CELL BIOL INT, V34, P41, DOI 10.1042/CBI20090016; Zhang ZC, 2015, STEM CELLS DEV, V24, P2709, DOI 10.1089/scd.2015.0067; Zhang ZT, 2013, BRAIN RES BULL, V95, P70, DOI 10.1016/j.brainresbull.2013.01.006; Zhao GZ, 2016, MOL MED REP, V14, P897, DOI 10.3892/mmr.2016.5291; Zhao XC, 2012, J NEUROCHEM, V121, P362, DOI 10.1111/j.1471-4159.2012.07696.x; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	73	16	17	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6833	6847		10.1096/fj.201800548	http://dx.doi.org/10.1096/fj.201800548			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29912587	Bronze			2022-12-28	WOS:000449359700037
J	Gao, M; Li, XY; He, YF; Han, LS; Qiu, DH; Ling, L; Liu, HL; Liu, JG; Gu, L				Gao, Min; Li, Xiaoyan; He, Yongfu; Han, Longsen; Qiu, Danhong; Ling, Li; Liu, Honglin; Liu, Jianguo; Gu, Ling			SIRT7 functions in redox homeostasis and cytoskeletal organization during oocyte maturation	FASEB JOURNAL			English	Article						sirtuins; meiosis; oxidative stress; oocyte quality; obesity	HIGH-FAT DIET; OXIDATIVE STRESS; IN-VITRO; MITOCHONDRIAL-FUNCTION; CALORIE RESTRICTION; HUMAN ANEUPLOIDY; INDUCED OBESITY; MOUSE OOCYTES; HUMAN EMBRYOS; CELL-DEATH	SIRT7, a member of the sirtuin family, with coenzyme NAD catalyzes protein deacetylation and has been implicated in multiple biologic processes; however, its function in mammalian oocytes remains to be explored. Here, we report disrupted meiotic maturation upon specific knockdown of SIRT7 in mouse oocytes. In particular, disorganized spindle/chromosomes and the loss of the cortical actin cap are readily observed in SIRT7-depleted oocytes, generating aneuploid eggs. Furthermore, we found that SIRT7 depletion markedly elevated reactive oxygen species levels in oocytes, thereby compromising the developmental competence of early embryos. Of note, SIRT7 protein level is significantly decreased in oocytes from obese mice, and the forced expression of exogenous SIRT7 ameliorates maternal obesity-associated meiotic defects and oxidative stress in oocytes. In summary, our data suggest that SIRT7 is an essential factor in the determination of oocyte quality and may mediate the effects of obesity on female reproduction.Gao, M., Li, X., He, Y., Han, L., Qiu, D., Ling, L., Liu, H., Liu, J., Gu, L. SIRT7 functions in redox homeostasis and cytoskeletal organization during oocyte maturation.	[Gao, Min; Li, Xiaoyan; He, Yongfu; Liu, Honglin; Gu, Ling] Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China; [Han, Longsen; Qiu, Danhong; Ling, Li] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63103 USA	Nanjing Agricultural University; Nanjing Medical University; Saint Louis University	Gu, L (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China.	lgu@njau.edu.cn	liu, honglin/HDN-0409-2022; li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022	liu, honglin/0000-0002-1254-3163; He, Yongfu/0000-0003-3967-454X	National Natural Science Foundation of China [31771660]; Fundamental Research Funds for the Central Universities [KJQN201519]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grant 31771660, and the Fundamental Research Funds for the Central Universities (KJQN201519). The authors declare no conflicts of interest.	BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bedaiwy MA, 2004, FERTIL STERIL, V82, P593, DOI 10.1016/j.fertnstert.2004.02.121; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370; Dumollard R, 2009, SEMIN CELL DEV BIOL, V20, P346, DOI 10.1016/j.semcdb.2008.12.013; Eichenlaub-Ritter U, 2004, REPROD BIOMED ONLINE, V8, P45, DOI 10.1016/S1472-6483(10)60497-X; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Greiss S, 2009, MOL CELLS, V28, P407, DOI 10.1007/s10059-009-0169-x; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Han LS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15366; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kiran S, 2013, FEBS J, V280, P3451, DOI 10.1111/febs.12346; Leary C, 2015, HUM REPROD, V30, P122, DOI 10.1093/humrep/deu276; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Liu L, 2000, BIOL REPROD, V62, P1745, DOI 10.1095/biolreprod62.6.1745; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; Ma RJ, 2014, FASEB J, V28, P4026, DOI 10.1096/fj.14-250886; Machtinger R, 2012, HUM REPROD, V27, P3198, DOI 10.1093/humrep/des308; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Minge CE, 2008, ENDOCRINOLOGY, V149, P2646, DOI 10.1210/en.2007-1570; Oellerich MF, 2012, CIRC RES, V110, P1238, DOI 10.1161/CIRCRESAHA.111.246488; Oliva J, 2008, EXP MOL PATHOL, V85, P155, DOI 10.1016/j.yexmp.2008.08.002; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Reynolds KA, 2015, REPROD FERT DEVELOP, V27, P716, DOI 10.1071/RD14251; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Scheffler I. E., 2002, MITOCHONDRIAL ELECT; Shaeib F, 2013, FREE RADICAL BIO MED, V58, P154, DOI 10.1016/j.freeradbiomed.2012.12.007; Sohrabi M, 2015, SINGAP MED J, V56, P573, DOI 10.11622/smedj.2015085; Tilly JL, 2013, CELL METAB, V17, P838, DOI 10.1016/j.cmet.2013.05.007; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yi KX, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0002; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zeng HT, 2007, HUM REPROD, V22, P1681, DOI 10.1093/humrep/dem070; Zhang L, 2015, CELL CYCLE, V14, P2959, DOI 10.1080/15384101.2015.1026517; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095; Zhao HC, 2016, HUM REPROD, V31, P607, DOI 10.1093/humrep/dev345	53	21	25	6	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6228	6238		10.1096/fj.201800078RR	http://dx.doi.org/10.1096/fj.201800078RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29879377	Bronze			2022-12-28	WOS:000447172000038
J	Klauss, S; Schorn, S; Teller, S; Steenfadt, H; Friess, H; Ceyhan, GO; Demir, IE				Klauss, Sarah; Schorn, Stephan; Teller, Steffen; Steenfadt, Hendrik; Friess, Helmut; Ceyhan, Gueralp O.; Demir, Ihsan Ekin			Genetically induced vs. classical animal models of chronic pancreatitis: a critical comparison	FASEB JOURNAL			English	Review						mouse models; Atg5; genetic	ENDOPLASMIC-RETICULUM STRESS; DIBUTYLTIN DICHLORIDE DBTC; HUMAN CATIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; L-ARGININE; MOUSE MODELS; ALCOHOLIC PANCREATITIS; IMPAIRED AUTOPHAGY; ACINAR-CELLS; ER STRESS	Chronic pancreatitis (CP) is an utmost complex disease that is pathogenetically linked to pancreas-intrinsic (e.g., duct obstruction), environmental-toxic (e.g., alcohol, smoking), and genetic factors. Studying such a complex disease naturally requires validated experimental models. In the past 2 decades, the various animal models of CP usually addressed either the pancreas-intrinsic (e.g., the caerulein model), the environmental-toxic (e.g., diet-induced models), or the genetic component of CP. As such, these models were far from mirroring CP in its full spectrum, and the correct choice of models was vital for valid scientific conclusions on CP. The quest for mechanistic, genetic models gave rise to models based on gene modification and transgene insertion, such as the PRSS1 and the IL-1/IL-1 models. Recently, we witnessed the development of highly exciting models that rely on the importance of autophagy in CP, that is, the murine pancreas-specific Atg5 and LAMP2 knockout models. Today, critical comparison of these several models is more important than ever for guiding research on CP in an efficient direction. The present review outlines the characteristics of the new genetic models in comparison with the well-known classic models for CP, notes the caveats in the choice of models, and also indicates novel directions for model development.Klauss, S., Schorn, S., Teller, S., Steenfadt, H., Friess, H., Ceyhan, G. O., Demir, I. K. Genetically induced vs. classical animal models of chronic pancreatitis: a critical comparison.	[Klauss, Sarah; Schorn, Stephan; Teller, Steffen; Steenfadt, Hendrik; Friess, Helmut; Ceyhan, Gueralp O.; Demir, Ihsan Ekin] Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany	Technical University of Munich	Demir, IE (corresponding author), Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany.	ekin.demir@tum.de	Schorn, Stephan/AAZ-8009-2020					Aghdassi A. A., 2016, PANCREAPEDIA EXOCRIN; Aghdassi AA, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-26; Ahmadi A, 2016, CENT EUR J IMMUNOL, V41, P54, DOI 10.5114/ceji.2016.58816; Antonucci L, 2015, P NATL ACAD SCI USA, V112, pE6166, DOI 10.1073/pnas.1519384112; Apte MV, 2010, J GASTROEN HEPATOL, V25, P1816, DOI 10.1111/j.1440-1746.2010.06445.x; Archer H, 2006, GASTROENTEROLOGY, V131, P1844, DOI 10.1053/j.gastro.2006.09.049; Athwal T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.120; Bai H, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-115; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Berger Z, 1997, INT J PANCREATOL, V21, P165; Biczo G, 2018, GASTROENTEROLOGY, V154, P689, DOI 10.1053/j.gastro.2017.10.012; Boerma D, 2003, DIGEST SURG, V20, P520, DOI 10.1159/000073688; Bynigeri RR, 2017, WORLD J GASTROENTERO, V23, P382, DOI 10.3748/wjg.v23.i3.382; Cano DA, 2006, GASTROENTEROLOGY, V131, P1856, DOI 10.1053/j.gastro.2006.10.050; Case RM, 2006, PANCREATOLOGY, V6, P180, DOI 10.1159/000091849; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Chen QM, 2010, PANCREAS, V39, P1220, DOI 10.1097/MPA.0b013e3181df1c90; Demir IE, 2015, NAT REV GASTRO HEPAT, V12, P649, DOI 10.1038/nrgastro.2015.166; Demir IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060529; Demols A, 2002, AM J PHYSIOL-GASTR L, V282, pG1105, DOI 10.1152/ajpgi.00431.2001; Diakopoulos KN, 2015, GASTROENTEROLOGY, V148, P626, DOI 10.1053/j.gastro.2014.12.003; Diamanti MA, 2017, J EXP MED, V214, P423, DOI 10.1084/jem.20161867; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dolensek J, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1024405; Edgington-Mitchell LE, 2016, AM J PHYSIOL-GASTR L, V311, pG548, DOI 10.1152/ajpgi.00047.2016; Endo S, 2017, GASTROENTEROLOGY, V152, P1492, DOI 10.1053/j.gastro.2017.01.010; Feng DC, 2012, INT J BIOL SCI, V8, P249, DOI 10.7150/ijbs.3967; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Foss CA, 2017, J NUCL MED, V58, P1685, DOI 10.2967/jnumed.117.189571; Foster JR, 2014, TOXICOL PATHOL, V42, P243, DOI 10.1177/0192623313508479; Fredstrom SB, 2009, PANCREAS, V38, P344, DOI 10.1097/MPA.0b013e318184ff83; Friess H, 2002, GUT, V50, P682, DOI 10.1136/gut.50.5.682; FUKUI H, 1991, J HEPATOL, V12, P162, DOI 10.1016/0168-8278(91)90933-3; Gabbi C, 2008, P NATL ACAD SCI USA, V105, P15052, DOI 10.1073/pnas.0808097105; Gao Y, 2012, MOL CELL BIOL, V32, P5129, DOI 10.1128/MCB.01009-12; GOTO M, 1995, DIGEST DIS SCI, V40, P2356, DOI 10.1007/BF02063237; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Gukovsky I, 2015, GASTROENTEROLOGY, V148, P501, DOI 10.1053/j.gastro.2015.01.012; Han S, 2013, AM J PHYSIOL-GASTR L, V305, pG139, DOI 10.1152/ajpgi.00370.2012; Hao WR, 2017, P NATL ACAD SCI USA, V114, P5011, DOI 10.1073/pnas.1620264114; Harris J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00083; He H, 1998, WORLD J GASTROENTERO, V4, P533, DOI 10.3748/wjg.v4.i6.533; Hegyi E, 2017, DIGEST DIS SCI, V62, P1692, DOI 10.1007/s10620-017-4601-3; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; Hu N, 2017, PANCREATOLOGY, V17, P247, DOI 10.1016/j.pan.2017.01.006; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Hyun JJ, 2014, CLIN ENDOSC, V47, P212, DOI 10.5946/ce.2014.47.3.212; Ichimura Y, 2011, EXP ANIM TOKYO, V60, P329, DOI 10.1538/expanim.60.329; Iovanna JL, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00226; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kanak MA, 2017, J GASTROENTEROL, V52, P352, DOI 10.1007/s00535-016-1238-5; Kirkbride MB, 1912, J EXP MED, V15, P101, DOI 10.1084/jem.15.1.101; Komar HM, 2017, PANCREAS, V46, P986, DOI 10.1097/MPA.0000000000000896; Lamme B, 2007, BRIT J SURG, V94, P849, DOI 10.1002/bjs.5722; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Lew D, 2017, DIGEST DIS SCI, V62, P1702, DOI 10.1007/s10620-017-4602-2; Li J, 2008, PANCREAS, V37, P189, DOI 10.1097/MPA.0b013e31816459b7; Li J, 2008, ACTA PHARMACOL SIN, V29, P646, DOI 10.1111/j.1745-7254.2008.00805.x; Li N, 2013, J CLIN INVEST, V123, P2231, DOI 10.1172/JCI64498; Li X, 2016, BBA-MOL BASIS DIS, V1862, P1839, DOI 10.1016/j.bbadis.2016.06.017; LIEBER CS, 1994, METHOD ENZYMOL, V233, P585; Lin WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116229; Lohr JM, 2017, UNITED EUR GASTROENT, V5, P153, DOI 10.1177/2050640616684695; Longnecker D., 2014, PANCREAPEDIA EXOCRIN, DOI 10.3998/panc.2014.3; Machicado JD, 2017, AM J GASTROENTEROL, V112, P633, DOI 10.1038/ajg.2017.42; Mareninova OA, 2015, CELL MOL GASTROENTER, V1, P678, DOI 10.1016/j.jcmgh.2015.07.006; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Marrache F, 2008, GASTROENTEROLOGY, V135, P1277, DOI 10.1053/j.gastro.2008.06.078; Mayerle J., 2013, **DROPPED REF**; McCool BA, 2003, BRAIN RES, V963, P165, DOI 10.1016/S0006-8993(02)03966-5; McIlwrath SL, 2015, WORLD J GASTROENTERO, V21, P836, DOI 10.3748/wjg.v21.i3.836; Merkord J, 1998, HUM EXP TOXICOL, V17, P144, DOI 10.1191/096032798678908431; Merkord J, 1999, ANN NY ACAD SCI, V880, P231, DOI 10.1111/j.1749-6632.1999.tb09527.x; Miller JR, 2011, HPB, V13, P759, DOI 10.1111/j.1477-2574.2011.00354.x; MIZUNUMA T, 1984, J NUTR, V114, P467, DOI 10.1093/jn/114.3.467; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mori M, 2009, EXP ANIM TOKYO, V58, P409, DOI 10.1538/expanim.58.409; Mrazek AA, 2015, J SURG RES, V196, P8, DOI 10.1016/j.jss.2015.02.032; Nakayama S, 2014, PANCREAS, V43, P28, DOI 10.1097/MPA.0b013e3182a7c76b; Nemeth BC, 2014, AM J PHYSIOL-GASTR L, V306, pG466, DOI 10.1152/ajpgi.00419.2013; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Norman JG, 1996, J SURG RES, V63, P231, DOI 10.1006/jsre.1996.0253; Patel AG, 1999, ANN SURG, V230, P672, DOI 10.1097/00000658-199911000-00009; Pinho AV, 2011, GUT, V60, P958, DOI 10.1136/gut.2010.225920; Rastellini C, 2015, AM J PHYSIOL-GASTR L, V309, pG554, DOI 10.1152/ajpgi.00076.2015; Reber PU, 1998, SURGERY, V124, P561, DOI 10.1067/msy.1998.90269; Reed A., 2014, PANCREAPEDIA EXOCRIN; Romac JMJ, 2012, AM J PHYSIOL-GASTR L, V302, pG535, DOI 10.1152/ajpgi.00287.2011; Rosendahl J, 2018, GUT, V67, P1855, DOI 10.1136/gutjnl-2017-314454; Sah RP, 2014, J BIOL CHEM, V289, P27551, DOI 10.1074/jbc.M113.528174; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M., 2016, GENETIC RISK FACTORS; SAKAKIBARA A, 1982, AM J GASTROENTEROL, V77, P498; Saluja AK, 2013, GASTROENTEROLOGY, V144, P1194, DOI 10.1053/j.gastro.2013.01.070; Schneider A, 2002, BEST PRACT RES CL GA, V16, P347, DOI 10.1053/bega.2002.0311; Schwartz ES, 2013, J NEUROSCI, V33, P5603, DOI 10.1523/JNEUROSCI.1806-12.2013; Schwartz ES, 2011, GASTROENTEROLOGY, V140, P1283, DOI 10.1053/j.gastro.2010.12.033; Selig L, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-30; Senate Commission on Animal Protection and Experimentation of the Deutsche Forschungsgemeinschaft, 2016, AN EXP RES; Sendler M, 2015, GASTROENTEROLOGY, V149, P765, DOI 10.1053/j.gastro.2015.05.012; Shapiro JP, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.15; Silva A, 2011, AM J PHYSIOL-GASTR L, V300, pG968, DOI 10.1152/ajpgi.00497.2010; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Stevens T, 2004, AM J GASTROENTEROL, V99, P2256, DOI 10.1111/j.1572-0241.2004.40694.x; Sun GF, 2014, MOL BIOSYST, V10, P467, DOI 10.1039/c3mb70406h; Sun Y, 2014, PANCREAS, V43, P148, DOI 10.1097/MPA.0b013e318296991e; Treiber M, 2011, GASTROENTEROLOGY, V141, P1473, DOI 10.1053/j.gastro.2011.06.087; Uc A, 2016, PANCREAS, V45, P1365, DOI 10.1097/MPA.0000000000000713; Van Audenaerde JRM, 2017, ONCOTARGET, V8, P56968, DOI 10.18632/oncotarget.18185; van Minnen LP, 2007, J GASTROINTEST SURG, V11, P682, DOI 10.1007/s11605-007-0088-0; van Westerloo DJ, 2005, AM J PATHOL, V166, P721, DOI 10.1016/S0002-9440(10)62293-6; Vera-Portocarrero L, 2005, NEUROSIGNALS, V14, P158, DOI 10.1159/000087654; Vera-Portocarrero LP, 2003, ANESTHESIOLOGY, V98, P474, DOI 10.1097/00000542-200302000-00029; Vonlaufen A, 2007, GASTROENTEROLOGY, V133, P1293, DOI 10.1053/j.gastro.2007.06.062; Watson P, 2015, J SMALL ANIM PRACT, V56, P3, DOI 10.1111/jsap.12293; WEAVER C, 1994, EXP MOL PATHOL, V60, P71, DOI 10.1006/exmp.1994.1007; Weniger M., 2016, OXID MED CELL LONGEV, V2016, P1; Weylandt KH, 2008, BBA-MOL BASIS DIS, V1782, P634, DOI 10.1016/j.bbadis.2008.08.011; Whitcomb DC, 2016, PANCREATOLOGY, V16, P218, DOI 10.1016/j.pan.2016.02.001; Whitcomb DC, 2004, NAT CLIN PRACT GASTR, V1, P46, DOI 10.1038/ncpgasthep0025; Whitcomb DC, 2013, GASTROENTEROLOGY, V144, P1292, DOI 10.1053/j.gastro.2013.01.069; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Xiao AY, 2016, LANCET GASTROENTEROL, V1, P45, DOI 10.1016/S2468-1253(16)30004-8; Xiao XW, 2017, DIABETES, V66, P2646, DOI 10.2337/db17-0537; Xu B, 2014, INT J CLIN EXP PATHO, V7, P3620; Xu SP, 2015, PANCREAS, V44, P882, DOI 10.1097/MPA.0000000000000380; Yamaguchi T, 2005, PANCREAS, V31, P365, DOI 10.1097/01.mpa.0000179729.61457.e5; Zator Z, 2017, THER ADV GASTROENTER, V10, P323, DOI 10.1177/1756283X16684687; Zhan XB, 2016, AM J PHYSIOL-GASTR L, V311, pG343, DOI 10.1152/ajpgi.00372.2015; Zhang H, 2016, WORLD J GASTROENTERO, V22, P2960, DOI 10.3748/wjg.v22.i10.2960; Zhang LP, 2015, NEUROSCIENCE, V311, P166, DOI 10.1016/j.neuroscience.2015.10.028; Zhang LP, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-66; Zhang TT, 2013, PANCREATOLOGY, V13, P491, DOI 10.1016/j.pan.2013.08.003; Zhao JB, 2013, WORLD J GASTROENTERO, V19, P7222, DOI 10.3748/wjg.v19.i42.7222; Zhao P, 1998, ACAD RADIOL, V5, P850, DOI 10.1016/S1076-6332(98)80245-6; Zhu HW, 2015, INT J CLIN EXP PATHO, V8, P11164	140	9	10	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5778	5792		10.1096/fj.201800241RR	http://dx.doi.org/10.1096/fj.201800241RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29863911	Bronze			2022-12-28	WOS:000447172000003
J	Brook, A; Hoaksey, A; Gurung, R; Yoong, EEC; Sneyd, R; Baynes, GC; Bischof, H; Jones, S; Higgins, LE; Jones, C; Greenwood, SL; Jones, RL; Gram, M; Lang, I; Desoye, G; Myers, J; Schneider, H; Hansson, SR; Crocker, IP; Brownbill, P				Brook, Adam; Hoaksey, Annie; Gurung, Rekha; Yoong, Edward E. C.; Sneyd, Rosanna; Baynes, Georgia C.; Bischof, Helen; Jones, Sarah; Higgins, Lucy E.; Jones, Carolyn; Greenwood, Susan L.; Jones, Rebecca L.; Gram, Magnus; Lang, Ingrid; Desoye, Gernot; Myers, Jenny; Schneider, Henning; Hansson, Stefan R.; Crocker, Ian P.; Brownbill, Paul			Cell free hemoglobin in the fetoplacental circulation: a novel cause of fetal growth restriction?	FASEB JOURNAL			English	Article						endothelium; vascular compromise; blood-flow resistance; nitric oxide; stillbirth	UMBILICAL ARTERY DOPPLER; NITRIC-OXIDE; HEME OXYGENASE-1; AMNIOTIC-FLUID; BLOOD-FLOW; IN-VITRO; MATERNAL HYPERTENSION; HUMAN PLACENTA; GAMMA-CHAIN; ADULT LIFE	Cell free hemoglobin impairs vascular function and blood flow in adult cardiovascular disease. In this study, we investigated the hypothesis that free fetal hemoglobin (fHbF) compromises vascular integrity and function in the fetoplacental circulation, contributing to the increased vascular resistance associated with fetal growth restriction (FGR). Women with normal and FGR pregnancies were recruited and their placentas collected freshly postpartum. FGR fetal capillaries showed evidence of erythrocyte vascular packing and extravasation. Fetal cord blood fHbF levels were higher in FGR than in normal pregnancies (P < 0.05) and the elevation of fHbF in relation to heme oxygenase-1 suggests a failure of expected catabolic compensation, which occurs in adults. During ex vivo placental perfusion, pathophysiological fHbF concentrations significantly increased fetal-side microcirculatory resistance (P < 0.05). fHbF sequestered NO in acute and chronic exposure models (P < 0.001), and fHbF-primed placental endothelial cells developed a proinflammatory phenotype, demonstrated by activation of NF-B pathway, generation of IL-1 and TNF- (both P < 0.05), uncontrolled angiogenesis, and disruption of endothelial cell flow alignment. Elevated fHbF contributes to increased fetoplacental vascular resistance and impaired endothelial protection. This unrecognized mechanism for fetal compromise offers a novel insight into FGR as well as a potential explanation for associated poor fetal outcomes such as fetal demise and stillbirth.Brook, A., Hoaksey, A., Gurung, R., Yoong, E. E. C., Sneyd, R., Baynes, G. C., Bischof, H., Jones, S., Higgins, L. E., Jones, C., Greenwood, S. L., Jones, R. L., Gram, M., Lang, I., Desoye, G., Myers, J., Schneider, H., Hansson, S. R., Crocker, I. P., Brownbill, P. Cell free hemoglobin in the fetoplacental circulation: a novel cause of fetal growth restriction?	[Brook, Adam; Hoaksey, Annie; Gurung, Rekha; Yoong, Edward E. C.; Sneyd, Rosanna; Baynes, Georgia C.; Bischof, Helen; Higgins, Lucy E.; Jones, Carolyn; Greenwood, Susan L.; Jones, Rebecca L.; Myers, Jenny; Crocker, Ian P.; Brownbill, Paul] Univ Manchester, Sch Med Sci, Div Dev Biol & Med, Maternal & Fetal Hlth Res Ctr,Fac Biol Med & Hlth, Manchester, Lancs, England; [Brook, Adam; Hoaksey, Annie; Gurung, Rekha; Yoong, Edward E. C.; Sneyd, Rosanna; Baynes, Georgia C.; Bischof, Helen; Higgins, Lucy E.; Jones, Carolyn; Greenwood, Susan L.; Jones, Rebecca L.; Myers, Jenny; Crocker, Ian P.; Brownbill, Paul] Manchester Univ Natl Hlth Serv NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England; [Jones, Sarah] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England; [Gram, Magnus] Lund Univ, Inst Clin Sci, Div Infect Med, Lund, Sweden; [Hansson, Stefan R.] Lund Univ, Inst Clin Sci, Dept Obstet & Gynecol, Lund, Sweden; [Lang, Ingrid] Karl Franzens Univ Graz, Inst Histol & Embryol, Graz, Austria; [Desoye, Gernot] Karl Franzens Univ Graz, Dept Clin Obstet & Gynecol, Graz, Austria; [Schneider, Henning] Univ Bern, Dept Obstet & Gynecol, Inselspital, Bern, Switzerland	University of Manchester; University of Manchester; Manchester Metropolitan University; Lund University; Lund University; University of Graz; University of Graz; University of Bern	Brownbill, P (corresponding author), St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Oxford Rd, Manchester M13 9WL, Lancs, England.	paul.brownbill@manchester.ac.uk	Gram, Magnus/AAM-4825-2021; Brownbill, Paul/I-2412-2015	Gram, Magnus/0000-0002-5880-2925; Jones, Carolyn/0000-0002-0026-9494; Lang-Olip, Ingrid/0000-0003-0403-4884; Jones, Sarah/0000-0001-8154-3928; Desoye, Gernot/0000-0002-5715-3230; Brownbill, Paul/0000-0002-8328-7072; Myers, Jenny/0000-0003-0913-2096; Higgins, Lucy/0000-0003-0993-497X; Jones, Rebecca/0000-0002-3924-0269	British Heart Foundation [PG/11/11/28725]; Action Research Endowment Fund	British Heart Foundation(British Heart Foundation); Action Research Endowment Fund	The authors are grateful to the staff of the delivery unit at St. Mary's Hospital for their assistance in obtaining placental tissue. This research was funded by the British Heart Foundation (Grant PG/11/11/28725), and was facilitated by the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network (Manchester, United Kingdom). The support of an Action Research Endowment Fund is also acknowledged. The authors declare no conflicts of interest.	Ahmed A, 2000, MOL MED, V6, P391, DOI 10.1007/BF03401783; Alberry M, 2007, ARCH DIS CHILD-FETAL, V92, pF62, DOI 10.1136/adc.2005.082297; Basu S, 2014, PAEDIATR INT CHILD H, V34, P189, DOI 10.1179/2046905514Y.0000000124; Brownbill P, 2007, ENDOCRINOLOGY, V148, P4734, DOI 10.1210/en.2007-0180; Cecconi D, 2011, ELECTROPHORESIS, V32, P3630, DOI 10.1002/elps.201100256; Centlow M, 2008, FERTIL STERIL, V90, P1834, DOI 10.1016/j.fertnstert.2007.09.030; Chinni E, 2010, THROMB RES, V125, P267, DOI 10.1016/j.thromres.2009.09.024; Deem S, 2002, CIRC RES, V91, P626, DOI 10.1161/01.RES.0000036268.47509.02; Elad D, 2014, TRAFFIC, V15, P122, DOI 10.1111/tra.12130; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Gerber S, 2006, EUR J OBSTET GYN R B, V126, P20, DOI 10.1016/j.ejogrb.2005.07.008; Ghosh GS, 2009, BJOG-INT J OBSTET GY, V116, P424, DOI 10.1111/j.1471-0528.2008.02057.x; Gordijn SJ, 2016, ULTRASOUND OBST GYN, V48, P333, DOI 10.1002/uog.15884; Gram M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138111; Hansson SR, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00516; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Hracsko Z, 2009, IN VIVO, V23, P727; Jensen FB, 2007, J EXP BIOL, V210, P3387, DOI 10.1242/jeb.008748; JONES CJP, 1978, VIRCHOWS ARCH A, V379, P229, DOI 10.1007/BF00432638; Jones S, 2015, J PHYSIOL-LONDON, V593, P3077, DOI 10.1113/JP270495; Junaid TO, 2014, PLACENTA, V35, P808, DOI 10.1016/j.placenta.2014.07.013; KAJITA A, 1969, BIOCHIM BIOPHYS ACTA, V175, P41, DOI 10.1016/0005-2795(69)90143-3; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P126, DOI 10.1002/uog.2832; Lang I, 2008, DIFFERENTIATION, V76, P1031, DOI 10.1111/j.1432-0436.2008.00302.x; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Martinelli S, 2009, ACTA OBSTET GYN SCAN, V88, P888, DOI 10.1080/00016340903090985; Lopes FCM, 2014, MICROVASC RES, V94, P106, DOI 10.1016/j.mvr.2014.05.009; Massion PB, 2003, CIRC RES, V93, P388, DOI 10.1161/01.RES.0000088351.58510.21; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; MULLEREBERHARD U, 1975, PEDIATR RES, V9, P519, DOI 10.1203/00006450-197506000-00001; MYATT L, 1991, AM J OBSTET GYNECOL, V164, P687, DOI 10.1016/S0002-9378(11)80047-5; NOBLE RW, 1971, J BIOL CHEM, V246, P2972; Okuda T, 2004, PRENATAL DIAG, V24, P881, DOI 10.1002/pd.1039; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pisaneschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045294; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sanchez-Vera I, 2005, OBSTET GYNECOL, V106, P345, DOI 10.1097/01.AOG.0000171112.95083.86; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Sohur US, 1999, GENE EXPRESSION, V8, P219; Spence D, 2012, PUBLIC HEALTH, V126, P561, DOI 10.1016/j.puhe.2012.03.010; Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83; Teramo KA, 2002, ACTA OBSTET GYN SCAN, V81, P245, DOI 10.1034/j.1600-0412.2002.810310.x; Veerbeek JHW, 2014, PLACENTA, V35, P696, DOI 10.1016/j.placenta.2014.06.375; Vergani P, 2010, ULTRASOUND OBST GYN, V36, P166, DOI 10.1002/uog.7583; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265; Wolk M, 2007, BRIT J CANCER, V97, P412, DOI 10.1038/sj.bjc.6603867; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zanardo V, 2013, TWIN RES HUM GENET, V16, P720, DOI 10.1017/thg.2013.15; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012	52	14	14	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5436	5446		10.1096/fj.201800264R	http://dx.doi.org/10.1096/fj.201800264R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29723064	Green Published, Green Accepted			2022-12-28	WOS:000447972500020
J	Pollock, LM; Xie, J; Bell, BA; Anand-Apte, B				Pollock, Lana M.; Xie, Jing; Bell, Brent A.; Anand-Apte, Bela			Retinoic acid signaling is essential for maintenance of the blood-retinal barrier	FASEB JOURNAL			English	Article						zebrafish; tight junctions; vasculature	IN-VIVO; BRAIN-BARRIER; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; VITAMIN-A; ZEBRAFISH; DIFFERENTIATION; RECEPTORS; BREAKDOWN; PHOTORECEPTORS	The predominant function of the blood-retinal barrier (BRB) is to maintain retinal homeostasis by regulating the influx and efflux between the blood and retina. Breakdown of the BRB occurs in a number of ocular diseases that result in vision loss. Understanding the molecular and cellular pathways involved in the development and maintenance of the BRB is critical to developing therapeutics for these conditions. To visualize the BRB in vivo, we used the transgenic Tg(l-fabp:DBP-EGFP:flk1:mCherry) zebrafish model that expresses vitamin D binding protein (a member of the albumin gene family) tagged to green fluorescent protein. Retinoic acid (RA) plays a number of important roles in vertebrate development and has been shown to play a protective role during inflammation-induced blood-brain barrier disruption. The role of RA in BRB development and maintenance remains unknown. To disrupt RA signaling, Tg(l-fabp:DBP-EGFP:flk1:mCherry) zebrafish were treated with N,N-diethylaminobenzaldehyde and 4-[(1E)-2-[5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoic acid, which are antagonists of retinal dehydrogenase and the RA receptor, respectively. Treatment with either compound resulted in BRB disruption and reduced visual acuity, whereas cotreatment with all-trans RA effectively rescued BRB integrity. Additionally, transgenic overexpression of Cyp26a1, which catalyzes RA degradation, resulted in breakdown of the BRB. Our results demonstrate that RA signaling is critical for maintenance of the BRB and could play a role in diseases such as diabetic macular edema.Pollock, L. M., Xie, J., Bell, B. A., Anand-Apte, B. Retinoic acid signaling is essential for maintenance of the blood-retinal barrier.	[Pollock, Lana M.; Xie, Jing; Bell, Brent A.; Anand-Apte, Bela] Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA; [Anand-Apte, Bela] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Anand-Apte, B (corresponding author), Cleveland Clin, Cole Eye Inst, 9500 Euclid Ave,I31, Cleveland, OH 44195 USA.	anandab@ccf.org			U.S. National Institutes of Health, National Eye Institute [EY016490, EY015638, EY026181, T32EY024236, P30EY025585]; Research to Prevent Blindness Unrestricted/Challenge Grant; Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE [R01EY027083, R01EY020861, P30EY025585, T32EY024236, R01EY026181] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted/Challenge Grant; Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Mariya Ali (Cleveland Clinic) and Alecia Cutler (Cleveland Clinic) for technical assistance; Dr. Johannes von Lintig (Case Western Reserve University) and Dr. Brian Perkins (Cleveland Clinic) for helpful discussions; Dr. Didier Stainier (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany), Dr. Suk-Won Jin (Yale Cardiovascular Research Center, New Haven, CT, USA), and Dr. Neil Chi (University of California, San Diego, La Jolla, CA, USA) for providing the Tg(flk1:mCherry) fish; Dr. Brant Weinstein (National Institutes of Health, Bethesda, MD, USA) for providing the Tg(fli1a:EGFP-cldn5b) fish; and Dr. Nicola Blum and Dr. Gerrit Begemann (both from the University of Bayreuth, Bayreuth, Germany) for providing the Tg(hsp70I: cyp26a1) fish. The authors also thank Amanda Mendelsohn (Center for Medical Art and Photography, Cleveland Clinic) for illustrations. This work was supported by U.S. National Institutes of Health, National Eye Institute Grants EY016490, EY015638, EY026181, T32EY024236, and P30EY025585; a Research to Prevent Blindness Unrestricted/Challenge Grant; and a Foundation Fighting Blindness Center Grant. The authors declare no conflicts of interest.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bell BA, 2014, EXP EYE RES, V129, P107, DOI 10.1016/j.exer.2014.10.018; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Bonney S, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0378-16.2017; Campbell M, 2013, ADV EXP MED BIOL, V763, P70; CUNHAVAZ J, 1975, BRIT J OPHTHALMOL, V59, P649, DOI 10.1136/bjo.59.11.649; Daniele LL, 2016, INVEST OPHTH VIS SCI, V57, P2942, DOI 10.1167/iovs.15-18996; Diaz-Coranguez M, 2017, VISION RES, V139, P123, DOI 10.1016/j.visres.2017.05.009; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Drager UC, 1997, PROG RETIN EYE RES, V16, P323, DOI 10.1016/S1350-9462(96)00029-8; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Hartsock A, 2014, DEV BIOL, V394, P327, DOI 10.1016/j.ydbio.2014.07.024; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Jung SH, 2016, BRIT J PHARMACOL, V173, P15, DOI 10.1111/bph.13279; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; Kelley MW, 1999, NEUROREPORT, V10, P2389, DOI 10.1097/00001756-199908020-00031; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; KREMPF M, 1991, INT J VITAM NUTR RES, V61, P38; Le HGT, 2012, VISUAL NEUROSCI, V29, P219, DOI 10.1017/S0952523812000296; LOHNES D, 1994, DEVELOPMENT, V120, P2723; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; McDowell RE, 2016, INVEST OPHTH VIS SCI, V57, P4762, DOI 10.1167/iovs.16-19424; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; Mueller K. P., 2011, JOVE-J VIS EXP, V56, P3556; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Rinner O, 2005, INVEST OPHTH VIS SCI, V46, P137, DOI 10.1167/iovs.04-0682; RUSSO JE, 1988, BIOCHEM PHARMACOL, V37, P1639, DOI 10.1016/0006-2952(88)90030-5; STENKAMP DL, 1993, INVEST OPHTH VIS SCI, V34, P2425; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Trasino SE, 2016, DIABETES OBES METAB, V18, P142, DOI 10.1111/dom.12590; Trasino SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15893; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wendling O, 2000, DEVELOPMENT, V127, P1553; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zhou YL, 2016, NEUROCHEM RES, V41, P813, DOI 10.1007/s11064-015-1756-1	45	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5674	5684		10.1096/fj.201701469R	http://dx.doi.org/10.1096/fj.201701469R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29874129	Bronze, Green Published			2022-12-28	WOS:000447972500039
J	Narayanan, SA; Metzger, CE; Bloomfield, SA; Zawieja, DC				Narayanan, S. Anand; Metzger, Corinne E.; Bloomfield, Susan A.; Zawieja, David C.			Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease	FASEB JOURNAL			English	Article						Crohn's disease; immunolymph; osteoimmunology; therapeutic intervention	TNBS-INDUCED COLITIS; SKELETAL-MUSCLE; MYOKINE IRISIN; IN-VITRO; LYMPHANGIOGENESIS; EXERCISE; EXPRESSION; MICE; PODOPLANIN; CYTOKINES	Inflammatory bowel disease (IBD) is a chronic disease with gastrointestinal dysfunction as well as comorbidities such as inflammation-induced bone loss and impaired immune response. Current treatments for IBD all have negative, potentially severe side effects. We aimed to test whether exogenous treatment with irisin, a novel immunomodulatory adipomyokine, could ameliorate IBD-induced lymphatic and bone alterations. Irisin treatment improved both gut and bone outcomes by mitigating inflammation and restoring structure. In the gut, IBD caused colonic lymphatic hyperproliferation into the mucosal and submucosal compartments. This proliferation in the rodent model is akin to what is observed in IBD patient case studies. In bone, IBD increased osteoclast surface and decreased bone formation. Both gut and osteocytes in bone exhibited elevated levels of TNF- and receptor activator of NF-B ligand (RANKL) protein expression. Exogenous irisin treatment restored normal colonic lymphatic architecture and increased bone formation rate concurrent with decreased osteoclast surfaces. After irisin treatment, gut and osteocyte TNF- and RANKL protein expression levels were no different from vehicle controls. Our data indicate that the systemic immunologic changes that occur in IBD are initiated by damage in the gut and likely linked through the lymphatic system. Additionally, irisin is a potential novel intervention mitigating both local inflammatory changes in the gut and distant changes in bone.Narayanan, S. A., Metzger, C. E., Bloomfield, S. A., Zawieja, D. C. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease.	[Narayanan, S. Anand; Zawieja, David C.] Texas A&M Univ, Dept Med Physiol, Hlth Sci Ctr, Temple, TX USA; [Metzger, Corinne E.; Bloomfield, Susan A.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Narayanan, SA (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Reynolds 339, College Stn, TX 77843 USA.; Metzger, CE (corresponding author), Bone Biol Lab 217,Heep Lab Bldg, College Stn, TX 77843 USA.	anarayan09@gmail.com; metzgercorinne@gmail.com			Department of Medical Physiology; Texas A&M University College of Education and Human Development Transforming Lives Seed Grant; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [U01HL123420]; Sydney and J.L. Huffines Institute for Sports Medicine and Human Performance; National Space Biomedical Research Institute Space Life Sciences Fellowship [NCC 9-58]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL123420] Funding Source: NIH RePORTER	Department of Medical Physiology; Texas A&M University College of Education and Human Development Transforming Lives Seed Grant; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sydney and J.L. Huffines Institute for Sports Medicine and Human Performance; National Space Biomedical Research Institute Space Life Sciences Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the Texas A&M University Health Science Center Integrated Microscope and Imaging Laboratory (supported by the Department of Medical Physiology) in providing the resources utilized in this work for immunofluorescence imaging. This work was supported by Texas A&M University College of Education and Human Development Transforming Lives Seed Grant (to S.A.B.), and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant U01HL123420 (to D.C.Z.). Additional funds were provided by the Sydney and J.L. Huffines Institute for Sports Medicine and Human Performance (to C.E.M.). S.A.N. was supported, in part, by the National Space Biomedical Research Institute Space Life Sciences Fellowship (NCC 9-58). The authors declare no conflicts of interest.	Agollah GD, 2015, WORLD J GASTROENTERO, V21, P12767, DOI 10.3748/wjg.v21.i45.12767; Agrawal Manasi, 2011, Curr Osteoporos Rep, V9, P251, DOI 10.1007/s11914-011-0077-9; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Antoniou E, 2016, ANN MED SURG, V11, P9, DOI 10.1016/j.amsu.2016.07.019; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Atzeni F, 2013, AUTOIMMUN REV, V12, P703, DOI 10.1016/j.autrev.2012.10.021; Baek K, 2014, J CELL PHYSIOL, V229, P640, DOI 10.1002/jcp.24487; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bjarnason I, 1997, GUT, V40, P228, DOI 10.1136/gut.40.2.228; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chen WS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11302; Chen YX, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12364; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; COOPER HS, 1993, LAB INVEST, V69, P238; Cordeiro OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151848; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Cromer W, 2015, INFLAMM BOWEL DIS, V21, P1553, DOI 10.1097/MIB.0000000000000402; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ding T, 2007, FUT RHEUMATOL, V2, P587, DOI DOI 10.2217/17460816.2.6.587; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Ebert T, 2014, EUR J ENDOCRINOL, V170, P501, DOI 10.1530/EJE-13-1053; Fakhoury M, 2014, J INFLAMM RES, V7, P113, DOI 10.2147/JIR.S65979; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Ganta VC, 2010, INFLAMM BOWEL DIS, V16, P1029, DOI 10.1002/ibd.21150; Geleff S, 2003, VIRCHOWS ARCH, V442, P231, DOI 10.1007/s00428-002-0744-4; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hofbauer LC, 1998, BIOCHEM BIOPH RES CO, V250, P776, DOI 10.1006/bbrc.1998.9394; Hos D, 2016, AM J PATHOL, V186, P159, DOI 10.1016/j.ajpath.2015.09.012; Ji H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5944; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Ko JK, 2014, CURR PHARM DESIGN, V20, P1082, DOI 10.2174/13816128113199990416; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Liao S, 2014, ANGIOGENESIS, V17, P325, DOI 10.1007/s10456-014-9416-7; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Malmborg P, 2016, J INTERN MED, V279, P241, DOI 10.1111/joim.12413; Manolagas SC, 2013, BONE, V54, P272, DOI 10.1016/j.bone.2012.09.017; Matsuo Y, 2015, J CACHEXIA SARCOPENI, V6, P62, DOI 10.1002/jcsm.12006; Mazur-Bialy AI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040701; Metzger CE, 2017, J BONE MINER RES, V32, P802, DOI 10.1002/jbmr.3027; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MOONEY EE, 1995, J CLIN PATHOL, V48, P335, DOI 10.1136/jcp.48.4.335; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Moschen AR, 2005, GUT, V54, P479, DOI 10.1136/gut.2004.044370; Qiao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18732; Rahier JF, 2011, ALIMENT PHARM THER, V34, P533, DOI 10.1111/j.1365-2036.2011.04759.x; Seibel MJ, 2013, LANCET DIABETES ENDO, V1, P59, DOI 10.1016/S2213-8587(13)70045-7; Shao L, 2017, BIOCHEM BIOPH RES CO, V487, P194, DOI 10.1016/j.bbrc.2017.04.020; Shin K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7196; Tan SD, 2006, J DENT RES, V85, P905, DOI 10.1177/154405910608501006; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011; Zawieja David C., 2009, Lymphatic Research and Biology, V7, P87, DOI 10.1089/lrb.2009.0007; Zhang J, 2017, BONE RES, V5, DOI 10.1038/boneres.2016.56; Zhang YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158038	64	35	36	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4848	4861		10.1096/fj.201800178R	http://dx.doi.org/10.1096/fj.201800178R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29596023	Bronze, Green Published			2022-12-28	WOS:000443817700020
J	Zhou, J; Zhao, LL; Yu, HY; Wang, YH; Zhang, W; Hu, SN; Zou, Z; Sun, JH				Zhou, Jiao; Zhao, Li-Lin; Yu, Hai-Ying; Wang, Yan-Hong; Zhang, Wei; Hu, Song-Nian; Zou, Zhen; Sun, Jiang-Hua			Immune tolerance of vector beetle to its partner plant parasitic nematode modulated by its insect parasitic nematode	FASEB JOURNAL			English	Article						tracheal immunity; antioxidative genes; Toll receptors; pinewood nematode	PINEWOOD NEMATODE; MONOCHAMUS-CAROLINENSIS; DUAL OXIDASE; DROSOPHILA; RESPONSES; ACTIVATION; INFECTION; PROTEIN; SYSTEM; LIFE	Immune response of insect vectors to transmitted pathogens or insect hosts against parasites are well studied, whereas the mechanism of tripartite interactions remains elusive. In this study, we investigated the immune interactions of the vector beetle Monochamus alternatus (Ma) to the devastating plant parasitic nematode Bursaphelenchus xylophilus (Bx) and the insect parasitic nematode Howardula phyllotretae (Hp). We report the unique immune mechanism by which the vector beetle tolerates many devastating Bx in its trachea, yet that immune tolerance is compromised by the parasitic nematode Hp. Contact with either nematode species triggers epithelial reactive oxygen species (ROS) production in Ma. Only the entry of Bx, not Hp, infection, induces increased expression of antioxidative genes, through which the ROS levels are balanced in the trachea of beetles. Furthermore, we found that up-regulation of antioxidative genes was induced by the interaction of Toll receptors. In contrast, beetles infected by Hp retain high levels of oxidative stress and melanization in trachea, and as a result, decrease Bx loading. This study highlights the role of Toll receptors in mediating the activation of antioxidative genes in immune tolerance to plant parasitic nematodes, and suggests the use of insect parasites as a biologic control.Zhou, J., Zhao, L.-L., Yu, H.-Y., Wang, Y.-H., Zhang, W., Hu, S.-N., Zou, Z., Sun, J.-H. Immune tolerance of vector beetle to its partner plant parasitic nematode modulated by its insect parasitic nematode.	[Zhou, Jiao; Zhao, Li-Lin; Wang, Yan-Hong; Zhang, Wei; Zou, Zhen; Sun, Jiang-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Yu, Hai-Ying; Hu, Song-Nian] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zou, Zhen; Sun, Jiang-Hua] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zou, Z; Sun, JH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zouzhen@ioz.ac.cn; sunjh@ioz.ac.cn	Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; Wang, Yin/HCI-9352-2022; zou, zhen/C-6134-2016; wang, yan/GSE-6489-2022; wangwangwang, yuanyaun/HHN-6432-2022	zou, zhen/0000-0003-3550-7656; Zhao, Lilin/0000-0002-3706-1267; Zhang, Wei/0000-0001-9580-6266; sun, jianghua/0000-0002-9465-3672	National Key Plan for Scientific Research and Development of China [2016YFC1200600, 2016YFD0500300, 2017YFD0200400]; National Natural Science Foundation of China [NSFC31572272, 31630013, 31672291, 31402013]; Chinese Academy of Sciences (CAS) Key Research Projects of the Frontier Science [QYZDB-SSW-SMC014, QYZDJ-SSW-SMC024]; China Postdoctoral Science Foundation [214M561058]	National Key Plan for Scientific Research and Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS) Key Research Projects of the Frontier Science; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is funded by the National Key Plan for Scientific Research and Development of China (2016YFC1200600, 2016YFD0500300, 2017YFD0200400), National Natural Science Foundation of China (NSFC31572272, 31630013, 31672291, 31402013), the Chinese Academy of Sciences (CAS) Key Research Projects of the Frontier Science (QYZDB-SSW-SMC014, QYZDJ-SSW-SMC024), and a Financial Grant from the China Postdoctoral Science Foundation (214M561058). The authors declare no conflicts of interest.	Aliota MT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000963; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Banerjee U, 2008, PROTOC EXCH, V10, P1, DOI [DOI 10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bednarova A, 2013, PHYSIOL ENTOMOL, V38, P54, DOI 10.1111/phen.12008; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Castillo JC, 2011, TRENDS PARASITOL, V27, P537, DOI 10.1016/j.pt.2011.09.001; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hamilton PT, 2014, MOL ECOL, V23, P1558, DOI 10.1111/mec.12603; Harris HL, 2010, SYMBIOSIS, V51, P37, DOI 10.1007/s13199-010-0065-3; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Katiyar D, 2011, CURR MED CHEM, V18, P2174, DOI 10.2174/092986711795656234; Kim BY, 2008, COMP BIOCHEM PHYS B, V150, P161, DOI 10.1016/j.cbpb.2008.02.009; Kim SH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00116; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Meng Q, 2015, INSECT BIOCHEM MOLEC, V64, P1, DOI 10.1016/j.ibmb.2015.06.014; Mota M., 2008, PINE WILT DIS WORLDW; Necibi S, 1998, J NEMATOL, V30, P246; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OLDHAM J. N., 1933, JOUR HELMINTHOL, V11, P119, DOI 10.1017/S0022149X00001796; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Perez-Lopez A, 2016, NAT REV IMMUNOL, V16, P135, DOI 10.1038/nri.2015.17; Richman A, 1996, CURR OPIN IMMUNOL, V8, P14, DOI 10.1016/S0952-7915(96)80099-9; Shapiro-Ilan DI, 2006, BIOL CONTROL, V38, P124, DOI 10.1016/j.biocontrol.2005.09.005; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931; WARREN JE, 1993, J NEMATOL, V25, P703; Wu SC, 2012, CELL HOST MICROBE, V11, P410, DOI 10.1016/j.chom.2012.03.004; Xiong GH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1509-1; Yaman Mustafa, 2002, Journal of Asia-Pacific Entomology, V5, P233, DOI 10.1016/S1226-8615(08)60159-4; Yuan CF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006645; Zhao LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12341; Zhao LL, 2014, TRENDS PARASITOL, V30, P299, DOI 10.1016/j.pt.2014.04.007; Zhao LL, 2013, CURR BIOL, V23, P2038, DOI 10.1016/j.cub.2013.08.041; Zhou J, 2017, INSECT SCI; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177; Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394	59	8	11	1	44	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4862	4877		10.1096/fj.201800247R	http://dx.doi.org/10.1096/fj.201800247R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29608332	Bronze			2022-12-28	WOS:000443817700021
J	Bastos, MF; Kayano, ACAV; Silva, JL; Dos-Santos, JCK; Judice, C; Blanco, YC; Shryock, N; Sercundes, MK; Ortolan, LS; Francelin, C; Leite, JA; Oliveira, R; Elias, RM; Camara, NOS; Lopes, SCP; Albrecht, L; Farias, AS; Vicente, CP; Werneck, CC; Giorgio, S; Verinaud, L; Epiphanio, S; Marinho, CRF; Lalwani, P; Amino, R; Aliberti, J; Costa, FTM				Bastos, Marcele F.; Kayano, Ana Carolina A. V.; Silva-Filho, Joao Luiz; Dos-Santos, Joao Conrado K.; Judice, Carla; Blanco, Yara C.; Shryock, Nathaniel; Sercundes, Michelle K.; Ortolan, Luana S.; Francelin, Carolina; Leite, Juliana A.; Oliveira, Rafaella; Elias, Rosa M.; Camara, Niels O. S.; Lopes, Stefanie C. P.; Albrecht, Letusa; Farias, Alessandro S.; Vicente, Cristina P.; Werneck, Claudio C.; Giorgio, Selma; Verinaud, Liana; Epiphanio, Sabrina; Marinho, Claudio R. F.; Lalwani, Pritesh; Amino, Rogerio; Aliberti, Julio; Costa, Fabio T. M.			Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria	FASEB JOURNAL			English	Article						brain; aryl-hydrocarbon receptor; tryptophan metabolism; endothelial cell activation	ARYL-HYDROCARBON RECEPTOR; INDUCIBLE FACTOR-I; BLOOD-BRAIN-BARRIER; CD8(+) T-CELLS; HEME OXYGENASE-1; COGNITIVE IMPAIRMENT; PATHWAY METABOLISM; AFRICAN CHILDREN; INFLAMMATION; SEQUESTRATION	Cerebral malaria (CM) is a multifactorial syndrome involving an exacerbated proinflammatory status, endothelial cell activation, coagulopathy, hypoxia, and accumulation of leukocytes and parasites in the brain microvasculature. Despite significant improvements in malaria control, 15% of mortality is still observed in CM cases, and 25% of survivors develop neurologic sequelae for lifeeven after appropriate antimalarial therapy. A treatment that ameliorates CM clinical signs, resulting in complete healing, is urgently needed. Previously, we showed a hyperbaric oxygen (HBO)-protective effect against experimental CM. Here, we provide molecular evidence that HBO targets brain endothelial cells by decreasing their activation and inhibits parasite and leukocyte accumulation, thus improving cerebral microcirculatory blood flow. HBO treatment increased the expression of aryl hydrocarbon receptor over hypoxia-inducible factor 1- (HIF-1), an oxygen-sensitive cytosolic receptor, along with decreased indoleamine 2,3-dioxygenase 1 expression and kynurenine levels. Moreover, ablation of HIF-1 expression in endothelial cells in mice conferred protection against CM and improved survival. We propose that HBO should be pursued as an adjunctive therapy in CM patients to prolong survival and diminish deleterious proinflammatory reaction. Furthermore, our data support the use of HBO in therapeutic strategies to improve outcomes of non-CM disorders affecting the brain.Bastos, M. F., Kayano, A. C. A. V., Silva-Filho, J. L., Dos-Santos, J. C. K., Judice, C., Blanco, Y. C., Shryock, N., Sercundes, M. K., Ortolan, L. S., Francelin, C., Leite, J. A., Oliveira, R., Elias, R. M., Camara, N. O. S., Lopes, S. C. P., Albrecht, L., Farias, A. S., Vicente, C. P., Werneck, C. C., Giorgio, S., Verinaud, L., Epiphanio, S., Marinho, C. R. F., Lalwani, P., Amino, R., Aliberti, J., Costa, F. T. M. Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.	[Bastos, Marcele F.; Kayano, Ana Carolina A. V.; Silva-Filho, Joao Luiz; Dos-Santos, Joao Conrado K.; Judice, Carla; Blanco, Yara C.; Leite, Juliana A.; Lopes, Stefanie C. P.; Albrecht, Letusa; Farias, Alessandro S.; Costa, Fabio T. M.] Univ Estadual Campinas, Dept Genet Evolut Microbiol & Immunol, Lab Trop Dis Prof Dr Luiz Jacintho da Silva, Campinas, SP, Brazil; [Francelin, Carolina; Verinaud, Liana] Univ Estadual Campinas, Dept Funct & Struct Biol, Campinas, SP, Brazil; [Werneck, Claudio C.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Campinas, SP, Brazil; [Giorgio, Selma] Univ Estadual Campinas, Dept Anim Biol, Campinas, SP, Brazil; [Shryock, Nathaniel; Aliberti, Julio] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Sercundes, Michelle K.; Ortolan, Luana S.; Vicente, Cristina P.; Epiphanio, Sabrina] Univ Sao Paulo, Dept Clin & Toxicol Anal, Sao Paulo, Brazil; [Elias, Rosa M.; Camara, Niels O. S.] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil; [Marinho, Claudio R. F.] Univ Sao Paulo, Dept Parasitol, Sao Paulo, Brazil; [Oliveira, Rafaella; Lopes, Stefanie C. P.; Lalwani, Pritesh] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Albrecht, Letusa] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Amino, Rogerio] Inst Pasteur, Unit Malaria Infect & Immun, Paris, France; [Aliberti, Julio] NIAID, Div Extramural Act, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Cincinnati Children's Hospital Medical Center; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Aliberti, J (corresponding author), NIAID, Div Extramural Act, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Aliberti, J (corresponding author), NIAID, Sci Review Program, Div Extramural Act, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Costa, FTM (corresponding author), Univ Estadual Campinas, Dept Genet Evolut Microbiol & Immunol, Lab Trop Dis Prof Dr Luiz Jacintho da Silva, UNICAMP, Rua Monteiro Lobato 255, BR-13083862 Campinas, SP, Brazil.	julio.aliberti@nih.gov; costaftm@unicamp.br	Werneck, Claudio C/C-7568-2012; Marinho, Claudio Romero Farias/F-7507-2012; Farias, Alessandro/AAH-2228-2020; Farias, Alessandro/C-6879-2012; dos Santos Ortolan, Luana/AAU-3092-2021; Camara, Niels OS/G-8336-2011; Epiphanio, Sabrina/C-7572-2012; Silva-Filho, João Luiz/I-5704-2016; Vicente, Cristina/D-8928-2012; Epiphanio, Sabrina/S-2564-2019; giorgio, selma/AAU-5377-2021; Albrecht, Letusa/I-1837-2012; camara, niels olsen saraiva/AAX-3269-2020; Francelin, Carolina/AAZ-9572-2020; Costa, Fabio/E-1181-2012	Werneck, Claudio C/0000-0002-9413-0572; Marinho, Claudio Romero Farias/0000-0002-1227-3845; Farias, Alessandro/0000-0001-6759-1819; Farias, Alessandro/0000-0001-6759-1819; Camara, Niels OS/0000-0001-5436-1248; Epiphanio, Sabrina/0000-0001-6094-9750; Silva-Filho, João Luiz/0000-0003-4762-2205; Vicente, Cristina/0000-0001-9896-4630; Epiphanio, Sabrina/0000-0001-6094-9750; Albrecht, Letusa/0000-0001-6406-2057; camara, niels olsen saraiva/0000-0001-5436-1248; Francelin, Carolina/0000-0001-7439-3124; Costa, Fabio/0000-0001-9969-7300; Lalwani, Pritesh/0000-0003-2996-0446; Lopes, Stefanie/0000-0002-6981-2192; dos Santos Ortolan, Luana/0000-0003-1153-9987	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/16525-2, 2014/20451-0, 2016/07030-0, 2016/12855-9]; FAPESP; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI118302-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI118302] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2012/16525-2 (to F.T.M.C.), 2014/20451-0 (to S.E.), 2016/07030-0 (to C.R.F.M.), and 2016/12855-9 (to J.L.S-F.); FAPESP (http://www.fapesp.br/en/); and U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant AI118302-02. A.S.F., C.C.W., S.G., L.V., S.E., C.R.F.M., and F.T.M.C. are Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq) research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Blanco YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003126; Brant F, 2014, INFECT IMMUN, V82, P3127, DOI 10.1128/IAI.01733-14; Cabrales P, 2013, VIRULENCE, V4, P686, DOI 10.4161/viru.26348; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Dondorp AM, 2003, REDOX REP, V8, P292, DOI 10.1179/135100003225002934; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Fecher RA, 2016, J IMMUNOL, V197, P565, DOI 10.4049/jimmunol.1600342; Feldmeier J., 2003, HYPERBARIC OXYGEN 20; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hempel C, 2011, AM J PATHOL, V179, P1939, DOI 10.1016/j.ajpath.2011.06.027; Howland SW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004963; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Howland SW, 2015, SEMIN IMMUNOPATHOL, V37, P221, DOI 10.1007/s00281-015-0476-6; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Hunt NH, 2007, NAT MED, V13, P667, DOI 10.1038/nm0607-667; Hunt NH, 2017, NEUROPHARMACOLOGY, V112, P389, DOI 10.1016/j.neuropharm.2016.02.029; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jacob A, 2015, J NEUROCHEM, V132, P373, DOI 10.1111/jnc.12972; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; John CC, 2008, AM J TROP MED HYG, V78, P198, DOI 10.4269/ajtmh.2008.78.198; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Lacerda-Queiroz N, 2010, EXP PARASITOL, V125, P271, DOI 10.1016/j.exppara.2010.02.002; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McBerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038384; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Moxon CA, 2013, BLOOD, V122, P842, DOI 10.1182/blood-2013-03-490219; Neubauer JA, 2012, RESP PHYSIOL NEUROBI, V184, P178, DOI 10.1016/j.resp.2012.06.027; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Owe-Young R, 2008, J NEUROCHEM, V105, P1346, DOI 10.1111/j.1471-4159.2008.05241.x; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Strasser B, 2017, NEUROPHARMACOLOGY, V112, P286, DOI 10.1016/j.neuropharm.2016.02.030; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Vignau J, 2004, BIOMED CHROMATOGR, V18, P872, DOI 10.1002/bmc.445; Vorrink SU, 2014, CHEM-BIOL INTERACT, V218, P82, DOI 10.1016/j.cbi.2014.05.001; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; WHO, 2015, WORLD MAL REP 2015; Zhang XQ, 2009, J CHROMATOGR B, V877, P1678, DOI 10.1016/j.jchromb.2009.04.013	54	3	5	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4470	4481		10.1096/fj.201700844R	http://dx.doi.org/10.1096/fj.201700844R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29558201	Green Published			2022-12-28	WOS:000439325400034
J	Tajpara, P; Schuster, C; Schon, E; Kienzl, P; Vierhapper, M; Mildner, M; Elbe-Burger, A				Tajpara, Pooja; Schuster, Christopher; Schoen, Elisabeth; Kienzl, Philip; Vierhapper, Martin; Mildner, Michael; Elbe-Buerger, Adelheid			Epicutaneous administration of the pattern recognition receptor agonist polyinosinic-polycytidylic acid activates the MDA5/MAVS pathway in Langerhans cells	FASEB JOURNAL			English	Article						therapeutic vaccination; skin; tape stripping; downstream signaling; nuclear translocation	DOUBLE-STRANDED-RNA; INTERFERON REGULATORY FACTOR-3; DERMAL DENDRITIC CELLS; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; HUMAN KERATINOCYTES; SKIN MODEL; CONTACT HYPERSENSITIVITY; EPIDERMAL-KERATINOCYTES	Together with keratinocytes (KCs) and the dense network of Langerhans cells (LCs), the epidermis is an ideal portal for vaccine delivery. Pattern recognition receptor agonists, in particular polyinosinic-polycytidylic acid [p(I:C)], are promising adjuvant candidates for therapeutic vaccination to generate protective T-cell immunity. Here we established an ex vivo skin explant model to study the expression and activation of double-stranded RNA (dsRNA)-sensing pattern recognition receptors in LCs and KCs in human skin. Whereas KCs expressed all known dsRNA sensing receptors at a constitutive and inducible level, LCs exclusively expressed melanoma differentiation-associated protein 5 (MDA5) in untreated skin and freshly isolated cells. Comparative assessments of downstream signaling pathways induced by p(I:C) revealed distinct mitochondrial antiviral-signaling protein, IFN-regulatory factor 3, and NF-B activation in LCs and KCs. Consequently, p(I:C) treatment of LCs significantly induced IFN- and IFN- mRNA expression, while in KCs an up-regulation of IFN- and TNF- mRNA was detectable. Stimulation of LCs with specific ligands revealed that not the TLR3- but only the MDA5-specific ligand induced IFN-2, IFN-, and TNF- cytokines, but no IL-6 and -8. In KCs, both ligands induced production of high IL-6 and IL-8 levels, and low IFN-2 and IFN- levels, indicating that different dsRNA-sensing receptors and/or downstream signaling pathways are activated in both cell types. Our data suggest that MDA5 may be an attractive adjuvant target for epicutaneous delivery of therapeutic vaccines with the goal to target LCs.Tajpara, P., Schuster, C., Schon, E., Kienzl, P., Vierhapper, M., Mildner, M., Elbe-Burger, A. Epicutaneous administration of the pattern recognition receptor agonist polyinosinic-polycytidylic acid activates the MDA5/MAVS pathway in Langerhans cells.	[Tajpara, Pooja; Schuster, Christopher; Schoen, Elisabeth; Kienzl, Philip; Elbe-Buerger, Adelheid] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Lab Cellular & Mol Immunobiol Skin, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; [Vierhapper, Martin] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Mildner, Michael] Med Univ Vienna, Res Div Biol & Pathobiol Skin, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Elbe-Burger, A (corresponding author), Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Lab Cellular & Mol Immunobiol Skin, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.; Mildner, M (corresponding author), Med Univ Vienna, Res Div Biol & Pathobiol Skin, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	michael.mildner@meduniwien.ac.at; adelheid.elbe-buerger@meduniwien.ac.at		Kienzl, Philip/0000-0002-0114-6904	Austrian Science Fund (FWF) [DK W1248-B30]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) DK W1248-B30. The authors thank W. Bauer, B. Reininger, J. Strobl and M. Buchberger (Department of Dermatology, Medical University of Vienna) for excellent help with the sorting and analysis of epidermal cells. The authors are grateful for helpful discussions with J. Stockl (Institute of Immunology, Medical University of Vienna) and R. de Martin (Department of Vascular Biology and Thrombosis Research, Medical University of Vienna). The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Furio L, 2009, J INVEST DERMATOL, V129, P1963, DOI 10.1038/jid.2009.21; Gnjatic S, 2010, CANCER J, V16, P382, DOI 10.1097/PPO.0b013e3181eaca65; Heaton SM, 2016, J EXP MED, V213, P1, DOI 10.1084/jem.20151531; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iram N, 2012, DEVELOPMENT, V139, P4210, DOI 10.1242/dev.083477; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Jacobs JL, 2013, J MOL BIOL, V425, P5009, DOI 10.1016/j.jmb.2013.10.007; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Meusel TR, 2002, J IMMUNOL, V168, P6429, DOI 10.4049/jimmunol.168.12.6429; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Miller LS, 2007, SEMIN IMMUNOPATHOL, V29, P15, DOI 10.1007/s00281-007-0061-8; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Oosterhoff D, 2013, J IMMUNOL, V190, P3338, DOI 10.4049/jimmunol.1200598; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Renn CN, 2006, J IMMUNOL, V177, P298, DOI 10.4049/jimmunol.177.1.298; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Schlupp P, 2014, Results Pharma Sci, V4, P26, DOI 10.1016/j.rinphs.2014.09.002; Seneschal J, 2014, J INVEST DERMATOL, V134, P686, DOI 10.1038/jid.2013.418; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Strittmatter GE, 2016, J INVEST DERMATOL, V136, P610, DOI 10.1016/j.jid.2015.12.022; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; Wang XY, 2013, PHOTODERMATOL PHOTO, V29, P41, DOI 10.1111/phpp.12011; Wellmann S, 2001, CLIN CHEM, V47, P654; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105	61	9	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4132	4144		10.1096/fj.201701090R	http://dx.doi.org/10.1096/fj.201701090R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509510	hybrid, Green Published			2022-12-28	WOS:000439325400007
J	Kim, D; Cho, S; Woo, JA; Liggett, SB				Kim, Donghwa; Cho, Soomin; Woo, Jung A.; Liggett, Stephen B.			A CREB-mediated increase in miRNA let-7f during prolonged -agonist exposure: a novel mechanism of (2)-adrenergic receptor down-regulation in airway smooth muscle	FASEB JOURNAL			English	Article						G protein; tachyphylaxis; asthma; microRNA	BITTER TASTE RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; BETA-2-ADRENERGIC RECEPTOR; EXPRESSION; ASTHMA; PHOSPHORYLATION; SUBSENSITIVITY; SALMETEROL; CELLS; DESENSITIZATION	(2)-Adrenergic receptors ((2)ARs) desensitize during continuous agonist activation, which manifests clinically as tachyphylaxis. -Agonist desensitization of (2)ARs in human airway smooth muscle (HASM) cells is recognized in the treatment of asthma and may be related to poor outcomes. Rapid events in desensitization include receptor phosphorylation and internalization, but mechanisms responsible for the decrease in receptor protein after prolonged agonist exposure (down-regulation) are ill defined. The microRNA (miRNA) let-7f regulates (2)AR expression by translational repression. In cultured HASM cells from nonasthmatic and asthmatic lungs, 18 h of -agonist exposure increased let-7f by 2-3-fold, concomitant with a approximate to 90% decrease in (2)ARs. Inhibition of let-7f attenuated this down-regulation response by approximate to 50%. The let-7f increase was found to be cAMP/PKA-dependent. The mechanism of the let-7f increase was found by chromatin immunoprecipitation to be from activated cAMP response element-binding protein (CREB) binding to the let-7f promoter, thereby increasing let-7f expression. Knockdown of CREB attenuated agonist-promoted (2)AR down-regulation by approximate to 50%. Thus, (2)AR down-regulation occurs as a result of not only internalized receptor degradation but also a novel cAMP/PKA/CREB-mediated increase in let-7f, which causes enhanced repression of the (2)AR gene, adrenoreceptor (2) (ADRB2) translation and represents approximate to 50% of the net loss of receptors observed after prolonged agonist exposure. This mechanism is apparent in asthmatic HASM cells, indicating relevance in a disease model.Kim, D., Cho, S., Woo, J. A., Liggett, S. B. A CREB-mediated increase in miRNA let-7f during prolonged -agonist exposure: a novel mechanism of (2)-adrenergic receptor down-regulation in airway smooth muscle.	[Kim, Donghwa; Cho, Soomin] Univ S Florida, Ctr Personalized Med, Morsani Coll Med, Tampa, FL 33635 USA; [Woo, Jung A.; Liggett, Stephen B.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33635 USA; [Liggett, Stephen B.] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33635 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liggett, SB (corresponding author), Univ S Florida, 12901 Bruce B Downs Blvd,MDC 2, Tampa, FL 33635 USA.	sliggett@health.usf.edu	Kim, Donghwa/AAJ-8148-2021	Kim, Donghwa/0000-0002-8994-8513; Liggett, Stephen B./0000-0002-0128-3669; Woo, Jung A/0000-0002-9194-1361	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL045967, HL114471]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL045967, R37HL045967, P01HL114471, R01HL045967] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Ashley Goss, Maria Castano, and Tara Rosin for technical assistance, and Lisa Steward for manuscript preparation and editing (all from the University of South Florida). This work was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL045967 and HL114471. The authors declare no conflicts of interest.	Aisenberg WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38231; An SS, 2016, J ALLERGY CLIN IMMUN, V138, P294, DOI 10.1016/j.jaci.2015.12.1315; Barnes NA, 2012, J IMMUNOL, V189, P253, DOI 10.4049/jimmunol.1101563; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Booth H, 1996, THORAX, V51, P1100, DOI 10.1136/thx.51.11.1100; BOUVIER M, 1989, J BIOL CHEM, V264, P16786; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; GRAINGER J, 1991, THORAX, V46, P105, DOI 10.1136/thx.46.2.105; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HARVEY JE, 1982, THORAX, V37, P280, DOI 10.1136/thx.37.4.280; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Kalra S, 1996, CHEST, V109, P953, DOI 10.1378/chest.109.4.953; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; LIGGETT SB, 1991, PHARMACOL RES, V24, P29, DOI 10.1016/1043-6618(91)90119-I; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Lipworth BJ, 1997, DRUG SAFETY, V16, P295, DOI 10.2165/00002018-199716050-00002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; McGraw DW, 2001, AM J PHYSIOL-LUNG C, V281, pL895, DOI 10.1152/ajplung.2001.281.4.L895; Mizuta K, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-89; Moore RH, 1999, J CELL SCI, V112, P329; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; NEWNHAM DM, 1995, THORAX, V50, P497, DOI 10.1136/thx.50.5.497; Panebra A, 2008, AM J PHYSIOL-LUNG C, V294, pL190, DOI 10.1152/ajplung.00277.2007; Panebra A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011819; Perez JM, 2003, NAT MED, V9, P1300, DOI 10.1038/nm930; Qiu ZJ, 2009, J BIOL CHEM, V284, P13099, DOI 10.1074/jbc.M807307200; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sears MR, 1998, LUNG BIOL HEALTH DIS, V115, P457; Swift SM, 2007, AM J RESP CELL MOL, V36, P236, DOI 10.1165/rcmb.2006-0257OC; Wang WCH, 2011, P NATL ACAD SCI USA, V108, P6246, DOI 10.1073/pnas.1101439108; Xue H, 2016, ONCOL REP, V35, P1771, DOI 10.3892/or.2016.4548	43	9	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3680	3688		10.1096/fj.201701278R	http://dx.doi.org/10.1096/fj.201701278R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29455573	Green Published			2022-12-28	WOS:000435104500016
J	Wu, HL; Zhao, YC; Huang, QL; Cai, MX; Pan, Q; Fu, MS; An, XH; Xia, ZJ; Liu, M; Jin, Y; He, L; Shang, J				Wu, Huali; Zhao, Yucheng; Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Xia, Zhenjiang; Liu, Meng; Jin, Yu; He, Ling; Shang, Jing			NK 1R/5-HT1AR interaction is related to the regulation of melanogenesis	FASEB JOURNAL			English	Article						protein-protein interaction; signaling cascades; NK1R; 5-HT1AR; heterdimerization	RESONANCE ENERGY-TRANSFER; CELL-SURFACE EXPRESSION; SUBSTANCE-P; SEROTONIN RECEPTORS; MELANIN SYNTHESIS; TRYPTOPHAN-HYDROXYLASE; NEUROKININ-1 RECEPTOR; TRANSCRIPTION FACTOR; DISULFIDE BONDS; UP-REGULATION	Substance P (SP) is a candidate mediator along the brain-skin axis and can mimic the effects of stress to regulate melanogenesis. Previously, we and others have found that the regulation of SP for pigmentary function was mediated by neurokinin 1 receptor (NK1R). Emerging evidence has accumulated that psychologic stress can induce dysfunction in the cutaneous serotonin 5-hydroxytryptamine (5-HT)-5-HT1A/1B receptor system, thereby resulting in skin hypopigmentation. Moreover, NK1R and 5-HTR (except 5-HT3) belong to GPCR. The present study aimed at assessing the possible existence of NK1R-5-HTR interactions and related melanogenic functions. Western blot and PCR detection revealed that SP reduced expression of 5-HT1A receptor via the NK1 receptor. Biochemical analyses showed that NK1R and 5-HT1AR could colocalize and interact in a cell and in the skin. When the N terminus of the NK1R protein was removed NK1R surface targeting was prevented, the interaction between NK1R-5-HT1AR decreased, and the depigmentation caused by SP and WAY100635 could be rescued. Importantly, pharmaceutical coadministration of NK1R agonist (SP) and 5-HT1A antagonist (WAY100635) enhanced the NK1-5-HT1A receptor coimmunoprecipitation along with the depigmentary response. SP and WAY100635 cooperation elicited activation of a signaling cascade (the extracellular, regulated protein kinase p-JNK signaling pathway) and inhibition of p70S6K1 phosphorylation and greatly reduced melanin production in vitro and in vivo in mice and zebrafish. Moreover, the SP-induced depigmentation response did not be occur in 5-htr1aa(+/-)zebrafish embryos. Taken together, the results of our systemic study increases our knowledge of the roles of NK1R and 5-HT1AR in melanogenesis and provides possible, novel therapeutic strategies for treatment of skin hypo/hyperpigmentation.	[Wu, Huali; Zhao, Yucheng; Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Wu, Huali; He, Ling] China Pharmaceut Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab Tradit Chinese Med TCM Evaluat &, Nanjing, Jiangsu, Peoples R China; [Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Shang, Jing] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Nanjing, Jiangsu, Peoples R China; [Xia, Zhenjiang; Shang, Jing] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining, Qinghai, Peoples R China; [Liu, Meng] Xinjiang Med Univ, Affiliated Tumor Hosp, Urumqi, Peoples R China; [Jin, Yu] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; Chinese Academy of Sciences; Xinjiang Medical University; University of California System; University of California Santa Barbara	Shang, J (corresponding author), China Pharmaceut Univ, 639 Longmian Rd, Nanjing 210009, Jiangsu, Peoples R China.	shangjing21cn@cpu.edu.cn			Science and Technology Plan Projects in Qinghai Province [2015-ZJ-733]; Science and Technology Plan Projects in Xinjiang [2014AB043]; National Natural Science Foundation of China [81603216]; CMA-L'OREAL China Skin/Hair Grant [S2017140917]; One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province [Y229461211]; Prospective Joint Research Project of Jiangsu Province [BY2016078-02]	Science and Technology Plan Projects in Qinghai Province; Science and Technology Plan Projects in Xinjiang; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CMA-L'OREAL China Skin/Hair Grant; One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province; Prospective Joint Research Project of Jiangsu Province	This study was supported by Science and Technology Plan Projects in Qinghai Province (2015-ZJ-733); Science and Technology Plan Projects in Xinjiang (2014AB043); The National Natural Science Foundation of China (81603216); 2017 CMA-L'OREAL China Skin/Hair Grant S2017140917; One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province (Y229461211); and Prospective Joint Research Project of Jiangsu Province (BY2016078-02). The authors declare no conflicts of interest.	AGNATI LF, 1983, ACTA PHYSIOL SCAND, V118, P293, DOI 10.1111/j.1748-1716.1983.tb07273.x; Aktan S, 1998, DERMATOLOGY, V197, P230, DOI 10.1159/000018002; Al Niami F, 2008, BRIT J HOSP MED, V69, P510, DOI 10.12968/hmed.2008.69.9.31046; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Arck PC, 2001, FASEB J, V15, P2536, DOI 10.1096/fj.00-0699fje; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; AZMITIA EC, 1969, SCIENCE, V166, P1274, DOI 10.1126/science.166.3910.1274; Bellot M, 2015, NAT CHEM BIOL, V11, P271, DOI [10.1038/NCHEMBIO.1766, 10.1038/nchembio.1766]; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chernova I, 2009, J LEUKOCYTE BIOL, V85, P154, DOI 10.1189/jlb.0408260; Choi TY, 2007, PIGM CELL RES, V20, P120, DOI 10.1111/j.1600-0749.2007.00365.x; Cooksey CJ, 1997, J BIOL CHEM, V272, P26226, DOI 10.1074/jbc.272.42.26226; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; Fadda F, 2000, NEWS PHYSIOL SCI, V15, P260; Falabella R, 2003, J EUR ACAD DERMATOL, V17, P355, DOI 10.1046/j.1468-3083.2003.00792_6.x; Fanelli F, 2013, PROG MOL BIOL TRANSL, V117, P105, DOI 10.1016/B978-0-12-386931-9.00005-2; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; FONG TM, 1992, J BIOL CHEM, V267, P25664; Franco R, 2008, BRAIN RES REV, V58, P475, DOI 10.1016/j.brainresrev.2008.06.002; Froger N, 2001, J NEUROSCI, V21, P8188, DOI 10.1523/JNEUROSCI.21-20-08188.2001; Fujita W, 2014, BIOCHEM PHARMACOL, V92, P448, DOI 10.1016/j.bcp.2014.09.015; Fukushima Y, 1997, FEBS LETT, V409, P283, DOI 10.1016/S0014-5793(97)00531-0; Fuxe K, 2014, NEUROPSYCHOPHARMACOL, V39, P131, DOI 10.1038/npp.2013.242; Gayen A, 2011, BBA-BIOMEMBRANES, V1808, P127, DOI 10.1016/j.bbamem.2010.09.023; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Holst B, 1996, EMBO J, V15, P3538, DOI 10.1002/j.1460-2075.1996.tb00723.x; Horrell EMW, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00095; Hu WP, 2004, NEUROSCI LETT, V365, P147, DOI 10.1016/j.neulet.2004.04.072; Jang JY, 2011, J ETHNOPHARMACOL, V137, P1207, DOI 10.1016/j.jep.2011.07.047; Jones K, 2002, PIGM CELL RES, V15, P335, DOI 10.1034/j.1600-0749.2002.02014.x; Katsanos GS, 2008, J BIOL REG HOMEOS AG, V22, P93; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kimyai-Asadi A, 2001, J CUTAN MED SURG, V5, P140, DOI 10.1007/s102270000016; Le Gouill C, 1999, J BIOL CHEM, V274, P12548, DOI 10.1074/jbc.274.18.12548; Lee MH, 2006, PHYTOCHEMISTRY, V67, P1262, DOI 10.1016/j.phytochem.2006.05.008; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; LEVITIN HP, 1980, GEN COMP ENDOCR, V40, P8, DOI 10.1016/0016-6480(80)90090-8; Liao S, 2012, EXP DERMATOL, V21, P635, DOI 10.1111/j.1600-0625.2012.01531.x; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lundeberg L, 2002, ARCH DERMATOL RES, V294, P393, DOI 10.1007/s00403-002-0350-y; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Martinez-Esparza M, 2001, INT J BIOCHEM CELL B, V33, P971, DOI 10.1016/S1357-2725(01)00068-1; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Minami M, 2001, EUR J PHARMACOL, V428, P215, DOI 10.1016/S0014-2999(01)01297-3; Mizusawa K, 2011, GEN COMP ENDOCR, V171, P75, DOI 10.1016/j.ygcen.2010.12.008; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Negroiu G, 2000, J BIOL CHEM, V275, P32200, DOI 10.1074/jbc.M005186200; Nordlind K, 2008, EXP DERMATOL, V17, P301, DOI 10.1111/j.1600-0625.2007.00670.x; Olivarius FD, 1999, J PHOTOCH PHOTOBIO B, V48, P42, DOI 10.1016/S1011-1344(99)00007-X; Park PJ, 2015, J INVEST DERMATOL, V135, P551, DOI 10.1038/jid.2014.423; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; Ping FF, 2012, INT J BIOCHEM CELL B, V44, P2342, DOI 10.1016/j.biocel.2012.09.025; Ptak K, 2009, J NEUROSCI, V29, P3720, DOI 10.1523/JNEUROSCI.5271-08.2009; Racke K, 1996, BEHAV BRAIN RES, V73, P83; Renner U, 2012, J CELL SCI, V125, P2486, DOI 10.1242/jcs.101337; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Rodriguez-Vallecillo E, 2014, PSYCHIAT CLIN N AM, V37, P625, DOI 10.1016/j.psc.2014.08.009; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, DERMATOLOGY, V211, P199, DOI 10.1159/000087012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Soriano A, 2009, J MED CHEM, V52, P5590, DOI 10.1021/jm900298c; Tansky MF, 2007, P NATL ACAD SCI USA, V104, P10691, DOI 10.1073/pnas.0703394104; Thomsen M, 2012, J INTERN MED, V271, P305, DOI 10.1111/j.1365-2796.2011.02447.x; Tobin DJ, 2006, CHEM SOC REV, V35, P52, DOI 10.1039/b505793k; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wang Q, 2014, CELL SIGNAL, V26, P1846, DOI 10.1016/j.cellsig.2014.04.017; Ward DT, 1998, J BIOL CHEM, V273, P14476, DOI 10.1074/jbc.273.23.14476; WESSELY SC, 1989, BRIT J PSYCHIAT, V155, P686; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Zhou J, 2016, EUR J PHARMACOL, V775, P106, DOI 10.1016/j.ejphar.2016.02.026; Zhou J, 2015, CYTOKINE, V74, P137, DOI 10.1016/j.cyto.2015.01.034; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z; Zmijewski MA, 2011, DERM-ENDOCRINOL, V3, P3, DOI 10.4161/derm.3.1.14617	86	4	6	3	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3193	3214		10.1096/fj.201700564RR	http://dx.doi.org/10.1096/fj.201700564RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29430989				2022-12-28	WOS:000432546000025
J	Choi, EK; Nguyen, TT; Iwase, S; Seo, YA				Choi, Eun-Kyung; Trang-Tiffany Nguyen; Iwase, Shigeki; Seo, Young Ah			Ferroportin disease mutations influence manganese accumulation and cytotoxicity	FASEB JOURNAL			English	Article						manganese transport; manganese toxicity; iron metabolism	IRON TRANSPORTER FERROPORTIN; FUNCTIONAL-ANALYSIS; HEREDITARY HEMOCHROMATOSIS; INTRACELLULAR TRAFFICKING; MOLECULAR-BASIS; PARKINSONISM; SLC30A10; PROTEIN; EFFLUX; EXPRESSION	Hemochromatosis is a frequent genetic disorder, characterized by the accumulation of excess iron across tissues. Mutations in the FPN1 gene, encoding a cell surface iron exporter [ferroportin (Fpn)], are responsible for hemochromatosis type 4, also known as ferroportin disease. Recently, Fpn has been implicated in the regulation of manganese (Mn), another essential nutrient required for numerous cellular enzymes. However, the roles of Fpn in Mn regulation remain ill-defined, and the impact of disease mutations on cellular Mn levels is unknown. Here, we provide evidence that Fpn can export Mn from cells into extracellular space. Fpn seems to play protective roles in Mn-induced cellular toxicity and oxidative stress. Finally, disease mutations interfere with the role of Fpn in controlling Mn levels as well as the stability of Fpn. These results define the function of Fpn as an exporter of both iron and Mn and highlight the potential involvement of Mn dysregulation in ferroportin disease.Choi, E.-K., Nguyen, T.-T., Iwase, S., Seo, Y. A. Ferroportin disease mutations influence manganese accumulation and cytotoxicity.	[Choi, Eun-Kyung; Trang-Tiffany Nguyen; Seo, Young Ah] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, 3850 SPH I,1415 Washington Hts, Ann Arbor, MI 48109 USA; [Iwase, Shigeki] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Seo, YA (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, 3850 SPH I,1415 Washington Hts, Ann Arbor, MI 48109 USA.	youngseo@umich.edu	Seo, Young Ah/AAT-5022-2020; Iwase, Shigeki/J-8294-2019	Seo, Young Ah/0000-0003-3884-0665; Iwase, Shigeki/0000-0003-2280-7422	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant [K99/R00 ES024340]; University of Michigan Protein Folding Disease Initiative grant; NIH National Institute of Neurological Disorders and Stroke [R01 NS089896]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES024340, P30ES017885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089896] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant; University of Michigan Protein Folding Disease Initiative grant; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Marianne Wessling-Resnick (Harvard School of Public Health, Boston, MA, USA) for providing insightful suggestions for the manuscript. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant K99/R00 ES024340 (to Y.A.S.), University of Michigan Protein Folding Disease Initiative grant (to Y.A.S.), and NIH National Institute of Neurological Disorders and Stroke Grant R01 NS089896 (to S.I.). The authors declare no conflicts of interest.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Arden KE, 2003, GUT, V52, P1215, DOI 10.1136/gut.52.8.1215; Aschemeyer S, 2018, BLOOD, V131, P899, DOI 10.1182/blood-2017-05-786590; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Callebaut I, 2014, HUM MOL GENET, V23, P4479, DOI 10.1093/hmg/ddu160; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Corradini E, 2005, BLOOD CELL MOL DIS, V35, P315, DOI 10.1016/j.bcmd.2005.07.010; Cunat S, 2007, CLIN CHEM, V53, P2060, DOI 10.1373/clinchem.2007.090605; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; Detivaud L, 2013, HUM MUTAT, V34, P1529, DOI 10.1002/humu.22396; DeWitt MR, 2013, BIOCHEM BIOPH RES CO, V432, P1, DOI 10.1016/j.bbrc.2013.01.058; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Goncalves AS, 2006, BIOCHEM J, V396, P265, DOI 10.1042/BJ20051682; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hetet G, 2003, BLOOD, V102, P1904, DOI 10.1182/blood-2003-02-0439; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Le Gac G, 2013, HUM MUTAT, V34, P1371, DOI 10.1002/humu.22369; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li JJ, 2015, CELL SYST, V1, P361, DOI 10.1016/j.cels.2015.11.002; Li XL, 2013, BIOMETALS, V26, P941, DOI 10.1007/s10534-013-9670-y; Liu XB, 2005, BLOOD CELL MOL DIS, V35, P33, DOI 10.1016/j.bcmd.2005.04.005; Lok CY, 2009, BLOOD, V114, P20, DOI 10.1182/blood-2009-01-199109; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089003; McDonald CJ, 2011, J HEPATOL, V54, P538, DOI 10.1016/j.jhep.2010.07.048; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2004, PFLUG ARCH EUR J PHY, V447, P801, DOI 10.1007/s00424-003-1102-3; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Mitchell CJ, 2014, AM J PHYSIOL-CELL PH, V306, pC450, DOI 10.1152/ajpcell.00348.2013; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Njajou OT, 2002, BLOOD CELL MOL DIS, V29, P439, DOI 10.1006/bcmd.2002.0581; Pietrangelo A, 2006, BLOOD CELL MOL DIS, V37, P192, DOI 10.1016/j.bcmd.2006.08.007; Pietrangelo A, 2017, HAEMATOLOGICA, V102, P1972, DOI 10.3324/haematol.2017.170720; Pietrangelo A, 2011, SEMIN LIVER DIS, V31, P302, DOI 10.1055/s-0031-1286061; Powell LW, 2016, LANCET, V388, P706, DOI 10.1016/S0140-6736(15)01315-X; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Rice AE, 2009, J MOL BIOL, V386, P717, DOI 10.1016/j.jmb.2008.12.063; Rosmorduc O, 2008, GASTROEN CLIN BIOL, V32, P321, DOI 10.1016/j.gcb.2008.01.030; Schimanski LM, 2005, BLOOD, V105, P4096, DOI 10.1182/blood-2004-11-4502; Seo YA, 2016, BIOCHEM J, V473, P4243, DOI 10.1042/BCJ20160674; Seo YA, 2016, BIOMETALS, V29, P147, DOI 10.1007/s10534-015-9904-2; Seo YA, 2015, FASEB J, V29, P2726, DOI 10.1096/fj.14-262592; Seo YA, 2013, NEUROTOXICOLOGY, V38, P67, DOI 10.1016/j.neuro.2013.06.002; Seo YA, 2011, AM J PHYSIOL-CELL PH, V300, pC1479, DOI 10.1152/ajpcell.00420.2010; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Sham RL, 2005, BLOOD CELL MOL DIS, V34, P157, DOI 10.1016/j.bcmd.2004.12.002; Sham RL, 2009, BLOOD, V114, P493, DOI 10.1182/blood-2009-04-216226; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Wu ZF, 2014, MOL NEUROBIOL, V50, P986, DOI 10.1007/s12035-014-8675-z; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	65	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2228	2240		10.1096/fj.201800831R	http://dx.doi.org/10.1096/fj.201800831R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30247984	Green Submitted, Green Published			2022-12-28	WOS:000457296600056
J	Lee, J; Son, HS; Lee, HI; Lee, GR; Jo, YJ; Hong, SE; Kim, N; Kwon, M; Kim, NY; Kim, HJ; Lee, YJ; Seo, EK; Jeong, W				Lee, Jiae; Son, Han Saem; Lee, Hye In; Lee, Gong-Rak; Jo, You-Jin; Hong, Seong-Eun; Kim, Narae; Kwon, Minjeong; Kim, Nam Young; Kim, Hyun Jin; Lee, Yoo Jin; Seo, Eun Kyoung; Jeong, Woojin			Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signaling	FASEB JOURNAL			English	Article						bone resorption; Nrf2; Rho GTPase	NF-KAPPA-B; BONE-RESORPTION; TYROSINE PHOSPHORYLATION; C-SRC; NUCLEAR-FACTOR; KEY REGULATOR; CRUCIAL ROLE; DC-STAMP; T-CELLS; IN-VIVO	Many bone diseases, such as osteoporosis and rheumatoid arthritis, are attributed to an increase in osteoclast number or activity; therefore, control of osteoclasts has significant clinical implications. This study shows how skullcapflavone II (SFII), a flavonoid with anti-inflammatory activity, regulates osteoclast differentiation, survival, and function. SFII inhibited osteoclastogenesis with decreased activation of MAPKs, Src, and cAMP response element-binding protein (CREB), which have been known to be redox sensitive. SFII decreased reactive oxygen species by scavenging them or activating nuclear factor-erythroid 2-related factor 2 (Nrf2), and its effects were partially reversed by hydrogen peroxide cotreatment or Nrf2 deficiency. In addition, SFII attenuated survival, migration, and bone resorption, with a decrease in the expression of integrin (3), Src, and p130 Crk-associated substrate, and the activation of RhoA and Rac1 in differentiated osteoclasts. Furthermore, SFII inhibited osteoclast formation and bone loss in an inflammation- or ovariectomy-induced osteolytic mouse model. These findings suggest that SFII inhibits osteoclastogenesis through redox regulation of MAPKs, Src, and CREB and attenuates the survival and resorption function by modulating the integrin pathway in osteoclasts. SFII has therapeutic potential in the treatment and prevention of bone diseases caused by excessive osteoclast activity.Lee, J., Son, H. S., Lee, H. I., Lee, G.-R., Jo, Y.-J., Hong, S.-E., Kim, N., Kwon, M., Kim, N. Y., Kim, H. J., Lee, Y. J., Seo, E. K., Jeong, W. Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signaling.	[Lee, Jiae; Son, Han Saem; Lee, Hye In; Lee, Gong-Rak; Jo, You-Jin; Hong, Seong-Eun; Kim, Narae; Kwon, Minjeong; Kim, Nam Young; Kim, Hyun Jin; Jeong, Woojin] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Dept Life Sci, Seoul, South Korea; [Lee, Yoo Jin; Seo, Eun Kyoung] Ewha Womans Univ, Coll Pharm, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Jeong, W (corresponding author), Ewha Womans Univ, Sci Bldg C,Room 211,52 Ewhayeodae Gil, Seoul 120750, South Korea.	jeongw@ewha.ac.kr			National Research Foundation (NRF) - Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning [2017R1A2B2012435, 2016R1A6A3A11931064, 2012R1A5A1048236]	National Research Foundation (NRF) - Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning	The authors thank Dr. Masayuki Yamamoto (Tohoku University Graduate School of Medicine, Sendai, Japan) for Nrf2 knockout mice. This work was supported by National Research Foundation (NRF) Grants 2017R1A2B2012435, 2016R1A6A3A11931064, and 2012R1A5A1048236, funded by the Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning. The authors declre no conflicts of interest.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen JR, 2011, J PHARMACOL EXP THER, V336, P734, DOI 10.1124/jpet.110.175091; Chiu YH, 2016, J CELL PHYSIOL, V231, P2402, DOI 10.1002/jcp.25389; Darden AG, 1996, J BONE MINER RES, V11, P671; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hong SE, 2017, FREE RADICAL BIO MED, V112, P191, DOI 10.1016/j.freeradbiomed.2017.07.030; Hong S, 2014, MOL CELL BIOL, V34, P3515, DOI 10.1128/MCB.00293-14; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jang HY, 2012, INT IMMUNOPHARMACOL, V12, P666, DOI 10.1016/j.intimp.2012.01.010; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Ke K, 2014, AM J PHYSIOL-ENDOC M, V307, pE61, DOI 10.1152/ajpendo.00044.2014; Kim H, 2013, J IMMUNOL, V190, P1312, DOI 10.4049/jimmunol.1202525; Kim HJ, 2006, FREE RADICAL BIO MED, V40, P1483, DOI 10.1016/j.freeradbiomed.2005.10.066; Kim I, 2017, BMB REP, V50, P454, DOI 10.5483/BMBRep.2017.50.9.026; Kim OS, 2015, MOL MED REP, V12, P1335, DOI 10.3892/mmr.2015.3502; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Latimer HR, 2016, MOL CELLS, V39, P40, DOI 10.14348/molcells.2016.2327; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee Kwang Jin, 2014, J Anal Methods Chem, V2014, P563702, DOI 10.1155/2014/563702; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lim HS, 2016, J MED FOOD, V19, P1032, DOI 10.1089/jmf.2016.0074; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Meurer S, 2005, J BIOL CHEM, V280, P33149, DOI 10.1074/jbc.M507565200; Moon HJ, 2012, BIOCHEM BIOPH RES CO, V418, P247, DOI 10.1016/j.bbrc.2012.01.005; Nagai Y, 2013, J BONE MINER RES, V28, P2449, DOI 10.1002/jbmr.1936; Nakamura I, 1998, J BIOL CHEM, V273, P11144, DOI 10.1074/jbc.273.18.11144; Nakamura I, 2012, MOD RHEUMATOL, V22, P167, DOI 10.1007/s10165-011-0530-8; Rao Leticia G., 2003, Journal of Medicinal Food, V6, P69, DOI 10.1089/109662003322233459; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEINBECK MJ, 1994, J CELL BIOL, V126, P765, DOI 10.1083/jcb.126.3.765; Tahtah Y, 2015, J CHROMATOGR A, V1408, P125, DOI 10.1016/j.chroma.2015.07.010; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tsai PJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21010015; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	53	19	19	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2026	2036		10.1096/fj.201800866RR	http://dx.doi.org/10.1096/fj.201800866RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30216110				2022-12-28	WOS:000457296600040
J	Mirandela, GD; Tamburrino, G; Hoskisson, PA; Zachariae, U; Javelle, A				Mirandela, Gaetan Dias; Tamburrino, Giulia; Hoskisson, Paul A.; Zachariae, Ulrich; Javelle, Arnaud			The lipid environment determines the activity of the Escherichia coli ammonium transporter AmtB	FASEB JOURNAL			English	Article						Amt/Mep/Rh; protein-lipids interaction; molecular dynamics simulation; SSME	PSEUDOHYPHAL GROWTH; MOLECULAR-DYNAMICS; FILAMENTOUS GROWTH; NH4+ TRANSPORT; YEAST AMMONIUM; CHANNEL AMTB; CROSS-TALK; PROTEIN; PERMEASE; CHARMM	The movement of ammonium across biologic membranes is a fundamental process in all living organisms and is mediated by the ubiquitous ammonium transporter/methylammonium permease/rhesus protein (Amt/Mep/Rh) family of transporters. Recent structural analysis and coupled mass spectrometry studies have shown that the Escherichia coli ammonium transporter AmtB specifically binds 1-palmitoyl-2-oleoyl phosphatidylglycerol (POPG). Upon POPG binding, several residues of AmtB undergo a small conformational change, which stabilizes the protein against unfolding. However, no studies have so far been conducted, to our knowledge, to explore whether POPG binding to AmtB has functional consequences. Here, we used an in vitro experimental assay with purified components, together with molecular dynamics simulations, to characterize the relation between POPG binding and AmtB activity. We show that the AmtB activity is electrogenic. Our results indicate that the activity, at the molecular level, of Amt in archaebacteria and eubacteria may differ. We also show that POPG is an important cofactor for AmtB activity and that, in the absence of POPG, AmtB cannot complete the full translocation cycle. Furthermore, our simulations reveal previously undiscovered POPG binding sites on the intracellular side of the lipid bilayer between the AmtB subunits. Possible molecular mechanisms explaining the functional role of POPG are discussed.Mirandela, G. D., Tamburrino, G., Hoskisson, P. A., Zachariae, U., Javelle, A. The lipid environment determines the activity of the Escherichia coli ammonium transporter AmtB.	[Mirandela, Gaetan Dias; Hoskisson, Paul A.; Javelle, Arnaud] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Tamburrino, Giulia; Zachariae, Ulrich] Univ Dundee, Sch Life Sci, Computat Biol, Dundee, Scotland; [Tamburrino, Giulia; Zachariae, Ulrich] Univ Dundee, Sch Sci & Engn, Phys, Dundee, Scotland	University of Strathclyde; University of Dundee; University of Dundee	Javelle, A (corresponding author), Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	arnaud.javelle@strath.ac.uk		Dias Mirandela, Gaetan/0000-0001-5871-6288; Zachariae, Ulrich/0000-0003-3287-8494; Hoskisson, Paul/0000-0003-4332-1640	University of Strathclyde; Chancellor's Fellowship from the University of Strathclyde; Scottish Universities' Physics Alliance (SUPA); Tenovus Scotland [S17-07]; Natural Environment Research Council [NE/M001415/1]; NERC [NE/M001415/1] Funding Source: UKRI	University of Strathclyde; Chancellor's Fellowship from the University of Strathclyde; Scottish Universities' Physics Alliance (SUPA); Tenovus Scotland; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank Dr. Andre Bazzone (Nanion Technologies, Munich, Germany) for helpful advice with SSME measurements. Special thanks to Prof. Iain Hunter (Strathclyde Institute of Pharmacy and Biomedical Sciences) for invaluable discussions and help during this project. G.D.M. was supported by a Ph.D. Studentship from the University of Strathclyde; A.J. was supported by a Chancellor's Fellowship from the University of Strathclyde; and G.T. and U.Z. acknowledge funding from the Scottish Universities' Physics Alliance (SUPA). A.J. acknowledges the support of Tenovus Scotland (Project S17-07), and P.A.H. acknowledges the support of the Natural Environment Research Council (Grant NE/M001415/1). The authors declare no conflicts of interest.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; BANUETT F, 1991, P NATL ACAD SCI USA, V88, P3922, DOI 10.1073/pnas.88.9.3922; Bazzone A, 2017, METHOD ENZYMOL, V594, P31, DOI 10.1016/bs.mie.2017.05.008; Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bostick DL, 2007, BIOPHYS J, V92, pL103, DOI 10.1529/biophysj.107.109165; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140; Cao Z, 2007, ANGEW CHEM INT EDIT, V46, P6811, DOI 10.1002/anie.200701348; Cong X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02397-0; Dabas N, 2007, EUKARYOT CELL, V6, P875, DOI 10.1128/EC.00307-06; Denning EJ, 2013, CHEM PHYS LIPIDS, V169, P57, DOI 10.1016/j.chemphyslip.2013.02.007; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799; MARESCA B, 1989, MICROBIOL REV, V53, P186, DOI 10.1128/MMBR.53.2.186-209.1989; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; McDonald TR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00352; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Monahan BJ, 2002, FUNGAL GENET BIOL, V36, P35, DOI 10.1016/S1087-1845(02)00004-X; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Neuhauser B, 2014, CHANNELS, V8, P496, DOI 10.4161/19336950.2014.967618; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patrick JW, 2018, P NATL ACAD SCI USA, V115, P2976, DOI 10.1073/pnas.1719813115; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Severi E, 2007, MOL MEMBR BIOL, V24, P161, DOI 10.1080/09687860601129420; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Smith DG, 2003, MOL MICROBIOL, V50, P259, DOI 10.1046/j.1365-2958.2003.03680.x; Teichert S, 2008, EUKARYOT CELL, V7, P187, DOI 10.1128/EC.00351-07; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; van den Berg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11337; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; Wacker T, 2014, P NATL ACAD SCI USA, V111, P9995, DOI 10.1073/pnas.1406409111; Wang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062745; Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x; Wickes BL, 1997, MOL MICROBIOL, V26, P951, DOI 10.1046/j.1365-2958.1997.6322001.x; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	70	17	17	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1989	1999		10.1096/fj.201800782R	http://dx.doi.org/10.1096/fj.201800782R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30211659	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000457296600037
J	Yao, J; Zheng, J; Cai, JY; Zeng, KN; Zhou, CR; Zhang, JB; Li, SH; Li, H; Chen, L; He, LY; Chen, HX; Fu, HY; Zhang, Q; Chen, GH; Yang, Y; Zhang, YC				Yao, Jia; Zheng, Jun; Cai, Jianye; Zeng, Kaining; Zhou, Chaorong; Zhang, Jiebin; Li, Shihui; Li, Hui; Chen, Liang; He, Liying; Chen, Huaxin; Fu, Hongyuan; Zhang, Qi; Chen, Guihua; Yang, Yang; Zhang, Yingcai			Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response	FASEB JOURNAL			English	Article						huc-MSC-EVs; MnSOD; MnTBAP	SUPEROXIDE-DISMUTASE; ISCHEMIA/REPERFUSION INJURY; LIVER-TRANSPLANTATION; STROMAL CELLS; MITOCHONDRIA; ANGIOGENESIS; MECHANISMS; ASTROCYTES; MOLECULES; INCREASE	Mesenchymal stem cells (MSCs) have been reported to exert therapeutic effects on immunoregulation, tissue repair, and regeneration from the bench to the bedside. Increasing evidence demonstrates that extracellular vesicles (EVs) derived from MSCs could contribute to these effects and are considered as a potential replacement for stem cell-based therapies. However, the efficacy and underlying mechanisms of EV-based treatment in hepatic ischemia-reperfusion injury (IRI) remain unclear. Here, we demonstrated that human umbilical cord MSC-EVs (huc-MSC-EVs) could protect against IRI-induced hepatic apoptosis by reducing the infiltration of neutrophils and alleviating oxidative stress in hepatic tissue in vivo. Meanwhile, huc-MSC-EVs reduced the respiratory burst of neutrophils and prevented hepatocytes from oxidative stress-induced cell death in vitro. Interestingly, we found that the mitochondria-located antioxidant enzyme, manganese superoxide dismutase (MnSOD), was encapsulated in huc-MSC-EVs and reduced oxidative stress in the hepatic IRI model. Knockdown of MnSOD in huc-MSCs decreased the level of MnSOD in huc-MSC-EVs and attenuated the antiapoptotic and antioxidant capacities of huc-MSC-EVs, which could be partially rescued by MnSOD mimetic manganese (III) 5,10,15,20-tetrakis (4-benzoic acid) porphyrin (MnTBAP). In summary, these findings provide new clues to reveal the therapeutic effects of huc-MSC-EVs on hepatic IRI and evaluate their preclinical application.Yao, J., Zheng, J., Cai, J., Zeng, K., Zhou, C., Zhang, J., Li, S., Li, H., Chen, L., He, L., Chen, H., Fu, H., Zhang, Q., Chen, G., Yang, Y., Zhang, Y. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response.	[Yao, Jia; Zheng, Jun; Cai, Jianye; Zeng, Kaining; Zhou, Chaorong; Zhang, Jiebin; Li, Shihui; Li, Hui; Chen, Liang; Fu, Hongyuan; Chen, Guihua; Yang, Yang; Zhang, Yingcai] Sun Yat Sen Univ, Affiliated Hosp 3, Organ Transplantat Res Ctr Guangdong Prov, Dept Hepat Surg,Organ Transplantat Inst, Guangzhou, Guangdong, Peoples R China; [Yao, Jia; Zheng, Jun; Cai, Jianye; Zeng, Kaining; Zhou, Chaorong; Zhang, Jiebin; Li, Shihui; Li, Hui; Chen, Liang; Fu, Hongyuan; Chen, Guihua; Yang, Yang; Zhang, Yingcai] Sun Yat Sen Univ, Affiliated Hosp 3, Organ Transplantat Res Ctr Guangdong Prov, Liver Transplantat Ctr,Organ Transplantat Inst, Guangzhou, Guangdong, Peoples R China; [Yao, Jia; Zheng, Jun; Cai, Jianye; Zeng, Kaining; Zhou, Chaorong; Zhang, Jiebin; Li, Hui; Chen, Liang; Fu, Hongyuan; Chen, Guihua; Yang, Yang; Zhang, Yingcai] Sun Yat Sen Univ, Affiliated Hosp 3, Guangdong Key Lab Liver Dis Res, Key Lab Liver Dis Biotherapy & Translat Med Guang, Guangzhou, Guangdong, Peoples R China; [Chen, Huaxin; Zhang, Qi] Sun Yat Sen Univ, Affiliated Hosp 3, Cell Gene Therapy Translat Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [He, Liying] Guangzhou Women & Childrens Med Ctr, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yang, Y; Zhang, YC (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Organ Transplantat Inst, Dept Hepat Surg, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.; Yang, Y; Zhang, YC (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Organ Transplantat Inst, Liver Transplantat Ctr, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.	yysysu@163.com; zhangyc3@mail.sysu.edu.cn	yang, yang/GVT-5210-2022; Cai, Jianye/GOK-2676-2022; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022		National Key Research and Development Program [2017YFA0104304]; National Natural Science Foundation of China [81570593, 81770648]; Guangdong Natural Science Foundation [2015A030312013]; Sci-Tech Research Development Program of Guangdong Province [2017A020215023]; Sci-Tech Research Development Program of Guangzhou City [158100076]; Sun Yat-Sen University Clinical Research 5010 Program [2014006]; Young Teacher Development Program of Sun Yat-Sen University [17ykpy57]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Sci-Tech Research Development Program of Guangdong Province; Sci-Tech Research Development Program of Guangzhou City; Sun Yat-Sen University Clinical Research 5010 Program; Young Teacher Development Program of Sun Yat-Sen University	This work was supported by grants from the National Key Research and Development Program (2017YFA0104304), National Natural Science Foundation of China (81570593 and 81770648), Guangdong Natural Science Foundation (2015A030312013), Sci-Tech Research Development Program of Guangdong Province (2017A020215023), Sci-Tech Research Development Program of Guangzhou City (No. 158100076), Sun Yat-Sen University Clinical Research 5010 Program (2014006), and Young Teacher Development Program of Sun Yat-Sen University (17ykpy57). The authors declare no conflicts of interest.	Akyurekli C, 2015, STEM CELL REV REP, V11, P150, DOI 10.1007/s12015-014-9545-9; Angulski ABB, 2017, STEM CELL REV REP, V13, P244, DOI 10.1007/s12015-016-9715-z; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Archambaud C, 2006, J BIOL CHEM, V281, P31812, DOI 10.1074/jbc.M606249200; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5; Borger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450; Boregowda SV, 2016, EBIOMEDICINE, V4, P62, DOI 10.1016/j.ebiom.2015.12.020; Brechard S, 2008, J LEUKOCYTE BIOL, V84, P1223, DOI 10.1189/jlb.0807553; Candas D, 2014, ANTIOXID REDOX SIGN, V20, P1599, DOI 10.1089/ars.2013.5305; Chen HX, 2017, HUM GENE THER, V28, P523, DOI 10.1089/hum.2016.106; Christ B, 2015, TRENDS MOL MED, V21, P673, DOI 10.1016/j.molmed.2015.09.004; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Crivelli B, 2017, J CONTROL RELEASE, V262, P104, DOI 10.1016/j.jconrel.2017.07.023; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Falchi AM, 2013, HISTOCHEM CELL BIOL, V139, P221, DOI 10.1007/s00418-012-1045-x; Gao F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.327; Ge M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.236; Giuliani M, 2011, BLOOD, V118, P3254, DOI 10.1182/blood-2010-12-325324; Haga H, 2017, LIVER TRANSPLANT, V23, P791, DOI 10.1002/lt.24770; Haga H, 2017, STEM CELL TRANSL MED, V6, P1262, DOI 10.1002/sctm.16-0226; Haga H, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.24900; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Jaeschke H, 1997, HEPATOLOGY, V25, P252, DOI 10.1053/jhep.1997.v25.ajhep0250252; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jin GX, 2013, INT J MOL MED, V31, P1395, DOI 10.3892/ijmm.2013.1340; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Karatzas T, 2014, J SURG RES, V191, P399, DOI 10.1016/j.jss.2014.06.024; Keshtkar S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0791-7; Kim HS, 2012, J PROTEOME RES, V11, P839, DOI 10.1021/pr200682z; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Kuzumoto Y, 2005, HEPATOLOGY, V42, P608, DOI 10.1002/hep.20827; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Li J, 2012, HEPATOLOGY, V56, P1044, DOI 10.1002/hep.25722; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lin BL, 2017, HEPATOLOGY, V66, P209, DOI 10.1002/hep.29189; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Marsh JW, 2004, LANCET ONCOL, V5, P480, DOI 10.1016/S1470-2045(04)01527-X; Oishi K, 2012, J SURG RES, V176, P164, DOI 10.1016/j.jss.2011.03.080; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pan GZ, 2012, J SURG RES, V178, P935, DOI 10.1016/j.jss.2012.04.070; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Peng Y, 2015, LEUKEMIA, V29, P636, DOI 10.1038/leu.2014.225; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Pietila M, 2012, STEM CELLS DEV, V21, P575, DOI 10.1089/scd.2011.0023; Pinar N, 2018, BIOMED PHARMACOTHER, V102, P758, DOI 10.1016/j.biopha.2018.03.147; Qiu C, 2017, AM J TRANSPLANT, V17, P3087, DOI 10.1111/ajt.14345; Ramirez E, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-172; Saidi RF, 2014, SURGERY, V156, P1225, DOI 10.1016/j.surg.2014.05.008; Saidi RF, 2014, J INVEST SURG, V27, P366, DOI 10.3109/08941939.2014.932473; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Serakinci N, 2016, CURR STEM CELL RES T, V11, P343, DOI 10.2174/1574888X11666160201115733; Sun CK, 2012, CRIT CARE MED, V40, P1279, DOI 10.1097/CCM.0b013e31823dae23; Sun K, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-26; Sun Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20975-0; Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465; Tejima K, 2004, GASTROENTEROLOGY, V127, P1488, DOI 10.1053/j.gastro.2004.07.023; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Valls-Lacalle L, 2016, CARDIOVASC RES, V109, P374, DOI 10.1093/cvr/cvv279; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Vilarinho S, 2012, CELL, V150, P1096, DOI 10.1016/j.cell.2012.08.030; Wang JC, 2015, ONCOTARGET, V6, P42825, DOI 10.18632/oncotarget.5739; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Yan YM, 2017, MOL THER, V25, P465, DOI 10.1016/j.ymthe.2016.11.019; Yang C, 2013, CURR GENE THER, V13, P305, DOI 10.2174/15665232113136660027; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479	71	76	85	4	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1695	1710		10.1096/fj.201800131RR	http://dx.doi.org/10.1096/fj.201800131RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30226809				2022-12-28	WOS:000457296600016
J	Evans, J; Infusini, G; McGovern, J; Cuttle, L; Webb, A; Nebl, T; Milla, L; Kimble, R; Kempf, M; Andrews, CJ; Leavesley, D; Salamonsen, LA				Evans, Jemma; Infusini, Giuseppe; McGovern, Jacqui; Cuttle, Leila; Webb, Andrew; Nebl, Thomas; Milla, Liz; Kimble, Roy; Kempf, Margit; Andrews, Christine J.; Leavesley, David; Salamonsen, Lois A.			Menstrual fluid factors facilitate tissue repair: identification and functional action in endometrial and skin repair	FASEB JOURNAL			English	Article						migration; menstruation; proteomics	GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; PROTEOMIC ANALYSIS; CELL-ADHESION; LACTOFERRIN; MIGRATION; CYTOKINE; VEGF; VITRONECTIN; EXPRESSION	Repair after damage is essential for tissue homeostasis. Postmenstrual endometrial repair is a cyclical manifestation of rapid, scar-free, tissue repair taking approximate to 3-5 d. Skin repair after wounding is slower (approximate to 2 wk). In the case of chronic wounds, it takes months to years to restore integrity. Herein, the unique rapid-repair endometrial environment is translated to the slower repair skin environment. Menstrual fluid (MF), the milieu of postmenstrual endometrial repair, facilitates healing of endometrial and keratinocyte wounds in vitro, promoting cellular adhesion and migration, stimulates keratinocyte migration in an ex vivo human skin reconstruct model, and promotes re-epithelialization in an in vivo porcine wound model. Proteomic analysis of MF identified a large number of proteins: migration inhibitory factor, neutrophil gelatinase-associated lipocalin, follistatin like-1, chemokine ligand-20, and secretory leukocyte protease inhibitor were selected for further investigation. Functionally, they promote repair of endometrial and keratinocyte wounds by promoting migration. Translation of these and other MF factors into a migration-inducing treatment paradigm could provide novel treatments for tissue repair.Evans, J., Infusini, G., McGovern, J., Cuttle, L., Webb, A., Nebl, T., Milla, L., Kimble, R., Kempf, M., Andrews, C. J., Leavesley, D., Salamonsen, L. A. Menstrual fluid factors facilitate tissue repair: identification and functional action in endometrial and skin repair.	[Evans, Jemma; Salamonsen, Lois A.] Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia; [Evans, Jemma; Salamonsen, Lois A.] Monash Univ, Dept Mol & Translat Med, Clayton, Vic, Australia; [Infusini, Giuseppe; Webb, Andrew; Nebl, Thomas; Milla, Liz] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [McGovern, Jacqui; Leavesley, David] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Cuttle, Leila] Queensland Univ Technol, Ctr Childrens Burns & Trauma Res, Inst Hlth & Biomed Innovat, Ctr Childrens Hlth Res,Sch Biomed Sci, Brisbane, Qld, Australia; [Kimble, Roy; Kempf, Margit; Andrews, Christine J.] Univ Queensland, Ctr Childrens Hlth Res, Ctr Childrens Burns & Trauma Res, South Brisbane, Qld, Australia; [Leavesley, David] Skin Res Inst Singapore, Singapore, Singapore	Hudson Institute of Medical Research; Monash University; Walter & Eliza Hall Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS)	Evans, J (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	jemma.evans@hudson.org.au	Leavesley, David/C-9532-2009; Andrews, Christine/J-4891-2015; Cuttle, Leila/U-9376-2017; Nebl, Thomas/N-1620-2017	Leavesley, David/0000-0002-1033-5459; Andrews, Christine/0000-0003-4513-1349; Cuttle, Leila/0000-0002-2282-4815; Nebl, Thomas/0000-0003-4003-9340; Milla, Liz/0000-0002-6139-4336; evans, jemma/0000-0002-3300-8127; Salamonsen, Lois/0000-0003-0558-7325	National Health Medical Research Council of Australia (NHHRC) [1047756]; Contributing to Australian Scholarship and Science (CASS) grant; Tissue Repair and Regeneration Program; Faculty of Health at Queensland University of Technology; National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship [1002028]; Victorian Government Infrastructure Support Program of the Hudson Institute from the Operational Infrastructure Research Support (OIRS) fund	National Health Medical Research Council of Australia (NHHRC)(National Health and Medical Research Council (NHMRC) of Australia); Contributing to Australian Scholarship and Science (CASS) grant; Tissue Repair and Regeneration Program; Faculty of Health at Queensland University of Technology; National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Infrastructure Support Program of the Hudson Institute from the Operational Infrastructure Research Support (OIRS) fund	The authors thank the women who volunteered for this study, and the patients who donated tissues; Rebecca D'Sylva, Patrick Martin, Samuel Hawthorn, and Laura Knott (all from Hudson Institute of Medical Research) for technical assistance; and Dr. Eugene Kapp (Walter and Eliza Hall Institute) for providing the Ludwig NR protein database. This study was funded by National Health Medical Research Council of Australia (NHHRC; Project Grant 1047756), a Contributing to Australian Scholarship and Science (CASS) grant, and the Tissue Repair and Regeneration Program and the Faculty of Health at Queensland University of Technology (to J.M.); National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship 1002028 (to L.A.S.); and the Victorian Government Infrastructure Support Program of the Hudson Institute, received from the Operational Infrastructure Research Support (OIRS) fund. The authors declare no conflicts of interest.	Allan GJ, 2008, J ENDOCRINOL, V199, P155, DOI 10.1677/JOE-08-0269; Bartelmez GW, 1933, CONTRIB EMBRYOL, V24, P143; Boomsma CM, 2009, REPROD BIOMED ONLINE, V18, P85, DOI 10.1016/S1472-6483(10)60429-4; Boomsma CM, 2009, HUM REPROD, V24, P1427, DOI 10.1093/humrep/dep011; Boomsma CM, 2010, FERTIL STERIL, V94, P1764, DOI 10.1016/j.fertnstert.2009.10.044; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; Chakrabarty KH, 1999, BRIT J DERMATOL, V141, P811, DOI 10.1046/j.1365-2133.1999.03153.x; Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x; Cheong Y, 2013, FERTIL STERIL, V99, P1093, DOI 10.1016/j.fertnstert.2013.01.144; Chevronnay HPG, 2009, ENDOCRINOLOGY, V150, P5094, DOI 10.1210/en.2009-0750; Choi JS, 2013, TISSUE ENG PT A, V19, P329, DOI [10.1089/ten.tea.2011.0738, 10.1089/ten.TEA.2011.0738]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dawson RA, 2006, TRANSPLANTATION, V81, P1668, DOI 10.1097/01.tp.0000226060.51572.89; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Evans J, 2016, NAT REV ENDOCRINOL, V12, P654, DOI 10.1038/nrendo.2016.116; Evans J, 2014, MOL HUM REPROD, V20, P787, DOI 10.1093/molehr/gau032; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; Evans J, 2011, BIOL REPROD, V85, P511, DOI 10.1095/biolreprod.111.090993; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Finnson KW, 2013, ADV WOUND CARE, V2, P195, DOI 10.1089/wound.2013.0429; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Greening DW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134890; Gwira JA, 2005, J BIOL CHEM, V280, P7875, DOI 10.1074/jbc.M413192200; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.26; Kimber I, 2002, BIOCHEM CELL BIOL, V80, P103, DOI 10.1139/o01-227; Kwon CH, 2013, MOL CELLS, V35, P226, DOI 10.1007/s10059-013-2269-x; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Lu RQ, 2012, BIOCHEM BIOPH RES CO, V419, P274, DOI 10.1016/j.bbrc.2012.02.008; LUDWIG H, 1991, ANN NY ACAD SCI, V622, P28, DOI 10.1111/j.1749-6632.1991.tb37848.x; Lyons TE, 2007, AM J SURG, V193, P49, DOI 10.1016/j.amjsurg.2006.07.010; Malik S, 2006, HUM REPROD, V21, P2158, DOI 10.1093/humrep/del089; MCLENNAN CE, 1965, OBSTET GYNECOL, V26, P605; Nagai MK, 2002, EXPERT OPIN BIOL TH, V2, P211, DOI 10.1517/14712598.2.2.211; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; NOYES RW, 1953, FERTIL STERIL, V4, P504; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; SCHLESSINGER J, 1983, CRC CR REV BIOCH MOL, V14, P93, DOI 10.3109/10409238309102791; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shivhare SB, 2015, J REPROD IMMUNOL, V112, P88, DOI 10.1016/j.jri.2015.09.001; Smith and Nephew, REGR BEC GEL; Sugino T, 2007, J PATHOL, V212, P152, DOI 10.1002/path.2156; Sundaram GM, 2013, NATURE, V495, P103, DOI 10.1038/nature11890; Sureshbabu A, 2009, BIOCHEM SOC T, V37, P882, DOI 10.1042/BST0370882; Takayama Y, 2002, BIOCHEM BIOPH RES CO, V299, P813, DOI 10.1016/S0006-291X(02)02748-1; Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148; Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x; Veraldi Kristen L, 2012, Open Rheumatol J, V6, P140, DOI 10.2174/1874312901206010140; Vijayan A, 2013, INT J BIOCHEM CELL B, V45, P2774, DOI 10.1016/j.biocel.2013.10.001; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Xie Y, 2010, TISSUE ENG PART C-ME, V16, P1111, DOI [10.1089/ten.tec.2009.0725, 10.1089/ten.TEC.2009.0725]; Yang HY, 2012, MOL CELL PROTEOMICS, V11, P1024, DOI 10.1074/mcp.M112.018390; Zang T, 2016, J PROTEOMICS, V146, P122, DOI 10.1016/j.jprot.2016.06.026	57	16	16	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					584	605		10.1096/fj.201800086R	http://dx.doi.org/10.1096/fj.201800086R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30036086	Green Submitted			2022-12-28	WOS:000457401500046
J	Rossitto, M; Marchive, C; Pruvost, A; Sellem, E; Ghettas, A; Badiou, S; Sutra, T; Poulat, F; Philibert, P; Boizet-Bonhoure, B				Rossitto, Moira; Marchive, Candice; Pruvost, Alain; Sellem, Eli; Ghettas, Aurelie; Badiou, Stephanie; Sutra, Thibault; Poulat, Francis; Philibert, Pascal; Boizet-Bonhoure, Brigitte			Intergenerational effects on mouse sperm quality after in utero exposure to acetaminophen and ibuprofen	FASEB JOURNAL			English	Article						NSAID; analgesic; germ cell; differentiation; sperm parameters	GERM-CELL DIFFERENTIATION; MALE REPRODUCTIVE DISORDERS; DNA METHYLATION; SERTOLI-CELLS; LEYDIG-CELL; ANDROGEN RECEPTOR; INTRAUTERINE EXPOSURE; ANOGENITAL DISTANCE; MILD ANALGESICS; READ ALIGNMENT	Nonsteroidal antiinflammatory drugs and analgesic drugs, such as N-acetyl-p-aminophenol (APAP; acetaminophen, paracetamol), are widely used by pregnant women. Accumulating evidence has indicated that these molecules can favor genital malformations in newborn boys and reproductive disorders in adults. However, the consequences on postnatal testis development and adult reproductive health after exposure during early embryogenesis are still unknown. Using the mouse model, we show that in utero exposure to therapeutic doses of the widely used APAP-ibuprofen combination during the sex determination period leads to early differentiation and decreased proliferation of male embryonic germ cells, and early 5-methylcytosine and extracellular matrix protein deposition in 13.5 d postcoitum exposed testes. Consequently, in postnatal testes, Sertoli-cell maturation is delayed, the Leydig-cell compartment is hyperplasic, and the spermatogonia A pool is decreased. This results in a reduced production of testosterone and in epididymal sperm parameter defects. We observed a reduced sperm count (19%) in utero-exposed (F0) adult males and also a reduced sperm motility (40%) in their offspring (F1) when both parents were exposed, which leads to subfertility among the 6 mo old F1 animals. Our study suggests that the use of these drugs during the critical period of sex determination affects the germ-line development and leads to adverse effects that could be passed to the offspring.Rossitto, M., Marchive, C., Pruvost, A., Sellem, E., Ghettas, A., Badiou, S., Sutra, T., Poulat, F., Philibert, P., Boizet-Bonhoure, B. Intergenerational effects on mouse sperm quality after in utero exposure to acetaminophen and ibuprofen.	[Rossitto, Moira; Marchive, Candice; Poulat, Francis; Philibert, Pascal; Boizet-Bonhoure, Brigitte] Univ Montpellier, CNRS, Inst Human Genet, Montpellier, France; [Pruvost, Alain; Ghettas, Aurelie] Univ Paris Saclay, INRA, CEA, Small Mol Anal Mass Spectrometry SMArt MS,SPI, Gif Sur Yvette, France; [Sellem, Eli] INRA Domaine Vilvert, Res & Dev Dept, Allice, Biol Reprod, Jouy En Josas, France; [Badiou, Stephanie; Sutra, Thibault; Philibert, Pascal] CHU Montpellier, Hop Lapeyronie, Dept Biochim & Hormonol, Montpellier, France; [Badiou, Stephanie; Sutra, Thibault; Philibert, Pascal] Univ Montpellier, CNRS, INSERM,Unite 1046, PhyMedExp,Unit Mixte Rech UMR 9214, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Boizet-Bonhoure, B (corresponding author), Univ Montpellier, CNRS, Inst Human Genet, UMR9002, 141 Rue Cardonille, F-34396 Montpellier 5, France.	brigitte.boizet@igh.cnrs.fr	Philibert, Pascal/C-6728-2008; POULAT, FRANCIS/AAV-2170-2020	Philibert, Pascal/0000-0001-6384-521X; POULAT, FRANCIS/0000-0003-2070-1296; PRUVOST, ALAIN/0000-0002-7781-7735; Sellem, Eliaou/0000-0001-9251-9077	Centre National de la Recherche Scientifique (CNRS), the University of Montpellier; National Agency for the Safety of Health Products (ANSM) [2013-041]	Centre National de la Recherche Scientifique (CNRS), the University of Montpellier; National Agency for the Safety of Health Products (ANSM)	The authors thank J. Cau, M.-P. Blanchard, and A. Sarrazin (Institute of Human Genetics Imaging Facility, MRI Montpellier, University of Montpellier) for their help in microscopy and FACS analysis, and N. Pirot and F. Bernex (Reseau d'Histologie de Montpellier, University of Montpellier) for advice on histology staining and analysis. The authors thank the staff of the Institute of Human Genetics Animal Care Facility. The authors also thank N. di Clemente (University of Paris Diderot) for providing antibody against Amh/Mis, and Veronique Vidal and Yannick Lopez (Helixio, groupe Hybrigenics, Saint-Beauzire, France) for providing RNA-seq data. The authors are grateful to D. Giorgi for critical reading of the report and P. Clair (qPCR platform, Biocampus Montpellier) for advice on statistical analysis. This study was supported by the Centre National de la Recherche Scientifique (CNRS), the University of Montpellier, and by National Agency for the Safety of Health Products (ANSM) Grant 2013-041. The authors declare no conflicts of interest.	Albert O, 2013, HUM REPROD, V28, P1890, DOI 10.1093/humrep/det112; Axelstad M, 2014, REPRODUCTION, V147, P489, DOI 10.1530/REP-13-0447; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; Ben Maamar M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44184; Bhagwat S, 2014, FERTIL STERIL, V101, P95, DOI 10.1016/j.fertnstert.2013.09.016; Boissonnas CC, 2013, FERTIL STERIL, V99, P624, DOI 10.1016/j.fertnstert.2013.01.124; Cejvanovic V, 2014, SCAND J RHEUMATOL, V43, P424, DOI 10.3109/03009742.2014.902099; Cha YI, 2006, DEV BIOL, V289, P263, DOI 10.1016/j.ydbio.2005.10.013; Chakraborty P, 2014, STEM CELLS, V32, P860, DOI 10.1002/stem.1584; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481; CHIABRANDO C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P247, DOI 10.1016/0167-4889(92)90044-C; Cui XR, 2016, EXP THER MED, V12, P1973, DOI 10.3892/etm.2016.3569; Dean A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19789; Dierkes G, 2014, INT J HYG ENVIR HEAL, V217, P592, DOI 10.1016/j.ijheh.2013.11.005; Fortier MA, 2008, J PHYSIOL PHARMACOL, V59, P65; Frungieri MB, 2015, REPRODUCTION, V149, pR169, DOI 10.1530/REP-14-0392; Gallavan RH, 1999, REPROD TOXICOL, V13, P383, DOI 10.1016/S0890-6238(99)00036-2; Georg I, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101907; Gromoll J, 1996, J CLIN ENDOCR METAB, V81, P1367, DOI 10.1210/jc.81.4.1367; GUPTA C, 1986, P NATL ACAD SCI USA, V83, P4346, DOI 10.1073/pnas.83.12.4346; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Holm JB, 2016, TOXICOL SCI, V150, P178, DOI 10.1093/toxsci/kfv332; Holm JB, 2015, TOXICOL SCI, V148, P288, DOI 10.1093/toxsci/kfv179; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jorgensen N, 2016, HUM REPROD, V31, P947, DOI 10.1093/humrep/dew021; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; Kristensen DM, 2012, INT J ANDROL, V35, P377, DOI 10.1111/j.1365-2605.2012.01282.x; Kristensen DM, 2016, NAT REV ENDOCRINOL, V12, P381, DOI 10.1038/nrendo.2016.55; Kristensen DM, 2018, P NATL ACAD SCI USA, V115, pE715, DOI 10.1073/pnas.1715035115; Kristensen DM, 2011, HUM REPROD, V26, P235, DOI 10.1093/humrep/deq323; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leverrier-Penna S., HUM REPROD; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lind DV, 2017, HUM REPROD, V32, P223, DOI 10.1093/humrep/dew285; Lindemann CB, 2016, CYTOSKELETON, V73, P652, DOI 10.1002/cm.21338; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Marques CJ, 2011, EPIGENETICS-US, V6, P1354, DOI 10.4161/epi.6.11.17993; Mazaud-Guittot S, 2013, J CLIN ENDOCR METAB, V98, pE1757, DOI 10.1210/jc.2013-2531; McGill MR, 2012, TOXICOL APPL PHARM, V264, P387, DOI 10.1016/j.taap.2012.08.015; McKenna L, 2006, J ADV NURS, V56, P636, DOI 10.1111/j.1365-2648.2006.04037.x; Moniot B, 2014, DEVELOPMENT, V141, P3561, DOI 10.1242/dev.103408; Moniot B, 2011, DEV DYNAM, V240, P2335, DOI 10.1002/dvdy.22726; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Naga Rani M A, 1989, J Indian Med Assoc, V87, P182; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Notarnicola C, 2006, GENE EXPR PATTERNS, V6, P695, DOI 10.1016/j.modgep.2006.01.001; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Hara L, 2015, BEST PRACT RES CL EN, V29, P595, DOI 10.1016/j.beem.2015.04.006; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Oduwole OO, 2018, J CLIN INVEST, V128, P1787, DOI 10.1172/JCI96794; Oh CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107577; Parab S, 2015, CELL TISSUE RES, V359, P665, DOI 10.1007/s00441-014-2039-x; Prescott LF, 2000, BRIT J CLIN PHARMACO, V49, P291, DOI 10.1046/j.1365-2125.2000.00167.x; Rahmoun M, 2017, NUCLEIC ACIDS RES, V45, P7191, DOI 10.1093/nar/gkx328; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Ratnasooriya WD, 2000, ASIAN J ANDROL, V2, P247; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rossitto M, 2015, SEMIN CELL DEV BIOL, V45, P84, DOI 10.1016/j.semcdb.2015.09.014; Rossitto M, 2015, REPRODUCTION, V149, pR49, DOI 10.1530/REP-14-0381; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Semet M, 2017, ANDROLOGY-US, V5, P640, DOI 10.1111/andr.12366; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shirakata Y, 2014, J REPROD DEVELOP, V60, P383, DOI 10.1262/jrd.2014-018; Siu SSN, 2000, HUM REPROD, V15, P2423, DOI 10.1093/humrep/15.11.2423; Skakkebaek NE, 2016, PHYSIOL REV, V96, P55, DOI 10.1152/physrev.00017.2015; Smarr MM, 2017, ANDROLOGY-US, V5, P1082, DOI 10.1111/andr.12413; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Stutz G, 2000, ARCH ANDROLOGY, V44, P117; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; TRAN D, 1987, J HISTOCHEM CYTOCHEM, V35, P733, DOI 10.1177/35.7.3295030; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tseng YT, 2015, REPRODUCTION, V150, pR77, DOI 10.1530/REP-14-0679; van den Driesche S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4097; Wakui S, 2014, TOXICOL PATHOL, V42, P877, DOI 10.1177/0192623313502879; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Yano CL, 2002, CONTRACEPTION, V66, P463, DOI 10.1016/S0010-7824(02)00407-9	93	13	13	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					339	357		10.1096/fj.201800488RRR	http://dx.doi.org/10.1096/fj.201800488RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979629	Green Submitted			2022-12-28	WOS:000457401500028
J	Wang, Y; Wang, EF; Zhang, YB; Madamsetty, VS; Ji, BA; Radisky, DC; Grande, JP; Misra, S; Mukhopadhyay, D				Wang, Ying; Wang, Enfeng; Zhang, Yuebo; Madamsetty, Vijay S.; Ji, Baoan; Radisky, Derek C.; Grande, Joseph P.; Misra, Sanjay; Mukhopadhyay, Debabrata			Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension	FASEB JOURNAL			English	Article						endothelium; NO; high blood pressure; miRNA	NITRIC-OXIDE SYNTHESIS; ASYMMETRIC DIMETHYLARGININE; RISK-FACTOR; DYSFUNCTION; SEMAPHORIN; RECEPTOR; ADMA; ANGIOGENESIS; REGULATOR; PATHWAY	Dimethylarginine dimethylaminohydrolases (DDAHs) are known to degrade asymmetric dimethylarginine, an endogenous inhibitor of NOS, and maintain vascular homeostasis; however, the regulatory pathways of DDAHs remain unclear. In this study, we aimed to define the role of transmembrane glycoprotein neuropilin-1 (NRP1) in the expression of DDAHs and investigate the potential roles of NRP1 in regulation of blood pressure. Short hairpin RNA-mediated knockdown of NRP1 reduced the level and mRNA stability of DDAH1 but not DDAH2 in HUVECs, whereas overexpression of NRP1 increased the mRNA stability of DDAH1. Meanwhile, mesenteric arteries and lung vascular endothelial cells of tamoxifen-inducible endothelial cell-specific NRP1 knockout mice exhibited decreased expression of DDAH1 and slightly increased expression of DDAH2. Mechanistically, the regulation of NRP1 on DDAH1 expression is mediated by a posttranscriptional mechanism involving miR-219-5p in HUVECs. Although the endothelial cell-specific NRP1 knockout mice did not exhibit any significant change in blood pressure at the basal level, they were more sensitive to low-dose angiotensin II infusion-induced increases in blood pressure. Our results show that NRP1 is required for full expression of DDAH1 in endothelial cells and that NRP1 contributes to protection from low-dose angiotensin II-induced increases in blood pressure.Wang, Y., Wang, E., Zhang, Y., Madamsetty, V. S., Ji, B., Radisky, D. C., Grande, J. P., Misra, S., Mukhopadhyay, D. Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension.	[Wang, Ying; Wang, Enfeng; Madamsetty, Vijay S.; Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA; [Zhang, Yuebo; Ji, Baoan; Radisky, Derek C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Grande, Joseph P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Misra, Sanjay] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Mukhopadhyay, D (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA.	mukhopadhyay.debabrata@mayo.edu	Madamsetty, Vijay Sagar/AAF-4804-2019; Grande, Joseph P./AAG-2128-2020	Madamsetty, Vijay Sagar/0000-0001-9883-190X; Grande, Joseph P./0000-0001-5674-1682; Wang, Ying/0000-0002-7852-386X	Microarray Core Facility at Mayo Clinic; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL140411]; NIH National Cancer Institute [CA78383-20]; Florida Department of Health Cancer Research Chair's Fund Florida Grant [3J-02]; American Heart Association [AHA-14POST20390029]; NATIONAL CANCER INSTITUTE [R01CA150190, R01CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140411] Funding Source: NIH RePORTER	Microarray Core Facility at Mayo Clinic; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Cancer Research Chair's Fund Florida Grant; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Alex Kolodkin (Johns Hopkins University, Baltimore, MD, USA) and Dr. Ralf H. Adams (Max Planck Institute, Munster, Germany) for the NRP1<SUP>flox/flox</SUP> mice and vascular endothelial-cadherin/Cre-ERT2 mice, respectively. They also thank Dr. Jordan D. Miller and Mr. Bruce E. Knudsen (Mayo Clinic) for assistance with the mouse blood pressure measurements. The authors thank the Microarray Core Facility at Mayo Clinic for their support and Brandy H. Edenfield (Mayo Clinic Jacksonville Histopathology Facility) for the kind help. The authors thank Dr. Luke H. Hoeppner (The Hormel Institute, University of Minnesota, Austin, MN, USA) for critically reviewing the manuscript, and Drs. DeLisa Fairweather and Katelyn A. Bruno (Mayo Clinic) for assistance with mouse lung endothelial cell isolation. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL140411, and NIH National Cancer Institute Grant CA78383-20 (both to D.M.), the Florida Department of Health Cancer Research Chair's Fund Florida Grant 3J-02 (to D.M.), and the American Heart Association Grant AHA-14POST20390029 (to Y.W.). The authors declare no conflicts of interest.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Ding H, 2010, CIRC RES, V106, P1145, DOI 10.1161/CIRCRESAHA.109.215616; Dowsett L, 2015, CIRCULATION, V131, P2217, DOI 10.1161/CIRCULATIONAHA.114.015064; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hu XL, 2011, ARTERIOSCL THROM VAS, V31, P1540, DOI 10.1161/ATVBAHA.110.222638; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Iannone L, 2014, BIOCHEM J, V462, P103, DOI 10.1042/BJ20140486; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lambden S, 2015, ARTERIOSCL THROM VAS, V35, P1382, DOI 10.1161/ATVBAHA.115.305278; Leiper JM, 2005, THER DRUG MONIT, V27, P744, DOI 10.1097/01.ftd.0000179849.42395.11; Leong Xin-Fang, 2015, Biomed Res Int, V2015, P528757, DOI 10.1155/2015/528757; Liao JK, 2013, J CLIN INVEST, V123, P540, DOI 10.1172/JCI66843; Luo ZM, 2010, HYPERTENSION, V56, P498, DOI 10.1161/HYPERTENSIONAHA.110.152959; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; OGAWA T, 1987, BIOCHEM BIOPH RES CO, V148, P671, DOI 10.1016/0006-291X(87)90929-6; Onozato ML, 2008, DIABETES, V57, P172, DOI 10.2337/db06-1772; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; VALLANCE P, 1992, LANCET, V339, P572; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang Y, 2016, J CELL SCI, V129, P3911, DOI 10.1242/jcs.190702; Wang Y, 2015, ARTERIOSCL THROM VAS, V35, P1401, DOI 10.1161/ATVBAHA.115.305566; Willeit P, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001833; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212	31	9	9	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					494	500		10.1096/fj.201800499R	http://dx.doi.org/10.1096/fj.201800499R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30118322	Green Published			2022-12-28	WOS:000457401500039
J	Ye, CJ; Yu, ZL; Xiong, YW; Wang, Y; Ruan, YN; Guo, YP; Chen, MM; Luan, SL; Zhang, EL; Liu, HB				Ye, Chengjin; Yu, Zhaoli; Xiong, Yiwei; Wang, Yu; Ruan, Yina; Guo, Yueping; Chen, Mianmian; Luan, Shilu; Zhang, Enli; Liu, Hebin			STAU1 binds to IBDV genomic double-stranded RNA and promotes viral replication via attenuation of MDA5-dependent interferon induction	FASEB JOURNAL			English	Article						RNA-binding protein; innate antiviral response; RIG-I-like receptors	BURSAL DISEASE VIRUS; PROTEIN-KINASE PKR; RIG-I; STRESS GRANULES; INNATE IMMUNITY; NUCLEOTIDE-SEQUENCE; ANTIVIRAL RESPONSE; SEGMENT-A; STAUFEN1; MDA5	Infectious bursal disease virus (IBDV) infection triggers the induction of type I IFN, which is mediated by melanoma differentiation-associated protein 5 recognition of the viral genomic double-stranded RNA (dsRNA). However, the mechanism of IBDV overcoming the type I IFN antiviral response remains poorly characterized. Here, we show that IBDV genomic dsRNA selectively binds to the host cellular RNA binding protein Staufen1 (STAU1) in vitro and in vivo. The viral dsRNA binding region was mapped to the N-terminal moiety of STAU1 (residues 1-468). Down-regulation of STAU1 impaired IBDV replication and enhanced IFN- transcription in response to IBDV infection, while having little effect on the viral attachment to the host cells and cellular entry. Conversely, overexpression of STAU1 but not the IBDV dsRNA-binding deficient STAU1 mutant (469-702) led to a suppression of IBDV dsRNA-induced IFN- promoter activity. Moreover, we found that the binding of STAU1 to IBDV dsRNA decreased the association of melanoma differentiation-associated protein 5 but not VP3 with the IBDV dsRNA in vitro. Finally, we showed that STAU1 and VP3 suppressed IFN- gene transcription in response to IBDV infection in an additive manner. Collectively, these findings provide a novel insight into the evasive strategies used by IBDV to escape the host IFN antiviral response.Ye, C., Yu, Z., Xiong, Y., Wang, Y., Ruan, Y., Guo, Y., Chen, M., Luan, S., Zhang, E., Liu, H. STAU1 binds to IBDV genomic double-stranded RNA and promotes viral replication via attenuation of MDA5-dependent interferon induction.	[Ye, Chengjin; Yu, Zhaoli; Wang, Yu; Ruan, Yina; Guo, Yueping; Chen, Mianmian; Luan, Shilu; Zhang, Enli; Liu, Hebin] Zhejiang A&F Univ, Dept Vet Med, Coll Anim Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Xiong, Yiwei; Liu, Hebin] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Peoples R China	Zhejiang A&F University; Xi'an Jiaotong-Liverpool University	Liu, HB (corresponding author), Zhejiang A&F Univ, 666 Wusu St, Hangzhou 311300, Zhejiang, Peoples R China.	hb1liu@foxmail.com			Natural Scientific Foundation of Zhejiang Province [LY18C180002]; China Postdoctoral Science Foundation [2017M621977]; National Natural Science Foundation of China [31470840, 31502061]; Science and Technology Foundation of Jiangsu province [BK20131181]; ZAFU Research and Development Fund [2014FR019, 2015FR008]	Natural Scientific Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Jiangsu province; ZAFU Research and Development Fund	This work was supported by the Natural Scientific Foundation of Zhejiang Province (LY18C180002), the China Postdoctoral Science Foundation (2017M621977), the National Natural Science Foundation of China (31470840 and 31502061), the Science and Technology Foundation of Jiangsu province (BK20131181), and the ZAFU Research and Development Fund (2014FR019 and 2015FR008). The authors declare no conflicts of interest.	Abrahamyan LG, 2010, J CELL SCI, V123, P369, DOI 10.1242/jcs.055897; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Blackham SL, 2013, J GEN VIROL, V94, P2429, DOI 10.1099/vir.0.051383-0; Boot HJ, 2000, J VIROL METHODS, V84, P49, DOI 10.1016/S0166-0934(99)00132-9; Busnadiego I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046768; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Cubas-Gaona LL, 2018, J VIROL, V92, DOI [10.1128/JVI.00364-18, 10.1128/jvi.00364-18]; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; Dixit U, 2016, NUCLEIC ACIDS RES, V44, P5271, DOI 10.1093/nar/gkw312; Eldaghayes I, 2006, VIRAL IMMUNOL, V19, P83, DOI 10.1089/vim.2006.19.83; Ferrero D, 2015, J VIROL, V89, P11165, DOI 10.1128/JVI.00218-15; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hayashi T, 2014, J INNATE IMMUN, V6, P58, DOI 10.1159/000351583; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KIBENGE FSB, 1990, J GEN VIROL, V71, P569, DOI 10.1099/0022-1317-71-3-569; Kim MY, 2014, NUCLEIC ACIDS RES, V42, P6999, DOI 10.1093/nar/gku388; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; Lee CC, 2014, ARCH VIROL, V159, P1671, DOI 10.1007/s00705-014-1983-9; Lee JH, 2011, BIOCHEM BIOPH RES CO, V414, P153, DOI 10.1016/j.bbrc.2011.09.042; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Li ZH, 2013, J VIROL, V87, P1221, DOI 10.1128/JVI.02421-12; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; Mendez F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123470; Milev MP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-41; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Smith Geoffrey L., 1994, Trends in Microbiology, V2, P81, DOI 10.1016/0966-842X(94)90539-8; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; SPIES U, 1989, NUCLEIC ACIDS RES, V17, P7982, DOI 10.1093/nar/17.19.7982; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; Ye C., 2017, J VIROL, V91; Ye CJ, 2018, J VIROL, V92, DOI 10.1128/JVI.01345-17; Ye CJ, 2014, J VIROL, V88, P11154, DOI 10.1128/JVI.01115-14; Yu L, 2001, AVIAN DIS, V45, P862, DOI 10.2307/1592866	58	16	17	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					286	300		10.1096/fj.201800062RR	http://dx.doi.org/10.1096/fj.201800062RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979632				2022-12-28	WOS:000457401500024
J	Tersey, SA; Levasseur, EM; Syed, F; Farb, TB; Orr, KS; Nelson, JB; Shaw, JL; Bokvist, K; Mather, KJ; Mirmira, RG				Tersey, Sarah A.; Levasseur, Esther M.; Syed, Farooq; Farb, Thomas B.; Orr, Kara S.; Nelson, Jennifer B.; Shaw, Janice L.; Bokvist, Krister; Mather, Kieren J.; Mirmira, Raghavendra G.			Episodic beta-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice	FASEB JOURNAL			English	Article						glucose intolerance; islet; cell dedifferentiation	ISLET; INSULIN; QUANTIFICATION; ACTIVATION; FAILURE; MASS; PCR; DNA	Loss of functional islet -cell mass through cellular death or dedifferentiation is thought to lead to dysglycemia during the progression from obesity to type 2 diabetes. To assess these processes in a mouse model of obesity, we performed measures of circulating cell-free differentially methylated insulin II (Ins2) DNA as a biomarker of -cell death and aldehyde dehydrogenase 1 family member A3 (ALDH1A3) and forkhead box 01 (Foxo1) immunostaining as markers of -cell dedifferentiation. Eight-week-old, C57BL/6J mice were fed a low-fat diet (LFD; 10% kcal from fat) or a high-fat diet (HFD; 60% kcal from fat) and were followed longitudinally for up to 13 wk to measure glycemic control and -cell mass, death, and dedifferentiation. Compared with LFD controls, -cell mass increased during the feeding period in HFD animals, and statistically greater -cell death (unmethylated Ins2) was detectable at 2 and 6 wk after diet initiation. Those times correspond to periods when significant step increases in fasting glucose and glucose intolerance, respectively, were detected. ALDH1A3 and Foxo1 immunostaining of the pancreas revealed evidence of -cell dedifferentiation by 13 wk when fed an HFD, but not in LFD controls. In conclusion, early episodic -cell death may be a feature of cellular turnover correlated with changes in glycemia during -cell mass accrual in obesity, whereas -cell dedifferentiation may be a feature seen later in established disease.Tersey, S. A., Levasseur, E. M., Syed, F., Farb, T. B., Orr, K. S., Nelson, J. B., Shaw, J. L., Bokvist, K., Mather, K. J., Mirmira, R. G. Episodic -cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice.	[Tersey, Sarah A.; Levasseur, Esther M.; Syed, Farooq; Orr, Kara S.; Nelson, Jennifer B.; Mather, Kieren J.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Tersey, Sarah A.; Syed, Farooq; Orr, Kara S.; Nelson, Jennifer B.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Levasseur, Esther M.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mather, Kieren J.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Farb, Thomas B.; Shaw, Janice L.; Bokvist, Krister] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Eli Lilly	Tersey, SA; Mirmira, RG (corresponding author), Indiana Univ Sch Med, 1044 W Walnut St,R4-W155, Indianapolis, IN 46202 USA.	stersey@iu.edu; rmirmira@iu.edu	Syed, Farooq/AAK-6781-2020; Mirmira, Raghavendra G/AAD-7592-2020; Mather, Kieren/ABE-4117-2020	Syed, Farooq/0000-0002-0284-0631; Mirmira, Raghavendra G/0000-0002-5013-6075; 	American Diabetes Association (ADA) [7-13-JF-56]; Lilly Research Awards Program; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [UC4 DK104166, T32 DK064466]; American Physiological Society Porter Fellowship; George and Francis Ball Foundation; Ball Brothers Foundation; Simmons Clinical Studies Fund; NIH NIDDK [P30 DK097512]; Eli Lilly and Co; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064466, P30DK097512, R01DK060581, UC4DK104166] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); Lilly Research Awards Program; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Physiological Society Porter Fellowship; George and Francis Ball Foundation; Ball Brothers Foundation; Simmons Clinical Studies Fund; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eli Lilly and Co(Eli Lilly); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Diabetes Association (ADA) Junior Faculty Award 7-13-JF-56 (to S.A.T.), a Lilly Research Awards Program grant (to R.G.M. and K.J.M.), U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants UC4 DK104166 (to R.G.M.) and T32 DK064466 (to E.M.L.), an American Physiological Society Porter Fellowship (to E.M.L.), grants from the George and Francis Ball Foundation and the Ball Brothers Foundation (to R.G.M.), and a Simmons Clinical Studies Fund grant (to R.G.M. and S.A.T.). This work used core services supported by NIH NIDDK Grant P30 DK097512 to the Indiana University School of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. R.G.M. and K.J.M. received partial research support for this study from Eli Lilly and Co; T.B.F. and J.L.S. are employees of Eli Lilly and Co; K.B. is a former employee of Eli Lilly and Co.; and R.G.M. and S.A.T. have filed patent applications for assays to measure beta-cell dysfunction and death.	Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Anderson EK, 2013, DIABETES, V62, P3180, DOI 10.2337/db12-1076; Blandino-Rosano M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16014; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Fisher MM, 2015, DIABETES, V64, P3867, DOI 10.2337/db15-0430; Fisher MM, 2013, ENDOCRINOLOGY, V154, P3476, DOI 10.1210/en.2013-1223; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Gupta D, 2017, J BIOL CHEM, V292, P12449, DOI [10.1074/jbc.M117.781047, 10.1074/jbc.m117.781047]; Gutierrez GD, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00022; Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Husseiny MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094591; Ishida E, 2017, DIABETES, V66, P2092, DOI 10.2337/db16-1213; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lakshmipathi J, 2016, DIABETES, V65, P1283, DOI 10.2337/db15-1398; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Ogihara T, 2010, J DIABETES INVEST, V1, P123, DOI 10.1111/j.2040-1124.2010.00021.x; Rui JX, 2017, CELL METAB, V25, P727, DOI 10.1016/j.cmet.2017.01.005; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Sims EK, 2013, AM J PHYSIOL-ENDOC M, V305, pE1495, DOI 10.1152/ajpendo.00366.2013; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Wang YJ, 2016, CELL METAB, V24, P616, DOI 10.1016/j.cmet.2016.09.007; Wang YJ, 2016, DIABETES, V65, P3028, DOI 10.2337/db16-0405	29	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6150	6158		10.1096/fj.201800150RR	http://dx.doi.org/10.1096/fj.201800150RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29812970	Green Published, Bronze			2022-12-28	WOS:000447172000032
J	Huang, J; Montani, JP; Verrey, F; Feraille, E; Ming, XF; Yang, ZH				Huang, Ji; Montani, Jean-Pierre; Verrey, Francois; Feraille, Eric; Ming, Xiu-Fen; Yang, Zhihong			Arginase-II negatively regulates renal aquaporin-2 and water reabsorption	FASEB JOURNAL			English	Article						collecting duct; copeptin; vasopressin; urine; osmolality	COLLECTING DUCT; MOUSE MODEL; RAT-KIDNEY; EXPRESSION; MICE; LOCALIZATION; GENE	Type-II l-arginine:ureahydrolase, arginase-II (Arg-II), is abundantly expressed in the kidney. The physiologic role played by Arg-II in the kidney remains unknown. Herein, we report that in mice that are deficient in Arg-II (Arg-II-/-), total and membrane-associated aquaporin-2 (AQP2) protein levels were significantly higher compared with wild-type (WT) controls. Water deprivation enhanced Arg-II expression, AQP2 levels, and membrane association in collecting ducts. Effects of water deprivation on AQP2 were stronger in Arg-II-/- mice than in WT mice. Accordingly, a decrease in urine volume and an increase in urine osmolality under water deprivation were more pronounced in Arg-II-/- mice than in WT mice, which correlated with a weaker increase in plasma osmolality in Arg-II-/- mice. There was no difference in vasopressin release under water deprivation conditions between either genotype of mice. Although total AQP2 and phosphorylated AQP2-S256 levels (mediated by PKA) in kidneys under water deprivation conditions were significantly higher in Arg-II-/- mice compared with WT animals, there is no difference in the ratio of AQP2-S256:AQP2. In cultured mouse collecting duct principal mCCD(cl1) cells, expression of both Arg-II and AQP2 were enhanced by the vasopressin type 2 receptor agonist, desamino-d-arginine vasopressin (dDAVP). Silencing Arg-II enhanced the expression and membrane association of AQP2 by dDAVP without influencing cAMP levels. In conclusion, in vivo and in vitro experiments demonstrate that Arg-II negatively regulates AQP2 and the urine-concentrating capability in kidneys via a mechanism that is not associated with the modulation of the cAMP pathway.Huang, J., Montani, J.-P., Verrey, F., Feraille, E., Ming, X.-F., Yang, Z. Arginase-II negatively regulates renal aquaporin-2 and water reabsorption.	[Huang, Ji; Montani, Jean-Pierre; Ming, Xiu-Fen; Yang, Zhihong] Univ Fribourg, Dept Med Cardiovasc & Aging Res, Div Physiol, Fribourg, Switzerland; [Huang, Ji; Montani, Jean-Pierre; Verrey, Francois; Feraille, Eric; Ming, Xiu-Fen; Yang, Zhihong] Natl Ctr Competence Res, Kidney Control Homeostasis, Zurich, Switzerland; [Verrey, Francois] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Feraille, Eric] Univ Geneva, Dept Cell Biol & Metab, Geneva, Switzerland	University of Fribourg; University of Zurich; University of Geneva	Ming, XF; Yang, ZH (corresponding author), Univ Fribourg, Dept Med, Chemin Musee 5, CH-1700 Fribourg, Switzerland.	xiu-fen.ming@unifr.ch; zhihong.yang@unifr.ch		Verrey, Francois/0000-0003-3250-9824; Feraille, Eric/0000-0003-1656-8365	Swiss National Science Foundation [31003A_159582/1]; Swiss Heart Foundation; National Centre of Competence in Research Program (NCCR-Kidney.CH)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; National Centre of Competence in Research Program (NCCR-Kidney.CH)	This work was supported by the Swiss National Science Foundation (31003A_159582/1), Swiss Heart Foundation, and the National Centre of Competence in Research Program (NCCR-Kidney.CH). The authors declare no conflicts of interest.	Borghese MFA, 2011, NEPHRON EXTRA, V1, P124, DOI 10.1159/000333066; Ash DE, 2004, J NUTR, V134, p2760S, DOI 10.1093/jn/134.10.2760S; Bjelakovic G, 2010, AMINO ACIDS, V39, P29, DOI 10.1007/s00726-010-0489-3; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Choi S, 2012, ACTA HISTOCHEM, V114, P487, DOI 10.1016/j.acthis.2011.09.002; Choi YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-31; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Huang J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00560; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kwon TH, 2013, KIDNEY RES CLIN PRAC, V32, P96, DOI 10.1016/j.krcp.2013.07.005; Lange PS, 2004, J NUTR, V134, p2812S, DOI 10.1093/jn/134.10.2812S; Levillain O, 2005, PFLUG ARCH EUR J PHY, V449, P491, DOI 10.1007/s00424-004-1336-8; MARPLES D, 1995, J CLIN INVEST, V95, P1838, DOI 10.1172/JCI117863; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; McDonough AA, 2015, AM J PHYSIOL-CELL PH, V308, pC426, DOI 10.1152/ajpcell.00400.2014; Ming XF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000992; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Morris SM, 2011, DIABETES, V60, P3015, DOI 10.2337/db11-0901; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nikolaeva S, 2016, J AM SOC NEPHROL, V27, P2997, DOI 10.1681/ASN.2015091055; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Ortiz MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104923; Pillai SM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008025; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; van Balkom BWM, 2004, AM J PHYSIOL-RENAL, V286, pF216, DOI 10.1152/ajprenal.00307.2003; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wu F, 1999, AM J PHYSIOL-RENAL, V276, pF874, DOI 10.1152/ajprenal.1999.276.6.F874; Yang ZH, 2006, CURR HYPERTENS REP, V8, P54, DOI 10.1007/s11906-006-0041-8; Yepuri G, 2012, AGING CELL, V11, P1005, DOI 10.1111/acel.12001; You HN, 2013, KIDNEY INT, V84, P1189, DOI 10.1038/ki.2013.215	34	7	8	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5520	5531		10.1096/fj.201701209R	http://dx.doi.org/10.1096/fj.201701209R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718707	Green Published, hybrid			2022-12-28	WOS:000447972500027
J	Schmidt, A; Bauknecht, P; Williams, EA; Augustinowski, K; Grunder, S; Jekely, G				Schmidt, Axel; Bauknecht, Philipp; Williams, Elizabeth A.; Augustinowski, Katrin; Gruender, Stefan; Jekely, Gaspar			Dual signaling of Wamide myoinhibitory peptides through a peptide-gated channel and a GPCR in Platynereis	FASEB JOURNAL			English	Article						peptide-gated ion channel; helix; FaNaC; neuropeptide; degenerin	3 HOMOLOGOUS SUBUNITS; ION-CHANNEL; NA+ CHANNEL; FUNCTIONAL-CHARACTERIZATION; NERVOUS-SYSTEM; HYDRA; NEUROPEPTIDE; RECEPTORS; AMILORIDE; PROTEIN	Neuropeptides commonly signal by metabotropic GPCRs. In some mollusks and cnidarians, RFamide neuropeptides mediate fast ionotropic signaling by peptide-gated ion channels that belong to the DEG/ENaC family. Here we describe a neuropeptide system with a dual mode of signaling by both a peptide-gated ion channel and a GPCR. We identified and characterized a peptide-gated channel in the marine annelid Platynereis dumerilii that is specifically activated by Wamide myoinhibitory peptides derived from the same proneuropeptide. The myoinhibitory peptide-gated ion channel (MGIC) belongs to the DEG/ENaC family and is paralogous to RFamide-gated ion channels. Platynereis myoinhibitory peptides also activate a previously described GPCR, MAG. We measured the potency of all Wamides on both MGIC and MAG and identified peptides that preferentially activate one or the other receptor. Analysis of a single-cell transcriptome resource indicates that MGIC and MAG signal in distinct target neurons. The identification of a Wamide-gated ion channel suggests that peptide-gated channels are more diverse and widespread in animals than previously appreciated. The possibility of neuropeptide signaling by both ionotropic and metabotropic receptors to different target cells in the same organism highlights an additional level of complexity in peptidergic signaling networks.Schmidt, A., Bauknecht, P., Williams, E. A., Augustinowski, K., Grunder, S., Jekely, G. Dual signaling of Wamide myoinhibitory peptides through a peptide-gated channel and a GPCR in Platynereis.	[Schmidt, Axel; Augustinowski, Katrin; Gruender, Stefan] Rhein Westfal Tech Hsch RWTH Aachen Univ, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Bauknecht, Philipp] Max Planck Inst Dev Biol, Tubingen, Germany; [Williams, Elizabeth A.; Jekely, Gaspar] Univ Exeter, Living Syst Inst, Exeter, Devon, England	RWTH Aachen University; Max Planck Society; University of Exeter	Grunder, S (corresponding author), Rhein Westfal Tech Hsch RWTH Aachen Univ, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.; Jekely, G (corresponding author), Univ Exeter, Stocker Rd, Exeter EX4 4QD, Devon, England.	sgruender@ukaachen.de; g.jekely@exeter.ac.uk	Schmidt, Axel/GLR-2893-2022; Gründer, Stefan/I-2495-2019; Jékely, Gáspár/I-8708-2012	Schmidt, Axel/0000-0002-9780-7243; Gründer, Stefan/0000-0002-7635-9883; Jékely, Gáspár/0000-0001-8496-9836; Bauknecht, Philipp/0000-0003-0423-8158; Williams, Elizabeth/0000-0003-3067-3137	International Max Planck Research School (IMPRS) "From Molecules to Organisms"; Deutsche Forschungsgemeinschaft [JE 777/1-1]	International Max Planck Research School (IMPRS) "From Molecules to Organisms"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank P. Lenzig [Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen] for expert technical assistance, and E. Lingueglia (Universite Cote d'Azur, Valbonne, France) for providing H. aspersa FaNaC. P.B. was supported by the International Max Planck Research School (IMPRS) "From Molecules to Organisms." E.A.W. was supported by a grant from Deutsche Forschungsgemeinschaft (JE 777/1-1). The authors declare no conflicts of interest.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bauknecht P, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0341-7; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Conzelmann M, 2013, P NATL ACAD SCI USA, V110, P8224, DOI 10.1073/pnas.1220285110; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Durrnagel S, 2012, J GEN PHYSIOL, V140, P391, DOI 10.1085/jgp.201210798; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Furukawa Y, 2006, PFLUG ARCH EUR J PHY, V451, P646, DOI 10.1007/s00424-005-1498-z; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Grunder S, 2015, J EXP BIOL, V218, P551, DOI 10.1242/jeb.111666; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jekely G, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.166710; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Kim YJ, 2010, P NATL ACAD SCI USA, V107, P6520, DOI 10.1073/pnas.0914764107; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Krishnan A, 2015, J EXP BIOL, V218, P562, DOI 10.1242/jeb.110312; Leng TD, 2016, CNS NEUROSCI THER, V22, P468, DOI 10.1111/cns.12524; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Nikitin M, 2015, GEN COMP ENDOCR, V212, P145, DOI 10.1016/j.ygcen.2014.03.049; Nusbaum MP, 2017, NAT REV NEUROSCI, V18, P389, DOI 10.1038/nrn.2017.56; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Schmidt A, 2017, MOL PHARMACOL, V92, P665, DOI 10.1124/mol.117.110064; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Thiel D, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170136; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064; Williams EA, 2017, ELIFE, V6, DOI 10.7554/eLife.26349; Williams EA, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-014-0093-6	41	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5338	5349		10.1096/fj.201800274R	http://dx.doi.org/10.1096/fj.201800274R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688813	Bronze, Green Submitted			2022-12-28	WOS:000447972500012
J	Kim, YH; Yoo, H; Hong, AR; Kwon, M; Kang, SW; Kim, K; Song, Y				Kim, Yo-Han; Yoo, Hanju; Hong, A-Reum; Kwon, Minseo; Kang, Sang-Wook; Kim, Kyunggon; Song, Youngsup			NEDD4L limits cAMP signaling through ubiquitination of CREB-regulated transcription coactivator 3	FASEB JOURNAL			English	Article						CRTC3; NEDD4-2; feedback regulation; adipose tissues	EPITHELIAL NA+ CHANNEL; CYCLIC-AMP; LIDDLES-SYNDROME; SODIUM-CHANNEL; WW DOMAINS; CELL-SURFACE; BETA-SUBUNIT; PHOSPHORYLATION; HYPERTENSION; EXPRESSION	The transcription factor cAMP-responsive element-binding protein (CREB) is involved in a variety of physiologic processes. Although its activity appears to be largely correlated with its phosphorylation status, cAMP-mediated dephosphorylation and the subsequent nuclear migration of the CREB-regulated transcription factors (CRTCs) are required to stimulate CREB transcriptional activity. Among the 3 identified mammalian homologs of CRTCs, CRTC3 has been shown to be expressed predominantly in adipose tissues in response to catecholamine signals that regulate lipid metabolism. Here, we show that prolonged cAMP signaling down-regulates CRTC3 in a proteasome-dependent manner and that neural precursor cell-expressed developmentally down-regulated gene 4-like (NEDD4L), a specific ubiquitin ligase for CRTC3, is responsible for this process. By recognizing the PY motif of CRTC3, NEDD4L interacts with CRTC3 and promotes its polyubiquitination. Interaction between NEDD4L and CRTC3 is further boosted by cAMP signaling, and this enhanced interaction appears to be dependent on the cAMP-mediated phosphorylation of NEDD4L at the Ser448 site. Furthermore, we show that food withdrawal stimulates NEDD4L phosphorylation in mice, which then show a decrease of adipose tissue CRTC3 protein levels. Together, these results suggest that NEDD4L plays a key role in the feedback regulation of cAMP signaling by limiting CRTC3 protein levels.Kim, Y.-H., Yoo, H., Hong, A.-R., Kwon, M., Kang, S.-W., Kim, K., Song, Y. NEDD4L limits cAMP signaling through ubiquitination of CREB-regulated transcription coactivator 3.	[Kim, Yo-Han; Yoo, Hanju; Hong, A-Reum; Kwon, Minseo; Kang, Sang-Wook; Song, Youngsup] Univ Ulsan, Convergence Med Res Ctr, Biomed Res Ctr,Coll Med, Dept Biomed Sci,Asan Med Ctr,Asan Inst Life Sci, Seoul, South Korea; [Kim, Yo-Han; Yoo, Hanju; Hong, A-Reum; Kwon, Minseo] Univ Ulsan, Convergence Med Res Ctr, Biomed Res Ctr,Coll Med, Dept Convergence Med,Asan Med Ctr,Asan Inst Life, Seoul, South Korea; [Kim, Kyunggon] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Song, Y (corresponding author), Univ Ulsan, Coll Med, Dept Biomed Sci, Olymp Ro 43 Gil 88, Seoul 05505, South Korea.	ysong@amc.seoul.kr		Yoo, Hanju/0000-0002-0332-6423	National Research Foundation of Korea [2017R1A2B2002691]; Asan Institute for Life Sciences [2017-611]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Sciences	The authors thank Dr. Wesley Sundquist (University of Utah, Salt Lake City, UT, USA) for providing NEDD4L and its variants, Donghwan Kim (Department of Biomedical Sciences, University of Ulsan College of Medicine) for mouse experiments, and the Clinical proteomics core facility at the ConveRgence mEDicine research cenTer (CREDIT), Asan Medical Center for supporting and instrumentation for mass spectrometry. The authors thank Ryan at Enago for the English language review. This work was supported by a National Research Foundation of Korea (2017R1A2B2002691) and by the Asan Institute for Life Sciences and Basic Science Program (2017-611). The authors declare no conflicts of interest.	ALBERTS AS, 1994, J BIOL CHEM, V269, P7623; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Fu JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078522; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Minegishi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27137; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Ou ZJ, 2014, MOL BIOL REP, V41, P125, DOI 10.1007/s11033-013-2844-4; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Van Eynde A, 1995, J BIOL CHEM, V270, P28068, DOI 10.1074/jbc.270.47.28068; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Weng L, 2015, CELL PHYSIOL BIOCHEM, V36, P1911, DOI 10.1159/000430160	36	12	12	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4053	4062		10.1096/fj.201701406R	http://dx.doi.org/10.1096/fj.201701406R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29505301				2022-12-28	WOS:000435104500048
J	Liu, GT; Kung, HN; Chen, CK; Huang, C; Wang, YL; Yu, CP; Lee, CP				Liu, Guan-Ting; Kung, Hsiu-Ni; Chen, Chung-Kuan; Huang, Cheng; Wang, Yung-Li; Yu, Cheng-Pu; Lee, Chung-Pei			Improving nuclear envelope dynamics by EBV BFRF1 facilitates intranuclear component clearance through autophagy	FASEB JOURNAL			English	Article						autophagic proteolysis; Epstein-Barr virus; vesicular nucleocytoplasmic transport; nuclear component catabolism	EPSTEIN-BARR-VIRUS; PROTEIN-QUALITY-CONTROL; MEMBRANE-FILTER ASSAY; EGRESS COMPLEX; SELECTIVE AUTOPHAGY; HUNTINGTONS-DISEASE; VIRAL REPLICATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MAMMALIAN-CELLS	Although a vesicular nucleocytoplasmic transport system is believed to exist in eukaryotic cells, the features of this pathway are mostly unknown. Here, we report that the BFRF1 protein of the Epstein-Barr virus improves vesicular transport of nuclear envelope (NE) to facilitate the translocation and clearance of nuclear components. BFRF1 expression induces vesicles that selectively transport nuclear components to the cytoplasm. With the use of aggregation-prone proteins as tools, we found that aggregated nuclear proteins are dispersed when these BFRF1-induced vesicles are formed. BFRF1-containing vesicles engulf the NE-associated aggregates, exit through from the NE, and putatively fuse with autophagic vacuoles. Chemical treatment and genetic ablation of autophagy-related factors indicate that autophagosome formation and autophagy-linked FYVE protein-mediated autophagic proteolysis are involved in this selective clearance of nuclear proteins. Remarkably, vesicular transport, elicited by BFRF1, also attenuated nuclear aggregates accumulated in neuroblastoma cells. Accordingly, induction of NE-derived vesicles by BFRF1 facilitates nuclear protein translocation and clearance, suggesting that autophagy-coupled transport of nucleus-derived vesicles can be elicited for nuclear component catabolism in mammalian cells.Liu, G.-T., Kung, H.-N., Chen, C.-K., Huang, C., Wang, Y.-L., Yu, C.-P., Lee, C.-P. Improving nuclear envelope dynamics by EBV BFRF1 facilitates intranuclear component clearance through autophagy.	[Liu, Guan-Ting; Chen, Chung-Kuan; Wang, Yung-Li; Yu, Cheng-Pu; Lee, Chung-Pei] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei, Taiwan; [Kung, Hsiu-Ni] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Huang, Cheng] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan	National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Yang Ming Chiao Tung University	Lee, CP (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, S214 Room,365 Min Te Rd, Taipei 11219, Taiwan.	chungpei@ntunhs.edu.tw	Kung, Hsiu-Ni/B-4832-2009	KUNG, HSIU-NI/0000-0001-6979-8346; Chen, Chung-Kuan/0000-0002-6973-2563	Ministry of Science and Technology, Taipei, Taiwan [MOST102-2320-B-227-002, MOST103-2320-B-227-001-MY3, MOST106-2320-B-227-001-MY3]	Ministry of Science and Technology, Taipei, Taiwan	For material support, the authors thank Dr. Elizabeth Sztul (University of Alabama at Birmingham, Birmingham, AL, USA) for plasmids expressing GFP170*; Drs. Pang-Hsien Tu and Wen-Chuan Shen (Academia Sinica, Taipai, Taiwan) for plasmids expressing Htt25Q-NLS and Htt81Q-NLS; Dr. Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) for ATG5 WT and null MEF cells; Dr. Ching-wa Tsai (National Taiwan University College of Medicine) for NA and Akata cells; and the National RNAi Core Facility (Taipei, Taiwan) for short hairpin RNA-containing lentiviral reagents. For technical support, the authors are grateful to Yun-Yu Sun (Image Core Lab at National Taiwan University Hospital); Hua-Man Hsu and Dr. Cheng-Yen Huang [First Core Facility at National Taiwan University College of Medicine, and the Imaging Core Facility of Nanotechnology of the University System of Taiwan-National Yang-Ming University (UST-YMU)] for the technical assistance on confocal and live-cell imaging; Horng-Tzer Shy (National Taiwan University College of Medicine) for EM sample preparation; and Drs. Mei-Ru Chen and Mei-Tzu Su (National Taiwan University College of Medicine) for equipment and cell line supports. Finally, the authors thank Drs. Anne Simonsen and Alf Hakon Lystad (Institute of Basic Medical Sciences, Oslo, Norway); Drs. Y. Henry Sun, Yijuang Chern, and Steve S.-L. Chen (Academia Sinica); and Dr. Yao Chang (National Health Research Institutes, Taipei, Taiwan) for experimental suggestions. This study was supported by Grants MOST102-2320-B-227-002, MOST103-2320-B-227-001-MY3, and MOST106-2320-B-227-001-MY3 from the Ministry of Science and Technology, Taipei, Taiwan). The authors declare no conflicts of interest.	Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bigalke JM, 2015, J VIROL, V89, P9150, DOI 10.1128/JVI.02530-14; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boban M, 2016, NUCLEUS-PHILA, V7, P41, DOI 10.1080/19491034.2016.1139273; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; Chang E, 2008, ANAL BIOCHEM, V373, P330, DOI 10.1016/j.ab.2007.09.015; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Chun WJ, 2001, NEUROBIOL DIS, V8, P391, DOI 10.1006/nbdi.2001.0390; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Eenjes E, 2016, J CELL SCI, V129, P1260, DOI 10.1242/jcs.179978; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; English L, 2009, AUTOPHAGY, V5, P1026, DOI 10.4161/auto.5.7.9163; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Fukuda M, 2008, AUTOPHAGY, V4, P824, DOI 10.4161/auto.6542; Gonnella R, 2005, J VIROL, V79, P3713, DOI 10.1128/JVI.79.6.3713-3727.2005; Granato M, 2014, J VIROL, V88, P12715, DOI 10.1128/JVI.02199-14; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hagen C, 2015, CELL, V163, P1692, DOI 10.1016/j.cell.2015.11.029; Hellberg T, 2016, ADV VIRUS RES, V94, P81, DOI 10.1016/bs.aivir.2015.10.002; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Isakson P, 2013, CELL DEATH DIFFER, V20, P12, DOI 10.1038/cdd.2012.66; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Lee CP, 2016, J VIROL, V90, P8994, DOI 10.1128/JVI.01235-16; Lee CP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002904; Lee JY, 2010, AUTOPHAGY, V6, P555, DOI 10.4161/auto.6.4.11812; Leigh KE, 2015, P NATL ACAD SCI USA, V112, P9010, DOI 10.1073/pnas.1511140112; Lye MF, 2015, EMBO J, V34, P2937, DOI 10.15252/embj.201592651; Lystad AH, 2014, EMBO REP, V15, P557, DOI 10.1002/embr.201338003; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Matunis MJ, 2006, METHODS, V39, P277, DOI 10.1016/j.ymeth.2006.06.003; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; Mijaljica D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040013; Mijaljica D, 2010, NUCLEUS-PHILA, V1, P213, DOI 10.4161/nucl.1.3.11738; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nowag H, 2014, EBIOMEDICINE, V1, P116, DOI 10.1016/j.ebiom.2014.11.007; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rose A, 2012, TRENDS CELL BIOL, V22, P509, DOI 10.1016/j.tcb.2012.07.003; Sarisky RT, 1996, J VIROL, V70, P8340, DOI 10.1128/JVI.70.12.8340-8347.1996; SEIGNEURIN JM, 1977, J VIROL, V24, P836, DOI 10.1128/JVI.24.3.836-845.1977; Shen WC, 2015, AUTOPHAGY, V11, P685, DOI 10.4161/auto.36098; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walzer SA, 2015, J BIOL CHEM, V290, P27452, DOI 10.1074/jbc.C115.686527; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zeev-Ben-Mordehai T, 2015, CELL REP, V13, P2645, DOI 10.1016/j.celrep.2015.11.008	61	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3968	3983		10.1096/fj.201701253R	http://dx.doi.org/10.1096/fj.201701253R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481305				2022-12-28	WOS:000435104500041
J	Houghton, MJ; Kerimi, A; Mouly, V; Tumova, S; Williamson, G				Houghton, Michael J.; Kerimi, Asimina; Mouly, Vincent; Tumova, Sarka; Williamson, Gary			Gut microbiome catabolites as novel modulators of muscle cell glucose metabolism	FASEB JOURNAL			English	Article						phenolic; flavonoid; microbiota; insulin; berry	COLONIC METABOLITES; HUMAN PLASMA; QUERCETIN; BUTYRATE; GLUT4; WHEAT; TRANSLOCATION; ANTHOCYANINS; STIMULATION; POLYPHENOLS	The gut microbiome supplies essential metabolites such as short-chain fatty acids to skeletal muscle mitochondria, and the composition and activity of the microbiota is in turn affected by muscle fitness. To further our understanding of the complex interactions between the gut microbiome and muscle, we examined the effect of microbiota-derived phenolic metabolites on the ability of human muscle cells to take up and metabolize glucose. As a model, we used the differentiated human skeletal muscle myoblast line, LHCN-M2, which expresses typical muscle phenotypic markers. We initially tested a selected panel of parent phenolic compounds and microbial metabolites, and their respective phenolic conjugates, as found in blood. Several of the tested compounds increased glucose uptake and metabolism, notably in high glucose- and insulin-treated myotubes. One of the most effective was isovanillic acid 3-O-sulfate (IVAS), a metabolite from the microbiome found in the blood, primarily derived from consumed cyanidin 3-O-glucoside, a major compound in berry fruits. IVAS stimulated a dose-dependent increase in glucose transport through glucose transporter GLUT4- and PI3K-dependent mechanisms. IVAS also up-regulated GLUT1, GLUT4, and PI3K p85 protein, and increased phosphorylation of Akt. The stimulation of glucose uptake and metabolism by a unique microbiome metabolite provides a novel link among diet, gut microbiota, and skeletal muscle energy source utilization.Houghton, M. J., Kerimi, A., Mouly, V., Tumova, S., Williamson, G. Gut microbiome catabolites as novel modulators of muscle cell glucose metabolism.	[Houghton, Michael J.; Kerimi, Asimina; Tumova, Sarka; Williamson, Gary] Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England; [Mouly, Vincent] Sorbonne Univ, INSERM, Inst Myol, Ctr Res Myol,Unite Mixte Rech Sci 974, Paris, France	University of Leeds; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Williamson, G (corresponding author), Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	g.williamson@leeds.ac.uk	Tumova, Sarka/AAD-6353-2019; Williamson, Gary/AAE-9665-2019; Houghton, Michael J/AAY-7751-2020	Tumova, Sarka/0000-0003-2044-4998; Williamson, Gary/0000-0002-5624-6267; Houghton, Michael J/0000-0001-6579-7995	European Research Council [POLYTRUE? 322467]	European Research Council(European Research Council (ERC)European Commission)	The authors acknowledge the platform for the immortalization of human cells of the Institut de Myologie in Paris, and thank S. Gardner (formerly at School of Food Science and Nutrition, University of Leeds, Leeds, United Kingdom) for helping to establish the muscle cells in our laboratory. The authors acknowledge funding from the European Research Council for an advanced grant (POLYTRUE? 322467). The authors declare no conflicts of interest.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Bareja A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090398; Barton W, 2018, GUT, V67, P625, DOI 10.1136/gutjnl-2016-313627; BASSHAM JA, 1974, ANAL BIOCHEM, V61, P479, DOI 10.1016/0003-2697(74)90415-1; Bhattacharya S, 2013, J AGR FOOD CHEM, V61, P11033, DOI 10.1021/jf402838a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Clark A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00319; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Czank C, 2013, AM J CLIN NUTR, V97, P995, DOI 10.3945/ajcn.112.049247; de Ferrars RM, 2014, BRIT J PHARMACOL, V171, P3268, DOI 10.1111/bph.12676; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158; Eid HM, 2015, PHARMACOGN MAG, V11, P74, DOI 10.4103/0973-1296.149708; Eid HM, 2010, MOL NUTR FOOD RES, V54, P991, DOI 10.1002/mnfr.200900218; Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; Franco-Obregon A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00018-17; Fumeaux R, 2010, ORG BIOMOL CHEM, V8, P5199, DOI 10.1039/c0ob00137f; Gardner S, 2012, AM J PHYSIOL-CELL PH, V303, pC1292, DOI 10.1152/ajpcell.00259.2012; Giacomoni F., 2014, 11 NUGOWEEK NUTRIGEN, P95; Ho GTT, 2017, J AGR FOOD CHEM, V65, P2677, DOI 10.1021/acs.jafc.6b05582; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Guy PA, 2009, J CHROMATOGR B, V877, P3965, DOI 10.1016/j.jchromb.2009.10.006; Iovino S, 2016, P NATL ACAD SCI USA, V113, P1889, DOI 10.1073/pnas.1525665113; Jung TH, 2015, J MICROBIOL BIOTECHN, V25, P1555, DOI 10.4014/jmb.1505.05078; Kawabata K, 2011, MOL NUTR FOOD RES, V55, P467, DOI 10.1002/mnfr.201000267; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Lauritzen HPMM, 2010, AM J PHYSIOL-ENDOC M, V299, pE169, DOI 10.1152/ajpendo.00066.2010; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Mach N, 2017, J SPORT HEALTH SCI, V6, P179, DOI 10.1016/j.jshs.2016.05.001; Manach C, 1998, FEBS LETT, V426, P331, DOI 10.1016/S0014-5793(98)00367-6; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; O'Leary KA, 2003, BIOCHEM PHARMACOL, V65, P479, DOI 10.1016/S0006-2952(02)01510-1; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Peyron S, 2001, J AGR FOOD CHEM, V49, P4694, DOI 10.1021/jf0106805; Pimpao RC, 2015, BRIT J NUTR, V113, P454, DOI 10.1017/S0007114514003511; Pimpao RC, 2014, MOL NUTR FOOD RES, V58, P1414, DOI 10.1002/mnfr.201300822; Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scazzocchio B, 2015, MOL NUTR FOOD RES, V59, P1472, DOI 10.1002/mnfr.201400816; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005; Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Steves CJ, 2016, J BONE MINER RES, V31, P261, DOI 10.1002/jbmr.2765; Stilling RM, 2016, NEUROCHEM INT, V99, P110, DOI 10.1016/j.neuint.2016.06.011; Stoupi S, 2010, MOL NUTR FOOD RES, V54, P747, DOI 10.1002/mnfr.200900123; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336; Torronen R, 2013, J NUTR, V143, P430, DOI 10.3945/jn.112.169771; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610; Williamson G, 2017, BIOCHEM PHARMACOL, V139, P24, DOI 10.1016/j.bcp.2017.03.012; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Wong CC, 2012, BIOCHEM PHARMACOL, V84, P564, DOI 10.1016/j.bcp.2012.05.011; Wong CC, 2011, BIOCHEM PHARMACOL, V81, P942, DOI 10.1016/j.bcp.2011.01.004; Yamamoto N, 2010, BIOSCI BIOTECH BIOCH, V74, P2036, DOI 10.1271/bbb.100305; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	65	35	38	3	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1887	1898		10.1096/fj.201801209R	http://dx.doi.org/10.1096/fj.201801209R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183376	Green Submitted			2022-12-28	WOS:000457296600030
J	Kodji, X; Arkless, KL; Kee, Z; Cleary, SJ; Aubdool, AA; Evans, E; Caton, P; Pitchford, SC; Brain, SD				Kodji, Xenia; Arkless, Kate L.; Kee, Zizheng; Cleary, Simon J.; Aubdool, Aisah A.; Evans, Elizabeth; Caton, Paul; Pitchford, Simon C.; Brain, Susan D.			Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis	FASEB JOURNAL			English	Article						TRP channels; neuropeptides; macrophages; oxidative stress; peroxynitrite	NITRIC-OXIDE SYNTHASE; GENE-RELATED PEPTIDE; SUBSTANCE-P; MOUSE MODEL; MAST-CELLS; SKIN; RECEPTOR; TRPA1; SUPEROXIDE; ITCH	Psoriasis is characterized by keratinocyte hyperproliferation, erythema, as well as a form of pruritus, involving cutaneous discomfort. There is evidence from both clinical and murine models of psoriasis that chemical or surgical depletion of small-diameter sensory nerves/nociceptors benefits the condition, but the mechanisms are unclear. Hence, we aimed to understand the involvement of sensory nerve mediators with a murine model of psoriasis and associated spontaneous behaviors, indicative of cutaneous discomfort. We have established an Aldara model of psoriasis in mice and chemically depleted the small-diameter nociceptors in a selective manner. The spontaneous behaviors, in addition to the erythema and skin pathology, were markedly improved. Attenuated inflammation was associated with reduced dermal macrophage influx and production of reactive oxygen/nitrogen species (peroxynitrite and protein nitrosylation). Subsequently, this directly influenced observed behavioral responses. However, the blockade of common sensory neurogenic mechanisms for transient receptor potential (TRP)V1, TRPA1, and neuropeptides (substance P and calcitonin gene-related peptide) using genetic and pharmacological approaches inhibited the behaviors but not the inflammation. Thus, a critical role of the established sensory TRP-neuropeptide pathway in influencing cutaneous discomfort is revealed, indicating the therapeutic potential of agents that block that pathway. The ongoing inflammation is mediated by a distinct sensory pathway involving macrophage activation.Kodji, X., Arkless, K. L., Kee, Z., Cleary, S. J., Aubdool, A. A., Evans, E., Caton, P., Pitchford, S. C., Brain, S. D. Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis.	[Kodji, Xenia; Arkless, Kate L.; Kee, Zizheng; Aubdool, Aisah A.; Brain, Susan D.] Kings Coll London, BHF, Cardiovasc Ctr Res Excellence, Vasc Biol & Inflammat Sect, London, England; [Cleary, Simon J.; Pitchford, Simon C.] Kings Coll London, Sackler Inst Pulm Pharmacol, Inst Pharmaceut Sci, London, England; [Evans, Elizabeth; Caton, Paul] Kings Coll London, Diabet Res Grp, Div Diabet & Nutr Sci, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Brain, SD (corresponding author), Kings Coll London, BHF, Ctr Res Excellence, Vasc Biol & Inflammat, Franklin Wilkins Bldg,Waterloo Campus, London SE1 9NH, England.	sue.brain@kcl.ac.uk		Pitchford, Simon/0000-0003-3961-0407; Aubdool, Dr. Aisah/0000-0002-4712-9421; Cleary, Simon/0000-0001-5573-6363; Brain, Susan/0000-0002-9684-8342	British Pharmacological Society's AJ Clark Studentship; Arthritis Research UK [21541]; Medical Research Council Doctoral Training Programme Studentship; British Heart Foundation	British Pharmacological Society's AJ Clark Studentship; Arthritis Research UK(Versus Arthritis); Medical Research Council Doctoral Training Programme Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	X.K. was funded by the British Pharmacological Society's AJ Clark Studentship and Arthritis Research UK (Project Grant 21541), S.J.C. was funded by Medical Research Council Doctoral Training Programme Studentship, and A.A.A. was funded by the British Heart Foundation. The authors declare no conflicts of interest.	Amatya B, 2011, BRIT J DERMATOL, V164, P1023, DOI 10.1111/j.1365-2133.2011.10241.x; Andersson DA, 2015, J BIOL CHEM, V290, P15185, DOI 10.1074/jbc.M115.644476; Andoh T, 2013, J PHARMACOL SCI, V123, P199, DOI 10.1254/jphs.13122SC; Aubdool AA, 2016, BRIT J PHARMACOL, V173, P2419, DOI 10.1111/bph.13519; Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bacchetti T, 2013, BRIT J DERMATOL, V168, P984, DOI 10.1111/bjd.12144; Baek JO, 2012, ARCH DERMATOL RES, V304, P699, DOI 10.1007/s00403-012-1272-y; Banvolgyi A, 2005, J NEUROIMMUNOL, V169, P86, DOI 10.1016/j.jneuroim.2005.08.012; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BERNSTEIN JE, 1986, J AM ACAD DERMATOL, V15, P504, DOI 10.1016/S0190-9622(86)70201-6; Bertin S, 2017, GUT, V66, P1584, DOI 10.1136/gutjnl-2015-310710; Boehncke W. H., 2017, CLIN REV ALLERGY IMM; Carlsson H, 2005, CANCER BIOL THER, V4, P998, DOI 10.4161/cbt.4.9.1969; Chan J, 1997, ARCH DERMATOL RES, V289, P611, DOI 10.1007/s004030050249; Cuzzocrea S, 1998, FREE RADICAL BIO MED, V24, P450, DOI 10.1016/S0891-5849(97)00280-3; Dantas RL, 2016, J PATHOL, V240, P366, DOI 10.1002/path.4786; DEWING SB, 1971, ARCH DERMATOL, V104, P220, DOI 10.1001/archderm.104.2.220; Dimon-Gadal S, 2000, J INVEST DERMATOL, V114, P984, DOI 10.1046/j.1523-1747.2000.00962.x; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Duval A, 2009, NEW ENGL J MED, V361, P1415, DOI 10.1056/NEJMc0906670; EKBLOM A, 1993, SKIN PHARMACOL, V6, P215; Esancy K, 2018, ELIFE, V7, DOI 10.7554/eLife.32036; Fernandes ES, 2013, FASEB J, V27, P1664, DOI 10.1096/fj.12-221218; Fernandes ES, 2011, ARTHRITIS RHEUM-US, V63, P819, DOI 10.1002/art.30150; Gibson RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100610; Guerard S, 2013, ARCH DERMATOL RES, V305, P879, DOI 10.1007/s00403-013-1404-z; Hajna Z, 2016, J MOL NEUROSCI, V60, P157, DOI 10.1007/s12031-016-0802-z; Hirsch S, 2013, PAIN, V154, P700, DOI 10.1016/j.pain.2013.01.002; HYLDEN JLK, 1981, BRAIN RES, V217, P212, DOI 10.1016/0006-8993(81)90203-1; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Jiang WY, 1998, INT J DERMATOL, V37, P572, DOI 10.1046/j.1365-4362.1998.00533.x; Kemeny A, 2018, J INVEST DERMATOL, V138, P1774, DOI 10.1016/j.jid.2018.02.040; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kodji X, 2016, CURR RES TRANSL MED, V64, P195, DOI 10.1016/j.retram.2016.09.002; KOLBBACHOFEN V, 1994, LANCET, V344, P139, DOI 10.1016/S0140-6736(94)91328-5; Kun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108164; LaMotte RH, 2011, EXP DERMATOL, V20, P778, DOI 10.1111/j.1600-0625.2011.01367.x; Lee Y, 2012, BIOCHEM BIOPH RES CO, V423, P647, DOI 10.1016/j.bbrc.2012.05.162; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Ljosaa TM, 2010, ACTA DERM-VENEREOL, V90, P39, DOI 10.2340/00015555-0764; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; NAUKKARINEN A, 1993, ARCH DERMATOL RES, V285, P341, DOI 10.1007/BF00371834; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; Omari SA, 2017, ADV PHARMACOL, V79, P173, DOI 10.1016/bs.apha.2017.01.002; Onderdijk AJ, 2017, METHODS MOL BIOL, V1559, P75, DOI 10.1007/978-1-4939-6786-5_6; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Prignano F, 2009, CLIN COSMET INVESTI, V2, P9; Quallo T, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.191; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; RODENAS J, 1995, FREE RADICAL BIO MED, V18, P869, DOI 10.1016/0891-5849(94)00215-6; Roller A, 2012, J IMMUNOL, V189, P4612, DOI 10.4049/jimmunol.1103173; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sakai K, 2016, PAIN, V157, P2536, DOI 10.1097/j.pain.0000000000000674; Salmon AM, 2004, NEUROSCI LETT, V360, P73, DOI 10.1016/j.neulet.2004.02.031; Simeoli R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01841-5; Stander S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010968; Stander S, 2004, EXP DERMATOL, V13, P129, DOI 10.1111/j.0906-6705.2004.0178.x; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Swindell WR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0415-3; Tattersall FD, 2000, NEUROPHARMACOLOGY, V39, P652, DOI 10.1016/S0028-3908(99)00172-0; Terhorst D, 2015, J IMMUNOL, V195, P4953, DOI 10.4049/jimmunol.1500551; Therene C, 2018, J INVEST DERMATOL, V138, P38, DOI 10.1016/j.jid.2017.05.039; Trevisan G, 2016, BRAIN, V139, P1361, DOI 10.1093/brain/aww038; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Ward NL, 2011, BRIT J DERMATOL, V164, P750, DOI 10.1111/j.1365-2133.2010.10129.x; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954	76	25	28	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1578	1594		10.1096/fj.201800395RR	http://dx.doi.org/10.1096/fj.201800395RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204499	hybrid, Green Published			2022-12-28	WOS:000457296600007
J	Meng, GM; Tang, XY; Yang, ZL; Zhao, Y; Curtis, JM; McMullen, TPW; Brindley, DN				Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Zhao, YuanYuan; Curtis, Jonathan M.; McMullen, Todd P. W.; Brindley, David N.			Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer	FASEB JOURNAL			English	Article						adiponectin; cytokines; lipid phosphate phosphatase 1; lysophosphatidic acid receptor; sphingosine 1-phosphate	TUMOR-GROWTH; KAPPA-B; EXPRESSION; INSULIN; CHEMOTHERAPY; OBESITY; GLUCOCORTICOIDS; ADIPOCYTES; CYTOKINES; RECEPTOR	Lysophosphatidate (LPA) signaling through 6 receptors is regulated by the balance of LPA production by autotaxin (ATX) vs. LPA degradation by lipid phosphate phosphatases (LPPs). LPA promotes an inflammatory cycle by increasing the synthesis of cyclooxygenase-2 and multiple inflammatory cytokines that stimulate further ATX production. We aimed to determine whether the anti-inflammatory glucocorticoid (GC) dexamethasone (Dex) functions partly by decreasing the ATX-LPA inflammatory cycle in adipose tissue, a major site of ATX secretion. Treatment of human adipose tissue with 10-1000 nM Dex decreased ATX secretion, increased LPP1 expression, and decreased mRNA expressions of IL-6, TNF-, peroxisome proliferator-activated receptor (PPAR)-, and adiponectin. Cotreatment with rosiglitazone (an insulin sensitizer), insulin, or both abolished Dex-induced decreases in ATX and adiponectin secretion, but did not reverse Dex-induced decreases in secretions of 20 inflammatory cytokines and chemokines. Dex-treated mice exhibited lower ATX activity in plasma, brain, and adipose tissue; decreased mRNA levels for LPA and sphingosine 1-phosphate (S1P) receptors in brain; and decreased plasma concentrations of LPA and S1P. Our results establish a novel mechanism for the anti-inflammatory effects of Dex through decreased signaling by the ATX-LPA-inflammatory axis. The GC action in adipose tissue has implications for the pathogenesis of insulin resistance and obesity in metabolic syndrome and breast cancer treatment.Meng, G., Tang, X., Yang, Z., Zhao, Y., Curtis, J. M., McMullen, T. P. W., Brindley, D. N. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.	[Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Brindley, David N.] Univ Alberta, Canc Res Inst Northern Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB, Canada; [Zhao, YuanYuan; Curtis, Jonathan M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [McMullen, Todd P. W.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca		Meng, Guanmin/0000-0002-6701-8980	Canadian Cancer Society Research Institute; Canadian Breast Cancer Foundation (CBCF); University of Alberta	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation (CBCF); University of Alberta(University of Alberta)	The work was supported by grants from the Canadian Cancer Society Research Institute and the Canadian Breast Cancer Foundation (CBCF) (to D.N.B.) and by a 75th Anniversary Graduate Studentship from the University of Alberta (to Z.Y.). The authors declare no conflicts of interest.	Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Benesch M.G.K., 2018, CANCERS, V10, pe73; Benesch MGK, 2017, TRENDS CANCER, V3, P748, DOI 10.1016/j.trecan.2017.09.004; Benesch MGK, 2016, J BIOMED RES, V30, P272, DOI 10.7555/JBR.30.20150058; Benesch MGK, 2015, FASEB J, V29, P3990, DOI 10.1096/fj.15-274480; Benesch MGK, 2015, ENDOCR-RELAT CANCER, V22, P593, DOI 10.1530/ERC-15-0045; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; BERTRAND F, 1995, J BIOL CHEM, V270, P24435, DOI 10.1074/jbc.270.41.24435; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; BRINDLEY DN, 1995, INT J OBESITY, V19, pS69; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Cook AM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1066062; Crozier M, 2015, BREAST CANCER RES TR, V154, P33, DOI 10.1007/s10549-015-3588-8; D'Souza K, 2017, ENDOCRINOLOGY, V158, P791, DOI 10.1210/en.2017-00035; Dalezis P, 2017, ANTI-CANCER DRUG, V28, P489, DOI 10.1097/CAD.0000000000000484; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Espaillat Mel Pilar, 2017, Advances in Biological Regulation, V63, P140, DOI 10.1016/j.jbior.2016.11.001; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gandy K Alexa Orr, 2013, Handb Exp Pharmacol, P275, DOI 10.1007/978-3-7091-1511-4_14; Gershuni VM, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0134-5; Hait NC, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4806541; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Honjo M, 2018, INVEST OPHTH VIS SCI, V59, P21, DOI 10.1167/iovs.17-22807; Honorat M, 2008, BIOCHEM BIOPH RES CO, V375, P308, DOI 10.1016/j.bbrc.2008.07.149; Jordan K, 2007, ONCOLOGIST, V12, P1143, DOI 10.1634/theoncologist.12-9-1143; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Knapp M, 2013, ADV MED SCI-POLAND, V58, P274, DOI 10.2478/ams-2013-0021; Koike S, 2010, BIOCHEM BIOPH RES CO, V400, P66, DOI 10.1016/j.bbrc.2010.08.008; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Li Zhenxing, 2016, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V32, P604; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Mattern J, 2007, CANCER BIOL THER, V6, P1345, DOI 10.4161/cbt.6.9.4765; Meng GM, 2017, FASEB J, V31, P4064, DOI 10.1096/fj.201700159R; Nagahashi M, 2018, CANCER RES, V78, P1713, DOI 10.1158/0008-5472.CAN-17-1423; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nakayama Y, 2015, BREAST CANCER-TOKYO, V22, P177, DOI 10.1007/s12282-013-0472-4; Nematollahi LR, 2009, METABOLISM, V58, P443, DOI 10.1016/j.metabol.2008.10.018; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Pacetti U, 2013, ANTICANCER RES, V33, P1721; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Rancoule C, 2012, J PHYSIOL BIOCHEM, V68, P635, DOI 10.1007/s13105-012-0181-z; Ray R, 2017, BLOOD, V129, P1177, DOI 10.1182/blood-2016-10-743757; SAAD MJA, 1994, MOL ENDOCRINOL, V8, P545, DOI 10.1210/me.8.5.545; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005; Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002; Sukumaran S, 2012, VITAM HORM, V90, P163, DOI 10.1016/B978-0-12-398313-8.00007-5; Sumida H, 2013, CLIN CHIM ACTA, V415, P74, DOI 10.1016/j.cca.2012.10.003; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tang XY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0607-x; Tang XY, 2015, J LIPID RES, V56, P2048, DOI 10.1194/jlr.R058362; Tang XY, 2014, J LIPID RES, V55, P2389, DOI 10.1194/jlr.M053462; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wang H, 2007, INT J ONCOL, V30, P947; Weichhart T, 2010, IMMUNOL LETT, V129, P50, DOI 10.1016/j.imlet.2009.12.025; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	70	16	16	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1899	1910		10.1096/fj.201801226R	http://dx.doi.org/10.1096/fj.201801226R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30192654				2022-12-28	WOS:000457296600031
J	Wu, JC; Luo, SZ; Liu, T; Lu, LG; Xu, MY				Wu, Jun-Cheng; Luo, Sheng-Zheng; Liu, Ting; Lu, Lun-Gen; Xu, Ming-Yi			linc-SCRG1 accelerates liver fibrosis by decreasing RNA-binding protein tristetraprolin	FASEB JOURNAL			English	Article						long noncoding RNA; hepatic stellate cell; TTP	HEPATIC STELLATE CELLS; LONG NONCODING RNA; MESSENGER-RNA; ACTIVATION; LNCRNA; PROLIFERATION; FIBROGENESIS; EXPRESSION; MECHANISM; GENE	The biologic roles of long noncoding RNAs (lncRNAs) in liver fibrosis remained unknown. Through microarray analysis, linc-SCRG1 (a lncRNA with transcript length 3118 bp) was found up-regulated 13.62-fold in human cirrhotic tissues. Quantitative PCR verified that linc-SCRG1 increased along with liver fibrosis progression in human tissues and in activated LX2 cells induced by TGF-1. Knockdown of linc-SCRG1 significantly reversed the effects of TGF-1 on LX2, including inhibiting activation, promoting apoptosis, reducing proliferation, lessening invasion, and down-regulating genes [fibrosis-related mRNA: -smooth muscle actin (-SMA), type I collagen, and B-cell lymphoma-2; invasion-related mRNA: matrix metallopeptidase-2 (MMP-2), MMP-9, and MMP-13; inflammation-related mRNA: TNF-, IL-6, and IL-10]. linc-SCRG1 had binding sites with tristetraprolin (TTP), a kind of RNA-binding protein, and specifically combined to TTP proteins. Overexpression of linc-SCRG1 would cause TTP mRNA unstably and proteins decreasing. TTP mRNA was proved having negative relevance with linc-SCRG1 and was gradually reduced during human liver fibrosis progression. Overexpressing TTP resulted in knockdown of lincSCRG1 and degraded downstream target genes (MMP-2 and TNF-) in activated LX2. Overexpressing TTP had the same effects as small interfering RNA-lincSCRG1 (si-lincSCRG1), whereas knockdown of TTP had reversal effects on si-lincSCRG1 in activated LX2. In summary, linc-SCRG1 reduced TTP and restricted its degradation of target genes TNF- and MMP-2. Therefore, linc-SCRG1 had a repressing TTP-elicited inactivation effect on hepatic stellate cell (HSC) phenotypes. Inhibition of linc-SCRG1 may be a novel therapeutic approach to inactivate HSCs and extenuate human liver fibrosis.Wu, J.-C., Luo, S.-Z., Liu, T., Lu, L.-G., Xu, M.-Y. linc-SCRG1 accelerates liver fibrosis by decreasing RNA-binding protein tristetraprolin.	[Wu, Jun-Cheng; Luo, Sheng-Zheng; Liu, Ting; Lu, Lun-Gen; Xu, Ming-Yi] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, 100 Haining Rd, Shanghai 200080, Peoples R China	Shanghai Jiao Tong University	Xu, MY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, 100 Haining Rd, Shanghai 200080, Peoples R China.	xumingyi2014@163.com		Xu, Mingyi/0000-0002-4834-3542	National Natural Science Foundation of China [81570547, 81770597, 81600480]; Development Program of China During the 13th Five-Year Plan Period Grant [2017ZX10203202003005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Program of China During the 13th Five-Year Plan Period Grant	This study was supported by National Natural Science Foundation of China Grants 81570547, 81770597, and 81600480, and by Development Program of China During the 13th Five-Year Plan Period Grant 2017ZX10203202003005. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Ballarino M, 2015, MOL CELL BIOL, V35, P728, DOI 10.1128/MCB.01394-14; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Bian EB, 2017, BBA-MOL BASIS DIS, V1863, P674, DOI 10.1016/j.bbadis.2016.12.009; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen PG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33593; Dirkx E, 2013, NAT CELL BIOL, V15, P1282, DOI 10.1038/ncb2866; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Kim J, 2016, NUCLEIC ACIDS RES, V44, P2378, DOI 10.1093/nar/gkw017; Klein S, 2012, LAB INVEST, V92, P1440, DOI 10.1038/labinvest.2012.106; Kumar P, 2014, FASEB J, V28, P5172, DOI 10.1096/fj.14-253229; Lee KW, 2014, J NUTR BIOCHEM, V25, P903, DOI 10.1016/j.jnutbio.2014.04.001; Liu LH, 2016, ONCOTARGET, V7, P15787, DOI 10.18632/oncotarget.7487; Liu YL, 2015, GENE, V564, P210, DOI 10.1016/j.gene.2015.03.050; Pandey GK, 2014, CANCER CELL, V26, P722, DOI 10.1016/j.ccell.2014.09.014; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Song XD, 2014, J CELL MOL MED, V18, P991, DOI 10.1111/jcmm.12243; Song YF, 2017, HEPATOLOGY, V66, P1183, DOI 10.1002/hep.29209; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Van Tubergen EA, 2013, CLIN CANCER RES, V19, P1169, DOI 10.1158/1078-0432.CCR-12-2927; Wang H, 2017, PANCREATOLOGY, V17, P237, DOI 10.1016/j.pan.2017.01.010; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7779; Wang XH, 2015, INT J CARDIOL, V187, P365, DOI 10.1016/j.ijcard.2015.03.195; Xie H, 2016, ONCOTARGET, V7, P51473, DOI 10.18632/oncotarget.10444; Yang JL, 2015, METABOLISM, V64, P1386, DOI 10.1016/j.metabol.2015.08.004; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Yu FJ, 2015, J BIOL CHEM, V290, P28286, DOI 10.1074/jbc.M115.683813; Zhao WP, 2011, J INTERF CYTOK RES, V31, P629, DOI 10.1089/jir.2010.0154; Zheng JJ, 2016, ONCOTARGET, V7, P62886, DOI 10.18632/oncotarget.11709; Zheng JJ, 2015, FEBS J, V282, P4810, DOI 10.1111/febs.13544	37	25	26	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2105	2115		10.1096/fj.201800098RR	http://dx.doi.org/10.1096/fj.201800098RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30226813				2022-12-28	WOS:000457296600047
J	Kashpur, O; Smith, A; Gerami-Naini, B; Maione, AG; Calabrese, R; Tellechea, A; Theocharidis, G; Liang, L; Pastar, I; Tomic-Canic, M; Mooney, D; Veves, A; Garlick, JA				Kashpur, Olga; Smith, Avi; Gerami-Naini, Behzad; Maione, Anna G.; Calabrese, Rossella; Tellechea, Ana; Theocharidis, Georgios; Liang, Liang; Pastar, Irena; Tomic-Canic, Marjana; Mooney, David; Veves, Aristidis; Garlick, Jonathan A.			Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes	FASEB JOURNAL			English	Article						chronic wound healing; 3D in vitro skin tissue; extracellular matrix; migration; reprogramming	EXTRACELLULAR-MATRIX; GENE-EXPRESSION; GENERATION; HETEROGENEITY; PROLIFERATION; MACROPHAGES; PERSISTENCE; DECADE; MEMORY; WOUNDS	Diabetic foot ulcers (DFUs) are a major complication of diabetes, and there is a critical need to develop novel cell- and tissue-based therapies to treat these chronic wounds. Induced pluripotent stem cells (iPSCs) offer a replenishing source of allogeneic and autologous cell types that may be beneficial to improve DFU wound-healing outcomes. However, the biologic potential of iPSC-derived cells to treat DFUs has not, to our knowledge, been investigated. Toward that goal, we have performed detailed characterization of iPSC-derived fibroblasts from both diabetic and nondiabetic patients. Significantly, gene array and functional analyses reveal that iPSC-derived fibroblasts from both patients with and those without diabetes are more similar to each other than were the primary cells from which they were derived. iPSC-derived fibroblasts showed improved migratory properties in 2-dimensional culture. iPSC-derived fibroblasts from DFUs displayed a unique biochemical composition and morphology when grown as 3-dimensional (3D), self-assembled extracellular matrix tissues, which were distinct from tissues fabricated using the parental DFU fibroblasts from which they were reprogrammed. In vivo transplantation of 3D tissues with iPSC-derived fibroblasts showed they persisted in the wound and facilitated diabetic wound closure compared with primary DFU fibroblasts. Taken together, our findings support the potential application of these iPSC-derived fibroblasts and 3D tissues to improve wound healing.Kashpur, O., Smith, A., Gerami-Naini, B., Maione, A. G., Calabrese, R., Tellechea, A., Theocharidis, G., Liang, L., Pastar, I., Tomic-Canic, M., Mooney, D., Veves, A., Garlick, J. A. Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes.	[Kashpur, Olga; Smith, Avi; Gerami-Naini, Behzad; Maione, Anna G.; Calabrese, Rossella; Garlick, Jonathan A.] Tufts Univ, Sch Dent Med, Dept Diagnost Sci, Boston, MA 02111 USA; [Tellechea, Ana; Theocharidis, Georgios; Veves, Aristidis] Harvard Univ, Microcirculat Lab, Boston, MA 02115 USA; [Tellechea, Ana; Theocharidis, Georgios] Harvard Univ, Beth Israel Deaconess Med Ctr, Joslin Beth Israel Deaconess Foot Ctr, Boston, MA 02215 USA; [Liang, Liang; Pastar, Irena; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Mooney, David] Harvard Univ, Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Tufts University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Joslin Diabetes Center, Inc.; University of Miami; Harvard University	Garlick, JA (corresponding author), Tufts Univ, Sch Dent Med, 136 Harrison Ave,Room 116, Boston, MA 02111 USA.	jonathan.garlick@tufts.edu	Pastar, Irena/AAD-3626-2020; Tellechea, Ana/O-8325-2019	Tellechea, Ana/0000-0001-9387-7706; Mooney, David/0000-0001-6299-1194; Theocharidis, Georgios/0000-0002-8895-9130; Smith, Avi/0000-0002-8904-7539; Pastar, Irena/0000-0003-0197-6198	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK98055-06]	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK98055-06 (to J.A.G.). The authors declare no conflicts of interest.	Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brem H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-75; Briquez PS, 2015, ADV WOUND CARE, V4, P479, DOI 10.1089/wound.2014.0603; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fleischmajer R, 1998, J CELL SCI, V111, P1929; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Galkowska H, 2005, WOUND REPAIR REGEN, V13, P248, DOI 10.1111/j.1067-1927.2005.130306.x; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gerami-Naini B, 2016, CELL REPROGRAM, V18, P214, DOI 10.1089/cell.2015.0087; Halfter W, 2015, FEBS J, V282, P4466, DOI 10.1111/febs.13495; Hehenberger K, 1998, J DERMATOL SCI, V16, P144, DOI 10.1016/S0923-1811(97)00042-X; Hehenberger Karin, 1998, Wound Repair and Regeneration, V6, P135, DOI 10.1046/j.1524-475X.1998.60207.x; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hewitt KJ, 2013, MOL ASPECTS MED, V34, P841, DOI 10.1016/j.mam.2012.08.002; Hewitt KJ, 2012, J CELL SCI, V125, P2276, DOI 10.1242/jcs.099192; Higuchi A, 2017, TRENDS BIOTECHNOL, V35, P1102, DOI 10.1016/j.tibtech.2017.06.016; Hochedlinger K., 2016, COLD SPRING HARB PER, V7, P1; Holmqvist S, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.9; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu SS, 2006, WOUND REPAIR REGEN, V14, P427, DOI 10.1111/j.1743-6109.2006.00148.x; Intine RV, 2012, CURR DIABETES REP, V12, P551, DOI 10.1007/s11892-012-0302-7; Iovino S, 2016, P NATL ACAD SCI USA, V113, P1889, DOI 10.1073/pnas.1525665113; Iovino S, 2014, DIABETES, V63, P4130, DOI 10.2337/db14-0109; Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077673; Kikuchi T, 2017, NATURE, V548, P592, DOI 10.1038/nature23664; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118266; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Lian XJ, 2014, STEM CELL REP, V3, P804, DOI 10.1016/j.stemcr.2014.09.005; Liang L, 2016, WOUND REPAIR REGEN, V24, P943, DOI 10.1111/wrr.12470; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Maione AG, 2016, WOUND REPAIR REGEN, V24, P630, DOI 10.1111/wrr.12437; Maione AG, 2015, TISSUE ENG PART C-ME, V21, P499, DOI [10.1089/ten.tec.2014.0414, 10.1089/ten.TEC.2014.0414]; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Margolis DJ, 2017, WOUND REPAIR REGEN, V25, P733, DOI 10.1111/wrr.12564; Mills JA, 2013, BLOOD, V122, P2047, DOI 10.1182/blood-2013-02-484444; Mohan RR, 2010, EXP EYE RES, V91, P238, DOI 10.1016/j.exer.2010.05.013; Nityanandam A, 2015, STEM CELLS DEV, V24, P1265, DOI 10.1089/scd.2015.0044; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Petrova A, 2014, STEM CELL REP, V2, P675, DOI 10.1016/j.stemcr.2014.03.009; Philippeos C, 2018, J INVEST DERMATOL, V138, P811, DOI 10.1016/j.jid.2018.01.016; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Pouyani T, 2012, IN VITRO CELL DEV-AN, V48, P493, DOI 10.1007/s11626-012-9541-9; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Sayed N, 2016, J AM COLL CARDIOL, V67, P2161, DOI 10.1016/j.jacc.2016.01.083; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Segal N, 2008, MATRIX BIOL, V27, P163, DOI 10.1016/j.matbio.2007.09.002; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Shamis Y, 2012, IN VITRO CELL DEV-AN, V48, P112, DOI 10.1007/s11626-011-9478-4; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Stone RC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf8611; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; Thom SR, 2016, DIABETES, V65, P486, DOI 10.2337/db15-0517; Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Wang Z, 2016, J DERMATOL SCI, V84, P186, DOI 10.1016/j.jdermsci.2016.08.002; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wicks K, 2015, DIABETES, V64, P4184, DOI 10.2337/db14-1895; Wicks K, 2014, SEMIN IMMUNOL, V26, P341, DOI 10.1016/j.smim.2014.04.006	72	22	23	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1262	1277		10.1096/fj.201801059	http://dx.doi.org/10.1096/fj.201801059			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30088952	Green Published, Bronze			2022-12-28	WOS:000457401500100
J	Leung, CS; Li, JT; Xu, F; Wong, ASL; Lui, KO				Leung, Cherry S.; Li, Jiatao; Xu, Feng; Wong, Alan S. L.; Lui, Kathy O.			Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants	FASEB JOURNAL			English	Article						ESCs; phagocytosis; endothelial cells; immune tolerance; xenotransplantation	REGULATORY PROTEIN ALPHA; TOLERANCE INDUCTION; ALLOGRAFT-REJECTION; SIRP-ALPHA; IN-VITRO; PHAGOCYTOSIS; ENGRAFTMENT; RECEPTOR; PROGENITORS; GENERATION	Like conventional transplants, immunosuppression is required to facilitate survival and function of human embryonic stem cell (hESC) derivatives after implantation into xenogeneic recipients. We have previously reported that T cells alone are sufficient to reject allogeneic murine ESC derivatives; and strategies that inhibit T-cell activation, including coreceptor and costimulation blockade, prevent hESC derivatives from being rejected. This study aimed to investigate, in addition to T cells, whether macrophages contribute to transplant rejection of hESC xenografts with nonobese diabetic (NOD)/SCID mice that lack functional T and B cells but have macrophages. We show that acute rejection against hESC-derived endothelial cells (hESC-ECs) was mediated, to some degree, by infiltrating macrophages that phagocytosed them. Transgenic expression of murine CD47 on cell surface of hESC-ECs mitigates macrophage-mediated phagocytosis and improves their survival after transplantation. Our results highlight that innate immune cells, such as macrophages, can reject hESC derivatives, raising concern against the use of NOD/SCID as transplant recipients for testing in vivo function of hESC-derived tissues. Augmenting CD47 signaling promotes survival and function of hESC derivatives after xenogeneic transplantation.Leung, C. S., Li, J., Xu, F., Wong, A. S. L., Lui, K. O. Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants.	[Leung, Cherry S.; Li, Jiatao; Lui, Kathy O.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Peoples R China; [Li, Jiatao; Lui, Kathy O.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Xu, Feng; Wong, Alan S. L.] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Wong, Alan S. L.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; University of Hong Kong	Lui, KO (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	kathyolui@cuhk.edu.hk	Lui, Kathy O./E-4883-2015; Lui, Kathy/AAC-8303-2020	Lui, Kathy O./0000-0002-1616-3643; Lui, Kathy/0000-0002-1616-3643; Xu, Feng/0000-0002-2517-9831; Wong, Alan S.L./0000-0003-1790-3233	Research Grants Council of Hong Kong [24110515, 14111916, C4024-16W, C4026-17WF]; Health and Medical Research Fund Grants [03140346, 04152566]; Croucher Foundation; Lui Chi Woo Institute of Innovative Medicine; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Health and Medical Research Fund Grants; Croucher Foundation; Lui Chi Woo Institute of Innovative Medicine; Chinese University of Hong Kong(Chinese University of Hong Kong)	The authors thank Prof. Joseph Wu (Stanford University, Stanford, CA, USA) for the kind gift of firefly luciferase-expressing hESC line, and Prof. Xiaoqiang Yao (Chinese University of Hong Kong) for the kind gift of mouse H5V EC line. The authors also thank Dr. Ting-hsuan Chen (City University of Hong Kong, Hong Kong, China) for helping with the in vivo BLI experiments, Xisheng Li and Yanli Zhou (both from the Chinese University of Hong Kong) for technical help. The authors thank Prof. Herman Waldmann (University of Oxford, Oxford, United Kingdom) and all members of the K.O.L. Laboratory for insightful discussions throughout the study. This work was supported by the Research Grants Council of Hong Kong (Grants 24110515, 14111916, C4024-16W, and C4026-17WF); Health and Medical Research Fund Grants 03140346 and 04152566; the Croucher Foundation (Innovation Award and Startup Award); Lui Chi Woo Institute of Innovative Medicine Seed Fund, Direct Grant, Faculty Innovation Award; and Postgraduate Studentships from the Chinese University of Hong Kong. The authors declare no conflicts of interest.	Abe M, 2002, J IMMUNOL, V168, P621, DOI 10.4049/jimmunol.168.2.621; Agulnick AD, 2015, STEM CELL TRANSL MED, V4, P1214, DOI 10.5966/sctm.2015-0079; Amash A, 2016, J IMMUNOL, V196, P3331, DOI 10.4049/jimmunol.1502198; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; He HZ, 2002, TRANSPLANTATION, V73, P853, DOI 10.1097/00007890-200203270-00005; Huber BC, 2013, STEM CELLS, V31, P2354, DOI 10.1002/stem.1501; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Kwong LS, 2014, IMMUNOLOGY, V143, P61, DOI 10.1111/imm.12290; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Lee TKW, 2014, HEPATOLOGY, V60, P179, DOI 10.1002/hep.27070; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Liu R, 2017, ONCOTARGET, V8, P39021, DOI 10.18632/oncotarget.16547; Lui K. O., 2008, STEMBOOK; Lui KO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6629; Lui KO, 2013, CELL RES, V23, P1172, DOI 10.1038/cr.2013.112; Lui KO, 2010, STEM CELLS, V28, P1905, DOI 10.1002/stem.506; Lui KO, 2009, CURR STEM CELL RES T, V4, P70, DOI 10.2174/157488809787169093; Menasche P, 2015, EUR HEART J, V36, P2011, DOI 10.1093/eurheartj/ehv189; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Schafer N, 2008, TRANSPL INT, V21, P778, DOI 10.1111/j.1432-2277.2008.00676.x; Schmidt A, 2007, J LEUKOCYTE BIOL, V81, P186, DOI 10.1189/jlb.0606377; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Steinert G, 2014, CANCER RES, V74, P1694, DOI 10.1158/0008-5472.CAN-13-1885; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Szot GL, 2015, CELL STEM CELL, V16, P148, DOI 10.1016/j.stem.2014.12.001; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; van den Bosch TPP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00346; Weiskopf K, 2016, J CLIN INVEST, V126, P2610, DOI 10.1172/JCI81603; Wu C, 2016, AM J TRANSPLANT, V16, P2563, DOI 10.1111/ajt.13808; Zhang HM, 2015, P NATL ACAD SCI USA, V112, pE6215, DOI 10.1073/pnas.1520032112	35	15	15	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					484	493		10.1096/fj.201800449R	http://dx.doi.org/10.1096/fj.201800449R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30004796				2022-12-28	WOS:000457401500038
J	Li, JF; Ying, YF; Xie, HY; Jin, K; Yan, HQ; Wang, S; Xu, MJ; Xu, X; Wang, X; Yang, K; Zheng, XY; Xie, LP				Li, Jiangfeng; Ying, Yufan; Xie, Haiyun; Jin, Ke; Yan, Huaqing; Wang, Song; Xu, Mingjie; Xu, Xin; Wang, Xiao; Yang, Kai; Zheng, Xiangyi; Xie, Liping			Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer	FASEB JOURNAL			English	Article						miRNA; metastasis; MEG3-DMR; DLK-DIO3 imprinted domain; urologic cancer	MESENCHYMAL TRANSITION; INHIBITS MIGRATION; CLIP-SEQ; EXPRESSION; METASTASIS; MICRORNAS; PROTEINS; INVASION; PROLIFERATION; STARBASE	Emerging evidence has elucidated that microRNAs (miRNAs) transcribed from miRNA cluster at DLK-DIO3 imprinted domain are involved in various cancers. However, as one member of this cluster, the underlying mechanisms and functions of miR-381-3p in bladder cancer (BCa) still remains elusive. Here we demonstrate that the hypermethylated status of upstream maternally expressed gene 3 divergent methylation region reduces the expression of miR-381-3p in BCa by bisulfite-sequencing PCR. In vitro and in vivo experiments indicate that overexpression of miR-381-3p significantly inhibits cell proliferation via inducing G(1) phase arrest and migration via down-regulating MET and CCNA2 induced EMT progression. CDK6/CCNA2/MET are all identified as the direct targets of miR-381-3p by bioinformatics analysis and dual-luciferase reporter assay. Furthermore, inhibition of CCNA2 mediated by miR-381-3p as the crucial biregulator not only participates in the proliferation regulation with CDK6 in cell cycle but also modulates the EMT progression via ROCK/AKT/-catenin/SNAIL pathway, which establishes an EMT circuit combined with miR-381-3p/MET/AKT/GSK-3/SNAIL pathway, and SNAIL is the last confocal target to induce EMT progression. To conclude, we propose 2 novel regulatory circuits mediated by miR-381-3p in BCa, which may assist in the development of more effective therapies against BCa in the future.Li, J., Ying, Y., Xie, H., Jin, K., Yan, H., Wang, S., Xu, M., Xu, X., Wang, X., Yang, K., Zheng, X., Xie, L. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.	[Li, Jiangfeng; Ying, Yufan; Xie, Haiyun; Jin, Ke; Yan, Huaqing; Wang, Song; Xu, Mingjie; Xu, Xin; Wang, Xiao; Yang, Kai; Zheng, Xiangyi; Xie, Liping] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Qingchun Rd 79, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zheng, XY; Xie, LP (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Qingchun Rd 79, Hangzhou 310003, Zhejiang, Peoples R China.	zheng_xy@zju.edu.cn; xielp@zju.edu.cn	Xie, li/HGE-6052-2022; Xie, Haiyun/HGD-1805-2022		National Natural Science Foundation of China [81472375, 81772744, 81702500]; Natural Science Foundation of Zhejiang Province [LY16H160012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Natural Science Foundation of China (81472375, 81772744, 81702500) and the Natural Science Foundation of Zhejiang Province (LY16H160012). Approval to conduct this study was obtained from the ethics committees of the First Affiliated Hospital, College of Medicine, Zhejiang University, in accordance with the guidelines of the Helsinki Declaration of 1975, revised in 1983. The authors declare no conflicts of interest.	Aaltomaa S, 1999, BRIT J CANCER, V80, P2001, DOI 10.1038/sj.bjc.6690634; An FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045606; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bendris N, 2014, CELL MOL LIFE SCI, V71, P4881, DOI 10.1007/s00018-014-1654-8; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Cao QH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0499-z; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Cheung CT, 2015, CARCINOGENESIS, V36, P914, DOI 10.1093/carcin/bgv069; Davidson B, 2001, GYNECOL ONCOL, V83, P249, DOI 10.1006/gyno.2001.6388; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; He XX, 2016, ONCOTARGETS THER, V9, P1231, DOI 10.2147/OTT.S99228; Kobayashi T, 2016, ASIAN J UROL, V3, P211, DOI 10.1016/j.ajur.2016.09.005; Li J., 2017, ONCOTARGET, V9, P3752, DOI DOI 10.18632/oncotarget.23365; Li JF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.331; Li JQ, 2002, HUM PATHOL, V33, P1006, DOI 10.1053/hupa.2002.125774; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liang Z, 2015, MOL CELLS, V38, P130, DOI 10.14348/molcells.2015.2146; Mashal RD, 1996, CANCER RES, V56, P4159; Posadas EM, 2016, ASIAN J UROL, V3, P167, DOI 10.1016/j.ajur.2016.09.008; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Schrier BP, 2004, EUR UROL, V45, P292, DOI 10.1016/j.eururo.2003.10.006; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Slaby O, 2017, BIOCHEM J, V474, P4219, DOI 10.1042/BCJ20170079; Song GL, 2016, INT J ONCOL, V49, P646, DOI 10.3892/ijo.2016.3539; Tian CY, 2017, ONCOL REP, V38, P3071, DOI 10.3892/or.2017.5956; TSAI HC, 2017, CELL DEATH DIS, V8; Wang X, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0069-6; Wang XX, 2016, MATER TODAY CHEM, V1-2, P7, DOI 10.1016/j.mtchem.2016.10.005; XIE YP, 2017, SCI REP UK, V7; Xu MJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0206-1; XU X, 2016, CELL DEATH DIS, V7; Xu X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-109; Xu X, 2013, MOL CELLS, V36, P62, DOI 10.1007/s10059-013-0044-7; Xue YB, 2017, BIOMED PHARMACOTHER, V86, P426, DOI 10.1016/j.biopha.2016.12.051; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Yuan G, 2018, ONCOL RES, V26, P1037, DOI 10.3727/096504017X15144748428127	37	45	46	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1374	1388		10.1096/fj.201800667R	http://dx.doi.org/10.1096/fj.201800667R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30138038	Bronze			2022-12-28	WOS:000457401500108
J	Li, M; Zhang, SQ; Zhao, W; Hou, CC; Ma, XL; Li, XK; Huang, BR; Chen, H; Chen, D				Li, Meng; Zhang, Shiqiang; Zhao, Wen; Hou, Congcong; Ma, Xiaoli; Li, Xuekun; Huang, Bingren; Chen, Hong; Chen, Deng			RYBP modulates stability and function of Ring1B through targeting UBE3A	FASEB JOURNAL			English	Article						polycomb-repressive complex 1; protein interaction; ubiquitination; proteasome	POLYCOMB PROTEIN RING1B; HISTONE H2A; UBIQUITIN LIGASE; SELF-UBIQUITINATION; LUNG-CANCER; EXPRESSION; RNF2; PROMOTES; COMPLEXES; INTERACTS	Ring1 and yin yang 1-binding protein (RYBP) are central components of noncanonical polycomb-repressive complex 1 (nc-PRC1), which represses target gene expression and is required for normal organismal development. However, the molecular function of RYBP in this complex is obscure. In this study, we showed that RYBP inhibits the polyubiquitination-mediated proteasomal degradation of Ring1B independently of its ubiquitin (Ub)-protein isopeptide ligase (E3) ligase activity, leading to its stabilization and increased catalytic activity toward monoubiquitination of histone H2A at lysine 119. Mechanistic dissection further disclosed that RYBP directly binds to ubiquitin protein ligase E3A (UBE3A) to promote its ubiquitination and proteasomal degradation in an autoubiquitination-independent manner. The resultant reduction of UBE3A protein level alleviates its effect on ubiquitination-mediated degradation of Ring1B, therefore resulting in increased stability and enhanced transcriptional repressor activity on its target genes. Thus, our current findings lay a foundation for understanding how RYBP functions in nc-PRC1 complexes, which is involved in development, stem cell maintenance, and carcinogenesis.Li, M., Zhang, S., Zhao, W., Hou, C., Ma, X., Li, X., Huang, B., Chen, H., Chen, D. RYBP modulates stability and function of Ring1B through targeting UBE3A.	[Li, Meng; Zhang, Shiqiang; Zhao, Wen; Hou, Congcong; Ma, Xiaoli; Huang, Bingren; Chen, Hong; Chen, Deng] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Dept Biochem & Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Li, Meng; Zhang, Shiqiang; Zhao, Wen; Hou, Congcong; Ma, Xiaoli; Huang, Bingren; Chen, Hong; Chen, Deng] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Li, Xuekun] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhejiang University	Chen, D (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Dept Biochem & Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.; Chen, D (corresponding author), Peking Union Med Coll, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	chendeng2001@hotmail.com			National Natural Science Foundation of China [81272229]; Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [2017-I2M-3-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine	This project was supported by the National Natural Science Foundation of China (81272229) and the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (2017-I2M-3-004). The authors declare no conflicts of interest.	Almeida M, 2017, SCIENCE, V356, P1081, DOI 10.1126/science.aal2512; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Bosch A, 2014, ONCOTARGET, V5, P2065, DOI 10.18632/oncotarget.1779; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen D, 2009, EMBO REP, V10, P166, DOI 10.1038/embor.2008.231; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dinglin XX, 2017, TRANSL ONCOL, V10, P280, DOI 10.1016/j.tranon.2017.01.004; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Hemenway CS, 1998, ONCOGENE, V16, P2541, DOI 10.1038/sj.onc.1202042; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Koike H, 2014, HEPATOLOGY, V60, P323, DOI 10.1002/hep.27046; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; LaSalle JM, 2015, EPIGENOMICS-UK, V7, P1213, DOI 10.2217/epi.15.70; Li HH, 2017, CELL STEM CELL, V20, P462, DOI 10.1016/j.stem.2016.12.002; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu S, 2018, NAT IMMUNOL, V19, P41, DOI 10.1038/s41590-017-0003-0; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Ma W, 2016, CELL SIGNAL, V28, P779, DOI 10.1016/j.cellsig.2016.03.012; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Neira JL, 2009, BIOCHEMISTRY-US, V48, P1348, DOI 10.1021/bi801933c; Novak RL, 2008, CANCER GENE THER, V15, P713, DOI 10.1038/cgt.2008.25; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Rose NR, 2016, ELIFE, V5, DOI [10.7554/elife.18591, 10.7554/eLife.18591]; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Su WJ, 2013, P NATL ACAD SCI USA, V110, P1720, DOI 10.1073/pnas.1211604110; Tan K, 2017, CELL SIGNAL, V29, P127, DOI 10.1016/j.cellsig.2016.10.011; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Voruganti S, 2015, CANCER LETT, V369, P386, DOI 10.1016/j.canlet.2015.09.003; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang W, 2014, ONCOTARGET, V5, P11604, DOI 10.18632/oncotarget.2598; Wen W, 2014, ONCOGENE, V33, P421, DOI 10.1038/onc.2012.605; Xia PY, 2014, CELL RES, V24, P943, DOI 10.1038/cr.2014.85; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107; Zhang JF, 2017, ONCOL LETT, V13, P3817, DOI 10.3892/ol.2017.5868	52	2	2	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					683	695		10.1096/fj.201800397R	http://dx.doi.org/10.1096/fj.201800397R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30040487				2022-12-28	WOS:000457401500053
J	Sisario, D; Memmel, S; Doose, S; Neubauer, J; Zimmermann, H; Flentje, M; Djuzenova, CS; Sauer, M; Sukhorukov, VL				Sisario, Dmitri; Memmel, Simon; Doose, Soeren; Neubauer, Julia; Zimmermann, Heiko; Flentje, Michael; Djuzenova, Cholpon S.; Sauer, Markus; Sukhorukov, Vladimir L.			Nanostructure of DNA repair foci revealed by superresolution microscopy	FASEB JOURNAL			English	Article						double-strand breaks; dSTORM; H2AX; DNA-PK; ionizing radiation	DOUBLE-STRAND BREAKS; DEPENDENT PROTEIN-KINASE; HISTONE H2AX; IONIZING-RADIATION; DAMAGE RESPONSE; PHOSPHORYLATED H2AX; CATALYTIC SUBUNIT; NUCLEOSOME CORE; GAMMA-H2AX FOCI; CHROMATIN FIBER	Induction of DNA double-strand breaks (DSBs) by ionizing radiation leads to formation of micrometer-sized DNA-repair foci, whose organization on the nanometer-scale remains unknown because of the diffraction limit (approximate to 200 nm) of conventional microscopy. Here, we applied diffraction-unlimited, direct stochastic optical-reconstruction microscopy (dSTORM) with a lateral resolution of approximate to 20 nm to analyze the focal nanostructure of the DSB marker histone H2AX and the DNA-repair protein kinase (DNA-PK) in irradiated glioblastoma multiforme cells. Although standard confocal microscopy revealed substantial colocalization of immunostained H2AX and DNA-PK, in our dSTORM images, the 2 proteins showed very little (if any) colocalization despite their close spatial proximity. We also found that H2AX foci consisted of distinct circular subunits (nanofoci) with a diameter of approximate to 45 nm, whereas DNA-PK displayed a diffuse, intrafocal distribution. We conclude that H2AX nanofoci represent the elementary, structural units of DSB repair foci, that is, individual H2AX-containing nucleosomes. dSTORM-based H2AX nanofoci counting and distance measurements between nanofoci provided quantitative information on the total amount of chromatin involved in DSB repair as well as on the number and longitudinal distribution of H2AX-containing nucleosomes in a chromatin fiber. We thus estimate that a single focus involves between approximate to 0.6 and approximate to 1.1 Mbp of chromatin, depending on radiation treatment. Because of their ability to unravel the nanostructure of DSB-repair foci, dSTORM and related single-molecule localization nanoscopy methods will likely emerge as powerful tools in biology and medicine to elucidate the effects of DNA damaging agents in cells.Sisario, D., Memmel, S., Doose, S., Neubauer, J., Zimmermann, H., Flentje, M., Djuzenova, C. S., Sauer, M., Sukhorukov, V. L. Nanostructure of DNA repair foci revealed by superresolution microscopy.	[Sisario, Dmitri; Doose, Soeren; Sauer, Markus; Sukhorukov, Vladimir L.] Univ Wurzburg, Dept Biotechnol & Biophys, Hubland, D-97074 Wurzburg, Germany; [Memmel, Simon; Flentje, Michael; Djuzenova, Cholpon S.] Univ Hosp Wurzburg, Dept Radiat Oncol, Wurzburg, Germany; [Neubauer, Julia; Zimmermann, Heiko] Fraunhofer Inst Biomed Engn IBMT, Sulzbach, Germany; [Zimmermann, Heiko] Univ Saarland, Mol & Zellulare Biotechnol Nanotechnol, Saarbrucken, Germany; [Zimmermann, Heiko] Univ Catolica Norte, Marine Sci, Antafogasta Coquimbo, Chile	University of Wurzburg; University of Wurzburg; Fraunhofer Gesellschaft; Saarland University; Universidad Catolica del Norte	Sukhorukov, VL (corresponding author), Univ Wurzburg, Dept Biotechnol & Biophys, Hubland, D-97074 Wurzburg, Germany.	sukhorukov@biozentrum.uni-wuerzburg.de	Sukhorukov, Vladimir L/ACO-0333-2022	Doose, Soren/0000-0002-6983-1182; Zimmermann, Heiko/0000-0001-8595-1304				Alagoz M, 2015, NUCLEIC ACIDS RES, V43, P7931, DOI 10.1093/nar/gkv722; Asaithamby A, 2008, RADIAT RES, V169, P437, DOI 10.1667/RR1165.1; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Britton S, 2013, J CELL BIOL, V202, P579, DOI 10.1083/jcb.201303073; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Cleaver JE, 2011, CELL CYCLE, V10, P3223, DOI 10.4161/cc.10.19.17448; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Deniz M, 2016, FASEB J, V30, P3786, DOI 10.1096/fj.201600453R; Djuzenova CS, 2015, EXP CELL RES, V330, P346, DOI 10.1016/j.yexcr.2014.08.013; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franke C, 2017, NAT METHODS, V14, P41, DOI [10.1038/NMETH.4073, 10.1038/nmeth.4073]; Friedrich T, 2012, RADIAT RES, V178, P385, DOI 10.1667/RR2964.1; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Jette N, 2015, PROG BIOPHYS MOL BIO, V117, P194, DOI 10.1016/j.pbiomolbio.2014.12.003; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Kroeber J, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0344-5; Lobachevsky P, 2016, CANCER LETT, V383, P212, DOI 10.1016/j.canlet.2016.09.010; Mah Li-Jeen, 2011, Genome Integr, V2, P3, DOI 10.1186/2041-9414-2-3; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Memmel S, 2017, ONCOTARGET, V8, P45298, DOI 10.18632/oncotarget.16847; Memmel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087052; Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475; Natale F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15760; Neal JA, 2014, MOL CELL BIOL, V34, P2162, DOI 10.1128/MCB.01554-13; Pankotai T, 2009, CELL CYCLE, V8, P4025; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perez RL, 2016, FASEB J, V30, P2767, DOI 10.1096/fj.201500106R; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Pospelova TV, 2009, CELL CYCLE, V8, P4112, DOI 10.4161/cc.8.24.10215; Reindl J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40616; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Rhodes D, 1997, NATURE, V389, P231, DOI 10.1038/38386; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Rybak P, 2016, ONCOTARGET, V7, P49574, DOI 10.18632/oncotarget.10411; Sak A, 2010, SEMIN RADIAT ONCOL, V20, P223, DOI 10.1016/j.semradonc.2010.05.004; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Svetlova MP, 2010, MUTAT RES-FUND MOL M, V685, P54, DOI 10.1016/j.mrfmmm.2009.08.001; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; van de Linde S, 2013, CHEM BIOL, V20, P8, DOI 10.1016/j.chembiol.2012.11.004; van Veelen LR, 2005, MUTAT RES-FUND MOL M, V574, P22, DOI 10.1016/j.mrfmmm.2005.01.019; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Zessin PJM, 2012, J STRUCT BIOL, V177, P344, DOI 10.1016/j.jsb.2011.12.015; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	59	11	11	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6469	6477		10.1096/fj.201701435	http://dx.doi.org/10.1096/fj.201701435			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29894665	hybrid			2022-12-28	WOS:000449359700010
J	Bezhaeva, T; de Vries, MR; Geelhoed, WJ; van der Veer, EP; Versteeg, S; van Alem, CMA; Voorzaat, BM; Eijkelkamp, N; van der Bogt, KE; Agoulnik, AI; van Zonneveld, AJ; Quax, PHA; Rotmans, JI				Bezhaeva, Taisiya; de Vries, Margreet R.; Geelhoed, Wouter J.; van der Veer, Eric P.; Versteeg, Sabine; van Alem, Carla M. A.; Voorzaat, Bram M.; Eijkelkamp, Niels; van der Bogt, Koen E.; Agoulnik, Alexander I.; van Zonneveld, Anton-Jan; Quax, Paul H. A.; Rotmans, Joris I.			Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas	FASEB JOURNAL			English	Article						hemodialysis vascular access; RXFP1; macrophages; VSMC; extracellular matrix	SMOOTH-MUSCLE-CELL; ARTERIAL; EXPRESSION; MIGRATION; INCREASES; REQUIRES; FAILURE; MODEL; HEMODIALYSIS; ACTIVATION	The pathophysiology of arteriovenous fistula (AVF) maturation failure is not completely understood but impaired outward remodeling (OR) and intimal hyperplasia are thought to be contributors. This adverse vascular response after AVF surgery results from interplay between vascular smooth muscle cells (VSMCs), the extracellular matrix (ECM), and inflammatory cells. Relaxin (RLN) is a hormone that acts on the vasculature via interaction with RLN/insulin-like peptide family receptor 1 (RXFP1), resulting in vasodilatation, ECM remodeling, and decreased inflammation. In the present study, we evaluated the consequences of RXFP1 knockout (Rxfp1(-/-)) on AVF maturation in a murine model of AVF failure. Rxfp1(-/-) mice showed a 22% decrease in vessel size at the venous outflow tract 14 d after AVF surgery. Furthermore, a 43% increase in elastin content was observed in the lesions of Rxfp1(-/-) mice and coincided with a 41% reduction in elastase activity. In addition, Rxfp1(-/-) mice displayed a 6-fold increase in CD45(+) leukocytes, along with a 2-fold increase in monocyte chemoattractant protein 1 (MCP1) levels, when compared with wild-type mice. In vitro, VSMCs from Rxfp1(-/-) mice exhibited a synthetic phenotype, as illustrated by augmentation of collagen, fibronectin, TGF-, and platelet-derived growth factor mRNA. In addition, VSMCs derived from Rxfp1(-/-) mice showed a 5-fold increase in cell migration. Finally, RXFP1 and RLN expression levels were increased in human AVFs when compared with unoperated cephalic veins. In conclusion, RXFP1 deficiency hampers elastin degradation and results in induced vascular inflammation after AVF surgery. These processes impair OR in murine AVF, suggesting that the RLN axis could be a potential therapeutic target for promoting AVF maturation.Bezhaeva, T., de Vries, M. R., Geelhoed, W. J., van der Veer, E. P., Versteeg, S., van Alem, C. M. A., Voorzaat, B. M., Eijkelkamp, N., van der Bogt, K. E., Agoulnik, A. I., van Zonneveld, A.-J., Quax, P. H. A., Rotmans, J. I. Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas.	[Bezhaeva, Taisiya; Geelhoed, Wouter J.; van der Veer, Eric P.; van Alem, Carla M. A.; Voorzaat, Bram M.; van Zonneveld, Anton-Jan; Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Internal Med, C7Q-36,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Bezhaeva, Taisiya; de Vries, Margreet R.; Geelhoed, Wouter J.; van der Veer, Eric P.; van Alem, Carla M. A.; van Zonneveld, Anton-Jan; Quax, Paul H. A.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Einthoven Lab Vasc & Regenerat Med, Leiden, Netherlands; [de Vries, Margreet R.; van der Bogt, Koen E.; Quax, Paul H. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Versteeg, Sabine; Eijkelkamp, Niels] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Versteeg, Sabine; Eijkelkamp, Niels] Univ Med Ctr Utrecht, Lab Neuroimmunol, Utrecht, Netherlands; [Versteeg, Sabine; Eijkelkamp, Niels] Univ Med Ctr Utrecht, Lab Dev Origins Dis, Utrecht, Netherlands; [van der Bogt, Koen E.] Haaglanden Med Ctr, Dept Surg, The Hague, Netherlands; [Agoulnik, Alexander I.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Haaglanden Medical Center; State University System of Florida; Florida International University	Rotmans, JI (corresponding author), Leiden Univ, Med Ctr, Dept Internal Med, C7Q-36,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	j.i.rotmans@lumc.nl	de Vries, Margreet/Z-5653-2019; van Zonneveld, Anton Jan/D-8060-2018; Rotmans, Joris I./G-8866-2014; Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019	van Zonneveld, Anton Jan/0000-0002-1676-7738; Rotmans, Joris I./0000-0001-9682-6234; Quax, Paul/0000-0002-6853-5760; Bezhaeva, Taisiya/0000-0002-9929-1420	Vidi Grant from ZonMw [917.15.328]; Leiden University Medical Center	Vidi Grant from ZonMw; Leiden University Medical Center	The authors thank Reshma A. Lalai (Department of Internal Medicine, Leiden University Medical Center) for her excellent assistance in performing experiments and data analysis. This study was supported by a Vidi Grant (917.15.328) to J.I.R. from ZonMw and the Leiden University Medical Center. The authors declare no conflicts of interest.	Al-Jaishi AA, 2014, AM J KIDNEY DIS, V63, P464, DOI 10.1053/j.ajkd.2013.08.023; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bennett RG, 2014, LIVER INT, V34, P416, DOI 10.1111/liv.12247; Bezhaeva T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10108-4; Brecht A, 2011, REGUL PEPTIDES, V166, P76, DOI 10.1016/j.regpep.2010.09.001; Burke SK, 2008, J AM SOC NEPHROL, V19, P252; Cernaro V, 2014, MED RES REV, V34, P77, DOI 10.1002/med.21277; Chan CY, 2007, J VASC SURG, V45, P804, DOI 10.1016/j.jvs.2006.12.063; Chan SL, 2011, FASEB J, V25, P3229, DOI 10.1096/fj.10-175471; Chen B, 2005, AM J OBSTET GYNECOL, V192, P1605, DOI 10.1016/j.ajog.2004.11.027; Chen B, 2009, FERTIL STERIL, V91, P1351, DOI 10.1016/j.fertnstert.2008.03.043; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Conrad KP, 2011, CURR HYPERTENS REP, V13, P409, DOI 10.1007/s11906-011-0231-x; Conrad KP, 2004, ENDOCRINOLOGY, V145, P3289, DOI 10.1210/en.2003-1612; Debrah DO, 2011, J APPL PHYSIOL, V111, P260, DOI 10.1152/japplphysiol.00845.2010; Debrah DO, 2005, HYPERTENSION, V46, P745, DOI 10.1161/01.HYP.0000184230.52059.33; Feng S, 2006, ENDOCRINOLOGY, V147, P407, DOI 10.1210/en.2005-0626; Finlay GA, 1996, AM J PATHOL, V149, P1405; Guzman RJ, 1997, SURGERY, V122, P273, DOI 10.1016/S0039-6060(97)90018-0; Hocevar BA, 2000, METH MOL B, V142, P55; Horton JS, 2011, BIOL REPROD, V85, P788, DOI 10.1095/biolreprod.110.089201; Ichii T, 2001, CIRC RES, V88, P460, DOI 10.1161/01.RES.88.5.460; Jelinic M, 2014, FASEB J, V28, P275, DOI 10.1096/fj.13-233429; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; Juncos JP, 2011, J AM SOC NEPHROL, V22, P43, DOI 10.1681/ASN.2010040373; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Kang L, 2016, AM J PHYSIOL-RENAL, V310, pF466, DOI 10.1152/ajprenal.00288.2015; Kang L, 2013, AM J PHYSIOL-RENAL, V305, pF545, DOI 10.1152/ajprenal.00234.2013; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V293, P1000, DOI 10.1016/S0006-291X(02)00331-5; Krishnamoorthy MK, 2008, KIDNEY INT, V74, P1410, DOI 10.1038/ki.2008.379; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee T, 2016, CLIN J AM SOC NEPHRO, V11, P1504, DOI 10.2215/CJN.02030216; Leo CH, 2017, BRIT J PHARMACOL, V174, P1002, DOI 10.1111/bph.13614; Liang M, 2015, KIDNEY INT, V88, P490, DOI 10.1038/ki.2015.73; Moore JB, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006183; Novak J, 2006, FASEB J, V20, P2352, DOI 10.1096/fj.06-6263com; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peden EK, 2017, J VASC SURG, V65, P1113, DOI 10.1016/j.jvs.2016.08.101; Rothuizen TC, 2013, NEPHROL DIAL TRANSPL, V28, P1085, DOI 10.1093/ndt/gft068; Roy-Chaudhury P, 2014, J VASC ACCESS, V15, P25, DOI 10.5301/jva.5000151; Roy-Chaudhury P, 2009, NEPHROL DIAL TRANSPL, V24, P2786, DOI 10.1093/ndt/gfn708; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Samuel CS, 2009, CURR OPIN NEPHROL HY, V18, P9, DOI 10.1097/MNH.0b013e32831b7096; Schinstock CA, 2011, CLIN J AM SOC NEPHRO, V6, P1996, DOI 10.2215/CJN.11251210; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; THYBERG J, 1994, CELL TISSUE RES, V276, P263, DOI 10.1007/BF00306112; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wong CY, 2016, JOVE-J VIS EXP, DOI 10.3791/53294; Wong CY, 2014, J VASC SURG, V59, P192, DOI 10.1016/j.jvs.2013.02.242; Wong CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30439; Xiao JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2953; Zhou X, 2015, DRUG DES DEV THER, V9, P4599, DOI 10.2147/DDDT.S85399	54	9	9	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6293	6304		10.1096/fj.201800437R	http://dx.doi.org/10.1096/fj.201800437R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29882709	Green Submitted, Bronze			2022-12-28	WOS:000447172000043
J	Ramon-Krauel, M; Pentinat, T; Bloks, VW; Cebria, J; Ribo, S; Perez-Wienese, R; Vila, M; Palacios-Marin, I; Fernandez-Perez, A; Vallejo, M; Tellez, N; Rodriguez, MA; Yanes, O; Lerin, C; Diaz, R; Plosch, T; Tietge, UJF; Jimenez-Chillaron, JC				Ramon-Krauel, Marta; Pentinat, Thais; Bloks, Vincent W.; Cebria, Judith; Ribo, Silvia; Perez-Wienese, Ricky; Vila, Maria; Palacios-Marin, Ivonne; Fernandez-Perez, Antonio; Vallejo, Mario; Tellez, Noelia; Angel Rodriguez, Miguel; Yanes, Oscar; Lerin, Carles; Diaz, Ruben; Plosch, Torsten; Tietge, Uwe J. F.; Jimenez-Chillaron, Josep C.			Epigenetic programming at the Mogat1 locus may link neonatal overnutrition with long-term hepatic steatosis and insulin resistance	FASEB JOURNAL			English	Article						neonatal overfeeding; nutritional epigenetics; childhood obesity	O-ACYLTRANSFERASE 1; HIGH-FAT DIET; WEIGHT-GAIN; MOUSE MODEL; IN-UTERO; GLUCOSE; LIFE; EXPRESSION; DISEASE; RISK	Postnatal overfeeding increases the risk of chronic diseases later in life, including obesity, insulin resistance, hepatic steatosis, and type 2 diabetes. Epigenetic mechanisms might underlie the long-lasting effects associated with early nutrition. Here we aimed to explore the molecular pathways involved in early development of insulin resistance and hepatic steatosis, and we examined the potential contribution of DNA methylation and histone modifications to long-term programming of metabolic disease. We used a well-characterized mouse model of neonatal overfeeding and early adiposity by litter size reduction. Neonatal overfeeding led to hepatic insulin resistance very early in life that persisted throughout adulthood despite normalizing food intake. Up-regulation of monoacylglycerol O-acyltransferase (Mogat)1 conceivably mediates hepatic steatosis and insulin resistance through increasing intracellular diacylglycerol content. Early and sustained deregulation of Mogat1 was associated with a combination of histone modifications that might favor Mogat1 expression. In sum, postnatal overfeeding causes extremely rapid derangements of hepatic insulin sensitivity that remain relatively stable until adulthood. Epigenetic mechanisms, particularly histone modifications, could contribute to such long-lasting effects. Our data suggest that targeting hepatic monoacylglycerol acyltransferase activity during early life might provide a novel strategy to improve hepatic insulin sensitivity and prevent late-onset insulin resistance and fatty liver disease.Ramon-Krauel, M., Pentinat, T., Bloks, V. W., Cebria, J., Ribo, S., Perez-Wienese, R., Vila, M., Palacios-Marin, I., Fernandez-Perez, A., Vallejo, M., Tellez, N., Rodriguez, M. ., Yanes, O., Lerin, C., Diaz, R., Plosch, T., Tietge, U. J. F., Jimenez-Chillaron, J. C. Epigenetic programming at the Mogat1 locus may link neonatal overnutrition with long-term hepatic steatosis and insulin resistance.	[Ramon-Krauel, Marta; Pentinat, Thais; Cebria, Judith; Ribo, Silvia; Perez-Wienese, Ricky; Vila, Maria; Palacios-Marin, Ivonne; Lerin, Carles; Diaz, Ruben; Jimenez-Chillaron, Josep C.] Inst Recerca St Joan de Deu, Endocrinol Dept, Barcelona, Spain; [Bloks, Vincent W.; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Sect Mol Metab & Nutr, Groningen, Netherlands; [Plosch, Torsten] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands; [Fernandez-Perez, Antonio; Vallejo, Mario; Tellez, Noelia; Angel Rodriguez, Miguel; Yanes, Oscar] Inst Salud Carlos III, Ciber Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Fernandez-Perez, Antonio; Vallejo, Mario] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Fernandez-Perez, Antonio; Vallejo, Mario] UAM, CSIC, Madrid, Spain; [Tellez, Noelia] Bellvitge Biomed Res Inst IDIBELL LHospitalet, Barcelona, Spain; [Angel Rodriguez, Miguel; Yanes, Oscar] Univ Rovira & Virgili, Dept Elect Engn, Tarragona, Spain; [Fernandez-Perez, Antonio] CDTI, Madrid, Spain	University of Groningen; University of Groningen; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Rovira i Virgili	Jimenez-Chillaron, JC (corresponding author), Inst Recerca St Joan de Deu, C Santa Rosa 39-57,3a Planta, Barcelona 08950, Spain.	jjimenezc@fsjd.org	Plösch, Torsten/X-6808-2019; Vallejo, Mario/ABG-4610-2020; Yanes, Oscar/N-3630-2016; Ribo, Silvia/ABI-5622-2020; Tellez, Noelia/C-1029-2008; Lerin, Carles/AAP-9916-2020; Vilà-Rovira, Maria/GLT-6460-2022; Bloks, Vincent Walter/A-7609-2012	Plösch, Torsten/0000-0002-9305-4045; Vallejo, Mario/0000-0002-6422-0323; Yanes, Oscar/0000-0003-3695-7157; Ribo, Silvia/0000-0001-8983-827X; Tellez, Noelia/0000-0001-7879-3256; Lerin, Carles/0000-0003-0950-4363; Rodriguez-Gomez, Miguel Angel/0000-0001-9568-9821; Fernandez-Perez, Antonio/0000-0001-6866-5824; Bloks, Vincent Walter/0000-0001-6493-7482; Vila-Rovira, Maria/0000-0003-0286-3961	Instituto de Salud Carlos III [PI14/00035, CP11/00312]; Ministerio de Economia y Competitividad [BFU2011-29739]; Netherlands Organization for Health Research and Development (ZonMW) [91211053]; Spanish Ministry of Economy and Competitiveness [BFU2014-52149-R]; National Council for Science and Technology in Mexico (CONACyT)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad(Spanish Government); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Spanish Ministry of Economy and Competitiveness(Spanish Government); National Council for Science and Technology in Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Instituto de Salud Carlos III (PI14/00035, CP11/00312 to J.J.C.), Ministerio de Economia y Competitividad (BFU2011-29739 to J.J.C.), the Netherlands Organization for Health Research and Development (ZonMW, Grant 91211053 to T.P.), and the Spanish Ministry of Economy and Competitiveness (BFU2014-52149-R to M.V.). I.P.-M. is supported by a National Council for Science and Technology in Mexico (CONACyT) Ph.D. Scholarship. M.R.-K. and T.P. share senior authorship. The authors declare no conflicts of interest.	Agarwal AK, 2016, J LIPID RES, V57, P616, DOI 10.1194/jlr.M065896; Andersen LG, 2012, INT J OBESITY, V36, P1306, DOI 10.1038/ijo.2012.134; Bei F, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0094-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Collden G, 2015, MOL METAB, V4, P15, DOI 10.1016/j.molmet.2014.10.003; Conceicao EPS, 2013, J NUTR BIOCHEM, V24, P81, DOI 10.1016/j.jnutbio.2012.02.010; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Du QW, 2015, PEPTIDES, V70, P23, DOI 10.1016/j.peptides.2015.05.003; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Finck BN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104132; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Habbout A, 2013, J NUTR, V143, P553, DOI 10.3945/jn.112.172825; Habbout A, 2012, BIOCHIMIE, V94, P117, DOI 10.1016/j.biochi.2011.09.023; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hayashi Y, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.4; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kayser BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121954; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Li G, 2013, DIABETES, V62, P2773, DOI 10.2337/db12-1306; Liu ZG, 2013, J ENDOCRINOL, V219, P131, DOI 10.1530/JOE-13-0111; Martinez D, 2014, CELL METAB, V19, P941, DOI 10.1016/j.cmet.2014.03.026; Oddy WH, 2014, ANN NUTR METAB, V64, P262, DOI 10.1159/000365031; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Pentinat T, 2010, ENDOCRINOLOGY, V151, P5617, DOI 10.1210/en.2010-0684; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Pruis MGM, 2014, ACTA PHYSIOL, V210, P215, DOI 10.1111/apha.12197; Raychaudhuri N, 2014, J NUTR BIOCHEM, V25, P1066, DOI 10.1016/j.jnutbio.2014.05.011; Rodrigues AL, 2007, J ENDOCRINOL, V195, P485, DOI 10.1677/JOE-07-0046; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Sankella S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162504; Sefcikova Z, 2011, PHYSIOL RES, V60, P337, DOI 10.33549/physiolres.931939; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Soufi N, 2014, J BIOL CHEM, V289, P30177, DOI 10.1074/jbc.M114.595850; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Yu JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29352; Yu JH, 2015, BIOCHEM BIOPH RES CO, V460, P715, DOI 10.1016/j.bbrc.2015.03.095	51	15	15	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6025	6037		10.1096/fj.201700717RR	http://dx.doi.org/10.1096/fj.201700717RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29812971	Bronze			2022-12-28	WOS:000447172000022
J	Tao, FF; Tian, XX; Ruan, SM; Shen, MH; Zhang, ZQ				Tao, Fangfang; Tian, Xinxin; Ruan, Shanming; Shen, Minhe; Zhang, Zhiqian			miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma	FASEB JOURNAL			English	Article						ovarian cancer; MiR-211; PHF19; MALAT1; ceRNA	NONCODING RNA MALAT1; HEPATOCELLULAR-CARCINOMA; CANCER PROLIFERATION; CELL-PROLIFERATION; TRANSCRIPTION FACTOR; BREAST-CANCER; LUNG-CANCER; PROMOTES; EXPRESSION; MELANOMA	Accumulating evidence has indicated that microRNAs (miRNAs) play an important role in the occurrence and progression of ovarian cancer (OC). However, the function of miRNAs implicated in OC remains unclear. This study investigated the potential role of miR-211 in OC. Gene Expression Omnibus database analysis indicated that miR-211 expression was significantly down-regulated in OC tissues compared with normal specimens. In addition, miR-211 overexpression apparently inhibited proliferation, migration, xenograft growth, and induced apoptosis in HEY-T30 and SKOV3 cells. Moreover, PHF19, a component of the polycomb group of proteins, was found to be a direct target of miR-211 based on the luciferase reporter assay and Western blot analysis. Consistently, survival analysis indicated that high PHF19 expression was associated with shorter survival time in patients with OC. Importantly, silence of PHF19 reduced proliferation, induced cell cycle arrest, promoted apoptosis, suppressed migration, and inhibited xenograft growth in SKOV3 cells. Restoration of PHF19 expression markedly reversed the inhibitory effect of miR-211 on OC. Moreover, our results indicate that the long noncoding RNA MALAT1 could sponge miR-211 as a competing endogenous RNA and potentially up-regulate PHF19 expression, thus facilitating the OC progression. These findings suggest that the MALAT1/miR-211/PHF19 axis may act as a key mediator in OC and provide new insight into the prevention of this disease.Tao, F., Tian, X., Ruan, S., Shen, M., Zhang, Z. miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma.	[Tao, Fangfang] Zhejiang Chinese Med Univ, Basic Med Coll, Dept Immunol & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Tian, Xinxin] Texas A&M Univ, Dept Biochem & Biophys, Texas A&M AgriLife Res, College Stn, TX 77843 USA; [Tian, Xinxin; Zhang, Zhiqian] Tianjin Int Joint Acad Biomed TJAB, Tianjin 300457, Peoples R China; [Ruan, Shanming; Shen, Minhe] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zhiqian] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Zhejiang Chinese Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Zhejiang Chinese Medical University; Nankai University	Zhang, ZQ (corresponding author), Tianjin Int Joint Acad Biomed TJAB, Tianjin 300457, Peoples R China.	zhangzhiqian@tjab.org	Ruan, Shanming/S-3999-2018; Zhang, Zhiqian/P-7746-2018; 田, 新新/P-6549-2019	Ruan, Shanming/0000-0003-1061-5255; Zhang, Zhiqian/0000-0003-1226-4807; 田, 新新/0000-0003-3504-9392; tao, fang fang/0000-0002-2090-2701	National Natural Science Foundation of China [81302896]; Zhejiang Provincial Public Welfare Project [2016C37056]; China Postdoctoral Science Foundation [2018M630694]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Public Welfare Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81302896), the Zhejiang Provincial Public Welfare Project (2016C37056), and the China Postdoctoral Science Foundation (2018M630694). F.T. and X.T. share first authorship. The authors declare no conflicts of interest.	An JH, 2017, ONCOTARGETS THER, V10, P5377, DOI 10.2147/OTT.S147586; [Anonymous], BIOSCI REP; Bai L, 2018, EXP CELL RES, V366, P161, DOI 10.1016/j.yexcr.2018.03.014; Ballare C, 2012, NAT STRUCT MOL BIOL, V19, P1257, DOI 10.1038/nsmb.2434; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Cheng Y, 2018, ONCOL RES; Chu TH, 2013, CANCER LETT, V337, P115, DOI 10.1016/j.canlet.2013.05.032; De Luca T, 2016, MOL CARCINOGEN, V55, P2304, DOI 10.1002/mc.22437; Deb B, 2018, J CELL PHYSIOL, V233, P3846, DOI 10.1002/jcp.26095; Gao K, 2016, J INSECT CONSERV, V20, P1, DOI 10.1007/s10841-015-9834-x; Ghislin S, 2012, CELL CYCLE, V11, P1634, DOI 10.4161/cc.20095; Guo LY, 2017, ONCOTARGET, V8, P68483, DOI 10.18632/oncotarget.19590; Hao NB, 2017, ONCOTARGET, V8, P81572, DOI 10.18632/oncotarget.19197; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Jiang GX, 2015, ONCOTARGET, V6, P9457, DOI 10.18632/oncotarget.3265; Jiang LT, 2018, MED SCI MONITOR, V24, P1794, DOI 10.12659/MSM.909450; Jin Y, 2017, EUR REV MED PHARMACO, V21, P3176; Karreth FA, 2013, CANCER DISCOV, V3, P1113, DOI 10.1158/2159-8290.CD-13-0202; Kuang DF, 2016, EXP MOL PATHOL, V101, P267, DOI 10.1016/j.yexmp.2016.09.008; Kwok ZH, 2018, INT J CANC; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080970; Li J, 2016, ONCOL REP, V36, P3241, DOI 10.3892/or.2016.5200; Li MJ, 2017, NUCLEIC ACIDS RES, V45, P5653, DOI 10.1093/nar/gkx331; Li SF, 2018, CANCER SCI, V109, P1346, DOI 10.1111/cas.13587; Lin CR, 2018, TRENDS CELL BIOL, V28, P287, DOI 10.1016/j.tcb.2017.11.008; Liu JH, 2017, FRONT BIOSCI-LANDMRK, V22, P66, DOI 10.2741/4472; Lou W, 2017, ONCOTARGET, V8, DOI 10.18632/oncotarget.23115; Lv T, 2018, BIOCHEM CELL BIOL, V96, P663, DOI 10.1139/bcb-2018-0031; Mahdian-shakib A, 2016, BIOMED PHARMACOTHER, V84, P592, DOI 10.1016/j.biopha.2016.09.087; Miao YF, 2016, ANN CLIN LAB SCI, V46, P418; Ning FY, 2018, AM J TRANSL RES, V10, P200; Pa M, 2017, ONCOL RES; Pal MK, 2015, CANCER BIOL MED, V12, P328, DOI 10.7497/j.issn.2095-3941.2015.0024; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Qin S, 2013, BIOCHEM BIOPH RES CO, V430, P547, DOI 10.1016/j.bbrc.2012.11.116; Slaby O, 2017, BIOCHEM J, V474, P4219, DOI 10.1042/BCJ20170079; Song C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10547-z; Tay Y, 2014, CELL RES, V24, P259, DOI 10.1038/cr.2014.21; Testa U., 2018, MEDICINES BASEL, V5; Toraih EA, 2018, BIOMED PHARMACOTHER, V102, P653, DOI 10.1016/j.biopha.2018.03.105; Vitiello M, 2017, ONCOTARGET, V8, P25395, DOI 10.18632/oncotarget.15915; Wang CY, 2015, INT J CLIN EXP PATHO, V8, P14013; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Worku T, 2017, CELL PHYSIOL BIOCHEM, V44, P948, DOI 10.1159/000485395; Wu D, 2016, ONCOL LETT, V11, P1189, DOI 10.3892/ol.2015.3983; Wu LQ, 2017, EXP THER MED, V13, P3055, DOI 10.3892/etm.2017.4304; Wu Q, 2015, J CELL MOL MED, V19, P2874, DOI 10.1111/jcmm.12681; Xia BR, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0322-4; Xia HW, 2016, ONCOTARGET, V7, P56209, DOI 10.18632/oncotarget.10941; Xu H, 2015, ONCOL REP, V34, P175, DOI 10.3892/or.2015.3957; Xue D, 2018, J CELL MOL MED, V22, P3223, DOI 10.1111/jcmm.13604; Yamamura S, 2018, CELL MOL LIFE SCI, V75, P467, DOI 10.1007/s00018-017-2626-6; Ye LG, 2016, TUMOR BIOL, V37, P1151, DOI 10.1007/s13277-015-3835-y; Yu HZ, 2016, BIOCHEM BIOPH RES CO, V476, P400, DOI 10.1016/j.bbrc.2016.05.133; Zaman MS, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-44; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743	57	51	52	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6330	6343		10.1096/fj.201800495RR	http://dx.doi.org/10.1096/fj.201800495RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29874124				2022-12-28	WOS:000447172000046
J	Thongsroy, J; Patchsung, M; Pongpanich, M; Settayanon, S; Mutirangura, A				Thongsroy, Jirapan; Patchsung, Maturada; Pongpanich, Monnat; Settayanon, Sirapat; Mutirangura, Apiwat			Reduction in replication-independent endogenous DNA double-strand breaks promotes genomic instability during chronological aging in yeast	FASEB JOURNAL			English	Article						RIND-EDSBs; epigenetics; senescence; DNA lesions; DNA damage	LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; HYPOMETHYLATION; REPAIR; HMGB1; METHYLATION; SIR2; RECOMBINATION; RECRUITMENT; MECHANISM	The mechanism that causes genomic instability in nondividing aging cells is unknown. Our previous study of mutant yeast suggested that 2 types of replication-independent endogenous DNA double-strand breaks (RIND-EDSBs) exist and that they play opposing roles. The first type, known as physiologic RIND-EDSBs, were ubiquitous in the G(0) phase of both yeast and human cells in certain genomic locations and may act as epigenetic markers. Low RIND-EDSB levels were found in mutants that lacked chromatin-condensing proteins, such as the high-mobility group box (HMGB) proteins and Sir2. The second type is referred to as pathologic RIND-EDSBs. High pathological RIND-EDSB levels were found in DSB repair mutants. Under normal physiologic conditions, these excess RIND-EDSBs are repaired in much the same way as DNA lesions. Here, chronological aging in yeast reduced physiological RIND-EDSBs and cell viability. A strong correlation was observed between the reduction in RIND-EDSBs and viability in aging yeast cells (r = 0.94, P < 0.0001). We used galactose-inducible HO endonuclease (HO) and nhp6a, an HMGB protein mutant, to evaluate the consequences of reduced physiological RIND-EDSB levels. The HO-induced cells exhibited a sustained reduction in RIND-EDSBs at various levels for several days. Interestingly, we found that lower physiologic RIND-EDSB levels resulted in decreased cell viability (r = 0.69, P < 0.0001). Treatment with caffeine, a DSB repair inhibitor, increased pathological RIND-EDSBs, which were distinguished from physiologic RIND-EDSBs by their lack of sequences prior to DSB in untreated cells [odds ratio (OR) 1]. Caffeine treatment in both the HO-induced and nhp6a cells markedly increased OR 1 breaks. Therefore, physiological RIND-EDSBs play an epigenetic role in preventing pathological RIND-EDSBs, a type of DNA damage. In summary, the reduction of physiological RIND-EDSB level is a genomic instability mechanism in chronologically aging cells.Thongsroy, J., Patchsung, M., Pongpanich, M., Settayanon, S., Mutirangura, A. Reduction in replication-independent endogenous DNA double-strand breaks promotes genomic instability during chronological aging in yeast.	[Thongsroy, Jirapan] Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand; [Patchsung, Maturada; Pongpanich, Monnat; Settayanon, Sirapat; Mutirangura, Apiwat] Chulalongkorn Univ, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok, Thailand; [Pongpanich, Monnat] Chulalongkorn Univ, Dept Math & Comp Sci, Bangkok, Thailand; [Pongpanich, Monnat] Chulalongkorn Univ, Fac Sci, Om Sci & Bioinformat Ctr, Bangkok, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Bangkok, Thailand	Walailak University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Mutirangura, A (corresponding author), Chulalongkom Univ, 254 Pathumwan, Bangkok 10330, Thailand.	mapiwat@chula.ac.th		Patchsung, Maturada/0000-0002-7831-2034; Pongpanich, Monnat/0000-0003-3228-3351; Settayanon, Sirapat/0000-0003-4957-0920	Thailand Research Fund [DPG5980005, TRG5880214]; Anantara Siam Bangkok Hotel; Four Seasons Bangkok Hotel Care for Cancer Fun Run; Thai Red Cross Society; Development of New Faculty Staff, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University [GDNS 59-009-23-005]; Institute of Research and Development Walailak University [WU_IRG60_05]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0131/2554]	Thailand Research Fund(Thailand Research Fund (TRF)); Anantara Siam Bangkok Hotel; Four Seasons Bangkok Hotel Care for Cancer Fun Run; Thai Red Cross Society; Development of New Faculty Staff, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University; Institute of Research and Development Walailak University; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This work was supported by the Thailand Research Fund (Grants DPG5980005 and TRG5880214); the Anantara Siam Bangkok Hotel and Four Seasons Bangkok Hotel Care for Cancer Fun Run, in coordination with the Thai Red Cross Society; the Development of New Faculty Staff, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University (Grant GDNS 59-009-23-005 to M.P); the Institute of Research and Development Walailak University Grant WU_IRG60_05 (to J.T); and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant PHD/0131/2554 to M.P. and A.M.). The authors declare no conflicts of interest.	Barral S, 2014, INT J MOL SCI, V15, P1554, DOI 10.3390/ijms15011554; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Dotiwala F, 2013, P NATL ACAD SCI USA, V110, pE41, DOI 10.1073/pnas.1218065109; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Freire-Beneitez V, 2016, NUCLEIC ACIDS RES, V44, P9166, DOI 10.1093/nar/gkw594; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; Ha CW, 2011, AGING-US, V3, P319, DOI 10.18632/aging.100299; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Jintaridth P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070386; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kongruttanachok N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-70; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Leonov A, 2017, ONCOTARGET, V8, P69328, DOI 10.18632/oncotarget.20614; Little AJ, 2013, NUCLEIC ACIDS RES, V41, P3289, DOI 10.1093/nar/gks1461; Liu Y, 2010, BBA-GENE REGUL MECH, V1799, P119, DOI 10.1016/j.bbagrm.2009.11.008; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mavragani IV, 2017, CANCERS, V9, DOI 10.3390/cancers9070091; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Patchsung M, 2018, EPIGENOMICS-UK, V10, P175, DOI 10.2217/epi-2017-0096; Polymenis M, 2012, CELL CYCLE, V11, P3531, DOI 10.4161/cc.22041; Pongpanich M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-750; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Postnikoff SDL, 2014, METHODS MOL BIOL, V1163, P223, DOI 10.1007/978-1-4939-0799-1_17; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Putiri EL, 2011, CLIN EPIGENETICS, V2, P299, DOI 10.1007/s13148-010-0017-z; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Thongsroy J, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0395-6; Thongsroy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072706; Torano EG, 2012, CLIN CHEM LAB MED, V50, P1733, DOI 10.1515/cclm-2011-0902; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; Vijg J., 2017, TRANSL MED AGING, V1, P5; WILSON VL, 1983, SCIENCE, V220, P1054; Yamanaka S, 2002, BIOCHEM BIOPH RES CO, V292, P268, DOI 10.1006/bbrc.2002.6647; Yaneva M, 2005, NUCLEIC ACIDS RES, V33, P5320, DOI 10.1093/nar/gki821	48	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6252	6260		10.1096/fj.201800218RR	http://dx.doi.org/10.1096/fj.201800218RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29812972				2022-12-28	WOS:000447172000040
J	Maruyama, H; Taguchi, A; Nishikawa, Y; Guili, C; Mikame, M; Nameta, M; Yamaguchi, Y; Ueno, M; Imai, N; Ito, Y; Nakagawa, T; Narita, I; Ishii, S				Maruyama, Hiroki; Taguchi, Atsumi; Nishikawa, Yuji; Guili, Chu; Mikame, Mariko; Nameta, Masaaki; Yamaguchi, Yutaka; Ueno, Mitsuhiro; Imai, Naofumi; Ito, Yumi; Nakagawa, Takahiko; Narita, Ichiei; Ishii, Satoshi			Medullary thick ascending limb impairment in the Gla(tm)Tg(CAG-A4GALT) Fabry model mice	FASEB JOURNAL			English	Article						polyuria; mitochondria-rich cell; uromodulin; Na+-K+-2Cl(-) cotransporter; Na+-K+-ATPase	ANGIOKERATOMA CORPORIS DIFFUSUM; ENZYME REPLACEMENT THERAPY; DISTAL CONVOLUTED TUBULE; TAMM-HORSFALL PROTEIN; CUFF BLOOD-PRESSURE; COTRANSPORTER NKCC2; ALPHA-GALACTOSIDASE; RENAL PATHOLOGY; MOUSE MODEL; RAT-KIDNEY	A main feature of Fabry disease is nephropathy, with polyuria an early manifestation; however, the mechanism that underlies polyuria and affected tubules is unknown. To increase globotriaosylceramide (Gb3) levels, we previously crossbred asymptomatic Gla(tm) mice with transgenic mice that expressed human Gb3 synthase (A4GALT) and generated the Gla(tm)Tg(CAG-A4GALT) symptomatic Fabry model mice. Additional analyses revealed that these mice exhibit polyuria and renal dysfunction without remarkable glomerular damage. In the present study, we investigated the mechanism of polyuria and renal dysfunction in these mice. Gb3 accumulation was mostly detected in the medulla; medullary thick ascending limbs (mTALs) were the most vacuolated tubules. mTAL cells contained lamellar bodies and had lost their characteristic structure (i.e., extensive infolding and numerous elongated mitochondria). Decreased expression of the major moleculesNa(+)-K+-ATPase, uromodulin, and Na+-K+-2Cl(-) cotransporterthat are involved in Na+ reabsorption in mTALs and the associated loss of urine-concentrating ability resulted in progressive water- and salt-loss phenotypes. Gla(tm)Tg(CAG-A4GALT) mice exhibited fibrosis around mTALs and renal dysfunction. These and other features were consistent with pathologic findings in patients with Fabry disease. Results demonstrate that mTAL dysfunction causes polyuria and renal impairment and contributes to the pathophysiology of Fabry nephropathy.Maruyama, H., Taguchi, A., Nishikawa, Y., Guili, C., Mikame, M., Nameta, M., Yamaguchi, Y., Ueno, M., Imai, N., Ito, Y., Nakagawa, T., Narita, I., Ishii, S. Medullary thick ascending limb impairment in the Gla(tm)Tg(CAG-A4GALT) Fabry model mice.	[Maruyama, Hiroki; Taguchi, Atsumi; Guili, Chu; Mikame, Mariko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Clin Neurosci, Niigata, Niigata, Japan; [Imai, Naofumi; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Niigata, Japan; [Ito, Yumi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Hlth Promot Med, Niigata, Niigata, Japan; [Nameta, Masaaki] Niigata Univ, Electron Microscope Core Facil, Niigata, Niigata, Japan; [Taguchi, Atsumi; Ishii, Satoshi] Oita Univ, Dept Matrix Med, Fac Med, Yufu, Japan; [Nishikawa, Yuji] Asahikawa Med Univ, Div Tumor Pathol, Dept Pathol, Asahikawa, Hokkaido, Japan; [Yamaguchi, Yutaka] Yamaguchis Pathol Lab, Matsudo, Chiba, Japan; [Ueno, Mitsuhiro] Joetsu Univ Educ, Univ Hlth Ctr, Joetsu, Japan; [Nakagawa, Takahiko] Nara Med Univ, Future Basic Med, Kashihara, Nara, Japan; [Ishii, Satoshi] GlycoPharma Corp, Oita, Japan	Niigata University; Niigata University; Niigata University; Niigata University; Oita University; Asahikawa Medical College; Joetsu University Education; Nara Medical University	Maruyama, H (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Clin Neurosci, Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata 9518120, Japan.	hirokim@med.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017	Narita, Ichiei/0000-0001-7692-3096; Ishii, Shoken/0000-0002-5814-5494	Japan Society for the Promotion of Science (KAKENHI) [JP 23390223]; Sanofi (Tokyo, Japan)	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sanofi (Tokyo, Japan)	The authors thank Yoko Okada (Asahikawa Medical University), Keiko Yamagiwa, Akiko Seino, Kazumasa Sato, Kaori Takahashi (all from Niigata University Graduate School of Medical and Dental Sciences), Dr. Mitsutoshi Fukagawa (Joetsu General Hospital), and Kanako Oda (Brain Research Institute, Niigata University) for technical assistance. This work was supported by the Japan Society for the Promotion of Science (KAKENHI) Grant-in-Aid for Scientific Research (B) (JP 23390223; to H.M. and S.I.). H.M. has received research support from Sanofi (Tokyo, Japan). S.I. is an employee of and shareholder in GlycoPharma Corp. The remaining authors declare no conflicts of interest.	Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; [Anonymous], HUM GEN MUT DAT; Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; BHAGAT CI, 1984, CLIN CHEM, V30, P1703; Biancini GB, 2016, CLIN CHIM ACTA, V461, P41, DOI 10.1016/j.cca.2016.07.016; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; BURKHOLDER PM, 1980, ARCH PATHOL LAB MED, V104, P17; Christensen EI, 2007, J AM SOC NEPHROL, V18, P698, DOI 10.1681/ASN.2006080822; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; COLLEY JR, 1958, BRIT MED J, V1, P1266, DOI 10.1136/bmj.1.5082.1266; Colvin R. B., 2015, DIAGNOSTIC PATHOLOGY, P416; Desnick RJ, 2002, CLIN NEPHROL, V57, P1; Desnick RJ, 2001, METABOLIC MOL BASES, V8, P3733; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Fogo AB, 2010, NEPHROL DIAL TRANSPL, V25, P2168, DOI 10.1093/ndt/gfp528; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Grunfeld JP, 2003, ACTA PAEDIATR, V92, P5, DOI 10.1080/08035320310000366; HENRY EW, 1963, CAN MED ASSOC J, V89, P206; Hoorn EJ, 2011, AM J HYPERTENS, V24, P534, DOI 10.1038/ajh.2011.7; Kanda A, 2000, VIRCHOWS ARCH, V436, P36, DOI 10.1007/PL00008196; KATZ AI, 1979, AM J PHYSIOL, V237, pF114, DOI 10.1152/ajprenal.1979.237.2.F114; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; KONE BC, 1984, AM J ANAT, V171, P217, DOI 10.1002/aja.1001710207; Labilloy A, 2014, MOL GENET METAB, V111, P184, DOI 10.1016/j.ymgme.2013.10.010; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Moes AD, 2014, PFLUG ARCH EUR J PHY, V466, P107, DOI 10.1007/s00424-013-1407-9; Mount D. B., 2015, BRENNER RECTORS KIDN, P144; Mount DB, 2014, CLIN J AM SOC NEPHRO, V9, P1974, DOI 10.2215/CJN.04480413; Munger K. A., 2015, BRENNER RECTORS KIDN, P83; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; PARCHOUX B, 1978, PEDIATRIE, V33, P757; PARKINSON J, 1961, AM J MED, V31, P951, DOI 10.1016/0002-9343(61)90037-7; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Seyberth HW, 2011, PEDIATR NEPHROL, V26, P1789, DOI 10.1007/s00467-011-1871-4; Singh P., 2015, BRENNER RECTORS KIDN, P122; Subramanya AR, 2014, CLIN J AM SOC NEPHRO, V9, P2147, DOI 10.2215/CJN.05920613; Taguchi A, 2013, BIOCHEM J, V456, P373, DOI 10.1042/BJ20130825; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Valbuena C, 2011, VIRCHOWS ARCH, V458, P477, DOI 10.1007/s00428-011-1051-8; Vylet'al P, 2008, J INHERIT METAB DIS, V31, P508, DOI 10.1007/s10545-008-0900-3; Weidemann F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-116; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Welker P, 2007, AM J PHYSIOL-REG I, V292, pR1328, DOI 10.1152/ajpregu.00166.2006; Wornell P, 2006, PEDIATR NEPHROL, V21, P1185, DOI 10.1007/s00467-006-0110-x	52	9	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4544	4559		10.1096/fj.201701374R	http://dx.doi.org/10.1096/fj.201701374R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29553830	Green Published			2022-12-28	WOS:000439325400040
J	Jung, MY; Kang, JH; Hernandez, DM; Yin, XQ; Andrianifahanana, M; Wang, YL; Gonzalez-Guerrico, A; Limper, AH; Lupu, R; Leof, EB				Jung, Mi-Yeon; Kang, Jeong-Han; Hernandez, Danielle M.; Yin, Xueqian; Andrianifahanana, Mahefatiana; Wang, Youli; Gonzalez-Guerrico, Anatilde; Limper, Andrew H.; Lupu, Ruth; Leof, Edward B.			Fatty acid synthase is required for profibrotic TGF- signaling	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; metabolism; fibrosis	IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; SREBP TRANSCRIPTION FACTORS; ELEMENT-BINDING PROTEINS; GENE-EXPRESSION; CANCER-CELLS; MAMMALIAN TARGET; OVARIAN-CANCER; MYOFIBROBLAST DIFFERENTIATION; MOLECULAR-MECHANISMS	Evidence is provided that the fibroproliferative actions of TGF- are dependent on a metabolic adaptation that sustains pathologic growth. Specifically, profibrotic TGF- signaling is shown to require fatty acid synthase (FASN), an essential anabolic enzyme responsible for the de novo synthesis of fatty acids. With the use of pharmacologic and genetic approaches, we show that TGF--stimulated FASN expression is independent of Smad2/3 and is mediated via mammalian target of rapamycin complex 1. In the absence of FASN activity or protein, TGF--driven fibrogenic processes are reduced with no apparent toxicity. Furthermore, as increased FASN expression was also observed to correlate with the degree of lung fibrosis in bleomycin-treated mice, inhibition of FASN was examined in a murine-treatment model of pulmonary fibrosis. Remarkably, inhibition of FASN not only decreased expression of profibrotic targets, but lung function was also stabilized/improved, as assessed by peripheral blood oxygenation.Jung, M.-Y., Kang, J.-H., Hernandez, D. M., Yin, X., Andrianifahanana, M., Wang, Y., Gonzalez-Guerrico, A., Limper, A. H., Lupu, R., Leof, E. B. Fatty acid synthase is required for profibrotic TGF- signaling.	[Jung, Mi-Yeon; Kang, Jeong-Han; Hernandez, Danielle M.; Yin, Xueqian; Andrianifahanana, Mahefatiana; Limper, Andrew H.; Leof, Edward B.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Gonzalez-Guerrico, Anatilde; Lupu, Ruth] Mayo Clin, Coll Med, Dept Lab Med & Pathol, 2-12 Stabile,200 Second St SW, Rochester, MN 55905 USA; [Wang, Youli] Augusta Univ, Div Nephrol, Augusta, GA USA	Mayo Clinic; Mayo Clinic; University System of Georgia; Augusta University	Lupu, R (corresponding author), Mayo Clin, Coll Med, Dept Lab Med & Pathol, 2-12 Stabile,200 Second St SW, Rochester, MN 55905 USA.; Leof, EB (corresponding author), Mayo Clin, Coll Med, Thorac Dis Res Unit, 8-58 Stabile,200 Second St SW, Rochester, MN 55905 USA.	lupu.ruth@mayo.edu; leof.edward@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Hernandez, Danielle M./0000-0003-0867-4950	Public Health Service from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM-55816, GM-54200]; Mayo Brain Specialized Programs of Research Excellence (SPORE) [CA-108961]; Caerus Foundation [91736058]; Mayo Foundation; Public Health Service Grant from the NIH National Cancer Institute [CA-116623]; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA116623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055816, R01GM054200, R01GM055816] Funding Source: NIH RePORTER	Public Health Service from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; Mayo Brain Specialized Programs of Research Excellence (SPORE); Caerus Foundation; Mayo Foundation; Public Health Service Grant from the NIH National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants GM-55816 and GM-54200 from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences, a pilot grant from the Mayo Brain Specialized Programs of Research Excellence (SPORE) (CA-108961), the Caerus Foundation (91736058), and the Mayo Foundation (to E.B.L.), as well as Public Health Service Grant CA-116623 from the NIH National Cancer Institute (to R.L.). The authors declare no conflicts of interest.	Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Alli PM, 2005, ONCOGENE, V24, P39, DOI 10.1038/sj.onc.1208174; Andrianifahanana M, 2016, FASEB J, V30, P3733, DOI 10.1096/fj.201600428R; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; Bengoechea-Alonso MT, 2006, CELL CYCLE, V5, P1708, DOI 10.4161/cc.5.15.3131; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Beyer C, 2012, CURR OPIN RHEUMATOL, V24, P274, DOI 10.1097/BOR.0b013e3283524b9a; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Canestaro WJ, 2016, CHEST, V149, P756, DOI 10.1016/j.chest.2015.11.013; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Grunt TW, 2009, BIOCHEM BIOPH RES CO, V385, P454, DOI 10.1016/j.bbrc.2009.05.085; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Jo HE, 2016, DRUG AGING, V33, P321, DOI 10.1007/s40266-016-0366-1; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kurotsu S, 2014, J PHARMACOL EXP THER, V350, P79, DOI 10.1124/jpet.114.213009; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomis-King H, 2013, CURR OPIN PHARMACOL, V13, P377, DOI 10.1016/j.coph.2013.03.015; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Menendez JA, 2006, INT J MOL MED, V18, P1081; Menendez JA, 2017, EXPERT OPIN THER TAR, V21, P1001, DOI 10.1080/14728222.2017.1381087; MOSELEY PL, 1986, J CLIN INVEST, V78, P1150, DOI 10.1172/JCI112695; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ohol YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144648; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Svensson RU, 2016, COLD SH Q B, V81, P93, DOI [10.1101/sqb.2016.81.030874, 10.1101/sqb.2016.81.030574]; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Tomek K, 2011, MOL CANCER RES, V9, P1767, DOI 10.1158/1541-7786.MCR-10-0467; Ventura R, 2015, EBIOMEDICINE, V2, P808, DOI 10.1016/j.ebiom.2015.06.020; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Yang CS, 2015, ONCOGENE, V34, P3264, DOI 10.1038/onc.2014.271; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	76	33	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3803	3815		10.1096/fj.201701187R	http://dx.doi.org/10.1096/fj.201701187R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475397	Green Published			2022-12-28	WOS:000435104500027
J	Wang, C; Xu, WJ; Liang, ML; Huang, D; Huang, K				Wang, Cheng; Xu, Wenjing; Liang, Minglu; Huang, Dan; Huang, Kai			CTRP13 inhibits atherosclerosis via autophagy-lysosome-dependent degradation of CD36	FASEB JOURNAL			English	Article						macrophage; lipid uptake; trapping; post-transcriptional	FOAM CELL-FORMATION; MECHANISMS; MACROPHAGES; IMMUNE; MOUSE	C1q/tumor necrosis factor-related protein 13 (CTRP13) is a secreted adipokine that can ameliorate abnormal glucose and lipid metabolism. However, the functional role of CTRP13 in the development of atherosclerotic plaques has yet to be described. In this study, we collected blood samples from patients of coronary artery diseases and apolipoprotein E (ApoE)(-/-) mice that were fed a Western diet for 12 wk to induce atherosclerosis and found that serum CTRP13 level was decreased. En face staining of aortas and aortic sinus in ApoE(-/-) mice showed that ectopic CTRP13 infusion in vivo dramatically decreased lesion areas, as well as reduced inflammatory responses with less macrophage content. In primary peritoneal macrophages in vitro, CTRP13 supplement reduced oxidized LDL uptake, foam-cell formation, and trapping, together with the suppressed cluster of differentiation 36 (CD36) protein levels. Reduced CD36 protein level was attributed to the autophagy-lysosome-dependent degradation of CD36 at the post-transcriptional level. The blocking of autophagy-lysosome induction could increase CD36 protein level, foam-cell formation, and migration, thus abolishing the protective effects of CTRP13 on atherosclerosis. In summary, these findings define CTRP13 as a novel approach for preventing atherosclerotic plaque formation via modulation of lipid uptake and foam-cell migration.Wang, C., Xu, W., Liang, M., Huang, D., Huang, K. CTRP13 inhibits atherosclerosis via autophagy-lysosome-dependent degradation of CD36.	[Wang, Cheng; Xu, Wenjing; Liang, Minglu; Huang, Dan; Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Gene Res, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China; [Wang, Cheng; Xu, Wenjing; Huang, Dan; Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, K (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Gene Res, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China.	huangkaiunion@gmail.com		Huang, Kai/0000-0001-7567-4024	National Natural Science Foundation of China [30971245, 81000112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 30971245 to K.H. and 81000112 to D.H.). The authors declare no conflicts of interest.	Afrookhteh A, 2017, CLIN LAB, V63, P327, DOI 10.7754/Clin.Lab.2016.160609; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chistiakov DA, 2017, J MOL MED, V95, P1153, DOI 10.1007/s00109-017-1575-8; Demers A, 2015, ARTERIOSCL THROM VAS, V35, P2517, DOI 10.1161/ATVBAHA.115.306032; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ilhan F, 2015, WORLD J CLIN CASES, V3, P345, DOI 10.12998/wjcc.v3.i4.345; Jeong SJ, 2017, ENDOCRINOL METAB, V32, P41, DOI 10.3803/EnM.2017.32.1.41; Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1; Liu ZY, 2017, CIRC RES, V121, P1047, DOI 10.1161/CIRCRESAHA.117.311546; Luo YT, 2017, CELL RES, V27, P352, DOI 10.1038/cr.2017.8; Maiuri MC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/584715; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Mendez-Barbero N, 2013, EMBO MOL MED, V5, P1901, DOI 10.1002/emmm.201302842; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Ou HX, 2018, SCI CHINA LIFE SCI, V61, P1212, DOI 10.1007/s11427-017-9240-2; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Schulz C., 2014, SCI TRANSL MED, V6, DOI DOI 10.1126/SCITRANSLMED.3008922239PS224898743; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Shanaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168082; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI [10.1089/ars.2009.2469, 10.1089/ARS.2009.2469]; Turco E, 2016, J STRUCT BIOL, V196, P29, DOI 10.1016/j.jsb.2016.04.005; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Xu WJ, 2018, J MOL MED, V96, P159, DOI 10.1007/s00109-017-1608-3; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050; Zheng Qingwen, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P127	32	27	29	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2290	2300		10.1096/fj.201801267RR	http://dx.doi.org/10.1096/fj.201801267RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30222079				2022-12-28	WOS:000457296600061
J	Robert, A; Tian, PR; Adam, SA; Kittisopikul, M; Jaqaman, K; Goldman, RD; Gelfand, VI				Robert, Amelie; Tian, Peirun; Adam, Stephen A.; Kittisopikul, Mark; Jaqaman, Khuloud; Goldman, Robert D.; Gelfand, Vladimir I.			Kinesin-dependent transport of keratin filaments: a unified mechanism for intermediate filament transport	FASEB JOURNAL			English	Article						vimentin; KIF5B; photoconversion	HEAVY-CHAIN; TARGETED DISRUPTION; VIMENTIN; DYNAMICS; ACTIN; NEUROFILAMENTS; MOVEMENT; BINDING; TAIL; ORGANIZATION	Keratin intermediate filaments (IFs) are the major cytoskeletal component in epithelial cells. The dynamics of keratin IFs have been described to depend mostly on the actin cytoskeleton, but the rapid transport of fully polymerized keratin filaments has not been reported. In this work, we used a combination of photoconversion experiments and clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeats-associated protein 9 genome editing to study the role of microtubules and microtubule motors in keratin filament transport. We found that long keratin filaments, like other types of IFs, are transported along microtubules by kinesin-1. Our data revealed that keratin and vimentin are nonconventional kinesin-1 cargoes because their transport did not require kinesin light chains, which are a typical adapter for kinesin-dependent cargo transport. Furthermore, we found that the same domain of the kinesin heavy chain tail is involved in keratin and vimentin IF transport, strongly suggesting that multiple types of IFs move along microtubules using an identical mechanism.Robert, A., Tian, P., Adam, S. A., Kittisopikul, M., Jaqaman, K., Goldman, R. D., Gelfand, V. I. Kinesin-dependent transport of keratin filaments: a unified mechanism for intermediate filament transport.	[Robert, Amelie; Tian, Peirun; Adam, Stephen A.; Kittisopikul, Mark; Goldman, Robert D.; Gelfand, Vladimir I.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave,Ward 11-100, Chicago, IL 60611 USA; [Kittisopikul, Mark; Jaqaman, Khuloud] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Jaqaman, Khuloud] Univ Texas Southwestern Med Ctr Dallas, Lyda Hill Dept Bioinformat, Dallas, TX 75390 USA	Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gelfand, VI (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave,Ward 11-100, Chicago, IL 60611 USA.	vgelfand@northwestern.edu	tian, peirun/GQZ-8607-2022; Kittisopikul, Mark/V-7680-2019; Gelfand, Vladimir/D-2545-2013	Kittisopikul, Mark/0000-0002-9558-6248; Adam, Stephen/0000-0003-3444-7655; Gelfand, Vladimir/0000-0002-6361-2798; Jaqaman, Khuloud/0000-0003-3471-1911	U.S. National Institutes of Health, National Institute of General Medical Science [P01GM09697, R01 GM52111]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971, R35GM119619, R01GM052111] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Fatima Gyoeva (Institute of Protein Research, Russian Academy of Sciences, Moscow, Russia) for the C terminus and head domain polyclonal antibodies against kinesin, and David Kirchenbuechler (Center for Advanced Microscopy/Nikon Imaging Center, Northwestern University, Chicago, IL, USA) for help with quantification of IF distribution. Research reported in this publication was supported by the of the U.S. National Institutes of Health, National Institute of General Medical Science (P01GM09697 and R01 GM52111). The authors declare no conflicts of interest.	Costigliola N, 2017, P NATL ACAD SCI USA, V114, P5195, DOI 10.1073/pnas.1614610114; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; Gan Z, 2016, CELL SYST, V3, P252, DOI 10.1016/j.cels.2016.08.007; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi049288l; GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0; Hackney DD, 2009, BIOCHEMISTRY-US, V48, P3448, DOI 10.1021/bi8022575; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOLLENBECK PJ, 1989, J CELL SCI, V92, P621; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; HUNT RC, 1990, J CELL PHYSIOL, V145, P187, DOI 10.1002/jcp.1041450202; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; Jones J.C.R., 2017, COLD SPRING HARB PER, V9; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Leduc C, 2017, J CELL BIOL, V216, P1689, DOI 10.1083/jcb.201607045; Leube Rudolf E, 2011, Bioarchitecture, V1, P39; Liovic M, 2003, J CELL SCI, V116, P1417, DOI 10.1242/jcs.00363; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Moch M, 2013, P NATL ACAD SCI USA, V110, P10664, DOI 10.1073/pnas.1306020110; Nieuwenhuizen RPJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131756; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Robert A, 2016, BIOESSAYS, V38, P232, DOI 10.1002/bies.201500142; Robert A, 2015, P NATL ACAD SCI USA, V112, pE3505, DOI 10.1073/pnas.1505303112; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Sanghvi-Shah R, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00081; Schwarz N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09007; Seeger MA, 2010, J BIOL CHEM, V285, P8155, DOI 10.1074/jbc.M109.068247; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; Shimi T, 2015, MOL BIOL CELL, V26, P4075, DOI 10.1091/mbc.E15-07-0461; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Theiss C, 2005, EUR J CELL BIOL, V84, P29, DOI 10.1016/j.ejcb.2004.09.001; Uchida A, 2013, P NATL ACAD SCI USA, V110, pE2696, DOI 10.1073/pnas.1221835110; Uchida A, 2009, MOL BIOL CELL, V20, P4997, DOI 10.1091/mbc.E09-04-0304; Van Ginkel M., 2002, IMAGE ANAL USING ORI; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; Wang L, 2001, MOL BIOL CELL, V12, P3257, DOI 10.1091/mbc.12.10.3257; Wang Z, 2013, DEVELOPMENT, V140, P617, DOI 10.1242/dev.085969; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707; Windoffer R, 1999, J CELL SCI, V112, P4521; Woll S, 2005, EUR J CELL BIOL, V84, P311, DOI 10.1016/j.ejcb.2004.12.004; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	51	11	11	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					388	399		10.1096/fj.201800604R	http://dx.doi.org/10.1096/fj.201800604R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29944446	Green Published			2022-12-28	WOS:000457401500031
J	Tang, CZ; Yang, JT; Liu, QH; Wang, YR; Wang, WS				Tang, Chao-Zhi; Yang, Jun-Tang; Liu, Qing-Hui; Wang, Ya-Ru; Wang, Wen-Sheng			Up-regulated miR-192-5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2-mediated TGF-1 signaling pathway	FASEB JOURNAL			English	Article						synaptic transmission; hippocampal dentate gyrus; dendrite; cAMP; HPLC mass spectrometry	STRESS; METAANALYSIS; FIBULIN-2; RISK; ANTIDEPRESSANTS; PLASTICITY; BEHAVIORS; PROTECTS; DISEASE; MEMORY	Depression represents a condition characterized by cognitive deficits and neural dysfunction and has recently been correlated with microRNAs (miRs) and their respective target genes. The present study was conducted with the goal of investigating the expression of miR-192-5p and its target gene fibulin (Fbln)-2 in an attempt to evaluate their roles in the occurrence and progression of cognitive impairment and neural function in mice with chronic unpredictable mild stress (CUMS)-induced depression through regulation of the TGF-1 signal transduction pathway. Verification of the targeting relationship between miR-192-5p and Fbln2 was provided in the form of initial bioinformatics prediction, followed by a further verification in the form of a dual-luciferase reporter gene assay. Normal mice and models induced by CUMS were assigned into various groups, whereas mimics, inhibitors, and small interfering RNA were introduced to validate the regulatory mechanism by which miR-192-5p regulates Fbln2 depression. Novel object recognition, tail suspension testing, and Morris water maze were all employed 28 d after transfection. Hippocampal electrophysiological recordings, Golgi staining, HPLC mass spectrometry, and fluorescence immunohistochemistry were performed to further evaluate cognitive function and neuron regeneration. CUMS-induced depression was determined to represent a predisposing factor for cognitive impairment and damage to neural function in mice, highlighted by novel object recognition, learning and memory abilities, population spike amplitude, synaptic transmission, cAMP levels, neuronal regeneration, and increased behavioral changes that resemble depression. Furthermore, increased Fbln2 expression, an activated TGF-1 signaling pathway, and decreased expression of miR-192-5p, synaptophysin, brain-derived neurotrophic factor, N-methyl-d-aspartate receptor subunit 2B, and calmodulin-dependent protein kinase II were noted. Up-regulated miR-192-5p targeting Fbln2 acts to alleviate CUMS-induced depression by inhibiting the TGF-1 signaling pathway, resulting in the enhanced cognitive function in novel object recognition, learning and memory ability, population spike amplitude, synaptic transmission, neuron regeneration, and alleviation of behavioral symptoms. The central findings of the present study indicate that up-regulated levels of miR-192-5p expression act to suppress activation of the TGF-1 signaling pathway by means of binding to Fbln2, thereby ameliorating cognitive impairment and strengthening neural function in a mouse model of depression.Tang, C.-Z., Yang, J.-T., Liu, Q.-H., Wang, Y.-R., Wang, W.-S. Up-regulated miR-192-5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2-mediated TGF-1 signaling pathway.	[Tang, Chao-Zhi; Yang, Jun-Tang; Liu, Qing-Hui; Wang, Ya-Ru; Wang, Wen-Sheng] Henan Normal Univ, Coll Life Sci, Lab Mol Med, 46 Jianshe East Rd, Xinxiang 453007, Henan, Peoples R China	Henan Normal University	Wang, WS (corresponding author), Henan Normal Univ, Coll Life Sci, Lab Mol Med, 46 Jianshe East Rd, Xinxiang 453007, Henan, Peoples R China.	041128@htu.cn			Key Scientific and Technological Project of Henan Province [172102310053]; Doctoral Scientific Research Start-up Foundation of Henan Normal University [QD17150]; Natural Science Foundation of Henan Province [162300410217]	Key Scientific and Technological Project of Henan Province; Doctoral Scientific Research Start-up Foundation of Henan Normal University; Natural Science Foundation of Henan Province	The authors thank the reviewers for helpful comments on the manuscript. The work was supported by Key Scientific and Technological Project of Henan Province Grant 172102310053; Doctoral Scientific Research Start-up Foundation of Henan Normal University Grant QD17150; and Natural Science Foundation of Henan Province Grant 162300410217. The authors declare no conflicts of interest.	Amin ND, 2015, SCIENCE, V350, P1525, DOI 10.1126/science.aad2509; Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Bonetti L, 2017, CLIN NEUROPHYSIOL, V128, P1923, DOI 10.1016/j.clinph.2017.07.004; Calero M Dolores, 2009, Rev Esp Geriatr Gerontol, V44, P323, DOI 10.1016/j.regg.2009.06.012; Cangemi C, 2014, ADV CLIN CHEM, V67, P245, DOI 10.1016/bs.acc.2014.09.008; Caraci F, 2012, EUR NEUROPSYCHOPHARM, V22, P281, DOI 10.1016/j.euroneuro.2011.08.006; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chiang YP, 2012, EXP THER MED, V3, P560, DOI 10.3892/etm.2011.436; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; COLLIN SP, 1989, VISION RES, V29, P765, DOI 10.1016/0042-6989(89)90089-8; Dai YT, 2010, J ETHNOPHARMACOL, V128, P482, DOI 10.1016/j.jep.2010.01.016; Radice PD, 2015, MOL CELL NEUROSCI, V67, P75, DOI 10.1016/j.mcn.2015.06.004; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Engel DF, 2018, NEUROCHEM RES, V43, P387, DOI 10.1007/s11064-017-2433-3; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Feinberg-Gorenshtein G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078713; Hodes GE, 2010, NEUROSCI LETT, V484, P12, DOI 10.1016/j.neulet.2010.07.084; Hong M, 2013, NEUROIMMUNOMODULAT, V20, P39, DOI 10.1159/000343100; Krattinger R, 2016, AM J PHYSIOL-GASTR L, V310, pG1044, DOI 10.1152/ajpgi.00297.2015; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Leonardi GC, 2012, INT J MOL MED, V30, P991, DOI 10.3892/ijmm.2012.1089; Li YC, 2017, APPL IMMUNOHISTO M M, V25, P251, DOI 10.1097/PAI.0000000000000296; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054369, 10.1371/journal.pone.0055108, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994]; Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Moon S, 2017, ONCOTARGET, V8, P35184, DOI 10.18632/oncotarget.17059; Nguyen HT, 2017, HUM MOL GENET, V26, P3797, DOI 10.1093/hmg/ddx264; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Ossowska G, 2004, POL J PHARMACOL, V56, P305; Peng WF, 2016, EPILEPSY RES, V119, P77, DOI 10.1016/j.eplepsyres.2015.09.013; Pennisi M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8154969; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Trebaticka J, 2017, PHYSIOL RES, V66, P363, DOI 10.33549/physiolres.933430; Tsuda T, 2012, J MOL CELL CARDIOL, V52, P273, DOI 10.1016/j.yjmcc.2011.11.001; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P371, DOI 10.1007/s002130050473; Wuwongse S, 2010, PROG NEUROBIOL, V91, P362, DOI 10.1016/j.pneurobio.2010.04.005; Zhang HX, 2014, CLIN SCI, V126, P275, DOI 10.1042/CS20120636; Zhang HY, 2015, J ZHEJIANG UNIV-SC B, V16, P62, DOI 10.1631/jzus.B1400166; Zhang XC, 2018, BRAIN STRUCT FUNCT, V223, P749, DOI 10.1007/s00429-017-1521-0; Zhang YF, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21873; Zhao LX, 2013, NEURAL REGEN RES, V8, P2441, DOI 10.3969/j.issn.1673-5374.2013.26.005	50	22	28	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					606	618		10.1096/fj.201800210RR	http://dx.doi.org/10.1096/fj.201800210RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30118321				2022-12-28	WOS:000457401500047
J	Beaumont, M; Neyrinck, AM; Olivares, M; Rodriguez, J; Serra, AD; Roumain, M; Bindels, LB; Cani, PD; Evenepoel, P; Muccioli, GG; Demoulin, JB; Delzenne, NM				Beaumont, Martin; Neyrinck, Audrey M.; Olivares, Marta; Rodriguez, Julie; Serra, Audrey de Rocca; Roumain, Martin; Bindels, Laure B.; Cani, Patrice D.; Evenepoel, Pieter; Muccioli, Giulio G.; Demoulin, Jean-Baptiste; Delzenne, Nathalie M.			The gut microbiota metabolite indole alleviates liver inflammation in mice	FASEB JOURNAL			English	Article						gut-liver axis; LPS; Kupffer cells; cholesterol metabolism; PCLS	ARYL-HYDROCARBON RECEPTOR; HIGH-FAT DIET; TRYPTOPHAN-METABOLITES; INDOXYL SULFATE; DISEASE; HOST; CHOLESTEROL; SUSCEPTIBILITY; OXYSTEROLS; EXPRESSION	The gut microbiota regulates key hepatic functions, notably through the production of bacterial metabolites that are transported via the portal circulation. We evaluated the effects of metabolites produced by the gut microbiota from aromatic amino acids (phenylacetate, benzoate, p-cresol, and indole) on liver inflammation induced by bacterial endotoxin. Precision-cut liver slices prepared from control mice, Kupffer cell (KC)-depleted mice, and obese mice (ob/ob) were treated with or without LPS and bacterial metabolites. We observed beneficial effects of indole that dose-dependently reduced the LPS-induced up-regulation of proinflammatory mediators at both mRNA and protein levels in precision-cut liver slices prepared from control or ob/ob mice. KC depletion partly prevented the antiinflammatory effects of indole, notably through a reduction of nucleotide-binding domain and leucine-rich repeat containing (NLR) family pyrin domain-containing 3 (NLRP3) pathway activation. In vivo, the oral administration of indole before an LPS injection reduced the expression of key proteins of the NF-B pathway and downstream proinflammatory gene up-regulation. Indole also prevented LPS-induced alterations of cholesterol metabolism through a transcriptional regulation associated with increased 4-hydroxycholesterol hepatic levels. In summary, indole appears as a bacterial metabolite produced from tryptophan that is able to counteract the detrimental effects of LPS in the liver. Indole could be a new target to develop innovative strategies to decrease hepatic inflammation.Beaumont, M., Neyrinck, A. M., Olivares, M., Rodriguez, J., de Rocca Serra, A., Roumain, M., Bindels, L. B., Cani, P. D., Evenepoel, P., Muccioli, G. G., Demoulin, J.-B., Delzenne, N. M. The gut microbiota metabolite indole alleviates liver inflammation in mice.	[Beaumont, Martin; Neyrinck, Audrey M.; Olivares, Marta; Rodriguez, Julie; Bindels, Laure B.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Ave Mounier 73,Box B1-73-11, B-1200 Brussels, Belgium; [Serra, Audrey de Rocca; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Pole Expt Med, Brussels, Belgium; [Roumain, Martin; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Brussels, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Walloon Excellence Life Sci & Biotechnol WELBIO, Brussels, Belgium; [Evenepoel, Pieter] Katholieke Univ KU Leuven Leuven, Dept Immunol & Microbiol, Lab Nephrol, Leuven, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Ave Mounier 73,Box B1-73-11, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; Olivares, Marta/O-9899-2019; Neyrinck, Audrey/AAE-7929-2019; D., Cani Patrice/M-8055-2016; Rodriguez, Julie/AAM-7813-2020; Sevilla, Marta Olivares/A-7691-2019; Bindels, Laure/T-7846-2019	Delzenne, Nathalie/0000-0003-2115-6082; Olivares, Marta/0000-0002-7966-2781; Neyrinck, Audrey/0000-0002-9435-3338; D., Cani Patrice/0000-0003-2040-2448; Bindels, Laure/0000-0003-3747-3234; Beaumont, Martin/0000-0002-1559-2067; Rodriguez, Julie/0000-0002-8271-3893; Muccioli, Giulio/0000-0002-1600-9259; Roumain, Martin/0000-0001-8915-795X	European Union (EU) [613979]; Belgium National Scientific Research Fund (FRS-FNRS) (Belgium); Marie Curie Actions of the European Commission; European Research Council [336452-ENIGMO]; FRS-FNRS via the Fund for Strategic Fundamental Research (FRFS)-Walloon Excellence in Life Sciences and Biotechnology (WELBIO) [WELBIO-CGR-2017]; FRS-FNRS	European Union (EU)(CGIAREuropean Commission); Belgium National Scientific Research Fund (FRS-FNRS) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Marie Curie Actions of the European Commission(European Commission); European Research Council(European Research Council (ERC)European Commission); FRS-FNRS via the Fund for Strategic Fundamental Research (FRFS)-Walloon Excellence in Life Sciences and Biotechnology (WELBIO)(Fonds de la Recherche Scientifique - FNRSWELBIO); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	The authors thank V. Allaeys and B. Es Saadi (Metabolism and Nutrition Research Group, Louvain Drug Research Institute) for their skillful technical assistance. N.M.D. is a recipient of an European Union (EU) grant (613979 MyNewGut Project) and Belgium National Scientific Research Fund (FRS-FNRS) (Belgium) grants. M.O. is a beneficiary of a "MOVE-IN Louvain" Incoming Postdoctoral Fellowship cofunded by the Marie Curie Actions of the European Commission. P.D.C., a senior research associate at the FRS-FNRS, is a recipient of a 2013 European Research Council Starting grant (336452-ENIGMO) and a 2015 Baillet Latour grant for medical research, and is supported by the FRS-FNRS via the Fund for Strategic Fundamental Research (FRFS)-Walloon Excellence in Life Sciences and Biotechnology (WELBIO) under Grant WELBIO-CGR-2017. A.D.R.S. is a recipient of a postdoctoral fellowship from FRS-FNRS. The authors declare no conflicts of interest.	Andriamihaja M, 2015, FREE RADICAL BIO MED, V85, P219, DOI 10.1016/j.freeradbiomed.2015.04.004; Banoglu E, 2002, EUR J DRUG METAB PH, V27, P135, DOI 10.1007/BF03190428; Banoglu E, 2001, EUR J DRUG METAB PH, V26, P235, DOI 10.1007/BF03226377; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Beaumont M, 2017, AM J CLIN NUTR, V106, P1005, DOI 10.3945/ajcn.117.158816; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Brandl K, 2017, AM J PHYSIOL-GASTR L, V312, pG413, DOI 10.1152/ajpgi.00361.2016; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494; Cheng YT, 2015, DRUG METAB DISPOS, V43, P1536, DOI 10.1124/dmd.115.063677; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Feingold KR, 2010, J LIPID RES, V51, P682, DOI 10.1194/jlr.E005454; Gaudichon C, 2002, GASTROENTEROLOGY, V123, P50, DOI 10.1053/gast.2002.34233; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Jennis M., NEUROGASTROENTEROL M, V30; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Klemashevich C, 2014, CURR OPIN BIOTECH, V26, P85, DOI 10.1016/j.copbio.2013.10.006; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002; Llopis M, 2016, GUT, V65, P830, DOI 10.1136/gutjnl-2015-310585; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Mutemberezi V, 2016, PROG LIPID RES, V64, P152, DOI 10.1016/j.plipres.2016.09.002; Mutemberezi V, 2016, ANAL BIOANAL CHEM, V408, P733, DOI 10.1007/s00216-015-9150-z; Neyrinck A. M., MOL NUTR FOOD RES, V61; Neyrinck AM, 2004, J NUTR, V134, P1124, DOI 10.1093/jn/134.5.1124; Neyrinck Audrey M, 2004, Comp Hepatol, V3 Suppl 1, pS45, DOI 10.1186/1476-5926-2-S1-S45; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Osawa Y, 2011, J BIOL CHEM, V286, P34800, DOI 10.1074/jbc.M111.235473; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Portune KJ, 2016, TRENDS FOOD SCI TECH, V57, P213, DOI 10.1016/j.tifs.2016.08.011; QUIROGA J, 1993, PHARMACOL THERAPEUT, V58, P67, DOI 10.1016/0163-7258(93)90067-N; Rasmussen MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154629; Ritze Y, 2014, BRIT J NUTR, V112, P1, DOI 10.1017/S0007114514000440; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Schulman IG, 2017, FEBS LETT, V591, P2978, DOI 10.1002/1873-3468.12702; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Sonowal R, 2017, P NATL ACAD SCI USA, V114, pE7506, DOI 10.1073/pnas.1706464114; Strnad P, 2017, NAT REV GASTRO HEPAT, V14, P55, DOI 10.1038/nrgastro.2016.168; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Whitfield-Cargile CM, 2016, GUT MICROBES, V7, P246, DOI 10.1080/19490976.2016.1156827; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Xu JL, 2012, DRUG METAB DISPOS, V40, P259, DOI 10.1124/dmd.111.039925; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zheng XJ, 2011, J PROTEOME RES, V10, P5512, DOI 10.1021/pr2007945	59	87	90	4	52	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6681	6693		10.1096/fj.201800544	http://dx.doi.org/10.1096/fj.201800544			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906245	Green Published, hybrid			2022-12-28	WOS:000449359700026
J	Edogawa, S; Peters, SA; Jenkins, GD; Gurunathan, SV; Sundt, WJ; Johnson, S; Lennon, RJ; Dyer, RB; Camilleri, M; Kashyap, PC; Farrugia, G; Chen, J; Singh, RJ; Grover, M				Edogawa, Shoko; Peters, Stephanie A.; Jenkins, Gregory D.; Gurunathan, Sakteesh V.; Sundt, Wendy J.; Johnson, Stephen; Lennon, Ryan J.; Dyer, Roy B.; Camilleri, Michael; Kashyap, Purna C.; Farrugia, Gianrico; Chen, Jun; Singh, Ravinder J.; Grover, Madhusudan			Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota	FASEB JOURNAL			English	Article						lactulose; permeability; indomethacin; gender; microbiome	NONSTEROIDAL ANTIINFLAMMATORY DRUG; IRRITABLE-BOWEL-SYNDROME; ESTROGEN-RECEPTOR-BETA; ILEAL ULCER FORMATION; GASTROINTESTINAL-TRACT; INDUCED ENTEROPATHY; CAPSULE ENDOSCOPY; GUT PERMEABILITY; DOUBLE-BLIND; RATS	Intestinal barrier function and microbiota are integrally related and play critical roles in maintenance of host physiology. Sex is a key biologic variable for several disorders. Our aim was to determine sex-based differences in response to perturbation and subsequent recovery of intestinal barrier function and microbiota in healthy humans. Twenty-three volunteers underwent duodenal biopsies, mucosal impedance, and in vivo permeability measurement. Permeability testing was repeated after administration of indomethacin, then 4 to 6 wk after its discontinuation. Duodenal and fecal microbiota composition was determined using 16S rRNA amplicon sequencing. Healthy women had lower intestinal permeability and higher duodenal and fecal microbial diversity than healthy men. Intestinal permeability increases after indomethacin administration in both sexes. However, only women demonstrated decreased fecal microbial diversity, including an increase in Prevotella abundance, after indomethacin administration. Duodenal microbiota composition did not show sex-specific changes. The increase in permeability and microbiota changes normalized after discontinuation of indomethacin. In summary, women have lower intestinal permeability and higher microbial diversity. Intestinal permeability is sensitive to perturbation but recovers to baseline. Gut microbiota in women is sensitive to perturbation but appears to be more stable in men. Sex-based differences in intestinal barrier function and microbiome should be considered in future studies.Edogawa, S., Peters, S. A., Jenkins, G. D., Gurunathan, S. V., Sundt, W. J., Johnson, S., Lennon, R. J., Dyer, R. B., Camilleri, M., Kashyap, P. C., Farrugia, G., Chen, J., Singh, R. J., Grover, M. Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota.	[Edogawa, Shoko; Peters, Stephanie A.; Gurunathan, Sakteesh V.; Sundt, Wendy J.; Camilleri, Michael; Kashyap, Purna C.; Grover, Madhusudan] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Jenkins, Gregory D.; Johnson, Stephen; Lennon, Ryan J.; Chen, Jun] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Jenkins, Gregory D.; Johnson, Stephen] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Dyer, Roy B.; Singh, Ravinder J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Farrugia, Gianrico] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Grover, M (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Physiol & Biomed Engn, Enter NeuroSci Program, 200 First St SW, Rochester, MN 55905 USA.	grover.madhusudan@mayo.edu		Peters, Stephanie/0000-0001-9241-1533	Mayo Clinic Department of Laboratory Medicine and Pathology, Mayo Clinic Division of Gastroenterology and Hepatology; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23 DK103911]; Mayo Clinic Center for Individualized Medicine; Takeda; Ironwood; Napo; DongA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK103911, P30DK084567] Funding Source: NIH RePORTER	Mayo Clinic Department of Laboratory Medicine and Pathology, Mayo Clinic Division of Gastroenterology and Hepatology; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Mayo Clinic Center for Individualized Medicine; Takeda(Takeda Pharmaceutical Company Ltd); Ironwood; Napo; DongA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank L. Anderson (Mayo Clinic) for administrative assistance. This project was funded by grants from the Mayo Clinic Department of Laboratory Medicine and Pathology, Mayo Clinic Division of Gastroenterology and Hepatology, and by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant K23 DK103911 (to M.G.). J.C. is supported by Mayo Clinic Center for Individualized Medicine. M.G. has served on the advisory board or received research support from Takeda, DongA, Ironwood, and Napo. The remaining authors declare no conflicts of interest.	Baldwin EA, 2015, PEERJ, V3, DOI 10.7717/peerj.1398; Basivireddy J, 2005, INT J BIOCHEM CELL B, V37, P2321, DOI 10.1016/j.biocel.2005.05.010; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; BJARNASON I, 1992, GUT, V33, P1204, DOI 10.1136/gut.33.9.1204; Bjarnason I, 2018, GASTROENTEROLOGY, V154, P500, DOI 10.1053/j.gastro.2017.10.049; Blackler RW, 2015, BRIT J PHARMACOL, V172, P992, DOI 10.1111/bph.12961; Bokulich NA, 2016, CLIN MICROBIOL INFEC, V22, P464, DOI 10.1016/j.cmi.2016.01.013; Braniste V, 2009, J PHYSIOL-LONDON, V587, P3317, DOI 10.1113/jphysiol.2009.169300; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Chen J, BIORXIV; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cremonini F, 2005, GASTROENTEROL CLIN N, V34, P189, DOI 10.1016/j.gtc.2005.02.008; Diebel ME, 2015, J TRAUMA ACUTE CARE, V78, P94, DOI 10.1097/TA.0000000000000499; Edogawa S, 2015, DIGESTION, V92, P99, DOI 10.1159/000437395; Endo H, 2011, J GASTROENTEROL, V46, P894, DOI 10.1007/s00535-011-0410-1; Farhadi A, 2010, ALCOHOL, V44, P447, DOI 10.1016/j.alcohol.2010.05.004; France MM, 2017, J CELL SCI, V130, P307, DOI 10.1242/jcs.193482; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Grover M, 2016, NEUROGASTROENT MOTIL, V28, P1114, DOI 10.1111/nmo.12802; Hagiwara Mari, 2004, Journal of Medical Investigation, V51, P43, DOI 10.2152/jmi.51.43; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Homma H, 2005, AM J PHYSIOL-GASTR L, V288, pG466, DOI 10.1152/ajpgi.00036.2004; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Kelly P, 2004, AM J TROP MED HYG, V70, P412; KENT TH, 1969, AM J PATHOL, V54, P237; Kinouchi T, 1998, MICROBIOL IMMUNOL, V42, P347, DOI 10.1111/j.1348-0421.1998.tb02294.x; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Koga H, 1999, AM J PHYSIOL-GASTR L, V276, pG576, DOI 10.1152/ajpgi.1999.276.3.G576; Kosek MN, 2017, J PEDIATR GASTR NUTR, V65, P31, DOI 10.1097/MPG.0000000000001610; Lanas A, 2006, DIGESTION, V73, P136, DOI 10.1159/000089789; Leffler DA, 2012, AM J GASTROENTEROL, V107, P1554, DOI 10.1038/ajg.2012.211; Leite AZA, 2001, GUT, V48, P163, DOI 10.1136/gut.48.2.163; Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; Lue A, 2016, WORLD J GASTROENTERO, V22, P10477, DOI 10.3748/wjg.v22.i48.10477; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Montalto M, 2010, ALIMENT PHARM THER, V32, P209, DOI 10.1111/j.1365-2036.2010.04324.x; Moussa L, 2013, CLIN NUTR, V32, P51, DOI 10.1016/j.clnu.2012.05.021; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Peters SA, 2017, AM J GASTROENTEROL, V112, P913, DOI 10.1038/ajg.2017.48; Pigrau M, 2016, NEUROGASTROENT MOTIL, V28, P463, DOI 10.1111/nmo.12717; Rao AS, 2011, AM J PHYSIOL-GASTR L, V301, pG919, DOI 10.1152/ajpgi.00168.2011; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; ROBERT A, 1977, PROSTAGLANDINS, V14, P333, DOI 10.1016/0090-6980(77)90178-2; Rogers M. A., 2016, CLIN MICROBIOL INFEC, V22, pe1, DOI 10.1016/j.cmi.2015.10.003; Scarpignato C, 2017, GASTROENTEROLOGY, V152, P980, DOI 10.1053/j.gastro.2016.12.007; Shaikh M, 2015, CLIN CHIM ACTA, V442, P24, DOI 10.1016/j.cca.2014.12.040; Sigthorsson G, 1998, GUT, V43, P506, DOI 10.1136/gut.43.4.506; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Sugimori S, 2008, DIGESTION, V78, P208, DOI 10.1159/000190403; Syer SD, 2015, J GASTROENTEROL, V50, P387, DOI 10.1007/s00535-014-1032-1; Uejima M, 1996, MICROBIOL IMMUNOL, V40, P553, DOI 10.1111/j.1348-0421.1996.tb01108.x; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008	58	25	25	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6615	6625		10.1096/fj.201800560R	http://dx.doi.org/10.1096/fj.201800560R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29897814	Bronze, Green Published			2022-12-28	WOS:000449359700021
J	Liu, HS; Xue, Q; Cao, WJ; Yang, F; Ma, LN; Liu, WJ; Zhang, KS; Liu, XT; Zhu, ZX; Zheng, HX				Liu, Huisheng; Xue, Qiao; Cao, Weijun; Yang, Fan; Ma, Linna; Liu, Wenjie; Zhang, Keshan; Liu, Xiangtao; Zhu, Zixiang; Zheng, Haixue			Foot-and-mouth disease virus nonstructural protein 2B interacts with cyclophilin A, modulating virus replication	FASEB JOURNAL			English	Article						3A; protein interaction; innate immunity; cyclosporine A	BETA SIGNALING PATHWAY; INFLUENZA-A VIRUS; STRUCTURAL PROTEIN; SECRETORY PATHWAY; INFECTION; BINDING; 3A; SYSTEM; TARGET; GENES	Foot-and-mouth disease (FMD) is a highly contagious virus that affects cloven-hoofed animals. To understand better the role of nonstructural protein 2B of the causative agent FMD virus (FMDV) in the process of virus replication, we identified a porcine host protein, cyclophilin A (CypA), which interacts with FMDV 2B. The 2B-CypA interaction was confirmed by coimmunoprecipitation and GST pull-down assays. CypA showed antiviral functions during FMDV infection. Overexpression of CypA decreased FMDV leader protein (L-pro) and 3A at protein levels. CypA-induced reduction of L-pro enhanced the synthesis of host proteins and increased the integrality of host eukaryotic translation initiation factor (eIF)-4 (eIF4G). The reduction of L-pro and 3A was dependent on the proteasome pathway. No interaction was identified between CypA and L-pro or 3A. However, CypA-induced reduction of L-pro and 3A was suppressed by 2B, and disruption of 2B-CypA interaction impaired this inhibitive effect induced by 2B. In summary, our findings identify the antiviral role of CypA against FMDV and provide key insights into how FMDV antagonizes host antiviral response by 2B protein.Liu, H., Xue, Q., Cao, W., Yang, F., Ma, L., Liu, W., Zhang, K., Liu, X., Zhu, Z., Zheng, H. Foot-and-mouth disease virus nonstructural protein 2B interacts with cyclophilin A, modulating virus replication.	[Liu, Huisheng; Xue, Qiao; Cao, Weijun; Yang, Fan; Ma, Linna; Liu, Wenjie; Zhang, Keshan; Liu, Xiangtao; Zhu, Zixiang; Zheng, Haixue] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Natl Foot & Mouth Dis Reference Lab,Key Lab Anim, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Zhu, ZX; Zheng, HX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, 1 Xujiaping Rd, Lanzhou 730046, Gansu, Peoples R China.	zhuzixiang@126.com; haixuezheng@163.com			Facility Center Department, Lanzhou Veterinary Research Institute; National Natural Sciences Foundation of China [U1501213, 31672585]; Gansu Science Foundation [1606RJYA280, 1606RJDA313]	Facility Center Department, Lanzhou Veterinary Research Institute; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Science Foundation	The authors thank the Facility Center Department, Lanzhou Veterinary Research Institute for support during the course of the work. This work was supported by the National Natural Sciences Foundation of China Grants U1501213 (to X.L.) and 31672585 (to H.Z.); Gansu Science Foundation for Distinguished Young Scholars Grant 1606RJDA313 (to Z.Z.); and the Gansu Science Foundation for Young Scholars Grant 1606RJYA280 (to F.Y.). The authors declare no conflicts of interest.	BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Bobardt M, 2013, J HEPATOL, V58, P16, DOI 10.1016/j.jhep.2012.08.007; Cai YuHan, 2015, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V45, P686; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai H., 2013, THESIS; Dai YaJuan, 2012, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V34, P432; Dawar FU, 2017, CURR ISSUES MOL BIOL, V21, P1, DOI 10.21775/cimb.021.001; de Wilde AH, 2013, J VIROL, V87, P1454, DOI 10.1128/JVI.02078-12; Du YJ, 2014, J VIROL, V88, P4908, DOI 10.1128/JVI.03668-13; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gladue DP, 2014, J VIROL, V88, P2737, DOI 10.1128/JVI.03059-13; Gladue DP, 2013, J VIROL, V87, P6794, DOI 10.1128/JVI.00448-13; Gladue DP, 2012, J VIROL, V86, P12080, DOI 10.1128/JVI.01610-12; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; He HY, 2013, PROTEOMICS, V13, P1121, DOI 10.1002/pmic.201100579; He HY, 2012, BIOCHEM BIOPH RES CO, V422, P664, DOI 10.1016/j.bbrc.2012.05.050; Hopkins S, 2015, BBA-GEN SUBJECTS, V1850, P2103, DOI 10.1016/j.bbagen.2014.11.011; Lei Y., 2014, THESIS; Li D, 2016, FASEB J, V30, P1757, DOI 10.1096/fj.15-281410; Li D, 2016, CELL CYCLE, V15, P850, DOI 10.1080/15384101.2016.1151584; Li D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21888; Li J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28978; Li XY, 2013, VET MICROBIOL, V166, P35, DOI 10.1016/j.vetmic.2013.04.028; Liu W, 2017, ELIFE, V6, DOI 10.7554/eLife.24425; Liu XL, 2013, VIRUSES-BASEL, V5, P182, DOI 10.3390/v5010182; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037277; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031063; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; Liu YQ, 2015, VET RES, V46, DOI 10.1186/s13567-015-0273-1; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Moffat K, 2005, J VIROL, V79, P4382, DOI 10.1128/JVI.79.7.4382-4395.2005; Moffat K, 2007, J VIROL, V81, P1129, DOI 10.1128/JVI.00393-06; Moraes MP, 2011, VACCINE, V29, P9431, DOI 10.1016/j.vaccine.2011.10.037; Mu H. F., 2017, ACTA MICROBIOLOGICA, P1; Park SJ, 2015, GENE, V558, P152, DOI 10.1016/j.gene.2014.12.052; Qing J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004422; Rai DK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0452-8; Russi S, 2017, J SYNCHROTRON RADIAT, V24, P73, DOI 10.1107/S1600577516017343; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sun SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102541; Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Wang N., 2015, BIOMED RES INT, V2015; Yang X, 2014, J GEN VIROL, V95, P1330, DOI 10.1099/vir.0.063644-0; Zheng HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055228; Zhu ZX, 2016, J VIROL, V90, P11106, DOI 10.1128/JVI.01310-16; Zhu ZX, 2013, BIOCHEM BIOPH RES CO, V436, P204, DOI 10.1016/j.bbrc.2013.05.074; Zhu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055920	50	15	16	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6706	6723		10.1096/fj.201701351	http://dx.doi.org/10.1096/fj.201701351			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906248	Bronze			2022-12-28	WOS:000449359700028
J	Tang, TT; Yang, ZC; Zhu, QH; Wu, Y; Sun, K; Alahdal, M; Zhang, YF; Xing, Y; Shen, YM; Xia, TS; Xi, T; Pan, Y; Jin, L				Tang, Tingting; Yang, Zhaocong; Zhu, Qinhua; Wu, You; Sun, Kun; Alahdal, Murad; Zhang, Yanfeng; Xing, Yun; Shen, Yumeng; Xia, Tiansong; Xi, Tao; Pan, Yi; Jin, Liang			Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cell metastasis, proliferation, and self-renewal by targeting E-cadherin	FASEB JOURNAL			English	Article						3D semi-solid culture; microRNA; MCF-7; EMT	EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; MICRORNAS; SURVIVAL; INVASION; GROWTH; ASSAY	Breast cancer stem cells (BCSCs), a small subset of breast cancer cells with stem cell-like properties, are essential in tumor formation, metastasis, resistance to anticancer therapies, and cancer recurrence. MicroRNAs (miRNAs) are involved in tumorigenicity by regulating specific oncogenes and tumor-suppressor genes, and their roles in BCSCs are becoming apparent. A novel, 3-dimensional (3D), semisolid culture system was established to culture MCF-7 spheroid cells with high percentage of BCSCs. The differences in miRNA expression among the MCF-7 parental cells, BCSC-enriched MCF-7 spheroid cells, and CD44(+)/CD24(-) MCF-7 cells were evaluated by miRNA microarray, and the high expression of miR-210 in MCF-7 spheroid cells and CD44(+)/CD24(-) MCF-7 cells was verified by quantitative RT-PCR. MCF-7 cells were cultured in a hypoxic chamber to detect the effect of hypoxia on miR-210 expression and the stemness of the cells. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), transwell, and sphere-formation assays were performed to detect the proliferation, migration, and self-renewal ability of miR-210-overexpressed MCF-7 cells and MCF-7 spheroid cells with miR-210 knocked down. The target of miR-210 was validated with a dual-luciferase reporter assay and Western blotting. In vivo xenograft assay and metastasis assay were performed to study the effects of miR-210 targeting E-cadherin on BCSCs growth and lung metastasis, and the tumors were assessed by immunohistochemistry and immunofluorescence. We developed a novel 3D, semisolid culture system to culture MCF-7 spheroid cells, which are enriched in BCSCs, and found, by performing miRNAs expression profiling, miR-210 was up-regulated in those cells compared with MCF-7 parental cells. High miR-210 expression was also detected in CD44(+)/CD24(-) MCF-7 cells and human CD44(+)/CD24(-) breast cancer cells, which was demonstrated to be partially due to the hypoxic microenvironment around BCSCs in MCF-7 spheroids or solid tumors. Ectopic expression of miR-210 in MCF-7 cells promoted their migration, invasion, proliferation, and self-renewal in both in vitro and in vivo studies. We further reported that miR-210 suppressed E-cadherin expression by targeting the open reading frame region of E-cadherin mRNA and by up-regulation of E-cadherin transcription repressor, Snail. Accordingly, E-cadherin overexpression compromises the migration, invasion, proliferation, and self-renewal ability of miR-210-overexpressed MCF-7 both in vitro and in vivo. These findings reveal a novel regulatory pathway centered on hypoxia-mediated miR-210 targeting of E-cadherin, which contributes to the properties and breast tumorigenesis of BCSCs.Tang, T., Yang, Z., Zhu, Q., Wu, Y., Sun, K., Alahdal, M., Zhang, Y., Xing, Y., Shen, Y., Xia, T., Xi, T., Pan, Y., Jin, L. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cell metastasis, proliferation, and self-renewal by targeting E-cadherin.	[Tang, Tingting; Yang, Zhaocong; Zhu, Qinhua; Wu, You; Alahdal, Murad; Zhang, Yanfeng; Xing, Yun; Shen, Yumeng; Xi, Tao; Pan, Yi; Jin, Liang] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Druggabil Biopharmaceut, 24 Tongjia Lane, Nanjing 210009, Jiangsu, Peoples R China; [Sun, Kun] Nanjing 3 Senior Sch, Nanjing, Jiangsu, Peoples R China; [Xia, Tiansong] Nanjing Med Univ, Affiliated Hosp 1, Breast Dis Ctr Jiangsu Prov, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing Medical University	Pan, Y; Jin, L (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Druggabil Biopharmaceut, 24 Tongjia Lane, Nanjing 210009, Jiangsu, Peoples R China.	panyi@cpu.edu.cn; ljstemcell@cpu.edu.cn	Pan, Yi/AAJ-2341-2021; Alahdal, Murad/AAO-2213-2020	Alahdal, Murad/0000-0003-1444-6014; Xi, Tao/0000-0001-8065-2639; Pan, Yi/0000-0002-5742-3202	National Natural Science Foundation of China [81570696, 81702941, 81202077]; Qing Lan Project; Program for Jiangsu Province Innovative Research Team; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu [BK20171506]; Fundamental Research Funds for the Central Universities [2016ZPY010, 2632017PY06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qing Lan Project(Jiangsu Polytech Institute); Program for Jiangsu Province Innovative Research Team; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to Huiqian Huang (California Institute of Technology, Pasadena, CA, USA) for critical reviewing and editing of the paper as well as providing some scientific advice. This project was funded by the National Natural Science Foundation of China (Grants 81570696, 81702941, and 81202077), and was supported by the Qing Lan Project, the Program for Jiangsu Province Innovative Research Team, the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Natural Science Foundation of Jiangsu (Grant BK20171506), and the Fundamental Research Funds for the Central Universities (Grants 2016ZPY010 and 2632017PY06). All data generated or analyzed during this study have been included in this published article and its Supplemental Information files. The authors declare no conflicts of interest.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bertoli G, 2015, THERANOSTICS, V5, P1122, DOI 10.7150/thno.11543; Boo L, 2016, INT J BIOL SCI, V12, P427, DOI 10.7150/ijbs.12777; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Corn PG, 2008, CANCER BIOL THER, V7, P265, DOI 10.4161/cbt.7.2.5745; Ding L, 2015, INT J CLIN EXP MED, V8, P2299; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Hajra KM, 2002, CANCER RES, V62, P1613; Hong L, 2012, GENE, V507, P135, DOI 10.1016/j.gene.2012.07.025; Hwang-Verslues WW, 2011, ONCOGENE, V30, P2463, DOI 10.1038/onc.2010.618; Imamura Y, 2015, ONCOL REP, V33, P1837, DOI 10.3892/or.2015.3767; Jin L, 2013, P NATL ACAD SCI USA, V110, P3907, DOI 10.1073/pnas.1301889110; Kim JH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.117; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Liu DY, 2016, ONCOTARGETS THER, V9, P5245, DOI 10.2147/OTT.S110969; Liu SL, 2012, J MAMMARY GLAND BIOL, V17, P15, DOI 10.1007/s10911-012-9242-8; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakashima S, 2017, EUR J DERMATOL, V27, P464, DOI 10.1684/ejd.2017.3084; Pan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25798; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schwarzenbacher D, 2013, INT J MOL SCI, V14, P14712, DOI 10.3390/ijms140714712; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singhai R, 2011, N AM J MED SCI, V3, P227, DOI 10.4297/najms.2011.3227; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Takahashi RU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8318; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang XM, 2017, AM J CANCER RES, V7, P1738; Zhang Y, 2017, CANCER BIOTHER RADIO, V32, P297, DOI 10.1089/cbr.2017.2270	37	56	57	1	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6965	6981		10.1096/fj.201801013R	http://dx.doi.org/10.1096/fj.201801013R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30188754	Bronze			2022-12-28	WOS:000449359700047
J	Yang, CY; Chiu, LL; Chang, CC; Chuang, HC; Tan, TH				Yang, Chia-Yu; Chiu, Li-Li; Chang, Chih-Chi; Chuang, Huai-Chia; Tan, Tse-Hua			Induction of DUSP14 ubiquitination by PRMT5-mediated arginine methylation	FASEB JOURNAL			English	Article						TCR signaling; MKP6; TAB1; TAK1; TRAF2	SPECIFICITY PHOSPHATASE 14; T-CELL DEVELOPMENT; PROTEIN METHYLATION; KINASE; DEFICIENCY; PHOSPHORYLATION; ACTIVATION; SUPPRESSOR; EXPRESSION; REGULATOR	Dual-specificity phosphatase (DUSP)14 (also known as MAP-kinase phosphatase 6) inhibits T-cell receptor (TCR) signaling and T-cell-mediated immune responses by inactivation of the TGF- activated kinase 1 binding protein (TAB1)-TGF- activated kinase 1 (TAK1) complex and ERK. DUSP14 phosphatase activity is induced by the E3 ligase TNF receptor associated factor (TRAF)2-mediated Lys63-linked ubiquitination. Here we report an interaction between DUSP14 and protein arginine methyltransferase (PRMT)5 by proximity ligation assay; similarly, DUSP14 directly interacted with TAB1 but not TAK1. DUSP14 is methylated by PRMT5 at arginine 17, 38, and 45 residues. The DUSP14 triple-methylation mutant was impaired in PRMT5-mediated arginine methylation, TRAF2-mediated lysine ubiquitination, and DUSP14 phosphatase activity. Consistently, DUSP14 methylation, TRAF2 binding, and DUSP14 ubiquitination were attenuated by PRMT5 short hairpin RNA knockdown. Furthermore, DUSP14 was inducibly interacted with PRMT5 and was methylated during TCR signaling in T cells. Together, these findings reveal a novel regulatory mechanism of DUSP14 by which PRMT5-mediated arginine methylation may sequentially stimulate TRAF2-mediated DUSP14 ubiquitination and phosphatase activity, leading to inhibition of TCR signaling.Yang, C.-Y., Chiu, L.-L., Chang, C.-C., Chuang, H.-C., Tan, T.-H. Induction of DUSP14 ubiquitination by PRMT5-mediated arginine methylation.	[Yang, Chia-Yu; Chang, Chih-Chi; Chuang, Huai-Chia; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan; [Chiu, Li-Li] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; Baylor College of Medicine	Chuang, HC; Tan, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	cinth@nhri.org.tw; ttan@nhri.org.tw	Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021; Chuang, Huai-Chia/E-9486-2016	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; 	National Health Research Institutes of Taiwan [IM-105-PP-01, IM-105-SP-01]; Taiwan Ministry of Science and Technology [105-2314-B-400-027, 106-2321-B-400-013]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Taiwan Ministry of Science and Technology	The authors thank the Institute of Biological Chemistry (Academia Sinica, Taipei City, Taiwan) for use of its LTQ-Orbitrap XL hybrid mass spectrometer to analyze the proteomics data. This work was supported by grants from the National Health Research Institutes of Taiwan (IM-105-PP-01 and IM-105-SP-01 to T.-H.T.), and the Taiwan Ministry of Science and Technology (105-2314-B-400-027 and 106-2321-B-400-013 to T.-H.T.). The authors declare no conflicts of interest.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chen YR, 2017, ONCOGENE, V36, P6509, DOI 10.1038/onc.2017.255; Chuang HC, 2016, ONCOTARGET, V7, P57593, DOI 10.18632/oncotarget.11419; Chuang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5602; Elkouris M, 2016, CELL REP, V15, P2733, DOI 10.1016/j.celrep.2016.05.051; Hu D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9419; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Huang CY, 2012, EUR J IMMUNOL, V42, P476, DOI 10.1002/eji.201041295; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Lountos GT, 2009, ACTA CRYSTALLOGR D, V65, P1013, DOI 10.1107/S0907444909023762; Marti F, 2001, J IMMUNOL, V166, P197, DOI 10.4049/jimmunol.166.1.197; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Ruan JW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.220; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Sipos A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40590; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Waller H, 2010, J VIROL METHODS, V165, P202, DOI 10.1016/j.jviromet.2010.01.020; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Wang SY, 2018, HEPATOLOGY, V67, P1320, DOI 10.1002/hep.29616; Wang XH, 2012, J BIOL CHEM, V287, P11037, DOI 10.1074/jbc.M111.310946; Wilczek C, 2011, J BIOL CHEM, V286, P42221, DOI 10.1074/jbc.M111.303677; Yang CY, 2016, CELL SIGNAL, V28, P145, DOI 10.1016/j.cellsig.2015.10.017; Yang CY, 2014, J IMMUNOL, V192, P1547, DOI 10.4049/jimmunol.1300989; Yang JH, 2014, NUCLEIC ACIDS RES, V42, P9908, DOI 10.1093/nar/gku705; Zheng H, 2013, J BIOL CHEM, V288, P819, DOI 10.1074/jbc.M112.412643	32	13	13	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6760	6770		10.1096/fj.201800244RR	http://dx.doi.org/10.1096/fj.201800244RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29920217	Green Published			2022-12-28	WOS:000449359700031
J	Zhao, L; Lu, ZG; He, X; Mughal, MN; Fang, R; Zhou, YQ; Zhao, JL; Gasser, RB; Grevelding, CG; Ye, Q; Hu, M				Zhao, Lu; Lu, Zhigang; He, Xin; Mughal, Mudassar N.; Fang, Rui; Zhou, Yanqin; Zhao, Junlong; Gasser, Robin B.; Grevelding, Christoph G.; Ye, Qing; Hu, Min			Serine/threonine protein phosphatase 1 (PP1) controls growth and reproduction in Schistosoma japonicum	FASEB JOURNAL			English	Article						catalytic subunits; RNA interference; transcriptomics; development; reproductive maturation	RNA INTERFERENCE; IN-VITRO; MANSONI; EXPRESSION; SPERMATOGENESIS; IDENTIFICATION; REGENERATION; CYTOKINESIS; SENSITIVITY; PROSPECTS	Schistosomiasis is a human parasitic disease caused by flatworms of the genus Schistosoma. Adult female schistosomes produce numerous eggs that are responsible for the pathogenesis and transmission of the disease, and the maturation of female gonads depends on the permanent pairing of females and males. Signaling protein kinases have been proven to control female gonad differentiation after pairing; however, little is known about the roles of protein phosphatases in the developmental and reproductive biology of schistosomes. Here we explored 3 genes encoding catalytic subunits of serine/threonine protein phosphatase 1 (PP1c) that were structurally and evolutionarily conserved in Schistosoma japonicum. In situ hybridization showed transcripts of 3 Sj-pp1c genes mainly localized in the reproductive organs and tissues. Triple knockdown of Sj-pp1c genes by RNA interference caused stunted growth and decreased pairing stability of worm pairs, as well as a remarkable reduction in cell proliferation activity and defects in reproductive maturation and fecundity. Transcriptomic analysis post-RNA interference suggested that Sj-pp1c genes are involved in controlling worm development and maturation mainly by regulating cell proliferation, eggshell synthesis, nutritional metabolism, cytoskeleton organization, and neural process. Our study provides the first insight into the fundamental contribution of Sj-PP1c to molecular mechanisms underlying the reproductive biology of schistosomes.Zhao, L., Lu, Z., He, X., Mughal, M. N., Fang, R., Zhou, Y., Zhao, J., Gasser, R. B., Grevelding, C. G., Ye, Q., Hu, M. Serine/threonine protein phosphatase 1 (PP1) controls growth and reproduction in Schistosoma japonicum.	[Zhao, Lu; He, Xin; Mughal, Mudassar N.; Fang, Rui; Zhou, Yanqin; Zhao, Junlong; Gasser, Robin B.; Ye, Qing; Hu, Min] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China; [Lu, Zhigang; Grevelding, Christoph G.] Justus Liebig Univ, Inst Parasitol, Biomed Res Ctr Seltersberg BFS, Giessen, Germany; [Gasser, Robin B.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia	Huazhong Agricultural University; Justus Liebig University Giessen; University of Melbourne	Ye, Q; Hu, M (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.	qingye198173@163.com; mhu@mail.hzau.edu.cn	Mughal, Mudassar N/M-7589-2015; Gasser, Robin/ABH-6185-2020	Gasser, Robin/0000-0002-4423-1690; Lu, Zhigang/0000-0001-6553-5944; Zhao, Lu/0000-0003-4996-660X	National Key Basic Research Program (973 Program) of China [2015CB150300]; Fundamental Research Funds for the Central Universities [2662017PY084]; National Natural Science Foundation [31201897]; Huazhong Agricultural University Scientific and Technology Self-Innovation Foundation [2015RC005]; LOEWE Center Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases (DRUID) within the Hessian Excellence Initiative (Justus Liebig Universit); Natural Science Foundation of Hubei Province [2017CFA020]	National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University Scientific and Technology Self-Innovation Foundation; LOEWE Center Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases (DRUID) within the Hessian Excellence Initiative (Justus Liebig Universit); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The authors thank Prof. Kemei Peng (College of Veterinary Medicine, Huazhong Agricultural University) for technical assistance. They also thank Novogene Bioinformatics Technology Co. (Beijing, China) for RNA-seq library construction and bioinformatics analysis through a service contract. This work was supported by the National Key Basic Research Program (973 Program) of China (Grant 2015CB150300) and the Fundamental Research Funds for the Central Universities (Grant 2662017PY084; to M.H.), by the National Natural Science Foundation (Grant 31201897; to Q.Y.), by funds from Huazhong Agricultural University Scientific and Technology Self-Innovation Foundation (Program 2015RC005; to R.B.G.), and the LOEWE Center Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases (DRUID) within the Hessian Excellence Initiative (Justus Liebig Universit; to C.G.G.). This work was also supported by the Natural Science Foundation of Hubei Province (Grant 2017CFA020; to M.H., R.F., Y.Z., and J.Z.). The authors declare no conflicts of interest.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Adam C, 2010, DEV GENES EVOL, V220, P123, DOI 10.1007/s00427-010-0332-6; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P53; BAIROCH A, 1993, NUCLEIC ACIDS RES, V21, P3097, DOI 10.1093/nar/21.13.3097; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Braschi S, 2006, MEM I OSWALDO CRUZ, V101, P205, DOI 10.1590/S0074-02762006000900032; Cai PF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004684; Campbell BE, 2011, BIOTECHNOL ADV, V29, P28, DOI 10.1016/j.biotechadv.2010.08.008; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen P. H., 1995, CULTIVATION IN VITRO; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; Cogswell AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001907; Cogswell AA, 2011, MOL BIOCHEM PARASIT, V178, P46, DOI 10.1016/j.molbiopara.2011.03.001; Cohen PTW, 2002, J CELL SCI, V115, P241; Collins JJ, 2013, NATURE, V494, P476, DOI 10.1038/nature11924; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; Daher W, 2006, BIOCHEM J, V395, P433, DOI 10.1042/BJ20051597; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Diniz PP, 2014, ACTA TROP, V140, P193, DOI 10.1016/j.actatropica.2014.09.006; Dombradi V., 2003, PROTEIN PHOSPHATASES, P21; Gelmedin V, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006147; Grevelding CG, 2018, TRENDS PARASITOL, V34, P246, DOI 10.1016/j.pt.2017.12.001; Hahnel S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00170; Jayashankar V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075766; Jones MK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000334; Kirchner J, 2007, GENETICS, V176, P273, DOI 10.1534/genetics.106.069914; Korrodi-Gregorio L, 2014, TRANSL RES, V164, P366, DOI 10.1016/j.trsl.2014.07.001; Kumar Rajinder, 2002, Malar J, V1, P5, DOI 10.1186/1475-2875-1-5; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; Lee KY, 2014, BIOCHEM BIOPH RES CO, V448, P385, DOI 10.1016/j.bbrc.2014.04.109; Lin Q, 1999, MOL PHYLOGENET EVOL, V12, P57, DOI 10.1006/mpev.1998.0560; Liu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003856; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep31150; Ma GX, 2015, ACTA TROP, V149, P148, DOI 10.1016/j.actatropica.2015.05.026; McManus DR, 2001, VACCINE, V20, P870, DOI 10.1016/S0264-410X(01)00405-4; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Morales ME, 2008, MOL BIOCHEM PARASIT, V157, P160, DOI 10.1016/j.molbiopara.2007.10.009; Myers J. L., 2010, RES DESIGN STAT ANAL; Orr GA, 2000, INFECT IMMUN, V68, P1350, DOI 10.1128/IAI.68.3.1350-1358.2000; Patocka N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003878; Patocka N, 2013, MOL BIOCHEM PARASIT, V187, P32, DOI 10.1016/j.molbiopara.2012.11.008; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Pereira TC, 2008, EXP PARASITOL, V118, P619, DOI 10.1016/j.exppara.2007.11.017; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Pica-Mattoccia L, 2004, INT J PARASITOL, V34, P527, DOI 10.1016/j.ijpara.2003.12.003; Pica-Mattoccia L, 2009, ACTA TROP, V111, P82, DOI 10.1016/j.actatropica.2009.01.012; Raghavan S, 2000, CURR BIOL, V10, P269, DOI 10.1016/S0960-9822(00)00364-X; Ribeiro P, 2010, CAN J ZOOL, V88, P1, DOI 10.1139/Z09-126; Rouhana L, 2010, DEV BIOL, V341, P429, DOI 10.1016/j.ydbio.2010.02.037; Shalaby KA, 2003, VACCINE, V22, P130, DOI 10.1016/s0264-410X(03)00535-8; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Silva Joana V, 2014, Curr Mol Pharmacol, V7, P136; Sinha N, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110239; Skelly PJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004246; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tebeje BM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1799-4; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Wang JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14693; Wang JP, 2016, INT J PARASITOL, V46, P405, DOI 10.1016/j.ijpara.2016.03.004; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; Wasilewski MM, 1996, MOL BIOCHEM PARASIT, V81, P179, DOI 10.1016/0166-6851(96)02703-X; Poh WT, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130138; Wu JC, 2012, GENETICS, V190, P143, DOI 10.1534/genetics.111.135376; Xiao Xiang, 2007, Journal of Zhejiang University-Science B, V8, P498, DOI 10.1631/jzus.2007.B0498; Xiong YN, 2013, PARASITOL INT, V62, P522, DOI 10.1016/j.parint.2013.07.008; Xiong YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066396; Yang Wen, 1997, Parasitology International, V46, P45, DOI 10.1016/S1383-5769(97)00008-1; Yang YX, 2012, PARASITOL RES, V111, P1251, DOI 10.1007/s00436-012-2959-x; Yokoyama D, 1998, BIOCHEM BIOPH RES CO, V247, P18, DOI 10.1006/bbrc.1998.8730; You H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003254; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao L, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2524-7; Zhong Fei, 2004, Chinese Journal of Zoonoses, V20, P561	82	6	6	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6626	6642		10.1096/fj.201800725R	http://dx.doi.org/10.1096/fj.201800725R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29879373	Bronze			2022-12-28	WOS:000449359700022
J	Alhouayek, M; Buisseret, B; Paquot, A; Guillemot-Legris, O; Muccioli, GG				Alhouayek, Mireille; Buisseret, Baptiste; Paquot, Adrien; Guillemot-Legris, Owein; Muccioli, Giulio G.			The endogenous bioactive lipid prostaglandin D-2-glycerol ester reduces murine colitis via DP1 and PPAR gamma receptors	FASEB JOURNAL			English	Article						Crohn's disease; eicosanoids; prostanoid; 15d-PGJ2-G	INFLAMMATORY BOWEL DISEASES; ULCERATIVE-COLITIS; GLYCEROL ESTERS; COX-2 INHIBITOR; SULFONIC-ACID; CANCER-CELLS; COLON-CANCER; D-2; MICE; RATS	Cyclooxygenase-2 (COX-2) has long been implicated in the pathogenesis of inflammatory bowel diseases (IBDs). COX-2 is mostly known for the production of prostaglandins (PGs) from arachidonic acid. However, it also metabolizes the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide into the less well-studied bioactive lipids PG-glycerol esters (PG-Gs) and PG-ethanolamides (PG-EAs or prostamides). We previously showed that PGD(2)-G, a product of 2-AG oxygenation by COX-2, has anti-inflammatory effects. Therefore, we used the dextran sulfate sodium (DSS)-induced model of colitis in mice to explore the role of PGD(2)-G in murine models of IBD. Colon inflammation was assessed using macroscopic and histologic scores, myeloperoxidase activity, and expression of inflammatory mediators by real-time quantitative PCR and ELISA. We also compared the effects of PGD(2)-G with those of PGD(2) and PGD(2)-EA. Finally, we used receptor antagonists to gain mechanistic insight into the receptors responsible for the observed effects. PGD(2)-G reduced DSS-induced colitis, but PGD(2) and PGD(2)-EA did not have the same effect. Furthermore, we showed that PGD(2)-G is an agonist of the PGD(2) receptor 1 (DP1) and that some of the effects of PGD(2)-G were blocked by antagonism of peroxisome proliferator-activated receptor and DP1. Therefore, PGD(2)-G could be one of the products from the COX-2/prostaglandin D synthase axis to exert beneficial effects in colitis.Alhouayek, M., Buisseret, B., Paquot, A., Guillemot-Legris, O., Muccioli, G. G. The endogenous bioactive lipid prostaglandin D-2-glycerol ester reduces murine colitis via DP1 and PPAR receptors.	[Alhouayek, Mireille; Buisseret, Baptiste; Paquot, Adrien; Guillemot-Legris, Owein; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Bioanal & Pharmacol Bioact Lipids Lab B1 72 01, Ave E Mounier 72, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	Alhouayek, Mireille/R-5058-2018	Alhouayek, Mireille/0000-0002-9193-0718; Guillemot-Legris, Owein/0000-0003-3738-3423; Muccioli, Giulio/0000-0002-1600-9259	European Crohn's and Colitis Organisation (ECCO) [J.0071.15]; FRS-FNRS (Belgium); FRS-FNRS (Fonds National de la Recherche Scientifique), Belgium; European Crohn's and Colitis Organisation (ECCO); FRS-FNRS (Belgium) [J.0071.15]	European Crohn's and Colitis Organisation (ECCO); FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS (Fonds National de la Recherche Scientifique), Belgium(Fonds de la Recherche Scientifique - FNRS); European Crohn's and Colitis Organisation (ECCO); FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The MASSMET platform (https://uclouvain.be/en/research-institutes/ldri/massmet.html) is acknowledged for providing the access to the ultraperformance liquid chromatography-MS/MS. This work was supported by a grant from the European Crohn's and Colitis Organisation (ECCO) and Grant J.0071.15 from the FRS-FNRS (Belgium) to G.G.M. M.A. and O.G.-L. are postdoctoral researchers from the FRS-FNRS (Fonds National de la Recherche Scientifique), Belgium. The authors declare no conflicts of interest.	Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Alhouayek M, 2015, FASEB J, V29, P650, DOI 10.1096/fj.14-255208; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Alhouayek M, 2012, TRENDS MOL MED, V18, P615, DOI 10.1016/j.molmed.2012.07.009; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chicca A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0307-7; Cuzzocrea S, 2004, CRIT CARE MED, V32, P457, DOI 10.1097/01.CCM.0000109446.38675.61; Cuzzocrea S, 2003, BRIT J PHARMACOL, V138, P678, DOI 10.1038/sj.bjp.0705077; Galvez J, 2000, BRIT J PHARMACOL, V130, P1949, DOI 10.1038/sj.bjp.0703505; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Guillemot-Legris O, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0666-8; Hasenoehrl C, 2016, NEUROGASTROENT MOTIL, V28, P1765, DOI 10.1111/nmo.12931; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Iwanaga K, 2014, CANCER RES, V74, P3011, DOI 10.1158/0008-5472.CAN-13-2792; Izzo AA, 2015, HANDB EXP PHARMACOL, V231, P423, DOI 10.1007/978-3-319-20825-1_15; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li JJ, 2017, EMBO MOL MED, V9, P571, DOI 10.15252/emmm.201606987; Ligresti A, 2016, PHYSIOL REV, V96, P1593, DOI 10.1152/physrev.00002.2016; Manna JD, 2014, J BIOL CHEM, V289, P33741, DOI 10.1074/jbc.M114.582353; Martin AR, 2005, INFLAMM RES, V54, P145, DOI 10.1007/s00011-004-1337-2; Martin AR, 2003, EUR J PHARMACOL, V481, P281, DOI 10.1016/j.ejphar.2003.09.033; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Okayama M, 2007, DIGEST DIS SCI, V52, P2095, DOI 10.1007/s10620-006-9597-z; Patsos HA, 2005, GUT, V54, P1741, DOI 10.1136/gut.2005.073403; Patsos HA, 2010, INT J ONCOL, V37, P187, DOI 10.3892/ijo_00000666; Radnai B, 2016, J CROHNS COLITIS, V10, P1087, DOI 10.1093/ecco-jcc/jjw061; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Raman P, 2011, MOL PHARMACOL, V80, P201, DOI 10.1124/mol.110.070441; Paiotti APR, 2012, J MOL HISTOL, V43, P307, DOI 10.1007/s10735-012-9400-8; Ross RA, 2002, J PHARMACOL EXP THER, V301, P900, DOI 10.1124/jpet.301.3.900; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Savinainen JR, 2014, MOL PHARMACOL, V86, P522, DOI 10.1124/mol.114.094284; Sturino CF, 2007, J MED CHEM, V50, P794, DOI 10.1021/jm0603668; Sturm EM, 2014, J IMMUNOL, V193, P827, DOI 10.4049/jimmunol.1303484; Urquhart P, 2015, BBA-MOL CELL BIOL L, V1851, P366, DOI 10.1016/j.bbalip.2014.12.015; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Washida K, 2010, STROKE, V41, P1798, DOI 10.1161/STROKEAHA.110.583948; Witkamp R, 2016, EUR J PHARMACOL, V785, P96, DOI 10.1016/j.ejphar.2015.08.051; Zamuner SR, 2005, AM J PATHOL, V167, P1293, DOI 10.1016/S0002-9440(10)61216-3	50	16	17	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5000	5011		10.1096/fj.201701205R	http://dx.doi.org/10.1096/fj.201701205R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29630407				2022-12-28	WOS:000443817700031
J	Elattar, S; Dimri, M; Satyanarayana, A				Elattar, Sawsan; Dimri, Manali; Satyanarayana, Ande			The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting	FASEB JOURNAL			English	Article						cachexia; beige adipocyte; Ebf2; Prdm16; Ucp1	NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; PPAR-GAMMA; ZINC-ALPHA-2-GLYCOPROTEIN ZAG; FAT-CELL; ACTIVATION; CACHEXIA; SWITCH; INTERLEUKIN-6; ADIPOGENESIS	Cachexia is a complex tissue-wasting syndrome characterized by inflammation, hypermetabolism, increased energy expenditure, and anorexia. Browning of white adipose tissue (WAT) is one of the significant factors that contribute to energy wasting in cachexia. By utilizing a cell implantation model, we demonstrate here that the lipid mobilizing factor zinc-(2)-glycoprotein (ZAG) induces WAT browning in mice. Increased circulating levels of ZAG not only induced lipolysis in adipose tissues but also caused robust browning in WAT. Stimulating WAT progenitors with ZAG recombinant protein or expression of ZAG in mouse embryonic fibroblasts (MEFs) strongly enhanced brown-like differentiation. At the molecular level, ZAG stimulated peroxisome proliferator-activated receptor (PPAR) and early B cell factor 2 expression and promoted their recruitment to the PR/SET domain 16 (Prdm16) promoter, leading to enhanced expression of Prdm16, which determines brown cell fate. In brown adipose tissue, ZAG stimulated the expression of PPAR and PPAR coactivator 1 and promoted recruitment of PPAR to the uncoupling protein 1 (Ucp1) promoter, leading to increased expression of Ucp1. Overall, our results reveal a novel function of ZAG in WAT browning and highlight the targeting of ZAG as a potential therapeutic application in humans with cachexia.Elattar, S., Dimri, M., Satyanarayana, A. The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting.	[Elattar, Sawsan; Dimri, Manali; Satyanarayana, Ande] Augusta Univ, Dept Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA USA	University System of Georgia; Augusta University	Satyanarayana, A (corresponding author), Augusta Univ, 1410 Laney Walker Blvd,Room CN3150, Augusta, GA 30912 USA.	sande@augusta.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DP2DK105565]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK105565] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Patrick Seale (University of Pennsylvania, Philadelphia, PA, USA) for providing control and Prdm16 luciferase reporter vectors, and Dr. Mark Christian (University of Warwick, Coventry, United Kingdom) for providing Ucp1 luciferase vector. The authors thank Jinling Yuan (Georgia Cancer Center) for animal care and Georgia Cancer Center Small Animal Imaging Resource (Augusta, GA, USA) for technical help with multispectral optical imaging. The authors thank Dr. Rhea-Beth Markowitz (Augusta University) for reviewing and editing the manuscript. This research is supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant DP2DK105565 to A.S.). The authors declare no conflicts of interest.	Abdul-Rahman PS, 2007, ELECTROPHORESIS, V28, P1989, DOI 10.1002/elps.200600629; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Bayliss TJ, 2011, EXPERT OPIN BIOL TH, V11, P1663, DOI 10.1517/14712598.2011.627850; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Bing C, 2002, BRIT J CANCER, V86, P612, DOI 10.1038/sj.bjc.6600101; Bondar OP, 2007, CLIN CHEM, V53, P673, DOI 10.1373/clinchem.2006.079681; BUERGI W, 1961, J BIOL CHEM, V236, P1066; Busquets S, 1998, FEBS LETT, V440, P348, DOI 10.1016/S0014-5793(98)01485-9; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Hale LP, 2001, CLIN CANCER RES, V7, P846; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2010, CLIN ENDOCRINOL, V72, P334, DOI 10.1111/j.1365-2265.2009.03658.x; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Patil M, 2017, DIABETES, V66, P1611, DOI 10.2337/db16-1079; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Sanders PM, 2004, CANCER LETT, V212, P71, DOI 10.1016/j.canlet.2004.03.021; Satyanarayana A, 2012, FASEB J, V26, P309, DOI 10.1096/fj.11-190892; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Stine RR, 2016, MOL METAB, V5, P57, DOI 10.1016/j.molmet.2015.11.001; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; TAYLOR DD, 1992, CANCER RES, V52, P829; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; van Hall G, 2008, J CLIN ENDOCR METAB, V93, P2851, DOI 10.1210/jc.2007-2223; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wargent ET, 2013, J ENDOCRINOL, V216, P157, DOI 10.1530/JOE-12-0402; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Yusuf B, 2013, DEV GROWTH DIFFER, V55, P330, DOI 10.1111/dgd.12043	54	40	43	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4727	4743		10.1096/fj.201701465RR	http://dx.doi.org/10.1096/fj.201701465RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570397	Green Published			2022-12-28	WOS:000443817700009
J	Li, JJ; Xie, JG; Liu, SS; Li, X; Zhang, DL; Wang, XQ; Jiang, JQ; Hu, W; Zhang, Y; Jin, BQ; Zhuang, R; Yin, W				Li, Junjie; Xie, Jiangang; Liu, Shanshou; Li, Xiao; Zhang, Dongliang; Wang, Xianqi; Jiang, Jinquan; Hu, Wei; Zhang, Yuan; Jin, Boquan; Zhuang, Ran; Yin, Wen			ADAR1 attenuates allogeneic graft rejection by suppressing miR-21 biogenesis in macrophages and promoting M2 polarization	FASEB JOURNAL			English	Article						microRNA; RNA edit; transplantation rejection	ADENOSINE-DEAMINASE ADAR1; PROTEIN-KINASE PKR; M-1/M-2 MACROPHAGES; RNA; RECEPTOR; ACTIVATION; EXPRESSION; VIRUS; ROLES; GENE	ADAR1 (adenosine deaminase acting on double-stranded RNA 1) is an RNA-editing enzyme that mediates adenosine-to-inosine RNA editing events, an important post-transcriptional modification mechanism that can alter the coding properties of mRNA or regulate microRNA biogenesis. ADAR1 also regulates the innate immune response. Here, we have demonstrated that ADAR1 expression increased in LPS-stimulated macrophages. Silencing ADAR1 by using small interfering RNA in macrophages resulted in the pronounced polarization of macrophages to M1, whereas ADAR1 overexpression promoted M2 polarization, which indicated that ADAR1 can inhibit macrophage hyperpolarization and prevent immune hyperactivity. The RNA-RNP immunoprecipitation binding assay demonstrated a direct interaction between ADAR1 and miR-21 precursor. Significant up-regulation in IL-10 and down-regulation in miR-21 were observed in ADAR1-overexpressing macrophages. We evaluated miR-21 target mRNAs and macrophage polarization signaling pathways and found that forkhead box protein O1 (Foxo1) was up-regulated in cells that overexpressed ADAR1. In a mouse allogeneic skin transplantation model, grafts in the ADAR1-overexpressed group survived longer and suffered less immune cell infiltration. In ADAR1-overexpressed recipients, splenic macrophages were significantly polarized to M2, and levels of sera IL-10 were markedly higher than those in the control group. In summary, ADAR1 modulates macrophage M2 polarization via the ADAR1-miR-21-Foxo1-IL-10 axis, thereby suppressing allogeneic graft rejection.Li, J., Xie, J., Liu, S., Li, X., Zhang, D., Wang, X., Jiang, J., Hu, W., Zhang, Y., Jin, B., Zhuang, R., Yin, W. ADAR1 attenuates allogeneic graft rejection by suppressing miR-21 biogenesis in macrophages and promoting M2 polarization.	[Li, Junjie; Xie, Jiangang; Liu, Shanshou; Wang, Xianqi; Jiang, Jinquan; Yin, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Emergency, Xian 710032, Shaanxi, Peoples R China; [Li, Xiao] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Zhang, Dongliang] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian, Shaanxi, Peoples R China; [Xie, Jiangang; Zhang, Dongliang; Hu, Wei; Zhang, Yuan; Zhuang, Ran] Fourth Mil Med Univ, Sch Basic Med Sci, Transplant Immunol Lab, Xian, Shaanxi, Peoples R China; [Hu, Wei; Jin, Boquan; Zhuang, Ran] Fourth Mil Med Univ, Sch Basic Med Sci, Dept Immunol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yin, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Emergency, Xian 710032, Shaanxi, Peoples R China.; Zhuang, R (corresponding author), Fourth Mil Med Univ, Dept Immunol, 169 Changlexilu Rd, Xian 710032, Shaanxi, Peoples R China.	fmmuzhr@fmmu.edu.cn; xjyyyw@fmmu.edu.cn	Zhuang, Ran/I-7336-2019	Zhuang, Ran/0000-0002-3614-0422	National Natural Science Foundation of China [81500492, 81671575, 91442105, 81370388]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Shuzhong Guo (Xijing Hospital) for academic vision and advice. This work was supported by the National Natural Science Foundation of China (Grants 81500492, 81671575, 91442105, and 81370388). The authors declare no conflicts of interest.	Ahluwalia PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00107; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Boesten LSM, 2006, FASEB J, V20, P953, DOI 10.1096/fj.05-4530fje; Cachat A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0093-9; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Chawla G, 2014, NUCLEIC ACIDS RES, V42, P5245, DOI 10.1093/nar/gku145; Chen T, 2015, CELL RES, V25, P459, DOI 10.1038/cr.2015.24; Chen Y, 2017, EXP HEMATOL ONCOL, V6, DOI 10.1186/s40164-017-0083-4; Cho CJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040799; Chung S, 2015, J LEUKOCYTE BIOL, V97, P327, DOI 10.1189/jlb.3A0514-251R; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cunha C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6986175; Galore-Haskel G, 2015, ONCOTARGET, V6, P28999, DOI 10.18632/oncotarget.4905; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; He X, 2016, EBIOMEDICINE, V13, P339, DOI 10.1016/j.ebiom.2016.10.024; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Mannon RB, 2012, CURR OPIN ORGAN TRAN, V17, P20, DOI 10.1097/MOT.0b013e32834ee5b6; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2017, J IMMUNOL, V199, P2194, DOI 10.4049/jimmunol.1701141; Muhlberg L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1160181; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; Narayanan M, 2013, TRANSPLANTATION, V95, P566, DOI 10.1097/TP.0b013e318277438f; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohman M, 2007, BIOCHIMIE, V89, P1171, DOI 10.1016/j.biochi.2007.06.002; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Salehi S, 2015, CURR OPIN ORGAN TRAN, V20, P446, DOI 10.1097/MOT.0000000000000209; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Song C, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120129; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115855; Weiden MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108476; Zhao HQ, 2015, GENOME RES, V25, P66, DOI 10.1101/gr.176107.114; Zhuang R, 2013, NUCLEIC ACIDS RES, V41, P7905, DOI 10.1093/nar/gkt565; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	50	13	14	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5162	5173		10.1096/fj.201701449R	http://dx.doi.org/10.1096/fj.201701449R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29694248	Bronze			2022-12-28	WOS:000443817700043
J	Wang, LX; Liu, XH; Wang, HH; Yuan, H; Chen, SJ; Chen, Z; The, H; Zhou, J; Zhu, J				Wang, Luxiang; Liu, Xiaohui; Wang, Haihong; Yuan, Hao; Chen, Saijuan; Chen, Zhu; de The, Hugues; Zhou, Jun; Zhu, Jun			RNF4 regulates zebrafish granulopoiesis through the DNMT1-C/EBP alpha axis	FASEB JOURNAL			English	Article						SUMOylation; myelopoiesis; STUbL; neutrophil	PROTEIN 4 RNF4; DNA METHYLATION; GENE-EXPRESSION; C/EBP-ALPHA; SUMO; UBIQUITIN; HEMATOPOIESIS; SUMOYLATION; LIGASE; STEM	RING finger protein 4 (RNF4) is a multifunctional small ubiquitin-related modifier (SUMO)-targeted ubiquitin E3 ligase (STUbL) ubiquitously expressed in all tissues, and which mainly participates in DNA repair and in chromatin and transcriptional regulation. Although RNF4 has been implicated in hematopoietic disorders, its ontogenic role during hematopoietic development remains undiscovered. We generated a zebrafish rnf4 knockout line by using transcription activator-like effector nucleases technology to address the impact of rnf4 during hematopoiesis. Rnf4-deficient zebrafish embryos exhibited sharply decreased neutrophils numbers during both primitive and definitive hematopoiesis. Mechanistic studies revealed that repression of the key granulocytic activator, CCAAT/enhancer-binding protein (c/ebp), via promoter hypermethylation by SUMOylated DNA methyltransferase 1 (DNMT1) was the main cause of impaired granulopoiesis in rnf4-deficient zebrafish. In addition, for the first time, we identified DNMT1 as a potential new STUbL substrate of RNF4, with knockdown of dnmt1 largely restoring primitive and definitive granulopoiesis in rnf4-deficient zebrafish. Collectively, RNF4 is indispensable for zebrafish granulopoiesis through regulation of the DNMT1-C/EBP functional axis.Wang, L., Liu, X., Wang, H., Yuan, H., Chen, S., Chen, Z., de The, H., Zhou, J., Zhu, J. RNF4 regulates zebrafish granulopoiesis through the DNMT1-C/EBP axis.	[Wang, Luxiang; Liu, Xiaohui; Wang, Haihong; Yuan, Hao; Chen, Saijuan; Chen, Zhu; de The, Hugues; Zhou, Jun; Zhu, Jun] Shanghai Jiao Tong Univ, CNRS LIA Hematol & Canc, Sino French Res Ctr Life Sci & Genom, State Key Lab Med Genom,Rui Jin Hosp,Sch Med, 197 Rui Jin Rd 2, Shanghai 200025, Peoples R China; [de The, Hugues; Zhu, Jun] Univ Paris 07, Hop St Louis, Equipe Labellisee Ligue Natl Canc 11, INSERM,CNRS,UMR 944 7212, Paris, France	Chinese Academy of Sciences; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Zhou, J; Zhu, J (corresponding author), Shanghai Jiao Tong Univ, CNRS LIA Hematol & Canc, Sino French Res Ctr Life Sci & Genom, State Key Lab Med Genom,Rui Jin Hosp,Sch Med, 197 Rui Jin Rd 2, Shanghai 200025, Peoples R China.	junjun_j@yahoo.com; zhuj1966@yahoo.com			National Natural Science Foundation of China [31471375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank D. A. Jones (University of Utah, Salt Lake City) for providing the dnmt1 plasmid. The authors also thank J. Chen for cell sorting. The authors are grateful to M. Dong, M. Deng, Y. Chen, Y. Jin, and Z. Ruan (all from Shanghai Jiao Tong University School of Medicine, Shanghai, China) for technical support. This work was supported in part by research funding from the National Natural Science Foundation of China (31471375). The authors declare no conflicts of interest.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bewick AJ, 2017, MOL BIOL EVOL, V34, P654, DOI 10.1093/molbev/msw264; Bojovic BB, 2008, DNA CELL BIOL, V27, P289, DOI 10.1089/dna.2007.0680; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Creton S, 2010, CELL, V143, P848, DOI 10.1016/j.cell.2010.11.026; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Dong ZW, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-17; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182/blood-2011-06-358564; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hendriks IA, 2015, CELL REP, V10, P1778, DOI 10.1016/j.celrep.2015.02.033; Hirota K, 2014, GENES CELLS, V19, P743, DOI 10.1111/gtc.12173; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Jagannathan-Bogdan M, 2013, DEVELOPMENT, V140, P2463, DOI 10.1242/dev.083147; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lallemand-Breitenbach V, 2012, TRENDS MOL MED, V18, P36, DOI 10.1016/j.molmed.2011.10.001; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lee B, 2009, BIOCHEM J, V421, P449, DOI 10.1042/BJ20090142; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu XH, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0115-7; Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80; Ma O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095784; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Musialik E, 2014, LEUKEMIA RES, V38, P850, DOI 10.1016/j.leukres.2014.04.013; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Ronnerblad M, 2014, BLOOD, V123, pE79, DOI 10.1182/blood-2013-02-482893; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Takayama K, 2014, GENE EXPR PATTERNS, V14, P105, DOI 10.1016/j.gep.2014.01.005; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Wang L, 2013, DEVELOPMENT, V140, P2755, DOI 10.1242/dev.092825; Wang Y, 2014, J BIOL CHEM, V289, P33808, DOI 10.1074/jbc.C114.611558; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Xie J, 2015, J CLIN INVEST, V125, P1523, DOI 10.1172/JCI79325; Yuan H, 2011, BLOOD, V117, P7014, DOI 10.1182/blood-2010-12-325712	52	1	2	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4930	4940		10.1096/fj.201701450RR	http://dx.doi.org/10.1096/fj.201701450RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29634367				2022-12-28	WOS:000443817700026
J	Nakano, T; Seino, K; Wakabayashi, I; Stafforini, DM; Topham, MK; Goto, K				Nakano, Tomoyuki; Seino, Keiko; Wakabayashi, Ichiro; Stafforini, Diana M.; Topham, Matthew K.; Goto, Kaoru			Deletion of diacylglycerol kinase epsilon confers susceptibility to obesity via reduced lipolytic activity in murine adipocytes	FASEB JOURNAL			English	Article						adipose triglyceride lipase; hormone-sensitive lipase; lipid droplet; PKC; type 2 diabetes	HIGH-FAT-DIET; HEPATIC INSULIN-RESISTANCE; TRANSCRIPTION FACTOR FOXO1; ADIPOSE-TISSUE; LIPID-METABOLISM; ACYLTRANSFERASE-2 DGAT2; ENDOPLASMIC-RETICULUM; ENERGY-METABOLISM; MICE; LOCALIZATION	Lipid metabolism is closely involved with signal transduction and energy homeostasis. Excess calorie intake causes abnormal lipid metabolism, promoting obesity and insulin resistance. Diacylglycerol (DG) represents not only a lipidic second messenger but also an intermediate metabolite for triglyceride metabolism in the endoplasmic reticulum (ER). However, it remains undetermined how the roles of DG in signaling and energy homeostasis is regulated within the cell. Of DG kinases (DGKs), which are enzymes that phosphorylate DG, DGK epsilon resides in the ER. This study examined how DGK epsilon is implicated in signal transduction and lipid homeostasis. DGK epsilon-deficient mice were fed a high-fat diet (HFD) for 40 d. We observed that DGK epsilon deficiency promotes fat accumulation in adipocytes and subsequently promotes insulin resistance in mice fed an HFD. This abnormal fat metabolism is mediated by down-regulation of lipolytic activities, such as adipose triglyceride lipase and hormone-sensitive lipase. In addition, activation of DG-sensitive PKC leads to insulin resistance in adipose tissue, which may be caused by delayed metabolism of DG. Our data suggest that DGK epsilon links the second messenger signaling system to energy homeostasis in adipocytes and that its deficiency results in abnormal lipid metabolism such as obesity and insulin resistance.Nakano, T., Seino, K., Wakabayashi, I., Stafforini, D. M., Topham, M. K., Goto, K. Deletion of diacylglycerol kinase epsilon confers susceptibility to obesity via reduced lipolytic activity in murine adipocytes.	[Nakano, Tomoyuki; Seino, Keiko; Goto, Kaoru] Yamagata Univ, Dept Anat & Cell Biol, Sch Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan; [Wakabayashi, Ichiro] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo, Japan; [Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Yamagata University; Hyogo College of Medicine; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Nakano, T; Goto, K (corresponding author), Yamagata Univ, Dept Anat & Cell Biol, Sch Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	t-nakano@med.id.yamagata-u.ac.jp; kgoto@med.id.yamagata-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26460265, 17H04012]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-Aid 26460265 (to T.N.) and 17H04012 (to K.G.). The authors declare no conflicts of interest.	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415; Benoit B, 2013, NUTR RES, V33, P952, DOI 10.1016/j.nutres.2013.07.017; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Dolley G, 2009, MOL GENET METAB, V97, P149, DOI 10.1016/j.ymgme.2009.02.011; Fan NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088299; Goto K, 2007, INT REV CYTOL, V264, P25, DOI 10.1016/S0074-7696(07)64002-9; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jiang LQ, 2016, AM J PHYSIOL-ENDOC M, V310, pE51, DOI 10.1152/ajpendo.00209.2015; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kobayashi N, 2007, EUR J CELL BIOL, V86, P433, DOI 10.1016/j.ejcb.2007.05.002; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Li SY, 2005, DIABETES OBES METAB, V7, P448, DOI 10.1111/j.1463-1326.2004.00387.x; Lowe CE, 2013, OBESITY, V21, P1823, DOI 10.1002/oby.20297; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Manneras-Holm L, 2017, J LIPID RES, V58, P907, DOI [10.1194/jlr.m074443, 10.1194/jlr.M074443]; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsui H, 2014, BBA-MOL CELL BIOL L, V1841, P1440, DOI 10.1016/j.bbalip.2014.07.007; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Ong KT, 2013, FASEB J, V27, P313, DOI 10.1096/fj.12-213454; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Skinner JR, 2009, J BIOL CHEM, V284, P30941, DOI 10.1074/jbc.M109.013995; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	50	9	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4121	4131		10.1096/fj.201701050R	http://dx.doi.org/10.1096/fj.201701050R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509511				2022-12-28	WOS:000439325400006
J	Bao, H; Chen, YX; Huang, K; Zhuang, F; Bao, M; Han, Y; Chen, XH; Shi, Q; Yao, QP; Qi, YX				Bao, Han; Chen, Yuan-Xiu; Huang, Kai; Zhuang, Fei; Bao, Min; Han, Yue; Chen, Xiao-Hu; Shi, Qian; Yao, Qing-Ping; Qi, Ying-Xin			Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p	FASEB JOURNAL			English	Article						intercellular communication; microRNA; vascular homeostasis; BCLAF1	CIRCULATING MICROPARTICLES; SHEAR-STRESS; DYSFUNCTION; APOPTOSIS; PROTEIN; CANCER; BCLAF1; RAT; PATHOPHYSIOLOGY; TRANSCRIPTION	Endothelial cells (ECs) are located at the interface between flowing blood and the vessel wall, and abnormal EC proliferation induced by pathologic environments plays an important role in vascular remodeling in hypertensive conditions. Exchanges of information between blood components and ECs are important for EC function. Hence, the present study sought to determine how platelets induce EC dysfunction under hypertensive conditions. EC proliferation was increased in renal hypertensive rats established by abdominal aortic coarctation compared with control rats and that elevated thrombin in plasma promoted platelet activation, which may induce the release of platelet-derived microparticles (PMPs). MicroRNA (MiR) array and qPCR revealed a higher level of miR-142-3p in platelets and PMPs. In vitro, PMPs delivered miR-142-3p into ECs and enhanced their proliferation via Bcl-2-associated transcription factor (BCLAF)1 and its downstream genes. These results indicate that PMPs deliver miR-142-3p from activated platelets into ECs and that miR-142-3p may play important roles in EC dysfunction in hypertensive conditions and may be a novel therapeutic target for maintaining EC homeostasis in hypertension.Bao, H., Chen, Y.-X., Huang, K., Zhuang, F., Bao, M., Han, Y., Chen, X.-H., Shi, Q., Yao, Q.-P., Qi, Y.-X. Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p.	[Bao, Han; Chen, Yuan-Xiu; Huang, Kai; Zhuang, Fei; Bao, Min; Han, Yue; Chen, Xiao-Hu; Shi, Qian; Yao, Qing-Ping; Qi, Ying-Xin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Yao, QP; Qi, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China.	qpyao@sjtu.edu.cn; qiyx@sjtu.edu.cn			National Natural Science Foundation of China [11222223, 11625209, 11572199]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China Grants 11625209, 11572199, and 11222223 (all to Y.-X.Q.). The authors declare no conflicts of interest.	Aissa KA, 2015, ARTERIOSCL THROM VAS, V35, P930, DOI 10.1161/ATVBAHA.115.305377; Barton CH, 2001, KIDNEY INT, V60, P1083, DOI 10.1046/j.1523-1755.2001.0600031083.x; Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Cines DB, 1998, BLOOD, V91, P3527; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Dai L, 2009, ELECTROPHORESIS, V30, P1119, DOI 10.1002/elps.200800505; Dewi IS, 2017, CARDIOVASC RES, V113, P440, DOI 10.1093/cvr/cvw244; Duarte D, 2013, ALLERGY, V68, P1073, DOI 10.1111/all.12190; Efrati S, 2007, J HYPERTENS, V25, P1041, DOI 10.1097/HJH.0b013e32807fb09c; Goubran H, 2015, TRANSFUS APHER SCI, V53, P168, DOI 10.1016/j.transci.2015.10.014; Han Y, 2015, BBA-MOL CELL RES, V1853, P1165, DOI 10.1016/j.bbamcr.2015.02.013; Ishida K, 2016, ACTA PHYSIOL, V216, P211, DOI 10.1111/apha.12561; Ismail EAR, 2013, CLIN APPL THROMB-HEM, V19, P424, DOI 10.1177/1076029612456733; Jiang P, 2015, EXP BIOL MED, V240, P876, DOI 10.1177/1535370214565076; Jones R, 2014, ULTRASTRUCT PATHOL, V38, P93, DOI 10.3109/01913123.2013.846450; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Li Q, 2015, J HYPERTENS, V33, P1128, DOI 10.1097/HJH.0000000000000587; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Lovren F, 2013, CLIN CHEM, V59, P1166, DOI 10.1373/clinchem.2012.199711; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Naqvi AR, 2016, SCI REP-UK, V6, DOI 10.1038/srep32925; Nishimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC812, DOI 10.1152/ajpcell.00347.2005; Orieux G, 2014, J NEUROSCI, V34, P1530, DOI 10.1523/JNEUROSCI.3227-13.2014; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Renert AF, 2009, J PROTEOME RES, V8, P4810, DOI 10.1021/pr9005316; Rojas E, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0463-7; Schock SC, 2014, BIOCHEM BIOPH RES CO, V450, P912, DOI 10.1016/j.bbrc.2014.06.096; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; SCHWARTZ SM, 1977, CIRC RES, V41, P248, DOI 10.1161/01.RES.41.2.248; SCHWARTZ SM, 1984, PROG CARDIOVASC DIS, V26, P355, DOI 10.1016/0033-0620(84)90010-0; Shen B, 2016, TUMOR BIOL, V37, P7371, DOI 10.1007/s13277-015-4410-2; Sheu JJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0381-8; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; van Balkom BWM, 2013, BLOOD, V121, P3997, DOI 10.1182/blood-2013-02-478925; Vaziri ND, 1995, AM J PHYSIOL-RENAL, V269, pF838, DOI 10.1152/ajprenal.1995.269.6.F838; Wang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41058; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Xiong Y, 2013, CELL RES, V23, P820, DOI 10.1038/cr.2013.56; Yeh JJ, 2010, BLOOD, V115, P4247, DOI 10.1182/blood-2009-09-241166; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883	45	44	47	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3912	3923		10.1096/fj.201701073R	http://dx.doi.org/10.1096/fj.201701073R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481306				2022-12-28	WOS:000435104500036
J	Hu, CM; Tsao, N; Wang, YT; Chen, YJ; Chang, ZF				Hu, Chun-Mei; Tsao, Ning; Wang, Yi-Ting; Chen, Yu-Ju; Chang, Zee-Fen			Thymidylate kinase is critical for DNA repair via ATM-dependent Tip60 complex formation	FASEB JOURNAL			English	Article						TMPK; DNA damage; TIP60; ATM	RIBONUCLEOTIDE REDUCTASE; DEOXYRIBONUCLEOTIDE; ACTIVATION	Cellular supply of deoxythymidine triphosphate (dTTP) is crucial for DNA replication and repair. Thymidylate kinase (TMPK) catalyzes the conversion of thymidine monophosphate to thymidine diphosphate, which is an essential step for dTTP synthesis. Despite their major cellular localization in cytosol, TMPK and ribonucleotide reductase (RNR) are detected at DNA damage sites for local dNDP formation. Because deoxyuridine diphosphate is synthesized by RNR, the simultaneous recruitment of TMPK and RNR to DNA damage sites is critical for preventing deoxyuridine triphosphate-mediated toxic repair. This study investigates the mechanism responsible for the recruitment of TMPK to DNA damage sites. Our data demonstrate the requirement of ataxia telangiectasia mutated (ATM) kinase activity for TMPK recruitment to DNA lesion sites. Moreover, we find that TMPK is able to form the complex with histone acetyltransferase Tip60 and RNR. Inhibition of ATM kinase reduces the complex formation and TMPK phosphorylation. Our analysis further shows the presence of TMPK phosphorylation at serine 88, which is an ATM kinase consensus site. A phosphorylation-defective mutation at this site suppresses TMPK recruitment to DNA damage sites and the complex formation with Tip60. Finally, we provide evidence that this site is critical for the function of TMPK in DNA repair but not for catalytic activity. Together, these findings suggest that Tip60-ATM signaling has a functional contribution to the recruitment of TMPK to DNA damage sites, thereby increasing local dTTP synthesis for DNA repair.Hu, C.-M., Tsao, N., Wang, Y.-T., Chen, Y.-J., Chang, Z.-F. Thymidylate kinase is critical for DNA repair via ATM-dependent Tip60 complex formation.	[Hu, Chun-Mei] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Wang, Yi-Ting; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Hu, Chun-Mei; Tsao, Ning] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan; [Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Inst Mol Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan; [Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Ctr Precis Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan.; Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Ctr Precis Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan.	zfchang@ntu.edu.tw	Chen, Yu-Ju/E-9481-2015	Chen, Yu-Ju/0000-0002-3178-6697	Center of Precision Medicine from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan; Ministry of Scinece and Technology of the Republic of China (MOST) [107-3017-F-002-002, 107-2321-B-002-041]	Center of Precision Medicine from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan; Ministry of Scinece and Technology of the Republic of China (MOST)	The authors thank Dr. Li-Jung Juan (Genomics Research Center, Academia Sinica) for providing the HA-Tip60 plasmid, Dr. Ming-Yun Hsieh (Graduate Institute of Biochemistry and Molecular Biology, National Yang-Ming University) for technical assistance, and the Core Facility at Institute of Biological Chemistry, Academia Sinica, for performing the MS/MS analysis of postmodification of TMPK peptides. This study was supported by the Center of Precision Medicine from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan, and by Ministry of Scinece and Technology of the Republic of China (MOST) Grants 107-3017-F-002-002 and 107-2321-B-002-041. The authors declare no conflicts of interest.	Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Boissan M, 2018, LAB INVEST, V98, P164, DOI 10.1038/labinvest.2017.137; Chen CW, 2016, CELL REP, V16, P1287, DOI 10.1016/j.celrep.2016.06.094; Hu CM, 2012, CANCER CELL, V22, P36, DOI 10.1016/j.ccr.2012.04.038; HUANG SH, 1994, DNA CELL BIOL, V13, P461, DOI 10.1089/dna.1994.13.461; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Si WD, 2010, GENETICS, V185, P443, DOI 10.1534/genetics.110.115196; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; TAKEISHI K, 1985, NUCLEIC ACIDS RES, V13, P2035, DOI 10.1093/nar/13.6.2035; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Tsao N, 2016, BIOCHEM J, V473, P1237, DOI 10.1042/BCJ20160122; Tsao N, 2015, CELL CYCLE, V14, P354, DOI 10.4161/15384101.2014.987618; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001	23	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2017	2025		10.1096/fj.201800856R	http://dx.doi.org/10.1096/fj.201800856R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199284				2022-12-28	WOS:000457296600039
J	Meng, TG; Lu, XK; Guo, L; Hou, GM; Ma, XS; Li, QN; Huang, L; Fan, LH; Zhao, ZH; Ou, XH; OuYang, YC; Schatten, H; Li, L; Wang, ZB; Sun, QY				Meng, Tie-Gang; Lu, Xukun; Guo, Lei; Hou, Guan-Mei; Ma, Xue-Shan; Li, Qian-Nan; Huang, Lin; Fan, Li-Hua; Zhao, Zheng-Hui; Ou, Xiang-Hong; OuYang, Ying-Chun; Schatten, Heide; Li, Lei; Wang, Zhen-Bo; Sun, Qing-Yuan			Mettl14 is required for mouse postimplantation development by facilitating epiblast maturation	FASEB JOURNAL			English	Article						N6-methyladenosine; embryogenesis; naive state; primed state; gene expression	NUCLEAR-RNA; N6-METHYLADENOSINE; TRANSITION; METHYLATION; DEMETHYLASE; DERIVATION; COMPLEX; CULTURE; CELLS	N6-methyladenosine (m(6)A) is the most prevalent and reversible internal modification of mammalian messenger and noncoding RNAs mediated by specific m(6)A writer, reader, and eraser proteins. As an m(6)A writer, the methyltransferase-like 3-methyltransferase-like 14 (METTL14)-Wilms tumor 1-associated protein complex dynamically regulates m(6)A modification and plays important roles in diverse biologic processes. However, our knowledge about the complete functions of this RNA methyltransferase complex, the contributions of each component to the methylation, and their effects on different biologic pathways are still limited. By using both in vivo and in vitro models, we here report that METTL14 is indispensable for postimplantation embryonic development by facilitating the conversion from naive to primed state of the epiblast. Depletion of Mettl14 leads to conspicuous embryonic growth retardation from embryonic d 6.5, mainly as a result of resistance to differentiation, which further leads to embryonic lethality early in gestation. Our data highlight the critical function of METTL14 as an m(6)A modification regulator in orchestrating early mouse embryogenesis.Meng, T.-G., Lu, X., Guo, L., Hou, G.-M., Ma, X.-S., Li, Q.-N., Huang, L., Fan, L.-H., Zhao, Z.-H., Ou, X.-H., OuYang, Y.-C., Schatten, H., Li, L., Wang, Z.-B., Sun, Q.-Y. Mettl14 is required for mouse postimplantation development by facilitating epiblast maturation.	[Meng, Tie-Gang; Lu, Xukun; Guo, Lei; Hou, Guan-Mei; Ma, Xue-Shan; Li, Qian-Nan; Huang, Lin; Fan, Li-Hua; Zhao, Zheng-Hui; OuYang, Ying-Chun; Li, Lei; Wang, Zhen-Bo; Sun, Qing-Yuan] Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Meng, Tie-Gang; Lu, Xukun; Fan, Li-Hua; Zhao, Zheng-Hui; Li, Lei; Wang, Zhen-Bo; Sun, Qing-Yuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Guo, Lei; Ou, Xiang-Hong] Guangdong Second Prov Gen Hosp, Fertil Preservat Lab, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Wang, ZB; Sun, QY (corresponding author), Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.	wangzb@ioz.ac.cn; sunqy@ioz.ac.cn	Zhao, Zhenghui/AAY-6120-2020	Sun, Qing-Yuan/0000-0002-0148-2414; Meng, Tie-Gang/0000-0001-8069-0256; Li, Lei/0000-0001-5478-5681	National Key Research and Development Program of China [2016YFA0100400, 2016YFC1000600]; National Natural Science Foundation of China [31472055, 31671559]; Youth Innovation Promotion Association [CAS 2017114]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association	This work was supported, in part, by the National Key Research and Development Program of China (2016YFA0100400, 2016YFC1000600), the National Natural Science Foundation of China (31472055, 31671559), and the Youth Innovation Promotion Association (CAS 2017114). The authors declare no conflicts of interest.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bartosovic M, 2017, NUCLEIC ACIDS RES, V45, P11356, DOI 10.1093/nar/gkx778; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397; Huang X, 2017, ELIFE, V6, DOI 10.7554/eLife.33333; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kalkan T, 2017, DEVELOPMENT, V144, P1221, DOI 10.1242/dev.142711; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	26	38	40	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1179	1187		10.1096/fj.201800719R	http://dx.doi.org/10.1096/fj.201800719R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30110177	Green Submitted, Bronze			2022-12-28	WOS:000457401500093
J	Miller, JJ; Aoki, K; Mascari, CA; Beltrame, AK; Sokumbi, O; North, PE; Tiemeyer, M; Kriegel, AJ; Dahms, NM				Miller, James J.; Aoki, Kazuhiro; Mascari, Carly A.; Beltrame, Angela K.; Sokumbi, Olayemi; North, Paula E.; Tiemeyer, Michael; Kriegel, Alison J.; Dahms, Nancy M.			-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease	FASEB JOURNAL			English	Article						lysosomal storage disease; glycobiology; kidney; heart; animal model	ALPHA-GALACTOSIDASE; CLINICAL-MANIFESTATIONS; RENAL LESION; STORAGE; MODEL; SUBSTITUTION; HYPERTROPHY; OSTEOPENIA; PROTEIN; COHORT	Fabry disease is an X-linked lysosomal storage disease caused by -galactosidase A (-Gal A) deficiency. Kidney and heart failure are frequent complications in adulthood and greatly contribute to patient morbidity and mortality. Because -Gal A-deficient mouse models do not recapitulate cardiorenal findings observed in patients, a nonmouse model may be beneficial to our understanding of disease pathogenesis. In this study, we evaluated disease processes in a recently generated Fabry rat model. We found that male Fabry rats weighed significantly less than wild-type (WT) males, whereas female Fabry rats weighed significantly more than WT females. Whereas no difference in female survival was detected, we observed that male Fabry rats had a decreased lifespan. Skin histology revealed that inflammation and lipoatrophy may be chief disease mediators in patients. With respect to the kidney and heart, we found that both organs accumulate -Gal A substrates, including the established biomarkers, globotriaosylceramide and globotriaosylsphingosine. Longitudinal serum and urine chemistry panels demonstrated pronounced renal tubule dysfunction, which was confirmed histologically. Mitral valve thickening was observed in Fabry rats using echocardiography. We conclude that Fabry rats recapitulate important kidney and heart phenotypes experienced by patients and can be further used to study disease mechanisms and test therapies.Miller, J. J., Aoki, K., Mascari, C. A., Beltrame, A. K., Sokumbi, O., North, P. E., Tiemeyer, M., Kriegel, A. J., Dahms, N. M., -Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease.	[Miller, James J.; Mascari, Carly A.; Beltrame, Angela K.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Sokumbi, Olayemi] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [North, Paula E.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Kriegel, Alison J.] Med Coll Wisconsin, Dept Physiol, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University System of Georgia; University of Georgia	Dahms, NM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.; Kriegel, AJ (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	akriegel@mcw.edu; ndahms@mcw.edu		Beltrame, Angela/0000-0003-0233-2618; Mascari, Carly/0000-0001-7594-9120; Aoki, Kazuhiro/0000-0003-0029-4291; Sokumbi, Olayemi/0000-0001-8060-4311	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01DK042667]; NIH National Institute of Neurological Disorders and Stroke [R21NS095627]; NIH National Institute of Allergy and Infectious Diseases [R21AI129873]; NIH National Institute of General Medical Sciences [P41GM103490]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [F30DK113641]; NIH National Heart, Lung, and Blood Institute [R24HL114474];  [T32GM080202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL114474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667, F30DK113641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, T32GM080202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS095627] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. David Mattson for guidance, especially during the early stages of this project. The authors also thank Christine Duris, Stephanie Wirsbinski, Tatunya Bufford, and Qiuhui Yang of the Children's Hospital of Wisconsin Children's Research Institute Histology Core for histology and immunohistochemistry services. The electron microscopy services and interpretation by Clive Wells are greatly appreciated. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK042667 and NIH National Institute of Neurological Disorders and Stroke Grant R21NS095627 (to N.M.D.), NIH National Institute of Allergy and Infectious Diseases Grant R21AI129873 (to K.A.), NIH National Institute of General Medical Sciences Grant P41GM103490 (to M.T.), and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant F30DK113641 (to J.J.M.). J.J.M. is a trainee of the Medical College of Wisconsin Medical Scientist Training Program, which is partially supported by T32GM080202. The Fabry rat model was generated under R24HL114474, a resource grant from NIH National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Ballabio A, 2016, EMBO MOL MED, V8, P73, DOI 10.15252/emmm.201505966; Barbey F, 2006, ARTERIOSCL THROM VAS, V26, P839, DOI 10.1161/01.ATV.0000209649.60409.38; BURKHOLDER PM, 1980, ARCH PATHOL LAB MED, V104, P17; Burton BK, 2017, J PEDIATR-US, V190, P130, DOI 10.1016/j.jpeds.2017.06.048; Cat AND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033743; COLLEY JR, 1958, BRIT MED J, V1, P1266, DOI 10.1136/bmj.1.5082.1266; Cox-Brinkman J, 2007, EUR J HUM GENET, V15, P535, DOI 10.1038/sj.ejhg.5201798; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; DEAN KJ, 1977, BIOCHEM BIOPH RES CO, V77, P1411, DOI 10.1016/S0006-291X(77)80136-8; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Elliott S, 2016, MOL GENET METAB, V118, P304, DOI 10.1016/j.ymgme.2016.05.015; Faggiano A, 2006, J CLIN ENDOCR METAB, V91, P4319, DOI 10.1210/jc.2006-0858; Fall B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168346; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Germain DP, 2005, CLIN GENET, V68, P93, DOI 10.1111/j.1399-0004.2005.00457.x; HENRY EW, 1963, CAN MED ASSOC J, V89, P206; Hopkin RJ, 2008, PEDIATR RES, V64, P550, DOI 10.1203/PDR.0b013e318183f132; Hopkins PV, 2015, J PEDIATR-US, V166, P172, DOI 10.1016/j.jpeds.2014.09.023; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Kampmann C, 2008, ACTA PAEDIATR, V97, P463, DOI 10.1111/j.1651-2227.2008.00700.x; KRETCHMER N, 1974, KIDNEY INT, V5, P96, DOI 10.1038/ki.1974.13; Kriegel AJ, 2008, PHYSIOL GENOMICS, V36, P35, DOI 10.1152/physiolgenomics.00054.2008; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P819, DOI 10.1152/physiolgenomics.00175.2011; Labilloy A, 2014, MOL GENET METAB, V111, P184, DOI 10.1016/j.ymgme.2013.10.010; Lakoma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108641; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Mersebach H, 2007, GENET MED, V9, P812, DOI 10.1097/GIM.0b013e31815cb197; Miller JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99171; Niemann M, 2011, ULTRASOUND MED BIOL, V37, P37, DOI 10.1016/j.ultrasmedbio.2010.10.017; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; PABICO RC, 1973, AM J MED, V55, P415, DOI 10.1016/0002-9343(73)90140-X; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Ries M, 2006, GENET MED, V8, P96, DOI 10.1097/01.gim.0000200950.25118.dd; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rozenfeld P, 2017, MOL GENET METAB, V122, P19, DOI 10.1016/j.ymgme.2017.09.004; Sanchez-Nino MD, 2015, HUM MOL GENET, V24, P5720, DOI 10.1093/hmg/ddv291; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Shin YJ, 2015, MOL MED REP, V12, P5049, DOI 10.3892/mmr.2015.4010; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Taguchi A, 2013, BIOCHEM J, V456, P373, DOI 10.1042/BJ20130825; UUMLCEYLER N, 2016, MOL PAIN, V12; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vedder AC, 2007, J INHERIT METAB DIS, V30, P68, DOI 10.1007/s10545-006-0484-8; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321	48	14	14	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					418	429		10.1096/fj.201800771R	http://dx.doi.org/10.1096/fj.201800771R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979634	Green Published			2022-12-28	WOS:000457401500033
J	Nam, DH; Kim, E; Benham, A; Park, HK; Soibam, B; Taffet, GE; Kaelber, JT; Suh, JH; Taegtmeyer, H; Entman, ML; Reineke, EL				Nam, Deok Hwa; Kim, Eunah; Benham, Ashley; Park, Hye-Kyung; Soibam, Benjamin; Taffet, George E.; Kaelber, Jason T.; Suh, Ji Ho; Taegtmeyer, Heinrich; Entman, Mark L.; Reineke, Erin L.			Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function	FASEB JOURNAL			English	Article						cardiac metabolism; cardiac stress; hypertrophy; fibrosis; heart failure	CARDIAC-HYPERTROPHY; REGULATOR; GROWTH	Coordinated changes in signaling pathways and gene expression in hearts subjected to prolonged stress maintain cardiac function. Loss of steroid receptor coactivator-2 (SRC-2) results in a reversal to the fetal gene program and disrupts the response to pressure overload, accompanied by prominent effects on metabolism and growth signaling, including increased AMPK activation. We proposed that early metabolic stress driven by AMPK activation induces contractile dysfunction in mice lacking SRC-2. We used 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) to activate AMPK transiently before transverse aortic constriction (TAC) in wild-type and cardiomyocyte-specific SRC-2 knockout (CKO) animals. In contrast to AMPK activities during stress, in unstressed hearts, AICAR induced a mild activation of Akt signaling, and, in SRC-2-CKO mice, partially relieved an NAD(+) deficiency and increased antioxidant signaling. These molecular changes translated to a mild hypertrophic response to TAC with decreased maladaptive remodeling, including markedly decreased fibrosis. Additionally, preactivation of AMPK in SRC-2-CKO mice was accompanied by a dramatic improvement in cardiac function compared with saline-treated SRC-2-CKO mice. Our results show that altered molecular signaling before stress onset has extended effects on sustained cardiac stress responses, and prestress modulation of transient growth and metabolism pathways may control those effects.Nam, D. H., Kim, E., Benham, A., Park, H.-K., Soibam, B., Taffet, G. E., Kaelber, J. T., Suh, J. H., Taegtmeyer, H., Entman, M. L., Reineke, E. L. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.	[Nam, Deok Hwa; Kim, Eunah; Park, Hye-Kyung; Suh, Ji Ho; Reineke, Erin L.] Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA; [Benham, Ashley] Texas Heart Inst, Houston, TX 77025 USA; [Soibam, Benjamin] Univ Houston Downtown, Dept Comp Sci & Engn Technol, Houston, TX USA; [Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Taegtmeyer, Heinrich] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Div Cardiol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Texas Heart Institute; University of Houston System; University of Houston; University of Houston Downtown; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Reineke, EL (corresponding author), Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA.	elreineke@houstonmethodist.org		Kaelber, Jason/0000-0001-9426-1030	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [R00-HL118159-01]; Souki Mitochondrial Project Fund [R01-HL061483, R01-HL089792]; U.S. Army Department of Defense [68847MAREP/W911NF1610480]; NIH National Cancer Institute [P30-CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL118159, R01HL061483, R01HL089792] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); Souki Mitochondrial Project Fund; U.S. Army Department of Defense(United States Department of Defense); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Hong Chen (Houston Methodist Research Institute), and, Katherina Marcelo, Jennifer Pocius, Thuy Pham, and Alejandro Granillo Ibanez (all from Baylor College of Medicine) for technical assistance with surgery and cardiac imaging and molecular analysis. Histology was performed at the Pathology and Histology Core at Baylor College of Medicine with the assistance of Zahida Sayeeduddin. This work was supported by the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI; Grant R00-HL118159-01 to E.L.R.), the Souki Mitochondrial Project Fund (Grants R01-HL061483 to H.T. and R01-HL089792 to M.L.E.), and the U.S. Army Department of Defense (Grant 68847MAREP/W911NF1610480 to B.S.). The Pathology and Histology Core at Baylor College of Medicine is supported by funding from the NIH National Cancer Institute (Grant P30-CA125123). The authors declare no conflicts of interest.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baskin KK, 2011, TRENDS CARDIOVAS MED, V21, P124, DOI 10.1016/j.tcm.2012.03.010; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Cieslik KA, 2013, J MOL CELL CARDIOL, V63, P26, DOI 10.1016/j.yjmcc.2013.07.005; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li YH, 2003, ULTRASOUND MED BIOL, V29, P1281, DOI 10.1016/S0301-5629(03)00986-4; Meng RS, 2009, EUR J PHARMACOL, V620, P63, DOI 10.1016/j.ejphar.2009.08.024; Meng RS, 2011, ARCH BIOCHEM BIOPHYS, V511, P1, DOI 10.1016/j.abb.2011.04.010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Reineke EL, 2014, J BIOL CHEM, V289, P17721, DOI 10.1074/jbc.M113.539908; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Suh JH, 2017, J BIOL CHEM, V292, P21643, DOI 10.1074/jbc.M117.804740; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Taffet GE, 1996, AM J PHYSIOL-HEART C, V270, pH2204; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505	28	7	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					711	721		10.1096/fj.201800602R	http://dx.doi.org/10.1096/fj.201800602R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024790	Green Published, Bronze			2022-12-28	WOS:000457401500055
J	Fan, DJ; Cao, SN; Zhou, QM; Zhang, Y; Yue, L; Han, C; Yang, B; Wang, Y; Ma, Z; Zhu, LX; Liu, CP				Fan, Dongjie; Cao, Shunan; Zhou, Qiming; Zhang, You; Yue, Lei; Han, Chang; Yang, Bo; Wang, Yu; Ma, Zhuo; Zhu, Lingxiang; Liu, Chuanpeng			Exploring the roles of substrate-binding surface of the chaperone site in the chaperone activity of trigger factor	FASEB JOURNAL			English	Article						folding; protein aggregation; electrostatic interaction; hydrophobic interaction	NASCENT CHAIN; PPIASE DOMAIN; PROTEIN; DNAK; DYNAMICS; RIBOSOME; FORMS	Trigger factor (TF) is a key component of the prokaryotic chaperone network, which is involved in many basic cellular processes, such as protein folding, protein trafficking, and ribosome assembly. The major chaperone site of TF has a cradle-like structure in which protein substrate may fold without interference from other proteins. Here, we investigated in vivo and in vitro the roles of hydrophobic and charged patches on the edge and interior of cradle during TF-assisted protein folding. Our results showed that most of the surface of the cradle was involved in TF-assisted protein folding, which was larger than found in early studies. Although the inner surface of cradle was mostly hydrophobic, both hydrophobic and electrostatic patches were indispensable for TF to facilitate correct protein folding. However, hydrophobic patches were more important for the antiaggregation activity of TF. Furthermore, it was found that the patches on the surface of cradle were involved in TF-assisted protein folding in a spatial and temporal order. These results suggest that the folding-favorable interface between the cradle and substrate was dynamic during TF-assisted protein folding, which enabled TF to be involved in the folding of substrate in an aggressive manner rather than acting as a classic holdase.Fan, D., Cao, S., Zhou, Q., Zhang, Y., Yue, L., Han, C., Yang, B., Wang, Y., Ma, Z., Zhu, L., Liu, C. Exploring the roles of substrate-binding surface of the chaperone site in the chaperone activity of trigger factor.	[Fan, Dongjie; Zhou, Qiming; Zhang, You; Yue, Lei; Han, Chang; Wang, Yu; Ma, Zhuo; Liu, Chuanpeng] Harbin Inst Technol, Sch Life Sci & Technol, 2 Yikuang St, Harbin 150080, Heilongjiang, Peoples R China; [Fan, Dongjie] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Cao, Shunan] State Ocean Adm, Polar Res Inst China, Key Lab Polar Sci, Shanghai, Peoples R China; [Zhou, Qiming] ChosenMed Technol Co Ltd, Econ & Technol Dev Area, Jinghai Ind Pk, Beijing, Peoples R China; [Yang, Bo] Nantong Univ, Sch Life Sci, Nantong, Jiangsu, Peoples R China; [Zhu, Lingxiang] NRIFP, Beijing, Peoples R China	Harbin Institute of Technology; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Polar Research Institute of China; State Oceanic Administration; Nantong University	Liu, CP (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, 2 Yikuang St, Harbin 150080, Heilongjiang, Peoples R China.; Zhu, LX (corresponding author), NRIFP, Beijing, Peoples R China.	zhulingxiang@nrifp.org.cn; liucp74@hotmail.com			National Natural Science Foundation of China [31270118, 31570133]; Chinese Ministry of Education, Scientific Research Foundation for the Returned Overseas Chinese Scholars	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education, Scientific Research Foundation for the Returned Overseas Chinese Scholars	This work was supported by National Natural Science Foundation of China Grants 31270118 and 31570133, and by the Chinese Ministry of Education, Scientific Research Foundation for the Returned Overseas Chinese Scholars. The authors declare no conflicts of interest.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Can MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176262; Deeng J, 2016, J MOL BIOL, V428, P3588, DOI 10.1016/j.jmb.2016.06.007; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Fan DJ, 2017, J CELL BIOCHEM, V118, P141, DOI 10.1002/jcb.25620; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gupta R, 2010, FEBS LETT, V584, P3620, DOI 10.1016/j.febslet.2010.07.036; GUTHRIE B, 1990, J BACTERIOL, V172, P5555, DOI 10.1128/jb.172.10.5555-5562.1990; Haldar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00771-6; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koubek J, 2017, J MOL BIOL, V429, P1733, DOI 10.1016/j.jmb.2017.03.029; Kramer G, 2002, ARCH BIOCHEM BIOPHYS, V403, P63, DOI 10.1016/S0003-9861(02)00213-8; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Li ZY, 2001, FEBS LETT, V506, P108, DOI 10.1016/S0014-5793(01)02896-4; Lin KF, 2012, BIOPHYS J, V102, P2818, DOI 10.1016/j.bpj.2012.04.048; Liu CP, 2010, INT J BIOCHEM CELL B, V42, P890, DOI 10.1016/j.biocel.2010.01.019; Liu CP, 2005, J BIOL CHEM, V280, P13315, DOI 10.1074/jbc.M414151200; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nilsson OB, 2016, J MOL BIOL, V428, P1356, DOI 10.1016/j.jmb.2016.02.014; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Saio T, 2018, ELIFE, V7, DOI 10.7554/eLife.35731; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Sheng XR, 2001, FEBS LETT, V508, P318, DOI 10.1016/S0014-5793(01)03092-7; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Singhal K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004444; Singhal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059683; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thomas AS, 2013, BIOPHYS J, V105, P732, DOI 10.1016/j.bpj.2013.06.028; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Yang F, 2016, MOL MICROBIOL, V102, P992, DOI 10.1111/mmi.13529; Zeng LL, 2006, BIOCHIMIE, V88, P613, DOI 10.1016/j.biochi.2005.11.006; Zhang HJ, 1998, BIOCHEM J, V333, P401, DOI 10.1042/bj3330401; Zhou QM, 2010, WORLD J MICROB BIOT, V26, P1323, DOI 10.1007/s11274-009-0305-y	47	0	0	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6655	6665		10.1096/fj.201701576	http://dx.doi.org/10.1096/fj.201701576			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906241	Bronze			2022-12-28	WOS:000449359700024
J	Zhou, XP; Ma, CY; Hu, B; Tao, YQ; Wang, JK; Huang, XP; Zhao, TF; Han, B; Li, H; Liang, CZ; Chen, QX; Li, FC				Zhou, Xiaopeng; Ma, Chiyuan; Hu, Bin; Tao, Yiqing; Wang, Jingkai; Huang, Xianpeng; Zhao, Tengfei; Han, Bin; Li, Hao; Liang, Chengzhen; Chen, Qixin; Li, Fangcai			FoxA2 regulates the type II collagen-induced nucleus pulposus-like differentiation of adipose-derived stem cells by activation of the Shh signaling pathway	FASEB JOURNAL			English	Article						Itg2; intervertebral disc degeneration; regeneration; extracellular matrix; transcription factor	EXTRACELLULAR MATRIX INTERACTIONS; INTERVERTEBRAL DISC; ANNULUS FIBROSUS; SONIC HEDGEHOG; IN-VITRO; REGENERATION; DEGENERATION; INTEGRINS; EXPRESSION; PHENOTYPE	Adipose tissue-derived stem cell (ADSC)-based therapy is promising for the treatment of intervertebral disc (IVD) degeneration, but the difficulty in inducing nucleus pulposus (NP)-like differentiation limits its clinical applications. Forkhead box (Fox)-A2 is an essential transcription factor for the formation of a normal NP. We demonstrated that type II collagen stimulates NP-like differentiation of ADSCs, partly by increasing the expression of FoxA2. We constructed FoxA2-overexpressing and -knockdown ADSCs by using lentiviral vectors. FoxA2 overexpression significantly enhanced NP-specific gene expression and the synthesis of glycosaminoglycan and collagen, whereas FoxA2 knockdown decreased NP-like differentiation and the expression of aggrecan and collagen II. The enhanced NP-like differentiation related to FoxA2 overexpression was partially rescued by an Shh signaling pathway inhibitor. In addition, FoxA2 inhibited the expression of Itg-2 and further promoted NP-like differentiation induced by type II collagen. Furthermore, FoxA2-overexpressing ADSCs combined with type II collagen hydrogels promoted regeneration of degenerated NP in vivo. Our findings suggest that FoxA2 plays an essential role in the NP-like differentiation of ADSCs by activating the Shh signaling pathway.Zhou, X., Ma, C., Hu, B., Tao, Y., Wang, J., Huang, X., Zhao, T., Han, B., Li, H., Liang, C., Chen, Q., Li, F. FoxA2 regulates the type II collagen-induced nucleus pulposus-like differentiation of adipose-derived stem cells by activation of the Shh signaling pathway.	[Zhou, Xiaopeng; Ma, Chiyuan; Hu, Bin; Tao, Yiqing; Wang, Jingkai; Huang, Xianpeng; Zhao, Tengfei; Han, Bin; Li, Hao; Liang, Chengzhen; Chen, Qixin; Li, Fangcai] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China; [Zhou, Xiaopeng; Ma, Chiyuan; Hu, Bin; Tao, Yiqing; Wang, Jingkai; Huang, Xianpeng; Zhao, Tengfei; Han, Bin; Li, Hao; Liang, Chengzhen; Chen, Qixin; Li, Fangcai] Zhejiang Univ, Dept Orthoped, Res Inst, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, FC (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China.	lifangcai@zju.edu.cn			National Nature Science Foundation of China [81401011, 81401822, 81472114, 81572177]; Key General Science and Technology Planning Project [2016C33151]; Nature Science Foundation of Zhejiang Province Grant [Y13H060001]; Health Foundation of Zhejiang Province [2016142263, 2016146428]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key General Science and Technology Planning Project; Nature Science Foundation of Zhejiang Province Grant; Health Foundation of Zhejiang Province	This study was partly supported by National Nature Science Foundation of China Grants 81401011 (to T.Z.), 81401822 (to C.L.), 81472114 (to Q.C.), and 81572177 (to F.L.); Key General Science and Technology Planning Project Grant 2016C33151 (to F.L.); Nature Science Foundation of Zhejiang Province Grant and Y13H060001 (to F.L.); and Health Foundation of Zhejiang Province Grants 2016142263 (to B.H.) and 2016146428 (to C.L.). The authors declare no conflicts of interest.	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Bellas E, 2014, CURR OPIN CELL BIOL, V31, P92, DOI 10.1016/j.ceb.2014.09.006; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Chen EEM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.429; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Choi KS, 2012, MECH DEVELOP, V129, P255, DOI 10.1016/j.mod.2012.07.003; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Clarke LE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4505; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Dal-Pra S, 2011, DEV BIOL, V350, P484, DOI 10.1016/j.ydbio.2010.12.018; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; Fontana G, 2015, ADV DRUG DELIVER REV, V84, P146, DOI 10.1016/j.addr.2014.08.008; Frith JE, 2012, STEM CELLS DEV, V21, P2442, DOI 10.1089/scd.2011.0615; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Guillaume O, 2015, J BIOMATER APPL, V29, P1230, DOI 10.1177/0885328214557905; Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Huang B, 2011, SPINE, V36, P2252, DOI 10.1097/BRS.0b013e318209fd85; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang L, 2016, ACS NANO, V10, P207, DOI 10.1021/acsnano.5b03157; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; Komada M, 2012, CONGENIT ANOM, V52, P72, DOI 10.1111/j.1741-4520.2012.00368.x; Lu ZF, 2008, J CELL MOL MED, V12, P2812, DOI 10.1111/j.1582-4934.2008.00278.x; Maier JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055528; Mercuri J, 2014, J BIOMED MATER RES A, V102, P4380, DOI 10.1002/jbm.a.35104; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Priyadarshani P, 2016, OSTEOARTHR CARTILAGE, V24, P206, DOI 10.1016/j.joca.2015.08.014; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2015, ADV DRUG DELIVER REV, V84, P159, DOI 10.1016/j.addr.2014.06.009; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shi X, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.38; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Tao YQ, 2016, BIOFACTORS, V42, P212, DOI 10.1002/biof.1266; Tao YQ, 2015, GROWTH FACTORS, V33, P326, DOI 10.3109/08977194.2015.1088532; Totaro A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15206; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tsaryk R, 2015, ACTA BIOMATER, V20, P10, DOI 10.1016/j.actbio.2015.03.041; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Vaillant C, 2009, CEREBELLUM, V8, P291, DOI 10.1007/s12311-009-0094-8; Vazin T, 2014, BIOMATERIALS, V35, P941, DOI 10.1016/j.biomaterials.2013.10.025; Walker MH, 2004, SPINE J, V4, p158S, DOI DOI 10.1016/j.spinee.2004.07.010; Wang JK, 2016, EXP BIOL MED, V241, P2104, DOI 10.1177/1535370216662362; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Zhou XP, 2018, J BIOMED MATER RES A, V106, P1258, DOI 10.1002/jbm.a.36325; Zhou XP, 2016, J BIOMED MATER RES A, V104, P1687, DOI 10.1002/jbm.a.35701; Zhu YX, 2017, BIOMATER SCI-UK, V5, P784, DOI 10.1039/c7bm00001d	52	10	11	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6582	6595		10.1096/fj.201800373R	http://dx.doi.org/10.1096/fj.201800373R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29890089	Bronze			2022-12-28	WOS:000449359700019
J	Mirciov, CSG; Wilkins, SJ; Anderson, GJ; Frazer, DM				Mirciov, Cornel S. G.; Wilkins, Sarah J.; Anderson, Gregory J.; Frazer, David M.			Food deprivation increases hepatic hepcidin expression and can overcome the effect of Hfe deletion in male mice	FASEB JOURNAL			English	Article						Hamp; hereditary hemochromatosis; iron deficiency; stimulated erythropoiesis	IRON HOMEOSTASIS; BETA-THALASSEMIA; MOUSE-LIVER; METABOLISM; REGULATOR; BMP6; GENE; HEMOCHROMATOSIS; IDENTIFICATION; FERROPORTIN	Iron-loading disorders, such as hereditary hemochromatosis, are associated with inappropriately low expression of the iron regulatory hormone, hepcidin. A recent study has demonstrated that food deprivation can increase hepcidin production in mice. We have examined this effect in more detail to determine whether the pathway(s) that are responsible might provide novel targets for pharmaceutical intervention in disorders of iron homeostasis. C57BL/6 mice were deprived of food for 5, 10, 16, or 24 h before euthanasia, then blood and tissue samples were collected for analysis. The effect of food deprivation was also examined in Hfe(-/-) mice, a model of hereditary hemochromatosis, as well as mice that were maintained on an iron-deficient diet or injected with erythropoietin. Food deprivation increased the hepatic expression of the gene that encodes hepcidin, hepcidin antimicrobial peptide 1 (Hamp1), with maximal expression observed after 16 h, and was able to overcome the reduction in Hamp1 expression associated with Hfe deficiency. Food deprivation also increased Hamp1 expression in response to stimuli that more strongly suppress the gene, such as iron deficiency and erythropoietin treatment, but the effects were not significant. These results indicate that Hamp1 induction by food deprivation is independent of HFE and suggest that targeting the pathway regulated by food deprivation could have clinical benefit in iron-loading conditions.Mirciov, C. S. G., Wilkins, S. J., Anderson, G. J., Frazer, D. M. Food deprivation increases hepatic hepcidin expression and can overcome the effect of Hfe deletion in male mice.	[Mirciov, Cornel S. G.; Wilkins, Sarah J.; Anderson, Gregory J.; Frazer, David M.] QIMR Berghofer Med Res Inst, Iron Metab Lab, 300 Herston Rd, Herston, Qld 4006, Australia; [Mirciov, Cornel S. G.; Anderson, Gregory J.] Univ Queensland, Sch Med, St Lucia, Qld, Australia; [Anderson, Gregory J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Frazer, DM (corresponding author), QIMR Berghofer Med Res Inst, Iron Metab Lab, 300 Herston Rd, Herston, Qld 4006, Australia.	david.frazer@qimrberghofer.edu.au	Frazer, David M/L-3570-2014; Anderson, Gregory/G-4148-2013	Frazer, David M/0000-0003-4098-1379; Anderson, Gregory/0000-0002-8814-5866; Mirciov, Cornel/0000-0002-9083-2614	National Health and Medical Research Council of Australia [APP1051764]; Australian Government Research Training Program Scholarship; QIMR Berghofer Higher Degrees Committee	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); QIMR Berghofer Higher Degrees Committee	This work was supported by project Grant APP1051764 (to G.J.A. and D.M.F.) and a Senior Research Fellowship (to G.J.A.) from the National Health and Medical Research Council of Australia, an Australian Government Research Training Program Scholarship (to C.S.G.M.), and a Top Up Award from the QIMR Berghofer Higher Degrees Committee (to C.S.G.M.). The authors declare no conflicts of interest.	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Aslam MF, 2014, FASEB J, V28, P3671, DOI 10.1096/fj.14-251520; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Canali S, 2017, AM J HEMATOL, V92, P1204, DOI 10.1002/ajh.24888; Casu C, 2016, BLOOD, V128, P265, DOI 10.1182/blood-2015-10-676742; Darshan D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001687; Darshan D, 2010, HAEMATOL-HEMATOL J, V95, P1660, DOI 10.3324/haematol.2010.022426; Frazer DM, 2014, BIOFACTORS, V40, P206, DOI 10.1002/biof.1148; Frazer DM, 2003, BLOOD CELL MOL DIS, V30, P288, DOI 10.1016/S1079-9796(03)00039-1; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kim DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34630; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Olivieri NF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011767; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rombout-Sestrienkova E, 2016, BRIT J HAEMATOL, V175, P759, DOI 10.1111/bjh.14376; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977; Sokolovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-361; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Troutt JS, 2012, CLIN CHEM, V58, P1225, DOI 10.1373/clinchem.2012.186866; Vecchi C, 2014, GASTROENTEROLOGY, V146, P1060, DOI 10.1053/j.gastro.2013.12.016; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	32	3	3	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6079	6088		10.1096/fj.201701497RR	http://dx.doi.org/10.1096/fj.201701497RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29799786				2022-12-28	WOS:000447172000026
J	An, R; Schmid, R; Klausing, A; Robering, JW; Weber, M; Bauerle, T; Detsch, R; Boccaccini, AR; Horch, RE; Boos, AM; Weigand, A				An, Ran; Schmid, Rafael; Klausing, Anne; Robering, Jan W.; Weber, Maximilian; Baeuerle, Tobias; Detsch, Rainer; Boccaccini, Aldo R.; Horch, Raymund E.; Boos, Anja M.; Weigand, Annika			Proangiogenic effects of tumor cells on endothelial progenitor cells vary with tumor type in an in vitro and in vivo rat model	FASEB JOURNAL			English	Article						cancer; neovascularization; cytokines; hydrogel	HEPATOCELLULAR-CARCINOMA; INDUCED ANGIOGENESIS; CANCER-RESEARCH; GROWTH-FACTOR; ACTIVIN-A; METASTASIS; PROGRESSION; BIOLOGY; ANGIOPOIETIN-2; EXPRESSION	Endothelial progenitor cells (EPCs) contribute to neovascularization in tumors. However, the relationship of EPCs and tumor-induced angiogenesis still remains to be clarified. The present study aimed at investigating the influence of 4 different tumor types on angiogenic properties of EPCs in an in vitro and in vivo rat model. It could be demonstrated that in vitro proliferation, migration, and angiogenic abilities and genetic modifications of EPCs are controlled in a tumor-type-dependent manner. The proangiogenic effect of mammary carcinoma, osteosarcoma, and rhabdomyosarcoma cells was more pronounced compared to colon carcinoma cells. Coinjection of encapsulated tumor cells, especially mammary carcinoma cells, and EPCs in a rat model confirmed a contributing effect of EPCs in tumor vascularization. Cytokines secreted by tumors such as monocyte chemoattractant protein 1, macrophage inflammatory protein 2, and TNF-related apoptosis-inducing ligand play a pivotal role in the tumor cell-EPC interaction, leading to enhanced migration and angiogenesis. With the present study, we were able to decipher possible underlying mechanisms by which EPCs are stimulated by tumor cells and contribute to tumor vascularization. The present study will contribute to a better understanding of tumor-induced vascularization, thus facilitating the development of therapeutic strategies targeting tumor-EPC interactions.An, R., Schmid, R., Klausing, A., Robering, J. W., Weber, M., Bauerle, T., Detsch, R., Boccaccini, A. R., Horch, R. E., Boos, A. M., Weigand, A. Proangiogenic effects of tumor cells on endothelial progenitor cells vary with tumor type in an in vitro and in vivo rat model.	[An, Ran; Schmid, Rafael; Klausing, Anne; Robering, Jan W.; Weber, Maximilian; Horch, Raymund E.; Boos, Anja M.; Weigand, Annika] Univ Hosp Erlangen, Lab Tissue Engn & Regenerat Med, Dept Plast & Hand Surg, Erlangen, Germany; [Baeuerle, Tobias] Univ Hosp Erlangen, Dept Radiol, Erlangen, Germany; [Detsch, Rainer; Boccaccini, Aldo R.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Mat Sci & Engn, Erlangen, Germany; [An, Ran] Huazhong Univ Sci & Technol, Union Plast & Aesthet Hosp, Wuhan Union Hosp, Wuhan, Hubei, Peoples R China	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Huazhong University of Science & Technology	Weigand, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, Krankenhausstr 12, D-91054 Erlangen, Germany.; Weigand, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Lab Tissue Engn & Regenerat Med, Krankenhausstr 12, D-91054 Erlangen, Germany.	annika.weigand@uk-erlangen.de	Boccaccini, Aldo R./N-9782-2019; Boccaccini, Aldo R/C-7905-2013	Boccaccini, Aldo R./0000-0002-7377-2955; Bauerle, Tobias/0000-0002-0206-6199; Detsch, Rainer/0000-0001-9383-428X	Staedtler Foundation (University of Erlangen-Nurnberg); Manfred Roth Foundation; Forschungsstiftung Medizin; University of Erlangen-Nurnberg; Interdisciplinary Center for Clinical Research (IZKF; Faculty of Medicine, FAU); German Research Foundation (DFG) within the Collaborative Research Center TRR225; Marohn-Stiftung; Sofie-Wallner Stiftung; Xue Hong and Hans Georg Geis Foundation	Staedtler Foundation (University of Erlangen-Nurnberg); Manfred Roth Foundation; Forschungsstiftung Medizin; University of Erlangen-Nurnberg; Interdisciplinary Center for Clinical Research (IZKF; Faculty of Medicine, FAU); German Research Foundation (DFG) within the Collaborative Research Center TRR225; Marohn-Stiftung; Sofie-Wallner Stiftung; Xue Hong and Hans Georg Geis Foundation	The authors thank J. Jordan, C. Gillmann, and L. Seyler (University Hospital of Erlangen) for their technical support with the 3D imaging; S. Reakasame [Friedrich-Alexander University Erlangen-Nurnberg (FAU)] for technical support with the 3D encapsulation of the cells; E. Nakashima (Keio University Tokyo, Japan) for providing TR-BME2 cells; A. Raabe [University Cancer Center Hamburg (UCCH)] for providing R1H cells; P. J. K. Kuppen (Leiden University Medical Center, Leiden, The Netherlands) for providing MCR86 cells; T. L. M. ten Hagen (Erasmus Medical Center, Rotterdam, The Netherlands) for providing ROS-1 cells; and S. Fleischer and I. Arnold-Herberth (both from the University Hospital of Erlangen) for their excellent technical support. This work was supported, in part, by the Staedtler Foundation (University of Erlangen-Nurnberg), the Manfred Roth Foundation, the Forschungsstiftung Medizin, University of Erlangen-Nurnberg, Interdisciplinary Center for Clinical Research (IZKF; Faculty of Medicine, FAU), the German Research Foundation (DFG) within the Collaborative Research Center TRR225 (Subproject C03), Marohn-Stiftung, Sofie-Wallner Stiftung, and the Xue Hong and Hans Georg Geis Foundation. The authors declare no conflicts of interest.	Adamcic U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053385; Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Cantarella G, 2006, BRIT J CANCER, V94, P1428, DOI 10.1038/sj.bjc.6603092; Cartland S. P., INT J MOL SCI; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chwalek K, 2014, ADV DRUG DELIVER REV, V79-80, P30, DOI 10.1016/j.addr.2014.05.006; de la Puente P, 2013, CLIN CANCER RES, V19, P3360, DOI 10.1158/1078-0432.CCR-13-0462; De Palma M, 2006, BBA-REV CANCER, V1766, P159, DOI 10.1016/j.bbcan.2006.06.003; Farnsworth RH, 2014, ONCOGENE, V33, P3496, DOI 10.1038/onc.2013.304; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Gordon MS, 2010, INT J CANCER, V126, P1777, DOI 10.1002/ijc.25026; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Gupta MK, 2003, WORLD J GASTROENTERO, V9, P1144, DOI 10.3748/wjg.v9.i6.1144; Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061; Hwang CM, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014105; Ivanovska J, 2016, TISSUE ENG PART C-ME, V22, P708, DOI [10.1089/ten.TEC.2015.0452, 10.1089/ten.tec.2015.0452]; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Leto G, 2006, CLIN EXP METASTAS, V23, P117, DOI 10.1007/s10585-006-9010-5; Li WM, 2000, CYTOKINE, V12, P1017, DOI 10.1006/cyto.1999.0678; Liao YY, 2016, ONCOTARGET, V7, P4310, DOI 10.18632/oncotarget.6708; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Marlicz W, 2016, ONCOL REP, V36, P3635, DOI 10.3892/or.2016.5179; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Moldobaeva A, 2005, AM J PHYSIOL-LUNG C, V288, pL1117, DOI 10.1152/ajplung.00370.2004; Nagyova M, 2014, IN VITRO CELL DEV-AN, V50, P656, DOI 10.1007/s11626-014-9750-5; Nanobashvili J., 2003, EUR SURG, V35, P214, DOI 10.1007/s10353-003-0012-0; Ochiya T, 2014, ANGIOGENESIS, V17, P17, DOI 10.1007/s10456-013-9372-7; Oikonomou E, 2013, BIOFACTORS, V39, P343, DOI 10.1002/biof.1112; Pardali E., INT J MOL SCI; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Pelus LM, 2002, CRIT REV ONCOL HEMAT, V43, P257, DOI 10.1016/S1040-8428(01)00202-5; Pena B, 2017, ACS APPL MATER INTER, V9, P31645, DOI 10.1021/acsami.7b11438; Pirisi M, 2000, CANCER DETECT PREV, V24, P150; Poggio P, 2011, J CELL PHYSIOL, V226, P2139, DOI 10.1002/jcp.22549; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Russell JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-177; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sarker B, 2015, INT J BIOL MACROMOL, V78, P72, DOI 10.1016/j.ijbiomac.2015.03.061; Secchiero P, 2004, NEOPLASIA, V6, P364, DOI 10.1593/neo.03421; Shih YT, 2015, GUT, V64, P1132, DOI 10.1136/gutjnl-2013-306302; Shih YT, 2012, CELL SIGNAL, V24, P779, DOI 10.1016/j.cellsig.2011.11.013; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Wang H, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0353-9; Wang Y, 2016, ACTA OCEANOL SIN, V35, P1, DOI 10.1007/s13131-016-0858-1; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yu Y, 2008, EXP CELL RES, V314, P3198, DOI 10.1016/j.yexcr.2008.08.001; Zecchin A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01750	60	9	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5587	5601		10.1096/fj.201800135RR	http://dx.doi.org/10.1096/fj.201800135RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746168				2022-12-28	WOS:000447972500032
J	Larkin, BP; Glastras, SJ; Chen, H; Pollock, CA; Saad, S				Larkin, Benjamin P.; Glastras, Sarah J.; Chen, Hui; Pollock, Carol A.; Saad, Sonia			DNA methylation and the potential role of demethylating agents in prevention of progressive chronic kidney disease	FASEB JOURNAL			English	Review						epigenetics; fetal programming; obesity; type 2 diabetes; diabetic kidney disease	BODY-MASS INDEX; MATERNAL OBESITY; FIBROBLAST ACTIVATION; EPIGENETIC REGULATION; PANCREATIC-ISLETS; RISK; MECHANISMS; EXPRESSION; HYPOXIA; HEALTH	Chronic kidney disease (CKD) is a global epidemic, and its major risk factors include obesity and type 2 diabetes. Obesity not only promotes metabolic dysregulation and the development of diabetic kidney disease but also may independently lead to CKD by a variety of mechanisms, including endocrine and metabolic dysfunction, inflammation, oxidative stress, altered renal hemodynamics, and lipotoxicity. Deleterious renal effects of obesity can also be transmitted from one generation to the next, and it is increasingly recognized that offspring of obese mothers are predisposed to CKD. Epigenetic modifications are changes that regulate gene expression without altering the DNA sequence. Of these, DNA methylation is the most studied. Epigenetic imprints, particularly DNA methylation, are laid down during critical periods of fetal development, and they may provide a mechanism by which maternal-fetal transmission of chronic disease occurs. Our current review explores the evidence for the role of DNA methylation in the development of CKD, diabetic kidney disease, diabetes, and obesity. DNA methylation has been implicated in renal fibrosisthe final pathophysiologic pathway in the development of end-stage kidney diseasewhich supports the notion that demethylating agents may play a potential therapeutic role in preventing development and progression of CKD.Larkin, B. P., Glastras, S. J., Chen, H., Pollock, C. A., Saad, S. DNA methylation and the potential role of demethylating agents in prevention of progressive chronic kidney disease.	[Larkin, Benjamin P.; Glastras, Sarah J.; Pollock, Carol A.; Saad, Sonia] Univ Sydney, Kolling Inst Med Res, Renal Res Lab, Sydney, NSW, Australia; [Glastras, Sarah J.] Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, Sydney, NSW, Australia; [Chen, Hui; Saad, Sonia] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Technology Sydney	Saad, S (corresponding author), Royal North Shore Hosp, Kolling Inst Med Res, Renal Res Lab, Level 9,Reserve Rd, St Leonards, NSW 2065, Australia.	sonia.saad@sydney.edu.au	Chen, Hui/R-6137-2019; Glastras, Sarah J./AAL-2541-2020; Chen, Hui/D-2005-2014	Chen, Hui/0000-0001-6883-3752; Glastras, Sarah J./0000-0002-9317-1348; Chen, Hui/0000-0001-6883-3752; Larkin, Benjamin/0000-0002-7278-1112; Saad, Sonia/0000-0001-8067-8046	University of Technology Sydney; National Natural Science Foundation of China; Northern Sydney Local Health District; University of Sydney through a Sydney Medical School Foundation	University of Technology Sydney; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northern Sydney Local Health District; University of Sydney through a Sydney Medical School Foundation	H.C. is supported by an Equity Fellowship awarded by the University of Technology Sydney, and a Research Fellowship for International Young Scientists awarded by National Natural Science Foundation of China. The salary of S.S. has been jointly supported by Northern Sydney Local Health District and the University of Sydney through a Sydney Medical School Foundation. The authors declare no conflicts of interest.	Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Afkarian M, 2016, JAMA-J AM MED ASSOC, V316, P602, DOI 10.1001/jama.2016.10924; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Arce C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-10; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Beckerman P, 2014, NEPHROL DIAL TRANSPL, V29, P1821, DOI 10.1093/ndt/gfu026; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Chen H, 2014, DIABETOLOGIA, V57, P614, DOI 10.1007/s00125-013-3132-5; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Chen Z, 2016, P NATL ACAD SCI USA, V113, pE3002, DOI 10.1073/pnas.1603712113; Chu AY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01297-7; Cutfield WS, 2007, PEDIATR RES, V61, p68R, DOI 10.1203/pdr.0b013e318045764c; de Boer IH, 2014, LANCET DIABETES ENDO, V2, P793, DOI 10.1016/S2213-8587(14)70155-X; Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dotsch J, 2012, PEDIATR NEPHROL, V27, P513, DOI 10.1007/s00467-011-1781-5; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; Ekstrom TJ, 2009, J NEPHROL, V22, P442; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Glastras SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172644; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27769; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Glastras SJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0032-3; Gotoh K, 2013, NEPHROL DIAL TRANSPL, V28, P1120, DOI 10.1093/ndt/gfs440; Gu TW, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-21; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hayashi K, 2015, ARCH IMMUNOL THER EX, V63, P193, DOI 10.1007/s00005-014-0326-6; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Higgins DF, 2014, J AM SOC NEPHROL, V25, P865, DOI 10.1681/ASN.2014010006; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hsu CW, 2014, J AM SOC NEPHROL, V25, P2105, DOI 10.1681/ASN.2013060582; Iacobazzi V, 2013, MOL GENET METAB, V110, P25, DOI 10.1016/j.ymgme.2013.07.012; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Kandler M. R., 2011, COCHRANE DB SYST REV, V9; Kato S, 2012, NEPHRON EXTRA, V2, P159, DOI 10.1159/000339437; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Ko YA, 2013, SEMIN NEPHROL, V33, P354, DOI 10.1016/j.semnephrol.2013.05.007; Kovesdy CP, 2017, AM J NEPHROL, V45, P283, DOI 10.1159/000458467; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; KULAKAUSKAS S, 1994, GENE, V142, P9, DOI 10.1016/0378-1119(94)90348-4; Kurdyukov Sergey, 2016, Biology-Basel, V5, DOI 10.3390/biology5010003; Li PKT, 2012, NAT REV NEPHROL, V8, P77, DOI 10.1038/nrneph.2011.194; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23421; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Maghbooli Z, 2015, DIABETES-METAB RES, V31, P183, DOI 10.1002/dmrr.2584; Maghbooli Z, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-69; Mao YJ, 2015, EBIOMEDICINE, V2, P7, DOI 10.1016/j.ebiom.2014.10.016; Marumo T, 2015, J AM SOC NEPHROL, V26, P2388, DOI 10.1681/ASN.2014070665; Mau T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00438; Mendelson MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002215; Mimura I, 2013, SEMIN NEPHROL, V33, P375, DOI 10.1016/j.semnephrol.2013.05.009; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Nomura Y, 2014, REPROD SCI, V21, P131, DOI 10.1177/1933719113492206; Ozieh MN, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2303-3; PIERPONT GL, 1980, CIRCULATION, V61, P323, DOI 10.1161/01.CIR.61.2.323; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Reddy MA, 2015, KIDNEY INT, V88, P250, DOI 10.1038/ki.2015.148; Reddy MA, 2015, DIABETOLOGIA, V58, P443, DOI 10.1007/s00125-014-3462-y; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Sapienza C, 2011, EPIGENETICS-US, V6, P20, DOI 10.4161/epi.6.1.13362; Sharp GC, 2015, INT J EPIDEMIOL, V44, P1288, DOI 10.1093/ije/dyv042; Singh Lalit P, 2013, J Clin Exp Ophthalmol, V4, DOI 10.4172/2155-9570.1000287; Smyth LJ, 2014, AM J PHYSIOL-RENAL, V307, pF757, DOI 10.1152/ajprenal.00306.2014; Smyth LJ, 2014, EPIGENETICS-US, V9, P366, DOI 10.4161/epi.27161; Stangenberg S, 2015, AM J PHYSIOL-RENAL, V308, pF1189, DOI 10.1152/ajprenal.00638.2014; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Suliman ME, 2005, NEPHROL DIAL TRANSPL, V20, P16, DOI 10.1093/ndt/gfh447; Swan EJ, 2015, DIABETIC MED, V32, P1110, DOI 10.1111/dme.12775; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tain YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020381; Tampe B, 2017, KIDNEY INT, V91, P157, DOI 10.1016/j.kint.2016.07.042; Tampe B, 2015, EBIOMEDICINE, V2, P19, DOI 10.1016/j.ebiom.2014.11.005; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Tanaka S, 2014, AM J PHYSIOL-RENAL, V307, pF1187, DOI 10.1152/ajprenal.00425.2014; Thomas MC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0723-9; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Tregouet DA, 2008, DIABETES, V57, P2843, DOI 10.2337/db08-0073; Tsujimoto T, 2014, J EPIDEMIOL, V24, P444, DOI 10.2188/jea.JE20140028; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wang V, 2016, SEMIN NEPHROL, V36, P319, DOI 10.1016/j.semnephrol.2016.05.008; Whaley-Connell A, 2017, KIDNEY INT, V92, DOI 10.1016/j.kint.2016.12.034; Wing MR, 2014, NEPHROL DIAL TRANSPL, V29, P864, DOI 10.1093/ndt/gft537; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Woroniecki R, 2011, PEDIATR NEPHROL, V26, P705, DOI 10.1007/s00467-010-1714-8; Wu BC, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000154; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Zambrano P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-44; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a; Zeisberg EM, 2013, J PATHOL, V229, P264, DOI 10.1002/path.4120; Zeisberg EM., 2016, J CLIN EPIGENET, V2, P2472; Zhang L, 2017, KIDNEY INT, V92, P140, DOI 10.1016/j.kint.2017.01.010; Zhao J, 2013, INT J OBESITY, V37, P140, DOI 10.1038/ijo.2012.8; Zinovkina LA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1571, DOI 10.1134/S0006297915120044	98	23	24	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5215	5226		10.1096/fj.201800205R	http://dx.doi.org/10.1096/fj.201800205R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688808				2022-12-28	WOS:000447972500002
J	Sundar, IK; Rashid, K; Gerloff, J; Rangel-Moreno, J; Li, DM; Rahman, I				Sundar, Isaac K.; Rashid, Kahkashan; Gerloff, Janice; Rangel-Moreno, Javier; Li, Dongmei; Rahman, Irfan			Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema	FASEB JOURNAL			English	Article						cigarette smoke; HDAC2; DNA damage; inflammation	OBSTRUCTIVE PULMONARY-DISEASE; DNA-DAMAGE RESPONSE; NF-KAPPA-B; CIGARETTE-SMOKE; ACTIVATING FACTOR; HDAC2; EMPHYSEMA; CELLS; COPD; MICE	Histone deacetylase 2 (HDAC2), a critical determinant of chromatin remodeling, is reduced as a consequence of oxidative stress-mediated DNA damage and impaired repair. Cigarette smoke (CS) exposure causes DNA damage and cellular senescence. However, no information is available on the role of HDAC2 in CS-induced DNA damage, stress-induced premature senescence (SIPS), and senescence-associated secretory phenotype (SASP) during the pathogenesis of chronic obstructive pulmonary disease (COPD)/emphysema. We hypothesized that CS causes persistent DNA damage and cellular senescence via HDAC2-dependent mechanisms. We used HDAC2 global knockout (KO) and HDAC2 lung epithelial cell-specific KO [Clara cell-specific HDAC2 deletion (HDAC2 CreCC10)] mice to determine whether HDAC2 is a major player in CS-induced oxidative stress, SIPS, and SASP. HDAC2 KO mice exposed to CS show exaggerated DNA damage, inflammatory response, and decline in lung function leading to airspace enlargement. Chronic CS exposure augments lung senescence-associated -galactosidase activity in HDAC2 KO, but not in HDAC2 CreCC10 mice. HDAC2 lung epithelial cell-specific KO did not further augment CS-induced inflammatory response and airspace enlargement but instead caused an increase in lymphoid aggregate formation. Our study reveals that HDAC2 is a key player regulating CS-induced DNA damage, inflammatory response, and cellular senescence leading to COPD/emphysema.Sundar, I. K., Rashid, K., Gerloff, J., Rangel-Moreno, J., Li, D., Rahman, I. Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema.	[Sundar, Isaac K.; Rashid, Kahkashan; Gerloff, Janice; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA; [Rangel-Moreno, Javier] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Li, Dongmei] Univ Rochester, Med Ctr, Dept Clin & Translat Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012	Sundar, Isaac K/0000-0001-6742-3460; Rangel-Moreno, Javier/0000-0002-9738-1182	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [2R01HL085613, 3R01HL085613-09S1]; Department of Medicine at the University of Rochester; NIH, National Institute of Allergy and Infectious Diseases (NIAID) [RO1AI111914]; University of Rochester CTSA from the NIH, National Center for Advancing Translational Sciences [UL1 TR002001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111914] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Medicine at the University of Rochester; NIH, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Rochester CTSA from the NIH, National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Drs. Hongwei Yao, Tanveer Ahmad, and Chad Lerner for their technical assistance. This work was supported by the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grants 2R01HL085613 and 3R01HL085613-09S1 (to I.R.); the Department of Medicine at the University of Rochester and the NIH, National Institute of Allergy and Infectious Diseases (NIAID) Grant RO1AI111914 (to J.R.-M.); and in part by the University of Rochester CTSA award number UL1 TR002001 from the NIH, National Center for Advancing Translational Sciences (to D.L.). The authors declare no conflicts of interest.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Adenuga D, 2010, BIOCHEM BIOPH RES CO, V403, P452, DOI 10.1016/j.bbrc.2010.11.054; Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Ahmad T, 2017, AM J RESP CELL MOL, V56, P38, DOI 10.1165/rcmb.2016-0198OC; Ahmad T, 2015, FASEB J, V29, P2912, DOI 10.1096/fj.14-268276; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen Y, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-10; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Demaria M, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1299666; Dovey OM, 2013, BLOOD, V121, P1335, DOI 10.1182/blood-2012-07-441949; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Heink S, 2017, NAT IMMUNOL, V18, P474, DOI 10.1038/ni0417-474b; Hodge G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00617; Hodge G, 2015, RESP RES, V16, DOI 10.1186/s12931-014-0161-7; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hsieh HH, 2017, J CELL SCI, V130, P3272, DOI 10.1242/jcs.204974; Huang DM, 2017, ONCOTARGET, V8, P56726, DOI 10.18632/oncotarget.18089; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kim RY, 2017, J ALLERGY CLIN IMMUN, V139, P519, DOI 10.1016/j.jaci.2016.04.038; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969; Laan M, 1999, J IMMUNOL, V162, P2347; Lai TW, 2018, CHEST, V153, P863, DOI 10.1016/j.chest.2017.10.031; Lehmann M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02367-2016; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; Meja KK, 2008, AM J RESP CELL MOL, V39, P312, DOI 10.1165/rcmb.2008-0012OC; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Polverino F, 2015, AM J RESP CRIT CARE, V192, P695, DOI 10.1164/rccm.201501-0107OC; Quintana FJ, 2017, NAT IMMUNOL, V18, P8, DOI 10.1038/ni.3637; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Seys LJM, 2015, AM J RESP CRIT CARE, V192, P706, DOI 10.1164/rccm.201501-0103OC; Solleti SK, 2016, FASEB J, V30, P2615, DOI 10.1096/fj.201500159R; Sundar IK, 2018, AM J RESP CELL MOL, V59, P189, DOI 10.1165/rcmb.2017-0390OC; Sundar IK, 2016, AM J PHYSIOL-LUNG C, V311, pL1245, DOI 10.1152/ajplung.00253.2016; Tan CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147380; Tanaka T, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-26; Thurn KT, 2013, MOL CANCER THER, V12, P2078, DOI 10.1158/1535-7163.MCT-12-1242; To M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0588-8; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Tuder RM, 2008, AM J RESP CELL MOL, V39, P1, DOI 10.1165/rcmb.2008-0117TR; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Van Pottelberge GR, 2010, EUR RESPIR J, V36, P781, DOI 10.1183/09031936.00140409; Wagner M, 2001, FEBS LETT, V499, P101, DOI 10.1016/S0014-5793(01)02524-8; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Wen LF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00066; Winter M, 2013, EMBO J, V32, P3176, DOI 10.1038/emboj.2013.243; Xia ML, 2018, J ASTHMA, V55, P337, DOI 10.1080/02770903.2017.1337788; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080007; Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533	70	14	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4955	4971		10.1096/fj.201701518R	http://dx.doi.org/10.1096/fj.201701518R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29630406	Green Published			2022-12-28	WOS:000443817700028
J	Touch, S; Assmann, KE; Aron-Wisnewsky, J; Marquet, F; Rouault, C; Fradet, M; Mosbah, H; Isnard, R; Helft, G; Lehuen, A; Poitou, C; Clement, K; Andre, S				Touch, Sothea; Assmann, Karen E.; Aron-Wisnewsky, Judith; Marquet, Florian; Rouault, Christine; Fradet, Magali; Mosbah, Helena; Isnard, Richard; Helft, Gerard; Lehuen, Agnes; Poitou, Christine; Clement, Karine; Andre, Sebastien		MetaCardis Consortium	Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders	FASEB JOURNAL			English	Article						inflammation; lymphocytes; metabolism; cardiology	NATRIURETIC PEPTIDE LEVELS; DECOMPENSATED HEART-FAILURE; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ADIPOSE-TISSUE; OBESITY; INFLAMMATION; MR1; PROGRESSION	The disruption of systemic immune homeostasis is a key mediator in the progression of cardiometabolic diseases (CMDs). We aimed to extend knowledge regarding the clinical relevance of CMD-associated variation of circulating mucosal-associated invariant T (MAIT) cell abundance and to explore underlying cellular mechanisms. We analyzed cross-sectional data from 439 participants of the Metagenomics in Cardiometabolic Diseases (MetaCardis) study, stratified into 6 groups: healthy control subjects and patients with metabolic syndrome (MS), obesity, type 2 diabetes mellitus (T2DM), and coronary artery disease (CAD) without, or with congestive heart failure (CAD-CHF). Blood MAIT cell frequency was significantly decreased in all CMD groups, including early (MS) and later (CAD and CAD-CHF) stages of disease progression. Reduced MAIT cell abundance was associated with increased glycosylated hemoglobin, inflammation markers, and deterioration of cardiac function. Glucose dose dependently promoted MAIT cell apoptosis in vitro, independently of anti-CD3 and cytokine-mediated activation. This outcome suggests the prominence of metabolic over an antigenic or cytokine-rich environment to promote MAIT cell reduction in patients with CMD. In summary, all stages of CMDs are characterized by reduced circulating MAIT cells. Chronically elevated blood glucose levels could contribute to this decline. These data extend the pathologic relevance of MAIT cell loss and suggest that MAIT cell abundance may serve as an indicator of cardiometabolic health.Touch, S., Assmann, K. E., Aron-Wisnewsky, J., Marquet, F., Rouault, C., Fradet, M., Mosbah, H., MetaCardis Consortium, Isnard, R., Helft, G., Lehuen, A., Poitou, C., Clement, K., Andre, S. Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders.	[Touch, Sothea; Assmann, Karen E.; Aron-Wisnewsky, Judith; Marquet, Florian; Rouault, Christine; Mosbah, Helena; Poitou, Christine; Clement, Karine; Andre, Sebastien] Sorbonne Univ, INSERM, Unite Mixte Rech Sci UMR S 1166, Nutri Team, Paris, France; [Touch, Sothea; Assmann, Karen E.; Aron-Wisnewsky, Judith; Marquet, Florian; Rouault, Christine; Fradet, Magali; Isnard, Richard; Helft, Gerard; Poitou, Christine; Clement, Karine; Andre, Sebastien; MetaCardis Consortium] Hop La Pitie Salpetriere, ICAN, Paris, France; [Aron-Wisnewsky, Judith; Mosbah, Helena; Poitou, Christine; Clement, Karine] Hop La Pitie Salpetriere, AP HP, Dept Nutr, Paris, France; [Mosbah, Helena] Hop La Pitie Salpetriere, AP HP, Dept Endocrinol, Paris, France; [Isnard, Richard; Helft, Gerard] Hop La Pitie Salpetriere, AP HP, Dept Cardiol, Paris, France; [Lehuen, Agnes] Inst Cochin, INSERM, Unite 1016, Paris, France; [Lehuen, Agnes] CNRS, UMR 8104, Paris, France; [Lehuen, Agnes] Univ Paris 05, Sorbonne Paris Cite, Lab Excellence Inflamex, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Clement, K; Andre, S (corresponding author), Inst Cardiometab & Nutr, UMR S 1166, Team Nutri 6, 91 Blvd Hop, F-75013 Paris, France.	karine.clement@aphp.fr; sebastien.andre@upmc.fr	Poitou, Christine/GVT-6117-2022; ARON-WISNEWSKY, judith/AAH-7608-2020	Poitou, Christine/0000-0001-7769-6331; ANDRE, Sebastien/0000-0002-7543-153X; Kerneis, Mathieu/0000-0002-7141-5209; Salem, Joe-Elie/0000-0002-0331-3307; Assmann, Karen/0000-0003-3618-9573	Agence Nationale de la Recherche (ANR OB-MAIT); European Union's Seventh Framework Program for research, technological development, and demonstration [HEALTH-F4-2012-305312]; Societe Francaise de Nutrition (SFN); Fondation Coeur et Arteres; F-CRIN-FORCE network	Agence Nationale de la Recherche (ANR OB-MAIT); European Union's Seventh Framework Program for research, technological development, and demonstration; Societe Francaise de Nutrition (SFN); Fondation Coeur et Arteres; F-CRIN-FORCE network	The authors thank the subjects for their participation in the MetaCardis study, and particularly the patient associations [Alliance du Coeur and Collectif National des Associations d'Obeses (CNAO)]. The authors also thank Dr. Dominique Bonnefont-Rousselot and Randa Bittar (Department of Metabolic Biochemistry, Pitie-Salpetriere Hospital) for the analysis of plasma lipid profiles; Dr. Michele Guerre-Millo (Sorbonne Universite, INSERM, UMR_S 1166, Nutriomics Team) for helpful discussion and critical comments of the manuscript; and Marianne Grain and Aurelie Gestin (Institute of Cardiometabolism and Nutrition (ICAN), Pitie-Salpetriere Hospital), who contributed to flow cytometry experiments. The authors thank the nurses, technicians, clinical research assistant, and data managers from the clinical investigation platform at the Institute of Cardiometabolism and Nutrition (ICAN) for patient investigations and the Clinical Investigation Center from Pitie-Salpetriere Hospital for investigation of the healthy control subjects. Quantal Medical supervised the regulatory aspect of the clinical intervention and contributed to the processing and management of electronic data. The authors acknowledge the flow cytometry core facility Cyto-ICAN for assistance with the generation of flow cytometry data. This work was supported by Agence Nationale de la Recherche (ANR OB-MAIT) and the European Union's Seventh Framework Program for research, technological development, and demonstration under grant agreement HEALTH-F4-2012-305312 (MetaCardis). Assistance Publique-Hopitaux de Paris is the promoter of the clinical investigation. The authors also thank Societe Francaise de Nutrition (SFN), Fondation Coeur et Arteres, and F-CRIN-FORCE network for support. The authors declare no conflicts of interest.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Blom G., 1958, STAT ESTIMATES TRANS; Caer C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02660-w; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Carolan E, 2015, J IMMUNOL, V194, P5775, DOI 10.4049/jimmunol.1402945; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; Fouad YM, 2014, WORLD J HEPATOL, V6, P41, DOI 10.4254/wjh.v6.i1.41; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Guarner V, 2015, INTERD T GERONT GERI, V40, P99, DOI 10.1159/000364934; Guo FJ, 2014, OBESITY, V22, P110, DOI 10.1002/oby.20585; Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291; Hiejima E, 2015, INFLAMM BOWEL DIS, V21, P1529, DOI 10.1097/MIB.0000000000000397; Hinks TSC, 2016, IMMUNOLOGY, V148, P1, DOI 10.1111/imm.12582; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kurioka A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.51; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee OJ, 2014, EXP GERONTOL, V49, P47, DOI 10.1016/j.exger.2013.11.003; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246; Novak J, 2014, SCAND J IMMUNOL, V80, P271, DOI 10.1111/sji.12193; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Scholze J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-529; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Sharma PK, 2015, IMMUNOLOGY, V145, P443, DOI 10.1111/imm.12461; Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051; Walker LJ, 2014, SCAND J IMMUNOL, V80, P462, DOI 10.1111/sji.12237; Wong EB, 2017, IMMUNOLOGY, V150, P45, DOI 10.1111/imm.12673; Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312	48	26	26	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5078	5089		10.1096/fj.201800052RR	http://dx.doi.org/10.1096/fj.201800052RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29957059				2022-12-28	WOS:000443817700037
J	Lim, DH; Lee, S; Han, JY; Choi, MS; Hong, JS; Seong, Y; Kwon, YS; Lee, YS				Lim, Do-Hwan; Lee, Seungjae; Han, Jee Yun; Choi, Min-Seok; Hong, Jae-Sang; Seong, Youngmo; Kwon, Young-Soo; Lee, Young Sik			Ecdysone-responsive microRNA-252-5p controls the cell cycle by targeting Abi in Drosophila	FASEB JOURNAL			English	Article						20E; Ago1; CLIP-seq; microRNA; cyclin	GENE-EXPRESSION; INDUCIBLE GENE; BINDING-SITES; EARLY PUFF; ENCODES 2; RNA; TRANSCRIPTION; RECEPTOR; COMPLEX; PROTEIN	The steroid hormone ecdysone has a central role in the developmental transitions of insects through its control of responsive protein-coding and microRNA (miRNA) gene expression. However, the complete regulatory network controlling the expression of these genes remains to be elucidated. In this study, we performed cross-linking immunoprecipitation coupled with deep sequencing of endogenous Argonaute 1 (Ago1) protein, the core effector of the miRNA pathway, in Drosophila S2 cells. We found that regulatory interactions between miRNAs and their cognate targets were substantially altered by Ago1 in response to ecdysone signaling. Additionally, during the larva-to-adult metamorphosis, miR-252-5p was up-regulated via the canonical ecdysone-signaling pathway. Moreover, we provide evidence that miR-252-5p targets Abelson interacting protein (Abi) to decrease the protein levels of cyclins A and B, controlling the cell cycle. Overall, our data suggest a potential role for the ecdysone/miR-252-5p/Abi regulatory axis partly in cell-cycle control during metamorphosis in Drosophila.Lim, D.-H., Lee, S., Han, J. Y., Choi, M.-S., Hong, J.-S., Seong, Y., Kwon, Y.-S., Lee, Y. S. Ecdysone-responsive microR-252-5p controls the cell cycle by targeting Abi in Drosophila.	[Lim, Do-Hwan; Lee, Seungjae; Han, Jee Yun; Choi, Min-Seok; Hong, Jae-Sang; Lee, Young Sik] Korea Univ, Coll Life Sci & Biotechnol, Room 316,W Bldg,145 Anam Ro, Seoul 02841, South Korea; [Lim, Do-Hwan; Lee, Seungjae; Choi, Min-Seok; Hong, Jae-Sang; Lee, Young Sik] Korea Univ, Inst Anim Mol Biotechnol, Seoul, South Korea; [Seong, Youngmo; Kwon, Young-Soo] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Lim, Do-Hwan; Han, Jee Yun] Univ Calif San Diego, La Jolla, CA 92093 USA	Korea University; Korea University; Sejong University; University of California System; University of California San Diego	Lee, YS (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Room 316,W Bldg,145 Anam Ro, Seoul 02841, South Korea.	ys-lee@korea.ac.kr	Lim, Dohwan/ABA-2685-2020	Lee, Seungjae/0000-0001-9081-2835; Lim, Do-Hwan/0000-0002-2054-1416; Lee, Seungjae/0000-0001-5626-9656	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2058193]; Korea University	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea University	The authors thank the Bloomington Stock Center (Indiana University Bloomington, Bloomington, IN, USA) for fly strains, and the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA, USA) for fly antibodies. The authors also thank S. Bogdan (Universitat Munster, Munster, Germany) for providing anti-Abi antibodies. This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2058193 to Y.S.L.), and Korea University grants (to Y.S.L. and D.-H.L.). The authors declare no conflicts of interest.	Althammer S, 2011, BIOINFORMATICS, V27, P3333, DOI 10.1093/bioinformatics/btr570; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Boudreau RL, 2014, NEURON, V81, P294, DOI 10.1016/j.neuron.2013.10.062; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Busto GU, 2015, GENETICS, V200, P569, DOI 10.1534/genetics.114.169623; Carthew R. W., 2006, CSH PROTOC, V2006; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cohen S, 2010, SEMIN CELL DEV BIOL, V21, P727, DOI 10.1016/j.semcdb.2010.07.004; Cranna N, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-3; Crevel G, 2005, J CELL SCI, V118, P2451, DOI 10.1242/jcs.02361; DIBELLO PR, 1991, GENETICS, V129, P385; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gaken J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks145; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guo YF, 2016, BIOL OPEN, V5, P1648, DOI 10.1242/bio.017525; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ishidate T, 2014, CELL CYCLE, V13, P1384, DOI 10.4161/cc.28656; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Jin H, 2012, GENE DEV, V26, P1427, DOI 10.1101/gad.192872.112; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KG, 2007, CELL CYCLE, V6, P1487; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim DH, 2013, J CELL BIOCHEM, V114, P418, DOI 10.1002/jcb.24379; Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034; Lin TY, 2004, J BIOMED SCI, V11, P902, DOI 10.1159/000081837; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Marrone AK, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-26; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Nonaka M, 2004, MOL IMMUNOL, V40, P897, DOI 10.1016/j.molimm.2003.10.009; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Pollitt AY, 2008, CURR BIOL, V18, P203, DOI 10.1016/j.cub.2008.01.026; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Schertel C, 2012, GENETICS, V192, P1543, DOI 10.1534/genetics.112.145383; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Seong Y, 2014, NUCLEIC ACIDS RES, V42, P12806, DOI 10.1093/nar/gku957; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Towler BP, 2015, RNA BIOL, V12, P728, DOI 10.1080/15476286.2015.1040978; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Wu YC, 2012, DEV CELL, V23, P202, DOI 10.1016/j.devcel.2012.05.013; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	69	12	13	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4519	4533		10.1096/fj.201701185RR	http://dx.doi.org/10.1096/fj.201701185RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29543534				2022-12-28	WOS:000439325400038
J	Mbanefo, EC; Le, L; Pennington, LF; Odegaard, JI; Jardetzky, TS; Alouffi, A; Falcone, FH; Hsieh, MH				Mbanefo, Evaristus C.; Le, Loc; Pennington, Luke F.; Odegaard, Justin I.; Jardetzky, Theodore S.; Alouffi, Abdulaziz; Falcone, Franco H.; Hsieh, Michael H.			Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis	FASEB JOURNAL			English	Article						infiltrin; anti-inflammatory; ifosfamide; urothelial; Schistosoma	RECOMBINANT HUMAN INTERLEUKIN-4; SCHISTOSOMA-MANSONI EGGS; SOUTHWEST-ONCOLOGY-GROUP; CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; MOUSE URINARY-BLADDER; RENAL-CELL CARCINOMA; PHASE-II TRIAL; MALIGNANT-MELANOMA; ADVANCED CANCER; VISCERAL PAIN	Chemotherapy-induced hemorrhagic cystitis (CHC) can be difficult to manage. Prior work suggests that IL-4 alleviates ifosfamide-induced hemorrhagic cystitis (IHC), but systemically administered IL-4 causes significant side effects. We hypothesized that the Schistosoma hematobium homolog of IL-4-inducing principle from Schistosoma mansoni eggs (H-IPSE), would reduce IHC and associated bladder pathology. IPSE binds IgE on basophils and mast cells, triggering IL-4 secretion by these cells. IPSE is also an infiltrin, translocating into the host nucleus to modulate gene transcription. Mice were administered IL-4, H-IPSE protein or its nuclear localization sequence (NLS) mutant, with or without neutralizing anti-IL-4 antibody, or 2-mercaptoethane sulfonate sodium (MESNA; a drug used to prevent IHC), followed by ifosfamide. Bladder tissue damage and hemoglobin content were measured. Spontaneous and evoked pain, urinary frequency, and bladdergene expression analysis were assessed. Pain behaviors were interpreted in a blinded fashion. One dose of H-IPSE was superior to MESNA and IL-4 in suppressing bladder hemorrhage in an IL-4-dependent fashion and comparable with MESNA in dampening ifosfamide-triggered pain behaviors in an NLS-dependent manner. H-IPSE also accelerated urothelial repair following IHC. Our work represents the first therapeutic exploitation of a uropathogen-derived host modulatory molecule in a clinically relevant bladder disease model and indicates that IPSE may be an alternative to MESNA for mitigating CHC.Mbanefo, E. C., Le, L., Pennington, L. F., Odegaard, J. I., Jardetzky, T. S., Alouffi, A., Falcone, F. H., Hsieh, M. H. Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis.	[Mbanefo, Evaristus C.; Le, Loc; Hsieh, Michael H.] Biomed Res Inst, Bladder Immunol Grp, Rockville, MD 20852 USA; [Mbanefo, Evaristus C.; Hsieh, Michael H.] Childrens Natl Med Ctr, Div Urol, Washington, DC 20010 USA; [Pennington, Luke F.; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Odegaard, Justin I.] OneOme, Redwood City, CA USA; [Alouffi, Abdulaziz] King Abdulaziz City Sci & Technol, Life Sci & Environm Sect, Riyadh, Saudi Arabia; [Falcone, Franco H.] Univ Nottingham, Sch Pharm, Div Mol Therapeut & Formulat, Nottingham, England; [Hsieh, Michael H.] George Washington Univ, Dept Urol, Washington, DC USA	Children's National Health System; Stanford University; King Abdulaziz City for Science & Technology; University of Nottingham; George Washington University	Hsieh, MH (corresponding author), Biomed Res Inst, 9410 Key West Ave, Rockville, MD 20850 USA.	mhsieh@afbr-bri.org	Falcone, Franco/AAE-8026-2021; Mbanefo, Evaristus/AAY-8504-2020; Alouffi, Abdulaziz/AAK-2328-2020; Falcone, Franco H/F-9210-2013	Falcone, Franco/0000-0002-1732-9932; Alouffi, Abdulaziz/0000-0001-8863-3870; Falcone, Franco H/0000-0002-1732-9932; Pennington, Luke/0000-0002-7947-8714	Margaret A. Stirewalt Endowment; U.S. National Institutes of Health; National Institute of Allergy and Infectious Diseases [R56AI119168]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK113504]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI119168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113504] Funding Source: NIH RePORTER	Margaret A. Stirewalt Endowment; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors appreciate Jesse Nussbaum (University of California San Francisco, San Francisco, CA, USA) for helpful discussions, and gratefully acknowledge funding from the Margaret A. Stirewalt Endowment, U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases (Grant R56AI119168) and National Institute of Diabetes and Digestive and Kidney Diseases (Grant R01DK113504, both awarded to M.H.H.). The authors declare no conflicts of interest.	Abdi SAH, 2016, BASIC CLIN PHARMACOL, V119, P598, DOI 10.1111/bcpt.12627; Ackert-Bicknell Cheryl L, 2015, Curr Protoc Mouse Biol, V5, P95, DOI 10.1002/9780470942390.mo140195; Advani SH, 1998, AUST NZ J MED, V28, P410, DOI 10.1111/j.1445-5994.1998.tb01976.x; Lima MVA, 2007, CANCER CHEMOTH PHARM, V59, P643, DOI 10.1007/s00280-006-0307-5; ANDRIOLE GL, 1987, J CLIN ONCOL, V5, P799, DOI 10.1200/JCO.1987.5.5.799; ATKINS MB, 1992, J CLIN ONCOL, V10, P1802, DOI 10.1200/JCO.1992.10.11.1802; Bon K, 2003, J UROLOGY, V170, P1008, DOI 10.1097/01.ju.0000079766.49550.94; Boucher M, 2000, J UROLOGY, V164, P203, DOI 10.1016/S0022-5347(05)67495-2; Macedo FYB, 2008, EXP TOXICOL PATHOL, V59, P425, DOI 10.1016/j.etp.2007.10.010; Macedo FYB, 2012, INFLAMMATION, V35, P297, DOI 10.1007/s10753-011-9319-3; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choi SH, 2009, J KOREAN MED SCI, V24, P684, DOI 10.3346/jkms.2009.24.4.684; Davis ID, 2000, GROWTH FACTORS, V17, P287, DOI 10.3109/08977190009028972; Delafosse L, 2016, J BIOTECHNOL, V227, P103, DOI 10.1016/j.jbiotec.2016.04.028; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Fu CL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002605; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Furlanut M, 2003, ONCOLOGY-BASEL, V65, P2, DOI 10.1159/000073350; Giacomin P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13797; Giles FJ, 1999, J INTERF CYTOK RES, V19, P1253, DOI 10.1089/107999099312911; GILLEECE MH, 1992, BRIT J CANCER, V66, P204, DOI 10.1038/bjc.1992.243; Golubeva AV, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.260; GOMES TNA, 1995, BRAZ J MED BIOL RES, V28, P1103; GRAY KJ, 1986, J UROLOGY, V136, P497, DOI 10.1016/S0022-5347(17)44929-9; HADER JE, 1993, J UROLOGY, V149, P1617, DOI 10.1016/S0022-5347(17)36462-5; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hsieh YJ, 2014, INFECT IMMUN, V82, P2087, DOI 10.1128/IAI.01578-13; Kaur I, 2011, INFECT IMMUN, V79, P1779, DOI 10.1128/IAI.01048-10; Klastersky J, 2003, ONCOLOGY-BASEL, V65, P7, DOI 10.1159/000073351; Korkmaz A, 2007, CELL BIOL TOXICOL, V23, P303, DOI 10.1007/s10565-006-0078-0; Kyung YS, 2011, ARCH TOXICOL, V85, P51, DOI 10.1007/s00204-010-0523-y; Laird JMA, 2002, J NEUROSCI, V22, P8352; Lawson M, 2008, SCAND J UROL NEPHROL, V42, P309, DOI 10.1080/00365590701570953; Lee Gilho, 2011, Int Neurourol J, V15, P4, DOI 10.5213/inj.2011.15.1.4; Leite CAVG, 2015, J UROLOGY, V194, P1777, DOI 10.1016/j.juro.2015.07.088; Leventhal L., 2008, CURR PROTOC PHARM; Liao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023786; Lin CH, 2014, AUTOIMMUN REV, V13, P114, DOI 10.1016/j.autrev.2013.09.011; Lukacs NW, 1996, J LEUKOCYTE BIOL, V60, P573, DOI 10.1002/jlb.60.5.573; Lv JW, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/358184; Macedo FYB, 2011, CANCER CHEMOTH PHARM, V67, P935, DOI 10.1007/s00280-010-1392-z; Majhail NS, 2004, INVEST NEW DRUG, V22, P421, DOI 10.1023/B:DRUG.0000036684.67675.fe; Manikandan R, 2010, INDIAN J UROL, V26, P159, DOI 10.4103/0970-1591.65380; MARGOLIN K, 1994, J IMMUNOTHER, V15, P147, DOI 10.1097/00002371-199402000-00009; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; Matz EL, 2017, UROLOGY, V100, P16, DOI 10.1016/j.urology.2016.07.030; Meyer NH, 2015, J BIOL CHEM, V290, P22111, DOI 10.1074/jbc.M115.675066; Meyer NH, 2011, BIOMOL NMR ASSIGN, V5, P225, DOI 10.1007/s12104-011-9305-6; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Olivar T, 1999, EUR J PAIN, V3, P141, DOI 10.1053/eujp.1998.0105; Oter S, 2004, UROL RES, V32, P185, DOI 10.1007/s00240-003-0398-y; Pedalino M, 2010, UROLOG J, V77, P38, DOI 10.1177/0391560310077017S07; Pennington LF, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00301-17; PRENDIVILLE J, 1993, EUR J CANCER, V29A, P1700, DOI 10.1016/0959-8049(93)90108-R; Ribeiro RA, 2002, J UROLOGY, V167, P2229, DOI 10.1016/S0022-5347(05)65134-8; Rogler G, 2015, PHARMACOL RES, V100, P220, DOI 10.1016/j.phrs.2015.07.005; Rosche B, 2013, PARASITE, V20, DOI 10.1051/parasite/2013056; Saito Y, 2016, JPN J CLIN ONCOL, V46, P856, DOI 10.1093/jjco/hyw093; SAKURAI M, 1986, JPN J CLIN ONCOL, V16, P153, DOI 10.1093/oxfordjournals.jjco.a039132; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; SHEPHERD JD, 1991, J CLIN ONCOL, V9, P2016, DOI 10.1200/JCO.1991.9.11.2016; SHULMAN LN, 1993, HEMATOL ONCOL CLIN N, V7, P325, DOI 10.1016/S0889-8588(18)30243-0; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; STADLER WM, 1995, CANCER, V76, P1629, DOI 10.1002/1097-0142(19951101)76:9<1629::AID-CNCR2820760920>3.0.CO;2-Q; Taylor CW, 2000, ANTI-CANCER DRUG, V11, P695, DOI 10.1097/00001813-200010000-00004; Vokes EE, 1998, CANCER J SCI AM, V4, P46; Watanabe K, 2011, J TROP PEDIATRICS, V57, P263, DOI 10.1093/tropej/fmq027; Whitehead RP, 1998, J IMMUNOTHER, V21, P440, DOI 10.1097/00002371-199811000-00006; Whitehead RP, 2002, J IMMUNOTHER, V25, P352, DOI 10.1097/00002371-200207000-00007; Wolfson W, 2013, CHEM BIOL, V20, P135, DOI 10.1016/j.chembiol.2013.02.008; Young SD, 2006, CLIN CANCER RES, V12, P3092, DOI 10.1158/1078-0432.CCR-05-2255; Yu WQ, 2014, AM J PHYSIOL-RENAL, V306, pF1296, DOI 10.1152/ajprenal.00074.2014	75	14	15	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4408	4419		10.1096/fj.201701415R	http://dx.doi.org/10.1096/fj.201701415R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29613835	Green Published, Green Accepted			2022-12-28	WOS:000439325400029
J	Ren, XF; Schmidt, W; Huang, YY; Lu, HS; Liu, WJ; Bu, WM; Eckenhoff, R; Cammarato, A; Gao, WD				Ren, Xianfeng; Schmidt, William; Huang, Yiyuan; Lu, Haisong; Liu, Wenjie; Bu, Weiming; Eckenhoff, Roderic; Cammarato, Anthony; Gao, Wei Dong			Fropofol decreases force development in cardiac muscle	FASEB JOURNAL			English	Article						excitation contraction coupling; myofilament protein; intracellular calcium; fropofol; in vitro motility	FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; VITRO MOTILITY ASSAY; DILATED CARDIOMYOPATHY; HEART-FAILURE; CLINICAL-MANIFESTATIONS; MYOCARDIAL-CONTRACTION; VENTRICULAR-MUSCLE; INDUCED DEPRESSION; CA2+ SENSITIVITY; STRONG BINDING	Supranormal contractile properties are frequently associated with cardiac diseases. Anesthetic agents, including propofol, can depress myocardial contraction. We tested the hypothesis that fropofol, a propofol derivative, reduces force development in cardiac muscles via inhibition of cross-bridge cycling and may therefore have therapeutic potential. Force and intracellular Ca2+ concentration ([Ca2+](i)) transients of rat trabecular muscles were determined. Myofilament ATPase, actin-activated myosin ATPase, and velocity of actin filaments propelled by myosin were also measured. Fropofol dose dependently decreased force without altering [Ca2+](i) in normal and pressure-induced hypertrophied-hypercontractile muscles. Similarly, fropofol depressed maximum Ca2+-activated force (F-max) and increased the [Ca2+](i) required for 50% of F-max (Ca-50) at steady state without affecting the Hill coefficient in both intact and skinned cardiac fibers. The drug also depressed cardiac myofibrillar and actin-activated myosin ATPase activity. In vitro actin sliding velocity was significantly reduced when fropofol was introduced during rigor binding of cross-bridges. The data suggest that the depressing effects of fropofol on cardiac contractility are likely to be related to direct targeting of actomyosin interactions. From a clinical standpoint, these findings are particularly significant, given that fropofol is a nonanesthetic small molecule that decreases myocardial contractility specifically and thus may be useful in the treatment of hypercontractile cardiac disorders.Ren, X., Schmidt, W., Huang, Y., Lu, H., Liu, W., Bu, W., Eckenhoff, R., Cammarato, A., Gao, W. D. Fropofol decreases force development in cardiac muscle.	[Ren, Xianfeng] China Japan Friendship Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Schmidt, William; Cammarato, Anthony] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Ross 1050,720 Rutland Ave, Baltimore, MD 21205 USA; [Huang, Yiyuan; Gao, Wei Dong] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Zayed 6208,1800 Orleans St, Baltimore, MD 21287 USA; [Lu, Haisong] Fuwai Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Liu, Wenjie] South China Univ, Dept Anesthesiol, Sch Med, Hengyang, Peoples R China; [Bu, Weiming; Eckenhoff, Roderic] Univ Penn, Perelman Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA	China-Japan Friendship Hospital; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Pennsylvania; Pennsylvania Medicine	Schmidt, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Ross 1050,720 Rutland Ave, Baltimore, MD 21205 USA.; Gao, WD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Zayed 6208,1800 Orleans St, Baltimore, MD 21287 USA.	wschmid6@jhmi.edu; wgao3@jhmi.edu	Gao, Wei/GXH-0380-2022; Huang, Yi-yuan/AAG-7324-2020	Huang, Yi-yuan/0000-0002-0698-2784	Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StARR) Award from the Department of Anesthesiology and Critical Care Medicine (Johns Hopkins University School of Medicine); American Heart Association-Global Innovation Award (AHA-GIA) [17GRNT33670387]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM055867, GM008076]; NIH National Institute of Neurological Disease and Stroke Grant [NS080519]; NIH National Heart, Lung, and Blood Institute Grant [T32HL007227-38, R01HL124091]; AHA Grant [17POST33630159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007227, R01HL124091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076, R01GM055867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080519] Funding Source: NIH RePORTER	Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StARR) Award from the Department of Anesthesiology and Critical Care Medicine (Johns Hopkins University School of Medicine); American Heart Association-Global Innovation Award (AHA-GIA); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Neurological Disease and Stroke Grant; NIH National Heart, Lung, and Blood Institute Grant; AHA Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in part, by a Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StARR) Award from the Department of Anesthesiology and Critical Care Medicine (Johns Hopkins University School of Medicine; to W.D.G.); American Heart Association-Global Innovation Award (AHA-GIA) (17GRNT33670387; to W.D.G.); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants GM055867 and GM008076, and NIH National Institute of Neurological Disease and Stroke Grant NS080519 (to R.E.); NIH National Heart, Lung, and Blood Institute Grant T32HL007227-38 (to W.S.) and R01HL124091 (to A.C.); and AHA Grant 17POST33630159 (to W.S.). The authors declare no conflicts of interest.	Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Chang AN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00460; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Dai TY, 2007, J PHYSIOL-LONDON, V580, P951, DOI 10.1113/jphysiol.2007.129254; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Ding WG, 2011, J PHARMACOL EXP THER, V339, P825, DOI 10.1124/jpet.111.185272; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; GAO WD, 1994, CIRC RES, V74, P408, DOI 10.1161/01.RES.74.3.408; GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036; Gao WD, 2012, CIRC RES, V111, P1002, DOI 10.1161/CIRCRESAHA.112.270827; Gorga JA, 2003, BIOPHYS J, V85, P2484, DOI 10.1016/S0006-3495(03)74671-2; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Greenberg MJ, 2010, CYTOSKELETON, V67, P273, DOI 10.1002/cm.20441; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Guinto PJ, 2009, AM J PHYSIOL-HEART C, V297, pH614, DOI 10.1152/ajpheart.01143.2008; Hanley PJ, 2004, ANESTHESIOLOGY, V101, P999, DOI 10.1097/00000542-200410000-00027; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Ly S, 2012, BIOCHEMISTRY-US, V51, P6413, DOI 10.1021/bi3006835; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Meng T, 2016, FASEB J, V30, P2915, DOI 10.1096/fj.201600290RR; Orzechowski M, 2014, ARCH BIOCHEM BIOPHYS, V545, P63, DOI 10.1016/j.abb.2014.01.001; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Ryan JJ, 2014, CIRC RES, V115, P176, DOI 10.1161/CIRCRESAHA.113.301129; Schiattarella GG, 2015, CIRCULATION, V131, P1435, DOI 10.1161/CIRCULATIONAHA.115.013894; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; Sharma K, 2014, CIRC RES, V115, P79, DOI 10.1161/CIRCRESAHA.115.302922; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Spoladore R, 2012, EUR HEART J, V33, P1724, DOI 10.1093/eurheartj/ehs150; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Tardiff JC, 2015, CARDIOVASC RES, V105, P457, DOI 10.1093/cvr/cvv023; UCHIDA K, 1977, J BIOCHEM, V82, P469; Viswanathan MC, 2017, CELL REP, V20, P2612, DOI 10.1016/j.celrep.2017.08.070; Woll KA, 2015, ACS CHEM NEUROSCI, V6, P927, DOI 10.1021/acschemneuro.5b00078; Yip GW, 2009, J HUM HYPERTENS, V23, P295, DOI 10.1038/jhh.2008.141; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	45	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4203	4213		10.1096/fj.201701442R	http://dx.doi.org/10.1096/fj.201701442R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29522375	Green Published			2022-12-28	WOS:000439325400012
J	Marosi, K; Moehl, K; Navas-Enamorado, I; Mitchell, SJ; Zhang, YQ; Lehrmann, E; Aon, MA; Cortassa, S; Becker, KG; Mattson, MP				Marosi, Krisztina; Moehl, Keelin; Navas-Enamorado, Ignacio; Mitchell, Sarah J.; Zhang, Yongqing; Lehrmann, Elin; Aon, Miguel A.; Cortassa, Sonia; Becker, Kevin G.; Mattson, Mark P.			Metabolic and molecular framework for the enhancement of endurance by intermittent food deprivation	FASEB JOURNAL			English	Article						exercise; intermittent fasting; muscle; mitochondrial biogenesis; ketone	DISEASE RISK MARKERS; CHAIN AMINO-ACID; SKELETAL-MUSCLE; DIETARY RESTRICTION; UNCOUPLING PROTEIN-3; CALORIC RESTRICTION; ENERGY-INTAKE; WEIGHT-LOSS; OXIDATIVE CAPACITY; GLUCOSE-METABOLISM	Evolutionary considerations suggest that the body has been optimized to perform at a high level in the food-deprived state when fatty acids and their ketone metabolites are a major fuel source for muscle cells. Because controlled food deprivation in laboratory animals and intermittent energy restriction in humans is a potent physiologic stimulus for ketosis, we designed a study to determine the impact of intermittent food deprivation during endurance training on performance and to elucidate the underlying cellular and molecular mechanisms. Male mice were randomly assigned to either ad libitum feeding or alternate-day food deprivation (ADF) groups, and half of the mice in each diet group were trained daily on a treadmill for 1 mo. A run to exhaustion endurance test performed at the end of the training period revealed superior performance in the mice maintained on ADF during training compared to mice fed ad libitum during training. Maximal O-2 consumption was increased similarly by treadmill training in mice on ADF or ad libitum diets, whereas respiratory exchange ratio was reduced in ADF mice on food-deprivation days and during running. Analyses of gene expression in liver and soleus tissues, and metabolomics analysis of blood suggest that the metabolic switch invoked by ADF and potentiated by exercise strongly modulates molecular pathways involved in mitochondrial biogenesis, metabolism, and cellular plasticity. Our findings demonstrate that ADF engages metabolic and cellular signaling pathways that result in increased metabolic efficiency and endurance capacity.Marosi, K., Moehl, K., Navas-Enamorado, I., Mitchell, S. J., Zhang, Y., Lehrmann, E., Aon, M. A., Cortassa, S., Becker, K. G., Mattson, M. P. Metabolic and molecular framework for the enhancement of endurance by intermittent food deprivation.	[Marosi, Krisztina; Moehl, Keelin; Mattson, Mark P.] NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA; [Navas-Enamorado, Ignacio] NIA, Translat Gerontol, Intramural Res Program, Baltimore, MD 21224 USA; [Zhang, Yongqing; Lehrmann, Elin; Becker, Kevin G.] NIA, Gene Express & Genom Unit Core Facil, Intramural Res Program, Baltimore, MD 21224 USA; [Aon, Miguel A.; Cortassa, Sonia] NIA, Lab Cardiovasc Sci, Intramural Res Program, Baltimore, MD 21224 USA; [Mitchell, Sarah J.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University	Mattson, MP (corresponding author), NIH, Biomed Res Ctr, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.	mark.mattson@nih.gov	Moehl, Keelin/W-3227-2019; Cortassa, Sonia/AAO-1633-2020; Aon, Miguel Antonio/A-6564-2008	Moehl, Keelin/0000-0001-7720-3664; Cortassa, Sonia/0000-0001-7224-9858; Aon, Miguel Antonio/0000-0002-4355-5431; Lehrmann, Elin/0000-0002-9869-9475; Navas Enamorado, Ignacio/0000-0003-2197-2864	Intramural Research Program of the U.S. National Institutes of Health, National Institute of Aging; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health, National Institute of Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health, National Institute of Aging. The authors declare no conflicts of interest.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Anton SD, 2018, OBESITY, V26, P254, DOI 10.1002/oby.22065; Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bhutani S, 2013, OBESITY, V21, P1370, DOI 10.1002/oby.20353; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Burke LM, 2007, J SPORT SCI, V25, pS29, DOI 10.1080/02640410701607239; Burke LM, 2017, J PHYSIOL-LONDON, V595, P2785, DOI 10.1113/JP273230; Calbet JAL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00483; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; Catenacci VA, 2016, OBESITY, V24, P1874, DOI 10.1002/oby.21581; Cermak NM, 2013, SPORTS MED, V43, P1139, DOI 10.1007/s40279-013-0079-0; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Conforto TL, 2015, MOL ENDOCRINOL, V29, P1286, DOI 10.1210/me.2015-1028; CONLEE RK, 1990, METABOLISM, V39, P289, DOI 10.1016/0026-0495(90)90049-I; Cox PJ, 2016, CELL METAB, V24, P256, DOI 10.1016/j.cmet.2016.07.010; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Evans M, 2017, J PHYSIOL-LONDON, V595, P2857, DOI 10.1113/JP273185; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Franklin MP, 2017, DIABETES, V66, P2112, DOI 10.2337/db16-1519; Geisler JG, 2017, ALZHEIMERS DEMENT, V13, P582, DOI 10.1016/j.jalz.2016.08.001; Gibala MJ, 2013, NESTLE NUTR WORKS SE, V76, P51, DOI 10.1159/000350256; Godar RJ, 2015, AUTOPHAGY, V11, P1537, DOI 10.1080/15548627.2015.1063768; Gualano AB, 2011, J SPORT MED PHYS FIT, V51, P82; Harries LW, 2012, AGING CELL, V11, P262, DOI 10.1111/j.1474-9726.2011.00782.x; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; HAWKES K, 1991, PHILOS T R SOC B, V334, P243, DOI 10.1098/rstb.1991.0113; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kalinkovich A, 2017, AGEING RES REV, V35, P200, DOI 10.1016/j.arr.2016.09.008; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kephart WC, 2016, AMINO ACIDS, V48, P779, DOI 10.1007/s00726-015-2125-8; LAMBERT EV, 1994, EUR J APPL PHYSIOL O, V69, P287, DOI 10.1007/BF00392032; Leckey JJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00806; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lyons CL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050247; Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Mattson MP, 2015, AGEING RES REV, V20, P37, DOI 10.1016/j.arr.2014.12.011; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Miller BF, 2015, J APPL PHYSIOL, V118, P1502, DOI 10.1152/japplphysiol.00588.2014; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Moro T, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1044-0; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Murray AJ, 2016, FASEB J, V30, P4021, DOI 10.1096/fj.201600773R; Nabben M, 2008, PHYSIOL BEHAV, V94, P259, DOI 10.1016/j.physbeh.2007.11.039; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nelson AR, 2012, MED SCI SPORT EXER, V44, P57, DOI 10.1249/MSS.0b013e3182290371; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Perez-Suarez I, 2017, J APPL PHYSIOL, V123, P1276, DOI 10.1152/japplphysiol.00454.2017; Pilegaard H, 2004, P NUTR SOC, V63, P221, DOI 10.1079/PNS2004345; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Ramalingam L, 2012, DIABETES, V61, P2424, DOI 10.2337/db11-1525; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Seals DR, 2009, J PHYSIOL-LONDON, V587, P5541, DOI 10.1113/jphysiol.2009.178822; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Smith CO, 2017, BIOCHEM J, V474, P2067, DOI 10.1042/BCJ20160623; STANFORD CB, 1994, AM J PHYS ANTHROPOL, V94, P213, DOI 10.1002/ajpa.1330940206; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360, DOI 10.1152/jappl.1995.78.4.1360; Tinsley GM, 2017, EUR J SPORT SCI, V17, P200, DOI 10.1080/17461391.2016.1223173; VanZyl CG, 1996, J APPL PHYSIOL, V80, P2217, DOI 10.1152/jappl.1996.80.6.2217; Varady KA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-146; Vijayakumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044777; Volek JS, 2015, EUR J SPORT SCI, V15, P13, DOI 10.1080/17461391.2014.959564; Wan RQ, 2003, J NUTR, V133, P1921, DOI 10.1093/jn/133.6.1921; WERNIG A, 1990, J PHYSIOL-LONDON, V428, P639, DOI 10.1113/jphysiol.1990.sp018232; Wijngaarden MA, 2013, AM J PHYSIOL-ENDOC M, V304, pE1012, DOI 10.1152/ajpendo.00008.2013; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE622, DOI 10.1152/ajpendo.2000.279.3.E622	88	28	28	3	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3844	3858		10.1096/fj.201701378RR	http://dx.doi.org/10.1096/fj.201701378RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29485903	Green Published			2022-12-28	WOS:000435104500030
J	Wangsa, D; Quintanilla, I; Torabi, K; Vila-Casadesus, M; Ercilla, A; Klus, G; Yuce, Z; Galofre, C; Cuatrecasas, M; Lozano, JJ; Agell, N; Cimini, D; Castells, A; Ried, T; Camps, J				Wangsa, Darawalee; Quintanilla, Isabel; Torabi, Keyvan; Vila-Casadesus, Maria; Ercilla, Amaia; Klus, Gregory; Yuce, Zeynep; Galofre, Claudia; Cuatrecasas, Miriam; Jose Lozano, Juan; Agell, Neus; Cimini, Daniela; Castells, Antoni; Ried, Thomas; Camps, Jordi			Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness	FASEB JOURNAL			English	Article						genomic instability; aneuploidy; lagging chromosomes; invasive front; colorectal cancer	GENOMIC INSTABILITY; MITOTIC ERRORS; ANEUPLOIDY; EVOLUTION; CENTROSOMES; ATR; TUMORIGENESIS; CONSEQUENCES; POLYPLOIDY; TOLERANCE	A considerable proportion of tumors exhibit aneuploid karyotypes, likely resulting from the progressive loss of chromosomes after whole-genome duplication. Here, by using isogenic diploid and near-tetraploid (4N) single-cell-derived clones from the same parental cell lines, we aimed at exploring how polyploidization affects cellular functions and how tetraploidy generates chromosome instability. Gene expression profiling in 4N clones revealed a significant enrichment of transcripts involved in cell cycle and DNA replication. Increased levels of replication stress in 4N cells resulted in DNA damage, impaired proliferation caused by a cell cycle delay during S phase, and higher sensitivity to S phase checkpoint inhibitors. In fact, increased levels of replication stress were also observed in nontransformed, proliferative posttetraploid RPE1 cells. Additionally, replication stress promoted higher levels of intercellular genomic heterogeneity and ongoing genomic instability, which could be explained by high rates of mitotic defects, and was alleviated by the supplementation of exogenous nucleosides. Finally, our data found that 4N cancer cells displayed increased migratory and invasive capacity, both in vitro and in primary colorectal tumors, indicating that tetraploidy can promote aggressive cancer cell behavior.-Wangsa, D., Quintanilla, I., Torabi, K., Vila-Casadesus, M., Ercilla, A., Klus, G., Yuce, Z., Galofre, C., Cuatrecasas, M., Lozano, J. J., Agell, N., Cimini, D., Castells, A., Ried, T., Camps, J. Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.	[Wangsa, Darawalee; Klus, Gregory; Yuce, Zeynep; Ried, Thomas] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Quintanilla, Isabel; Torabi, Keyvan; Vila-Casadesus, Maria; Galofre, Claudia; Castells, Antoni; Camps, Jordi] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Gastrointestinal & Pancreat Oncol Grp, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Cuatrecasas, Miriam] Hosp Clin Barcelona, CDB, Dept Pathol, Barcelona, Spain; [Torabi, Keyvan; Camps, Jordi] Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Bellaterra, Spain; [Vila-Casadesus, Maria; Jose Lozano, Juan] CIBEREHD, Bioinformat Unit, Barcelona, Spain; [Ercilla, Amaia; Agell, Neus] Univ Barcelona, Fac Med, IDIBAPS, Dept Biol Cellular Immunol & Neurociencies, Barcelona, Spain; [Yuce, Zeynep] Dokuz Eylul Univ, Sch Med, Dept Med Biol & Genet, Izmir, Turkey; [Cimini, Daniela] Virginia Tech, Biocomplex Inst, Dept Biol Sci, Blacksburg, VA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Dokuz Eylul University; Virginia Polytechnic Institute & State University	Ried, T (corresponding author), NCI, Ctr Canc Res, 50 South Dr, Bethesda, MD 20802 USA.; Camps, J (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Gastrointestinal & Pancreat Oncol Grp, Rossello 149-153,4th Floor, Barcelona 08036, Spain.	riedt@mail.nih.gov; jcamps@clinic.cat	Cuatrecasas, Miriam/C-9156-2019; Ercilla, Amaia/Y-1824-2019; Agell, Neus/E-9640-2016; Camps, Jordi/AAG-3080-2020; Cimini, Daniela/A-3039-2016; Castells, Antoni/ABC-1002-2021; Vila-Casadesus, Maria/J-8207-2016	Cuatrecasas, Miriam/0000-0003-3063-0110; Ercilla, Amaia/0000-0001-8999-7131; Agell, Neus/0000-0002-1205-6074; Camps, Jordi/0000-0002-3165-3640; Cimini, Daniela/0000-0002-4082-4894; Castells, Antoni/0000-0001-8431-2033; Vila-Casadesus, Maria/0000-0001-6597-7953; Lozano, Juan Jose/0000-0001-7613-3908; Quintanilla Leo, Isabel/0000-0002-6057-0342; Torabi, Keyvan/0000-0002-9067-0061	NIH; CIBEREHD Program; Instituto de Salud Carlos III; European Regional Development Fund (ERDF) [CP13/00160, PI14/00783]; European Commission MC-CIG (COLONGEVA); Spanish Association Against Cancer (AECC) [GCB13131592CAST]; Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya [2014 SGR 135, 2014 SGR 903]; National Service Foundation (NSF) [MCB-1517506]; Ministerio de Educacion, Cultura y Deporte; Ministerio de Ciencia e Innovacion; Scientific and Technological Research Council of Turkey (TUBITAK) 2219 Program; NATIONAL CANCER INSTITUTE [ZIABC010833] Funding Source: NIH RePORTER; Direct For Biological Sciences [1517506] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIBEREHD Program; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); European Commission MC-CIG (COLONGEVA)(European Commission); Spanish Association Against Cancer (AECC); Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); National Service Foundation (NSF); Ministerio de Educacion, Cultura y Deporte(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Scientific and Technological Research Council of Turkey (TUBITAK) 2219 Program(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Z. Storchova (Technische Universitat Kaiserslautern, Kaiserslauter, Germany) for kindly providing cell lines; A. Bosch and M. Calvo (University of Barcelona) for assessing the data analysis; and Z. Wong [U.S. National Institutes of Health (NIH)], R. Ebner (NIH), and S. D. Rutledge (Virginia Tech) for critical reading. The authors are also grateful to B. Chen (NIH) for editorial assistance. This work was supported by the Intramural Program of the NIH, the CIBEREHD Program, and grants to J.C. from Instituto de Salud Carlos III, and cofunded by the European Regional Development Fund (ERDF) (CP13/00160 and PI14/00783), the European Commission MC-CIG (COLONGEVA), the Spanish Association Against Cancer (AECC, GCB13131592CAST), and the Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya (2014 SGR 135 and 2014 SGR 903). Further support was provided by National Service Foundation (NSF) Grant MCB-1517506 to D.C. I.Q., and M.V.-C. received a Formacion de Profesorado Universitario (FPU)-fellowship from Ministerio de Educacion, Cultura y Deporte; K.T. received a Personal Investigador en Formacio from the Universitat Autnonoma de Barcelona; A.E. received a Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion; and Z.Y. received a fellowship from the Scientific and Technological Research Council of Turkey (TUBITAK) 2219 Program. CIBEREHD is funded by the Instituto de Salud Carlos III. The authors declare no conflicts of interest.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Baia G, 2008, NEOPLASIA, V10, P604, DOI 10.1593/neo.08356; Bakhoum SF, 2014, CANCER DISCOV, V4, P1281, DOI 10.1158/2159-8290.CD-14-0403; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Camps J, 2005, FASEB J, V19, P828, DOI 10.1096/fj.04-2276fje; Camps J, 2004, INT J CANCER, V110, P869, DOI 10.1002/ijc.20195; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Eykelenboom JK, 2013, CELL REP, V5, P1095, DOI 10.1016/j.celrep.2013.10.027; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuffer C, 2013, CHROMOSOMA, V122, P305, DOI 10.1007/s00412-013-0414-0; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; Kuznetsova AY, 2015, CELL CYCLE, V14, P2810, DOI 10.1080/15384101.2015.1068482; Lamm N, 2016, CELL STEM CELL, V18, P253, DOI 10.1016/j.stem.2015.11.003; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mackay DR, 2015, MOL BIOL CELL, V26, P2217, DOI 10.1091/mbc.E14-11-1563; Nicholson JM, 2015, ELIFE, V4, DOI 10.7554/eLife.05068; Nicholson JM, 2011, ADV CANCER RES, V112, P43, DOI 10.1016/B978-0-12-387688-1.00003-X; Ogden A, 2013, CANCER METAST REV, V32, P269, DOI 10.1007/s10555-012-9413-5; Passerini V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10754; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Potapova TA, 2016, MOL BIOL CELL, V27, P3065, DOI 10.1091/mbc.E16-05-0268; Ried T, 2012, BBA-GENE REGUL MECH, V1819, P784, DOI 10.1016/j.bbagrm.2012.02.020; Ruiz S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9036; Rutledge SD, 2016, CURR OPIN CELL BIOL, V40, P41, DOI 10.1016/j.ceb.2016.02.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; Sheltzer JM, 2017, CANCER CELL, V31, P240, DOI 10.1016/j.ccell.2016.12.004; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Silkworth WT, 2012, MOL BIOL CELL, V23, P401, DOI 10.1091/mbc.E11-02-0095; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wilhelm T, 2014, P NATL ACAD SCI USA, V111, P763, DOI 10.1073/pnas.1311520111; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	60	32	32	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3502	3517		10.1096/fj.201700247RR	http://dx.doi.org/10.1096/fj.201700247RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452566	Green Published			2022-12-28	WOS:000435104500003
J	Jiang, RL; Prell, C; Lonnerdal, B				Jiang, Rulan; Prell, Christine; Loennerdal, Bo			Milk osteopontin promotes brain development by up-regulating osteopontin in the brain in early life	FASEB JOURNAL			English	Article						myelination; OPN mouse model; NG2-glia proliferation and differentiation; signaling pathways	MESSENGER-RNA; RECOMBINANT OSTEOPONTIN; PRETERM INFANTS; IN-VIVO; LACTOFERRIN; EXPRESSION; GROWTH; MOUSE; PROTEIN; MYELIN	Osteopontin (OPN) is a pleiotropic protein and is abundantly present in milk. Its functions include immune modulation and cellular proliferation and differentiation. OPN is highly expressed in the brain. We investigated the effects of milk-derived OPN on brain development of mouse pups. Wild-type (WT) dams producing OPN+ milk and OPN knockout (KO) dams producing OPN- milk nursed WT pups (OPN+/+), yielding 2 pup treatment groups, OPN+ OPN+/+ and OPN- OPN+/+, for comparison. Preliminary studies supported use of this model by showing high concentrations of OPN in milk of WT dams and no OPN in milk of OPN KO dams, and production of similar amounts of milk by WT and KO dams. The ability of ingested milk OPN to enter the brain was revealed by appearance of orally gavaged [I-125]-labeled and antibody-probed milk OPN in brains of pups. Brain OPN mRNA levels were similar in both nursed groups, but the brain OPN protein level was significantly lower in the OPN- OPN+/+ group at postnatal days 6 and 8. Behavior tests showed impaired memory and learning ability in OPN- OPN+/+ pups. In addition, our study revealed increased expression of myelination-related proteins and elevated proliferation and differentiation of NG-2 glia into oligodendrocytes in the brain of OPN+ OPN+/+ pups, accompanied by increased activation of ERK-1/2 and PI3K/Akt signaling. We concluded that milk OPN can play an important role in brain development and behavior in infancy by promoting myelination.Jiang, R., Prell, C., Lonnerdal, B. Milk osteopontin promotes brain development by up-regulating osteopontin in the brain in early life.	[Jiang, Rulan; Loennerdal, Bo] Univ Calif Davis, Dept Nutr, 3217C Meyer Hall, Davis, CA 95616 USA; [Prell, Christine] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany	University of California System; University of California Davis; University of Munich	Lonnerdal, B (corresponding author), Univ Calif Davis, Dept Nutr, 3217C Meyer Hall, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu			Mead Johnson Nutrition	Mead Johnson Nutrition	The authors thank Patricia Kysar (Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis), for assistance with the electron microscopy; and Dr. Judy Hills (Department of Nutrition, University of California, Davis) for a critical reading of the manuscript. This study was supported by a research grant from Mead Johnson Nutrition. The authors declare no conflicts of interest.	Albertsson AM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0197-0; Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; APPLEBY P, 1983, J REPROD IMMUNOL, V5, P203, DOI 10.1016/0165-0378(83)90236-X; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bercury KK, 2015, DEV CELL, V32, P447, DOI 10.1016/j.devcel.2015.01.016; Bhatt A, 2014, NEURAL REGEN RES, V9, P1347, DOI 10.4103/1673-5374.137586; Bonestroo HJC, 2015, DEV NEUROSCI-BASEL, V37, P142, DOI 10.1159/000369093; Boudry G, 2010, J PEDIATR GASTR NUTR, V51, P380, DOI 10.1097/MPG.0b013e3181eb5ad6; Bozzola J. J., 1992, ELECT MICROSCOPY PRI; Branchi I, 2002, GENES BRAIN BEHAV, V1, P135, DOI 10.1034/j.1601-183X.2002.10301.x; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chatterton DEW, 2004, TRENDS FOOD SCI TECH, V15, P373, DOI 10.1016/j.tifs.2003.12.004; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Choi JS, 2004, EXP BRAIN RES, V154, P275, DOI 10.1007/s00221-003-1657-4; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Chun HB, 2011, J CEREBR BLOOD F MET, V31, P2267, DOI 10.1038/jcbfm.2011.104; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; da Silva APB, 2009, LAB INVEST, V89, P1169, DOI 10.1038/labinvest.2009.80; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Donovan SM, 2014, J NUTR, V144, P1910, DOI 10.3945/jn.114.197558; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Ek CJ, 2012, NEUROTOXICOLOGY, V33, P586, DOI 10.1016/j.neuro.2011.12.009; Fillebeen C, 1999, J BIOL CHEM, V274, P7011, DOI 10.1074/jbc.274.11.7011; Fischer R, 2007, INT IMMUNOPHARMACOL, V7, P1387, DOI 10.1016/j.intimp.2007.05.019; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; FOX M. W., 1965, ANIM BEHAV, V13, P234; Gao W, 2015, CEREB CORTEX, V25, P2919, DOI 10.1093/cercor/bhu088; Gao W, 2015, BRAIN STRUCT FUNCT, V220, P1173, DOI 10.1007/s00429-014-0710-3; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Haarmann A, 2015, ACTA NEUROPATHOL, V129, P639, DOI 10.1007/s00401-015-1417-0; Hamilton GF, 2017, NEUROSCIENCE, V352, P52, DOI 10.1016/j.neuroscience.2017.03.058; Harada E, 2002, J VET MED A, V49, P358, DOI 10.1046/j.1439-0442.2002.00457.x; HUTCHENS TW, 1991, PEDIATR RES, V29, P243, DOI 10.1203/00006450-199103000-00005; HUTCHENS TW, 1991, P NATL ACAD SCI USA, V88, P2994, DOI 10.1073/pnas.88.8.2994; Ishii A, 2013, J NEUROSCI, V33, P175, DOI 10.1523/JNEUROSCI.4403-12.2013; Janssen CIF, 2015, J NUTR BIOCHEM, V26, P24, DOI 10.1016/j.jnutbio.2014.08.002; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jiang RL, 2013, FASEB J, V27; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Jou MY, 2013, PEDIATR RES, V73, P596, DOI 10.1038/pr.2013.27; Kalluri HSG, 2012, INT J DEV NEUROSCI, V30, P359, DOI 10.1016/j.ijdevneu.2012.04.003; Kang SJ, 2012, J IMMUNOL, V188, P1108, DOI 10.4049/jimmunol.1102084; Kumari S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06888-4; Lee MY, 2001, CELL TISSUE RES, V306, P179, DOI 10.1007/s004410100456; Lonnerdal B, 2016, J PEDIATR GASTR NUTR, V62, P650, DOI 10.1097/MPG.0000000000001005; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Mazaheri N, 2018, CELL MOL NEUROBIOL, V38, P891, DOI 10.1007/s10571-017-0563-4; McDonald JM, 2006, J ANIM SCI, V84, P300, DOI 10.2527/2006.842300x; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MIKOGAMI T, 1994, AM J PHYSIOL, V267, pG308, DOI 10.1152/ajpgi.1994.267.2.G308; Miyata S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00390; Nagatomo T, 2004, CLIN EXP IMMUNOL, V138, P47, DOI 10.1111/j.1365-2249.2004.02549.x; Nemir M, 2000, J BIOL CHEM, V275, P969, DOI 10.1074/jbc.275.2.969; Nurliyana AR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0700-0; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Pocivavsek A, 2012, EUR J NEUROSCI, V35, P1605, DOI 10.1111/j.1460-9568.2012.08064.x; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Rittling SR, 2015, J DENT RES, V94, P1638, DOI 10.1177/0022034515605270; Rittling SR, 1997, CELL GROWTH DIFFER, V8, P1061; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Selvaraju R, 2004, MOL CELL NEUROSCI, V25, P707, DOI 10.1016/j.mcn.2003.12.014; Shiga T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146136; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Su ZG, 2014, MOL PHARMACEUT, V11, P1823, DOI 10.1021/mp500238m; Suzuki H, 2010, CRIT CARE MED, V38, P612, DOI 10.1097/CCM.0b013e3181c027ae; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Thinwa J, 2014, J IMMUNOL, V193, P1373, DOI 10.4049/jimmunol.1400145; Tian D, 2015, NAT NEUROSCI, V18, P182, DOI 10.1038/nn.3911; Tong ZX, 2018, BIOMATERIALS, V154, P60, DOI 10.1016/j.biomaterials.2017.10.038; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; van Velthoven CTJ, 2011, STROKE, V42, P2294, DOI 10.1161/STROKEAHA.110.608315; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Willingham K, 2014, JOVE-J VIS EXP, DOI 10.3791/51007; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132	92	20	26	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1681	1694		10.1096/fj.201701290RR	http://dx.doi.org/10.1096/fj.201701290RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199283	Bronze			2022-12-28	WOS:000457296600015
J	Li, T; Xu, WL; Gao, LS; Guan, GP; Zhang, ZY; He, PY; Xu, HZ; Fan, LF; Yan, F; Chen, G				Li, Tao; Xu, Weilin; Gao, Liansheng; Guan, Guoping; Zhang, Zhongyuan; He, Pingyou; Xu, Hangzhe; Fan, Linfeng; Yan, Feng; Chen, Gao			Mesencephalic astrocyte-derived neurotrophic factor affords neuroprotection to early brain injury induced by subarachnoid hemorrhage via activating Akt-dependent prosurvival pathway and defending blood-brain barrier integrity	FASEB JOURNAL			English	Article						neuronal apoptosis; transmission electron microscopy; flow cytometry; neurofunctions	CEREBRAL-ARTERY OCCLUSION; INHIBITOR MK-2206; PRIMATE MODEL; CELL-DEATH; RAT MODEL; MANF; APOPTOSIS; ISCHEMIA; VASOSPASM; NECROSIS	This study aimed to explore the neuroprotective effect of mesencephalic astrocyte-derived neurotrophic factor (MANF) protein on early brain injury caused by subarachnoid hemorrhage (SAH) and the relevant mechanisms in experimental rats, expecting to understand whether MANF was a potential therapeutic target for SAH treatment. A perforation model of SAH was introduced into the study. Recombinant human MANF (rh-MANF) and protein kinase B (Akt) inhibitor (MK2206) were used to explore the effect and the mechanisms. Multiple approaches for systemic assessment were employed in the research, including the Garcia test, the SAH grade, Evans blue (EB) dye leakage, brain-water content (BWC), the rotarod test, and the Morris water-navigation task, as were biotechniques, such as immunohistochemistry, Western blot, transmission electron microscopy, and flow cytometry. MANF was mainly expressed in rat neurons, and its expression increased significantly at 3 h after SAH induction and peaked at 24 h. Stereotactic injection of rh-MANF into the cerebroventricle significantly increased the level of MANF, p-Akt, p-mouse double minute 2 homolog (p-MDM2), and B-cell lymphoma 2 (Bcl-2) in brain tissue, whereas it down-regulated the expression of P53, Bcl-2-associated X protein (Bax), and cleaved caspase-3, which indicated that neuronal apoptosis was remarkably suppressed. Expression of matrix metallopeptidase 9 (MMP-9) was also suppressed by the rh-MANF injection. Furthermore, neurologic deficits, EB dye leakage, and BWC were reduced, and long-lasting neuroprotection was noted with rh-MANF administration. The antiapoptotic and blood-brain barrier (BBB) protective effect could be offset by administering MK2206. MANF could alleviate neuronal apoptosis by activating Akt-dependent prosurvival pathway and abate BBB damage via MMP-9 suppression. MANF showed not only transient but also long-lasting neuroprotective properties. The rh-MANF as a potential drug for treating SAH might be of clinical use.Li, T., Xu, W., Gao, L., Guan, G., Zhang, Z., He, P., Xu, H., Fan, L., Yan, F., Chen, G. Mesencephalic astrocyte-derived neurotrophic factor affords neuroprotection to early brain injury induced by subarachnoid hemorrhage via activating Akt-dependent prosurvival pathway and defending blood-brain barrier integrity.	[Li, Tao; Xu, Weilin; Gao, Liansheng; Zhang, Zhongyuan; He, Pingyou; Xu, Hangzhe; Fan, Linfeng; Yan, Feng; Chen, Gao] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Guan, Guoping] Fenghua Hosp, Dept Neurosurg, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Chen, G (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	d-chengao@zju.edu.cn		yan, feng/0000-0001-8663-6859	National Natural Science Foundation of China [81571106]; Zhejiang Provincial Natural Science Foundation of China [Y18H090013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (Grant 81571106) and the Zhejiang Provincial Natural Science Foundation of China (Grant Y18H090013). The authors declare no conflicts of interest.	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Alleyne CH, 2010, NEUROLOGY, V74, P1486, DOI 10.1212/WNL.0b013e3181e0ef1a; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Chen YC, 2012, DEV BIOL, V370, P237, DOI 10.1016/j.ydbio.2012.07.030; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Gao C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-7; Gao GS, 2017, EXP THER MED, V14, P3926, DOI 10.3892/etm.2017.4934; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Gules I, 2003, ACT NEUR S, V86, P483; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hao F, 2017, EXP NEUROL, V291, P120, DOI 10.1016/j.expneurol.2017.01.008; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Iuliano BA, 2004, J NEUROSURG, V100, P287, DOI 10.3171/jns.2004.100.2.0287; Jing CH, 2012, NEUROSCIENCE, V213, P144, DOI 10.1016/j.neuroscience.2012.03.055; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; Kim Y, 2017, TRANSL RES, V188, P1, DOI 10.1016/j.trsl.2017.06.010; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; le Roux AA, 2010, NEUROSURG CLIN N AM, V21, P235, DOI 10.1016/j.nec.2009.10.014; Liang XP, 2014, STROKE, V45, P3048, DOI 10.1161/STROKEAHA.114.006092; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Liu R, 2017, STROKE, V48, P1369, DOI 10.1161/STROKEAHA.117.016850; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Matlik K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.371; Meguro T, 2001, J NEUROCHEM, V77, P1128, DOI 10.1046/j.1471-4159.2001.00313.x; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Rose MJ, 2011, CURR OPIN ANESTHESIO, V24, P500, DOI 10.1097/ACO.0b013e32834ad45b; Sehba FA, 2004, J NEUROSURG, V101, P633, DOI 10.3171/jns.2004.101.4.0633; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Shen YJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-254; Shridhar R, 1996, CANCER RES, V56, P5576; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Venti M, 2012, FRONT NEUROL NEUROSC, V30, P149, DOI 10.1159/000333625; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090433; Wirth F P, 1986, Clin Neurosurg, V33, P125; Yan F, 2017, MOL NEUROBIOL, V54, P1808, DOI 10.1007/s12035-016-9790-9; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Yang W, 2014, J NEUROL SCI, V344, P129, DOI 10.1016/j.jns.2014.06.042; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Zhao H, 2013, J MOL NEUROSCI, V51, P671, DOI 10.1007/s12031-013-0042-4; Zhao YY, 2014, DRUG DES DEV THER, V8, P1827, DOI 10.2147/DDDT.S67961; Zhou CM, 2004, J CEREBR BLOOD F MET, V24, P419, DOI 10.1097/00004647-200404000-00007; Zhu LN, 2017, NEUROL SCI, V38, P1741, DOI 10.1007/s10072-017-3042-2	60	25	27	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1727	1741		10.1096/fj.201800227RR	http://dx.doi.org/10.1096/fj.201800227RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30211660				2022-12-28	WOS:000457296600018
J	Ednie, AR; Deng, W; Yip, KP; Bennett, ES				Ednie, Andrew R.; Deng, Wei; Yip, Kay-Pong; Bennett, Eric S.			Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy	FASEB JOURNAL			English	Article							GENE-EXPRESSION PROFILES; SIALIC-ACID; CONGENITAL DISORDERS; CHANNEL ACTIVITY; CALCIUM-BINDING; HEART-FAILURE; DISRUPTION; IDENTIFICATION; MODULATION; PROTEINS	Protein glycosylation is an essential posttranslational modification that affects a myriad of physiologic processes. Humans with genetic defects in glycosylation, which result in truncated glycans, often present with significant cardiac deficits. Acquired heart diseases and their associated risk factors were also linked to aberrant glycosylation, highlighting its importance in human cardiac disease. In both cases, the link between causation and corollary remains enigmatic. The glycosyltransferase gene, mannosyl (-1,3-)-glycoprotein -1,2-N-acetylglucosaminyltransferase (Mgat1), whose product, N-acetylglucosaminyltransferase 1 (GlcNAcT1) is necessary for the formation of hybrid and complex N-glycan structures in the medial Golgi, was shown to be at reduced levels in human end-stage cardiomyopathy, thus making Mgat1 an attractive target for investigating the role of hybrid/complex N-glycosylation in cardiac pathogenesis. Here, we created a cardiomyocyte-specific Mgat1 knockout (KO) mouse to establish a model useful in exploring the relationship between hybrid/complex N-glycosylation and cardiac function and disease. Biochemical and glycomic analyses showed that Mgat1KO cardiomyocytes produce predominately truncated N-glycan structures. All Mgat1KO mice died significantly younger than control mice and demonstrated chamber dilation and systolic dysfunction resembling human dilated cardiomyopathy (DCM). Data also indicate that a cardiomyocyte L-type voltage-gated Ca2+ channel (Ca-v) subunit (21) is a GlcNAcT1 target, and Mgat1KO Ca-v activity is shifted to more-depolarized membrane potentials. Consistently, Mgat1KO cardiomyocyte Ca2+ handling is altered and contraction is dyssynchronous compared with controls. The data demonstrate that reduced hybrid/complex N-glycosylation contributes to aberrant cardiac function at whole-heart and myocyte levels drawing a direct link between altered glycosylation and heart disease. Thus, the Mgat1KO provides a model for investigating the relationship between systemic reductions in glycosylation and cardiac disease, showing that clinically relevant changes in cardiomyocyte hybrid/complex N-glycosylation are sufficient to cause DCM and early death.Ednie, A. R., Deng, W., Yip, K.-P., Bennett, E. S. Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy.	[Ednie, Andrew R.; Bennett, Eric S.] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Boonshoft Sch Med, 143 Biol Sci 2,3640 Colonel Glenn Hwy, Dayton, OH 45435 USA; [Ednie, Andrew R.; Bennett, Eric S.] Wright State Univ, Coll Sci & Math, Dayton, OH 45435 USA; [Deng, Wei; Yip, Kay-Pong] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL USA; [Deng, Wei] Rutgers New Jersey Med Sch, Newark, NJ USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; State University System of Florida; University of South Florida; Rutgers State University New Brunswick; Rutgers State University Medical Center	Bennett, ES (corresponding author), Wright State Univ, Dept Neurosci Cell Biol & Physiol, Boonshoft Sch Med, 143 Biol Sci 2,3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	eric.bennett@wright.edu	Deng, Wei/AAJ-5955-2021; Yip, Kay-Pong/H-4639-2012	Yip, Kay-Pong/0000-0003-4364-6701	National Science Foundation [IOS-1146882, IOS-1660926, CMMI-1266331]; American Heart Association [14GRNT20450148, 15POST25710010]; U.S. National Institutes of Health, National Heart, Lung, Blood Institute [1R01HL102171]	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); U.S. National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jamey Marth (University of California-Santa Barbara and Sanford Burnham Prebys Medical Discovery Institute, Santa Barbara, CA, USA) for providing the Mgat1 and LoxP-flanked mouse strain, and Dr. Beyong Cha (University of South Florida Morsani College of Medicine Lisa Muma Weitz Laboratory for Advanced Microscopy and Cell Imaging, Tampa, FL, USA), for his collection of the Ca2+ spark data. This work was supported in part by grants from the National Science Foundation (IOS-1146882, IOS-1660926, and CMMI-1266331 to E.S.B.); an American Heart Association, Greater Southeast Affiliate Grant-In-Aid (14GRNT20450148 to E.S.B.), and a Postdoctoral Fellowship (15POST25710010 to A.R.E.); and a grant from the U.S. National Institutes of Health, National Heart, Lung, Blood Institute (1R01HL102171 to E.S.B.). The authors declare no conflicts of interest.	[Anonymous], 2009, ESSENTIALS GLYCOBIOL; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bokenes J, 2005, J APPL PHYSIOL, V98, P1712, DOI 10.1152/japplphysiol.00630.2004; Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Deng W, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0574-1; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Ednie AR, 2015, J BIOL CHEM, V290, P2769, DOI 10.1074/jbc.M114.605139; Ednie AR, 2013, J MOL CELL CARDIOL, V59, P117, DOI 10.1016/j.yjmcc.2013.02.013; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Felix R, 1997, J NEUROSCI, V17, P6884; FERMINI B, 1991, AM J PHYSIOL, V260, pH735, DOI 10.1152/ajpheart.1991.260.3.H735; Footitt EJ, 2009, J INHERIT METAB DIS, V32, pS313, DOI 10.1007/s10545-009-1262-1; FRANK JS, 1977, CIRC RES, V41, P702, DOI 10.1161/01.RES.41.5.702; Fuller W, 2001, ANAL BIOCHEM, V293, P216, DOI 10.1006/abio.2001.5127; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; GANSS B, 1993, EUR J BIOCHEM, V217, P275, DOI 10.1111/j.1432-1033.1993.tb18243.x; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Heinzel FR, 2011, J MOL CELL CARDIOL, V50, P390, DOI 10.1016/j.yjmcc.2010.11.008; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hollingworth S, 2001, J GEN PHYSIOL, V118, P653, DOI 10.1085/jgp.118.6.653; Hwang JJ, 2002, PHYSIOL GENOMICS, V10, P31, DOI 10.1152/physiolgenomics.00122.2001; Jacob S, 2013, MOL CELL BIOCHEM, V377, P11, DOI 10.1007/s11010-013-1560-7; JAQUES LW, 1977, J BIOL CHEM, V252, P4533; Kaji H, 2012, J PROTEOME RES, V11, P4553, DOI 10.1021/pr300346c; Keller RS, 2001, AM J PATHOL, V158, P1079, DOI 10.1016/S0002-9440(10)64055-2; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Lakdawala NK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P228, DOI 10.1161/CIRCEP.111.962050; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Liu MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060931; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marengo FD, 1998, J MOL CELL CARDIOL, V30, P127, DOI 10.1006/jmcc.1997.0579; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Marques-da-Silva D, 2017, J INHERIT METAB DIS, V40, P657, DOI 10.1007/s10545-017-0066-y; Matsuo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111097; McCauley MD, 2011, TRENDS CARDIOVAS MED, V21, P48, DOI 10.1016/j.tcm.2012.02.004; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Nagai-Okatani C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150210; Ness TL, 2015, BIOCHEM MOL BIOL EDU, V43, P358, DOI 10.1002/bmb.20876; Nival M, 2015, J MOL CELL CARDIOL, V79, P32, DOI 10.1016/j.yjmcc.2014.10.018; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Platano D, 2000, BIOPHYS J, V78, P2959, DOI 10.1016/S0006-3495(00)76835-4; Pugach EK, 2015, J MOL CELL CARDIOL, V86, P54, DOI 10.1016/j.yjmcc.2015.06.019; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Shirokova N, 2013, J MOL CELL CARDIOL, V58, P217, DOI 10.1016/j.yjmcc.2012.12.009; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Stanley P, 2016, J MOL BIOL, V428, P3166, DOI 10.1016/j.jmb.2016.03.025; Steele EM, 2014, BIOPHYS J, V106, P566, DOI 10.1016/j.bpj.2013.12.040; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Tian Y, 2014, PROTEOM CLIN APPL, V8, P595, DOI 10.1002/prca.201400009; Tyagi, 2000, Pathophysiology, V7, P177, DOI 10.1016/S0928-4680(00)00046-8; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Wang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004133; Wang T, 2014, PROTEIN PEPTIDE LETT, V21, P976, DOI 10.2174/0929866521666140626111237; Weintraub R. G., 2017, DILATED CARDIOMYOPAT; YAMAMOTO K, 1994, J BIOCHEM, V116, P229, DOI 10.1093/oxfordjournals.jbchem.a124510; Yang S, 2015, PROTEOMICS, V15, P567, DOI 10.1002/pmic.201400151; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Yung CK, 2004, GENOMICS, V83, P281, DOI 10.1016/j.ygeno.2003.08.007	69	8	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1248	1261		10.1096/fj.201801057R	http://dx.doi.org/10.1096/fj.201801057R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30138037	Bronze, Green Published			2022-12-28	WOS:000457401500099
J	Si, HW; Wang, XY; Zhang, LY; Parnell, LD; Admed, B; LeRoith, T; Ansah, TA; Zhang, LJ; Li, JW; Ordovas, JM; Si, HZ; Liu, DM; Lai, CQ				Si, Hongwei; Wang, Xiaoyong; Zhang, Longyun; Parnell, Laurence D.; Admed, Bulbul; LeRoith, Tanya; Ansah, Twum-Ampofo; Zhang, Lijuan; Li, Jianwei; Ordovas, Jose M.; Si, Hongzong; Liu, Dongmin; Lai, Chao-Qiang			Dietary epicatechin improves survival and delays skeletal muscle degeneration in aged mice	FASEB JOURNAL			English	Article						antiaging; extracellular matrix pathway; nicotinamide pathway; PPAR pathway; lifespan	LIFE-SPAN; EXTRACELLULAR-MATRIX; PPAR-GAMMA; OXIDATIVE STRESS; GENE-EXPRESSION; RESVERATROL; EXERCISE; (-)-EPICATECHIN; RESTRICTION; RESISTANCE	We recently reported that epicatechin, a bioactive compound that occurs naturally in various common foods, promoted general health and survival of obese diabetic mice. It remains to be determined whether epicatechin extends health span and delays the process of aging. In the present study, epicatechin or its analogue epigallocatechin gallate (EGCG) (0.25% w/v in drinking water) was administered to 20-mo-old male C57BL mice fed a standard chow. The goal was to determine the antiaging effect. The results showed that supplementation with epicatechin for 37 wk strikingly increased the survival rate from 39 to 69%, whereas EGCG had no significant effect. Consistently, epicatechin improved physical activity, delayed degeneration of skeletal muscle (quadriceps), and shifted the profiles of the serum metabolites and skeletal muscle general mRNA expressions in aging mice toward the profiles observed in young mice. In particular, we found that dietary epicatechin significantly reversed age-altered mRNA and protein expressions of extracellular matrix and peroxisome proliferator-activated receptor pathways in skeletal muscle, and reversed the age-induced declines of the nicotinate and nicotinamide pathway both in serum and skeletal muscle. The present study provides evidence that epicatechin supplementation can exert an antiaging effect, including an increase in survival, an attenuation of the aging-related deterioration of skeletal muscles, and a protection against the aging-related decline in nicotinate and nicotinamide metabolism.Si, H., Wang, X., Zhang, L., Parnell, L. D., Admed, B., LeRoith, T., Ansah, T.-A., Zhang, L., Li, J., Ordovas, J. M., Si, H., Liu, D., Lai, C.-Q. Dietary epicatechin improves survival and delays skeletal muscle degeneration in aged mice.	[Si, Hongwei; Wang, Xiaoyong; Zhang, Longyun; Admed, Bulbul; Zhang, Lijuan] Tennessee State Univ, Dept Human Sci, 3500 John A Merritt Blvd, Nashville, TN 37209 USA; [Li, Jianwei] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Parnell, Laurence D.; Lai, Chao-Qiang] Tufts Univ, USDA ARS, Boston, MA 02111 USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [LeRoith, Tanya] Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Ansah, Twum-Ampofo] Meharry Med Coll, Dept Neurosci & Pharmacol, Nashville, TN 37208 USA; [Ordovas, Jose M.] Autonomous Univ Madrid UAM, Campus Universal Excellence CEI, Res Inst Food & Hlth Sci, Madrid Inst Adv Studies IMDEA, Madrid, Spain; [Ordovas, Jose M.] Super Council Sci Invest CSIC, Madrid, Spain; [Si, Hongzong] Qingdao Univ, Inst Computat Sci & Engn, Qingdao, Peoples R China; [Liu, Dongmin] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Tennessee State University; Tennessee State University; Tufts University; United States Department of Agriculture (USDA); Tufts University; United States Department of Agriculture (USDA); Meharry Medical College; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Qingdao University; Virginia Polytechnic Institute & State University	Si, HW (corresponding author), Tennessee State Univ, Dept Human Sci, 3500 John A Merritt Blvd, Nashville, TN 37209 USA.; Liu, DM (corresponding author), Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.; Lai, CQ (corresponding author), Tufts Univ, USDA ARS, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.	hsi@tnstate.edu; doliu@vt.edu; chaoqiang.lai@ars.usda.gov		Ahmed, Bulbul/0000-0002-9143-4538; Lai, Chao-Qiang/0000-0003-1107-8375	U.S. Department of Agriculture (USDA) Evans-Allen Program [TENX-1506-FS, TENX-1103-FS]; USDA 1890 Faculty Fellowship [58-8050-6-006]	U.S. Department of Agriculture (USDA) Evans-Allen Program; USDA 1890 Faculty Fellowship	D. L. (doliu@ vt. edu) contributed equally to this work with H.S. and C.-Q.L. and can be contacted with questions and concerns. This work was supported by grants from the U.S. Department of Agriculture (USDA) Evans-Allen Program (TENX-1506-FS and TENX-1103-FS to H.S.) and a USDA 1890 Faculty Fellowship (58-8050-6-006 to H.S. and C.-Q.L.). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the USDA. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA. The USDA is an equal opportunity provider and employer. The authors declare no conflicts of interest.	Bartel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005274; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Carrillo JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25948; Catoire M, 2015, FASEB J, V29, P1615, DOI 10.1096/fj.14-263699; Catoire M, 2014, PHYSIOL GENOMICS, V46, P256, DOI 10.1152/physiolgenomics.00174.2013; Das SK, 2017, MOL CELL ENDOCRINOL, V455, P148, DOI 10.1016/j.mce.2017.04.011; Duarte DA, 2015, J NUTR BIOCHEM, V26, P64, DOI 10.1016/j.jnutbio.2014.09.003; Ferguson MC, 2010, NEUROPHARMACOLOGY, V59, P31, DOI 10.1016/j.neuropharm.2010.03.013; Fu ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18502; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gao C, 2015, NEUROCHEM RES, V40, P818, DOI 10.1007/s11064-015-1532-2; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; Hindle AG, 2009, J EXP BIOL, V212, P790, DOI 10.1242/jeb.025387; Hollenberg NK, 2007, CIRCULATION, V116, P2360, DOI 10.1161/CIRCULATIONAHA.107.738070; Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Lai CQ, 2018, AM J CLIN NUTR, V108, P188, DOI 10.1093/ajcn/nqy081; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Martinez-Huenchullan SF, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13599; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Moreno-Ulloa A, 2015, J GERONTOL A-BIOL, V70, P1370, DOI 10.1093/gerona/glu131; Murphy Sherry L, 2017, Natl Vital Stat Rep, V66, P1; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924; Pattison JS, 2003, PHYSIOL GENOMICS, V15, P34, DOI 10.1152/physiolgenomics.00040.2003; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Rinholm JE, 2007, NEUROSCIENCE, V145, P579, DOI 10.1016/j.neuroscience.2006.12.041; Rivas DA, 2012, J APPL PHYSIOL, V113, P1727, DOI 10.1152/japplphysiol.00412.2012; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sawai M, 2017, J BIOL CHEM, V292, P15538, DOI 10.1074/jbc.M117.803171; Schaffler A, 2004, BBA-GENE STRUCT EXPR, V1678, P150, DOI 10.1016/j.bbaexp.2004.02.006; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Shen LR, 2013, AGE, V35, P1133, DOI 10.1007/s11357-012-9438-2; Shen LR, 2013, BIOFACTORS, V39, P133, DOI 10.1002/biof.1086; Si HW, 2014, J NUTR BIOCHEM, V25, P581, DOI 10.1016/j.jnutbio.2014.02.001; Si HW, 2011, J NUTR, V141, P1095, DOI 10.3945/jn.110.134270; Stearns-Reider KM, 2017, AGING CELL, V16, P518, DOI 10.1111/acel.12578; Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496; Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070; Sung B, 2004, J GERONTOL A-BIOL, V59, P997; Zhang KR, 2012, HEART, V98, pE48, DOI 10.1136/heartjnl-2012-302920a.115; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhou Lan, 2014, Zhongguo Zhong Yao Za Zhi, V39, P1083	52	34	34	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					965	977		10.1096/fj.201800554RR	http://dx.doi.org/10.1096/fj.201800554RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30096038	hybrid, Green Published			2022-12-28	WOS:000457401500076
J	Song, K; Guo, Y; Wang, XL; Cai, H; Zheng, WC; Li, N; Song, XK; Ao, L; Guo, Z; Zhao, WY				Song, Kai; Guo, You; Wang, Xianlong; Cai, Hao; Zheng, Weicheng; Li, Na; Song, Xuekun; Ao, Lu; Guo, Zheng; Zhao, Wenyuan			Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit	FASEB JOURNAL			English	Article						CRC; relapse risk; relative expression orderings; fluorouracil	DIFFERENTIAL EXPRESSION ANALYSIS; PERSONALIZED APPROACH; BIOMARKER DISCOVERY; DRUG-SENSITIVITY; COLON; THERAPY; RISK; IDENTIFICATION; ADENOCARCINOMA; RECURRENCE	The current study suggests that the identification of predictive signatures of fluorouracil (5-FU) response for stage II and III colorectal cancer (CRC) could be confounded by chemotherapy-irrelevant low relapse risk. Using the samples of patients with stage II and III CRC who were treated with curative surgery only, we identified a signature with which to predict chemotherapy-irrelevant relapse risk for patients after curative surgery. By applying this signature to the samples of patients with stage II and III CRC who were treated with 5-FU-based adjuvant chemotherapy (ACT) after surgery, we predicted the relapse risk if treated with surgery only. From high-risk samples, we further identified another signature with which to predict therapeutic benefit from 5-FU-based ACT. On the basis of the relative expression orderings of gene pairs, a postsurgery relapse risk signature that consisted of 44 gene pairs was developed and verified in 3 independent data sets. A 5-FU therapeutic benefit signature that consisted of 4 gene pairs was then developed to predict the response of 5-FU-based ACT for those patients with high relapse risk after curative surgery. The signature was verified in 4 independent datasets. For patients with stage II and III CRC, the coupled signatures can first identify patients with high relapse risk after curative surgery, then predict therapeutic benefit from 5-FU-based ACT.Song, K., Guo, Y., Wang, X., Cai, H., Zheng, W., Li, N., Song, X., Ao, L., Guo, Z., Zhao, W. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.	[Song, Kai; Zheng, Weicheng; Song, Xuekun; Guo, Zheng; Zhao, Wenyuan] Harbin Med Univ, Dept Syst Biol, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China; [Guo, You] Gannan Med Univ, Affiliated Hosp 1, Ganzhou, Jiangxi, Peoples R China; [Wang, Xianlong; Cai, Hao; Zheng, Weicheng; Li, Na; Ao, Lu; Guo, Zheng] Fujian Med Univ, Dept Bioinformat, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Fujian, Peoples R China; [Guo, Zheng] Fujian Med Univ, Fujian Key Lab Tumor Microbiol, Fuzhou, Fujian, Peoples R China	Harbin Medical University; Gannan Medical University; Fujian Medical University; Fujian Medical University	Guo, Z; Zhao, WY (corresponding author), Harbin Med Univ, Dept Syst Biol, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China.	guoz@ems.hrbmu.edu.cn; zhaowenyuan@ems.hrbmu.edu.cn	Wang, Xianlong/AFU-4519-2022	Wang, Xianlong/0000-0001-8195-2027; , lu/0000-0001-7378-4967	National Natural Science Foundation of China [61601151, 81572935, 21534008]; Natural Science Foundation of Heilongjiang Province [C2016037]; Joint Scientific and Technology Innovation Fund of Fujian Province [2016Y9044]; Health and Family Planning Commission of Fujian Province [2017-ZQN-56]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Joint Scientific and Technology Innovation Fund of Fujian Province; Health and Family Planning Commission of Fujian Province	This work was supported by the National Natural Science Foundation of China (Grants 61601151, 81572935, and 21534008), the Natural Science Foundation of Heilongjiang Province (Grant C2016037), the Joint Scientific and Technology Innovation Fund of Fujian Province (Grant 2016Y9044), and the Health and Family Planning Commission of Fujian Province (Grant 2017-ZQN-56). The authors declare no conflicts of interest.	Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Cai H, 2015, ONCOTARGET, V6, P44593, DOI 10.18632/oncotarget.6260; Chen R, 2017, ONCOTARGET, V8, P6652, DOI 10.18632/oncotarget.14257; Cheng J, 2017, ONCOTARGET, V8, P30265, DOI 10.18632/oncotarget.15754; Crans GG, 2008, STAT MED, V27, P3598, DOI 10.1002/sim.3221; Dalerba P, 2016, NEW ENGL J MED, V374, P211, DOI 10.1056/NEJMoa1506597; Duffaud F, 2000, B CANCER, V87, P881, DOI 10.1093/jnci/92.3.205; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Figueredo A., 2008, COCHRANE DB SYST REV, V2008; Freidin MB, 2012, J MOL DIAGN, V14, P140, DOI 10.1016/j.jmoldx.2011.11.002; Gao SW, 2016, JAMA ONCOL, V2, P37, DOI 10.1001/jamaoncol.2015.3413; Geeleher P, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1050-9; Gelsomino G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-137; Gong X, 2011, MOL CANCER THER, V10, P752, DOI 10.1158/1535-7163.MCT-10-0837; Graham JS, 2012, EXPERT REV ANTICANC, V12, P99, DOI [10.1586/ERA.11.189, 10.1586/era.11.189]; Guan QZ, 2016, ONCOTARGET, V7, P68909, DOI 10.18632/oncotarget.11996; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Negrei C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00172; Niedzwiecki D, 2011, J CLIN ONCOL, V29, P3146, DOI 10.1200/JCO.2010.32.5357; Qi LS, 2016, BRIT J CANCER, V115, P1513, DOI 10.1038/bjc.2016.370; Qi LS, 2016, BRIEF BIOINFORM, V17, P233, DOI 10.1093/bib/bbv064; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Scholer LV, 2017, CLIN CANCER RES, V23, P5437, DOI 10.1158/1078-0432.CCR-17-0510; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sloothaak DAM, 2014, EJSO-EUR J SURG ONC, V40, P263, DOI 10.1016/j.ejso.2013.12.002; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Tong M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.51; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Tsuji S, 2012, BRIT J CANCER, V106, P126, DOI 10.1038/bjc.2011.505; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang HW, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btu522; Xu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15474; Yamaguchi K, 2013, ONCOL LETT, V6, P659, DOI 10.3892/ol.2013.1433; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhao WY, 2016, ONCOTARGET, V7, P19060, DOI 10.18632/oncotarget.7956; Zou M, 2015, METHODS, V83, P3, DOI 10.1016/j.ymeth.2015.05.011	49	11	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					151	162		10.1096/fj.201800222RRR	http://dx.doi.org/10.1096/fj.201800222RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957060				2022-12-28	WOS:000457401500012
J	Wang, X; Jiang, L; Wallerman, O; Younis, S; Yu, Q; Klaesson, A; Tengholm, A; Welsh, N; Andersson, L				Wang, Xuan; Jiang, Lin; Wallerman, Ola; Younis, Shady; Yu, Qian; Klaesson, Axel; Tengholm, Anders; Welsh, Nils; Andersson, Leif			ZBED6 negatively regulates insulin production, neuronal differentiation, and cell aggregation in MIN6 cells	FASEB JOURNAL			English	Article						-cells; cell adhesion; transcriptome analysis; ChIP-seq	PANCREATIC BETA-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; R-CADHERIN; GROWTH; IGF2; MUSCLE; BIRTH	Zinc finger BED domain containing protein 6 (Zbed6) has evolved from a domesticated DNA transposon and encodes a transcription factor unique to placental mammals. The aim of the present study was to investigate further the role of ZBED6 in insulin-producing cells, using mouse MIN6 cells, and to evaluate the effects of Zbed6 knockdown on basal -cell functions, such as morphology, transcriptional regulation, insulin content, and release. Zbed6-silenced cells and controls were characterized with a range of methods, including RNA sequencing, chromatin immunoprecipitation sequencing, insulin content and release, subplasma membrane Ca2+ measurements, cAMP determination, and morphologic studies. More than 700 genes showed differential expression in response to Zbed6 knockdown, which was paralleled by increased capacity to generate cAMP, as well as by augmented subplasmalemmal calcium concentration and insulin secretion in response to glucose stimulation. We identified >4000 putative ZBED6-binding sites in the MIN6 genome, with an enrichment of ZBED6 sites at upregulated genes, such as the -cell transcription factors v-maf musculoaponeurotic fibrosarcoma oncogene homolog A and Nk6 homeobox 1. We also observed altered morphology/growth patterns, as indicated by increased cell clustering, and in the appearance of axon-like Neurofilament, medium polypeptide and tubulin 3, class III-positive protrusions. We conclude that ZBED6 acts as a transcriptional regulator in MIN6 cells and that its activity suppresses insulin production, cell aggregation, and neuronal-like differentiation.Wang, X., Jiang, L., Wallerman, O., Younis, S., Yu, Q., Klaesson, A., Tengholm, A., Welsh, N., Andersson, L. ZBED6 negatively regulates insulin production, neuronal differentiation, and cell aggregation in MIN6 cells.	[Wang, Xuan; Yu, Qian; Tengholm, Anders; Welsh, Nils] Uppsala Univ, Sci Life Lab, Dept Med Cell Biol, Husargatan 3,Box 571, SE-75123 Uppsala, Sweden; [Jiang, Lin; Younis, Shady; Klaesson, Axel; Andersson, Leif] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden; [Jiang, Lin] Chinese Acad Agr Sci, Inst Anim Sci, Key Lab Farm Anim Genet Resources & Utilizat, Minist Agr China, Beijing, Peoples R China; [Wallerman, Ola; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Younis, Shady] Ain Shams Univ, Dept Anim Prod, Cairo, Egypt	Uppsala University; Uppsala University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Swedish University of Agricultural Sciences; Egyptian Knowledge Bank (EKB); Ain Shams University	Andersson, L (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.; Welsh, N (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Cell Biol, BMC, Husargatan 3,Box 571, SE-75123 Uppsala, Sweden.	nils.welsh@mcb.uu.se; leif.andersson@imbim.uu.se		Younis, Shady/0000-0002-4319-1738; YU, QIAN/0000-0003-4888-9446	Uppsala University and Hospital; SciLife Lab-Uppsala; Swedish Research Council [80576801, 70374401]; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Diabetes Association; Family Ernfors Fund; Barndiabetesfonden; EXODIAB; Novo-Nordisk Foundation; Beijing Natural Science Foundation [6164040]	Uppsala University and Hospital; SciLife Lab-Uppsala; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Diabetes Association; Family Ernfors Fund; Barndiabetesfonden; EXODIAB; Novo-Nordisk Foundation(Novo Nordisk Foundation); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, SciLife Lab-Uppsala, and the Swedish Research Council (80576801 and 70374401). Computer resources were supplied by UPPMAX. This work was supported by the Swedish Research Council, Knut and Alice Wallenberg Foundation, Swedish Diabetes Association, Family Ernfors Fund, Barndiabetesfonden, EXODIAB, and Novo-Nordisk Foundation. L.J. was supported by Beijing Natural Science Foundation (6164040). The authors declare no conflicts of interest.	Andersson L, 2010, TRANSCR-AUSTIN, V1, P144, DOI 10.4161/trns.1.3.13343; [Anonymous], [No title captured], DOI DOI 10.3760/CMA.J.ISSN.0578-1426.2016.06.006; Apostolopoulou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033289; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barbagallo D, 2014, MOL BIOL CELL, V25, P2333, DOI 10.1091/mbc.E14-02-0703; Belo J, 2013, STEM CELLS DEV, V22, P2935, DOI 10.1089/scd.2013.0106; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bonacci TM, 2012, CELL SIGNAL, V24, P2102, DOI 10.1016/j.cellsig.2012.07.015; Calderari S, 2007, DIABETOLOGIA, V50, P1463, DOI 10.1007/s00125-007-0676-2; Casellas A, 2015, J BIOL CHEM, V290, P16772, DOI 10.1074/jbc.M115.642041; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Dioum EM, 2011, P NATL ACAD SCI USA, V108, P20713, DOI 10.1073/pnas.1118526109; Ebrahimie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090885; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HUTTON JC, 1993, MOL ENDOCRINOL, V7, P1151, DOI 10.1210/me.7.9.1151; Idevall-Hagren O, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003932; Jiang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094187; Kragl M, 2010, ADV EXP MED BIOL, V654, P217, DOI 10.1007/978-90-481-3271-3_10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Martens GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024134; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Mercader JM, 2017, DIABETES, V66, P2903, DOI 10.2337/db17-0187; POLAK M, 1993, P NATL ACAD SCI USA, V90, P5781, DOI 10.1073/pnas.90.12.5781; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Szabat M, 2012, DIABETES, V61, P1365, DOI 10.2337/db11-1361; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vidaltamayo R, 1996, ENDOCRINE, V4, P19, DOI 10.1007/BF02738870; Wang X, 2013, P NATL ACAD SCI USA, V110, P15997, DOI 10.1073/pnas.1303625110; Younis S, 2018, P NATL ACAD SCI USA, V115, pE2048, DOI 10.1073/pnas.1719278115; Zhang Y., 2008, GENOME BIOL, V9	37	10	10	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					88	100		10.1096/fj.201600835R	http://dx.doi.org/10.1096/fj.201600835R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957057				2022-12-28	WOS:000457401500007
J	Saraiva, AL; Veras, FP; Peres, RS; Talbot, J; de Lima, KA; Luiz, JP; Carballido, JM; Cunha, TM; Cunha, FQ; Ryffel, B; Alves, JC				Saraiva, Andre L.; Veras, Flavio P.; Peres, Raphael S.; Talbot, Jhimmy; de Lima, Kalil A.; Luiz, Joao P.; Carballido, Jose M.; Cunha, Thiago M.; Cunha, Fernando Q.; Ryffel, Bernhard; Alves-Filho, Jose C.			Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of T(h)17 cells in the lymph nodes	FASEB JOURNAL			English	Article						Sucnr1; GPR91; autoimmune disease; inflammation; metabolism	COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; JOINT INFLAMMATION; BONE EROSION; GPR91; MICE; AUTOIMMUNITY; ACTIVATION; EXPRESSION	Rheumatoid arthritis is a chronic inflammatory disease that leads to significant changes in metabolic activity. Succinate, an intermediate of the tricarboxylic acid cycle, has emerged as a metabolic mediator of the innate immune response. However, the involvement of succinate in the generation of the adaptive immune response and establishment of autoimmune response has not been addressed thus far. Here we demonstrated that the succinate-sensing receptor (Sucnr1/GPR91) plays a critical role in the development of immune-mediated arthritis. We found that Sucnr1 acts as a chemotactic gradient sensor that guides dendritic cells (DCs) into the lymph nodes, orchestrating the expansion of the T helper (T-h)17-cell population and the development of experimental antigen-induced arthritis. Sucnr1(-/-) mice show reduced articular hyperalgesia, neutrophil infiltration and inflammatory cytokines in the joint, and reduced frequency of T(h)17 cells in draining lymph nodes. Adoptive transfer of wild-type (WT) DCs into Sucnr1(-/-) mice restored the development of arthritis. Moreover, DC-depleted mice transferred with Sucnr1(-/-) DCs developed less arthritis than mice transferred with WT DCs. In contrast, succinate given together with the immunization boosted the recruitment of DCs and the frequency of T(h)17 cells in draining lymph nodes, increasing arthritis severity. Therefore, the blockade of Sucnr1 may represent a novel therapeutic target of arthritis.Saraiva, A. L., Veras, F. P., Peres, R. S., Talbot, J., de Lima, K. A., Luiz, J. P., Carballido, J. M., Cunha, T. M., Cunha, F. Q., Ryffel, B., Alves-Filho, J. C. Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of T(h)17 cells in the lymph nodes.	[Saraiva, Andre L.; Veras, Flavio P.; Peres, Raphael S.; Talbot, Jhimmy; de Lima, Kalil A.; Luiz, Joao P.; Cunha, Thiago M.; Cunha, Fernando Q.; Alves-Filho, Jose C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil; [Cunha, Thiago M.; Cunha, Fernando Q.; Alves-Filho, Jose C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Ctr Res Inflammatory Dis, Sao Paulo, Brazil; [Carballido, Jose M.] Novartis Inst Biomed Res, Basel, Switzerland; [Ryffel, Bernhard] Univ Orleans, Unite Mixte Rech 7355, Mol & Expt Immunol & Neurogenet, CNRS, Orleans, France	Universidade de Sao Paulo; Universidade de Sao Paulo; Novartis; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Alves, JC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Immunol, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.	jcafilho@usp.br	Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Thiago M/B-7729-2012; Cunha, Fernando Q/M-3090-2014; Veras, Flávio Protásio/AAD-6274-2021	Alves-Filho, Jose Carlos/0000-0002-9918-8714; Cunha, Thiago M/0000-0003-1084-0065; Sanches Peres, Raphael/0000-0002-0417-779X; Cunha, Fernando Queiroz/0000-0003-4755-1670; Alves de Lima, Kalil/0000-0002-9149-168X; Protasio Veras, Flavio/0000-0002-6222-4064	Sao Paulo Research Foundation (FAPESP) [2011/19670-0, 2013/08216-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank the staff at the Laboratory of Inflammation and Pain for technical assistance. This work was supported by grants from the Sao Paulo Research Foundation (FAPESP) under Grant Agreements 2011/19670-0 (Projeto Tematico) and 2013/08216-2 (Center for Research in Inflammatory Diseases). The authors declare no conflicts of interest.	Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; BRACKERTZ D, 1977, J IMMUNOL, V118, P1645; Freitag J, 2016, IMMUNOL CELL BIOL, V94, P925, DOI 10.1038/icb.2016.77; Grespan R, 2008, ARTHRITIS RHEUM, V58, P2030, DOI 10.1002/art.23597; Guerrero ATG, 2006, PHARMACOL BIOCHEM BE, V84, P244, DOI 10.1016/j.pbb.2006.05.008; Han YP, 2015, J IMMUNOL, V195, P4126, DOI 10.4049/jimmunol.1401842; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Koenders MI, 2005, AM J PATHOL, V167, P141, DOI 10.1016/S0002-9440(10)62961-6; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Li Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00532; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; McCreath KJ, 2015, DIABETES, V64, P1154, DOI 10.2337/db14-0346; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Page G, 2002, J IMMUNOL, V168, P5333, DOI 10.4049/jimmunol.168.10.5333; Pinto LG, 2010, PAIN, V148, P247, DOI 10.1016/j.pain.2009.11.006; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; RUBIN BB, 1990, AM J PHYSIOL, V259, pH525, DOI 10.1152/ajpheart.1990.259.2.H525; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Sozzani S, 2017, J AUTOIMMUN, V85, P126, DOI 10.1016/j.jaut.2017.07.012; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; THOMAS R, 1994, J IMMUNOL, V152, P2613; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Weyand CM, 2017, NAT REV RHEUMATOL, V13, P1, DOI 10.1038/nrrheum.2017.49; Williams RO, 1998, CLIN EXP IMMUNOL, V114, P330	33	30	30	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6550	6558		10.1096/fj.201800285	http://dx.doi.org/10.1096/fj.201800285			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29894669	Bronze			2022-12-28	WOS:000449359700016
J	Pappritz, K; Savvatis, K; Miteva, K; Kerim, B; Dong, FQ; Fechner, H; Muller, I; Brandt, C; Lopez, B; Gonzalez, A; Ravassa, S; Klingel, K; Diez, J; Reinke, P; Volk, HD; Van Linthout, S; Tschope, C				Pappritz, Kathleen; Savvatis, Konstantinos; Miteva, Kapka; Kerim, Bahtiyar; Dong, Fengquan; Fechner, Henry; Mueller, Irene; Brandt, Christine; Lopez, Begona; Gonzalez, Arantxa; Ravassa, Susana; Klingel, Karin; Diez, Javier; Reinke, Petra; Volk, Hans-Dieter; Van Linthout, Sophie; Tschoepe, Carsten			Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis	FASEB JOURNAL			English	Article						inflammation; fibrosis; monocytes	COLLAGEN CROSS-LINKING; HEART-FAILURE; INFLAMMATORY CARDIOMYOPATHY; REPLICATION; SUPPRESSION; ACTIVATION; INFARCTION; EXPRESSION; MONOCYTES; INFECTION	Regulatory T (T-reg) cells offer new therapeutic options for controlling undesired systemic and local immune responses. The aim of the current study was to determine the impact of therapeutic T-reg administration on systemic and cardiac inflammation and remodeling in coxsackievirus B3 (CVB3) -induced myocarditis. Therefore, syngeneic T-reg cells were applied intravenously in CVB3-infected mice 3 d after infection. Compared with CVB3 + PBS mice, CVB3 + T-reg mice exhibited lower left ventricle (LV) chemokine expression, accompanied by reduced cardiac presence of proinflammatory Ly6C(high)CCR2(high)Cx3Cr1(low) monocytes and higher retention of proinflammatory Ly6C(mid)CCR2(high)Cx3Cr1(low) monocytes in the spleen. In addition, splenic myelopoiesis was reduced in CVB3 + T-reg compared with CVB3 + PBS mice. Coculture of T-reg cells with splenocytes isolated from mice 3 d post-CVB3 infection further demonstrated the ability of T-reg cells to modulate monocyte differentiation in favor of the anti-inflammatory Ly6C(low)CCR2(low)Cx3Cr1(high) subset. T-reg-mediated immunomodulation was paralleled by lower collagen 1 protein expression and decreased levels of soluble and insoluble collagen in LV of CVB3 + T-reg compared with CVB3 + PBS mice. In agreement with these findings, LV systolic and diastolic function was improved in CVB3 + T-reg mice compared with CVB3 + PBS mice. In summary, adoptive T-reg transfer in the inflammatory phase of viral-induced myocarditis protects the heart against inflammatory damage and fibrosis via modulation of monocyte subsets.Pappritz, K., Savvatis, K., Miteva, K., Kerim, B., Dong, F., Fechner, H., Muller, I., Brandt, C., Lopez, B., Gonzalez, A., Ravassa, S., Klingel, K., Diez, J., Reinke, P., Volk, H.-D., Van Linthout, S., Tschope, C. Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis.	[Pappritz, Kathleen; Savvatis, Konstantinos; Miteva, Kapka; Kerim, Bahtiyar; Dong, Fengquan; Mueller, Irene; Brandt, Christine; Reinke, Petra; Volk, Hans-Dieter; Van Linthout, Sophie; Tschoepe, Carsten] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Campus Virchow Klinikum, Berlin, Germany; [Pappritz, Kathleen; Mueller, Irene; Van Linthout, Sophie; Tschoepe, Carsten] Charite Univ Med Berlin, Dept Cardiol, Campus Virchow Klinikum, Augustenburger Pl 1, D-13353 Berlin, Germany; [Reinke, Petra] Charite Univ Med Berlin, Dept Nephrol & Intens Med, Campus Virchow Klinikum, Berlin, Germany; [Volk, Hans-Dieter] Charite Univ Med Berlin, Inst Med Immunol, Campus Virchow Klinikum, Berlin, Germany; [Pappritz, Kathleen; Mueller, Irene; Van Linthout, Sophie; Tschoepe, Carsten] DZHK German Ctr Cardiovasc Res, Berlin, Germany; [Savvatis, Konstantinos] Barts Hlth Natl Hlth Serv NHS Trust, Barts Heart Ctr, Inherited Cardiovasc Dis Unit, London, England; [Savvatis, Konstantinos] Queen Mary Univ London, William Harvey Res Inst, London, England; [Miteva, Kapka] Humanitas Univ, Dept Biomed Sci, Humanitas Clin & Res Ctr, Adapt Immun Lab, Milan, Italy; [Fechner, Henry] Tech Univ Berlin, Inst Biotechnol, Dept Appl Biochem, Berlin, Germany; [Lopez, Begona; Gonzalez, Arantxa; Ravassa, Susana; Diez, Javier] Univ Navarra, Dept Cardiol & Cardiac Surg, Ctr Appl Med Res CIMA, Pamplona, Spain; [Klingel, Karin] Univ Hosp Tuebingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Diez, Javier] Carlos III Inst Hlth, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Barts Health NHS Trust; University of London; Queen Mary University London; Humanitas University; Technical University of Berlin; University of Navarra; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III	Tschope, C (corresponding author), Charite Univ Med Berlin, Dept Cardiol, Campus Virchow Klinikum, Augustenburger Pl 1, D-13353 Berlin, Germany.	carsten.tschoepe@charite.de	Savvatis, Konstantinos/AAJ-9012-2020; González, Arantxa/D-6860-2017; Díez, Javier/D-7014-2017; volk, hans-dieter/AAV-8053-2021; Ravassa, Susana/I-2567-2017	González, Arantxa/0000-0001-5986-6528; Díez, Javier/0000-0002-3414-6919; volk, hans-dieter/0000-0002-7743-6668; Tschope, Carsten/0000-0001-5243-8985; Reinke, Petra/0000-0003-0771-4375; Ravassa, Susana/0000-0001-5926-5677	Deutsche Forschungsgemeinschaft (DFG) via a Berlin-Brandenburg School for Regenerative Therapies (BSRT) Clinical Scientist Stipendium	Deutsche Forschungsgemeinschaft (DFG) via a Berlin-Brandenburg School for Regenerative Therapies (BSRT) Clinical Scientist Stipendium(German Research Foundation (DFG))	The authors acknowledge the assistance of the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) Flow Cytometry Laboratory. The authors thank Annika Koschel (Berlin-Brandenburg Center for Regenerative Therapies), Babette Dieringer (Technische Universitat Berlin), Kerstin Puhl (Charite University Medicine Berlin), Marzena Sosnowski (Charite University Medicine Berlin), and Georg Zingler (Charite University Medicine Berlin) (in alphabetical order) for excellent technical support. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) via a Berlin-Brandenburg School for Regenerative Therapies (BSRT) Clinical Scientist Stipendium (to K.S.). The authors declare no conflicts of interest.	Abou-El-Enein M, 2017, CLIN PHARMACOL THER, V101, P35, DOI 10.1002/cpt.523; Cao YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074955; Carthy CM, 2003, VIROLOGY, V313, P147, DOI 10.1016/S0042-6822(03)00242-3; Ding Q, 2006, J IMMUNOL, V177, P3606, DOI 10.4049/jimmunol.177.6.3606; Dominguez F, 2016, REV ESP CARDIOL, V69, P178, DOI [10.1016/j.rec.2015.10.015, 10.1016/j.recesp.2015.10.018]; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Garmaroudi FS, 2015, FUTURE MICROBIOL, V10, P629, DOI [10.2217/FMB.15.5, 10.2217/fmb.15.5]; Heymans S, 2016, J AM COLL CARDIOL, V68, P2348, DOI 10.1016/j.jacc.2016.09.937; Jagger AL, 2012, J AUTOIMMUN, V38, P29, DOI 10.1016/j.jaut.2011.11.015; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Klingel K, 1996, J VIROL, V70, P8888, DOI 10.1128/JVI.70.12.8888-8895.1996; Koch M, 2010, INT IMMUNOPHARMACOL, V10, P207, DOI 10.1016/j.intimp.2009.11.001; Lee JH, 2009, J IMMUNOL, V183, P6377, DOI 10.4049/jimmunol.0901268; Lei H, 2015, AM J TRANSPLANT, V15, P2625, DOI 10.1111/ajt.13315; Lei H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00184; Leuschner F, 2015, EUR HEART J, V36, P1478, DOI 10.1093/eurheartj/ehu225; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lopez B, 2016, J AM COLL CARDIOL, V67, P251, DOI 10.1016/j.jacc.2015.10.063; Lopez B, 2012, HYPERTENSION, V60, P677, DOI 10.1161/HYPERTENSIONAHA.112.196113; Marchant DJ, 2010, CIRCULATION, V121, P2609, DOI 10.1161/CIRCULATIONAHA.110.960054; Miteva K, 2017, STEM CELL TRANSL MED, V6, P1249, DOI 10.1002/sctm.16-0353; Miteva K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028513; Muller I, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004125; Muller I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182643; Myers JM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85851; Savvatis K, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0449-2; Savvatis K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041047; Saxena A, 2014, AM J PHYSIOL-HEART C, V307, pH1233, DOI 10.1152/ajpheart.00328.2014; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tschope C, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.003870; Van Linthout S, 2011, EUR HEART J, V32, P2168, DOI 10.1093/eurheartj/ehq467; Van Linthout S, 2014, CIRC RES, V115, P540, DOI 10.1161/CIRCRESAHA.114.304951; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710; Yuan J, 2010, J IMMUNOL, V185, P4004, DOI 10.4049/jimmunol.1001718; Zibadi S, 2010, CARDIOVASC TOXICOL, V10, P190, DOI 10.1007/s12012-010-9078-7	47	25	25	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6066	6078		10.1096/fj.201701408R	http://dx.doi.org/10.1096/fj.201701408R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29863913	Bronze			2022-12-28	WOS:000447172000025
J	Patyra, K; Jaeschke, H; Lof, C; Jannari, M; Ruohonen, ST; Undeutsch, H; Khalil, M; Kero, A; Poutanen, M; Toppari, J; Chen, M; Weinstein, LS; Paschke, R; Kero, J				Patyra, Konrad; Jaeschke, Holger; Lof, Christoffer; Jannari, Meeri; Ruohonen, Suvi T.; Undeutsch, Henriette; Khalil, Moosa; Kero, Andreina; Poutanen, Matti; Toppari, Jorma; Chen, Min; Weinstein, Lee S.; Paschke, Ralf; Kero, Jukka			Partial thyrocyte-specific G alpha(s) deficiency leads to rapid-onset hypothyroidism, hyperplasia, and papillary thyroid carcinoma-like lesions in mice	FASEB JOURNAL			English	Article						Gnas; thyroglobulin-Cre; Gs; G protein	THYROTROPIN RECEPTOR; CELL PROLIFERATION; SOMATIC MUTATIONS; ALPHA-SUBUNIT; TSH RECEPTOR; MOUSE MODEL; L-THYROXINE; SERUM TSH; IN-VIVO; HORMONE	Thyroid function is controlled by thyroid-stimulating hormone (TSH), which binds to its G protein-coupled receptor [thyroid-stimulating hormone receptor (TSHR)] on thyrocytes. TSHR can potentially couple to all G protein families, but it mainly activates the G(s)- and G(q/11)-mediated signaling cascades. To date, there is a knowledge gap concerning the role of the individual G protein cascades in thyroid pathophysiology. Here, we demonstrate that the thyrocyte-specific deletion of G(s) protein subunit (G(s)) in adult mice [tamoxifen-inducible G(s) protein subunit deficient (iTG(s)KO) mice] rapidly impairs thyrocyte function and leads to hypothyroidism. Consequently, iTG(s)KO mice show reduced food intake and activity. However, body weight and the amount of white adipose tissue were decreased only in male iTG(s)KO mice. Unexpectedly, hyperplastic follicles and papillary thyroid cancer-like tumor lesions with increased proliferation and slightly increased phospho-ERK1/2 staining were found in iTG(s)KO mice at an older age. These tumors developed from nonrecombined thyrocytes still expressing G(s) in the presence of highly elevated serum TSH. In summary, we report that partial thyrocyte-specific G(s) deletion leads to hypothyroidism but also to tumor development in thyrocytes with remaining G(s) expression. Thus, these mice are a novel model to elucidate the pathophysiological consequences of hypothyroidism and TSHR/G(s)/cAMP-mediated tumorigenesis.Patyra, K., Jaeschke, H., Lof, C., Jannari, M., Ruohonen, S. T., Undeutsch, H., Khalil, M., Kero, A., Poutanen, M., Toppari, J., Chen, M., Weinstein, L. S., Paschke, R., Kero, J. Partial thyrocyte-specific G(s) deficiency leads to rapid-onset hypothyroidism, hyperplasia, and papillary thyroid carcinoma-like lesions in mice.	[Patyra, Konrad; Jaeschke, Holger; Lof, Christoffer; Jannari, Meeri; Ruohonen, Suvi T.; Undeutsch, Henriette; Poutanen, Matti; Toppari, Jorma; Kero, Jukka] Turku Univ Hosp, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku, Finland; [Patyra, Konrad; Lof, Christoffer; Ruohonen, Suvi T.; Poutanen, Matti; Kero, Jukka] Turku Univ Hosp, Turku Ctr Dis Modeling, Turku, Finland; [Kero, Andreina; Toppari, Jorma; Kero, Jukka] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Khalil, Moosa] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Paschke, Ralf] Univ Calgary, Arnie Charbonneau Canc Res Inst, Calgary, AB, Canada; [Chen, Min; Weinstein, Lee S.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Jaeschke, Holger] Univ Duisburg Essen, Univ Hosp Essen, Dept Endocrinol Diabet & Metab, Essen, Germany; [Undeutsch, Henriette] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Undeutsch, Henriette] Harvard Med Sch, Boston, MA USA	University of Turku; University of Turku; University of Turku; University of Calgary; University of Calgary; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Duisburg Essen; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kero, J (corresponding author), Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	jukka.kero@utu.fi	Kero, Andreina/AAY-5816-2020; kero, jukka/G-3448-2014	kero, jukka/0000-0001-8767-7222; Lof, Christoffer/0000-0002-7149-5528	Finnish Pediatric and Medical Foundations; Erityisvaltionosuus (EVO) grant from Turku University Hospital; Academy of Finland; Sigrid Juselius Foundation; Jalmari and Rauha Ahokas Foundation; Turku University Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	Finnish Pediatric and Medical Foundations; Erityisvaltionosuus (EVO) grant from Turku University Hospital; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jalmari and Rauha Ahokas Foundation; Turku University Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Nina Messner, Heli Niittymaki, Katri Hovirinta, and Heidi Liljenback (Turku Center for Disease Modeling, Turku, Finland); Taina Kirjonen, Anna Kostiander, and Katariina Tanner (Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku) for skillful technical assistance with the experiments; and Biocenter Finland Cell Imaging Core for providing the laser capture microscope device. This work was supported be the Finnish Pediatric and Medical Foundations, an Erityisvaltionosuus (EVO) grant from Turku University Hospital, the Academy of Finland, the Sigrid Juselius Foundation, the Jalmari and Rauha Ahokas Foundation (to J.K.), and the Turku University Foundation (to K.P). The authors declare no conflicts of interest.	Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; Bianco AC, 2014, THYROID, V24, P88, DOI 10.1089/thy.2013.0109; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Brewer C, 2007, CANCER RES, V67, P8002, DOI 10.1158/0008-5472.CAN-07-2471; Calebiro D, 2016, J CLIN INVEST, V126, P3383, DOI 10.1172/JCI84894; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; Eszlinger M, 2014, MOL CELL ENDOCRINOL, V393, P39, DOI 10.1016/j.mce.2014.05.023; Fiore E, 2010, ENDOCR-RELAT CANCER, V17, P231, DOI 10.1677/ERC-09-0251; Fiore E, 2012, J CLIN ENDOCR METAB, V97, P1134, DOI 10.1210/jc.2011-2735; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Gozu HI, 2006, EUR J ENDOCRINOL, V155, P535, DOI 10.1530/eje.1.02253; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; GRASSO P, 1991, MUTAT RES, V248, P271, DOI 10.1016/0027-5107(91)90062-S; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; HERVAS F, 1975, ENDOCRINOLOGY, V97, P91, DOI 10.1210/endo-97-1-91; Jeker LT, 1999, BIOCHEM BIOPH RES CO, V257, P511, DOI 10.1006/bbrc.1999.0468; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Kim CS, 2009, THYROID, V19, P1317, DOI 10.1089/thy.2009.1609; Kimura ET, 2003, CANCER RES, V63, P1454; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LEDENT C, 1992, EMBO J, V11, P537, DOI 10.1002/j.1460-2075.1992.tb05084.x; Lu CX, 2010, ENDOCRINOLOGY, V151, P1929, DOI 10.1210/en.2009-1017; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Mendoza A, 2017, PHARMACOL THERAPEUT, V173, P135, DOI 10.1016/j.pharmthera.2017.02.012; MICHIELS FM, 1994, P NATL ACAD SCI USA, V91, P10488, DOI 10.1073/pnas.91.22.10488; Narumi S, 2011, J CLIN ENDOCR METAB, V96, pE1340, DOI 10.1210/jc.2011-0070; Orim F, 2014, THYROID, V24, P502, DOI 10.1089/thy.2013.0038; Palos-Paz F, 2008, EUR J ENDOCRINOL, V159, P623, DOI 10.1530/EJE-08-0313; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Pazaitou-Panayiotou K, 2012, HORM METAB RES, V44, P255, DOI 10.1055/s-0031-1299741; Rakov H, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0159-1; Rakov H, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0089-3; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; STEIN SA, 1994, MOL ENDOCRINOL, V8, P129, DOI 10.1210/me.8.2.129; Trulzsch B, 2001, J MOL MED, V78, P684, DOI 10.1007/s001090000170; Undeutsch H, 2015, ENDOCRINOLOGY, V156, P1590, DOI 10.1210/en.2014-1767; Undeutsch H, 2014, GENESIS, V52, P333, DOI 10.1002/dvg.22740; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Weinstein LS, 1999, TRENDS ENDOCRIN MET, V10, P81, DOI 10.1016/S1043-2760(98)00124-6; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Zou M, 2016, ONCOGENE, V35, P1909, DOI 10.1038/onc.2015.253	47	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6239	6251		10.1096/fj.201800211R	http://dx.doi.org/10.1096/fj.201800211R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29799790	Bronze			2022-12-28	WOS:000447172000039
J	Silbernagel, N; Walecki, M; Schafer, MKH; Kessler, M; Zobeiri, M; Rinne, S; Kiper, AK; Komadowski, MA; Vowinkel, KS; Wemhoner, K; Fortmuller, L; Schewe, M; Dolga, AM; Scekic-Zahirovic, J; Matschke, LA; Culmsee, C; Baukrowitz, T; Monassier, L; Ullrich, ND; Dupuis, L; Just, S; Budde, T; Fabritz, L; Decher, N				Silbernagel, Nicole; Walecki, Magdalena; Schaefer, Martin K. -H.; Kessler, Mirjam; Zobeiri, Mehrnoush; Rinne, Susanne; Kiper, Aytug K.; Komadowski, Marlene A.; Vowinkel, Kirsty S.; Wemhoener, Konstantin; Fortmueller, Lisa; Schewe, Marcus; Dolga, Amalia M.; Scekic-Zahirovic, Jelena; Matschke, Lina A.; Culmsee, Carsten; Baukrowitz, Thomas; Monassier, Laurent; Ullrich, Nina D.; Dupuis, Luc; Just, Steffen; Budde, Thomas; Fabritz, Larissa; Decher, Niels			The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function	FASEB JOURNAL			English	Article						HCN channels; ALS; cardiac arrhythmia	HCN CHANNELS; ENDOPLASMIC-RETICULUM; CATION CURRENT; CYCLIC-AMP; LATE-ONSET; TRAFFICKING; TRIP8B; EXPRESSION; MUTATION; FAMILY	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels encode neuronal and cardiac pacemaker currents. The composition of pacemaker channel complexes in different tissues is poorly understood, and the presence of additional HCN modulating subunits was speculated. Here we show that vesicle-associated membrane protein-associated protein B (VAPB), previously associated with a familial form of amyotrophic lateral sclerosis 8, is an essential HCN1 and HCN2 modulator. VAPB significantly increases HCN2 currents and surface expression and has a major influence on the dendritic neuronal distribution of HCN2. Severe cardiac bradycardias in VAPB-deficient zebrafish and VAPB(-/-) mice highlight that VAPB physiologically serves to increase cardiac pacemaker currents. An altered T-wave morphology observed in the ECGs of VAPB(-/-) mice supports the recently proposed role of HCN channels for ventricular repolarization. The critical function of VAPB in native pacemaker channel complexes will be relevant for our understanding of cardiac arrhythmias and epilepsies, and provides an unexpected link between these diseases and amyotrophic lateral sclerosis.Silbernagel, N., Walecki, M., Schafer, M.-K. H., Kessler, M., Zobeiri, M., Rinne, S., Kiper, A. K., Komadowski, M. A., Vowinkel, K. S., Wemhoner, K., Fortmuller, L., Schewe, M., Dolga, A. M., Scekic-Zahirovic, J., Matschke, L. A., Culmsee, C., Baukrowitz, T., Monassier, L., Ullrich, N. D., Dupuis, L., Just, S., Budde, T., Fabritz, L., Decher, N. The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function.	[Silbernagel, Nicole; Walecki, Magdalena; Rinne, Susanne; Kiper, Aytug K.; Komadowski, Marlene A.; Vowinkel, Kirsty S.; Wemhoener, Konstantin; Matschke, Lina A.; Decher, Niels] Philipps Univ Marburg, Inst Physiol & Pathophysiol, Vegetat Physiol, Deutschhausstr 1-2, D-35037 Marburg, Germany; [Schaefer, Martin K. -H.; Komadowski, Marlene A.] Philipps Univ Marburg, Inst Anat & Cell Biol, Marburg, Germany; [Dolga, Amalia M.; Culmsee, Carsten] Philipps Univ Marburg, Inst Pharmacol & Clin Pharm, Marburg, Germany; [Kessler, Mirjam; Just, Steffen] Univ Hosp Ulm, Dept Internal Med 2, Mol Cardiol, Ulm, Germany; [Fortmueller, Lisa; Fabritz, Larissa] Univ Hosp Munster, Dept Cardiol Electrophysiol 2, Munster, Germany; [Fabritz, Larissa] Univ Hosp Munster, Div Rhythmol, Munster, Germany; [Fabritz, Larissa] Univ Hosp Munster, Dept Genet Epidemiol, Inst Human Genet, Munster, Germany; [Zobeiri, Mehrnoush; Budde, Thomas] Univ Munster, Inst Physiol 1, Munster, Germany; [Schewe, Marcus; Baukrowitz, Thomas] Univ Kiel, Inst Physiol, Kiel, Germany; [Scekic-Zahirovic, Jelena; Monassier, Laurent] Univ Strasbourg, Lab Pharmacol & Toxicol NeuroCardiovasc, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, INSERM, Fac Med, Strasbourg, France; [Ullrich, Nina D.] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Fabritz, Larissa] Univ Birmingham, Univ Hosp Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Fabritz, Larissa] Univ Birmingham, Univ Hosp Birmingham, Dept Cardiol, Birmingham, W Midlands, England	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Ulm University; University of Munster; University of Munster; University of Munster; University of Munster; University of Kiel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ruprecht Karls University Heidelberg; University of Birmingham; University of Birmingham	Decher, N (corresponding author), Philipps Univ Marburg, Inst Physiol & Pathophysiol, Vegetat Physiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Monassier, Laurent/AAE-4446-2022; Decher, Niels/AAF-5002-2020; Kiper, Aytug Kadir/AAG-5093-2019; Dupuis, Luc/A-6981-2012; Dolga, Amalia/C-9664-2018; Culmsee, Carsten/ABC-3120-2021; Kiper, Aytug K/N-2340-2018; Ullrich, Nina/U-8217-2019	Kiper, Aytug Kadir/0000-0003-2850-2523; Culmsee, Carsten/0000-0002-5121-5015; Kiper, Aytug K/0000-0003-2850-2523; Ullrich, Nina/0000-0002-1077-3125; Schewe, Marcus/0000-0002-6192-5651; Dolga, Amalia/0000-0001-5400-5614; Baukrowitz, Thomas/0000-0003-4562-0505; Dupuis, Luc/0000-0002-0902-5824; Fabritz, Larissa/0000-0002-9241-1733	Atrial Fibrillation Network (AFNET), (CATCH ME European Research Consortium) [633196]; British Heart Foundation [FS/13/43/30324]; Leducq Foundation; IZKF Munster grant [Bud3/001/016]; University Medical Center Giessen and Marburg (UKGM); Deutsche Forschungsgemeinschaft [DE 1482/2-1]	Atrial Fibrillation Network (AFNET), (CATCH ME European Research Consortium); British Heart Foundation(British Heart Foundation); Leducq Foundation(Leducq Foundation); IZKF Munster grant; University Medical Center Giessen and Marburg (UKGM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Oxana Nowak and Andrea Schubert for technical assistance, Nikolaj Klocker (Heinrich Heine University Dusseldorf, Dusseldorf, Germany) for the <SUP>EGFP</SUP>HCN2<INF>Ex</INF><SUP>HA</SUP> construct and technical advice on the ELISA assays, Caspar Hoogenraad (Utrecht University, Utrecht, Netherlands) for the <SUP>HA</SUP>VAPB construct, Bernd Fakler (University of Freiburg, Freiburg, Germany) for the HCN1 and HCN2 pBF1 constructs, and Vijay Renigunta (Philipps-University Marburg, Marburg, Germany) for the HCN4-pBR3-N construct and technical advice on the Y2H screen. The authors thank Omer Guran (University of Birmingham) for expert help with blinded ECG analysis. L.F. was supported, in part, by the Atrial Fibrillation Network (AFNET), (CATCH ME European Research Consortium; 633196), the British Heart Foundation (FS/13/43/30324), and the Leducq Foundation. T.B. was supported by a IZKF Munster grant (Bud3/001/016). S.R. and A.K.K. were supported by a Research Grant of the University Medical Center Giessen and Marburg (UKGM). This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DE 1482/2-1) to N.D. The authors declare no conflicts of interest.	Anagnostou G, 2010, NEUROBIOL AGING, V31, P969, DOI 10.1016/j.neurobiolaging.2008.07.005; Asai H, 2007, J NEUROL SCI, V254, P78, DOI 10.1016/j.jns.2007.01.007; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen XD, 2005, J NEUROSCI, V25, P5803, DOI 10.1523/JNEUROSCI.1153-05.2005; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Decher N, 2017, EMBO MOL MED, V9, P403, DOI 10.15252/emmm.201606690; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DiFrancesco JC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00071; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dolga AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.30; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fenske S, 2013, CIRCULATION, V128, P2585, DOI 10.1161/CIRCULATIONAHA.113.003712; Fenske S, 2011, TRENDS CARDIOVAS MED, V21, P216, DOI 10.1016/j.tcm.2012.05.013; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Finsterer J, 2016, INT J CARDIOL, V203, P508, DOI 10.1016/j.ijcard.2015.10.176; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Friedrich C, 2014, EMBO MOL MED, V6, P937, DOI 10.15252/emmm.201303783; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Hofmann F, 2012, CARDIOVASC RES, V95, P317, DOI 10.1093/cvr/cvs184; Hu L, 2013, J GEN PHYSIOL, V142, P599, DOI 10.1085/jgp.201311013; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kanyshkova T, 2009, J NEUROSCI, V29, P8847, DOI 10.1523/JNEUROSCI.0689-09.2009; Kessler M, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0468-7; Langenbacher AD, 2005, P NATL ACAD SCI USA, V102, P17699, DOI 10.1073/pnas.0502679102; Leroy F, 2014, ELIFE, V3, DOI 10.7554/eLife.04046; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; Marques VD, 2008, J CLIN NEUROPHYSIOL, V25, P233, DOI 10.1097/WNP.0b013e31817ed219; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Meder B, 2011, BIOCHEM BIOPH RES CO, V408, P218, DOI 10.1016/j.bbrc.2011.03.121; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Murata Y, 1997, ACTA NEUROL SCAND, V96, P118; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Renigunta V, 2014, MOL BIOL CELL, V25, P1877, DOI [10.1091/mbc.E13-0592, 10.1091/mbc.E13-10-0592]; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Sartiani L, 2002, J PHYSIOL-LONDON, V545, P81, DOI 10.1113/jphysiol.2002.021535; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Shemisa Kamal, 2014, J Med Case Rep, V8, P224, DOI 10.1186/1752-1947-8-224; SHIMIZU T, 1994, J NEUROL SCI, V124, P45, DOI 10.1016/0022-510X(94)90009-4; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	64	9	9	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6159	6173		10.1096/fj.201800246R	http://dx.doi.org/10.1096/fj.201800246R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29879376	hybrid, Green Published			2022-12-28	WOS:000447172000033
J	Gnimassou, O; Fernandez-Verdejo, R; Brook, M; Naslain, D; Balan, E; Sayda, M; Cegielski, J; Nielens, H; Decottignies, A; Demoulin, JB; Smith, K; Atherton, PJ; Francaux, M; Deldicque, L				Gnimassou, Olouyomi; Fernandez-Verdejo, Rodrigo; Brook, Matthew; Naslain, Damien; Balan, Estelle; Sayda, Mariwan; Cegielski, Jessica; Nielens, Henri; Decottignies, Anabelle; Demoulin, Jean-Baptiste; Smith, Kenneth; Atherton, Philip J.; Francaux, Marc; Deldicque, Louise			Environmental hypoxia favors myoblast differentiation and fast phenotype but blunts activation of protein synthesis after resistance exercise in human skeletal muscle	FASEB JOURNAL			English	Article						hypoxia-inducible factor; deuterium; autophagy; redd1; tissue oxygenation index	BLOOD-FLOW RESTRICTION; UBIQUITIN LIGASES; SATELLITE CELL; HYPERTROPHY; ADAPTATIONS; ALTITUDE; INSULIN; PHOSPHORYLATION; TRANSCRIPTION; MYOGENESIS	We hypothesized that a single session of resistance exercise performed in moderate hypoxic (FiO(2): 14%) environmental conditions would potentiate the anabolic response during the recovery period spent in normoxia. Twenty subjects performed a 1-leg knee extension session in normoxic or hypoxic conditions. Muscle biopsies were taken 15 min and 4 h after exercise in the vastus lateralis of the exercised and the nonexercised legs. Blood and saliva samples were taken at regular intervals before, during, and after the exercise session. The muscle fractional-protein synthetic rate was determined by deuterium incorporation into proteins, and the protein-degradation rate was determined by methylhistidine release from skeletal muscle. We found that: 1) hypoxia blunted the activation of protein synthesis after resistance exercise; 2) hypoxia down-regulated the transcriptional program of autophagy; 3) hypoxia regulated the expression of genes involved in glucose metabolism at rest and the genes involved in myoblast differentiation and fusion and in muscle contraction machinery after exercise; and 4) the hypoxia-inducible factor-1 pathway was not activated at the time points studied. Contrary to our hypothesis, environmental hypoxia did not potentiate the short-term anabolic response after resistance exercise, but it initiated transcriptional regulations that could potentially translate into satellite cell incorporation and higher force production in the long term.Gnimassou, O., Fernandez-Verdejo, R., Brook, M., Naslain, D., Balan, E., Sayda, M., Cegielski, J., Nielens, H., Decottignies, A., Demoulin, J.-B., Smith, K., Atherton, P. J., Fancaux, M., Deldicque, L. Environmental hypoxia favors myoblast differentiation and fast phenotype but blunts activation of protein synthesis after resistance exercise in human skeletal muscle.	[Gnimassou, Olouyomi; Fernandez-Verdejo, Rodrigo; Naslain, Damien; Balan, Estelle; Nielens, Henri; Francaux, Marc; Deldicque, Louise] Catholic Univ Louvain, Inst Neurosci, Pl Pierre Coubertin,1 Box L08-10-01, B-1348 Louvain, Belgium; [Fernandez-Verdejo, Rodrigo] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Nutr & Dietet, Santiago, Chile; [Brook, Matthew; Sayda, Mariwan; Cegielski, Jessica; Smith, Kenneth; Atherton, Philip J.] Univ Nottingham, Med Res Council, Arthrit Res UK Ctr Excellence Musculoskeletal Age, Derby, England; [Brook, Matthew; Sayda, Mariwan; Cegielski, Jessica; Smith, Kenneth; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp, Clin Metab & Mol Physiol, Derby, England; [Decottignies, Anabelle; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Brussels, Belgium	Universite Catholique Louvain; Pontificia Universidad Catolica de Chile; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; University of Nottingham; Universite Catholique Louvain	Deldicque, L (corresponding author), Catholic Univ Louvain, Inst Neurosci, Pl Pierre Coubertin,1 Box L08-10-01, B-1348 Louvain, Belgium.	louise.deldicque@uclouvain.be	Brook, Matthew/W-4689-2019	Fernandez-Verdejo, Rodrigo/0000-0002-5948-2281; Atherton, Philip/0000-0002-7286-046X; Brook, Matthew/0000-0002-9245-3095; Deldicque, Louise/0000-0003-3393-5278	Fonds National de la Recherche Scientifique [J.0050.16]; Agence Francaise de Lutte contre le Dopage; Sports Ministry of the Brussels-Wallonia Federation	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Agence Francaise de Lutte contre le Dopage; Sports Ministry of the Brussels-Wallonia Federation	The authors thank the participants and Adelie Jadot (Institute of Neuroscience, Universite Catholique de Louvain) for technical assistance and organization of the experiments. This work was supported by the Fonds National de la Recherche Scientifique (Grant J.0050.16) and by the Agence Francaise de Lutte contre le Dopage. M.F. was supported by the Sports Ministry of the Brussels-Wallonia Federation. Data collection took place at Universite Catholique de Louvain, and data analyses took place at Universite Catholique de Louvain and the University of Nottingham. The authors declare no conflicts of interest.	Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Baldi Simonetta, 2010, Int J Chron Obstruct Pulmon Dis, V5, P29; Beall CM, 2013, AM J HUM BIOL, V25, P141, DOI 10.1002/ajhb.22355; Beaudry M, 2016, J CELL SCI, V129, P2887, DOI 10.1242/jcs.188904; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brocherie F, 2015, MED SCI SPORT EXER, V47, P2140, DOI 10.1249/MSS.0000000000000630; BROOKS GA, 1991, J APPL PHYSIOL, V70, P919, DOI 10.1152/jappl.1991.70.2.919; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chaudhary P, 2012, AVIAT SPACE ENVIR MD, V83, P1037, DOI 10.3357/ASEM.3278.2012; D'Hulst G, 2013, ACTA PHYSIOL, V208, P251, DOI 10.1111/apha.12086; D'Hulst G, 2017, J APPL PHYSIOL, V122, P406, DOI 10.1152/japplphysiol.00264.2016; D'Hulst G, 2015, EUR J APPL PHYSIOL, V115, P1219, DOI 10.1007/s00421-015-3103-2; Doria C, 2011, J APPL PHYSIOL, V111, P1597, DOI 10.1152/japplphysiol.01439.2010; Etheridge T, 2011, AM J PHYSIOL-ENDOC M, V301, pE697, DOI 10.1152/ajpendo.00276.2011; Flueck M, 2009, HIGH ALT MED BIOL, V10, P183, DOI 10.1089/ham.2008.1104; Francaux M., 2013, CELL MOL EXERC PHYSL, V2, pE5; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Gundermann DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1198, DOI 10.1152/ajpendo.00600.2013; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kurobe K, 2015, CLIN PHYSIOL FUNCT I, V35, P197, DOI 10.1111/cpf.12147; Lee WH, 2009, MOL CANCER THER, V8, P2791, DOI 10.1158/1535-7163.MCT-09-0420; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; Manimmanakorn A, 2013, EUR J APPL PHYSIOL, V113, P1767, DOI 10.1007/s00421-013-2605-z; Masschelein E, 2014, FASEB J, V28, P1022, DOI 10.1096/fj.13-239863; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Santos JL, 2001, NUTRITION, V17, P305, DOI 10.1016/S0899-9007(00)00551-7; Sheffield-Moore M, 2014, J CACHEXIA SARCOPENI, V5, P19, DOI 10.1007/s13539-013-0117-7; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Wilkinson D. J., 2015, PHYSL REP, V3, P3; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005	46	15	15	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5272	5284		10.1096/fj.201800049RR	http://dx.doi.org/10.1096/fj.201800049RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29672220	Green Submitted, Bronze			2022-12-28	WOS:000447972500007
J	Cho, HJ; Mook-Jung, I				Cho, Hyun Jin; Mook-Jung, Inhee			O-GlcNAcylation regulates endoplasmic reticulum exit sites through Sec31A modification in conventional secretory pathway	FASEB JOURNAL			English	Article						ER-Golgi; transport; COPII vesicles; ERES; ALG-2	BETA-N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; NUCLEOCYTOPLASMIC PROTEINS; COPII COAT; SUBSTRATE-SPECIFICITY; ALZHEIMER-DISEASE; VESICLE FORMATION; QUALITY-CONTROL; CELL BIOLOGY; SYNAPSIN I	The conventional secretory pathway is indispensable for eukaryotic cells. Newly synthesized membrane and secretory proteins are released from the endoplasmic reticulum (ER) through ER-derived vesicles to their appropriate destination. Vesicle formation is important for steady protein trafficking. O-GlcNAcylation (O-GlcNAc) is a unique protein glycosylation signature, whose dynamic regulation by O-GlcNAc transferase and O-GlcNAcase occurs exclusively for nuclear and cytoplasmic proteins. Because of this locally limited property, the role of O-GlcNAc in the conventional protein secretory pathway is unknown. We report that Sec31A on COPII vesicles, a specific coat-protein complex for anterograde trafficking in the ER-Golgi network, is O-GlcNAcylated on S964, which accelerates COPII vesicle formation through control of its binding affinity to apoptosis-linked gene 2, a calcium-binding protein. Together, O-GlcNAc on Sec31A regulates conventional secretory vesicle trafficking in the ER-Golgi network. These modifications accelerate COPII vesicle formation and accelerated anterograde transport of vesicles within the ER-Golgi networks.Cho, H. J., Mook-Jung, I. O-GlcNAcylation regulates endoplasmic reticulum exit sites through Sec31A modification in conventional secretory pathway.	[Cho, Hyun Jin; Mook-Jung, Inhee] Seoul Natl Univ, Dept Biochem & Biomed Sci, Coll Med, 28 Yungun Dong, Seoul 110799, South Korea	Seoul National University (SNU)	Mook-Jung, I (corresponding author), Seoul Natl Univ, Dept Biochem & Biomed Sci, Coll Med, 28 Yungun Dong, Seoul 110799, South Korea.	inhee@snu.ac.kr			National Research Foundation (NRF) [2015R1A2A1A05001794, 2014M3-C7A1046047, 2015M3C7A1028790]; Medical Research Council (MRC) [2011-0030738]; Basic Research Program grant from the NRF [2016R1A6A3A11930270]	National Research Foundation (NRF); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basic Research Program grant from the NRF	The authors thank all members of the Alzlab (Seoul National University College of Medicine). This work was supported grants from the National Research Foundation (NRF; 2015R1A2A1A05001794, 2014M3-C7A1046047, 2015M3C7A1028790), Medical Research Council (MRC; 2011-0030738; to I.M.-J.) and a Basic Research Program grant from the NRF (2016R1A6A3A11930270 to H.J.C.). The authors declare no conflicts of interest.	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Campsteijn C, 2016, CURR OPIN CELL BIOL, V41, P1, DOI 10.1016/j.ceb.2016.03.008; Carrillo LD, 2011, J BIOL CHEM, V286, P6650, DOI 10.1074/jbc.M110.191627; Cha MY, 2015, HUM MOL GENET, V24, P6492, DOI 10.1093/hmg/ddv358; Cho HJ, 2014, EMBO J, V33, P2314, DOI 10.15252/embj.201487807; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; Foerster S, 2014, BBA-MOL BASIS DIS, V1842, P1333, DOI 10.1016/j.bbadis.2014.05.014; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Goulabchand R, 2014, AUTOIMMUN REV, V13, P742, DOI 10.1016/j.autrev.2014.02.005; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kolarova M., 2012, INT J ALZHEIMERS DIS, V2012, P13; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; Li JJ, 2010, METHODS MOL BIOL, V600, P1, DOI 10.1007/978-1-60761-454-8_1; Lodish H, 2000, OVERVIEW SECRETORY P; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Martinez MR, 2017, BIOCHEM SOC T, V45, P237, DOI 10.1042/BST20160153; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; MOULLIER P, 1986, EUR J BIOCHEM, V161, P197, DOI 10.1111/j.1432-1033.1986.tb10142.x; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sollner TH, 1996, EXPERIENTIA, V52, P1021; Stankewich MC, 2006, J CELL SCI, V119, P958, DOI 10.1242/jcs.02751; Szul T, 2011, PHYSIOLOGY, V26, P348, DOI 10.1152/physiol.00017.2011; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Tarabykina S, 2004, FRONT BIOSCI-LANDMRK, V9, P1817, DOI 10.2741/1358; Theard D, 2007, MOL BIOL CELL, V18, P2313, DOI 10.1091/mbc.E06-11-1040; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara Natasha Elizabeth, 2004, Methods Mol Biol, V284, P175; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, CURR ORG CHEM, V8, P369, DOI 10.2174/1385272043485873; Zanetti G, 2013, ELIFE, V2, DOI 10.7554/eLife.00951; Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	77	10	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4641	4657		10.1096/fj.201701523R	http://dx.doi.org/10.1096/fj.201701523R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913562				2022-12-28	WOS:000443817700003
J	Tutakhel, OAZ; Bianchi, F; Smits, DA; Bindels, RJM; Hoenderop, JGJ; van der Wijst, J				Tutakhel, Omar A. Z.; Bianchi, Frans; Smits, Daniel A.; Bindels, Rene J. M.; Hoenderop, Joost G. J.; van der Wijst, Jenny			Dominant functional role of the novel phosphorylation site S811 in the human renal NaCl cotransporter	FASEB JOURNAL			English	Article						hypertension; kidney; NCC; splice variant	NA+-CL-COTRANSPORTER; SODIUM-CHLORIDE COTRANSPORTER; GENETIC-VARIATION; MG2+ TRANSPORTER; STRUCTURAL UNIT; BLOOD-PRESSURE; HYPERTENSION; MUTATIONS; VASOPRESSIN; EXPRESSION	The NaCl cotransporter (NCC) is essential for electrolyte homeostasis and control of blood pressure. The human SLC12A3 gene, which encodes NCC, gives rise to 3 isoforms, of which only the shortest isoform [NaCl cotransporter isoform 3 (NCC3)] has been studied extensively. All NCC isoforms share key phosphorylation sites at T55 and T60 that are essential mediators of NCC function. Recently, a novel phosphorylation site at S811 was identified in isoforms 1 and 2 [NaCl cotransporter splice variant (NCCSV)], which are only present in humans and higher primates. The aim of the current study, therefore, is to investigate the role of S811 phosphorylation in the regulation of NCC by a combination of biochemical and fluorescent microscopy analyses. We demonstrate that hypotonic low-chloride buffer increases S811 phosphorylation, whereas phosphorylation-deficient S811A mutant hinders phosphorylation at T55 and T60 in NCCSV and NCC3. NCCSV S811A impairs NCC3 activity in a dominant-negative fashion, although it does not affect plasma membrane abundance. This effect may be explained by the heterodimerization of NCCSV with NCC3. Taken together, our study highlights the dominant-negative effect of NCCSV on T55 and T60 phosphorylation and NCC activity. Here, we reveal a new function of NCCSV in humans that broadens the understanding on NCC regulation in blood pressure control.Tutakhel, O. A. Z., Bianchi, F., Smits, D. A., Bindels, R. J. M., Hoenderop, J. G. J., van der Wijst, J. Dominant functional role of the novel phosphorylation site S811 in the human renal NaCl cotransporter.	[Tutakhel, Omar A. Z.; Bianchi, Frans; Smits, Daniel A.; Bindels, Rene J. M.; Hoenderop, Joost G. J.; van der Wijst, Jenny] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	van der Wijst, J (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	jenny.vanderwijst@radboudumc.nl	van der Wijst, Jenny/T-1620-2019; Bianchi, Frans/E-8796-2018; van der Wijst, Jenny/D-9726-2016; Tutakhel, Omar A.Z./G-3638-2016; Bindels, René JM/B-9824-2013; Tutakhel, Omar/AAW-6591-2021	van der Wijst, Jenny/0000-0002-1547-516X; Bianchi, Frans/0000-0002-9385-9695; van der Wijst, Jenny/0000-0002-1547-516X; Tutakhel, Omar A.Z./0000-0002-1872-8409; Bindels, René JM/0000-0003-1167-1339; Smits, Daan/0000-0002-3090-4321	Netherlands Organization for Scientific Research [VENI 863.13.010, VICI 016.130.668]; Dutch Kidney Foundation [PHD12.14, 16OI04]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation	The authors thank Marco A. Valdez-Flores (Department of Physiology, Radboud Institute for Molecular Life Sciences), Sjoerd Verkaart (Department of Physiology, Radboud Institute for Molecular Life Sciences), Geert van den Bogaart (Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences), and Danielle R. J. Verboogen (Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences) for technical assistance and advice. This work was supported by the Netherlands Organization for Scientific Research (VENI 863.13.010 and VICI 016.130.668) and the Dutch Kidney Foundation (PHD12.14 and 16OI04). The authors declare no conflicts of interest.	Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Barber P. R., 2005, SPIE P, V5700; Bianchi G, 1973, Clin Sci Mol Med Suppl, V45 Suppl 1, p135s; Bloch MJ, 2016, J AM SOC HYPERTENS, V10, P753, DOI 10.1016/j.jash.2016.08.006; Boudoulas KD, 2017, PROG CARDIOVASC DIS, V59, P636, DOI 10.1016/j.pcad.2016.12.003; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Cameron AC, 2016, DRUGS, V76, P1529, DOI 10.1007/s40265-016-0642-8; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Castaneda-Bueno M, 2017, P NATL ACAD SCI USA, V114, pE879, DOI 10.1073/pnas.1620315114; Coffman TM, 2008, HYPERTENSION, V51, P811, DOI 10.1161/HYPERTENSIONAHA.105.063636; DAHL LK, 1975, CIRC RES, V36, P692, DOI 10.1161/01.RES.36.6.692; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; Dimke H, 2011, J AM SOC NEPHROL, V22, P508, DOI 10.1681/ASN.2010060606; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Heinzen EL, 2007, AM J HUM GENET, V80, P876, DOI 10.1086/516650; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Hurd TW, 2013, J AM SOC NEPHROL, V24, P967, DOI 10.1681/ASN.2012101034; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lin SH, 2005, J CLIN ENDOCR METAB, V90, P2500, DOI 10.1210/jc.2004-1905; Lin WC, 2014, P NATL ACAD SCI USA, V111, P2996, DOI 10.1073/pnas.1321155111; Lu ZX, 2012, WIRES RNA, V3, P581, DOI 10.1002/wrna.120; Maruyama IN, 2014, CELLS-BASEL, V3, P304, DOI 10.3390/cells3020304; Mastroianni N, 1996, AM J HUM GENET, V59, P1019; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mistry AC, 2016, BIOCHEM J, V473, P3237, DOI 10.1042/BCJ20160312; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Mullins LJ, 2006, PHYSIOL REV, V86, P709, DOI 10.1152/physrev.00016.2005; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pathare G, 2017, AM J PHYSIOL-RENAL, V312, pF1063, DOI 10.1152/ajprenal.00644.2016; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rieg T, 2013, AM J PATHOL, V182, P96, DOI 10.1016/j.ajpath.2012.09.014; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Saritas T, 2013, J AM SOC NEPHROL, V24, P407, DOI 10.1681/ASN.2012040404; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schmitt R, 1999, AM J PHYSIOL-RENAL, V276, pF367, DOI 10.1152/ajprenal.1999.276.3.F367; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Tutakhel OAZ, 2016, AM J PHYSIOL-RENAL, V310, pF204, DOI 10.1152/ajprenal.00429.2015; Urbanova M, 2011, FOLIA BIOL-PRAGUE, V57, P65; Valdez-Flores MA, 2016, AM J PHYSIOL-RENAL, V311, pF1159, DOI 10.1152/ajprenal.00124.2016; Vargas-Poussou R, 2011, J AM SOC NEPHROL, V22, P693, DOI 10.1681/ASN.2010090907; Verboogen DRJ, 2017, ELIFE, V6, DOI 10.7554/eLife.23525; Vijftigschild LAW, 2013, CYTOM PART A, V83A, P576, DOI 10.1002/cyto.a.22275; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wynne BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03510-5; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033; Yang SS, 2013, J AM SOC NEPHROL, V24, P1587, DOI 10.1681/ASN.2012070742; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x; Zhou B, 2010, J AM SOC NEPHROL, V21, P82, DOI 10.1681/ASN.2008121275	71	1	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4482	4493		10.1096/fj.201701047R	http://dx.doi.org/10.1096/fj.201701047R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29547703	Green Submitted			2022-12-28	WOS:000439325400035
J	Ciciliot, S; Albiero, M; Campanaro, S; Poncina, N; Tedesco, S; Scattolini, V; Dalla Costa, F; Cignarella, A; Vettore, M; Di Gangi, IM; Bogialli, S; Avogaro, A; Fadini, GP				Ciciliot, Stefano; Albiero, Mattia; Campanaro, Stefano; Poncina, Nicol; Tedesco, Serena; Scattolini, Valentina; Dalla Costa, Francesca; Cignarella, Andrea; Vettore, Monica; Di Gangi, Iole Maria; Bogialli, Sara; Avogaro, Angelo; Fadini, Gian Paolo			Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance	FASEB JOURNAL			English	Article						oxidative stress; inflammation; gut bacteria; microbiome; metabolic syndrome	HIGH-FAT DIET; OXIDATIVE STRESS; GLUCOSE-TOLERANCE; LIFE-SPAN; DELETION; HOST; MICE; PROMOTES; PROTECTS; GENE	The 66 kDa isoform of the mammalian Shc gene promotes adipogenesis, and p66Shc(-/-) mice accumulate less body weight than wild-type (WT) mice. As the metabolic consequences of the leaner phenotype of p66Shc(-/-) mice is debated, we hypothesized that gut microbiota may be involved. We confirmed that p66Shc(-/-) mice gained less weight than WT mice when on a high-fat diet (HFD), but they were not protected from insulin resistance and glucose intolerance. p66Shc deletion significantly modified the composition of gut microbiota and their modification after an HFD. This was associated with changes in gene expression of Il-1b and regenerating islet-derived protein 3 (Reg3g) in the gut and in systemic trimethylamine N-oxide and branched chain amino acid levels, despite there being no difference in intestinal structure and permeability. Depleting gut microbiota at the end of HFD rendered both strains more glucose tolerant but improved insulin sensitivity only in p66Shc(-/-) mice. Microbiota-depleted WT mice cohoused with microbiota-competent p66Shc(-/-) mice became significantly more insulin resistant than WT mice cohoused with WT mice, despite no difference in weight gain. These findings reconcile previous inconsistent observations on the metabolic phenotype of p66Shc(-/-) mice and illustrate the complex microbiome-host-genotype interplay under metabolic stress.Ciciliot, S., Albiero, M., Campanaro, S., Poncina, N., Tedesco, S., Scattolini, V., Dalla Costa, F., Cignarella, A., Vettore, M., Di Gangi, I. M., Bogialli, S., Avogaro, A., Fadini, G. P. Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance.	[Ciciliot, Stefano; Albiero, Mattia; Poncina, Nicol; Tedesco, Serena; Scattolini, Valentina; Dalla Costa, Francesca; Fadini, Gian Paolo] Venetian Inst Mol Med, Padua, Italy; [Campanaro, Stefano] Univ Padua, Dept Biol, Padua, Italy; [Scattolini, Valentina; Cignarella, Andrea; Vettore, Monica; Avogaro, Angelo; Fadini, Gian Paolo] Univ Padua, Dept Med, Padua, Italy; [Di Gangi, Iole Maria; Bogialli, Sara] Univ Padua, Dept Chem, Padua, Italy	Veneto Institute Molecular Medicine; University of Padua; University of Padua; University of Padua	Fadini, GP (corresponding author), Univ Padua, Med Sch, Dept Med, Via Giustiniani 2, I-35128 Padua, Italy.	gianpaolo.fadini@unipd.it	Avogaro, Angelo/S-3808-2016; Fadini, Gian Paolo/M-4575-2019; bogialli, sara/AAA-9818-2021; Campanaro, Stefano/I-5657-2019; Albiero, Mattia/AAG-4257-2019; Ciciliot, Stefano/L-3887-2019	Fadini, Gian Paolo/0000-0002-6510-2097; bogialli, sara/0000-0002-9152-3602; Albiero, Mattia/0000-0003-4142-9738; Ciciliot, Stefano/0000-0002-5833-6581; Cignarella, Andrea/0000-0002-4820-4876; Scattolini, Valentina/0000-0002-0855-9402; AVOGARO, ANGELO/0000-0002-1177-0516	Italian Ministry of University [PRIN 2015ZTT5KB]; Oviesse Co.	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Oviesse Co.	G.P.F. is the guarantor of this work, and as such, has full access to all the data in the study, and takes responsibility for the integrity of the data and its accuracy of the data analysis. This work was supported by grants from the Italian Ministry of University (PRIN 2015ZTT5KB to G.P.F.) and from the Oviesse Co. to the Venetian Institute of Molecular Medicine. The authors declare no conflicts of interest.	Albiero M, 2014, DIABETES, V63, P1353, DOI 10.2337/db13-0894; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Ciciliot S, 2015, DIABETOLOGIA, V58, P2352, DOI 10.1007/s00125-015-3667-8; de Sablet T, 2016, CELL MICROBIOL, V18, P1871, DOI 10.1111/cmi.12632; Dumas ME, 2017, CELL REP, V20, P136, DOI 10.1016/j.celrep.2017.06.039; Fadini GP, 2010, DIABETES, V59, P2306, DOI 10.2337/db09-1727; Forman HJ, 2010, ANN NY ACAD SCI, V1203, P35, DOI 10.1111/j.1749-6632.2010.05551.x; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Giorgio M, 2016, AGING CELL, V15, P446, DOI 10.1111/acel.12448; Graiani G, 2005, HYPERTENSION, V46, P433, DOI 10.1161/01.HYP.0000174986.73346.ba; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Walker A, 2014, ISME J, V8, P2380, DOI 10.1038/ismej.2014.79; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	29	9	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4004	4015		10.1096/fj.201701409R	http://dx.doi.org/10.1096/fj.201701409R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29466053				2022-12-28	WOS:000435104500044
J	Oh, SM; Lim, YJ; Choi, JA; Lee, J; Cho, SN; Go, D; Kim, SH; Song, CH				Oh, Sung-Man; Lim, Yun-Ji; Choi, Ji-Ae; Lee, Junghwan; Cho, Soo-Na; Go, Dam; Kim, Seon-Hwa; Song, Chang-Hwa			TNF--mediated ER stress causes elimination of Mycobacterium fortuitum reservoirs by macrophage apoptosis	FASEB JOURNAL			English	Article						infection; nontuberculous mycobacteria; endoplasmic reticulum	ENDOPLASMIC-RETICULUM STRESS; CYTOKINE SECRETION; TUBERCULOSIS; ACTIVATION; DEFENSE; DISEASE; SNARES	Mycobacterium fortuitum (MF), a rapidly growing nontuberculosis mycobacterium, is recognized as an important human pathogen. We investigated whether the endoplasmic reticulum (ER) stress response is associated with the apoptosis of MF-infected macrophages. The expression of ER molecular chaperones was significantly induced by MF infection. We found that MF-induced reactive oxygen species (ROS) generation plays a critical role in the induction of ER stress-mediated apoptosis. Excess TNF- in the ER led to ER stress-mediated apoptosis during MF infection. The intracellular survival of MF was significantly increased by TNF- knockdown compared with the control. This is the first report of MF-induced TNF- as a cause of ER stress in macrophages. Furthermore, we found that TLR2-mediated ER stress response contributed to the elimination of intracellular MF in vivo. These results suggest that TNF--mediated ER stress during MF infection contributes to the suppression of intracellular survival of MF in macrophages. Our findings provide new insight into the importance of ER stress in mycobacterial infection.Oh, S.-M., Lim, Y.-J., Choi, J.-A., Lee, J., Cho, S.-N., Go, D., Kim, S.-H., Song, C.-H. TNF--mediated ER stress causes elimination of Mycobacterium fortuitum reservoirs by macrophage apoptosis.	[Oh, Sung-Man; Lim, Yun-Ji; Choi, Ji-Ae; Lee, Junghwan; Cho, Soo-Na; Go, Dam; Kim, Seon-Hwa; Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Dept Microbiol, 266 Munhwa Ro, Daejeon 35015, South Korea; [Oh, Sung-Man; Lim, Yun-Ji; Choi, Ji-Ae; Lee, Junghwan; Cho, Soo-Na; Go, Dam; Kim, Seon-Hwa; Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Dept Med Sci, Daejeon, South Korea; [Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Daejeon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University	Song, CH (corresponding author), Chungnam Natl Univ, Coll Med, Dept Microbiol, 266 Munhwa Ro, Daejeon 35015, South Korea.	songch@cnu.ac.kr	Song, Chang-Hwa/AAD-7917-2022	Song, Chang-Hwa/0000-0002-9490-0573	National Research Foundation of Korea (NRF) grant - Korean government (MEST) [NRF-2016R1A2B2008178]	National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF-2016R1A2B2008178). The authors declare no conflicts of interest.	Blair P, 2017, J INFECT CHEMOTHER, V23, P177, DOI 10.1016/j.jiac.2016.08.016; Butler RE, 2010, CELL MICROBIOL, V12, P1186, DOI 10.1111/j.1462-5822.2010.01463.x; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Choi J, 2013, IEEE ICCE, P7, DOI 10.1109/ICCE.2013.6486771; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000; Han JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32079; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kavoosi G, 2009, PARASITOLOGY, V136, P1193, DOI 10.1017/S0031182009990473; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Lim YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37211; Lim YJ, 2015, APOPTOSIS, V20, P358, DOI 10.1007/s10495-014-1080-2; Lim YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028531; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Morinaga N, 2008, CELL MICROBIOL, V10, P921, DOI 10.1111/j.1462-5822.2007.01094.x; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Murray RZ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00538; Porvaznik I, 2017, ADV EXP MED BIOL, V944, P19, DOI 10.1007/5584_2016_45; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	29	11	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3993	4003		10.1096/fj.201701407R	http://dx.doi.org/10.1096/fj.201701407R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481309				2022-12-28	WOS:000435104500043
J	Wang, RZ; Fu, T; You, K; Li, SW; Zhao, N; Yang, JN; Zhuang, SM				Wang, Ruizhi; Fu, Tao; You, Kai; Li, Siwen; Zhao, Na; Yang, Jine; Zhuang, Shi-Mei			Identification of a TGF-beta-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells	FASEB JOURNAL			English	Article						miR-195; noncoding RNA; TGF- signaling; HDAC1; hepatocellular carcinoma	HEPATOCELLULAR-CARCINOMA CELLS; TGF-BETA RECEPTOR; SUPPRESSES TUMORIGENICITY; LIVER FIBROSIS; LUNG-CANCER; EXPRESSION; PROMOTER; SP1; MICRORNA-195; REPRESSION	Resistance to TGF--induced growth repression is prevalent in various cancer cells, but the underlying mechanisms remain unclear. In this study, we showed that activation of TGF- signaling caused Sma- and Mad-related family (Smad) 2 and Smad3 to bind directly to the promoter region of miR-195, and then activated miR-195 transcription in normal hepatocytes. Conversely, miR-195 inhibited the expression of Smad7 by binding to its 3-UTR, thereby strengthening TGF--Smad signaling. These data identify a novel TGF--miR-195 positive regulatory circuitry in normal hepatocytes. Further investigation revealed that HDAC1, a histone deacetylase that was abnormally overexpressed in hepatocellular carcinoma, could bind to the miR-195 promoter via Smad3 and cause hypoacetylation in the histones associated with the miR-195 promoter in hepatoma cells. This resulted in transcriptional repression of miR-195 and, subsequently, disruption of the TGF--miR-195 regulatory loop and evasion of TGF--mediated growth inhibition. Moreover, silencing HDAC1 in hepatoma cells restored TGF--mediated growth suppression, but this effect was attenuated if miR-195 expression decreased. These findings suggest that HDAC1-induced miR-195 down-regulation is an important mechanism for tumor cells to resist the cytostatic activity of TGF-, and highlight the importance of TGF--Smad2/3-miR-195-Smad7 circuitry in preventing uncontrolled cell proliferation.Wang, R., Fu, T., You, K., Li, S., Zhao, N., Yang, J., Zhuang, S.-M. Identification of a TGF--miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells.	[Wang, Ruizhi; Fu, Tao; You, Kai; Li, Siwen; Zhao, Na; Yang, Jine; Zhuang, Shi-Mei] Sun Yat Sen Univ, Affiliated Hosp 1, Sch Life Sci,Minist Educ,State Key Lab Biocontrol, Collaborat Innovat Ctr Canc Med,Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China; [Wang, Ruizhi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yang, JN; Zhuang, SM (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Xin Gang Xi Rd 135, Guangzhou 510275, Guangdong, Peoples R China.	lssyje@mail.sysu.edu.cn; zhuangshimei@163.com		Zhuang, Shi-Mei/0000-0002-2512-3942; Zhao, Na/0000-0002-8161-3380	National Key Research and Development Program of China [2017YFA0504400]; National Natural Science Foundation of China [91440205, 81572400, 81402421]; Natural Science Foundation of Guangdong Province [2014A030313119, 2017A030313107]; Fundamental Research Funds for the Central Universities [171gjc32, 17ykpy33]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Wangjing Zhong (School of Life Sciences, Sun Yat-sen University) for technical assistance. This work was supported by National Key Research and Development Program of China Grant 2017YFA0504400, National Natural Science Foundation of China Grants 91440205, 81572400, and 81402421, Natural Science Foundation of Guangdong Province Grants 2014A030313119 and 2017A030313107, and the Fundamental Research Funds for the Central Universities (Grants 171gjc32 and 17ykpy33). The authors declare no conflicts of interest.	Bhattacharya A, 2013, ONCOGENE, V32, P3175, DOI 10.1038/onc.2012.324; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding J, 2013, HEPATOLOGY, V58, P654, DOI 10.1002/hep.26378; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Kang SH, 1999, ONCOGENE, V18, P7280, DOI 10.1038/sj.onc.1203146; Kim HJ, 2011, BBA-GENE REGUL MECH, V1809, P184, DOI 10.1016/j.bbagrm.2011.01.004; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Osada H, 2001, CANCER RES, V61, P8331; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Roderburg C, 2013, J HEPATOL, V58, P736, DOI 10.1016/j.jhep.2012.11.022; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Wang JY, 2010, BIOCHEM BIOPH RES CO, V393, P291, DOI 10.1016/j.bbrc.2010.01.127; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Ward SV, 2003, VIROLOGY, V313, P553, DOI 10.1016/S0042-6822(03)00347-7; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Zhang HT, 2004, CLIN CANCER RES, V10, P2359, DOI 10.1158/1078-0432.CCR-0959-3; Zhao N, 2016, BBA-GENE REGUL MECH, V1859, P933, DOI 10.1016/j.bbagrm.2016.05.006	26	7	7	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3936	3945		10.1096/fj.201701199R	http://dx.doi.org/10.1096/fj.201701199R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465312				2022-12-28	WOS:000435104500038
J	Xu, YY; Jiang, YQ; Li, C; He, MD; Rusyniak, WG; Annamdevula, N; Ochoa, J; Leavesley, SJ; Xu, JP; Rich, TC; Lin, MT; Zha, XM				Xu, Yuanyuan; Jiang, Yu-Qing; Li, Ce; He, Mindi; Rusyniak, W. George; Annamdevula, Naga; Ochoa, Juan; Leavesley, Silas J.; Xu, Jiangping; Rich, Thomas C.; Lin, Mike T.; Zha, Xiang-Ming			Human ASIC1a mediates stronger acid-induced responses as compared with mouse ASIC1a	FASEB JOURNAL			English	Article						acidosis; trafficking; neuronal injury; calcium	SENSING ION CHANNELS; SYNAPTIC PLASTICITY; ACTIVATED CURRENTS; PROTON RECEPTOR; INNATE FEAR; 1A; TRAFFICKING; CONTRIBUTES; AMYGDALA; NEUROPROTECTION	Acid-sensing ion channels (ASICs) are the major proton receptor in the brain and a key mediator of acidosis-induced neuronal injuries in disease. Most of published data on ASIC function came from studies performed in mice, and relatively little is known about potential differences between human and mouse ASICs (hASIC and mASIC, respectively). This information is critical for us to better interpret the functional importance of ASICs in human disease. Here, we examined the expression of ASICs in acutely resected human cortical tissue. Compared with mouse cortex, human cortical tissue showed a similar ratio of ASIC1a:ASIC2a expression, had reduced ASIC2b level, and exhibited a higher membrane:total ratio of ASIC1a. We further investigated the mechanism for higher surface trafficking of hASIC1a in heterologous cells. A single amino acid at position 285 was critical for increased N-glycosylation and surface expression of hASIC1a. Consistent with the changes in trafficking and current, cells expressing hASIC1a or mASIC1a S285P mutant had a higher acid-activated calcium increase and exhibited worsened acidotoxicity. These data suggest that ASICs are likely to have a larger impact on acidosis-induced neuronal injuries in humans than mice, and this effect is, at least in part, a result of more efficient trafficking of hASIC1a.Xu, Y., Jiang, Y.-Q., Li, C., He, M., Rusyniak, W. G., Annamdevula, N., Ochoa, J., Leavesley, S. J., Xu, J., Rich, T. C., Lin, M. T., Zha, X.-M. Human ASIC1a mediates stronger acid-induced responses as compared with mouse ASIC1a.	[Xu, Yuanyuan; Jiang, Yu-Qing; Li, Ce; He, Mindi; Lin, Mike T.; Zha, Xiang-Ming] Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA; [Rusyniak, W. George] Univ S Alabama, Coll Med, Dept Neurosurg, Mobile, AL 36688 USA; [Annamdevula, Naga; Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Ochoa, Juan] Univ S Alabama, Dept Neurol, Coll Med, Mobile, AL 36688 USA; [Leavesley, Silas J.] Univ S Alabama, Coll Engn, Chem & Biomol Engn, Mobile, AL 36688 USA; [Xu, Yuanyuan; Xu, Jiangping] Southern Med Univ, Sch Pharmaceut Sci, Dept Neuropharmacol & Drug Discovery, Guangzhou, Guangdong, Peoples R China; [Jiang, Yu-Qing] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Li, Ce] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai, Peoples R China	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; Southern Medical University - China; Hebei Medical University; Fudan University	Zha, XM (corresponding author), Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA.; Xu, JP (corresponding author), Southern Med Univ, Dept Neuropharmacol & Drug Discovery, Guangzhou, Guangdong, Peoples R China.	jpx@sum.edu.cn; zha@southalabama.edu	Xu, Jiangping/D-1456-2012	Zha, Xiangming/0000-0001-9490-2731	South Medical University; Third Hospital of Hebei Medical University; China Scholarship Council; American Heart Association (AHA) [16PRE27130004]; U.S. National Institutes of Health (NIH)/American Recovery and Reinvestment Act equipment grants [S10RR027535, S10OD020149]; National Natural Science Foundation of China [81773698]; NIH/National Institute of Neurological Disorders and Stroke [R01NS102495, R21NS093522]; AHA [13SDG13970009]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102495, R21NS093522] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020149] Funding Source: NIH RePORTER	South Medical University; Third Hospital of Hebei Medical University; China Scholarship Council(China Scholarship Council); American Heart Association (AHA)(American Heart Association); U.S. National Institutes of Health (NIH)/American Recovery and Reinvestment Act equipment grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AHA(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Lan Jing, Yufan Zhou, Nan Jiang, and Junjun Wu (all from the University of South Alabama) for assistance on pilot experiments. Y.X. was supported, in part, by a fellowship from South Medical University. Y.-Q.J. was supported by a fellowship from The Third Hospital of Hebei Medical University. C.L. was supported, in part, by a scholarship from the China Scholarship Council. N.A. was supported, in part, by a fellowship from the American Heart Association (AHA; 16PRE27130004). The Nikon A1R confocal microscope, FRET imaging, and analysis were funded by U.S. National Institutes of Health (NIH)/American Recovery and Reinvestment Act equipment grants (S10RR027535 and S10OD020149). This work was supported, in part, by the National Natural Science Foundation of China (Grant 81773698 to J.X.) and NIH/National Institute of Neurological Disorders and Stroke Grants R01NS102495 and R21NS093522, and AHA Grant 13SDG13970009 (to X.-M.Z.). The authors declare no conflicts of interest.	Annamdevula NS, 2013, SENSORS-BASEL, V13, P9267, DOI 10.3390/s130709267; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Chen XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021970; Chen XM, 2010, EUR J PHARMACOL, V648, P15, DOI 10.1016/j.ejphar.2010.09.005; Chiang PH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10143; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; FRENKEL C, 1993, BRIT J ANAESTH, V71, P15, DOI 10.1093/bja/71.1.15; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gonzalez-Inchauspe C, 2017, J NEUROSCI, V37, P2589, DOI 10.1523/JNEUROSCI.2566-16.2017; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Huang Y, 2015, NEUROPHARMACOLOGY, V94, P42, DOI 10.1016/j.neuropharm.2014.12.010; Jiang N, 2017, J CEREBR BLOOD F MET, V37, P528, DOI 10.1177/0271678X16630558; Jing Lan, 2011, PLoS One, V6, pe26909, DOI 10.1371/journal.pone.0026909; Jing L, 2012, J NEUROSCI, V32, P4080, DOI 10.1523/JNEUROSCI.5021-11.2012; Leavesley SJ, 2013, CYTOM PART A, V83, P898, DOI 10.1002/cyto.a.22340; Li MH, 2010, J PHYSIOL-LONDON, V588, P3883, DOI 10.1113/jphysiol.2010.192922; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lin SH, 2015, EUR J NEUROSCI, V41, P1553, DOI 10.1111/ejn.12905; Liu MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep23350; Meng QY, 2009, NEUROSCIENCE, V159, P1126, DOI 10.1016/j.neuroscience.2009.01.069; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ochoa JG, 2016, NEUROL RES INT, V2016, DOI 10.1155/2016/5380907; Petroff EY, 2008, P NATL ACAD SCI USA, V105, P3140, DOI 10.1073/pnas.0712280105; Pidoplichko VI, 2014, J NEUROSCI, V34, P3130, DOI 10.1523/JNEUROSCI.4009-13.2014; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Quintana P, 2015, J PHYSIOL-LONDON, V593, P4373, DOI 10.1113/JP270701; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; Wang YZ, 2015, ELIFE, V4, DOI 10.7554/eLife.05682; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wu JJ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0190-x; Wu JJ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0185-7; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072379; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	50	16	16	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3832	3843		10.1096/fj.201701367R	http://dx.doi.org/10.1096/fj.201701367R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29447005	Green Published			2022-12-28	WOS:000435104500029
J	Giudetti, AM; Testini, M; Vergara, D; Priore, P; Damiano, F; Gallelli, CA; Romano, A; Villani, R; Cassano, T; Siculella, L; Gnoni, GV; Moles, A; Coccurello, R; Gaetani, S				Giudetti, Anna M.; Testini, Mariangela; Vergara, Daniele; Priore, Paola; Damiano, Fabrizio; Gallelli, Cristina Anna; Romano, Adele; Villani, Rosanna; Cassano, Tommaso; Siculella, Luisa; Gnoni, Gabriele V.; Moles, Anna; Coccurello, Roberto; Gaetani, Silvana			Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet	FASEB JOURNAL			English	Article						fatty acids; liver steatosis; lipogenesis	DE-NOVO LIPOGENESIS; BODY-MASS INDEX; SOCIAL STRESS; SYMPATHETIC INNERVATION; UNCOUPLING PROTEIN-1; GENE-EXPRESSION; CITRATE CARRIER; ENERGY-BALANCE; WEIGHT; THERMOGENESIS	It is widely accepted that chronic stress may alter the homeostatic mechanisms of body weight control. In this study, we followed the metabolic changes occurring in mice when chronic stress caused by psychosocial defeat (CPD) is associated with ad libitum exposure to a palatable high-fat diet (HFD). In this model, CPD mice consumed more HFD than unstressed (Un) mice without gaining body weight. We focused on metabolic processes involved in weight control, such as de novo lipogenesis (DNL), fatty acid -oxidation (FAO), and thermogenesis. The activity and expression of DNL enzymes were reduced in the liver and white adipose tissue of mice consuming the HFD. Such effects were particularly evident in stressed mice. In both CPD and Un mice, HFD consumption increased the hepatic expression of the mitochondrial FAO enzyme carnitine palmitoyltransferase-1. In the liver of mice consuming the HFD, stress exposure prevented accumulation of triacylglycerols; however, accumulation of triacylglycerols was observed in Un mice under the same dietary regimen. In brown adipose tissue, stress increased the expression of uncoupling protein-1, which is involved in energy dissipation, both in HFD and control diet-fed mice. We consider increased FAO and energy dissipation responsible for the antiobesity effect seen in CPD/HFD mice. However, CPD associated with HFD induced hepatic oxidative stress.Giudetti, A. M., Testini, M., Vergara, D., Priore, P., Damiano, F., Gallelli, C. A., Romano, A., Villani, R., Cassano, T., Siculella, L., Gnoni, G. V., Moles, A., Coccurello, R., Gaetani, S. Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet.	[Giudetti, Anna M.; Testini, Mariangela; Vergara, Daniele; Priore, Paola; Damiano, Fabrizio; Siculella, Luisa; Gnoni, Gabriele V.] Univ Salento, Dept Biol & Environm Sci & Technol, Via Prov Lecce Monteroni, I-73100 Lecce, Italy; [Gallelli, Cristina Anna; Romano, Adele; Gaetani, Silvana] Sapienza Univ Rome, Dept Physiol & Pharmacol V Espamer, Rome, Italy; [Villani, Rosanna] Univ Foggia, Dept Med & Occupat Sci, Foggia, Italy; [Cassano, Tommaso] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Moles, Anna; Coccurello, Roberto] Natl Res Council CNR, Inst Cell Biol & Neurobiol IBCN, Rome, Italy; [Moles, Anna] Genomia Srl, Bresso, Italy; [Coccurello, Roberto] IRCCS, FSL, Rome, Italy	University of Salento; Sapienza University Rome; University of Foggia; University of Foggia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR)	Giudetti, AM (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Via Prov Lecce Monteroni, I-73100 Lecce, Italy.	anna.giudetti@unisalento.it	Damiano, Fabrizio/AAF-9594-2020; Giudetti, Anna Maria/ABF-4049-2021; villani, rosanna/K-5753-2018; Vergara, Daniele/K-3831-2014; Coccurello, Roberto/F-8460-2015	Damiano, Fabrizio/0000-0001-7828-9519; villani, rosanna/0000-0001-9875-019X; Vergara, Daniele/0000-0002-2396-7674; ROMANO, ADELE/0000-0003-3874-2627	Italian Ministry for Education, University, and Research [Project of Significant National Interest (PRIN)] [2009ESX7T3]	Italian Ministry for Education, University, and Research [Project of Significant National Interest (PRIN)](Ministry of Education, Universities and Research (MIUR))	The authors gratefully acknowledge the Consiglio Nazionale delle Ricerche/European Mouse Mutant Archive (CNR/EMMA) Animal Research Facility (Monterotondo, Rome, Italy). This research was supported by the Italian Ministry for Education, University, and Research [Project of Significant National Interest (PRIN) 2009ESX7T3]. The authors declare no conflicts of interest.	Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bartolomucci A., 2009, PLOS ONE, V4; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Coccurello R, 2018, EUR J NUTR, V57, P1485, DOI 10.1007/s00394-017-1434-y; Coccurello R, 2009, NEUROSCI BIOBEHAV R, V33, P537, DOI 10.1016/j.neubiorev.2008.05.018; Crichton PG, 2017, BIOCHIMIE, V134, P35, DOI 10.1016/j.biochi.2016.12.016; Dadomo H, 2011, PROG NEURO-PSYCHOPH, V35, P1461, DOI 10.1016/j.pnpbp.2010.11.016; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Denjean F, 1999, FEBS LETT, V444, P181, DOI 10.1016/S0014-5793(99)00056-3; Finger BC, 2012, PSYCHONEUROENDOCRINO, V37, P729, DOI 10.1016/j.psyneuen.2011.06.015; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano A, 2005, J HISTOCHEM CYTOCHEM, V53, P679, DOI 10.1369/jhc.4A6566.2005; Giudetti AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060817; Gnoni A, 2016, J PHYSIOL BIOCHEM, V72, P485, DOI 10.1007/s13105-016-0495-3; Gnoni GV, 2010, ENDOCRINOLOGY, V151, P1551, DOI 10.1210/en.2009-1352; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515; Kakimoto PA, 2016, REDOX BIOL, V8, P216, DOI 10.1016/j.redox.2016.01.009; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Lee G, 2017, CELL, V171, P1545, DOI 10.1016/j.cell.2017.10.037; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Moles A, 2006, PSYCHONEUROENDOCRINO, V31, P623, DOI 10.1016/j.psyneuen.2006.01.004; Motoyama K, 2009, PHYSIOL GENOMICS, V37, P79, DOI 10.1152/physiolgenomics.90358.2008; Patterson ZR, 2013, ENDOCRINOLOGY, V154, P1080, DOI 10.1210/en.2012-1834; Prasad A, 1996, PHYSIOL BEHAV, V60, P1039, DOI 10.1016/0031-9384(96)00135-7; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; Rodriguez-Sureda V, 2007, ATHEROSCLEROSIS, V195, P57, DOI 10.1016/j.atherosclerosis.2006.11.038; Sanghez V, 2016, STRESS, V19, P214, DOI 10.3109/10253890.2016.1151491; Sanghez V, 2013, PSYCHONEUROENDOCRINO, V38, P2933, DOI 10.1016/j.psyneuen.2013.07.022; Sato T, 2006, TOXICOLOGY, V227, P248, DOI 10.1016/j.tox.2006.08.009; Schonfeld P, 2010, BBA-BIOENERGETICS, V1797, P929, DOI 10.1016/j.bbabio.2010.01.010; Scott KA, 2012, CURR OBES REP, V1, DOI 10.1007/s13679-011-0006-3; Serviddio G, 2011, FREE RADICAL BIO MED, V51, P2234, DOI 10.1016/j.freeradbiomed.2011.09.004; Seydoux J, 1978, Experientia Suppl, V32, P153; Siculella L, 2006, J BIOL CHEM, V281, P19072, DOI 10.1074/jbc.M507237200; Siculella L, 2016, BBA-MOL CELL BIOL L, V1861, P471, DOI 10.1016/j.bbalip.2016.02.003; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tamashiro KLK, 2007, AM J PHYSIOL-REG I, V293, pR1864, DOI 10.1152/ajpregu.00371.2007; Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030; Yau YHC, 2013, MINERVA ENDOCRINOL, V38, P255; ZHANG D, 2016, HEPATIC NOVO LIPOGEN, P1	47	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1428	1439		10.1096/fj.201801130R	http://dx.doi.org/10.1096/fj.201801130R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30133327	Bronze			2022-12-28	WOS:000457401500112
J	Li, LQ; Kolodziej, T; Jafari, N; Chen, J; Zhu, HN; Rajfur, Z; Huang, C				Li, Liqing; Kolodziej, Tomasz; Jafari, Naser; Chen, Jing; Zhu, Haining; Rajfur, Zenon; Huang, Cai			Cdk5-mediated phosphorylation regulates phosphatidylinositol 4-phosphate 5-kinase type I 90 activity and cell invasion	FASEB JOURNAL			English	Article						phosphatidylinositol kinase; cell migration; fibronectin; secretion; extracellular matrix protein	CYCLIN-DEPENDENT KINASE-5; FOCAL ADHESION DYNAMICS; EXOSOME SECRETION; PHOSPHATE KINASE; PLASMA-MEMBRANE; N-WASP; FIBRONECTIN; MIGRATION; CANCER; PROTEIN	Phosphatidylinositol 4-phosphate 5-kinase type I (PIPKI90) regulates cell migration, invasion, and metastasis. However, it is unknown how cellular signals regulate those processes. Here, we show that cyclin-dependent kinase 5 (Cdk5), a protein kinase that regulates cell migration and invasion, phosphorylates PIPKI90 at S453, and that Cdk5-mediated PIPKI90 phosphorylation is essential for cell invasion. Moreover, Cdk5-mediated phosphorylation down-regulates the activity of PIPKI90 and the secretion of fibronectin, an extracellular matrix protein that regulates cell migration and invasion. Furthermore, inhibition of PIPKI activity with the chemical inhibitor UNC3230 suppresses fibronectin secretion in a dose-dependent manner, whereas depletion of Cdk5 enhances fibronectin secretion. With total internal reflection fluorescence microscopy, we found that secreted fibronectin appears as round dots, which colocalize with Tks5 and CD9 but not with Zyxin. These data suggest that Cdk5-mediated PIPKI90 phosphorylation regulates cell invasion by controlling PIPKI90 activity and fibronectin secretion.Li, L., Koodziej, T., Jafari, N., Chen, J., Zhu, H., Rajfur, Z., Huang, C. Cdk5-mediated phosphorylation regulates phosphatidylinositol 4-phosphate 5-kinase type I 90 activity and cell invasion.	[Li, Liqing; Kolodziej, Tomasz; Jafari, Naser; Huang, Cai] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Chen, Jing; Zhu, Haining] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Kolodziej, Tomasz; Rajfur, Zenon] Jagiellonian Univ, Inst Phys, Fac Phys Astron & Appl Comp Sci, Krakow, Poland	University of Kentucky; University of Kentucky; University of Kentucky; Jagiellonian University	Rajfur, Z (corresponding author), Jagiellonian Univ, Inst Phys, Fac Phys Astron & Appl Comp Sci, Krakow, Poland.; Huang, C (corresponding author), Univ Kentucky, Markey Canc Ctr, Dept Pharmacol & Nutr Sci, BBSRB Room B359,741 South Limestone St, Lexington, KY 40506 USA.	zenon.rajfur@uj.edu.pl; cai-huang@uky.edu	LI, LI/GVS-5344-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Zhu, Haining/A-6076-2008; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020	Zhu, Haining/0000-0001-5498-6694; 	American Cancer Society [RSG-13-184-01CSM]; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01 GM122994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122994] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Research Scholar Grant RSG-13-184-01CSM (to C.H.) and U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM122994 (to C.H.). The authors declare no conflicts of interest.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Bhandari D, 2015, P NATL ACAD SCI USA, V112, pE4874, DOI 10.1073/pnas.1514157112; Bisht S, 2015, TRANSL ONCOL, V8, P295, DOI 10.1016/j.tranon.2015.06.002; Branch KM, 2012, BIOL OPEN, V1, P711, DOI 10.1242/bio.20121867; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Durand N, 2016, SCI REP-UK, V6, DOI 10.1038/srep35963; Eggers JP, 2011, CLIN CANCER RES, V17, P6140, DOI 10.1158/1078-0432.CCR-10-2288; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; HONEYMAN TW, 1983, BIOCHEM J, V212, P489, DOI 10.1042/bj2120489; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang C, 2010, BIOTECHNIQUES, V49, P881, DOI 10.2144/000113550; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jafari N, 2016, J BIOL CHEM, V291, P25729, DOI 10.1074/jbc.M116.742742; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jeon M, 2015, EXP CELL RES, V333, P116, DOI 10.1016/j.yexcr.2015.02.019; Ji C, 2017, CELL REP, V20, P1409, DOI 10.1016/j.celrep.2017.07.041; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Knowles LM, 2013, CANCER RES, V73, P6175, DOI 10.1158/0008-5472.CAN-13-0602; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Li H, 2017, ONCOGENE, V36, P5668, DOI 10.1038/onc.2017.166; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Liang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep02932; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Ohshima T, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00458; Quintavalle M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002032; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Sinha S, 2016, J CELL BIOL, V214, P197, DOI 10.1083/jcb.201601025; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Sung Bong Hwan, 2011, Bioarchitecture, V1, P257; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Thapa N, 2012, CELL ADHES MIGR, V6, P409, DOI 10.4161/cam.21192; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Wu CY, 2014, BRIT J PHARMACOL, V171, P5541, DOI 10.1111/bph.12777; Wu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024775; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200	63	5	5	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					631	642		10.1096/fj.201800296R	http://dx.doi.org/10.1096/fj.201800296R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30040488	Green Published			2022-12-28	WOS:000457401500049
J	Qu, CB; Zhang, SS; Wang, WS; Li, M; Wang, YJ; van der Heijde-Mulder, M; Shokrollahi, E; Hakim, MS; Raat, NJH; Peppelenbosch, MP; Pan, QW				Qu, Changbo; Zhang, Shaoshi; Wang, Wenshi; Li, Meng; Wang, Yijin; van der Heijde-Mulder, Marieke; Shokrollahi, Ehsan; Hakim, Mohamad S.; Raat, Nicolaas J. H.; Peppelenbosch, Maikel P.; Pan, Qiuwei			Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target	FASEB JOURNAL			English	Article						MPTP; HEV; virus-host interaction; ETC	PERMEABILITY TRANSITION PORE; NUCLEOTIDE SYNTHESIS; REACTIVE OXYGEN; ATP SYNTHASE; ACTIVATION; ANTIMYCIN; MECHANISM; IMMUNITY; CHANNEL; CELLS	Hepatitis E virus (HEV) infection has emerged as a global health problem. However, no approved medication is available, and the infection biology remains largely elusive. Electron transport chain (ETC), a key component of the mitochondria, is the main site that produces ATP and reactive oxygen species (ROS). By profiling the role of the different complexes of the mitochondrial ETC, we found that pharmacological inhibition of complex III, a well-defined drug target for the treatment of malaria and Pneumocystis pneumonia, potently restricts HEV replication. This effect demonstrated in our HEV models is equivalent to the anti-HEV potency of ribavirin, a widely used off-label treatment for patients with chronic HEV. Mechanistically, we found that this effect is independent of ATP production, ROS level, and pyridine depletion. By using pharmacological inhibitors and genetic approaches, we found that mitochondrial permeability transition pore (MPTP), a newly identified component of ETC, provides basal defense against HEV infection. HEV interferes with the opening of the MPTP. Furthermore, inhibition of the MPTP attenuated the anti-HEV effect of complex III inhibitors, suggesting that the MPTP mediates the antiviral effects of these inhibitors. These findings reveal new insights on HEV-host interactions and provide viable anti-HEV targets for therapeutic development.Qu, C., Zhang, S., Wang, W., Li, M., Wang, Y., van der Heijde-Mulder, M., Shokrollahi, E., Hakim, M. S., Raat, N. J. H., Peppelenbosch, M. P., Pan, Q. Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.	[Qu, Changbo; Zhang, Shaoshi; Wang, Wenshi; Li, Meng; Wang, Yijin; van der Heijde-Mulder, Marieke; Hakim, Mohamad S.; Peppelenbosch, Maikel P.; Pan, Qiuwei] Erasmus Univ, Dept Gastroenterol & Hepatol, Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Shokrollahi, Ehsan; Raat, Nicolaas J. H.] Erasmus Univ, Dept Anesthesiol, Lab Expt Anesthesiol, Med Ctr,Erasmus MC, Rotterdam, Netherlands; [Wang, Yijin] Beijing 302 Hosp, Dept Pathol & Hepatol, Beijing, Peoples R China; [Hakim, Mohamad S.] Univ Gadjah Mada, Dept Microbiol, Fac Med, Yogyakarta, Indonesia	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Fifth Medical Center of Chinese PLA General Hospital; Gadjah Mada University	Pan, QW (corresponding author), Erasmus MC, Dept Gastroenterol & Hepatol, Univ Med Ctr, Room Na 1011,Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	q.pan@erasmusmc.nl	Wang, Yijin/AAA-8753-2022; Wang, Yijin/HCH-6264-2022; wang, yijin/GRS-5538-2022; Hakim, Mohamad S./AAB-4765-2019	Wang, Yijin/0000-0002-3700-1766; Hakim, Mohamad S./0000-0001-8341-461X; Pan, Qiuwei/0000-0001-9982-6184; Peppelenbosch, Maikel/0000-0001-9112-6028	Dutch Digestive Foundation (MLDS) for Career Development Grant [CDG 1304]; Dutch Cancer Society (KWF) Young Investigator Grant [10140]; National Natural Science Foundation of China [31770186]; China Scholarship Council [201509110121, 201303250056, 201506100033]	Dutch Digestive Foundation (MLDS) for Career Development Grant; Dutch Cancer Society (KWF) Young Investigator Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	The authors thank Dr. Suzanne U. Emerson (U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases) for kindly providing the plasmids to generate subgenomic and full-length HEV genotype 3 cell culture systems. This work was supported by Dutch Digestive Foundation (MLDS) for Career Development Grant CDG 1304 (to Q.P.); Dutch Cancer Society (KWF) Young Investigator Grant 10140 (to Q.P.); National Natural Science Foundation of China Grant 31770186 (to Y.W.); and the China Scholarship Council for funding Ph.D. Fellowship Grants 201509110121 (to C.Q.), 201303250056 (to W.W.), and 201506100033 (to M.L.). The authors declare no conflicts of interest.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brault C, 2013, VIRUSES-BASEL, V5, P954, DOI 10.3390/v5030954; Buskiewicz IA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1933; Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022; Claus C, 2013, J VIROL, V87, P8481, DOI 10.1128/JVI.00533-13; De Marchi E, 2014, CELL CALCIUM, V56, P1, DOI 10.1016/j.ceca.2014.03.004; Debing Y, 2014, GASTROENTEROLOGY, V147, P1008, DOI 10.1053/j.gastro.2014.08.040; Debing Y, 2014, ANTIVIR RES, V102, P106, DOI 10.1016/j.antiviral.2013.12.005; Debing Y, 2014, ANTIMICROB AGENTS CH, V58, P267, DOI 10.1128/AAC.01795-13; Degli Esposti Davide, 2012, Biochem Res Int, V2012, P387626, DOI 10.1155/2012/387626; Ding Q, 2017, P NATL ACAD SCI USA, V114, P1147, DOI 10.1073/pnas.1614955114; El-Bacha T, 2013, INT J BIOCHEM CELL B, V45, P41, DOI 10.1016/j.biocel.2012.09.021; Gattermann N, 2004, NUCLEOS NUCLEOT NUCL, V23, P1275, DOI 10.1081/NCN-200027545; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040; Khare S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005058; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kim SJ, 2018, MITOCHONDRION, V41, P21, DOI 10.1016/j.mito.2017.11.007; Ma XQ, 2011, CHEM BIOL, V18, P1474, DOI 10.1016/j.chembiol.2011.08.009; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; MAGUIRE JJ, 1992, BIOCHEM BIOPH RES CO, V188, P190, DOI 10.1016/0006-291X(92)92368-8; Mahmoudabadi G, 2017, P NATL ACAD SCI USA, V114, pE4324, DOI 10.1073/pnas.1701670114; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Moin SM, 2007, J BIOL CHEM, V282, P21124, DOI 10.1074/jbc.M701696200; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nobre L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136883; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Pham NA, 2000, CYTOMETRY, V41, P245, DOI 10.1002/1097-0320(20001201)41:4<245::AID-CYTO2>3.0.CO;2-#; Qu CB, 2017, ARCH VIROL, V162, P2989, DOI 10.1007/s00705-017-3444-8; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038; Shi YX, 2016, WORLD J GASTROENTERO, V22, P8161, DOI 10.3748/wjg.v22.i36.8161; Shukla P, 2012, J VIROL, V86, P5697, DOI 10.1128/JVI.00146-12; Taddeo EP, 2014, MOL METAB, V3, P124, DOI 10.1016/j.molmet.2013.11.003; Todt D, 2016, GUT, V65, P1733, DOI 10.1136/gutjnl-2015-311000; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang Ting, 2013, Curr Pathobiol Rep, V1, P179; Wang YJ, 2016, ANTIMICROB AGENTS CH, V60, P2834, DOI 10.1128/AAC.02700-15; Wang YJ, 2014, GASTROENTEROLOGY, V146, P1775, DOI 10.1053/j.gastro.2014.02.036; Yin X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006417; Zhou X, 2017, J INFECT DIS, V215, P1197, DOI 10.1093/infdis/jix079; Zhou XY, 2014, J HEPATOL, V61, P746, DOI 10.1016/j.jhep.2014.05.026	49	12	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1008	1019		10.1096/fj.201800620R	http://dx.doi.org/10.1096/fj.201800620R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30070932	Bronze, Green Published			2022-12-28	WOS:000457401500079
J	Carion, TW; Greenwood, M; Ebrahim, AS; Jerome, A; Suvas, S; Gronert, K; Berger, EA				Carion, Thomas W.; Greenwood, Matthew; Ebrahim, Abdul Shukkur; Jerome, Andrew; Suvas, Susmit; Gronert, Karsten; Berger, Elizabeth A.			Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis	FASEB JOURNAL			English	Article						lipid mediators; resolution; ocular infection; inflammation	LIPID MEDIATORS; ANTIINFLAMMATORY CYTOKINES; INFLAMMATION; RESOLUTION; RECEPTOR; CIRCUITS; EYE; MECHANISMS; RESOLVINS; APOPTOSIS	Although autacoids primarily derived from the cyclooxygenase-2 and 5-lipoxygenase (LOX) pathways are essential mediators of inflammation, endogenous specialized proresolving mediators (SPMs) act as robust agonists of resolution. SPM biosynthesis is initiated by the conversion of arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid primarily via the 12/15-LOX pathway. Although 12/15-LOX activity is prominent in the cornea, the role of SPM pathway activation during infection remains largely unknown and is the focus of the current study. Pseudomonas keratitis was induced in resistant BALB/c and susceptible C57BL/6 (B6) mice. Biosynthetic pathways for proinflammatory autacoids and SPMs were assessed. Divergent lipid mediator profiles demonstrate the importance of 15-LOX pathways in the pathogenesis of ocular infectious disease. Results indicate that an imbalance of LOX enzymatic pathways contributes to susceptibility observed in B6 mice where deficient activation of SPM circuits, as indicated by reduced 15-hydroxy-eicosatetraenoic acid and 17-hydroxydocosahexaenoic acid levels, prevented transition toward resolution and led to chronic inflammation. In sharp contrast, BALB/c mice demonstrated a well-balanced axis of 5-LOX/12-LOX/15-LOX pathways, resulting in sufficient proresolving bioactive metabolite formation and immune homeostasis. Furthermore, a novel immunoregulatory role for 15-LOX was revealed in inflammatory cells (polymorphonuclear leukocytes and macrophages), which influenced phagocytic activity. These data provide evidence that SPM circuits are essential for host defense during bacterial keratitis.Carion, T. W., Greenwood, M., Ebrahim, A. S., Jerome, A., Suvas, S., Gronert, K., Berger, E. A. Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis.	[Carion, Thomas W.; Ebrahim, Abdul Shukkur; Jerome, Andrew; Suvas, Susmit; Berger, Elizabeth A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave,8263 Scott Hall, Detroit, MI 48201 USA; [Suvas, Susmit] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA; [Greenwood, Matthew; Gronert, Karsten] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Suvas, Susmit; Berger, Elizabeth A.] Kresge Eye Inst, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University; University of California System; University of California Berkeley	Berger, EA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave,8263 Scott Hall, Detroit, MI 48201 USA.	eberger@med.wayne.edu	Berger, Elizabeth/W-6893-2019	Greenwood, Matthew/0000-0003-1471-7945; Jerome, Andrew/0000-0002-6748-8114	U.S. National Institutes of Health, National Eye Institute [R01 EY023226, P30EY004068, R01 EY026082]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022417, R01EY023226, R01EY026082, P30EY004068] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health, National Eye Institute Grants R01 EY023226 (to E.A.B.), P30EY004068 (Core Grant), and R01 EY026082 (to K.G.), and by Research to Prevent Blindness. The authors declare no conflicts of interest.	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Berger EA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003457; Berger EA, 2012, INVEST OPHTH VIS SCI, V53, P7432, DOI 10.1167/iovs.12-9894; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Carion TW, 2015, INVEST OPHTH VIS SCI, V56, P6932, DOI 10.1167/iovs.15-17315; CHEN XS, 1994, J BIOL CHEM, V269, P13979; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; COLOTTA F, 1992, BLOOD, V80, P2012; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Fredman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024422; Gao Y, 2015, J IMMUNOL, V195, P3086, DOI 10.4049/jimmunol.1500610; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Gronert K, 2005, PROSTAG LEUKOTR ESS, V73, P221, DOI 10.1016/j.plefa.2005.05.009; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; HAZLETT LD, 1987, INVEST OPHTH VIS SCI, V28, P1978; Henriksson JT, 2009, INVEST OPHTH VIS SCI, V50, P3648, DOI 10.1167/iovs.08-2941; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Huang X, 2003, INVEST OPHTH VIS SCI, V44, P3409, DOI 10.1167/iovs.03-0162; Jhanji V, 2007, J CATARACT REFR SURG, V33, P1488, DOI 10.1016/j.jcrs.2007.04.015; Kenchegowda S, 2010, J LIPID RES, V51, P879, DOI 10.1194/jlr.R001347; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li HF, 1997, CURR EYE RES, V16, P214, DOI 10.1076/ceyr.16.3.214.15412; Li N, 2010, J OCUL PHARMACOL TH, V26, P431, DOI 10.1089/jop.2010.0019; Liclican EL, 2010, THESCIENTIFICWORLDJO, V10, P1029, DOI 10.1100/tsw.2010.99; LOTTI R, 1992, EYE, V6, P400, DOI 10.1038/eye.1992.82; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; McClellan SA, 2003, J IMMUNOL, V170, P5219, DOI 10.4049/jimmunol.170.10.5219; Park SH, 2009, CORNEA, V28, P68, DOI 10.1097/ICO.0b013e318182259b; Rattanatam T, 2001, CORNEA, V20, P290, DOI 10.1097/00003226-200104000-00010; ROUX KH, 1995, PCR METH APPL, V4, pS185; Rudner XL, 2000, J IMMUNOL, V164, P6576, DOI 10.4049/jimmunol.164.12.6576; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2004, HISTOCHEM CELL BIOL, V122, P305, DOI 10.1007/s00418-004-0695-8; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Szliter EA, 2007, J IMMUNOL, V178, P1105, DOI 10.4049/jimmunol.178.2.1105; Tanaka N, 2018, CIRC J, V82, P596, DOI 10.1253/circj.CJ-17-0294; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wei J, 2017, MOL ASPECTS MED, V58, P37, DOI 10.1016/j.mam.2017.03.006; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhou Z, 2008, INVEST OPHTH VIS SCI, V49, P4458, DOI 10.1167/iovs.08-1906	51	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5026	5038		10.1096/fj.201701502R	http://dx.doi.org/10.1096/fj.201701502R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913556	Bronze, Green Published			2022-12-28	WOS:000443817700033
J	Weber, A; Barth, M; Selig, JI; Raschke, S; Dakaras, K; Hof, A; Hesse, J; Schrader, J; Lichtenberg, A; Akhyari, P				Weber, Andreas; Barth, Mareike; Selig, Jessica Isabel; Raschke, Silja; Dakaras, Konstantinos; Hof, Alexander; Hesse, Julia; Schrader, Juergen; Lichtenberg, Artur; Akhyari, Payam			Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment	FASEB JOURNAL			English	Article						CD73; NT5E; CD39; calcification; aortic stenosis	AORTIC-VALVE DISEASE; VASCULAR CALCIFICATION; ARTERIAL CALCIFICATION; ALKALINE-PHOSPHATASE; FUNCTIONAL-ANALYSIS; HEART; STENOSIS; CD39; CD73; ECTO-5'-NUCLEOTIDASE	Calcific aortic valve disease is an active disease process with lipoprotein deposition, chronic inflammation, and progressive leaflet degeneration. Expression of ectonucleotidases, a group of membrane-bound enzymes that regulate the metabolism of ATP and its metabolites, may coregulate the degeneration process of valvular interstitial cells (VICs). The aim of this study was to investigate the role of the enzymes of the purinergic system in the degeneration process of VICs. Ovine VICs were cultivated in vitro under different prodegenerative conditions and treated with inhibitors of ectonucleoside triphosphate diphosphohydrolase 1 (CD39)/ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), and 5-nucleotidase (CD73), as well as with adenosine and adenosine receptor agonists. Experiments were performed both in 2-dimensional (2-D) and 3-dimensional (3-D) cell-culture models. Our main findings were that VICs continuously release ATP. Inhibition of ATP hydrolyzing enzymes (CD39 and ENPP1) resulted in profound prodegenerative effects with a vigorous up-regulation of CD39, ENPP1, and CD73, as well as TGF-1 and osteopontin at the gene level. In our 3-D model, the effect was more pronounced than in 2-D monolayers. Increasing adenosine levels, as well as stimulating the adenosine receptors A(2A) and A(2B), exhibited strong prodegenerative effects, whereas conversely, lowering adenosine levels by inhibition of CD73 resulted in protective effects against degeneration. Dysregulation of any one of these enzymes plays an important role in the degeneration process of VICs. Stimulation of ATP and adenosine has prodegenerative effects, whereas lowering the adenosine levels exerts a protective effect.Weber, A., Barth, M., Selig, J. I., Raschke, S., Dakaras, K., Hof, A., Hesse, J., Schrader, J., Lichtenberg, A., Akhyari, P. Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment.	[Weber, Andreas; Barth, Mareike; Selig, Jessica Isabel; Raschke, Silja; Dakaras, Konstantinos; Hof, Alexander; Lichtenberg, Artur; Akhyari, Payam] Heinrich Heine Univ, Fac Med, Dept Cardiovasc Surg, Moorenstr 5, D-40225 Dusseldorf, Germany; [Hesse, Julia; Schrader, Juergen] Heinrich Heine Univ, Fac Med, Dept Mol Cardiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Lichtenberg, A (corresponding author), Heinrich Heine Univ, Fac Med, Dept Cardiovasc Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.	artur.lichtenberg@med.uni-duesseldorf.de	Akhyari, Payam/AAK-8866-2020; Barth, Mareike/AAB-2975-2020	Akhyari, Payam/0000-0002-6452-8678; Barth, Mareike/0000-0002-6118-6799	Deutsche Forschungsgemeinschaft (DFG) [GZ: LI 1994/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors are grateful to G. Muller (Department of Cardiovascular Surgery, Heinrich-Heine-University) for technical assistance and B. Steckel (Department of Molecular Cardiology, Heinirich-Heine-University) for conducting the ATP measurements. The authors thank N. Niazy (Department of Cardiovascular Surgery, Heinrich-Heine-University) for critical reading. This study was supported by grants from Deutsche Forschungsgemeinschaft to A.L. and P.A. (DFG; GZ: LI 1994/1-1). The authors also thank the Susanne Bunnenberg Foundation for generously supporting the infrastructure of cardiovascular laboratories at University Hospital Dusseldorf. The authors declare no conflicts of interest.	Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Barth M, 2012, CELL TISSUE RES, V348, P295, DOI 10.1007/s00441-011-1315-2; BOYER JL, 1990, J BIOL CHEM, V265, P13515; Burnstock Geoffrey, 2013, Keio Journal of Medicine, V62, P63, DOI 10.2302/kjm.2013-0003-RE; Chen NX, 2011, AM J NEPHROL, V34, P211, DOI 10.1159/000330175; Chester AH, 2007, PHILOS T R SOC B, V362, P1437, DOI 10.1098/rstb.2007.2126; Coburn SP, 1998, J CLIN ENDOCR METAB, V83, P3951, DOI 10.1210/jc.83.11.3951; Cote N, 2012, EUR J PHARMACOL, V689, P139, DOI 10.1016/j.ejphar.2012.05.016; De Giorgi M, 2014, NUCLEOS NUCLEOT NUCL, V33, P313, DOI 10.1080/15257770.2014.896466; Eschenhagen T, 1997, FASEB J, V11, P683, DOI 10.1096/fasebj.11.8.9240969; Fish RS, 2013, EUR J CLIN INVEST, V43, P405, DOI 10.1111/eci.12055; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gan XT, 2014, MOL CELL BIOCHEM, V394, P237, DOI 10.1007/s11010-014-2100-9; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Hof A, 2016, EUR J CARDIO-THORAC, V50, P446, DOI 10.1093/ejcts/ezw057; Jin H, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf9109; Kamath AR, 2008, INT J ANGIOL, V17, P63; Kaniewska E, 2014, NUCLEOS NUCLEOT NUCL, V33, P305, DOI 10.1080/15257770.2014.885985; Kaniewska-Bednarczuk E, 2016, NUCLEOS NUCLEOT NUCL, V35, P713, DOI 10.1080/15257770.2016.1163377; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Lee SY, 2015, BIOCHEM PHARMACOL, V93, P171, DOI 10.1016/j.bcp.2014.11.002; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Mackenzie NCW, 2012, BONE, V51, P961, DOI 10.1016/j.bone.2012.07.014; Mahmut A, 2015, CARDIOVASC RES, V106, P109, DOI 10.1093/cvr/cvv027; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Paloian NJ, 2016, KIDNEY INT, V89, P1027, DOI 10.1016/j.kint.2015.12.046; Pasipoularides A, 2017, TOHOKU J EXP MED, V243, P255, DOI 10.1620/tjem.243.255; Pasipoularides A, 2016, J CARDIOVASC TRANSL, V9, P374, DOI 10.1007/s12265-016-9695-z; Pasipoularides A, 2016, J CARDIOVASC TRANSL, V9, P102, DOI 10.1007/s12265-016-9679-z; Perrotta I, 2016, APPL IMMUNOHISTO M M, V24, P128, DOI 10.1097/PAI.0000000000000144; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Regateiro FS, 2013, CLIN EXP IMMUNOL, V171, P1, DOI 10.1111/j.1365-2249.2012.04623.x; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; Schuchardt M, 2012, KIDNEY INT, V81, P256, DOI 10.1038/ki.2011.326; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0; Thron C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139419; Toma I, 2012, CELL TISSUE RES, V347, P155, DOI 10.1007/s00441-011-1189-3; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163	45	7	7	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4356	4369		10.1096/fj.201701326R	http://dx.doi.org/10.1096/fj.201701326R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29558203				2022-12-28	WOS:000439325400025
J	Woll, KA; Zhou, XJ; Bhanu, NV; Garcia, BA; Covarrubias, M; Miller, KW; Eckenhoff, RG				Woll, Kellie A.; Zhou, Xiaojuan; Bhanu, Natarajan V.; Garcia, Benjamin A.; Covarrubias, Manuel; Miller, Keith W.; Eckenhoff, Roderic G.			Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors	FASEB JOURNAL			English	Article						photoaffinity labeling; isoflurane; sevoflurane; crosslinking	GAMMA-AMINOBUTYRIC-ACID; GATED ION CHANNELS; GENERAL-ANESTHETICS; SYNAPTIC INHIBITION; SUBUNIT COMPOSITION; LIGAND; ISOFLURANE; PROPOFOL; SUBTYPES; PURIFICATION	Most general anesthetics enhance GABA type A (GABA(A)) receptor activity at clinically relevant concentrations. Sites of action of volatile anesthetics on the GABA(A) receptor remain unknown, whereas sites of action of many intravenous anesthetics have been identified in GABA(A) receptors by using photolabeling. Here, we used photoactivatable analogs of isoflurane (AziISO) and sevoflurane (AziSEVO) to locate their sites on (132L) and (13) GABA(A) receptors. As with isoflurane and sevoflurane, AziISO and AziSEVO enhanced the currents elicited by GABA. AziISO and AziSEVO each labeled 10 residues in (13) receptors and 9 and 8 residues, respectively, in (132L) receptors. Photolabeled residues were concentrated in transmembrane domains and located in either subunit interfaces or in the interface between the extracellular domain and the transmembrane domain. The majority of these transmembrane residues were protected from photolabeling with the addition of excess parent anesthetic, which indicated specificity. Binding sites were primarily located within +/- and +/- subunit interfaces, but residues in the +/- interface were also identified, which provided a basis for differential receptor subtype sensitivity. Isoflurane and sevoflurane did not always share binding sites, which suggests an unexpected degree of selectivity.Woll, K. A., Zhou, X., Bhanu, N. V., Garcia, B. A., Covarrubias, M., Miller, K. W., Eckenhoff, R. G. Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors.	[Woll, Kellie A.; Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Bhanu, Natarajan V.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Zhou, Xiaojuan; Miller, Keith W.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Jefferson University; Jefferson University	Eckenhoff, RG (corresponding author), Univ Penn, 311A John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu		Covarrubias, Manuel/0000-0002-0881-4143	U.S. National Institutes of Health [P01-GM55876, GM107117, GM110174, P01-GM58448, AI118891]; National Science Foundation Graduate Research Fellowship Program [DGE-1321851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448, P01GM055876, R01GM107117, R01GM110174] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health Grants P01-GM55876, GM107117, GM110174, P01-GM58448 (National Institute of General Medical Sciences), and AI118891 (Department of Defense); and by the National Science Foundation Graduate Research Fellowship Program (DGE-1321851). The authors declare no conflicts of interest.	Arcario MJ, 2017, J BIOL CHEM, V292, P9480, DOI 10.1074/jbc.M117.780197; Barber AF, 2012, J BIOL CHEM, V287, P40425, DOI 10.1074/jbc.M112.405787; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Bayley H, 1983, LAB TECHNIQUES BIOCH, V12; Brickley SG, 1999, J NEUROSCI, V19, P2960; BROWN CL, 1983, NEUROSCI LETT, V35, P37, DOI 10.1016/0304-3940(83)90523-2; BROWN CL, 1984, J NEUROCHEM, V43, P272, DOI 10.1111/j.1471-4159.1984.tb06707.x; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; CURTIS DR, 1971, BRAIN RES, V32, P69, DOI 10.1016/0006-8993(71)90156-9; Dai SP, 2012, ANESTHESIOLOGY, V116, P816, DOI 10.1097/ALN.0b013e31824be0e3; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; Eckenhoff RG, 2010, ACS CHEM NEUROSCI, V1, P139, DOI 10.1021/cn900014m; Forman SA, 2016, ANESTH ANALG, V123, P1263, DOI 10.1213/ANE.0000000000001368; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kinde MN, 2016, ANESTHESIOLOGY, V124, P664, DOI 10.1097/ALN.0000000000001005; Lambert S, 2005, EUR J PHARMACOL, V516, P23, DOI 10.1016/j.ejphar.2005.04.030; Lea WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007150; Lees G, 1998, ANESTHESIOLOGY, V88, P206, DOI 10.1097/00000542-199801000-00029; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Liang QS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143363; Lioudyno MI, 2013, J NEUROSCI, V33, P16310, DOI 10.1523/JNEUROSCI.0344-13.2013; MIHIC SJ, 1994, MOL PHARMACOL, V46, P851; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Ogawa SK, 2011, NEUROPHARMACOLOGY, V60, P701, DOI 10.1016/j.neuropharm.2010.11.016; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen Richard W, 2015, Adv Pharmacol, V73, P167, DOI 10.1016/bs.apha.2014.11.005; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Sanchis-Segura C, 2007, NEUROSCI LETT, V416, P275, DOI 10.1016/j.neulet.2007.02.024; Schrodinger L., 2017, PYMOL MOL GRAPHICS S; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; Stewart DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111470; Tretter V, 1997, J NEUROSCI, V17, P2728; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Werner DF, 2011, J PHARMACOL EXP THER, V336, P134, DOI 10.1124/jpet.110.170431; Woll KA, 2017, ACS CHEM BIOL, V12, P1353, DOI 10.1021/acschembio.7b00222; Woll KA, 2016, ANESTH ANALG, V123, P1253, DOI 10.1213/ANE.0000000000001365; Woll KA, 2016, J BIOL CHEM, V291, P20473, DOI 10.1074/jbc.M116.736975; Woll KA, 2015, ACS CHEM NEUROSCI, V6, P927, DOI 10.1021/acschemneuro.5b00078; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zhang X, 2015, MOL CELL PROTEOMICS, V14, P724, DOI 10.1074/mcp.M114.042556	60	14	15	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4172	4189		10.1096/fj.201701347R	http://dx.doi.org/10.1096/fj.201701347R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29505303	Green Published			2022-12-28	WOS:000439325400010
J	Aran, G; Sanjurjo, L; Barcena, C; Simon-Coma, M; Tellez, E; Vazquez-Vitali, M; Garrido, M; Guerra, L; Diaz, E; Ojanguren, I; Elortza, F; Planas, R; Sala, M; Armengol, C; Sarrias, MR				Aran, Gemma; Sanjurjo, Lucia; Barcena, Cristina; Simon-Coma, Marina; Tellez, Erica; Vazquez-Vitali, Maria; Garrido, Marta; Guerra, Laura; Diaz, Esther; Ojanguren, Isabel; Elortza, Felix; Planas, Ramon; Sala, Margarita; Armengol, Carolina; Sarrias, Maria-Rosa			CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78)	FASEB JOURNAL			English	Article						soluble protein-; immunoglobulin protein; cirrhosis; hepatoblastoma	LARGE GENE LISTS; APOPTOSIS INHIBITOR; FATTY LIVER; HEPATITIS-C; PROTEIN; AIM; MACROPHAGE; MICE; CD36; METASTASIS	CD5-like (CD5L) is a soluble scavenger cysteine-rich protein that modulates inflammatory responses. We studied the involvement of CD5L in liver cancer. Immunohistochemistry (IHC) of CD5L in 60 hepatocellular carcinomas and 34 adjacent nontumor livers, showed that CD5L staining was higher in tumor than in nontumor tissue (Mann-Whitney test; P = 0.0039). High CD5L correlated with elevated proliferation (Ki67, linear regression; P < 0.0001) and lower patient event-free survival (log-rank; P = 0.0185). Accordingly, CD5L expression was detected in the liver cancer cell lines Huh7, HepG2, and SNU-398. In vitro technologies using these cell lines, including small interfering RNA (siRNA) and cDNA transfection, showed that CD5L promoted colony formation and cell proliferation and protected against cisplatin-induced apoptosis. To find a molecular explanation for these roles, novel CD5L-interacting protein ligands in liver cancer cells were identified by immunoprecipitation followed by mass spectrometry. Among these, the molecular chaperone of the unfolded protein response (UPR), heat shock protein (HSP)-A5, was selected for validation. The interaction was confirmed by confocal microscopy in the Huh7 and HepG2 cell lines. Furthermore, functional experiments revealed that CD5L activates the UPR and autophagy mechanisms in Huh7 cells, thereby providing a novel molecular link between the UPR and autophagy in liver cancer.Aran, G., Sanjurjo, L., Barcena, C., Simon-Coma, M., Tellez, E., Vazquez-Vitali, M., Garrido, M., Guerra, L., Diaz, E., Ojanguren, I., Elortza, F., Planas, R., Sala, M., Armengol, C., Sarrias, M.-R. CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).	[Aran, Gemma; Sanjurjo, Lucia; Barcena, Cristina; Tellez, Erica; Sarrias, Maria-Rosa] Hlth Sci Res Inst Germans Trias & Pujol IGTP, Innate Immun Grp, Badalona, Spain; [Sanjurjo, Lucia] Network Biomed Res Diabet & Associated Metab Dis, Madrid, Spain; [Simon-Coma, Marina; Vazquez-Vitali, Maria; Armengol, Carolina] IGTP, Program Predict & Personalized Med Canc PMPCC, Childhood Liver Oncol Grp, Badalona, Spain; [Simon-Coma, Marina; Elortza, Felix; Planas, Ramon; Sala, Margarita; Armengol, Carolina; Sarrias, Maria-Rosa] Network Biomed Res Hepat & Digest Dis CIBEREHD, Madrid, Spain; [Garrido, Marta] Vall Hebron Hosp, Pathol Dept, Barcelona, Spain; [Guerra, Laura] Hosp Univ La Paz, Pathol Dept, Madrid, Spain; [Diaz, Esther] Josep Trueta Hosp, Pathol Dept, Girona, Spain; [Ojanguren, Isabel] Hosp Univ Germans Trias & Pujol Hosp HUGTiP, Pathol Dept, Badalona, Spain; [Planas, Ramon; Sala, Margarita] Hosp Univ Germans Trias & Pujol Hosp HUGTiP, Gastroenterol Dept, Badalona, Spain; [Elortza, Felix] Ctr Cooperat Res Biosci CIC BioGUNE, Prote Platform, Derio, Spain	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; Hospital Universitario La Paz; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; CIC bioGUNE	Sarrias, MR (corresponding author), Hlth Sci Res Inst Germans Trias & Pujol, Innate Immun Grp, Ctra Can Ruti,Caml Escoles S-N,Edifici Recerca, Badalona 08916, Spain.	mrsarrias@igtp.cat	Elortza, Felix/ABG-4183-2020; Sala, Margarita/AAP-6515-2020; Sanjurjo, Lucía/K-9221-2015; Aran, Gemma/L-4159-2015	Sanjurjo, Lucía/0000-0003-4006-8010; Barcena, Cristina/0000-0002-9640-5568; ARMENGOL, CAROLINA/0000-0002-4690-4027; Elortza, Felix/0000-0001-8839-5438; Aran, Gemma/0000-0003-2005-8843; G Pastrian, Laura/0000-0002-8478-8522	Fundacio la Marato de TV3 [MTV3 2013-3610]; Instituto de Salud Carlos III, ISCIII; ERDF [FIS IP10/01565, IP13/1906, IP16/0974, FIS IP13/02340]; AGAUR [2017-SGR-490]; IGTP; Ramon y Cajal [RYC-2010-07249]; Juan de la Cierva [FJCI-2014-20505];  [CPII14/00021]	Fundacio la Marato de TV3; Instituto de Salud Carlos III, ISCIII(Instituto de Salud Carlos IIIEuropean Commission); ERDF(European Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); IGTP; Ramon y Cajal(Spanish Government); Juan de la Cierva(Instituto de Salud Carlos III); 	The authors thank Marco Fernandez, Gerard Requena, and Pilar Armengol [Innate Immunity Group, Health Sciences Research Institute Germans Trias i Pujol (IGTP)]; Marta Valeri [Vall d'Hebron Research Institute (VHIR)]; Montserrat Martin (Hospital Universitari Germans Trias i Pujol); and the following contributors of tissue samples and clinical databases: Isabel Serra (IGTP); Piotr Czauderna (Medical University of Gdansk, Gdansk, Poland); Rudolf Maibach (International Breast Cancer Study Group, Bern, Switzerland); Margaret Childs (University of Nottingham, Nottingham, United Kingdom); Francisco Hernandez (Hospital Universitario La Paz); Carlos Huertas (Josep Trueta Hospital); Susana Coll (Hospital del Mar, Barcelona, Spain); Maria Varela (Hospital Central de Asturias, Oviedo, Spain); Mireia Miquel (Consorci Hospital Parc Tauli, Sabadell, Spain): and Bruce Morland [Children's Hospital National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom]. This work was supported by grants from the Fundacio la Marato de TV3 (MTV3 2013-3610) (to M.-R.S.); the Instituto de Salud Carlos III, ISCIII, and ERDFs (FIS IP10/01565, IP13/1906, IP16/0974, and FIS IP13/02340) (to M.-R.S. and C.A.); AGAUR 2017-SGR-490; a scholarship from the IGTP (to E.T.); grants from the Miguel Servet (CPII14/00021) (to M.R.S.), Ramon y Cajal (RYC-2010-07249) (to C.A.), and Juan de la Cierva (FJCI-2014-20505) (to C.B.). The IGTP is a member of the Centres de Recerca de Catalunya (CERCA) network of institutes. The authors declare no conflicts of interest.	Amezaga N, 2014, J LEUKOCYTE BIOL, V95, P509, DOI 10.1189/jlb.1212660; Anitua E, 2015, J TISSUE ENG REGEN M, V9, pE1, DOI 10.1002/term.1721; Arai S, 2016, NAT MED, V22, P183, DOI 10.1038/nm.4012; Arbelaiz A, 2017, HEPATOLOGY, V66, P1125, DOI 10.1002/hep.29291; Armengol C, 2011, INT J BIOCHEM CELL B, V43, P265, DOI 10.1016/j.biocel.2009.07.012; Armengol C, 2013, CRIT REV IMMUNOL, V33, P57; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Casas C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00177; Chen JL, 2014, J LIPID RES, V55, P32, DOI 10.1194/jlr.M039453; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gerdes MJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00366; Gray J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-271; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iannaccone A, 2017, EXP EYE RES, V155, P64, DOI 10.1016/j.exer.2016.12.006; Kojima J, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-30; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Li Y, 2011, CANCER RES, V71, P5488, DOI 10.1158/0008-5472.CAN-10-4225; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Maehara N, 2014, CELL REP, V9, P61, DOI 10.1016/j.celrep.2014.08.058; Mera K, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-27; Meyers R. L., 2016, LANCET ONCOL, V2045, P1; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Nassir F, 2013, J LIPID RES, V54, P2988, DOI 10.1194/jlr.M037812; Sanjurjo L, 2015, J LEUKOCYTE BIOL, V98, P173, DOI 10.1189/jlb.3RU0215-074R; Sanjurjo L, 2015, AUTOPHAGY, V11, P487, DOI 10.1080/15548627.2015.1017183; Sanjurjo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079670; Sarvari J, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8351; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055981; Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866; Yamazaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109123; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Ye LY, 2016, CANCER RES, V76, P818, DOI 10.1158/0008-5472.CAN-15-0977; Yusa S, 1999, EUR J IMMUNOL, V29, P1086, DOI 10.1002/(SICI)1521-4141(199904)29:04<1086::AID-IMMU1086>3.3.CO;2-O; Zhao S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1401-z; Zimmermann A, 2005, EUR J CANCER, V41, P1503, DOI 10.1016/j.ejca.2005.02.035	51	22	22	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3878	3891		10.1096/fj.201700941RR	http://dx.doi.org/10.1096/fj.201700941RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465313				2022-12-28	WOS:000435104500033
J	Aumailley, L; Dubois, MJ; Brennan, TA; Garand, C; Paquet, ER; Pignolo, RJ; Marette, A; Lebel, M				Aumailley, Lucie; Dubois, Marie Julie; Brennan, Tracy A.; Garand, Chantal; Paquet, Eric R.; Pignolo, Robert J.; Marette, Andre; Lebel, Michel			Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein	FASEB JOURNAL			English	Article						Werner syndrome; ascorbate; metabolomic; gulonolactone oxidase; aging	WERNER-SYNDROME PROTEIN; COLONY-STIMULATING FACTOR; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASES; ASCORBIC-ACID; SYNDROME GENE; INFLAMMATION; COMPLEX; LACKING; LEPTIN	Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-family DNA helicase (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several phenotypic features of WS. In this study, we generated a Wrn mutant line that, like humans, relies entirely on dietary sources of vitamin C (ascorbate) to survive, by crossing them to mice that lack the gulonolactone oxidase enzyme required for ascorbate synthesis. In the presence of 0.01% ascorbate (w/v) in drinking water, double-mutant mice exhibited a severe reduction in lifespan, small size, sterility, osteopenia, and metabolic profiles different from wild-type (WT) mice. Although increasing the dose of ascorbate to 0.4% improved dramatically the phenotypes of double-mutant mice, the metabolic and cytokine profiles were different from age-matched WT mice. Finally, double-mutant mice treated with 0.01% ascorbate revealed a permanent activation of all the 3 branches of the ER stress response pathways due to a severe chronic oxidative stress in the ER compartment. In addition, markers associated with the ubiquitin-proteasome-dependent ER-associated degradation pathway were increased. Augmenting the dose of ascorbate reversed the activation of this pathway to WT levels rendering this pathway a potential therapeutic target in WS.Aumailley, L., Dubois, M. J., Brennan, T. A., Garand, C., Paquet, E. R., Pignolo, R. J., Marette, A., Lebel, M. Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein.	[Aumailley, Lucie; Garand, Chantal; Lebel, Michel] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [Dubois, Marie Julie; Marette, Andre] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Fac Med, Quebec City, PQ, Canada; [Brennan, Tracy A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Paquet, Eric R.] Univ Laval, Ctr Rech Canc, Hop Hotel Dieu Quebec, Quebec City, PQ, Canada; [Pignolo, Robert J.] Mayo Clin, Coll Med, Dept Med, Rochester, MN USA	Laval University; Laval University; University of Pennsylvania; Pennsylvania Medicine; Laval University; Mayo Clinic	Lebel, M (corresponding author), Univ Laval, Ctr Rech, CHU Quebec, Ctr Hosp, 2705 Laurier Blvd,Local T-2-04, Quebec City, PQ G1V 4G2, Canada.	michel.lebel@crchudequebec.ulaval.ca		Paquet, Eric/0000-0001-9194-1655; Garand, Chantal/0000-0003-0716-6487; Marette, Andre/0000-0003-3950-5973	Canadian Institutes of Health Research; U.S. National Institutes of Health (NIH) National Institute on Aging [R01AG028873]; NATIONAL INSTITUTE ON AGING [R01AG028873] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health (NIH) National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the Canadian Institutes of Health Research (to M.L. and A.M.), and by U.S. National Institutes of Health (NIH) National Institute on Aging Grant R01AG028873 (to R.J.P.). L.A. is a scholar from the Fondation du Centre Hospitalier Universitaire de Quebec. The authors declare no conflicts of interest.	Aumailley L, 2016, AGING-US, V8, P458, DOI 10.18632/aging.100902; Aumailley L, 2015, EXP GERONTOL, V72, P192, DOI 10.1016/j.exger.2015.10.012; Aumailley L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140292; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Banhegyi G, 2014, BBA-MOL CELL RES, V1843, P1909, DOI 10.1016/j.bbamcr.2014.05.016; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Carrero D, 2016, DIS MODEL MECH, V9, P719, DOI 10.1242/dmm.024711; Castro E, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-5; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Cooper MP, 2000, GENE DEV, V14, P907; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; D'Amario D, 2018, PHARMACOL RES, V127, P67, DOI 10.1016/j.phrs.2017.06.001; D'Aniello C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/8936156; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Gieseg SP, 2009, FRONT BIOSCI-LANDMRK, V14, P1230, DOI 10.2741/3305; Gils A, 2004, THROMB HAEMOSTASIS, V91, P425, DOI 10.1160/TH03-12-0764; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037; Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937; Hofer AC, 2005, J GERONTOL A-BIOL, V60, P10, DOI 10.1093/gerona/60.1.10; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; Jiang H, 2014, INT UROL NEPHROL, V46, P879, DOI 10.1007/s11255-013-0610-0; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kompare M, 2008, SEMIN PEDIATR NEUROL, V15, P140, DOI 10.1016/j.spen.2008.05.008; Korovila I, 2017, REDOX BIOL, V13, P550, DOI 10.1016/j.redox.2017.07.008; Labbe A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184; Labbe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-127; Lasic D, 2014, PSYCHIAT DANUB, V26, P214; Lebel M, 2003, AM J PATHOL, V162, P1559, DOI 10.1016/S0002-9440(10)64290-3; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebel M, 2010, ANN NY ACAD SCI, V1197, P40, DOI 10.1111/j.1749-6632.2010.05189.x; Lemus Leticia, 2014, Cells, V3, P824, DOI 10.3390/cells3030824; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Martinez G, 2017, AGING CELL, V16, P615, DOI 10.1111/acel.12599; Mashima R, 2003, ANAL BIOCHEM, V313, P28, DOI 10.1016/S0003-2697(02)00537-7; Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Mori S, 2001, INT J OBESITY, V25, P292, DOI 10.1038/sj.ijo.0801529; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; Oshima J, 2017, AGEING RES REV, V33, P105, DOI 10.1016/j.arr.2016.03.002; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683; Puskas F, 1998, FEBS LETT, V430, P293, DOI 10.1016/S0014-5793(98)00678-4; Quiroga C, 2013, BBA-MOL CELL RES, V1833, P3295, DOI 10.1016/j.bbamcr.2013.09.006; Rudyk O, 2014, REDOX BIOL, V2, P803, DOI 10.1016/j.redox.2014.06.005; Sadowski M, 2014, ATHEROSCLEROSIS, V237, P555, DOI 10.1016/j.atherosclerosis.2014.10.020; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Suzuki K, 2003, EXERC IMMUNOL REV, V9, P48; Szarka A, 2014, PROTOPLASMA, V251, P489, DOI 10.1007/s00709-013-0560-5; Takemoto M, 2013, GERIATR GERONTOL INT, V13, P475, DOI 10.1111/j.1447-0594.2012.00913.x; Trapeaux J, 2013, BRIT J PHARMACOL, V169, P1587, DOI 10.1111/bph.12236; Unterwurzacher I, 2008, CLIN CHEM LAB MED, V46, P1589, DOI 10.1515/CCLM.2008.323; Vincenz-Donnelly L, 2017, FREE RADICAL BIO MED, V108, P383, DOI 10.1016/j.freeradbiomed.2017.03.031; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010	76	3	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3623	3640		10.1096/fj.201701176R	http://dx.doi.org/10.1096/fj.201701176R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452565	Green Published			2022-12-28	WOS:000435104500012
J	Chen, SS; Mei, XH; Yin, A; Yin, H; Cui, XB; Chen, SY				Chen, Sisi; Mei, Xiaohan; Yin, Amelia; Yin, Hang; Cui, Xiao-Bing; Chen, Shi-You			Response Gene to Complement 32 Suppresses Adipose Tissue Thermogenic Genes through Inhibiting Beta3 Adrenergic Receptor mTORC1 Signaling	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Meeting Abstract	Scientific Sessions of the American-Heart-Association on Vascular Discovery - From Genes to Medicine	MAY 10-12, 2018	San Francisco, CA	Amer Heart Assoc					[Chen, Sisi; Mei, Xiaohan; Yin, Amelia; Yin, Hang; Cui, Xiao-Bing; Chen, Shi-You] Univ Georgia, Athens, GA 30602 USA	University System of Georgia; University of Georgia					American Heart Association-American Stroke Association [17SDG32790003] Funding Source: Medline; NHLBI NIH HHS [R01 HL135854, R01 HL123302, R01 HL119053] Funding Source: Medline; NIAMS NIH HHS [R01 AR070178] Funding Source: Medline	American Heart Association-American Stroke Association(American Heart Association); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))			0	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	MAY	2018	38			1		168				10.1161/atvb.38.suppl_1.168	http://dx.doi.org/10.1161/atvb.38.suppl_1.168			2	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology; Cardiovascular System & Cardiology	JO3WN	29579398				2022-12-28	WOS:000497511500119
J	Esparza-Molto, PB; Nuevo-Tapioles, C; Chamorro, M; Najera, L; Torresano, L; Santacatterina, F; Cuezva, JM				Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Najera, Laura; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.			Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues	FASEB JOURNAL			English	Article						mitochondria; Lrpprc; oxphos; traslational efficiency; protein phosphorylation	BETA-F1-ATPASE MESSENGER-RNA; ENERGY-METABOLISM; MITOCHONDRIAL; SYNTHASE; PROTEIN; CANCER; TRANSLATION; PHOSPHORYLATION; COORDINATION; ORGANIZATION	The ATPase inhibitory factor 1 (IF1) is an intrinsically disordered protein that regulates the activity of the mitochondrial ATP synthase. Phosphorylation of S39 in IF1 prevents it from binding to the enzyme and thus abolishes its inhibitory activity. Dysregulation of IF1 is linked to different human diseases, providing a relevant biomarker of cancer progression. However, the tissue content of IF1 relative to the abundance of the ATP synthase is unknown. In this study, we characterized the tissue-specific expression of IF1 in human and mouse tissues and quantitated the content of IF1 and of ATP synthase. We found relevant differences in IF1 expression between human and mouse tissues and found that in high-energy-demanding tissues, the molar content of IF1 exceeds that of the ATP synthase. In these tissues, a fraction of IF1 is bound to the enzyme, and the other fraction is phosphorylated and hence is unable to bind the enzyme. Post-transcriptional control accounts for most of the regulated expression of IF1, especially in mouse heart, where IF1 mRNA translation is repressed by the leucine-rich pentatricopeptide repeat containing protein. Overall, these findings enlighten the cellular biology of IF1 and pave the way to development of additional models that address its role in pathophysiology.Esparza-Molto, P. B., Nuevo-Tapioles, C., Chamorro, M., Najera, L., Torresano, L., Santacatterina, F., Cuezva, J. M. Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues.	[Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.] Univ Autonoma Madrid, CSIC, CBMSO, Dept Biol Mol, Madrid, Spain; [Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.] Inst Invest Hosp 12 Octubre I 12, Madrid, Spain; [Najera, Laura] Hosp Univ Puerta de Hierro, Serv Anat Patol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Hospital Puerta de Hierro-Majadahonda	Cuezva, JM (corresponding author), Univ Autonoma Madrid, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Invest Hosp 12 Octubre,ISCIII, Dept Biol Mol,Ctr Biol Mol Severo Ochoa,CSIC, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	jmcuezva@cbm.csic.es	Cuezva, Jose M/AAR-5392-2020; Nuevo-Tapioles, Cristina/F-5970-2016; Nuevo-Tapioles, Cristina/AAT-5772-2021; Esparza-Moltó, Pau B./S-5584-2018; Santacatterina, Fulvio/F-5722-2016	Nuevo-Tapioles, Cristina/0000-0001-5809-2030; Santacatterina, Fulvio/0000-0002-4831-5402; Esparza-Molto, Pau B./0000-0001-9034-1121	Fundacion La Caixa (Obra Social La Caixa); Formacion de Personal Investigador-Ministerio de Economia y Competitividad (FPI-MINECO); Fondo Social Europeo; Ministry of Economy and Enterprise (MINECO) [SAF2016-75916-R]; Centro de Investigacion Biomedica en Red de Enfermedades Raras- Instituto de Salud Carlos III (CIBERER-ISCIII); Fundacion Ramon Areces	Fundacion La Caixa (Obra Social La Caixa); Formacion de Personal Investigador-Ministerio de Economia y Competitividad (FPI-MINECO); Fondo Social Europeo(European Social Fund (ESF)European Commission); Ministry of Economy and Enterprise (MINECO); Centro de Investigacion Biomedica en Red de Enfermedades Raras- Instituto de Salud Carlos III (CIBERER-ISCIII); Fundacion Ramon Areces	The authors thank Cristina Nunez de Arenas and Brenda Sanchez-Garrido [Departamento de Biologia Molecular, Centro de Biologia Molecular Severo Ochoa (CBMSO), Consejo Superior de Investigaciones Cientificas (CSIC) - Universidad Autonoma de Madrid (UAM); Centro de Investigacion Biomedica en Red de Enfermedades Raras-Instituto de Salud Carlos III (CIBERER-ISCIII); Instituto de Investigacion Hospital 12 de Octubre (i+12)] for excellent technical assistance.This work was supported by predoctoral fellowships from Fundacion La Caixa (Obra Social La Caixa) (to P.B.E.-M.) and Formacion de Personal Investigador-Ministerio de Economia y Competitividad (FPI-MINECO) and Fondo Social Europeo (to C.N.-T.). This work was also supported by grants from the Ministry of Economy and Enterprise (MINECO; SAF2016-75916-R), Centro de Investigacion Biomedica en Red de Enfermedades Raras- Instituto de Salud Carlos III (CIBERER-ISCIII), and Fundacion Ramon Areces. The authors declare no conflicts of interest.	Acebo P, 2009, TRANSL ONCOL, V2, P138, DOI 10.1593/tlo.09106; Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cuezva JM, 2002, CANCER RES, V62, P6674; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; de Heredia ML, 2000, J BIOL CHEM, V275, P7430, DOI 10.1074/jbc.275.10.7430; Di Benedetto G, 2014, J PHYSIOL-LONDON, V592, P305, DOI 10.1113/jphysiol.2013.259135; Esparza-Molto PB, 2017, CELL MOL LIFE SCI, V74, P2151, DOI 10.1007/s00018-017-2462-8; Faccenda D, 2017, CELL REP, V18, P1869, DOI 10.1016/j.celrep.2017.01.070; Formentini L, 2017, DIABETOLOGIA, V60, P2052, DOI 10.1007/s00125-017-4379-z; Formentini L, 2017, CELL REP, V19, P1202, DOI 10.1016/j.celrep.2017.04.036; Formentini L, 2014, EMBO J, V33, P762, DOI 10.1002/embj.201386392; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Garcia-Bermudez J., 2016, BIOPROTOC, V6, pE1905; Garcia-Bermudez J, 2016, BBA-BIOENERGETICS, V1857, P1167, DOI 10.1016/j.bbabio.2016.02.004; Garcia-Bermudez J, 2015, CELL REP, V12, P2143, DOI 10.1016/j.celrep.2015.08.052; Genoux A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0672-9; Gordon-Smith DJ, 2001, J MOL BIOL, V308, P325, DOI 10.1006/jmbi.2001.4570; Izquierdo JM, 1997, MOL CELL BIOL, V17, P5255, DOI 10.1128/MCB.17.9.5255; IZQUIERDO JM, 1995, J BIOL CHEM, V270, P10342, DOI 10.1074/jbc.270.17.10342; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413; Matic I, 2016, PHARMACOL RES, V103, P56, DOI 10.1016/j.phrs.2015.10.010; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Ortega AD, 2010, J CELL SCI, V123, P2685, DOI 10.1242/jcs.065920; ROUSLIN W, 1989, J BIOL CHEM, V264, P15224; ROUSLIN W, 1993, AM J PHYSIOL, V264, pC209, DOI 10.1152/ajpcell.1993.264.1.C209; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sanchez-Arago M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.9; Sanchez-Arago M, 2013, EMBO REP, V14, P638, DOI 10.1038/embor.2013.72; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Santacatterina F, 2016, ONCOTARGET, V7, P490, DOI 10.18632/oncotarget.6357; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Willers IM, 2012, BBA-BIOENERGETICS, V1817, P838, DOI 10.1016/j.bbabio.2012.03.005; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Xu J., 2005, CHINA ED TECHNOLOGY; Yang K., 2017, FRONTIERMED, P1, DOI DOI 10.1038/s41598-016-0028-x	44	13	14	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1836	1851		10.1096/fj.201800756R	http://dx.doi.org/10.1096/fj.201800756R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204502	Bronze			2022-12-28	WOS:000457296600026
J	Fettel, J; Kuhn, B; Guillen, NA; Surun, D; Peters, M; Bauer, R; Angioni, C; Geisslinger, G; Schnutgen, F; zu Heringdorf, DM; Werz, O; Meybohm, P; Zacharowski, K; Steinhilber, D; Roos, J; Maier, TJ				Fettel, Jasmin; Kuehn, Benjamin; Guillen, Nathalie A.; Sueruen, Duran; Peters, Marcus; Bauer, Rebekka; Angioni, Carlo; Geisslinger, Gerd; Schnuetgen, Frank; zu Heringdorf, Dagmar Meyer; Werz, Oliver; Meybohm, Patrick; Zacharowski, Kai; Steinhilber, Dieter; Roos, Jessica; Maier, Thorsten J.			Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity	FASEB JOURNAL			English	Article						calcium; inactivation of 5-LO; inflammation; leukotriene formation; lipid mediators	SPHINGOSINE 1-PHOSPHATE; EXTRACELLULAR CALCIUM; HUMAN NEUTROPHILS; ARACHIDONIC-ACID; INACTIVATION; ACTIVATION; GENERATION; INHIBITION; TRANSLOCATION; BIOSYNTHESIS	Sphingosine-1-phosphate (S1P) is involved in the regulation of important cellular processes, including immune-cell trafficking and proliferation. Altered S1P signaling is strongly associated with inflammation, cancer progression, and atherosclerosis; however, the mechanisms underlying its pathophysiologic effects are only partially understood. This study evaluated the effects of S1P in vitro and in vivo on the biosynthesis of leukotrienes (LTs), which form a class of lipid mediators involved in the pathogenesis of inflammatory diseases. Here, we report for the first time that S1P potently suppresses LT biosynthesis in Ca2+-ionophore-stimulated intact human neutrophils. S1P treatment resulted in intracellular Ca2+ mobilization, perinuclear translocation, and finally irreversible suicide inactivation of the LT biosynthesis key enzyme 5-lipoxygenase (5-LO). Agonist studies and S1P receptor mRNA expression analysis provided evidence for a S1P receptor 4-mediated effect, which was confirmed by a functional knockout of S1P4 in HL60 cells. Systemic administration of S1P in wild-type mice decreased both macrophage and neutrophil migration in the lungs in response to LPS and significantly attenuated 5-LO product formation, whereas these effects were abrogated in 5-LO or S1P4 knockout mice. In summary, targeting the 5-LO pathway is an important mechanism to explain S1P-mediated pathophysiologic effects. Furthermore, agonism at S1P4 represents a novel effective strategy in pharmacotherapy of inflammation.Fettel, J., Kuhn, B., Guillen, N. A., Surun, D., Peters, M., Bauer, R., Angioni, C., Geisslinger, G., Schnutgen, F., Meyer zu Heringdorf, D., Werz, O., Meybohm, P., Zacharowski, K., Steinhilber, D., Roos, J., Maier, T. J. Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity.	[Fettel, Jasmin; Kuehn, Benjamin; Guillen, Nathalie A.; Bauer, Rebekka; Steinhilber, Dieter] Goethe Univ, Inst Pharmaceut Chem, Frankfurt, Germany; [Sueruen, Duran; Schnuetgen, Frank] Goethe Univ, Dept Med 2, Hematol Oncol, Frankfurt, Germany; [Meybohm, Patrick; Zacharowski, Kai; Roos, Jessica; Maier, Thorsten J.] Goethe Univ, Dept Anesthesiol Intens Care Med & Pain Therapy, Univ Hosp, Frankfurt, Germany; [Angioni, Carlo; Geisslinger, Gerd] Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany; [zu Heringdorf, Dagmar Meyer] Goethe Univ, Inst Gen Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Peters, Marcus] Ruhr Univ Bochum, Dept Expt Pneumol, Bochum, Germany; [Werz, Oliver] Friedrich Schiller Univ, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Ruhr University Bochum; Friedrich Schiller University of Jena	Maier, TJ (corresponding author), Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	thorstenjuergen.maier@kgu.de	Bauer, Rebekka/GWV-5012-2022; Heringdorf, Dagmar Meyer zu/A-7705-2018; Schnütgen, Frank/ABD-8637-2020	Heringdorf, Dagmar Meyer zu/0000-0003-1246-9677; Schnütgen, Frank/0000-0002-2426-6685; Zacharowski, Kai/0000-0002-0212-9110; Peters, Marcus/0000-0003-1850-2845	German Research Foundation (DFG) [Sonderforschungsbereich (SFB-1039), Teilprojekt B-01]; Else Kroner-Fresenius-Foundation (EKFS); Graduate School Translational Research Innovation-Pharma (TRIP); DFG [MA-5825/2-1, MA-5825/1-1, SCHN1166/4-1]; Aarhus University Research Foundation (AUFF)	German Research Foundation (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Foundation (EKFS); Graduate School Translational Research Innovation-Pharma (TRIP); DFG(German Research Foundation (DFG)); Aarhus University Research Foundation (AUFF)	The authors thank A. Weigert (Institute of Biochemistry I, Goethe University) for providing S1P4<SUP>-/-</SUP> mice. This work was funded by the German Research Foundation (DFG) Sonderforschungsbereich (SFB-1039, Teilprojekt B-01), the Else Kroner-Fresenius-Foundation (EKFS), and the Graduate School Translational Research Innovation-Pharma (TRIP), the DFG (MA-5825/1-1 and SCHN1166/4-1), and the Aarhus University Research Foundation (AUFF). T.J.M. received support from the Heisenberg Program provided by the DFG (MA-5825/2-1). The authors declare no conflicts of interest.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; AHARONY D, 1986, J BIOL CHEM, V261, P1512; AHARONY D, 1987, PROSTAGLANDINS, V33, P85, DOI 10.1016/0090-6980(87)90307-8; Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brock TG, 1998, BIOCHEM J, V329, P519; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen LY, 2008, AM J PHYSIOL-LUNG C, V295, pL326, DOI 10.1152/ajplung.00393.2007; Claas RF, 2010, CELL SIGNAL, V22, P476, DOI 10.1016/j.cellsig.2009.11.001; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; DeCarolis E, 1996, EUR J BIOCHEM, V235, P416; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hafner AK, 2015, BBA-MOL CELL BIOL L, V1851, P1465, DOI 10.1016/j.bbalip.2015.08.010; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hornig M, 2012, BBA-MOL CELL BIOL L, V1821, P279, DOI 10.1016/j.bbalip.2011.11.001; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lundqvist H, 1996, J LEUKOCYTE BIOL, V59, P270, DOI 10.1002/jlb.59.2.270; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; MCCOLL SR, 1991, J IMMUNOL, V146, P1204; NOGUCHI M, 1994, BBA-LIPID LIPID MET, V1215, P300, DOI 10.1016/0005-2760(94)90057-4; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; PERCIVAL MD, 1992, EUR J BIOCHEM, V210, P109, DOI 10.1111/j.1432-1033.1992.tb17397.x; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pyne NJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00026; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Roos J, 2018, ANTIOXID REDOX SIGN, V28, P1265, DOI 10.1089/ars.2017.7155; Rosengarten M, 2016, EUR J IMMUNOL, V46, P400, DOI 10.1002/eji.201545848; ROUZER CA, 1988, J BIOL CHEM, V263, P10980; Salomone S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00009; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SCHATZMUNDING M, 1991, EUR J BIOCHEM, V197, P487, DOI 10.1111/j.1432-1033.1991.tb15936.x; Schulze T, 2011, FASEB J, V25, P4024, DOI 10.1096/fj.10-179028; Skorey KI, 1998, BIOCHEMISTRY-US, V37, P8027, DOI 10.1021/bi980371g; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; STEINHILBER D, 1989, J CHROMATOGR-BIOMED, V493, P361, DOI 10.1016/S0378-4347(00)82742-5; Suomalainen L, 2005, AM J PATHOL, V166, P773, DOI 10.1016/S0002-9440(10)62298-5; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; TATESON JE, 1988, BRIT J PHARMACOL, V94, P528, DOI 10.1111/j.1476-5381.1988.tb11557.x; Urbano M, 2011, BIOORG MED CHEM LETT, V21, P6739, DOI 10.1016/j.bmcl.2011.09.049; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Werz O, 2002, FASEB J, V16, P1441, DOI 10.1096/fj.01-0909fje; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; WONG A, 1988, BIOCHEMISTRY-US, V27, P6763, DOI 10.1021/bi00418a018; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Yatomi Y, 1997, J BIOCHEM, V121, P969	61	23	24	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1711	1726		10.1096/fj.201800221R	http://dx.doi.org/10.1096/fj.201800221R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30188757				2022-12-28	WOS:000457296600017
J	Kalpage, HA; Bazylianska, V; Recanati, MA; Fite, A; Liu, J; Wan, JM; Mantena, N; Malek, MH; Podgorski, I; Heath, EI; Vaishnav, A; Edwards, BF; Grossman, LI; Sanderson, TH; Lee, I; Huttemann, M				Kalpage, Hasini A.; Bazylianska, Viktoriia; Recanati, Maurice A.; Fite, Alemu; Liu, Jenney; Wan, Junmei; Mantena, Nikhil; Malek, Moh H.; Podgorski, Izabela; Heath, Elizabeth I.; Vaishnav, Asmita; Edwards, Brian F.; Grossman, Lawrence I.; Sanderson, Thomas H.; Lee, Icksoo; Huttemann, Maik			Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis	FASEB JOURNAL			English	Review						electron transport chain; ischemia-reperfusion; phosphorylation; reactive oxygen species; signal transduction	HISTONE CHAPERONE ACTIVITY; NITRIC-OXIDE; TYROSINE PHOSPHORYLATION; IN-VIVO; OXIDATIVE STRESS; PEROXIDASE-ACTIVITY; LIFE-SPAN; STRUCTURAL TRANSITIONS; ENZYMATIC METHYLATION; LYSINE ACETYLATION	Cytochrome c (Cytc) plays a vital role in the mitochondrial electron transport chain (ETC). In addition, it is a key regulator of apoptosis. Cytc has multiple other functions including ROS production and scavenging, cardiolipin peroxidation, and mitochondrial protein import. Cytc is tightly regulated by allosteric mechanisms, tissue-specific isoforms, and post-translational modifications (PTMs). Distinct residues of Cytc are modified by PTMs, primarily phosphorylations, in a highly tissue-specific manner. These modifications downregulate mitochondrial ETC flux and adjust the mitochondrial membrane potential ((m)), to minimize reactive oxygen species (ROS) production under normal conditions. In pathologic and acute stress conditions, such as ischemia-reperfusion, phosphorylations are lost, leading to maximum ETC flux, (m) hyperpolarization, excessive ROS generation, and the release of Cytc. It is also the dephosphorylated form of the protein that leads to maximum caspase activation. We discuss the complex regulation of Cytc and propose that it is a central regulatory step of the mammalian ETC that can be rate limiting in normal conditions. This regulation is important because it maintains optimal intermediate (m), limiting ROS generation. We examine the role of Cytc PTMs, including phosphorylation, acetylation, methylation, nitration, nitrosylation, and sulfoxidation and consider their potential biological significance by evaluating their stoichiometry.Kalpage, H. A., Bazylianska, V., Recanati, M. A., Fite, A., Liu, J., Wan, J., Mantena, N., Malek, M. H., Podgorski, I., Heath, E. I., Vaishnav, A., Edwards, B. F., Grossman, L. I., Sanderson, T. H., Lee, I., Huttemann, M. Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis.	[Kalpage, Hasini A.; Bazylianska, Viktoriia; Recanati, Maurice A.; Fite, Alemu; Liu, Jenney; Wan, Junmei; Mantena, Nikhil; Grossman, Lawrence I.; Huttemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 540 E Canfield, Detroit, MI 48201 USA; [Bazylianska, Viktoriia; Wan, Junmei; Vaishnav, Asmita; Edwards, Brian F.; Huttemann, Maik] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA; [Recanati, Maurice A.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Malek, Moh H.; Sanderson, Thomas H.; Huttemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA; [Podgorski, Izabela] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Heath, Elizabeth I.] Wayne State Univ, Sch Med, Dept Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Malek, Moh H.] Wayne State Univ, Dept Hlth Care Sci, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA; [Sanderson, Thomas H.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Sanderson, Thomas H.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si, Chungcheongnam, South Korea	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Dankook University	Huttemann, M (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 540 E Canfield, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu	Kalpage, Hasini/AAG-1538-2019; Sanderson, Thomas H/K-6656-2012; , Malik/AAB-7437-2021	Sanderson, Thomas H/0000-0003-0112-8164; , Malik/0000-0002-5993-7709; Huttemann, Maik/0000-0001-6310-7081; Recanati, Maurice Andre/0000-0003-0974-3962	U.S. National Institutes of Health (NIH), Institute of General Medical Sciences [R01 GM116807]; NIH National Institute of Neurological Disorders and Stroke [R01 NS091242, R42 NS105238]; Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-16-1-0175]; Karmanos Cancer Institute Prostate Cancer Research Team (PCRT) Postdoctoral Award Program; U.S. Department of Defense; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R42NS105238, R01NS091242] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), Institute of General Medical Sciences; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; Karmanos Cancer Institute Prostate Cancer Research Team (PCRT) Postdoctoral Award Program; U.S. Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health (NIH), Institute of General Medical Sciences Grant R01 GM116807, and NIH National Institute of Neurological Disorders and Stroke Grants R01 NS091242, and R42 NS105238; the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award W81XWH-16-1-0175; and the Karmanos Cancer Institute Prostate Cancer Research Team (PCRT) Postdoctoral Award Program. Opinions, interpretations, conclusions, and recommendations are those of the authors, and are not necessarily endorsed by the funding agencies including the U.S. Department of Defense or the NIH. The authors declare no conflicts of interest.	Abriata LA, 2009, J BIOL CHEM, V284, P17, DOI 10.1074/jbc.M807203200; Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Alonso D, 2002, NEUROSCIENCE, V111, P47, DOI 10.1016/S0306-4522(01)00571-1; Alvarez-Paggi D, 2017, CHEM REV, V117, P13382, DOI 10.1021/acs.chemrev.7b00257; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Arany I, 2013, AM J NEPHROL, V38, P226, DOI 10.1159/000354357; Arany I, 2013, ANTICANCER RES, V33, P3119; Arany I, 2013, NEPHROL DIAL TRANSPL, V28, P1417, DOI 10.1093/ndt/gfs596; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; ASCENZI P, 1994, J INORG BIOCHEM, V53, P273, DOI 10.1016/0162-0134(94)85114-X; BACKUS M, 1993, AM J PHYSIOL, V265, pC178, DOI 10.1152/ajpcell.1993.265.1.C178; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Beresewicz M, 2006, NEUROCHEM INT, V48, P568, DOI 10.1016/j.neuint.2005.11.020; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2004, CELL CYCLE, V3, P252; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; BRAND MD, 1984, BIOCHEM J, V217, P453, DOI 10.1042/bj2170453; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; BREMS DN, 1981, J BIOL CHEM, V256, P1688; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Cammack R., 1995, BIOENERGETICS PRACTI, P93; Capdevila DA, 2015, BIOCHEMISTRY-US, V54, P7491, DOI 10.1021/acs.biochem.5b00922; Capdevila DA, 2014, CHEM COMMUN, V50, P2592, DOI 10.1039/c3cc47207h; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Cherney MM, 2013, BIOCHEMISTRY-US, V52, P837, DOI 10.1021/bi301599g; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Covian R, 2012, AM J PHYSIOL-HEART C, V303, pH940, DOI 10.1152/ajpheart.00077.2012; Cruthirds DL, 2003, ARCH BIOCHEM BIOPHYS, V412, P27, DOI 10.1016/S0003-9861(03)00039-0; Dalmonte ME, 2009, J BIOL CHEM, V284, P32331, DOI 10.1074/jbc.M109.050146; De Rocco D, 2014, BBA-MOL BASIS DIS, V1842, P269, DOI 10.1016/j.bbadis.2013.12.002; Deacon OM, 2017, BIOCHEMISTRY-US, V56, P6111, DOI 10.1021/acs.biochem.7b00890; DELANGE RJ, 1969, J BIOL CHEM, V244, P1385; Diaz-Moreno I, 2018, FEBS LETT, V592, P172, DOI 10.1002/1873-3468.12959; Diaz-Moreno I, 2011, BBA-BIOENERGETICS, V1807, P1616, DOI 10.1016/j.bbabio.2011.09.012; Dickerson R., 1975, ENZYMES, V11, P397; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2236; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Elena-Real CA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0408-1; FAROOQUI J, 1981, J BIOL CHEM, V256, P5041; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; FROST B, 1989, INT J BIOCHEM, V21, P1407, DOI 10.1016/0020-711X(89)90163-8; Garcia-Heredia JM, 2012, FEBS LETT, V586, P154, DOI 10.1016/j.febslet.2011.12.007; Garcia-Heredia JM, 2011, J BIOL INORG CHEM, V16, P1155, DOI 10.1007/s00775-011-0804-9; Garcia-Heredia JM, 2010, BBA-BIOENERGETICS, V1797, P981, DOI 10.1016/j.bbabio.2010.03.009; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Godoy LC, 2009, P NATL ACAD SCI USA, V106, P2653, DOI 10.1073/pnas.0809279106; Gonzalez-Arzola K, 2017, NUCLEIC ACIDS RES, V45, P2150, DOI 10.1093/nar/gkw1215; Gonzalez-Arzola K, 2015, P NATL ACAD SCI USA, V112, P9908, DOI 10.1073/pnas.1508040112; Guerra-Castellano A, 2018, P NATL ACAD SCI USA, V115, P7955, DOI 10.1073/pnas.1806833115; Guerra-Castellano A, 2016, BBA-BIOENERGETICS, V1857, P387, DOI 10.1016/j.bbabio.2016.01.011; Guerra-Castellano A, 2015, CHEM-EUR J, V21, P15004, DOI 10.1002/chem.201502019; HAGIHARA Y, 1994, J MOL BIOL, V237, P336, DOI 10.1006/jmbi.1994.1234; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hojlund K, 2009, J PROTEOME RES, V8, P4954, DOI 10.1021/pr9007267; HOLZSCHU D, 1987, J BIOL CHEM, V262, P7125; Hosp F, 2017, MITOCHONDRION, V33, P58, DOI 10.1016/j.mito.2016.07.012; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kaim G, 1999, EMBO J, V18, P4118, DOI 10.1093/emboj/18.15.4118; Kapralov AA, 2011, BBA-BIOMEMBRANES, V1808, P2147, DOI 10.1016/j.bbamem.2011.04.009; Kawai C, 2013, J BIOENERG BIOMEMBR, V45, P421, DOI 10.1007/s10863-013-9507-y; KIM CS, 1980, BIOCHIM BIOPHYS ACTA, V622, P144, DOI 10.1016/0005-2795(80)90166-X; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Konig AC, 2014, MITOCHONDRION, V19, P252, DOI 10.1016/j.mito.2014.03.004; Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Korshunov SS, 1999, FEBS LETT, V462, P192, DOI 10.1016/S0014-5793(99)01525-2; Kunz WS, 2000, J BIOL CHEM, V275, P27741; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; MacMillan-Crow LA, 2001, FREE RADICAL BIO MED, V31, P1603, DOI 10.1016/S0891-5849(01)00750-X; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Mahapatra G, 2017, J BIOL CHEM, V292, P64, DOI 10.1074/jbc.M116.744664; Martinez-Fabregas J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.280; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MILLS GC, 1991, J THEOR BIOL, V152, P177, DOI 10.1016/S0022-5193(05)80451-5; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Moreno-Beltran B, 2017, P NATL ACAD SCI USA, V114, pE3041, DOI 10.1073/pnas.1618008114; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; MORRISS GM, 1979, J EMBRYOL EXP MORPH, V54, P17; Muneeswaran G, 2017, BIOPHYS CHEM, V230, P117, DOI 10.1016/j.bpc.2017.09.004; Nakagawa H, 2007, BIOL PHARM BULL, V30, P15, DOI 10.1248/bpb.30.15; Nicholls D.G., 1992, BIOENERGETICS, V2, P22; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Oursler MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC156, DOI 10.1152/ajpcell.00092.2004; PAIK WK, 1989, BIOCHEM CELL BIOL, V67, P602; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; PAL PK, 1975, BIOCHEMISTRY-US, V14, P4325, DOI 10.1021/bi00690a029; Parakra RD, 2018, DALTON T, V47, P9128, DOI 10.1039/c8dt02185f; PARK KS, 1987, J BIOL CHEM, V262, P14702; Patriarca A, 2009, BIOCHEMISTRY-US, V48, P3279, DOI 10.1021/bi801837e; Pecina P, 2010, BIOCHEMISTRY-US, V49, P6705, DOI 10.1021/bi100486s; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Pierron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026269; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; POLASTRO E, 1978, INT J BIOCHEM, V9, P795, DOI 10.1016/0020-711X(78)90028-9; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rajagopal BS, 2013, BIOCHEM J, V456, P441, DOI 10.1042/BJ20130758; Rodriguez-Roldan V, 2008, BIOCHEMISTRY-US, V47, P12371, DOI [10.1021/bi801329s, 10.1021/bi800910v]; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Sanderson TH, 2008, J NEUROCHEM, V106, P1248, DOI 10.1111/j.1471-4159.2008.05473.x; Sanderson TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078627; Schmidt TR, 2005, P NATL ACAD SCI USA, V102, P6379, DOI 10.1073/pnas.0409714102; Schonhoff CM, 2003, J BIOL CHEM, V278, P18265, DOI 10.1074/jbc.M212459200; SCOTT WA, 1969, BIOCHEMISTRY-US, V8, P4282, DOI 10.1021/bi00839a009; Sharpe MA, 1998, BIOCHEM J, V332, P9, DOI 10.1042/bj3320009; Sinkler CA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1534056; Smith-Hammond CL, 2014, MITOCHONDRION, V19, P154, DOI 10.1016/j.mito.2014.04.012; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Sun L, 2010, AM J PHYSIOL-RENAL, V299, pF1014, DOI 10.1152/ajprenal.00414.2010; Ueta E, 2003, INT J CANCER, V103, P717, DOI 10.1002/ijc.10832; Velayutham Murugesan, 2016, Biochem Biophys Rep, V5, P96; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Vitvitsky V, 2018, ACS CHEM BIOL, V13, P2300, DOI 10.1021/acschembio.8b00463; Vladimirov YA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P998, DOI 10.1134/S0006297906090082; WAN B, 1993, AM J PHYSIOL, V265, pH453, DOI 10.1152/ajpheart.1993.265.2.H453; Wang ZB, 2003, PROTEIN PEPTIDE LETT, V10, P247, DOI 10.2174/0929866033479013; Wang ZH, 2014, MOL BIOSYST, V10, P3130, DOI 10.1039/c4mb00285g; WEBB M, 1980, BIOCHIM BIOPHYS ACTA, V593, P290, DOI 10.1016/0005-2728(80)90066-3; Winter DL, 2015, PROTEOMICS, V15, P2166, DOI 10.1002/pmic.201400521; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Yoo BK, 2015, P NATL ACAD SCI USA, V112, pE1697, DOI 10.1073/pnas.1423098112; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; Zhang H, 2001, ANAL BIOCHEM, V298, P170, DOI 10.1006/abio.2001.5348; Zhang ZL, 2003, GENE, V312, P61, DOI 10.1016/S0378-1119(03)00579-1; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	153	100	105	3	53	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1540	1553		10.1096/fj.201801417R	http://dx.doi.org/10.1096/fj.201801417R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30222078	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000457296600004
J	Mukherjee, R; Bhattacharya, A; Sau, A; Basu, S; Chakrabarti, S; Chakrabarti, O				Mukherjee, Rukmini; Bhattacharya, Anshu; Sau, Abhishek; Basu, Samita; Chakrabarti, Saikat; Chakrabarti, Oishee			Calmodulin regulates MGRN1-GP78 interaction mediated ubiquitin proteasomal degradation system	FASEB JOURNAL			English	Article						ubiquitin E3 ligase; calcium; apo CaM; holo CaM; proteasome	ENDOPLASMIC-RETICULUM; CALCIUM HOMEOSTASIS; FORCE-FIELD; WEB SERVER; GP78; LIGASE; MITOCHONDRIA; ASSOCIATION; MAHOGUNIN; CONTACTS	The mechanism by which the endoplasmic reticulum (ER) ubiquitin ligases sense stress to potentiate their activity is poorly understood. GP78, an ER E3 ligase, is best known for its role in ER-associated protein degradation, although its activity is also linked to mitophagy, ER-mitochondria junctions, and MAPK signaling, thus highlighting the importance of understanding its regulation. In healthy cells, Mahogunin really interesting new gene (RING) finger 1 (MGRN1) interacts with GP78 and proteasomally degrades it to alleviate mitophagy. Here, we identify calmodulin (CaM) as the adapter protein that senses fluctuating cytosolic Ca2+ levels and modulates the Ca2+-dependent MGRN1-GP78 interactions. When stress elevates cytosolic Ca2+ levels in cultured and primary neuronal cells, CaM binds to both E3 ligases and inhibits their interaction. Molecular docking, simulation, and biophysical studies show that CaM interacts with both proteins with different affinities and binding modes. The physiological impact of this interaction switch manifests in the regulation of ER-associated protein degradation, ER-mitochondria junctions, and relative distribution of smooth ER and rough ER.Mukherjee, R., Bhattacharya, A., Sau, A., Basu, S., Chakrabarti, S., Chakrabarti, O. Calmodulin regulates MGRN1-GP78 interaction mediated ubiquitin proteasomal degradation system.	[Mukherjee, Rukmini; Chakrabarti, Oishee] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, India; [Sau, Abhishek; Basu, Samita] Saha Inst Nucl Phys, Div Chem Sci, Kolkata, India; [Mukherjee, Rukmini] Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Bhattacharya, Anshu; Chakrabarti, Saikat] Indian Inst Chem Biol CSIB IICB, Council Sci & Ind Res, Struct Biol & Bioinformat Div, CN 6,Sect 5, Kolkata 700091, India; [Basu, Samita; Chakrabarti, Oishee] Homi Bhabha Natl Inst, Mumbai, India	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Homi Bhabha National Institute	Chakrabarti, S (corresponding author), Indian Inst Chem Biol CSIB IICB, Council Sci & Ind Res, Struct Biol & Bioinformat Div, CN 6,Sect 5, Kolkata 700091, India.; Chakrabarti, O (corresponding author), Saha Inst Nucl Phys, Sect 1,Block AF, Kolkata 700064, India.	saikat@iicb.res.in; oishee.chakrabarti@saha.ac.in	Mukherjee, Rukmini/GPX-7606-2022	Mukherjee, Rukmini/0000-0001-7955-6324; Bhattacharya, Anshu/0000-0002-7383-3594	Integrative Biology on Omics Platform Project, intramural funding of the Department of Atomic Energy, Government of India; Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India; Council of Scientific and Industrial Research (CSIR); CSIR, University Grants Commission [F2-32/1998, SA-1]	Integrative Biology on Omics Platform Project, intramural funding of the Department of Atomic Energy, Government of India; Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR, University Grants Commission	The authors thank I. R. Nabi, E. Snapp, and R. Koppito for the plasmids; R. S. Hegde [Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, United Kingdom] for the antibodies; and P. K. Chakraborty [TowaOptics (I) Pvt. Ltd., New Delhi, India] for help with the microscopy experiments. The authors also thank the members of the O.C. and S.C. laboratories for their help and support. The authors thank A. Chakrabarti (Saha Institute of Nuclear Physics), K. Chattopadhyay (Indian Institute of Chemical Biology), S. N. Bhattacharyya (Indian Institute of Chemical Biology), and R. S. Hegde (MRC Laboratory of Molecular Biology) for their valuable advice at different stages of the study. O.C. and R.M. are supported by the Integrative Biology on Omics Platform Project, intramural funding of the Department of Atomic Energy, Government of India. O.C. is partially funded by the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India. S.C. acknowledges the Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIB-IICB) for infrastructural support, A.B. acknowledges the Council of Scientific and Industrial Research (CSIR) for a Ph.D. fellowship; and A.S acknowledges financial support from CSIR, University Grants Commission (F2-32/1998; SA-1). The authors declare no conflicts of interest.	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Bagur R, 2017, MOL CELL, V66, P780, DOI 10.1016/j.molcel.2017.05.028; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P84, DOI DOI 10.1145/1188455.1188544; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Braganza A, 2017, J BIOL CHEM, V292, P2470, DOI 10.1074/jbc.M116.766824; Chakrabarti KS, 2017, STRUCTURE, V25, P794, DOI 10.1016/j.str.2017.03.016; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Chhangani D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01972; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cota CD, 2006, DEV DYNAM, V235, P3438, DOI 10.1002/dvdy.20992; Dagher R, 2009, BBA-MOL CELL RES, V1793, P1068, DOI 10.1016/j.bbamcr.2008.11.019; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Ekberg JA, 2014, BIOCHEM J, V457, P27, DOI 10.1042/BJ20131275; Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607; Goetz JG, 2007, J CELL SCI, V120, P3553, DOI 10.1242/jcs.03486; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Laub M, 1998, EUR J BIOCHEM, V255, P422, DOI 10.1046/j.1432-1327.1998.2550422.x; Li L, 2015, MOL BIOL CELL, V26, P3828, DOI 10.1091/mbc.E15-02-0120; Li X., 2017, ENVIRON SCI POLLUT R, V8, P1; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Lin Qi, 2010, Bulletin of Botanical Research, V30, P4; Liu F, 2017, P NATL ACAD SCI USA, V114, pE3927, DOI 10.1073/pnas.1615949114; Lopez-Crisosto C, 2015, BBA-MOL BASIS DIS, V1852, P2096, DOI 10.1016/j.bbadis.2015.07.011; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Mitra Kasturi, 2010, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0425s46; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mukherjee R, 2017, BBA-MOL CELL RES, V1864, P1227, DOI 10.1016/j.bbamcr.2017.03.001; Mukherjee R, 2016, J CELL SCI, V129, P757, DOI 10.1242/jcs.176537; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rieusset J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0416-1; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Shukla D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10910; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Srivastava D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.1; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang PTC, 2015, J CELL SCI, V128, P2759, DOI 10.1242/jcs.171132; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xue LC, 2016, BIOINFORMATICS, V32, P3676, DOI 10.1093/bioinformatics/btw514; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914	60	9	10	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1927	1945		10.1096/fj.201701413RRR	http://dx.doi.org/10.1096/fj.201701413RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30230921				2022-12-28	WOS:000457296600033
J	Ince, LM; Zhang, ZG; Beesley, S; Vonslow, RM; Saer, B; Matthews, LC; Begley, N; Gibbs, JE; Ray, DW; Loudon, ASI				Ince, Louise M.; Zhang, Zhenguang; Beesley, Stephen; Vonslow, Ryan M.; Saer, Ben R.; Matthews, Laura C.; Begley, Nicola; Gibbs, Julie E.; Ray, David W.; Loudon, Andrew S. I.			Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells	FASEB JOURNAL			English	Article						circadian rhythms; inflammation; endocrinology; Ccsp-GR-; -S; LysM-GR-; -Y	INNATE IMMUNITY; GM-CSF; RECEPTOR; LUNG; LIPOPOLYSACCHARIDE; GRANULOCYTES; TRAFFICKING; MACROPHAGES; MIGRATION; CLOCKS	The circadian clock is a critical regulator of immune function. We recently highlighted a role for the circadian clock in a mouse model of pulmonary inflammation. The epithelial clock protein Bmal1 was required to regulate neutrophil recruitment in response to inflammatory challenge. Bmal1 regulated glucocorticoid receptor (GR) recruitment to the neutrophil chemokine, CXC chemokine ligand 5 (CXCL5), providing a candidate mechanism. We now show that clock control of pulmonary neutrophilia persists without rhythmic glucocorticoid availability. Epithelial GR-null mice had elevated expression of proinflammatory chemokines in the lung under homeostatic conditions. However, deletion of GR in the bronchial epithelium blocked rhythmic CXCL5 production, identifying GR as required to confer circadian control to CXCL5. Surprisingly, rhythmic pulmonary neutrophilia persisted, despite nonrhythmic CXCL5 responses, indicating additional circadian control mechanisms. Deletion of GR in myeloid cells alone did not prevent circadian variation in pulmonary neutrophilia and showed reduced neutrophilic inflammation in response to dexamethasone treatment. These new data show GR is required to confer circadian control to some inflammatory chemokines, but that this alone is insufficient to prevent circadian control of neutrophilic inflammation in response to inhaled LPS, with additional control mechanisms arising in the myeloid cell lineage.Ince, L. M., Zhang, Z., Beesley, S., Vonslow, R. M., Saer, B. R., Matthews, L. C., Begley, N., Gibbs, J. E., Ray, D. W., Loudon, A. S. I. Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells.	[Ince, Louise M.; Zhang, Zhenguang; Beesley, Stephen; Vonslow, Ryan M.; Saer, Ben R.; Matthews, Laura C.; Begley, Nicola; Gibbs, Julie E.; Ray, David W.; Loudon, Andrew S. I.] Univ Manchester, Sch Med Sci, Div Diabet Endocrinol & Gastroenterol, AV Hill Bldg,Oxford Rd, Manchester, Lancs, England; [Ince, Louise M.] Ludwig Maximilian Univ Munchen, Walter Brendel Ctr Expt Med, Munich, Germany; [Beesley, Stephen] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Matthews, Laura C.] Univ Leeds, Leeds Inst Canc & Pathol, Fac Med & Hlth, Leeds, W Yorkshire, England	University of Manchester; University of Munich; State University System of Florida; Florida State University; University of Leeds	Ray, DW; Loudon, ASI (corresponding author), Univ Manchester, Sch Med Sci, Div Diabet Endocrinol & Gastroenterol, AV Hill Bldg,Oxford Rd, Manchester, Lancs, England.	david.w.ray@manchester.ac.uk; andrew.loudon@manchester.ac.uk	beesley, stephen j/B-4841-2017; Ince, Louise/K-6149-2019	beesley, stephen j/0000-0001-6010-124X; Ince, Louise/0000-0002-2093-0876; Ray, David/0000-0002-4739-6773; Loudon, Andrew/0000-0003-3648-445X; Gibbs, Julie/0000-0002-4248-2947	Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, United Kingdom); BBSRC [BB/K003097/1]; Wellcome Trust [107849/Z/15/Z]; MRC [MR/P023576/1, MR/K015885/1, MR/P011853/2, MR/M008908/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Prof. Hugh Piggins, Dr. Alun Hughes, and Dr. David Spiller for their assistance with the bioluminescence recordings of lung sections; Dr. David Bechtold for assistance with surgical techniques; Louise Hunter for technical assistance during in vivo experiments; Peter Walker for training in histologic techniques and use of equipment; Dr. Gareth Howell for flow cytometry/fluorescence-activated cell sorting services; Stacey Holden, Michal Smiga, and Dr. Andy Hayes in the Genomic Core; Dr. Yasutaka Mizoro and Dr. Robert Maidstone for statistical input; the staff of the In Vivo Unit for their contribution to this paper (all from the University of Manchester); and Prof. Karen Chapman (University of Edinburgh, Edinburgh, United Kingdom) for the GR plasmid used for in situ hybridization. L.M.I. and S.B. were supported by postgraduate training studentships from the Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, United Kingdom). A.S.I.L. acknowledges grant support from the BBSRC (Grant BB/K003097/1), and D.W.R. and A.S.I.L. are Wellcome Investigators, Wellcome Trust (107849/Z/15/Z). The authors declare no conflicts of interest.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Banuelos J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177884; Betsuyaku T, 2004, MICRON, V35, P229, DOI 10.1016/j.micron.2003.11.015; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Caratti G, 2015, CLIN ENDOCRINOL, V83, P441, DOI 10.1111/cen.12728; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Charmandari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025612; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; de Kloet ER, 2008, ENDOCRINOLOGY, V149, P3241, DOI 10.1210/en.2008-0471; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Gelati M, 2002, ARCH NEUROL-CHICAGO, V59, P774, DOI 10.1001/archneur.59.5.774; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kriebs A, 2017, P NATL ACAD SCI USA, V114, P8776, DOI 10.1073/pnas.1704955114; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Mitzner W, 2000, AM J PATHOL, V157, P93, DOI 10.1016/S0002-9440(10)64521-X; Mizgerd JP, 2002, SEMIN IMMUNOL, V14, P123, DOI 10.1006/smim.2001.0349; Mizobe K, 1997, J NEUROIMMUNOL, V73, P81, DOI 10.1016/S0165-5728(96)00169-5; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Okabe T, 2016, J CELL SCI, V129, P4143, DOI 10.1242/jcs.190959; Pariollaud M, 2018, J CLIN INVEST, V128, P2281, DOI 10.1172/JCI93910; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Prodanovic D, 2018, FASEB J, V32, P1692, DOI 10.1096/fj.201700730R; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Sujino M, 2012, ENDOCRINOLOGY, V153, P2277, DOI 10.1210/en.2011-1794; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Trebble PJ, 2013, J CELL SCI, V126, P3159, DOI 10.1242/jcs.124784; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	43	28	29	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					126	139		10.1096/fj.201800026RR	http://dx.doi.org/10.1096/fj.201800026RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29965797	Green Published, hybrid			2022-12-28	WOS:000457401500010
J	Dai, WW; Miller, WP; Toro, AL; Black, AJ; Dierschke, SK; Feehan, RP; Kimball, SR; Dennis, MD				Dai, Weiwei; Miller, William P.; Toro, Allyson L.; Black, Adam J.; Dierschke, Sadie K.; Feehan, Robert P.; Kimball, Scot R.; Dennis, Michael D.			Deletion of the stress-response protein REDD1 promotes ceramide-induced retinal cell death and JNK activation	FASEB JOURNAL			English	Article						high-fat diet; apoptosis; retinopathy; sphingolipids; type 2 diabetes	DIABETIC-RETINOPATHY; KINASE-B; INDUCED APOPTOSIS; SKELETAL-MUSCLE; REPRESSOR REDD1; INSULIN ACTION; MECHANISM; AKT; INHIBITION; EXPRESSION	The role of dyslipidemia in the development of retinal dysfunction remains poorly understood. Using an animal model of diet-induced obesity/pre-type 2 diabetes, we investigated molecular defects in the retina arising from consumption of a diet high in saturated fats and sugars (i.e., a Western diet). We found that feeding mice a Western diet increased the abundance of retinal sphingolipids, attenuated protein kinase B (Akt) phosphorylation, enhanced JNK activation, and increased retinal cell death. When we used palmitate or C6-ceramide (Cer) to assess sphingolipid-mediated signaling in cultured murine and human cells, we observed similar effects on Akt, JNK, and cell death. Furthermore, both Western diet and C6-Cer exposure enhanced expression of the stress-response protein regulated in development and DNA damage response 1 (REDD1) and loss of REDD1 increased C6-Cer-induced JNK activation and cell death. Exogenous REDD1 expression repressed JNK-mediated phosphorylation in cultured cells. We found that thioredoxin-interacting protein (TXNIP) expression was elevated in REDD1-deficient cell lines and C6-Cer promoted TXNIP expression in both wild-type and REDD1-deficient cells. Likewise, TXNIP knockdown attenuated JNK activation and caspase 3 cleavage after either C6-Cer exposure or REDD1 deletion. The results support a model wherein Cer-induced REDD1 expression attenuates TXNIP-dependent JNK activation and retinal cell death.Dai, W., Miller, W. P., Toro, A. L., Black, A. J., Dierschke, S. K., Feehan, R. P., Kimball, S. R., Dennis, M. D. Deletion of the stress-response protein REDD1 promotes ceramide-induced retinal cell death and JNK activation.	[Dai, Weiwei; Miller, William P.; Toro, Allyson L.; Black, Adam J.; Dierschke, Sadie K.; Feehan, Robert P.; Kimball, Scot R.; Dennis, Michael D.] Penn State Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Dennis, MD (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	mdennis@psu.edu		MILLER, WILLIAM PHILLIP/0000-0003-0157-6389; Dennis, Michael/0000-0002-0645-6864	American Diabetes Association Pathway [1-14-INI-04]; U.S. National Institutes of Health (NIH)/National Eye Institute [EY023612]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [DK13499, DK15658]; NIH/National Cancer Institute [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002016, UL1TR002014] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R00EY023612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658, R01DK013499] Funding Source: NIH RePORTER	American Diabetes Association Pathway(American Diabetes Association); U.S. National Institutes of Health (NIH)/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Leonard Jefferson (Department of Cellular and Molecular Physiology, Penn State College of Medicine) for critically evaluating the manuscript, Dr. Gail Seigel (Ross Eye Institute, State University of New York, Buffalo, NY, USA) for permission to use the R28 retinal cell line, Dr. Leif Ellisen (Department of Medicine, Harvard Medical School, Boston, MA, USA) for providing REDD1 WT and knockout MEFs, and the staff of the Flow Cytometry Core Facility (Penn State University College of Medicine, Hershey, PA, USA) for assistance. The research was supported by The American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04 and U.S. National Institutes of Health (NIH)/National Eye Institute Grant EY023612 (to M.D.D.) and NIH/National Institute of Diabetes and Digestive and Kidney Diseases Grants DK13499 and DK15658 (to S.R.K.). Services and products in support of the research project were generated by the Virginia Commonwealth University Massey Cancer Center (Richmond, VA, USA) Lipidomics Shared Resource, supported, in part, with funding from NIH/National Cancer Institute Grant P30 CA016059. The authors declare no conflicts of interest.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alvarez-Garcia O, 2016, OSTEOARTHR CARTILAGE, V24, P1639, DOI 10.1016/j.joca.2016.04.015; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Bourbon NA, 2002, J BIOL CHEM, V277, P3286, DOI 10.1074/jbc.M110541200; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Chang RCA, 2015, INVEST OPHTH VIS SCI, V56, P2367, DOI 10.1167/iovs.14-16143; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chen H, 2012, ADV EXP MED BIOL, V723, P553, DOI 10.1007/978-1-4614-0631-0_70; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Choi S., 2015, MEDIAT INFLAMM, V2015; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; Devi TS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.190; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Dungan CM, 2016, LIPIDS, V51, P905, DOI 10.1007/s11745-016-4168-3; Fox TE, 2006, DIABETES, V55, P3573, DOI 10.2337/db06-0539; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; Hammer SS, 2017, VISION RES, V139, P228, DOI 10.1016/j.visres.2017.04.010; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hsieh CT, 2014, CELL SIGNAL, V26, P1400, DOI 10.1016/j.cellsig.2014.03.004; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Iqbal J, 2017, TRENDS ENDOCRIN MET, V28, P506, DOI 10.1016/j.tem.2017.03.005; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Kady NM, 2018, DIABETES, V67, P769, DOI 10.2337/db17-1034; Kelleher AR, 2013, AM J PHYSIOL-ENDOC M, V304, pE229, DOI 10.1152/ajpendo.00409.2012; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcal AC, 2013, CELL BIOCHEM FUNCT, V31, P65, DOI 10.1002/cbf.2861; Mbata O, 2017, WORLD J DIABETES, V8, P317, DOI 10.4239/wjd.v8.i7.317; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Miller WP, 2018, DIABETES, V67, P110, DOI 10.2337/db17-0728; Miller WP, 2017, J BIOL CHEM, V292, P1591, DOI 10.1074/jbc.M116.760868; Modjtahedi BS, 2016, SEMIN OPHTHALMOL, V31, P10, DOI 10.3109/08820538.2015.1114869; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Rajagopal R, 2016, DIABETES, V65, P1072, DOI 10.2337/db15-1255; Reuschel EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136323; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schofield JD, 2016, DIABETES THER, V7, P203, DOI 10.1007/s13300-016-0167-x; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Singh LP, 2013, J CLIN EXP OPHTHALMO, V4; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Ueda N, 2015, INT J MOL SCI, V16, P5076, DOI 10.3390/ijms16035076; Williamson DL, 2014, J APPL PHYSIOL, V117, P246, DOI 10.1152/japplphysiol.01350.2013; Wong TY, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.12; Wright AD, 2011, EYE, V25, P842, DOI 10.1038/eye.2011.62	61	9	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6883	6897		10.1096/fj.201800413RR	http://dx.doi.org/10.1096/fj.201800413RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29920218	Green Published			2022-12-28	WOS:000449359700041
J	Liutkeviciute, Z; Gil-Mansilla, E; Eder, T; Casillas-Perez, B; Di Giglio, MG; Muratspahic, E; Grebien, F; Rattei, T; Muttenthaler, M; Cremer, S; Gruber, CW				Liutkeviciute, Zita; Gil-Mansilla, Esther; Eder, Thomas; Casillas-Perez, Barbara; Di Giglio, Maria Giulia; Muratspahic, Edin; Grebien, Florian; Rattei, Thomas; Muttenthaler, Markus; Cremer, Sylvia; Gruber, Christian W.			Oxytocin-like signaling in ants influences metabolic gene expression and locomotor activity	FASEB JOURNAL			English	Article						vasopressin; vasotocin; inotocin; insect; G protein-coupled receptor	DIURETIC HORMONE; READ ALIGNMENT; VASOPRESSIN; RECEPTOR; BEHAVIOR; PEPTIDE; LIGAND; IDENTIFICATION; MORPHOLOGY; EVOLUTION	Ants are emerging model systems to study cellular signaling because distinct castes possess different physiologic phenotypes within the same colony. Here we studied the functionality of inotocin signaling, an insect ortholog of mammalian oxytocin (OT), which was recently discovered in ants. In Lasius ants, we determined that specialization within the colony, seasonal factors, and physiologic conditions down-regulated the expression of the OT-like signaling system. Given this natural variation, we interrogated its function using RNAi knockdowns. Next-generation RNA sequencing of OT-like precursor knock-down ants highlighted its role in the regulation of genes involved in metabolism. Knock-down ants exhibited higher walking activity and increased self-grooming in the brood chamber. We propose that OT-like signaling in ants is important for regulating metabolic processes and locomotion.Liutkeviite, Z., Gil-Mansilla, E., Eder, T., Casillas-Perez, B., Di Giglio, M. G., Muratspahi, E., Grebien, F., Rattei, T., Muttenthaler, M., Cremer, S., Gruber, C. W. Oxytocin-like signaling in ants influences metabolic gene expression and locomotor activity.	[Liutkeviciute, Zita; Gil-Mansilla, Esther; Di Giglio, Maria Giulia; Muratspahic, Edin; Gruber, Christian W.] Med Univ Vienna, Ctr Physiol & Pharmacol, Schwarzspanierstr 17, A-1090 Vienna, Austria; [Eder, Thomas; Rattei, Thomas] Univ Vienna, Div Computat Syst Biol CUBE, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Muttenthaler, Markus] Univ Vienna, Fac Chem, Inst Biol Chem, Vienna, Austria; [Eder, Thomas; Grebien, Florian] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Casillas-Perez, Barbara; Cremer, Sylvia] IST Austria, Klosterneuburg, Austria; [Muttenthaler, Markus] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Medical University of Vienna; University of Vienna; University of Vienna; Ludwig Boltzmann Institute; Institute of Science & Technology - Austria; University of Queensland	Gruber, CW (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Schwarzspanierstr 17, A-1090 Vienna, Austria.	christian.w.gruber@meduniwien.ac.at	Muttenthaler, Markus/AAF-5944-2021; Rattei, Thomas/F-1366-2011; Grebien, Florian/H-9234-2019	Muttenthaler, Markus/0000-0003-1996-4646; Rattei, Thomas/0000-0002-0592-7791; Grebien, Florian/0000-0003-4289-2281; Cremer, Sylvia/0000-0002-2193-3868; Eder, Thomas/0000-0002-0932-2052; Muratspahic, Edin/0000-0002-6011-0805; Gruber, Christian/0000-0001-6060-7048	Vienna Science and Technology Fund (WWTF) [LS13-017]; Austrian Science Fund (FWF) [I3243-B21]; European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme [636855-ONCOMECHAML, 714366-GUTPEPTIDES]; Australian Research Council [FT140100730, DE150100784]	Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme(European Research Council (ERC)); Australian Research Council(Australian Research Council)	The authors thank Dusan Zitnan, (Slovak Academy of Sciences) Silvia Hernandez Esteban (National Institute of Health Carlos III, Madrid, Spain), Ameya Sanjay Kasture, Daniela D. Pollak, Markus Gold-Binder (Medical University of Vienna), and Christopher D. Pull, Matthias Konrad, Sina Metzler, Line V. Ugelvig, Matthias A. Furst, Eva Flechl, and Anna V. Grasse (Institute of Science and Technology Austria) for valuable discussions and technical assistance, and Filip Naiser and Jiri Matas [Center for Machine Perception (CMP) Prague] for granting use of the Ferda software to obtain trajectories. The authors are grateful for high throughput sequencing performed at the Vienna Biocenter Core Facilities (VBCF) Next Generation Sequencing (NGS) Unit (www.vbcf.ac.at). This work was funded by the Vienna Science and Technology Fund (WWTF) through Project LS13-017 (to C.W.G., S.C., and M.M.). This project has received funding the Austrian Science Fund (FWF; I3243-B21; to C.W.G.), and from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (636855-ONCOMECHAML to F.G., and 714366-GUTPEPTIDES to M.M.). C.W.G. (FT140100730) and M.M. (DE150100784) were supported by Australian Research Council Fellowships. The authors declare no conflicts of interest.	Afinogenova Y, 2016, J CLIN PSYCHIAT, V77, pE1483, DOI 10.4088/JCP.15m10217; Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews S., 2010, FASTQC QUALITY CONTR; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beets Isabel, 2013, Worm, V2, pe24246, DOI 10.4161/worm.24246; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmayr C, 2013, J BIOL CHEM, V288, P28831, DOI 10.1074/jbc.M113.464776; Blevins JE, 2016, AM J PHYSIOL-REG I, V310, pR640, DOI 10.1152/ajpregu.00220.2015; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Caldwell HK, 2017, NEUROSCIENTIST, V23, P517, DOI 10.1177/1073858417708284; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cherasse S, 2017, HORM BEHAV, V96, P116, DOI 10.1016/j.yhbeh.2017.09.009; COAST GM, 1993, J EXP BIOL, V175, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAVIS NT, 1992, J COMP NEUROL, V320, P381, DOI 10.1002/cne.903200309; Di Giglio MG, 2017, SCI REP-UK, V7, DOI 10.1038/srep41002; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Doroszuk A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-167; Douglas AJ, 2007, PHYSIOL BEHAV, V91, P352, DOI 10.1016/j.physbeh.2007.04.012; FRANKS NR, 1990, B MATH BIOL, V52, P597, DOI 10.1016/S0092-8240(05)80368-4; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Gospocic J, 2017, CELL, V170, P748, DOI 10.1016/j.cell.2017.07.014; Gruber CW, 2014, EXP PHYSIOL, V99, P55, DOI 10.1113/expphysiol.2013.072561; Gruber CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032559; Gruber CW, 2011, PLANTA MED, V77, P207, DOI 10.1055/s-0030-1250317; Gruber CW, 2010, CURR PHARM DESIGN, V16, P3071; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Klockars OA, 2017, NEUROSCIENCE, V366, P54, DOI 10.1016/j.neuroscience.2017.10.008; Koehbach J, 2013, P NATL ACAD SCI USA, V110, P21183, DOI 10.1073/pnas.1311183110; Koto A, 2015, BEHAV ECOL SOCIOBIOL, V69, P583, DOI 10.1007/s00265-014-1869-6; Leng G, 2017, TRENDS ENDOCRIN MET, V28, P365, DOI 10.1016/j.tem.2017.02.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liutkeviciute Z., 2016, MOL NEUROENDOCRINOLO, P5; Liutkeviciute Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep39177; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masunari K, 2013, REGUL PEPTIDES, V187, P1, DOI 10.1016/j.regpep.2013.10.004; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mildner S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169244; Niculita H, 2007, ARTHROPOD STRUCT DEV, V36, P135, DOI 10.1016/j.asd.2006.10.002; Olszewski P. K., 2016, Journal of Neuroendocrinology, V28, P12376; PROUX JP, 1988, NEUROPEPTIDES, V12, P7, DOI 10.1016/S0143-4179(98)90003-8; PROUX JP, 1987, BIOCHEM BIOPH RES CO, V149, P180, DOI 10.1016/0006-291X(87)91621-4; Pull CD, 2013, NATURWISSENSCHAFTEN, V100, P1125, DOI 10.1007/s00114-013-1115-5; Qiu HL, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex002; R Development Core Team, 2009, R LANG ENV STAT COMP; Ratzka C, 2013, INSECT SOC, V60, P475, DOI 10.1007/s00040-013-0314-6; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schilman PE, 2008, J COMP PHYSIOL B, V178, P157, DOI 10.1007/s00360-007-0207-y; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scott E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09350-7; Silberman RE, 2016, INSECT SOC, V63, P299, DOI 10.1007/s00040-016-0469-z; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Sokolowska E, 2015, CHRONOBIOL INT, V32, P917, DOI 10.3109/07420528.2015.1052142; Spetter MS, 2017, PHYSIOL BEHAV, V176, P31, DOI 10.1016/j.physbeh.2017.03.007; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tao J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43547; TYRER NM, 1993, J COMP NEUROL, V329, P385, DOI 10.1002/cne.903290309; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036	70	7	7	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6808	6821		10.1096/fj.201800443	http://dx.doi.org/10.1096/fj.201800443			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29939785	Green Accepted			2022-12-28	WOS:000449359700035
J	Moore, PJ; Reidel, B; Ghosh, A; Sesma, J; Kesimer, M; Tarran, R				Moore, Patrick J.; Reidel, Boris; Ghosh, Arunava; Sesma, Juliana; Kesimer, Mehmet; Tarran, Robert			Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration	FASEB JOURNAL			English	Article						BPIFA1; -unsaturated aldehydes; airway surface liquid; ENaC; COPD	SURFACE LIQUID VOLUME; CYSTIC-FIBROSIS; ALPHA,BETA-UNSATURATED ALDEHYDES; MUCOCILIARY CLEARANCE; LUNG; ENAC; HYDRATION; PROTEINS; ACROLEIN; RELEASE	Chronic obstructive pulmonary disease (COPD) is a growing cause of morbidity and mortality worldwide. Cigarette smoke (CS) exposure, a major cause of COPD, dysregulates airway epithelial ion transport and diminishes airway surface liquid (ASL) volume. Short palate lung and nasal epithelial clone 1 (SPLUNC1) is secreted into the airway lumen where it maintains airway hydration via interactions with the epithelial Na+ channel (ENaC). Although ASL hydration is dysregulated in CS-exposed/COPD airways, effects of CS on SPLUNC1 have not been elucidated. We hypothesized that CS alters SPLUNC1 activity, therefore contributing to ASL dehydration. CS exposure caused irreversible SPLUNC1 aggregation and prevented SPLUNC1 from internalizing ENaC and maintaining ASL hydration. Proteomic analysis revealed -unsaturated aldehyde modifications to SPLUNC1's cysteine residues. Removal of these cysteines prevented SPLUNC1 from regulating ENaC/ASL volume. In contrast, SPX-101, a peptide mimetic of natural SPLUNC1, that internalizes ENaC, but does not contain cysteines was unaffected by CS. SPX-101 increased ASL hydration and attenuated ENaC activity in airway cultures after CS exposure and prolonged survival in a chronic airway disease model. These findings suggest that the CS-induced defects in SPLUNC1 can be circumvented, thus making SPX-101 a novel candidate for the treatment of mucus dehydration in COPD. Moore, P. J., Reidel, B., Ghosh, A., Sesma, J., Kesimer, M., Tarran, R. Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration.	[Moore, Patrick J.; Reidel, Boris; Ghosh, Arunava; Kesimer, Mehmet; Tarran, Robert] Univ N Carolina, Marsico Lung Inst, 7102 Marsico Hall,125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Tarran, Robert] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Sesma, Juliana] Spyryx Biosci, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tarran, R (corresponding author), Univ N Carolina, Marsico Lung Inst, 7102 Marsico Hall,125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	robert_tarran@med.unc.edu	, Mehmet Kesimer/AHB-9223-2022; Reidel, Boris/AAG-2714-2020; , PEP-MX Core/AGV-4051-2022; Moore, Patrick/GVR-8294-2022; Ghosh, Arunava/I-5939-2019	Ghosh, Arunava/0000-0001-9550-1366	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30DK065988]; NIH National Heart, Lung, and Blood Institute [HL135642, HL103940]; Cystic Fibrosis Foundation [R026-CR11]; Spyryx Biosciences; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Spyryx Biosciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the University of North Carolina CF Center Tissue Core for providing cells, Rodney Gilmore (University of North Carolina, Chapel Hill) for generating constructs, Dr. Colin Bingle (University of Sheffield, Sheffield, United Kingdom) for providing the full length SPLUNC1 construct, Dr. Michael Miley and Richard Feng (University of North Carolina) for purifying SPLUNC1 and SPLUNC1 cysteine mutants, Prof. Deborah Baines (St. George's University, London, United Kingdom) for providing the alpha ENaC-GFP construct, Dr. Bruce Stanton (Dartmouth College, Hanover, NH, USA) for providing the CFTR-GFP construct, and Dr. Brian Kuhlmann (University of North Carolina) for assistance with circular dichroism. This study was funded by Spyryx Biosciences, U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant P30DK065988, NIH National Heart, Lung, and Blood Institute Grant HL135642 and HL103940, and Cystic Fibrosis Foundation Grant R026-CR11. R.T. is a founder of and has equity in Spyryx Bioscience. J.S. is an employee of and has equity in Spyryx Bioscience. The authors declare no conflicts of interest.	Anderson WH, 2015, AM J RESP CRIT CARE, V192, P182, DOI 10.1164/rccm.201412-2230OC; Astrand ABM, 2015, AM J PHYSIOL-LUNG C, V308, pL22, DOI 10.1152/ajplung.00163.2014; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; DANIELE RP, 1977, AM REV RESPIR DIS, V116, P997; Dekhuijzen PNR, 1996, AM J RESP CRIT CARE, V154, P813, DOI 10.1164/ajrccm.154.3.8810624; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Eklund BM, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-17; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Hirota N, 2013, CHEST, V144, P1026, DOI 10.1378/chest.12-3073; Hobbs CA, 2013, AM J PHYSIOL-LUNG C, V305, pL990, DOI 10.1152/ajplung.00103.2013; Hobbs CA, 2013, J PHYSIOL-LONDON, V591, P4377, DOI 10.1113/jphysiol.2012.240861; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Huang MF, 2005, INDOOR AIR, V15, P135, DOI 10.1111/j.1600-0668.2005.00330.x; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Tran I, 2015, AM J RESP CELL MOL, V53, P159, DOI 10.1165/rcmb.2014-0107OC; Ichihashi K, 2001, J BIOL CHEM, V276, P23903, DOI 10.1074/jbc.M101947200; Kenche H, 2016, J BIOL CHEM, V291, P4763, DOI 10.1074/jbc.M115.712331; Kesimer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138988; Kim CS, 2018, FASEB J, V32, P2478, DOI 10.1096/fj.201701126R; Kirkham PA, 2004, BIOCHEM BIOPH RES CO, V318, P32, DOI 10.1016/j.bbrc.2004.04.003; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Lambert C, 2007, J BIOL CHEM, V282, P19666, DOI 10.1074/jbc.M611527200; Larstad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144463; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matalon S, 2015, AM J PHYSIOL-LUNG C, V309, pL1229, DOI 10.1152/ajplung.00319.2015; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Raju SV, 2013, AM J RESP CRIT CARE, V188, P1321, DOI 10.1164/rccm.201304-0733OC; Randell SH, 2011, METHODS MOL BIOL, V742, P285, DOI 10.1007/978-1-61779-120-8_18; Rasmussen JE, 2014, J BIOL CHEM, V289, P7671, DOI 10.1074/jbc.M113.545137; Scott DW, 2017, AM J RESP CRIT CARE, V196, P734, DOI 10.1164/rccm.201612-2445OC; Seys LJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129897; SMALDONE GC, 1993, CHEST, V103, P1390, DOI 10.1378/chest.103.5.1390; Takamiya R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08588-5; Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tran TN, 2014, BIOCHEMISTRY-US, V53, P361, DOI 10.1021/bi401404u; Tyrrell J, 2015, AM J PHYSIOL-LUNG C, V308, pL1068, DOI 10.1152/ajplung.00395.2014; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V293, pL1156, DOI 10.1152/ajplung.00081.2007; Walton WG, 2016, BIOCHEMISTRY-US, V55, P2979, DOI 10.1021/acs.biochem.6b00271; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Witschi H, 2005, TOXICOL SCI, V84, P81, DOI 10.1093/toxsci/kfi043; Wong LH, 2017, BBA-MOL CELL RES, V1864, P1439, DOI 10.1016/j.bbamcr.2017.05.019; Woollhead AM, 2006, J BIOL CHEM, V281, P5158, DOI 10.1074/jbc.M509947200; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhou-Suckow Z, 2017, CELL TISSUE RES, V367, P537, DOI 10.1007/s00441-016-2562-z	55	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6559	6574		10.1096/fj.201800345R	http://dx.doi.org/10.1096/fj.201800345R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29890087	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000449359700017
J	Suh, MY; Kim, TW; Lee, HT; Shin, J; Kim, JH; Jang, H; Kim, HJ; Kim, ST; Cho, EJ; Youn, HD				Suh, Min Young; Kim, Tae Wan; Lee, Han-Teo; Shin, Jihoon; Kim, Jae-Hwan; Jang, Hyonchol; Kim, Hye Ji; Kim, Seong-Tae; Cho, Eun-Jung; Youn, Hong-Duk			Abundance of C-terminal binding protein isoform is a prerequisite for exit from pluripotency in mouse embryonic stem cells	FASEB JOURNAL			English	Article						Ctbp isoforms; ESC differentiation; protein quantity	CTBP FAMILY PROTEINS; COREPRESSOR CTBP; NUCLEAR-LOCALIZATION; NETWORK; CORE; TRANSCRIPTION; ACTIVATION; COMPLEX; GENES; DIFFERENTIATION	Unlike lower organisms, mammals have 2 C-terminal binding protein (Ctbp) isoforms, Ctbp1 and Ctbp2. Ctbp2 is revealed as a key factor involved in determining cell fate decisions by regulating the epigenetic state in active embryonic stem cell (ESC) genes. However, the molecular mechanism underlying how Ctbp1 and Ctbp2 have different roles remains elusive. Here we demonstrate that Ctbp isoform abundance is important for mouse embryonic ESCs (mESCs) to exit from pluripotency. Temporal expression patterns of Ctbp isoforms were quite different; Ctbp2 is more highly expressed in mESCs and decreases during differentiation, while Ctbp1 is constantly expressed at a lower level. Ctbp2 knockdown, but not Ctbp1 knockdown, in mESCs resulted in impaired exit from pluripotency. Interestingly, Ctbp1 and Ctbp2 overexpression in Ctbp2-knockdown mESCs leads to exiting from pluripotency in a manner similar to that of wild-type mESCs. Quantification of Ctbp1 and Ctbp2 revealed that differentiation ability correlates with abundance of Ctbp isoform in undifferentiated mESCs, suggesting that a sufficient amount of Ctbp isoform is a prerequisite for exiting from pluripotency. The results support the contention that 2 redundant Ctbp isoforms regulate elaborate differentiation via temporally distinctive regulatory patterns in mESCs.Suh, M. Y., Kim, T. W., Lee, H.-T., Shin, J., Kim, J.-H., Jang, H., Kim, H. J., Kim, S.-T., Cho, E.-J., Youn, H.-D. Abundance of C-terminal binding protein isoform is a prerequisite for exit from pluripotency in mouse embryonic stem cells.	[Suh, Min Young; Lee, Han-Teo; Youn, Hong-Duk] Seoul Natl Univ, Grad Sch Convergence Sci, Dept Mol Med & Biopharmaceut Sci, Coll Med, Seoul, South Korea; [Kim, Tae Wan; Shin, Jihoon; Kim, Jae-Hwan; Kim, Hye Ji; Youn, Hong-Duk] Seoul Natl Univ, Ischem Hypox Dis Inst, Dept Biomed Sci,Coll Med, Natl Creat Res Ctr Epigenome Reprogramming Networ, Seoul, South Korea; [Kim, Hye Ji] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Jang, Hyonchol] Natl Canc Ctr, Res Inst, Div Canc Biol, Goyang, South Korea; [Kim, Seong-Tae] Sungkyunkwan Univ, Dept Mol Cell Biol, Coll Med, Suwon, South Korea; [Cho, Eun-Jung] Sungkyunkwan Univ, Coll Pharm, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Youn, HD (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul 03080, South Korea.	hdyoun@snu.ac.kr	kim, hye ji/AAF-8671-2019; Cho, Eun-Jung/AAR-1785-2020; Kim, Tae Wan/GRK-0135-2022	Cho, Eun-Jung/0000-0002-6610-5329; Jang, Hyonchol/0000-0003-1436-457X; Lee, Han-Teo/0000-0003-1840-6749; Kim, Tae Wan/0000-0002-0831-6881	National Research Foundation of Korea - Korean government [2012R1A3A2048767]; Education and Research Encouragement Fund of Seoul National University Hospital	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); Education and Research Encouragement Fund of Seoul National University Hospital	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (2012R1A3A2048767 to H.-D.Y.), and by the Education and Research Encouragement Fund of Seoul National University Hospital. The authors declare no conflicts of interest.	Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chinnadurai G, 2003, BIOESSAYS, V25, P9, DOI 10.1002/bies.10212; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Galonska C, 2015, CELL STEM CELL, V17, P462, DOI 10.1016/j.stem.2015.07.005; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Hwang IY, 2016, CELL METAB, V24, P494, DOI 10.1016/j.cmet.2016.06.014; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; Kim TW, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.147; Kim TW, 2015, STEM CELLS, V33, P2442, DOI 10.1002/stem.2046; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Tarleton HP, 2010, MECH DEVELOP, V127, P107, DOI 10.1016/j.mod.2009.10.002; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Van Hateren N, 2006, DEV DYNAM, V235, P490, DOI 10.1002/dvdy.20612; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	39	2	2	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6423	6435		10.1096/fj.201700837RRRR	http://dx.doi.org/10.1096/fj.201700837RRRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29894668				2022-12-28	WOS:000449359700006
J	Khurshed, M; Aarnoudse, N; Hulsbos, R; Hira, VVV; van Laarhoven, HWM; Wilmink, JW; Molenaar, RJ; van Noorden, CJF				Khurshed, Mohammed; Aarnoudse, Niels; Hulsbos, Renske; Hira, Vashendriya V. V.; van Laarhoven, Hanneke W. M.; Wilmink, Johanna W.; Molenaar, Remco J.; van Noorden, Cornelis J. F.			IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity	FASEB JOURNAL			English	Article						isocitrate dehydrogenase; chemosensitivity; cis-diamminedichloroplatinum; 2-hydroxyglutarate	ISOCITRATE DEHYDROGENASE 1; OXIDATIVE STRESS; MITOCHONDRIAL-DNA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; INTRAHEPATIC CHOLANGIOCARCINOMAS; ENERGETIC METABOLISM; IDH1 MUTATIONS; GLIOMA-CELLS; GLIOBLASTOMA; APOPTOSIS	Isocitrate dehydrogenase (IDH1)-1 is mutated in various types of human cancer, and the presence of this mutation is associated with improved responses to irradiation and chemotherapy in solid tumor cells. Mutated IDH1 (IDH1(MUT)) enzymes consume NADPH to produce d-2-hydroxyglutarate (d-2HG) resulting in the decreased reducing power needed for detoxification of reactive oxygen species (ROS), for example. The objective of the current study was to investigate the mechanism behind the chemosensitivity of the widely used anticancer agent cisplatin in IDH1(MUT) cancer cells. Oxidative stress, DNA damage, and mitochondrial dysfunction caused by cisplatin treatment were monitored in IDH1(MUT) HCT116 colorectal cancer cells and U251 glioma cells. We found that exposure to cisplatin induced higher levels of ROS, DNA double-strand breaks (DSBs), and cell death in IDH1(MUT) cancer cells, as compared with IDH1 wild-type (IDH1(WT)) cells. Mechanistic investigations revealed that cisplatin treatment dose dependently reduced oxidative respiration in IDH1(MUT) cells, which was accompanied by disturbed mitochondrial proteostasis, indicative of impaired mitochondrial activity. These effects were abolished by the IDH1(MUT) inhibitor AGI-5198 and were restored by treatment with d-2HG. Thus, our study shows that altered oxidative stress responses and a vulnerable oxidative metabolism underlie the sensitivity of IDH1(MUT) cancer cells to cisplatin.Khurshed, M., Aarnoudse, N., Hulsbos, R., Hira, V. V. V., van Laarhoven, H. W. M., Wilmink, J. W., Molenaar, R. J., van Noorden, C. J. F. IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity.	[Khurshed, Mohammed; Aarnoudse, Niels; Hulsbos, Renske; Hira, Vashendriya V. V.; van Laarhoven, Hanneke W. M.; Wilmink, Johanna W.; Molenaar, Remco J.; van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Canc Ctr Amsterdam, Dept Med Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands; [Khurshed, Mohammed; van Laarhoven, Hanneke W. M.; Wilmink, Johanna W.; Molenaar, Remco J.] Univ Amsterdam, Acad Med Ctr, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands; [van Noorden, Cornelis J. F.] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; National Institute of Biology - Slovenia	van Noorden, CJF (corresponding author), Univ Amsterdam, Acad Med Ctr, Canc Ctr Amsterdam, Dept Med Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	c.j.vannoorden@amc.uva.nl	van Laarhoven, Hanneke/AAW-3464-2021	van Laarhoven, H.W.M./0000-0003-1274-5643	Dutch Cancer Society [KWF-UVA 2014-6839, AMC2016.1-10460]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by Dutch Cancer Society Grants KWF-UVA 2014-6839 (to M.K., V.V.V.H., R.J.M., and C.J.F.V.N.) and AMC2016.1-10460 (to M.K., R.J.M., J.W.W., and C.J.F.V.N.). The authors declare no conflicts of interest.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Buckner JC, 2016, NEW ENGL J MED, V374, P1344, DOI 10.1056/NEJMoa1500925; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; Chieco P, 2013, PROG HISTOCHEM CYTO, V47, P211, DOI 10.1016/j.proghi.2012.09.001; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dehne N, 2001, TOXICOL APPL PHARM, V174, P27, DOI 10.1006/taap.2001.9171; Juan ME, 2008, J AGR FOOD CHEM, V56, P4813, DOI 10.1021/jf800175a; Esmaeili M, 2014, CANCER RES, V74, P4898, DOI 10.1158/0008-5472.CAN-14-0008; Fernandez SL, 2007, BIOL PROCED ONLINE, V9, P84, DOI 10.1251/bpo136; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Garrido N, 2008, BIOCHEM J, V414, P93, DOI 10.1042/BJ20071615; Gilbert MR, 2014, ACTA NEUROPATHOL, V127, P221, DOI 10.1007/s00401-013-1194-6; Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409; Goyal L, 2015, ONCOLOGIST, V20, P1019, DOI 10.1634/theoncologist.2015-0210; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Inapurapu S, 2017, IRAN J BASIC MED SCI, V20, P83, DOI 10.22038/ijbms.2017.8099; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Khurshed M, 2017, ONCOTARGET, V8, P49165, DOI 10.18632/oncotarget.17106; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Mohrenz IV, 2013, APOPTOSIS, V18, P1416, DOI 10.1007/s10495-013-0877-8; Molenaar R. J., 2017, JOVE-J VIS EXP; Molenaar RJ, 2015, CANCER RES, V75, P4790, DOI 10.1158/0008-5472.CAN-14-3603; Molenaar RJ, 2014, BBA-REV CANCER, V1846, P326, DOI 10.1016/j.bbcan.2014.05.004; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navis AC, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-18; Ndagi U, 2017, DRUG DES DEV THER, V11, P599, DOI 10.2147/DDDT.S119488; Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Poklar N, 1996, P NATL ACAD SCI USA, V93, P7606, DOI 10.1073/pnas.93.15.7606; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; Sulkowski PL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2463; Tran AN, 2014, NEURO-ONCOLOGY, V16, P414, DOI 10.1093/neuonc/not198; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Wolf DA, 2014, CANCER CELL, V26, P788, DOI 10.1016/j.ccell.2014.10.001; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037	49	22	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6344	6352		10.1096/fj.201800547R	http://dx.doi.org/10.1096/fj.201800547R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29879375	hybrid, Green Published			2022-12-28	WOS:000447172000047
J	Ma, YX; Qiao, XY; Zeng, RJ; Cheng, R; Zhang, J; Luo, YY; Nie, Y; Hu, Y; Yang, ZL; Zhang, J; Liu, L; Xu, WM; Xu, CC; Xu, LZ				Ma, Yaxian; Qiao, Xiaoyong; Zeng, Rujun; Cheng, Ran; Zhang, Jun; Luo, Yunyao; Nie, Ying; Hu, Ying; Yang, Zhilan; Zhang, Jing; Liu, Lin; Xu, Wenming; Xu, Charles C.; Xu, Liangzhi			Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells	FASEB JOURNAL			English	Article						cytokines; osteoporosis; exercise; bone-muscle interactions; osteoclastogenesis	CIRCULATING IRISIN; OSTEOPOROTIC FRACTURES; BONE; EXPRESSION; MUSCLE; PLASMA; SERUM; ASSOCIATION; MYOKINE; WEIGHT	The receptor activator of NF-B ligand-induced osteoclast differentiation has a critical role in the process of bone metabolism. Overactivation of osteoclastogenesis may result in a series of diseases. Irisin, a novel myokine, which was first reported in 2012, has been proposed to mediate the beneficial metabolic effects of exercise. Studies have demonstrated that irisin targets osteoblasts by promoting osteoblast proliferation and differentiation; however, the underlying mechanism regarding the effect of irisin on osteoclasts remains elusive. Using 2 types of osteoclast precursor cells, RAW264.7 cells and mouse bone marrow monocytes, we showed that irisin promoted osteoclast precursor cell proliferation but inhibited osteoclast differentiation. Irisin down-regulated the expression of osteoclast differentiation marker genes, including receptor activators of NF-B, nuclear factor of activated T cells, cytoplasmic 1, cathepsin K, and tartrate-resistant acid phosphatase (TRAP), as well as decreasing the number of TRAP-positive multinucleated cells and hydroxyapatite resorption pits. Furthermore, we showed that irisin suppressed the NF-B signaling pathway, but activated the p38 and JNK signaling pathways. In the presence of an inhibitor of p38 and JNK, irisin-induced promotion of RAW264.7 cell proliferation was attenuated. However, irisin-induced inhibition of osteoclast differentiation was not affected by either the p38 or JNK signaling pathway. Our study suggested the direct effect of irisin on osteoclastogenesis and revealed the mechanism responsible for the therapeutic potential of irisin in bone metabolism disease.Ma, Y., Qiao, X., Zeng, R., Cheng, R., Zhang, J., Luo, Y., Nie, Y., Hu, Y., Yang, Z., Zhang, J., Liu, L., Xu, W., Xu, C. C., Xu, L. Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells.	[Ma, Yaxian; Qiao, Xiaoyong; Zeng, Rujun; Cheng, Ran; Zhang, Jun; Luo, Yunyao; Nie, Ying; Hu, Ying; Yang, Zhilan; Zhang, Jing; Liu, Lin; Xu, Liangzhi] Sichuan Univ, Dept Obstet & Gynecol, West China Univ Hosp 2, 20 Sect 3,Ren Min Nan Rd, Chengdu 610041, Sichuan, Peoples R China; [Ma, Yaxian; Qiao, Xiaoyong; Zeng, Rujun; Cheng, Ran; Zhang, Jun; Luo, Yunyao; Nie, Ying; Hu, Ying; Yang, Zhilan; Zhang, Jing; Liu, Lin; Xu, Wenming; Xu, Liangzhi] Sichuan Univ Chinese Univ Hong Kong, Joint Lab Reprod Med, Hong Kong, Hong Kong, Peoples R China; [Ma, Yaxian; Qiao, Xiaoyong; Zeng, Rujun; Cheng, Ran; Zhang, Jun; Luo, Yunyao; Nie, Ying; Hu, Ying; Yang, Zhilan; Zhang, Jing; Liu, Lin; Xu, Wenming; Xu, Liangzhi] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Sichuan, Peoples R China; [Xu, Charles C.] Ohio State Univ, Coll Engn, Columbus, OH 43210 USA	Sichuan University; Sichuan University; University System of Ohio; Ohio State University	Xu, LZ (corresponding author), Sichuan Univ, Dept Obstet & Gynecol, West China Univ Hosp 2, 20 Sect 3,Ren Min Nan Rd, Chengdu 610041, Sichuan, Peoples R China.	xuliangzhi_art@126.com		Xu, wenming/0000-0002-3686-229X	Scientific Research Projects of the National Natural Science Fund [81671421]; Scientific Research Projects of Health and Family Planning Commission of Sichuan Province [16ZD016]	Scientific Research Projects of the National Natural Science Fund; Scientific Research Projects of Health and Family Planning Commission of Sichuan Province	This project was supported by Scientific Research Projects of the National Natural Science Fund (Grant 81671421) and Scientific Research Projects of Health and Family Planning Commission of Sichuan Province (Grant 16ZD016). The authors declare no conflicts of interest.	Anastasilakis AD, 2014, OSTEOPOROSIS INT, V25, P1633, DOI 10.1007/s00198-014-2673-x; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Battaglino R, 2002, J BONE MINER RES, V17, P763, DOI 10.1359/jbmr.2002.17.5.763; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Brix S, 2003, J ALLERGY CLIN IMMUN, V112, P1216, DOI 10.1016/j.jaci.2003.08.047; Castrogiovanni P, 2016, HISTOL HISTOPATHOL, V31, P1183, DOI 10.14670/HH-11-793; Catli G, 2016, J DIABETES COMPLICAT, V30, P1560, DOI 10.1016/j.jdiacomp.2016.07.019; Colaianni G, 2016, CURR OSTEOPOROS REP, V14, P132, DOI 10.1007/s11914-016-0313-4; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Colaianni G, 2015, P NATL ACAD SCI USA, V112, pE5763, DOI 10.1073/pnas.1519137112; Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182, DOI 10.1290/0510075.1; Daskalopoulou SS, 2014, EUR J ENDOCRINOL, V171, P343, DOI 10.1530/EJE-14-0204; Ding HF, 2012, J MATER SCI-MATER M, V23, P1055, DOI 10.1007/s10856-012-4574-x; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Du XL, 2016, HORM METAB RES, V48, P644, DOI 10.1055/s-0042-108730; Engin-Ustun Yaprak, 2016, J Menopausal Med, V22, P76, DOI 10.6118/jmm.2016.22.2.76; Goodman CA, 2015, BONE, V80, P24, DOI 10.1016/j.bone.2015.04.014; HATTERSLEY G, 1989, ENDOCRINOLOGY, V124, P1689, DOI 10.1210/endo-124-4-1689; Hew-Butler T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12262; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kim HJ, 2015, EXP GERONTOL, V70, P11, DOI 10.1016/j.exger.2015.07.006; Li YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16124; Lin IC, 2010, FOOD CHEM TOXICOL, V48, P2642, DOI 10.1016/j.fct.2010.06.034; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Lombardi G, 2016, ENDOCRINE, V54, P284, DOI 10.1007/s12020-015-0834-0; Omori A, 2015, BIOMED REP, V3, P483, DOI 10.3892/br.2015.452; Palermo A, 2015, CLIN ENDOCRINOL, V82, P615, DOI 10.1111/cen.12672; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Qiao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18732; Shi XL, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0123-9; Shoukry A, 2016, IUBMB LIFE, V68, P544, DOI 10.1002/iub.1511; So WY, 2016, INT J BIOCHEM CELL B, V78, P237, DOI 10.1016/j.biocel.2016.07.022; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Viitasalo A, 2016, PEDIATR OBES, V11, P299, DOI 10.1111/ijpo.12062; Zhang J, 2017, BONE RES, V5, DOI 10.1038/boneres.2016.56; Zhang Y, 2016, AM J PHYSIOL-ENDOC M, V311, pE530, DOI 10.1152/ajpendo.00094.2016; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	41	29	30	6	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5813	5823		10.1096/fj.201700983RR	http://dx.doi.org/10.1096/fj.201700983RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29771602				2022-12-28	WOS:000447172000005
J	Shi, LY; Ma, Y; Zhu, GY; Liu, JW; Zhou, CX; Chen, LJ; Wang, Y; Li, RC; Yang, ZX; Zhang, D				Shi, Li-Ya; Ma, Yang; Zhu, Gang-Yi; Liu, Jin-Wei; Zhou, Chun-Xiang; Chen, Liang-Jian; Wang, Yang; Li, Rui-Chao; Yang, Zhi-Xia; Zhang, Dong			Placenta-specific 1 regulates oocyte meiosis and fertilization through furin	FASEB JOURNAL			English	Article						Plac1; IGF1R; microvillus; Akt	FACTOR-I RECEPTOR; GROWTH-FACTOR; PROPROTEIN CONVERTASES; PLAC1; INHIBITION; EXPRESSION; PATHWAY; GENES; CELLS; ACTIVATION	Placenta-specific 1 (Plac1) has been found to be essential for placentation, and abnormal Plac1 expression and distribution is highly correlated with preeclampsia and implantation failure; however, its function in mammalian oocytes has not been elucidated. Here, we report that Plac1 was more prominent in mouse oocytes and enriched at the membrane region throughout meiosis. On the one hand, Plac1 knockdown severely disrupted microvillus organization; however, on the other hand, Plac1 significantly decreased oocyte maturation and increased aneuploidy, consequently disrupting normal fertilization. On the basis of immunoprecipitate matrix-assisted laser desorption/ionization, we established a working model, then verified and suggested that, at the germinal vesicle stage, Plac1 enriches the membrane to activate furin, and active furin subsequently activates IGF-1 receptor to maintain regular microvillus organization. Upon meiosis onset, active furin/IGF-1 receptor relocates into the cytoplasm to activate (phosphorylate) Akt to promote meiosis. In summary, our finding suggests that Plac1, a protein that is crucial for placentation, is also essential for oocyte meiosis and fertilization.Shi, L.-Y., Ma, Y., Zhu, G.-Y., Liu, J.-W., Zhou, C.-X., Chen, L.-J., Wang, Y., Li, R.-C., Yang, Z.-X., Zhang, D. Placenta-specific 1 regulates oocyte meiosis and fertilization through furin.	[Shi, Li-Ya; Ma, Yang; Zhu, Gang-Yi; Chen, Liang-Jian; Wang, Yang; Yang, Zhi-Xia; Zhang, Dong] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Liu, Jin-Wei] Zhejiang Prov Peoples Hosp, Dept Gynecol, Hangzhou, Zhejiang, Peoples R China; [Zhou, Chun-Xiang] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Prenatal Diag Ctr Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Li, Rui-Chao] Liuzhou Workers Hosp, Liuzhou, Peoples R China	Nanjing Medical University; Zhejiang Provincial People's Hospital; Nanjing University	Zhang, D (corresponding author), Nanjing Med Univ, 101 Longmiandadao, Nanjing 211166, Jiangsu, Peoples R China.	dong.ray.zhang@njmu.edu.cn	shi, liya/HDM-6854-2022; Zhang, Dong/AAM-8146-2021		National Basic Research Program of China (973 Program) [2013CB945504]; General Program of the National Natural Science Foundation of China [31471406, 31671561]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Hui Li and Xin Xie (Nanjing Medical University) for help with electron microscopy. This work was supported by the National Basic Research Program of China (973 Program; Grant 2013CB945504) and the General Program of the National Natural Science Foundation of China (Grants 31471406 and 31671561). The authors declare no conflicts of interest.	Benammar A, 2017, REPROD SCI, V24, P1062, DOI 10.1177/1933719116678688; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Chang WL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.148932; Chang WL, 2016, REPROD BIOL, V16, P218, DOI 10.1016/j.repbio.2016.07.001; Chang WL, 2014, REPRODUCTION, V148, P343, DOI 10.1530/REP-14-0052; Chen Y, 2011, PLACENTA, V32, P877, DOI 10.1016/j.placenta.2011.08.011; Cocchia M, 2000, GENOMICS, V68, P305, DOI 10.1006/geno.2000.6302; DONATH MY, 1994, P NATL ACAD SCI USA, V91, P1686, DOI 10.1073/pnas.91.5.1686; Fant M, 2002, MOL REPROD DEV, V63, P430, DOI 10.1002/mrd.10200; Fant M, 2007, MOL REPROD DEV, V74, P922, DOI 10.1002/mrd.20673; Galaviz-Hernandez C, 2003, GENE, V309, P81, DOI 10.1016/S0378-1119(03)00508-0; Gusscott S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161158; Hiraoka D, 2016, J CELL SCI, V129, P3153, DOI 10.1242/jcs.182170; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; Jaaks P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161396; Jin Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150462; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kim TR, 2012, FEBS LETT, V586, P303, DOI 10.1016/j.febslet.2011.12.036; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Koslowski M, 2009, J BIOL CHEM, V284, P28607, DOI 10.1074/jbc.M109.031120; Li RC, 2016, PEERJ, V4, DOI 10.7717/peerj.1849; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Matteo M, 2013, PLACENTA, V34, P335, DOI 10.1016/j.placenta.2013.01.006; Meng TG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.231; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Paillisson A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-76; Purwosunu Y, 2007, PRENATAL DIAG, V27, P772, DOI 10.1002/pd.1780; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Stawowy P, 2004, BIOCHEM BIOPH RES CO, V321, P531, DOI 10.1016/j.bbrc.2004.07.001; Tchabo Nana E, 2009, Cancer Immun, V9, P6; Turpeinen H, 2013, CURR GENOMICS, V14, P453, DOI 10.2174/1389202911314050010; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; Wu Y, 2017, ONCOL REP, V37, P465, DOI 10.3892/or.2016.5272; Yoon SO, 2017, MOL CELL, V67, P512, DOI 10.1016/j.molcel.2017.06.033; Zhou Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.106; Zylkiewicz E, 2010, ZYGOTE, V18, P195, DOI 10.1017/S0967199409990189	40	11	11	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5483	5494		10.1096/fj.201700922RR	http://dx.doi.org/10.1096/fj.201700922RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29723063				2022-12-28	WOS:000447972500024
J	Americo-Da-Silva, L; Diaz, J; Bustamante, M; Mancilla, G; Oyarzun, I; Verdejo, HE; Quiroga, C				Americo-Da-Silva, Luan; Diaz, Jheimmy; Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara			A new role for HERPUD1 and ERAD activation in osteoblast differentiation and mineralization	FASEB JOURNAL			English	Article						osteoblastogenesis; bone; proteostasis; proteasome	ENDOPLASMIC-RETICULUM; ALKALINE-PHOSPHATASE; PROTEASOMAL DEGRADATION; STRESS; CELLS; HOMEOSTASIS; CULTURE	Bone integrity depends on a finely tuned balance between bone synthesis by osteoblasts and resorption by osteoclasts. The secretion capacity of mature osteoblasts requires strict control of proteostasis. Endoplasmic reticulum-associated degradation (ERAD) prevents the accumulation of unfolded ER proteins via dislocation to the cytosol and degradation by the proteasome. The ER membrane protein, homocysteine-inducible endoplasmic reticulum protein with ubiquitin-like domain 1 (HERPUD1), is a key component of the ERAD multiprotein complex which helps to stabilize the complex and facilitate the efficient degradation of unfolded proteins. HERPUD1 expression is strongly up-regulated by the unfolded protein response and cellular stress. The aim of the current study was to establish whether HERPUD1 and ERAD play roles in osteoblast differentiation and maturation. We evaluated preosteoblastic MC3T3-E1 cell and primary rat osteoblast differentiation by measuring calcium deposit levels, alkaline phosphatase activity, and runt-related transcription factor 2 and osterix expression. We found that ERAD and proteasomal degradation were activated and that HERPUD1 expression was increased as osteoblast differentiation progressed. The absence of HERPUD1 blocked osteoblast mineralization in vitro and significantly reduced alkaline phosphatase activity. In contrast, HERPUD1 overexpression activated the osteoblast differentiation program. Our results demonstrate that HERPUD1 and ERAD are important for the activation of the osteoblast maturation program and may be useful new targets for elucidating bone physiology.Americo-Da-Silva, L., Diaz, J., Bustamante, M., Mancilla, G., Oyarzun, I., Verdejo, H. E., Quiroga, C. A new role for HERPUD1 and ERAD activation in osteoblast differentiation and mineralization.	[Americo-Da-Silva, Luan; Diaz, Jheimmy; Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara] Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Marcoleta 391,Diagonal Paraguay 362, Santiago 8330077, Chile; [Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara] Univ Chile, Adv Ctr Chron Dis, Santiago, Chile; [Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara] Pontificia Univ Catolica Chile, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile	Quiroga, C (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Marcoleta 391,Diagonal Paraguay 362, Santiago 8330077, Chile.	clquiroga@uc.cl	Diaz, Jheimmy/AAF-6886-2019; Quiroga, Clara/AAB-4180-2020	Verdejo, Hugo/0000-0003-0078-4792	Comision Nacional de Investigacion Cientifica y Tecnologica (Santiago, Chile) Grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11140470, 3160287, 1150359, 11171024]; Fondo de Financiamiento de Centros de Investigacion en areas Prioritarias (FONDAP) [15130011]	Comision Nacional de Investigacion Cientifica y Tecnologica (Santiago, Chile) Grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT); Fondo de Financiamiento de Centros de Investigacion en areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	The authors acknowledge the Advanced Microscopy Facility, Unidad de Microscopia Avanzada-Facultad de Medicina (UMA-MED), Pontificia Universidad Catolica de Chile, and Confocal Microscopy Unit, Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, for equipment and technical support, and Roberto Bravo-Sagua, Ph.D. [Instituto de Nutricion y Tecnologia de los Alimentos (INTA), Universidad de Chile, Santiago, Chile], for illustrations of our results. This work was supported by the Comision Nacional de Investigacion Cientifica y Tecnologica (Santiago, Chile) Grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 11140470 (to C.Q.), 3160287 (to M.B.), 1150359 (to H.V.), 11171024 (to J.D.), and Fondo de Financiamiento de Centros de Investigacion en areas Prioritarias (FONDAP) 15130011 (to H.V. and C.Q.). L.A.-D.-S. and J.D. are cofirst authors. The authors declare no conflicts of interest.	Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Bergmann TJ, 2016, AIMS BIOPHYS, V3, P456, DOI 10.3934/biophy.2016.4.456; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Edwards MH, 2015, BONE, V80, P126, DOI 10.1016/j.bone.2015.04.016; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Haarhaus M, 2017, NAT REV NEPHROL, V13, P429, DOI 10.1038/nrneph.2017.60; Haarhaus M, 2013, J VASC RES, V50, P167, DOI 10.1159/000346161; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Han Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06304-x; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jonason JH, 2014, METHODS MOL BIOL, V1130, P295, DOI 10.1007/978-1-62703-989-5_22; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Liu JH, 2017, 2017 13TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P6, DOI 10.1109/CIS.2017.00010; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Mihci E, 2012, J CLIN RES PEDIATR E, V4, P101, DOI [10.4274/Jcrpe.619, 10.4274/jcrpe.619]; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murray EJB, 1998, EXP CELL RES, V242, P460, DOI 10.1006/excr.1998.4090; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Quiroga C, 2013, BBA-MOL CELL RES, V1833, P3295, DOI 10.1016/j.bbamcr.2013.09.006; Reifenstein EC, 2011, CLIN ORTHOP RELAT R, V469, P2096, DOI 10.1007/s11999-011-1832-z; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sun FR, 2018, ONCOL RES, V26, P655, DOI 10.3727/096504017X15119525209765; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wong M. Y., 2017, CURR TOP MICROBIOL I; Wong N, 2013, DIABETOLOGIA, V56, P1569, DOI 10.1007/s00125-013-2908-y; Yan XZ, 2014, TISSUE ENG PART C-ME, V20, P198, DOI 10.1089/ten.tec.2012.0412; Zuo C, 2012, OSTEOPOROSIS INT, V23, P1653, DOI 10.1007/s00198-012-1909-x	49	9	10	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4681	4695		10.1096/fj.201701229RR	http://dx.doi.org/10.1096/fj.201701229RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570393				2022-12-28	WOS:000443817700006
J	Sarangi, PP; Chakraborty, P; Dash, SP; Ikeuchi, T; de Vega, S; Ambatipudi, K; Wahl, L; Yamada, Y				Sarangi, Pranita P.; Chakraborty, Papiya; Dash, Shiba Prasad; Ikeuchi, Tomoko; de Vega, Susana; Ambatipudi, Kiran; Wahl, Larry; Yamada, Yoshihiko			Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo	FASEB JOURNAL			English	Article						extracellular matrix; immunomodulation; inflammation	EXTRACELLULAR-MATRIX PROTEINS; FIBRONECTIN; INTEGRIN; INFLAMMATION; TISSUE; OSTEOARTHRITIS; MOLECULES; INTERACTS; FAMILY; ALPHA	Fibulin-7 (Fbln7) has been identified as the latest member of the fibulin family of secreted glycoproteins in developing teeth, functioning as a cell adhesion molecule and interacting with other matrix proteins, receptors, and growth factors. More recently, we have shown that the C-terminal Fbln7 fragment (Fbln7-C) has antiangiogenic activity in vitro. Fbln7 is also expressed in immune-privileged tissues, such as eye and placenta, but its functional significance is unknown. In the current study, we show that human monocytes adhere to both full-length Fbln7 (Fbln7-FL) and Fbln7-C, in part, via integrins (51) and (21). Morphologic studies and surface expression analyses of CD14, mannose receptor (CD206), major histocompatibility complex II, and CD11b receptors revealed that both Fbln7-FL and Fbln7-C inhibit M-CSF-induced monocyte differentiation. Fbln7-C had significantly greater negative effects on cell spreading and stress fiber formation, including the production of IL-6 and metalloproteinase-1/-9 compared with Fbln7-FL. Furthermore, in an LPS-induced systemic inflammation model, Fbln7-C and Fbln7-FL reduced the infiltration of immune cells, such as neutrophils and macrophages, to the inflamed peritoneum. Thus, these results suggest that Fbln7 and Fbln7-C could modulate the activity of immune cells and have therapeutic potential for inflammatory diseases.Sarangi, P. P., Chakraborty, P., Dash, S. P., Ikeuchi, T., de Vega, S., Ambatipudi, K., Wahl, L., Yamada, Y. Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo.	[Sarangi, Pranita P.; Ikeuchi, Tomoko; de Vega, Susana; Yamada, Yoshihiko] Natl Inst Dent & Craniofacial Res, Mol Biol Sect, NIH, Bethesda, MD USA; [Ambatipudi, Kiran] Natl Inst Dent & Craniofacial Res, Secretory Mech & Dysfunct Sect, NIH, Bethesda, MD USA; [Wahl, Larry] Natl Inst Dent & Craniofacial Res, Immunopathol Sect, NIH, Bethesda, MD USA; [Sarangi, Pranita P.; Chakraborty, Papiya; Dash, Shiba Prasad; Ambatipudi, Kiran] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India; [de Vega, Susana] Juntendo Univ, Sch Med, Res Inst Dis Old Age, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Juntendo University	Sarangi, PP (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India.; Yamada, Y (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, 30 Convent Dr,Bldg 30,Room 430, Bethesda, MD 20892 USA.	psarafbt@iitr.ac.in; yoshi.yamada@nih.gov	Ikeuchi, Tomoko/AAE-6417-2019; de Vega, Susana/AAH-4775-2020		Intramural Research Program of National Institute of Dental and Craniofacial Research [DE000485-26]; Department of Science and Technology, Government of India [YSS/2015/000451]; Department of Biotechnology, Government of India [102/IFD/SAN/1671/2014-2015]; Japan Society of Promotion of Science for Young Investigator [714175]; University Grants Commission, Government of India [2061430670]; Ministry of Human Resource Development, Government of India [MHR 02-23-200-429]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000485] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17K08770] Funding Source: KAKEN	Intramural Research Program of National Institute of Dental and Craniofacial Research; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Japan Society of Promotion of Science for Young Investigator(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University Grants Commission, Government of India(University Grants Commission, India); Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. James Melvin, Dr. Marjan Gucek, and Dr. Steve Swatkoski [all of the U.S. National Institutes of Health (NIH)] for granting access to the NIH, National Heart, Lung, and Blood Institute Proteomics Core Facility. This work was supported by the Intramural Research Program of National Institute of Dental and Craniofacial Research (DE000485-26; to Y.Y.) and funds from the Department of Science and Technology, Government of India (YSS/2015/000451; to P.P.S.), the Department of Biotechnology, Government of India (102/IFD/SAN/1671/2014-2015; to P.P.S.), a Japan Society of Promotion of Science for Young Investigator (714175; to T.I. and S.d.V.), University Grants Commission, Government of India (Sr. No-2061430670; to S.P.D.), and the Ministry of Human Resource Development, Government of India (MHR 02-23-200-429; to P.C.). The authors declare no conflicts of interest.	Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Coito AJ, 2000, AM J PATHOL, V157, P1207, DOI 10.1016/S0002-9440(10)64636-6; DAVIS LS, 1990, J IMMUNOL, V145, P785; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; de Vega S, 2014, ARCH BIOCHEM BIOPHYS, V545, P148, DOI 10.1016/j.abb.2014.01.013; Gonzalez A, 2008, FEMS IMMUNOL MED MIC, V53, P114, DOI 10.1111/j.1574-695X.2008.00411.x; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Kitamura N, 2000, CLIN EXP IMMUNOL, V120, P66, DOI 10.1046/j.1365-2249.2000.01162.x; KLUFTINGER JL, 1989, INFECT IMMUN, V57, P817, DOI 10.1128/IAI.57.3.817-822.1989; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lisi S, 2009, SCAND J RHEUMATOL, V38, P198, DOI 10.1080/03009740802520722; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; REDLINE RW, 1990, J CLIN INVEST, V85, P1951, DOI 10.1172/JCI114658; RUEGG CR, 1989, P NATL ACAD SCI USA, V86, P7437, DOI 10.1073/pnas.86.19.7437; Sarangi PP, 2017, J IMMUNOL, V199, P2930, DOI 10.4049/jimmunol.1700541; Sarangi PP, 2012, SHOCK, V38, P281, DOI 10.1097/SHK.0b013e31826136f8; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Xiang Y, 2006, J IMMUNOL, V176, P3196, DOI 10.4049/jimmunol.176.5.3196; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362; Zhou M, 2003, J BIOL CHEM, V278, P45406, DOI 10.1074/jbc.M309075200	28	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4889	4898		10.1096/fj.201700686RRR	http://dx.doi.org/10.1096/fj.201700686RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29634368	Green Published			2022-12-28	WOS:000443817700023
J	Lee, DK; Kim, JH; Kim, J; Choi, S; Park, M; Park, W; Kim, S; Lee, KS; Kim, T; Jung, J; Choi, YK; Ha, KS; Won, MH; Billiar, TR; Kwon, YG; Kim, YM				Lee, Dong-Keon; Kim, Ji-Hee; Kim, Joohwan; Choi, Seunghwan; Park, MinSik; Park, Wonjin; Kim, Suji; Lee, Kyu-Sun; Kim, Taesam; Jung, Jiwon; Choi, Yoon Kyung; Ha, Kwon-Soo; Won, Moo-Ho; Billiar, Timothy R.; Kwon, Young-Guen; Kim, Young-Myeong			REDD-1 aggravates endotoxin-induced inflammation via atypical NF-B activation	FASEB JOURNAL			English	Article						LPS; I kappa B alpha; endotoxemia; organ failure; macrophages	KAPPA-B; TYROSINE PHOSPHORYLATION; BIPHASIC ACTIVATION; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; ALPHA; KINASE; DEGRADATION; MECHANISMS	Regulated in development and DNA damage responses 1 (REDD-1), an inhibitor of mammalian target of rapamycin (mTOR), is induced by various cell stressors, including LPS, a major player in the pathogenesis of endotoxemic shock. However, the pathologic role of REDD-1 in endotoxemia is largely unknown. We found that LPS increased REDD-1 expression, nuclear transcription factor-B (NF-B) activation, and inflammation and that these responses were suppressed by REDD-1 knockdown and in REDD-1(+/-) macrophages. REDD-1 overexpression stimulated NF-B-dependent inflammation without additional LPS stimulation. REDD-1-induced NF-B activation was independent of 2 classic IKK-dependent NF-B pathways and the mTOR signaling pathway; however, REDD-1, particularly its C-terminal region (178-229), interacted with and sequestered IB, to elicit atypical NF-B activation during the delayed and persistent phases of inflammation after stimulation. Moreover, REDD-1 knockdown mitigated vascular inflammation and permeability in endotoxemic mice, resulting in decreases in immune cell infiltration, systemic inflammation, caspase-3 activation, apoptosis, and consequent mortality. We further confirmed the inflammatory and cytotoxic effects of REDD-1 in endotoxemic REDD-1(+/-) mice. Our data support the likelihood that REDD-1 exacerbates endotoxemic inflammation via atypical NF-B activation by sequestering IB.Lee, D.-K., Kim, J.-H., Kim, J., Choi, S., Park, M., Park, W., Kim, S., Lee, K.-S., Kim, T., Jung, J., Choi, Y. K., Ha, K.-S., Won, M.-H., Billiar, T. R., Kwon, Y.-G., Kim, Y.-M. REDD-1 aggravates endotoxin-induced inflammation via atypical NF-kappa B activation.	[Lee, Dong-Keon; Kim, Ji-Hee; Kim, Joohwan; Choi, Seunghwan; Park, MinSik; Park, Wonjin; Kim, Suji; Lee, Kyu-Sun; Kim, Taesam; Jung, Jiwon; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Gangwondaehak Gil 1, Chunchon 24341, Gangwon Do, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon, South Korea; [Choi, Yoon Kyung] Konkuk Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea; [Billiar, Timothy R.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul, South Korea	Kangwon National University; Kangwon National University; Konkuk University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yonsei University	Kim, YM (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Gangwondaehak Gil 1, Chunchon 24341, Gangwon Do, South Korea.	kymkim@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020; Choi, Yoon Kyung/AGX-0481-2022	Choi, Yoon Kyung/0000-0003-0242-9612; Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation (NRF) of Korea - Korean Ministry of Science and Information and Communication Technology Planning [NRF-2017R1A2B3004565]	National Research Foundation (NRF) of Korea - Korean Ministry of Science and Information and Communication Technology Planning	This work was supported by National Research Foundation (NRF) of Korea Grant NRF-2017R1A2B3004565 to Y.-M. Kim funded by the Korean Ministry of Science and Information and Communication Technology Planning. The authors declare no conflicts of interest.	Amiot F, 1997, MOL MED, V3, P864, DOI 10.1007/BF03401722; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Canty TG, 1999, CIRCULATION, V100, P361; Ejima K, 2004, ANTIOXID REDOX SIGN, V6, P850, DOI 10.1089/ars.2004.6.850; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fielhaber JA, 2012, J IMMUNOL, V188, P4535, DOI 10.4049/jimmunol.1003655; Han SJ, 2002, J BIOL CHEM, V277, P44715, DOI 10.1074/jbc.M202524200; Hashizume T, 2011, FEMS IMMUNOL MED MIC, V62, P57, DOI 10.1111/j.1574-695X.2011.00786.x; Hehner SP, 1999, J IMMUNOL, V163, P5617; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kang JL, 2006, TOXICOL SCI, V90, P470, DOI 10.1093/toxsci/kfj096; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Kim JH, 2014, ANTIOXID REDOX SIGN, V21, P2469, DOI 10.1089/ars.2014.5856; Lee DK, 2015, FEBS LETT, V589, P2859, DOI 10.1016/j.febslet.2015.08.004; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Li XM, 2009, EXPERT OPIN INV DRUG, V18, P1047, DOI 10.1517/13543780903018880; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nadon AM, 2014, AM J PATHOL, V184, P2382, DOI 10.1016/j.ajpath.2014.06.002; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pastor F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07182-z; Ramachandiran S, 2015, INT J CANCER, V136, P2341, DOI 10.1002/ijc.29301; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weil R, 1999, MOL CELL BIOL, V19, P6345; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104	39	15	17	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4585	4599		10.1096/fj.201701436R	http://dx.doi.org/10.1096/fj.201701436R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29547704				2022-12-28	WOS:000439325400043
J	Manti, M; Fornes, R; Qi, XJ; Folmerz, E; Hirschberg, AL; Barbosa, TD; Maliqueo, M; Benrick, A; Stener-Victorin, E				Manti, Maria; Fornes, Romina; Qi, Xiaojuan; Folmerz, Elin; Hirschberg, Angelica Linden; Barbosa, Thais de Castro; Maliqueo, Manuel; Benrick, Anna; Stener-Victorin, Elisabet			Maternal androgen excess and obesity induce sexually dimorphic anxiety-like behavior in the offspring	FASEB JOURNAL			English	Article						dihydrotestosterone; high-fat-high-sucrose; amygdala; polycystic ovary syndrome	POLYCYSTIC-OVARY-SYNDROME; HIGH-FAT DIET; LONG-TERM HEALTH; PSYCHIATRIC-DISORDERS; REDUCES ANXIETY; ANTI-ANXIETY; TESTOSTERONE; STRESS; BRAIN; WOMEN	Maternal polycystic ovary syndrome (PCOS), a condition associated with hyperandrogenism, is suggested to increase anxiety-like behavior in the offspring. Because PCOS is closely linked to obesity, we investigated the impact of an adverse hormonal or metabolic maternal environment and offspring obesity on anxiety in the offspring. The obese PCOS phenotype was induced by chronic high-fat-high-sucrose (HFHS) consumption together with prenatal dihydrotestosterone exposure in mouse dams. Anxiety-like behavior was assessed in adult offspring with the elevated-plus maze and open-field tests. The influence of maternal androgens and maternal and offspring diet on genes implicated in anxiety were analyzed in the amygdala and hypothalamus with real-time PCR (n = 47). Independent of diet, female offspring exposed to maternal androgens were more anxious and displayed up-regulation of adrenoceptor 1B in the amygdala and up-regulation of hypothalamic corticotropin-releasing hormone (Crh). By contrast, male offspring exposed to a HFHS maternal diet had increased anxiety-like behavior and showed up-regulation of epigenetic markers in the amygdala and up-regulation of hypothalamic Crh. Overall, there were substantial sex differences in gene expression in the brain. These findings provide novel insight into how maternal androgens and obesity exert sex-specific effects on behavior and gene expression in the offspring of a PCOS mouse model.Manti, M., Fornes, R., Qi, X., Folmerz, E., Linden Hirschberg, A., de Castro Barbosa, T., Maliqueo, M., Benrick, A., Stener-Victorin, E. Maternal androgen excess and obesity induce sexually dimorphic anxiety-like behavior in the offspring.	[Manti, Maria; Fornes, Romina; Qi, Xiaojuan; Folmerz, Elin; Barbosa, Thais de Castro; Maliqueo, Manuel; Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, von Eulers Vag 8,3 TR, S-17177 Stockholm, Sweden; [Hirschberg, Angelica Linden] Karolinska Inst, Dept Obstet & Gynecol, Stockholm, Sweden; [Qi, Xiaojuan] Qiqihar Med Univ, Dept Physiol, Qiqihar, Peoples R China; [Maliqueo, Manuel] Univ Chile, Sch Med, West Div, Endocrinol & Metab Lab, Santiago, Chile; [Benrick, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Benrick, Anna] Univ Skovde, Sch Hlth & Educ, Skovde, Sweden	Karolinska Institutet; Karolinska Institutet; Qiqihar Medical University; Universidad de Chile; University of Gothenburg; University of Skovde	Stener-Victorin, E (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, von Eulers Vag 8,3 TR, S-17177 Stockholm, Sweden.	elisabet.stener-victorin@ki.se	Stener-Victorin, Elisabet/W-6322-2018; Hirschberg, Angelica/AAK-6693-2020	Stener-Victorin, Elisabet/0000-0002-3424-1502; Manti, Maria/0000-0003-4370-4780	Swedish Medical Research Council [2014-2775]; Jane and Dan Ohlsson Foundation; Adlerbert Research Foundation; Novo Nordisk Foundation [NNF16OC0020744, NNF17OC0026724]; Strategic Research Programme (SRP) in Diabetes at Karolinska Institutet; Swedish government under the LUA/ALF Agreement [ALFGBG-429501]; Stockholm County Council; Karolinska Institutet	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Jane and Dan Ohlsson Foundation; Adlerbert Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Strategic Research Programme (SRP) in Diabetes at Karolinska Institutet; Swedish government under the LUA/ALF Agreement; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was funded by the Swedish Medical Research Council (Project 2014-2775); the Jane and Dan Ohlsson Foundation; the Adlerbert Research Foundation; the Novo Nordisk Foundation (Grants NNF16OC0020744 and NNF17OC0026724); the Strategic Research Programme (SRP) in Diabetes at Karolinska Institutet; the Swedish government under the LUA/ALF Agreement ALFGBG-429501, and the Regional Agreement on Medical Training and Clinical Research (to A.L.H.) between Stockholm County Council and Karolinska Institutet (all to E.S.-V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Cecchi M, 2002, NEUROPHARMACOLOGY, V43, P1139, DOI 10.1016/S0028-3908(02)00292-7; Celec P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00012; Cesta CE, 2016, PSYCHONEUROENDOCRINO, V73, P196, DOI 10.1016/j.psyneuen.2016.08.005; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Class QA, 2014, BRIT J PSYCHIAT, V205, P355, DOI 10.1192/bjp.bp.113.143693; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Cooney LG, 2017, HUM REPROD, V32, P1075, DOI 10.1093/humrep/dex044; Costine BA, 2010, PSYCHONEUROENDOCRINO, V35, P1473, DOI 10.1016/j.psyneuen.2010.04.015; Dokras A, 2012, FERTIL STERIL, V97, P225, DOI 10.1016/j.fertnstert.2011.10.022; Edinger KL, 2005, PSYCHONEUROENDOCRINO, V30, P418, DOI 10.1016/j.psyneuen.2004.11.001; Fekete EM, 2009, NEUROSCIENCE, V162, P5, DOI 10.1016/j.neuroscience.2009.03.078; Frye CA, 2004, PHARMACOL BIOCHEM BE, V78, P473, DOI 10.1016/j.pbb.2004.04.019; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Handa Robert J, 2011, Front Endocrinol (Lausanne), V2, P65, DOI 10.3389/fendo.2011.00065; Hu M, 2015, P NATL ACAD SCI USA, V112, P14348, DOI 10.1073/pnas.1507514112; Jedel E, 2010, HUM REPROD, V25, P450, DOI 10.1093/humrep/dep384; Lambert EA, 2015, CLIN ENDOCRINOL, V83, P812, DOI 10.1111/cen.12803; Mansson M, 2008, PSYCHONEUROENDOCRINO, V33, P1132, DOI 10.1016/j.psyneuen.2008.06.003; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; McAbee MD, 1999, ENDOCRINOLOGY, V140, P3674, DOI 10.1210/en.140.8.3674; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mueller SC, 2008, PSYCHONEUROENDOCRINO, V33, P973, DOI 10.1016/j.psyneuen.2008.04.005; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; O'Leary OF, 2014, P NATL ACAD SCI USA, V111, P15232, DOI 10.1073/pnas.1404090111; O'Reilly JR, 2013, CLIN ENDOCRINOL, V78, P9, DOI 10.1111/cen.12055; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Ressler IB, 2015, AM J PHYSIOL-ENDOC M, V308, pE1076, DOI 10.1152/ajpendo.00182.2014; Sasaki A, 2014, NEUROSCIENCE, V272, P92, DOI 10.1016/j.neuroscience.2014.04.012; Sasaki A, 2013, NEUROSCIENCE, V240, P1, DOI 10.1016/j.neuroscience.2013.02.044; Sirmans SM, 2014, J INVEST MED, V62, P868, DOI 10.1097/01.JIM.0000446834.90599.5d; Soubry A, 2015, INT J OBESITY, V39, P650, DOI 10.1038/ijo.2013.193; Suarez-Jimenez B, 2013, PHARMACOL BIOCHEM BE, V104, P97, DOI 10.1016/j.pbb.2013.01.004; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Vassiliadi DA, 2009, J CLIN ENDOCR METAB, V94, P3558, DOI 10.1210/jc.2009-0837; Wu YC, 2017, HUM REPROD, V32, P937, DOI 10.1093/humrep/dex042; Zhang R, 2017, MOL PSYCHIATR, V22, P733, DOI 10.1038/mp.2016.136	44	23	24	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4158	4171		10.1096/fj.201701263RR	http://dx.doi.org/10.1096/fj.201701263RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29565738				2022-12-28	WOS:000439325400009
J	Liu, Y; Leslie, PL; Jin, AW; Itahana, K; Graves, LM; Zhang, YP				Liu, Yong; Leslie, Patrick L.; Jin, Aiwen; Itahana, Koji; Graves, Lee M.; Zhang, Yanping			p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression	FASEB JOURNAL			English	Article						lipid biosynthesis; obesity; glucosidase; fatty acids; endoplasmic reticulum	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIA-ASSOCIATED MEMBRANES; UNFOLDED PROTEIN RESPONSE; ALPHA-GLUCOSIDASE-I; OXIDATIVE-PHOSPHORYLATION; RNA-BINDING; NUTRITIONAL REGULATION; HEPATIC LIPOGENESIS; GENE-EXPRESSION; CELL-SURFACE	Sustained endoplasmic reticulum (ER) stress plays a major role in the development of many metabolic diseases, including cardiovascular disease, nonalcoholic fatty liver disease, insulin resistance, obesity, and diabetes. p32 is a multicompartmental protein involved in the regulation of oxidative phosphorylation and glucose oxidation. p32 ablation is associated with resistance to age-associated and diet-induced obesity through a mechanism that remains largely unknown. Here, we show that p32 promotes lipid biosynthesis by modulating fatty acid-induced ER stress. We found that p32 interacts with endoplasmic reticulum-anchored enzyme mannosyl-oligosaccharide glucosidase I (GCS1), an ER lumen-anchored glucosidase that is essential for the processing of N-linked glycoproteins, and reduces GCS1 in a lysosome-dependent manner. We demonstrate that increased GCS1 expression alleviates fatty acid-induced ER stress and is critical for suppressing ER stress-associated lipogenic gene activation, as demonstrated by the down-regulation of Srebp1, Fasn, and Acc. Consistently, suppression of p32 leads to increased GCS1 expression and alleviates fatty acid-induced ER stress, resulting in reduced lipid accumulation. Thus, p32 and GCS1 are regulators of ER function and lipid homeostasis and are potential therapeutic targets for the treatment of obesity and diabetes.Liu, Y., Leslie, P. L., Jin, A., Itahana, K., Graves, L. M., Zhang, Y. p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression.	[Liu, Yong; Leslie, Patrick L.; Jin, Aiwen; Itahana, Koji; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC USA; [Liu, Yong; Leslie, Patrick L.; Jin, Aiwen; Itahana, Koji; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Leslie, Patrick L.] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Graves, Lee M.; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Liu, Yong; Zhang, Yanping] Xuzhou Med Coll, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Jiangsu, Peoples R China; [Itahana, Koji] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xuzhou Medical University; National University of Singapore	Zhang, YP (corresponding author), Univ N Carolina, Campus Box 7295, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu	Graves, Lee/AAG-5470-2021		U.S. National Institutes of Health, National Cancer Institute [CA127770, CA100302, CA167637, CA155235]; National Natural Science Foundation of China [81672618]; University of North Carolina Genetics and Molecular Biology Training Grant [5T32 GM007092]; National Natural Science Foundation of China (NSFC); Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; Singapore Ministry of Education AcRF Tier 2 Fund [MOE2013-T2-1-123]; NATIONAL CANCER INSTITUTE [R01CA167637, R01CA127770, R01CA100302, R01CA155235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of North Carolina Genetics and Molecular Biology Training Grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; Singapore Ministry of Education AcRF Tier 2 Fund(Ministry of Education, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Derek Franklin (University of North Carolina, Chapel Hill) for helpful advice and technical assistance, Jenny P. Ting and Haitao Wen (University of North Carolina, Chapel Hill) for sharing reagents and for helpful discussions, and Pamela Stanley (Albert Einstein College of Medicine, Bronx, NY, USA) for the gift of WT and mutant GCS1 plasmid DNA. This research was supported by the U.S. National Institutes of Health, National Cancer Institute Grants CA127770, CA100302, CA167637, and CA155235 (to Y.Z.); by National Natural Science Foundation of China Grant 81672618 (to Y.L.); by University of North Carolina Genetics and Molecular Biology Training Grant 5T32 GM007092 (to P.L.L.); and by grants from the National Natural Science Foundation of China (NSFC) and Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy (to Y.Z.). K.I. received funding from the Singapore Ministry of Education AcRF Tier 2 Fund (Grant MOE2013-T2-1-123). Y.Z. is the guarantor of this work and, as such, had full access to all data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors declare no conflicts of interest.	Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; BAUSE E, 1989, EUR J BIOCHEM, V183, P661, DOI 10.1111/j.1432-1033.1989.tb21096.x; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hong Y, 2004, J BIOL CHEM, V279, P49894, DOI 10.1074/jbc.M410121200; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Katoh T, 2013, GLYCOBIOLOGY, V23, P1142, DOI 10.1093/glycob/cwt051; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, AM J TRANSL RES, V4, P102; Liu Y, 2015, CELL DEATH DIFFER, V22, P1035, DOI 10.1038/cdd.2014.194; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06209-9; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; NEVEROVA I, 1994, ANAL BIOCHEM, V222, P190, DOI 10.1006/abio.1994.1472; Ning J, 2011, ENDOCRINOLOGY, V152, P2247, DOI 10.1210/en.2010-1036; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; PEARCE J, 1983, P NUTR SOC, V42, P263, DOI 10.1079/PNS19830031; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sparks S.E., 1993, GENEREVIEWS R; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Theurey P, 2017, TRENDS ENDOCRIN MET, V28, P32, DOI 10.1016/j.tem.2016.09.002; van Leeuwen HC, 2001, J CELL SCI, V114, P2115; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wek RC, 2010, NAT MED, V16, P374, DOI 10.1038/nm0410-374; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	51	9	9	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3892	3902		10.1096/fj.201701004RR	http://dx.doi.org/10.1096/fj.201701004RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465311	Green Published			2022-12-28	WOS:000435104500034
J	Mohammed, SG; Arjona, FJ; Verschuren, EHJ; Bakey, Z; Alkema, W; van Hijum, S; Schmidts, M; Bindels, RJM; Hoenderop, JGJ				Mohammed, Sami G.; Arjona, Francisco J.; Verschuren, Eric H. J.; Bakey, Zeineb; Alkema, Wynand; van Hijum, Sacha; Schmidts, Miriam; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Primary cilia-regulated transcriptome in the renal collecting duct	FASEB JOURNAL			English	Article						RNA-seq; fluid flow; electrolyte transport; iron uptake	EPITHELIAL NA+ CHANNELS; LARGE GENE LISTS; IRON-METABOLISM; SHEAR-STRESS; DEPENDENT REGULATION; KIDNEY-DISEASE; FLUID SHEAR; TRANSPORT; CELLS; FLOW	Renal tubular cells respond to mechanical stimuli generated by urinary flow to regulate the activity and transcript abundance of important genes for ion handling, cellular homeostasis, and proper renal development. The primary cilium, a mechanosensory organelle, is postulated to regulate this mRNA response. The aim of this study is to reveal the transcriptome changes of tubular epithelia in response to fluid flow and determine the role of primary cilia in this process. Inner-medullary collecting duct (CD) cells were subjected to either static or physiologically relevant fluid flow (approximate to 0.6 dyn/cm(2)). RNA-sequencing analysis of ciliated cells subjected to fluid flow showed up-regulation of 1379 genes and down-regulation of 1294 genes compared with static control cells. Strikingly, only 54 of these genes were identified as gene candidates sensitive to primary cilia sensing of fluid flow, of which 16 were linked to ion or water transport pathways in the CD. Validation by quantitative real-time PCR revealed that only the expression of transferrin receptor, which is involved in iron transport; and tribbles pseudokinase 3, which is involved in insulin signaling, were unequivocally regulated by primary cilia sensing of fluid flow. This study shows that the involvement of primary cilia in ion transport in the collecting duct is exceptionally specific.Mohammed, S. G., Arjona, F. J., Verschuren, E. H. J., Bakey, Z., Alkema, W., van Hijum, S., Schmidts, M., Bindels, R. J. M., Hoenderop, J. G. J. Primary cilia-regulated transcriptome in the renal collecting duct.	[Mohammed, Sami G.; Arjona, Francisco J.; Verschuren, Eric H. J.; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med, Nijmegen, Netherlands; [Bakey, Zeineb; Schmidts, Miriam] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Alkema, Wynand; van Hijum, Sacha] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Med Ctr, Nijmegen, Netherlands; [Schmidts, Miriam] Univ Freiburg, Med Fac, Ctr Pediat & Adolescent Med, Univ Hosp Freiburg, Freiburg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Freiburg	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol 286, Geert Grootplein Zuid 28,POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Verschuren, Eric/AAG-9346-2020; Verschuren, Eric/G-4259-2016; Bindels, René JM/B-9824-2013; Verschuren, Eric H.J./AAX-6774-2020; Alkema, Wynand/G-5826-2018; Mohammed, Sami Gemal/F-3894-2016; van Hijum, Sacha/F-6445-2014; Schmidts, Miriam/A-3777-2012; Arjona, Francisco J/P-6059-2015; Hoenderop, Joost G.J./H-8047-2014	Verschuren, Eric/0000-0003-4046-4849; Bindels, René JM/0000-0003-1167-1339; Alkema, Wynand/0000-0002-5523-9217; Mohammed, Sami Gemal/0000-0002-0903-8131; Schmidts, Miriam/0000-0002-1714-6749; Arjona, Francisco J/0000-0002-2479-0735; Hoenderop, Joost G.J./0000-0002-1816-8544; van Hijum, Sacha/0000-0003-0741-2991	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research [NWO VICI 016.130.668]; Radboud University Medical Center; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Excellence Fellowship); Deutsche Forschungsgemeinschaft (German Research Foundation) [DFG CRC1140 KIDGEM]; European Research Council (ERC StG TREATCilia) [716344]; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Hypatia Tenure Track Grant)	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Radboud University Medical Center; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Excellence Fellowship); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); European Research Council (ERC StG TREATCilia); Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Hypatia Tenure Track Grant)	The authors thank the Microscope Imaging Centre (Nijmegen, The Netherlands) for providing the FV1000 confocal laser scanning microscope. The authors are grateful to the Department of Molecular Biology at Radboud University Medical Center for providing the next-generation sequencing facility. This work was supported by grants from the Radboud Institute for Molecular Life Sciences (to J.G.J.H.), and the Netherlands Organization for Scientific Research (NWO VICI 016.130.668 to J.G.J.H.). M.S. acknowledges funding from Radboud University Medical Center, the Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Excellence Fellowship and Hypatia Tenure Track Grant), the Deutsche Forschungsgemeinschaft (German Research Foundation; DFG CRC1140 KIDGEM), and the European Research Council (ERC StG TREATCilia; Grant 716344). The authors declare no conflicts of interest.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; ANDREWS PM, 1974, AM J ANAT, V140, P81, DOI 10.1002/aja.1001400107; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Artunc F, 2016, NAT REV NEPHROL, V12, P721, DOI 10.1038/nrneph.2016.145; Baek JH, 2015, J CLIN INVEST, V125, P3198, DOI 10.1172/JCI81166; Baquero AF, 2011, AM J PHYSIOL-CELL PH, V300, pC860, DOI 10.1152/ajpcell.00318.2010; Bindels RJM, 2010, J AM SOC NEPHROL, V21, P1263, DOI 10.1681/ASN.2010010001; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Carrisoza-Gaytan R, 2016, AM J PHYSIOL-CELL PH, V310, pC243, DOI 10.1152/ajpcell.00328.2015; Carrisoza-Gaytan R, 2014, AM J PHYSIOL-RENAL, V307, pF195, DOI 10.1152/ajprenal.00634.2013; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Corcoran CC, 2017, AM J PHYSIOL-RENAL, V312, pF533, DOI 10.1152/ajprenal.00601.2016; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eaton AF, 2014, AM J PHYSIOL-LUNG C, V307, pL374, DOI 10.1152/ajplung.00040.2014; FITZGIBBONS JP, 1974, J CLIN INVEST, V54, P1428, DOI 10.1172/JCI107890; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Flores D, 2011, NEPHRON PHYSIOL, V117, P27, DOI 10.1159/000321640; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gillard A, 2006, AM J NEPHROL, V26, P34, DOI 10.1159/000091784; Hamada H, 2015, SEMIN CELL DEV BIOL, V47-48, P88, DOI 10.1016/j.semcdb.2015.10.011; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hoogewijs D, 2016, HYPOXIA, V4, P91, DOI 10.2147/HP.S97681; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingraham SE, 2010, PEDIATR RES, V68, P500, DOI 10.1203/PDR.0b013e3181f82f15; Kopan R, 2014, PEDIATR NEPHROL, V29, P651, DOI 10.1007/s00467-013-2661-y; Kunnen SJ, 2017, CELL MOL LIFE SCI, V74, P2283, DOI 10.1007/s00018-017-2460-x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Martines AMF, 2013, NAT REV NEPHROL, V9, P385, DOI 10.1038/nrneph.2013.98; Meneton P, 2004, AM J PHYSIOL-RENAL, V287, pF593, DOI 10.1152/ajprenal.00454.2003; MIGNON M, 1988, Revue du Praticien, V38, P203; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; Mohammed SG, 2017, FASEB J, V31, P1796, DOI 10.1096/fj.201600687RRR; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Morla L, 2013, J BIOL CHEM, V288, P10124, DOI 10.1074/jbc.M112.446393; Orhon I, 2016, NAT CELL BIOL, V18, P657, DOI 10.1038/ncb3360; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Piedagnel R, 2006, J CELL PHYSIOL, V206, P394, DOI 10.1002/jcp.20485; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Sakai Y, 2014, BIOL PHARM BULL, V37, P1068, DOI 10.1248/bpb.b14-00260; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; SIROTA JH, 1950, J CLIN INVEST, V29, P187, DOI 10.1172/JCI102245; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Su Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep39701; Tiwari S, 2007, AM J PHYSIOL-RENAL, V293, pF178, DOI 10.1152/ajprenal.00447.2006; Tourneur E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003152; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; Veeramuthumari P, 2013, INT J CLIN MED, V2013, P200, DOI [10.4236/ijcm.2013.44035, DOI 10.4236/IJCM.2013.44035]; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Wong YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045725; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Zhang DL, 2007, J AM SOC NEPHROL, V18, P401, DOI 10.1681/ASN.2006080908	68	9	9	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3653	3668		10.1096/fj.201701228R	http://dx.doi.org/10.1096/fj.201701228R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452568				2022-12-28	WOS:000435104500014
J	Tan, SW; Lu, Y; Xu, MY; Huang, XL; Liu, HL; Jiang, J; Wu, B				Tan, Siwei; Lu, Yu; Xu, Minyi; Huang, Xiaoli; Liu, Huiling; Jiang, Jie; Wu, Bin			beta-Arrestin1 enhances liver fibrosis through autophagy-mediated Snail signaling	FASEB JOURNAL			English	Article						hepatocytes; proliferation; hepatic stellate cells; activation; GSK-3 beta	HEPATIC STELLATE CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; BETA-ARRESTINS; HEPATOCYTES; GROWTH; SYNTHASE; FIBROGENESIS; EXPRESSION; PROLIFERATION; TRANSCRIPTION	GPCR mediator beta-arrestins (beta-arr1 and beta-arr2) regulate a variety of physiologic and pathologic processes, including hepatocellular carcinogenesis. However, the role of beta-arrestins in liver fibrosis remains unknown. beta-arr1, but not beta-arr2, was upregulated in liver fibrotic tissues in both humans and mice; moreover, autophagy was increased. beta-arr1 deficiency or autophagic inhibitor 3-methyladenine (3-MA) significantly blocked autophagy and downregulated liver fibrosis. Furthermore, -arr1 enhanced hepatocyte compensatory proliferation, and hepatic stellate cell growth with activation via autophagy resulted in liver fibrosis. In the fibrosis, -arr1 promoted nuclear translocation of Snail by downregulation of glycogen synthase kinase-3, and the nuclear translocation of Snail was abrogated either by -arr1 deficiency or by 3-MA. These results suggest that -arr1 promotes liver fibrosis via autophagy-mediated Snail signaling, and -arr1 may be a therapeutic target for liver fibrosis.Tan, S., Lu, Y., Xu, M., Huang, X., Liu, H., Jiang, J., Wu, B. beta-Arrestin1 enhances liver fibrosis through autophagy-mediated Snail signaling.	[Tan, Siwei; Lu, Yu; Xu, Minyi; Huang, Xiaoli; Liu, Huiling; Jiang, Jie; Wu, Bin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastroenterol, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China; [Tan, Siwei; Lu, Yu; Wu, Bin] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wu, B (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastroenterol, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.	wubin6@mail.sysu.edu.cn			National Natural Science Foundation of China [U1501224, 81700536]; Five-Five Project of The Third Affiliated Hospital of Sun Yat-Sen University [K00002]; Basic Research Programme of Young Teachers' Training Project of Sun Yat-Sen University [17ykpy51]; Science and Technology Planning Projects of Guangzhou City [201604020118, 201604020002]; Major Projects Incubator Programme of the National Key Basic Research Programme of China [2012CB526700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Five-Five Project of The Third Affiliated Hospital of Sun Yat-Sen University; Basic Research Programme of Young Teachers' Training Project of Sun Yat-Sen University; Science and Technology Planning Projects of Guangzhou City; Major Projects Incubator Programme of the National Key Basic Research Programme of China	The authors thank Prof. Robert J. Lefkowitz (Duke University, Durham, NC, USA) for providing the beta-arr1-WT and beta-arr1-KO mice and Prof. G. Pei (Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) for providing beta-arr1 plasmids. This work was partly supported by grants from the National Natural Science Foundation of China (U1501224 and 81700536), Five-Five Project of The Third Affiliated Hospital of Sun Yat-Sen University (K00002), Basic Research Programme of Young Teachers' Training Project of Sun Yat-Sen University (17ykpy51), Science and Technology Planning Projects of Guangzhou City (201604020118 and 201604020002), and Major Projects Incubator Programme of the National Key Basic Research Programme of China (2012CB526700).	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bi WR, 2012, HEPATO-GASTROENTEROL, V59, P1960, DOI 10.5754/hge11750; Calo N, 2016, GUT, V65, P1871, DOI 10.1136/gutjnl-2015-310822; Chen J, 2013, HEPATOLOGY, V57, P2287, DOI 10.1002/hep.26278; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; Cozzolino AM, 2013, J HEPATOL, V58, P65, DOI 10.1016/j.jhep.2012.08.023; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Deng X, 2008, J CELL PHYSIOL, V217, P138, DOI 10.1002/jcp.21481; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; El Magraoui F, 2015, CELLS-BASEL, V4, P596, DOI 10.3390/cells4040596; Forooghian F, 2007, J CLIN IMMUNOL, V27, P388, DOI 10.1007/s10875-007-9091-1; Gu YJ, 2015, ACTA PHARMACOL SIN, V36, P1277, DOI 10.1038/aps.2015.74; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Hu ZD, 2011, J CLIN IMMUNOL, V31, P346, DOI 10.1007/s10875-010-9492-4; Ibrahim SH, 2011, J HEPATOL, V54, P765, DOI 10.1016/j.jhep.2010.09.039; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Jiao JJ, 2016, J HEPATOL, V65, P344, DOI 10.1016/j.jhep.2016.04.020; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Kojima T, 2008, LIVER INT, V28, P534, DOI 10.1111/j.1478-3231.2007.01631.x; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Lovgren AK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001564; Martens S, 2016, J CELL BIOL, V215, P761, DOI 10.1083/jcb.201611116; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakaya M, 2012, J BIOL CHEM, V287, P35669, DOI 10.1074/jbc.M112.357871; Papeleu Peggy, 2006, Methods Mol Biol, V320, P229; Park JH, 2015, BIOCHIMIE, V113, P26, DOI 10.1016/j.biochi.2015.03.015; Qian H, 2015, CELL RES, V25, P930, DOI 10.1038/cr.2015.84; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Sato T, 2015, HEPATOL INT, V9, P330, DOI 10.1007/s12072-015-9620-6; Scarpa M, 2011, AM J PHYSIOL-GASTR L, V300, pG316, DOI 10.1152/ajpgi.00141.2010; Shaffer L, 2016, NAT MED, V22, P334, DOI 10.1038/nm0416-334; Sharma D, 2015, GENES IMMUN, V16, P576, DOI 10.1038/gene.2015.47; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Song Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436242; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Sun WY, 2013, J CELL BIOCHEM, V114, P1153, DOI 10.1002/jcb.24458; Sweeney P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10188; Tan SW, 2015, FREE RADICAL BIO MED, V87, P69, DOI 10.1016/j.freeradbiomed.2015.06.004; Tang Y, 2016, NAT CELL BIOL, V18, P917, DOI 10.1038/ncb3394; Wang P, 2014, AUTOPHAGY, V10, P1535, DOI 10.4161/auto.29203; Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806; Xu HY, 2018, J MOL MED, V96, P97, DOI 10.1007/s00109-017-1606-5; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	50	24	24	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2000	2016		10.1096/fj.201800828RR	http://dx.doi.org/10.1096/fj.201800828RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30216111				2022-12-28	WOS:000457296600038
J	Yang, X; Xu, WT; Huang, KL; Zhang, BY; Wang, HM; Zhang, XQ; Gong, LJ; Luo, YB; He, XY				Yang, Xuan; Xu, Wentao; Huang, Kunlun; Zhang, Boyang; Wang, Haomiao; Zhang, Xueqin; Gong, Lijing; Luo, Yunbo; He, Xiaoyun			Precision toxicology shows that troxerutin alleviates ochratoxin A-induced renal lipotoxicity	FASEB JOURNAL			English	Article						lipidomics; brown adipose activity; chronic kidney disease; energy metabolism; RNA-seq	FATTY-ACID OXIDATION; CHRONIC KIDNEY-DISEASE; LIPID-METABOLISM; CELL-DEATH; GENE-EXPRESSION; DNA-DAMAGE; RNA-SEQ; PROTEIN; CERAMIDE; STRESS	Lipotoxicity is the most common cause of severe kidney disease, with few treatment options available today. Precision toxicology can improve detection of subtle intracellular changes in response to exogenous substrates; thus, it facilitates in-depth research on bioactive molecules that may interfere with the onset of certain diseases. In the current study, troxerutin significantly relieved nephrotoxicity, increased endurance, and improved systemic energy metabolism and renal inflammation in OTA-induced nephrotic mice. Lipidomics showed that troxerutin effectively reduced the levels of triglycerides, phosphatidylcholines, and phosphatidylethanolamines in nephropathy. The mechanism was partly attributable to troxerutin in alleviating the aberrantly up-regulated expression of sphingomyelinase, the cystic fibrosis transmembrane conductance regulator, and chloride channel 2. Renal tubular epithelial cells, the main site of toxin-induced accumulation of lipids in the kidney, were subjected to transcriptomic profiling, which uncovered several metabolic factors relevant to aberrant lipid and lipoprotein metabolism. Our work provides new insights into the molecular features of toxin-induced lipotoxicity in renal tubular epithelial cells in vivo and demonstrates the function of troxerutin in alleviating OTA-induced nephrosis and associated systemic energy metabolism disorders.Yang, X., Xu, W., Huang, K., Zhang, B., Wang, H., Zhang, X., Gong, L., Luo, Y., He, X. Precision toxicology shows that troxerutin alleviates ochratoxin A-induced renal lipotoxicity.	[Yang, Xuan; Xu, Wentao; Huang, Kunlun; Zhang, Boyang; Wang, Haomiao; Zhang, Xueqin; Luo, Yunbo; He, Xiaoyun] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, 17 Qinghua Donglu, Beijing 100083, Peoples R China; [Xu, Wentao; Huang, Kunlun] Beijing Lab Food Qual & Safety, Beijing, Peoples R China; [Gong, Lijing] Beijing Sport Univ, China Acad Sport & Hlth Sci, Beijing, Peoples R China; [Luo, Yunbo; He, Xiaoyun] Minist Agr, Key Lab Safety Assessment Genetically Modified Or, Beijing, Peoples R China	China Agricultural University; Beijing Sport University; Ministry of Agriculture & Rural Affairs	He, XY (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, 17 Qinghua Donglu, Beijing 100083, Peoples R China.	hexiaoyun@cau.edu.cn	Zhang, Boyang/AAG-4852-2020	Zhang, Boyang/0000-0003-2210-3572; Kunlun, Huang/0000-0002-2350-5859	Genetically Modified Organisms Breeding Major Projects of China [2016ZX08011-005]	Genetically Modified Organisms Breeding Major Projects of China	The authors thank Kai Gao and Xudong Shi (Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences) for their assistance with PET-CT, and Shanghai ProfLeader Biotechnology Co., Ltd. for assistance with lipidomics. This work was supported by Genetically Modified Organisms Breeding Major Projects of China Grant 2016ZX08011-005. The authors declare no conflicts of interest.	Ahmad A, 2017, FASEB J, V31, P771, DOI 10.1096/fj.201600618R; Argaud L, 2004, AM J PHYSIOL-HEART C, V286, pH246, DOI 10.1152/ajpheart.00638.2003; Banga A, 2011, FASEB J, V25; BENNETT MJ, 1993, CLIN CHEM, V39, P897; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bol EK, 2016, FOOD CHEM TOXICOL, V89, P85, DOI 10.1016/j.fct.2016.01.013; Cantaluppi V, 2008, J AM SOC NEPHROL, V19, P1904, DOI 10.1681/ASN.2007111209; Carraro-Lacroix LR, 2010, CELL PHYSIOL BIOCHEM, V26, P563, DOI 10.1159/000322324; Chen W, 2017, FEBS J, V284, P1070, DOI [10.1111/febs.14038, 10.1111/febs.]; Cheung WW, 2014, J AM SOC NEPHROL, V25, P119, DOI 10.1681/ASN.2013040432; Chondronikola M, 2016, CELL METAB, V23, P1200, DOI 10.1016/j.cmet.2016.04.029; Chu EPF, 2017, MOL IMMUNOL, V82, P19, DOI 10.1016/j.molimm.2016.12.007; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; COHENFORTERRE L, 1984, BIOCHIM BIOPHYS ACTA, V801, P138, DOI 10.1016/0304-4165(84)90222-8; Cuppoletti J, 2015, FASEB J, V29; Cuppoletti J, 2014, AM J PHYSIOL-CELL PH, V307, pC479, DOI 10.1152/ajpcell.00077.2014; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Dionisi-Vici C, 2016, J INHERIT METAB DIS, V39, P689, DOI 10.1007/s10545-016-9956-7; Domijan AM, 2007, MOL NUTR FOOD RES, V51, P1147, DOI 10.1002/mnfr.200700079; Drewa G, 1998, NEOPLASMA, V45, P266; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eguchi Y, 2011, J GASTROENTEROL, V46, P70, DOI 10.1007/s00535-010-0340-3; Eknoyan Garabed, 2007, Curr Diab Rep, V7, P449, DOI 10.1007/s11892-007-0076-5; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Falkevall A, 2017, CELL METAB, V25, P713, DOI 10.1016/j.cmet.2017.01.004; Fan SH, 2009, INT IMMUNOPHARMACOL, V9, P91, DOI 10.1016/j.intimp.2008.10.008; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Fidaleo M, 2008, EXP TOXICOL PATHOL, V59, P391, DOI 10.1016/j.etp.2007.11.011; Freedman BI, 2013, AM J KIDNEY DIS, V62, P1165, DOI 10.1053/j.ajkd.2013.05.024; Geetha R, 2015, MOL CELL BIOCHEM, V407, P263, DOI 10.1007/s11010-015-2474-3; Gennari A, 2004, J BIOCHEM MOL TOXIC, V18, P43, DOI 10.1002/jbt.20006; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Gin H, 2000, DIABETES METAB, V26, P45; Gobe GC, 2003, SEMIN NEPHROL, V23, P416, DOI 10.1016/S0270-9295(03)00085-8; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Heuer JG, 2017, AM J PHYSIOL-RENAL, V312, pF951, DOI 10.1152/ajprenal.00443.2016; Heussner AH, 2007, TOXICOL IN VITRO, V21, P72, DOI 10.1016/j.tiv.2006.08.007; Hibi D, 2013, TOXICOLOGY, V304, P92, DOI 10.1016/j.tox.2012.12.005; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Jennings-Gee JE, 2010, TOXINS, V2, P1428, DOI 10.3390/toxins2061428; Jiang Y, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00270; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirk Rebecca, 2013, Nat Rev Nephrol, V9, P627, DOI 10.1038/nrneph.2013.194; Kumar A, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0003-8; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kuroda K, 2015, TOXICOL SCI, V144, P65, DOI 10.1093/toxsci/kfu267; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; LEAF A, 1973, CIRCULATION, V48, P455, DOI 10.1161/01.CIR.48.3.455; Lee SJ, 2017, BIOCHEM BIOPH RES CO, V493, P34, DOI 10.1016/j.bbrc.2017.09.082; Lee ZH, 2000, MOL BRAIN RES, V75, P237, DOI 10.1016/S0169-328X(99)00304-6; LeonS FE, 1996, LANCET, V348, P1039, DOI 10.1016/S0140-6736(05)64974-4; Lepenies J, 2011, NEPHRON CLIN PRACT, V119, pC97, DOI 10.1159/000324765; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Li SY, 2012, AM J PHYSIOL-RENAL, V303, pF437, DOI 10.1152/ajprenal.00111.2012; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Lu J, 2013, J IMMUNOL, V190, P3466, DOI 10.4049/jimmunol.1202862; Lunyera J, 2016, CLIN J AM SOC NEPHRO, V11, P379, DOI 10.2215/CJN.07500715; Macdonald JH, 2012, AM J KIDNEY DIS, V60, P930, DOI 10.1053/j.ajkd.2012.06.021; Marumo T, 2015, J AM SOC NEPHROL, V26, P2388, DOI 10.1681/ASN.2014070665; Mas S, 2017, NEFROLOGIA, V37, P229, DOI [10.1016/j.nefro.2017.01.011, 10.1016/j.nefroe.2017.06.004]; Mattu S, 2016, J HEPATOL, V64, P891, DOI 10.1016/j.jhep.2015.11.029; Mezzani A, 2003, AM HEART J, V145, P1102, DOI 10.1016/S0002-8703(03)00100-5; Mitchell NJ, 2017, FOOD CHEM TOXICOL, V100, P265, DOI 10.1016/j.fct.2016.12.037; Mohammedi K, 2016, METABOLISM, V65, P12, DOI 10.1016/j.metabol.2015.10.004; Nangaku M, 2013, AM J PHYSIOL-RENAL, V305, pF977, DOI 10.1152/ajprenal.00385.2013; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Panat NA, 2016, FOOD CHEM, V194, P32, DOI 10.1016/j.foodchem.2015.07.078; Perazella MA, 2010, AM J KIDNEY DIS, V55, P399, DOI 10.1053/j.ajkd.2009.10.046; Persu A, 2000, J AM SOC NEPHROL, V11, P2285, DOI 10.1681/ASN.V11122285; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Ramirez-Camacho I, 2016, BBA-MOL BASIS DIS, V1862, P1955, DOI 10.1016/j.bbadis.2016.07.021; Raucci FJ, 2010, CARDIOVASC RES, V86, P55, DOI 10.1093/cvr/cvp399; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; ROUSER G, 1969, LIPIDS, V4, P599, DOI 10.1007/BF02531047; Sauvant C, 2003, Mycotoxin Res, V19, P118, DOI 10.1007/BF02942949; Sauvant C, 2005, CELL PHYSIOL BIOCHEM, V15, P125, DOI 10.1159/000083660; Sauvant C, 2005, MOL NUTR FOOD RES, V49, P31, DOI 10.1002/mnfr.200400020; Schmelzer C, 2010, MOL NUTR FOOD RES, V54, P805, DOI 10.1002/mnfr.200900155; Shapiro H, 2011, NAT REV NEPHROL, V7, P110, DOI 10.1038/nrneph.2010.156; Shukla SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04469-z; Siddarth M, 2014, CHEMOSPHERE, V96, P174, DOI 10.1016/j.chemosphere.2013.10.029; Souza-Menezes J, 2009, Biophys Rev, V1, P3, DOI 10.1007/s12551-008-0002-3; Stachurska A, 2013, MOL NUTR FOOD RES, V57, P504, DOI 10.1002/mnfr.201200456; Szeto HH, 2016, KIDNEY INT, V90, P997, DOI 10.1016/j.kint.2016.06.013; Thomas NS, 2017, EUR J NUTR, V56, P2353, DOI 10.1007/s00394-016-1275-0; Tolonen N, 2009, DIABETOLOGIA, V52, P2522, DOI 10.1007/s00125-009-1541-2; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; Vergara L, 2002, J AM SOC NEPHROL, V13, p546A; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wanigasuriya KP, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-32; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; WHITTAM R, 1964, NATURE, V203, P720, DOI 10.1038/203720a0; Wu HJ, 2017, KIDNEY INT, V92, P1334, DOI 10.1016/j.kint.2017.06.033; Yang XA, 2017, TOXICOLOGY, V382, P75, DOI 10.1016/j.tox.2017.03.009; Zhang BY, 2017, ARCH TOXICOL, V91, P2539, DOI 10.1007/s00204-017-1971-4; Zhang BY, 2014, J PROTEOMICS, V101, P154, DOI 10.1016/j.jprot.2014.02.017; Zhang HY, 2009, NEPHROLOGY, V14, P302, DOI 10.1111/j.1440-1797.2008.01072.x; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zhang ZF, 2014, BIOCHEM PHARMACOL, V91, P74, DOI 10.1016/j.bcp.2014.07.002; Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357; Zhou MX, 2015, EXP THER MED, V10, P1265, DOI 10.3892/etm.2015.2711; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	111	19	19	3	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2212	2227		10.1096/fj.201800742R	http://dx.doi.org/10.1096/fj.201800742R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30247986				2022-12-28	WOS:000457296600055
J	El Motiam, A; Vidal, S; de la Cruz-Herrera, CF; Da Silva-Alvarez, S; Baz-Martinez, M; Seoane, R; Vidal, A; Rodriguez, MS; Xirodimas, DP; Carvalho, AS; Beck, HC; Matthiesen, R; Collado, M; Rivas, C				El Motiam, Ahmed; Vidal, Santiago; de la Cruz-Herrera, Carlos F.; Da Silva-Alvarez, Sabela; Baz-Martinez, Maite; Seoane, Rocio; Vidal, Anxo; Rodriguez, Manuel S.; Xirodimas, Dimitris P.; Carvalho, Ana Sofia; Beck, Hans Christian; Matthiesen, Rune; Collado, Manuel; Rivas, Carmen			Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function	FASEB JOURNAL			English	Article						SUMO; NEDD8; p53; ARF	RIBOSOMAL-PROTEIN L11; SUMO-1 MODIFICATION; ONCOPROTEIN MDM2; P53; PROMOTES; UBIQUITINATION; ACCUMULATION; DEGRADATION; CONJUGATION; INHIBITION	The ribosomal protein L11 (RPL11) integrates different types of stress into a p53-mediated response. Here, we analyzed the impact of the ubiquitin-like protein SUMO on the RPL11-mouse double-minute 2 homolog-p53 signaling. We show that small ubiquitin-related modifier (SUMO)1 and SUMO2 covalently modify RPL11. We find that SUMO negatively modulates the conjugation of the ubiquitin-like protein neural precursor cell-expressed developmentally downregulated 8 (NEDD8) to RPL11 and promotes the translocation of the RP outside of the nucleoli. Moreover, the SUMO-conjugating enzyme, Ubc9, is required for RPL11-mediated activation of p53. SUMOylation of RPL11 is triggered by ribosomal stress, as well as by alternate reading frame protein upregulation. Collectively, our data identify SUMO protein conjugation to RPL11 as a new regulator of the p53-mediated cellular response to different types of stress and reveal a previously unknown SUMO-NEDD8 interplay.El Motiam, A., Vidal, S., de la Cruz-Herrera, C. F., Da Silva-alvarez, S., Baz-Martinez, M., Seoane, R., Vidal, A., Rodriguez, M. S., Xirodimas, D. P., Carvalho, A. S., Beck, H. C., Matthiesen, R., Collado, M., Rivas, C. Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function.	[El Motiam, Ahmed; Vidal, Santiago; Baz-Martinez, Maite; Seoane, Rocio; Vidal, Anxo; Rivas, Carmen] Univ Santiago de Compostela, Ctr Invest Med Mol & Enfermedades Cron CIMUS, Santiago De Compostela, Spain; [El Motiam, Ahmed; Vidal, Santiago; Baz-Martinez, Maite; Seoane, Rocio; Vidal, Anxo; Rivas, Carmen] Inst Invest Sanitarias, Santiago De Compostela, Spain; [de la Cruz-Herrera, Carlos F.; Rivas, Carmen] CNB, CSIC, Dept Biol Mol & Celular, Madrid, Spain; [de la Cruz-Herrera, Carlos F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Da Silva-Alvarez, Sabela; Collado, Manuel] Complexo Hosp Univ Santiago De Compostela, Inst Invest Sanitaria Santiago Compostela, Serv Gallego Salud, Santiago De Compostela, Spain; [Rodriguez, Manuel S.] CNRS, USR 3505, Adv Technol Inst Life Sci ITAV, Toulouse, France; [Rodriguez, Manuel S.] Univ Toulouse III Paul Sabatier, Inst Pharmacol & Biol Struct, Toulouse, France; [Xirodimas, Dimitris P.] Univ Montpellier, CNRS, UMR 5237, Montpellier Cell Biol Res Ctr CRBM, Montpellier, France; [Carvalho, Ana Sofia; Matthiesen, Rune] Univ Nova Lisboa, Univ Nova Lisboa NOVA, Med Sch Fac, Fac Ciencias Med,Ctr Estudos Doencas Cron CEDOC, Lisbon, Portugal; [Beck, Hans Christian] Odense Univ Hosp, Ctr Clin Prote, Odense, Denmark	Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Toronto; Complexo Hospitalario Universitario de Santiago de Compostela; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universidade Nova de Lisboa; University of Southern Denmark; Odense University Hospital	Rivas, C (corresponding author), Univ Santiago de Compostela, CIMUS, Avda Barcelona, Santiago De Compostela 15706, Spain.	crivas@cnb.csic.es	Vidal, Santiago/AAA-5646-2019; Rivas, Carmen/AAB-6278-2019; Rivas, Carmen/L-3162-2017; Beck, Hans Christian/AAK-9147-2021; Seoane, Rocio/AAA-8330-2019; Collado, Manuel/K-8140-2014; Matthiesen, Rune/AAF-2167-2020; Baz-Martínez, Maite/L-4626-2017; elmotiam, ahmed/AAB-6287-2019; Vidal, Anxo/B-5010-2015	Vidal, Santiago/0000-0002-0105-4583; Rivas, Carmen/0000-0002-0518-7199; Rivas, Carmen/0000-0002-0518-7199; Seoane, Rocio/0000-0002-7536-8702; Collado, Manuel/0000-0002-0330-0880; Matthiesen, Rune/0000-0002-6353-2616; Baz-Martínez, Maite/0000-0001-9160-7833; elmotiam, ahmed/0000-0003-2855-1368; Vidal, Anxo/0000-0002-0866-4202; Carvalho, Ana Sofia/0000-0003-0657-1907; de la Cruz-Herrera, Carlos/0000-0002-7493-5154; Da Silva Alvarez, Sabela/0000-0003-2702-8524; Xirodimas, Dimitris/0000-0001-9275-1140; Beck, Hans Christian/0000-0002-7763-3637	Ministry of Ecomony and Competitiveness; Fondos Europeos de Desarrollo Regional (FEDER) [BFU-2014-58530]; Xunta de Galicia; Institut National du Cancer (INCa) [PLBIO16-251]	Ministry of Ecomony and Competitiveness; Fondos Europeos de Desarrollo Regional (FEDER)(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	The authors thank Dr. Yue Xong for depositing the RPL11 plasmid at Addgene. Funding at the laboratory of C.R. is provided by the Ministry of Ecomony and Competitiveness, Fondos Europeos de Desarrollo Regional (FEDER) (BFU-2014-58530), and Xunta de Galicia. A.E.M. is a fellow of the Spanish Formacion de Personal Investigador (FPI) Program. S.V. is a fellow of the "Iniciacion a la Investigacion" Program of Centro de Investigacion en Medicina Molecular (CIMUS), Universidade de Santiago de Compostela (USC). Funding at the laboratory of D.P.X. and M.S.R. is provided by Institut National du Cancer (INCa; PLBIO16-251). The authors declare no conflicts of interest.	Bailly A, 2016, ONCOGENE, V35, P415, DOI 10.1038/onc.2015.104; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2012, J BIOL CHEM, V287, P17120, DOI 10.1074/jbc.M111.311902; de la Cruz-Herrera CF, 2015, ONCOGENE, V34, P1442, DOI 10.1038/onc.2014.48; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Domingues P, 2015, CELL REP, V13, P1467, DOI 10.1016/j.celrep.2015.10.001; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Guo C, 2014, IUBMB LIFE, V66, P71, DOI 10.1002/iub.1244; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Nishimura K, 2015, CELL REP, V10, P1310, DOI 10.1016/j.celrep.2015.01.055; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Rizos H, 2005, CELL CYCLE, V4, P597, DOI 10.4161/cc.4.4.1588; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Wang S, 2015, J MOL CELL BIOL, V7, P154, DOI 10.1093/jmcb/mjv010; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	37	15	15	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					643	651		10.1096/fj.201800341RR	http://dx.doi.org/10.1096/fj.201800341RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024791	Green Submitted			2022-12-28	WOS:000457401500050
J	Hu, WH; Wang, HY; Kong, XP; Xiong, QP; Poon, KKM; Xu, L; Duan, R; Chan, GKL; Dong, TTX; Tsim, KWK				Hu, Wei-Hui; Wang, Huai-You; Kong, Xiang-Peng; Xiong, Qing-Ping; Poon, Karman Ka-Man; Xu, Li; Duan, Ran; Chan, Gallant Kar-Lun; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung			Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling	FASEB JOURNAL			English	Article						herbal medicine; vasculogenesis; VEGFR2	ENDOTHELIAL-CELL SURVIVAL; POLYGONUM-CUSPIDATUM; TUMOR ANGIOGENESIS; METASTASIS; EXPRESSION; BEVACIZUMAB; SUNITINIB; DISCOVERY; STRESS; HEALTH	Polydatin, also called piceid, is a stilbenoid glucoside of a resveratrol derivative. It derives mainly from the root and rhizome of Polygonum cuspidatum Sieb. et Zucc. Although the role of P. cuspidatum root in angiogenesis has been reported, the active chemical or chemicals responsible for such function is not known. Here, polydatin was proposed to bind VEGF, which therefore altered the functions of VEGF in angiogenesis. Several lines of evidence supported the pharmaceutical effects of polydatin in VEGF-induced angiogenesis. In human umbilical vein endothelial cells, polydatin inhibited VEGF-stimulated cell proliferation, cell migration, and tube formation. Moreover, polydatin showed suppressive effects on the subintestinal vessel formation in zebrafish embryos. In signaling cascades, polydatin application attenuated VEGF-induced phosphorylations of VEGF receptor 2 and JNK. Moreover, the VEGF-induced phosphorylations of Akt, eNOS, and Erk were significantly decreased in the presence of polydatin. In parallel, the formation of reactive oxygen species, triggered by VEGF, was markedly decreased under polydatin application. Thus, our results supported the angiogenic roles of polydatin, as well as its signaling mechanism in blocking VEGF-mediated responses. The current study provides support for the possible development of polydatin as a potential therapeutic agent for treatment and prevention of angiogenesis-related diseases.Hu, W.-H., Wang, H.-Y., Kong, X.-P., Xiong, Q.-P., Poon, K. K.-M., Xu, L., Duan, R., Chan, G. K.-L., Dong, T. T.-X., Tsim, K. W.-K. Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling.	[Hu, Wei-Hui; Wang, Huai-You; Kong, Xiang-Peng; Xu, Li; Duan, Ran; Chan, Gallant Kar-Lun; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung] HKUST, Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen, Peoples R China; [Hu, Wei-Hui; Xiong, Qing-Ping; Poon, Karman Ka-Man; Xu, Li; Duan, Ran; Chan, Gallant Kar-Lun; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Ctr Chinese Med, Hong Kong, Peoples R China; [Xiong, Qing-Ping] Huaiyin Inst Technol, Jiangsu Key Lab Reg Resource Exploitat & Med Res, Lianyungang, Jiangsu, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Huaiyin Institute of Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Chinese Med, Clear Water Bay Rd, Hong Kong, Peoples R China.	botsim@ust.hk		Wang, Huai-You/0000-0003-1407-9912	Hong Kong Research Grants Council Theme-Based Research Scheme [T13-607/12R]; Innovation Technology Fund [UIM/288, UIM/302, UIT/137, ITS/022/16FP]; Shenzhen Science and Technology Committee Research Grants [CKFW2,016,082,916,015,476, JCYJ20,170,413,173,747,440, ZDSYS201,707,281,432,317, JCYJ20,160,229,205,726,699, JCYJ20,160,229,205,812,004, JCYJ20,160,229,210,027,564, 20,170,326];  [TUYF15SC01]	Hong Kong Research Grants Council Theme-Based Research Scheme(Hong Kong Research Grants Council); Innovation Technology Fund; Shenzhen Science and Technology Committee Research Grants; 	The authors thank Z. Wen and S. Zhao (Hong Kong University of Science and Technology) for their assistance in the zebrafish assay. This study was supported by Hong Kong Research Grants Council Theme-Based Research Scheme (T13-607/12R), Innovation Technology Fund (UIM/288, UIM/302, UIT/137, ITS/022/16FP), TUYF15SC01, Shenzhen Science and Technology Committee Research Grants (CKFW2,016,082,916,015,476, JCYJ20,170,413,173,747,440, ZDSYS201,707,281,432,317, JCYJ20,160,229,205,726,699, JCYJ20,160,229,205,812,004, JCYJ20,160,229,210,027,564 and 20,170,326). The authors declare no conflicts of interest.	Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chan GKL, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/1502457; Chen LY, 2013, FOOD CHEM TOXICOL, V52, P28, DOI 10.1016/j.fct.2012.10.037; Cheng YF, 2006, BRAIN RES, V1110, P193, DOI 10.1016/j.brainres.2006.06.065; Cho H, 2013, BRIT J OPHTHALMOL, V97, P1032, DOI 10.1136/bjophthalmol-2013-303344; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 1996, EUR J CANCER, V32A, P2413, DOI 10.1016/S0959-8049(96)00387-5; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Gao JAP, 2010, FITOTERAPIA, V81, P953, DOI 10.1016/j.fitote.2010.06.023; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Han JH, 2012, IMMUNOPHARM IMMUNOT, V34, P191, DOI 10.3109/08923973.2011.590499; He YD, 2012, BRIT J DERMATOL, V167, P941, DOI 10.1111/j.1365-2133.2012.10951.x; Hu WH, 2018, PHYTOMEDICINE, V42, P135, DOI 10.1016/j.phymed.2018.03.029; Huang M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0665-9; Huang ZS, 1999, WORLD J GASTROENTERO, V5, P41; Jordan KC, 2008, NUTR RES, V28, P13, DOI 10.1016/j.nutres.2007.11.005; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Liu HH, 2011, J CELL BIOCHEM, V112, P3695, DOI 10.1002/jcb.23303; Lou JS, 2017, ONCOTARGET, V8, P93131, DOI 10.18632/oncotarget.21862; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Maragoudakis ME, 2000, GEN PHARMACOL-VASC S, V35, P225, DOI 10.1016/S0306-3623(01)00111-2; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Pandir D, 2014, CYTOTECHNOLOGY, V66, P677, DOI 10.1007/s10616-013-9621-z; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Shan B, 2008, FOOD CHEM, V109, P530, DOI 10.1016/j.foodchem.2007.12.064; Stewart MW, 2014, EXPERT REV CLIN PHAR, V7, P167, DOI 10.1586/17512433.2014.884458; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Xing WW, 2009, BIOMED PHARMACOTHER, V63, P457, DOI 10.1016/j.biopha.2008.06.035; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	43	22	24	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					532	544		10.1096/fj.201800750R	http://dx.doi.org/10.1096/fj.201800750R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29989844				2022-12-28	WOS:000457401500042
J	Lenting, K; Khurshed, M; Peeters, TH; van den Heuvel, CNAM; van Lith, SAM; de Bitter, T; Hendriks, W; Span, PN; Molenaar, RJ; Botman, D; Verrijp, K; Heerschap, A; ter Laan, M; Kusters, B; van Ewijk, A; Huynen, MA; van Noorden, CJF; Leenders, WPJ				Lenting, Krissie; Khurshed, Mohammed; Peeters, Tom H.; van den Heuvel, Corina N. A. M.; van Lith, Sanne A. M.; de Bitter, Tessa; Hendriks, Wiljan; Span, Paul N.; Molenaar, Remco J.; Botman, Dennis; Verrijp, Kiek; Heerschap, Arend; ter Laan, Mark; Kusters, Benno; van Ewijk, Anne; Huynen, Martijn A.; van Noorden, Cornelis J. F.; Leenders, William P. J.			Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress	FASEB JOURNAL			English	Article						metabolism; anaplerosis; glycolysis; neurotransmitters; diffuse infiltration	T-2 RELAXATION; ONCOMETABOLITE 2-HYDROXYGLUTARATE; EXPRESSION ANALYSIS; MOUSE-BRAIN; RAT-BRAIN; IDH1; MUTATION; GROWTH; CELLS; INHIBITOR	Diffuse gliomas often carry point mutations in isocitrate dehydrogenase (IDH1(mut)), resulting in metabolic stress. Although IDHmut gliomas are difficult to culture in vitro, they thrive in the brain via diffuse infiltration, suggesting brain-specific tumor-stroma interactions that can compensate for IDH-1 deficits. To elucidate the metabolic adjustments in clinical IDHmut gliomas that contribute to their malignancy, we applied a recently developed method of targeted quantitative RNA next-generation sequencing to 66 clinical gliomas and relevant orthotopic glioma xenografts, with and without the endogenous IDH-1(R132H) mutation. Datasets were analyzed in R using Manhattan plots to calculate distance between expression profiles, Ward's method to perform unsupervised agglomerative clustering, and the Mann Whitney U test and Fisher's exact tests for supervised group analyses. The significance of transcriptome data was investigated by protein analysis, in situ enzymatic activity mapping, and in vivo magnetic resonance spectroscopy of orthotopic IDH1(mut)- and IDHwt-glioma xenografts. Gene set enrichment analyses of clinical IDH1(mut) gliomas strongly suggest a role for catabolism of lactate and the neurotransmitter glutamate, whereas, in IDHwt gliomas, processing of glucose and glutamine are the predominant metabolic pathways. Further evidence of the differential metabolic activity in these cancers comes from in situ enzymatic mapping studies and preclinical in vivo magnetic resonance spectroscopy imaging. Our data support an evolutionary model in which IDHmut glioma cells exist in symbiosis with supportive neuronal cells and astrocytes as suppliers of glutamate and lactate, possibly explaining the diffuse nature of these cancers. The dependency on glutamate and lactate opens the way for novel approaches in the treatment of IDHmut gliomas.Lenting, K., Khurshed, M., Peeters, T. H., van den Heuvel, C. N. A. M., van Lith, S. A. M., de Bitter, T., Hendriks, W., Span, P. N., Molenaar, R. J., Botman, D., Verrijp, K., Heerschap, A., ter Laan, M., Kusters, B., van Ewijk, A., Huynen, M. A., van Noorden, C. J. F., Leenders, W. P. J. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.	[Lenting, Krissie; van den Heuvel, Corina N. A. M.; van Ewijk, Anne; Leenders, William P. J.] Radboud Inst Mol Life Sci, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Hendriks, Wiljan] Radboud Inst Mol Life Sci, Dept Cell Biol, Nijmegen, Netherlands; [Huynen, Martijn A.; van Noorden, Cornelis J. F.] Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Lenting, Krissie; van den Heuvel, Corina N. A. M.; van Lith, Sanne A. M.; de Bitter, Tessa; Verrijp, Kiek; Kusters, Benno; Leenders, William P. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands; [Peeters, Tom H.; Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Radiotherapy & Oncoimmunol Lab, Dept Radiat Oncol, Nijmegen, Netherlands; [ter Laan, Mark] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Nijmegen, Netherlands; [Khurshed, Mohammed; Molenaar, Remco J.; Botman, Dennis; van Noorden, Cornelis J. F.] Acad Med Ctr, Canc Ctr Amsterdam, Dept Med Biol, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Leenders, WPJ (corresponding author), Radboud Inst Mol Life Sci, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands.	william.leenders@radboudumc.nl	Huynen, Martijn A/A-1530-2014; Lenting, Krissie/M-9665-2015; Leenders, William/O-2541-2019; Laan, Mark ter/L-4466-2015; Peeters, Tom/Q-4922-2019; van Lith, Sanne AM/D-9732-2016; verrijp, kiek/F-4783-2018; Span, Paul/G-4710-2012; Hendriks, Wiljan J.A.J./A-5214-2013	Huynen, Martijn A/0000-0001-6189-5491; Lenting, Krissie/0000-0002-7166-2621; Leenders, William/0000-0003-0066-220X; Laan, Mark ter/0000-0002-9213-430X; Peeters, Tom/0000-0001-6244-6938; Span, Paul/0000-0002-1930-6638; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; van Lith, Sanne/0000-0001-8584-2546	Dutch Cancer Society [UvA 2014-6839]; Stichting StopHersentumoren; Eurostars; Academic Medical Center (AMC) Ph.D. scholarship; Europees Fonds voor Regionale Ontwikkeling/GO (European Fund for Regional Development (EFRO/GO) Project Ultrasense NMR	Dutch Cancer Society(KWF Kankerbestrijding); Stichting StopHersentumoren; Eurostars; Academic Medical Center (AMC) Ph.D. scholarship; Europees Fonds voor Regionale Ontwikkeling/GO (European Fund for Regional Development (EFRO/GO) Project Ultrasense NMR	The authors thank Dr. Alex Hoischen for helpful discussions and Carlijn van de Water (both from Radboud University Medical Center) for help with the smMIP design. This work was supported by Dutch Cancer Society Grant UvA 2014-6839 (to K.L. and M.K.), Stichting StopHersentumoren (to C.N.A.M.V.D.H.), and Eurostars (to C.N.A.M.V.D.H. and W.P.J.L.); an Academic Medical Center (AMC) Ph.D. scholarship (to R.J.M.) and Europees Fonds voor Regionale Ontwikkeling/GO (European Fund for Regional Development (EFRO/GO) Project Ultrasense NMR (to T.H.P.). The authors declare no conflicts of interest.	Baldock AL, 2014, NEURO-ONCOLOGY, V16, P779, DOI 10.1093/neuonc/nou027; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Botman D, 2014, J HISTOCHEM CYTOCHEM, V62, P802, DOI 10.1369/0022155414549071; Botman D, 2014, J HISTOCHEM CYTOCHEM, V62, P813, DOI 10.1369/0022155414551177; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Caretti V, 2011, BRAIN PATHOL, V21, P441, DOI 10.1111/j.1750-3639.2010.00468.x; Chen RH, 2014, P NATL ACAD SCI USA, V111, P14217, DOI 10.1073/pnas.1409653111; Chieco P, 2013, PROG HISTOCHEM CYTO, V47, P211, DOI 10.1016/j.proghi.2012.09.001; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Claes A, 2008, BRAIN PATHOL, V18, P423, DOI 10.1111/j.1750-3639.2008.00141.x; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Cuyas E, 2015, ONCOTARGET, V6, P12279, DOI 10.18632/oncotarget.3733; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Bitter T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11035-0; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; de Groot JF, 2005, CANCER RES, V65, P1934, DOI 10.1158/0008-5472.CAN-04-3626; Eijkelenboom A, 2016, J MOL DIAGN, V18, P851, DOI 10.1016/j.jmoldx.2016.06.010; Esmaeili M, 2014, CANCER RES, V74, P4898, DOI 10.1158/0008-5472.CAN-14-0008; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Flaherty A. L., 2014, J CLIN ONCOL S, V32, P213; Guilfoyle DN, 2003, MAGNET RESON MED, V49, P576, DOI 10.1002/mrm.10371; Hamans B, 2013, NEURO-ONCOLOGY, V15, P1615, DOI 10.1093/neuonc/not129; Jalbert LE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44792; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Khurshed M, 2017, ONCOTARGET, V8, P49165, DOI 10.18632/oncotarget.17106; Lenting K, 2017, ACTA NEUROPATHOL, V133, P263, DOI 10.1007/s00401-017-1671-4; Lerchundi R, 2015, P NATL ACAD SCI USA, V112, P11090, DOI 10.1073/pnas.1508259112; Li SC, 2013, NEURO-ONCOLOGY, V15, P57, DOI 10.1093/neuonc/nos261; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Malzkorn B, 2011, BRAIN PATHOL, V21, P619, DOI 10.1111/j.1750-3639.2011.00536.x; Massucci FA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-103; Mazor T, 2017, P NATL ACAD SCI USA, V114, P10743, DOI 10.1073/pnas.1708914114; Min JL, 2007, EUR J HUM GENET, V15, P791, DOI 10.1038/sj.ejhg.5201829; Molenaar RJ, 2018, ONCOGENE, V37, P1949, DOI 10.1038/s41388-017-0077-z; Molenaar RJ, 2015, CANCER RES, V75, P4790, DOI 10.1158/0008-5472.CAN-14-3603; Molenaar RJ, 2014, BBA-REV CANCER, V1846, P326, DOI 10.1016/j.bbcan.2014.05.004; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; Navis AC, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-18; Navis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058262; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Philips T, 2017, J CLIN INVEST, V127, P3277, DOI 10.1172/JCI90610; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Rossetto M, 2011, REV NEUROL-FRANCE, V167, P699, DOI 10.1016/j.neurol.2011.08.002; Schwarcz A, 2001, MAGN RESON MED, V46, P1246, DOI 10.1002/mrm.1324; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Xin L, 2008, NMR BIOMED, V21, P396, DOI 10.1002/nbm.1205; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	62	24	24	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					557	571		10.1096/fj.201800907RR	http://dx.doi.org/10.1096/fj.201800907RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30001166				2022-12-28	WOS:000457401500044
J	Wang, WJ; Lollis, EM; Bordeleau, F; Reinhart-King, CA				Wang, Wenjun; Lollis, Emmanuel M.; Bordeleau, Francois; Reinhart-King, Cynthia A.			Matrix stiffness regulates vascular integrity through focal adhesion kinase activity	FASEB JOURNAL			English	Article						substrate compliance; endothelial barrier function; VE-cadherin	VE-CADHERIN; TYROSINE PHOSPHORYLATION; BARRIER DISRUPTION; FAK; PERMEABILITY; METASTASIS; CANCER; EXTRAVASATION; P120-CATENIN; INHIBITION	Tumor vasculature is known to be more permeable than the vasculature found in healthy tissue, which in turn can lead to a more aggressive tumor phenotype and impair drug delivery into tumors. While the stiffening of the stroma surrounding solid tumors has been reported to increase vascular permeability, the mechanism of this process remains unclear. Here, we utilize an in vitro model of tumor stiffening, ex ovo culture, and a mouse model to investigate the molecular mechanism by which matrix stiffening alters endothelial barrier function. Our data indicate that the increased endothelial permeability caused by heightened matrix stiffness can be prevented by pharmaceutical inhibition of focal adhesion kinase (FAK) both in vitro and ex ovo. Matrix stiffness-mediated FAK activation determines Src localization to cell-cell junctions, which then induces increased vascular endothelial cadherin phosphorylation both in vitro and in vivo. Endothelial cells in stiff tumors have more activated Src and higher levels of phosphorylated vascular endothelial cadherin at adherens junctions compared to endothelial cells in more compliant tumors. Altogether, our data indicate that matrix stiffness regulates endothelial barrier integrity through FAK activity, providing one mechanism by which extracellular matrix stiffness regulates endothelial barrier function. Additionally, our work also provides further evidence that FAK is a promising potential target for cancer therapy because FAK plays a critical role in the regulation of endothelial barrier integrity.Wang, W., Lollis, E. M., Bordeleau, F., Reinhart-King, C. A. Matrix stiffness regulates vascular integrity through focal adhesion kinase activity.	[Wang, Wenjun; Bordeleau, Francois; Reinhart-King, Cynthia A.] Vanderbilt Univ, Dept Biomed Engn, PMB 351631, Nashville, TN 37235 USA; [Lollis, Emmanuel M.] Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY USA; [Reinhart-King, Cynthia A.] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA	Vanderbilt University; Cornell University; Cornell University	Reinhart-King, CA (corresponding author), Vanderbilt Univ, Dept Biomed Engn, PMB 351631, Nashville, TN 37235 USA.	cynthia.reinhart-king@vanderbilt.edu		Wang, Wenjun/0000-0003-0907-6282	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL127499]; Cancer Research Society; NIH National Cancer Institute [K99CA212270]; NATIONAL CANCER INSTITUTE [K99CA212270] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127499] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research Society; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge support from the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (R01HL127499 to C.A.R.-K.), the Scholarship for the Next Generation of Scientists from the Cancer Research Society, and the NIH National Cancer Institute (K99CA212270 to F.B.). The authors declare no conflicts of interest.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Aragon-Sanabria V, 2017, SCI REP-UK, V7, DOI 10.1038/srep45835; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Azzi S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00211; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Bordeleau F, 2017, P NATL ACAD SCI USA, V114, P492, DOI 10.1073/pnas.1613855114; Bordeleau F, 2015, P NATL ACAD SCI USA, V112, P8314, DOI 10.1073/pnas.1505421112; Bordeleau F, 2014, AM J PHYSIOL-CELL PH, V306, pC110, DOI 10.1152/ajpcell.00283.2013; Bryant PW, 2012, BIOL OPEN, V1, P723, DOI 10.1242/bio.20121008; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2013, PROG MOL BIOL TRANSL, V116, P119, DOI 10.1016/B978-0-12-394311-8.00006-6; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Infante JR, 2012, J CLIN ONCOL, V30, P1527, DOI 10.1200/JCO.2011.38.9346; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Lampugnani M. G., 2017, COLD SPRING HARB PER, V9, DOI 10.1101/cshperspect.a029322; Lampugnani MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029322; LaValley DJ, 2017, CONVERG SCI PHYS ONC, V3, DOI 10.1088/2057-1739/aa9263; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maskarinec G, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3378; Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Urbano RL, 2017, BIOPHYS J, V113, P645, DOI 10.1016/j.bpj.2017.06.033; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Zebda N, 2012, MICROVASC RES, V83, P71, DOI 10.1016/j.mvr.2011.06.007; Zijlstra A, 2006, BLOOD, V107, P317, DOI 10.1182/blood-2005-04-1458	52	29	29	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1199	1208		10.1096/fj.201800841R	http://dx.doi.org/10.1096/fj.201800841R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30102569	Green Published			2022-12-28	WOS:000457401500095
J	Wei, WJ; Zhang, S; Fleming, J; Chen, Y; Li, ZH; Fan, SH; Liu, Y; Wang, W; Wang, T; Liu, Y; Ren, BG; Wang, M; Jiao, JJ; Chen, YY; Zhou, Y; Zhou, YF; Gu, SJ; Zhang, XL; Wan, L; Chen, T; Zhou, L; Chen, Y; Zhang, XE; Li, CY; Zhang, HT; Bi, LJ				Wei, Wenjing; Zhang, Shuai; Fleming, Joy; Chen, Ying; Li, Zihui; Fan, Shanghua; Liu, Yi; Wang, Wei; Wang, Ting; Liu, Ying; Ren, Baiguang; Wang, Ming; Jiao, Jianjian; Chen, Yuanyuan; Zhou, Ying; Zhou, Yafeng; Gu, Shoujin; Zhang, Xiaoli; Wan, Li; Chen, Tao; Zhou, Lin; Chen, Yong; Zhang, Xian-En; Li, Chuanyou; Zhang, Hongtai; Bi, Lijun			Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features	FASEB JOURNAL			English	Article						Cas6; metal ion dependence; mature crRNA; hairpin	PROCESSES PRE-CRRNA; CRYSTAL-STRUCTURE; RNA RECOGNITION; CAS SYSTEMS; PROTEIN; EVOLUTION; COMPLEX; DNA; CLASSIFICATION; SEQUENCE	Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems are prokaryotic adaptive immune systems against invading nucleic acids. CRISPR locus variability has been exploited in evolutionary and epidemiological studies of Mycobacterium tuberculosis, the causative agent of tuberculosis, for over 20 yr, yet the biological function of this type III-A system is largely unexplored. Here, using cell biology and biochemical, mutagenic, and RNA-seq approaches, we show it is active in invader defense and has features atypical of type III-A systems: mature CRISPR RNA (crRNA) in its crRNA-CRISPR/Cas protein complex are of uniform length (approximate to 71 nt) and appear not to be subject to 3-end processing after Cas6 cleavage of repeat RNA 8 nt from its 3 end. crRNAs generated resemble mature crRNA in type I systems, having both 5 (8 nt) and 3 (28 nt) repeat tags. Cas6 cleavage of repeat RNA is ion dependent, and accurate cleavage depends on the presence of a 3 hairpin in the repeat RNA and the sequence of its stem base nucleotides. This study unveils further diversity among CRISPR/Cas systems and provides insight into the crRNA recognition mechanism in M. tuberculosis, providing a foundation for investigating the potential of a type III-A-based genome editing system.Wei, W., Zhang, S., Fleming, J., Chen, Y., Li, Z., Fan, S., Liu, Y., Wang, W., Wang, T., Liu, Y., Ren, B., Wang, M., Jiao, J., Chen, Y., Zhou, Y., Zhou, Y., Gu, S., Zhang, X., Wan, L., Chen, T., Zhou, L., Chen, Y., Zhang, X.-E., Li, C., Zhang, H., Bi, L. Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features.	[Wei, Wenjing; Zhang, Shuai; Fleming, Joy; Chen, Ying; Fan, Shanghua; Wang, Ting; Liu, Ying; Ren, Baiguang; Wang, Ming; Jiao, Jianjian; Chen, Yuanyuan; Gu, Shoujin; Wan, Li; Zhang, Xian-En; Zhang, Hongtai; Bi, Lijun] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Wei, Wenjing; Zhang, Shuai; Fleming, Joy; Chen, Ying; Fan, Shanghua; Wang, Ting; Liu, Ying; Ren, Baiguang; Wang, Ming; Jiao, Jianjian; Chen, Yuanyuan; Gu, Shoujin; Wan, Li; Zhang, Xian-En; Zhang, Hongtai; Bi, Lijun] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wei, Wenjing; Zhang, Shuai] Univ Chinese Acad Sci, Beijing, Peoples R China; [Fleming, Joy; Zhou, Ying; Zhou, Yafeng; Zhang, Xiaoli; Chen, Yong; Zhang, Xian-En; Bi, Lijun] Foshan Univ, Sch Stomatol & Med, Foshan, Peoples R China; [Li, Zihui; Liu, Yi; Wang, Wei; Li, Chuanyou] Capital Med Univ, Beijing Chest Hosp, Beijing 101149, Peoples R China; [Gu, Shoujin] Shanghai Univ Engn Sci, Sch Chem & Chem Engn, Shanghai, Peoples R China; [Chen, Tao; Zhou, Lin] Ctr TB Control Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Bi, Lijun] Guangdong Prov Key Lab TB Syst Biol & Translat Me, Foshan, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Foshan University; Capital Medical University; Shanghai University of Engineering Science	Zhang, HT (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China.; Zhang, HT (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Li, CY (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing 101149, Peoples R China.; Bi, LJ (corresponding author), Chinese Acad Sci, Key Lab RNA Biol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.; Bi, LJ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	lichuanyou6688@hotmail.com; hongtaizhang@aliyun.com; blj@ibp.ac.cn	ZHANG, Xian-En/AAJ-5579-2021; Chen, Yuanyuan/GXG-2130-2022	Fan, Shanghua/0000-0002-6596-8472	National Key Research and Development Program of China [2017YFD0500300]; National Natural Science Foundation of China [U1401224, 31400127, 31770148, 31770150]; CAS Science and Technology Service Network Program [KFZD-SW-207]; Strategic Priority Research Program of the CAS [XDA09030308, XDPB0302]; Special Fund for Public Welfare Research and Capacity Building in Guangdong Province [2014B030301002]; CAS Youth Innovation Promotion Association [2015072]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Science and Technology Service Network Program; Strategic Priority Research Program of the CAS; Special Fund for Public Welfare Research and Capacity Building in Guangdong Province; CAS Youth Innovation Promotion Association	The authors thank Prof. Yanli Wang, Prof. Tao Jiang, and Prof. Guofeng Zhu [all from the Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS)] for constructive discussions on the manuscript; Zhenwei Yang of the Protein Science Core Facility at the Institute of Biophysics (CAS) for technical help with the isothermal calorimetry experiments; Dr. Hongjie Zhang (IBP Radioactive Isotope Laboratory for guidance in the safe handling of radiolabeled chemicals; and Lin Su, Tailin Liu, and Fansi Kong (Bionova Biotech Co. Ltd., Beijing, China) for help with RNA sequencing and analysis. This work was supported by National Key Research and Development Program of China Grant 2017YFD0500300; National Natural Science Foundation of China Grants U1401224, 31400127, 31770148, and 31770150; CAS Science and Technology Service Network Program Grant KFZD-SW-207; Strategic Priority Research Program of the CAS Grants XDA09030308 and XDPB0302; Special Fund for Public Welfare Research and Capacity Building in Guangdong Province Grant 2014B030301002; and CAS Youth Innovation Promotion Association Grant 2015072. The authors declare no conflicts of interest.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Guan J, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00403-17; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; He LM, 2012, J CELL BIOCHEM, V113, P2464, DOI 10.1002/jcb.24121; Hinc K, 2006, ACTA BIOCHIM POL, V53, P497; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jesser R, 2019, RNA BIOL, V16, P481, DOI 10.1080/15476286.2018.1447742; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Killelea T, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160297; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lee MC, 2017, CRYSTALS, V7, DOI 10.3390/cryst7110344; [李勇鹏 Li Yongpeng], 2016, [东北林业大学学报, Journal of North-East Forestry University], V44, P34; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2017.02.018, 10.1016/j.cell.2016.12.038]; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Park HM, 2012, PROTEINS, V80, P1895, DOI 10.1002/prot.24061; PEREZSTABLE C, 1984, P NATL ACAD SCI-BIOL, V81, P5291, DOI 10.1073/pnas.81.17.5291; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Reeks J, 2013, BIOCHEM J, V452, P223, DOI 10.1042/BJ20130269; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; RIORDAN JF, 1977, ANN CLIN LAB SCI, V7, P119; Sefcikova J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700019; Shao YM, 2016, STRUCTURE, V24, P547, DOI 10.1016/j.str.2016.02.009; Shao YM, 2013, STRUCTURE, V21, P385, DOI 10.1016/j.str.2013.01.010; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sokolowski RD, 2014, NUCLEIC ACIDS RES, V42, P6532, DOI 10.1093/nar/gku308; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Wakefield N, 2015, FEBS LETT, V589, P3197, DOI 10.1016/j.febslet.2015.09.005; Walker FC, 2017, NUCLEIC ACIDS RES, V45, P2112, DOI 10.1093/nar/gkw891; Wang RY, 2012, PROTEIN SCI, V21, P405, DOI 10.1002/pro.2028; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; WHO, 2017, WHO GLOB TUB REP 201; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	63	16	20	2	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1496	1509		10.1096/fj.201800557RR	http://dx.doi.org/10.1096/fj.201800557RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979631				2022-12-28	WOS:000457401500117
J	Zhang, XS; Lu, Y; Wu, Q; Dai, HB; Li, W; Lv, SY; Zhou, XM; Zhang, X; Hang, CH; Wang, J				Zhang, Xiangsheng; Lu, Yue; Wu, Qi; Dai, Haibin; Li, Wei; Lv, Shengyin; Zhou, Xiaoming; Zhang, Xin; Hang, Chunhua; Wang, Jian			Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway	FASEB JOURNAL			English	Article						early brain injury; inflammation; microglia; neuroprotection	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; MOUSE MODEL; POSSIBLE INVOLVEMENT; ISCHEMIC-STROKE; OXIDATIVE STRESS; CEREBRAL EDEMA; ACTIVATION; NEUROPROTECTION; INFLAMMATION	Inflammation plays a key role in the progression of subarachnoid hemorrhage (SAH). Here, we examined the effects of astaxanthin (ATX) on the inflammatory response and secondary damage after SAH and the underlying mechanisms of action. In vivo, a prechiasmatic cistern injection model was established in rats and mice. In addition, neuron-microglia cocultures were exposed to oxyhemoglobin to mimic SAH in vitro. Western blotting revealed that protein expression of TLR4 was markedly increased in microglia at 24 h after SAH, with consequent increases in the downstream molecules myeloid differentiation factor 88 and NF-kB. Treatment with ATX significantly inhibited the TLR4 activation, increased sirtuin 1 expression, and inhibited the subsequent inflammatory response both in vivo and in vitro. ATX also significantly decreased high-mobility group box 1 nuclear translocation and secretion in neurons, an effect that was reversed by the sirtuin 1-specific inhibitor sirtinol. ATX administered 4 h after SAH ameliorated cerebral inflammation, brain edema, and neuronal death and improved neurologic function. ATX reduced neuronal death but did not improve neurologic function in TLR4 knockout mice. These results suggest that ATX reduces the proinflammatory response and secondary brain injury after SAH, primarily by increasing sirtuin 1 levels and inhibiting the TLR4 signaling pathway.Zhang, X., Lu, Y., Wu, Q., Dai, H., Li, W., Lv, S., Zhou, X., Zhang, X., Hang, C., Wang, J. Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway.	[Zhang, Xiangsheng; Lu, Yue; Dai, Haibin; Li, Wei; Hang, Chunhua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Qi; Lv, Shengyin; Zhang, Xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhang, Xiangsheng; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Zhou, Xiaoming] Second Mil Med Univ, Changzheng Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China	Nanjing University; Nanjing University; Johns Hopkins University; Naval Medical University	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Zhang, X (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	zhangxsp@163.com; hang_neurosurgery@163.com	Wang, Jian/I-4874-2019; Li, Wei/ABE-4301-2021	Wang, Jian/0000-0003-2291-640X; LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of China [81471183, 81501022, 81771292]; American Heart Association [17GRNT33660766]; Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University; China Scholarship Council(China Scholarship Council)	The authors thank Dr. Bo Yu and YanLing Han (both from Jinling Hospital) for their generous assistance with pathologic examinations. The authors also thank Claire Levine, M.S., ELS, for assistance with manuscript preparation and the J.W. laboratory team members for insightful input. This work was supported by the National Natural Science Foundation of China (Grants 81471183 to Xin Zhang, 81501022 to Xiangsheng Zhang, and 81771292 to C.H.), the American Heart Association Grant-in-Aid (17GRNT33660766), and a Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University. Xiangsheng Zhang is a recipient of the China Scholarship Council Joint Ph.D. training award. The authors declare no conflicts of interest.	Alhadidi Q, 2018, MOL NEUROBIOL, V55, P1676, DOI 10.1007/s12035-017-0432-7; Brea D, 2011, REV NEUROLOGIA, V52, P12, DOI 10.33588/rn.5201.2010494; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng YY, 2015, J BIOCHEM, V158, P299, DOI 10.1093/jb/mvv041; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Dzaye ODA, 2016, J NEUROPATH EXP NEUR, V75, P429, DOI 10.1093/jnen/nlw016; Fadakar K, 2014, REV NEUROSCIENCE, V25, P699, DOI 10.1515/revneuro-2013-0069; Gong LL, 2016, EUR J NEUROSCI, V43, P1674, DOI 10.1111/ejn.13257; Han XN, 2019, J CEREBR BLOOD F MET, V39, P1531, DOI 10.1177/0271678X18762645; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Hwang J. S., 2015, TUMOR BIOL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128014; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lan KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12285-8; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lei CY, 2015, STROKE, V46, P500, DOI 10.1161/STROKEAHA.114.006825; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-230; Li Q, 2017, J CEREBR BLOOD F MET, V37, P3110, DOI 10.1177/0271678X17709186; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Q, 2017, NEUROBIOL DIS, V108, P173, DOI 10.1016/j.nbd.2017.08.011; Lin QQ, 2017, LIFE SCI, V170, P100, DOI 10.1016/j.lfs.2016.11.026; Lv SY, 2018, WORLD NEUROSURG, V111, pE355, DOI 10.1016/j.wneu.2017.12.076; Pan LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099526; Raghavan A, 2012, NEURODEGENER DIS, V9, P1, DOI 10.1159/000329724; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Sakai S, 2009, J BIOL CHEM, V284, P28172, DOI 10.1074/jbc.M109.001099; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Siler DA, 2015, STROKE, V46, P1916, DOI 10.1161/STROKEAHA.114.008560; Siler DA, 2014, TRANSL STROKE RES, V5, P227, DOI 10.1007/s12975-014-0329-y; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Sukumari-Ramesh S, 2016, TRANSL STROKE RES, V7, P141, DOI 10.1007/s12975-015-0421-y; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Sun XB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-157; Tian XD, 2017, CURR DRUG DELIV, V14, P785, DOI 10.2174/1567201813666160808111933; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JP, 2015, BRAIN BEHAV IMMUN, V45, P98, DOI 10.1016/j.bbi.2014.12.015; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wu HJ, 2015, MAR DRUGS, V13, P5750, DOI 10.3390/md13095750; Wu H, 2015, NEUROBIOL AGING, V36, P1439, DOI 10.1016/j.neurobiolaging.2014.12.029; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Wu QJ, 2017, INFLAMMATION, V40, P1245, DOI 10.1007/s10753-017-0567-8; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Ye QY, 2013, MAR DRUGS, V11, P1019, DOI 10.3390/md11041019; Zhang J, 2017, BBA-GEN SUBJECTS, V1861, P1715, DOI 10.1016/j.bbagen.2017.03.007; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhang XS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081331; Zhang XS, 2014, J SURG RES, V192, P206, DOI 10.1016/j.jss.2014.05.029; Zhang XS, 2014, MAR DRUGS, V12, P4291, DOI 10.3390/md12084291; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zhang XS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00611; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhang Z, 2017, J CEREBR BLOOD F MET, V37, P25, DOI 10.1177/0271678X16655814; Zhang ZY, 2018, EXP NEUROL, V301, P13, DOI 10.1016/j.expneurol.2017.12.005; Zhao D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1007-2; Zheng D, 2014, NEUROPHARMACOLOGY, V84, P13, DOI 10.1016/j.neuropharm.2014.04.013; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004	74	44	49	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					722	737		10.1096/fj.201800642RR	http://dx.doi.org/10.1096/fj.201800642RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30048156				2022-12-28	WOS:000457401500056
J	Xu, XH; Bao, Y; Wang, XT; Yan, FY; Guo, SC; Ma, YY; Xu, D; Jin, L; Xu, JB; Wang, JC				Xu, Xiang-Hong; Bao, Yang; Wang, Xiaotian; Yan, Fengyang; Guo, Shicheng; Ma, Yanyun; Xu, Dong; Jin, Li; Xu, Jibin; Wang, Jiucun			Hypoxic-stabilized EPAS1 proteins transactivate DNMT1 and cause promoter hypermethylation and transcription inhibition of EPAS1 in non-small cell lung cancer	FASEB JOURNAL			English	Article						hypoxia; methylation; bisulfite-sequencing PCR; Ms-SNuPE	MAMMALIAN DNA METHYLTRANSFERASES; INDUCIBLE FACTOR (HIF)-1-ALPHA; GENE-EXPRESSION; METHYLATION; EPIGENETICS; REPRESSION; BLADDER; GROWTH; MODEL	Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality globally. Although cigarette smoking is by far the most important risk factor for lung cancer, the aberrant expression of oncogenes and tumor suppressor genes contributes a great deal to tumorigenesis. Here, we reveal that aberrant expression of endothelial PAS domain-containing protein 1 (EPAS1) gene, which encodes hypoxia inducible factor 2, has a critical role in NSCLC. Our results showed EPAS1 mRNA was down-regulated in 82.5% of NSCLC tissues, and a new region of EPAS1 promoter was found to be highly methylated in lung cancer cell lines and NSCLC tissues. Moreover, the methylation rates were negatively correlated to EPAS1 mRNA expression in lung tissues. Further, demethylation analysis demonstrated EPAS1 was regulated by DNA methyltransferases (DNMTs) in NSCLC. In contrast, DNMT1 was verified as an EPAS1 target gene by chromatin immunoprecipitation assay and could be transactivated by stabilized EPAS1 proteins in hypoxic lung cells, thereby decreasing EPAS1 mRNA expression by methylation regulation. Collectively, our study suggests there might be a mechanism of negative-feedback regulation for EPAS1 in NSCLC. That is, hypoxic-stabilized EPAS1 proteins transactivated DNMT1, which further promoted the hypermethylation of EPAS1 promoter and decreased EPAS1 mRNA expression levels in NSCLC.Xu, X.-H., Bao, Y., Wang, X., Yan, F., Guo, S., Ma, Y., Xu, D., Jin, L., Xu, J., Wang, J. Hypoxic-stabilized EPAS1 proteins transactivate DNMT1 and cause promoter hypermethylation and transcription inhibition of EPAS1 in non-small cell lung cancer.	[Xu, Xiang-Hong; Wang, Xiaotian; Yan, Fengyang; Guo, Shicheng; Ma, Yanyun; Jin, Li; Wang, Jiucun] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai, Peoples R China; [Xu, Dong] Fudan Univ, Huashan Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Jin, Li; Wang, Jiucun] Fudan Univ, Human Phenome Inst, Shanghai, Peoples R China; [Xu, Xiang-Hong] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Shanghai, Peoples R China; [Bao, Yang] Yangzhou Univ, Affiliated Hosp, Dept Cardiothorac Surg, Yangzhou, Jiangsu, Peoples R China; [Xu, Jibin] Second Mil Med Univ, Changzheng Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Tongji University; Yangzhou University; Naval Medical University	Xu, JB (corresponding author), Second Mil Med Univ, Changzheng Hosp, 415 Fengyang Rd, Shanghai 200433, Peoples R China.; Wang, JC (corresponding author), Fudan Univ, Sch Life Sci, 2005 Songhu Rd, Shanghai 200438, Peoples R China.	jibinx@yahoo.com; jcwang@fudan.edu.cn	Jin, Li/M-5063-2019; MA, YAN/HHN-2912-2022; Jin, Li/C-1468-2009; Guo, Shicheng/A-1204-2016	Jin, Li/0000-0002-4546-2415; Guo, Shicheng/0000-0002-7047-9972	National Science Foundation of China [31521003, 81501270, 81172228]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; 111 Project from the Ministry of Education [B13016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project; 111 Project from the Ministry of Education(Ministry of Education, China - 111 Project)	The authors thank Prof. Jian Yu (Shanghai Cancer Institute, Shanghai, China) for providing MBD-sequencing data. This study was supported by grants from the National Science Foundation of China (Grants 31521003, 81501270, and 81172228), Shanghai Municipal Science and Technology Major Project (Grant 2017SHZDZX01), and the 111 Project (Grant B13016) from the Ministry of Education. The authors declare no conflicts of interest.	Altenberger C, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0568-5; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ansari J, 2016, TRANSL LUNG CANCER R, V5, P155, DOI 10.21037/tlcr.2016.02.02; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Chen CC, 2013, J BIOL CHEM, V288, P9084, DOI 10.1074/jbc.M112.445585; Cui J, 2016, TUMOR BIOL, V37, P13455, DOI 10.1007/s13277-016-5237-1; Dawe DE, 2016, LUNG CANCER, V99, P180, DOI 10.1016/j.lungcan.2016.07.016; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Forde PM, 2014, CLIN CANCER RES, V20, P2244, DOI 10.1158/1078-0432.CCR-13-2088; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Guo SC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-014-0035-3; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Heller G, 2013, CARCINOGENESIS, V34, P513, DOI 10.1093/carcin/bgs363; Jeltsch A, 2016, NUCLEIC ACIDS RES, V44, P8556, DOI 10.1093/nar/gkw723; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaminsky Zachary, 2009, V507, P241, DOI 10.1007/978-1-59745-522-0_18; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Lachance G, 2014, P NATL ACAD SCI USA, V111, P7783, DOI 10.1073/pnas.1322909111; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Noguera R, 2009, CLIN CANCER RES, V15, P7130, DOI 10.1158/1078-0432.CCR-09-0223; Poon CC, 2017, INT J CANCER, V140, P1945, DOI 10.1002/ijc.30533; Raspaglio G, 2014, GENE, V542, P173, DOI 10.1016/j.gene.2014.03.037; Rawluszko-Wieczorek AA, 2014, MOL CANCER RES, V12, P1112, DOI 10.1158/1541-7786.MCR-14-0054; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Shields PG, 2002, ONCOGENE, V21, P6870, DOI 10.1038/sj.onc.1205832; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vindrieux D, 2014, ONCOTARGET, V5, P1004, DOI 10.18632/oncotarget.1681; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Xu XH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07465; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861	40	27	27	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6694	6705		10.1096/fj.201700715	http://dx.doi.org/10.1096/fj.201700715			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29920222				2022-12-28	WOS:000449359700027
J	Cai, J; Chen, HY; Peng, SJ; Meng, JL; Wang, Y; Zhou, Y; Qian, XP; Sun, XY; Pang, XW; Zhang, Y; Zhang, J				Cai, Juan; Chen, Hong-Yan; Peng, Shu-Jie; Meng, Jun-Ling; Wang, Yan; Zhou, Yu; Qian, Xiao-Ping; Sun, Xiu-Yuan; Pang, Xue-Wen; Zhang, Yu; Zhang, Jun			USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling	FASEB JOURNAL			English	Article						TBK1; ubiquitination; deubiquitination; degradation; innate immunity	E3 UBIQUITIN LIGASE; BINDING KINASE 1; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; INNATE IMMUNITY; PROTEASOMAL DEGRADATION; INTERFERON-PRODUCTION; SUMO DEUBIQUITINASE	Ubiquitination and deubiquitination are important post-translational regulatory mechanisms responsible for fine tuning the antiviral signaling. In this study, we identified a deubiquitinase, the ubiquitin-specific peptidase 7/herpes virus associated ubiquitin-specific protease (USP7/HAUSP) as an important negative modulator of virus-induced signaling. Overexpression of USP7 suppressed Sendai virus and polyinosinic-polycytidylic acid and poly(deoxyadenylic-deoxythymidylic)-induced ISRE and IFN- activation, and enhanced virus replication. Knockdown or knockout of endogenous USP7 expression had the opposite effect. Coimmunoprecipitation assays showed that USP7 physically interacted with tripartite motif (TRIM)27. This interaction was enhanced after SeV infection. In addition, TNF receptor-associated factor family member-associated NF-kappa-B-binding kinase (TBK)-1 was pulled down in the TRIM27-USP7 complex. Overexpression of USP7 promoted the ubiquitination and degradation of TBK1 through promoting the stability of TRIM27. Knockout of endogenous USP7 led to enhanced TRIM27 degradation and reduced TBK1 ubiquitination and degradation, resulting in enhanced type I IFN signaling. Our findings suggest that USP7 acts as a negative regulator in antiviral signaling by stabilizing TRIM27 and promoting the degradation of TBK1.Cai, J., Chen, H.-Y., Peng, S.-J., Meng, J.-L., Wang, Y., Zhou, Y., Qian, X.-P., Sun, X.-Y., Pang, X.-W., Zhang, Y., Zhang, J. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling.	[Cai, Juan; Chen, Hong-Yan; Peng, Shu-Jie; Meng, Jun-Ling; Wang, Yan; Zhou, Yu; Qian, Xiao-Ping; Sun, Xiu-Yuan; Pang, Xue-Wen; Zhang, Yu; Zhang, Jun] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing, Peoples R China	Peking University	Zhang, J (corresponding author), Peking Univ, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	junzhang@bjmu.edu.cn			National Natural Science Foundation of China [31470843]; Program for New Century Excellent Talents in University [NCET-13-0018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The authors thank Drs. Takashi Fujita (Kyoto University, Kyoto, Japan), Tom Maniatis (Columbia University School of Medicine, New York, NY, USA), and Zhijian Chen (University of Texas Southwestern Medical Center, Dallas, TX, USA) for RIG-I-, TBK1-, IKK epsilon-, and MAVS-expressing vectors. The authors also thank Drs. Hong-Bing Shu (Wuhan University, Wuhan, China), Hong Tang (Institut Pasteur of Shanghai, Chinese Academy of Science, Shanghai, China), Zhengfan Jiang (Peking University, Peking, China), and Dan-Ying Chen (Peking University) for vectors or reagents. This work was supported by grants from the National Natural Science Foundation of China Grant 31470843, and Program for New Century Excellent Talents in University Grant NCET-13-0018 (to J.Z.). The authors declare no conflicts of interest.	Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; An T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005179; Antrobus R, 2008, VIRUS RES, V137, P64, DOI 10.1016/j.virusres.2008.05.017; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Cui J, 2014, CELL RES, V24, P400, DOI 10.1038/cr.2013.170; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Gu MD, 2016, EMBO J, V35, P2553, DOI 10.15252/embj.201694060; Hao H, 2015, MOL CELL, V59, P956, DOI 10.1016/j.molcel.2015.07.033; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Kalamvoki M, 2012, J VIROL, V86, P12871, DOI 10.1128/JVI.01981-12; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khoronenkova SV, 2012, CELL CYCLE, V11, P2409, DOI 10.4161/cc.20800; Khoronenkova SV, 2011, NUCLEIC ACIDS RES, V39, P2604, DOI 10.1093/nar/gkq1210; Lecona E, 2016, NAT STRUCT MOL BIOL, V23, P270, DOI 10.1038/nsmb.3185; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Li XL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aae0435; Lin M, 2016, MOL CELL, V64, P267, DOI 10.1016/j.molcel.2016.08.029; Liu D, 2015, MOL CELL BIOL, V35, P2400, DOI 10.1128/MCB.00090-15; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Morotti A, 2014, LEUKEMIA, V28, P1326, DOI 10.1038/leu.2013.370; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Panda S, 2015, IMMUNITY, V43, P647, DOI 10.1016/j.immuni.2015.09.010; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Saul VV, 2015, BBA-MOL CELL RES, V1853, P136, DOI 10.1016/j.bbamcr.2014.10.008; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Smits VAJ, 2016, BIOESSAYS, V38, P863, DOI 10.1002/bies.201600096; Song GH, 2016, NAT IMMUNOL, V17, P1342, DOI 10.1038/ni.3588; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang LJ, 2013, J VIROL, V87, P4507, DOI 10.1128/JVI.00031-13; Wang LQ, 2016, EBIOMEDICINE, V13, P99, DOI 10.1016/j.ebiom.2016.10.018; Xiang WW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501889; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamaguchi L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00136-5; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Ye JS, 2014, J VIROL, V88, P12765, DOI 10.1128/JVI.02037-14; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zaman MMU, 2013, MOL CELL BIOL, V33, P4971, DOI 10.1128/MCB.00465-13; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhan ZZ, 2015, J IMMUNOL, V195, P3849, DOI 10.4049/jimmunol.1403083; Zhang J, 2014, PROTEIN CELL, V5, P503, DOI 10.1007/s13238-014-0058-8; Zhang L, 2014, J IMMUNOL, V193, P2230, DOI 10.4049/jimmunol.1302634; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhao YL, 2012, CELL SIGNAL, V24, P2197, DOI 10.1016/j.cellsig.2012.06.017; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	78	32	32	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5238	5249		10.1096/fj.201700473RR	http://dx.doi.org/10.1096/fj.201700473RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688809	Bronze			2022-12-28	WOS:000447972500004
J	Bai, Y; Liu, C; Fu, L; Gong, XS; Dou, C; Cao, Z; Quan, HY; Li, JM; Kang, F; Dai, JJ; Zhao, CR; Dong, SW				Bai, Yun; Liu, Chuan; Fu, Lei; Gong, Xiaoshan; Dou, Ce; Cao, Zhen; Quan, Hongyu; Li, Jianmei; Kang, Fei; Dai, Jingjin; Zhao, Chunrong; Dong, Shiwu			Mangiferin enhances endochondral ossification-based bone repair in massive bone defect by inducing autophagy through activating AMP-activated protein kinase signaling pathway	FASEB JOURNAL			English	Article						endochondral bone formation; chondrocyte; bone regeneration	MESENCHYMAL STEM-CELLS; KAPPA-B; MTOR; GROWTH; CHONDROCYTES; DEGRADATION; EXPRESSION; DELETION; DAMAGE	Endochondral ossification is crucial for bone formation in both adult bone repair process and embryo long-bone development. In endochondral ossification, bone marrow-derived mesenchymal stem cells (BMSCs) first differentiate to chondrocytes, then BMSC-derived chondrocytes endure a hypertrophic process to generate new bone. Endochondral ossification-based bone repair is a promising strategy to cure massive bone defect, which is a major clinical issue in orthopedics. However, challenges still remain for this novel strategy. One challenge is to ensure the sufficient hypertrophic differentiation. Another is to maintain the survival of the above hypertrophic chondrocytes under the hypoxic environment of massive bone defect. To solve this issue, mangiferin (MAG) was introduced to endochondral ossification-based bone repair. In this report, we proved MAG to be a novel autophagy inducer, which promoted BMSC-derived hypertrophic chondrocyte survival against hypoxia-induced injury through inducing autophagy. Furthermore, MAG enhances hypertrophic differentiation of BMSC-derived chondrocytes via upregulating key hypertrophic markers. Mechanistically, MAG induced autophagy in BMSC-derived chondrocytes by promoting AMPK phosphorylation. Additionally, MAG balanced the expression of sex-determining region Y-box 9 and runt-related transcription factor 2 to facilitate hypertrophic differentiation. These results indicated that MAG was a potential drug to improve the efficacy of endochondral ossification-based bone repair in massive bone defects.Bai, Y., Liu, C., Fu, L., Gong, X., Dou, C., Cao, Z., Quan, H., Li, J., Kang, F., Dai, J., Zhao, C., Dong, S. Mangiferin enhances endochondral ossification-based bone repair in massive bone defect by inducing autophagy through activating AMP-activated protein kinase signaling pathway.	[Bai, Yun; Liu, Chuan] Third Mil Med Univ, Sch Basic Med, Dept Anat Histol & Embryol, Chongqing, Peoples R China; [Bai, Yun; Liu, Chuan; Gong, Xiaoshan; Dou, Ce; Cao, Zhen; Quan, Hongyu; Li, Jianmei; Kang, Fei; Dai, Jingjin; Zhao, Chunrong; Dong, Shiwu] Third Mil Med Univ, Sch Biomed Engn, Dept Biomed Mat Sci, Gaotanyan St 30, Chongqing 400038, Peoples R China; [Dong, Shiwu] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Liu, Chuan] Peoples Liberat Army, Army Gen Hosp, Inst Trauma Orthoped, Beijing, Peoples R China; [Fu, Lei] Peoples Liberat Army, Hosp 89, Inst Trauma Orthoped, Weifang, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Dong, SW (corresponding author), Third Mil Med Univ, Sch Biomed Engn, Dept Biomed Mat Sci, Gaotanyan St 30, Chongqing 400038, Peoples R China.	dongshiwu@tmmu.edu.cn	Dou, Ce/B-8841-2012	Dou, Ce/0000-0002-6983-6354	National Key Technology Research and Development Program of China [2017YFC1103300]; Nature Science Foundation of China [81271980]; Key Project of Logistics Research Plan of the People's Liberation Army (PLA) [BWS13C014]	National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Logistics Research Plan of the People's Liberation Army (PLA)	This work was funded by grants from the National Key Technology Research and Development Program of China (2017YFC1103300), Nature Science Foundation of China (81271980), and Key Project of Logistics Research Plan of the People's Liberation Army (PLA; BWS13C014). The authors declare no conflicts of interest.	Andreu GP, 2005, EUR J PHARMACOL, V513, P47, DOI 10.1016/j.ejphar.2005.03.007; Ang E, 2011, J CELL BIOCHEM, V112, P89, DOI 10.1002/jcb.22800; Bach Quang Le, 2017, Bioengineering-Basel, V4, DOI 10.3390/bioengineering4020035; Bahney CS, 2016, TISSUE ENG PT A, V22, P427, DOI [10.1089/ten.tea.2014.0705, 10.1089/ten.TEA.2014.0705]; Bernhard J, 2017, BIOMATERIALS, V139, P202, DOI 10.1016/j.biomaterials.2017.05.045; BRIGHTON CT, 1972, J BONE JOINT SURG AM, VA 54, P323, DOI 10.2106/00004623-197254020-00010; Cao Z, 2018, J CELL PHYSIOL, V233, P2332, DOI 10.1002/jcp.26105; Carames B, 2015, ARTHRITIS RHEUMATOL, V67, P1568, DOI 10.1002/art.39073; Cinque L, 2015, NATURE, V528, P272, DOI 10.1038/nature16063; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Gao S, 2014, EXP BIOL MED, V239, P366, DOI 10.1177/1535370213518169; Gawlitta D, 2010, TISSUE ENG PART B-RE, V16, P385, DOI [10.1089/ten.teb.2009.0712, 10.1089/ten.TEB.2009.0712]; Gold-Smith F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070396; HEPPENSTALL RB, 1975, CLIN ORTHOP RELAT R, P357; Hinton RJ, 2017, J DENT RES, V96, P23, DOI 10.1177/0022034516668321; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaivalya M, 2011, J BIOCHEM MOL TOXIC, V25, P108, DOI 10.1002/jbt.20366; Kang XM, 2017, J BONE MINER RES, V32, P2128, DOI 10.1002/jbmr.3134; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Knuth CA, 2017, EUR CELLS MATER, V34, P142, DOI 10.22203/eCM.v034a10; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Oliveira SM, 2009, TISSUE ENG PT A, V15, P635, DOI 10.1089/ten.tea.2008.0052; Pal PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107220; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Shen C, 2015, APOPTOSIS, V20, P1176, DOI 10.1007/s10495-015-1146-9; Srinivas V, 2009, CELLS TISSUES ORGANS, V189, P88, DOI 10.1159/000151428; Tchetina EV, 2013, ARTHRITIS, DOI 10.1155/2013/461486; Thompson EM, 2016, TISSUE ENG PT A, V22, P556, DOI [10.1089/ten.tea.2015.0457, 10.1089/ten.TEA.2015.0457]; Vuppalapati KK, 2015, J BONE MINER RES, V30, P2249, DOI 10.1002/jbmr.2575; Wang XF, 2015, AUTOPHAGY, V11, P1998, DOI 10.1080/15548627.2015.1091551; Xia G, 2017, BIOCHEM BIOPH RES CO, V491, P807, DOI 10.1016/j.bbrc.2017.06.184; Xing JC, 2014, J SURG RES, V192, P454, DOI 10.1016/j.jss.2014.05.037; Yan B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11151; Yu YY, 2010, BONE, V47, P65, DOI 10.1016/j.bone.2010.03.012; Zhang MA, 2013, APOPTOSIS, V18, P423, DOI 10.1007/s10495-013-0811-0; Zhang QJ, 2017, AFR J TRADIT COMPLEM, V14, P263, DOI 10.21010/ajtcam.v14i1.28; Zhang Y, 2015, ANN RHEUM DIS, V74, P1432, DOI 10.1136/annrheumdis-2013-204599; Zhou JM, 2015, BBA-MOL CELL RES, V1853, P370, DOI 10.1016/j.bbamcr.2014.11.003	41	19	21	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4573	4584		10.1096/fj.201701411R	http://dx.doi.org/10.1096/fj.201701411R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29547701				2022-12-28	WOS:000439325400042
J	Jover, E; Silvente, A; Marin, F; Martinez-Gonzalez, J; Orriols, M; Martinez, CM; Puche, CM; Valdes, M; Rodriguez, C; Hernandez-Romero, D				Jover, Eva; Silvente, Ana; Marin, Francisco; Martinez-Gonzalez, Jose; Orriols, Mar; Martinez, Carlos M.; Maria Puche, Carmen; Valdes, Mariano; Rodriguez, Cristina; Hernandez-Romero, Diana			Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification	FASEB JOURNAL			English	Article						PLOD1; LOX; BAPN; dipyridyl; extracellular matrix	CORONARY-ARTERY CALCIFICATION; CALCIUM-PHOSPHATE DEPOSITION; LYSYL OXIDASE LOX; ATHEROSCLEROTIC LESIONS; MYOCARDIAL COLLAGEN; OXIDATIVE STRESS; OSTEOBLASTS; EXPRESSION; STIFFNESS; CULTURE	Vascular smooth muscle cells (VSMCs) transdifferentiate into osteoblast-like cells during vascular calcification, inducing active remodeling and calcification of the extracellular matrix (ECM). Intracellular and extracellular enzymes, such as lysyl hydroxylase 1 (PLOD1) and lysyl oxidase (LOX), contribute to ECM maturation and stabilization. We assessed the contribution of these enzymes to hyperphosphatemia-induced calcification. Human and murine VSMCs were differentiated into functional osteoblast-like cells by high-phosphate medium (HPM) conditioning. HPM promoted ECM calcification and up-regulated osteoblast markers associated with induction of LOX and PLOD1 expression and with an increase in ECM-insoluble collagen deposition. Murine VSMCs from transgenic mice overexpressing LOX (TgLOX) exhibited an increase in HPM-dependent calcification and osteoblast commitment compared with wild-type cells. Similarly, enhanced HPM-induced calcification was detected in aorta from TgLOX. Conversely, -aminopropionitrile (a LOX inhibitor) and LOX knockdown abrogated VSMC calcification and transdifferentiation. We found a significant positive association between LOX expression and vascular calcification in human atherosclerotic lesions. Likewise, 2,2-dipyridil (a PLOD inhibitor) and PLOD1 knockdown impaired HPM-induced ECM mineralization and osteoblast commitment. Our findings identify LOX and PLOD as critical players in vascular calcification and highlight the importance of ECM remodeling in this process.Jover, E., Silvente, A., Marin, F., Martinez-Gonzalez, J., Orriols, M., Martinez, C. M., Puche, C. M., Valdes, M., Rodriguez, C., Hernandez-Romero, D. Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification.	[Jover, Eva; Silvente, Ana; Marin, Francisco; Maria Puche, Carmen; Valdes, Mariano; Hernandez-Romero, Diana] Univ Murcia, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain; [Jover, Eva] Univ Bristol, Bristol Med Sch Translat Hlth Sci, Bristol, Avon, England; [Marin, Francisco; Martinez-Gonzalez, Jose; Orriols, Mar; Valdes, Mariano; Rodriguez, Cristina; Hernandez-Romero, Diana] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Martinez-Gonzalez, Jose] Inst Invest Biomed IIB St Pau, IIBB, CSIC, Barcelona, Spain; [Martinez, Carlos M.] CIBEREHD, Madrid, Spain; [Rodriguez, Cristina] IIB St Pau, Inst Recerca Hosp, Santa Creu & St Pau Programa, ICCC, Barcelona, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Bristol; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Rodriguez, C (corresponding author), Hosp Santa Creu & Sant Pau, Pabellon ICCC,C Antoni Maria Claret 167, Barcelona 08025, Spain.; Hernandez-Romero, D (corresponding author), LAIB, IMIB Arrixaca, Lab 2 08, Calle Campo, Madrid, Spain.; Hernandez-Romero, D (corresponding author), Cartagena S-N, Murcia 30120, Spain.	crodriguezs@santpau.cat; dianahr@um.es	Garcia, Eva Jover/AAB-2523-2021; Marin, Francisco/AAD-9429-2022; Rodriguez, Cristina/D-3099-2011; MARTINEZ, CARLOS MANUEL/E-4986-2016	Garcia, Eva Jover/0000-0003-0628-9944; Rodriguez, Cristina/0000-0002-6472-5647; Marin, Francisco/0000-0001-7246-7708; MARTINEZ, CARLOS MANUEL/0000-0003-3307-1326	Spanish Society of Cardiology-Daiichi-Sankyo Project 2012; Abbott Vascular research grant; Boston Scientific research grant, Instituto de Salud Carlos III (ISCIII) [PI15/01016]; Boston Scientific research grant, Instituto de Salud Carlos III (ISCIII) [Red de Investigacion Cardiovascular] [RD12/0042/0049, RD12/0042/0053]; Ministerio de Economia, Industria y Competitividad (MINECO) [SAF2015-64767R]; Fondo Europeo de Desarrollo Regional (FEDER)	Spanish Society of Cardiology-Daiichi-Sankyo Project 2012; Abbott Vascular research grant; Boston Scientific research grant, Instituto de Salud Carlos III (ISCIII); Boston Scientific research grant, Instituto de Salud Carlos III (ISCIII) [Red de Investigacion Cardiovascular]; Ministerio de Economia, Industria y Competitividad (MINECO); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	The authors thank Dr. Perez-Andreu (Hospital Universitario Virgen de la Arrixaca) for help in obtaining surgical samples, Esther Pena (ICCC) for technical assistance in confocal studies, and Prof. Paolo Madeddu (Bristol Medical School of Translational Health Sciences). This work was supported by Spanish Society of Cardiology-Daiichi-Sankyo Project 2012, Abbott Vascular research grant and Boston Scientific research grant, Instituto de Salud Carlos III (ISCIII) [PI15/01016, Red de Investigacion Cardiovascular (RD12/0042/0049 and RD12/0042/0053)], Ministerio de Economia, Industria y Competitividad (MINECO; SAF2015-64767R), and Fondo Europeo de Desarrollo Regional (FEDER), a way to build Europe. The authors declare no conflicts of interest.	Akiyoshi T, 2016, ATHEROSCLEROSIS, V244, P51, DOI 10.1016/j.atherosclerosis.2015.11.005; Alford AI, 2010, BONE, V46, P464, DOI 10.1016/j.bone.2009.08.058; Aoki C, 2013, LAB INVEST, V93, P1170, DOI 10.1038/labinvest.2013.105; Badenhorst D, 2003, CARDIOVASC RES, V57, P632, DOI 10.1016/S0008-6363(02)00733-2; Bailey M, 2004, CARDIOVASC PATHOL, V13, P146, DOI 10.1016/S1054-8807(04)00009-2; BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Bonucci E., 2006, BIOL CALCIFICATION N, P394; Boraldi F, 2009, PROTEOM CLIN APPL, V3, P1084, DOI 10.1002/prca.200900007; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Burdan F, 2009, FOLIA HISTOCHEM CYTO, V47, P5, DOI 10.2478/v10042-009-0007-1; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; Chiu YW, 2010, KIDNEY INT, V77, P1107, DOI 10.1038/ki.2010.70; Churchman Adrian T., 2009, V467, P127, DOI 10.1007/978-1-59745-241-0_7; De la Fuente A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010496; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; GALVIN RJS, 1991, CONNECT TISSUE RES, V26, P217; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Hutson HN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163858; IKEDA H, 1994, BIOCHEM BIOPH RES CO, V200, P1701, DOI 10.1006/bbrc.1994.1648; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jover E, 2015, J MOL CELL CARDIOL, V82, P218, DOI 10.1016/j.yjmcc.2015.03.015; Kim EC, 2012, J ENDODONT, V38, P769, DOI 10.1016/j.joen.2012.03.014; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; KUBOKI Y, 1992, CALCIFIED TISSUE INT, V50, P473, DOI 10.1007/BF00296780; Kubow KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9026; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Martinez-Martinez E, 2016, J MOL CELL CARDIOL, V92, P96, DOI 10.1016/j.yjmcc.2016.01.012; Martinez-Revelles S, 2017, ANTIOXID REDOX SIGN, V27, P379, DOI 10.1089/ars.2016.6642; Nabavi N, 2008, J BIOL CHEM, V283, P19678, DOI 10.1074/jbc.M802517200; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Norton GR, 1997, CIRCULATION, V96, P1991, DOI 10.1161/01.CIR.96.6.1991; Orriols M, 2014, THROMB HAEMOSTASIS, V112, P812, DOI 10.1160/TH14-01-0024; Pischon N, 2009, CALCIFIED TISSUE INT, V85, P119, DOI 10.1007/s00223-009-9252-8; Rahman SU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112078; Rodriguez C, 2008, DRUG NEWS PERSPECT, V21, P218, DOI 10.1358/dnp.2008.21.4.1213351; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Ross M. H., 2011, HISTOLOGY; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shemesh J, 2011, AM J HYPERTENS, V24, P681, DOI 10.1038/ajh.2011.28; Shibata Y, 2013, NANOMED-NANOTECHNOL, V9, P1036, DOI 10.1016/j.nano.2013.04.008; Shindyapina AV, 2014, REJUV RES, V17, P116, DOI 10.1089/rej.2013.1475; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Sugitani Hideki, 2002, J Atheroscler Thromb, V9, P292; Trion A, 2004, AM HEART J, V147, P808, DOI 10.1016/j.ahj.2003.10.047; Villa-Bellosta R, 2011, CIRC J, V75, P2705, DOI 10.1253/circj.CJ-11-0477; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Wei Y, 2017, J CLIN INVEST, V127, P3675, DOI 10.1172/JCI94624; Wilson R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014159; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	56	39	39	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4459	4469		10.1096/fj.201700653R	http://dx.doi.org/10.1096/fj.201700653R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29547702				2022-12-28	WOS:000439325400033
J	Tomilin, V; Reif, GA; Zaika, O; Wallace, DP; Pochynyuk, O				Tomilin, Viktor; Reif, Gail A.; Zaika, Oleg; Wallace, Darren P.; Pochynyuk, Oleh			Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+](i) homeostasis in human autosomal-dominant polycystic kidney disease cells	FASEB JOURNAL			English	Article						distal tubule; polycystins; glycosylation	EPITHELIAL NA+ CHANNEL; COLLECTING DUCT CELLS; DISTAL NEPHRON; TRPV4 CHANNEL; MOLECULAR DETERMINANTS; CALCIUM-ENTRY; FLOW; ALDOSTERONE; ACTIVATION; SECRETION	Autosomal-dominant polycystic kidney disease (ADPKD) is a devastating disorder that is characterized by a progressive decline in renal function as a result of the development of fluid-filled cysts. Defective flow-mediated [Ca2+](i) responses and disrupted [Ca2+](i) homeostasis have been repeatedly associated with cyst progression in ADPKD. We have previously demonstrated that the transient receptor potential vanilloid type 4 (TRPV4) channel is imperative for flow-mediated [Ca2+](i) responses in murine distal renal tubule cells. To determine whether compromised TRPV4 function contributes to aberrant Ca2+ regulation in ADPKD, we assessed TRPV4 function in primary cells that were cultured from ADPKD and normal human kidneys (NHKs). Single-channel TRPV4 activity and TRPV4-dependent Ca2+ influxes were drastically reduced in ADPKD cells, which correlated with distorted [Ca2+](i) signaling. Whereas total TRPV4 protein levels were comparable in NHK and ADPKD cells, we detected a marked decrease in TRPV4 glycosylation in ADPKD cells. Tunicamycin-induced deglycosylation inhibited TRPV4 activity and compromised [Ca2+](i) signaling in NHK cells. Overall, we demonstrate that TRPV4 glycosylation and channel activity are diminished in human ADPKD cells compared with NHK cells, and that this contributes significantly to the distorted [Ca2+](i) dynamics. We propose that TRPV4 stimulation may be beneficial for restoring [Ca2+](i) homeostasis in cyst cells, thereby interfering with ADPKD progression.Tomilin, V., Reif, G. A., Zaika, O., Wallace, D. P., Pochynyuk, O. Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+](i) homeostasis in human autosomal-dominant polycystic kidney disease cells.	[Tomilin, Viktor; Zaika, Oleg; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA; [Reif, Gail A.; Wallace, Darren P.] Univ Kansas, Med Ctr, Jared Grantham Kidney Inst, Kansas City, KS 66103 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Kansas; University of Kansas Medical Center	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	oleh.m.pochynyuk@uth.tmc.edu		Wallace, Darren/0000-0003-4616-7669	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK095029, R01-DK081579]; American Heart Association Grant [17GRNT33660488]; American Society of Nephrology Ben J. Lipps Research Fellowship; University of Kansas Cancer Center's Biospecimen Repository [P30-CA168524]; PKD Biomarkers and Biomaterials Core in the Kansas PKD Research and Translational Core Center at University of Kansas Medical Center [DK106912]; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK106912, R01DK081579, R01DK095029, R01DK119170] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Grant(American Heart Association); American Society of Nephrology Ben J. Lipps Research Fellowship; University of Kansas Cancer Center's Biospecimen Repository; PKD Biomarkers and Biomaterials Core in the Kansas PKD Research and Translational Core Center at University of Kansas Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK095029 (to O.P.) and R01-DK081579 (D.P.W.), American Heart Association Grant 17GRNT33660488 (to O.P.), and the American Society of Nephrology Ben J. Lipps Research Fellowship (to V.T.). Human tissues were obtained with the assistance of the University of Kansas Cancer Center's Biospecimen Repository (P30-CA168524) and hospitals participating in the PKD Foundation's tissue donation program. Primary cultures of ADPKD and NHK cells were generated by the PKD Biomarkers and Biomaterials Core in the Kansas PKD Research and Translational Core Center at University of Kansas Medical Center (DK106912; to D.P.W.). The authors declare no conflicts of interest.	Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Du J, 2012, J AM SOC NEPHROL, V23, P1172, DOI 10.1681/ASN.2011100972; Ecder T, 2013, CURR HYPERTENS REV, V9, P2, DOI 10.2174/1573402111309010002; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Inoue Y, 2014, J AM SOC NEPHROL, V25, P2789, DOI 10.1681/ASN.2013060614; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Lamande SR, 2011, NAT GENET, V43, P1142, DOI 10.1038/ng.945; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Mamenko M, 2015, AM J PHYSIOL-RENAL, V308, pF275, DOI 10.1152/ajprenal.00485.2014; Mamenko M, 2013, HYPERTENSION, V62, P1111, DOI 10.1161/HYPERTENSIONAHA.113.01797; Mamenko M, 2013, J BIOL CHEM, V288, P20306, DOI 10.1074/jbc.M113.466797; Mamenko Mykola, 2013, Methods Mol Biol, V998, P371, DOI 10.1007/978-1-62703-351-0_29; Mamenko M, 2012, HYPERTENSION, V60, P1234, DOI 10.1161/HYPERTENSIONAHA.112.200469; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Mamenko MV, 2017, KIDNEY INT, V91, P1398, DOI 10.1016/j.kint.2016.12.010; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Mekahli D, 2013, CELL MOL LIFE SCI, V70, P2697, DOI 10.1007/s00018-012-1188-x; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Pei Y, 2011, NEPHRON CLIN PRACT, V118, pC19, DOI 10.1159/000320887; Pinto CS, 2016, J AM SOC NEPHROL, V27, P1124, DOI 10.1681/ASN.2015010047; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2009, J BIOL CHEM, V284, P25512, DOI 10.1074/jbc.M109.015917; Prieto MC, 2017, AM J PHYSIOL-RENAL, V313, pF1243, DOI 10.1152/ajprenal.00152.2017; Retailleau K, 2014, J PHYSIOL-LONDON, V592, P2453, DOI 10.1113/jphysiol.2014.271346; Siroky BJ, 2006, AM J PHYSIOL-RENAL, V290, pF1320, DOI 10.1152/ajprenal.00463.2005; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Torres VE, 2012, NAT REV NEPHROL, V8, P66, DOI 10.1038/nrneph.2011.196; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 1997, AM J KIDNEY DIS, V30, P703, DOI 10.1016/S0272-6386(97)90496-0; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zhang ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073424	57	12	12	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4612	4623		10.1096/fj.201701535RR	http://dx.doi.org/10.1096/fj.201701535RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29553832	Green Published			2022-12-28	WOS:000439325400045
J	Wang, YF; Huang, YT; Liu, YB; Li, JP; Hao, YL; Yin, PH; Liu, ZJ; Chen, JZ; Wang, Y; Wang, NP; Zhang, P				Wang, Yinfang; Huang, Yitong; Liu, Youbin; Li, Jinping; Hao, Yilong; Yin, Peihao; Liu, Zongjun; Chen, Jingzhou; Wang, Ying; Wang, Nanping; Zhang, Peng			Microtubule associated tumor suppressor 1 interacts with mitofusins to regulate mitochondrial morphology in endothelial cells	FASEB JOURNAL			English	Article						MTUS1; angiogenesis; reactive oxygen species	ANGIOGENIC FUNCTION; FUSION; PROTEIN; FISSION; IDENTIFICATION; CONTRIBUTES; DYSFUNCTION; EXPRESSION; DYNAMICS; DISEASE	Mitochondria are dynamic organelles that are able to change their morphology and cellular distribution by either fission or fusion. However, the molecular mechanisms controlling mitochondrial dynamics in vascular endothelial cells (ECs) remain largely unknown. In this study, we observed that knockdown of microtubule-associated tumor suppressor 1 (MTUS1) in ECs inhibited tube formation and migration, accompanied with decreased promigratory signalings. We showed that MTUS1 was localized in the outer membrane of mitochondria in ECs. Knockdown of MTUS1 disturbed the elongated mitochondrial network and induced the formation of perinuclear clusters of mitochondria. Importantly, mitochondrial motility and fusion were suppressed, whereas generation of reactive oxygen species was increased in MTUS1 knockdown ECs. Mechanistically, we showed that the N-terminal coiled-coil domain of MTUS1 interacted with the mitochondrial membrane proteins, mitofusin-1 and mitofusin-2, to maintain mitochondrial morphology in ECs. This study illustrated a novel role of MTUS1 in mitochondrial morphology and EC angiogenic responses.Wang, Y., Huang, Y., Liu, Y., Li, J., Hao, Y., Yin, P., Liu, Z., Chen, J., Wang, Y., Wang, N., Zhang, P. Microtubule associated tumor suppressor 1 interacts with mitofusins to regulate mitochondrial morphology in endothelial cells.	[Wang, Yinfang; Huang, Yitong; Li, Jinping; Hao, Yilong; Yin, Peihao; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China; [Liu, Youbin; Liu, Zongjun; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovasc Med, Shanghai, Peoples R China; [Chen, Jingzhou] Chinese Acad Med Sci, Key Lab Clin Cardiovasc Genet, Peking Union Med Coll, Sino German Lab Mol Med,Fuwai Hosp,Minist Educ, Beijing, Peoples R China; [Wang, Ying] Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China; [Zhang, Peng] Anhui Med Univ, Shanghai Putuo Cent Sch Clin Med, Hefei, Anhui, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Mayo Clinic; Dalian Medical University; Anhui Medical University	Liu, ZJ; Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovasc Med, Cent Lab, 164 Rd Lanxi, Shanghai 200062, Peoples R China.	lzj72@126.com; zhangnep@hotmail.com		Wang, Nanping/0000-0002-8528-8132; Wang, Ying/0000-0002-7852-386X	National Natural Science Foundation of China [81570398, 81770443, 81502142, 81774076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Aihua Li (Department of Hematology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) for technical assistance and plasmid and adenovirus construction. This study was supported by the National Natural Science Foundation of China (81570398, 81770443, 81502142, and 81774076). The authors declare no conflicts of interest.	Bundschu K, 2014, DEV DYNAM, V243, P699, DOI 10.1002/dvdy.24102; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fujita T, 2009, HYPERTENSION, V53, P688, DOI 10.1161/HYPERTENSIONAHA.108.128140; Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779; Garcia-Quintans N, 2016, FREE RADICAL BIO MED, V93, P41, DOI 10.1016/j.freeradbiomed.2016.01.021; Giedt RJ, 2012, FREE RADICAL BIO MED, V52, P348, DOI [10.1016/j.freeradbiomed.2011.10.491, 10.1007/s10439-012-0568-6]; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ito S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003521; Li JM, 2007, MOL ENDOCRINOL, V21, P499, DOI 10.1210/me.2006-0005; Lin JR, 2015, ARTERIOSCL THROM VAS, V35, P1413, DOI 10.1161/ATVBAHA.115.305706; Lin ZX, 2016, EUR J PHARMACOL, V793, P76, DOI 10.1016/j.ejphar.2016.10.039; Lugus JJ, 2011, J MOL CELL CARDIOL, V51, P885, DOI 10.1016/j.yjmcc.2011.07.023; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Modjtahedi N, 2016, TRENDS BIOCHEM SCI, V41, P245, DOI 10.1016/j.tibs.2015.12.004; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Pyakurel A, 2015, MOL CELL, V58, P244, DOI 10.1016/j.molcel.2015.02.021; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wang YF, 2017, FASEB J, V31, P2026, DOI 10.1096/fj.201600988RR; Wang YF, 2015, AM J PHYSIOL-CELL PH, V308, pC496, DOI 10.1152/ajpcell.00317.2014; Wang YY, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.603.9125; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Williamson C.D., 2015, CURR PROTOC CELL BIO, V68; Zhang J., 2010, INT J PSYCHOL STUDIE, V2, P1, DOI DOI 10.1038/NC0MMS1099; Zhao TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1209-x; Zhou Q, 2015, VASC PHARMACOL, V72, P163, DOI 10.1016/j.vph.2015.05.007; Zuern C, 2012, INT J ONCOL, V40, P1079, DOI 10.3892/ijo.2011.1311	40	7	7	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4504	4518		10.1096/fj.201701143RR	http://dx.doi.org/10.1096/fj.201701143RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29558204				2022-12-28	WOS:000439325400037
J	Wei, JX; Dong, S; Yao, KN; Martinez, MFYM; Fleisher, PR; Zhao, YT; Ma, HC; Zhao, J				Wei, Jianxin; Dong, Su; Yao, Kangning; Martinez, Maria Francesca Ysabelle M.; Fleisher, Paine R.; Zhao, Yutong; Ma, Haichun; Zhao, Jing			Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit	FASEB JOURNAL			English	Article						ubiquitination; protein stability; Cdc42 GTPase	DEGRADATION; STABILITY; MIGRATION; COMPLEX; TARGET; SKP2	Ubiquitin E3 ligases mediate ubiquitination and degradation of intracellular proteins. We have shown that a relatively new Skp, Cullin, F-box (SCF) protein E3 ligase, SCF FBXL19, has an anti-inflammatory effect and controls actin cytoskeleton dynamics via targeting cell membrane receptor and small GTPases for their ubiquitination and degradation, but the molecular regulation of its subunit FBXL19 stability remains unclear. Here we show that FBXL19 degradation is controlled by the balance between its ubiquitination and acetylation. FBXL19 is an unstable protein with a half-life of approximate to 3 h. FBXL19 can be polyubiquitinated, and the proteasome inhibitor MG-132 prolongs FBXL19 half-life, suggesting that FBXL19 degradation is mediated in the ubiquitin-proteasome system. FBXL19 can also be acetylated, and enhancing acetylation of FBXL19 by a deacetylase inhibitor reduces FBXL19 ubiquitination levels. Acetylation-mimic FBXL19 mutant exhibits a longer half-life than wild type. An acetyltransferase CBP catalyzes acetylation of FBXL19. Inhibition or down-regulation of CBP reduces FBXL19 stability, whereas it is increased in CBP-overexpressing cells. Taken together, the data indicate that CBP-mediated acetylation reduces ubiquitination and stabilizes FBXL19. Further, we demonstrate that FBXL19 targets small GTPase Cdc42 for its ubiquitination and degradation, whereas this effect is reversed by inhibition of CBP, suggesting that CBP increases the effect of SCF FBXL19 E3 ligase through acetylation and stabilization of FBXL19. Our study reveals a new molecular model for regulation of SCF E3 ligase function by acetylation and stabilization of its subunit F-box protein.Wei, J., Dong, S., Yao, K., Martinez, M. F. Y. M., Fleisher, P. R., Zhao, Y., Ma, H., Zhao, J. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.	[Wei, Jianxin; Dong, Su; Yao, Kangning; Martinez, Maria Francesca Ysabelle M.; Fleisher, Paine R.; Zhao, Yutong; Zhao, Jing] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Dong, Su; Ma, Haichun] Jilin Univ, Hosp 1, Dept Anesthesia, Changchun, Jilin, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jilin University	Zhao, J (corresponding author), Univ Pittsburgh, Dept Med, 3459 Fifth Ave,NW 628 MUH, Pittsburgh, PA 15213 USA.	zhaoj@upmc.edu			U.S. National Institutes of Health [R01 HL112791, HL136294, HL131665, R01GM115389]; American Lung Association Biomedical Research [RG350146]; American Heart Association [16GRNT30660001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136294, R01HL131665, R01HL112791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Biomedical Research; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Mary J. Kaltreider (Department of Medicine, University of Pittsburgh) for technical assistance. This study was supported by U.S. National Institutes of Health Grants R01 HL112791, HL136294, and HL131665 (National Heart, Lung, and Blood Institute; to Y.Z.) and R01GM115389 (National Institute of General Medical Sciences; to J.Z.); by American Lung Association Biomedical Research Grant RG350146 (to J.Z.); and by American Heart Association Grant 16GRNT30660001 (to Y.Z.). The authors declare no conflicts of interest.	Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Dong S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-76; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hochstrasser Mark, 1992, Current Opinion in Cell Biology, V4, P1024, DOI 10.1016/0955-0674(92)90135-Y; Hu G, 1999, MOL CELL BIOL, V19, P724; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; Murali A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.305; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Wei JX, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9660; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; WILKINSON KD, 1987, ANTI-CANCER DRUG DES, V2, P211; Willems AR, 1999, PHILOS T ROY SOC B, V354, P1533, DOI 10.1098/rstb.1999.0497; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhao J, 2013, FASEB J, V27, P2611, DOI 10.1096/fj.12-223099; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341	31	13	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4284	4292		10.1096/fj.201701069R	http://dx.doi.org/10.1096/fj.201701069R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29522376	Bronze, Green Published			2022-12-28	WOS:000439325400019
J	Chiang, N; Riley, IR; Dalli, J; Rodriguez, AR; Spur, BW; Serhan, CN				Chiang, Nan; Riley, Ian R.; Dalli, Jesmond; Rodriguez, Ana R.; Spur, Bernd W.; Serhan, Charles N.			New maresin conjugates in tissue regeneration pathway counters leukotriene D-4-stimulated vascular responses	FASEB JOURNAL			English	Article						resolution; inflammation; resolvin; omega-3; leukocyte; lipoxygenase	CIONA-INTESTINALIS; LIPID MEDIATORS; INFLAMMATION; RESOLUTION; BIOSYNTHESIS; SELECTIVITY; RECEPTORS; ENZYMES	Resolution of acute inflammation is governed, in part, by lipid mediator class switching from proinflammatory eicosanoids to specialized proresolving mediators, including a recently identified new pathway of mediators, termed maresin conjugates in tissue regeneration (MCTR), which includes MCTR1, MCTR2, and MCTR3. Here, we addressed whether each MCTR can impact the known vascular actions of cysteinyl leukotrienes. Leukotriene D-4 (LTD4; 1.5 nmol/mouse) initiated vascular leakage in mouse cremaster vessels, which was reduced (>75%) by MCTR1 and MCTR2 (0.15 nmol each). With isolated Ciona intestinalis (sea squirt) primordial hearts, LTD4 (1-100 nM) induced negative inotropic action and lowered heartbeats 20-30%. Each MCTR (1-100 nM) prevented LTD4-reduced heart rates. With human cysteinyl leukotriene receptor-1 (CysLT1) expressed in CHO cells, each MCTR (10-100 nM) significantly reduced LTD4-initiated signaling. To assess the contribution of CysLT1 in the proresolving actions of MCTR, we carried out human macrophage (M phi) phagocytosis. Each MCTR (0.1-10 nM) stimulated human M phi phagocytosis of live Escherichia coli, whereas LTD4 did not stimulate phagocytosis. MCTR-activated phagocytosis was significantly blocked by a pharmacologic receptor antagonist (MK571). With both CHO-CysLT1 and human M phi s, each MCTR competed for specific [H-3]-LTD4 binding with apparent lower affinity than LTD4. Thus, each MCTR functionally interacts with human CysLT1 to pharmacologically counter-regulate vascular responses and stimulate physiologic phagocytosis with M phi s.Chiang, N., Riley, I. R., Dalli, J., Rodriguez, A. R., Spur, B. W., Serhan, C. N. New maresin conjugates in tissue regeneration pathway counters leukotriene D-4-stimulated vascular responses.	[Chiang, Nan; Riley, Ian R.; Dalli, Jesmond; Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA; [Chiang, Nan; Riley, Ian R.; Dalli, Jesmond; Serhan, Charles N.] Harvard Med Sch, Boston, MA USA; [Rodriguez, Ana R.; Spur, Bernd W.] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ USA; [Dalli, Jesmond] John Vane Sci Ctr, William Harvey Res Inst, London, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rowan University; Rowan University School of Osteopathic Medicine; University of London; Queen Mary University London	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Harvard Inst Med, 60 Fenwood Rd,BTM 3-016, Boston, MA 02115 USA.	cserhan@partners.org	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Spur, Bernd/0000-0002-7581-4741; Dalli, Jesmond/0000-0001-6328-3640; Rodriguez Rosich, Ana/0000-0002-4802-2845	U.S. National Institutes of Health, National Institute of General Medical Sciences [P01-GM095467, R01-GM38765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Enis Hrustic (Center for Marine Research, Ruder Boskovic Institute, Rovinj, Croatia) for helpful discussion, and Mary Small (Brigham and Women's Hospital, Boston, MA, USA) for assistance with manuscript preparation. This work was supported, in part, by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants P01-GM095467 and R01-GM38765 (to C.N.S.). The authors declare no conflicts of interest.	Aagaard L, 2014, INT J CLIN PHARM-NET, V36, P243, DOI 10.1007/s11096-014-9924-y; Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Capra V, 2004, BIOCHEM PHARMACOL, V67, P1569, DOI 10.1016/j.bcp.2003.12.027; Dalli J, 2016, P NATL ACAD SCI USA, V113, P12232, DOI 10.1073/pnas.1607003113; Dalli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149319; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Davidson B, 2007, SEMIN CELL DEV BIOL, V18, P16, DOI 10.1016/j.semcdb.2006.12.007; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Gronert K, 2001, AM J PATHOL, V158, P3, DOI 10.1016/S0002-9440(10)63937-5; HATTORI Y, 1984, J PHARMACOL EXP THER, V230, P646; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Knight J, 1999, BBA-MOL CELL BIOL L, V1436, P467, DOI 10.1016/S0005-2760(98)00153-2; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; KURACHI Y, 1989, NATURE, V337, P555, DOI 10.1038/337555a0; Levi R., 1988, BIOL LEUKOTRIENES; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Peters MF, 2009, J BIOMOL SCREEN, V14, P246, DOI 10.1177/1087057108330115; Piper P. J., 1981, SRS LEUKOTRIENES; Pope EC, 2002, J EXP BIOL, V205, P1577; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Rodriguez AR, 2015, TETRAHEDRON LETT, V56, P3936, DOI 10.1016/j.tetlet.2015.04.131; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687	26	28	28	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4043	4052		10.1096/fj.201701493R	http://dx.doi.org/10.1096/fj.201701493R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29490167	Green Published, Bronze			2022-12-28	WOS:000435104500047
J	Jia, WW; Wu, WJ; Yang, D; Xiao, CX; Su, ZH; Huang, Z; Li, ZZ; Qin, M; Huang, MW; Liu, SY; Long, F; Mao, JC; Liu, XH; Zhu, YZ				Jia, Wanwan; Wu, Weijun; Yang, Di; Xiao, Chenxi; Su, Zhenghua; Huang, Zheng; Li, Zhongzheng; Qin, Ming; Huang, Mengwei; Liu, Siyu; Long, Fen; Mao, Jianchun; Liu, Xinhua; Zhu, Yi Zhun			Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis	FASEB JOURNAL			English	Article						platelet-derived growth factor; epigenetic alteration; proliferating cell nuclear antigen; GSK J4	CELL NUCLEAR ANTIGEN; NF-KAPPA-B; GROWTH-FACTOR; SYNOVIAL FIBROBLASTS; H3K27 DEMETHYLASE; INHIBITION; INFLAMMATION; EPIGENETICS; GENE; PCNA	Rheumatoid arthritis (RA) is an immune-mediated disease with the characteristics of progressive joint destruction, deformity, and disability. Epigenetic changes have been implicated in the development of some autoimmune disorders, resulting in an alteration of gene transcription. Here, we investigated how Jumonji C family of histone demethylases (JMJD3) regulated the proliferation and activation of fibroblast-like synoviocytes (FLSs), which are involved in RA joint destruction and pathologic process. The JMJD3 expression and proliferation markers in RA-FLS were higher than those in healthy-FLS and were upregulated in platelet-derived growth factor (PDGF)-induced FLS. Elevated JMJD3 promoted the proliferation and migration of FLS. Treatment with JMJD3 small interfering RNA or inhibitor glycogen synthase kinase (GSK) J4 led to decreased proliferation and migration of FLS. Interestingly, induction of proliferating cell nuclear antigen (PCNA), a major player of the cell-cycle regulation, was correlated with trimethylated lysine 27 in histone H3 loss around the gene promoters. The knockdown of JMJD3 abolished PCNA expression in PDGF-induced FLS and further inhibited cell proliferation and migration, suggesting that JMJD3/PCNA played a crucial role in aspects of FLS proliferation and migration. In vivo, the ability of GSK J4 to hinder collagen-induced arthritis (CIA) in DBA/1 mice was evaluated. We found that GSK J4 markedly attenuated the severity of arthritis in CIA mice. The therapeutic effects were associated with ameliorated joint swelling and reduced bone erosion and destruction. This study revealed how JMJD3 integrated with epigenetic processes to regulate RA-FLS proliferation and invasion. These data suggested that JMJD3 might contribute to rheumatoid synovial hyperplasia and have the potential as a novel therapeutic target for RA.Jia, W., Wu, W., Yang, D., Xiao, C., Su, Z., Huang, Z., Li, Z., Qin, M., Huang, M., Liu, S., Long, F., Mao, J., Liu, X., Zhu, Y. Z. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.	[Jia, Wanwan; Wu, Weijun; Yang, Di; Xiao, Chenxi; Su, Zhenghua; Qin, Ming; Huang, Mengwei; Liu, Siyu; Long, Fen; Liu, Xinhua; Zhu, Yi Zhun] Fudan Univ, Shanghai Key Lab Bioact Small Mol, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Jia, Wanwan; Zhu, Yi Zhun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Jia, Wanwan; Zhu, Yi Zhun] Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China; [Huang, Zheng] Shanghai Univ Tradit Chinese Med, Guanghua Integrat Med Hosp, Shanghai Acad Chinese Med Sci, Inst Arthrit Res, Shanghai, Peoples R China; [Li, Zhongzheng] Ninth Hosp, Ningbo, Zhejiang, Peoples R China; [Mao, Jianchun] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Rheumatol, Shanghai, Peoples R China	Fudan University; Macau University of Science & Technology; Macau University of Science & Technology; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Zhu, YZ (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China.; Liu, XH (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai, Peoples R China.	liuxinhua@fudan.edu.cn; yzzhu@must.edu.mo	Zhu, Yi Zhun/ABG-8449-2021; Liu, Siyu/GYV-4856-2022	Zhu, Yi Zhun/0000-0001-7700-8041; 	National Natural Science Foundation of China [81673428, 81330080]; Key Laboratory Program of the Education Commission of Shanghai Municipality [ZDSYS14005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Program of the Education Commission of Shanghai Municipality	This work was supported by grants from the National Natural Science Foundation of China (81673428; 81330080) and a Key Laboratory Program of the Education Commission of Shanghai Municipality (ZDSYS14005). The authors declare no conflicts of interest.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bottini N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0372-9; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Cheon H, 2004, SCAND J IMMUNOL, V60, P455, DOI 10.1111/j.0300-9475.2004.01505.x; Cheon H, 2002, CLIN EXP IMMUNOL, V127, P547, DOI 10.1046/j.1365-2249.2002.01785.x; Das ND, 2012, CELL BIOCHEM FUNCT, V30, P224, DOI 10.1002/cbf.1839; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Greer JM, 2012, BIOL-TARGETS THER, V6, P307, DOI 10.2147/BTT.S24067; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Juengel A, 2010, CURR OPIN RHEUMATOL, V22, P284, DOI 10.1097/BOR.0b013e3283389641; Keith MP, 2012, CLIN PHARMACOL THER, V92, P440, DOI 10.1038/clpt.2012.124; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; LAFYATIS R, 1989, J CLIN INVEST, V83, P1267, DOI 10.1172/JCI114011; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee HY, 2014, MOL CELLS, V37, P43, DOI 10.14348/molcells.2014.2250; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Morozov VM, 2017, ONCOTARGET, V8, P62131, DOI 10.18632/oncotarget.19100; Neidhart M, 2000, ARTHRITIS RHEUM, V43, P1719, DOI 10.1002/1529-0131(200008)43:8<1719::AID-ANR7>3.0.CO;2-4; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Pap T, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2005.042424; Park WY, 2016, CANCER RES, V76, P161, DOI 10.1158/0008-5472.CAN-15-0536; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; REMMERS EF, 1991, SEMIN ARTHRITIS RHEU, V21, P191, DOI 10.1016/0049-0172(91)90009-O; SANO H, 1990, J CELL BIOL, V110, P1417, DOI 10.1083/jcb.110.4.1417; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; Strietholt S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2500; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; THORNTON SC, 1991, CLIN EXP IMMUNOL, V86, P79; Trenkmann M, 2010, CLIN REV ALLERG IMMU, V39, P10, DOI 10.1007/s12016-009-8166-6; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83	42	31	32	3	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4031	4042		10.1096/fj.201701483R	http://dx.doi.org/10.1096/fj.201701483R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481307				2022-12-28	WOS:000435104500046
J	Pederson, T				Pederson, Thoru			Gene Therapy Now?	FASEB JOURNAL			English	Editorial Material																		ATCHISON RW, 1965, SCIENCE, V149, P754, DOI 10.1126/science.149.3685.754; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Bradbury R., 1962, SOMETHING WICKED THI; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Gruntman AM, 2018, FASEB J, V32, P1733, DOI 10.1096/fj.201700982R; Pederson T, 2018, FASEB J, V32, P1121, DOI 10.1096/fj.180301ufm; Pederson T, 2017, FASEB J, V31, P3711, DOI 10.1096/fj.170901ufm	7	3	3	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1731	1732		10.1096/fj.180401ufm	http://dx.doi.org/10.1096/fj.180401ufm			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29592791				2022-12-28	WOS:000429051400001
J	Bershitsky, SY; Logvinova, DS; Shchepkin, DV; Kopylova, GV; Matyushenko, AM				Bershitsky, Sergey Y.; Logvinova, Daria S.; Shchepkin, Daniil V.; Kopylova, Galina V.; Matyushenko, Alexander M.			Myopathic mutations in the beta-chain of tropomyosin differently affect the structural and functional properties of beta beta- and alpha beta-dimers	FASEB JOURNAL			English	Article						tropomyosin isoforms; actin-myosin interaction; Ca2+-regulation of muscle contraction; in vitro motility assay	2 STABILIZING SUBSTITUTIONS; ACTIN-MYOSIN INTERACTION; SKELETAL-MUSCLE; THIN FILAMENT; CARDIAC MYOSIN; MIDDLE PART; CONTRACTION; ISOFORMS; SUBFRAGMENT-1; PROTEINS	Tropomyosin (Tpm) is an actin-binding protein that plays a vital role in the regulation of muscle contraction. Fast skeletal muscles express 2 Tpm isoforms, (Tpm 1.1) and (Tpm 2.2), resulting in the existence of 2 forms of dimeric Tpm molecule: -homodimer and -heterodimer. -Homodimer is unstable and absent in the native state, despite which most of the studies of myopathy-relating Tpm mutations have been performed on the -homodimer. Here, we applied different methods to investigate the effects of myopathic mutations R133W and N202K in the -chain of Tpm on properties of -heterodimers and to compare them with the features of -homodimers with the same mutations. The results show that properties of -Tpm and -Tpm with substitutions in the -chain differ significantly, and this indicates that the effects of myopathic mutations in the Tpm -chain should be studied on the Tpm -heterodimer.Bershitsky, S. Y., Logvinova, D. S., Shchepkin, D. V., Kopylova, G. V., Matyushenko, A. M. Myopathic mutations in the -chain of tropomyosin differently affect the structural and functional properties of beta beta- and alpha beta-dimers.	[Bershitsky, Sergey Y.; Logvinova, Daria S.; Shchepkin, Daniil V.; Kopylova, Galina V.; Matyushenko, Alexander M.] Russian Acad Sci, Inst Immunol & Physiol, Ekaterinburg, Russia; [Logvinova, Daria S.; Matyushenko, Alexander M.] Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, Leninsky Prospect 33,Bldg 2, Moscow 119071, Russia	Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences	Matyushenko, AM (corresponding author), Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, Leninsky Prospect 33,Bldg 2, Moscow 119071, Russia.	ammatyushenko@mail.ru	Bershitsky, Sergey/AAE-6814-2019; Bershitsky, Sergey/S-4829-2016; Kopylova, Galina/ABF-2117-2020; Shchepkin, Daniil/ABF-1160-2020	Bershitsky, Sergey/0000-0001-5342-1739; Kopylova, Galina/0000-0003-2976-2108; 	Russian Foundation for Basic Research [16-34-00654]; Foundation for Basic Research [16-04-00688];  [01201351368];  [AAAA-A18-118020590135-3]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Foundation for Basic Research; ; 	CD measurements were carried out on the equipment of the Shared-Access Equipment Centre "Industrial Biotechnology" of Federal Research Center "Fundamentals of Biotechnology" of the Russian Academy of Sciences. This work was supported by the Russian Foundation for Basic Research Grant 16-34-00654, State Program 01201351368 to A.M.M., and Foundation for Basic Research Grant 16-04-00688 and State Program AAAA-A18-118020590135-3 to S.Y.B. The authors declare no conflicts of interest.	Abdul-Hussein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072396; Bacchiocchi C, 2002, BIOPHYS J, V82, P1524, DOI 10.1016/S0006-3495(02)75505-7; BAILEY K, 1953, PROC R SOC SER B-BIO, V141, P45, DOI 10.1098/rspb.1953.0015; Bicer S, 2013, J MUSCLE RES CELL M, V34, P211, DOI 10.1007/s10974-013-9346-9; BRONSON DD, 1982, J BIOL CHEM, V257, P3937; Clemmens EW, 2005, J PHYSIOL-LONDON, V566, P737, DOI 10.1113/jphysiol.2005.084194; Colpan M, 2017, ARCH BIOCHEM BIOPHYS, V630, P18, DOI 10.1016/j.abb.2017.07.006; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREASER ML, 1971, J BIOL CHEM, V246, P4226; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Janco M, 2012, BIOCHEMISTRY-US, V51, P9880, DOI 10.1021/bi301323n; Jin YT, 2016, J MUSCLE RES CELL M, V37, P41, DOI 10.1007/s10974-016-9443-7; Kalyva A, 2012, BIOCHEMISTRY-US, V51, P6388, DOI 10.1021/bi300340r; Khaitlina SY, 2015, INT REV CEL MOL BIO, V318, P255, DOI 10.1016/bs.ircmb.2015.06.002; Kopylova GV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P260, DOI 10.1134/S0006297913030073; Kremneva E, 2006, FEBS J, V273, P588, DOI 10.1111/j.1742-4658.2005.05092.x; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Lehman W, 2016, COMPR PHYSIOL, V6, P1043, DOI 10.1002/cphy.c150030; LEHRER SS, 1987, ARCH BIOCHEM BIOPHYS, V256, P1, DOI 10.1016/0003-9861(87)90419-X; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345; Marttila M, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-15; Marttila M, 2014, HUM MUTAT, V35, P779, DOI 10.1002/humu.22554; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Matyushenko AM, 2015, BIOPHYS CHEM, V196, P77, DOI 10.1016/j.bpc.2014.10.001; Matyushenko AM, 2014, FEBS J, V281, P2004, DOI 10.1111/febs.12756; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Muthuchamy M, 1998, J MOL CELL CARDIOL, V30, P1545, DOI 10.1006/jmcc.1998.0720; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Nevzorov IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1507, DOI 10.1134/S0006297911130098; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107; Oe M, 2016, MEAT SCI, V118, P129, DOI 10.1016/j.meatsci.2016.04.013; Ohlsson M, 2008, NEUROLOGY, V71, P1896, DOI 10.1212/01.wnl.0000336654.44814.b8; Orzechowski M, 2014, BIOPHYS J, V107, P694, DOI 10.1016/j.bpj.2014.06.034; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Cruz PMR, 2014, NEUROMUSCULAR DISORD, V24, P1103, DOI 10.1016/j.nmd.2014.07.005; Schreckenbach T, 2014, NEUROMUSCULAR DISORD, V24, P117, DOI 10.1016/j.nmd.2013.10.002; Shchepkin DV, 2011, BIOCHEM BIOPH RES CO, V415, P104, DOI 10.1016/j.bbrc.2011.10.022; Shchepkin DV, 2010, BIOCHEM BIOPH RES CO, V401, P159, DOI 10.1016/j.bbrc.2010.09.040; Shchepkin DV, 2017, BIOCHEM BIOPH RES CO, V490, P324, DOI 10.1016/j.bbrc.2017.06.043; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tajsharghi H, 2007, NEUROLOGY, V68, P772, DOI 10.1212/01.wnl.0000256339.40667.fb; Tajsharghi H, 2012, NEUROMUSCULAR DISORD, V22, P923, DOI 10.1016/j.nmd.2012.05.018; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; WILLIAMS DL, 1981, BIOCHEMISTRY-US, V20, P3856, DOI 10.1021/bi00516a029	49	8	8	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1963	1971		10.1096/fj.201800755R	http://dx.doi.org/10.1096/fj.201800755R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199282				2022-12-28	WOS:000457296600035
J	Gallot, YS; Bohnert, KR; Straughn, AR; Xiong, GY; Hindi, SM; Kumar, A				Gallot, Yann S.; Bohnert, Kyle R.; Straughn, Alex R.; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok			PERK regulates skeletal muscle mass and contractile function in adult mice	FASEB JOURNAL			English	Article						ER stress; unfolded protein response; cancer cachexia; proteostasis; lewis lung carcinoma	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; AMINO-ACID-METABOLISM; ER STRESS; TRANSLATIONAL CONTROL; POTENTIAL ROLE; GROWTH; ATROPHY; INHIBITION; PATHWAYS	Skeletal muscle mass is regulated by the coordinated activation of several anabolic and catabolic pathways. The endoplasmic reticulum (ER) is a major site of protein folding and a reservoir for calcium ions. Accretion of misfolded proteins or depletion in calcium concentration causes stress in the ER, which leads to the activation of a signaling network known as the unfolded protein response (UPR). In the present study, we investigated the role of the protein kinase R-like endoplasmic reticulum kinase (PERK) arm of the UPR in the regulation of skeletal muscle mass and function in naive conditions and in a mouse model of cancer cachexia. Our results demonstrate that the targeted inducible deletion of PERK reduces skeletal muscle mass, strength, and force production during isometric contractions. Deletion of PERK also causes a slow-to-fast fiber type transition in skeletal muscle. Furthermore, short hairpin RNA-mediated knockdown or pharmacologic inhibition of PERK leads to atrophy in cultured myotubes. While increasing the rate of protein synthesis, the targeted deletion of PERK leads to the increased expression of components of the ubiquitin-proteasome system and autophagy in skeletal muscle. Ablation of PERK also increases the activation of calpains and deregulates the gene expression of the members of the FGF19 subfamily. Furthermore, the targeted deletion of PERK increases muscle wasting in Lewis lung carcinoma tumor-bearing mice. Our findings suggest that the PERK arm of the UPR is essential for the maintenance of skeletal muscle mass and function in adult mice.Gallot, Y. S., Bohnert, K. R., Straughn, A. R., Xiong, G., Hindi, S. M., Kumar, A. PERK regulates skeletal muscle mass and contractile function in adult mice.	[Gallot, Yann S.; Bohnert, Kyle R.; Straughn, Alex R.; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	Gallot, Yann Simon/GQI-2372-2022; Straughn, Alex/AAJ-9727-2021; Gallot, Yann Simon/ABC-1826-2021; Gallot, Yann Simon/GNO-9167-2022	Gallot, Yann Simon/0000-0003-4447-1448; Straughn, Alex/0000-0002-6516-8096; Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448; Kumar, Ashok/0000-0001-8571-2848	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Disease [AG029623, AR059810, AR068313]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068313, R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Disease Grants AG029623, AR059810 and AR068313 (to A.K.) Figure 1A was produced with the assistance of Servier Medical Art (https://smart.servier.com).The authors declare no conflicts of interest.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Afroze D, 2019, FEBS J, V286, P379, DOI 10.1111/febs.14358; Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Benoit B, 2017, NAT MED, V23, P990, DOI 10.1038/nm.4363; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bohnert KR, 2018, J CELL PHYSIOL, V233, P67, DOI 10.1002/jcp.25852; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Chalil S, 2015, BIOCHEM BIOPH RES CO, V468, P702, DOI 10.1016/j.bbrc.2015.11.019; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Dutt V, 2018, BBA-GEN SUBJECTS, V1862, P895, DOI 10.1016/j.bbagen.2017.12.015; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Gallot YS, 2017, ONCOTARGET, V8, P112565, DOI 10.18632/oncotarget.22575; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindi SM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98441; Hindi SM, 2014, HUM MOL GENET, V23, P1492, DOI 10.1093/hmg/ddt536; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Li CKC, 2009, AM J PATHOL, V175, P1030, DOI 10.2353/ajpath.2009.090196; Li DJ, 2016, METABOLISM, V65, P747, DOI 10.1016/j.metabol.2016.02.009; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Ma L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186128; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Mielcarek M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005021; Miyake M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179955; Miyake M, 2016, FASEB J, V30, P798, DOI 10.1096/fj.15-275990; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Murachi T, 1980, Adv Enzyme Regul, V19, P407; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rieusset J, 2012, BIOCHEM BIOPH RES CO, V417, P439, DOI 10.1016/j.bbrc.2011.11.135; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Xiong GY, 2017, ELIFE, V6, DOI 10.7554/eLife.22871; Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zismanov V, 2016, CELL STEM CELL, V18, P79, DOI 10.1016/j.stem.2015.09.020	66	30	30	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1946	1962		10.1096/fj.201800683RR	http://dx.doi.org/10.1096/fj.201800683RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204503	Green Published			2022-12-28	WOS:000457296600034
J	Poli, G; Sarchielli, E; Guasti, D; Benvenuti, S; Ballerini, L; Mazzanti, B; Armignacco, R; Cantini, G; Lulli, M; Chortis, V; Arlt, W; Romagnoli, P; Vannelli, GB; Mannelli, M; Luconi, M				Poli, Giada; Sarchielli, Erica; Guasti, Daniele; Benvenuti, Susanna; Ballerini, Lara; Mazzanti, Benedetta; Armignacco, Roberta; Cantini, Giulia; Lulli, Matteo; Chortis, Vasileios; Arlt, Wiebke; Romagnoli, Paolo; Vannelli, Gabriella Barbara; Mannelli, Massimo; Luconi, Michaela			Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture	FASEB JOURNAL			English	Article						steroidogenesis; organoid; embryonic development; adrenal cortex; chromaffin	EXTRACELLULAR-MATRIX; GROWTH-FACTORS; ORGANOIDS; CORTEX; MOUSE; IDENTIFICATION; PROLIFERATION; BIOLOGY	The adrenal gland is a multiendocrine organ with a steroidogenic mesenchymal cortex and an inner catecholamine-producing medulla of neuroendocrine origin. After embryonic development, this plastic organ undergoes a functional postnatal remodeling. Elucidating these complex processes is pivotal for understanding the early bases of functional endocrine disorders and tumors affecting the mature gland. We developed an in vitro human adrenal cell model derived from fetal adrenal specimens at different gestational ages, consisting of neuroendocrine and cortical components and expressing the zona and functional markers of the original fetal organ. These cortical and neuroendocrine progenitor cells retain in vitro an intrinsic gestational-age-related differentiation and functional program. In vitro these cells spontaneously form 3-dimensional structure organoids with a structure similar to the fetal gland. The organoids show morphofunctional features and adrenal steroidogenic factor, steroid acute regulatory, cytochrome-P450-17A1, dosage-sensitive, sex-reversal, adrenal hypoplasia-critical region on chromosome X protein , NOTCH1, and nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3; stem (BMI1, nestin); and chromaffin (chromogranin A, tyrosine hydroxylase) markers similar to those of the populations of origin. This in vitro human adrenal system represents a unique but preliminar model for investigating the pathophysiological processes underlying physiologic adrenal remodeling and pathologic alterations involved in organ hypo- and hyperplasia and cancer.Poli, G., Sarchielli, E., Guasti, D., Benvenuti, S., Ballerini, L., Mazzanti, B., Armignacco, R., Cantini, G., Lulli, M., Chortis, V., Arlt, W., Romagnoli, P., Vannelli, G. B., Mannelli, M., Luconi, M. Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture.	[Poli, Giada; Benvenuti, Susanna; Armignacco, Roberta; Cantini, Giulia; Mannelli, Massimo; Luconi, Michaela] Univ Florence, Endocrinol Unit, Florence, Italy; [Lulli, Matteo] Univ Florence, Dept Expt & Clin Biomed Sci, Gen Pathol Unit, Florence, Italy; [Sarchielli, Erica; Guasti, Daniele; Romagnoli, Paolo; Vannelli, Gabriella Barbara] Univ Florence, Histol & Embryol Unit, Florence, Italy; [Ballerini, Lara; Mazzanti, Benedetta] Univ Florence, Dept Expt & Clin Med, Haematol Unit, Florence, Italy; [Chortis, Vasileios; Arlt, Wiebke] Univ Birmingham, IMSR, Birmingham, W Midlands, England	University of Florence; University of Florence; University of Florence; University of Florence; University of Birmingham	Luconi, M (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Endocrinol Unit, Viale Pieraccini 6, I-50139 Florence, Italy.	michaela.luconi@unifi.it	Cantini, Giulia/K-7626-2016; Romagnoli, Paolo/AAJ-9636-2020; Luconi, Michaela/W-9522-2019; Lulli, Matteo/J-8623-2016; Arlt, Wiebke/B-6310-2009	Luconi, Michaela/0000-0001-5186-064X; Lulli, Matteo/0000-0002-8528-4094; Arlt, Wiebke/0000-0001-5106-9719; CANTINI, GIULIA/0000-0002-9159-9199; DANIELE, GUASTI/0000-0002-2856-6829	Seventh Framework Program (FP7/2007-2013) Grant ENS@T-Cancer [259735]; Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant [IG2015-17691]; MRC [G0900567, G0801473] Funding Source: UKRI	Seventh Framework Program (FP7/2007-2013) Grant ENS@T-Cancer; Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research received funding from the Seventh Framework Program (FP7/2007-2013) Grant 259735 ENS@T-Cancer, and was supported by Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant IG2015-17691 (to M.L.). The authors declare no conflicts of interest.	Battista MC, 2005, J CLIN ENDOCR METAB, V90, P5426, DOI 10.1210/jc.2005-0666; Beaujean D, 2003, EXP NEUROL, V184, P348, DOI 10.1016/j.expneurol.2003.07.007; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Caroccia B, 2010, ENDOCRINOLOGY, V151, P1375, DOI 10.1210/en.2009-1243; Chamoux E, 2005, BRAZ J MED BIOL RES, V38, P1495, DOI 10.1590/S0100-879X2005001000006; Chamoux E, 2002, J CLIN ENDOCR METAB, V87, P1819, DOI 10.1210/jc.87.4.1819; Chamoux E, 2001, J CLIN ENDOCR METAB, V86, P2090, DOI 10.1210/jc.86.5.2090; Del Valle Ignacio, 2017, Wellcome Open Res, V2, P25, DOI 10.12688/wellcomeopenres.11253.2; Di Franco A, 2016, STEM CELLS, V34, P1679, DOI 10.1002/stem.2336; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; Ehrhart-Bornstein M, 2010, CELL MOL NEUROBIOL, V30, P1417, DOI 10.1007/s10571-010-9571-3; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Goto M, 2006, J CLIN INVEST, V116, P953, DOI 10.1172/JCI25091; Guasti L, 2011, MOL CELL ENDOCRINOL, V336, P117, DOI 10.1016/j.mce.2010.11.010; HAASEMATTHIAS, 2011, ENDOCR DEV, V20, P28; Hassan-Smith ZK, 2015, J CLIN ENDOCR METAB, V100, P2673, DOI 10.1210/jc.2015-1516; Huang CCJ, 2010, ENDOCRINOLOGY, V151, P1119, DOI 10.1210/en.2009-0814; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Ishimoto H, 2011, ENDOCR REV, V32, P317, DOI 10.1210/er.2010-0001; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Ivell R., 2017, ENDOCRINOLOGY TESTIS, P1; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014; Lebbe M, 2017, ENDOCRINOLOGY, V158, P1474, DOI 10.1210/en.2016-1851; Lerario AM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00052; Lumb R, 2015, DEV GROWTH DIFFER, V57, P146, DOI 10.1111/dgd.12189; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Parlato R, 2009, ENDOCRINOLOGY, V150, P1775, DOI 10.1210/en.2008-1107; Parviainen H, 2007, MOL CELL ENDOCRINOL, V265, P17, DOI 10.1016/j.mce.2006.12.033; Penny MK, 2017, MOL CELL ENDOCRINOL, V445, P42, DOI 10.1016/j.mce.2016.12.005; Ratcliffe J, 2003, J CLIN ENDOCR METAB, V88, P3272, DOI 10.1210/jc.2003-022056; Sicard F, 2007, P NATL ACAD SCI USA, V104, P2007, DOI 10.1073/pnas.0610898104; Simunovic M, 2017, DEVELOPMENT, V144, P976, DOI 10.1242/dev.143529; Spencer SJ, 1999, J CLIN ENDOCR METAB, V84, P1110, DOI 10.1210/jc.84.3.1110; Steenblock C, 2017, MOL CELL ENDOCRINOL, V441, P156, DOI 10.1016/j.mce.2016.09.011; Terada T, 2015, MICROSC RES TECHNIQ, V78, P59, DOI 10.1002/jemt.22445; Walczak EM, 2015, NAT REV ENDOCRINOL, V11, P14, DOI 10.1038/nrendo.2014.166; Wood MA, 2011, MOL CELL ENDOCRINOL, V336, P206, DOI 10.1016/j.mce.2010.11.012; Xing Y, 2017, DEVELOPMENT, V144, P3798, DOI 10.1242/dev.150516; Xing YW, 2015, ENDOCRIN METAB CLIN, V44, P243, DOI 10.1016/j.ecl.2015.02.001; Ziegler CG, 2008, ENDOCRINOLOGY, V149, P320, DOI 10.1210/en.2007-0645	41	19	22	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2263	2277		10.1096/fj.201801028RR	http://dx.doi.org/10.1096/fj.201801028RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30247985				2022-12-28	WOS:000457296600059
J	Boccella, S; Guida, F; De Logu, F; De Gregorio, D; Mazzitelli, M; Belardo, C; Iannotta, M; Serra, N; Nassini, R; de Novellis, V; Geppetti, P; Maione, S; Luongo, L				Boccella, Serena; Guida, Francesca; De Logu, Francesco; De Gregorio, Danilo; Mazzitelli, Mariacristina; Belardo, Carmela; Iannotta, Monica; Serra, Nicola; Nassini, Romina; de Novellis, Vito; Geppetti, Pierangelo; Maione, Sabatino; Luongo, Livio			Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain	FASEB JOURNAL			English	Article						dimethylfumarate; beta-hydroxybutyrate; Schwann cells; peripheral neuropathy; sciatic nerve	MULTIPLE-SCLEROSIS; POSTHERPETIC NEURALGIA; SEX-DIFFERENCES; ANIMAL-MODEL; FUMARATE; RAT; HYPERSENSITIVITY; HYDROXYBUTYRATE; PREGABALIN; GENDER	The mechanisms underlying neuropathic pain are poorly understood. Here we show the unexplored role of the hydroxyl carboxylic acid receptor type 2 (HCAR2) in 2 models of neuropathic pain. We used an oral treatment with dimethyl fumarate and the HCAR2 endogenous ligand -hydroxybutyrate (BHB) in wild-type (WT) and HCAR2-null mice. We found an up-regulation of the HCAR2 in the sciatic nerve and the dorsal root ganglia in neuropathic mice. Accordingly, acute and chronic treatment with dimethylfumarate (DMF) and BHB reduced the tactile allodynia. This effect was completely lost in the HCAR2-null mice after a 2-d starvation protocol, in which the BHB reached the concentration able to activate the HCAR2-reduced tactile allodynia in female WT mice, but not in the HCAR2-null mice. Finally, we showed that chronic treatment with DMF reduced the firing of the ON cells (cells responding with an excitation after noxious stimulation) of the rostral ventromedial medulla. Our results pave the way for investigating the mechanisms by which HCAR2 regulates neuropathic pain plasticity.Boccella, S., Guida, F., De Logu, F., De Gregorio, D., Mazzitelli, M., Belardo, C., Iannotta, M., Serra, N., Nassini, R., de Novellis, V., Geppetti, P., Maione, S., Luongo, L. Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain.	[Boccella, Serena; Guida, Francesca; Belardo, Carmela; Iannotta, Monica; de Novellis, Vito; Maione, Sabatino; Luongo, Livio] Univ Campania L Vanvitelli, Dept Expt Med, Via Costantinopoli 16, I-80138 Naples, Italy; [Serra, Nicola] Univ Campania L Vanvitelli, Dept Radiol, Naples, Italy; [De Logu, Francesco; Nassini, Romina; Geppetti, Pierangelo] Univ Florence, Sect Clin Pharmacol & Oncol, Dept Hlth Sci, Florence, Italy; [De Gregorio, Danilo] McGill Univ, Neurobiol Psychiat Unit, Dept Psychiat, Montreal, PQ, Canada; [Mazzitelli, Mariacristina] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Florence; McGill University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Maione, S; Luongo, L (corresponding author), Univ Campania L Vanvitelli, Dept Expt Med, Via Costantinopoli 16, I-80138 Naples, Italy.	sabatino.maione@unicampania.it; livio.luongo@gmail.com	Belardo, Carmela/AAA-9319-2022; de logu, francesco/AAC-5065-2022; Nassini, Romina/AAC-5051-2022; De Gregorio, Danilo/AAC-2010-2022; Luongo, Livio/GXV-1993-2022; Geppetti, Pierangelo/AHA-7897-2022	de logu, francesco/0000-0001-8360-6929; Nassini, Romina/0000-0002-9223-8395; De Gregorio, Danilo/0000-0002-8623-0661; Serra, Nicola/0000-0001-8086-6362; belardo, carmela/0000-0001-7588-462X; Maione, Sabatino/0000-0003-3850-6704	Project of National Interest (FIRB) Luongo, Futuro Ricerca 2012; University of Campania; Department of Experimental Medicine, University of Campania L. Vanvitelli	Project of National Interest (FIRB) Luongo, Futuro Ricerca 2012; University of Campania; Department of Experimental Medicine, University of Campania L. Vanvitelli	The authors thank Prof. Stefan Offermanns (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany) for kindly providing the HCAR2-null mice. This work was supported by the Project of National Interest (FIRB) Luongo, Futuro Ricerca 2012, and funding from the University of Campania (to L.L.). The authors also thank the Department of Experimental Medicine, University of Campania L. Vanvitelli for supporting the publication fees. S.B., F.G., and F.D.L. share first authorship. The authors declare no conflicts of interest.	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Clausen BH, 2017, EXP NEUROL, V295, P144, DOI 10.1016/j.expneurol.2017.06.011; Coraggio V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010281; Cordaro M, 2017, J NEUROTRAUM, V34, P3027, DOI 10.1089/neu.2016.4678; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; D'Aniello A, 2017, NEUROSCI LETT, V651, P151, DOI 10.1016/j.neulet.2017.04.041; Daemen MARC, 1998, NEUROL RES, V20, P41; De Logu F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01739-2; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dworkin RH, 2003, NEUROLOGY, V60, P1274, DOI 10.1212/01.WNL.0000055433.55136.55; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Graff EC, 2016, METABOLISM, V65, P102, DOI 10.1016/j.metabol.2015.10.001; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Gronseth G, 2008, NEUROLOGY, V71, P1183, DOI 10.1212/01.wnl.0000326598.83183.04; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kasarello K, 2017, PHARMACOL REP, V69, P702, DOI 10.1016/j.pharep.2017.02.017; Kim H, 2017, PAIN, V158, P2376, DOI 10.1097/j.pain.0000000000001042; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Makker PGS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170814; Mapplebeck JCS, 2016, PAIN, V157, pS2, DOI 10.1097/j.pain.0000000000000389; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Newman JC, 2014, DIABETES RES CLIN PR, V106, P173, DOI 10.1016/j.diabres.2014.08.009; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Offermanns S, 2017, TRENDS ENDOCRIN MET, V28, P227, DOI [10.1016/J.tem.2016.11.007, 10.1016/j.tem.2016.11.007]; Parodi B, 2015, ACTA NEUROPATHOL, V130, P279, DOI 10.1007/s00401-015-1422-3; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Qian J, 2017, BRIT J PHARMACOL, V174, P1961, DOI 10.1111/bph.13788; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Sabatowski R, 2004, PAIN, V109, P26, DOI 10.1016/j.pain.2004.01.001; Skaper SD, 2017, NEUROSCIENTIST, V23, P478, DOI 10.1177/1073858416687249; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Zou XH, 2009, BIOMATERIALS, V30, P1532, DOI 10.1016/j.biomaterials.2008.12.012	44	26	26	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1062	1073		10.1096/fj.201801033R	http://dx.doi.org/10.1096/fj.201801033R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30085883	Bronze			2022-12-28	WOS:000457401500084
J	Khan, SI; Shihata, WA; Andrews, KL; Lee, MKS; Moore, XL; Jefferis, AM; Vinh, A; Gaspari, T; Dragoljevic, D; Jennings, GL; Murphy, AJ; Chin-Dusting, JPF				Khan, Shanzana I.; Shihata, Waled A.; Andrews, Karen L.; Lee, Man K. S.; Moore, Xiao-Lei; Jefferis, Ann-Maree; Vinh, Antony; Gaspari, Tracey; Dragoljevic, Dragana; Jennings, Garry L.; Murphy, Andrew J.; Chin-Dusting, Jaye P. F.			Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat	FASEB JOURNAL			English	Article						cyclooxygenase; cardiac hypertrophy; vascular function; renal fibrosis; prostanoids	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENDOTHELIUM-DEPENDENT CONTRACTIONS; ACUTE CORONARY SYNDROMES; ANGIOTENSIN-II; DIFFERENTIAL INHIBITION; CYCLOOXYGENASE-2; PROSTAGLANDINS; CELLS; CLOPIDOGREL; THROMBOXANE	Despite its well-known antithrombotic properties, the effect of aspirin on blood pressure (BP) and hypertension pathology is unclear. The hugely varying doses used clinically have contributed to this confusion, with high-dose aspirin still commonly used due to concerns about the efficacy of low-dose aspirin. Because prostaglandins have been shown to both promote and inhibit T-cell activation, we also explored the immunomodulatory properties of aspirin in hypertension. Although the common preclinical high dose of 100 mg/kg/d improved vascular dysfunction and cardiac hypertrophy, this effect was accompanied by indices of elevated adaptive immunity, renal T-cell infiltration, renal fibrosis, and BP elevation in stroke-prone spontaneously hypertensive rats and in angiotensin II-induced hypertensive mice. The cardioprotective effects of aspirin were conserved with a lower dose (10 mg/kg/d) while circumventing heightened adaptive immunity and elevated BP. We also show that low-dose aspirin improves renal fibrosis. Differential inhibition of the COX-2 isoform may underlie the disparate effects of the 2 doses. Our results demonstrate the efficacy of low-dose aspirin in treating a vast array of cardiovascular parameters and suggest modulation of adaptive immunity as a novel mechanism underlying adverse cardiovascular profiles associated with COX-2 inhibitors. Clinical studies should identify the dose of aspirin that achieves maximal cardioprotection with a new awareness that higher doses of aspirin could trigger undesired autoimmunity in hypertensive individuals. This work also warrants an evaluation of high-dose aspirin and COX-2 inhibitor therapy in sufferers of inflammatory conditions who are already at increased risk for cardiovascular disease.Khan, S. I., Shihata, W. A., Andrews, K. L., Lee, M. K. S., Moore, X.-L., Jefferis, A.-M., Vinh, A., Gaspari, T., Dragoljevic, D., Jennings, G. L., Murphy, A. J., Chin-Dusting, J. P. F. Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.	[Khan, Shanzana I.; Shihata, Waled A.; Andrews, Karen L.; Moore, Xiao-Lei; Jefferis, Ann-Maree; Gaspari, Tracey; Chin-Dusting, Jaye P. F.] Monash Univ, Biomed Discovery Inst, Dept Pharmacol, Clayton, Vic, Australia; [Khan, Shanzana I.; Shihata, Waled A.; Andrews, Karen L.; Lee, Man K. S.; Jefferis, Ann-Maree; Dragoljevic, Dragana; Jennings, Garry L.; Murphy, Andrew J.; Chin-Dusting, Jaye P. F.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Khan, Shanzana I.; Shihata, Waled A.; Lee, Man K. S.; Dragoljevic, Dragana] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Vinh, Antony] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Jennings, Garry L.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	Monash University; Baker Heart and Diabetes Institute; Monash University; La Trobe University; University of Sydney	Khan, SI (corresponding author), Monash Univ, Dept Pharmacol, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia.	shanzana.khan@monash.edu	Jennings, Garry/B-3914-2009; Gaspari, Tracey/AAD-3092-2019; Vinh, Antony/I-1563-2014	Vinh, Antony/0000-0001-8367-6134; Murphy, Andrew/0000-0001-7039-7777	National Health and Medical Research Council of Australia Program Grant; Victorian Government	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by the National Health and Medical Research Council of Australia Program Grant and in part, by the Victorian Government's Infrastructure Support Program. The authors declare no conflicts of interest.	Amin AR, 1999, CELL MOL LIFE SCI, V56, P305, DOI 10.1007/s000180050432; Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Bautista LE, 2010, CURR HYPERTENS REP, V12, P282, DOI 10.1007/s11906-010-0115-5; Bulut D, 2003, J HYPERTENS, V21, P1663, DOI 10.1097/00004872-200309000-00015; Cheng HF, 2005, CURR PHARM DESIGN, V11, P1795, DOI 10.2174/1381612053764922; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dovizio M, 2015, BIOCHEM SOC T, V43, P707, DOI 10.1042/BST20140322; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; FRIES JF, 1993, ARCH INTERN MED, V153, P2465, DOI 10.1001/archinte.153.21.2465; Fu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4436; Fukuda S, 2004, EXP ANIM TOKYO, V53, P67, DOI 10.1538/expanim.53.67; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hall HM, 2014, CIRC-CARDIOVASC QUAL, V7, P701, DOI 10.1161/CIRCOUTCOMES.113.000822; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; HIRSH J, 1989, CHEST, V95, pS12; Horl WH, 2010, PHARMACEUTICALS, V3, P2291, DOI 10.3390/ph3072291; Hughson MD, 2008, AM J KIDNEY DIS, V52, P18, DOI 10.1053/j.ajkd.2008.03.023; Kanbak G, 2014, CLIN EXP HYPERTENS, V36, P1, DOI 10.3109/10641963.2013.783046; Kim Gheun-Ho, 2008, Electrolyte Blood Press, V6, P35, DOI 10.5049/EBP.2008.6.1.35; Kirkby NS, 2013, FASEB J, V27, P3938, DOI 10.1096/fj.12-215533; Kraakman MJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.31; LIVIO M, 1989, J PHARMACOL EXP THER, V248, P334; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; LORENZ RL, 1984, LANCET, V1, P1261; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; McQuay HJ, 2007, BRIT J CLIN PHARMACO, V63, P271, DOI 10.1111/j.1365-2125.2006.02723.x; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Nangaku M, 2002, KIDNEY INT, V62, P922, DOI 10.1046/j.1523-1755.2002.00519.x; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rodriguez-Iturbe B, 2012, CLIN EXP PHARMACOL P, V39, P96, DOI 10.1111/j.1440-1681.2011.05482.x; Rovati GE, 2010, TRENDS PHARMACOL SCI, V31, P102, DOI 10.1016/j.tips.2009.11.007; Sampson AK, 2014, HYPERTENSION, V64, P1376, DOI 10.1161/HYPERTENSIONAHA.114.03756; SCHARSCHMIDT L, 1986, AM J MED, V81, P30, DOI 10.1016/0002-9343(86)90906-X; Sousa T., 2014, J NEPHROL THER, V13; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Tang EHC, 2008, PHYSIOL GENOMICS, V32, P409, DOI 10.1152/physiolgenomics.00136.2007; TOHGI H, 1992, STROKE, V23, P1400, DOI 10.1161/01.STR.23.10.1400; Virdis A, 2012, EUR HEART J, V33, P2225, DOI 10.1093/eurheartj/ehr138; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; VOISIN EM, 1990, REGUL TOXICOL PHARM, V12, P107, DOI 10.1016/S0273-2300(05)80052-2; WEKSLER BB, 1983, NEW ENGL J MED, V308, P800, DOI 10.1056/NEJM198304073081402; WIENTJES MG, 1988, J PHARMACOL EXP THER, V245, P809; YAO CC, 2013, NAT COMMUN, V4; Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689; Zhang MZ, 2015, J CLIN INVEST, V125, P4281, DOI 10.1172/JCI81550	51	6	6	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1510	1521		10.1096/fj.201701498RR	http://dx.doi.org/10.1096/fj.201701498RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30156911	Bronze			2022-12-28	WOS:000457401500118
J	Choi, S; Snider, JM; Olakkengil, N; Lambert, JM; Anderson, AK; Ross-Evans, JS; Cowart, LA; Snider, AJ				Choi, Songhwa; Snider, Justin M.; Olakkengil, Nicole; Lambert, Johana M.; Anderson, Andrea K.; Ross-Evans, Jessica S.; Cowart, L. Ashley; Snider, Ashley J.			Myristate-induced endoplasmic reticulum stress requires ceramide synthases 5/6 and generation of C14-ceramide in intestinal epithelial cells	FASEB JOURNAL			English	Article						ER stress; IL-6; XBP1	INFLAMMATORY-BOWEL-DISEASE; UNFOLDED PROTEIN RESPONSE; SPHINGOSINE KINASE 1; FREE FATTY-ACIDS; ER STRESS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; SKELETAL-MUSCLE; DIETARY-FAT; APOPTOSIS	Saturated fatty acids (SFAs) have been shown to induce endoplasmic reticulum (ER) stress and chronic inflammatory responses, as well as alter sphingolipid metabolism. Disruptions in ER stress and sphingolipid metabolism have also been implicated in intestinal inflammation. Therefore, to elucidate the roles of SFAs in ER stress and inflammation in intestinal epithelial cells, we examined myristate (C14:0) and palmitate (C16:0). Myristate, but not palmitate, induced ER stress signaling, including activation of inositol-requiring enzyme 1 (IRE1) and X-box binding protein 1 (XBP1) signaling. Myristate significantly increased C14-ceramide levels, whereas palmitate increased several long-chain ceramides. To define the role of ceramide synthases (CerSs) in myristate-induced ER stress, we used the pharmacologic inhibitor, fumonisin B1 (FB1), and small interfering RNA (siRNA) for CerS5 and 6, the primary isoforms that are involved in C14-ceramide generation. FB1 and siRNA for CerS5 or 6 suppressed myristate-induced C14-ceramide generation and XBP1 splicing (XBP1s). Moreover, increased XBP1s induced the downstream expression of IL-6 in a CerS5/6-dependent manner. In addition, a myristate-enriched milk fat-based diet, but not a lard-based diet, increased C14-ceramide, XBP1s, and IL-6 expression in vivo. Taken together, our data suggest that myristate modulates ER stress and cytokine production in the intestinal epithelium via CerS5/6 and C14-ceramide generation.Choi, S., Snider, J. M., Olakkengil, N., Lambert, J. M., Anderson, A. K., Ross-Evans, J. S., Cowart, L. A., Snider, A. J. Myristate-induced endoplasmic reticulum stress requires ceramide synthases 5/6 and generation of C14-ceramide in intestinal epithelial cells.	[Choi, Songhwa; Snider, Justin M.; Olakkengil, Nicole] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; [Choi, Songhwa; Snider, Justin M.; Snider, Ashley J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley J.] SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA; [Lambert, Johana M.; Anderson, Andrea K.; Cowart, L. Ashley] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Lambert, Johana M.; Anderson, Andrea K.; Ross-Evans, Jessica S.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Cowart, L. Ashley] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Snider, Ashley J.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Virginia Commonwealth University; Medical University of South Carolina; Hunter Holmes McGuire Veterinary Affairs Medical Center	Snider, AJ (corresponding author), SUNY Stony Brook, 100 Nicolls Rd.,Hlth Sci Ctr,L15-023, Stony Brook, NY 11794 USA.	ashley.snider@stonybrookmedicine.edu		Olakkengil, Nicole/0000-0002-3128-008X	Veteran's Administration Career Development Award; U.S. National Institutes of Health (NIH), National Cancer Institute [P01-CA097132]; NIH, National Heart, Lung, and Blood Institute [R01-HL117233]; Department of Veteran's Affairs Merit Grant [I01BX000200]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000200] Funding Source: NIH RePORTER	Veteran's Administration Career Development Award; U.S. National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veteran's Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Lina M. Obeid for expertise and suggestions for examining CerS, and Yusuf A. Hannun for expert advice in sphingolipid biology (both from the Stony Brook University School of Medicine). The authors also thank the Stony Brook University Lipidomics Shared Resource Core for lipid analysis. This work was supported by the Veteran's Administration Career Development Award (to A.J.S.); U.S. National Institutes of Health (NIH), National Cancer Institute Grant P01-CA097132 (to A.J.S.); NIH, National Heart, Lung, and Blood Institute Grant R01-HL117233; and the Department of Veteran's Affairs Merit Grant I01BX000200 (to L.A.C.). The contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government. The authors declare no conflicts of interest.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Cheng CY, 2017, J MANUF SYST, V42, P1, DOI 10.1016/j.jmsy.2016.10.005; Choi S., 2015, MEDIAT INFLAMM, V2015; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Espaillat MP, 2018, FASEB J, V32, P2339, DOI 10.1096/fj.201700585R; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Geng T, 2013, DIABETOLOGIA, V56, P2078, DOI 10.1007/s00125-013-2973-2; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kim S, 2015, J IMMUNOL, V194, P4498, DOI 10.4049/jimmunol.1401399; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Liu Z, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-71; Lovejoy JC, 2001, METABOLISM, V50, P86, DOI 10.1053/meta.2001.19440; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Negroni A, 2014, DIGEST LIVER DIS, V46, P788, DOI 10.1016/j.dld.2014.05.013; Nestel PJ, 2008, J AM COLL NUTR, V27, p735S, DOI 10.1080/07315724.2008.10719751; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Ross JS, 2013, J BIOL CHEM, V288, P22193, DOI 10.1074/jbc.M113.477786; Russo SB, 2013, J BIOL CHEM, V288, P13397, DOI 10.1074/jbc.M112.428185; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.36; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	47	19	19	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5724	5736		10.1096/fj.201800141R	http://dx.doi.org/10.1096/fj.201800141R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29768040	Bronze, Green Published			2022-12-28	WOS:000447972500043
J	Hua, L; Zhuo, Y; Jiang, DD; Li, J; Huang, XH; Zhu, YG; Li, Z; Yan, LJ; Jin, C; Jiang, XM; Che, LQ; Fang, ZF; Lin, Y; Xu, SY; Li, J; Feng, B; Wu, D				Hua, Lun; Zhuo, Yong; Jiang, Dandan; Li, Jing; Huang, Xiaohua; Zhu, Yingguo; Li, Zhen; Yan, Lijun; Jin, Chao; Jiang, Xuemei; Che, Lianqiang; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Li, Jian; Feng, Bin; Wu, De			Identification of hepatic fibroblast growth factor 21 as a mediator in 17-estradiol-induced white adipose tissue browning	FASEB JOURNAL			English	Article						FGF21; E2; ER; mTOR	ESTROGEN-RECEPTOR-ALPHA; DIETARY-PROTEIN DILUTION; SKELETAL-MUSCLE; INDUCED OBESITY; SEX-DIFFERENCES; FEMALE MICE; FGF21; LIVER; METABOLISM; ACTIVATION	Both ovarian E2 and hepatic fibroblast growth factor 21 (FGF21) are critical for energy homeostasis and white adipose tissue browning. Estrogen receptor (ER) is abundantly expressed in liver. However, whether FGF21 has a role in E2-induced white adipose tissue browning remains uncertain. In this study, we showed that hepatic Fgf21 expression and secretion during estrus cycle changed with the tetradian oscillatory secretion of circulation E2 in adult, female mice, with their peak expressions and secretions at the proestrus. In addition, exogenous E2 robustly stimulated liver Fgf21 expression and elevated serum FGF21 concentrations, which induced browning gene expression and reduced the tissue weight in subcutaneous white adipose in mice with ovariectomies. The inhibitor of mammalian target of rapamycin (mTOR) and of ER blocked the induction effect of E2 on the expression of Fgf21 in primary hepatocytes, which revealed that E2 might stimulate FGF21 expression via the ER-mTOR pathway. Furthermore, FGF21 liver-specific deficiency abolished E2-induced white adipose browning in mice with ovariectomies. This study indicates that ovarian E2 increased liver FGF21 expression directly, which in turn, functioned as an endocrine signal to influence inguinal white adipose tissue browning.Hua, L., Zhuo, Y., Jiang, D., Li, J., Huang, X., Zhu, Y., Li, Z., Yan, L., Jin, C., Jiang, X., Che, L., Fang, Z., Lin, Y., Xu, S., Li, J., Feng, B., Wu, D. Identification of hepatic fibroblast growth factor 21 as a mediator in 17-estradiol-induced white adipose tissue browning.	[Hua, Lun; Zhuo, Yong; Jiang, Dandan; Li, Jing; Huang, Xiaohua; Zhu, Yingguo; Li, Zhen; Yan, Lijun; Jin, Chao; Jiang, Xuemei; Che, Lianqiang; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Li, Jian; Feng, Bin; Wu, De] Sichuan Agr Univ, Minist Educ China, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Hua, Lun; Zhuo, Yong; Jiang, Dandan; Li, Jing; Huang, Xiaohua; Zhu, Yingguo; Li, Zhen; Yan, Lijun; Jin, Chao; Jiang, Xuemei; Che, Lianqiang; Fang, Zhengfeng; Lin, Yan; Li, Jian; Feng, Bin; Wu, De] Sichuan Agr Univ, Minist Educ China, Key Lab Anim Dis Resistant Nutr, Chengdu, Sichuan, Peoples R China	Ministry of Education, China; Sichuan Agricultural University; Ministry of Education, China; Sichuan Agricultural University	Feng, B; Wu, D (corresponding author), Sichuan Agr Univ, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.	fengbin@sicau.edu.cn; wude@sicau.edu.cn	Feng, Bin/GLU-0109-2022; Xu, Shengyu/AFN-8288-2022; FENG, BIN/E-9505-2017	Xu, Shengyu/0000-0002-4415-8542; FENG, BIN/0000-0001-6258-2729; Huang, Xiaohua/0000-0003-4150-0477	National Natural Science Foundation of China [31772616]; 1000 Talent Program from the Sichuan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1000 Talent Program from the Sichuan Province	This work was supported by the National Natural Science Foundation of China (Grant 31772616) to D.W. B.F. was a recipient of the 1000 Talent Program from the Sichuan Province. The funders had no role in the design, analysis, or writing of this article. The authors declare no conflicts of interest.	BonDurant LD, 2017, CELL METAB, V25, P935, DOI 10.1016/j.cmet.2017.03.005; Chapnik N, 2017, J NUTR BIOCHEM, V40, P116, DOI 10.1016/j.jnutbio.2016.10.017; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Ciana P, 2003, NAT MED, V9, P82, DOI 10.1038/nm809; Cyphert HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094996; Della Torre S, 2017, CELL METAB, V25, P499, DOI 10.1016/j.cmet.2017.01.006; Della Torre S, 2016, CELL REP, V15, P360, DOI 10.1016/j.celrep.2016.03.019; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Feng B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081710; Feng B, 2014, DIABETES, V63, P2924, DOI 10.2337/db14-0066; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Fortress AM, 2013, LEARN MEMORY, V20, P147, DOI 10.1101/lm.026732.112; Frank AP, 2018, PHYSIOL BEHAV, V187, P24, DOI 10.1016/j.physbeh.2017.09.026; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Hart-Unger S, 2017, INT J OBESITY, V41, P945, DOI 10.1038/ijo.2017.50; Keipert S, 2015, MOL METAB, V4, P537, DOI 10.1016/j.molmet.2015.04.006; Kim JH, 2014, MOL METAB, V3, P177, DOI 10.1016/j.molmet.2013.12.009; Laeger T, 2016, CELL REP, V16, P707, DOI 10.1016/j.celrep.2016.06.044; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Larson KR, 2017, ENDOCRINOLOGY, V158, P3477, DOI 10.1210/en.2017-00331; Maida A, 2016, J CLIN INVEST, V126, P3263, DOI 10.1172/JCI85946; de Morentin PBM, 2014, CELL METAB, V20, P41, DOI 10.1016/j.cmet.2014.03.031; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Mitra S, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00244, 10.3389/fnbeh.2016.00215]; Olofsson LE, 2009, P NATL ACAD SCI USA, V106, P15932, DOI 10.1073/pnas.0904747106; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Shimizu N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7693; Singhal G, 2016, MOL METAB, V5, P690, DOI 10.1016/j.molmet.2016.05.010; Solon-Biet SM, 2016, CELL METAB, V24, P555, DOI 10.1016/j.cmet.2016.09.001; Song P., 2018, CELL METAB; Torres MJ, 2018, CELL METAB, V27, P167, DOI 10.1016/j.cmet.2017.10.003; Villa A, 2012, P NATL ACAD SCI USA, V109, P11806, DOI 10.1073/pnas.1205797109; Wanders D, 2017, DIABETES, V66, P858, DOI 10.2337/db16-1212; Weigt C, 2012, MOL CELL ENDOCRINOL, V351, P227, DOI 10.1016/j.mce.2011.12.013	41	19	19	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5602	5611		10.1096/fj.201800240R	http://dx.doi.org/10.1096/fj.201800240R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718710				2022-12-28	WOS:000447972500033
J	Razzoli, M; Emmett, MJ; Lazar, MA; Bartolomucci, A				Razzoli, Maria; Emmett, Matthew J.; Lazar, Mitchell A.; Bartolomucci, Alessandro			-Adrenergic receptors control brown adipose UCP-1 tone and cold response without affecting its circadian rhythmicity	FASEB JOURNAL			English	Article						thermogenesis; locomotor activity; molecular clock; brown adipocytes; Rev-erb	REV-ERB-ALPHA; CLOCK; THERMOGENESIS; DISRUPTION; DISEASE; MOUSE; TEMPERATURE; ADIPOCYTES; ADAPTATION; EXPRESSION	Brown adipose tissue (BAT) thermogenic functions are primarily mediated by uncoupling protein (UCP)-1. Ucp1 gene expression is highly induced by cold temperature, via sympathetic nervous system and -adrenergic receptors (ARs). Ucp1 is also repressed by the clock gene Rev-erb, contributing to its circadian rhythmicity. In this study, we investigated mice lacking ARs (-less mice) to test the relationship between AR signaling and the BAT molecular clock. We found that in addition to controlling the induction of Ucp1 and other key BAT genes at near freezing temperatures, ARs are essential for the basal expression of BAT Ucp1 at room temperature. Remarkably, although basal Ucp1 expression is low throughout day and night in -less mice, the circadian rhythmicity of Ucp1 and clock genes in BAT is maintained. Thus, the requirement of AR signaling for BAT activity is independent of the circadian rhythmicity of Ucp1 expression and circadian oscillation of the molecular clock genes. On the other hand, we found that ARs are essential for the normal circadian rhythms of locomotor activity. Our results demonstrate that in addition to controlling the BAT response to extreme cold, AR signaling is necessary to maintain basal Ucp1 tone and to couple BAT circadian rhythmicity to the central clock.Razzoli, M., Emmett, M. J., Lazar, M. A., Bartolomucci, A. -Adrenergic receptors control brown adipose UCP-1 tone and cold response without affecting its circadian rhythmicity.	[Razzoli, Maria; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Emmett, Matthew J.; Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine	Bartolomucci, A (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	abartolo@umn.edu	Lazar, Mitchell A/AAF-3738-2019	Lazar, Mitchell/0000-0001-8653-1280	U.S. National Institutes of Health, National Institute of Digestive Diabetes and Kidney Diseases [DK102496, DK45586, F30 DK104513]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, F30DK104513, R01DK102496] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Digestive Diabetes and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank B. B. Lowell (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) for providing the beta-less mice. This work was supported by U.S. National Institutes of Health, National Institute of Digestive Diabetes and Kidney Diseases Grants DK102496 (to A. B.), DK45586 (to M.A.L.), and F30 DK104513 (to M.J.E). The authors declare no conflicts of interest.	Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Aujard F, 2007, EXP GERONTOL, V42, P1079, DOI 10.1016/j.exger.2007.08.007; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chappuis S, 2013, MOL METAB, V2, P184, DOI 10.1016/j.molmet.2013.05.002; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Li SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070109; O'Keeffe SM, 2012, NEUROSCIENCE, V201, P219, DOI 10.1016/j.neuroscience.2011.11.002; Peirce V, 2013, LANCET DIABETES ENDO, V1, P353, DOI 10.1016/S2213-8587(13)70055-X; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; Reilly DF, 2008, ARTERIOSCL THROM VAS, V28, P121, DOI 10.1161/ATVBAHA.107.152538; Rosenwasser AM, 1996, PHYSIOL BEHAV, V60, P373, DOI 10.1016/0031-9384(96)00059-5; ROSENWASSER AM, 1989, PHARMACOL BIOCHEM BE, V33, P291, DOI 10.1016/0091-3057(89)90502-9; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolensky MH, 2016, CHRONOBIOL INT, V33, P1101, DOI 10.1080/07420528.2016.1184678; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; WELSH DK, 1986, J GERONTOL, V41, P579, DOI 10.1093/geronj/41.5.579; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhu BK, 2017, CELL METAB, V25, P1305, DOI 10.1016/j.cmet.2017.05.004; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	34	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5640	5646		10.1096/fj.201800452R	http://dx.doi.org/10.1096/fj.201800452R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29715048	Green Published			2022-12-28	WOS:000447972500036
J	Si, WX; Xie, W; Deng, WB; Xiao, Y; Karnik, SS; Xu, CQ; Chen, QY; Wang, QK				Si, Wenxia; Xie, Wen; Deng, Wenbing; Xiao, Yi; Karnik, Sadashiva S.; Xu, Chengqi; Chen, Qiuyun; Wang, Qing Kenneth			Angiotensin II increases angiogenesis by NF-kappa B-mediated transcriptional activation of angiogenic factor AGGF1	FASEB JOURNAL			English	Article						AT1R; AT2R; p65	KLIPPEL-TRENAUNAY-SYNDROME; ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; SIGNALING PATHWAY; TYPE-2 RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION; CELLS; CARCINOMA; SYSTEM	Angiogenic factor with G-patch and FHA domains 1 (AGGF1) is involved in vascular development, angiogenesis, specification of hemangioblasts, and differentiation of veins. When mutated, however, it causes Klippel-Trenaunay syndrome, a vascular disorder. In this study, we show that angiotensin II (AngII)the major effector of the renin-angiotensin system and one of the most important regulators of the cardiovascular systeminduces the expression of AGGF1 through NF-B, and that AGGF1 plays a key role in AngII-induced angiogenesis. AngII significantly up-regulated the levels of AGGF1 mRNA and protein in HUVECs at concentrations of 10-40 g/ml but not >60 g/ml. AngII type 1 receptor (AT1R) inhibitor losartan inhibited AngII-induced up-regulation of AGGF1, whereas AT2R inhibitor PD123319 further increased AngII-induced up-regulation of AGGF1. Up-regulation of AGGF1 by AngII was blocked by NF-B inhibitors, and p65 binds directly to a binding site at the promoter/regulatory region of AGGF1 and transcriptionally activates AGGF1 expression. AngII-induced endothelial tube formation was blocked by small interfering RNAs (siRNAs) for RELA (RELA proto-oncogene, NF-B subunit)/p65 or AGGF1, and the effect of RELA siRNA was rescued by AGGF1. AngII-induced angiogenesis from aortic rings was severely impaired in Aggf1(+/-) mice, and the effect was restored by AGGF1. These data suggest that AngII acts as a critical regulator of AGGF1 expression through NF-B, and that AGGF1 plays a key role in AngII-induced angiogenesis.Si, W., Xie, W., Deng, W., Xiao, Y., Karnik, S. S., Xu, C., Chen, Q., Wang, Q. K. Angiotensin II increases angiogenesis by NF-B-mediated transcriptional activation of angiogenic factor AGGF1.	[Si, Wenxia; Xie, Wen; Deng, Wenbing; Xu, Chengqi; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ,CardioX Inst, Wuhan, Hubei, Peoples R China; [Xiao, Yi; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Phys, Wuhan, Hubei, Peoples R China; [Si, Wenxia] Hubei Polytech Univ, Huangshi Cent Hosp, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Edong Healthcare Grp,Sch Med, Huangshi, Peoples R China; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Ctr Cardiovasc Genet, Cleveland, OH 44106 USA; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Learner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Wang, Qing Kenneth] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hubei Polytechnic University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Chen, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.	chenq3@ccf.org; qkwang@mail.hust.edu.cn	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753; Xu, Chengqi/0000-0002-4269-6830; Wang, Qing/0000-0002-5639-8519	China National Natural Science Foundation [81630002, 91439129, 31430047, 81600263]; Innovative Team Grant from Hubei Province [2017CFA014]; 2016 Top-Notch Innovative Talent Development Project Award from the Bureau of Human Resources and Social Security of Wuhan City; Chinese National Basic Research Program (973 Project) [2013CB531101]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL121358, R01 HL126729]; Hubei Province Natural Science Programs [2016CFB224, 2014CFA074]; Outstanding Medical Academic Leader Program of Hubei Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121358, R01HL126729, R01HL132351] Funding Source: NIH RePORTER	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Innovative Team Grant from Hubei Province; 2016 Top-Notch Innovative Talent Development Project Award from the Bureau of Human Resources and Social Security of Wuhan City; Chinese National Basic Research Program (973 Project)(National Basic Research Program of China); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hubei Province Natural Science Programs; Outstanding Medical Academic Leader Program of Hubei Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. George Stalk (Cleveland Clinic) for quinacrine. This study was supported by China National Natural Science Foundation Grants 81630002, 91439129, 31430047, and 81600263; Innovative Team Grant 2017CFA014 from Hubei Province; a 2016 Top-Notch Innovative Talent Development Project Award from the Bureau of Human Resources and Social Security of Wuhan City; the Chinese National Basic Research Program (973 Project 2013CB531101); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants R01 HL121358 and R01 HL126729; Hubei Province Natural Science Programs (2016CFB224 and 2014CFA074); and the Outstanding Medical Academic Leader Program of Hubei Province. The authors declare no conflicts of interest.	Buharalioglu CK, 2011, AM J PHYSIOL-HEART C, V301, pH1043, DOI 10.1152/ajpheart.01018.2010; Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chua CC, 1998, BBA-MOL CELL RES, V1401, P187, DOI 10.1016/S0167-4889(97)00129-8; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Escobar Elizabeth, 2004, Current Vascular Pharmacology, V2, P385, DOI 10.2174/1570161043385556; Fan C, 2009, J BIOL CHEM, V284, P23331, DOI 10.1074/jbc.M109.036079; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Han CJ, 2010, ATHEROSCLEROSIS, V212, P206, DOI 10.1016/j.atherosclerosis.2010.05.020; Harada M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122603; Horiuchi M, 1999, HYPERTENSION, V33, P613, DOI 10.1161/01.HYP.33.2.613; HSUEH WA, 1995, ADV EXP MED BIOL, V377, P217; Hu FY, 2013, CELL SIGNAL, V25, P1645, DOI 10.1016/j.cellsig.2013.04.007; Jani TS, 2010, J BIOL CHEM, V285, P19162, DOI 10.1074/jbc.M109.091645; Jing T, 2009, INT J MOL MED, V24, P103, DOI 10.3892/ijmm_00000213; JOHNSTON CI, 1992, J HYPERTENS, V10, pS13; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Kashiwada T, 2015, DEVELOPMENT, V142, P497, DOI 10.1242/dev.115576; Kim S, 2000, ARTERIOSCL THROM VAS, V20, P2539, DOI 10.1161/01.ATV.20.12.2539; LENOBLE FAC, 1993, AM J PHYSIOL, V264, pR460, DOI 10.1152/ajpregu.1993.264.2.R460; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Munk VC, 2007, HYPERTENSION, V49, P1178, DOI 10.1161/HYPERTENSIONAHA.106.080242; Munzenmaier DH, 1996, HYPERTENSION, V27, P760, DOI 10.1161/01.HYP.27.3.760; Pei NN, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0542-0; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Scheidegger KJ, 1999, J BIOL CHEM, V274, P3522, DOI 10.1074/jbc.274.6.3522; STACHOWIAK MK, 1994, J CELL BIOL, V127, P203, DOI 10.1083/jcb.127.1.203; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; VISWANATHAN M, 1992, PEPTIDES, V13, P783, DOI 10.1016/0196-9781(92)90187-8; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com; Wolf G, 2002, LAB INVEST, V82, P1305, DOI 10.1097/01.LAB.0000029207.92039.2F; Xu Y, 2014, BBA-MOL BASIS DIS, V1842, P712, DOI 10.1016/j.bbadis.2014.01.007; Yamamoto Y, 2008, HYPERTENS RES, V31, P1241, DOI 10.1291/hypres.31.1241; Yao YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00171-w; Yao YF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005889; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107634; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	41	17	20	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5051	5062		10.1096/fj.201701543RR	http://dx.doi.org/10.1096/fj.201701543RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29641288	Green Published			2022-12-28	WOS:000443817700035
J	Wang, T; Thien, C; Wang, C; Ni, M; Gao, JJ; Wang, A; Jiang, Q; Tuan, RS; Zheng, QJ; Zheng, MH				Wang, Tao; Thien, Christine; Wang, Carolyn; Ni, Ming; Gao, Junjie; Wang, Allan; Jiang, Qing; Tuan, Rocky S.; Zheng, Qiujian; Zheng, Ming H.			3D uniaxial mechanical stimulation induces tenogenic differentiation of tendon-derived stem cells through a PI3K/AKT signaling pathway	FASEB JOURNAL			English	Article						bioreactor; mechanical loading; tendon formation; mechanobiology	CYCLIC TENSILE STRAIN; ACHILLES-TENDON; GENE-EXPRESSION; BIOARTIFICIAL TENDONS; SCLERAXIS EXPRESSION; BIOREACTOR SYSTEM; KINASE; AKT; ACTIVATION; REPAIR	The tendon is a mechanosensitive tissue, but little is known about how mechanical stimulation selectively signals tenogenic differentiation and neo-tendon formation. In this study, we compared the impact of uniaxial and biaxial mechanical loading on tendon-derived stem cells (TDSCs). Our data show that there are variations in cell signaling and cell differentiation of mouse TDSCs in response to uniaxial and biaxial loading in monolayer culture. Whereas uniaxial loading induced TDSCs toward tenogenic and osteogenic differentiation, biaxial loading induced osteogenic, adipogenic, and chondrogenic differentiation of TDSCs. Furthermore, by applying uniaxial loading on 3-dimensional (3D) TDSC constructs, tenogenic-specific differentiation and neo-tendon formation were observed, results that were replicated in human TDSCs. We also showed that uniaxial loading induced PKB (AKT) phosphorylation (pAKT), whereas biaxial loading induced pERK. Most importantly, we found that inhibition of the PI3K/AKT signaling pathway could attenuate tenogenic differentiation and tendon formation in 3D TDSC constructs subjected to uniaxial loading. Taken together, our study highlights the importance of appropriate mechanobiological stimulation in 3D cell niches on tendon-like tissue formation and demonstrates that uniaxial mechanical loading plays an essential role in tenogenic differentiation and tendon formation by activating the PI3K/AKT signaling pathway.Wang, T., Thien, C., Wang, C., Ni, M., Gao, J., Wang, A., Jiang, Q., Tuan, R. S., Zheng, Q., Zheng, M. H. 3D uniaxial mechanical stimulation induces tenogenic differentiation of tendon-derived stem cells through a PI3K/AKT signaling pathway.	[Wang, Tao; Zheng, Qiujian; Zheng, Ming H.] Guangdong Acad Med Sci, Guangdong Gen Hosp, Div Orthopaed Surg, Dept Surg, Guangzhou, Guangdong, Peoples R China; [Wang, Tao; Thien, Christine; Wang, Carolyn; Gao, Junjie; Wang, Allan; Zheng, Ming H.] Univ Western Australia, Sch Biomed Sci, Ctr Orthopaed Translat Res, Nedlands, WA, Australia; [Ni, Ming] Chinese Peoples Liberat Army, Dept Orthopaed, Gen Hosp, Beijing, Peoples R China; [Wang, Allan] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Jiang, Qing] Nanjing Univ, Drum Tower Hosp, Dept Sports Med & Adult Reconstruct, Sch Med, Nanjing, Jiangsu, Peoples R China; [Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15261 USA; [Tuan, Rocky S.] Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Tuan, Rocky S.] Inst Tissue Engn & Regenerat Med, Hong Kong, Hong Kong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Western Australia; Chinese People's Liberation Army General Hospital; University of Western Australia; Nanjing University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong	Zheng, QJ (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, 106 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Zheng, MH (corresponding author), Univ Western Australia, Fac Med Dent & Hlth Sci, 35 Stirling Hwy, Crawley, WA 6009, Australia.	zqj650@126.com; minghao.zheng@uwa.edu.au	Thien, Christine/GQP-0424-2022	Wang, Carolyn/0000-0002-4345-119X; Thien, Christine/0000-0003-3884-5546; Zheng, Minghao/0000-0003-1185-4768	Australia Research Council Linkage Grant [LP150100905]; National Natural Science Foundation of China [8180090299]; Guangdong Science and Technology Department [2015B020225007]	Australia Research Council Linkage Grant(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department	This work is supported by the Australia Research Council Linkage Grant (LP150100905), National Natural Science Foundation of China (8180090299), and Guangdong Science and Technology Department (2015B020225007). The authors declare no conflicts of interest.	Ansorge HL, 2012, J ORTHOP RES, V30, P448, DOI 10.1002/jor.21542; Ansorge HL, 2011, ANN BIOMED ENG, V39, P1904, DOI 10.1007/s10439-011-0299-0; Azuma N, 2000, J VASC SURG, V32, P789, DOI 10.1067/mva.2000.107989; Bakker AD, 2016, J CELL PHYSIOL, V231, P1283, DOI 10.1002/jcp.25228; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Charoenpanich A, 2014, TISSUE ENG PT A, V20, P67, DOI [10.1089/ten.tea.2013.0006, 10.1089/ten.TEA.2013.0006]; Chiu CZ, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-50; Cong X. X., 2018, STEM CELLS; Cosgrove BD, 2016, NAT MATER, V15, P1297, DOI [10.1038/NMAT4725, 10.1038/nmat4725]; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Gao JJ, 2016, ONCOTARGET, V7, P26966, DOI 10.18632/oncotarget.9034; Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619; Govoni M, 2017, TISSUE ENG PT A, V23, P811, DOI [10.1089/ten.tea.2016.0407, 10.1089/ten.TEA.2016.0407]; Ishikawa S, 2012, AM J PHYSIOL-HEART C, V302, pH2536, DOI 10.1152/ajpheart.00940.2011; Jones ER, 2013, BBA-MOL CELL RES, V1833, P2596, DOI 10.1016/j.bbamcr.2013.06.019; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Li YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13149; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Liu Y, 2017, FASEB J, V31, P3800, DOI 10.1096/fj.201601181R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ni M, 2013, BIOMATERIALS, V34, P2024, DOI 10.1016/j.biomaterials.2012.11.046; Niehoff A, 2008, J ORTHOP RES, V26, P616, DOI 10.1002/jor.20542; Paterno J, 2011, WOUND REPAIR REGEN, V19, P49, DOI 10.1111/j.1524-475X.2010.00643.x; Qi J, 2011, J APPL PHYSIOL, V110, P1425, DOI 10.1152/japplphysiol.00477.2010; Rice KM, 2007, EXP PHYSIOL, V92, P963, DOI 10.1113/expphysiol.2007.037275; Scott A, 2011, J MUSCULOSKEL NEURON, V11, P124; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Spangenburg EE, 2009, APPL PHYSIOL NUTR ME, V34, P328, DOI 10.1139/H09-010; Stanley RL, 2007, J ANAT, V211, P325, DOI 10.1111/j.1469-7580.2007.00781.x; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Trumbull A, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0150-9; Wall ME, 2007, AM J PHYSIOL-CELL PH, V293, pC1532, DOI 10.1152/ajpcell.00065.2007; Wall ME, 2007, CELL MOTIL CYTOSKEL, V64, P121, DOI 10.1002/cm.20170; Wang T, 2018, J ORTHOP RES, V36, P566, DOI 10.1002/jor.23752; Wang T, 2015, J ORTHOP RES, V33, P1888, DOI 10.1002/jor.22960; Wang T, 2013, BIOTECHNOL BIOENG, V110, P1495, DOI 10.1002/bit.24809; Ward DF, 2007, STEM CELLS DEV, V16, P467, DOI 10.1089/scd.2007.0034; Yanagiya T, 2007, OBESITY, V15, P572, DOI 10.1038/oby.2007.547; Yang HS, 2016, CELL PHYSIOL BIOCHEM, V38, P237, DOI 10.1159/000438625; Yu HS, 2016, J TISSUE ENG, V7, DOI [10.1177/2041731415618342, 10.1177/2041731416676337]; Zhang ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20300; Zhong XH, 2014, EXP THER MED, V7, P295, DOI 10.3892/etm.2013.1394	45	35	37	3	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4804	4814		10.1096/fj.201701384R	http://dx.doi.org/10.1096/fj.201701384R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29596022				2022-12-28	WOS:000443817700016
J	Jia, LY; Zhou, XY; Huang, XJ; Xu, XH; Jia, YH; Wu, YT; Yao, JL; Wu, YM; Wang, K				Jia, Linyan; Zhou, Xinyao; Huang, Xiaojie; Xu, Xianghong; Jia, Yuanhui; Wu, Yingting; Yao, Julei; Wu, Yanming; Wang, Kai			Maternal and umbilical cord serum-derived exosomes enhance endothelial cell proliferation and migration	FASEB JOURNAL			English	Article						microRNA; hepatocyte growth factor; angiogenesis; pregnancy	STEM-CELLS; ANGIOGENESIS; MICROPARTICLES; PREECLAMPSIA; MICRORNAS; GROWTH; CONTRIBUTES; REGULATORS; CANCER	We investigated the role of exosomes derived from maternal and umbilical cord blood in the regulation of angiogenesis. We report here that both maternal exosomes (MEs) and umbilical exosomes (UEs) significantly enhance HUVEC proliferation, migration, and tube formation. Importantly, ME-treated HUVECs (MEXs) displayed significantly increased migration, but not proliferation or tube formation, compared with UE-treated HUVECs (UEXs). We found that the expression of a subset of migration-related microRNAs (miRNAs), including miR-210-3p, miR-376c-3p, miR-151a-5p, miR-296-5p, miR-122-5p, and miR-550a-5p, among others, were significantly increased or decreased in UEs, and this altered expression was likely correlated with the differential regulation of HUVEC migration. We also found that the mRNA expression of hepatocyte growth factor (HGF) was up-regulated in MEXs and UEXs and, moreover, that inhibiting HGF partially abolished the enhanced cell migration induced by UEs. Our results suggest that both MEs and UEs greatly enhanced endothelial cell (EC) functions and differentially regulated EC migration, which was mostly attributed to the different expression profiles of exosomal miRNA. These findings highlight the importance of exosomes in the regulation of angiogenesis during pregnancy. Exosomal miRNAs, in particular, may be of great significance for the regulation of angiogenesis in maintaining normal pregnancy.Jia, L., Zhou, X., Huang, X., Xu, X., Jia, Y., Wu, Y., Yao, J., Wu, Y., Wang, K. Maternal and umbilical cord serum-derived exosomes enhance endothelial cell proliferation and migration.	[Jia, Linyan; Huang, Xiaojie; Xu, Xianghong; Jia, Yuanhui; Yao, Julei; Wang, Kai] Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, GaoKe West Rd 2699, Shanghai 201204, Peoples R China; [Zhou, Xinyao] Tongji Univ, Sch Med, Unit Fetal Med, Shanghai Matern & Infant Hosp 1, Shanghai, Peoples R China; [Wu, Yingting] Tongji Univ, Sch Med, Dept Lab Med, Shanghai Matern & Infant Hosp 1, Shanghai, Peoples R China; [Wu, Yanming] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA	Tongji University; Tongji University; Tongji University; University of Texas System; University of Texas Health San Antonio	Wang, K (corresponding author), Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, GaoKe West Rd 2699, Shanghai 201204, Peoples R China.	kaiwangcn@yahoo.com		Wu, Yanming/0000-0003-3357-3051	National Key Research and Development Program of China [2017YFA0104600]; National Natural Science Foundation of China [81601312, 81501270]; Shanghai Municipal Medical and Health Discipline Construction Project [2017ZZ02015]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Medical and Health Discipline Construction Project	This research was supported, in part, by National Key Research and Development Program of China (2017YFA0104600; to K. W.), National Natural Science Foundation of China (81601312; to X.Z.; 81501270; to X.X.), and Shanghai Municipal Medical and Health Discipline Construction Project (2017ZZ02015; to K.W.). The authors declare no conflicts of interest.	Alcayaga-Miranda F, 2016, ONCOTARGET, V7, P44462, DOI 10.18632/oncotarget.9852; Aliotta JM, 2016, CARDIOVASC RES, V110, P319, DOI 10.1093/cvr/cvw054; Baek R, 2016, J IMMUNOL METHODS, V438, P11, DOI 10.1016/j.jim.2016.08.007; Buendia P, 2015, FASEB J, V29, P173, DOI 10.1096/fj.14-249706; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Gong X, 2013, BIOCHEM BIOPH RES CO, V439, P493, DOI 10.1016/j.bbrc.2013.08.096; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Jonsson ME, 2015, DEVELOPMENT, V142, P3166, DOI 10.1242/dev.122747; Kambe S, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121616; Li N, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0551-0; Liang HW, 2016, J HEPATOL, V64, P278, DOI 10.1016/j.jhep.2015.09.013; Liang XL, 2016, J CELL SCI, V129, P2182, DOI 10.1242/jcs.170373; Liu C, 2016, ONCOTARGET, V7, P76250, DOI 10.18632/oncotarget.12841; Ma XJ, 2017, MOL MED REP, V16, P1565, DOI 10.3892/mmr.2017.6701; Mahmoud AM, 2017, FASEB J, V31, P4636, DOI 10.1096/fj.201601244RR; Maroun CR, 2014, PHARMACOL THERAPEUT, V142, P316, DOI 10.1016/j.pharmthera.2013.12.014; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Salomon C, 2017, PROG MOL BIOL TRANSL, V145, P163, DOI 10.1016/bs.pmbts.2016.12.006; Salomon C, 2017, J CLIN ENDOCR METAB, V102, P3182, DOI 10.1210/jc.2017-00672; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Selmaj I, 2017, ANN NEUROL, V81, P703, DOI 10.1002/ana.24931; Skow RJ, 2017, CLIN SCI, V131, P2223, DOI 10.1042/CS20171036; Su MT, 2011, HUM REPROD UPDATE, V17, P803, DOI 10.1093/humupd/dmr027; Su R, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0737-1; Tang YT, 2017, INT J MOL MED, V40, P834, DOI 10.3892/ijmm.2017.3080; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Teng XM, 2015, CELL PHYSIOL BIOCHEM, V37, P2415, DOI 10.1159/000438594; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Wang K, 2017, BIOMED PHARMACOTHER, V91, P517, DOI 10.1016/j.biopha.2017.04.050; Wang P, 2016, ONCOL REP, V36, P247, DOI 10.3892/or.2016.4815; Xu JF, 2017, ONCOTARGET, V8, P75968, DOI 10.18632/oncotarget.18373; Yang XM, 2017, AM J CANCER RES, V7, P1738; Zhou XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19910	37	40	41	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4534	4543		10.1096/fj.201701337RR	http://dx.doi.org/10.1096/fj.201701337RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29570394				2022-12-28	WOS:000439325400039
J	Xu, DC; Lv, JY; He, LL; Fu, LL; Hu, RK; Cao, Y; Mei, CL				Xu, Dechao; Lv, Jiayi; He, Liangliang; Fu, Lili; Hu, Ruikun; Cao, Ying; Mei, Changlin			Scribble influences cyst formation in autosomal-dominant polycystic kidney disease by regulating Hippo signaling pathway	FASEB JOURNAL			English	Article						YAP; polycystin-2; zebrafish	CELL POLARITY; PRONEPHROS DEVELOPMENT; EPITHELIAL POLARITY; BETA-CATENIN; RENAL CYSTS; ZEBRAFISH; PROTEIN; COMPLEX; YAP; REVEALS	Polarity complexes, including the PAR (Partitioning-defective), CRB (Crumbs) and SCRIB (Scribble) complexes, are required for the physiologic establishment, stabilization, and maintenance of a functional apical-basolateral polarity. Inactivation of some of the polarity complexes results in cystic kidneys, and apical-basolateral polarity defects are commonly observed in autosomal-dominant polycystic kidney disease (ADPKD); however, little is known about the role that polarity complexes play in ADPKD. Here, we demonstrate that Scribble, a core protein of the SCRIB complex, is down-regulated in ADPKD cell lines and the zebrafish model of this disease (pkd2 morphants). Overexpression of Scribble could reduce cyst formation in pkd2 morphants, and loss of scrib led to a dilated pronephric duct in zebrafish. Furthermore, the Hippo signaling pathway was inactivated in scrib mutants and pkd2 morphants in which Yes-associated protein (YAP), which is physiologically located in the cytoplasm, was translocated to the nucleus. Of note, overexpression of cytoplasmic YAP, instead of nuclear YAP, could reduce cyst formation in pkd2 morphants. Consistently, knockout of yap resulted in cystic kidneys in zebrafish, which was rescued by the overexpression of cytoplasmic YAP, but not nuclear YAP. Finally, scrib and yap had a genetic interaction with pkd2 in cyst formation, and the overexpression of Scribble attenuated the down-regulation of cytoplasmic YAP in ADPKD. Altogether, our data indicate that Scribble induces the phosphorylation of YAP and, consequently, influences cyst formation in ADPKD by mediating YAP nucleocytoplasmic shuttling.Xu, D., Lv, J., He, L., Fu, L., Hu, R., Cao, Y., Mei, C. Scribble influences cyst formation in autosomal-dominant polycystic kidney disease by regulating Hippo signaling pathway.	[Xu, Dechao; Lv, Jiayi; He, Liangliang; Fu, Lili; Mei, Changlin] Second Mil Med Univ, Dept Nephrol, Changzheng Hosp, Kidney Inst,Peoples Liberat Army, 415 Fengyang Rd, Shanghai 200003, Peoples R China; [Hu, Ruikun; Cao, Ying] Tongji Univ, Sch Life Sci & Technol, Dept Mol & Cell Biol, 1239 Siping Rd, Shanghai 200092, Peoples R China	Naval Medical University; Tongji University	Mei, CL (corresponding author), Second Mil Med Univ, Dept Nephrol, Changzheng Hosp, Kidney Inst,Peoples Liberat Army, 415 Fengyang Rd, Shanghai 200003, Peoples R China.; Cao, Y (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Mol & Cell Biol, 1239 Siping Rd, Shanghai 200092, Peoples R China.	yingcao@tongji.edu.cn; changlinmei@smmu.edu.cn		Xu, Dechao/0000-0002-4241-4880	National Natural Science Foundation of China [31371172, 81670612]; Three-Year Project of Action for Shanghai Public Health System [GWIV-18]; National Key Research and Development Program of China [2016YFC0901502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Three-Year Project of Action for Shanghai Public Health System; National Key Research and Development Program of China	The authors thank Wenyan Xu and Miaomiao Jin (both of Tongji University) for superb technical assistance. This work was supported by grants from The National Natural Science Foundation of China (31371172, 81670612), the Three-Year Project of Action for Shanghai Public Health System (GWIV-18), and the National Key Research and Development Program of China (2016YFC0901502). The authors declare no conflicts of interest.	Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen BE, 2016, NAT CHEM BIOL, V12, P686, DOI 10.1038/nchembio.2119; Chen CH, 2009, DEV DYNAM, V238, P2850, DOI 10.1002/dvdy.22105; Duning K, 2010, J BIOL CHEM, V285, P33584, DOI 10.1074/jbc.C110.146381; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; Happe H, 2011, J PATHOL, V224, P133, DOI 10.1002/path.2856; He LL, 2015, INT J BIOL SCI, V11, P935, DOI 10.7150/ijbs.11346; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Jaffe KM, 2016, CELL REP, V14, P1841, DOI 10.1016/j.celrep.2016.01.069; Kim I, 2009, J AM SOC NEPHROL, V20, P2556, DOI 10.1681/ASN.2009030271; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Naylor RW, 2013, J AM SOC NEPHROL, V24, P77, DOI 10.1681/ASN.2012070756; Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/j.devcel.2007.07.017; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Weide T, 2017, J AM SOC NEPHROL, V28, P2093, DOI 10.1681/ASN.2016040474; Wilson PD, 2011, BBA-MOL BASIS DIS, V1812, P1239, DOI 10.1016/j.bbadis.2011.05.008; Wong JS, 2016, AM J PHYSIOL-RENAL, V311, pF241, DOI 10.1152/ajprenal.00500.2015; Wuthrich RP, 2012, NEW ENGL J MED, V367, P2440, DOI 10.1056/NEJMe1211857; Xu WY, 2017, J AM SOC NEPHROL, V28, P118, DOI 10.1681/ASN.2015080906; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng WY, 2016, NAT CELL BIOL, V18, P1244, DOI 10.1038/ncb3413	49	18	18	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4394	4407		10.1096/fj.201701376RR	http://dx.doi.org/10.1096/fj.201701376RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29529391				2022-12-28	WOS:000439325400028
J	Agoro, R; Montagna, A; Goetz, R; Aligbe, O; Singh, G; Coe, LM; Mohammadi, M; Rivella, S; Sitara, D				Agoro, Rafiou; Montagna, Anna; Goetz, Regina; Aligbe, Onyedikachi; Singh, Gurinder; Coe, Lindsay M.; Mohammadi, Moosa; Rivella, Stefano; Sitara, Despina			Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia	FASEB JOURNAL			English	Article						chronic kidney disease; erythropoietin; FGF23; iron	CHRONIC KIDNEY-DISEASE; DOMINANT HYPOPHOSPHATEMIC RICKETS; VITAMIN-D METABOLISM; ERYTHROPOIETIN DEFICIENCY; CARDIOVASCULAR EVENTS; IRON; PHOSPHATE; FIBROBLAST-GROWTH-FACTOR-23; INFLAMMATION; EXPRESSION	Severe anemia and iron deficiency are common complications in chronic kidney disease. The cause of renal anemia is multifactorial and includes decreased erythropoietin (Epo) production, iron deficiency, and inflammation, and it is currently treated with injections of synthetic Epo. However, the use of recombinant Epo has several adverse effects. We previously reported that high fibroblast growth factor 23 (FGF23) levels in mice are associated with decreased red blood cell production, whereas genetic inactivation of Fgf23 results in expansion of the erythroid lineage. The present study is the first to show that high FGF23 levels in a mouse model of renal failure contribute to renal anemia, and inhibiting FGF23 signaling stimulates erythropoiesis and abolishes anemia and iron deficiency. Moreover, we show that inhibition of FGF23 signaling significantly decreases erythroid cell apoptosis and influences the commitment of hematopoietic stem cells toward the erythroid linage. Furthermore, we show that blocking FGF23 signaling attenuates inflammation, resulting in increased serum iron and ferritin levels. Our data clearly demonstrate that elevated FGF23 is a causative factor in the development of renal anemia and iron deficiency, and importantly, blocking FGF23 signaling represents a novel approach to stimulate erythropoiesis and possibly improve survival for millions of chronic kidney disease patients worldwide.Agoro, R., Montagna, A., Goetz, R., Aligbe, O., Singh, G., Coe, L. M., Mohammadi, M., Rivella, S., Sitara, D. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.	[Agoro, Rafiou; Montagna, Anna; Aligbe, Onyedikachi; Singh, Gurinder; Coe, Lindsay M.; Sitara, Despina] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Goetz, Regina; Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10010 USA; [Sitara, Despina] NYU, Sch Med, Dept Med, New York, NY 10010 USA; [Rivella, Stefano] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	New York University; New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sitara, D (corresponding author), NYU, Coll Dent, 345 East 24th St,Room 902C, New York, NY 10010 USA.	ds199@nyu.edu	kasaei, fahime/T-7197-2018; Mohammadi, Moosa/ABA-6745-2020; Goetz, Regina/M-2411-2019; Agoro, Rafiou/AAI-2916-2020	Mohammadi, Moosa/0000-0003-2434-9437; Goetz, Regina/0000-0003-3681-4703; AGORO, RAFIOU/0000-0002-5461-7685; SITARA, DESPINA/0000-0002-4836-5039	American Heart Association [12SDG12080152]; U.S. Department of Defense [W81XWH-16-1-0598]; U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research [DE 13686]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank M. N. T. Wada (University of Sao Paulo, Sao Paulo, Brazil and New York University School of Dentistry, New York, USA) and R. C. Bernstein (New York University College of Dentistry) for technical assistance. The authors are grateful to W. R. Abrams (New York University College of Dentistry) for invaluable assistance with the technical visualization of the data, and M. Gregory and P. Lopez (New York University School of Medicine) for assistance with flow cytometry and flow data analyses. This work was supported in part by funds from the American Heart Association (12SDG12080152) and the U.S. Department of Defense (W81XWH-16-1-0598; to D.S.), and the U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research (DE 13686; to M. M.). The authors declare no conflicts of interest.	Andrukhova O, 2014, EMBO MOL MED, V6, P744, DOI 10.1002/emmm.201303716; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Asari S, 2005, EXP HEMATOL, V33, P26, DOI 10.1016/j.exphem.2004.10.001; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Braithwaite V, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-27; Coe LM, 2014, J BIOL CHEM, V289, P9795, DOI 10.1074/jbc.M113.527150; Cole J, 2000, J CLIN INVEST, V106, P1391, DOI 10.1172/JCI10557; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Frede S, 2011, BLOOD, V117, P4905, DOI 10.1182/blood-2010-07-298083; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kalantar-Zadeh K, 2004, NEPHROL DIAL TRANSPL, V19, P141, DOI 10.1093/ndt/gfg493; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; LIPKIN GW, 1990, NEPHROL DIAL TRANSPL, V5, P920, DOI 10.1093/ndt/5.11.920; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mendoza JM, 2017, KIDNEY INT, V91, P711, DOI 10.1016/j.kint.2016.10.021; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pan XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025839; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Querbes W, 2012, BLOOD, V120, P1916, DOI 10.1182/blood-2012-04-423715; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF769, DOI 10.1152/ajprenal.00248.2006; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Silverberg D, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI [10.1093/ndt//gfg1084, 10.1093/ndt/gfg1056]; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Souma T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00167; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Tsai MH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003049; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Zhang F, 1996, EXP HEMATOL, V24, P1469	61	68	71	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3752	3764		10.1096/fj.201700667R	http://dx.doi.org/10.1096/fj.201700667R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481308	Green Published			2022-12-28	WOS:000435104500023
J	Brummer, T; Pigoni, M; Rossello, A; Wang, HH; Noy, PJ; Tomlinson, MG; Blobel, CP; Lichtenthaler, SF				Brummer, Tobias; Pigoni, Martina; Rossello, Armando; Wang, Huanhuan; Noy, Peter J.; Tomlinson, Michael G.; Blobel, Carl P.; Lichtenthaler, Stefan F.			The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation	FASEB JOURNAL			English	Article						ADAM17; GI254023X; Alzheimer's; tetraspanin15; NrCAM	AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE ADAM10; CELL-ADHESION; DISINTEGRIN/METALLOPROTEINASE ADAM10; TSPANC8 TETRASPANINS; REGULATED PROTEOLYSIS; NOTCH ACTIVATION; N-CADHERIN; CLEAVAGE; TRAFFICKING	The transmembrane protein, ADAM10 (a disintegrin and metalloprotease 10), has key physiologic functionsfor example, during embryonic development and in the brain. During transit through the secretory pathway, immature ADAM10 (proADAM10) is converted into its proteolytically active, mature form (mADAM10). Increasing or decreasing the abundance and/or activity of mADAM10 is considered to be a therapeutic approach for the treatment of such diseases as Alzheimer's disease and cancer. Yet biochemical detection and characterization of mADAM10 has been difficult. In contrast, proADAM10 is readily detected-for example, in immunoblots-which suggests that mADAM10 is only a fraction of total cellular ADAM10. Here, we demonstrate that mADAM10, but not proADAM10, unexpectedly undergoes rapid, time-dependent degradation upon biochemical cell lysis in different cell lines and in primary neurons, which prevents the detection of the majority of mADAM10 in immunoblots. This degradation required the catalytic activity of ADAM10, was efficiently prevented by adding active site inhibitors to the lysis buffer, and did not affect proADAM10, which suggests that ADAM10 degradation occurred in an intramolecular and autoproteolytic manner. Inhibition of postlysis autoproteolysis demonstrated efficient cellular ADAM10 maturation with higher levels of mADAM10 than proADAM10. Moreover, a cycloheximide chase experiment revealed that mADAM10 is a long-lived protein with a half-life of approximately 12 h. In summary, our study demonstrates that mADAM10 autoproteolysis must be blocked to allow for the proper detection of mADAM10, which is essential for the correct interpretation of biochemical and cellular studies of ADAM10.-Brummer, T., Pigoni, M., Rossello, A., Wang, H., Noy, P. J., Tomlinson, M. G., Blobel, C. P., Lichtenthaler, S. F. The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.	[Brummer, Tobias; Pigoni, Martina; Wang, Huanhuan; Lichtenthaler, Stefan F.] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Brummer, Tobias; Pigoni, Martina; Lichtenthaler, Stefan F.] Klinikum Rechts Der Isar, Sch Med, Neuroprote, Munich, Germany; [Blobel, Carl P.; Lichtenthaler, Stefan F.] Tech Univ Munich, Inst Adv Study, Munich, Germany; [Rossello, Armando] Univ Pisa, Dept Pharm, Pisa, Italy; [Wang, Huanhuan] Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Noy, Peter J.; Tomlinson, Michael G.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Blobel, Carl P.] Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med, Dept Med, New York, NY USA; [Blobel, Carl P.] Weill Cornell Med, Dept Physiol Biophys & Syst Biol, New York, NY USA; [Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Technical University of Munich; University of Pisa; Hangzhou Normal University; University of Birmingham; Cornell University; Cornell University	Lichtenthaler, SF (corresponding author), DZNE, Feodor Lynen Str 17, D-81377 Munich, Germany.; Lichtenthaler, SF (corresponding author), TUM, Feodor Lynen Str 17, D-81377 Munich, Germany.	stefan.lichtenthaler@dzne.de	Rossello, Armando/S-7332-2019	Rossello, Armando/0000-0002-6795-8091; Pigoni, Martina/0000-0002-7896-6978; Tomlinson, Michael/0000-0002-1189-0091	Deutsche Forschungsgemeinschaft [FOR2290]; Centers of Excellence in Neurodegeneration; Helmholtz-Israel Program; Breuer foundation Alzheimer Award; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01-GM64750]; medical faculty of Technische Universitat Munchen (Klinikum Rechts der Isar); British Heart Foundation Project [PG/13/92/30587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centers of Excellence in Neurodegeneration; Helmholtz-Israel Program; Breuer foundation Alzheimer Award; U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); medical faculty of Technische Universitat Munchen (Klinikum Rechts der Isar); British Heart Foundation Project(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following funding agencies: Deutsche Forschungsgemeinschaft (FOR2290), the Centers of Excellence in Neurodegeneration, the Helmholtz-Israel Program and the Breuer foundation Alzheimer Award (to S.F.L.), and the U.S. National Institutes of Health, National Institute of General Medical Sciences (Grant R01-GM64750; to C.P.B.). T.B. was supported by a fellowship from the medical faculty of Technische Universitat Munchen (Klinikum Rechts der Isar). P.J.N. was funded by the British Heart Foundation Project (Grant PG/13/92/30587; to M.G.T.). The authors thank Linda Troeberg (University of Oxford, Oxford, England) for help with the calculation of K<INF>i</INF> values. The authors declare no conflicts of interest.	Alabi RO, 2016, CIRC RES, V119, P519, DOI 10.1161/CIRCRESAHA.115.307738; Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Camodeca C, 2016, EUR J MED CHEM, V111, P193, DOI 10.1016/j.ejmech.2016.01.053; Chen AC, 2015, J CELL BIOL, V211, P1157, DOI 10.1083/jcb.201502001; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Epis R, 2010, BRAIN, V133, P3323, DOI 10.1093/brain/awq217; Gaida MM, 2010, INT J MOL MED, V26, P281, DOI 10.3892/ijmm_00000463; Glomski K, 2011, BLOOD, V118, P1163, DOI 10.1182/blood-2011-04-348557; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hoffmann FS, 2015, J IMMUNOL, V194, P542, DOI 10.4049/jimmunol.1402070; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones JC, 2016, ANNU REV PHYSIOL, V78, P243, DOI 10.1146/annurev-physiol-021014-071720; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lopez-Perez E, 2001, J NEUROCHEM, V76, P1532, DOI 10.1046/j.1471-4159.2001.00180.x; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matthews AL, 2017, BIOCHEM SOC T, V45, P719, DOI 10.1042/BST20160290; Matthews AL, 2017, PLATELETS, V28, P333, DOI 10.1080/09537104.2016.1184751; Musardo S, 2014, NEURODEGENER DIS, V13, P72, DOI 10.1159/000354233; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagara Y, 2012, BIOCHEM BIOPH RES CO, V417, P462, DOI 10.1016/j.bbrc.2011.11.140; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Pasciuto E, 2015, NEURON, V87, P382, DOI 10.1016/j.neuron.2015.06.032; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prox J, 2013, J NEUROSCI, V33, P12915, DOI 10.1523/JNEUROSCI.5910-12.2013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Romi E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5058; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Saraceno C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.492; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Siney EJ, 2017, MOL NEUROBIOL, V54, P3893, DOI 10.1007/s12035-016-0053-6; Storey E, 1999, EUR J NEUROSCI, V11, P1779, DOI 10.1046/j.1460-9568.1999.00599.x; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Susuki K, 2013, NEURON, V78, P469, DOI 10.1016/j.neuron.2013.03.005; Taverna M, 2013, J ALZHEIMERS DIS, V37, P667, DOI 10.3233/JAD-130509; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Woods N, 2015, ONCOTARGET, V6, P35931, DOI 10.18632/oncotarget.5933; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084617; Zimmermann M, 2004, J NEUROCHEM, V90, P1489, DOI 10.1111/j.1471-4159.2004.02680.x; Zocchi MR, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1123367	66	16	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3560	3573		10.1096/fj.201700823RR	http://dx.doi.org/10.1096/fj.201700823RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29430990	Green Published			2022-12-28	WOS:000435104500007
J	Hauk, V; Vota, D; Gallino, L; Calo, G; Paparini, D; Merech, F; Ochoa, F; Zotta, E; Ramhorst, R; Waschek, J; Leiros, CP				Hauk, Vanesa; Vota, Daiana; Gallino, Lucila; Calo, Guillermina; Paparini, Daniel; Merech, Fatima; Ochoa, Federico; Zotta, Elsa; Ramhorst, Rosanna; Waschek, James; Perez Leiros, Claudia			Trophoblast VIP deficiency entails immune homeostasis loss and adverse pregnancy outcome in mice	FASEB JOURNAL			English	Article						trophoblast function; immunoregulation; early pregnancy	VASOACTIVE-INTESTINAL-PEPTIDE; REGULATORY T-CELLS; ENDOTHELIAL GROWTH-FACTOR; MATERNAL-FETAL INTERFACE; CIRCADIAN-RHYTHMS; EMBRYONIC GROWTH; VEGF EXPRESSION; GENITAL-TRACT; FEMALE; SYSTEM	Immune homeostasis maintenance throughout pregnancy is critical for normal fetal development. Trophoblast cells differentiate into an invasive phenotype and contribute to the transformation of maternal arteries and the functional shaping of decidual leukocyte populations. Insufficient trophoblast invasion, inadequate vascular remodeling, and a loss of immunologic homeostasis are associated with pregnancy complications, such as preeclampsia and intrauterine growth restriction. Vasoactive intestinal peptide (VIP) is a pleiotropic neuropeptide synthetized in trophoblasts at the maternal-placental interface. It regulates the function of trophoblast cells and their interaction with decidual leukocytes. By means of a murine model of pregnancy in normal maternal background with VIP-deficient trophoblast cells, here we demonstrate that trophoblast VIP is critical for trophoblast function: VIP gene haploinsufficiency results in lower matrix metalloproteinase 9 expression, and reduced migration and invasion capacities. A reduced number of regulatory T cells at the implantation sites along with a lower expression of proangiogenic and antiinflammatory markers were also observed. Findings detected in the implantation sites at early stages were followed by an abnormal placental structure and lower fetal weight. This effect was overcome by VIP treatment of the early pregnant mice. Our results support the relevance of trophoblast-synthesized VIP as a critical factor in vivo for trophoblast-cell function and immune homeostasis maintenance in mouse pregnancy.Hauk, V., Vota, D., Gallino, L., Calo, G., Paparini, D., Merech, F., Ochoa, F., Zotta, E., Ramhorst, R., Waschek, J., Leiros, C. P. Trophoblast VIP deficiency entails immune homeostasis loss and adverse pregnancy outcome in mice.	[Hauk, Vanesa; Vota, Daiana; Gallino, Lucila; Calo, Guillermina; Paparini, Daniel; Merech, Fatima; Ramhorst, Rosanna; Perez Leiros, Claudia] Univ Buenos Aires, Fac Ciencias Exactas & Nat IQUIBICEN, Inst Quim Biol, Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Ochoa, Federico; Zotta, Elsa] Univ Buenos Aires, Fac Med, Dept Ciencias Fisiol, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Buenos Aires, DF, Argentina; [Zotta, Elsa] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiopatol, Buenos Aires, DF, Argentina; [Waschek, James] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Leiros, CP (corresponding author), Univ Buenos Aires, CONICET, IQUIBICEN, Dept Biol Chem,Lab Immunopharmacol,Sch Sci, Ciudad Univ,Pab 2,Int Guiraldes 2160, RA-1428 Buenos Aires, DF, Argentina.	cpleiros@qb.fcen.uba.ar	Calo, Guillermina/GYU-9098-2022	Paparini, Daniel Esteban/0000-0002-3335-4564	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) National Agency of Science and Technology Projects [PICT 2014-0657, 2015-1281, 2016-0464, 2016-1937]; University of Buenos Aires Secretaria de Ciencia y Tecnica (UBACyT)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) National Agency of Science and Technology Projects; University of Buenos Aires Secretaria de Ciencia y Tecnica (UBACyT)	The authors acknowledge P. Pomata (Instituto de Biologia y Medicina Experimental-Consejo Nacional de Investigaciones Cientificas y Tecnicas (IByME-CONICET), for expert contribution to LCM assays, and M. Brahamian and Z. Naguila (both from Central Animal Facility of the School of Sciences, University of Buenos Aires, Argentina) for expert technical assistance with the VIP-deficient colony breeding. This work was funded by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) National Agency of Science and Technology Projects (PICT 2014-0657 to C.P.L., 2015-1281 to D.V., 2016-0464 to R.R., and 2016-1937 to V.H.), and the University of Buenos Aires Secretaria de Ciencia y Tecnica (2014-2017 to C.P.L. and UBACyT 2016 to R.R.). The authors declare no conflicts of interest.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Calo G, 2017, HUM REPROD, V32, P55, DOI 10.1093/humrep/dew292; Collado B, 2005, BBA-MOL CELL RES, V1744, P224, DOI 10.1016/j.bbamcr.2005.04.009; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Croy B.A., 2013, GUIDE INVESTIGATION; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; El-Dayem T., 2016, INT J REPROD CONTRAC, V5, P1593; Eliezer G, 2007, J MOL NEUROSCI, V33, P278, DOI 10.1007/s12031-007-9003-0; Ernerudh J, 2011, AM J REPROD IMMUNOL, V66, P31, DOI 10.1111/j.1600-0897.2011.01049.x; Fernandez-Martinez AB, 2010, CANCER LETT, V299, P11, DOI 10.1016/j.canlet.2010.07.019; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fitzgerald JS, 2010, AM J REPROD IMMUNOL, V63, P492, DOI 10.1111/j.1600-0897.2010.00824.x; Fraccaroli L, 2015, J LEUKOCYTE BIOL, V98, P49, DOI 10.1189/jlb.1A1014-492RR; Fraccaroli L, 2014, NEUROIMMUNOMODULAT, V21, P21, DOI 10.1159/000355039; Fraccaroli L, 2009, BRIT J PHARMACOL, V156, P116, DOI 10.1111/j.1476-5381.2008.00055.x; Gallino L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18633; Gomariz RP, 2010, CURR PHARM DESIGN, V16, P1063, DOI 10.2174/138161210790963841; GRESSENS P, 1993, NATURE, V362, P155, DOI 10.1038/362155a0; GRESSENS P, 1994, J CLIN INVEST, V94, P2020, DOI 10.1172/JCI117555; Hauk V, 2014, AM J REPROD IMMUNOL, V71, P120, DOI 10.1111/aji.12167; Hill JM, 2002, PEPTIDES, V23, P1803, DOI 10.1016/S0196-9781(02)00137-7; Hill JM, 1996, J CLIN INVEST, V97, P202, DOI 10.1172/JCI118391; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Huppertz B, 2014, J REPROD IMMUNOL, V101, P74, DOI 10.1016/j.jri.2013.04.003; Kappou D, 2015, EXP THER MED, V9, P1091, DOI 10.3892/etm.2015.2280; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Lash GE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023010; Li MY, 2006, J CLIN INVEST, V116, P2653, DOI 10.1172/JC128462; Lim MA, 2008, INT J DEV NEUROSCI, V26, P423, DOI 10.1016/j.ijdevneu.2008.03.002; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lodde BM, 2006, ANN RHEUM DIS, V65, P195, DOI 10.1136/ard.2005.038232; Loh DH, 2014, J BIOL RHYTHM, V29, P355, DOI 10.1177/0748730414549767; Maduna T, 2016, J NEUROSCI RES, V94, P1472, DOI 10.1002/jnr.23915; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Marzioni D, 2005, J CLIN ENDOCR METAB, V90, P2378, DOI 10.1210/jc.2004-1512; Matson BC, 2014, CELL MOL IMMUNOL, V11, P456, DOI 10.1038/cmi.2014.71; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Moser G, 2010, HUM REPROD, V25, P1127, DOI 10.1093/humrep/deq035; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; OTTESEN B, 1982, AM J OBSTET GYNECOL, V143, P414, DOI 10.1016/0002-9378(82)90083-7; OTTESEN B, 1995, AM J OBSTET GYNECOL, V172, P1615, DOI 10.1016/0002-9378(95)90506-5; Paparini D, 2015, MOL HUM REPROD, V21, P930, DOI 10.1093/molehr/gav059; Passemard S, 2011, J CLIN INVEST, V121, P3072, DOI 10.1172/JCI43824; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Pringle KG, 2007, PLACENTA, V28, P286, DOI 10.1016/j.placenta.2006.04.006; Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Roca V, 2009, REPRODUCTION, V138, P733, DOI 10.1530/REP-09-0171; Rosignoli F, 2006, ANN NY ACAD SCI, V1070, P525, DOI 10.1196/annals.1317.073; Said SI, 2007, PEPTIDES, V28, P1620, DOI 10.1016/j.peptides.2007.06.007; Sasaki Y, 2007, CLIN EXP IMMUNOL, V149, P139, DOI 10.1111/j.1365-2249.2007.03397.x; Schumacher A, 2014, AM J REPROD IMMUNOL, V72, P158, DOI 10.1111/aji.12238; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Spong CY, 1999, ENDOCRINOLOGY, V140, P917, DOI 10.1210/en.140.2.917; St Hilaire RC, 2010, PEPTIDES, V31, P1517, DOI 10.1016/j.peptides.2010.04.024; Stepan H, 2007, J CLIN ENDOCR METAB, V92, P2831, DOI 10.1210/jc.2006-2774; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Vota D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26364; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Yang J, 2013, PEPTIDES, V42, P105, DOI 10.1016/j.peptides.2013.01.007	69	11	11	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1801	1810		10.1096/fj.201800592RR	http://dx.doi.org/10.1096/fj.201800592RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204500				2022-12-28	WOS:000457296600023
J	Oshima, H; Kok, SY; Nakayama, M; Murakami, K; Voon, DCC; Kimura, T; Oshima, M				Oshima, Hiroko; Kok, Sau-Yee; Nakayama, Mizuho; Murakami, Kazuhiro; Voon, Dominic Chih-Cheng; Kimura, Takashi; Oshima, Masanobu			Stat3 is indispensable for damage-induced crypt regeneration but not for Wnt-driven intestinal tumorigenesis	FASEB JOURNAL			English	Article						colon cancer; organoids; anoikis; integrin; FAK	STEM-CELLS; EPITHELIAL-CELLS; WNT/BETA-CATENIN; COLON-CANCER; ACTIVATION; PROLIFERATION; SURVIVAL; IL-6; INFLAMMATION; PROGRESSION	Signal transducer and activator of transcription 3 (Stat3) has been shown to play a role in intestinal regeneration and colitis-associated colon carcinogenesis. However, the role of Stat3 in the Wnt-driven sporadic intestinal tumorigenesis remains poorly understood. We examined the roles of Stat3 in intestinal regeneration and tumorigenesis by organoid culture experiments using Stat3(IEC) mouse-derived intestinal epithelial cells in which Stat3 was disrupted. The regeneration of intestinal mucosa and organoid formation were significantly suppressed by Stat3 disruption, which was compensated by Wnt activation. Furthermore, once organoids were recovered, Stat3 was no longer required for organoid growth. These results indicate that Stat3 and Wnt signaling cooperatively protect epithelial cells at the early phase of intestinal regeneration. In contrast, intestinal tumorigenesis was not suppressed by Stat3 disruption in adenomatous polyposis coli (Apc)(716) and Apc(716) Tgfbr2(IEC) mice, thus indicating that Stat3 is not required for Wnt activation-driven intestinal tumorigenesis. Mechanistically, Itga5 and Itga6 were down-regulated by Stat3 disruption, and focal adhesion kinase (FAK) activation was also suppressed. Notably, FAK inhibitor suppressed the organoid formation of wild-type epithelial cells. These results indicate that Stat3 is indispensable for the survival of epithelial cells through the activation of integrin signaling and the downstream FAK pathway; however, it is not required for the Wnt signaling-activated normal or tumor epithelial cells.Oshima, H., Kok, S.-Y., Nakayama, M., Murakami, K., Voon, D. C.-C., Kimura, T., Oshima, M. Stat3 is indispensable for damage-induced crypt regeneration but not for Wnt-driven intestinal tumorigenesis.	[Oshima, Hiroko; Kok, Sau-Yee; Nakayama, Mizuho; Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Oshima, Hiroko; Nakayama, Mizuho; Oshima, Masanobu] Kanazawa Univ, World Premier Int Res Ctr Initiat WPI, Nanolife Sci Inst NanoLSI, Kanazawa, Ishikawa, Japan; [Murakami, Kazuhiro] Kanazawa Univ, Canc Res Inst, Div Stem Cell Biol, Kanazawa, Ishikawa, Japan; [Voon, Dominic Chih-Cheng] Kanazawa Univ, Inst Frontier Sci Initiat InFiniti, Canc Res Core, Kanazawa, Ishikawa, Japan; [Kimura, Takashi] Hokkaido Univ, Lab Comparat Pathol, Fac Vet Med, Sapporo, Hokkaido, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Hokkaido University	Oshima, M (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan.	oshimam@staff.kanazawa-u.ac.jp	Murakami, Kazuhiro/AAC-4569-2019; Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004; Murakami, Kazuhiro/0000-0003-1759-9542; Voon, Dominic Chih-Cheng/0000-0002-2963-9305; Oshima, Hiroko/0000-0001-6855-4008; , Kok/0000-0001-5314-3521	Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) [JP17gm0410014]; AMED [JP17ck0106259]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [JP18H04030, JP16K07111]; Takeda Science Foundation; Mitsubishi Foundation	Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); AMED; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	The authors thank M. Watanabe, A. Tsuda, and Y. Jomen (Division of Genetics, Cancer Research Institute, Kanazawa University) for their technical assistance. This study was supported by the Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (JP17gm0410014) and AMED (JP17ck0106259); and Grants-in-Aid for Scientific Research (A) (JP18H04030) and (C) (JP16K07111) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; and Mitsubishi Foundation. The authors declare no conflicts of interest.	Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Corvinus FM, 2005, NEOPLASIA, V7, P545, DOI 10.1593/neo.04571; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fujii M, 2015, NAT PROTOC, V10, P1474, DOI 10.1038/nprot.2015.088; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Jeffery V, 2017, J IMMUNOL, V199, P304, DOI 10.4049/jimmunol.1600960; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lee J, 2012, J BIOL CHEM, V287, P18182, DOI 10.1074/jbc.M111.328831; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Matthews JR, 2011, CELL DEATH DIFFER, V18, P1934, DOI 10.1038/cdd.2011.77; Mihara E, 2016, ELIFE, V5, DOI 10.7554/eLife.11621; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Oshima H, 2015, CANCER RES, V75, P766, DOI 10.1158/0008-5472.CAN-14-2036; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Oudhoff MJ, 2016, DEV CELL, V37, P47, DOI 10.1016/j.devcel.2016.03.002; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Phesse TJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005411; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Roeser JC, 2015, ONCOGENE, V34, P6029, DOI 10.1038/onc.2015.98; Sakai E, 2018, CANCER RES, V78, P1334, DOI 10.1158/0008-5472.CAN-17-3303; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Takeda K, 1998, J IMMUNOL, V161, P4652; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Willson TA, 2013, INFLAMM BOWEL DIS, V19, P512, DOI 10.1097/MIB.0b013e31828028ad	42	5	5	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1873	1886		10.1096/fj.201801176R	http://dx.doi.org/10.1096/fj.201801176R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30156908	Green Published, hybrid			2022-12-28	WOS:000457296600029
J	Wei, JY; Guo, FF; Zhang, MY; Xian, MH; Wang, TT; Gao, JH; Wu, HW; Song, L; Zhang, Y; Li, DF; Yang, HJ; Huang, LQ				Wei, Junying; Guo, Feifei; Zhang, Minyu; Xian, Minghua; Wang, Tingting; Gao, Jinhuan; Wu, Hongwei; Song, Lei; Zhang, Yi; Li, Defeng; Yang, Hongjun; Huang, Luqi			Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure	FASEB JOURNAL			English	Article						personalized medicine; biomarker; traditional Chinese medicine	PLURIPOTENT STEM-CELL; ACID-BINDING PROTEIN; MYOCARDIAL DYSFUNCTION; PRECISION MEDICINE; ADJUVANT TREATMENT; SHENMAI INJECTION; QILI QIANGXIN; DOUBLE-BLIND; QUANTIFICATION; CARDIOMYOCYTES	Increasing attention has been paid to the application of precision medicine in heart failure (HF), and biomarker-based personalized medical care has shown great progress in HF management. Additionally, multicomponent drugs represented by traditional Chinese medicine (TCM) are demonstrating safety and efficacy in the management of HF. However, the potential mechanism is unclear, and the ambiguous clinical locations of TCM remain a hindrance to its extensive application. To meet this requirement, a precise investigation on the efficacy of multicomponent drugs against HF using the signature biomarkers-oriented approach was developed and applied to a conventional drug for cardiac disease, YiXinShu (YXS). On the basis of in vitro and in vivo efficacy evaluation of YXS against HF, and with the aid of proteomics and network pharmacology approaches, specific signatures regulated by YXS against HF were identified. YXS may show distinctive treatment features for those HF patients showing the elevation of fatty acid-binding protein 3 and cytoskeleton-associated protein 5, as well as other classic HF biomarkers. This study provides the first precise investigation of the efficacy of multicomponent drugs against HF and offers a practicable and low-cost approach for personalized management of HF.Wei, J., Guo, F., Zhang, M., Xian, M., Wang, T., Gao, J., Wu, H., Song, L., Zhang, Y., Li, D., Yang, H., Huang, L. Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure.	[Wei, Junying; Guo, Feifei; Xian, Minghua; Wang, Tingting; Gao, Jinhuan; Wu, Hongwei; Zhang, Yi; Li, Defeng; Yang, Hongjun] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Materia Med, Inst Chinese Materia Med, Beijing, Peoples R China; [Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Materia Med, State Key Lab Breeding Base Daodi Herbs, Dongzhimen Nanxiao Rd 16, Beijing, Peoples R China; [Zhang, Minyu] Capital Med Univ, Sch Tradit Chinese Med, Beijing Key Lab TCM Collateral Dis Theory Res, Beijing, Peoples R China; [Song, Lei] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Capital Medical University; Academy of Military Medical Sciences - China	Huang, LQ (corresponding author), China Acad Chinese Med Sci, Natl Resource Ctr Chinese Materia Med, State Key Lab Breeding Base Daodi Herbs, Dongzhimen Nanxiao Rd 16, Beijing, Peoples R China.; Wei, JY; Yang, HJ (corresponding author), Inst Chinese Materia Med, Dongzhimen Nanxiao Rd 16, Beijing 100700, Peoples R China.	13683350075@163.com; hongjun0420@vip.sina.com; huangluqi01@126.com	wang, tingting/AAK-2640-2020		National Science and Technology Major Project [2014ZX09201021-009]; National Program on Key Basic Research Project [2015CB554406]; National Natural Science Foundation of China [81330086, 81603422, 81703951, IPX0001125000/PXD008489]	National Science and Technology Major Project; National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge financial support from the National Science and Technology Major Project (2014ZX09201021-009 to H.Y.), the National Program on Key Basic Research Project (2015CB554406 to H.Y.), and the National Natural Science Foundation of China (81330086 to H.Y., 81603422, and 81703951 to F.G.). All data related to this study have been made publicly available on iProX (http://www.iprox.org/) with ID IPX0001125000/PXD008489. The authors declare no conflicts of interests.	Abukar Y, 2016, AM J PHYSIOL-REG I, V310, pR94, DOI 10.1152/ajpregu.00205.2015; Arimoto T, 2005, J CARD FAIL, V11, P56, DOI 10.1016/j.cardfail.2004.03.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bayes-Genis A, 2018, EUR HEART J, V39, P2793, DOI 10.1093/eurheartj/ehx027; Cai J, 2015, STEM CELL REP, V5, P963, DOI 10.1016/j.stemcr.2015.10.020; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Ding C, 2013, MOL CELL PROTEOMICS, V12, P2370, DOI 10.1074/mcp.O112.025023; Ertl G, 2014, EUR HEART J, V35, P470, DOI 10.1093/eurheartj/eht555; Fridman MD, 2017, CLIN SCI, V131, P439, DOI 10.1042/CS20160414; Fu F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17927; Gan XT, 2014, CIRC-HEART FAIL, V7, P491, DOI 10.1161/CIRCHEARTFAILURE.113.000978; Genth-Zotz S, 2004, INT J CARDIOL, V96, P397, DOI 10.1016/j.ijcard.2003.08.008; Ginghina C, 2011, J Med Life, V4, P280; Gunaseeli I, 2010, CURR MED CHEM, V17, P759, DOI 10.2174/092986710790514480; Hao PP, 2015, NAT REV CARDIOL, V12, P115, DOI 10.1038/nrcardio.2014.177; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu ZY, 2014, THERANOSTICS, V4, P215, DOI 10.7150/thno.7868; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenei ZM, 2013, CELL STRESS CHAPERON, V18, P809, DOI 10.1007/s12192-013-0425-z; Kostin S, 2000, Heart Fail Rev, V5, P271; Lainscak M, 2010, EUR J HEART FAIL, V12, P193, DOI 10.1093/eurjhf/hfp185; Layne K, 2017, BRIT J CLIN PHARMACO, V83, P20, DOI 10.1111/bcp.13013; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep36949; Li XL, 2013, J AM COLL CARDIOL, V62, P1065, DOI 10.1016/j.jacc.2013.05.035; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Liu ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21146; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Medhekar SK, 2016, INT J STEM CELLS, V9, P21, DOI 10.15283/ijsc.2016.9.1.21; Niizeki T, 2007, J CARD FAIL, V13, P120, DOI 10.1016/j.cardfail.2006.10.014; Qi JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42843; Ruiz-Castaneda G., 2015, J RECEPT SIG TRANSD, V2015, P1; Schuetz P, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14079; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shi LW, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0939-2; Shimizu Y, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002368; Sun J, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1174-1; Tang WHW, 2013, J AM COLL CARDIOL, V62, P1073, DOI 10.1016/j.jacc.2013.05.028; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Wang NY, 2002, CIRC J, V66, P763, DOI 10.1253/circj.66.763; Wang XY, 2016, DRUG DES DEV THER, V10, P3725, DOI 10.2147/DDDT.S112333; Wei HM, 2015, J ETHNOPHARMACOL, V169, P347, DOI 10.1016/j.jep.2015.04.016; Wei JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29823; Wei JY, 2014, J PROTEOME RES, V13, P5724, DOI 10.1021/pr5007119; Wilmut I, 2007, CELL STEM CELL, V1, P593, DOI 10.1016/j.stem.2007.11.013; Xian SX, 2016, J ETHNOPHARMACOL, V186, P136, DOI 10.1016/j.jep.2016.03.066; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zhang FB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/802784; Zhang MY, 2017, MOL BIOSYST, V13, P1469, DOI 10.1039/c6mb00813e; Zhao YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23025; Zhou Q, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005052.pub5	53	11	14	0	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2187	2198		10.1096/fj.201800673RR	http://dx.doi.org/10.1096/fj.201800673RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30230922				2022-12-28	WOS:000457296600053
J	Curley, M; Milne, L; Smith, S; Jorgensen, A; Frederiksen, H; Hadoke, P; Potter, P; Smith, LB				Curley, Michael; Milne, Laura; Smith, Sarah; Jorgensen, Anne; Frederiksen, Hanne; Hadoke, Patrick; Potter, Paul; Smith, Lee B.			A young testicular microenvironment protects Leydig cells against age-related dysfunction in a mouse model of premature aging	FASEB JOURNAL			English	Article						testis; testosterone; gonadotropin; steroidogenesis	BROWN-NORWAY RAT; FOLLICLE-STIMULATING-HORMONE; PLASMA TESTOSTERONE LEVELS; LATE-ONSET HYPOGONADISM; DAILY SPERM PRODUCTION; LUTEINIZING-HORMONE; SEMINIFEROUS TUBULES; BINDING GLOBULIN; SERTOLI-CELLS; ANDROGEN DEFICIENCY	Testicular Leydig cells (LCs) are the primary source of circulating androgen in men. As men age, circulating androgen levels decline. However, whether reduced LC steroidogenesis results from specific effects of aging within LCs or reflects degenerative alterations to the wider supporting microenvironment is unclear; inability to separate intrinsic LC aging from that of the testicular microenvironment in vivo has made this question difficult to address. To resolve this, we generated novel mouse models of premature aging, driven by CDGSH iron sulfur domain 2 (Cisd2) deletion, to separate the effects of cell intrinsic aging from extrinsic effects of aging on LC function. At 6 mo of age, constitutive Cisd2-deficient mice display signs of premature aging, including testicular atrophy, reduced LC and Sertoli cell (SC) number, decreased circulating testosterone, increased luteinizing hormone/testosterone ratio, and decreased expression of steroidogenic mRNAs, appropriately modeling primary testicular dysfunction observed in aging men. However, mice with Cisd2 deletion (and thus premature aging) restricted to either LCs or SCs were protected against testicular degeneration, demonstrating that age-related LCs dysfunction cannot be explained by intrinsic aging within either the LC or SC lineages alone. We conclude that age-related LC dysfunction is largely driven by aging of the supporting testicular microenvironment.Curley, M., Milne, L., Smith, S., JOrgensen, A., Frederiksen, H., Hadoke, P., Potter, P., Smith, L. B. A Young testicular microenvironment protects Leydig cells against age-related dysfunction in a mouse model of premature aging.	[Curley, Michael; Milne, Laura; Smith, Sarah; Smith, Lee B.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Hadoke, Patrick] Univ Edinburgh, Queens Med Res Inst, British Heart Fdn, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Jorgensen, Anne; Frederiksen, Hanne] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark; [Jorgensen, Anne; Frederiksen, Hanne] Univ Copenhagen, Rigshosp, Int Ctr Res & Res Training Endocrine Disrupt Male, Copenhagen, Denmark; [Potter, Paul] MRC Harwell, MRC Mammalian Genet Unit, Harwell, Berks, England; [Smith, Lee B.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia	University of Edinburgh; University of Edinburgh; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; MRC Harwell; University of Newcastle	Smith, LB (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	lee.smith@ed.ac.uk	Potter, Paul Keith/GWU-6398-2022; Frederiksen, Hanne/N-8632-2013; Jørgensen, Anne/S-8681-2016	Potter, Paul Keith/0000-0003-2689-2361; Frederiksen, Hanne/0000-0002-3180-9879; Jørgensen, Anne/0000-0002-6409-198X; Smith, Lee/0000-0002-4103-3074	Biotechnology and Biological Sciences Research Council Doctoral Training Partnerships (BBSRC DTP) [BB/J01446X/1]; Medical Research Council Programme [MR/N002970/1]; International Center for Research and Research Training in Endocrine Disrupting Effects of Male Reproduction and Child Health (EDMaRC); MRC [MR/N002970/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council Doctoral Training Partnerships (BBSRC DTP); Medical Research Council Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); International Center for Research and Research Training in Endocrine Disrupting Effects of Male Reproduction and Child Health (EDMaRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Nathan Jeffery and Mike Dodds [both from the Medical Research Council (MRC) Centre for Reproductive Health] for technical support. This work was supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Partnerships (BBSRC DTP) Grant BB/J01446X/1 and a Medical Research Council Programme Grant MR/N002970/1 (to L.B.S.) and by the International Center for Research and Research Training in Endocrine Disrupting Effects of Male Reproduction and Child Health (EDMaRC). The authors declare no conflicts of interest.	Ahangarpour A, 2014, WORLD J MENS HEALTH, V32, P176, DOI 10.5534/wjmh.2014.32.3.176; Ariyaratne HBS, 2000, BIOL REPROD, V63, P165, DOI 10.1095/biolreprod63.1.165; Badrinarayanan R, 2006, BIOCHEM CELL BIOL, V84, P745, DOI 10.1139/O06-074; BAMBINO TH, 1981, ENDOCRINOLOGY, V108, P2142, DOI 10.1210/endo-108-6-2142; Beattie MC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107052; Brand JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100409; BRONSON FH, 1977, ENDOCRINOLOGY, V101, P939, DOI 10.1210/endo-101-3-939; Cao LC, 2004, J STEROID BIOCHEM, V88, P61, DOI 10.1016/j.jsbmb.2003.10.007; Cao WL, 2016, CELL CYCLE, V15, P1093, DOI 10.1080/15384101.2016.1156269; Carrero D, 2016, DIS MODEL MECH, V9, P719, DOI 10.1242/dmm.024711; Chen HL, 2015, EXP GERONTOL, V72, P8, DOI 10.1016/j.exger.2015.08.014; Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023; Chen HL, 2004, ENDOCRINOLOGY, V145, P4441, DOI 10.1210/en.2004-0639; Chen HL, 2002, ENDOCRINOLOGY, V143, P1637, DOI 10.1210/en.143.5.1637; Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8; Chen HL, 1996, ENDOCRINOLOGY, V137, P3447, DOI 10.1210/en.137.8.3447; CHEN HL, 1994, J ANDROL, V15, P551; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Chu Y, 2010, ENDOCRINOLOGY, V151, P5669, DOI 10.1210/en.2010-0772; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; COQUELIN A, 1982, AM J PHYSIOL, V243, pE257, DOI 10.1152/ajpendo.1982.243.3.E257; Culty M, 2002, J ANDROL, V23, P439; CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Diemer T, 2003, ENDOCRINOLOGY, V144, P2882, DOI 10.1210/en.2002-0090; ELEFTHERIOU BE, 1974, GERONTOLOGY, V20, P231, DOI 10.1159/000212019; Fabbri E, 2016, J GERONTOL A-BIOL, V71, P1202, DOI 10.1093/gerona/glw021; Farrell JB, 2008, DIABETES EDUCATOR, V34, P799, DOI 10.1177/0145721708323100; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; FINCH CE, 1977, ENDOCRINOLOGY, V101, P1310, DOI 10.1210/endo-101-4-1310; FLOOD JF, 1995, PHYSIOL BEHAV, V57, P669, DOI 10.1016/0031-9384(94)00318-1; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gao HB, 1996, ENDOCRINOLOGY, V137, P1714, DOI 10.1210/en.137.5.1714; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; GOSDEN RG, 1982, J REPROD FERTIL, V64, P127, DOI 10.1530/jrf.0.0640127; Gunes S, 2016, J ASSIST REPROD GEN, V33, P441, DOI 10.1007/s10815-016-0663-y; HALES DB, 1989, ENDOCRINOLOGY, V124, P2099, DOI 10.1210/endo-124-5-2099; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hu XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12982; Hutchison GR, 2008, BIOL REPROD, V78, P352, DOI 10.1095/biolreprod.107.064006; Ing NH, 2014, J STEROID BIOCHEM, V143, P451, DOI 10.1016/j.jsbmb.2014.07.003; Jiang H, 2014, INT UROL NEPHROL, V46, P879, DOI 10.1007/s11255-013-0610-0; JOHNSON L, 1986, J ANDROL, V7, P316; JOHNSON L, 1990, BIOL REPROD, V42, P281, DOI 10.1095/biolreprod42.2.281; Joseph DR, 1997, BIOL REPROD, V56, P21, DOI 10.1095/biolreprod56.1.21; KALER LW, 1978, ANAT REC, V192, P513, DOI 10.1002/ar.1091920405; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Levy S, 1999, J ANDROL, V20, P356; Liao CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010098; Lo MJ, 2000, J INVEST MED, V48, P335; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075; Luo LD, 2005, J ANDROL, V26, P25; Luo LD, 1996, J ANDROL, V17, P509; Luo LD, 2001, J ANDROL, V22, P149; Mahmoud AM, 2003, J CLIN ENDOCR METAB, V88, P179, DOI 10.1210/jc.2002-020408; Martin LJ, 2008, J MOL ENDOCRINOL, V41, P165, DOI 10.1677/JME-07-0145; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Morales E, 2004, HISTOL HISTOPATHOL, V19, P445, DOI 10.14670/HH-19.445; Morley JE, 1997, METABOLISM, V46, P410, DOI 10.1016/S0026-0495(97)90057-3; NEAVES WB, 1985, BIOL REPROD, V33, P259, DOI 10.1095/biolreprod33.1.259; NEAVES WB, 1984, J CLIN ENDOCR METAB, V59, P756, DOI 10.1210/jcem-59-4-756; NELSON JF, 1975, ACTA ENDOCRINOL-COP, V80, P744, DOI 10.1530/acta.0.0800744; O'Hara L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084541; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; PANIAGUA R, 1991, J ELECTRON MICR TECH, V19, P241, DOI 10.1002/jemt.1060190209; PANIAGUA R, 1987, BIOL REPROD, V36, P939, DOI 10.1095/biolreprod36.4.939; Perheentupa A, 2009, MOL CELL ENDOCRINOL, V299, P2, DOI 10.1016/j.mce.2008.11.004; Petersen PM, 2015, J ANAT, V226, P175, DOI 10.1111/joa.12261; Purnell JQ, 2004, J CLIN ENDOCR METAB, V89, P281, DOI 10.1210/jc.2003-030440; Pye SR, 2014, J CLIN ENDOCR METAB, V99, P1357, DOI 10.1210/jc.2013-2052; Ramamoorthy S, 2013, MOL CELL BIOL, V33, P1711, DOI 10.1128/MCB.01151-12; Rebourcet D, 2017, ENDOCRINOLOGY, V158, P2955, DOI 10.1210/en.2017-00196; Rebourcet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105687; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7; SCHAISON G, 1978, ACTA ENDOCRINOL-COP, V89, P126, DOI 10.1530/acta.0.0890126; Shabalina IG, 2015, FASEB J, V29, P3274, DOI 10.1096/fj.15-271825; Sinha I, 2014, CELL TISSUE RES, V357, P815, DOI 10.1007/s00441-014-1900-2; Smith LB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002697; Smith TB, 2013, REPRODUCTION, V146, P253, DOI 10.1530/REP-13-0186; Soeborg T, 2017, CLIN CHIM ACTA, V468, P180, DOI 10.1016/j.cca.2017.03.002; Tajar A, 2012, J CLIN ENDOCR METAB, V97, P1508, DOI 10.1210/jc.2011-2513; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Thoolen B, 2010, J REPROD CONTRACEPT, V38, p5S; VERMEULEN A, 1993, J CLIN ENDOCR METAB, V76, P1140, DOI 10.1210/jc.76.5.1140; VERMEULEN A, 1968, STEROIDS, V11, P609, DOI 10.1016/S0039-128X(68)80009-1; WANG C, 1993, ENDOCRINOLOGY, V133, P2773, DOI 10.1210/en.133.6.2773; Wang CH, 2014, HUM MOL GENET, V23, P4770, DOI 10.1093/hmg/ddu193; Wang JH, 2016, ONCOTARGET, V7, P22988, DOI 10.18632/oncotarget.8453; WANG YM, 1989, MOL CELL ENDOCRINOL, V63, P85, DOI 10.1016/0303-7207(89)90084-1; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; WRIGHT WW, 1993, J ANDROL, V14, P110; Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Yang H, 2011, MOL IMAGING BIOL, V13, P391, DOI 10.1007/s11307-010-0341-x; Yeap BB, 2018, CLIN ENDOCRINOL, V88, P88, DOI 10.1111/cen.13484; Yeap BB, 2014, CLIN ENDOCRINOL, V81, P100, DOI 10.1111/cen.12407	107	13	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					978	995		10.1096/fj.201800612R	http://dx.doi.org/10.1096/fj.201800612R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30080443	Green Published, hybrid			2022-12-28	WOS:000457401500077
J	Dhanasekaran, K; Bose, A; Rao, VJ; Boopathi, R; Shankar, SR; Rao, VK; Swaminathan, A; Vasudevan, M; Taneja, R; Kundu, TK				Dhanasekaran, Karthigeyan; Bose, Arnab; Rao, Vinay J.; Boopathi, Ramachandran; Shankar, Shilpa Rani; Rao, Vinay Kumar; Swaminathan, Amrutha; Vasudevan, Madavan; Taneja, Reshma; Kundu, Tapas K.			Unraveling the role of aurora A beyond centrosomes and spindle assembly: implications in muscle differentiation	FASEB JOURNAL			English	Article						E2F4; subcellular localization; gene network	KINASE-ACTIVITY; A KINASE; E2F4; EXPRESSION; MYOD; TRANSCRIPTION; ACTIVATION; GROWTH	Aurora kinases are critical mitotic serine/threonine kinases and are often implicated in tumorigenesis. Recent studies of the interphase functions for aurora kinase (Aurk)A have considerably expanded our understanding of its role beyond mitosis. To identify the unknown targets of AurkA, we used peptide array-based screening and found E2F4 to be a novel substrate. Phosphorylation of E2F4 by AurkA at Ser75 regulates its DNA binding and subcellular localization. Because E2F4 plays an important role in skeletal muscle differentiation, we attempted to gain insight into E2F4 phosphorylation in this context. We observed that a block in E2F4 phosphorylation retained it better within the nucleus and inhibited muscle differentiation. RNA sequencing analysis revealed a perturbation of the gene network involved in the process of muscle differentiation and mitochondrial biogenesis. Collectively, our findings establish a novel role of AurkA in the process of skeletal muscle differentiation.Dhanasekaran, K., Bose, A., Rao, V. J., Boopathi, R., Shankar, S. R., Rao, V. K., Swaminathan, A., Vasudevan, M., Taneja, R., Kundu, T. K. Unravelling the role of aurora A beyond centrosomes and spindle assembly: implications in muscle differentiation.	[Dhanasekaran, Karthigeyan; Bose, Arnab; Rao, Vinay J.; Boopathi, Ramachandran; Swaminathan, Amrutha; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Jakkur PO, Bangalore 560064, Karnataka, India; [Shankar, Shilpa Rani; Rao, Vinay Kumar; Taneja, Reshma] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol Cellular Differentiat & Apoptosis, Singapore, Singapore; [Vasudevan, Madavan] Bionivid Technol Private Ltd, Bangalore, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); National University of Singapore	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Jakkur PO, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	Dhanasekaran, Karthigeyan/AAO-6380-2021; Swaminathan, Amrutha/F-8409-2016; Taneja, Reshma/F-9658-2014	Swaminathan, Amrutha/0000-0002-0177-3756; Taneja, Reshma/0000-0002-2151-2094; Kundu, Tapas/0000-0001-7790-214X; Reshma, Taneja/0000-0001-6214-6177; Rao, Vinay/0000-0002-2188-7670	Government of India's Council of Scientific and Industrial Research (CSIR); Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR); Sir J.C. Bose National Fellowship, Department of Science and Technology, Government of India; Department of Biotechnology, Government of India, through Chromatin and Disease: Program Support [BT/01/CEIB/10/111/01]	Government of India's Council of Scientific and Industrial Research (CSIR); Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)(Department of Science & Technology (India)); Sir J.C. Bose National Fellowship, Department of Science and Technology, Government of India; Department of Biotechnology, Government of India, through Chromatin and Disease: Program Support	The authors thank Suma Bangalore Srinivas, Jawaharial Nehru Centre for Advanced Scientific Research for confocal imaging. K.D., A.B., and A.S. were supported by grants from Government of India's Council of Scientific and Industrial Research (CSIR). T.K.K. acknowledges Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) for partial financial support. T.K.K. is a recipient of Sir J.C. Bose National Fellowship, Department of Science and Technology, Government of India. This work was supported by grants from the Department of Biotechnology, Government of India, through Chromatin and Disease: Program Support (Grant BT/01/CEIB/10/111/01 dated 30.09.2011). The authors declare no conflicts of interest.	Amabile G, 2009, CELL DEATH DIFFER, V16, P321, DOI 10.1038/cdd.2008.156; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Ayoob JC, 2000, CELL MOTIL CYTOSKEL, V45, P67, DOI 10.1002/(SICI)1097-0169(200001)45:1<67::AID-CM7>3.3.CO;2-K; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; CORBEIL HB, 1995, ONCOGENE, V11, P909; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Ferri P, 2009, J CELL BIOCHEM, V108, P1302, DOI 10.1002/jcb.22360; Fry CJ, 1997, MOL CELL BIOL, V17, P1966, DOI 10.1128/MCB.17.4.1966; Good LF, 1996, J CELL PHYSIOL, V168, P580, DOI 10.1002/(SICI)1097-4652(199609)168:3<580::AID-JCP10>3.0.CO;2-3; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Karthigeyan D, 2011, MED RES REV, V31, P757, DOI 10.1002/med.20203; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Li FQ, 2000, MOL CELL BIOL, V20, P5129, DOI 10.1128/MCB.20.14.5129-5139.2000; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; Puri PL, 1998, CANCER RES, V58, P1325; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Sardon T, 2010, EMBO REP, V11, P977, DOI 10.1038/embor.2010.171; Takitoh T, 2012, J NEUROSCI, V32, P11050, DOI 10.1523/JNEUROSCI.5664-11.2012; Tomita M, 2010, CANCER SCI, V101, P1204, DOI 10.1111/j.1349-7006.2010.01499.x; Torchia EC, 2013, J INVEST DERMATOL, V133, P78, DOI 10.1038/jid.2012.249; Troiani S, 2005, J PROTEOME RES, V4, P1296, DOI 10.1021/pr050018e; Turnacioglu KK, 1997, CELL STRUCT FUNCT, V22, P73, DOI 10.1247/csf.22.73; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; Wang DW, 2012, CELL MOL LIFE SCI, V69, P1855, DOI 10.1007/s00018-011-0901-5; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yan M, 2016, MED RES REV, V36, P1036, DOI 10.1002/med.21399	32	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					219	230		10.1096/fj.201800997	http://dx.doi.org/10.1096/fj.201800997			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29995440				2022-12-28	WOS:000457401500018
J	Guo, SW; Gao, SZ; Liu, RD; Shen, J; Shi, XH; Bai, SJ; Wang, H; Zheng, KL; Shao, Z; Liang, CY; Peng, SY; Jin, G				Guo, Shiwei; Gao, Suizhi; Liu, Rendong; Shen, Jing; Shi, Xiaohan; Bai, Sijia; Wang, Huan; Zheng, Kailian; Shao, Zhuo; Liang, Chuanyu; Peng, Siying; Jin, Gang			Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer	FASEB JOURNAL			English	Article						pancreatic cancer; PDX model; NSG mice	PATIENT-DERIVED XENOGRAFTS; ENDOTHELIAL GROWTH-FACTOR; MOUSE MODELS; TUMOR-GROWTH; VEGF; ESTABLISHMENT; ANGIOGENESIS; ENGRAFTMENT; EXPRESSION; ALIGNMENT	A patient-derived xenograft (PDX) approach, which relies on direct transplantation of tumor specimens into an immunocompromised animal, is a commonly used method for investigating tumor therapy predictions in vivo. This study evaluated influencing factors, including clinical, oncological, and genetic variables, for a pancreatic PDX model in mice. Tumor specimens were obtained from 121 patients with pancreatic ductal adenocarcinoma who underwent surgical resection at the Changhai Pancreatic Surgery Medical Center (Shanghai, China) between April 2016 and February 2017. Pancreatic cancer (PC) samples <3 mm(3) were subcutaneously implanted into the NOD/Shi-scid/IL-2Rnull (NSG) mice. Once the xenograft reached 300-500 mm(3) or reached 180 d after cell inoculation, the tumor was excised. Part of the tumor was subsequently transplanted to next-generation mice, and another part was analyzed by using immunohistochemistry. Among the 121 patients with PC, tumor xenograft was successfully generated in 86 patients (71.1%). Primary tumor >3.5 cm in size was independently associated with xenograft formation rate. In addition, several enriched mutated genes within the VEGF pathway and higher microvessel density were found in the positive group (with xenograft) compared with the negative group (without xenograft). We concluded that tumor size and mutated VEGF pathway in PC are important factors affecting PDX model construction with NSG mice.Guo, S., Gao, S., Liu, R., Shen, J., Shi, X., Bai, S., Wang, H., Zheng, K., Shao, Z., Liang, C., Peng, S., Jin, G. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.	[Guo, Shiwei; Gao, Suizhi; Liu, Rendong; Shen, Jing; Shi, Xiaohan; Bai, Sijia; Wang, Huan; Zheng, Kailian; Shao, Zhuo; Jin, Gang] Second Mil Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, Shanghai 200433, Peoples R China; [Liang, Chuanyu; Peng, Siying] Beijing IDMO Co Ltd, Beijing, Peoples R China	Naval Medical University	Jin, G (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, Shanghai 200433, Peoples R China.	jingang@sohu.com			National Natural Science Foundation of China [81672830]; Shanghai Municipal Education Commission [2017-01-07-00-07-E00012]; Shanghai Science and Technology Committee [16140903800]; Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund [ZJ2017-ZD-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund	The authors thank Beijing IDMO Co. Ltd and LinkDoc Database (Beijing, China) for all their support. This study was supported by the National Natural Science Foundation of China (81672830), the Shanghai Municipal Education Commission (2017-01-07-00-07-E00012), the Shanghai Science and Technology Committee (16140903800), and the Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund (ZJ2017-ZD-014). The authors declare no conflicts of interest.	ATALA A, 2016, J UROLOGY, V196, P1817; Bagri A, 2010, CLIN CANCER RES, V16, P3887, DOI 10.1158/1078-0432.CCR-09-3100; Bankert RB, 2002, FRONT BIOSCI-LANDMRK, V7, pC44, DOI 10.2741/bankert; Behrens D, 2016, EUR J CANCER, V61, pS59, DOI 10.1016/S0959-8049(16)61205-4; Behrens D, 2017, PHARMACOL THERAPEUT, V173, P146, DOI 10.1016/j.pharmthera.2017.02.013; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Chijiwa T, 2015, INT J ONCOL, V47, P61, DOI 10.3892/ijo.2015.2997; Cho SY, 2016, MOL CELLS, V39, P77, DOI 10.14348/molcells.2016.2350; Choi SYC, 2014, ADV DRUG DELIVER REV, V79-80, P222, DOI 10.1016/j.addr.2014.09.009; Colvin EK, 2014, SEMIN CELL DEV BIOL, V27, P61, DOI 10.1016/j.semcdb.2014.02.004; Covassin L, 2011, CLIN EXP IMMUNOL, V166, P269, DOI 10.1111/j.1365-2249.2011.04462.x; Cree IA, 2010, CURR OPIN PHARMACOL, V10, P375, DOI 10.1016/j.coph.2010.05.001; Crivellato E, 2011, INT J DEV BIOL, V55, P365, DOI 10.1387/ijdb.103214ec; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fong D, 2014, HISTOPATHOLOGY, V64, P683, DOI 10.1111/his.12307; Fujii E, 2008, PATHOL INT, V58, P559, DOI 10.1111/j.1440-1827.2008.02271.x; Fukasawa M, 2004, CLIN CANCER RES, V10, P3327, DOI 10.1158/1078-0432.CCR-03-0820; Georgiadou D, 2014, EJSO-EUR J SURG ONC, V40, P1331, DOI 10.1016/j.ejso.2014.01.004; Gerhardt Holger, 2008, P68, DOI 10.1007/978-0-387-78632-2_6; Hidalgo M, 2015, PANCREATOLOGY, V15, P8, DOI 10.1016/j.pan.2014.10.001; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hiroshima Y, 2015, PANCREATOLOGY, V15, P295, DOI 10.1016/j.pan.2015.02.008; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Hotz HG, 2002, J GASTROINTEST SURG, V6, P159, DOI 10.1016/S1091-255X(01)00040-3; Hylander BL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-110; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jun E, 2016, ANTICANCER RES, V36, P517; Jung J, 2016, ONCOTARGET, V7, P62533, DOI 10.18632/oncotarget.11530; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kleger A, 2014, ANN ONCOL, V25, P1260, DOI 10.1093/annonc/mdu013; Klinghammer K, 2015, INT J CANCER, V136, P2940, DOI 10.1002/ijc.29344; Knudsen ES, 2016, ONCOTARGET, V7, P78396, DOI 10.18632/oncotarget.11893; Ko AH, 2015, J CLIN ONCOL, V33, P1779, DOI 10.1200/JCO.2014.59.7625; Kopetz S, 2012, CLIN CANCER RES, V18, P5160, DOI 10.1158/1078-0432.CCR-12-2408; Landis MD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3355; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang K, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0021; Liang QL, 2010, MED ONCOL, V27, P1164, DOI 10.1007/s12032-009-9354-1; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Logsdon CD, 2015, AM J PHYSIOL-GASTR L, V309, pG283, DOI 10.1152/ajpgi.00169.2015; Mattie Mike, 2013, Neoplasia, V15, P1138; Melzer C, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0143-0; Murphy B, 2016, CANCER RES, V76, P5798, DOI 10.1158/0008-5472.CAN-16-0122; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schafer R, 2003, CIRCULATION, V108, P1585, DOI 10.1161/01.CIR.0000091085.12422.19; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Spadi R, 2016, WORLD J CLIN ONCOL, V7, P27, DOI 10.5306/wjco.v7.i1.27; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westphalen CB, 2012, CANCER J, V18, P502, DOI 10.1097/PPO.0b013e31827ab4c4; Yang JF, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500250; ZHANG LH, 2015, SCI REP UK, V5	58	13	16	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					873	884		10.1096/fj.201800617R	http://dx.doi.org/10.1096/fj.201800617R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30091943	Bronze			2022-12-28	WOS:000457401500068
J	Kneppers, A; Leermakers, P; Pansters, N; Backx, E; Gosker, H; van Loon, L; Schols, A; Langen, R; Verdijk, L				Kneppers, Anita; Leermakers, Pieter; Pansters, Nicholas; Backx, Evelien; Gosker, Harry; van Loon, Luc; Schols, Annemie; Langen, Ramon; Verdijk, Lex			Coordinated regulation of skeletal muscle mass and metabolic plasticity during recovery from disuse	FASEB JOURNAL			English	Article						remobilization; remodeling; protein turnover; myogenesis; mitophagy	SATELLITE CELL; MITOCHONDRIAL DYNAMICS; PGC-1-ALPHA OVEREXPRESSION; CREATINE SUPPLEMENTATION; LEG IMMOBILIZATION; GENE-EXPRESSION; FIBER SIZE; ATROPHY; REGENERATION; EXERCISE	Skeletal muscle regeneration after disuse is essential for muscle maintenance and involves the regulation of both mass- and metabolic plasticity-related processes. However, the relation between these processes during recovery from disuse remains unclear. In this study, we explored the potential interrelationship between the molecular regulation of muscle mass and oxidative metabolism during recovery from disuse. Molecular profiles were measured in biopsies from the vastus lateralis of healthy men after 1-leg cast immobilization and after 1 wk reloading, and in mouse gastrocnemius obtained before and after hindlimb suspension and during reloading (RL-1, -2, -3, -5, and -8 d). Cluster analysis of the human recovery response revealed correlations between myogenesis and autophagy markers in 2 clusters, which were distinguished by the presence of markers of early myogenesis, autophagosome formation, and mitochondrial turnover vs. markers of late myogenesis, autophagy initiation, and mitochondrial mass. In line with these findings, an early transient increase in B-cell lymphoma-2 interacting protein-3 and sequestosome-1 protein, and GABA type A receptor-associated protein like-1 protein and mRNA and a late increase in myomaker and myosin heavy chain-8 mRNA, microtubule-associated protein 1 light chain 3-II:I ratio, and FUN14 domain-containing-1 mRNA and protein were observed in mice. In summary, the regulatory profiles of protein, mitochondrial, and myonuclear turnover are correlated and temporally associated, suggesting a coordinated regulation of muscle mass- and oxidative metabolism-related processes during recovery from disuse.Kneppers, A., Leermakers, P., Pansters, N., Backx, E., Gosker, H., van Loon, L., Schols, A., Langen, R., Verdijk, L. Coordinated regulation of skeletal muscle mass and metabolic plasticity during recovery from disuse.	[Kneppers, Anita; Leermakers, Pieter; Pansters, Nicholas; Gosker, Harry; Schols, Annemie; Langen, Ramon] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Resp Med, Maastricht, Netherlands; [Backx, Evelien; van Loon, Luc; Verdijk, Lex] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands	Maastricht University; Maastricht University	Verdijk, L (corresponding author), Maastricht Univ, Dept Human Biol, POB 616, NL-6200 MD Maastricht, Netherlands.	lex.verdijk@maastrichtuniversity.nl	van Loon, Luc J.C./ABG-9158-2020; Leermakers, Pieter/AAY-1341-2021; van Loon, Luc J C/G-5920-2010; Verdijk, Lex B/H-4468-2016	van Loon, Luc J.C./0000-0002-6768-9231; Leermakers, Pieter/0000-0002-0145-742X; van Loon, Luc J C/0000-0002-6768-9231; Verdijk, Lex B/0000-0002-9196-8767; Gosker, Harry/0000-0002-7659-0225; Kneppers, Anita/0000-0003-4901-5468	TI Food and Nutrition, a public-private partnership for precompetitive research in food and nutrition [36]; Lung Foundation/Netherlands Asthma Foundation [NAF 3.2.07.017]; transnational University Limburg (tUL)	TI Food and Nutrition, a public-private partnership for precompetitive research in food and nutrition; Lung Foundation/Netherlands Asthma Foundation; transnational University Limburg (tUL)	The authors thank Marco Kelders, Chiel de Theije, and Antoine Zorenc (all of Maastricht University) for excellent technical assistance in performing the molecular analyses, and Roy Haast (Maastricht Centre for Systems Biology, Maastricht University) for support in conducting the cluster analysis. The original work from which human muscle biopsies were obtained (36) was funded by TI Food and Nutrition, a public-private partnership for precompetitive research in food and nutrition; and the mouse study was funded by Grant NAF 3.2.07.017 from the Lung Foundation/Netherlands Asthma Foundation and the transnational University Limburg (tUL). For the current work, the researchers had sole responsibility for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The authors declare no conflicts of interest.	Abreu P, 2017, LIFE SCI, V170, P33, DOI 10.1016/j.lfs.2016.11.016; Andrianjafiniony T, 2010, AM J PHYSIOL-CELL PH, V299, pC307, DOI 10.1152/ajpcell.00069.2010; Backx EMP, 2017, SPORTS MED, V47, P1661, DOI 10.1007/s40279-016-0670-2; Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; Bierbrauer J, 2012, CRIT CARE MED, V40, P647, DOI 10.1097/CCM.0b013e31823295e6; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brooks NE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00099; Call JA, 2017, AM J PHYSIOL-CELL PH, V312, pC724, DOI 10.1152/ajpcell.00348.2016; Ceco E, 2017, AM J RESP CELL MOL, V57, P28, DOI 10.1165/rcmb.2016-0355TR; Chacon-Cabrera A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164951; Deldicque L, 2008, J APPL PHYSIOL, V104, P371, DOI 10.1152/japplphysiol.00873.2007; Dideriksen K, 2016, EXP GERONTOL, V82, P8, DOI 10.1016/j.exger.2016.05.009; Dirks ML, 2014, ACTA PHYSIOL, V210, P628, DOI 10.1111/apha.12200; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Dirks ML, 2014, J NUTR, V144, P1196, DOI 10.3945/jn.114.194217; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; Ferraro E, 2014, ANTIOXID REDOX SIGN, V21, P154, DOI 10.1089/ars.2013.5773; Ferreira R, 2006, EUR J APPL PHYSIOL, V97, P340, DOI 10.1007/s00421-006-0197-6; Fortini P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.50; Fortini P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00237; Frick C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041650; Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211; Gram M, 2014, EUR J SPORT SCI, V14, P376, DOI 10.1080/17461391.2013.823466; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd; Hortobagyi T, 2000, J PHYSIOL-LONDON, V524, P293, DOI 10.1111/j.1469-7793.2000.00293.x; Hvid LG, 2014, EXP GERONTOL, V52, P1, DOI 10.1016/j.exger.2014.01.012; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Joanisse S, 2017, GERONTOLOGY, V63, P91, DOI 10.1159/000450922; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kang C, 2016, ACTA PHYSIOL, V218, P188, DOI 10.1111/apha.12690; Kang CH, 2016, FREE RADICAL BIO MED, V93, P32, DOI 10.1016/j.freeradbiomed.2015.12.032; Kang CH, 2015, FASEB J, V29, P4092, DOI 10.1096/fj.14-266619; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kelleher AR, 2015, AM J PHYSIOL-ENDOC M, V308, pE122, DOI 10.1152/ajpendo.00341.2014; Kim B, 2013, AM J PHYSIOL-REG I, V305, pR927, DOI 10.1152/ajpregu.00502.2012; Kim J, 2015, J EXERC REHABIL, V11, P244, DOI 10.12965/jer.150237; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Liu J, 2014, FREE RADICAL BIO MED, V69, P116, DOI 10.1016/j.freeradbiomed.2014.01.003; Lopez-Lluch G, 2017, ACTA PHYSIOL, V219, P20, DOI 10.1111/apha.12750; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Marzetti E, 2017, AGING CLIN EXP RES, V29, P11, DOI 10.1007/s40520-016-0704-5; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Mozdziak PE, 2001, J APPL PHYSIOL, V91, P183, DOI 10.1152/jappl.2001.91.1.183; Nichenko AS, 2016, AM J PHYSIOL-CELL PH, V311, pC190, DOI 10.1152/ajpcell.00066.2016; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Paddon-Jones D, 2004, J CLIN ENDOCR METAB, V89, P4351, DOI 10.1210/jc.2003-032159; Pansters NAM, 2015, BBA-MOL BASIS DIS, V1852, P490, DOI 10.1016/j.bbadis.2014.12.006; Park S, 2014, J APPL PHYSIOL, V116, P797, DOI 10.1152/japplphysiol.00955.2013; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Reidy PT, 2017, REJUV RES, V20, P449, DOI 10.1089/rej.2017.1942; Remels AHV, 2014, AM J PHYSIOL-ENDOC M, V306, pE615, DOI 10.1152/ajpendo.00452.2013; Rizzoli R, 2013, CALCIFIED TISSUE INT, V93, P101, DOI 10.1007/s00223-013-9758-y; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Seene T, 2012, ARCH GERONTOL GERIAT, V54, P374, DOI 10.1016/j.archger.2011.05.002; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Slimani L, 2012, AM J PHYSIOL-ENDOC M, V303, pE1335, DOI 10.1152/ajpendo.00379.2012; Smith HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094356; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; Stevens-Lapsley JE, 2010, AM J PHYSIOL-ENDOC M, V299, pE730, DOI 10.1152/ajpendo.00230.2010; Suetta C, 2013, J PHYSIOL-LONDON, V591, P3789, DOI 10.1113/jphysiol.2013.257121; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Takahashi H, 2017, EXP GERONTOL, V92, P56, DOI 10.1016/j.exger.2017.02.075; Tanner RE, 2015, J PHYSIOL-LONDON, V593, P4259, DOI 10.1113/JP270699; Theriault ME, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-35; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Wall BT, 2013, NUTR REV, V71, P195, DOI 10.1111/nure.12019; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; Washington TA, 2011, ACTA PHYSIOL, V202, P657, DOI 10.1111/j.1748-1716.2011.02281.x; Waskom Michael, 2017, MWASKOM SEABORN V0 8, DOI [https://doi.org/10.5281/zenodo.883859, 10.5281/zenodo.883859, DOI 10.5281/ZEN0D0.883859]; White JR, 2015, EXP GERONTOL, V64, P17, DOI 10.1016/j.exger.2015.02.007; Wu H, 2015, ANTIOXID REDOX SIGN, V22, P1032, DOI 10.1089/ars.2014.6204; Ye F, 2013, EXP PHYSIOL, V98, P1038, DOI 10.1113/expphysiol.2012.070722; Yu ZB, 2007, AM J PHYSIOL-CELL PH, V292, pC1192, DOI 10.1152/ajpcell.00462.2006	84	8	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1288	1298		10.1096/fj.201701403RRR	http://dx.doi.org/10.1096/fj.201701403RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30133324	Green Submitted, Bronze			2022-12-28	WOS:000457401500102
J	Latorre, E; Ostler, EL; Faragher, RGA; Harries, LW				Latorre, Eva; Ostler, Elizabeth L.; Faragher, Richard G. A.; Harries, Lorna W.			FOXO1 and ETV6 genes may represent novel regulators of splicing factor expression in cellular senescence	FASEB JOURNAL			English	Article						aging; fibroblasts; AKT; ERK; signaling	TRANSCRIPTION FACTORS; CELLS; PATHWAY; TARGET; AKT; PROLIFERATION; HEMATOPOIESIS; HOMEOSTASIS; INHIBITION; MECHANISMS	Cellular plasticity is a key facet of cellular homeostasis requiring correct temporal and spatial patterns of alternative splicing. Splicing factors, which orchestrate this process, demonstrate age-related dysregulation of expression; they are emerging as potential influences on aging and longevity. The upstream drivers of these alterations are still unclear but may involve aberrant cellular signaling. We compared the phosphorylation status of proteins in multiple signaling pathways in early and late passage human primary fibroblasts. We then assessed the impact of chemical inhibition or targeted knockdown of direct downstream targets of the ERK and AKT pathways on splicing factor expression, cellular senescence, and proliferation kinetics in senescent primary human fibroblasts. Components of the ERK and AKT signaling pathways demonstrated altered activation during cellular aging. Inhibition of AKT and ERK pathways led to up-regulation of splicing factor expression, reduction in senescent cell load, and partial reversal of multiple cellular senescence phenotypes in a dose-dependent manner. Furthermore, targeted knockdown of the genes encoding the downstream targets FOXO1 or ETV6 was sufficient to mimic these observations. Our results suggest that age-associated dysregulation of splicing factor expression and cellular senescence may derive in part from altered activity of ERK and AKT signaling and may act in part through the ETV6 and FOXO1 transcription factors. Targeting the activity of downstream effectors of ERK and AKT may therefore represent promising targets for future therapeutic intervention.Latorre, E., Ostler, E. L., Faragher, R. G. A., Harries, L. W. FOXO1 and ETV6 genes may represent novel regulators of splicing factor expression in cellular senescence.	[Latorre, Eva; Harries, Lorna W.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Ostler, Elizabeth L.; Faragher, Richard G. A.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England	University of Exeter; University of Brighton	Harries, LW (corresponding author), Univ Exeter, Sch Med, Inst Biomed & Clin Studies, Barrack Rd, Exeter EX2 5DW, Devon, England.	l.w.harries@exeter.ac.uk	Latorre, Eva/Y-7043-2019	Latorre, Eva/0000-0002-5797-3909; Faragher, Richard/0000-0001-8366-9014; Ostler, Elizabeth/0000-0001-6092-8423	Dunhill Medical Trust [R386/1114]	Dunhill Medical Trust(Dunhill Medical Trust)	The authors thank N. Jeffery and B. Lee (Institute of Biomedical and Clinical Sciences, University of Exeter) for technical assistance. The authors also thank R. Ames (Centre for Biomedical Modelling and Analysis, University of Exeter) for help in the analysis of the ChIP data. This work was supported by the Dunhill Medical Trust (Grant R386/1114). The authors declare no conflicts of interest.	Alkhatib A, 2012, J EXP MED, V209, P395, DOI 10.1084/jem.20110216; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Arai T, 2015, GENES CELLS, V20, P340, DOI 10.1111/gtc.12226; Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Bullock N, 2017, J PATHOL, V241, P437, DOI 10.1002/path.4846; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; de Magalhaes JP, 2004, EXP CELL RES, V300, P1, DOI 10.1016/j.yexcr.2004.07.006; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Deschenes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dimozi A, 2015, EUR CELLS MATER, V30, P89, DOI 10.22203/eCM.v030a07; Faragher Richard Ga, 2017, F1000Res, V6, P1219, DOI 10.12688/f1000research.10903.1; Fontana L, 2012, CIRC RES, V110, P1139, DOI 10.1161/CIRCRESAHA.111.246470; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789; Hock H, 2017, SEMIN HEMATOL, V54, P98, DOI 10.1053/j.seminhematol.2017.04.005; Holly AC, 2013, MECH AGEING DEV, V134, P356, DOI 10.1016/j.mad.2013.05.006; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kajita K, 2013, J GASTROENTEROL, V48, P1222, DOI 10.1007/s00535-012-0745-2; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Krech T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-287; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lareau LF, 2015, MOL BIOL EVOL, V32, P1072, DOI 10.1093/molbev/msv002; Latorre E, 2018, CLIN SCI, V132, P313, DOI 10.1042/CS20171556; Latorre E, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0147-7; Latorre E, 2017, AGEING RES REV, V36, P165, DOI 10.1016/j.arr.2017.04.004; Lee BP, 2016, AGING CELL, V15, P903, DOI 10.1111/acel.12499; Lin XZ, 2013, HISTOL HISTOPATHOL, V28, P1547, DOI 10.14670/HH-28.1547; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Olsson M, 2018, ANN NY ACAD SCI, V1422, P5, DOI 10.1111/nyas.13443; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; Rasighaemi P, 2017, CRIT REV ONCOL HEMAT, V116, P106, DOI 10.1016/j.critrevonc.2017.05.011; Rhim JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26547; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023; Tarn WY, 2007, J BIOMED SCI, V14, P517, DOI 10.1007/s11373-007-9161-7; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Wang Q, 2017, BRIT J CANCER, V117, P159, DOI 10.1038/bjc.2017.153; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479; Wood SH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0847-2; Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	55	20	21	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1086	1097		10.1096/fj.201801154R	http://dx.doi.org/10.1096/fj.201801154R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30088951	Bronze			2022-12-28	WOS:000457401500086
J	Lewis, WR; Bales, KL; Revell, DZ; Croyle, MJ; Engle, SE; Song, CJ; Malarkey, EB; Uytingco, CR; Shan, D; Antonellis, PJ; Nagy, TR; Kesterson, RA; Mrug, MM; Martens, JR; Berbari, NF; Gross, AK; Yoder, BK				Lewis, Wesley R.; Bales, Katie L.; Revell, Dustin Z.; Croyle, Mandy J.; Engle, Staci E.; Song, Cheng Jack; Malarkey, Erik B.; Uytingco, Cedric R.; Shan, Dan; Antonellis, Patrick J.; Nagy, Tim R.; Kesterson, Robert A.; Mrug, Michal M.; Martens, Jeffrey R.; Berbari, Nicolas F.; Gross, Alecia K.; Yoder, Bradley K.			Mks6 mutations reveal tissue- and cell type-specific roles for the cilia transition zone	FASEB JOURNAL			English	Article						ciliopathy; cystic kidney disease; retinal degeneration; obesity	CYST FORMATION; MONOCLONAL-ANTIBODIES; JOUBERT SYNDROME; PROTEINS; MEMBRANE; CC2D2A; TRANSPORT; RHODOPSIN; COMPLEX; OBESITY	The transition zone (TZ) is a domain at the base of the cilium that is involved in maintaining ciliary compartment-specific sensory and signaling activity by regulating cilia protein composition. Mutations in TZ proteins result in cilia dysfunction, often causing pleiotropic effects observed in a group of human diseases classified as ciliopathies. The purpose of this study is to describe the importance of the TZ component Meckel-Gruber syndrome 6 (Mks6) in several organ systems and tissues regarding ciliogenesis and cilia maintenance using congenital and conditional mutant mouse models. Similar to MKS, congenital loss of Mks6 is embryonic lethal, displaying cilia loss and altered cytoskeletal microtubule modifications but only in specific cell types. Conditional Mks6 mutants have a variable cystic kidney phenotype along with severe retinal degeneration with mislocalization of phototransduction cascade proteins. However, other phenotypes, such as anosmia and obesity, which are typically associated with cilia and TZ dysfunction, were not evident. These data indicate that despite Mks6 being a core TZ component, it has tissue- or cell type-specific functions important for cilia formation and cilia sensory and signaling activities. Lewis, W. R., Bales, K. L., Revell, D. Z., Croyle, M. J., Engle, S. E., Song, C. J., Malarkey, E. B., Uytingco, C. R., Shan, D., Antonellis, P. J., Nagy, T. R., Kesterson, R. A., Mrug, M. M., Martens, J. R., Berbari, N. F., Gross, A. K., Yoder, B. K. Mks6 mutations reveal tissue- and cell type-specific roles for the cilia transition zone.	[Lewis, Wesley R.; Revell, Dustin Z.; Croyle, Mandy J.; Song, Cheng Jack; Malarkey, Erik B.; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Bales, Katie L.; Gross, Alecia K.] Univ Alabama Birmingham, Dept Optometry & Vis Sci, 906 Shelby Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA; [Shan, Dan; Mrug, Michal M.] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA; [Nagy, Tim R.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Engle, Staci E.; Antonellis, Patrick J.; Berbari, Nicolas F.] Indiana Univ Purdue Univ, Dept Biol, SL306,723 W Michigan St, Indianapolis, IN 46202 USA; [Uytingco, Cedric R.; Martens, Jeffrey R.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida	Gross, AK (corresponding author), Univ Alabama Birmingham, Dept Optometry & Vis Sci, 906 Shelby Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.; Berbari, NF (corresponding author), Indiana Univ Purdue Univ, Dept Biol, SL306,723 W Michigan St, Indianapolis, IN 46202 USA.	nberbari@iupui.edu; agross@uab.edu	Gross, Alecia K./AAJ-1792-2021	Gross, Alecia K./0000-0003-1857-6633; Berbari, Nicolas/0000-0003-2863-1069; Engle, Staci/0000-0002-8116-5063	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK065655, R01DK115752, R01DK114008]; NIH National Institute on Deafness and Other Communication Disorders Grant [R01DC009606]; NIH National Eye Institute (NEI) [R01EY019311]; E. Matilda Ziegler Foundation; Pilot and Feasibility Award from the Center for Diabetes and Metabolic Diseases [P30 DK097512]; NIH NIDDK [P30 DK074038, P30 DK05336, P60 DK079626, P30DK079337, P30DK079626, P30DK074038]; NIH NEI [P30EY003039]; NIH Instrumentation Grant [S10RR026887]; NIH National Cancer Institute [P30CA13148]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30AR048311]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089918] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, R01DK114008, P30DK074038, R01DK115752, P30DK079337, P30DK097512, R01DK065655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009606] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Deafness and Other Communication Disorders Grant; NIH National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); E. Matilda Ziegler Foundation; Pilot and Feasibility Award from the Center for Diabetes and Metabolic Diseases; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Mary Ann Accavitti-Loper (University of Alabama at Birmingham) and Logan S. Whitehouse (Indiana University Purdue University Indianapolis, Indianapolis, IN, USA) for technical assistance on the project. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants R01DK065655, R01DK115752 (to B.K.Y.), and R01DK114008 (to N.F.B.); NIH National Institute on Deafness and Other Communication Disorders Grant R01DC009606 (to J.R.M.); and NIH National Eye Institute (NEI) R01EY019311 (to A.K.G.). Additional support was from the E. Matilda Ziegler Foundation (to A.K.G.) and Pilot and Feasibility Award from the Center for Diabetes and Metabolic Diseases (P30 DK097512; to N.F.B.). Center support for the project was provided by NIH NIDDK Grants P30DK074038, P30DK079337, P30DK079626, and NIH NEI Grant P30EY003039, and the NIH Instrumentation Grant S10RR026887. Services provided in this publication through the University of Alabama at Birmingham Transgenic & Genetically Engineered Models (TGEMS) facility (R.A.K.) are supported by NIH National Cancer Institute Grant P30CA13148, NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant P30AR048311, and NIH NIDDK Grants P30 DK074038, P30 DK05336, and P60 DK079626. The authors declare no conflicts of interest.	Awata J, 2014, J CELL SCI, V127, P4714, DOI 10.1242/jcs.155275; Bachmann-Gagescu R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005575; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Barker AR, 2014, ORGANOGENESIS, V10, P96, DOI 10.4161/org.27375; Berbari NF, 2013, CYTOSKELETON, V70, P24, DOI 10.1002/cm.21088; Berbari NF, 2011, DEV BIOL, V360, P66, DOI 10.1016/j.ydbio.2011.09.001; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Guo DF, 2011, TRENDS ENDOCRIN MET, V22, P286, DOI 10.1016/j.tem.2011.02.009; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Joiner AM, 2015, J NEUROSCI, V35, P13761, DOI 10.1523/JNEUROSCI.1708-15.2015; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Klink BU, 2017, ELIFE, V6, DOI 10.7554/eLife.27434; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; McIntyre JC, 2012, NAT MED, V18, P1423, DOI 10.1038/nm.2860; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Noor A, 2008, AM J HUM GENET, V82, P1011, DOI 10.1016/j.ajhg.2008.01.021; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Reish NJ, 2013, INVEST OPHTH VIS SCI, V54, P6675, DOI 10.1167/iovs.13-12550; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Sharma N, 2013, J AM SOC NEPHROL, V24, P456, DOI 10.1681/ASN.2012020154; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Starremans PG, 2008, KIDNEY INT, V73, P1394, DOI 10.1038/ki.2008.111; Stratigopoulos G, 2016, J CLIN INVEST, V126, P1897, DOI 10.1172/JCI85526; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Tadenev ALD, 2011, P NATL ACAD SCI USA, V108, P10320, DOI 10.1073/pnas.1016531108; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Veleri S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5207; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Williams CL, 2017, MOL THER, V25, P904, DOI 10.1016/j.ymthe.2017.02.006; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116	47	12	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1440	1455		10.1096/fj.201801149R	http://dx.doi.org/10.1096/fj.201801149R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30133325	Bronze, Green Published			2022-12-28	WOS:000457401500113
J	Lichner, Z; Saleeb, R; Butz, H; Ding, Q; Nofech-Mozes, R; Riad, S; Farag, M; Varkouhi, AK; dos Santos, CC; Kapus, A; Yousef, GM				Lichner, Zsuzsanna; Saleeb, Rola; Butz, Henriett; Ding, Qiang; Nofech-Mozes, Roy; Riad, Sara; Farag, Mina; Varkouhi, Amir K.; dos Santos, Claudia C.; Kapus, Andras; Yousef, George M.			Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance	FASEB JOURNAL			English	Article						kidney cancer; differential drug response; receptor tyrosine kinase inhibitor	TO-MESENCHYMAL TRANSITION; G-PROTEIN; DOWN-REGULATION; CARCINOMA; METASTASIS; SURVIVAL; DRUG; INHIBITION; EXPRESSION; VEGF	Sunitinib is the standard-of-care, first-line treatment for advanced renal cell carcinoma (RCC). Characteristics of treatment-resistant RCC have been described; however, complex tumor adaptation mechanisms obstruct the identification of significant operators in resistance. We hypothesized that resistance is a late manifestation of early, treatment-induced histomolecular alterations; therefore, studying early drug response may identify drivers of resistance. We describe an epithelioid RCC growth pattern in RCC xenografts, which emerges in sunitinib-sensitive tumors and is augmented during resistance. This growth modality is molecularly and morphologically related to the RCC spheroids that advance during in vitro treatment. Based on time-lapse microscopy, mRNA and microRNA screening, and tumor behavior-related characteristics, we propose that the spheroid and adherent RCC growth patterns differentially respond to sunitinib. Gene expression analysis indicated that sunitinib promoted spheroid formation, which provided a selective survival advantage under treatment. Functional studies confirm that E-cadherin is a key contributor to the survival of RCC cells under sunitinib treatment. In summary, we suggest that sunitinib-resistant RCC cells exist in treatment-sensitive tumors and are histologically identifiable.Lichner, Z., Saleeb, R., Butz, H., Ding, Q., Nofech-Mozes, R., Riad, S., Farag, M., Varkouhi, A. K., dos Santos, C. C., Kapus, A., Yousef, G. M. Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance.	[Lichner, Zsuzsanna; Saleeb, Rola; Butz, Henriett; Ding, Qiang; Nofech-Mozes, Roy; Riad, Sara; Farag, Mina; Varkouhi, Amir K.; dos Santos, Claudia C.; Kapus, Andras; Yousef, George M.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Varkouhi, Amir K.; dos Santos, Claudia C.] St Michaels Hosp, Viral Vector & Cell Therapy Core VICTOR, Toronto, ON, Canada; [Lichner, Zsuzsanna; Saleeb, Rola; Ding, Qiang; Yousef, George M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [dos Santos, Claudia C.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [dos Santos, Claudia C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Kapus, Andras] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Butz, Henriett] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary; [Butz, Henriett] Semmelweis Univ HAS SE, Budapest, Hungary	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Hungarian Academy of Sciences; Semmelweis University	Yousef, GM (corresponding author), St Michaels Hosp, Dept Lab Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	yousefg@smh.ca		Kapus, Andras/0000-0002-6610-9530; Saleeb, Rola/0000-0002-1937-3101; Varkouhi, Amir Khashayar/0000-0002-1794-7546; dos Santos, Claudia/0000-0002-6446-8791	Animal Care Committee of the Keenan Research Centre; Canadian Institutes of Health Research [MOP-119606]; Kidney Foundation of Canada [KFOC130030]; Prostate Cancer Canada Movember Discovery Grants [D2013-39]; Kidney Research Scientist Core Education; National Training Program Postdoctoral Award from the Kidney Foundation of Canada	Animal Care Committee of the Keenan Research Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Prostate Cancer Canada Movember Discovery Grants; Kidney Research Scientist Core Education; National Training Program Postdoctoral Award from the Kidney Foundation of Canada	The authors are grateful for the dedicated work of Vidya Beharry (St. Michael's Hospital) regarding the immunohistochemistry stains; for the advice and support we received from the Animal Care Committee of the Keenan Research Centre; and for the animal care and handling expertise of Danielle Gifford and Alex Rivera (Keenan Research Centre for Biomedical Sciences, St. Michael's Hospital), which they have generously shared with us. The authors also thank Samantha Levin (Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada) for proofreading the manuscript and for helpful comments. This work was supported by grants from the Canadian Institutes of Health Research (MOP-119606), the Kidney Foundation of Canada (KFOC130030), and Prostate Cancer Canada Movember Discovery Grants (D2013-39). Z.L. was supported by the Kidney Research Scientist Core Education and the National Training Program Postdoctoral Award from the Kidney Foundation of Canada. The authors declare no conflicts of interest.	Adelaiye R, 2015, MOL CANCER THER, V14, P513, DOI 10.1158/1535-7163.MCT-14-0208; Berkers J, 2013, J UROLOGY, V189, P1930, DOI 10.1016/j.juro.2012.11.133; Butz H, 2018, ONCOTARGET, V9, P4661, DOI 10.18632/oncotarget.23163; Carlo MI, 2016, NAT REV UROL, V13, P420, DOI 10.1038/nrurol.2016.103; Chen GF, 2014, CELL RES, V24, P1121, DOI 10.1038/cr.2014.112; Chinello C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106684; Demetri GD, 2009, CLIN CANCER RES, V15, P5902, DOI 10.1158/1078-0432.CCR-09-0482; Dufies M, 2017, CANCER RES, V77, P1212, DOI 10.1158/0008-5472.CAN-16-3088; Ebos JML, 2014, EMBO MOL MED, V6, P1561, DOI 10.15252/emmm.201403989; Elias BC, 2015, J CELL SCI, V128, P4293, DOI 10.1242/jcs.164509; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Giuliano S, 2015, AUTOPHAGY, V11, P1891, DOI 10.1080/15548627.2015.1085742; Grunwald V, 2015, EUR UROL, V67, P952, DOI 10.1016/j.eururo.2014.12.036; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Ibragimova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077309; Larkin JMG, 2007, NAT CLIN PRACT ONCOL, V4, P470, DOI 10.1038/ncponc0901; Lawson KA, 2016, CLIN CANCER RES, V22, P5839, DOI 10.1158/1078-0432.CCR-16-0143; Lichner Z, 2015, ONCOTARGET, V6, P5567, DOI 10.18632/oncotarget.1901; Liu D, 2017, ONCOIMMUNOLOGY, V7; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; New DC, 2007, FEBS J, V274, P6025, DOI 10.1111/j.1742-4658.2007.06116.x; Ni D, 2014, CLIN CANCER RES, V20, P1779, DOI 10.1158/1078-0432.CCR-13-1687; Nikitenko LL, 2013, CLIN CANCER RES, V19, P5740, DOI 10.1158/1078-0432.CCR-13-1712; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Patyna S, 2008, TOXICOL PATHOL, V36, P905, DOI 10.1177/0192623308326151; Penzvalto Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059503; Qian CN, 2013, NAT REV UROL, V10, P300, DOI 10.1038/nrurol.2013.26; Ruan HL, 2017, INT J ONCOL, V51, P336, DOI 10.3892/ijo.2017.4010; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Stewart GD, 2015, CLIN CANCER RES, V21, P4212, DOI 10.1158/1078-0432.CCR-15-0207; Stewart K, 2014, SEMIN CELL DEV BIOL, V36, P13, DOI 10.1016/j.semcdb.2014.09.001; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tomlinson JS, 2001, CANCER RES, V61, P5231; Varna M, 2015, CLIN CANCER RES, V21, P916, DOI 10.1158/1078-0432.CCR-14-0666; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Weiswald LB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-106; XI W, 2017, NAT COMMUN, V8; Xiong J, 2017, ONCOTARGET, V8, P6555, DOI 10.18632/oncotarget.14149; Zhang SW, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4810734; Zhang YH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0442-8	44	3	3	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1347	1359		10.1096/fj.201800596R	http://dx.doi.org/10.1096/fj.201800596R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148679	Bronze			2022-12-28	WOS:000457401500106
J	Luo, RF; Hu, S; Liu, QJ; Han, MK; Wang, FF; Qiu, MJ; Li, SC; Li, XS; Yang, TX; Fu, XD; Wang, WD; Li, CL				Luo, Renfei; Hu, Shan; Liu, Qiaojuan; Han, Mengke; Wang, Feifei; Qiu, Miaojuan; Li, Suchun; Li, Xiaosa; Yang, Tianxin; Fu, Xiaodong; Wang, Weidong; Li, Chunling			Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration	FASEB JOURNAL			English	Article						kidney; water channel; gasotransmitter; cAMP	CYSTATHIONINE BETA-SYNTHASE; AQUAPORIN-2 WATER CHANNEL; NA-K-2CL COTRANSPORTER; GAMMA-LYASE; MOLECULAR-MECHANISMS; PHYSIOLOGY; PROPARGYLGLYCINE; INHIBITION; H2S	Increasing evidence supports the important role of H2S in renal physiology and the pathogenesis of kidney injury. Whether H2S regulates water metabolism in the kidney and the potential mechanism are still unknown. The present study was conducted to determine the role of H2S in urine concentration. Inhibition of both cystathionine--lyase (CSE) and cystathionine--synthase (CBS), 2 major enzymes for endogenous H2S production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla. Mice treated with both PPG and AOAA developed a urine concentration defect in response to dehydration that was accompanied by reduced AQP-2 protein expression. Inhibition of CSE alone was associated with a mild decrease in AQP-2 protein level in the renal medulla of heterozygous CBS mice. GYY4137, a slow H2S donor, markedly improved urine concentration and prevented the down-regulation of renal AQP-2 protein expression in mice with lithium-induced nephrogenic diabetes insipidus (NDI). GYY4137 significantly increased cAMP levels in cell lysates prepared from inner medullary collecting duct (IMCD) suspensions. AQP-2 protein expression was also upregulated, but was significantly inhibited by the adenyl cyclase inhibitor MDL12330A or the PKA inhibitor H89, but not the vasopressin 2 receptor (V2R) antagonist tolvaptan. Inhibition of endogenous H2S production impaired urine concentration in mice, whereas an exogenous H2S donor improved urine concentration in lithium-induced NDI by increasing AQP-2 expression in the collecting duct principal cells. H2S upregulated AQP-2 protein expression, probably via the cAMP-PKA pathway.Luo, R., Hu, S., Liu, Q., Han, M., Wang, F., Qiu, M., Li, S., Li, X., Yang, T., Fu, X., Wang, W., Li, C. Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.	[Luo, Renfei; Hu, Shan; Liu, Qiaojuan; Han, Mengke; Wang, Feifei; Qiu, Miaojuan; Li, Suchun; Yang, Tianxin; Wang, Weidong; Li, Chunling] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Li, Xiaosa; Fu, Xiaodong] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Yang, Tianxin] Univ Utah, Dept Med, Vet Affairs Med Ctr, Salt Lake City, UT 84112 USA	Sun Yat Sen University; Guangzhou Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Wang, WD; Li, CL (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	wangwd6@mail.sysu.edu.cn; lichl3@mail.sysu.edu.cn		Li, Suchun/0000-0002-5748-681X; Wang, Weidong/0000-0003-2523-3145	Natural Science Foundation of China [81570635, 81670646, 81370822]; Natural Science Foundation of Guangdong Province [2014A020212623, 2014A030313168, 2016A020215034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104072] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002817] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Natural Science Foundation of China Grants 81570635, 81670646, and 81370822, and Natural Science Foundation of Guangdong Province Grants 2014A020212623, 2014A030313168, and 2016A020215034. The authors declare no conflicts of interest.	Altaany Z, 2013, J CELL MOL MED, V17, P879, DOI 10.1111/jcmm.12077; Bankir L, 2017, J INTERN MED, V282, P284, DOI 10.1111/joim.12645; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Cao X, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00385; Castrop H, 2014, AM J PHYSIOL-RENAL, V307, pF991, DOI 10.1152/ajprenal.00432.2014; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Christ-Crain M, 2016, NAT REV ENDOCRINOL, V12, P168, DOI 10.1038/nrendo.2015.224; Feliers D, 2016, ANTIOXID REDOX SIGN, V25, P720, DOI 10.1089/ars.2015.6596; Ge SN, 2014, ANTIOXID REDOX SIGN, V21, P2061, DOI 10.1089/ars.2013.5304; Igarashi P, 1996, J BIOL CHEM, V271, P9666, DOI 10.1074/jbc.271.16.9666; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Jin S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00682; Jung HJ, 2018, J AM SOC NEPHROL, V29, P1490, DOI 10.1681/ASN.2017050545; Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI 10.1002/lt.21810; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Knepper MA, 2015, NEW ENGL J MED, V373, P196, DOI 10.1056/NEJMc1505505; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Koning AM, 2015, NITRIC OXIDE-BIOL CH, V46, P37, DOI 10.1016/j.niox.2015.01.005; Konno R, 2000, ARCH TOXICOL, V74, P473, DOI 10.1007/s002040000156; Kwong RWM, 2015, AM J PHYSIOL-CELL PH, V309, pC60, DOI 10.1152/ajpcell.00053.2015; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Li C, 2008, J AM SOC NEPHROL, V19, P225, DOI 10.1681/ASN.2007010029; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Li CL, 2011, AM J PHYSIOL-RENAL, V300, pF1255, DOI 10.1152/ajprenal.00469.2010; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Olson KR, 2008, AM J PHYSIOL-REG I, V295, pR669, DOI 10.1152/ajpregu.00807.2007; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Perniss A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03742-5; Roy A, 2012, AM J HYPERTENS, V25, P74, DOI 10.1038/ajh.2011.149; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Tang GH, 2013, ANTIOXID REDOX SIGN, V19, P1634, DOI 10.1089/ars.2012.4805; Triguero A, 1997, BRIT J NUTR, V78, P823, DOI 10.1079/BJN19970198; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang WD, 2015, AM J PHYSIOL-RENAL, V308, pF910, DOI 10.1152/ajprenal.00649.2014; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WORK J, 1985, AM J PHYSIOL, V249, pF698, DOI 10.1152/ajprenal.1985.249.5.F698; Xia M, 2009, J PHARMACOL EXP THER, V329, P1056, DOI 10.1124/jpet.108.149963; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420	43	22	22	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					469	483		10.1096/fj.201800436R	http://dx.doi.org/10.1096/fj.201800436R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30036087	Green Published			2022-12-28	WOS:000457401500037
J	Wang, CM; Gu, LY; Ruan, YL; Geng, X; Xu, M; Yang, NN; Yu, L; Jiang, YC; Zhu, C; Yang, Y; Zhou, Y; Guan, XW; Luo, WQ; Liu, Q; Dong, XZ; Yu, G; Lan, L; Tang, ZX				Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Xu, Miao; Yang, Niuniu; Yu, Lei; Jiang, Yucui; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Luo, Wenqin; Liu, Qin; Dong, Xinzhong; Yu, Guang; Lan, Lei; Tang, Zongxiang			Facilitation of MrgprD by TRP-A1 promotes neuropathic pain	FASEB JOURNAL			English	Article						MrgprA1; dorsal root ganglia (DRG); protein kinase A (PKA)	DORSAL-HORN NEURONS; RECEPTOR; PROTEIN; TRPA1; ITCH; MODEL; COLD; RAT; IDENTIFICATION; EXCITABILITY	Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas-related GPCR D (MrgprD) is specifically expressed in small-diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)-A1 was the ion channel downstream of MrgprD, and the -alanine-induced calcium signal was attributed mostly to TRP-A1 function. We further showed that PKA serves as a downstream mediator of -alanine-activated MrgprD signaling to activate TRP-A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP-A1 plasmids. Finally, we found that the -alanine-induced pain behavior was increased, whereas the itching behavior was unchanged in CCI models compared with sham-injured animals. Knockout of TRPA1 also attenuated the -alanine-induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI-induced neuropathic pain through the PKA-TRP-A1 pathway. TRP-A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.Wang, C., Gu, L., Ruan, Y., Geng, X., Xu, M., Yang, N., Yu, L., Jiang, Y., Zhu, C., Yang, Y., Zhou, Y., Guan, X., Luo, W., Liu, Q., Dong, X., Yu, G., Lan, L., Tang, Z. Facilitation of MrgprD by TRP-A1 promotes neuropathic pain.	[Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Yang, Niuniu; Yu, Lei; Jiang, Yucui; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, Sch Med & Life Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Yu, Lei; Jiang, Yucui; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, Key Lab Chinese Med Prevent & Treatment Neurol Di, Nanjing, Jiangsu, Peoples R China; [Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, State Key Lab Cultivat Base Tradit Chinese Med Qu, Nanjing, Jiangsu, Peoples R China; [Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, Key Lab Drug Target & Drug Degenerat Dis Jiangsu, Nanjing, Jiangsu, Peoples R China; [Xu, Miao; Lan, Lei] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing 210046, Jiangsu, Peoples R China; [Yang, Niuniu] Yangzhou Univ, Jiangsu Key Lab Integrated Tradit Chinese & Weste, Dept Tradit Chinese & Western Med, Yangzhou, Jiangsu, Peoples R China; [Luo, Wenqin] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Qin] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Liu, Qin] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO USA; [Liu, Qin] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing Normal University; Yangzhou University; University of Pennsylvania; Pennsylvania Medicine; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Lan, L (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing 210046, Jiangsu, Peoples R China.; Yu, G (corresponding author), Nanjing Univ Chinese Med, 138 Xianlin Rd, Nanjing 210023, Jiangsu, Peoples R China.	yuguang928@126.com; lanlei@njnu.edu.cn	Luo, Wen/GRO-5989-2022; Yu, Lei/ABD-6127-2021	yang, niuniu/0000-0002-3335-3887	National Science Foundation of China [31471007, 31771163, 81600966]; Natural Science Foundation of Jiangsu Province [16KJB320005, BK20151571]; Natural Science Fund Project of Colleges in Jiangsu Province [BK20161042]; Jiangsu Keypoint Research and Invention Program [BE2017728]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project in Jiangsu Province; Hunan Cooperative Innovation Center for Molecular Target New Drug Study; Postdoctoral Science Foundation of China [M601863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Fund Project of Colleges in Jiangsu Province; Jiangsu Keypoint Research and Invention Program; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project in Jiangsu Province; Hunan Cooperative Innovation Center for Molecular Target New Drug Study; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science Foundation of China Grants 31471007 and 31771163 (to Z.T.) and 81600966 (to C.W.); the Natural Science Foundation of Jiangsu Province Grants 16KJB320005 (to C.W) and BK20151571 (to G.Y.); a Natural Science Fund Project of Colleges in Jiangsu Province Grant BK20161042 (to C.W.); and Jiangsu Keypoint Research and Invention Program Grant BE2017728 (to G.Y.). The project was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and sponsored by a grant from the Qing Lan Project in Jiangsu Province (to Z.T.). This work was also supported by the Hunan Cooperative Innovation Center for Molecular Target New Drug Study, and Postdoctoral Science Foundation of China (M601863). C.W. and L.G. are co-senior authors. The authors declare no conflicts of interest.	Ajit SK, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/326020; Akiyama T, 2014, NEUROSCIENCE, V266, P38, DOI 10.1016/j.neuroscience.2014.02.005; Basso L, 2017, CURR OPIN PHARMACOL, V32, P9, DOI 10.1016/j.coph.2016.10.002; Bender E, 2002, P NATL ACAD SCI USA, V99, P8573, DOI 10.1073/pnas.122016499; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Farghaly HSM, 2016, EUR J PHARMACOL, V776, P139, DOI 10.1016/j.ejphar.2016.02.046; Foster E, 2015, NEURON, V85, P1289, DOI 10.1016/j.neuron.2015.02.028; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LaMotte RH, 2011, EXP DERMATOL, V20, P778, DOI 10.1111/j.1600-0625.2011.01367.x; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2015, HANDB EXP PHARMACOL, V226, P71, DOI 10.1007/978-3-662-44605-8_5; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Ma WY, 2005, PAIN, V113, P386, DOI 10.1016/j.pain.2004.11.018; Meents JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170097; Nightingale S, 2012, NAT REV DRUG DISCOV, V11, P101, DOI 10.1038/nrd3624; Peng JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12029; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Qu LT, 2014, BRAIN, V137, P1039, DOI 10.1093/brain/awu007; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Tetzner A, 2016, HYPERTENSION, V68, P185, DOI 10.1161/HYPERTENSIONAHA.116.07572; Trevisan G, 2016, BRAIN, V139, P1361, DOI 10.1093/brain/aww038; van Hecke O, 2014, PAIN, V155, P1907, DOI 10.1016/j.pain.2014.06.006; Veldhuis NA, 2015, PHARMACOL REV, V67, P36, DOI 10.1124/pr.114.009555; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Wang CM, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0054-x; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Zhuo RG, 2014, J PHYSIOL BIOCHEM, V70, P185, DOI 10.1007/s13105-013-0292-1; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	40	35	38	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1360	1373		10.1096/fj.201800615RR	http://dx.doi.org/10.1096/fj.201800615RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148678	Green Published, Bronze			2022-12-28	WOS:000457401500107
J	Watts, SW; Darios, ES; Mullick, AE; Garver, H; Saunders, TL; Hughes, ED; Filipiak, WE; Zeidler, MG; McMullen, N; Sinal, CJ; Kumar, RK; Ferland, DJ; Fink, GD				Watts, Stephanie W.; Darios, Emma S.; Mullick, Adam E.; Garver, Hannah; Saunders, Thomas L.; Hughes, Elizabeth D.; Filipiak, Wanda E.; Zeidler, Michael G.; McMullen, Nichole; Sinal, Christopher J.; Kumar, Ramya K.; Ferland, David J.; Fink, Gregory D.			The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension	FASEB JOURNAL			English	Article						blood pressure; adipokines; vascular contraction	POLYCYSTIC-OVARY-SYNDROME; ABDOMINAL VISCERAL FAT; SERUM CHEMERIN; ADIPOKINE CHEMERIN; METABOLIC SYNDROME; PLASMA CHEMERIN; ADIPOSE-TISSUE; DOCA-SALT; VASCULAR REACTIVITY; INTERNATIONAL UNION	Measures of the adipokine chemerin are elevated in multiple cardiovascular diseases, including hypertension, but little mechanistic work has been done to implicate chemerin as being causative in such diseases. The chemerin knockout (KO) rat was created to test the hypothesis that removal of chemerin would reduce pressure in the normal and hypertensive state. Western analyses confirmed loss of chemerin in the plasma and tissues of the KO vs. wild-type (WT) rats. Chemerin concentration in plasma and tissues was lower in WT females than in WT males, as determined by Western analysis. Conscious male and female KO rats had modest differences in baseline measures vs. the WT that included systolic, diastolic, mean arterial and pulse pressures, and heart rate, all measured telemetrically. The mineralocorticoid deoxycorticosterone acetate (DOCA) and salt water, combined with uninephrectomy as a hypertensive stimulus, elevated mean and systolic blood pressures of the male KO higher than the male WT. By contrast, all pressures in the female KO were lower than their WT throughout DOCA-salt treatment. These results revealed an unexpected sex difference in chemerin expression and the ability of chemerin to modify blood pressure in response to a hypertensive challenge.Watts, S. W., Darios, E. S., Mullick, A. E., Garver, H., Saunders, T. L., Hughes, E. D., Filipiak, W. E., Zeidler, M. G., McMullen, N., Sinal, C. J., Kumar, R. K., Ferland, D. J., Fink, G. D. The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension.	[Watts, Stephanie W.; Darios, Emma S.; Garver, Hannah; Kumar, Ramya K.; Ferland, David J.; Fink, Gregory D.] Michigan State Univ, Dept Pharmacol & Toxicol, 1355 Bogue St,Room B445, E Lansing, MI 48824 USA; [Mullick, Adam E.] Ionis Pharmaceut, Carlsbad, CA USA; [Saunders, Thomas L.] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI USA; [Saunders, Thomas L.; Hughes, Elizabeth D.; Filipiak, Wanda E.; Zeidler, Michael G.] Univ Michigan, Transgen Anim Model Core, Ann Arbor, MI 48109 USA; [McMullen, Nichole; Sinal, Christopher J.] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada	Michigan State University; Ionis Pharmaceuticals, Inc.; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Dalhousie University	Watts, SW (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, 1355 Bogue St,Room B445, E Lansing, MI 48824 USA.	wattss@msu.edu		Ferland, David/0000-0002-8780-5383; Sinal, Christopher/0000-0001-8301-3349; Saunders, Thom/0000-0003-2015-101X; McMullen, Nichole/0000-0002-0710-5900	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [HL 117847]	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Bridget Seitz (Department of Pharmacology and Toxicology, Michigan State University) for helping with blood procurement for making plasma samples. This work was supported by the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute, (Grant HL 117847). The authors declare no conflicts of interest.	Aksu F, 2017, CARDIOL J, V24, P276, DOI 10.5603/CJ.a2017.0031; Alfadda AA, 2012, MOL CELLS, V33, P591, DOI 10.1007/s10059-012-0012-7; Martinez-Garcia MA, 2013, J CLIN ENDOCR METAB, V98, pE388, DOI 10.1210/jc.2012-3414; Arica PC, 2018, J INVEST SURG, V31, P89, DOI 10.1080/08941939.2017.1280564; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Blaszak J, 2015, RENAL FAILURE, V37, P1033, DOI 10.3109/0886022X.2015.1040707; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cetin O, 2017, J OBSTET GYNAECOL, V37, P195, DOI 10.1080/01443615.2016.1233947; Chang SS, 2016, OBESITY, V24, P1522, DOI 10.1002/oby.21534; Charles River Laboratories, 2016, RES CLIN LAB PAR CRL; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai SY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0261-4; Darios ES, 2016, AM J PHYSIOL-HEART C, V311, pH498, DOI 10.1152/ajpheart.00998.2015; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; Daxer J, 2017, J PEDIATR ENDOCR MET, V30, P57, DOI 10.1515/jpem-2016-0378; Dessein PH, 2014, J RHEUMATOL, V41, P1746, DOI 10.3899/jrheum.140122; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Duan DM, 2012, J PERINAT MED, V40, P121, DOI 10.1515/JPM.2011.127; Ebert T, 2018, J CLIN ENDOCR METAB, V103, P1015, DOI 10.1210/jc.2017-02085; Eichelmann F, 2017, ENDOCR CONNECT, V6, P340, DOI 10.1530/EC-17-0098; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Feng XW, 2012, BIOMARKERS, V17, P248, DOI 10.3109/1354750X.2012.658864; Ferland DJ, 2017, VASC PHARMACOL, V88, P30, DOI 10.1016/j.vph.2016.11.009; Ferland DJ, 2015, PHARMACOL RES, V99, P351, DOI 10.1016/j.phrs.2015.07.018; Filipiak WE, 2006, TRANSGENIC RES, V15, P673, DOI 10.1007/s11248-006-9002-x; Geng LA, 2006, MOL BIOTECHNOL, V33, P23; Giachini FR, 2010, HYPERTENSION, V55, P172, DOI 10.1161/HYPERTENSIONAHA.109.140459; Godlewska U, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00353; Gonzalez-Alvarez R, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0020-0, 10.1186/S40659-015-0020-0]; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Gu P, 2015, J HYPERTENS, V33, P1624, DOI 10.1097/HJH.0000000000000588; Gu P, 2014, CLIN EXP HYPERTENS, V36, P326, DOI 10.3109/10641963.2013.827697; Han J, 2016, J KOREAN MED SCI, V31, P924, DOI 10.3346/jkms.2016.31.6.924; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WC, 2011, DIABETES RES CLIN PR, V91, P159, DOI 10.1016/j.diabres.2010.11.016; Huang R, 2015, CLIN CHIM ACTA, V450, P366, DOI 10.1016/j.cca.2015.09.015; Kawanishi H, 2007, CLIN EXP PHARMACOL P, V34, P280, DOI 10.1111/j.1440-1681.2007.04580.x; Kennedy AJ, 2018, PHARMACOL REV, V70, P174, DOI 10.1124/pr.116.013177; Kennedy AJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004421; Kort DH, 2015, GYNECOL ENDOCRINOL, V31, P152, DOI 10.3109/09513590.2014.968547; Kostopoulos CG, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-56; Kukla M, 2010, SCAND J GASTROENTERO, V45, P235, DOI 10.3109/00365520903443852; Kunimoto H, 2015, AM J PHYSIOL-HEART C, V309, pH1017, DOI 10.1152/ajpheart.00820.2014; Lange DL, 1998, HYPERTENSION, V31, P403, DOI 10.1161/01.HYP.31.1.403; Leiherer A, 2016, VASC PHARMACOL, V77, P60, DOI 10.1016/j.vph.2015.08.010; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Lobato NS, 2012, LIFE SCI, V91, P600, DOI 10.1016/j.lfs.2012.04.013; Lu B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001990; Luque-Ramirez M, 2013, HUM REPROD, V28, P1908, DOI 10.1093/humrep/det097; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mattern A, 2014, IUBMB LIFE, V66, P19, DOI 10.1002/iub.1242; MCBURNEY MW, 1994, SOMAT CELL MOLEC GEN, V20, P515, DOI 10.1007/BF02255842; Meric M, 2014, MED SCI MONITOR, V20, P698, DOI 10.12659/MSM.890784; Mui RK, 2018, AM J PHYSIOL-HEART C, V314, pH863, DOI 10.1152/ajpheart.00536.2017; Neves KB, 2015, HYPERTENSION, V66, P657, DOI 10.1161/HYPERTENSIONAHA.115.05616; Neves KB, 2014, CLIN SCI, V127, P111, DOI 10.1042/CS20130286; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Pohl R, 2015, EXP MOL PATHOL, V98, P295, DOI 10.1016/j.yexmp.2015.02.005; Provoost S, 2016, J IMMUNOL, V196, P1882, DOI 10.4049/jimmunol.1501113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Regn M, 2016, J MOL CELL CARDIOL, V99, P57, DOI 10.1016/j.yjmcc.2016.08.010; Rodriguez-Penas D, 2015, CELL PHYSIOL BIOCHEM, V37, P176, DOI 10.1159/000430343; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Rourke JL, 2013, OBES REV, V14, P245, DOI 10.1111/obr.12009; Schmid A, 2016, CYTOKINE, V80, P56, DOI 10.1016/j.cyto.2016.02.010; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Shin HY, 2012, CLIN ENDOCRINOL, V77, P47, DOI 10.1111/j.1365-2265.2011.04217.x; Sledzinskaa M, 2017, ADV MED SCI-POLAND, V62, P383, DOI 10.1016/j.advms.2017.04.002; STALLONE JN, 1995, AM J PHYSIOL-REG I, V268, pR40, DOI 10.1152/ajpregu.1995.268.1.R40; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Stepan H, 2011, REGUL PEPTIDES, V168, P69, DOI 10.1016/j.regpep.2011.03.005; Takahashi M, 2013, ENDOCR J, V60, P37, DOI 10.1507/endocrj.EJ12-0201; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Tostes RCA, 2000, J CARDIOVASC PHARM, V36, pS99; Wang D, 2013, GENET MOL RES, V12, P5986, DOI 10.4238/2013.November.26.8; Wang LQ, 2015, ENDOCRINE, V48, P299, DOI 10.1007/s12020-014-0286-y; Wargent ET, 2015, PEERJ, V3, DOI 10.7717/peerj.753; Watts SW, 2013, ARTERIOSCL THROM VAS, V33, P1320, DOI 10.1161/ATVBAHA.113.301476; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Wolk K, 2016, REV ENDOCR METAB DIS, V17, P305, DOI 10.1007/s11154-016-9381-0; Xiong W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165305; Yamawaki H, 2012, BIOCHEM BIOPH RES CO, V423, P152, DOI 10.1016/j.bbrc.2012.05.103; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Yang SY, 2016, GYNECOL ENDOCRINOL, V32, P38, DOI 10.3109/09513590.2015.1075501; Zhang GW, 2017, ANN CLIN BIOCHEM, V54, P342, DOI 10.1177/0004563216664367; Zhang O, 2015, CLIN CHIM ACTA, V448, P27, DOI 10.1016/j.cca.2015.05.018; Zhao DD, 2015, MED SCI MONITOR, V21, P3121, DOI 10.12659/MSM.895866; Zhao L, 2014, ALLERGY, V69, P763, DOI 10.1111/all.12408; Zylla S, 2017, OBESITY, V25, P468, DOI 10.1002/oby.21735	96	15	15	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6596	6614		10.1096/fj.201800479	http://dx.doi.org/10.1096/fj.201800479			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906243	Green Published, Green Submitted			2022-12-28	WOS:000449359700020
J	Biswas, S; Watters, J; Bachay, G; Varshney, S; Hunter, DD; Hu, HY; Brunken, WJ				Biswas, Saptarshi; Watters, Jared; Bachay, Galina; Varshney, Shweta; Hunter, Dale D.; Hu, Huaiyu; Brunken, William J.			Laminin-dystroglycan signaling regulates retinal arteriogenesis	FASEB JOURNAL			English	Article						extracellular matrix; basement membrane; CNS angiogenesis; vascular remodeling	BLOOD-BRAIN-BARRIER; MOUSE RETINA; ARTERIAL MORPHOGENESIS; ENDOTHELIAL-CELLS; GAMMA-3 CHAIN; IN-VIVO; ANGIOGENESIS; MODEL; VEGF; MICE	Proper arteriovenous morphogenesis is crucial for maintaining normal tissue perfusion. However, our understanding of how arterial morphogenesis is regulated in the CNS is incomplete. In this study, we asked whether vascular basement membrane (BM) laminins, specifically the 3-containing isoforms, regulate retinal arterial morphogenesis. We provide evidence that laminin-3 is deposited at both arterial and venous BMs during arteriogenesis. Vascular BM laminin-3 bound dystroglycan (DG), a laminin receptor preferentially expressed by arterial endothelial cells (ECs) during arteriogenesis. Blockade of laminin-DG binding in vitro led to decreased Delta-like ligand (DLL)-4 expression in ECs. Moreover, genetic deletion of the laminin-3- and EC-specific deletion of DG led to similar defects in retinal arteriogenesis, including reduced Dll4 expression, hyperbranching and reduced smooth muscle coverage. These results implicate a newly identified laminin-3-DG signaling cascade that regulates arterial Dll4/Notch signaling to specify and stabilize retinal arteries.Biswas, S., Watters, J., Bachay, G., Varshney, S., Hunter, D. D., Hu, H., Brunken, W. J. Laminin-dystroglycan signaling regulates retinal arteriogenesis.	[Biswas, Saptarshi; Watters, Jared; Bachay, Galina; Hunter, Dale D.; Hu, Huaiyu; Brunken, William J.] SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA; [Biswas, Saptarshi; Watters, Jared; Bachay, Galina; Hunter, Dale D.; Hu, Huaiyu; Brunken, William J.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Biswas, Saptarshi; Watters, Jared; Bachay, Galina; Hunter, Dale D.; Hu, Huaiyu; Brunken, William J.] SUNY Upstate Med Univ, Ctr Vis Res, Syracuse, NY 13210 USA; [Varshney, Shweta] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Varshney, Shweta] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Brunken, WJ (corresponding author), SUNY Upstate Med Univ, Neurosci Res Bldg,505 Irving Ave, Syracuse, NY 13210 USA.	brunkenw@upstate.edu			U.S. National Institutes of Health, National Eye Institute [R01EY12676]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY012676] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank members of the Center for Vision Research for their help and input during the study, and Dmitri Serjanov [Department of Ophthalmology, Department of Neuroscience and Physiology, and The Center for Vision Research, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA] for reading the manuscript. This work was funded by U.S. National Institutes of Health, National Eye Institute Grant R01EY12676 (to W.J.B.), and an Unrestricted Grant to the Department of Ophthalmology (Robert Fechtner, M.D., Chair and Principal Investigator) from Research to Prevent Blindness. The authors declare no conflicts of interest.	Aitsebaomo J, 2008, CIRC RES, V103, P929, DOI 10.1161/CIRCRESAHA.108.184937; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Biswas S, 2017, AM J PATHOL, V187, P2112, DOI 10.1016/j.ajpath.2017.05.016; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; Crist AM, 2017, GENE EXPR PATTERNS, V23-24, P22, DOI 10.1016/j.gep.2017.01.002; Cristofaro B, 2013, DEVELOPMENT, V140, P1720, DOI 10.1242/dev.092304; Deng Y, 2013, BLOOD, V121, P3988, DOI 10.1182/blood-2012-12-474601; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gnanaguru G, 2013, DEVELOPMENT, V140, P2050, DOI 10.1242/dev.087817; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; HENKIND P, 1974, BRIT J OPHTHALMOL, V58, P413, DOI 10.1136/bjo.58.4.413; Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kitagawa M, 2013, MECH DEVELOP, V130, P458, DOI 10.1016/j.mod.2013.07.001; Li YN, 2012, MATRIX BIOL, V31, P120, DOI 10.1016/j.matbio.2011.12.002; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lobov IB, 2011, BLOOD, V117, P6728, DOI 10.1182/blood-2010-08-302067; Macdonald PR, 2010, J STRUCT BIOL, V170, P398, DOI 10.1016/j.jsb.2010.02.004; Oppizzi ML, 2008, TRAFFIC, V9, P2063, DOI 10.1111/j.1600-0854.2008.00822.x; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Pinzon-Duarte G, 2010, INVEST OPHTH VIS SCI, V51, P1773, DOI 10.1167/iovs.09-4645; Reck SD, 2005, J NEURO-OPHTHALMOL, V25, P205, DOI 10.1097/01.wno.0000177301.82963.9f; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Sawaguchi S, 2017, ELIFE, V6, DOI 10.7554/eLife.24419; Simons M, 2015, CIRC RES, V116, P1712, DOI 10.1161/CIRCRESAHA.116.302953; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; Uemura AK, 2006, EXP CELL RES, V312, P676, DOI 10.1016/j.yexcr.2005.10.030; Yu M, 2013, HUM GENE THER, V24, P317, DOI 10.1089/hum.2012.084	40	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6261	6273		10.1096/fj.201800232R	http://dx.doi.org/10.1096/fj.201800232R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29874128	Green Published, Bronze			2022-12-28	WOS:000447172000041
J	Li, XY; Zhu, GM; Gou, X; He, WY; Yin, HB; Yang, XY; Li, J				Li, Xinyuan; Zhu, Gongmin; Gou, Xin; He, Weiyang; Yin, Hubin; Yang, Xiaoyu; Li, Jie			Negative feedback loop of autophagy and endoplasmic reticulum stress in rapamycin protection against renal ischemia-reperfusion injury during initial reperfusion phase	FASEB JOURNAL			English	Article						sirolimus; acute kidney injury; kidney transplantation	DELAYED GRAFT FUNCTION; ISCHEMIA/REPERFUSION INJURY; IMMUNOSUPPRESSIVE DRUGS; LIVER ISCHEMIA; TUBULAR CELLS; KIDNEY; SIROLIMUS; RECOVERY; FAILURE; INVOLVEMENT	Rapamycin, an immunosuppressant, is widely used in patients with kidney transplant. However, the therapeutic effects of rapamycin remain controversial. Additionally, previous studies have revealed deleterious effects of rapamycin predominantly when administered for 24 h. Few studies, however, have focused on the short-term effects of rapamycin administered only during the initial reperfusion phase. As such, we designed this study to explore the potential effects and mechanisms of rapamycin under a specific therapeutic regimen in which rapamycin is mixed in the perfusate during the initial reperfusion phase (within 24 h). Interestingly, we found that rapamycin maintained renal function and attenuated ischemia-reperfusion (I/R)-induced apoptosis in vivo and in vitro during the initial reperfusion phase, especially at 8 h after reperfusion. Simultaneously, rapamycin activated autophagy and inhibited endoplasmic reticulum (ER) stress and 3 pathways of unfolding protein response: ATF6, PERK, and IRE1. Interestingly, we further found that the protective effects of rapamycin were suppressed when autophagy was inhibited by chloroquine and 3-methyladenine or when ER stress was induced by thapsigargin. Moreover, in terms of the regulatory effects of rapamycin, a negative-feedback loop between autophagy and ER stress occurred, with autophagy inhibiting ER stress and increased ER stress promoting autophagy during the initial reperfusion phase of renal I/R injury. Our study provides evidence that immediate reperfusion with rapamycin during the initial reperfusion phase repairs renal function and reduces apoptosis via activating autophagy, which could further inhibit ER stress. These results suggest a novel treatment modality for application during the initial reperfusion phase of renal I/R injury caused by kidney transplantation.Li, X., Zhu, G., Gou, X., He, W., Yin, H., Yang, X., Li, J. Negative feedback loop of autophagy and endoplasmic reticulum stress in rapamycin protection against renal ischemia-reperfusion injury during initial reperfusion phase.	[Li, Xinyuan; Zhu, Gongmin; Gou, Xin; He, Weiyang; Yin, Hubin; Yang, Xiaoyu; Li, Jie] Chongqing Med Univ, Dept Urol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Li, Xinyuan; Zhu, Gongmin; Yin, Hubin; Yang, Xiaoyu; Li, Jie] Chongqing Key Lab Mol Oncol & Epigenet, Chongqing, Peoples R China	Chongqing Medical University	Li, J (corresponding author), Chongqing Med Univ, Dept Urol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China.	beatwind@163.com			Key Programme of Chongqing Health Authority (China) [2013-1-006, 20142010]	Key Programme of Chongqing Health Authority (China)	This study was supported by Grants 2013-1-006 and 20142010 from the Key Programme of Chongqing Health Authority (China). The authors declare no conflicts of interest.	Boratynska M, 2005, TRANSPL P, V37, P839, DOI 10.1016/j.transproceed.2004.12.010; Cheng HF, 2015, KIDNEY INT, V88, P85, DOI 10.1038/ki.2015.69; Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771; Chong ZZ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-45; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P374, DOI 10.4161/oxim.3.6.14787; Cicora F, 2010, TRANSPL P, V42, P365, DOI 10.1016/j.transproceed.2009.11.013; Cicora F, 2012, MEDICINA-BUENOS AIRE, V72, P3; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Das A, 2012, J MOL CELL CARDIOL, V53, P858, DOI 10.1016/j.yjmcc.2012.09.007; Fervenza FC, 2004, NEPHROL DIAL TRANSPL, V19, P1288, DOI 10.1093/ndt/gfh079; Goncalves GM, 2007, TRANSPL P, V39, P417, DOI 10.1016/j.transproceed.2007.01.027; Guan XJ, 2015, CELL PHYSIOL BIOCHEM, V36, P285, DOI 10.1159/000374071; Gustafsson AB, 2008, AUTOPHAGY, V4, P416, DOI 10.4161/auto.5655; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hong J, 2017, INT J VASC MED, V2017, DOI [10. 1155/2017/2049217, DOI 10.1155/2017/2049217]; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Kaushal GP, 2012, KIDNEY INT, V82, P1250, DOI 10.1038/ki.2012.337; Li M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030332; Lieberthal W, 2001, AM J PHYSIOL-RENAL, V281, pF693, DOI 10.1152/ajprenal.2001.281.4.F693; Liu DX, 2017, MOL NEUROBIOL, V54, P5440, DOI 10.1007/s12035-016-0079-9; Liu L, 2012, CONTEMPORARY INNOVATION AND DEVELOPMENT IN STATISTICAL SCIENCE, P92; Long SA, 2012, DIABETES, V61, P2340, DOI 10.2337/db12-0049; Melk A, 2016, AUTOPHAGY, V12, P596, DOI 10.1080/15548627.2015.1135284; Messer JS, 2017, CELL MOL LIFE SCI, V74, P1281, DOI 10.1007/s00018-016-2403-y; Nakagawa S, 2012, EUR J PHARMACOL, V696, P143, DOI 10.1016/j.ejphar.2012.09.010; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nishihara K, 2010, AM J PHYSIOL-RENAL, V298, pF923, DOI 10.1152/ajprenal.00567.2009; Parra C, 2010, TRANSPL P, V42, P245, DOI 10.1016/j.transproceed.2009.11.018; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Rao J, 2014, AM J TRANSPLANT, V14, P1552, DOI 10.1111/ajt.12711; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Sehgal SN, 1998, CLIN BIOCHEM, V31, P335, DOI 10.1016/S0009-9120(98)00045-9; Simon JF, 2004, AM J NEPHROL, V24, P393, DOI 10.1159/000079734; Taniguchi M, 2015, CURR OPIN NEPHROL HY, V24, P345, DOI 10.1097/MNH.0000000000000141; TULLIUS SG, 1995, TRANSPLANTATION, V59, P313, DOI 10.1097/00007890-199502150-00001; Wang DW, 2012, AUTOPHAGY, V8, P954, DOI 10.4161/auto.19927; Wang LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079814; Wang LH, 2014, SCI CHINA LIFE SCI, V57, P171, DOI 10.1007/s11427-014-4607-4; Wang YL, 2013, BIOCHEM BIOPH RES CO, V434, P352, DOI 10.1016/j.bbrc.2013.03.077; Wu H, 2016, INT J CARDIOL, V208, P65, DOI 10.1016/j.ijcard.2016.01.119; Yakupoglu Yarkin K, 2003, Exp Clin Transplant, V1, P8; Yin XL, 2011, AM J CHINESE MED, V39, P853, DOI 10.1142/S0192415X11009251; Zandstra J, 2015, PHARM RES-DORDR, V32, P3238, DOI 10.1007/s11095-015-1700-8; Zhang C, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00029; Zhang XN, 2014, AUTOPHAGY, V10, P1801, DOI 10.4161/auto.32136; Zhang YL, 2015, EXP BIOL MED, V240, P1590, DOI 10.1177/1535370215581306; Zhu J, 2015, TRANSPL P, V47, P1646, DOI 10.1016/j.transproceed.2015.05.013	50	8	11	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6002	6018		10.1096/fj.201800299R	http://dx.doi.org/10.1096/fj.201800299R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29771603	Bronze			2022-12-28	WOS:000447172000020
J	Li, Y; Zou, X; Gao, J; Cao, K; Feng, ZH; Liu, JK				Li, Yuan; Zou, Xuan; Gao, Jing; Cao, Ke; Feng, Zhihui; Liu, Jiankang			APR3 modulates oxidative stress and mitochondrial function in ARPE-19 cells	FASEB JOURNAL			English	Article						phase II enzymes; nuclear factor (erythroid-derived 2)-like 2; age-related macular degeneration; apoptosis	PIGMENT EPITHELIAL-CELLS; MACULAR DEGENERATION; MOLECULAR-MECHANISMS; ANTIOXIDANT RESPONSE; TRANSCRIPTION FACTOR; GLUTATHIONE GSH; NRF2; RPE; DEPLETION; DYSFUNCTION	Impairment of retinal pigment epithelial (RPE) cells is considered a key contributor to the development of age-related macular degeneration. Apoptosis-related protein 3 (APR3) was recently discovered after treatment with all-trans retinoic acid, a pivotal molecule in RPE cells. However, the function of APR3 remains poorly understood. In the present study, we found that APR3 could interact with nuclear factor (erythroid-derived 2)-like 2, which is a regulator of phase II enzymes, and that knockdown of APR3 promoted nuclear factor (erythroid-derived 2)-like 2 nuclear translocation and activated expression of phase II enzymes, which was accompanied by improved redox status and mitochondrial activity. Overexpression of APR3 revealed its mitochondrial localization and induced a robust production of reactive oxygen species that was accompanied by impaired mitochondrial oxygen consumption, complex activity, and lower ATP content, resulting in significant changes in mitochondrial structure, which may contribute to cell apoptosis. High doses of all-trans retinoic acid treatment were found to significantly induce APR3 expression, increase reactive oxygen species levels, and decrease ATP content, which were abolished by knockdown of APR3. These results indicate that APR3 plays a vital role in regulating redox status and mitochondrial activity and thus suggest APR3 might be a potential novel target for study of treatment of age-related macular degeneration.Li, Y., Zou, X., Gao, J., Cao, K., Feng, Z., Liu, J. APR3 modulates oxidative stress and mitochondrial function in ARPE-19 cells.	[Li, Yuan; Gao, Jing; Cao, Ke; Feng, Zhihui; Liu, Jiankang] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Li, Yuan; Gao, Jing; Cao, Ke; Feng, Zhihui; Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian, Shaanxi, Peoples R China; [Zou, Xuan] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Feng, ZH; Liu, JK (corresponding author), Xi An Jiao Tong Univ, 28 West Xianning Rd, Xian 710049, Shaanxi, Peoples R China.	zhfeng@mail.xjtu.edu.cn; j.liu@mail.xjtu.edu.cn	Liu, Jiankang/A-1610-2011; Zou, Xuan/A-6452-2015; Feng, Zhihui/E-7408-2011	Feng, Zhihui/0000-0002-2448-6565	National Basic Research Program [2015CB553602, 2014CB548200]; National Natural Science Foundation of China [81571050, 31570777, 91439113]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank X. Wang (School of Life Science and Technology, Xi'an Jiaotong University) for his technical support for immunofluorescence staining. This study was supported by the National Basic Research Program (2015CB553602, 2014CB548200) and the National Natural Science Foundation of China (81571050, 31570777, 91439113). The authors declare no conflicts of interest.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Beard KM, 2003, MOL CELL BIOCHEM, V252, P331, DOI 10.1023/A:1025544309616; Bhattacharya S, 2012, INVEST OPHTH VIS SCI, V53, P8350, DOI 10.1167/iovs.12-10495; Botta D, 2008, DRUG METAB REV, V40, P465, DOI [10.1080/03602530802186587, 10.1080/03602530802186587 ]; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Carreno H, 2013, NEUROTOXICOL TERATOL, V40, P35, DOI 10.1016/j.ntt.2013.06.001; Chang YC, 2016, J PHARMACOL SCI, V132, P262, DOI 10.1016/j.jphs.2016.11.002; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; Dickman ED, 1997, DEVELOPMENT, V124, P3111; Feng ZH, 2010, J NUTR BIOCHEM, V21, P1222, DOI 10.1016/j.jnutbio.2009.10.010; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao XQ, 2004, P NATL ACAD SCI USA, V101, P10446, DOI 10.1073/pnas.0403886101; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Han S, 2016, MOL MED REP, V13, P3121, DOI 10.3892/mmr.2016.4926; Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Kokotas H, 2011, CLIN CHEM LAB MED, V49, P601, DOI 10.1515/CCLM.2011.091; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Li X, 2008, FREE RADICAL BIO MED, V44, P1465, DOI 10.1016/j.freeradbiomed.2008.01.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Sachdeva MM, 2014, EXP EYE RES, V119, P111, DOI 10.1016/j.exer.2013.10.024; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; SASTRE J, 1989, LIFE SCI, V45, P183, DOI 10.1016/0024-3205(89)90293-2; SMAALAND R, 1992, BRIT J CANCER, V66, P39, DOI 10.1038/bjc.1992.213; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Taylor H R, 1990, Trans Am Ophthalmol Soc, V88, P163; Tokarz P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060898; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang HB, 2016, MOL VIS, V22, P189; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004; Zhao LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124978; Zhu F, 2000, BIOTECHNIQUES, V29, P310, DOI 10.2144/00292st06; Zou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.190; Zou X, 2011, FEBS LETT, V585, P2410, DOI 10.1016/j.febslet.2011.06.024	47	1	1	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5851	5861		10.1096/fj.201800001RR	http://dx.doi.org/10.1096/fj.201800001RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29792731				2022-12-28	WOS:000447172000008
J	Tiram, G; Ferber, S; Ofek, P; Eldar-Boock, A; Ben-Shushan, D; Yeini, E; Krivitsky, A; Blatt, R; Almog, N; Henkin, J; Amsalem, O; Yavin, E; Cohen, G; Lazarovici, P; Lee, JS; Ruppin, E; Milyavsky, M; Grossman, R; Ram, Z; Calderon, M; Haag, R; Satchi-Fainaro, R				Tiram, Galia; Ferber, Shiran; Ofek, Paula; Eldar-Boock, Anat; Ben-Shushan, Dikla; Yeini, Eilam; Krivitsky, Adva; Blatt, Roni; Almog, Nava; Henkin, Jack; Amsalem, Orit; Yavin, Eylon; Cohen, Gadi; Lazarovici, Philip; Lee, Joo Sang; Ruppin, Eytan; Milyavsky, Michael; Grossman, Rachel; Ram, Zvi; Calderon, Marcelo; Haag, Rainer; Satchi-Fainaro, Ronit			Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma	FASEB JOURNAL			English	Article						angiogenic switch; TSP-1 peptidomimetic; EGFR inhibitiors; nanomedicine; polyglycerol-amine	IN-VIVO; MACROMOLECULAR THERAPEUTICS; PROLONGS SURVIVAL; BETA ACTIVATION; GROWTH; THROMBOSPONDIN-1; BEVACIZUMAB; CANCER; TEMOZOLOMIDE; EGFR	Glioblastoma is an aggressive and invasive brain malignancy with high mortality rates despite current treatment modalities. In this study, we show that a 7-gene signature, previously found to govern the switch of glioblastomas from dormancy to aggressive tumor growth, correlates with improved overall survival of patients with glioblastoma. Using glioblastoma dormancy models, we validated the role of 2 genes from the signature, thrombospondin-1 (TSP-1) and epidermal growth factor receptor (EGFR), as regulators of glioblastoma dormancy and explored their therapeutic potential. EGFR up-regulation was reversed using EGFR small interfering RNA polyplex, antibody, or small-molecule inhibitor. The diminished function of TSP-1 was augmented via a peptidomimetic. The combination of EGFR inhibition and TSP-1 restoration led to enhanced therapeutic efficacy in vitro, in 3-dimensional patient-derived spheroids, and in a subcutaneous human glioblastoma model in vivo. Systemic administration of the combination therapy to mice bearing intracranial murine glioblastoma resulted in marginal therapeutic outcomes, probably due to brain delivery challenges, p53 mutation status, and the aggressive nature of the selected cell line. Nevertheless, this study provides a proof of concept for exploiting regulators of tumor dormancy for glioblastoma therapy. This therapeutic strategy can be exploited for future investigations using a variety of therapeutic entities that manipulate the expression of dormancy-associated genes in glioblastoma as well as in other cancer types.Tiram, G., Ferber, S., Ofek, P., Eldar-Boock, A., Ben-Shushan, D., Yeini, E., Krivitsky, A., Blatt, R., Almog, N., Henkin, J., Amsalem, O., Yavin, E., Cohen, G., Lazarovici, P., Lee, J. S., Ruppin, E., Milyavsky, M., Grossman, R., Ram, Z., Calderon, M., Haag, R., Satchi-Fainaro, R. Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.	[Tiram, Galia; Ferber, Shiran; Ofek, Paula; Eldar-Boock, Anat; Ben-Shushan, Dikla; Yeini, Eilam; Krivitsky, Adva; Blatt, Roni; Ruppin, Eytan; Satchi-Fainaro, Ronit] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Room 607, IL-69978 Tel Aviv, Israel; [Milyavsky, Michael] Tel Aviv Univ, Sackler Fac Med, Dept Pathol, Tel Aviv, Israel; [Almog, Nava] Tufts Univ, Sch Med, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Henkin, Jack] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [Amsalem, Orit; Yavin, Eylon; Cohen, Gadi; Lazarovici, Philip] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med, Jerusalem, Israel; [Lee, Joo Sang; Ruppin, Eytan] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Lee, Joo Sang; Ruppin, Eytan] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Satchi-Fainaro, Ronit] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Grossman, Rachel; Ram, Zvi] Tel Aviv Sourasky Med Ctr, Dept Neurosurg, Tel Aviv, Israel; [Calderon, Marcelo; Haag, Rainer] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tufts University; Northwestern University; Hebrew University of Jerusalem; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Free University of Berlin	Satchi-Fainaro, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Room 607, IL-69978 Tel Aviv, Israel.	ronitsf@tauex.tau.ac.il	Lazarovici, Philip/S-5261-2018; Cohen, Guy/B-1363-2019; Rubin, Limor/GLU-5299-2022; Calderon, Marcelo/A-3594-2013; Satchi-Fainaro, Ronit/F-9137-2011	Lazarovici, Philip/0000-0003-3650-4721; Cohen, Guy/0000-0002-9608-1081; Calderon, Marcelo/0000-0002-2734-9742; Ofek, Paula/0000-0002-8516-1107; Calderon, Marcelo/0000-0002-3108-3852; Satchi-Fainaro, Ronit/0000-0002-7360-7837; Ben-Shushan, Dikla/0000-0002-7576-0149	German-Israel Foundation; Tel Aviv University; Freie Universitat Berlin; European Research Council under the European Union [POLYDORM 617445]; Magneton Program of the Office of the Chief Scientist of the Israel Ministry of Industry, Trade and Labor; Israel Science Foundation [918/14]; Nancy and Peter Brown friends of The Israel Cancer Association (ICA) USA [20150909]; Morris Kahn Foundation; Naomi Foundation; Joseph Sagol President's Ph.D. fellowship for neurosciences studies; Bundesministerium fur Bildung und Forschung (BMBF) within the Biotransporter Project [13N11536]; Collaborative Research Center [(SFB) 765]; Focus Area Nanoscale; BMBF through NanoMatFutur Award [13N12561]	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); Tel Aviv University; Freie Universitat Berlin; European Research Council under the European Union(European Research Council (ERC)); Magneton Program of the Office of the Chief Scientist of the Israel Ministry of Industry, Trade and Labor; Israel Science Foundation(Israel Science Foundation); Nancy and Peter Brown friends of The Israel Cancer Association (ICA) USA; Morris Kahn Foundation; Naomi Foundation; Joseph Sagol President's Ph.D. fellowship for neurosciences studies; Bundesministerium fur Bildung und Forschung (BMBF) within the Biotransporter Project(Federal Ministry of Education & Research (BMBF)); Collaborative Research Center; Focus Area Nanoscale; BMBF through NanoMatFutur Award(Federal Ministry of Education & Research (BMBF))	The authors thank Prof. Itai Benhar (Tel Aviv University), Dr. Moshe Elkabets, and Dr. Limor Cohen (Ben-Gurion University of the Negev, Beersheba, Israel) for insightful advice on antibodies and small molecules targeting EGFR. R.S.-F and R.H. were supported by the German-Israel Foundation. R.S.-F, M.C., and R.H. thank Tel Aviv University and Freie Universitat Berlin for financial support to organize collaborative workshops. The Satchi-Fainaro laboratory (Tel Aviv University) has received partial funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/European Research Council (ERC) Consolidator Grant Agreement POLYDORM 617445; the Magneton Program of the Office of the Chief Scientist of the Israel Ministry of Industry, Trade and Labor, the Israel Science Foundation (918/14); from Nancy and Peter Brown friends of The Israel Cancer Association (ICA) USA, in memory of Kenny and Michael Adler (20150909); and from the Morris Kahn Foundation. P.O. (Tel Aviv University) thanks the Naomi Foundation for the Global Research and Training Fellowship in Medical and Life Sciences. S.F. (Tel Aviv University) was partially funded by the Joseph Sagol President's Ph.D. fellowship for neurosciences studies. R.H. was supported by the Bundesministerium fur Bildung und Forschung (BMBF) within the Biotransporter Project (13N11536) and the Collaborative Research Center (SFB) 765. M.C. was supported by the Focus Area Nanoscale and the BMBF through NanoMatFutur Award 13N12561. The authors declare no conflicts of interest.	Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Amsalem O, 2017, J CONTROL RELEASE, V257, P144, DOI 10.1016/j.jconrel.2016.05.043; Belmadani S, 2007, AM J PATHOL, V171, P777, DOI 10.2353/ajpath.2007.070056; Bilal E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003047; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Campbell N, 2011, MOL CANCER THER, V10, P1876, DOI 10.1158/1535-7163.MCT-11-0402; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Choi SH, 2015, MOL THER, V23, P235, DOI 10.1038/mt.2014.214; Chu LY, 2013, BLOOD, V122, P1822, DOI 10.1182/blood-2013-01-482315; Danhier F, 2015, INT J PHARMACEUT, V481, P154, DOI 10.1016/j.ijpharm.2015.01.051; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Diaz RJ, 2017, J NEURO-ONCOL, V133, P455, DOI 10.1007/s11060-017-2477-x; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Ferber S, 2017, ELIFE, V6, DOI 10.7554/eLife.25281; Fischer W, 2010, BIOCONJUGATE CHEM, V21, P1744, DOI 10.1021/bc900459n; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Groger D, 2013, BIOCONJUGATE CHEM, V24, P1507, DOI 10.1021/bc400047f; Guo NH, 1997, CANCER RES, V57, P1735; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; He S, 2017, DRUG DELIV, V24, P471, DOI 10.1080/10717544.2016.1267821; Hoekstra R, 2005, J CLIN ONCOL, V23, P5188, DOI 10.1200/JCO.2005.05.013; Hsu SC, 1996, CANCER RES, V56, P5684; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Kil WJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-25; Kramer M, 2004, CHEMBIOCHEM, V5, P1081, DOI 10.1002/cbic.200300905; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Minder P, 2015, NEOPLASIA, V17, P634, DOI 10.1016/j.neo.2015.08.002; Nabors LB, 2010, ARCH NEUROL-CHICAGO, V67, P313, DOI 10.1001/archneurol.2010.16; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Ofek P, 2016, NANOMED-NANOTECHNOL, V12, P2201, DOI 10.1016/j.nano.2016.05.016; Ofek P, 2010, FASEB J, V24, P3122, DOI 10.1096/fj.09-149641; Ong BYS, 2009, BIOMATERIALS, V30, P3189, DOI 10.1016/j.biomaterials.2009.02.030; Padfield E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00005; Pallero MA, 2010, J VASC RES, V47, P309, DOI 10.1159/000265565; Resnier P, 2013, INT J PHARMACEUT, V454, P748, DOI 10.1016/j.ijpharm.2013.04.001; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Sahora AI, 2012, J VET INTERN MED, V26, P1169, DOI 10.1111/j.1939-1676.2012.00966.x; Satchi-Fainaro R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044395; Shen G, 2015, CHINESE MED J-PEKING, V128, P2126, DOI 10.4103/0366-6999.161403; Simantov R, 2003, FRONT BIOSCI-LANDMRK, V8, pS874, DOI 10.2741/1168; Sunder A, 2000, CHEM-EUR J, V6, P2499, DOI 10.1002/1521-3765(20000717)6:14<2499::AID-CHEM2499>3.3.CO;2-D; Sunder A, 1999, ANGEW CHEM INT EDIT, V38, P3552, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3552::AID-ANIE3552>3.3.CO;2-7; Therneau TM, 2000, MODELING SURVIVAL DA; Timotheadou Eleni, 2011, Chemother Res Pract, V2011, P878912, DOI 10.1155/2011/878912; Tiram G, 2016, ACS NANO, V10, P2028, DOI 10.1021/acsnano.5b06189; Tiram G, 2014, J BIOMED NANOTECHNOL, V10, P50, DOI 10.1166/jbn.2014.1715; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wenger KJ, 2017, ONCOL LETT, V14, P1141, DOI 10.3892/ol.2017.6251; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; ZABRENETZKY V, 1994, INT J CANCER, V59, P191, DOI 10.1002/ijc.2910590209; Zhang GB, 2013, J NEURO-ONCOL, V113, P251, DOI 10.1007/s11060-013-1102-x; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740	63	11	11	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5835	5850		10.1096/fj.201701568R	http://dx.doi.org/10.1096/fj.201701568R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29856660	Bronze			2022-12-28	WOS:000447172000007
J	Turashvili, G; Lightbody, ED; Tyryshkin, K; SenGupta, SK; Elliott, BE; Madarnas, Y; Ghaffari, A; Day, A; Nicol, CJB				Turashvili, Gulisa; Lightbody, Elizabeth D.; Tyryshkin, Kathrin; SenGupta, Sandip K.; Elliott, Bruce E.; Madarnas, Yolanda; Ghaffari, Abdi; Day, Andrew; Nicol, Christopher J. B.			Novel prognostic and predictive microRNA targets for triple-negative breast cancer	FASEB JOURNAL			English	Article						next-generation sequencing; overall survival; relapse-free survival; treatment response; biomarkers	DOWN-REGULATION; EXPRESSION PROFILES; SORTING NEXIN; SELF-RENEWAL; TUMOR GROWTH; P-CADHERIN; CELL-LINES; METASTASIS; BASAL; PROLIFERATION	Triple-negative breast cancers (TNBCs) account for approximate to 25% of all invasive carcinomas and represent a large subset of aggressive, high-grade tumors. Despite current research focused on understanding the genetic landscape of TNBCs, reliable prognostic and predictive biomarkers remain limited. Although dysregulated microRNAs (miRNAs) have emerged as key players in many cancer types, the role of miRNAs in TNBC disease progression is unclear. We performed miRNA profiling of 51 TNBCs by next-generation sequencing to reveal differentially expressed miRNAs. A total of 228 miRNAs were identified. Three miRNAs (miR-224-5p, miR-375, and miR-205-5p) separated the tumors based on basal status. Six miRNAs (high let-7d-3p, miR-203b-5p, and miR-324-5p; low miR-30a-3p, miR-30a-5p, and miR-199a-5p) were significantly associated with decreased overall survival (OS) and 5 miRNAs (high let-7d-3p; low miR-30a-3p, miR-30a-5p, miR-30c-5p, and miR-128-3p) with decreased relapse-free survival (RFS). On multivariate analysis, high expression of let-7d-3p and low expression of miR-30a were independent predictors of decreased OS and RFS. High expression of miR-95-3p was significantly associated with decreased OS and RFS in patients treated with anthracycline-based chemotherapy. Five miRNAs (let-7d-3p, miR-30a-3p, miR-30c-5p, miR-128-3p, and miR-95-3p) were validated by quantitative RT-PCR. Our findings unveil novel prognostic and predictive miRNA targets for TNBC, including a miRNA signature that predicts patient response to anthracycline-based chemotherapy. This may improve clinical management and/or lead to the development of novel therapies.Turashvili, G., Lightbody, E. D., Tyryshkin, K., SenGupta, S. K., Elliott, B. E., Madarnas, Y., Ghaffari, A., Day, A., Nicol, C. J. B. Novel prognostic and predictive microRNA targets for triple-negative breast cancer.	[Turashvili, Gulisa; SenGupta, Sandip K.; Madarnas, Yolanda; Day, Andrew] Kingston Hlth Sci Ctr, Kingston, ON, Canada; [Turashvili, Gulisa; Lightbody, Elizabeth D.; Tyryshkin, Kathrin; SenGupta, Sandip K.; Elliott, Bruce E.; Ghaffari, Abdi; Nicol, Christopher J. B.] Queens Univ, Dept Pathol & Mol Med, Canc Res Inst, Kingston, ON, Canada; [Lightbody, Elizabeth D.; Elliott, Bruce E.; Nicol, Christopher J. B.] Queens Univ, Div Canc Biol & Genet, Canc Res Inst, Kingston, ON, Canada; [Nicol, Christopher J. B.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Turashvili, Gulisa] Univ Toronto, Dept Pathol, Mt Sinai Hosp, Toronto, ON, Canada	McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Nicol, CJB (corresponding author), Queens Univ, Canc Res Inst, 10 Stuart St,Rm 317, Kingston, ON K7L 3N6, Canada.	nicolc@queensu.ca		Turashvili, Gulisa/0000-0001-6125-5865	Clinical Trainee Cancer Research Development Grant (Department of Oncology, Queen's University); Clinical Trainee Cancer Research Development Grant (Kingston General Hospital Foundation Cancer Research Fund); Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship; Breast Cancer Action Kingston; Kingston General Hospital Foundation; Canadian Breast Cancer Foundation, Ontario Chapter [369649]	Clinical Trainee Cancer Research Development Grant (Department of Oncology, Queen's University); Clinical Trainee Cancer Research Development Grant (Kingston General Hospital Foundation Cancer Research Fund); Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship; Breast Cancer Action Kingston; Kingston General Hospital Foundation; Canadian Breast Cancer Foundation, Ontario Chapter	The authors thank Drs. Xiao (Nick) Zhang, Jennifer Good, and Harriet Feilotter (Department of Pathology and Molecular Medicine Sequencing Core Facility, Queen's University) for their technical expertise and help with the sequencing; Dr. Neil Renwick (Queen's University) for his miRNA expertise and advice during these studies; Dr. Robert Gooding (Queen's University) for his bioinformatic analysis expertise; Queen's Center for Advanced Computing for data storage; Katherine Beaulieu (Queen's University) for her help in analyzing the sequencing data; and Dr. Stanley K. Liu (Sunnybrook Health Sciences Center, Toronto, ON, Canada) for generously providing the miR-95 overexpressing TNBC cell line for validation analysis. Funding for these studies was generously provided by the Clinical Trainee Cancer Research Development Grant (Department of Oncology, Queen's University, and Kingston General Hospital Foundation Cancer Research Fund; to G.T.); Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship (to E.D.L.); Breast Cancer Action Kingston and Kingston General Hospital Foundation (to C.J.B.N. and S.K.S.); and Canadian Breast Cancer Foundation, Ontario Chapter 369649 (to C.J.B.N.). The authors declare no conflicts of interest.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Bahrami A, 2018, J CELL PHYSIOL, V233, P774, DOI 10.1002/jcp.25813; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Barh D, 2010, CURR ONCOL, V17, P70; Bockhorn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2393; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cascione L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055910; Chang JTH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168284; Chang YY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0301-9; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Chen XC, 2014, BIOMED PHARMACOTHER, V68, P589, DOI 10.1016/j.biopha.2014.04.008; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; D'Ippolito E, 2013, INT J MOL SCI, V14, P22202, DOI 10.3390/ijms141122202; den Hollander P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00250; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Fan B, 2015, INT J ONCOL, V47, P1025, DOI 10.3892/ijo.2015.3080; Fang Y, 2014, BRAZ J MED BIOL RES, V47, P60, DOI 10.1590/1414-431X20133324; Geyer FC, 2017, AM J PATHOL, V187, P2139, DOI 10.1016/j.ajpath.2017.03.016; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Huang XY, 2013, CANCER RES, V73, P6972, DOI 10.1158/0008-5472.CAN-13-1657; Huang ZH, 2011, CANCER RES, V71, P2582, DOI 10.1158/0008-5472.CAN-10-3032; Hwang SJ, 2015, ONCOTARGET, V6, P20434, DOI 10.18632/oncotarget.3886; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krishnan P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1899-0; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Li L, 2017, CANCER LETT, V400, P89, DOI 10.1016/j.canlet.2017.04.034; Li WT, 2016, INT J ONCOL, V48, P1155, DOI 10.3892/ijo.2016.3319; Liu Y, 2015, BREAST CANCER RES TR, V152, P183, DOI 10.1007/s10549-015-3460-x; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Massihnia D, 2016, ONCOTARGET, V7, P60712, DOI 10.18632/oncotarget.10858; Mathe A, 2015, INT J MOL SCI, V16, P28347, DOI 10.3390/ijms161226090; Matos I, 2005, VIRCHOWS ARCH, V447, P688, DOI 10.1007/s00428-005-0010-7; Mehrpour M, 2010, CANCER LETT, V290, P1, DOI 10.1016/j.canlet.2009.07.009; Nassar FJ, 2017, PHARMACOL THERAPEUT, V172, P34, DOI 10.1016/j.pharmthera.2016.11.012; O'Bryan S, 2017, EUR J CANCER, V72, P1, DOI 10.1016/j.ejca.2016.11.004; Perez-Rivas LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091884; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Ren RH, 2017, ONCOTARGET, V8, P70982, DOI 10.18632/oncotarget.20237; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stewart DA, 2016, J PROTEOME RES, V15, P3225, DOI 10.1021/acs.jproteome.6b00430; Svoboda M, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-31; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tanic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038847; Thakur S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158946; Toyama T, 2012, JPN J CLIN ONCOL, V42, P256, DOI 10.1093/jjco/hys001; Turashvili G, 2011, MODERN PATHOL, V24, P64, DOI 10.1038/modpathol.2010.189; Vickers MM, 2012, CLIN EXP METASTAS, V29, P123, DOI 10.1007/s10585-011-9435-3; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang XD, 2012, EUR J CANCER, V48, P1227, DOI 10.1016/j.ejca.2011.10.001; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Wong-Brown MW, 2015, BREAST CANCER RES TR, V150, P71, DOI 10.1007/s10549-015-3293-7; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoshida GJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0221-y; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeng RC, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0477-z; Zhang N, 2014, ONCOGENE, V33, P3119, DOI 10.1038/onc.2013.286; Zhang YQ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0135851, 10.1080/15592324.2015.1035851]; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Zhao Yulei, 2018, Mol Cancer Res, V16, P1046, DOI 10.1158/1541-7786.MCR-17-0593; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064; Zhu YH, 2011, CLIN CANCER RES, V17, P7105, DOI 10.1158/1078-0432.CCR-11-0071	85	36	35	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5937	5954		10.1096/fj.201800120R	http://dx.doi.org/10.1096/fj.201800120R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29812973	Bronze			2022-12-28	WOS:000447172000015
J	Xu, D; Luo, HWW; Hu, W; Hu, SWW; Yuan, C; Wang, GHH; Zhang, L; Yu, H; Magdalou, J; Chen, LBB; Wang, H				Xu, Dan; Luo, Hanwen W.; Hu, Wen; Hu, Shuwei W.; Yuan, Chao; Wang, Guihua H.; Zhang, Li; Yu, Hong; Magdalou, Jacques; Chen, Liaobin B.; Wang, Hui			Intrauterine programming mechanism for hypercholesterolemia in prenatal caffeine-exposed female adult rat offspring	FASEB JOURNAL			English	Article						glucocorticoids; cholesterol; epigenetic; HMGCR; C/EBP alpha	DENSITY-LIPOPROTEIN CHOLESTEROL; THRIFTY PHENOTYPE HYPOTHESIS; CARDIOVASCULAR RISK-FACTORS; METABOLIC SYNDROME; GROWTH RESTRICTION; DNA METHYLATION; EPIGENETIC MODIFICATION; PROTEIN RESTRICTION; GENE-EXPRESSION; FETAL	Clinical and animal studies have indicated that hypercholesterolemia and its associated diseases have intrauterine developmental origins. Our previous studies showed that prenatal caffeine exposure (PCE) led to fetal overexposure to maternal glucocorticoids (GCs) and increased serum total cholesterol levels in adult rat offspring. This study further confirms the intrauterine programming of PCE-induced hypercholesterolemia in female adult rat offspring. Pregnant Wistar rats were intragastrically administered caffeine (30, 60, and 120 mg/kg/d) from gestational day (GD)9 to 20. Female rat offspring were euthanized at GD20 and postnatal wk 12; several adult rat offspring were additionally subjected to ice-water swimming stimulation to induce chronic stress prior to death. The effects of GCs on cholesterol metabolism and epigenetic regulation were verified using the L02 cell line. The results showed that PCE induced hypercholesterolemia in adult offspring, which manifested as significantly higher levels of serum total cholesterol and LDL cholesterol (LDL-C) as well as higher ratios of LDL-C/HDL cholesterol. We further found that the cholesterol levels were increased in fetal livers but were decreased in fetal blood, accompanied by increased maternal blood cholesterol levels and reduced placental cholesterol transport. Furthermore, analysis of PCE offspring in the uterus and in a postnatal basal/chronic stress state and the results of in vitro experiments showed that hepatic cholesterol metabolism underwent GC-dependent changes and was associated with cholesterol synthase via abnormalities in 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) histone acetylation. We concluded that, to compensate for intrauterine placentally derived decreases in fetal blood cholesterol levels, high intrauterine GC levels activated fetal hepatic CCAAT enhancer binding protein signaling and down-regulated Sirtuin1 expression, which mediated the high levels of histone acetylation (via H3K9ac and H3K14ac) and expression of HMGCR. This GC-dependent cholesterol metabolism programming effect was sustained through adulthood, leading to the occurrence of hypercholesterolemia.Xu, D., Luo, H. W., Hu, W., Hu, S. W., Yuan, C., Wang, G. H., Zhang, L., Yu, H., Magdalou, J., Chen, L. B., Wang, H. Intrauterine programming mechanism for hypercholesterolemia in prenatal caffeine-exposed female adult rat offspring.	[Xu, Dan; Luo, Hanwen W.; Hu, Wen; Hu, Shuwei W.; Yuan, Chao; Wang, Guihua H.; Zhang, Li; Wang, Hui] Wuhan Univ, Zhongnan Hosp, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China; [Xu, Dan; Yu, Hong; Chen, Liaobin B.; Wang, Hui] Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, Wuhan, Hubei, Peoples R China; [Luo, Hanwen W.; Chen, Liaobin B.] Hubei Prov Key Lab Developmentally Originated Dis, Wuhan, Hubei, Peoples R China; [Magdalou, Jacques] Univ Lorraine, UMR 7365, CNRS, Fac Med, Vandoeuvre Les Nancy, France	Wuhan University; Wuhan University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine	Chen, LBB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthopaed Surg, Wuhan 430071, Hubei, Peoples R China.; Wang, H (corresponding author), Wuhan Univ, Basic Med Sch, Dept Pharmacol, 185 East Lake Rd, Wuhan 430071, Hubei, Peoples R China.	lbchen@whu.edu.cn; wanghui19@whu.edu.cn			National Key Research and Development Program of China [2017YFC1001300]; National Natural Science Foundation of China [81430089, 81673524, 81671472]; Hubei Province Health and Family Planning Scientific Research Project [WJ2017C0003]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Health and Family Planning Scientific Research Project	This work was supported by National Key Research and Development Program of China Grant 2017YFC1001300; National Natural Science Foundation of China Grants 81430089, 81673524, and 81671472; and Hubei Province Health and Family Planning Scientific Research Project Grant WJ2017C0003. The authors declare no conflicts of interest.	Alworth LC, 2002, TOXICOL APPL PHARM, V183, P10, DOI 10.1006/taap.2002.9459; Ao Y, 2015, TOXICOL APPL PHARM, V287, P128, DOI 10.1016/j.taap.2015.05.007; Ayaori M, 2006, ARTERIOSCL THROM VAS, V26, P163, DOI 10.1161/01.ATV.0000193513.29074.52; Azadbakht L, 2014, NUTRITION, V30, P150, DOI [10.1016/j.nut.2013.06.005, 10.]; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Baumann M, 2013, PLACENTA, V34, P1079, DOI 10.1016/j.placenta.2013.06.309; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Cabrero A, 2005, MOL CELL BIOCHEM, V275, P173, DOI 10.1007/s11010-005-1353-8; Chorostowska-Wynimko J, 2004, INT J TISSUE REACT, V26, P53; Cong RH, 2012, J NUTR BIOCHEM, V23, P1647, DOI 10.1016/j.jnutbio.2011.11.007; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Duan YJ, 2014, COMP BIOCHEM PHYS A, V176, P59, DOI 10.1016/j.cbpa.2014.07.010; Efstathiou SP, 2012, CIRCULATION, V125, P902, DOI 10.1161/CIRCULATIONAHA.111.034546; Feng YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154758; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2005, EARLY HUM DEV, V81, P723, DOI 10.1016/j.earlhumdev.2005.06.007; Gale CR, 2001, J CLIN ENDOCR METAB, V86, P267, DOI 10.1210/jc.86.1.267; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Ho SM, 2007, REPROD TOXICOL, V23, P267, DOI 10.1016/j.reprotox.2007.01.004; Huang J, 2012, CLIN EXP PHARMACOL P, V39, P357, DOI 10.1111/j.1440-1681.2012.05676.x; Huang YF, 2015, CLIN ENDOCRINOL, V83, P78, DOI 10.1111/cen.12663; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kanaoka Tsuyoshi, 2012, Ann Vasc Dis, V5, P36, DOI 10.3400/avd.oa.11.00068; Kaufmann PA, 2000, J AM COLL CARDIOL, V36, P103, DOI 10.1016/S0735-1097(00)00697-5; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Lejskova M, 2012, PHYSIOL RES, V61, P587, DOI 10.33549/physiolres.932313; Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Liu J, 2006, AM J CARDIOL, V98, P1363, DOI 10.1016/j.amjcard.2006.06.032; Liu XM, 2014, J CLIN BIOCHEM NUTR, V55, P40, DOI 10.3164/jcbn.13-100; Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Luo HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17746; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Ono K, 2012, J CARDIOL, V60, P339, DOI 10.1016/j.jjcc.2012.07.014; Pecks U, 2012, J PERINAT MED, V40, P287, DOI [10.1515/jpm.2011.135, 10.1515/JPM.2011.135]; Pecks U, 2012, HYPERTENS PREGNANCY, V31, P156, DOI 10.3109/10641955.2010.544805; Sohi G, 2011, SEMIN REPROD MED, V29, P246, DOI 10.1055/s-0031-1275523; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Szostak-Wegierek Dorota, 2011, Med Wieku Rozwoj, V15, P203; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Trapani L, 2012, WORLD J HEPATOL, V4, P184, DOI 10.4254/wjh.v4.i6.184; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; Wadsack C, 2007, AM J PHYSIOL-ENDOC M, V292, pE476, DOI 10.1152/ajpendo.00547.2005; Wang LL, 2014, TOXICOL LETT, V224, P311, DOI 10.1016/j.toxlet.2013.11.006; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007; Xia LP, 2014, TOXICOL LETT, V226, P98, DOI 10.1016/j.toxlet.2014.01.023; Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016; Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497; Zhang HT, 2007, MOL PHARMACOL, V71, P1319, DOI 10.1124/mol.106.032011; Zheng Rui-Dan, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P543; Zhou D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165224	62	13	13	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5563	5576		10.1096/fj.201701557R	http://dx.doi.org/10.1096/fj.201701557R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718709	Bronze			2022-12-28	WOS:000447972500030
J	Fang, QQ; Wang, XF; Zhao, WY; Chen, CY; Zhang, MX; Shi, BH; Zhang, LY; Tan, WQ				Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Chen, Chun-Ye; Zhang, Min-Xia; Shi, Bang-Hui; Zhang, Li-Yun; Tan, Wei-Qiang			The source of ACE during scar formation is from both bone marrow and skin tissue	FASEB JOURNAL			English	Article						Wound healing; TGF-1; TNF-; fibrosis; transgenic mouse	ANGIOTENSIN-CONVERTING ENZYME; WOUND-HEALING DEFECT; TGF-BETA; BLOOD-PRESSURE; MICE; FIBROSIS; HYPERTENSION; SYSTEM; INHIBITION	Angiotensin-converting enzyme (ACE) has been found in the pathogenesis of various fibrosis diseases, and ACE inhibitor (ACEI) may affect wound healing and cutaneous fibrosis. However, there is no scientific evidence as to where the ACE is produced during scar formation. Whether it is from the cutaneous tissue or the bone marrow, or both remains unknown. In this study, we investigated the source of ACE using bone marrow transplantation in genetically modified mice, analyzed the inflammatory milieu and some growth factors in the middle of the wound healing period (4 d after the wound was induced). After having deleted the ACE from bone marrow or skin tissue, the wound/scar width in the low-ACE groups were narrower than those in wild-type (WT) controls. Loosely arranged collagen deposition and reduced vessel density were also detected in ACE-deficient mice. Lower ACE levels during scar formation were also accompanied by lower levels of TGF-1. In the middle of the wound healing period, ACE levels affected the inflammatory cells significantly. In the mice with a deficiency in ACE, the expression of TGF-1 and TNF- decreased, but not that of IL-4. Our findings indicate that both bone marrow and skin tissue release ACE during scar formation. Deleting either of them can affect the inflammatory cells and growth factors and reduce the expression of TGF-1, resulting in a decreased level of scarring.Fang, Q.-Q., Wang, X.-F., Zhao, W.-Y., Chen, C.-Y., Zhang, M.-X., Shi, B.-H., Zhang, L.-Y., Tan, W.-Q. The source of ACE during scar formation is from both bone marrow and skin tissue.	[Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Zhang, Li-Yun; Tan, Wei-Qiang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Plast Surg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Tan, Wei-Qiang] Zhejiang Univ, Sch Med, Affiliated Sir Run Run Shaw Hosp, Dept Plast Surg, Hangzhou, Zhejiang, Peoples R China; [Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Chen, Chun-Ye; Zhang, Min-Xia; Shi, Bang-Hui; Zhang, Li-Yun; Tan, Wei-Qiang] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Plast Surg, Yiwu, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Tan, WQ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Plast Surg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	tanweixxxx@zju.edu.cn	Tan, Wei-Qiang/GYI-8422-2022; fang, qingqing/GZK-4330-2022	Tan, Wei-Qiang/0000-0001-5610-2418; Zhao, Wanyi/0000-0001-9604-4005	National Natural Science Foundation of China [81671918, 81372072]; National Key Research Program of China [2016YFC1101004]; Zhejiang Provincial Science and Technology Project of China [2016C33134]; Zhejiang Provincial Medical and Healthy Science Foundation of China [2018KY874]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research Program of China; Zhejiang Provincial Science and Technology Project of China; Zhejiang Provincial Medical and Healthy Science Foundation of China	The authors thank Dr. Kenneth E. Bernstein (Director of Experimental Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, USA) for providing laboratory facilities; Y.-Y. Hu (Zhejiang University) for helping design Figs. 1 and 7; and B. Zheng (Zhejiang University) for helping analyze the pathology shown in Fig. 1. This study was supported by the National Natural Science Foundation of China (81671918 to Q.-Q.F., C.-Y.C., M.-X.Z., L.-Y.Z., W.-Q.T., and 81372072 to L.-Y.Z., W.-Q.T.), the National Key Research Program of China (2016YFC1101004 to W.-Q.T.), Zhejiang Provincial Science and Technology Project of China (2016C33134 to W.-Q.T.), and Zhejiang Provincial Medical and Healthy Science Foundation of China (2018KY874 to W.-Q.T.). The authors declare no conflicts of interest.	Abbas G, 2011, AM J THER, V18, pE202, DOI 10.1097/MJT.0b013e3181df8df5; Bernstein KE, 2014, CURR OPIN NEPHROL HY, V23, P106, DOI 10.1097/01.mnh.0000441047.13912.56; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Brilla CG, 2003, HERZ, V28, P744, DOI 10.1007/s00059-003-2524-6; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Cogliati B, 2015, J DERMATOL SCI, V79, P50, DOI 10.1016/j.jdermsci.2015.03.019; Cole J, 2002, CIRC RES, V90, P87, DOI 10.1161/hh0102.102360; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Esther CR, 1996, LAB INVEST, V74, P953; FALKENHAHN M, 1995, HYPERTENSION, V25, P219, DOI 10.1161/01.HYP.25.2.219; Gaddam Ravinder Reddy, 2014, Inflammation & Allergy Drug Targets, V13, P224; Galeano M, 2008, WOUND REPAIR REGEN, V16, P208, DOI 10.1111/j.1524-475X.2008.00361.x; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Iannello Silvai, 2006, MedGenMed, V8, P60; Ikushima H, 2011, CURR PHARM BIOTECHNO, V12, P2099, DOI 10.2174/138920111798808419; Kolesnyk I, 2010, NETH J MED, V68, P15; Krum H, 2007, J HYPERTENS, V25, P25, DOI 10.1097/HJH.0b013e3280113950; Morihara K, 2006, J AM ACAD DERMATOL, V54, P251, DOI 10.1016/j.jaad.2005.09.027; Myerson SG, 2001, CIRCULATION, V103, P226; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; NG KKF, 1967, NATURE, V216, P762, DOI 10.1038/216762a0; Nystrom A, 2013, J CLIN INVEST, V123, P3498, DOI 10.1172/JCI68127; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Re R, 2007, AM J PHYSIOL-HEART C, V293, pH905, DOI 10.1152/ajpheart.00552.2007; Sharifi AM, 2005, PHARMACOL RES, V52, P438, DOI 10.1016/j.phrs.2005.07.004; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Sindrilaru A, 2009, BLOOD, V113, P5266, DOI 10.1182/blood-2008-07-166702; Skipworth JRA, 2011, ALIMENT PHARM THER, V34, P840, DOI 10.1111/j.1365-2036.2011.04810.x; Tan WSD, 2018, CURR OPIN PHARMACOL, V40, P9, DOI 10.1016/j.coph.2017.12.002; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Thomas JR, 2012, ARCH FACIAL PLAST S, V14, P162, DOI 10.1001/archfacial.2012.223; Uzun H, 2013, PLAST RECONSTR SURG, V132, p361E, DOI 10.1097/PRS.0b013e31829acf0a; Verrecchia F, 2004, CELL SIGNAL, V16, P873, DOI 10.1016/j.cellsig.2004.02.007; Wang YW, 2014, J INVEST DERMATOL, V134, P2016, DOI 10.1038/jid.2014.84; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618	38	7	8	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5199	5208		10.1096/fj.201701575RRR	http://dx.doi.org/10.1096/fj.201701575RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29750573	Bronze			2022-12-28	WOS:000443817700046
J	Sioud, M; Westby, P; Vasovic, V; Floisand, Y; Peng, Q				Sioud, Mouldy; Westby, Phuong; Vasovic, Vlada; Floisand, Yngvar; Peng, Qian			Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies	FASEB JOURNAL			English	Article						immunotherapy; targeted therapy; phage display; immune effector cells	IMMUNE-CHECKPOINT BLOCKADE; CANCER-THERAPY; RITUXIMAB; CELLS; DIFFERENTIATION; EXPRESSION; CHALLENGES; STRATEGIES; LYMPHOMA; PROTEINS	mAbs have emerged as a promising strategy for the treatment of cancer. However, in several malignancies, no effective antitumor mAbs are yet available. Identifying therapeutic mAbs that recognize common tumor antigens could render the treatment widely applicable. Here, a human single-chain variable fragment (scFv) antibody library was sequentially affinity selected against a panel of human cancer cell lines and an antibody fragment (named MS5) that bound to solid and blood cancer cells was identified. The MS5 scFv was fused to the human IgG1 Fc domain to generate an antibody (MS5-Fc fusion) that induced antibody-dependent cellular cytotoxicity and phagocytosis of cancer cells by macrophages. In addition, the MS5-Fc antibody bound to primary leukemia cells and induced antibody-dependent cellular cytotoxicity. In the majority of analyzed cancer cells, the MS5-Fc antibody induced cell surface redistribution of the receptor complexes, but not internalization, thus maximizing the accessibility of the IgG1 Fc domain to immune effector cells. In vitro stability studies showed that the MS5-Fc antibody was stable after 6 d of incubation in human serum, retaining approximate to 60% of its initial intact form. After intravenous injections, the antibody localized into tumor tissues and inhibited the growth of 3 different human tumor xenografts (breast, lymphoma, and leukemia). These antitumor effects were associated with tumor infiltration by macrophages and NK cells. In the Ramos B-cell lymphoma xenograft model, the MS5-Fc antibody exhibited a comparable antitumor effect as rituximab, a chimeric anti-CD20 IgG1 mAb. These results indicate that human antibodies with pan-cancer abilities can be generated from phage display libraries, and that the engineered MS5-Fc antibody could be an attractive agent for further clinical investigation.Sioud, M., Westby, P., Vasovic, V., FlOisand, Y., Peng, Q. Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies.	[Sioud, Mouldy; Westby, Phuong] Univ Hosp, Radiumhosp, Rikshosp, Dept Canc Immunol, Oslo, Norway; [Vasovic, Vlada; Peng, Qian] Univ Hosp, Radiumhosp, Rikshosp, Dept Pathol, Oslo, Norway; [Floisand, Yngvar] Univ Hosp, Radiumhosp, Rikshosp, Dept Hematol, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Sioud, M (corresponding author), Oslo Univ Hosp, N-0340 Oslo, Norway.	mouldy.sioud@rr-research.no		Vasovic, Vlada/0000-0001-8985-1992	Norwegian Cancer Society [182593]	Norwegian Cancer Society(Norwegian Cancer Society)	The authors thank the excellent technical assistance from Anne Mobergslien (Department of Cancer Immunology, Oslo University Hospital). They also thank Linn A. Rosenberg (Department of Cancer Immunology, Oslo University Hospital) for helping with the preparation of recombinant proteins, Ingrid Kjonstad (Department of Cancer Immunology, Oslo University Hospital) for analyzing the antibody stability, Dr. Morten Oksvold (Department of Pathology, Oslo University Hospital) for assisting with the confocal microscopic images, Dr. Hans-Petter Hersleth (Department of Biosciences, Oslo University) for assisting with size-exclusion chromatography analysis, and Dr. Anne Dybwad (Norwegian Medicines Agency, Oslo, Norway) for critical reading of the manuscript. This work was funded by the Norwegian Cancer Society (Grant 182593) awarded to M.S. The authors declare no conflicts of interest.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anthony D, 2014, FASEB J, V28, P3867, DOI 10.1096/fj.14-250332; BATOR JM, 1989, J IMMUNOL METHODS, V125, P167, DOI 10.1016/0022-1759(89)90090-2; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; Broussas Matthieu, 2013, Methods Mol Biol, V988, P305, DOI 10.1007/978-1-62703-327-5_19; Cohnen A, 2013, BLOOD, V122, P1411, DOI 10.1182/blood-2012-07-441832; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; Frenzel A, 2016, MABS-AUSTIN, V8, P1177, DOI 10.1080/19420862.2016.1212149; Glassman Patrick M., 2014, Cancer Biology Medicine, V11, P20, DOI 10.7497/j.issn.2095-3941.2014.01.002; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Hatjiharissi E, 2007, BLOOD, V110, P2561, DOI 10.1182/blood-2007-01-070656; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; Hourigan CS, 2013, NAT REV CLIN ONCOL, V10, P460, DOI 10.1038/nrclinonc.2013.100; Inoue Y, 2017, CANCER SCI, V108, P455, DOI 10.1111/cas.13162; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mhyre AJ, 2009, BLOOD, V113, P649, DOI 10.1182/blood-2008-04-152686; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Musto P, 2011, EXPERT OPIN BIOL TH, V11, P551, DOI 10.1517/14712598.2011.567262; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Parslow AC, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030014; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roberts CJ, 2011, INT J PHARMACEUT, V418, P318, DOI 10.1016/j.ijpharm.2011.03.064; Said JW, 2013, MODERN PATHOL, V26, pS42, DOI 10.1038/modpathol.2012.178; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sioud M, 2007, EUR J IMMUNOL, V37, P2834, DOI 10.1002/eji.200737112; Sioud M, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12643; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Tsirigotis P, 2016, ANN MED, V48, P428, DOI 10.1080/07853890.2016.1186827; Unverdorben F, 2016, MABS-AUSTIN, V8, P120, DOI 10.1080/19420862.2015.1113360	41	5	5	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5063	5077		10.1096/fj.201701544R	http://dx.doi.org/10.1096/fj.201701544R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913558				2022-12-28	WOS:000443817700036
J	Martinez-Calle, M; Olmeda, B; Dietl, P; Frick, M; Perez-Gil, J				Martinez-Calle, Marta; Olmeda, Barbara; Dietl, Paul; Frick, Manfred; Perez-Gil, Jesus			Pulmonary surfactant protein SP-B promotes exocytosis of lamellar bodies in alveolar type II cells	FASEB JOURNAL			English	Article						surface tension; purinergic signaling; P2Y(2); calcium; lung surfactant	LUNG EPITHELIAL-CELLS; AIR-LIQUID INTERFACE; IN-VITRO CONVERSION; SP-C; RESONANCE SPECTROSCOPY; PURINERGIC RECEPTORS; EXTRACELLULAR ATP; SECRETION; MEMBRANES; RELEASE	The release of pulmonary surfactant by alveolar type II (ATII) cells is essential for lowering surface tension at the respiratory air-liquid interface, stabilizing the lungs against physical forces tending to alveolar collapse. Hydrophobic surfactant protein (SP)-B ensures the proper packing of newly synthesized surfactant particles, promotes the formation of the surface active film at the alveolar air-liquid interface and maintains its proper structure along the respiratory dynamics. We report that membrane-associated SP-B efficiently induces secretion of pulmonary surfactant by ATII cells, at the same level as potent secretagogues such as ATP. The presence in the extracellular medium of lipid-protein complexes containing SP-B activates the P2Y(2) purinergic signaling pathway that ultimately triggers exocytosis of lamellar bodies by ATII cells. Our data suggest that SP-B prompts Ca2+-dependent surfactant secretion via ATP release from ATII cells. This result implies that SP-B is not only an essential component for the biophysical function of surfactant but is also a central element in the alveolar homeostasis by eliciting autocrine and paracrine cell stimulation.Martinez-Calle, M., Olmeda, B., Dietl, P., Frick, M., Perez-Gil, J. Pulmonary surfactant protein SP-B promotes exocytosis of lamellar bodies in alveolar type II cells.	[Martinez-Calle, Marta; Olmeda, Barbara; Perez-Gil, Jesus] Univ Complutense Madrid, Dept Biochem & Mol Biol, Fac Biol, Madrid, Spain; [Martinez-Calle, Marta; Olmeda, Barbara; Perez-Gil, Jesus] Univ Complutense Madrid, Res Inst, Hosp 12 Octubre, Madrid, Spain; [Dietl, Paul; Frick, Manfred] Ulm Univ, Inst Gen Physiol, Ulm, Germany	Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Ulm University	Perez-Gil, J (corresponding author), Univ Complutense, Dept Bioquim, Fac Biol, Jose Antonio Novais 12, E-28040 Madrid, Spain.	jperezgil@bio.ucm.es	Olmeda, Bárbara/H-1440-2015; Calle, Marta Martínez/H-1451-2015; Frick, Manfred/E-1374-2012; Perez-Gil, Jesus/H-3102-2019	Olmeda, Bárbara/0000-0001-6004-1603; Calle, Marta Martínez/0000-0003-1198-2532; Frick, Manfred/0000-0002-4763-1104; Perez-Gil, Jesus/0000-0003-3587-7147	Spanish Ministry of Economy and Competitiveness [BIO2012-30733, BIO2015-67930-R, EEBB-I-2015-10363]; Regional Government of Madrid [P2013/MIT-2807]; Deutsche Forschungsgemeinschaft (DFG) [DI1402/3-1]; Ministry of Science, Research, and the Arts of Baden-Wurttemberg [Az: 32-7533.-6-10/15/5]; DFG [SFB 1149/1, A05]; Formacion de Personal Investigador (FPI) Fellowship from the Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government); Regional Government of Madrid; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Science, Research, and the Arts of Baden-Wurttemberg; DFG(German Research Foundation (DFG)); Formacion de Personal Investigador (FPI) Fellowship from the Spanish Ministry of Economy and Competitiveness	This work was funded by grants from the Spanish Ministry of Economy and Competitiveness (BIO2012-30733, BIO2015-67930-R), the Regional Government of Madrid (P2013/MIT-2807), Deutsche Forschungsgemeinschaft (DFG) Grant DI1402/3-1 (to P.D.), and by grants from the Ministry of Science, Research, and the Arts of Baden-Wurttemberg (Az: 32-7533.-6-10/15/5) and DFG (SFB 1149/1, A05 (to M.F.). M.M.-C. is a recipient of a Formacion de Personal Investigador (FPI) Fellowship from the Spanish Ministry of Economy and Competitiveness. This work was also supported by a short-term stay funded by Spanish Ministry of Economy and Competitiveness (EEBB-I-2015-10363). The authors declare no conflicts of interest.	Ashino Y, 2000, AM J PHYSIOL-LUNG C, V279, pL5, DOI 10.1152/ajplung.2000.279.1.L5; BERNARDINO DLS, 2013, FARADAY DISCUSS, V161, P535; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cabre EJ, 2012, BBA-BIOMEMBRANES, V1818, P1717, DOI 10.1016/j.bbamem.2012.03.008; Cabre EJ, 2009, BIOPHYS J, V97, P768, DOI 10.1016/j.bpj.2009.04.057; Cruz A, 1998, BIOCHEMISTRY-US, V37, P9488, DOI 10.1021/bi971558v; Cruz A, 2000, EUR BIOPHYS J BIOPHY, V29, P204, DOI 10.1007/PL00006647; Dietl P, 2012, CELL CALCIUM, V52, P296, DOI 10.1016/j.ceca.2012.04.010; DOBBS LG, 1987, P NATL ACAD SCI USA, V84, P1010, DOI 10.1073/pnas.84.4.1010; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Fois G, 2018, J GEN PHYSIOL, V150, P277, DOI 10.1085/jgp.201711870; Frick M, 2004, AM J PHYSIOL-LUNG C, V286, pL210, DOI 10.1152/ajplung.00332.2003; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Gunther A, 1999, AM J RESP CRIT CARE, V159, P244; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 2004, AM J PHYSIOL-LUNG C, V286, pL1009, DOI 10.1152/ajplung.00342.2003; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Hobi N, 2016, BBA-MOL CELL RES, V1863, P2124, DOI 10.1016/j.bbamcr.2016.04.028; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; Lu D, 2012, FASEB J, V26, P2580, DOI 10.1096/fj.12-204677; Miklavc P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00171; Miklavc P, 2009, BIOCHEM J, V424, P7, DOI 10.1042/BJ20091094; MORROW MR, 1993, BIOCHEMISTRY-US, V32, P4397, DOI 10.1021/bi00067a032; NICHOLAS TE, 1982, RESP PHYSIOL, V49, P315, DOI 10.1016/0034-5687(82)90119-0; Olmeda B, 2017, ANN ANAT, V209, P78, DOI 10.1016/j.aanat.2016.09.008; Olmeda B, 2015, FASEB J, V29, P4236, DOI 10.1096/fj.15-273458; Olmeda B, 2010, BBA-BIOMEMBRANES, V1798, P1281, DOI 10.1016/j.bbamem.2010.03.008; Parra E, 2015, CHEM PHYS LIPIDS, V185, P153, DOI 10.1016/j.chemphyslip.2014.09.002; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; PEREZGIL J, 1993, BIOCHIM BIOPHYS ACTA, V1168, P261, DOI 10.1016/0005-2760(93)90181-8; PEREZGIL J, 1995, BIOCHEMISTRY-US, V34, P3964, DOI 10.1021/bi00012a014; Putman E, 1996, BIOCHEM J, V320, P599, DOI 10.1042/bj3200599; Ramsingh R, 2011, AM J PHYSIOL-LUNG C, V300, pL587, DOI 10.1152/ajplung.00345.2010; Ravasio A, 2011, AM J PHYSIOL-CELL PH, V300, pC1456, DOI 10.1152/ajpcell.00427.2010; RICE WR, 1987, J APPL PHYSIOL, V63, P692, DOI 10.1152/jappl.1987.63.2.692; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Ryan MA, 2005, BIOCHEMISTRY-US, V44, P861, DOI 10.1021/bi0485575; Sarker M, 2011, BIOCHEMISTRY-US, V50, P4867, DOI 10.1021/bi200167d; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schurch D, 2010, BIOPHYS J, V99, P3290, DOI 10.1016/j.bpj.2010.09.039; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; STRAYER DS, 1993, J BIOL CHEM, V268, P18679; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Taneva SG, 2000, BIOPHYS J, V79, P2010, DOI 10.1016/S0006-3495(00)76449-6; UEDA T, 1994, AM J RESP CRIT CARE, V149, P1254, DOI 10.1164/ajrccm.149.5.8173767; VANDENBUSSCHE G, 1992, BIOCHEMISTRY-US, V31, P9169, DOI 10.1021/bi00153a008; Velasquez S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00096; VELDHUIZEN RAW, 1993, BIOCHEM J, V295, P141, DOI 10.1042/bj2950141; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; White MK, 2000, EXP CELL RES, V255, P67, DOI 10.1006/excr.1999.4764; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861	53	20	22	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4600	4611		10.1096/fj.201701462RR	http://dx.doi.org/10.1096/fj.201701462RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29543530				2022-12-28	WOS:000439325400044
J	Zhuang, SY; Hua, XW; He, K; Zhou, T; Zhang, J; Wu, HY; Ma, X; Xia, Q; Zhang, JJ				Zhuang, Shaoyong; Hua, Xiangwei; He, Kang; Zhou, Tao; Zhang, Jiang; Wu, Haoyu; Ma, Xiong; Xia, Qiang; Zhang, Jianjun			Inhibition of GSK-3 induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis	FASEB JOURNAL			English	Article						cholestatic liver disease; glycogen synthase kinase-3; bile duct ligation; hepatic progenitor cell	HEPATIC PROGENITOR CELLS; NF-KAPPA-B; BILIARY ATRESIA; ACTIVATION; AP-1; PATHWAY; DISEASE; TRANSPLANTATION; TRANSCRIPTION; TRANSITION	The contribution of glycogen synthase kinase-3 (GSK-3) to cholestatic liver disease (CLD) remains unknown. We investigated the role and mechanism of GSK-3 in vivo in liver tissues of patients with CLD and the bile duct ligation (BDL) mouse model and in vitro using a hepatic progenitor cell (HPC) and hepatic stellate cell (HSC) coculture system. In liver tissues of patients with CLD, expression of the inactive form of GSK-3, phospho-GSK-3(Ser9), was increased in HPCs. GSK-3 inhibition by SB216763 treatment aggravated liver fibrosis and elevated the expression of osteopontin (OPN) in the BDL mouse model. OPN was significantly overexpressed in liver tissues and serum from patients with CLD. In an HPC and HSC coculture system, inhibition of GSK-3 induced OPN production, which activated HSCs in a cholestatic environment. The expression of activator protein 1 (AP-1), an important downstream transcription factor of GSK-3, was significantly increased in liver tissues of patients with CLD and SB216763-treated BDL mice. Finally, OPN expression was directly modulated by AP-1. These observations indicate that GSK-3 inhibition up-regulates OPN expression via AP-1 activation, which accelerates the progression of cholestatic liver fibrosis in patients with CLD and in BDL mice.Zhuang, S., Hua, X., He, K., Zhou, T., Zhang, J., Wu, H., Ma, X., Xia, Q., Zhang, J. Inhibition of GSK-3 induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis.	[Zhuang, Shaoyong; He, Kang; Zhou, Tao; Wu, Haoyu; Xia, Qiang; Zhang, Jianjun] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Zhuang, Shaoyong; He, Kang; Zhou, Tao; Wu, Haoyu; Xia, Qiang; Zhang, Jianjun] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Liver Transplantat Ctr, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Ma, Xiong] Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol & Hepatol, Shanghai Inst Digest Dis,Ren Ji Hosp, Shanghai, Peoples R China; [Ma, Xiong] Shanghai Jiao Tong Univ, Key Lab Gastroenterol & Hepatol, Minist Hlth, Shanghai, Peoples R China; [Hua, Xiangwei] Qingdao Univ, Inst Transplantat Sci, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Zhang, Jiang] Univ Munich, Dept Med 2, Campus Grosshadern, Munich, Germany	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Qingdao University; University of Munich	Xia, Q; Zhang, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg, 160 Pujian Rd, Shanghai 200127, Peoples R China.; Xia, Q; Zhang, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Liver Transplantat Ctr, 160 Pujian Rd, Shanghai 200127, Peoples R China.	xiaqiang@shsmu.edu.cn; zhang.jianjun@icloud.com	He, Kang/GLR-2308-2022	Ma, Xiong/0000-0001-9616-4672; Zhang, Jianjun/0000-0002-9853-3416	National Natural Science Fund of China [81400671]; Scientific and Technological Innovation and Action Project of Shanghai Science and Technology Commission [15411950401]; Key Joint Research Program of the Shanghai Health Bureau [2013ZYJB0001]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Innovation and Action Project of Shanghai Science and Technology Commission; Key Joint Research Program of the Shanghai Health Bureau	The authors thank Prof. Min Li (Department of Laboratory Medicine, Ren Ji Hospital) for technical support. This study was supported by the National Natural Science Fund of China (Grant 81400671), the Scientific and Technological Innovation and Action Project of Shanghai Science and Technology Commission (Grant 15411950401), and the Key Joint Research Program of the Shanghai Health Bureau (Grant 2013ZYJB0001). The authors declare no conflicts of interest.	Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Bergmann C, 2011, ANN RHEUM DIS, V70, P2191, DOI 10.1136/ard.2010.147140; Camandola S, 1999, FREE RADICAL BIO MED, V26, P1108, DOI 10.1016/S0891-5849(98)00298-6; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chen CL, 2006, AM J TRANSPLANT, V6, P2672, DOI 10.1111/j.1600-6143.2006.01528.x; Coombes JD, 2015, GUT, V64, P1120, DOI 10.1136/gutjnl-2013-306484; Friedman S L, 1996, Prog Liver Dis, V14, P101; Fu HL, 2014, J HEPATOL, V61, P816, DOI 10.1016/j.jhep.2014.05.017; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Gu Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.275; Gupta K, 2016, CANCER RES, V76, P2743, DOI 10.1158/0008-5472.CAN-15-2290; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hua XW, 2015, J INTERF CYTOK RES, V35, P606, DOI 10.1089/jir.2014.0128; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Li LD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6881; Li SY, 2017, FEBS LETT, V591, P1394, DOI 10.1002/1873-3468.12645; Liang YX, 2015, BIOCHEM BIOPH RES CO, V463, P70, DOI 10.1016/j.bbrc.2015.05.020; Lin JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9390; Lyle AN, 2014, J BIOL CHEM, V289, P275, DOI 10.1074/jbc.M113.489641; Ma PF, 2017, J HEPATOL, V67, P770, DOI 10.1016/j.jhep.2017.05.022; MadanKumar P, 2014, TOXICOL APPL PHARM, V277, P210, DOI 10.1016/j.taap.2014.03.008; Montori-Grau M, 2013, CELL SIGNAL, V25, P1318, DOI 10.1016/j.cellsig.2013.02.014; Moran-Salvador E, 2013, J HEPATOL, V59, P1045, DOI 10.1016/j.jhep.2013.06.023; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Pandey MK, 2016, THERANOSTICS, V6, P571, DOI 10.7150/thno.14334; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Smart DE, 2001, J BIOL CHEM, V276, P24414, DOI 10.1074/jbc.M101840200; Sofola O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001087; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Tolosa L, 2011, LIVER INT, V31, P1231, DOI 10.1111/j.1478-3231.2011.02609.x; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020150; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; Wang C, 2016, THERANOSTICS, V6, P1205, DOI 10.7150/thno.15083; Wang JZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41038; Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373; Wang YH, 2009, DIABETES, V58, P1391, DOI 10.2337/db08-1697; XU X, 2016, CELL DEATH DIS, V7; Yamazaki T, 2012, CELL MED, V3, P121, DOI 10.3727/215517912X639441; Zekry A, 2003, LIVER TRANSPLANT, V9, P339, DOI 10.1053/jlts.2003.50063	42	10	10	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4494	4503		10.1096/fj.201701137R	http://dx.doi.org/10.1096/fj.201701137R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29529390				2022-12-28	WOS:000439325400036
J	Gelfand, JA; Nazarian, RM; Kashiwagi, S; Brauns, T; Martin, B; Kimizuka, Y; Korek, S; Botvinick, E; Elkins, K; Thomas, L; Locascio, J; Parry, B; Kelly, KM; Poznansky, MC				Gelfand, Jeffrey A.; Nazarian, Rosalynn M.; Kashiwagi, Satoshi; Brauns, Timothy; Martin, Brent; Kimizuka, Yoshifumi; Korek, Skylar; Botvinick, Elliot; Elkins, Kristen; Thomas, Logan; Locascio, Joseph; Parry, Blair; Kelly, Kristen M.; Poznansky, Mark C.			A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking	FASEB JOURNAL			English	Article						dendritic cell; intradermal vaccination; Langerhans cell	DENDRITIC CELLS; DELIVERY; IMMUNOGENICITY; EFFICACY	Many vaccines require adjuvants to enhance immunogenicity, but there are few safe and effective intradermal (i.d.) adjuvants. Murine studies have validated the potency of laser illumination of skin as an adjuvant for i.d. vaccination with advantages over traditional adjuvants. We report a pilot clinical trial of low-power, continuous-wave, near-infrared laser adjuvant treatment, representing the first human trial of the safety, tolerability, and cutaneous immune cell trafficking changes produced by the laser adjuvant. In this trial we demonstrated a maximum tolerable energy dose of 300 J/cm(2) to a spot on the lower back. The irradiated spot was biopsied 4 h later, as was a control spot. Paired biopsies were submitted for histomorphologic and immunohistochemical evaluation in a blinded fashion as well as quantitative PCR analysis for chemokines and cytokines. Similar to prior murine studies, highly significant reductions in CD1a(+) Langerhans cells in the dermis and CD11c(+) dermal dendritic cells were observed, corresponding to the increased migratory activity of these cells; changes in the epidermis were not significant. There was no evidence of skin damage. The laser adjuvant is a safe, well-tolerated adjuvant for i.d. vaccination in humans and results in significant cutaneous immune cell trafficking.Gelfand, J. A., Nazarian, R. M., Kashiwagi, S., Brauns, T., Martin, B., Kimizuka, Y., Korek, S., Botvinick, E., Elkins, K., Thomas, L., Locascio, J., Parry, B., Kelly, K. M., Poznansky, M. C. A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking.	[Gelfand, Jeffrey A.; Kashiwagi, Satoshi; Brauns, Timothy; Kimizuka, Yoshifumi; Korek, Skylar; Poznansky, Mark C.] Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Boston, MA 02114 USA; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Dermatol, Dermatopathol Unit, Boston, MA 02114 USA; [Locascio, Joseph] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Parry, Blair] Massachusetts Gen Hosp, Emergency Dept, Boston, MA 02114 USA; [Martin, Brent; Elkins, Kristen; Thomas, Logan; Kelly, Kristen M.] Univ Calif Irvine, Sch Med, Dept Dermatol, Irvine, CA 92717 USA; [Botvinick, Elliot; Kelly, Kristen M.] Univ Calif Irvine, Sch Med, Beckman Laser Inst, Irvine, CA 92717 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of California System; University of California Irvine; University of California System; University of California Irvine	Poznansky, MC (corresponding author), Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Bldg 149,MGH East,Room 5-425,13th St, Charlestown, MA 02129 USA.	mpoznansky@mgh.harvard.edu	Poznansky, Mark C/M-4996-2015; Gelfand, Jeffrey A/G-1885-2018; Nazarian, Rosalynn/AFL-3176-2022; Kashiwagi, Satoshi/T-2420-2019	Poznansky, Mark C/0000-0003-1344-7103; Gelfand, Jeffrey A/0000-0002-4118-5676; Nazarian, Rosalynn/0000-0003-4003-7193; Kelly, Kristen/0000-0002-5988-2197	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R41AI114012, R42AI114012, R01AI105131]; MGH Vaccine and Immunotherapy Center Innovation Fund; Seth Sprague Foundation; Edmund C. Lynch, Jr. Cancer Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R42AI114012, R01AI105131] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MGH Vaccine and Immunotherapy Center Innovation Fund; Seth Sprague Foundation; Edmund C. Lynch, Jr. Cancer Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Patricia Della Pelle (MGH Histopathology Core) for excellent technical support. This work was supported by the U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases (Grants R41AI114012, R42AI114012, and R01AI105131 to S.K.); the MGH Vaccine and Immunotherapy Center Innovation Fund; the Edmund C. Lynch, Jr. Cancer Fund; and the Seth Sprague Foundation. The authors declare no conflicts of interest.	Chen B, 2008, LASER SURG MED, V40, P358, DOI 10.1002/lsm.20630; Chen X., 2016, BIOL TREAT SUBSTANCE, P309, DOI [10.1007/978-3-319-23150-1_17, DOI 10.1007/978-3-319-23150-1_17]; Chen XY, 2014, J CONTROL RELEASE, V192, P310, DOI 10.1016/j.jconrel.2014.08.006; Chen XY, 2013, EXPERT REV VACCINES, V12, P1313, DOI 10.1586/14760584.2013.844070; Chen XY, 2012, VACCINE, V31, P159, DOI 10.1016/j.vaccine.2012.10.069; Chen XY, 2012, CLIN CANCER RES, V18, P2240, DOI 10.1158/1078-0432.CCR-11-2654; Chen XY, 2012, J CONTROL RELEASE, V159, P43, DOI 10.1016/j.jconrel.2012.01.002; Chen XY, 2011, EXPERT REV VACCINES, V10, P1397, DOI [10.1586/ERV.11.112, 10.1586/erv.11.112]; Chen XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013776; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Darvin ME, 2010, SKIN PHARMACOL PHYS, V23, P40, DOI 10.1159/000257262; Defrin R, 2006, CLIN J PAIN, V22, P130, DOI 10.1097/01.ajp.0000154048.68273.d8; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Egemen A, 1998, VACCINE, V16, P1511, DOI 10.1016/S0264-410X(98)80006-6; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Garcon N, 2018, PLOTKINS VACCINES, P61; Ghassemi S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aap9419; GREENE LC, 1958, FED PROC, V17, P60; Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113; House R, 2009, HUM VACCINES, V5, P788, DOI 10.4161/hv.10689; Hu JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111292; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Isbert C, 2004, LASER SURG MED, V35, P284, DOI 10.1002/lsm.20097; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Kashiwagi Satoshi, 2016, J Vaccines Vaccin, V7; Kashiwagi S, 2014, HUM VACC IMMUNOTHER, V10, P1892, DOI 10.4161/hv.28840; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kimizuka Y, 2017, VACCINE, V35, P2404, DOI 10.1016/j.vaccine.2017.03.036; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Llamas-Velasco M, 2012, ACTAS DERMO-SIFILOGR, V103, P100, DOI 10.1016/j.ad.2011.05.006; Mattsson J, 2015, MUCOSAL IMMUNOL, V8, P815, DOI 10.1038/mi.2014.111; Mohanty SK, 2006, PHOTOCH PHOTOBIO SCI, V5, P134, DOI 10.1039/b506061c; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Muller A, 2013, LASER PHOTONICS REV, V7, P605, DOI 10.1002/lpor.201200051; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; Zastrow L, 2009, SKIN PHARMACOL PHYS, V22, P31, DOI 10.1159/000188083	41	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3074	3081		10.1096/fj.201801095R	http://dx.doi.org/10.1096/fj.201801095R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30192655	Green Published, Green Submitted			2022-12-28	WOS:000457296600122
J	Gimenez-Bastida, JA; Boeglin, WE; Boutaud, O; Malkowski, MG; Schneider, C				Gimenez-Bastida, Juan A.; Boeglin, William E.; Boutaud, Olivier; Malkowski, Michael G.; Schneider, Claus			Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15R-prostaglandins that inhibit platelet aggregation	FASEB JOURNAL			English	Article						arachidonic acid; stereocontrol; biosynthesis; leukocytes	LOW-DOSE ASPIRIN; ENDOPEROXIDE H SYNTHASE-1; ARACHIDONIC-ACID; PROSTAGLANDIN E-2; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SITE RESIDUES; OXYGENATION; MECHANISM; BINDING	Aspirin (acetylsalicylic acid) inhibits prostaglandin (PG) synthesis by transfer of its acetyl group to a serine residue in the cyclooxygenase (COX) active site. Acetylation of Ser530 inhibits catalysis by preventing access of arachidonic acid substrate in the COX-1 isoenzyme. Acetylated COX-2, in contrast, gains a new catalytic activity and forms 15R hydroxy-eicosatetraenoic acid (15R-HETE) as alternate product. Here we show that acetylated COX-2 also retains COX activity, forming predominantly 15R-configuration PGs (70 or 62% 15R, respectively, determined using radiolabeled substrate or LC-MS analysis). Although the K-m of arachidonic acid for acetylated COX-2 was approximate to 3-fold lower than for uninhibited COX-2, the catalytic efficiency for PG formation by the acetylated enzyme was reduced 10-fold due to a concomitant decrease in V-max. Aspirin increased 15R-PGD(2) but not 15R-PGE(2) in isolated human leukocytes activated with LPS to induce COX-2. 15R-PGD(2) inhibited human platelet aggregation induced by the thromboxane receptor agonist U46,619, and this effect was abrogated by an antagonist of the DP1 prostanoid receptor. We conclude that acetylation of Ser530 in COX-2 not only triggers formation of 15R-HETE but also allows oxygenation and cyclization of arachidonic acid to a 15R-PG endoperoxide. 15R-PGs are novel products of aspirin therapy via acetylation of COX-2 and may contribute to its antiplatelet and other pharmacologic effects.Gimenez-Bastida, J. A., Boeglin, W. E., Boutaud, O., Malkowski, M. G., Schneider, C. Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15R-prostaglandins that inhibit platelet aggregation.	[Gimenez-Bastida, Juan A.; Boeglin, William E.; Boutaud, Olivier; Schneider, Claus] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, RRB 514,23rd Ave S, Nashville, TN 37232 USA; [Gimenez-Bastida, Juan A.; Boeglin, William E.; Boutaud, Olivier; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, RRB 514,23rd Ave S, Nashville, TN 37232 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY USA	Vanderbilt University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schneider, C (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, RRB 514,23rd Ave S, Nashville, TN 37232 USA.; Schneider, C (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, RRB 514,23rd Ave S, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Gimenez Bastida, Juan Antonio/T-2721-2017	Gimenez Bastida, Juan Antonio/0000-0002-1244-8764	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01GM076592, R01GM118412, R01GM115386]; American Heart Association [16POST30690001, 14GRNT20460090]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30DK058404]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118412, R01GM115386, R01GM076592] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; American Heart Association(American Heart Association); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants R01GM076592 and R01GM118412 (to C.S.) and R01GM115386 (to M.G.M.). O.B. was supported, in part, by American Heart Association Grant 14GRNT20460090. J.A.G.-B. was supported by a postdoctoral award from the American Heart Association (16POST30690001). Mass spectrometric analyses were in part performed through Vanderbilt University Medical Center's Digestive Disease Research Center, supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant P30DK058404 Core Scholarship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. The authors declare no conflicts of interest.	Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Boutaud O, 2016, CANCER PREV RES, V9, P855, DOI 10.1158/1940-6207.CAPR-16-0094; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Cossette C, 2007, J PHARMACOL EXP THER, V320, P173, DOI 10.1124/jpet.106.111062; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Friedman EA, 2015, THROMB RES, V136, P493, DOI 10.1016/j.thromres.2015.05.027; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3206, DOI 10.1021/bi052338h; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; GILES H, 1988, PROSTAGLANDINS, V35, P277, DOI 10.1016/0090-6980(88)90093-7; Gimenez-Bastida JA, 2017, FASEB J, V31, P1867, DOI 10.1096/fj.201601136R; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HARTER HR, 1979, NEW ENGL J MED, V301, P577, DOI 10.1056/NEJM197909133011103; HECKER M, 1987, EUR J BIOCHEM, V169, P113, DOI 10.1111/j.1432-1033.1987.tb13587.x; HIRSH PD, 1981, NEW ENGL J MED, V304, P687; HOLTZMAN MJ, 1992, J BIOL CHEM, V267, P21438; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; MAIN IHM, 1975, BRIT J PHARMACOL, V54, P309, DOI 10.1111/j.1476-5381.1975.tb07570.x; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MANCINI JA, 1994, FEBS LETT, V342, P33, DOI 10.1016/0014-5793(94)80579-2; MILLER WL, 1976, PROSTAGLANDINS, V11, P77, DOI 10.1016/0090-6980(76)90175-1; NISHIZAWA EE, 1975, PROSTAGLANDINS, V9, P109, DOI 10.1016/S0090-6980(75)80122-5; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Patrignani P, 2016, J AM COLL CARDIOL, V68, P967, DOI 10.1016/j.jacc.2016.05.083; Patrignani P, 2015, BBA-MOL CELL BIOL L, V1851, P422, DOI 10.1016/j.bbalip.2014.09.016; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Peng S, 2002, J AM CHEM SOC, V124, P10785, DOI 10.1021/ja026880u; PRESTON FE, 1981, NEW ENGL J MED, V304, P76, DOI 10.1056/NEJM198101083040203; Reina E, 2013, J PHARM PHARMACOL, V65, P1643, DOI 10.1111/jphp.12138; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Schneider C, 2007, METHOD ENZYMOL, V433, P145, DOI 10.1016/S0076-6879(07)33008-5; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; SHIO H, 1970, EXPERIENTIA, V26, P355, DOI 10.1007/BF01896883; Smith JP, 2010, THROMB RES, V126, pE23, DOI 10.1016/j.thromres.2010.04.003; Tani K, 2001, BIOORG MED CHEM LETT, V11, P2025, DOI 10.1016/S0960-894X(01)00359-6; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tosco P, 2013, J AM CHEM SOC, V135, P10404, DOI 10.1021/ja402870k; Tsai AL, 2002, J BIOL CHEM, V277, P38311, DOI 10.1074/jbc.M206961200; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; Valmsen K, 2001, P NATL ACAD SCI USA, V98, P7700, DOI 10.1073/pnas.131022398; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; WHITTLE BJR, 1978, PROSTAG OTH LIPID M, V16, P373, DOI 10.1016/0090-6980(78)90216-2; Xiao GS, 1997, BIOCHEMISTRY-US, V36, P1836, DOI 10.1021/bi962476u	54	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1033	1041		10.1096/fj.201801018R	http://dx.doi.org/10.1096/fj.201801018R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30096040	Green Published, Bronze			2022-12-28	WOS:000457401500081
J	He, D; Zhang, JH; Wu, WW; Yi, N; He, W; Lu, P; Li, B; Yang, N; Wang, D; Xue, ZG; Zhang, P; Fan, GP; Zhu, XM				He, Di; Zhang, Junhui; Wu, Wanwan; Yi, Ning; He, Wen; Lu, Ping; Li, Bin; Yang, Nan; Wang, Di; Xue, Zhigang; Zhang, Peng; Fan, Guoping; Zhu, Xianmin			A novel immunodeficient rat model supports human lung cancer xenografts	FASEB JOURNAL			English	Article						CRISPR; Cas9; patient-derived xenograft; lung SCC	TUMOR XENOGRAFTS; LYMPHOID DEVELOPMENT; CELL-DEVELOPMENT; IMMUNE-SYSTEM; GAMMA-CHAIN; MOUSE MODEL; MICE; EXPRESSION; GENE; ENGRAFTMENT	Patient-derived xenograft (PDX) animal models allow the exogenous growth of human tumors, offering an irreplaceable preclinical tool for oncology research. Mice are the most commonly used host for human PDX models, however their small body size limits the xenograft growth, sample collection, and drug evaluation. Therefore, we sought to develop a novel rat model that could overcome many of these limitations. We knocked out Rag1, Rag2, and Il2rg in Sprague Dawley (SD) rats by clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 technology. The development of lymphoid organs is significantly impaired in Rag1(-/-)Rag2(-/-)Il2rg(-/Y) (designated as SD-RG) rats. Consequently, SD-RG rats are severely immunodeficient with an absence of mature T, B, and NK cells in the immune system. After subcutaneous injection of tumor cell lines of different origin, such as NCI-H460, U-87MG, and MDA-MB-231, the tumors grow significantly faster and larger in SD-RG rats than in nonobese diabetic-Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ mice. Most important of all, we successfully established a PDX model of lung squamous cell carcinoma in which the grafts recapitulate the histopathologic features of the primary tumor for several passages. In conclusion, the severely immunodeficient SD-RG rats support fast growth of PDX compared with mice, thus holding great potential to serve as a new model for oncology research.He, D., Zhang, J., Wu, W., Yi, N., He, W., Lu, P., Li, B., Yang, N., Wang, D., Xue, Z., Zhang, P., Fan, G., Zhu, X. A novel immunodeficient rat model supports human lung cancer xenografts.	[He, Di; Wu, Wanwan; Wang, Di; Zhang, Peng; Fan, Guoping; Zhu, Xianmin] Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Dept Thorac Surg, 1239 Siping Rd, Shanghai 200433, Peoples R China; [Zhang, Junhui; Yi, Ning; He, Wen; Lu, Ping; Xue, Zhigang] Tongji Univ, Dept Regenerat Med, Translat Ctr Stem Cell Res, Tongji Hosp,Suzhou Inst,Sch Med, Shanghai, Peoples R China; [Li, Bin] Alphacait AL Biotech Co, Hangzhou, Zhejiang, Peoples R China; [Yang, Nan] PharmaLegacy Labs Co, Shanghai, Peoples R China; [Fan, Guoping; Zhu, Xianmin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Tongji University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, XM (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Dept Thorac Surg, 1239 Siping Rd, Shanghai 200433, Peoples R China.; Fan, GP; Zhu, XM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu; xianminzhu@hotmail.com	Zhu, Xianmin/M-6437-2017	Zhu, Xianmin/0000-0003-1405-9700; Lu, Ping/0000-0002-0127-3911	National Program on the Key Basic Research Project (973 Program) [2015CB964702, 2015CB964601]; National Natural Science Foundation of China [81570521, 81470244, 81622001, 81430026, 91642108]; Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality [18140903900, 15140903900]; Fundamental Research Funds for the Central Universities; Jiangsu Science and Technology Planning Project [BM2014052]; Guangxi Science and Technology Planning Project [14251001]; EyeCure Therapeutics (Jiangsu, China)	National Program on the Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Science and Technology Planning Project; Guangxi Science and Technology Planning Project; EyeCure Therapeutics (Jiangsu, China)	The authors thank P.Z. for his equal contribution to leading the project with G.F. and X.Z. The authors also thank Jiayu Chen, Xiaochen Kou, Yanhong Zhao, and Wenqiang Liu in Shaorong Gao's group at Tongji University for their kind help in zygote microinjection and transfer. This work was supported by the National Program on the Key Basic Research Project (973 Program 2015CB964702 and 2015CB964601); the National Natural Science Foundation of China (Grants 81570521, 81470244, 81622001, 81430026, and 91642108); the Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality (Grants 18140903900 and 15140903900); the Fundamental Research Funds for the Central Universities (to X.Z.); the Jiangsu Science and Technology Planning Project (Grant BM2014052); and the Guangxi Science and Technology Planning Project (Grant 14251001), with additional funding from EyeCure Therapeutics (Jiangsu, China). The authors declare no conflicts of interest.	Aparicio S, 2015, NAT REV CANCER, V15, P311, DOI 10.1038/nrc3944; BANKSSCHLEGEL SP, 1985, CANCER RES, V45, P1187; Belinsky SA, 2015, ANNU REV PHYSIOL, V77, P453, DOI 10.1146/annurev-physiol-021014-072018; Belinsky SA, 2011, CANCER RES, V71, P454, DOI 10.1158/0008-5472.CAN-10-3184; Bertotti A, 2015, NATURE, V526, P263, DOI 10.1038/nature14969; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; CANCER G, 2012, NATURE, V491, P288, DOI DOI 10.1038/NATURE11404; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Elmore SA, 2012, TOXICOL PATHOL, V40, P148, DOI 10.1177/0192623311427571; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hosur V, 2017, J CELL BIOCHEM, V118, P3043, DOI 10.1002/jcb.26002; HOWARD RB, 1991, CANCER RES, V51, P3274; Ilie M, 2015, CANCER MED-US, V4, P201, DOI 10.1002/cam4.357; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Jung CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31455; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Kim HR, 2017, ANN ONCOL, V28, P1250, DOI 10.1093/annonc/mdx098; Lavender KJ, 2013, BLOOD, V122, P4013, DOI 10.1182/blood-2013-06-506949; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Liu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep11397; Loukopoulos P, 2004, PANCREAS, V29, P193, DOI 10.1097/00006676-200410000-00004; March TH, 2001, VET PATHOL, V38, P483, DOI 10.1354/vp.38-5-483; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Mazurier F, 1999, J INTERF CYTOK RES, V19, P533, DOI 10.1089/107999099313983; Menoret S., 2018, TRANSPLANTATION; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Taira T, 2012, LUNG CANCER, V76, P423, DOI 10.1016/j.lungcan.2011.11.010; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YY, 2017, MOL THER-NUCL ACIDS, V6, P269, DOI 10.1016/j.omtn.2017.01.003; Weeden CE, 2017, MOL CANCER THER, V16, P1610, DOI 10.1158/1535-7163.MCT-17-0174; Xu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28508; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zhao XM, 2012, NEURO-ONCOLOGY, V14, P574, DOI 10.1093/neuonc/nos061; Zschemisch NH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-60	60	16	16	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					140	150		10.1096/fj.201800102RR	http://dx.doi.org/10.1096/fj.201800102RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29944447				2022-12-28	WOS:000457401500011
J	Hu, F; Liu, HC; Su, DQ; Chen, HJ; Chan, SO; Wang, Y; Wang, J				Hu, Fang; Liu, Huai-Cun; Su, Dong-Qiang; Chen, Hai-Jing; Chan, Sun-On; Wang, Yun; Wang, Jun			Nogo-A promotes inflammatory heat hyperalgesia by maintaining TRPV-1 function in the rat dorsal root ganglion neuron	FASEB JOURNAL			English	Article						RTN4A; inflammatory pain; cytoskeleton	PRIMARY SENSORY NEURONS; NEURITE OUTGROWTH INHIBITOR; MYELIN-ASSOCIATED INHIBITOR; AXON REGENERATION; MESSENGER-RNA; MICE LACKING; SPINAL-CORD; RECEPTOR; PROTEIN; KINASE	Nogo-A is a key inhibitory molecule of axon regeneration in oligodendrocytes. However, little is known about its role in adult neurons. In this study, we showed an important function of Nogo-A on regulation of inflammatory pain in dorsal root ganglion (DRG) neurons. In adult rats with complete Freund's adjuvant (CFA) hind paw inflammation, DRG neurons showed a significant increase in Nogo-A expression. Disruption of Nogo-A signaling with Nogo-66 receptor antagonist peptide, Nogo-A blocking antibody, Nogo-A short hairpin RNA, or Nogo-A gene knockout attenuated CFA-induced inflammatory heat hyperalgesia. Moreover, disruption of Nogo-A signaling suppressed the function and expression in DRG neurons of the transient receptor potential vanilloid subfamily member (TRPV)-1 channel, which is known to be the endogenous transducer of noxious heat during inflammation. These effects were accompanied with a reduction in LIM domain kinase (LIMK)/cofilin phosphorylation and actin polymerization. Similar disruption of actin filament architecture by direct action of Latrunculin A reduced the TRPV-1 activity and up-regulation of TRPV-1 protein caused by CFA. We conclude that Nogo-A plays an essential role in the development of inflammatory heat hyperalgesia, partly through maintaining TRPV-1 function via activation of the LIMK/cofilin pathway, which regulates actin filament dynamics. These findings support a therapeutic potential of modulating Nogo-A signaling in pain management.Hu, F., Liu, H.-C., Su, D.-Q., Chen, H.-J., Chan, S.-O., Wang, Y., Wang, J. Nogo-A promotes inflammatory heat hyperalgesia by maintaining TRPV-1 function in the rat dorsal root ganglion neuron.	[Hu, Fang; Chen, Hai-Jing; Wang, Yun] Peking Univ, Hlth Sci Ctr,Dept Neurobiol, Natl Hlth Commiss,Neurosci Res Inst, Key Lab Neurosci,Minist Educ & Neurosci, Beijing, Peoples R China; [Hu, Fang] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China; [Liu, Huai-Cun; Su, Dong-Qiang; Wang, Jun] Peking Univ, Sch Basic Med Sci, Dept Anat & Histol, 38 Xueyuan Rd, Beijing 100083, Peoples R China; [Chan, Sun-On] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Wang, Yun] Peking Univ, McGovern Inst Brain Res, Peking Univ Int Data Grp PKU IDG, Beijing, Peoples R China	Peking University; Qingdao University; Peking University; Chinese University of Hong Kong; Peking University	Wang, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Anat & Histol, 38 Xueyuan Rd, Beijing 100083, Peoples R China.; Wang, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Neurosci Res Inst, Dept Neurobiol, Beijing 100083, Peoples R China.	wangy66@bjmu.edu.cn; wangjun74008@bjmu.edu.cn	Chan, Sun-On/R-6547-2018	Chan, Sun-On/0000-0002-3221-3786	National Natural Science Foundation of China [31471119, 31720103908, 31530028]; Beijing Natural Science Foundation [7132130]; Ministry of Science and Technology of China 973 Program [2014CB542204]; National Science and Technology Support Project Grant [2015BAI08B02]; General Research Fund of Hong Kong Research Grant Council [CUHK461612, CUHK14113815]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Science and Technology Support Project Grant; General Research Fund of Hong Kong Research Grant Council	This work was supported by National Natural Science Foundation of China Grants 31471119 (to J.W.), and 31720103908 and 31530028 (to Y.W.); Beijing Natural Science Foundation Grant 7132130 (to J.W.); Ministry of Science and Technology of China 973 Program Grant 2014CB542204 (to Y.W.); National Science and Technology Support Project Grant 2015BAI08B02 (to Y. W.); and General Research Fund of Hong Kong Research Grant Council Project Grants CUHK461612 and CUHK14113815 (to S.-O.C.). The authors declare no conflicts of interest.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Diaz-Franulic I, 2016, MOL PHARMACOL, V90, P300, DOI 10.1124/mol.116.104430; Dina OA, 2003, NEURON, V39, P613, DOI 10.1016/S0896-6273(03)00473-2; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Fukiage C, 1997, BBA-MOL BASIS DIS, V1361, P304, DOI 10.1016/S0925-4439(97)00043-4; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; HOUGH C, 1994, J NEUROCHEM, V62, P421; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Hu FH, 2005, J NEUROSCI, V25, P5298, DOI 10.1523/JNEUROSCI.5235-04.2005; Huber AB, 2002, J NEUROSCI, V22, P3553; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; IGWE OJ, 1994, PAIN, V58, P63, DOI 10.1016/0304-3959(94)90185-6; Iobbi C, 2017, CEREB CORTEX, V27, P2779, DOI 10.1093/cercor/bhw122; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Li Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005353; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Nyatia E, 2007, RES VET SCI, V83, P287, DOI 10.1016/j.rvsc.2007.01.011; O'Neill P, 2004, DEV DYNAM, V231, P109, DOI 10.1002/dvdy.20116; Oertle T, 2003, J NEUROSCI, V23, P5393; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Sousa-Valente J, 2014, BRIT J PHARMACOL, V171, P2508, DOI 10.1111/bph.12532; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Vajda F, 2015, CELL DEATH DIFFER, V22, P323, DOI 10.1038/cdd.2014.147; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Wang J, 2008, J NEUROSCI RES, V86, P2581, DOI 10.1002/jnr.21717; Wang J, 2010, BRAIN RES, V1306, P8, DOI 10.1016/j.brainres.2009.10.018; Willi R, 2009, GENES BRAIN BEHAV, V8, P181, DOI 10.1111/j.1601-183X.2008.00460.x; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhu HH, 2008, PAIN, V137, P574, DOI 10.1016/j.pain.2007.10.025	48	10	12	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					668	682		10.1096/fj.201800382RR	http://dx.doi.org/10.1096/fj.201800382RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30024789				2022-12-28	WOS:000457401500052
J	Lieber, AD; Beier, UH; Xiao, HY; Wilkins, BJ; Jiao, J; Li, XMS; Schugar, RC; Strauch, CM; Wang, ZN; Brown, JM; Hazen, SL; Bokulich, NA; Ruggles, KV; Akimova, T; Hancock, WW; Blaser, MJ				Lieber, Arnon D.; Beier, Ulf H.; Xiao, Haiyan; Wilkins, Benjamin J.; Jiao, Jing; Li, Xinmin S.; Schugar, Rebecca C.; Strauch, Christopher M.; Wang, Zeneng; Brown, J. Mark; Hazen, Stanley L.; Bokulich, Nicholas A.; Ruggles, Kelly V.; Akimova, Tatiana; Hancock, Wayne W.; Blaser, Martin J.			Loss of HDAC6 alters gut microbiota and worsens obesity	FASEB JOURNAL			English	Article						microbiome; HDAC; T-regulatory cells; inflammation	REGULATORY T-CELLS; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GERM-FREE; FAT; INFLAMMATION; METABOLISM; GROWTH; INHIBITION; COLITIS	Alterations in gut microbiota are known to affect intestinal inflammation and obesity. Antibiotic treatment can affect weight gain by elimination of histone deacetylase (HDAC) inhibitor-producing microbes, which are anti-inflammatory by augmenting regulatory T (T-reg) cells. We asked whether mice that lack HDAC6 and have potent suppressive T-reg cells are protected from microbiota-induced accelerated weight gain. We crossed wild-type and HDAC6-deficient mice and subjected the offspring to perinatal penicillin, inducing weight gain via microbiota disturbance. We observed that male HDAC6-deficient mice were not protected and developed profoundly accelerated weight gain. The antibiotic-exposed HDAC6-deficient mice showed a mixed immune phenotype with increased CD4(+) and CD8(+) T-cell activation yet maintained the enhanced T-reg cell-suppressive function phenotype characteristic of HDAC6-deficient mice. 16S rRNA sequencing of mouse fecal samples reveals that their microbiota diverged with time, with HDAC6 deletion altering microbiome composition. On a high-fat diet, HDAC6-deficient mice were depleted in representatives of the S24-7 family and Lactobacillus but enriched with Bacteroides and Parabacteroides; these changes are associated with obesity. Our findings further our understanding of the influence of HDACs on microbiome composition and are important for the development of HDAC6 inhibitors in the treatment of human diseases.Lieber, A. D., Beier, U. H., Xiao, H., Wilkins, B. J., Jiao, J., Li, X. S., Schugar, R. C., Strauch, C. M., Wang, Z., Brown, J. M., Hazen, S. L., Bokulich, N. A., Ruggles, K. V., Akimova, T., Hancock, W. W., Blaser, M. J. Loss of HDAC6 alters gut microbiota and worsens obesity.	[Lieber, Arnon D.; Bokulich, Nicholas A.; Blaser, Martin J.] NYU, Sch Med, Dept Med, 550 First Ave,CD689, New York, NY 10016 USA; [Lieber, Arnon D.; Bokulich, Nicholas A.; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ruggles, Kelly V.] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY USA; [Ruggles, Kelly V.] NYU, Sch Med, Appl Bioinformat Labs, New York, NY USA; [Beier, Ulf H.; Xiao, Haiyan; Jiao, Jing] Univ Penn, Childrens Hosp Philadelphia, Div Nephrol, Dept Pediat, Philadelphia, PA 19104 USA; [Akimova, Tatiana; Hancock, Wayne W.] Univ Penn, Childrens Hosp Philadelphia, Div Transplant Immunol, Dept Pathol & Lab Med,Biesecker Ctr Pediat Liver, Philadelphia, PA 19104 USA; [Wilkins, Benjamin J.] Univ Penn, Childrens Hosp Philadelphia, Div Anat Pathol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Li, Xinmin S.; Schugar, Rebecca C.; Strauch, Christopher M.; Wang, Zeneng; Brown, J. Mark; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Blaser, Martin J.] New York Harbor Dept Vet Affairs Med Ctr, New York, NY USA; [Xiao, Haiyan] Ft Wayne Med Lab Corp, Ft Wayne, IN USA; [Bokulich, Nicholas A.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA	New York University; New York University; New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cleveland Clinic Foundation; Northern Arizona University	Blaser, MJ (corresponding author), NYU, Sch Med, Dept Med, 550 First Ave,CD689, New York, NY 10016 USA.	martin.blaser@nyumc.org	Hazen, Stanley L/ABD-5845-2021; Wang, Zeneng/AAK-6119-2021	Beier, Ulf/0000-0002-3672-572X; Bokulich, Nicholas/0000-0002-1784-8935; Blaser, Martin/0000-0003-2447-2443; Ruggles, Kelly/0000-0002-0152-0863	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI095353, AI073489, AI095276]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK090989]; NIH NIAID [AI122285]; Laffey McHugh Foundation; American Society of Nephrology; C D Fund; Transatlantic Network of the Leducq Foundation; NIH National Cancer Institute [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087, P50CA150964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI095353, U01AI122285] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laffey McHugh Foundation; American Society of Nephrology; C D Fund; Transatlantic Network of the Leducq Foundation; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Grants AI095353 (to U.H.B.), AI073489 and AI095276 (to W.W.H.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK090989 and NIH NIAID Grant AI122285 (to M.J.B.); by funds from the Laffey McHugh Foundation and American Society of Nephrology (to U.H.B.); and by the C & D Fund and the Transatlantic Network of the Leducq Foundation (to M.J.B. and S.L.H.). The NYU Langone Medical Center Genome Technology Center, supported by the NIH National Cancer Institute (P30CA016087), provided expert DNA sequencing. The authors declare no conflicts of interest.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Akimova T, 2014, MUCOSAL IMMUNOL, V7, P1209, DOI 10.1038/mi.2014.10; Akimova T, 2016, METHODS MOL BIOL, V1371, P43, DOI 10.1007/978-1-4939-3139-2_4; Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Berletch JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005079; Blaser MJ, 2017, NAT REV IMMUNOL, V17, P461, DOI 10.1038/nri.2017.77; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer N, 2016, P NATL ACAD SCI USA, V113, pE2993, DOI 10.1073/pnas.1605997113; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; FORBES M, 1959, J NUTR, V67, P69, DOI 10.1093/jn/67.1.69; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang JB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09211-3; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; JUKES TH, 1953, PHARMACOL REV, V5, P381; Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Levine MH, 2016, KIDNEY INT, V89, P1016, DOI 10.1016/j.kint.2015.12.051; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li XMS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99096; Liang WF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109757, 10.1371/journal.pone.0090827]; Liu YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029035; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mahana D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0297-9; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Popkin BM, 1998, NUTR REV, V56, P106; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068596; Qian H, 2017, J CLIN INVEST, V127, P1353, DOI 10.1172/JCI85963; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Ruiz VE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00531-6; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Schulfer AF, 2018, NAT MICROBIOL, V3, P234, DOI 10.1038/s41564-017-0075-5; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; TAYLOR JH, 1955, NATURE, V176, P312, DOI 10.1038/176312a0; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang LQ, 2015, J CLIN INVEST, V125, P3304, DOI 10.1172/JCI83084; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xiao HY, 2016, INT J CANCER, V138, P2477, DOI 10.1002/ijc.29979; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	76	26	28	3	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1098	1109		10.1096/fj.201701586R	http://dx.doi.org/10.1096/fj.201701586R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30102568	Green Published			2022-12-28	WOS:000457401500087
J	Nixon, BR; Sebag, SC; Glennon, MS; Hall, EJ; Kounlavong, ES; Freeman, ML; Becker, JR				Nixon, Benjamin R.; Sebag, Sara C.; Glennon, Michael S.; Hall, Eric J.; Kounlavong, Emily S.; Freeman, Michael L.; Becker, Jason R.			Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response	FASEB JOURNAL			English	Article						nuclear translocation; cancer biology; signal transduction	STRAND BREAK REPAIR; GLUCOCORTICOID-RECEPTOR; CATALYTIC SUBUNIT; STATISTICAL-MODEL; INDEPENDENT ROLE; AUTOPHOSPHORYLATION; PATHWAY; BINDING; TUMOR; CRAF	Raf1/c-Raf is a well-characterized serine/threonine-protein kinase that links Ras family members with the MAPK/ERK signaling cascade. We have identified a novel splice isoform of human Raf1 that causes protein truncation and loss of the C-terminal kinase domain (Raf1-tr). We found that Raf1-tr has increased nuclear localization compared with full-length Raf1, and this finding was secondary to reduced binding of Raf1-tr to the cytoplasmic chaperone FK506 binding protein 5. We show that Raf1-tr has increased binding to DNA-dependent protein kinase (DNA-PK), which inhibits DNA-PK function and causes amplification of irradiation- and bleomycin-induced DNA damage. We found that the human colorectal cancer cell line, HCT-116, displayed reduced expression of Raf1-tr, and reintroduction of Raf1-tr sensitized the cells to bleomycin-induced apoptosis. Furthermore, we identified differential Raf1-tr expression in breast cancer cell lines and showed that breast cancer cells with increased Raf1-tr expression become sensitized to bleomycin-induced apoptosis. Collectively, these results demonstrate a novel Raf1 isoform in humans that has a unique noncanonical role in regulating the double-stranded DNA damage response pathway through modulation of DNA-PK function.Nixon, B. R., Sebag, S. C., Glennon, M. S., Hall, E. J., Kounlavong, E. S., Freeman, M. L., Becker, J. R. Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response.	[Nixon, Benjamin R.; Sebag, Sara C.; Glennon, Michael S.; Hall, Eric J.; Kounlavong, Emily S.; Becker, Jason R.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, 2220 Pierce Ave,342 Preston Res Bldg, Nashville, TN 37232 USA; [Freeman, Michael L.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA; [Becker, Jason R.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Becker, JR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, 2220 Pierce Ave,342 Preston Res Bldg, Nashville, TN 37232 USA.	jason.becker@vanderbilt.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [K08HL116803, R01HL136824, T32HL105334]; PhRMA Foundation; American Heart Association [PTF29620009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105334, R01HL136824, K08HL116803] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PhRMA Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mass spectrometry was performed in the Vanderbilt Mass Spectrometry Research Center Proteomics Core Laboratory, and the authors thank Hayes McDonald (Vanderbilt University School of Medicine) for his advice and technical support. The authors also thank David Cortez (Vanderbilt University School of Medicine) for thoughtful discussion and review of the manuscript. This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grants K08HL116803 and R01HL136824 to J.R.B., and T32HL105334 to B.R.N.); the PhRMA Foundation (Postdoctoral Fellowship to S.C.S.); and the American Heart Association (Grant PTF29620009 to B.R.N.). The authors declare no conflicts of interest.	Advani SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9154; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Eisenhardt AE, 2016, ONCOTARGET, V7, P26628, DOI 10.18632/oncotarget.8427; Geil WM, 2014, FEBS J, V281, P1170, DOI 10.1111/febs.12693; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kung JE, 2016, STRUCTURE, V24, P7, DOI 10.1016/j.str.2015.10.020; Lukic I, 2015, J MOL NEUROSCI, V55, P951, DOI 10.1007/s12031-014-0451-z; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; Neal JA, 2014, MOL CELL BIOL, V34, P2162, DOI 10.1128/MCB.01554-13; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Panaccione A, 2017, ORAL ONCOL, V66, P38, DOI 10.1016/j.oraloncology.2016.12.011; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rauch J, 2011, CANCER RES, V71, P4664, DOI 10.1158/0008-5472.CAN-10-4447; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rui LX, 2016, P NATL ACAD SCI USA, V113, pE7260, DOI 10.1073/pnas.1610970113; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Thymiakou E, 2011, JOVE-J VIS EXP, DOI 10.3791/2631; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Weber CK, 2001, CANCER RES, V61, P3595; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	41	4	4	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1138	1150		10.1096/fj.201800336R	http://dx.doi.org/10.1096/fj.201800336R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30106602	Green Published, Bronze			2022-12-28	WOS:000457401500090
J	Park, TS; Park, J; Lee, JH; Park, JW; Park, BC				Park, Tae Sub; Park, Joonghoon; Lee, Jeong Hyo; Park, Jeong-Woong; Park, Byung-Chul			Disruption of G(0)/G(1) switch gene 2 (G0S2) reduced abdominal fat deposition and altered fatty acid composition in chicken	FASEB JOURNAL			English	Article						CRISPR; Cas9 nuclease; knockout; primordial germ cell	ADIPOSE LIPOLYSIS; ENERGY-METABOLISM; TISSUE; LIVER; DIET; EXPRESSION; MICE	Chicken as a food source is one of the most widespread domestic animals, and it has been used extensively as a research model. The clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) system is the most efficient and reliable tool for precise genome-targeted modification and has generated considerable excitement for industrial applications, as well as biologic science. Unlike in mammals, germline-transmittable primordial germ cells (PGCs) in chicken were used as an alternative strategy for the production of genetically altered chickens. Here, by combining the CRISPR-Cas9 platform and germ cell-mediated germline transmission, we generated G(0)/G(1) switch gene 2 (G0S2) knockout (KO) chickens, and G0S2 null KO chickens showed a dramatic reduction of abdominal fat deposition without affecting other economic traits. Additionally, G0S2 null KO chickens had altered fatty acid compositions in their blood and abdominal fat compared with wild-type chickens under normal dietary conditions. The global mRNA sequencing data showed that G0S2 disruption in chickens would activate the adipose tissue-specific peroxisomal oxidation pathway, and enoyl-coenzyme A (CoA), hydratase/3-hydroxyacyl CoA dehydrogenase might be a target molecule in metabolic homeostasis in the chicken adipose tissue. Our results demonstrate that the CRISPR-Cas9 system with chicken PGCs can facilitate the production of specific genome-edited chickens for practical applications, as well as basic research.Park, T. S., Park, J., Lee, J. H., Park, J.-W., Park, B.-C. Disruption of G(0)/G(1) switch gene 2 (G0S2) reduced abdominal fat deposition and altered fatty acid composition in chicken.	[Park, Tae Sub; Park, Joonghoon; Park, Byung-Chul] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun, Gangwon Do, South Korea; [Park, Tae Sub; Park, Joonghoon; Lee, Jeong Hyo; Park, Jeong-Woong; Park, Byung-Chul] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang Gun, Gangwon Do, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Park, TS; Park, BC (corresponding author), Seoul Natl Univ, Grad Sch Int Agr Technol, 1447 Pyeongchang Daero, Pyeongchang 25354, Gangwon, South Korea.	taesubpark@snu.ac.kr; bcpark@snu.ac.kr		Lee, Jeong Hyo/0000-0002-1848-5347	Korean Rural Development Administration, Cooperative Research Program for Agriculture Science and Technology Development [PJ01334801]	Korean Rural Development Administration, Cooperative Research Program for Agriculture Science and Technology Development	This work was carried out with the support of the Korean Rural Development Administration, Cooperative Research Program for Agriculture Science and Technology Development (Project PJ01334801). The authors declare no conflicts of interest.	Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Campos RLR, 2009, ANIM GENET, V40, P729, DOI 10.1111/j.1365-2052.2009.01910.x; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Gao F, 2009, ENDOCR J, V56, P487, DOI 10.1507/endocrj.K08E-322; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hansen M, 2015, OBESITY, V23, P2022, DOI 10.1002/oby.21223; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Nielsen TS, 2012, J CLIN ENDOCR METAB, V97, pE1348, DOI 10.1210/jc.2012-1159; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Shin SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100905; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; Skopp A, 2016, ARCH PHYSIOL BIOCHEM, V122, P47, DOI 10.3109/13813455.2015.1122066; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zhang XD, 2017, BBA-MOL CELL BIOL L, V1862, P1146, DOI 10.1016/j.bbalip.2017.06.007; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	22	17	17	3	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1188	1198		10.1096/fj.201800784R	http://dx.doi.org/10.1096/fj.201800784R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30085885	Bronze			2022-12-28	WOS:000457401500094
J	Ramirez, VT; van Oeffelen, WEPA; Torres-Fuentes, C; Chruscicka, B; Druelle, C; Golubeva, AV; van de Wouw, M; Dinan, TG; Cryan, JF; Schellekens, H				Ramirez, Valerie T.; van Oeffelen, Wesley E. P. A.; Torres-Fuentes, Cristina; Chruscicka, Barbara; Druelle, Clementine; Golubeva, Anna V.; van de Wouw, Marcel; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet			Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists	FASEB JOURNAL			English	Article						GHSR-1a; GPCR; probe of dependence	HORMONE SECRETAGOGUE RECEPTOR; HIGH CONSTITUTIVE ACTIVITY; CANCER-ANOREXIA-CACHEXIA; G-PROTEIN; GHS-R; ALLOSTERIC MODULATION; CELL-PROLIFERATION; IN-VITRO; LIGANDS; ANAMORELIN	The ghrelin receptor [growth hormone secretagogue receptor (GHSR)-1a] represents a promising pharmacologic target for the treatment of metabolic disorders, including obesity and cachexia, via central appetite modulation. The GHSR-1a has a complex pharmacology, highlighted by G-protein-dependent and -independent downstream signaling pathways and high basal constitutive activity. The functional selectivity and signaling bias of many GHSR-1a-specific ligands has not been fully characterized. In this study, we investigated the pharmacologic properties of ghrelin, MK-0677, L692,585, and [d-Lys3]-growth hormone-releasing peptide-6 (Dlys), JMV2959, and [d-Arg(1),d-Phe(5),d-Trp(7, 9),Leu(11)]-substance P (SP-analog). We investigated their effect on basal GHSR-1a constitutive signaling, ligand-directed downstream GHSR-1a signaling, functional selectivity, and signaling bias. Dlys behaved as a partial antagonist with a strong bias toward GHSR-1a--arrestin signaling, whereas JMV2959 acted as a full unbiased GHSR-1a antagonist. Moreover, the SP-analog behaved as an inverse agonist increasing G-protein-dependent signaling, but only at high concentrations, whereas, at low concentrations, the SP-analog attenuated -arrestin-dependent signaling. Considering the limited success in the clinical development of GHSR-1a-targeted drugs so far, these findings provide a novel insight into the pharmacologic characteristics of GHSR-1a ligands and their signaling bias, which has important implications in the design of novel, more selective GHSR-1a ligands with predictable functional outcome and selectivity for preclinical and clinical drug development.Ramirez, V. T., van Oeffelen, W. E. P. A., Torres-Fuentes, C., Chrucicka, B., Druelle, C., Golubeva, A. V., van de Wouw, M., Dinan, T. G., Cryan, J. F., Schellekens, H. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists.	[Ramirez, Valerie T.; Torres-Fuentes, Cristina; Chruscicka, Barbara; Druelle, Clementine; Golubeva, Anna V.; van de Wouw, Marcel; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Alimentary Pharmabiot Ctr APC Microbiome Ireland, Cork, Ireland; [van Oeffelen, Wesley E. P. A.; van de Wouw, Marcel; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Dinan, Timothy G.] Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Food Hlth Ireland, Cork, Ireland	University College Cork; University College Cork; University College Cork; Teagasc; University College Cork	Schellekens, H (corresponding author), Food Hlth Ireland, APC Microbiome Ireland, Dept Anat & Neurosci, Western Rd.,Western Gateway Bldg, Cork T12 XF62, Ireland.; Schellekens, H (corresponding author), Univ Coll Cork, Cork T12 XF62, Ireland.	h.schellekens@ucc.ie	Torres-Fuentes, Cristina/J-5551-2019; Dinan, Timothy/ABA-8284-2020; Cryan, John F./A-6950-2013; Chruścicka-Smaga, Barbara/AAQ-1633-2020	Torres-Fuentes, Cristina/0000-0002-2917-6910; Cryan, John F./0000-0001-5887-2723; Schellekens, Harriet/0000-0002-6065-3797; van de Wouw, Marcel/0000-0002-2607-314X	Science Foundation Ireland Research Centre [SFI/12/RC/2273]; Enterprise Ireland [TC2013-0001]; Irish Health Research Board [HRA_POR/2011/23, HRA_POR/2012/32]	Science Foundation Ireland Research Centre(Science Foundation Ireland); Enterprise Ireland; Irish Health Research Board	The authors thank Naomi Hoevenaars for assistance with the internalization assay and Felipe G. Serrano (Illustrative Science, Santiago, Chile) for graphics work. The study was funded by Science Foundation Ireland Research Centre Grant SFI/12/RC/2273 to the Alimentary Pharmabiotic Centre (APC) Microbiome Ireland (to H.S., J.F.C., and T.G.D.); by Enterprise Ireland Grant TC2013-0001 (to H.S. and J.F.C.); and the Irish Health Research Board, Health Research Awards HRA_POR/2011/23 and HRA_POR/2012/32 (to W.E.P.A.V.O.). The authors declare no conflicts of interest.	Abegg K, 2017, DIABETES OBES METAB, V19, P1740, DOI 10.1111/dom.13020; Al Massadi O, 2017, TRENDS NEUROSCI, V40, P167, DOI 10.1016/j.tins.2016.12.003; Allas S, 2013, ENDOCR DEV, V25, P157, DOI 10.1159/000346065; Bartuzi D, 2019, J BIOMOL STRUCT DYN, V37, P36, DOI 10.1080/07391102.2017.1417914; Bayliss JA, 2016, J NEUROSCI, V36, P3049, DOI 10.1523/JNEUROSCI.4373-15.2016; Beck B, 2004, LIFE SCI, V76, P473, DOI 10.1016/j.lfs.2004.09.001; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Berrout L, 2018, BRAIN RES, V1678, P20, DOI 10.1016/j.brainres.2017.09.028; Bologna Z, 2017, BIOMOL THER, V25, P12, DOI 10.4062/biomolther.2016.165; Bouzo-Lorenzo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22495; Camina JP, 2006, J NEUROENDOCRINOL, V18, P65, DOI 10.1111/j.1365-2826.2005.01379.x; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Carreira MC, 2006, J ENDOCRINOL, V191, P147, DOI 10.1677/joe.1.06714; Cavalier M, 2015, EUR J NEUROSCI, V42, P2568, DOI 10.1111/ejn.13013; Chebani Y, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0374; Chen JH, 2011, J CELL BIOCHEM, V112, P2931, DOI 10.1002/jcb.23209; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Cong WN, 2010, CNS NEUROL DISORD-DR, V9, P557, DOI 10.2174/187152710793361513; Currow D, 2017, ANN ONCOL, V28, P1949, DOI 10.1093/annonc/mdx192; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Delporte C, 2012, J OBES, V2012, DOI 10.1155/2012/535624; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Evron T, 2014, J BIOL CHEM, V289, P33442, DOI 10.1074/jbc.M114.581397; Fernandez G, 2018, ENDOCRINOLOGY, V159, P1021, DOI 10.1210/en.2017-03101; Garcia JM, 2015, LANCET ONCOL, V16, P108, DOI 10.1016/S1470-2045(14)71154-4; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gomez JL, 2014, ALCOHOL CLIN EXP RES, V38, P2436, DOI 10.1111/acer.12499; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Howick K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020273; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Leach K, 2017, PHARMACOL RES, V116, P105, DOI 10.1016/j.phrs.2016.12.006; Lee JH, 2014, FEBS LETT, V588, P4708, DOI 10.1016/j.febslet.2014.10.044; Lien GS, 2016, EUR J PHARMACOL, V776, P124, DOI 10.1016/j.ejphar.2016.02.044; Liu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27499; Liu G, 2007, J PHARMACOL EXP THER, V322, P1036, DOI 10.1124/jpet.107.123141; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; Mason BL, 2014, ANNU REV PHYSIOL, V76, P519, DOI 10.1146/annurev-physiol-021113-170310; Mear Y, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00087; Mosa R, 2018, AM J PHYSIOL-REG I, V314, pR71, DOI 10.1152/ajpregu.00157.2017; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Moulin A, 2007, CHEMMEDCHEM, V2, P1242, DOI 10.1002/cmdc.200700015; Moulin A, 2013, AMINO ACIDS, V44, P301, DOI 10.1007/s00726-012-1355-2; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Osterstock G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009159; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Pastor-Cavada E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36456; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Pietra C, 2014, J CACHEXIA SARCOPENI, V5, P329, DOI 10.1007/s13539-014-0159-5; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rossi F, 2009, ATHEROSCLEROSIS, V203, P97, DOI 10.1016/j.atherosclerosis.2008.06.015; Sanger GJ, 2014, NEUROGASTROENT MOTIL, V26, P149, DOI 10.1111/nmo.12300; Santos-Zas I, 2013, INT J BIOCHEM CELL B, V45, P1281, DOI 10.1016/j.biocel.2013.03.014; Schellekens H, 2015, ACS CHEM NEUROSCI, V6, P1186, DOI 10.1021/cn500318q; Schellekens H, 2013, J PHARM PHARMACOL, V65, P528, DOI 10.1111/jphp.12010; Schellekens H, 2013, VITAM HORM, V91, P285, DOI 10.1016/B978-0-12-407766-9.00013-4; Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473; Schellekens H, 2010, NEUROPHARMACOLOGY, V58, P2, DOI 10.1016/j.neuropharm.2009.06.024; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Torres-Fuentes C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103118; Toth K, 2018, SYNAPSE, V72, DOI 10.1002/syn.22012; Traebert M, 2002, J NEUROENDOCRINOL, V14, P580, DOI 10.1046/j.1365-2826.2002.00810.x; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Ueno S, 2012, P NATL ACAD SCI USA, V109, P11121, DOI 10.1073/pnas.1203561109; Vodnik M, 2016, HORM METAB RES, V48, P1, DOI 10.1055/s-0035-1564149; Zhang HJ, 2015, EXPERT OPIN PHARMACO, V16, P1245, DOI 10.1517/14656566.2015.1041500	78	16	16	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					518	531		10.1096/fj.201800655R	http://dx.doi.org/10.1096/fj.201800655R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020830				2022-12-28	WOS:000457401500041
J	Zhao, B; Xu, N; Li, R; Yu, FY; Zhang, F; Yang, F; Ge, XJ; Li, YC; Du, J				Zhao, Bin; Xu, Na; Li, Ran; Yu, Feiyan; Zhang, Fang; Yang, Fang; Ge, Xuejun; Li, Yan Chun; Du, Jie			Vitamin D/VDR signaling suppresses microRNA-802-induced apoptosis of keratinocytes in oral lichen planus	FASEB JOURNAL			English	Article						vitamin D receptor; NF-kappa B; Bcl2	D-RECEPTOR; MALIGNANT-TRANSFORMATION; EXPRESSION; CYTOKINES; PROLIFERATION; DIAGNOSIS; BARRIER; CANCER	Vitamin D is known to play a protective role in inflammatory diseases. Although the suppressive effect of vitamin D/vitamin D receptor (VDR) signaling has been shown in the context of oral lichen planus (OLP), the molecular basis of its regulatory function remains poorly understood. Herein, we reported that miR-802 overexpression in OLP could aggravate apoptosis of oral keratinocytes by targeting B-cell lymphoma 2 mRNA. In addition, vitamin D/VDR signaling was able to suppress miR-802 expression in LPS-treated or activated CD4(+) T cell-stimulated human oral keratinocytes by blocking NF-B pathways, thereby inhibiting OLP apoptosis. Consistent with the results in vitro, we showed that miR-802 expression was enhanced in oral keratinocytes from VDR-/- mice, and an inverse correlation between VDR and miR-802 was found in human biopsy specimens of OLP. Collectively, our data suggest that vitamin D/VDR signaling suppresses oral keratinocyte apoptosis by targeting miR-802.Zhao, B., Xu, N., Li, R., Yu, F., Zhang, F., Yang, F., Ge, X., Li, Y. C., Du, J. Vitamin D/VDR signaling suppresses microRNA-802-induced apoptosis of keratinocytes in oral lichen planus.	[Zhao, Bin; Xu, Na; Li, Ran; Yu, Feiyan; Zhang, Fang; Yang, Fang; Ge, Xuejun; Du, Jie] Shanxi Med Univ Sch & Hosp Stomatol, Dept Oral Med, 56 Xinjian South Rd, Taiyuan 030001, Shanxi, Peoples R China; [Li, Yan Chun; Du, Jie] Univ Chicago, Dept Med, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Du, J (corresponding author), Shanxi Med Univ Sch & Hosp Stomatol, Dept Oral Med, 56 Xinjian South Rd, Taiyuan 030001, Shanxi, Peoples R China.	dj1243@hotmail.com		zhao, zhao bin/0000-0001-8948-0693; Du, Jie/0000-0003-2821-2497	Stomatological Hospital of Shanxi Medical University; Shanxi International Scientific Cooperation Programs Foundation [2014081058]	Stomatological Hospital of Shanxi Medical University; Shanxi International Scientific Cooperation Programs Foundation	This study was supported, in part, by a grant from the Stomatological Hospital of Shanxi Medical University and the Shanxi International Scientific Cooperation Programs Foundation (2014081058). The authors declare no conflicts of interest.	Aghbari SMH, 2018, ARCH DERMATOL RES, V310, P209, DOI 10.1007/s00403-018-1805-0; Ahmadi-Motamayel F, 2017, IRAN J IMMUNOL, V14, P316, DOI IJIv14i4A6; Benguella L., 2018, MED MALADIES INFECT, V13, P30140; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Brant Juliana M. Caldeira, 2008, Braz. Dent. J., V19, P179, DOI 10.1590/S0103-64402008000300001; Chen Y, 2013, J BIOL CHEM, V288, P19450, DOI 10.1074/jbc.M113.467670; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Cheng YSL, 2016, OR SURG OR MED OR PA, V122, P332, DOI 10.1016/j.oooo.2016.05.004; Cheng YSL, 2011, ORAL ONCOL, V47, P1122, DOI 10.1016/j.oraloncology.2011.07.032; Choi YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29186; Danielsson K, 2017, ACTA DERM-VENEREOL, V97, P214, DOI 10.2340/00015555-2533; De Rossi Scott S, 2014, Dent Clin North Am, V58, P299, DOI 10.1016/j.cden.2014.01.001; Ding M, 2014, ORAL DIS, V20, P205, DOI 10.1111/odi.12090; Du J, 2017, ORAL DIS, V23, P770, DOI 10.1111/odi.12659; Du J, 2015, INFLAMM BOWEL DIS, V21, P2495, DOI 10.1097/MIB.0000000000000526; Fitzpatrick SG, 2014, J AM DENT ASSOC, V145, P45, DOI 10.14219/jada.2013.10; Gorouhi F, 2014, SCI WORLD J, DOI 10.1155/2014/742826; Hao JL, 2017, KIDNEY INT, V91, P106, DOI 10.1016/j.kint.2016.07.017; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Khan A, 2003, J ORAL PATHOL MED, V32, P77, DOI 10.1034/j.1600-0714.2003.00077.x; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Li N, 2014, BIOTECHNOL LETT, V36, P1753, DOI 10.1007/s10529-014-1545-y; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Lim WC, 2005, NAT CLIN PRACT GASTR, V2, P308, DOI 10.1038/ncpgasthep0215; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Lu R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/701094; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Pan ZX, 2010, J CELL BIOCHEM, V111, P1482, DOI 10.1002/jcb.22878; Paul Mayura, 2013, J Oral Maxillofac Pathol, V17, P10, DOI 10.4103/0973-029X.110690; Silverman S, 1997, AM J DENT, V10, P259; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Thongprasom K, 2018, ORAL DIS, V24, P172, DOI 10.1111/odi.12712; van der Meij EH, 2003, J ORAL PATHOL MED, V32, P507, DOI 10.1034/j.1600-0714.2003.00125.x; Wang D., 2017, BIOSCI REP, V37; Wang J, 2016, BIOMED PHARMACOTHER, V80, P373, DOI 10.1016/j.biopha.2016.02.043; Wang YN, 2016, INT IMMUNOPHARMACOL, V36, P67, DOI 10.1016/j.intimp.2016.04.010; Wu X., 2017, CELL PROLIFERAT, V50, P3; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang XY, 2017, EUR REV MED PHARMACO, V21, P4071; ZHAO B, 2018, SCI REP UK, V8	41	21	21	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1042	1050		10.1096/fj.201801020RRR	http://dx.doi.org/10.1096/fj.201801020RRR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30074824	Bronze			2022-12-28	WOS:000457401500082
J	Sonett, J; Goldklang, M; Sklepkiewicz, P; Gerber, A; Trischler, J; Zelonina, T; Westerterp, M; Lemaitre, V; Okada, Y; D'Armiento, J				Sonett, Jarrod; Goldklang, Monica; Sklepkiewicz, Piotr; Gerber, Adam; Trischler, Jordis; Zelonina, Tina; Westerterp, Marit; Lemaitre, Vincent; Okada, Yasunori; D'Armiento, Jeanine			A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure	FASEB JOURNAL			English	Article						COPD; LXR agonist; lipid transporters; cholesterol efflux; macrophage	CHOLESTEROL EFFLUX; ACCELERATES ATHEROSCLEROSIS; CIGARETTE-SMOKING; GENE-EXPRESSION; DEFICIENCY; MACROPHAGES; LIPOPROTEIN; HDL; ELASTASE; TLR4	Macrophage infiltration is common to both emphysema and atherosclerosis, and cigarette smoke down-regulates the macrophage cholesterol efflux transporter ATP binding cassette (ABC)A1. This decreased cholesterol efflux results in lipid-laden macrophages. We hypothesize that cigarette smoke adversely affects cholesterol transport via an ABCA1-dependent mechanism in macrophages, enhancing TLR4/myeloid differentiation primary response gene 88 (Myd88) signaling and resulting in matrix metalloproteinase (MMP) up-regulation and exacerbation of pulmonary inflammation. ABCA1 is significantly down-regulated in the lung upon smoke exposure conditions. Macrophages exposed to cigarette smoke in vivo and in vitro exhibit impaired cholesterol efflux correlating with significantly decreased ABCA1 expression, up-regulation of the TLR4/Myd88 pathway, and downstream MMP-9 and MMP-13 expression. Treatment with liver X receptor (LXR) agonist restores ABCA1 expression after short-term smoke exposure and attenuates the inflammatory response; after long-term smoke exposure, there is also attenuated physiologic and morphologic changes of emphysema. In vitro, treatment with LXR agonist decreases macrophage inflammatory activation in wild-type but not ABCA1 knockout mice, suggesting an ABCA1-dependent mechanism of action. These studies demonstrate an important association between cigarette smoke exposure and cholesterol-mediated pathways in the macrophage inflammatory response. Modulation of these pathways through manipulation of ABCA1 activity effectively blocks cigarette smoke-induced inflammation and provides a potential novel therapeutic approach for the treatment of chronic obstructive pulmonary disease.Sonett, J., Goldklang, M., Sklepkiewicz, P., Gerber, A., Trischler, J., Zelonina, T., Westerterp, M., Lemaitre, V., Okada, V., D'Armiento, J. A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure.	[Sonett, Jarrod; Goldklang, Monica; Sklepkiewicz, Piotr; Gerber, Adam; Trischler, Jordis; Zelonina, Tina; Lemaitre, Vincent; D'Armiento, Jeanine] Columbia Univ, Dept Anesthesiol, Coll Phys & Surg, Ctr Mol Pulm Dis, New York, NY USA; [Westerterp, Marit] Columbia Univ, Coll Phys & Surg, Dept Med, Div Mol Med, New York, NY USA; [Westerterp, Marit] Univ Groningen, Univ Med Ctr Groningen, Mol Genet Sect, Dept Pediat, Groningen, Netherlands; [Okada, Yasunori] Juntendo Univ, Dept Pathophysiol Locomot & Neoplast Dis, Grad Sch Med, Tokyo, Japan	Columbia University; Columbia University; University of Groningen; Juntendo University	D'Armiento, J (corresponding author), Ctr Mol Pulm Dis Anesthesiol & Physiol & Cellular, 630 West 168th St,P&S 12-402, New York, NY 10032 USA.; D'Armiento, J (corresponding author), Ctr LAM & Rare Lung Dis, 630 West 168th St,P&S 12-402, New York, NY 10032 USA.	jmd12@cumc.columbia.edu	Okada, Yasunori/B-5550-2014	Okada, Yasunori/0000-0001-9208-4755; Westerterp, Marit/0000-0003-2230-1659	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01 HL086936, K08 HL126071, T32 HL007343]; NIH National Institute of General Medical Sciences [T32 GM008464]; Stony Wold-Herbert Fund; Netherlands Organization of Scientific Research VIDI [917.15.350]; University of Groningen (Groningen, The Netherlands); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL086936, K08HL126071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008464] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stony Wold-Herbert Fund; Netherlands Organization of Scientific Research VIDI; University of Groningen (Groningen, The Netherlands)(Netherlands Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Alan Tall (Columbia University) for the donation of LysmCreAbca1<SUP>flox/flox</SUP> mice, and Dr. Emilio Arteaga-Solis (Columbia University) for assistance with the airway mechanics assessment. This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants R01 HL086936 (to J.D.), K08 HL126071 (to M.G.), T32 HL007343 (Principal Investigator: Dr. Ira Goldberg, supported M.G.), NIH National Institute of General Medical Sciences Grant T32 GM008464 (Principal Investigator: Dr. Charles Emala, supported A.G.), and the Stony Wold-Herbert Fund (to A.G.). M.W. was supported by the Netherlands Organization of Scientific Research VIDI grant 917.15.350 and a Rosalind Franklin Fellowship from the University of Groningen (Groningen, The Netherlands). J.S., M.G., and P.S. contributed equally to this work.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; AQEL NM, 1985, J PATHOL, V146, P197, DOI 10.1002/path.1711460306; Baldan A, 2008, J IMMUNOL, V180, P3560, DOI 10.4049/jimmunol.180.5.3560; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Bochem AE, 2013, EUR HEART J, V34, P286, DOI 10.1093/eurheartj/ehs376; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chavez-Santoscoy AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3883; Cirillo DJ, 2002, AM J EPIDEMIOL, V155, P842, DOI 10.1093/aje/155.9.842; Dai XY, 2007, INFLAMMATION, V30, P105, DOI 10.1007/s10753-007-9026-2; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; FELDMAN J, 1991, PEDIATRICS, V88, P259; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P267, DOI 10.1164/ajrccm.152.1.7599834; Flaveny CA, 2015, CANCER CELL, V28, P42, DOI 10.1016/j.ccell.2015.05.007; Foronjy RF, 2005, EXP LUNG RES, V31, P547, DOI 10.1080/019021490951522; Freund K M, 1993, Ann Epidemiol, V3, P417, DOI 10.1016/1047-2797(93)90070-K; FUJITA J, 1990, AM REV RESPIR DIS, V142, P57, DOI 10.1164/ajrccm/142.1.57; GADEK JE, 1979, SCIENCE, V206, P1315, DOI 10.1126/science.316188; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Goldklang M, 2012, AM J PHYSIOL-LUNG C, V302, pL1200, DOI 10.1152/ajplung.00454.2010; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hirama N, 2007, RESPIROLOGY, V12, P191, DOI 10.1111/j.1440-1843.2006.01009.x; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; Jubinville E, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00681-2017; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kratzer A, 2013, AM J RESP CELL MOL, V48, P725, DOI 10.1165/rcmb.2012-0173OC; Laurencikiene J, 2012, INT J OBESITY, V36, P1494, DOI 10.1038/ijo.2012.21; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Maes T, 2006, INT ARCH ALLERGY IMM, V141, P354, DOI 10.1159/000095462; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mansur AD, 1997, INT J CARDIOL, V62, P151, DOI 10.1016/S0167-5273(97)00203-9; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Moffatt RJ, 2004, PREV MED, V38, P637, DOI 10.1016/j.ypmed.2003.12.002; Moreno JA, 2014, AM J RESP CELL MOL, V51, P536, DOI 10.1165/rcmb.2013-0103OC; MOSKOWITZ WB, 1990, CIRCULATION, V81, P586, DOI 10.1161/01.CIR.81.2.586; Ortiz-Munoz G, 2009, FASEB J, V23, P3129, DOI 10.1096/fj.08-127928; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; Peng DC, 2011, BRIT J PHARMACOL, V162, P1792, DOI 10.1111/j.1476-5381.2011.01202.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Speen AM, 2016, J BIOL CHEM, V291, P25192, DOI 10.1074/jbc.M116.732362; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yu S, 2016, FASEB J, V30, P2570, DOI 10.1096/fj.201600244R; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	56	16	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6724	6736		10.1096/fj.201701381	http://dx.doi.org/10.1096/fj.201701381			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906247	Bronze, Green Published			2022-12-28	WOS:000449359700029
J	Yan, QX; Chen, XM; Gong, HZ; Qiu, P; Xiao, X; Dang, SY; Hong, A; Ma, Y				Yan, Qiuxia; Chen, Xueming; Gong, Huizhen; Qiu, Pei; Xiao, Xing; Dang, Shiying; Hong, An; Ma, Yi			Delivery of a TNF--derived peptide by nanoparticles enhances its antitumor activity by inducing cell-cycle arrest and caspase-dependent apoptosis	FASEB JOURNAL			English	Article						P16; nanoselenium; slow-release carrier; prostate cancer	TUMOR-NECROSIS-FACTOR; PROSTATE-CANCER; SELENIUM NANOPARTICLES; IN-VITRO; MULTIDRUG-RESISTANCE; COMBINATION THERAPY; ELEMENTAL SELENIUM; TARGETED DELIVERY; ALPHA; CISPLATIN	Prostate cancer is the second-most common malignancy of the male genitourinary system. TNF- has attracted intense attention as a potential therapeutic agent against various cancers. However, its therapeutic application is restricted by short half life and severe toxic side-effects. In this study, we constructed a stable nanodrug, called TNF--derived polypeptide (P16)-conjugated, chitosan (CTS)-modified selenium nanoparticle (SC; SCP), which is composed of SC as a slow-release carrier conjugated to P16. SCP had significant inhibitory effects on multiple types of tumor cells, especially DU145 prostate cancer cells, but not on RWPE-1 normal human prostate epithelial cells. SCP could induce G(0)/G(1) cell-cycle arrest and apoptosis in DU145 cells more effectively than could P16 and TNF-. In DU145 xenograft tumor models, SCP exerted much stronger antitumor effects than P16 or estramustine (the clinical drug for prostate cancer) but caused fewer toxic side-effects. In addition, SCP significantly inhibited proliferation and accelerated apoptosis in DU145 xenograft tumors. Further mechanistic studies revealed that SCP exerted antitumor effects via activation of the p38 MAPK/JNK pathway, thus inducing G(0)/G(1) cell-cycle arrest and caspase-dependent apoptosis. These findings suggest that SCP may represent a potential long-lasting therapeutic agent for human prostate cancer with fewer side effects.Yan, Q., Chen, X., Gong, H., Qiu, P., Xiao, X., Dang, S., Hong, A., Ma, Y. Delivery of a TNF--derived peptide by nanoparticles enhances its antitumor activity by inducing cell-cycle arrest and caspase-dependent apoptosis.	[Yan, Qiuxia; Chen, Xueming; Gong, Huizhen; Qiu, Pei; Xiao, Xing; Dang, Shiying; Hong, An; Ma, Yi] Jinan Univ, Inst Biomed, Dept Cellular Biol, Natl Engn Res Ctr Genet Med,Key Lab Bioengn Med G, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China; [Yan, Qiuxia] Guangzhou Med Univ, Affiliated Hosp 6, Ctr Reprod Med, Qingyuan Peoples Hosp, Qingyuan, Peoples R China	Jinan University; Guangzhou Medical University	Ma, Y (corresponding author), Jinan Univ, Inst Biomed, Dept Cellular Biol, Natl Engn Res Ctr Genet Med,Key Lab Bioengn Med G, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China.	tmayi@jnu.edu.cn			National Natural Science Foundation of China [81741130, 81373314]; Natural Science Foundation of Guangdong Province [2015A030313333]; Science and Technology Planning Project of Guangdong Province [2014A020210015, 2013B090500105]; Guangzhou Municipal Science and Technology Program [201707010245, 201704020117]; Medical Research Foundation of Guangdong Province [B2014426]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Guangzhou Municipal Science and Technology Program; Medical Research Foundation of Guangdong Province	The authors thank the Key Laboratory of Bioengineering Medicine of Guangdong Province, Jinan University, and the Center for Reproductive Medicine, The Sixth Affiliated Hospital of Guangzhou Medical University. The authors also thank American Journal Experts for the English language editing. This work was supported by the National Natural Science Foundation of China (Grants 81741130 and 81373314); Natural Science Foundation of Guangdong Province (Grant 2015A030313333); Science and Technology Planning Project of Guangdong Province (Grants 2014A020210015 and 2013B090500105); Guangzhou Municipal Science and Technology Program (Grants 201707010245 and 201704020117); and Medical Research Foundation of Guangdong Province (Grant B2014426). The authors declare no conflicts of interest.	Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Chauhan VP, 2013, NAT MATER, V12, P958, DOI 10.1038/nmat3792; Chen BL, 2015, INT J NANOMED, V10, P3303, DOI 10.2147/IJN.S79306; Chen GQ, 2016, ONCOTARGET, V7, P50302, DOI 10.18632/oncotarget.10367; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; Creagh EM, 2014, TRENDS IMMUNOL, V35, P631, DOI 10.1016/j.it.2014.10.004; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Devalliere J, 2014, FASEB J, V28, P908, DOI 10.1096/fj.13-238527; Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108; Errami Y, 2013, J BIOL CHEM, V288, P3460, DOI 10.1074/jbc.M112.423061; Fang XY, 2014, RHEUMATOL INT, V34, P1175, DOI 10.1007/s00296-013-2873-2; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Goldar Samira, 2015, Asian Pac J Cancer Prev, V16, P2129; Gordon R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-82; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Khan N, 2014, CARCINOGENESIS, V35, P415, DOI 10.1093/carcin/bgt321; Kulhari H, 2015, NANOMED-NANOTECHNOL, V11, P1511, DOI 10.1016/j.nano.2015.04.007; KURODA K, 1995, INT J CANCER, V63, P152, DOI 10.1002/ijc.2910630127; Lacy JM, 2014, ONCOL LETT, V8, P1391, DOI 10.3892/ol.2014.2388; Li JH, 2015, CELL MOL BIOENG, V8, P137, DOI 10.1007/s12195-015-0381-z; Li M, 2010, ANTI-CANCER DRUG, V21, P243, DOI 10.1097/CAD.0b013e328333d5ce; Li Y, 2018, FASEB J, V32, P2992, DOI 10.1096/fj.201701033RRR; Liu JF, 2014, INT J NANOMED, V9, P197, DOI 10.2147/IJN.S55875; Liu RH, 2012, J CONTROL RELEASE, V161, P893, DOI 10.1016/j.jconrel.2012.05.002; Liu T, 2015, NANOMED-NANOTECHNOL, V11, P947, DOI 10.1016/j.nano.2015.01.009; Liu W, 2012, ACS NANO, V6, P6578, DOI 10.1021/nn202452c; Lucas R, 1998, EUR J IMMUNOL, V28, P3577, DOI 10.1002/(SICI)1521-4141(199811)28:11<3577::AID-IMMU3577>3.0.CO;2-#; Ma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13595; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Mukai Y, 2009, J MOL BIOL, V385, P1221, DOI 10.1016/j.jmb.2008.11.053; Nava AC, 2015, INT J CANCER, V137, P2492, DOI 10.1002/ijc.29614; Nomura T, 2010, PHARMAZIE, V65, P93, DOI 10.1691/ph.2010.9265; Nomura T, 2010, YAKUGAKU ZASSHI, V130, P63, DOI 10.1248/yakushi.130.63; Ohtani T, 2006, FEBS LETT, V580, P1597, DOI 10.1016/j.febslet.2006.01.092; Orlando S, 2015, NUCLEIC ACIDS RES, V43, P6860, DOI 10.1093/nar/gkv593; Paolella BR, 2011, STEM CELLS, V29, P1090, DOI 10.1002/stem.660; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Prabaharan M, 2015, INT J BIOL MACROMOL, V72, P1313, DOI 10.1016/j.ijbiomac.2014.10.052; Pritchard T, 2016, J DRUG TARGET, V24, P441, DOI 10.3109/1061186X.2015.1086360; Rastogi V, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/670815; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Sandhu GS, 2013, SEMIN ONCOL, V40, P276, DOI 10.1053/j.seminoncol.2013.04.003; Santo L, 2015, SEMIN ONCOL, V42, P788, DOI 10.1053/j.seminoncol.2015.09.024; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Speeckaert MM, 2012, AM J NEPHROL, V36, P261, DOI 10.1159/000342333; Swanson TA, 2011, PROSTATE, V71, P1548, DOI 10.1002/pros.21371; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013; Wang N, 2015, ACS APPL MATER INTER, V7, P14933, DOI 10.1021/acsami.5b03739; Wang ZL, 2013, NANOSCALE, V5, P2065, DOI 10.1039/c2nr33685e; Wiens GD, 2011, DEV COMP IMMUNOL, V35, P1324, DOI 10.1016/j.dci.2011.03.031; Yan JK, 2016, DRUG DELIV, V23, P1757, DOI 10.3109/10717544.2015.1069423; Yan Z, 2006, CYTOTHERAPY, V8, P415, DOI 10.1080/14653240600845278; Yang QQ, 2015, ACS APPL MATER INTER, V7, P6661, DOI 10.1021/am509204u; Yuan YG, 2017, INT J NANOMED, V12, P6487, DOI 10.2147/IJN.S135482; Zhang JS, 2008, TOXICOL SCI, V101, P22, DOI 10.1093/toxsci/kfm221; ZHANG XM, 1992, J BIOL CHEM, V267, P24069; Zhang YB, 2014, MOL PHARMACEUT, V11, P1282, DOI 10.1021/mp400749f; Zhang YB, 2013, NANOMED-NANOTECHNOL, V9, P74, DOI 10.1016/j.nano.2012.04.002; Zhao SJ, 2017, INT J NANOMED, V12, P2143, DOI 10.2147/IJN.S130566	66	17	17	4	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6948	6964		10.1096/fj.201800377R	http://dx.doi.org/10.1096/fj.201800377R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30161002	Bronze			2022-12-28	WOS:000449359700046
J	Jadapalli, JK; Halade, GV				Jadapalli, Jeevan Kumar; Halade, Ganesh V.			Unified nexus of macrophages and maresins in cardiac reparative mechanisms	FASEB JOURNAL			English	Review						myocardial infarction; myocardium repair; myocardium regeneration; inflammation; resolution of inflammation	CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; LIPID MEDIATORS; ACUTE-INFLAMMATION; TISSUE REGENERATION; PROTECTIVE ACTIONS; 1 BIOSYNTHESIS; IMMUNE-SYSTEM; FATTY-ACIDS; RESOLUTION	Macrophages are immune-sensing big eater phagocytic cells responsible for an innate, adaptive, and regenerative response. After myocardial infarction, macrophages predominantly clear the deceased cardiomyocyte apoptotic or necrotic neutrophils to develop a regenerative and reparative program with the activation of the lipoxygenase-mediated maresin (MaR) metabolome at the site of ischemic injury. The specialized proresolving molecule and macrophage mediator in resolving inflammation, MaR-1, produced by human macrophages, has potent defining effects that limit polymorphonuclear neutrophil infiltration, enhance uptake of apoptotic PMNs, regulate inflammation resolution and tissue regeneration, and reduce pain. In addition to proresolving and anti-inflammatory actions, MaR-1 displays potent tissue regenerative effects in stroke and is an antinociceptive. Macrophages actively participate in the biosynthesis of bioactive MaR-2, which exhibits anti-inflammatory, proresolving, and atherosclerotic effects. A new class of macrophage-derived molecules, MaR conjugates in tissue regeneration, is identified that regulates phagocytosis and the repair and regeneration of damaged tissue. The presented review provides a current summary of the effect of MaR in resolution pathophysiology, with relevance to a cardiac repair program.Jadapalli, J. K., Halade, G. V. Unified nexus of macrophages and maresins in cardiac reparative mechanisms.	[Jadapalli, Jeevan Kumar; Halade, Ganesh V.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 310A Zeigler Res Bldg,703 19th St South,MC 7755, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Halade, GV (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 310A Zeigler Res Bldg,703 19th St South,MC 7755, Birmingham, AL 35294 USA.	ganeshhalade@uabmc.edu	Jadapalli, Jeevan Kumar/I-5181-2017	Jadapalli, Jeevan Kumar/0000-0002-0871-0758	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health [AT006704]; NIH National Heart, Lung, and Blood Institute [HL132989]; University of Alabama at Birmingham Pittman Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132989] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham Pittman Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health Grant AT006704, and NIH National Heart, Lung, and Blood Institute Grant HL132989 (both to G.V.H.); and The University of Alabama at Birmingham Pittman Scholar Award (to G.V.H.). The authors declare no conflicts of interest.	Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; Bliederhaeuser C, 2016, ACTA NEUROPATHOL, V131, P379, DOI 10.1007/s00401-015-1504-2; Bobryshev YV, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9582430; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brogliato AR, 2012, SHOCK, V38, P620, DOI 10.1097/SHK.0b013e318272ff8a; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Calderone A., 2017, CARDIOVASC REGEN MED, V4, pe1508; Chen L, 2016, INFLAMMATION, V39, P1981, DOI 10.1007/s10753-016-0433-0; Chiang N, 2018, FASEB J, V32, P4043, DOI 10.1096/fj.201701493R; Chistiakov DA, 2015, INT J CARDIOL, V184, P436, DOI 10.1016/j.ijcard.2015.03.055; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; Clarke SA, 2016, J MOL CELL CARDIOL, V93, P115, DOI 10.1016/j.yjmcc.2015.11.028; Colas RA, 2016, J IMMUNOL, V197, P4444, DOI 10.4049/jimmunol.1600837; Dalli J, 2016, P NATL ACAD SCI USA, V113, P12232, DOI 10.1073/pnas.1607003113; Dalli J, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0001-2014; Dalli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149319; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Darehzereshki A, 2015, DEV BIOL, V399, P91, DOI 10.1016/j.ydbio.2014.12.018; Deng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102362; Dick SA, 2016, CIRC RES, V119, P159, DOI 10.1161/CIRCRESAHA.116.308030; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Frantz S, 2014, CARDIOVASC RES, V102, P240, DOI 10.1093/cvr/cvu025; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gentek R, 2017, ADV EXP MED BIOL, V1003, P251, DOI 10.1007/978-3-319-57613-8_12; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Godwin JW, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0027-y; Gordon SM, 2008, EUR J IMMUNOL, V38, P3257, DOI 10.1002/eji.200838855; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Halade GV, 2018, FASEB J, V32, P3717, DOI 10.1096/fj.201701173RR; Halade GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1818; Halade GV, 2018, AM J PHYSIOL-HEART C, V314, pH255, DOI 10.1152/ajpheart.00528.2017; Halade GV, 2017, COMPR PHYSIOL, V7, P1463, DOI 10.1002/cphy.c170011; Halade GV, 2017, AM J PHYSIOL-HEART C, V313, pH89, DOI 10.1152/ajpheart.00040.2017; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Han CY, 2015, CELL RES, V25, P1137, DOI 10.1038/cr.2015.110; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Haubner BJ, 2016, CIRC RES, V118, P216, DOI 10.1161/CIRCRESAHA.115.307017; Haubner BJ, 2012, AGING-US, V4, P966, DOI 10.18632/aging.100526; He LK, 2001, J BURN CARE REHABIL, V22, P58, DOI 10.1097/00004630-200101000-00012; Hong S, 2014, CHEM BIOL, V21, P1318, DOI 10.1016/j.chembiol.2014.06.010; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; Huang WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066613; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kain V, 2015, J MOL CELL CARDIOL, V87, P225, DOI 10.1016/j.yjmcc.2015.08.019; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Konfino T, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001320; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Leor J, 2016, SEMIN CELL DEV BIOL, V58, P26, DOI 10.1016/j.semcdb.2016.04.012; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Lindsey ML, 2016, BBA-MOL BASIS DIS, V1862, P2288, DOI 10.1016/j.bbadis.2016.05.013; Linehan E, 2015, EUR J MICROBIOL IMMU, V5, P14, DOI [10.1556/EuJMI-D-14-00035, 10.1556/EUJMI-D-14-00035]; Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; Mahmoud AI, 2014, NAT PROTOC, V9, P305, DOI 10.1038/nprot.2014.021; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Matsukawa A, 1999, J IMMUNOL, V163, P6148; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nadal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035253; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2016, CIRC RES, V119, P414, DOI 10.1161/CIRCRESAHA.116.309194; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Nielsen SR, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9624760; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Orr SK, 2015, AM J PHYSIOL-LUNG C, V308, pL904, DOI 10.1152/ajplung.00370.2014; Perrier P, 2004, J IMMUNOL, V172, P7031, DOI 10.4049/jimmunol.172.11.7031; Pinto AR, 2014, AGING-US, V6, P399, DOI 10.18632/aging.100669; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Prelog M, 2006, AUTOIMMUN REV, V5, P136, DOI 10.1016/j.autrev.2005.09.008; Rodriguez AR, 2015, TETRAHEDRON LETT, V56, P256, DOI 10.1016/j.tetlet.2014.11.082; Sager HB, 2017, J THORAC DIS, V9, pS30, DOI 10.21037/jtd.2016.11.17; Samokhvalov IM, 2014, CELL MOL LIFE SCI, V71, P957, DOI 10.1007/s00018-013-1364-7; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sansbury BE, 2016, CIRC RES, V119, P113, DOI 10.1161/CIRCRESAHA.116.307308; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tang S, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2438247; ter Horst EN, 2015, INT J MOL SCI, V16, P29583, DOI 10.3390/ijms161226187; Tian W, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006674; Tourki B, 2017, FASEB J, V31, P4226, DOI 10.1096/fj.201700109R; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Viola J, 2015, SEMIN IMMUNOL, V27, P184, DOI 10.1016/j.smim.2015.03.013; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; von Hundelshausen P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00294; Wang CW, 2016, INFECT IMMUN, V84, P658, DOI 10.1128/IAI.01131-15; Weinberger T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00107; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	116	16	16	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5227	5237		10.1096/fj.201800254R	http://dx.doi.org/10.1096/fj.201800254R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29750575	Green Published, Bronze			2022-12-28	WOS:000447972500003
J	Hamann, I; Krys, D; Glubrecht, D; Bouvet, V; Marshall, A; Vos, L; Mackey, JR; Wuest, M; Wuest, F				Hamann, Ingrit; Krys, Daniel; Glubrecht, Darryl; Bouvet, Vincent; Marshall, Alison; Vos, Larissa; Mackey, John R.; Wuest, Melinda; Wuest, Frank			Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancereffects of hypoxia	FASEB JOURNAL			English	Article						glucose metabolism; fructose metabolism; positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; BIOLOGICAL MARKER EXPRESSION; GLUCOSE TRANSPORTERS; F-18-FLUORODEOXYGLUCOSE UPTAKE; FLUORODEOXYGLUCOSE UPTAKE; INDUCIBLE FACTOR-1-ALPHA; F-18-FDG UPTAKE; CYTOCHALASIN-B; CANCER; FRUCTOSE	Elevated growth in breast cancer (BC) activates hypoxia-inducible factor (HIF1) and downstream, facilitative glucose transporter 1 (GLUT1), which can be visualized with 2-deoxy-2-[F-18]fluoro-d-glucose ([F-18]FDG). GLUT5 (fructose) and GLUT2 (glucose/fructose) might provide alternative targets for BC imaging as to why effects of hypoxia on GLUT1/2/5 levels and function were examined in human BC models. GLUT1/2/5 and HIF1 mRNA was analyzed in BC patient biopsies. In MCF10A, MCF7, and MDA-MB231 cells, [F-18]FDG, 6-deoxy-6-[F-18]fluoro-d-fructose (6-[F-18]FDF) and [F-18]-fluoroazomycin arabinoside were used in radiotracer experiments, whereas GLUT1/2/5 mRNA was analyzed with real-time PCR and protein levels determined via Western blot/immunohistochemistry. Positron emission tomography imaging was performed in MCF7 and MDA-MB231 tumor-bearing mice. Glucose/fructose/cytochalasin B reduced cellular 6-[F-18]FDF uptake by 50%, indicating functional involvement of GLUT2. With GLUT5 staining lower than GLUT1, 6-[F-18]FDF revealed lower uptake than [F-18]FDG [standardized uptake value (SUV)(6-[)(18)(F]FDF, 120 min) 0.77 +/- 0.06 vs. SUV[F]FDG, 120 min18 1.08 +/- 0.07] in MDA-MB231 tumors and was blocked by 20% with cytochalasin B after 10 min. Whereas correspondence between 6-[F-18]FDF uptake and GLUT5 protein was low, high GLUT2 levels were detected in all cell lines and tumor models. Besides GLUT1, GLUT5 seems to be regulated under hypoxia on the molecular and functional level. Additionally, results strongly support a functional involvement of GLUT2 in fructose metabolism, possibly by compensating for the weaker expression and function of GLUT5 in BC.Hamann, I., Krys, D., Glubrecht, D., Bouvet, V., Marshall, A., Vos, L., Mackey, J. R., Wuest, M., Wuest, F. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancereffects of hypoxia.	[Hamann, Ingrit; Krys, Daniel; Glubrecht, Darryl; Bouvet, Vincent; Marshall, Alison; Vos, Larissa; Mackey, John R.; Wuest, Melinda; Wuest, Frank] Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada	University of Alberta	Wuest, F (corresponding author), Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	wuest@ualberta.ca			Alberta Cancer Foundation (ACF); Canadian Breast Cancer Foundation (CBCF); Dianne and Irving Kipnes Foundation; ACF	Alberta Cancer Foundation (ACF); Canadian Breast Cancer Foundation (CBCF); Dianne and Irving Kipnes Foundation; ACF(United States Department of Health & Human Services)	The authors thank Dr. John Wilson, David Clendening, and Blake Lazurko (Edmonton PET Center) for [<SUP>18</SUP>F] production on a biomedical cyclotron. The authors thank Angela Westover, Jeff McPherson, and Kristan Nagy-Colombo [Edmonton Radiopharmaceutical Center (ERC), Edmonton, AB, Canada] for production and availability of clinical PET radiotracer [<SUP>18</SUP>F]FDG. The authors greatly acknowledge Ali Akbari (Edmonton PET Center) for preparation of [<SUP>18</SUP>F]FAZA. The authors thank Dan McGinn (Vivarium of the Cross Cancer Institute, Edmonton, AB, Canada) for supporting the animal work and Hans-Soenke Jans (University of Alberta) for technical support of the preclinical imaging facility. The authors thank Dr. Frederick West (Department of Chemistry, University of Alberta) for providing a labeling precursor for the synthesis of radiotracer 6-[<SUP>18</SUP>F]FDF. I.H. thanks the Alberta Cancer Foundation (ACF) for a postdoctoral fellowship award. The authors also gratefully acknowledge the Dianne and Irving Kipnes Foundation, ACF, and the Canadian Breast Cancer Foundation (CBCF) for supporting this work. The authors declare no conflicts of interest.	Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bourgeois AC, 2013, RADIOL CLIN N AM, V51, P781, DOI 10.1016/j.rcl.2013.06.003; Bouvet V, 2014, AM J NUCL MED MOLEC, V4, P248; Chapman DW, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0027-5; Cheng JY, 2013, J NUCL MED, V54, P333, DOI 10.2967/jnumed.112.111963; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; Concha II, 1997, BLOOD, V89, P4190, DOI 10.1182/blood.V89.11.4190; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Godoy A, 2006, J CELL PHYSIOL, V207, P614, DOI 10.1002/jcp.20606; Gowrishankar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026902; HAMACHER K, 1986, J NUCL MED, V27, P235; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; JONES MN, 1980, FEBS LETT, V115, P1, DOI 10.1016/0014-5793(80)80713-7; JUNG CY, 1977, J BIOL CHEM, V252, P5456; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; Kaira K, 2013, ANTICANCER RES, V33, P4219; Kapoor K, 2016, P NATL ACAD SCI USA, V113, P4711, DOI 10.1073/pnas.1603735113; Kent C, 2015, CLIN BREAST CANCER, V15, P403, DOI 10.1016/j.clbc.2015.06.008; Krzeslak A, 2012, PATHOL ONCOL RES, V18, P721, DOI 10.1007/s12253-012-9500-5; Lachaal M, 2000, BBA-BIOMEMBRANES, V1466, P379, DOI 10.1016/S0005-2736(00)00205-4; Lin YC, 2017, CLIN OTOLARYNGOL, V42, P608, DOI 10.1111/coa.12783; Lopci E, 2014, AM J NUCL MED MOLEC, V4, P365; Vercher-Conejero JL, 2015, DIAGNOSTICS, V5, P61, DOI 10.3390/diagnostics5010061; Mano Y, 2014, AM J CLIN PATHOL, V142, P391, DOI 10.1309/AJCPG8AFJ5NRKLLM; McManus J, 2015, MOL BIOSYST, V11, P2680, DOI 10.1039/c5mb00310e; Park SI, 2013, ONKOLOGIE, V36, P169, DOI 10.1159/000349944; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Reischl G, 2005, APPL RADIAT ISOTOPES, V62, P897, DOI 10.1016/j.apradiso.2004.12.004; Sato-Tadano A, 2013, CANCER SCI, V104, P1380, DOI 10.1111/cas.12238; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Smith TAD, 2013, NUCL MED BIOL, V40, P858, DOI 10.1016/j.nucmedbio.2013.05.006; SOULE HD, 1990, CANCER RES, V50, P6075; Tanasova M, 2013, CHEMBIOCHEM, V14, P1263, DOI 10.1002/cbic.201300164; Tian M, 2012, ACAD RADIOL, V19, P420, DOI 10.1016/j.acra.2011.12.006; Trayner BJ, 2009, BIOORGAN MED CHEM, V17, P5488, DOI 10.1016/j.bmc.2009.06.034; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Vermeulen JF, 2013, CELL ONCOL, V36, P333, DOI 10.1007/s13402-013-0138-4; Wood IS, 2007, BIOCHEM BIOPH RES CO, V361, P468, DOI 10.1016/j.bbrc.2007.07.032; Wuest M, 2018, MOL PHARMACOL, V93, P79, DOI 10.1124/mol.117.110007; Wuest M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0609-9; Wuest M, 2013, J LABELLED COMPD RAD, V56, P244, DOI 10.1002/jlcr.2997; Wuest M, 2011, NUCL MED BIOL, V38, P461, DOI 10.1016/j.nucmedbio.2010.11.004; ZamoraLeon SP, 1996, P NATL ACAD SCI USA, V93, P1847, DOI 10.1073/pnas.93.5.1847	47	42	45	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5104	5118		10.1096/fj.201800360R	http://dx.doi.org/10.1096/fj.201800360R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913554	Bronze			2022-12-28	WOS:000443817700039
J	Zhou, J; An, XH; Dong, JJ; Wang, YC; Zhong, H; Duan, LL; Ling, JJ; Ping, FF; Shang, J				Zhou, Jia; An, Xiaohong; Dong, Jinjin; Wang, Yichuan; Zhong, Hui; Duan, Lanlan; Ling, Jingjing; Ping, Fengfeng; Shang, Jing			IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo	FASEB JOURNAL			English	Article						interleukin-17; autophagy; mitochondria; oxidative stress; depigmentary disorder	REGULATORY T-CELLS; OXIDATIVE STRESS; SKIN; INTERLEUKIN-17; FAMILY; KERATINOCYTES; PIGMENTATION; RECEPTOR; INFLAMMASOME; NEUTROPHILS	Vitiligo is a depigmentary disorder that develops as a result of the progressive disappearance of epidermal melanocytes. Stress can precipitate or exacerbate a skin disease through psychosomatic mechanisms. Stress exposure induces vitiligo-like symptoms in mice, as cellular damage to melanocytes causes synthetic pigment loss. Stress also increases IL-17, IL-1, and antimelanocyte IgG in model mouse serum. Up-regulation of the IL-1 transcript in patients suggests its possible role in autoimmune pathogenesis of vitiligo. We demonstrate that IL-17 promoted IL-1 secretion from keratinocytes. Mitochondrial dysfunction, which can induce the excessive production of reactive oxygen species (ROS), is emerging as a mechanism that underlies various inflammatory and autoimmune diseases. In this study, we demonstrate that IL-17 inhibits melanogenesis of zebrafish, normal human epidermal melanocytes, and B16F10 cells. IL-17 increased mitochondrial dysfunction and ROS accumulation, which was related to autophagy induction. Autophagy is needed for autophagic apoptosis of B16F10 cells induced by IL-17. To inhibit ROS generation, B16F10 cells were pretreated with N-acetyl-l-cysteine (NAC), which inhibited autophagy. 3-Methyladenine (3-MA) also had an inhibiting effect on autophagy. NAC or 3-MA pretreatments inhibited IL-17-mediated cell apoptosis. In summary, IL-17 induces the cellular stress microenvironment in melanocytes to promote autophagic cell apoptosis in vitiligo.Zhou, J., An, X., Dong, J., Wang, Y., Zhong, H., Duan, L., Ling, J., Ping, F., Shang, J. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo.	[Zhou, Jia; An, Xiaohong; Dong, Jinjin; Wang, Yichuan; Zhong, Hui; Duan, Lanlan; Ling, Jingjing; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Jia; An, Xiaohong; Dong, Jinjin; Wang, Yichuan; Zhong, Hui; Duan, Lanlan; Ling, Jingjing; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab Tradit Chinese Med TCM Evaluat &, Nanjing, Jiangsu, Peoples R China; [Ping, Fengfeng] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Jiangnan University; Nanjing Medical University	Ping, FF (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Peoples R China.; Shang, J (corresponding author), Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	pffzjtg2015@163.com; shangjing21cn@cpu.edu.cn		ping, fengfeng/0000-0003-4444-4976; ling, jingjing/0000-0002-8028-6891	National Natural Science Foundation of China [81503176]; Jiangsu Youth Medical Talents [QNRC2016194, QNRC2016195]; Medical Innovation Team of Jiangsu Province [CXTDB2017016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Youth Medical Talents; Medical Innovation Team of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (Grant 81503176), Jiangsu Youth Medical Talents (Grants QNRC2016194 and QNRC2016195), and the Medical Innovation Team of Jiangsu Province (Grant CXTDB2017016). The authors declare no conflicts of interest.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Basak PY, 2009, J AM ACAD DERMATOL, V60, P256, DOI 10.1016/j.jaad.2008.09.048; Bassiouny DA, 2011, CLIN EXP DERMATOL, V36, P292, DOI 10.1111/j.1365-2230.2010.03972.x; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; de Koning HD, 2015, BRIT J DERMATOL, V173, P448, DOI 10.1111/bjd.13857; Denat L, 2014, J INVEST DERMATOL, V134, P1512, DOI 10.1038/jid.2014.65; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dyring-Andersen B, 2017, BRIT J DERMATOL, V177, pE321, DOI 10.1111/bjd.15533; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Guerra L, 2010, CURR DRUG METAB, V11, P451, DOI 10.2174/138920010791526105; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kotobuki Y, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00945.x; Laddha NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107020; Lima AL, 2016, BRIT J DERMATOL, V174, P514, DOI 10.1111/bjd.14214; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Ongenae K, 2006, J EUR ACAD DERMATOL, V20, P1, DOI 10.1111/j.1468-3083.2005.01369.x; Ono S, 2014, ACTA DERM-VENEREOL, V94, P329, DOI 10.2340/00015555-1713; Ping FF, 2012, NEUROSCI LETT, V514, P173, DOI 10.1016/j.neulet.2012.02.087; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Richmond JM, 2013, CURR OPIN IMMUNOL, V25, P676, DOI 10.1016/j.coi.2013.10.010; Rodriguez-Vallecillo E, 2014, PSYCHIAT CLIN N AM, V37, P625, DOI 10.1016/j.psc.2014.08.009; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Silverberg JI, 2015, CUTIS, V95, P255; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Speeckaert R, 2015, AUTOIMMUN REV, V14, P332, DOI 10.1016/j.autrev.2014.12.003; van Beelen AJ, 2007, CURR OPIN ALLERGY CL, V7, P374, DOI 10.1097/ACI.0b013e3282ef869e; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weiner L, 2014, PIGM CELL MELANOMA R, V27, P1014, DOI 10.1111/pcmr.12301; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]; Xie H, 2016, J DERMATOL SCI, V81, P3, DOI 10.1016/j.jdermsci.2015.09.003; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhou J, 2014, J DERMATOL SCI, V73, P110, DOI 10.1016/j.jdermsci.2013.09.005	48	41	41	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4899	4916		10.1096/fj.201701242RR	http://dx.doi.org/10.1096/fj.201701242RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29613836				2022-12-28	WOS:000443817700024
J	Chan, CP; Yuen, CK; Cheung, PHH; Fung, SY; Lui, PY; Chen, H; Kok, KH; Jin, DY				Chan, Chi-Ping; Yuen, Chun-Kit; Cheung, Pak-Hin Hinson; Fung, Sin-Yee; Lui, Pak-Yin; Chen, Honglin; Kok, Kin-Hang; Jin, Dong-Yan			Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase	FASEB JOURNAL			English	Article						RIG-I; antiviral response; PA; PB1; PB2	I INTERFERON-PRODUCTION; INDUCIBLE GENE I; SENSOR RIG-I; INNATE IMMUNITY; INDUCED ACTIVATION; NS1 PROTEIN; INFECTION; INHIBITION; REPLICATION; INDUCTION	PACT is a double-stranded RNA-binding protein that has been implicated in host-influenza A virus (IAV) interaction. PACT facilitates the action of RIG-I in the activation of the type I IFN response, which is suppressed by the viral nonstructural protein NS1. PACT is also known to interact with the IAV RNA polymerase subunit PA. Exactly how PACT exerts its antiviral activity during IAV infection remains to be elucidated. In the current study, we demonstrated the interplay between PACT and IAV polymerase. Induction of IFN- by the IAV RNP complex was most robust when both RIG-I and PACT were expressed. PACT-dependent activation of IFN- production was suppressed by the IAV polymerase subunits, polymerase acidic protein, polymerase basic protein 1 (PB1), and PB2. PACT associated with PA, PB1, and PB2. Compromising PACT in IAV-infected A549 cells resulted in the augmentation of viral RNA (vRNA) transcription and replication and IFN- production. Furthermore, vRNA replication was boosted by knockdown of PACT in both A549 cells and IFN-deficient Vero cells. Thus, the antiviral activity of PACT is mediated primarily via its interaction with and inhibition of IAV polymerase. Taken together, our findings reveal a new facet of the host-IAV interaction in which the interplay between PACT and IAV polymerase affects the outcome of viral infection and antiviral response.Chan, C.-P., Yuen, C.-K., Cheung, P.-H. H., Fung, S.-Y., Lui, P.-Y., Chen, H., Kok, K.-H., Jin, D.-Y. Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase.	[Chan, Chi-Ping; Cheung, Pak-Hin Hinson; Fung, Sin-Yee; Lui, Pak-Yin; Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, 3rd Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Yuen, Chun-Kit; Chen, Honglin; Kok, Kin-Hang] Univ Hong Kong, Dept Microbiol, 5th Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Jin, DY (corresponding author), Univ Hong Kong, Sch Biomed Sci, 3rd Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Kok, KH; Jin, DY (corresponding author), Univ Hong Kong, Dept Microbiol, 5th Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	khkok@hku.hk; dyjin@hku.hk	Chan, Chi Ping/AAB-9463-2020; Kok, Kin-Hang/C-4184-2009; Jin, Dong-Yan/C-4287-2009	Chan, Chi Ping/0000-0001-6876-0864; Cheung, Pak Hin Hinson/0000-0003-3682-7571; /0000-0003-3426-332X; Jin, Dong-Yan/0000-0002-2778-3530	Hong Kong Research Grants Council [C7011-15R, ECS-27121515]; Hong Kong Health and Medical Research Fund [HKM-15-M01, 15140662]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Health and Medical Research Fund	The authors thank Connie Cepko (Harvard Medical School, Boston, MA, USA), Takashi Fujita (KyotoUniversity, Kyoto, Japan), and Yoshihiro Kawaoka (University of Wisconsin, Madison, WI, USA) for reagents, and Jasper Ho, Edwin Kong, and Sam Yuen (all from The University of Hong Kong) for critical reading of the manuscript. This work was supported by the Hong Kong Research Grants Council (C7011-15R and ECS-27121515) and the Hong Kong Health and Medical Research Fund (HKM-15-M01 and 15140662). The authors declare no conflicts of interest.	Ahmad S, 2015, TRENDS BIOCHEM SCI, V40, P576, DOI 10.1016/j.tibs.2015.08.001; Anchisi S, 2016, J VIROL, V90, P586, DOI 10.1128/JVI.01671-15; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Benitez AA, 2015, CELL REP, V11, P1714, DOI 10.1016/j.celrep.2015.05.032; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung NN, 2017, J GEN VIROL, V98, P946, DOI 10.1099/jgv.0.000758; Coch C, 2017, MOL THER, V25, P2093, DOI 10.1016/j.ymthe.2017.07.003; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Ding Z, 2017, ONCOTARGET, V8, P49655, DOI 10.18632/oncotarget.17912; Eisfeld AJ, 2015, NAT REV MICROBIOL, V13, P28, DOI 10.1038/nrmicro3367; Fitzgerald ME, 2017, NUCLEIC ACIDS RES, V45, P1442, DOI 10.1093/nar/gkw816; Gabriel G, 2014, CURR TOP MICROBIOL, V385, P35, DOI 10.1007/82_2014_386; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Ho TH, 2016, J VIROL, V90, P1557, DOI 10.1128/JVI.02161-15; Hsu SF, 2015, J VIROL, V89, P3671, DOI 10.1128/JVI.03610-14; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Kew C, 2013, J VIROL, V87, P13141, DOI 10.1128/JVI.02564-13; Kim JS, 2017, EUR HEART J-CARD PHA, V3, P91, DOI 10.1093/ehjcvp/pvw040; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Kok KH, 2013, CELL HOST MICROBE, V14, P5, DOI 10.1016/j.chom.2013.07.004; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; Lai MC, 2016, FEBS J, V283, P88, DOI 10.1111/febs.13553; Lee MK, 2016, NUCLEIC ACIDS RES, V44, P8407, DOI 10.1093/nar/gkw525; Lee SMY, 2014, P NATL ACAD SCI USA, V111, P3793, DOI 10.1073/pnas.1324266111; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li WZ, 2014, J VIROL, V88, P10432, DOI 10.1128/JVI.01383-14; Liedmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6645; Liu GQ, 2015, J VIROL, V89, P6067, DOI 10.1128/JVI.00232-15; Lui PY, 2017, J IMMUNOL, V199, P1846, DOI 10.4049/jimmunol.1601493; Lui PY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.33; Luthra P, 2013, CELL HOST MICROBE, V14, P74, DOI 10.1016/j.chom.2013.06.010; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Marc D, 2014, J GEN VIROL, V95, P2594, DOI 10.1099/vir.0.069542-0; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez-Cidoncha M, 2014, J VIROL, V88, P4632, DOI 10.1128/JVI.00014-14; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prantner D, 2017, J BIOL CHEM, V292, P292, DOI 10.1074/jbc.M116.763268; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shin D, 2017, J VIROL, V91, DOI 10.1128/JVI.02260-16; Siu KL, 2014, J VIROL, V88, P4866, DOI 10.1128/JVI.03649-13; Song WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6509; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Tawaratsumida K, 2014, J VIROL, V88, P9038, DOI 10.1128/JVI.00830-14; To KKW, 2014, CURR OPIN PULM MED, V20, P225, DOI 10.1097/MCP.0000000000000047; To KKW, 2015, CURR OPIN VIROL, V14, P7, DOI 10.1016/j.coviro.2015.04.010; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Weber M, 2015, CELL HOST MICROBE, V17, P309, DOI 10.1016/j.chom.2015.01.005; Weber-Gerlach M, 2016, CURR OPIN IMMUNOL, V42, P71, DOI 10.1016/j.coi.2016.05.016; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yao H, 2015, MOL CELL, V58, P541, DOI 10.1016/j.molcel.2015.03.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Yuen CK, 2016, J VIROL, V90, P3902, DOI 10.1128/JVI.00129-16; Zhang YL, 2016, J IMMUNOL, V197, P824, DOI 10.4049/jimmunol.1501563	68	9	9	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4380	4393		10.1096/fj.201701361R	http://dx.doi.org/10.1096/fj.201701361R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29513570				2022-12-28	WOS:000439325400027
J	Manna, I; Iaccino, E; Dattilo, V; Barone, S; Vecchio, E; Mimmi, S; Filippelli, E; Demonte, G; Polidoro, S; Granata, A; Scannapieco, S; Quinto, I; Valentino, P; Quattrone, A				Manna, Ida; Iaccino, Enrico; Dattilo, Vincenzo; Barone, Stefania; Vecchio, Eleonora; Mimmi, Selena; Filippelli, Enrica; Demonte, Giulio; Polidoro, Serena; Granata, Alfredo; Scannapieco, Sara; Quinto, Ileana; Valentino, Paola; Quattrone, Aldo			Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients	FASEB JOURNAL			English	Article						exosomes; biomarkers; response to drugs	CIRCULATING MICRORNAS; INTERFERON-BETA; EXTRACELLULAR VESICLES; BIOMARKERS; MECHANISM; BIOGENESIS; REVEALS; SYSTEM	Multiple sclerosis (MS) is an autoimmune pathology leading to neurodegeneration. Because of the complexity and heterogenic etiology of this disease, diagnosis and treatment for individual patients are challenging. Exosome-associated microRNAs (miRNAs) have recently emerged as a new class of diagnostic biomarkers involved in both autoimmune and neurologic disorders. Interesting new evidence has emerged showing that circulating miRNAs are dysregulated in MS body fluids, including serum, plasma, and cerebrospinal fluid. We hypothesized that exosome-associated miRNAs could present a readily accessible blood-based assay for MS disease. We detected expression of miRNAs by quantitative PCR on a small cohort of MS patients. We analyzed circulating exosome-associated miRNAs of MS patients before and after therapy and found that 14 exosome-associated miRNAs were significantly down-regulated, while 2 exosome-associated miRNAs were significantly up-regulated in IFN--treated relapsing-remitting MS patients with response to therapy compared to those without response. We identified a serum miRNA panel that could be used to monitor the response to IFN- therapy. Overall, these data suggest that circulating exosome-associated miRNA profiling could represent an easily detectable biomarker of disease and treatment response.Manna, I., Iaccino, E., Dattilo, V., Barone, S., Vecchio, E., Mimmi, S., Filippelli, E., Demonte, G., Polidoro, S., Granata, A., Scannapieco, S., Quinto, I., Valentino, P., Quattrone, A. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.	[Manna, Ida; Quattrone, Aldo] CNR, Inst Mol Bioimaging & Physiol IBFM, Catanzaro, Italy; [Quattrone, Aldo] CNR, Neuroimaging Res Unit, Sect Germaneto, Catanzaro, Italy; [Iaccino, Enrico; Dattilo, Vincenzo; Vecchio, Eleonora; Mimmi, Selena; Quinto, Ileana] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy; [Barone, Stefania; Filippelli, Enrica; Demonte, Giulio; Polidoro, Serena; Granata, Alfredo; Scannapieco, Sara; Valentino, Paola] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, I-88100 Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Consiglio Nazionale delle Ricerche (CNR); Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Iaccino, E (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy.; Valentino, P (corresponding author), Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, I-88100 Catanzaro, Italy.	iaccino@unicz.it; p.vale@unicz.it	VALENTINO, Paola/AAA-4243-2019; Barone, Stefania/AAB-9887-2019; Mimmi, Selena/AAB-9585-2019; vecchio, eleonora/AAT-4287-2020; Dattilo, Vincenzo/AAB-3167-2020; Mimmi, Selena/J-7860-2016	VALENTINO, Paola/0000-0001-7863-9195; Mimmi, Selena/0000-0003-2187-9176; Dattilo, Vincenzo/0000-0001-8493-6188; Mimmi, Selena/0000-0003-2187-9176; vecchio, eleonora/0000-0001-8422-2679; Barone, Stefania/0000-0002-0239-8214; QUINTO, Ileana/0000-0001-8212-8515	Italian National Research Council	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported, in part, by the Italian National Research Council. The authors declare no conflicts of interest.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Angerstein C, 2012, MOL NEUROBIOL, V45, P520, DOI 10.1007/s12035-012-8270-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Ciregia F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00276; Comi G, 2017, LANCET, V389, P1347, DOI 10.1016/S0140-6736(16)32388-1; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; De Felice B, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-26; De Santis G, 2010, J NEUROIMMUNOL, V226, P165, DOI 10.1016/j.jneuroim.2010.06.009; Einarson TR, 2017, CURR MED RES OPIN, V33, P579, DOI 10.1080/03007995.2016.1276895; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fenoglio C, 2013, MULT SCLER J, V19, P1938, DOI 10.1177/1352458513485654; Gandhi R, 2015, MULT SCLER J, V21, P1095, DOI 10.1177/1352458515578771; Gandhi R, 2013, ANN NEUROL, V73, P729, DOI 10.1002/ana.23880; Guerau-de-Arellano M, 2012, J NEUROIMMUNOL, V248, P32, DOI 10.1016/j.jneuroim.2011.10.006; Hecker M, 2013, INT J MOL SCI, V14, P16087, DOI 10.3390/ijms140816087; Housley WJ, 2015, CLIN IMMUNOL, V161, P51, DOI 10.1016/j.clim.2015.06.015; Iaccino E, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0730-8; Ingwersen J, 2015, ANN CLIN TRANSL NEUR, V2, P43, DOI 10.1002/acn3.152; Jagot F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00129; Junker A, 2011, NAT REV NEUROL, V7, P56, DOI 10.1038/nrneurol.2010.179; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Krishnan SR, 2016, NEOPLASIA, V18, P25, DOI 10.1016/j.neo.2015.11.011; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lin ST, 2009, DIS MODEL MECH, V2, P178, DOI 10.1242/dmm.001065; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mancuso R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0504-2; Markowitz CE, 2007, NEUROLOGY, V68, pS8, DOI 10.1212/01.wnl.0000277703.74115.d2; Meira M, 2014, MULT SCLER J, V20, P1363, DOI 10.1177/1352458514524998; Meira M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897249; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Paap BK, 2013, J CLIN CELL IMMUNOL, V2013; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Potenza N, 2018, BBA-MOL BASIS DIS, V1864, P317, DOI 10.1016/j.bbadis.2017.09.024; Rio J, 2009, MULT SCLER, V15, P848, DOI 10.1177/1352458509104591; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Sarchielli P, 2008, NEUROSCI LETT, V435, P223, DOI 10.1016/j.neulet.2008.02.040; Selmaj I, 2017, ANN NEUROL, V81, P703, DOI 10.1002/ana.24931; Selmaj I, 2017, J NEUROIMMUNOL, V306, P1, DOI 10.1016/j.jneuroim.2017.02.002; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tufekci KU, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/807426; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Waschbisch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024604	52	69	72	3	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4241	4246		10.1096/fj.201701533R	http://dx.doi.org/10.1096/fj.201701533R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29505299				2022-12-28	WOS:000439325400015
J	Fang, C; Bian, GL; Ren, P; Xiang, J; Song, J; Yu, CY; Zhang, Q; Liu, L; Chen, K; Liu, FF; Zhang, K; Wu, CF; Sun, RX; Hu, D; Ju, G; Wang, J				Fang, Chao; Bian, Ganlan; Ren, Pan; Xiang, Jie; Song, Jun; Yu, Caiyong; Zhang, Qian; Liu, Ling; Chen, Kun; Liu, Fangfang; Zhang, Kun; Wu, Chunfeng; Sun, Ruixia; Hu, Dan; Ju, Gong; Wang, Jian			S1P transporter SPNS2 regulates proper postnatal retinal morphogenesis	FASEB JOURNAL			English	Article						retinal progenitor cell; apical junctional complex; cell cycle; migration; angiogenesis	SPHINGOSINE KINASE 1; ASYMMETRIC CELL-DIVISION; N-CADHERIN; SPHINGOSINE-1-PHOSPHATE; MIGRATION; NEUROGENESIS; PROLIFERATION; POLARITY; DIFFERENTIATION; MAINTENANCE	Spinster homolog 2 (SPNS2) is the membrane transporter of sphingosine-1-phosphate (S1P), and it participates in several physiologic processes by activating different S1P receptors (S1PRs). However, its functions in the nervous system remain largely unclear. We explored the important role of SPNS2 in the process of retinal morphogenesis using a spns2-deficient rat model. In the absence of the functional SPNS2 transporter, we observed progressively aggravating laminar disorganization of the epithelium at the postnatal stage of retinal development. Disrupted cell polarity, delayed cell-cycle exit of retinal progenitor cells, and insufficient migration of newborn neurons were proposed in this study as potential mechanisms accounting for this structural disorder. In addition, we analyzed the expression profiles of spns2 and s1prs, and proposed that SPNS2 regulated retinal morphogenesis by establishing the S1P level in the eye and activating S1PR3 signaling. These data indicate that SPNS2 is indispensable for normal retinal morphogenesis and provide new insights on the role of S1P in the developing retina using an established in vivo model.-Fang, C., Bian, G., Ren, P., Xiang, J., Song, J., Yu, C., Zhang, Q., Liu, L., Chen, K., Liu, F., Zhang, K., Wu, C., Sun, R., Hu, D., Ju, G., Wang, J. S1P transporter SPNS2 regulates proper postnatal retinal morphogenesis.	[Fang, Chao; Bian, Ganlan; Xiang, Jie; Song, Jun; Yu, Caiyong; Liu, Ling; Chen, Kun; Liu, Fangfang; Zhang, Kun; Ju, Gong] Fourth Mil Med Univ, Dept Neurobiol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China; [Ren, Pan] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast Surg, Xian, Shaanxi, Peoples R China; [Hu, Dan] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian, Shaanxi, Peoples R China; [Zhang, Qian] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Neurol, Sanya, Peoples R China; [Wu, Chunfeng; Sun, Ruixia; Wang, Jian] BIOS Biosci & Technol Ltd Co, BIOS Lab, Guangzhou, Guangdong, Peoples R China; [Wang, Jian] South China Univ Technol, Inst Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Jian] South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; South China University of Technology; South China University of Technology	Ju, G (corresponding author), Fourth Mil Med Univ, Dept Neurobiol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.; Wang, J (corresponding author), South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Med Sch, 382 Zhonghuan Rd East, Guangzhou 510006, Guangdong, Peoples R China.	jugong@fmmu.edu.cn; jwangsc@scut.edu.cn		Fang, Chao/0000-0003-1011-2113; yu, caiyong/0000-0002-4482-2319; Liu, Ling/0000-0002-8681-3656	National Natural Science Foundation of China [31571428, 31271127, 81371364, 81401019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank J. Qiu and L. Fei (both from the Department of Neurobiology, Fourth Military Medical University) for their technical assistance. This study was supported by the National Natural Science Foundation of China (Grants 31571428, 31271127, 81371364, and 81401019). The authors declare no conflicts of interest.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Balczerski B, 2012, DEV BIOL, V362, P230, DOI 10.1016/j.ydbio.2011.12.010; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bian G., 2014, THESIS; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Bradley E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110119; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Das RM, 2014, SCIENCE, V343, P200, DOI 10.1126/science.1247521; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fu PF, 2016, J BIOL CHEM, V291, P27187, DOI 10.1074/jbc.M116.758946; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Ghosh S, 2008, P NATL ACAD SCI USA, V105, P335, DOI 10.1073/pnas.0705713105; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Haldipur P, 2015, BIOL OPEN, V4, P865, DOI 10.1242/bio.009886; Harijith A, 2016, AM J PHYSIOL-LUNG C, V311, pL337, DOI 10.1152/ajplung.00447.2015; Hisano Y, 2013, BIOL OPEN, V2, P789, DOI 10.1242/bio.20134994; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Kanda A, 2013, J NEUROSCI, V33, P19341, DOI 10.1523/JNEUROSCI.1362-13.2013; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Kurusu M, 2012, DEV BIOL, V366, P204, DOI 10.1016/j.ydbio.2012.04.006; Lad EM, 2009, STEM CELLS DEV, V18, P7, DOI 10.1089/scd.2008.0169; Laurenzana A, 2015, J MOL MED, V93, P1145, DOI 10.1007/s00109-015-1292-0; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Martin-Bermudo MD, 2015, DEVELOPMENT, V142, P1492, DOI 10.1242/dev.110585; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Mendelson K, 2013, J BIOL CHEM, V288, P2143, DOI 10.1074/jbc.M112.427344; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Miranda GE, 2009, INVEST OPHTH VIS SCI, V50, P4416, DOI 10.1167/iovs.09-3388; Miyamoto Y, 2015, CELL ADHES MIGR, V9, P183, DOI 10.1080/19336918.2015.1005466; Mongan M, 2011, DEVELOPMENT, V138, P4001, DOI 10.1242/dev.065003; Morillo SM, 2010, P NATL ACAD SCI USA, V107, P109, DOI 10.1073/pnas.0906121107; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; Nohata N, 2016, DEV BIOL, V411, P183, DOI 10.1016/j.ydbio.2016.02.005; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Paulson AF, 2014, CELL ADHES MIGR, V8, P19, DOI 10.4161/cam.27839; Rago L, 2014, EMBO J, V33, P906, DOI 10.1002/embj.201386591; Ranty ML, 2009, GRAEF ARCH CLIN EXP, V247, P215, DOI 10.1007/s00417-008-0957-6; ROARK EF, 1992, DEVELOPMENT, V114, P973; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Romero-Aleman MM, 2012, J COMP NEUROL, V520, P2163, DOI 10.1002/cne.23034; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Shitamukai A, 2012, DEV GROWTH DIFFER, V54, P277, DOI 10.1111/j.1440-169X.2012.01345.x; Shkumatava A, 2005, EMBO REP, V6, P563, DOI 10.1038/sj.embor.7400416; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wert KJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4286; Yamaguchi M, 2010, MECH DEVELOP, V127, P247, DOI 10.1016/j.mod.2010.03.004; Yu C.Y., 2016, THESIS; Zhang M, 2015, BIOMATERIALS, V72, P163, DOI 10.1016/j.biomaterials.2015.08.052	77	11	12	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3597	3613		10.1096/fj.201701116R	http://dx.doi.org/10.1096/fj.201701116R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452570				2022-12-28	WOS:000435104500010
J	Han, X; Xie, HB; Wang, YD; Zhao, CT				Han, Xiao; Xie, Haibo; Wang, Yadong; Zhao, Chengtian			Radial spoke proteins regulate otolith formation during early zebrafish development	FASEB JOURNAL			English	Article						lrrc23; rsph4a; rsph3; otic vesicle; cilia	PRIMARY CILIARY DYSKINESIA; INNER-EAR; HAIR-CELLS; CENTRAL APPARATUS; CENTRAL-COMPLEX; DYNEIN; MUTATIONS; FLAGELLA; DEFECTS; MOTILITY	Radial spokes are structurally conserved, macromolecular complexes that are essential for the motility of 9 + 2 motile cilia. In Chlamydomonas species, mutations in radial spoke proteins result in ciliary motility defects. However, little is known about the function of radial spoke proteins during embryonic development. Here, we investigated the role of a novel radial spoke protein, leucine-rich repeat containing protein 23 (Lrrc23), during zebrafish embryonic development. Mutations in lrrc23 resulted in a selective otolith formation defect during early ear development. Similar otolith defects were also present in the radial spoke head 3 homolog (rsph3) and radial spoke head 4 homolog A (rsph4a) radial spoke mutants. Notably, the radial spoke protein mutations specifically affected ciliary motility in the otic vesicle (OV), whereas motile cilia in other organs functioned normally. Via high-speed video microscopy, we found that motile cilia formation was stochastic and transient in the OV. Importantly, all the motile cilia in the OV beat circularly, in contrast to the planar beating pattern of typical 9 + 2 motile cilia. We identified the key time frame for motile cilia formation during OV development. Finally, we showed that the functions of radial spoke proteins were conserved between zebrafish and Tetrahymena. Together, our results suggest that radial spoke proteins are essential for ciliary motility in the OV and that radial spoke-regulated OV motile cilia represent a unique type of cilia during early zebrafish embryonic development.Han, X., Xie, H., Wang, Y., Zhao, C. Radial spoke proteins regulate otolith formation during early zebrafish development.	[Han, Xiao; Xie, Haibo; Wang, Yadong; Zhao, Chengtian] Ocean Univ China, Coll Marine Life Sci, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Zhao, Chengtian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Zhao, CT (corresponding author), Ocean Univ China, 5 Yu Shan Rd, Qingdao 266003, Peoples R China.	chengtian_zhao@ouc.edu.cn		WANG, YADONG/0000-0003-3210-9900	Shandong Provincial Natural Science Foundation [JQ201506]; National Natural Science Foundation of China [31772456, 31422051]; Fundamental Research Funds for Central Universities [201762003, 201564011]	Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Dr. Shan Gao (Ocean University of China) and members of the Gao laboratory for the excellent support of the Tetrahymena experiments. The authors also thank members of the C.Z. laboratory for the helpful comments on an earlier version of this manuscript. This work was supported by the National Natural Science Foundation of China (Grants 31772456 and 31422051), Shandong Provincial Natural Science Foundation (JQ201506), and the Fundamental Research Funds for Central Universities (Grants 201762003 and 201564011). The authors declare no conflicts of interest.	Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Diener DP, 2011, CYTOSKELETON, V68, P389, DOI 10.1002/cm.20520; El Khouri E, 2016, AM J HUM GENET, V99, P489, DOI 10.1016/j.ajhg.2016.06.022; Gaertig J, 2013, METHOD ENZYMOL, V525, P265, DOI 10.1016/B978-0-12-397944-5.00013-4; GOODENOUGH UW, 1985, J CELL BIOL, V100, P2008, DOI 10.1083/jcb.100.6.2008; Gupta A, 2012, J CELL BIOL, V198, P115, DOI 10.1083/jcb.201111041; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; HOWARD DR, 1994, J CELL BIOL, V127, P1683, DOI 10.1083/jcb.127.6.1683; Jeanson L, 2015, AM J HUM GENET, V97, P153, DOI 10.1016/j.ajhg.2015.05.004; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Lin JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6727; Mochizuki K, 2008, GENE, V425, P79, DOI 10.1016/j.gene.2008.08.007; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Padma P, 2003, MOL BIOL CELL, V14, P774, DOI 10.1091/mbc.02-06-0089; Pigino Gaia, 2012, Bioarchitecture, V2, P50; Pigino G, 2011, J CELL BIOL, V195, P673, DOI 10.1083/jcb.201106125; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sedykh I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34437; Shinohara K, 2015, DEV CELL, V35, P236, DOI 10.1016/j.devcel.2015.10.001; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; SMITH EF, 1992, SCIENCE, V257, P1557, DOI 10.1126/science.1387971; Song Z, 2016, J GENET GENOMICS, V43, P107, DOI 10.1016/j.jgg.2016.02.001; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Tanimoto M, 2011, J NEUROSCI, V31, P3784, DOI 10.1523/JNEUROSCI.5554-10.2011; Urbanska P, 2015, MOL BIOL CELL, V26, P1463, DOI 10.1091/mbc.E14-11-1545; Vasudevan KK, 2015, MOL BIOL CELL, V26, P696, DOI 10.1091/mbc.E14-11-1506; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; Wu D, 2011, DEV CELL, V20, P271, DOI 10.1016/j.devcel.2010.12.006; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yu XW, 2011, DEVELOPMENT, V138, P487, DOI 10.1242/dev.057752; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004	37	8	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3984	3992		10.1096/fj.201701359R	http://dx.doi.org/10.1096/fj.201701359R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475374				2022-12-28	WOS:000435104500042
J	Cherezova, A; Tomilin, V; Buncha, V; Zaika, O; Ortiz, PA; Mei, F; Cheng, XD; Mamenko, M; Pochynyuk, O				Cherezova, Alena; Tomilin, Viktor; Buncha, Vadym; Zaika, Oleg; Ortiz, Pablo A.; Mei, Fang; Cheng, Xiaodong; Mamenko, Mykola; Pochynyuk, Oleh			Urinary concentrating defect in mice lacking Epac1 or Epac2	FASEB JOURNAL			English	Article						collecting duct; AQP2; NHE-3; urea; water deprivation	RENAL COLLECTING DUCT; THICK ASCENDING LIMB; UREA TRANSPORTER; COTRANSPORTER NKCC2; PARATHYROID-HORMONE; APICAL EXOCYTOSIS; CA2+ MOBILIZATION; DISTAL NEPHRON; NHE3 ACTIVITY; VASOPRESSIN	cAMP is a universal second messenger regulating a plethora of processes in the kidney. Two downstream effectors of cAMP are PKA and exchange protein directly activated by cAMP (Epac), which, unlike PKA, is often linked to elevation of [Ca2+](i). While both Epac isoforms (Epac1 and Epac2) are expressed along the nephron, their relevance in the kidney remains obscure. We combined ratiometric calcium imaging with quantitative immunoblotting, immunofluorescent confocal microscopy, and balance studies in mice lacking Epac1 or Epac2 to determine the role of Epac in renal water-solute handling. Epac1(-/-) and Epac2(-/-) mice developed polyuria despite elevated arginine vasopressin levels. We did not detect major deficiencies in arginine vasopressin [Ca2+](i) signaling in split-opened collecting ducts or decreases in aquaporin water channel type 2 levels. Instead, sodium-hydrogen exchanger type 3 levels in the proximal tubule were dramatically reduced in Epac1(-/-) and Epac2(-/-) mice. Water deprivation revealed persisting polyuria, impaired urinary concentration ability, and augmented urinary excretion of Na+ and urea in both mutant mice. In summary, we report a nonredundant contribution of Epac isoforms to renal function. Deletion of Epac1 and Epac2 decreases sodium-hydrogen exchanger type 3 expression in the proximal tubule, leading to polyuria and osmotic diuresis.Cherezova, A., Tomilin, V., Buncha, V., Zaika, O., Ortiz, P. A., Mei, F., Cheng, X., Mamenko, M., Pochynyuk, O. Urinary concentrating defect in mice lacking Epac1 or Epac2.	[Cherezova, Alena; Buncha, Vadym; Mamenko, Mykola] Augusta Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA; [Tomilin, Viktor; Zaika, Oleg; Mei, Fang; Cheng, Xiaodong; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA; [Cheng, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Ortiz, Pablo A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA	University System of Georgia; Augusta University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Henry Ford Health System; Henry Ford Hospital	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	oleh.m.pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015; Cheng, Xiaodong/O-8176-2019	Mamenko, Mykola/0000-0001-8683-0715; Cheng, Xiaodong/0000-0002-3479-1694	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK095029, DK119170]; American Heart Association (AHA) [17GRNT33660488]; American Society of Nephrology Ben J. Lipps Research Fellowship [AHA-15SDG25550150]; NIH National Institute of General Medical Sciences [GM066170, GM122536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK119170, R01DK095029, R01DK107263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R35GM122536] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association (AHA)(American Heart Association); American Society of Nephrology Ben J. Lipps Research Fellowship; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Alicia McDonough (Keck School of Medicine, University of Southern California, Los Angeles, CA, USA) for the insights and advice on technical aspects of renal transporter detection; and Svetlana Cherezova for her invaluable help with schematic illustration of the nephron. This research was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK095029 and DK119170 (to O.P.), American Heart Association (AHA) Grant 17GRNT33660488 (to O.P.), American Society of Nephrology Ben J. Lipps Research Fellowship (to V.T.), AHA-15SDG25550150 (to M.M.), and NIH National Institute of General Medical Sciences Grants GM066170 and GM122536 (to X.C.). The authors declare no conflicts of interest.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Balasubramanian L, 2008, PFLUG ARCH EUR J PHY, V456, P747, DOI 10.1007/s00424-007-0371-7; Banerjee U, 2015, GENE, V570, P157, DOI 10.1016/j.gene.2015.06.063; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Bockenhauer D, 2015, NAT REV NEPHROL, V11, P576, DOI 10.1038/nrneph.2015.89; Bradford EM, 2009, AM J PHYSIOL-GASTR L, V296, pG886, DOI 10.1152/ajpgi.90520.2008; Broere N, 2009, PFLUG ARCH EUR J PHY, V457, P1079, DOI 10.1007/s00424-008-0579-1; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; Danziger J, 2015, CLIN J AM SOC NEPHRO, V10, P852, DOI 10.2215/CJN.10741013; de Bruijn PIA, 2015, AM J PHYSIOL-RENAL, V309, pF146, DOI 10.1152/ajprenal.00154.2015; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fenton RA, 2017, KIDNEY INT, V92, P397, DOI 10.1016/j.kint.2017.02.001; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Good DW, 1996, AM J PHYSIOL-RENAL, V270, pF691, DOI 10.1152/ajprenal.1996.270.4.F691; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Klein JD, 2016, J AM SOC NEPHROL, V27, P1448, DOI 10.1681/ASN.2014121267; Klein JD, 2011, COMPR PHYSIOL, V1, P699, DOI 10.1002/cphy.c100030; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Lezoualc'h F, 2016, CIRC RES, V118, P881, DOI 10.1161/CIRCRESAHA.115.306529; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Li Y, 2008, AM J PHYSIOL-RENAL, V295, pF525, DOI 10.1152/ajprenal.00448.2007; Lobo MJ, 2016, J CELL SCI, V129, P2599, DOI 10.1242/jcs.185629; Mamenko M, 2016, J AM SOC NEPHROL, V27, P2035, DOI 10.1681/ASN.2014121200; Mamenko M, 2013, J BIOL CHEM, V288, P20306, DOI 10.1074/jbc.M113.466797; Mamenko Mykola, 2013, Methods Mol Biol, V998, P371, DOI 10.1007/978-1-62703-351-0_29; Mamenko M, 2012, HYPERTENSION, V60, P1234, DOI 10.1161/HYPERTENSIONAHA.112.200469; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Mount DB, 2014, CLIN J AM SOC NEPHRO, V9, P1974, DOI 10.2215/CJN.04480413; Palmer LG, 2015, CLIN J AM SOC NEPHRO, V10, P676, DOI 10.2215/CJN.12391213; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Pereira L, 2013, CIRCULATION, V127, P913, DOI 10.1161/CIRCULATIONAHA.12.148619; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Robichaux WG, 2018, PHYSIOL REV, V98, P919, DOI 10.1152/physrev.00025.2017; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Tsalkova T, 2012, P NATL ACAD SCI USA, V109, P18613, DOI 10.1073/pnas.1210209109; Uchida S, 2005, MOL CELL BIOL, V25, P7357, DOI 10.1128/MCB.25.16.7357-7363.2005; Wade JB, 2000, AM J PHYSIOL-RENAL, V278, pF52, DOI 10.1152/ajprenal.2000.278.1.F52; Wang PY, 2017, BIOORG MED CHEM LETT, V27, P1633, DOI 10.1016/j.bmcl.2017.02.065; Wang YH, 2009, J AM SOC NEPHROL, V20, P2018, DOI 10.1681/ASN.2008121225; Wiederkehr MR, 2001, KIDNEY INT, V59, P197, DOI 10.1046/j.1523-1755.2001.00480.x; Wilson JLL, 2013, CLIN EXP NEPHROL, V17, P751, DOI 10.1007/s10157-013-0789-5; Yan JB, 2013, MOL CELL BIOL, V33, P918, DOI 10.1128/MCB.01227-12; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yip KP, 2011, AM J PHYSIOL-RENAL, V300, pF540, DOI 10.1152/ajprenal.00544.2009; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zhu YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09344	64	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2156	2170		10.1096/fj.201800435R	http://dx.doi.org/10.1096/fj.201800435R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252533	Green Published			2022-12-28	WOS:000457296600051
J	Barnett, JT; Kad, NM				Barnett, Jamie T.; Kad, Neil M.			Understanding the coupling between DNA damage detection and UvrA's ATPase using bulk and single molecule kinetics	FASEB JOURNAL			English	Article						cooperativity; fluorescence imaging; DNA repair; DNA tightropes	ESCHERICHIA-COLI-UVRA; NUCLEOTIDE EXCISION-REPAIR; PROTEIN; BINDING; DOMAINS; DIMERIZATION; COMPLEXES; NUCLEASE; ROLES	Nucleotide excision repair (NER) protects cells against diverse types of DNA damage, principally UV irradiation. In Escherichia coli, damage is recognized by 2 key enzymes: UvrA and UvrB. Despite extensive investigation, the role of UvrA's 2 ATPase domains in NER remains elusive. Combining single-molecule fluorescence microscopy and classic biochemical methods, we have investigated the role of nucleotide binding in UvrA's kinetic cycle. Measurement of UvrA's steady-state ATPase activity shows it is stimulated upon binding DNA (k(cat) 0.71-1.07/s). Despite UvrA's ability to discriminate damage, we find UV-damaged DNA does not alter the steady-state ATPase. To understand how damage affects UvrA, we studied its binding to DNA under various nucleotide conditions at the single molecule level. We have found that both UV damage and nucleotide cofactors affect the attached lifetime of UvrA. In the presence of ATP and UV damage, the lifetime is significantly greater compared with undamaged DNA. To reconcile these observations, we suggest that UvrA uses negative cooperativity between its ATPase sites that is gated by damage recognition. Only in the presence of damage is the second site activated, most likely in a sequential manner.Barnett, J. T., Kad, N. M. Understanding the coupling between DNA damage detection and UvrA's ATPase using bulk and single molecule kinetics.	[Barnett, Jamie T.; Kad, Neil M.] Univ Kent, Sch Biol Sci, Canterbury CT2 7NH, Kent, England	University of Kent	Kad, NM (corresponding author), Univ Kent, Sch Biol Sci, Canterbury CT2 7NH, Kent, England.	n.kad@kent.ac.uk		Kad, Neil/0000-0002-3491-8595; Barnett, Jamie/0000-0003-0731-7249	Biotechnology and Biological Sciences Research Council [BB/P00847X/1, BB/M019144/1, BB/I003460/1, BB/M01603X/1]; Biotechnology and Biological Sciences Research Council [1666540] Funding Source: researchfish; BBSRC [1666540, BB/I003460/1, BB/P00847X/1, BB/M019144/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Kad group for discussion; Bennett Van Houten (University of Pittsburgh, Pittsburgh, PA, USA), Chris Mulligan, Alex Moores, and Michael Geeves (all of the University of Kent) for reading the manuscript; the National Institute of Genetics, Japan for access to their excellent collection of materials; and Alex Moores for constructing the empty mScarlet vector used in this study. This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/P00847X/1, BB/M019144/1, and BB/I003460/1 (to N.M.K.) and BB/M01603X/1 (to J.T.B.). The authors declare no conflicts of interest.	Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Croteau DL, 2006, J BIOL CHEM, V281, P26370, DOI 10.1074/jbc.M603093200; DellaVecchia MJ, 2004, J BIOL CHEM, V279, P45245, DOI 10.1074/jbc.M408659200; HUSAIN I, 1986, J BIOL CHEM, V261, P4895; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Jaciuk M, 2011, NAT STRUCT MOL BIOL, V18, P191, DOI 10.1038/nsmb.1973; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kraithong T, 2017, DNA REPAIR, V51, P60, DOI 10.1016/j.dnarep.2017.02.003; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Malta E, 2007, BIOCHEMISTRY-US, V46, P9080, DOI 10.1021/bi7002235; MAZUR SJ, 1991, BIOCHEMISTRY-US, V30, P4432, DOI 10.1021/bi00232a009; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3824, DOI 10.1021/bi00230a004; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3834, DOI 10.1021/bi00230a005; OH EY, 1989, NUCLEIC ACIDS RES, V17, P4145, DOI 10.1093/nar/17.11.4145; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; Pakotiprapha D, 2008, MOL CELL, V29, P122, DOI 10.1016/j.molcel.2007.10.026; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SEEBERG E, 1982, P NATL ACAD SCI-BIOL, V79, P988, DOI 10.1073/pnas.79.4.988; Springall L, 2018, NUCLEIC ACIDS RES, V46, P1256, DOI 10.1093/nar/gkx1244; Springall L, 2016, METHODS MOL BIOL, V1431, P141, DOI 10.1007/978-1-4939-3631-1_11; Stracy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12568; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; THIAGALINGAM S, 1991, J BIOL CHEM, V266, P11395; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; Wagner K, 2010, DNA REPAIR, V9, P1176, DOI 10.1016/j.dnarep.2010.08.008; YEUNG AT, 1983, P NATL ACAD SCI-BIOL, V80, P6157, DOI 10.1073/pnas.80.20.6157	30	7	7	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					763	769		10.1096/fj.201800899R	http://dx.doi.org/10.1096/fj.201800899R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020831	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000457401500059
J	Mao, CZ; Zheng, L; Zhou, YM; Wu, HY; Xia, JB; Liang, CQ; Guo, XF; Peng, WT; Zhao, H; Cai, WB; Kim, SK; Park, KS; Cai, DQ; Qi, XF				Mao, Cheng-Zhou; Zheng, Li; Zhou, Yi-Min; Wu, Hai-Yan; Xia, Jing-Bo; Liang, Chi-Qian; Guo, Xiao-Fang; Peng, Wen-Tao; Zhao, Hui; Cai, Wei-Bin; Kim, Soo-Ki; Park, Kyu-Sang; Cai, Dong-Qing; Qi, Xu-Feng			CRISPR/Cas9-mediated efficient and precise targeted integration of donor DNA harboring double cleavage sites in Xenopus tropicalis	FASEB JOURNAL			English	Article						knock-in; gene labeling; mammalian cells	HUMAN-CELLS; KNOCK-IN; GENOME; ZEBRAFISH; MUTAGENESIS; SYSTEM; GENERATION; FREQUENCY; HOMOLOGY; GENES	The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 system has emerged as a powerful tool for knock-in of DNA fragments via donor plasmid and homology-independent DNA repair mechanism; however, conventional integration includes unnecessary plasmid backbone and may result in the unfaithful expression of the modified endogenous genes. Here, we report an efficient and precise CRISPR/Cas9-mediated integration strategy using a donor plasmid that harbors 2 of the same cleavage sites that flank the cassette at both sides. After the delivery of donor plasmid, together with Cas9 mRNA and guide RNA, into cells or fertilized eggs, concurrent cleavages at both sides of the exogenous cassette and the desired chromosomal site result in precise targeted integration without plasmid backbone. We successfully used this approach to precisely integrate the EGFP reporter gene into the myh6 locus or the GAPDH locus in Xenopus tropicalis or human cells, respectively. Furthermore, we demonstrate that replacing conventional terminators with the endogenous 3UTR of target genes in the cassette greatly improves the expression of reporter gene after integration. Our efficient and precise method will be useful for a variety of targeted genome modifications, not only in X. tropicalis, but also in mammalian cells, and can be readily adapted to many other organisms.Mao, C.-Z., Zheng, L., Zhou, Y.-M., Wu, H.-Y., Xia, J.-B., Liang, C.-Q., Guo, X.-F., Peng, W.-T., Zhao, H., Cai, W.-B., Kim, S.-K., Park, K.-S., Cai, D.-Q., Qi, X.-F. CRISPR/Cas9-mediated efficient and precise targeted integration of donor DNA harboring double cleavage sites in Xenopus tropicalis.	[Mao, Cheng-Zhou; Zhou, Yi-Min; Wu, Hai-Yan; Xia, Jing-Bo; Liang, Chi-Qian; Guo, Xiao-Fang; Peng, Wen-Tao; Cai, Dong-Qing; Qi, Xu-Feng] Jinan Univ, Dept Dev & Regenerat Biol, Key Lab Regenerat Med, Minist Educ, Guangzhou 510632, Guangdong, Peoples R China; [Mao, Cheng-Zhou; Cai, Wei-Bin] Sun Yat Sen Univ, Guangdong Engn & Technol Res Ctr Dis Model Anim, Guangzhou, Guangdong, Peoples R China; [Zheng, Li] Guangdong Univ Technol, Coll Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhao, Hui] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Transient Receptor Potentia, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Kim, Soo-Ki] Yonsei Univ, Wonju Coll Med, Dept Microbiol, Wonju, South Korea; [Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea	Jinan University; Sun Yat Sen University; Guangdong University of Technology; Chinese University of Hong Kong; Yonsei University; Yonsei University	Cai, DQ; Qi, XF (corresponding author), Jinan Univ, Dept Dev & Regenerat Biol, Key Lab Regenerat Med, Minist Educ, Guangzhou 510632, Guangdong, Peoples R China.	tdongbme@jnu.edu.cn; qixufeng@jnu.edu.cn	Zhao, Hui/B-8429-2016	Zhao, Hui/0000-0001-8160-6415; Park, Kyu-Sang/0000-0003-0322-9807	National Key Research and Development Program of China [2016YFE0204700, 2017YFA0103302]; Major Research Plan of the National Natural Science Foundation of China-Key Program [91649203]; National Natural Science Foundation of China [81570222, 81770240, 81270183]; Guangdong Natural Science Funds for Distinguished Young Scholar [2014A030306011]; Guangdong Science and Technology Planning Project [2014A050503043, 2016A020221034]; New Star of Pearl River on Science and Technology of Guangzhou [2014J2200002]; Top Young Talents of Guangdong Province Special Support Program [87315007]; Foundation for Distinguished Young Talents in Higher Education of Guangdong Province [2013LYM0026]; Fundamental Research Funds for the Central Universities [21617436]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2013-693]	National Key Research and Development Program of China; Major Research Plan of the National Natural Science Foundation of China-Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholar; Guangdong Science and Technology Planning Project; New Star of Pearl River on Science and Technology of Guangzhou; Top Young Talents of Guangdong Province Special Support Program; Foundation for Distinguished Young Talents in Higher Education of Guangdong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The authors thank Yong-Long Chen (Southern University of Science and Technology, Shenzhen, China) for technical help and plasmids supplying. This work was supported by grants from the National Key Research and Development Program of China (2016YFE0204700 and 2017YFA0103302), the Major Research Plan of the National Natural Science Foundation of China-Key Program (91649203), the National Natural Science Foundation of China (81570222, 81770240, and 81270183), the Guangdong Natural Science Funds for Distinguished Young Scholar (2014A030306011), the Guangdong Science and Technology Planning Project (2014A050503043 and 2016A020221034), the New Star of Pearl River on Science and Technology of Guangzhou (2014J2200002), the Top Young Talents of Guangdong Province Special Support Program (87315007), the Foundation for Distinguished Young Talents in Higher Education of Guangdong Province (2013LYM0026), the Fundamental Research Funds for the Central Universities (21617436), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2013-693). C.-Z.M. and L.Z. contributed as co-first authors on this work. The authors declare no conflicts of interest.	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bhattacharya D, 2015, DEV BIOL, V408, P196, DOI 10.1016/j.ydbio.2015.11.003; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; FLEMING GH, 1995, PLANT SCI, V110, P187, DOI 10.1016/0168-9452(95)04196-2; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hagmann M, 1996, BIOL CHEM H-S, V377, P239, DOI 10.1515/bchm3.1996.377.4.239; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Li J, 2015, ONCOTARGET, V6, P17891, DOI 10.18632/oncotarget.4547; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Liu Y, 2014, METHODS, V69, P58, DOI 10.1016/j.ymeth.2014.02.011; Love NR, 2011, DEVELOPMENT, V138, P5451, DOI 10.1242/dev.066498; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Naert T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35264; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakanishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36252; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Pai AA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006338; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Simpson Deborah J., 2007, Environmental Biosafety Research, V6, P55, DOI 10.1051/ebr:2007027; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Tandon P, 2017, DEV BIOL, V426, P325, DOI 10.1016/j.ydbio.2016.04.009; Thesleff I, 1998, ACTA ODONTOL SCAND, V56, P321, DOI 10.1080/000163598428248; Van Nieuwenhuysen Tom, 2015, Oncoscience, V2, P555; Vignali R, 2000, DEVELOPMENT, V127, P1455; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yeh HS, 2016, MOL CELLS, V39, P281, DOI 10.14348/molcells.2016.0035; Yergeau DA, 2010, METHODS, V51, P92, DOI 10.1016/j.ymeth.2010.03.001	38	5	5	0	58	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6495	6509		10.1096/fj.201800093	http://dx.doi.org/10.1096/fj.201800093			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29897811	Bronze			2022-12-28	WOS:000449359700012
J	Reichenbach, A; Stark, R; Mequinion, M; Lockie, SH; Lemus, MB; Mynatt, RL; Luquet, S; Andrews, ZB				Reichenbach, Alex; Stark, Romana; Mequinion, Mathieu; Lockie, Sarah H.; Lemus, Moyra B.; Mynatt, Randall L.; Luquet, Serge; Andrews, Zane B.			Carnitine acetyltransferase (Crat) in hunger-sensing AgRP neurons permits adaptation to calorie restriction	FASEB JOURNAL			English	Article						rebound weight gain; body composition; RER; feeding behavior; metabolic flexibility	FAT-FREE MASS; METABOLIC FLEXIBILITY; LIPID-METABOLISM; NERVOUS-SYSTEM; ADIPOSE-TISSUE; ENERGY-INTAKE; FOOD-INTAKE; ADULT MICE; STIMULATION; MYOSTATIN	Hunger-sensing agouti-related peptide (AgRP) neurons ensure survival by adapting metabolism and behavior to low caloric environments. This adaption is accomplished by consolidating food intake, suppressing energy expenditure, and maximizing fat storage (nutrient partitioning) for energy preservation. The intracellular mechanisms responsible are unknown. Here we report that AgRP carnitine acetyltransferase (Crat) knockout (KO) mice exhibited increased fatty acid utilization and greater fat loss after 9 d of calorie restriction (CR). No differences were seen in mice with ad libitum food intake. Eleven days ad libitum feeding after CR resulted in greater food intake, rebound weight gain, and adiposity in AgRP Crat KO mice compared with wild-type controls, as KO mice act to restore pre-CR fat mass. Collectively, this study highlights the importance of Crat in AgRP neurons to regulate nutrient partitioning and fat mass during chronically reduced caloric intake. The increased food intake, body weight gain, and adiposity in KO mice after CR also highlights the detrimental and persistent metabolic consequence of impaired substrate utilization associated with CR. This finding may have significant implications for postdieting weight management in patients with metabolic diseases.Reichenbach, A., Stark, R., Mequinion, M., Lockie, S. H., Lemus, M. B., Mynatt, R. L., Luquet, S., Andrews, Z. B. Carnitine acetyltransferase (Crat) in hunger-sensing AgRP neurons permits adaptation to calorie restriction.	[Reichenbach, Alex; Stark, Romana; Mequinion, Mathieu; Lockie, Sarah H.; Lemus, Moyra B.; Andrews, Zane B.] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Reichenbach, Alex; Stark, Romana; Mequinion, Mathieu; Lockie, Sarah H.; Lemus, Moyra B.; Andrews, Zane B.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Mynatt, Randall L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Gene Nutrient Interact Lab, Baton Rouge, LA USA; [Mynatt, Randall L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Transgen Core Facil, Baton Rouge, LA USA; [Luquet, Serge] Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat,Unite Mixte Rech 8251, Paris, France	Monash University; Monash University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Andrews, ZB (corresponding author), Monash Univ, Wellington Rd, Clayton, Vic 3183, Australia.	zane.andrews@monash.edu	Luquet, serge/AAT-1809-2021; Mynatt, Randall L/N-1980-2017	Luquet, serge/0000-0001-8668-6645; Mynatt, Randall L/0000-0003-4399-0019; REICHENBACH, ALEXANDER/0000-0002-3520-8341; Stark, Romana/0000-0002-4264-0060; Andrews, Zane B./0000-0002-9097-7944; Lockie, Sarah/0000-0002-3833-4714	Australian National Health and Medical Research Council (NHMRC) grant [1126724, 1084344]; U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence [8P20GM103528]; NIH Nutrition Obesity Research Centers [2P30-DK072476-11A1]; Australian Government Research Training Program Scholarship; Australian NHMRC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC) grant(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nutrition Obesity Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Doug Compton (Research Diets, New Brunswick, NJ, USA) for helping construct and establish the BioDaq feeding cages. This study was supported by an Australian National Health and Medical Research Council (NHMRC) grant and fellowship (1126724, 1084344) to Z.B.A. This work used the Pennington Biomedical Research Center Transgenic Core, which is supported, in part, by the U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence (8P20GM103528) and the NIH Nutrition Obesity Research Centers (2P30-DK072476-11A1). A.R. is supported through an Australian Government Research Training Program Scholarship. S.H.L. and R.S. are supported by an Australian NHMRC Early Career Research Fellowship. The authors declare no conflicts of interest.	Abu Shamsi N, 2014, PHYSIOL BEHAV, V128, P188, DOI 10.1016/j.physbeh.2014.02.021; Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Beutler LR, 2017, NEURON, V96, P461, DOI 10.1016/j.neuron.2017.09.043; Boldrin L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04896-y; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Chen Y., 2016, ELIFE, V5; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Darabian S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159958; Dodd GT, 2017, CELL METAB, V26, P375, DOI 10.1016/j.cmet.2017.07.013; Dulloo AG, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12250; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Gastaldelli A, 2017, CLIN SCI, V131, P2701, DOI 10.1042/CS20170987; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Hopkins M, 2016, INT J OBESITY, V40, P312, DOI 10.1038/ijo.2015.155; Jackowski S, 2014, BIOCHEM SOC T, V42, P1118, DOI 10.1042/BST20140156; Jansson JO, 2018, P NATL ACAD SCI USA, V115, P427, DOI 10.1073/pnas.1715687114; Joly-Amado A, 2014, BEST PRACT RES CL EN, V28, P725, DOI 10.1016/j.beem.2014.03.003; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Kuperman Y, 2016, CELL METAB, V23, P1185, DOI 10.1016/j.cmet.2016.04.017; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lockie SH, 2013, MOL METAB, V2, P329, DOI 10.1016/j.molmet.2013.08.003; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; Mauvoisin D, 2017, CELL REP, V20, P1729, DOI 10.1016/j.celrep.2017.07.065; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Neufeld-Cohen A, 2016, P NATL ACAD SCI USA, V113, pE1673, DOI 10.1073/pnas.1519650113; Nogueiras R, 2010, OBES REV, V11, P185, DOI 10.1111/j.1467-789X.2009.00669.x; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; O'Rahilly S, 2008, DIABETES, V57, P2905, DOI 10.2337/db08-0210; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Park S, 2017, AGING CELL, V16, P339, DOI 10.1111/acel.12558; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Reichenbach A, 2018, CELL REP, V22, P1745, DOI 10.1016/j.celrep.2018.01.067; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Carneiro BTS, 2009, CHRONOBIOL INT, V26, P1273, DOI 10.3109/07420520903404480; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Shi ZG, 2017, J CLIN INVEST, V127, P2868, DOI 10.1172/JCI92008; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Steculorum SM, 2016, CELL, V165, P125, DOI 10.1016/j.cell.2016.02.044; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Tan K, 2014, MOL METAB, V3, P694, DOI 10.1016/j.molmet.2014.07.002; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Weise CM, 2015, HUM BRAIN MAPP, V36, P2406, DOI 10.1002/hbm.22780; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011	51	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6923	6933		10.1096/fj.201800634R	http://dx.doi.org/10.1096/fj.201800634R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29932868	Green Published			2022-12-28	WOS:000449359700044
J	Ogasawara, R; Suginohara, T				Ogasawara, Riki; Suginohara, Takeshi			Rapamycin-insensitive mechanistic target of rapamycin regulates basal and resistance exercise-induced muscle protein synthesis	FASEB JOURNAL			English	Article						skeletal muscle; contraction; translation; metabolism; AZD8055	HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; IN-VIVO; MTOR; PHOSPHORYLATION; HYPERTROPHY; METABOLISM; GROWTH; PRAS40; AMPK	We investigated whether rapamycin-insensitive mechanistic target of rapamycin (mTOR) signaling plays a role in regulating resistance exercise-induced muscle protein synthesis. We used a rodent model of resistance exercise and compared the effect of rapamycin, an allosteric mTOR inhibitor, with the effect of AZD8055, an ATP-competitive mTOR kinase inhibitor. The right gastrocnemius muscle of male Sprague-Dawley rats age 11 wk was contracted isometrically via percutaneous electrical stimulation (100 Hz, 5 sets of ten 3-s contractions, 7 s of rest between contractions, 3 min of rest between sets), and the left gastrocnemius muscle served as control. Vehicle, rapamycin, or AZD8055 were intraperitoneally injected 1 h before resistance exercise. Results indicated that both rapamycin and AZD8055 inhibited mTOR complex 1 (mTORC1)/70-kDa ribosomal protein S6 kinase signaling similarly, whereas mTORC1/eukaryotic translation initiation factor 4E-binding protein 1 signaling was greatly inhibited by AZD8055. Moreover, only AZD8055 inhibited the phosphorylation of Akt at Ser473, a downstream target of mTORC2. AZD8055, but not rapamycin, completely inhibited the resistance exercise-induced increase in muscle protein synthesis. We conclude that the resistance exercise-induced increase in muscle protein synthesis is an mTOR signaling-dependent process. Furthermore, both rapamycin-sensitive and -insensitive mTOR signaling regulate this event.Ogasawara, R., Suginohara, T. Rapamycin-insensitive mechanistic target of rapamycin regulates basal and resistance exercise-induced muscle protein synthesis.	[Ogasawara, Riki; Suginohara, Takeshi] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Nagoya, Aichi 4668555, Japan	Nagoya Institute of Technology	Ogasawara, R (corresponding author), Nagoya Inst Technol, Dept Life Sci & Appl Chem, Nagoya, Aichi 4668555, Japan.	ogasawara.riki@nitech.ac.jp	理紀, 小笠原/HGC-1855-2022; Ogasawara, Riki/AAD-7221-2020	Ogasawara, Riki/0000-0002-2600-1613	Japan Society for the Promotion of Science [26702028]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) (26702028 to R.O.). The authors declare no conflicts of interest.	Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kleinert M, 2016, MOL METAB, V5, P646, DOI 10.1016/j.molmet.2016.06.007; Kleinert M, 2014, MOL METAB, V3, P630, DOI 10.1016/j.molmet.2014.06.004; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Mi WT, 2015, ONCOTARGET, V6, P13962, DOI 10.18632/oncotarget.3920; Ogasawara R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31142; Rosborough BR, 2014, AM J TRANSPLANT, V14, P2173, DOI 10.1111/ajt.12799; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Wiza C, 2013, DIABETOLOGIA, V56, P1118, DOI 10.1007/s00125-013-2861-9; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011; You JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047258; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019	29	36	37	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5824	5834		10.1096/fj.201701422R	http://dx.doi.org/10.1096/fj.201701422R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29757673	Bronze			2022-12-28	WOS:000447172000006
J	Oakley, RH; Ramamoorthy, S; Foley, JF; Busada, JT; Lu, NZ; Cidlowski, JA				Oakley, Robert H.; Ramamoorthy, Sivapriya; Foley, Julie F.; Busada, Jonathan T.; Lu, Nick Z.; Cidlowski, John A.			Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice	FASEB JOURNAL			English	Article						translational isoforms; knockin mice; respiratory distress	CHROMAFFIN CELL-DEVELOPMENT; TRANSLATIONAL ISOFORMS; HUMAN MONOCYTES; MECHANISMS; EXPRESSION; STRESS; SEPSIS; SYSTEM	Glucocorticoids are primary stress hormones, and their synthetic derivatives are widely used clinically. The therapeutic efficacy of these steroids is limited by side effects and glucocorticoid resistance. Multiple glucocorticoid receptor (GR) isoforms are produced from a single gene by alternative translation initiation; however, the role individual isoforms play in tissue-specific responses to glucocorticoids is unknown. We have generated knockin mice that exclusively express the most active receptor isoform, GR-C3. GR-C3 knockin mice die at birth due to respiratory distress. Microarray analysis of fibroblasts from wild-type and GR-C3 mice indicated that most genes regulated by GR-C3 were unique to this isoform. Antenatal glucocorticoid administration rescued GR-C3 knockin mice from neonatal death. Dual-energy X-ray absorptiometry revealed no major alterations in body composition for rescued knockin mice. Rescued female, but not male, GR-C3 mice exhibited increased wheel running activity in the light portion of the day. LPS administration induced premature mortality in rescued GR-C3 knockin mice, and gene expression studies revealed a deficiency in the ability of GR-C3 to repress a large cohort of immune and inflammatory response genes. These findings demonstrate that specific GR translational isoforms can influence development, circadian rhythm, and inflammation through the regulation of distinct gene networks.Oakley, R. H., Ramamoorthy, S., Foley, J. F., Busada, J. T., Lu, N. Z., Cidlowski, J. A. Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice.	[Oakley, Robert H.; Ramamoorthy, Sivapriya; Busada, Jonathan T.; Lu, Nick Z.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, Dept Hlth & Human Serv, NIH, Res Triangle Pk, NC USA; [Foley, Julie F.] NIEHS, Cellular & Mol Pathol Branch, Dept Hlth & Human Serv, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of General Medical Sciences Postdoctoral Research Associate Training Program Grant [1Fi2GM123974-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057, ZICES102445, ZIAES090079] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of General Medical Sciences Postdoctoral Research Associate Training Program Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Kevin Gerrish and Rick D. Fannin (Molecular Genomics Core Laboratory, National Institute of Environmental Health Sciences) for assistance with microarray and nanostring analyses. This work was supported by the Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences, and by NIH National Institute of General Medical Sciences Postdoctoral Research Associate Training Program Grant 1Fi2GM123974-01 (to J.T.B). The authors declare no conflicts of interest.	Almli LM, 2013, AM J MED GENET B, V162B, P262, DOI 10.1002/ajmg.b.32145; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bender IK, 2013, MOL ENDOCRINOL, V27, P1577, DOI 10.1210/me.2013-1009; Bianchini R, 2006, J PHARMACOL EXP THER, V319, P887, DOI 10.1124/jpet.106.108480; Blotta MH, 1997, J IMMUNOL, V158, P5589; Cao Y, 2013, BLOOD, V121, P1553, DOI 10.1182/blood-2012-05-432336; CHAMPIGNY G, 1994, EMBO J, V13, P2177, DOI 10.1002/j.1460-2075.1994.tb06494.x; Chapin WJ, 2015, PHARMACOGENET GENOM, V25, P126, DOI 10.1097/FPC.0000000000000116; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Crawford LW, 2010, TOXICOL PATHOL, V38, P872, DOI 10.1177/0192623310374329; Dendoncker K, 2017, CYTOKINE GROWTH F R, V35, P85, DOI 10.1016/j.cytogfr.2017.04.002; Kulkarni NN, 2016, IMMUNOBIOLOGY, V221, P245, DOI 10.1016/j.imbio.2015.09.001; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Landgraf D, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0483-7; Li CYC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002269; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Nehme A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-58; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Peffer ME, 2014, MOL CELL BIOL, V34, P2611, DOI 10.1128/MCB.01121-13; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sinclair D, 2011, MOL PSYCHIATR, V16, P504, DOI 10.1038/mp.2010.28; Sinclair D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-84; Sinclair D, 2011, NEUROPSYCHOPHARMACOL, V36, P2698, DOI 10.1038/npp.2011.160; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Unsicker K, 2013, MECH DEVELOP, V130, P324, DOI 10.1016/j.mod.2012.11.004; Whirledge S, 2013, ENDOCRINOLOGY, V154, P499, DOI 10.1210/en.2012-1748	33	9	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5258	5271		10.1096/fj.201701153R	http://dx.doi.org/10.1096/fj.201701153R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29672221	Green Published			2022-12-28	WOS:000447972500006
J	Yang, SS; Liu, B; Ji, KY; Fan, RW; Dong, CS				Yang, Shanshan; Liu, Bo; Ji, Kaiyuan; Fan, Ruiwen; Dong, Changsheng			MicroRNA-5110 regulates pigmentation by cotargeting melanophilin and WNT family member 1	FASEB JOURNAL			English	Article						MLPH; WNT1; RAB27A; MYO5A	TRANSCRIPTION FACTOR; MELANOMA-CELLS; MYOSIN-VA; EXPRESSED MICRORNAS; DOWN-REGULATION; BINDING DOMAIN; COAT COLOR; MELANOCYTES; PROTEIN; MITF	Mammalian pigmentation requires the production of melanin by melanocytes and its transfer to neighboring keratinocytes. These complex processes are regulated by several molecular pathways. Melanophilin (MLPH) and WNT family member 1 (WNT1), known to be involved in melanin transfer and melanin production, respectively, were predicted to be targets of microRNA-5110 using bioinformatics. In the current study, we investigated the effects of microRNA-5110 on pigmentation in alpaca (Vicugna pacos) melanocytes. In situ hybridization identified high levels of microRNA-5110 in the cytoplasm of alpaca melanocytes. Luciferase activity assays confirmed that MLPH and WNT1 were targeted by microRNA-5110 in these cells. Overexpression and knockdown of microRNA-5110 in alpaca melanocytes downregulated and upregulated MLPH and WNT1 expression at the mRNA and protein levels, respectively. In addition, overexpression and knockdown of microRNA-5110 in alpaca melanocytes decreased and increased, respectively, the mRNA levels of the melanin transfer-related genes, rat sarcoma (RAS)-associated binding (RAB27a) and myosin 5a (MYO5a); the mRNA levels of microphthalmia-associated transcription factor (MITF), tyrosinase (TYR), and tyrosinase-related protein (TYRP)1; and the production of total alkali melanin and pheomelanin. In contrast, overexpression and knockdown of microRNA-5110 increased and decreased the mRNA levels of TYRP2, respectively. Overexpression of microRNA-5110 also increased eumelanin. These results indicate that microRNA-5110 regulates pigmentation in alpaca melanocytes by directly targeting MLPH and WNT1 to affect eumelanin production and transfer.Yang, S., Liu, B., Ji, K., Fan, R., Dong, C. MicroRNA-5110 regulates pigmentation by cotargeting melanophilin and WNT family member 1.	[Yang, Shanshan; Liu, Bo; Ji, Kaiyuan; Fan, Ruiwen; Dong, Changsheng] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Peoples R China	Shanxi Agricultural University	Fan, RW (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Peoples R China.; Dong, CS (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 080301, Peoples R China.	ruiwenfan@163.com; csdong18@163.com			Young Sanjin Scholars Distinguished Professor Program; Aid Program for Innovation Team at Shanxi Agricultural University [CXTD201202]; 863 Project [2013AA102506]	Young Sanjin Scholars Distinguished Professor Program; Aid Program for Innovation Team at Shanxi Agricultural University; 863 Project	This study was supported by the Young Sanjin Scholars Distinguished Professor Program (to R.F.), the Aid Program for Innovation Team at Shanxi Agricultural University (CXTD201202), and the 863 Project (2013AA102506). The authors declare no conflicts of interest.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bai R, 2010, ASIAN AUSTRAL J ANIM, V23, P430, DOI 10.5713/ajas.2010.90465; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cecchi T, 2011, ITAL J ANIM SCI, V10, P159, DOI 10.4081/ijas.2011.e30; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dong CS, 2012, RNA, V18, P1679, DOI 10.1261/rna.033977.112; Dunn KJ, 2005, PIGM CELL RES, V18, P167, DOI 10.1111/j.1600-0749.2005.00226.x; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Liu JL, 2014, ARCH BIOCHEM BIOPHYS, V563, P13, DOI 10.1016/j.abb.2014.07.023; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; Prasad R, 2014, ONCOTARGET, V5, P10636, DOI 10.18632/oncotarget.2527; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Tian X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-555; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yang S, 2015, J ANIM SCI, V93, P1622, DOI 10.2527/jas.2014-8404; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhou JD, 2014, INT J CLIN EXP PATHO, V7, P7182; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004	37	10	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5405	5412		10.1096/fj.201800040R	http://dx.doi.org/10.1096/fj.201800040R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29733692	Green Published, hybrid			2022-12-28	WOS:000447972500017
J	Lee, YJ; Yu, JE; Kim, P; Lee, JY; Cheong, YC; Lee, YJ; Chang, J; Seong, BL				Lee, Young Jae; Yu, Ji Eun; Kim, Paul; Lee, Jeong-Yoon; Cheong, Yu Cheol; Lee, Yoon Jae; Chang, Jun; Seong, Baik Lin			Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens	FASEB JOURNAL			English	Article						antigen processing; invariable site; hemagglutinin; influenza virus	INFLUENZA-A VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; VACCINE DONOR STRAIN; CATHEPSIN-S; HONG-KONG; HEMAGGLUTININ GENES; CYSTEINE PROTEASES; ESCHERICHIA-COLI; INNATE IMMUNITY; T-CELLS	Antigenic variation in viral surface antigens is a strategy for escaping the host's adaptive immunity, whereas regions with pivotal functions for infection are less subject to antigenic variability. We hypothesized that genetically invariable and immunologically dormant regions of a viral surface antigen could be exposed to the host immune system and activated by rendering them susceptible to antigen-processing machinery in professional antigen-presenting cells (APCs). Considering the frequent antigen drift and shift in influenza viruses, we identified and used structural modeling to evaluate the conserved regions on the influenza hemagglutinin (HA) surface as potential epitopes. Mutant viruses containing the cleavage motifs of cathepsin S within HA were generated. Immunization of mice showed that the mutant, but not the wild-type virus, elicited specific antibodies against the cryptic epitope. Those antibodies were purified, and specific binding to HA was confirmed. These results suggest that an unnatural immune response can be elicited through the processing of target antigens in APCs, followed by presentation via the major histocompatibility complex, if not subjected to regulatory pathways. By harnessing the antigen-processing machinery, our study shows a proof-of-principle for designer vaccines with increased efficacy and safety by either activating cryptic, or inactivating naturally occurring, epitopes of viral antigens.Lee, Y. J., Yu, J. E., Kim, P., Lee, J.-Y., Cheong, Y. C., Lee, Y. J., Chang, J., Seong, B. L. Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens.	[Lee, Young Jae; Yu, Ji Eun; Kim, Paul; Cheong, Yu Cheol; Lee, Yoon Jae; Seong, Baik Lin] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, 134 Shinchondong, Seoul 03722, South Korea; [Chang, Jun; Seong, Baik Lin] Yonsei Univ, VTRC, Seoul, South Korea; [Lee, Jeong-Yoon; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea	Yonsei University; Yonsei University; Ewha Womans University	Seong, BL (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, 134 Shinchondong, Seoul 03722, South Korea.	blseong@yonsei.ac.kr		Lee, Young Jae/0000-0002-4902-2281; CHANG, JUN/0000-0002-8423-5987	Korean Health Technology Research and Development Project, Ministry of Health and Welfare [HI13C0826, HI15C2875, HI15C2934]; National Research Foundation of Korea - Ministry of Education [2014M3A9E4064743]	Korean Health Technology Research and Development Project, Ministry of Health and Welfare; National Research Foundation of Korea - Ministry of Education	This study was supported by the Korean Health Technology Research and Development Project, Ministry of Health and Welfare (Grants HI13C0826, HI15C2875, and HI15C2934) and the National Research Foundation of Korea funded by the Ministry of Education (Grant 2014M3A9E4064743). The authors declare no conflicts of interest.	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Ashkenazi A, 2013, BLOOD, V121, P2244, DOI 10.1182/blood-2012-11-468900; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Cezari MHS, 2002, BIOCHEM J, V368, P365, DOI 10.1042/BJ20020840; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Esposito S, 2011, J INFECTION, V63, P300, DOI 10.1016/j.jinf.2011.07.015; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; GETHING MJ, 1980, NATURE, V287, P301, DOI 10.1038/287301a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Giodini A, 2010, CURR OPIN IMMUNOL, V22, P94, DOI 10.1016/j.coi.2010.01.023; Gottlieb T, 2014, J AUTOIMMUN, V54, P15, DOI 10.1016/j.jaut.2014.07.005; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hartman IZ, 2010, NAT MED, V16, P1333, DOI 10.1038/nm.2248; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jang YH, 2016, VACCINE, V34, P1343, DOI 10.1016/j.vaccine.2016.01.053; Jang YH, 2014, VIRUSES-BASEL, V6, P3159, DOI 10.3390/v6083159; Jang YH, 2014, J VIROL METHODS, V196, P56, DOI 10.1016/j.jviromet.2013.10.035; Jang YH, 2013, VACCINE, V31, P3339, DOI 10.1016/j.vaccine.2013.05.080; Jang YH, 2013, YONSEI MED J, V54, P271, DOI 10.3349/ymj.2013.54.2.271; Jung EJ, 2010, EXP MOL MED, V42, P116, DOI 10.3858/emm.2010.42.2.013; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Klenk HD, 2011, BIOESSAYS, V33, P180, DOI 10.1002/bies.201000118; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee KH, 2006, VACCINE, V24, P1966, DOI 10.1016/j.vaccine.2005.10.051; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lutzner N, 2008, J BIOL CHEM, V283, P36185, DOI 10.1074/jbc.M806500200; Magadan JG, 2013, J VIROL, V87, P9742, DOI 10.1128/JVI.00471-13; Mason D, 2001, IMMUNOL REV, V182, P80, DOI 10.1034/j.1600-065X.2001.1820106.x; Mettu RR, 2016, J IMMUNOL METHODS, V432, P72, DOI 10.1016/j.jim.2016.02.013; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; Sahini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009268; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Steers NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042579; Subbarao K, 2013, TRENDS MICROBIOL, V21, P350, DOI 10.1016/j.tim.2013.04.003; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; tenOever BR, 2016, CELL HOST MICROBE, V19, P142, DOI 10.1016/j.chom.2016.01.006; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang L, 1995, ARCH VIROL, V140, P2201, DOI 10.1007/BF01323240; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252	68	3	3	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4658	4669		10.1096/fj.201701024RRR	http://dx.doi.org/10.1096/fj.201701024RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570395	Green Published, hybrid			2022-12-28	WOS:000443817700004
J	Schroeter, CB; Koehler, S; Kann, M; Schermer, B; Benzing, T; Brinkkoetter, PT; Rinschen, MM				Schroeter, Christina B.; Koehler, Sybille; Kann, Martin; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.; Rinschen, Markus M.			Protein half-life determines expression of proteostatic networks in podocyte differentiation	FASEB JOURNAL			English	Article						protein turnover; actin cytoskeleton; autophagy; lysosome; mass spectrometry	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY FILTRATION BARRIER; COLLECTING DUCT CELLS; PHOSPHOPROTEOMIC ANALYSIS; NEPHROTIC SYNDROME; PROTEOMIC ANALYSIS; ANALYSIS REVEALS; CULTURED PODOCYTES; SIGNALING PATHWAYS; GLOMERULAR PROTEIN	Podocytes are highly specialized, epithelial, postmitotic cells, which maintain the renal filtration barrier. When adapting to considerable metabolic and mechanical stress, podocytes need to accurately maintain their proteome. Immortalized podocyte cell lines are a widely used model for studying podocyte biology in health and disease in vitro. In this study, we performed a comprehensive proteomic analysis of the cultured human podocyte proteome in both proliferative and differentiated conditions at a depth of >7000 proteins. Similar to mouse podocytes, human podocyte differentiation involved a shift in proteostasis: undifferentiated podocytes have high expression of proteasomal proteins, whereas differentiated podocytes have high expression of lysosomal proteins. Additional analyses with pulsed stable-isotope labeling by amino acids in cell culture and protein degradation assays determined protein dynamics and half-lives. These studies unraveled a globally increased stability of proteins in differentiated podocytes. Mitochondrial, cytoskeletal, and membrane proteins were stabilized, particularly in differentiated podocytes. Importantly, protein half-lives strongly contributed to protein abundance in each state. These data suggest that regulation of protein turnover of particular cellular functions determines podocyte differentiation, a paradigm involving mitophagy and, potentially, of importance in conditions of increased podocyte stress and damage.Schroeter, C. B., Koehler, S., Kann, M., Schermer, B., Benzing, T., Brinkkoetter, P. T., Rinschen, M. M. Protein half-life determines expression of proteostatic networks in podocyte differentiation.	[Schroeter, Christina B.; Koehler, Sybille; Kann, Martin; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.; Rinschen, Markus M.] Univ Hosp Cologne, Dept Internal Med 2, Cologne, Germany; [Schroeter, Christina B.; Koehler, Sybille; Kann, Martin; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.; Rinschen, Markus M.] Univ Cologne, CMMC, Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Rinschen, Markus M.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Rinschen, Markus M.] Syst Biol Ageing Cologne SybaCol, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Rinschen, MM (corresponding author), Univ Hosp Cologne, CECAD Res Ctr, Nephrolab Cologne, Nephrol Forschungslab, Joseph Stelzmann St 26, D-50931 Cologne, Germany.	markus.rinschen@uk-koeln.de	Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019; Rinschen, Markus/N-7283-2019	Schermer, Bernhard/0000-0002-5194-9000; Rinschen, Markus/0000-0002-9252-1342	German Research Foundation (DFG) [KA3217/4-1, SCHE1562-2, SFB829, BR2955/4-1]; University of Cologne postdoctoral grant	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Cologne postdoctoral grant	The authors thank Moin Saleem (Bristol University, Bristol, United Kingdom) for providing cell lines. The authors thank Ruth Herzog and Angelika Koeser (University Hospital Cologne) for excellent technical support. The authors acknowledge the help of Christian Frese and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) Proteomics Core Facility. This work was supported by German Research Foundation (DFG) Grants KA3217/4-1 (to M.K.), SCHE1562-2 (to B.S.), SFB829 (to T.B.), and BR2955/4-1 (to P.T.B.); and a University of Cologne postdoctoral grant (to M.M.R.). The authors thank Peter Frommolt and Prerana Wagle (CECAD Bioinformatics Facility) for reprocessing of mRNA sequencing data. The authors declare no conflicts of interest.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Nguyen A, 2014, J BIOL CHEM, V289, P1688, DOI 10.1074/jbc.M113.515320; Bartram MP, 2016, HUM MOL GENET, V25, P1152, DOI 10.1093/hmg/ddv638; Barua M, 2014, KIDNEY INT, V85, P124, DOI 10.1038/ki.2013.354; Beeken M, 2014, J AM SOC NEPHROL, V25, P2511, DOI 10.1681/ASN.2013050522; Bierzynska A, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2016.00226; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chittiprol S, 2011, AM J PHYSIOL-RENAL, V301, pF660, DOI 10.1152/ajprenal.00234.2011; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; Dhondt I, 2017, MOL CELL PROTEOMICS, V16, P1621, DOI 10.1074/mcp.RA117.000049; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Endlich K, 2017, PFLUG ARCH EUR J PHY, V469, P937, DOI 10.1007/s00424-017-2025-8; Fierro-Monti I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080423; Frost LS, 2017, METHOD ENZYMOL, V587, P43, DOI 10.1016/bs.mie.2016.09.052; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gbadegesin RA, 2014, J AM SOC NEPHROL, V25, P1991, DOI 10.1681/ASN.2013090976; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Gee HY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10822; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8; Hartleben B, 2014, SEMIN NEPHROL, V34, P42, DOI 10.1016/j.semnephrol.2013.11.007; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Janech MG, 2007, AM J PHYSIOL-RENAL, V292, pF501, DOI 10.1152/ajprenal.00298.2006; Jeruschke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137043; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35671; Kambham N, 2000, AM J KIDNEY DIS, V36, P190, DOI 10.1053/ajkd.2000.8293; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kreutzer R, 2009, BBA-MOL BASIS DIS, V1792, P982, DOI 10.1016/j.bbadis.2009.07.004; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kruppa AJ, 2016, TRAFFIC, V17, P878, DOI 10.1111/tra.12410; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Larance M, 2013, MOL CELL PROTEOMICS, V12, P638, DOI 10.1074/mcp.M112.024547; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Matejas V, 2010, HUM MUTAT, V31, P992, DOI 10.1002/humu.21304; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NAGATA M, 1993, ANAT EMBRYOL, V187, P275; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Ni L, 2012, NEPHROLOGY, V17, P525, DOI 10.1111/j.1440-1797.2012.01619.x; Pasquier B, 2016, CELL MOL LIFE SCI, V73, P985, DOI 10.1007/s00018-015-2104-y; Pereira EM, 2016, AM J PHYSIOL-RENAL, V311, pF1015, DOI 10.1152/ajprenal.00283.2016; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rattan SIS, 2010, ADV EXP MED BIOL, V694, P1; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Regier D. S., 1993, GENEREVIEWS, P1993; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rinschen MM, 2017, J AM SOC NEPHROL, V28, P2867, DOI 10.1681/ASN.2016101119; Rinschen MM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8165; Rinschen MM, 2016, AM J PHYSIOL-CELL PH, V311, pC404, DOI 10.1152/ajpcell.00121.2016; Rinschen MM, 2016, HUM MOL GENET, V25, P1328, DOI 10.1093/hmg/ddw016; Rinschen MM, 2015, PROTEOM CLIN APPL, V9, P1053, DOI 10.1002/prca.201400201; Rinschen MM, 2015, PROTEOMICS, V15, P1326, DOI 10.1002/pmic.201400235; Rinschen MM, 2014, J AM SOC NEPHROL, V25, P1509, DOI 10.1681/ASN.2013070760; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; Saurus P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21664; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shimada M, 2012, NEPHROL DIAL TRANSPL, V27, P81, DOI 10.1093/ndt/gfr271; Swiatecka-Urban A, 2013, PEDIATR NEPHROL, V28, P1723, DOI 10.1007/s00467-012-2281-y; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Tra T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027485; Thong KM, 2013, NEPHRON CLIN PRACT, V124, P31, DOI 10.1159/000354716; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagle P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1695-x; Wasik AA, 2012, MOL BIOL CELL, V23, P3370, DOI 10.1091/mbc.E11-12-1010; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Yamamoto T, 2010, ADV CHRONIC KIDNEY D, V17, P487, DOI 10.1053/j.ackd.2010.09.005; Yang SP, 2015, DYNAMICS OF VEHICLE-ROAD COUPLED SYSTEM, P1, DOI 10.1007/978-3-662-45957-7_1; Zhang Y, 2015, DATA BRIEF, V4, P180, DOI 10.1016/j.dib.2015.05.013	97	10	10	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4696	4713		10.1096/fj.201701307R	http://dx.doi.org/10.1096/fj.201701307R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29694247				2022-12-28	WOS:000443817700007
J	Zheng, XJ; Zhou, KJ; Zhang, YJ; Han, XL; Zhao, AH; Liu, JJ; Qu, C; Ge, K; Huang, FJ; Hernandez, B; Yu, H; Panee, J; Chen, TL; Jia, WP; Jia, W				Zheng, Xiaojiao; Zhou, Kejun; Zhang, Yunjing; Han, Xiaolong; Zhao, Aihua; Liu, Jiajian; Qu, Chun; Ge, Kun; Huang, Fengjie; Hernandez, Brenda; Yu, Herbert; Panee, Jun; Chen, Tianlu; Jia, Weiping; Jia, Wei			Food withdrawal alters the gut microbiota and metabolome in mice	FASEB JOURNAL			English	Article						fasting; microbiome; metabolomics	SATURATED FATTY-ACIDS; AKKERMANSIA-MUCINIPHILA; CALORIC RESTRICTION; INSULIN-RESISTANCE; BRANCHED-CHAIN; ADIPOSE-TISSUE; AMINO-ACIDS; STARVATION; OBESITY; DIET	Food withdrawal as a health-enhancing measure has beneficial effects on aging, disease prevention, and treatment. However, the cellular and molecular mechanisms involving gut microbial changes and metabolic consequences resulting from food withdrawal have yet to be elucidated. In this study, we subjected lean and obese mice to a dietary intervention that consisted of a 4-d complete food withdrawal and an 8-d 50% food withdrawal, and we studied changes in cecal microbiome and host serum metabolome. The abundance of potentially pathogenic Proteobacteria was decreased and Akkermansia muciniphila was elevated by food withdrawal in mice fed a high-fat diet (HFD). Meanwhile, food withdrawal decreased the abundance of metabolites in branched chain amino acid, lipid, and free fatty acid metabolisms in host serum, more so in HFD mice than in normal mice. Microbial predicted function also showed that food withdrawal decreased the abundance of microbes associated with predicted diseases in the HFD group but not in the normal chow group. Correlation between the microbiome data and metabolomics data revealed a strong association between gut microbial and host metabolic changes in response to food withdrawal. In summary, our results showed that food withdrawal was safer and more metabolically beneficial to HFD-induced obese mice than to normal lean mice, and the beneficial effects were primarily derived from the changes in gut microbiota, which were closely associated with the host metabolome.Zheng, X., Zhou, K., Zhang, Y., Han, X., Zhao, A., Liu, J., Qu, C., Ge, K., Huang, F., Hernandez, B., Yu, H., Panee, J., Chen, T., Jia, W., Jia, W. Food withdrawal alters the gut microbiota and metabolome in mice.	[Zheng, Xiaojiao; Zhang, Yunjing; Han, Xiaolong; Zhao, Aihua; Liu, Jiajian; Qu, Chun; Ge, Kun; Huang, Fengjie; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Zheng, Xiaojiao; Zhang, Yunjing; Han, Xiaolong; Zhao, Aihua; Liu, Jiajian; Qu, Chun; Ge, Kun; Huang, Fengjie; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Zhou, Kejun; Hernandez, Brenda; Yu, Herbert; Panee, Jun; Jia, Wei] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System	Zheng, XJ; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, 600 Yishan Rd, Shanghai 200233, Peoples R China.; Zheng, XJ; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	joyzheng99@sjtu.edu.cn; wjia@cc.hawaii.edu	Jia, Wei/AAN-5102-2020	Jia, Wei/0000-0002-3739-8994	National Natural Science Foundation of China [31500954, 31501079, 81772530]; International Science and Technology Cooperation Program of China [2014DFA31870]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Natural Science Foundation of China (31500954, 31501079, and 81772530) and the International Science and Technology Cooperation Program of China (2014DFA31870). The authors declare no conflicts of interest.	Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chen TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20594; CHENG M, 1971, J COMP PHYSIOL PSYCH, V76, P206, DOI 10.1037/h0031374; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Connor WE, 1996, J LIPID RES, V37, P290; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eisen M., CHINESE BIGU YANG SH; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Funaki M, 2009, J MED INVESTIG, V56, P88, DOI 10.2152/jmi.56.88; Greer RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13329; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kobayashi T, 2015, BENEF MICROBES, V6, P735, DOI 10.3920/BM2014.0147; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; LAESSLE RG, 1988, BIOL PSYCHIAT, V23, P719, DOI 10.1016/0006-3223(88)90056-X; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Li GL, 2017, CELL METAB, V26, P801, DOI 10.1016/j.cmet.2017.10.007; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Lippert K, 2017, BENEF MICROBES, V8, P545, DOI 10.3920/BM2016.0184; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Madigan M.T., 2005, BROCK BIOL MICROORGA, V11; Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ni Y, 2015, EBIOMEDICINE, V2, P1513, DOI 10.1016/j.ebiom.2015.09.004; Park DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059470; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Perreault M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088539; Placanica JL, 2002, INT J EAT DISORDER, V32, P79, DOI 10.1002/eat.10066; Pregadio Fabrizio, 2008, ENCY TAOISM, Vi, P233; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Richards SE, 2008, ANAL CHEM, V80, P4876, DOI 10.1021/ac702584g; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Stice E, 2008, J ABNORM PSYCHOL, V117, P941, DOI 10.1037/a0013644; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700	47	25	27	2	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4878	4888		10.1096/fj.201700614R	http://dx.doi.org/10.1096/fj.201700614R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29620942	Green Published			2022-12-28	WOS:000443817700022
J	Mathews, CK				Mathews, Christopher K.			Still the most interesting enzyme in the world	FASEB JOURNAL			English	Editorial Material						ribonucleotide reductase; dNTPs; deoxyribonucleotide biosynthesis	HUMAN RIBONUCLEOTIDE REDUCTASE; STRUCTURAL BASIS		[Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, 2011 Ag & Life Sci Bldg, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Ag & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@oregonstate.edu						Ahmad MF, 2017, P NATL ACAD SCI USA, V114, P8241, DOI 10.1073/pnas.1620220114; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Brignole EJ, 2018, ELIFE, V7, DOI [10.7554/eLife.3150, 10.7554/eLife.31502]; Chen PYT, 2018, J BIOL CHEM, V293, P10404, DOI 10.1074/jbc.RA118.002569; Dassama LMK, 2013, BIOCHEMISTRY-US, V52, P6424, DOI 10.1021/bi400819x; Dragicevic I, 2015, CHEM-EUR J, V21, P6132, DOI 10.1002/chem.201405741; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Foskolou IP, 2017, MOL CELL, V66, P206, DOI 10.1016/j.molcel.2017.03.005; Grinberg IR, 2018, ELIFE, V7, DOI 10.7554/eLife.31529; Huff SE, 2018, J MED CHEM, V61, P666, DOI 10.1021/acs.jmedchem.7b00530; Johansson R, 2016, STRUCTURE, V24, P906, DOI 10.1016/j.str.2016.03.025; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Mathews CK, 2016, STRUCTURE, V24, P843, DOI 10.1016/j.str.2016.05.006; Nazaretyan SA, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00713-17; Parker MJ, 2018, P NATL ACAD SCI USA, V115, pE4594, DOI 10.1073/pnas.1800356115; Song Y, 2017, DEV CELL, V42, P301, DOI 10.1016/j.devcel.2017.06.013; STUBBE JA, 1990, J BIOL CHEM, V265, P5329	17	5	5	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4067	4069		10.1096/fj.201800790R	http://dx.doi.org/10.1096/fj.201800790R			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	30059250	Bronze			2022-12-28	WOS:000439325400001
J	Prasad, V; Wasser, Y; Hans, F; Goswami, A; Katona, I; Outeiro, TF; Kahle, PJ; Schulz, JB; Voigt, A				Prasad, Vibha; Wasser, Yasmine; Hans, Friederike; Goswami, Anand; Katona, Istvan; Outeiro, Tiago F.; Kahle, Philipp J.; Schulz, Joerg B.; Voigt, Aaron			Monitoring -synuclein multimerization in vivo	FASEB JOURNAL			English	Article						Parkinson's disease; synucleinopathy; protein aggregation; BiFC	ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DROSOPHILA MODEL; PROTEIN; PHOSPHORYLATION; TOXICITY; AGGREGATION; MUTATION; NEURODEGENERATION; NEUROTOXICITY	The pathophysiology of Parkinson's disease is characterized by the abnormal accumulation of -synuclein (-Syn), eventually resulting in the formation of Lewy bodies and neurites in surviving neurons in the brain. Although -Syn aggregation has been extensively studied in vitro, there is limited in vivo knowledge on -Syn aggregation. Here, we used the powerful genetics of Drosophila melanogaster and developed an in vivo assay to monitor -Syn accumulation by using a bimolecular fluorescence complementation assay. We found that both genetic and pharmacologic manipulations affected -Syn accumulation. Interestingly, we also found that alterations in the cellular protein degradation mechanisms strongly influenced -Syn accumulation. Administration of compounds identified as risk factors for Parkinson's disease, such as rotenone or heavy metal ions, had only mild or even no impact on -Syn accumulation in vivo. Finally, we show that increasing phosphorylation of -Syn at serine 129 enhances the accumulation and toxicity of -Syn. Altogether, our study establishes a novel model to study -Syn accumulation and illustrates the complexity of manipulating proteostasis in vivo.Prasad, V., Wasser, Y., Hans, F., Goswami, A., Katona, I., Outeiro, T. F., Kahle, P. J., Schulz, J. B., Voigt, A. Monitoring -synuclein multimerization in vivo.	[Prasad, Vibha; Wasser, Yasmine; Schulz, Joerg B.; Voigt, Aaron] Rheinisch Westfaelische TH RWTH Aachen Univ, Univ Med Ctr, Dept Neurol, Aachen, Germany; [Goswami, Anand; Katona, Istvan] Rheinisch Westfaelische TH RWTH Aachen Univ, Univ Med Ctr, Inst Neuropathol, Aachen, Germany; [Hans, Friederike; Kahle, Philipp J.] German Ctr Neurodegenerat Dis, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany; [Outeiro, Tiago F.] Univ Med Ctr Gottingen, Ctr Biostruct Imaging Neurodegenerat, Ctr Mol Physiol Brain, Dept Expt Neurodegenerat, Gottingen, Germany; [Outeiro, Tiago F.] Max Planck Inst Expt Med, Gottingen, Germany; [Outeiro, Tiago F.] Newcastle Univ, Med Sch, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Schulz, Joerg B.; Voigt, Aaron] Forschungszentrum Julich, Brain Inst Mol Neurosci & Neuroimaging, JARA, Aachen, Germany; [Schulz, Joerg B.; Voigt, Aaron] Rhein Westfal TH Aachen, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen; Max Planck Society; Newcastle University - UK; Helmholtz Association; Research Center Julich; RWTH Aachen University	Voigt, A (corresponding author), Rhein Westfal TH Aachen, Univ Med Ctr, Dept Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	avoigt@ukaachen.de	Katona, Istvan/AAD-4943-2022; Outeiro, Tiago/L-7351-2019; Schulz, Jorg B./D-9786-2012	Katona, Istvan/0000-0002-0955-8911; Outeiro, Tiago/0000-0003-1679-1727; Schulz, Jorg B./0000-0002-8903-0593; Wasser, Yasmine/0000-0002-7545-9508	Interdisciplinary Center for Clinical Research Aachen within the Faculty of Medicine at RWTH Aachen University [N7-3]; German Research Foundation (DFG) Center for Nanoscale Microscopy and Molecular Physiology of the Brain	Interdisciplinary Center for Clinical Research Aachen within the Faculty of Medicine at RWTH Aachen University; German Research Foundation (DFG) Center for Nanoscale Microscopy and Molecular Physiology of the Brain	The authors thank Claudia Krude and Hannelore Mader (Institute of Neuropathology, University Medical Center, RWTH Aachen University) for their excellent technical assistance with regard to electron microscopy. The authors also thank Sabine Hamm (Department of Neurology, University Medical Center, RWTH Aachen University) for excellent technical assistance. This work is supported by the Interdisciplinary Center for Clinical Research Aachen within the Faculty of Medicine at RWTH Aachen University (Clinical Neuroscience, Project N7-3). T.F.O. is supported by the German Research Foundation (DFG) Center for Nanoscale Microscopy and Molecular Physiology of the Brain. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bandopadhyay R., 2016, JOVE-J VIS EXP, V107, P53415; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Calap-Quintana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132376; Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Cho J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050644; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Collier TJ, 2017, MOVEMENT DISORD, V32, P983, DOI 10.1002/mds.27037; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Coyne AN, 2014, J NEUROSCI, V34, P15962, DOI 10.1523/JNEUROSCI.2526-14.2014; Dinter E, 2016, J NEUROCHEM, V138, P758, DOI 10.1111/jnc.13712; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Foo LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07179-8; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Goedert M, 2017, J PARKINSON DIS, V7, pS53, DOI 10.3233/JPD-179005; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Roberti MJ, 2012, BIOPHYS J, V102, P1598, DOI 10.1016/j.bpj.2012.03.010; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Krishna G, 2016, J SCI FOOD AGR, V96, P1745, DOI 10.1002/jsfa.7281; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lazaro DF, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0402-8; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Marmolino D, 2016, MOL CELL NEUROSCI, V71, P92, DOI 10.1016/j.mcn.2015.12.012; Melo TQ, 2017, EXP BRAIN RES, V235, P731, DOI 10.1007/s00221-016-4836-9; Meng H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15500; Muskus MJ, 2007, MOL CELL BIOL, V27, P8049, DOI 10.1128/MCB.00680-07; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Tue NT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/252049; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Oueslati A, 2016, J PARKINSON DIS, V6, P39, DOI 10.3233/JPD-160779; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Park Y, 2011, BIOCHEM BIOPH RES CO, V404, P638, DOI 10.1016/j.bbrc.2010.12.030; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Santner A, 2010, METALLOMICS, V2, P378, DOI 10.1039/b926659c; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Shin JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01561; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sudati JH, 2013, NEUROTOXICOLOGY, V37, P118, DOI 10.1016/j.neuro.2013.04.006; Suzuki M, 2015, HUM MOL GENET, V24, P6675, DOI 10.1093/hmg/ddv372; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Tanner C. M., 2011, ENV HLTH PERSPECT, V119, P886; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; VanPelt J, 2017, BBA-PROTEINS PROTEOM, V1865, P133, DOI 10.1016/j.bbapap.2016.11.005; Varma S, 2007, BBA-GEN SUBJECTS, V1770, P71, DOI 10.1016/j.bbagen.2006.07.016; Visanji NP, 2016, TRENDS NEUROSCI, V39, P750, DOI 10.1016/j.tins.2016.09.003; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132638; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wolozin B, 2002, NEUROSCIENTIST, V8, P22, DOI 10.1177/107385840200800107; Yedlapudi D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38510; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang L, 2013, HUM MOL GENET, V22, P2829, DOI 10.1093/hmg/ddt132; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	83	8	8	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2116	2131		10.1096/fj.201800148RRR	http://dx.doi.org/10.1096/fj.201800148RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252534				2022-12-28	WOS:000457296600048
J	Rust, R; Gantner, C; Schwab, ME				Rust, Ruslan; Gantner, Christina; Schwab, Martin E.			Pro- and antiangiogenic therapies: current status and clinical implications	FASEB JOURNAL			English	Review						vascularization; vascular repair; stroke; retinopathy; cancer	ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; CHRONIC MYOCARDIAL-ISCHEMIA; MESENCHYMAL STEM-CELLS; ANTI-VEGF THERAPY; VASCULAR-PERMEABILITY; PROGENITOR CELLS; IN-VITRO; INTRAVITREAL INJECTION; PROMOTES ANGIOGENESIS	Blood vessels nurture every part of the human body. Consequently, abnormalities in the vasculature are closely associated with a variety of diseases, including cerebral stroke, heart disease, retinopathy, and cancer. Pro- or antiangiogenic therapies can influence these diseases by regulating the growth of new blood vessels from a pre-existing vascular network or dampening excessive blood growth. However, clinical translation of these approaches is slow and challenging. In this review, we discuss recent preclinical approaches to regulate angiogenesis and their potential and risks in a clinical setting.Rust, R., Gantner, C., Schwab, M. E. Pro- and antiangiogenic therapies: current status and clinical implications.	[Rust, Ruslan; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Rust, Ruslan; Schwab, Martin E.] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Gantner, Christina] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rust, R (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	rust@irem.uzh.ch	Rust, Ruslan/ABA-2514-2020	Rust, Ruslan/0000-0003-3376-3453				Abcouwer SF., 2013, J CLIN CELL IMMUNOL, VSuppl 1, P1, DOI 10.4172/2155-9899; ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bertuccio C, 2011, J BIOL CHEM, V286, P39933, DOI 10.1074/jbc.M111.241620; Bogoslovsky T, 2010, NEUROLOGY, V75, P2059, DOI 10.1212/WNL.0b013e318200d741; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bronckaers A, 2014, PHARMACOL THERAPEUT, V143, P181, DOI 10.1016/j.pharmthera.2014.02.013; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Cerani A, 2013, CELL METAB, V18, P505, DOI 10.1016/j.cmet.2013.09.003; Chang SH, 2011, TRENDS MOL MED, V17, P650, DOI 10.1016/j.molmed.2011.06.008; Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Chou E, 2002, CIRCULATION, V105, P373, DOI 10.1161/hc0302.102143; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Cremolini C, 2015, LANCET ONCOL, V16, P1306, DOI 10.1016/S1470-2045(15)00122-9; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Erber R, 2003, FASEB J, V17, P338, DOI 10.1096/fj.03-0271fje; Erbs S, 2007, CIRCULATION, V116, P366, DOI 10.1161/CIRCULATIONAHA.106.671545; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; Fala Loretta, 2015, Am Health Drug Benefits, V8, P49; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fortuin FD, 2003, AM J CARDIOL, V92, P436, DOI 10.1016/S0002-9149(03)00661-1; Francis DP, 2013, INT J CARDIOL, V168, P3381, DOI 10.1016/j.ijcard.2013.04.152; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gomez R, 2006, ENDOCRINOLOGY, V147, P5400, DOI 10.1210/en.2006-0657; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Gotink KJ, 2010, ANGIOGENESIS, V13, P1, DOI 10.1007/s10456-009-9160-6; Gyongyosi M, 2005, CIRCULATION, V112, pI157, DOI 10.1161/01.CIRCULATIONAHA.105.525782; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Jackson TL, 2017, JAMA OPHTHALMOL, V135, P761, DOI 10.1001/jamaophthalmol.2017.1571; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kindler HL, 2007, ASCO GASTR CANC S, V25, P4508; King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kovacic JC, 2015, CIRC RES, V116, P1287, DOI 10.1161/CIRCRESAHA.115.306323; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Layne K, 2015, CARDIOVASC RES, V107, P410, DOI 10.1093/cvr/cvv201; Li Q, 2016, FEBS J, V283, P1720, DOI 10.1111/febs.13697; Liu ZH, 2012, CELL PHYSIOL BIOCHEM, V29, P851, DOI 10.1159/000258197; Lopez JJ, 1998, CARDIOVASC RES, V40, P272, DOI 10.1016/S0008-6363(98)00136-9; Lu HY, 2012, STROKE, V43, P838, DOI 10.1161/STROKEAHA.111.635235; Margolin K, 2001, J CLIN ONCOL, V19, P851, DOI 10.1200/JCO.2001.19.3.851; Marti-Fabregas J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124895; Mitsos S, 2012, ANGIOGENESIS, V15, P1, DOI 10.1007/s10456-011-9240-2; Nguyen PK, 2016, JAMA CARDIOL, V1, P831, DOI 10.1001/jamacardio.2016.2225; Nia PS, 2007, HISTOPATHOLOGY, V51, P354, DOI 10.1111/j.1365-2559.2007.02800.x; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Nohata N, 2012, ONCOTARGET, V3, P9; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Oduk Y, 2018, AM J PHYSIOL-HEART C, V314, pH278, DOI 10.1152/ajpheart.00471.2017; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Perin EC, 2017, CIRCULATION, V135, P1417, DOI 10.1161/CIRCULATIONAHA.116.025707; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Peterson TE, 2016, P NATL ACAD SCI USA, V113, P4470, DOI 10.1073/pnas.1525349113; Porta C, 2013, ONCOLOGY-BASEL, V84, P115, DOI 10.1159/000342099; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P331, DOI 10.3928/1542-8877-20050701-14; Rust R, 2018, TRENDS MOL MED, V24, P593, DOI 10.1016/j.molmed.2018.04.008; Rust R, 2017, J NEUROSCI, V37, P4658, DOI 10.1523/JNEUROSCI.0498-17.2017; Said SS, 2013, J VASC RES, V50, P35, DOI 10.1159/000345108; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schlottmann PG, 2015, NEW ENGL J MED, V373, P480, DOI 10.1056/NEJMc1505684; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Smith NR, 2013, CLIN CANCER RES, V19, P6943, DOI 10.1158/1078-0432.CCR-13-1637; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Van den Eynden GG, 2012, CLIN EXP METASTAS, V29, P541, DOI 10.1007/s10585-012-9469-1; van der Giet M, 2015, CURR PHARM DESIGN, V21, P3548, DOI 10.2174/1381612821666150225120314; Walchli T, 2013, P NATL ACAD SCI USA, V110, pE1943, DOI 10.1073/pnas.1216203110; Wang JX, 2016, PROCEEDINGS OF 2016 IEEE 9TH UK-EUROPE-CHINA WORKSHOP ON MILLIMETRE WAVES AND TERAHERTZ TECHNOLOGIES (UCMMT), P12, DOI 10.1109/UCMMT.2016.7873945; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Welti JC, 2012, ANGIOGENESIS, V15, P623, DOI 10.1007/s10456-012-9291-z; World Health Organization, 2017, WORLD HLTH STAT 2017, P116; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xue D, 2016, ONCOTARGET, V7, P78804, DOI [10.18632/oncotarget.12860, 10.18632/oncotarget.12972]; Yadav R, 2015, J CLIN DIAGN RES, V9, DOI 10.7860/JCDR/2015/14087.6213; Yin KJ, 2015, CURR VASC PHARMACOL, V13, P352, DOI 10.2174/15701611113119990016; Yu SW, 2007, J CEREBR BLOOD F MET, V27, P755, DOI 10.1038/sj.jcbfm.9600378; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zampetaki A, 2016, DIABETES, V65, P216, DOI 10.2337/db15-0389; Zhang J, 2010, J MOL CELL CARDIOL, V48, P1060, DOI 10.1016/j.yjmcc.2009.11.020; Zhang W, 2018, ACTA PHARMACOL SIN, V39, P1, DOI 10.1038/aps.2017.77; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zheng YJ, 2006, ARTERIOSCL THROM VAS, V26, P2019, DOI 10.1161/01.ATV.0000233336.53574.a1	127	31	32	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					34	48		10.1096/fj.201800640RR	http://dx.doi.org/10.1096/fj.201800640RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30085886	Bronze			2022-12-28	WOS:000457401500004
J	Takahata, Y; Nakamura, E; Hata, K; Wakabayashi, M; Murakami, T; Wakamori, K; Yoshikawa, H; Matsuda, A; Fukui, N; Nishimura, R				Takahata, Yoshifumi; Nakamura, Eriko; Hata, Kenji; Wakabayashi, Makoto; Murakami, Tomohiko; Wakamori, Kanta; Yoshikawa, Hiroshi; Matsuda, Akio; Fukui, Naoshi; Nishimura, Riko			Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5	FASEB JOURNAL			English	Article						osteoarthritis; transcription factor; articular cartilage; aggrecan; aggrecanase	MESSENGER-RNA EXPRESSION; ARTICULAR-CARTILAGE; AGGRECANASE ACTIVITY; IN-VITRO; KAPPA-B; INTERLEUKIN-1; CHONDROCYTES; DEGRADATION; HIF-2-ALPHA; DEFICIENT	Osteoarthritis is a common disease in joint cartilages. Because the molecular pathogenesis of osteoarthritis remains elusive, early diagnostic markers and effective therapeutic agents have not been developed. To understand the molecular mechanisms, we attempted to identify transcription factors involved in the onset of osteoarthritis. Microarray analysis of mouse articular cartilage cells indicated that retinoic acid, a destructive stimulus in articular cartilage, up-regulated expression of sex-determining region Y-box (Sox)4, a SoxC family transcription factor, together with increases in Adamts4 and Adamts5, both of which are aggrecanases of articular cartilages. Overexpression of Sox4 induced a disintegrin-like and metallopeptidase with thrombospondin type 4 and 5 motif (ADAMTS4 and ADAMTS5, respectively) expression in chondrogenic cell lines C3H10T1/2 and SW1353. In addition, luciferase reporter and chromatin immunoprecipitation assays showed that Sox4 up-regulated ADAMTS4 and Adamts5 gene promoter activities by binding to their gene promoters. Another SoxC family member, Sox11, evoked similar effects. To evaluate the roles of Sox4 and Sox11 in articular cartilage destruction, we performed organ culture experiments using mouse femoral head cartilages. Sox4 and Sox11 adenovirus infections caused destruction of articular cartilage associated with increased Adamts5 expression. Finally, SOX4 and SOX11 mRNA expression was increased in cartilage of patients with osteoarthritis compared with nonosteoarthritic subjects. Thus, Sox4, and presumably Sox11, are involved in osteoarthritis onset by up-regulating ADAMTS4 and ADAMTS5.Takahata, Y., Nakamura, E., Hata, K., Wakabayashi, M., Murakami, T., Wakamori, K., Yoshikawa, H., Matsuda, A., Fukui, N., Nishimura, R. Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5.	[Takahata, Yoshifumi; Nakamura, Eriko; Hata, Kenji; Murakami, Tomohiko; Wakamori, Kanta; Yoshikawa, Hiroshi; Nishimura, Riko] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Wakabayashi, Makoto; Matsuda, Akio] Asahi Kasei Pharma Corp, Lab Adv Drug Discovery Pharmaceut, Res Ctr, Izunokuni, Japan; [Fukui, Naoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Fukui, Naoshi] Natl Hosp Org Sagamihara Hosp, Clin Res Ctr, Sagamihara, Kanagawa, Japan	Osaka University; Asahi Kasei Pharma Corporation; University of Tokyo	Takahata, Y (corresponding author), Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	takahata@dent.osaka-u.ac.jp	Takahata, Yoshifumi/AAZ-6869-2021	Nishimura, Riko/0000-0001-7279-8363	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Health Foundation; Suzuken Memorial Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Foundation(Japan Health Foundation); Suzuken Memorial Foundation	This study was supported, in part, by the Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research (to Y.T. and R.N.), the Japan Health Foundation (to Y.T.), and Suzuken Memorial Foundation (to Y.T.). The authors declare no conflicts of interest.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2014, J CELL BIOL, V207, P657, DOI 10.1083/jcb.201405098; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Cai LP, 2001, CYTOKINE, V16, P10, DOI 10.1006/cyto.2001.0939; Chen Y, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.34; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; East CJ, 2007, J BIOL CHEM, V282, P8632, DOI 10.1074/jbc.M605750200; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V260, P318, DOI 10.1006/bbrc.1999.0909; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Ilic MZ, 2007, J BIOL CHEM, V282, P37420, DOI 10.1074/jbc.M703184200; Jeong JW, 2016, INT J MOL MED, V37, P452, DOI 10.3892/ijmm.2015.2443; Jules J, 2014, METHODS MOL BIOL, V1155, P109, DOI 10.1007/978-1-4939-0669-7_10; Kan A, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-4; Kato K, 2015, J BONE MINER RES, V30, P1560, DOI 10.1002/jbmr.2504; Kobayashi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13336; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Lefebvre V, 2016, CURR OSTEOPOROS REP, V14, P32, DOI 10.1007/s11914-016-0296-1; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Little CB, 2002, ARTHRITIS RHEUM-US, V46, P124, DOI 10.1002/1529-0131(200201)46:1<124::AID-ART10121>3.0.CO;2-X; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Rogerson FM, 2010, ARTHRITIS RHEUM-US, V62, P3365, DOI 10.1002/art.27661; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Shiraishi A, 2016, BIOCHEM BIOPH RES CO, V469, P62, DOI 10.1016/j.bbrc.2015.11.072; Snelling SJB, 2016, OSTEOARTHR CARTILAGE, V24, P883, DOI 10.1016/j.joca.2015.11.021; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Takahata Y, 2011, J BIOL CHEM, V286, P32906, DOI 10.1074/jbc.M111.253526; Takahata Y, 2009, J CELL PHYSIOL, V218, P268, DOI 10.1002/jcp.21594; Taniguchi Y, 2017, ARTHRITIS RHEUMATOL, V69, P598, DOI 10.1002/art.39976; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Tortorella MD, 2008, CURR PHARM BIOTECHNO, V9, P16, DOI 10.2174/138920108783497622; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Wang MN, 2011, ANN NY ACAD SCI, V1240, P61, DOI 10.1111/j.1749-6632.2011.06258.x; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Yatabe T, 2009, ANN RHEUM DIS, V68, P1051, DOI 10.1136/ard.2007.086884; Yoshida M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7653	54	35	37	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					619	630		10.1096/fj.201800259R	http://dx.doi.org/10.1096/fj.201800259R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30016600				2022-12-28	WOS:000457401500048
J	Tarry-Adkins, JL; Aiken, CE; Ashmore, TJ; Fernandez-Twinn, DS; Chen, JH; Ozanne, SE				Tarry-Adkins, Jane L.; Aiken, Catherine E.; Ashmore, Thomas J.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Ozanne, Susan E.			A suboptimal maternal diet combined with accelerated postnatal growth results in an altered aging profile in the thymus of male rats	FASEB JOURNAL			English	Article						developmental programming; involution; immunosenescence	MITOCHONDRIAL UNCOUPLING PROTEIN-1; TELOMERE LENGTH; PRENATAL UNDERNUTRITION; OXIDATIVE STRESS; AGE; EXPRESSION; SIZE; SENESCENCE.; VACCINATION; INVOLUTION	Reduced fetal nutrition and rapid postnatal growth accelerates the aging phenotype in many organ systems; however, effects on the immune system are unclear. We addressed this by studying the thymus from a rat model of developmental programming. The recuperated group was generated by in utero protein restriction, followed by cross-fostering to control-fed mothers, and were then compared with controls. Fat infiltration and adipocyte size increased with age (P < 0.001) and in recuperated thymi (P < 0.05). Cortex/medulla ratio decreased with age (P < 0.001) and decreased (P < 0.05) in 12-mo recuperated thymi. Age-associated decreases in thymic-epithelial cell (P < 0.01) and thymocyte markers (P < 0.01) were observed in both groups and was decreased (P < 0.05) in recuperated thymi. These data demonstrate effects of developmental programming upon thymic involution. The recuperated group had longer thymic telomeres than controls (P < 0.001) at 22 d and at 3 mo, which was associated with increased expression of telomere-length maintenance molecules [telomerase RNA component (Terc; P < 0.01), P23 (P = 0.02), and Ku70 and Ku80 (P < 0.01)]. By 12 mo, recuperated offspring had shorter thymic telomeres than controls had (P < 0.001) and reduced DNA damage-response markers [(DNA-PKcs, Mre11 (P < 0.01), Xrcc4 (P = 0.02), and -H2ax (P < 0.001], suggesting failure of earlier compensatory responses. Our results suggest that low birth weight with rapid postnatal growth results in premature thymic maturation, resulting in accelerated thymic aging. This could lead to increased age-associated vulnerability to infection.Tarry-Adkins, J. L., Aiken, C. E., Ashmore, T. J., Fernandez-Twinn, D. S., Chen, J.-H., Ozanne, S. E. A suboptimal maternal diet combined with accelerated postnatal growth results in an altered aging profile in the thymus of male rats.	[Tarry-Adkins, Jane L.; Aiken, Catherine E.; Ashmore, Thomas J.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England; [Tarry-Adkins, Jane L.; Aiken, Catherine E.; Ashmore, Thomas J.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Ozanne, Susan E.] Addenbrookes Hosp, Addenbrookes Treatment Ctr, Metab Dis Unit, MRC,Wellcome Trust,Inst Metab Sci, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Tarry-Adkins, JL (corresponding author), Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England.; Tarry-Adkins, JL (corresponding author), Addenbrookes Hosp, Addenbrookes Treatment Ctr, Metab Dis Unit, MRC,Wellcome Trust,Inst Metab Sci, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England.	janeadkins@googlemail.com	Fernandez-Twinn, Denise/B-3881-2011	Fernandez-Twinn, Denise/0000-0003-2610-277X; Ozanne, Susan/0000-0001-8753-5144	British Heart Foundation [PG/09/037/27387, FS/09/029/27902]; Medical Research Council (MRC) [MC_UU_12012/4]; Isaac Newton Trust/Wellcome Institutional Strategic Support Fund (ISSF)/University of Cambridge Joint Research Grant; MRC [MC_UU_12012/4, MC_UU_00014/4] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Isaac Newton Trust/Wellcome Institutional Strategic Support Fund (ISSF)/University of Cambridge Joint Research Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank James Warner, Gregory Strachan, and M. S. Martin-Gronert (University of Cambridge Metaboloc Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science) for technical assistance. This work was supported by The British Heart Foundation (Grants PG/09/037/27387 and FS/09/029/27902), the Medical Research Council (MRC; Grant MC_UU_12012/4), and by an Isaac Newton Trust/Wellcome Institutional Strategic Support Fund (ISSF)/University of Cambridge Joint Research Grant. S.E.O. is a member of the MRC Metabolic Diseases Unit. The authors declare no conflicts of interest.	Adams AE, 2008, BBA-BIOENERGETICS, V1777, P772, DOI 10.1016/j.bbabio.2008.04.020; Adams AE, 2010, BBA-BIOENERGETICS, V1797, P807, DOI 10.1016/j.bbabio.2010.04.016; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Aspinall R, 2000, J CLIN IMMUNOL, V20, P250, DOI 10.1023/A:1006611518223; Aspinall R, 1997, J IMMUNOL, V158, P3037; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871; Carroll AM, 2005, J BIOL CHEM, V280, P15534, DOI 10.1074/jbc.M413315200; Chen JH, 2010, CLIN SCI, V118, P429, DOI 10.1042/CS20090429; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Diala I, 2013, EMBO REP, V14, P356, DOI 10.1038/embor.2013.16; Dixit VD, 2010, CURR OPIN IMMUNOL, V22, P521, DOI 10.1016/j.coi.2010.06.010; Georgakopoulou EA, 2013, AGING-US, V5, P37; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gui JG, 2012, AGING DIS, V3, P280; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Kirwan M, 2009, BRIT J HAEMATOL, V144, P771, DOI 10.1111/j.1365-2141.2008.07516.x; Li Z, 2016, CELL DEATH DIFFER, V23, P1765, DOI 10.1038/cdd.2016.65; McDade TW, 2001, J NUTR, V131, P1225, DOI 10.1093/jn/131.4.1225; McDade TW, 2001, AM J CLIN NUTR, V74, P543; MILLER JF, 1961, LANCET, V2, P748; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; Moore SE, 2004, AM J CLIN NUTR, V80, P453, DOI 10.1093/ajcn/80.2.453; Olearo E, 2012, PRENATAL DIAG, V32, P662, DOI 10.1002/pd.3883; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Rezzani R, 2014, AGE, V36, P313, DOI 10.1007/s11357-013-9564-5; Sasaki T, 2010, GERIATR GERONTOL INT, V10, pS10, DOI 10.1111/j.1447-0594.2010.00601.x; Sfeir A, 2012, J CELL SCI, V125, P4173, DOI 10.1242/jcs.106831; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins Jane L, 2017, Ageing Res Rev, V39, P96, DOI 10.1016/j.arr.2016.08.003; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; Zlamy M, 2009, REJUV RES, V12, P249, DOI 10.1089/rej.2009.0864	42	9	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					239	253		10.1096/fj.201701350RR	http://dx.doi.org/10.1096/fj.201701350RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29975569	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000457401500020
J	Chen, B; Yang, Z; Yang, CW; Qin, WH; Gu, JT; Hu, CM; Chen, A; Ning, JL; Yi, B; Lu, KZ				Chen, Bing; Yang, Zhen; Yang, Congwen; Qin, Wenhan; Gu, Jianteng; Hu, Chuanmin; Chen, An; Ning, Jiaolin; Yi, Bin; Lu, Kaizhi			A self-organized actomyosin drives multiple intercellular junction disruption and directly promotes neutrophil recruitment in lipopolysaccharide-induced acute lung injury	FASEB JOURNAL			English	Article						tight junction; adhesion junction; F-actin; myosin; inflammation	KINASE INHIBITOR; RHO-KINASE; MYOSIN; ACTIN; CELLS; PHOSPHATASE; TRANSMIGRATION; PROLIFERATION; INFLAMMATION; DYSFUNCTION	Acute lung injury (ALI), with the hallmarks of vascular integrity disruption and neutrophil recruitment, is associated with high morbidity and mortality. Enhanced actomyosin assembly contributes to endothelial cell contact dysfunction. However, the roles and mechanisms of actomyosin assembly in ALI are not totally clear. We investigated the dynamic alterations and roles of actomyosin in ALI in vivo and in vitro models induced by LPS. Pulmonary levels of E-cadherin, vascular endothelial-cadherin, occludin, myosin phosphatase target subunit 1, and thymosin 4 were decreased, and the number and activity of neutrophils and the levels of actomyosin, p--associated protein kinase, p-myosin light-chain kinase, and profilin1 were increased within 3 d after LPS administration, and then, those alterations were recovered within the next 4 d, which was consistent with the alterations of lung histology, vascular permeability, edema, and serum levels of IL-6 and TNF-. Direct or indirect inhibition of increased F-actin or myosin assembly ameliorated the reduction of intercellular junction molecules, the activation and migration of neutrophils, and the degree of lung injury. Moreover, neutrophil activation further promoted actomyosin assembly and aggravated lung injury. Conclusively, the enhancement of self-organized actomyosin contributes to alveolar-capillary barrier disruption and neutrophil recruitment in inflammatory response, which is a potential therapeutic target for ALI.Chen, B., Yang, Z., Yang, C., Qin, W., Gu, J., Hu, C., Chen, A., Ning, J., Yi, B., Lu, K. A self-organized actomyosin drives multiple intercellular junction disruption and directly promotes neutrophil recruitment in lipopolysaccharide-induced acute lung injury.	[Chen, Bing; Yang, Zhen; Yang, Congwen; Qin, Wenhan; Gu, Jianteng; Ning, Jiaolin; Yi, Bin; Lu, Kaizhi] Third Mil Med Univ, Southwest Hosp, Coll Med Lab, Dept Anesthesia, Chongqing, Peoples R China; [Hu, Chuanmin; Chen, An] Third Mil Med Univ, Southwest Hosp, Coll Med Lab, Dept Clin Biochem, Chongqing, Peoples R China	Army Medical University; Army Medical University	Lu, KZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Anesthesia, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	lukaizhi2010@163.com	Hu, Chuanmin/AAB-9604-2021; yi, bin/ABF-6425-2021	Hu, Chuanmin/0000-0003-3949-6560; yi, bin/0000-0001-5840-2086; Yang, Congwen/0000-0001-7865-7158	National Science Foundation of China (NSFC) [81671961, 81270510, 81470267]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by Grants 81671961, 81270510, and 81470267 from the National Science Foundation of China (NSFC). The authors declare no conflicts of interest.	Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Barros-Becker F, 2017, J CELL SCI, V130, P3801, DOI 10.1242/jcs.206128; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Buyukafsar K, 2006, EUR J PHARMACOL, V541, P49, DOI 10.1016/j.ejphar.2006.04.042; Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919; Ceusters JD, 2012, VET IMMUNOL IMMUNOP, V150, P221, DOI 10.1016/j.vetimm.2012.09.008; Chaudhuri PK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19672; Chen Q, 2016, ONCOTARGET, V7, P55990, DOI 10.18632/oncotarget.10809; Du L, 2012, AM J RESP CELL MOL, V47, P597, DOI 10.1165/rcmb.2012-0094OC; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Farquhar RE, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00639; Guan CY, 2015, INT J CLIN EXP PATHO, V8, P9629; Hirano Y, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0782-3; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Ikebe M, 2008, BIOCHEM BIOPH RES CO, V369, P157, DOI 10.1016/j.bbrc.2008.01.057; JACOBSON W, 1993, BRIT J ANAESTH, V70, P522, DOI 10.1093/bja/70.5.522; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Koksel O, 2005, PHARMACOL RES, V51, P453, DOI 10.1016/j.phrs.2004.11.007; Konishi H, 2009, ANTICANCER RES, V29, P2091; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lin WC, 2011, J PHARMACOL EXP THER, V339, P45, DOI 10.1124/jpet.111.181560; Liu XC, 2013, DIGEST DIS SCI, V58, P107, DOI 10.1007/s10620-012-2304-3; Lockyer P, 2017, ARTERIOSCL THROM VAS, V37, P1524, DOI 10.1161/ATVBAHA.117.309521; Matthay M A, 1999, Chest, V116, p119S; Mei Y, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1732476; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Morris DC, 2017, NEUROSCI LETT, V659, P7, DOI 10.1016/j.neulet.2017.08.064; Muller WA, 2014, AM J PATHOL, V184, P886, DOI 10.1016/j.ajpath.2013.12.033; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; Ogut O, 2008, J CELL MOL MED, V12, P2158, DOI 10.1111/j.1582-4934.2008.00536.x; Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019; Rozencwajg S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1568-y; Schnittler H, 2016, HISTOCHEM CELL BIOL, V146, P651, DOI 10.1007/s00418-016-1501-0; Schnoor M, 2017, CELL MOL LIFE SCI, V74, P1985, DOI 10.1007/s00018-016-2449-x; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shi W, 2017, SHOCK, V48, P377, DOI 10.1097/SHK.0000000000000863; Singh RK, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0039-z; Sparks Dorothy, 2014, Conn Med, V78, P277; Suo J, 2014, J LEUKOCYTE BIOL, V96, P133, DOI 10.1189/jlb.3A1213-628R; Takanezawa Y, 2017, BIOCHEM BIOPH RES CO, V494, P641, DOI 10.1016/j.bbrc.2017.10.135; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Xue B, 2014, P NATL ACAD SCI USA, V111, pE4596, DOI 10.1073/pnas.1412271111; Yoshimura T, 2005, J IMMUNOL, V175, P5569; Young EJ, 2017, NEUROBIOL LEARN MEM, V139, P109, DOI 10.1016/j.nlm.2017.01.001; Yuan J, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0708-1; Yuan SY, 2012, MICROVASC RES, V83, P82, DOI 10.1016/j.mvr.2011.06.015; Zhao G, 2017, ONCOTARGET, V8, P68153, DOI 10.18632/oncotarget.19249; Zhao YG, 2017, J STEROID BIOCHEM, V174, P96, DOI 10.1016/j.jsbmb.2017.08.003; Zheng CX, 2015, P NATL ACAD SCI USA, V112, pE7239, DOI 10.1073/pnas.1500396113; Zhu XJ, 2004, BIOCHEM BIOPH RES CO, V321, P623, DOI 10.1016/j.bbrc.2004.05.229	53	9	9	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6197	6211		10.1096/fj.201701506RR	http://dx.doi.org/10.1096/fj.201701506RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29879372	Bronze			2022-12-28	WOS:000447172000036
J	Purhonen, J; Rajendran, J; Tegelberg, S; Smolander, OP; Pirinen, E; Kallijarvi, J; Fellman, V				Purhonen, Janne; Rajendran, Jayasimman; Tegelberg, Saara; Smolander, Olli-Pekka; Pirinen, Eija; Kallijarvi, Jukka; Fellman, Vineta			NAD(+) repletion produces no therapeutic effect in mice with respiratory chain complex III deficiency and chronic energy deprivation	FASEB JOURNAL			English	Article						GRACILE syndrome; mitochondrial disease; nicotinamide riboside; sirtuin; protein acetylation	FATTY-ACID OXIDATION; NICOTINAMIDE RIBOSIDE; MITOCHONDRIAL MYOPATHY; GENE-EXPRESSION; IRON-OVERLOAD; SIRT1; ACTIVATION; PROTECTS; GLUCOSE; DEGRADATION	Biosynthetic precursors of NAD(+) can replenish a decreased cellular NAD(+) pool and, supposedly via sirtuin (SIRT) deacetylases, improve mitochondrial function. We found decreased hepatic NAD(+) concentration and downregulated biosynthesis in Bcs1l(p.S78G) knock-in mice with respiratory chain complex III deficiency and mitochondrial hepatopathy. Aiming at ameliorating disease progression via NAD(+) repletion and improved mitochondrial function, we fed these mice nicotinamide riboside (NR), a NAD(+) precursor. A targeted metabolomics verified successful administration and suggested enhanced NAD(+) biosynthesis in the treated mice, although hepatic NAD(+) concentration was unchanged at the end point. In contrast to our expectations, NR did not improve the hepatopathy, hepatic mitochondrial respiration, or survival of Bcs1l(p.S78G) mice. We linked this lack of therapeutic effect to NAD(+)-independent activation of SIRT-1 and -3 via AMPK and cAMP signaling related to the starvation-like metabolic state of Bcs1l(p.S78G) mice. In summary, we describe an unusual metabolic state with NAD(+) depletion accompanied by energy deprivation signals, uncompromised SIRT function, and upregulated oxidative metabolism. Our study highlights that the knowledge of the underlying complex metabolic alterations is critical when designing therapies for mitochondrial dysfunction.Purhonen, J., Rajendran, J., Tegelberg, S., Smolander, O.-P., Pirinen, E., Kallijarvi, J., Fellman, V. NAD(+) repletion produces no therapeutic effect in mice with respiratory chain complex III deficiency and chronic energy deprivation.	[Purhonen, Janne; Rajendran, Jayasimman; Tegelberg, Saara; Kallijarvi, Jukka; Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland; [Purhonen, Janne; Rajendran, Jayasimman; Pirinen, Eija; Kallijarvi, Jukka] Univ Helsinki, Fac Med, Helsinki, Finland; [Smolander, Olli-Pekka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Tegelberg, Saara; Fellman, Vineta] Lund Univ, Pediat, Dept Clin Sci, Lund, Sweden	Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; Lund University	Kallijarvi, J (corresponding author), Univ Helsinki, Folkhalsan Res Ctr, Biomedicum C315b, POB 63,Haartmaninkatu 8, FI-00014 Helsinki, Finland.	jukka.kallijarvi@helsinki.fi	Rajendran, Jayasimman/ABD-4460-2021; Kallijarvi, Jukka/AAV-5091-2021; Pirinen, Eija/H-9153-2015; Smolander, Olli-Pekka/AAP-4468-2020	Rajendran, Jayasimman/0000-0003-3487-8260; Kallijarvi, Jukka/0000-0003-3773-7025; Pirinen, Eija/0000-0003-1495-3972; Smolander, Olli-Pekka/0000-0002-6795-7734; Purhonen, Janne/0000-0002-0635-4075	Academy of Finland [259296, 286359]; Swedish Research Council; Finnish Physicians' Society; Foundation for Pediatric Research in Finland; Folkhalsan Research Center; Biocentrum Helsinki; Sigrid Juselius Foundation;  [521-2011-3877]	Academy of Finland(Academy of Finland); Swedish Research Council(Swedish Research CouncilEuropean Commission); Finnish Physicians' Society; Foundation for Pediatric Research in Finland; Folkhalsan Research Center; Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); 	The authors thank Prof. Charles Brenner for the targeted NAD<SUP>+</SUP> metabolite profiling; Elisa Altay, Eva Hansson, Nikica Tomasic, Nada Bechara-Hirvonen, and Minna Tuominen for technical assistance; Dr. Petri Auvinen and the DNA Sequencing and Genomics Laboratory at the University of Helsinki for performing the transcriptomics; and the Meilahti Clinical Proteomics Core facility (Dr. Rabah Soliymani and Maciej Lalowski) supported by the Biocenter Finland and HiLIFE for performing HDMS<SUP>E</SUP> and bioinformatic analyzes. This study was supported by Prof. Howard T. Jacobs, who shared the expenses of the transcriptomics; and was funded by grant 259296 (to V.F.) and 286359 (to E. P.) from the Academy of Finland; grant 521-2011-3877 (to V.F.); and by the Swedish Research Council, Finnish Physicians' Society (to V.F.), Foundation for Pediatric Research in Finland (to V.F.), Folkhalsan Research Center (to V.F., J.K.), Biocentrum Helsinki (to E.P.), and Sigrid Juselius Foundation (to E.P.). The authors declare no conflicts of interest.	Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chang CM, 2015, MOL CELL, V60, P930, DOI 10.1016/j.molcel.2015.10.037; Davoudi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168774; Davoudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086767; Diguet N, 2018, CIRCULATION, V137, P2256, DOI 10.1161/CIRCULATIONAHA.116.026099; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elmore SA, 2016, TOXICOL PATHOL, V44, P173, DOI 10.1177/0192623315625859; Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6; Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kotarsky H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041156; Laakkonen EK, 2017, AGING CELL, V16, P1276, DOI 10.1111/acel.12661; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; Mitchell SJ, 2018, CELL METAB, V27, P667, DOI 10.1016/j.cmet.2018.02.001; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Purhonen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01109-4; Rajendran J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111824; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Shi W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600878; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wang ZR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12012; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	56	11	11	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5913	5926		10.1096/fj.201800090R	http://dx.doi.org/10.1096/fj.201800090R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29782205	Bronze			2022-12-28	WOS:000447172000013
J	Smith, CO; Wang, YT; Nadtochiy, SM; Miller, JH; Jonas, EA; Dirksen, RT; Nehrke, K; Brookes, PS				Smith, Charles O.; Wang, Yves T.; Nadtochiy, Sergiy M.; Miller, James H.; Jonas, Elizabeth A.; Dirksen, Robert T.; Nehrke, Keith; Brookes, Paul S.			Cardiac metabolic effects of K(Na)1.2 channel deletion and evidence for its mitochondrial localization	FASEB JOURNAL			English	Article						patch clamp; Slick; Slo2; 1; bithionol	2,3-BUTANEDIONE MONOXIME; ISCHEMIA-REPERFUSION; POTASSIUM CHANNELS; INTRACELLULAR NA+; K+ CHANNELS; SLACK; SODIUM; CARDIOPROTECTION; INHIBITION; SLO2.1	Controversy surrounds the molecular identity of mitochondrial K+ channels that are important for protection against cardiac ischemia-reperfusion injury. Although K(Na)1.2 (sodium-activated potassium channel encoded by Kcn2) is necessary for cardioprotection by volatile anesthetics, electrophysiological evidence for a channel of this type in mitochondria is lacking. The endogenous physiological role of a potential mito-K(Na)1.2 channel is also unclear. In this study, single channel patch clamp of 27 independent cardiac mitochondrial inner membrane (mitoplast) preparations from wild-type (WT) mice yielded 6 channels matching the known ion sensitivity, ion selectivity, pharmacology, and conductance properties of K(Na)1.2 (slope conductance, 138 +/- 1 pS). However, similar experiments on 40 preparations from Kcnt2(-/-) mice yielded no such channels. The K-Na opener bithionol uncoupled respiration in WT but not Kcnt2(-/-) cardiomyocytes. Furthermore, when oxidizing only fat as substrate, Kcnt2(-/-) cardiomyocytes and hearts were less responsive to increases in energetic demand. Kcnt2(-/-) mice also had elevated body fat, but no baseline differences in the cardiac metabolome. These data support the existence of a cardiac mitochondrial K(Na)1.2 channel, and a role for cardiac K(Na)1.2 in regulating metabolism under conditions of high energetic demand.Smith, C. O., Wang, Y. T., Nadtochiy, S. M., Miller, J. H., Jonas, E. A., Dirksen, R. T., Nehrke, K., Brookes, P. S. Cardiac metabolic effects of K(Na)1.2 channel deletion and evidence for its mitochondrial localization.	[Smith, Charles O.] Univ Rochester, Med Ctr, Dept Biochem, Rochester, NY 14642 USA; [Wang, Yves T.; Nadtochiy, Sergiy M.; Miller, James H.; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol & Perioperat Med, Rochester, NY 14642 USA; [Dirksen, Robert T.; Nehrke, Keith; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Nehrke, Keith] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Jonas, Elizabeth A.] Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, New Haven, CT 06510 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Yale University	Brookes, PS (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604, Rochester, NY 14642 USA.	paul_brookes@urmc.rochester.edu		Wang, Yves/0000-0003-2095-3506; Brookes, Paul/0000-0002-8639-8413; Nehrke, Keith/0000-0001-9697-726X	U.S. National Institutes of Health General Medical Research [R01-GM087483]; National Heart, Lung and Blood Institute [R01-HL071158]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR-059646]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS045876, R01NS081746] Funding Source: NIH RePORTER	U.S. National Institutes of Health General Medical Research; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Christopher Lingle (Washington University, St. Louis, MO, USA) for providing founders for the Kcnt2<SUP>-/-</SUP> mice; Kathleen Kinally (Emeritus, New York University, New York, NY, USA) for technical support in performing mitochondrial patch-clamp experiments; Dana Godfrey [University of Rochester Medical Center (URMC) Musculoskeletal Center] for support with the DEXA analyses; and Karen Bentley (URMC electron microscopy core) for support obtaining electron microscopic images. This work was funded by U.S. National Institutes of Health General Medical Research Grant R01-GM087483 (to P.S.B. and K.N.), National Heart, Lung and Blood Institute Grant R01-HL071158 (to P.S.B.), and National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01-AR-059646 (to R.T.D.). The authors declare no conflicts of interest.	Aittokallio T, 2010, BRIEF BIOINFORM, V11, P253, DOI 10.1093/bib/bbp059; Bay J, 2013, J MOL CELL CARDIOL, V61, P20, DOI 10.1016/j.yjmcc.2013.05.010; Bednarczyk P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068125; Bentzen BH, 2007, MOL PHARMACOL, V72, P1033, DOI 10.1124/mol.107.038331; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Biton B, 2012, J PHARMACOL EXP THER, V340, P706, DOI 10.1124/jpet.111.184622; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Checchetto V, 2016, BBA-BIOENERGETICS, V1857, P1258, DOI 10.1016/j.bbabio.2016.03.011; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Dolga AM, 2013, J BIOL CHEM, V288, P10792, DOI 10.1074/jbc.M113.453522; DRYER SE, 1989, J PHYSIOL-LONDON, V410, P283, DOI 10.1113/jphysiol.1989.sp017533; Eisfeld J, 1997, BIOCHEM BIOPH RES CO, V230, P489, DOI 10.1006/bbrc.1996.5852; Ertracht O, 2014, PHARMACOL THERAPEUT, V142, P33, DOI 10.1016/j.pharmthera.2013.11.003; Foster DB, 2012, CIRC RES, V111, P446, DOI 10.1161/CIRCRESAHA.112.266445; Frankenreiter S, 2017, CIRCULATION, V136, P2337, DOI 10.1161/CIRCULATIONAHA.117.028723; Garlid KD, 1997, CIRC RES, V81, P1072; Garlid KD, 1996, BBA-BIOENERGETICS, V1275, P123, DOI 10.1016/0005-2728(96)00061-8; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gururaj S, 2017, CELL REP, V21, P926, DOI 10.1016/j.celrep.2017.09.088; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kaczmarek LK, 2017, PHARMACOL REV, V69, P1, DOI 10.1124/pr.116.012864; Kaczmarek Leonard K, 2013, ISRN Neurosci, V2013; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Kawasaki Y, 2017, J PEDIATR-US, V191, P270, DOI 10.1016/j.jpeds.2017.08.057; Kim GE, 2014, CELL REP, V9, P1661, DOI 10.1016/j.celrep.2014.11.015; Kim GE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00209; Laskowski M, 2016, BBA-BIOENERGETICS, V1857, P1247, DOI 10.1016/j.bbabio.2016.03.007; Leanza L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00227; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Madaan P, 2018, BRAIN DEV-JPN, V40, P229, DOI 10.1016/j.braindev.2017.09.008; Martinez-Espinosa PL, 2015, ELIFE, V4, DOI 10.7554/eLife.10013; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nabbi R, 2014, PHYSIOL GENOMICS, V46, P169, DOI 10.1152/physiolgenomics.00118.2013; Nadtochiy SM, 2015, J MOL CELL CARDIOL, V88, P64, DOI 10.1016/j.yjmcc.2015.09.008; Nita II, 2015, CELL CALCIUM, V57, P69, DOI 10.1016/j.ceca.2014.12.007; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Ponnalagu D, 2017, HANDB EXP PHARMACOL, V240, P71, DOI 10.1007/164_2016_39; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Singh H, 2013, P NATL ACAD SCI USA, V110, P10836, DOI 10.1073/pnas.1302028110; Smith CO, 2017, BIOCHEM J, V474, P2067, DOI 10.1042/BCJ20160623; Soltysinska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103402; Stowe DF, 2013, BBA-BIOMEMBRANES, V1828, P427, DOI 10.1016/j.bbamem.2012.08.031; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Tano JY, 2014, AM J PHYSIOL-HEART C, V307, pH811, DOI 10.1152/ajpheart.00319.2014; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tejada MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169914; Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833; Tejada MD, 2012, BIOCHEM BIOPH RES CO, V424, P208, DOI 10.1016/j.bbrc.2012.06.038; Testai L, 2015, MED RES REV, V35, P520, DOI 10.1002/med.21332; Thomson SJ, 2015, J BIOL CHEM, V290, P14528, DOI 10.1074/jbc.M115.653089; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tripathy A, 1999, J MEMBRANE BIOL, V169, P189, DOI 10.1007/s002329900530; Watanabe Y, 2001, BRIT J PHARMACOL, V132, P1317, DOI 10.1038/sj.bjp.0703926; WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0; Wojtovich AP, 2016, ANESTHESIOLOGY, V124, P1065, DOI 10.1097/ALN.0000000000001046; Wojtovich AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028287; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; XIAO YF, 1995, LIFE SCI, V57, P335; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yang B, 2006, NEUROPHARMACOLOGY, V51, P896, DOI 10.1016/j.neuropharm.2006.06.003	65	15	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6135	6149		10.1096/fj.201800139R	http://dx.doi.org/10.1096/fj.201800139R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29863912	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000447172000031
J	Li, XL; Yu, T; Shan, HT; Jiang, H; Sun, J; Zhao, XG; Su, W; Yang, LD; Shan, HL; Liang, HH				Li, Xuelian; Yu, Tong; Shan, Huitong; Jiang, Hua; Sun, Jian; Zhao, Xiaoguang; Su, Wei; Yang, Lida; Shan, Hongli; Liang, Haihai			lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; long noncoding RNA; ceRNA; fibroblast	IDIOPATHIC PULMONARY-FIBROSIS; LONG NONCODING RNAS; CARDIAC FIBROSIS; EXPRESSION; GENE; PIRFENIDONE; MECHANISMS; PROGNOSIS; CANCER; AXIS	Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic parenchymal lung disease of unknown etiology and lacks an effective intervention. Long noncoding RNAs (lncRNAs) participate in organ fibrosis and various pulmonary diseases, but the role of lncRNAs in lung fibrosis is not fully understood. In the present study, we identified that lncRNA NONMMUT021928, designated as pulmonary fibrosis-associated lncRNA (PFAL), was up-regulated in the lungs of mice with experimental lung fibrosis, and in TGF-1-induced fibrotic lung fibroblasts. Further study showed that overexpression of PFAL promoted cell proliferation, migration, and fibroblast-myofibroblast transition. Overexpression further resulted in extracellular matrix deposition and fibrogenesis in lung fibroblasts through regulation of microRNA-18a (miR-18a). Importantly, knockdown of PFAL alleviated lung fibrosis both in vitro and in vivo. Mechanistically, our study showed that PFAL promoted lung-fibroblast activation and fibrogenesis by acting as a competing endogenous RNA for miR-18a: forced expression of PFAL inhibited the expression and activity of miR-18a, whereas silencing of PFAL had the opposite effect. Furthermore, we found that miR-18a was decreased during lung fibrosis in vitro and in vivo, as well as in patients with IPF. Moreover, knockdown of miR-18a led to fibrogenesis in lung fibroblasts, whereas enhanced expression of miR-18a attenuated TGF-1-induced lung fibrosis by directly targeting the regulation of connecting tissue growth factor. Taken together, these results revealed the effect and mechanism of lncRNA PFAL in pulmonary fibrosis and suggested that PFAL depletion may provide a novel strategy for the treatment of lung fibrosis.Li, X., Yu, T., Shan, H., Jiang, H., Sun, J., Zhao, X., Su, W., Yang, L., Shan, H., Liang, H. lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a.	[Li, Xuelian; Yu, Tong; Shan, Huitong; Jiang, Hua; Sun, Jian; Zhao, Xiaoguang; Su, Wei; Yang, Lida; Shan, Hongli; Liang, Haihai] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res, Minist Educ,Dept Pharmacol,Coll Pharm, Harbin, Heilongjiang, Peoples R China; [Yu, Tong; Shan, Huitong; Jiang, Hua; Sun, Jian; Zhao, Xiaoguang; Su, Wei; Shan, Hongli; Liang, Haihai] Harbin Med Univ, Heilongjiang Acad Med Sci, Northern Translat Med Res & Cooperat Ctr, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Liang, HH (corresponding author), Harbin Med Univ, Baojian Rd 157, Harbin 150081, Heilongjiang, Peoples R China.	lianghaihai@ems.hrbmu.edu.cn		Liang, Haihai/0000-0003-4446-7035; Xuelian, Li/0000-0001-9043-8580	National Natural Science Foundation of China [31671187, 81770284]; Scientific Fund of Heilongjiang Province for Youth [QC 2015100]; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2016197]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Fund of Heilongjiang Province for Youth; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province	This study was supported by the National Natural Science Foundation of China (Grants 31671187 and 81770284), the Scientific Fund of Heilongjiang Province for Youth (Grant QC 2015100), and the University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (Grant UNPYSCT-2016197). The authors declare no conflicts of interest.	Chen DL, 2017, THERANOSTICS, V7, P4836, DOI 10.7150/thno.20942; Chen L, 2017, J CELL BIOCHEM, V118, P1965, DOI 10.1002/jcb.25873; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Creemers EE, 2016, CIRC RES, V118, P108, DOI 10.1161/CIRCRESAHA.115.305242; da Rocha ST, 2017, NAT STRUCT MOL BIOL, V24, P197, DOI 10.1038/nsmb.3370; Du M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02229-1; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Feng M, 2018, MOL THER, V26, P148, DOI 10.1016/j.ymthe.2017.09.024; Flaherty K. R., 2017, BMJ OPEN RESP RES, V4, DOI DOI 10.1136/BMFRESP-2017; Fox JL, 2013, RNA, V19, P177, DOI 10.1261/rna.036467.112; Geng HZ, 2017, BIOCHEM BIOPH RES CO, V491, P329, DOI 10.1016/j.bbrc.2017.07.101; Guo YZ, 2016, GENE, V591, P129, DOI 10.1016/j.gene.2016.07.008; Jiang XY, 2017, EPIGENOMICS-UK, V9, P1233, DOI 10.2217/epi-2017-0020; Kurita Y, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0600-3; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Liang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.207; Liang HH, 2018, THERANOSTICS, V8, P1180, DOI 10.7150/thno.20846; Liang HH, 2016, J MOL MED, V94, P655, DOI 10.1007/s00109-016-1381-8; Liang HH, 2014, MOL THER, V22, P1122, DOI 10.1038/mt.2014.42; Liu HZ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.500; Liu Y, 2018, BBA-MOL BASIS DIS, V1864, P420, DOI 10.1016/j.bbadis.2017.11.003; Makiguchi T, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0427-3; Min HY, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0583-2; Ohgawara T, 2009, FEBS LETT, V583, P1006, DOI 10.1016/j.febslet.2009.02.025; Sun H, 2016, J CELL MOL MED, V20, P1234, DOI 10.1111/jcmm.12783; Vancheri C, 2018, AM J RESP CRIT CARE, V197, P356, DOI 10.1164/rccm.201706-1301OC; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xu XX, 2018, CANCER MED-US, V7, P21, DOI 10.1002/cam4.1238; Yan WW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11904-8; Yang GH, 2015, GENE, V562, P138, DOI 10.1016/j.gene.2015.02.065; Zhang K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00204-4; Zhang Q, 2017, MOL THER, V25, P728, DOI 10.1016/j.ymthe.2016.12.017; Zhang YD, 2018, DESALIN WATER TREAT, V115, P64, DOI 10.5004/dwt.2018.22210	34	37	42	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5285	5297		10.1096/fj.201800055R	http://dx.doi.org/10.1096/fj.201800055R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29683732	Bronze			2022-12-28	WOS:000447972500008
J	Luo, JJ; Bian, WP; Liu, Y; Huang, HY; Yin, Q; Yang, XJ; Pei, DS				Luo, Juan-Juan; Bian, Wan-Ping; Liu, Yi; Huang, Hai-Yang; Yin, Qian; Yang, Xiao-Jun; Pei, De-Sheng			CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy	FASEB JOURNAL			English	Article						gene editing; MMEJ; transgenesis; knock-in	ZINC-FINGER NUCLEASES; MEDIATED TARGETED INTEGRATION; TRANSGENIC ZEBRAFISH; HOMOLOGOUS RECOMBINATION; KNOCK-IN; SYSTEM; CLEAVAGE; REPAIR; GENES; TALEN	Numerous feasible methods for inserting large fragments of exogenous DNA sequences into the zebrafish genome have been developed, as has genome editing technology using programmable nucleases. However, the coding sequences of targeted endogenous genes are disrupted, and the expression patterns of inserted exogenous genes cannot completely recapitulate those of endogenous genes. Here we describe the establishment of a novel strategy for endogenous promoter-driven and microhomology-mediated end-joining-dependent integration of a donor vector using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9. We successfully integrated mCherry into the final coding sequence of targeted genes to generate seamless transgenic zebrafish lines with high efficiency. This novel seamless transgenesis technique not only maintained the integrity of the endogenous gene but also did not disrupt the function of targeted gene. Therefore, our microhomology-mediated end-joining-mediated transgenesis strategy may have broader applications in gene therapy. Moreover, this novel seamless gene-editing strategy in zebrafish provides a valuable new transgenesis technique, which was driven by endogenous promoters and in vivo animal reporter modes for translational medicine. It is expected to be a standard gene-editing technique in the field of zebrafish, leading to some important breakthroughs for studies in early embryogenesis.Luo, J.-J., Bian, W.-P., Liu, Y., Huang, H.-Y., Yin, Q., Yang, X.-J., Pei, D.-S. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.	[Luo, Juan-Juan; Yang, Xiao-Jun] Shantou Univ, Ctr Neurosci, Coll Med, 22 Xinling Rd, Shantou 515041, Peoples R China; [Luo, Juan-Juan; Bian, Wan-Ping; Liu, Yi; Huang, Hai-Yang; Yin, Qian; Pei, De-Sheng] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China; [Liu, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China	Shantou University; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, XJ (corresponding author), Shantou Univ, Ctr Neurosci, Coll Med, 22 Xinling Rd, Shantou 515041, Peoples R China.; Pei, DS (corresponding author), Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China.	yangx@stu.edu.cn; peids@cigit.ac.cn	Pei, De-Sheng/K-1466-2017	Pei, De-Sheng/0000-0001-6408-9575	Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing [CSTCCXLJRC201714]; National Natural Science Foundation of China [81572494]; Key Application and Development Program of the Chongqing Science and Technology Commission [cstc2014yykfC20004, cstc2014yykfC20002]; Natural Science Foundation of Guangdong Province [2015A030313440]; Hundred Talents Program of the Chinese Academy of Sciences	Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Application and Development Program of the Chongqing Science and Technology Commission; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing (CSTCCXLJRC201714 to D.-S.P.), the National Natural Science Foundation of China (81572494 to X.-J.Y.), the Key Application and Development Program of the Chongqing Science and Technology Commission (cstc2014yykfC20004 and cstc2014yykfC20002 to D.-S.P.), the Natural Science Foundation of Guangdong Province (2015A030313440 to X.-J.Y.), and the Hundred Talents Program of the Chinese Academy of Sciences (to D.-S.P.). The authors declare no conflicts of interest.	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bibikova M, 2002, GENETICS, V161, P1169; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Daniels RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100637; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grunwald DJ, 2013, NAT METHODS, V10, P303, DOI 10.1038/nmeth.2415; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Liu ZB, 2012, BIOCHEM BIOPH RES CO, V427, P223, DOI 10.1016/j.bbrc.2012.09.064; Lorens JB, 2004, J BIOCHEM BIOPH METH, V58, P101, DOI 10.1016/S0165-022X(03)00147-7; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nussleinvolhard C., 2001, ZEBRAFISH PRACTICAL, V18; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Thisse B, 2014, METHODS MOL BIOL, V1211, P53, DOI 10.1007/978-1-4939-1459-3_5; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JW, 2015, BIOTECHNIQUES, V58, P161, DOI 10.2144/000114261; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	50	16	17	0	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5132	5142		10.1096/fj.201800077RR	http://dx.doi.org/10.1096/fj.201800077RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29812974				2022-12-28	WOS:000443817700041
J	Chakraborty, PK; Murphy, B; Mustafi, SB; Dey, A; Xiong, XH; Rao, G; Naz, S; Zhang, M; Yang, D; Dhanasekaran, DN; Bhattacharya, R; Mukherjee, P				Chakraborty, Prabir Kumar; Murphy, Brennah; Mustafi, Soumyajit Banerjee; Dey, Anindya; Xiong, Xunhao; Rao, Geeta; Naz, Sarwat; Zhang, Min; Yang, Da; Dhanasekaran, Danny N.; Bhattacharya, Resham; Mukherjee, Priyabrata			Cystathionine -synthase regulates mitochondrial morphogenesis in ovarian cancer	FASEB JOURNAL			English	Article						mitofusin; ROS; JNK; fission	HYDROGEN-SULFIDE; BETA-SYNTHASE; MITOFUSIN 2; FUSION; FISSION; PROTEIN; MORPHOLOGY; PHOSPHORYLATION; BIOENERGETICS; DEGRADATION	Deregulation of mitochondrial morphogenesis, a dynamic equilibrium between mitochondrial fusion and fission processes, is now evolving as a key metabolic event that fuels tumor growth and therapy resistance. However, fundamental knowledge underpinning how cancer cells reprogram mitochondrial morphogenesis remains incomplete. Here, we report that cystathionine -synthase (CBS) reprograms mitochondrial morphogenesis in ovarian cancer (OvCa) cells by selectively regulating the stability of mitofusin 2 (MFN2). Clinically, high expression of both CBS and MFN2 implicates poor overall survival of OvCa patients, and a significant association between CBS and MFN2 expression exists in individual patients in the same data set. The silencing of CBS by small interfering RNA or inhibition of its catalytic activity by a small molecule inhibitor creates oxidative stress that activates JNK. Activated JNK phosphorylates MFN2 to recruit homologous to the E6-AP carboxyl terminus' domain-containing ubiquitin E3 ligase for its degradation via the ubiquitin-proteasome system. Supplementation with hydrogen sulfide or glutathione (the catalytic products of CBS enzymatic activity), anti-oxidants, or a JNK inhibitor restores MFN2 expression. In CBS-silenced orthotopic xenograft tumor tissues, MFN2 but not MFN1 is selectively downregulated. In summary, this report reveals a role for deregulated mitochondrial morphogenesis in OvCa, suggests one of the mechanisms for this deregulation, and provides a way to correct it through modulation of the metabolic enzyme CBS.Chakraborty, P. K., Murphy, B., Mustafi, S. B., Dey, A., Xiong, X., Rao, G., Naz, S., Zhang, M., Yang, D., Dhanasekaran, D. N., Bhattacharya, R., Mukherjee, P. Cystathionine -synthase regulates mitochondrial morphogenesis in ovarian cancer.	[Chakraborty, Prabir Kumar; Murphy, Brennah; Xiong, Xunhao; Rao, Geeta; Naz, Sarwat; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Mustafi, Soumyajit Banerjee; Dey, Anindya; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Chakraborty, Prabir Kumar; Xiong, Xunhao; Dhanasekaran, Danny N.; Bhattacharya, Resham; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 1409A, Oklahoma City, OK 73104 USA; [Zhang, Min; Yang, Da] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chakraborty, PK; Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 1409A, Oklahoma City, OK 73104 USA.	prabir-chakraborty@ouhsc.edu; priyabrata-mukherjee@ouhsc.edu	Naz, Sarwat/J-2794-2019		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL120585, CA136494, CA213278, CA157481]; Foundation for Women's Cancer (FWC); Laura Crandall Brown Foundation [05101101]; NATIONAL CANCER INSTITUTE [R01CA136494, R01CA213278, R01CA157481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120585] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for Women's Cancer (FWC); Laura Crandall Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL120585 (to P.M. and R.B.), CA136494 and CA213278 (to P.M.), and CA157481 (to R.B.) and Foundation for Women's Cancer (FWC), Laura Crandall Brown Foundation Grant 05101101 (to P.K.C.). The authors declare no conflicts of interest.	Abe K, 1996, J NEUROSCI, V16, P1066; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Chakraborty PK, 2015, ONCOTARGET, V6, P37367, DOI 10.18632/oncotarget.5424; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Dominy JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015008; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025; Hellmich MR, 2015, ANTIOXID REDOX SIGN, V22, P424, DOI 10.1089/ars.2014.5933; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Kashatus DF, 2018, BIOCHEM BIOPH RES CO, V500, P9, DOI 10.1016/j.bbrc.2017.06.192; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kong B, 2015, ANN NY ACAD SCI, V1350, P1, DOI 10.1111/nyas.12883; Kong B, 2014, J BIOL CHEM, V289, P27134, DOI 10.1074/jbc.M114.594812; Kruger WD, 2017, MOL GENET METAB, V121, P199, DOI 10.1016/j.ymgme.2017.05.011; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Li SS, 2015, ANTIOXID REDOX SIGN, V23, P630, DOI 10.1089/ars.2014.6186; Liu JQ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0099-1; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Maycotte P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698391; Modis K, 2016, PHARMACOL RES, V113, P116, DOI 10.1016/j.phrs.2016.08.023; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418; Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Snyder S. H., 2009, SCI SIGNAL, V2; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Veeranki S, 2015, AM J PHYSIOL-HEART C, V309, pH325, DOI 10.1152/ajpheart.00099.2015; Wang SSS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.18; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Xu Y, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.40; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	51	25	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4145	4157		10.1096/fj.201701095R	http://dx.doi.org/10.1096/fj.201701095R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29494264	Green Published			2022-12-28	WOS:000439325400008
J	Kou, YB; Liu, QY; Liu, WL; Sun, HX; Liang, M; Kong, FY; Zhang, B; Wei, YX; Liu, ZZ; Wang, YG				Kou, Yanbo; Liu, Qingya; Liu, Wenli; Sun, Hongxiang; Liang, Ming; Kong, Fanyun; Zhang, Bo; Wei, Yanxia; Liu, Zhuanzhuan; Wang, Yugang			LIGHT/TNFSF14 signaling attenuates beige fat biogenesis	FASEB JOURNAL			English	Article						obesity; cytokine; adipocyte; browning; metabolism	NF-KAPPA-B; INSULIN-RESISTANCE; LINKING OBESITY; LIGHT; INFLAMMATION; TNFSF14; MEMBER; THERMOGENESIS; SUPERFAMILY; APOPTOSIS	The physiologic signals that regulate beige adipogenesis remain incompletely understood, especially those that limit browning and prevent overexpenditure of energy. In this study, the TNF family member cytokine lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells (LIGHT), also known as TNF super family protein 14 (TNFSF14), can inhibit adipose precursor differentiation into beige adipocytes. In acute cold stress, LIGHT deficiency in mice accelerated browning in the subcutaneous white adipose tissue (scWAT). Further experiments showed that LIGHT interacting with lymphotoxin- receptor (LTR) on adipose precursors blocked beige fat biogenesis. LTR signals attenuated the JNK pathway, which contributed to their antibeiging effect. Blocking JNK activation using a small molecular inhibitor prevented cold-induced scWAT beiging. Furthermore, LIGHT/LTR signals acted as an attenuator of white adipogenesis. LIGHT deficiency in mice promoted obesity during high-fat diet feeding. These findings identify the LIGHT axis as a regulator of adipose tissue homeostasis and suggest that LIGHT signaling functions as a mechanism to divert energy in favor of immune activation.Kou, Y., Liu, Q., Liu, W., Sun, H., Liang, M., Kong, F., Zhang, B., Wei, Y., Liu, Z., Wang, Y. LIGHT/TNFSF14 signaling attenuates beige fat biogenesis.	[Kou, Yanbo; Liu, Qingya; Liu, Wenli; Sun, Hongxiang; Liang, Ming; Kong, Fanyun; Zhang, Bo; Wei, Yanxia; Liu, Zhuanzhuan; Wang, Yugang] Xuzhou Med Univ, Jiangsu Key Lab Immun & Metab, Xuzhou, Jiangsu, Peoples R China; [Kou, Yanbo; Liu, Qingya; Liu, Wenli; Sun, Hongxiang; Liang, Ming; Kong, Fanyun; Zhang, Bo; Wei, Yanxia; Liu, Zhuanzhuan; Wang, Yugang] Xuzhou Med Univ, Lab Infect & Immun, Dept Pathogen Biol & Immunol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Wang, YG (corresponding author), Xuzhou Med Univ, Dept Pathogen Biol & Immunol, Tongshan Rd 209, Xuzhou 221004, Jiangsu, Peoples R China.	wangyg@xzhmu.edu.cn	Liu, Qing/GWC-9222-2022; liu, qingqing/HHD-0360-2022	Wang, Yugang/0000-0002-0709-1924	National Natural Science Foundation of China [81770853, 81700774]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [KYLX14-1448]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China [16KJB310016]; Starting Foundation for Talents of Xuzhou Medical University [D2016029, 53591518]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China; Starting Foundation for Talents of Xuzhou Medical University	The authors thank Drs. Yang-Xin Fu and Mingzhao Zhu for providing critical reagents for the project. Project support was provided in part by Grants 81770853 (to Y.W.), 81700774 (to Y.K.) from the National Natural Science Foundation of China; Grant KYLX14-1448 from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in 2014; Grant 16KJB310016 from the Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China; and Grants D2016029 (to Y.W.) and 53591518 (to Y.K.) from the Starting Foundation for Talents of Xuzhou Medical University. Y.W. is a specially appointed professor by universities in Jiangsu Province. The authors declare no conflicts of interest.	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2012, CURR OPIN LIPIDOL, V23, P190, DOI 10.1097/MOL.0b013e328352dcef; Bassols J, 2010, INT J OBESITY, V34, P146, DOI 10.1038/ijo.2009.199; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Choi EK, 2014, J ENDOCRINOL, V220, P25, DOI 10.1530/JOE-13-0341; Dhall S, 2016, ADV WOUND CARE, V5, P421, DOI 10.1089/wound.2016.0687; DiSpirito JR, 2015, SEMIN IMMUNOL, V27, P315, DOI 10.1016/j.smim.2015.10.005; Goto T, 2016, CYTOKINE, V77, P107, DOI 10.1016/j.cyto.2015.11.001; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Halvorsen B, 2016, DIABETOLOGIA, V59, P2134, DOI 10.1007/s00125-016-4036-y; Krause P, 2014, GASTROENTEROLOGY, V146, P1752, DOI 10.1053/j.gastro.2014.02.010; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lim SG, 2013, CELL IMMUNOL, V285, P10, DOI 10.1016/j.cellimm.2013.08.002; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Okla M, 2018, INFLAMMATION, V41, P626, DOI 10.1007/s10753-017-0718-y; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rajbhandari P, 2018, CELL, V172, P218, DOI 10.1016/j.cell.2017.11.019; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saunders BM, 2018, IMMUNOL CELL BIOL, V96, P41, DOI 10.1111/imcb.1002; Tang HD, 2016, CANCER LETT, V370, P85, DOI 10.1016/j.canlet.2015.10.009; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tiller G, 2011, INT J OBESITY, V35, P208, DOI 10.1038/ijo.2010.126; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Wang YG, 2009, IMMUNOL REV, V229, P232, DOI 10.1111/j.1600-065X.2009.00762.x	33	12	13	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1595	1604		10.1096/fj.201800792R	http://dx.doi.org/10.1096/fj.201800792R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30148680	Bronze			2022-12-28	WOS:000457296600008
J	Margier, M; Collet, X; le May, C; Desmarchelier, C; Andre, F; Lebrun, C; Defoort, C; Bluteau, A; Borel, P; Lespine, A; Reboul, E				Margier, Marielle; Collet, Xavier; le May, Cedric; Desmarchelier, Charles; Andre, Francois; Lebrun, Chantal; Defoort, Catherine; Bluteau, Alice; Borel, Patrick; Lespine, Anne; Reboul, Emmanuelle			ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux	FASEB JOURNAL			English	Article						cholecalciferol; 25-hydroxycholecalciferol; bioavailability; enterocyte; MDR1	CHOLESTEROL EXCRETION; STEROID-HORMONES; FATTY-ACIDS; EXPRESSION; CACO-2; TRANSPORT; RECEPTOR; CELLS; MDR1A; MICE	Efficient intestinal absorption of dietary vitamin D is required in most people to ensure an adequate status. Thus, we investigated the involvement of ATP binding cassette subfamily B member 1 (ABCB1) in vitamin D intestinal efflux. Both cholecalciferol (D-3) and 25-hydroxycholecalciferol [25(OH)D-3] apical effluxes were decreased by chemical inhibition of ABCB1 in Caco-2 cells and increased by ABCB1 overexpression in Griptites or Madin-Darby canine kidney type II cells. Mice deficient for the 2 murine ABCB1s encoded by Abcb1a and Abcb1b genes (Abcb1(-/-)) displayed an accumulation of 25(OH)D-3 in plasma, intestine, brain, liver, and kidneys, together with an increased D-3 postprandial response after gavage compared with controls. 25(OH)D-3 efflux through Abcb1(-/-) intestinal explants was markedly decreased compared with controls. This reduction of 25(OH)D-3 transfer from plasma to lumen was further confirmed in vivo in intestine-perfused mice. Docking experiments established that both D-3 and 25(OH)D-3 could bind with high affinity to Caenorhabditis elegans P-glycoprotein, used as an ABCB1 model. Finally, in a group of 39 healthy male adults, a single-nucleotide polymorphism (SNP) in ABCB1 (rs17064) was significantly associated with the fasting plasma 25(OH)D-3 concentration. Thus, we showed here for the first time that ABCB1 is involved in neo-absorbed vitamin D efflux by the enterocytes and that it also contributes to vitamin D transintestinal excretion and likely impacts vitamin D status.Margier, M., Collet, X., le May, C., Desmarchelier, C., Andre, F., Lebrun, C., Defoort, C., Bluteau, A., Borel, P., Lespine, A., Reboul, E. ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux.	[Margier, Marielle; Desmarchelier, Charles; Defoort, Catherine; Borel, Patrick; Reboul, Emmanuelle] Aix Marseille Univ, Ctr Rech Cardiovasc & Nutr C2VN, INRA, INSERM, Marseille, France; [Collet, Xavier] Univ Toulouse III, Inst Metab & Cardiovasc Dis I2MC, INSERM, UMR 1048, Toulouse, France; [Lebrun, Chantal; Bluteau, Alice; Lespine, Anne] Univ Toulouse, Innovat Therapeut & Resistance InTheRes, ENVT, INRA,UMR 1436, Toulouse, France; [le May, Cedric] Univ Nantes, Inst Thorax, CNRS, INSERM, Nantes, France; [Andre, Francois] Univ Paris Saclay, Commissariat Energie Atom & Energies Alternat, Inst Biol Integrat Cellule I2BC, Inst Biol Frederic Joliot,CNRS,UMR 9198, Gif Sur Yvette, France; [Defoort, Catherine] Criblage Biol Marseille CriBioM, Fac Med Timone, Marseille, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lespine, A (corresponding author), INRA InTheRes, UMR 1436, 180 Chemin Tournefeuille,BP 93173, F-31027 Toulouse 3, France.; Reboul, E (corresponding author), Ctr Cardiovasc & Nutr Res C2VN, Fac Med Timone, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	anne.lespine@inra.fr; emmanuelle.reboul@univ-amu.fr	Borel, Patrick/A-4057-2015; Reboul, Emmanuelle/K-6637-2017; Le May, cedric/D-2691-2009	Borel, Patrick/0000-0001-9977-3238; Reboul, Emmanuelle/0000-0002-4576-1992; Le May, cedric/0000-0002-7554-792X; Desmarchelier, Charles/0000-0001-9970-7089	Provence-Alpes-Cote d'Azur Region; Centre Technique de Conservation des Produits Alimentaires (CTCPA; Avignon, France); Societe Francaise de Nutrition (SFN)	Provence-Alpes-Cote d'Azur Region(Region Provence-Alpes-Cote d'Azur); Centre Technique de Conservation des Produits Alimentaires (CTCPA; Avignon, France); Societe Francaise de Nutrition (SFN)	The authors acknowledge Marion Nowicki [Centre de Recherche en Cardiovasculaire et Nutrition (C2VN)] and Lea Lasvaux [Innovations Therapeutiques et Resistances (InTheRes)] for technical contributions, Ljubica Svilar [Criblage Biologique Marseille (CriBioM)] for valuable help with LC-MS<SUP>2</SUP> analyses, as well as Marion David (InTheRes) for sharing knowledge on docking experiments. M.M. received a doctoral fellowship (2015-2018) from Provence-Alpes-Cote d'Azur Region in partnership with the Centre Technique de Conservation des Produits Alimentaires (CTCPA; Avignon, France). This work was partly supported by a Research Price from the Societe Francaise de Nutrition (SFN). The authors declare no conflicts of interest.	Anderson PH, 2004, J STEROID BIOCHEM, V89-90, P111, DOI 10.1016/j.jsbmb.2004.03.089; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Borel P, 2013, J NUTR, V143, P448, DOI 10.3945/jn.112.172734; Collett A, 2004, PHARM RES-DORDR, V21, P819, DOI 10.1023/B:PHAM.0000026434.82855.69; Cui YJL, 2009, DRUG METAB DISPOS, V37, P203, DOI 10.1124/dmd.108.023721; David M, 2018, INT J PARASITOL-DRUG, V8, P145, DOI 10.1016/j.ijpddr.2018.02.001; David MA, 2016, INT J PARASITOL-DRUG, V6, P299, DOI 10.1016/j.ijpddr.2016.09.001; Desmarchelier C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101152; Desmarchelier C, 2016, J NUTR, V146, P2421, DOI 10.3945/jn.116.237115; Desmarchelier C, 2014, J CLIN ENDOCR METAB, V99, pE484, DOI 10.1210/jc.2013-3962; Garrigues A, 2002, MOL PHARMACOL, V62, P1288, DOI 10.1124/mol.62.6.1288; Goncalves A, 2016, FOOD CHEM, V206, P234, DOI 10.1016/j.foodchem.2016.03.048; Goncalves A, 2014, MOL NUTR FOOD RES, V58, P2297, DOI 10.1002/mnfr.201400339; Goncalves A, 2014, J BIOL CHEM, V289, P30743, DOI 10.1074/jbc.M114.587659; Goncalves A, 2013, J NUTR BIOCHEM, V24, P1751, DOI 10.1016/j.jnutbio.2013.03.004; Gow JM, 2008, DRUG METAB DISPOS, V36, P10, DOI 10.1124/dmd.107.017087; Hedman CJ, 2014, J CHROMATOGR B, V953, P62, DOI 10.1016/j.jchromb.2014.01.045; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holick MF, 2017, REV ENDOCR METAB DIS, V18, P153, DOI 10.1007/s11154-017-9424-1; HOLLANDER D, 1978, GUT, V19, P267, DOI 10.1136/gut.19.4.267; Jakulj L, 2016, CELL METAB, V24, P783, DOI 10.1016/j.cmet.2016.10.001; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kim WY, 2004, PHARM RES-DORDR, V21, P1284, DOI 10.1023/B:PHAM.0000033017.52484.81; Krecic-Shepard ME, 2000, CLIN PHARMACOL THER, V68, P286, DOI 10.1067/mcp.2000.109356; Le May C, 2013, ARTERIOSCL THROM VAS, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lindell M, 2003, EUR J CLIN INVEST, V33, P493, DOI 10.1046/j.1365-2362.2003.01154.x; MacLean C, 2008, DRUG METAB DISPOS, V36, P1249, DOI 10.1124/dmd.108.020859; Menez C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001883; Moszynska A, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170019; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Reboul E, 2011, MOL NUTR FOOD RES, V55, P691, DOI 10.1002/mnfr.201000553; Reeskamp LF, 2018, CURR OPIN LIPIDOL, V29, P10, DOI 10.1097/MOL.0000000000000473; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Schaid DJ, 2018, NAT REV GENET, V19, P491, DOI 10.1038/s41576-018-0016-z; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tachibana S, 2009, DRUG METAB DISPOS, V37, P1604, DOI 10.1124/dmd.109.027219; Uhr M, 2002, J NEUROENDOCRINOL, V14, P753, DOI 10.1046/j.1365-2826.2002.00836.x; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; Wang ZC, 2011, ANAL BIOCHEM, V418, P126, DOI 10.1016/j.ab.2011.06.043; Wimalawansa SJ, 2011, ANN NY ACAD SCI, V1240, pE1, DOI 10.1111/j.1749-6632.2011.06374.x; Xue Y, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/296531; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	44	17	17	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2084	2094		10.1096/fj.201800956R	http://dx.doi.org/10.1096/fj.201800956R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30222077	Green Submitted			2022-12-28	WOS:000457296600045
J	Xu, ZH; Miao, ZW; Jiang, QZ; Gan, DX; Wei, XG; Xue, XZ; Li, JQ; Zheng, F; Qin, XX; Fang, WG; Chen, YH; Li, B				Xu, Zhi-Hua; Miao, Zi-Wei; Jiang, Qian-Zhu; Gan, Dong-Xue; Wei, Xu-Ge; Xue, Xiao-Zhi; Li, Jue-Qi; Zheng, Fei; Qin, Xiao-Xue; Fang, Wen-Gang; Chen, Yu-Hua; Li, Bo			Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain	FASEB JOURNAL			English	Article						brain metastasis; prohibitin; mitochondrial membrane potential	MITOCHONDRIAL DYNAMICS; OXIDATIVE STRESS; EXPRESSION; METASTASIS; PROHIBITIN; MICROENVIRONMENT; APOPTOSIS; RECEPTOR; PROTEIN; FAMILY	Small cell lung cancer (SCLC) is the most aggressive histologic subtype of lung cancer, with a strong predilection for early brain metastases. Despite efforts and advances in new therapeutics for SCLC, the prognosis of patients with SCLC with brain metastases is consistently poor. Therefore, a better understanding of the mechanisms of SCLC brain metastasis is important in improving current treatments. In this study, elevated S100A16 levels were associated with SCLC brain metastases, which was a possible secondary event arising from the brain metastatic microenvironment. Using an in vitro cell coculture system, we found that the coculturing of SCLC cells with human brain microvascular endothelial cells (HBMECs) led to an increased expression of S100A16 in SCLC cells. Conversely, treatment of HBMECs with GW4869, an inhibitor of exosome release, significantly blocked this effect in the cocultured SCLC cells. Alternatively, the results from Western blot analyses and immunofluorescence indicated that the HBMEC exosomes purified by ultracentrifugation also induced the elevation and translocation from the cytoplasm to the nucleus of S100A16 in the recipient SCLC cells. The inhibition experiments demonstrated that elevated S100A16 contributed a benefit of HBMEC exosomes for the survival of the recipient SCLC cells under stress. Moreover, the elevation of S100A16 in SCLC cells prevented the loss of mitochondrial membrane potential (m) and enhanced resistance to apoptosis under stressful conditions, which were determined by Annexin V/propidium iodide and JC-1 assay. Further results showed that the S100A16-mediated protective effect was caused by the presence of an important element in m, prohibitin (PHB)-1, a protein in the mitochondrial inner membrane. Conversely, the delivery of PHB-1 siRNAs into S100A16 overexpressing SCLC cells weakened these protective effects. Our findings suggest that elevated S100A16 plays an active role in facilitating the survival of SCLC cells through modulating the mitochondrial function, identifying S100A16 as an important potential target in SCLC brain metastasis.Xu, Z.-H., Miao, Z.-W., Jiang, Q.-Z., Gan, D.-X., Wei, X.-G., Xue, X.-Z., Li, J.-Q., Zheng, F., Qin, X.-X., Fang, W.-G., Chen, Y.-H., Li. B. Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small cell lung cancer cell survival in brain.	[Xu, Zhi-Hua; Miao, Zi-Wei; Jiang, Qian-Zhu; Gan, Dong-Xue; Wei, Xu-Ge; Qin, Xiao-Xue; Fang, Wen-Gang; Chen, Yu-Hua; Li, Bo] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Biol, 77 Puhe Rd, Shenyang, Liaoning, Peoples R China; [Xu, Zhi-Hua; Miao, Zi-Wei; Jiang, Qian-Zhu; Gan, Dong-Xue; Wei, Xu-Ge; Qin, Xiao-Xue; Fang, Wen-Gang; Chen, Yu-Hua; Li, Bo] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang, Liaoning, Peoples R China; [Xue, Xiao-Zhi; Li, Jue-Qi; Zheng, Fei] China Med Univ, Dept Clin Med, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Li, B (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Biol, 77 Puhe Rd, Shenyang, Liaoning, Peoples R China.	bli28@cmu.edu.cn			National Natural Science Foundation of China [81672881, 81372336]; College Students Innovation and Entrepreneurships Training Foundation of Liaoning Province [201710159000089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College Students Innovation and Entrepreneurships Training Foundation of Liaoning Province	The authors thank Drs. Monique Stins and Kwang Sik Kim (John Hopkins University School of Medicine, Baltimore, MD, USA) for providing the HBMECs. This work was supported by National Natural Science Foundation of China Grants 81672881 (to B.L.) and 81372336 (to B.L.) and College Students Innovation and Entrepreneurships Training Foundation of Liaoning Province Grant 201710159000089 (to X.-Z.X.). The authors declare no conflicts of interest.	Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Blecharz KG, 2015, BIOL CELL, V107, P342, DOI 10.1111/boc.201500011; Bliss SA, 2016, CANCER RES, V76, P5832, DOI 10.1158/0008-5472.CAN-16-1092; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Chowdhury I, 2013, APOPTOSIS, V18, P1513, DOI 10.1007/s10495-013-0901-z; Chowdhury I, 2011, LIFE SCI, V89, P295, DOI 10.1016/j.lfs.2011.06.022; Ebben JD, 2016, INT J BIOCHEM CELL B, V78, P288, DOI 10.1016/j.biocel.2016.07.025; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Gill JG, 2016, COLD SH Q B, V81, P163, DOI 10.1101/sqb.2016.81.030791; Haga H, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.24900; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoshide R, 2017, CLIN EXP METASTAS, V34, P369, DOI 10.1007/s10585-017-9857-7; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu L, 2010, MED ONCOL, V27, P708, DOI 10.1007/s12032-009-9273-1; Kafka A, 2014, INT J MOL SCI, V15, P10635, DOI 10.3390/ijms150610635; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kargi HA, 1997, CANCER LETT, V119, P27, DOI 10.1016/S0304-3835(97)00254-1; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kim B, 2016, FREE RADICAL RES, V50, P1065, DOI 10.1080/10715762.2016.1210141; Kobayashi M, 2018, HUM PATHOL, V74, P148, DOI 10.1016/j.humpath.2018.01.001; Li B, 2013, ONCOGENE, V32, P2952, DOI 10.1038/onc.2012.313; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Li L, 2015, NEUROSCIENCE, V286, P27, DOI 10.1016/j.neuroscience.2014.11.037; Li XX, 2015, INT J CLIN EXP PATHO, V8, P14676; Liu Q, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0742-4; Liu Y, 2015, INT J BIOCHEM CELL B, V66, P11, DOI 10.1016/j.biocel.2015.06.019; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V313, P237, DOI 10.1016/j.bbrc.2003.11.115; Padilla L, 2017, ONCOGENE, V36, P6749, DOI 10.1038/onc.2017.283; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Preusser M, 2012, ACTA NEUROPATHOL, V123, P205, DOI 10.1007/s00401-011-0933-9; Saito Keita, 2015, Asian Pac J Cancer Prev, V16, P7039; Sapkota D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1622-1; Sapkota D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076058; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Shumakovich MA, 2017, FASEB J, V31, P5049, DOI 10.1096/fj.201700254R; Steinbichler TB, 2017, SEMIN CANCER BIOL, V44, P170, DOI 10.1016/j.semcancer.2017.02.006; Sturchler E, 2006, J BIOL CHEM, V281, P38905, DOI 10.1074/jbc.M605798200; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Trotta AP, 2017, CELL MOL LIFE SCI, V74, P1999, DOI 10.1007/s00018-016-2451-3; Woditschka S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju145; Wolff G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097033; Yadav N, 2014, MITOCHONDRION, V16, P18, DOI 10.1016/j.mito.2013.11.005; Yano S, 2000, CANCER RES, V60, P4959; Yousefi M, 2017, CELL ONCOL, V40, P419, DOI 10.1007/s13402-017-0345-5; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhou WB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0097-8	50	37	39	2	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1742	1757		10.1096/fj.201800428R	http://dx.doi.org/10.1096/fj.201800428R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183374				2022-12-28	WOS:000457296600019
J	Huang, YW; Zhu, QQ; Yang, XY; Xu, HH; Sun, B; Wang, XJ; Sheng, J				Huang, Ye-Wei; Zhu, Qiang-Qiang; Yang, Xiao-Ying; Xu, Huan-Huan; Sun, Bin; Wang, Xuan-Jun; Sheng, Jun			Wound healing can be improved by (-)-epigallocatechin gallate through targeting Notch in streptozotocin-induced diabetic mice	FASEB JOURNAL			English	Article						inflammation; collagen deposition; macrophage; natural compound; chronic skin ulcers	MACROPHAGES; INFLAMMATION; PHENOTYPE; MELLITUS; RECRUITMENT; NEUTROPHILS; ACTIVATION; CHEMOKINES; CYTOKINES; CELLS	Delayed wound healing is one of the most prominent clinical manifestations of diabetes and lacks satisfactory treatment options. Persistent inflammation occurs in the late phase of wound healing and impairs the healing process in mice with diabetes mellitus (DM). In this study, we observed that the late wound healing in streptozotocin (STZ)-induced DM mice could be improved by (-)-epigallocatechin gallate (EGCG). The macrophage accumulation, inflammation response, and Notch signaling can be inhibited by EGCG in the skin wounds of DM mice. Furthermore, we found that the LPS-induced inflammation response including overactivated Notch signaling, was inhibited by EGCG in mouse macrophages. Moreover, we confirmed that EGCG could directly bind with mouse Notch-1. In addition, our studies indicated that diabetic wound healing was improved by EGCG treatment before or after the inflammation phase by targeting the Notch signaling pathway, which suggests that the pre-existing diabetic wound healing can be improved by EGCG. To summarize, wound healing can be improved by EGCG through targeting Notch in STZ-induced DM mice. Our findings provide insight into the therapeutic strategy for diabetic wounds and offer EGCG as a novel potential medicine to treat chronic wounds.Huang, Y.-W., Zhu, Q.-Q., Yang, X.-Y., Xu, H.-H., Sun, B., Wang, X.-J., Sheng, J. Wound healing can be improved by (-)-epigallocatechin gallate through targeting Notch in streptozotocin-induced diabetic mice.	[Huang, Ye-Wei; Zhu, Qiang-Qiang; Yang, Xiao-Ying; Xu, Huan-Huan; Sun, Bin; Wang, Xuan-Jun; Sheng, Jun] Yunnan Agr Univ, Minist Educ, Key Lab Pu Erh Tea Sci, 452 Fengyuan Rd, Kunming 650201, Yunnan, Peoples R China; [Huang, Ye-Wei; Wang, Xuan-Jun] Yunnan Agr Univ, Coll Sci, Kunming, Yunnan, Peoples R China; [Zhu, Qiang-Qiang; Yang, Xiao-Ying; Xu, Huan-Huan; Sun, Bin] Yunnan Agr Univ, Coll Food Sci & Technol, Kunming, Yunnan, Peoples R China; [Wang, Xuan-Jun; Sheng, Jun] State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University; Yunnan Agricultural University; Yunnan Agricultural University	Wang, XJ; Sheng, J (corresponding author), Yunnan Agr Univ, Minist Educ, Key Lab Pu Erh Tea Sci, 452 Fengyuan Rd, Kunming 650201, Yunnan, Peoples R China.	wangxuanjun@gmail.com; shengj@ynau.edu.cn	Huang, Yewei/K-2418-2019; Zhu, Qiang-qiang/AAE-2548-2021	wang, xuanjun/0000-0003-1211-506X	National Natural Science Foundation of China [31460392]; Major Scientific and Technological Special Project of Yunnan Province [2017ZF003, 2018ZG013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project of Yunnan Province	This study was supported by grants from the National Natural Science Foundation of China (31460392) and Major Scientific and Technological Special Project of Yunnan Province (2017ZF003 and 2018ZG013). The authors declare no conflicts of interest.	Attinger CE, 2006, PLAST RECONSTR SURG, V117, p72S, DOI 10.1097/01.prs.0000225470.42514.8f; Baltzis D, 2014, ADV THER, V31, P817, DOI 10.1007/s12325-014-0140-x; Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Boniakowski AE, 2017, J IMMUNOL, V199, P17, DOI 10.4049/jimmunol.1700223; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Burrows Nilka R., 2011, Morbidity and Mortality Weekly Report, V60, P1549; Chakrawarti L, 2016, EXPERT OPIN THER PAT, V26, P907, DOI 10.1080/13543776.2016.1203419; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Dekel Y, 2009, LAB ANIMAL, V38, P55, DOI 10.1038/laban0209-55; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Gallagher KA, 2015, DIABETES, V64, P1420, DOI 10.2337/db14-0872; Hatanaka E, 2006, CLIN EXP IMMUNOL, V146, P443, DOI 10.1111/j.1365-2249.2006.03229.x; Jeffcoate WJ, 2008, DIABETIC MED, V25, P1380, DOI 10.1111/j.1464-5491.2008.02573.x; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kimball AS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00635; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kondo Y, 2000, BIOL PHARM BULL, V23, P1458; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Mirza RE, 2014, DIABETES, V63, P1103, DOI 10.2337/db13-0927; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Osaka N, 2007, J CELL BIOL, V176, P903, DOI 10.1083/jcb.200611015; Outtz H. H., 2011, THESIS; Outtz HH, 2011, BLOOD, V118, P3436, DOI 10.1182/blood-2010-12-327015; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shah A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051068; Sunkari V., 2012, THESIS; Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x; Wang TF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00433; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wu YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13393; Zhang M, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180644; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	36	39	42	3	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					953	964		10.1096/fj.201800337R	http://dx.doi.org/10.1096/fj.201800337R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30070931	Bronze			2022-12-28	WOS:000457401500075
J	Xiao, N; Li, H; Yu, WR; Gu, C; Fang, HS; Peng, YB; Mao, HS; Fang, Y; Ni, W; Yao, M				Xiao, Ning; Li, Hui; Yu, Weirong; Gu, Chuan; Fang, Houshun; Peng, Yinbo; Mao, Heshui; Fang, Yong; Ni, Wei; Yao, Min			SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation	FASEB JOURNAL			English	Article						STK38; LLL; MAPK activation	KINASE; PROTEINS; PHOSPHORYLATION; CONJUGATION; PATHWAY; SHAPE; SITE	A key member of the sentrin/small ubiquitin-like modifier (SUMO)-specific protease (SENP) family, SENP2 has been shown to implicate embryonic development, fatty acid metabolism, atherosclerosis, and neurodegenerative diseases. However, other biologic functions of SENP2 and its specific targets are incompletely understood. Here, we uncovered a novel role of SENP2 in negative regulation of keratinocyte migration, a process crucial to wound epithelialization. Defects in this function are often associated with the clinical phenotypes of chronic nonhealing wounds. Mechanistically, SENP2 as a specific de-SUMOylase targets NDR1 (nuclear Dbf2-related 1), also called STK38 (serine-threonine kinase 38), for de-SUMOylation and SUMO conjugation of NDR1 on Lys-465 attenuates its inhibition of p38/ERK1/2 activation by decreasing the association of NDR1 with MEK kinase 1/2. Significantly, low-level laser (LLL) irradiation increases NDR1 SUMOylation and subsequent p38/ERK1/2 activation via down-regulation of SENP2, leading to faster keratinocyte migration. Our findings fill the gaps that linger in the basic mechanisms underlying LLL therapy.Xiao, N., Li, H., Yu, W., Gu, C., Fang, H., Peng, Y., Mao, H., Fang, Y., Ni, W., Yao, M. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.	[Xiao, Ning] Shanghai Univ Tradit Chinese Med, Canc Inst Tradit Chinese Med, Longhua Hosp, 725 South Wanping Rd, Shanghai 200032, Peoples R China; [Xiao, Ning; Yu, Weirong; Gu, Chuan; Peng, Yinbo; Mao, Heshui; Fang, Yong; Ni, Wei; Yao, Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Burns & Plast Surg, 280 Mohe Rd, Shanghai 201900, Peoples R China; [Xiao, Ning; Yu, Weirong; Gu, Chuan; Peng, Yinbo; Mao, Heshui; Fang, Yong; Ni, Wei; Yao, Min] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai, Peoples R China; [Li, Hui; Fang, Houshun] Shanghai Jiao Tong Univ, Sch Med, Minist Hlth, Key Lab Pediat Hematol & Oncol, Shanghai, Peoples R China; [Li, Hui; Fang, Houshun] Shanghai Jiao Tong Univ, Sch Med, Pediat Translat Med Inst, Shanghai Childrens Med Ctr, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xiao, N (corresponding author), Shanghai Univ Tradit Chinese Med, Canc Inst Tradit Chinese Med, Longhua Hosp, 725 South Wanping Rd, Shanghai 200032, Peoples R China.; Yao, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Burns & Plast Surg, 280 Mohe Rd, Shanghai 201900, Peoples R China.	dynas1986@163.com; my058@vip.sina.com			National Natural Science Foundation of China [81501670, 81272113, 81500112]; China Postdoctoral Science Foundation [2016T90375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Dr. Jinke Cheng, Dr. Jun Tu, Dr. Xian Huang, and Dr. Ping Wang for plasmids and reagents. The authors are grateful to Dr. Xiujun Fu for checking the usage of English in this paper. This study was supported by grants from the National Natural Science Foundation of China (81501670, 81272113, and 81500112) as well as funding from the China Postdoctoral Science Foundation (2016T90375). The authors declare no conflicts of interest.	Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Enomoto A, 2008, ONCOGENE, V27, P1930, DOI 10.1038/sj.onc.1210828; Farivar S, 2014, J LASERS MED SCI, V5, P58; Fu J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004579; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heo KS, 2015, J CLIN INVEST, V125, P1299, DOI 10.1172/JCI76453; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7050021; Hirabayashi S, 2008, ONCOGENE, V27, P4281, DOI 10.1038/onc.2008.66; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Koo YD, 2015, DIABETES, V64, P2420, DOI 10.2337/db15-0115; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Li W, 2004, J INVEST DERMATOL, V123, P622, DOI 10.1111/j.0022-202X.2004.23416.x; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Paul I, 2017, SCI REP-UK, V7, DOI 10.1038/srep42800; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Raja, 2007, Front Biosci, V12, P2849; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wen MY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8167; Xiao N, 2015, J BIOL CHEM, V290, P1927, DOI 10.1074/jbc.M114.608703; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054	37	7	9	3	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					163	174		10.1096/fj.201800353R	http://dx.doi.org/10.1096/fj.201800353R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29969578				2022-12-28	WOS:000457401500013
J	Zhang, J; Huang, JQ; Qi, TY; Huang, YZ; Lu, YT; Zhan, TW; Gong, H; Zhu, ZY; Shi, YL; Zhou, JH; Yu, LY; Zhang, X; Cheng, HQ; Ke, YH				Zhang, Jie; Huang, Jiaqi; Qi, Tongyun; Huang, Yizhou; Lu, Yuting; Zhan, Tianwei; Gong, Hui; Zhu, Zhengyi; Shi, Yueli; Zhou, Jianhong; Yu, Luyang; Zhang, Xue; Cheng, Hongqiang; Ke, Yuehai			SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1	FASEB JOURNAL			English	Article						adherens junctions; permeability; vascular development; protein tyrosine phosphatase; vascular leakage	TYROSINE-PHOSPHATASE SHP2; LEUKOCYTE EXTRAVASATION; VASCULAR-PERMEABILITY; ACTIVATION; MECHANISMS; JUNCTIONS; INHIBITION; DISRUPTION; PROTEINS; KINASE	Vascular endothelial (VE)-cadherin junctional localization is known to play a central role in vascular development, endothelial barrier integrity, and homeostasis. The sarcoma homology domain containing protein tyrosine phosphatase (SHP)2 has been shown to be involved in regulating endothelial barrier function; however, the mechanisms remain largely unknown. In this work SHP2 knockdown in an HUVEC monolayer increased VE-cadherin internalization and endothelial barrier permeability. Loss of SHP2 specifically augmented the GTPase activity of ADP-ribosylation factor (ARF)-1. ARF1 knockdown or inhibition of its guanine nucleotide exchange factors (GEFs) markedly attenuated VE-cadherin internalization and barrier hyperpermeability induced by SHP2 deficiency. SHP2 knockdown increased the total and phosphorylated levels of MET, whose activity was necessary for ARF1 activation and VE-cadherin internalization. Furthermore, constitutive endothelium-specific deletion of Shp2 in mice led to disrupted endothelial cell junctions, massive hemorrhage, and lethality in embryos. Induced and endothelium-specific deletion of Shp2 in adult mice resulted in lung hyperpermeability. Inhibitors for ARF1-GEF or MET used in pregnant mice prevented the vascular leakage in endothelial Shp2-deleted embryos. Together, our findings define a novel role of SHP2 in stabilizing junctional VE-cadherin in the resting endothelial barrier through suppressing MET and ARF1 activation.Zhang, J., Huang, J., Qi, T., Huang, Y., Lu, Y., Zhan, T., Gong, H., Zhu, Z., Shi, Y., Zhou, J., Yu, L., Zhang, X., Cheng, H., Ke, Y. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.	[Zhang, Jie; Huang, Jiaqi; Lu, Yuting; Zhan, Tianwei; Gong, Hui; Zhu, Zhengyi; Shi, Yueli; Zhang, Xue; Cheng, Hongqiang; Ke, Yuehai] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, POB 59,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Qi, Tongyun; Huang, Yizhou; Zhou, Jianhong] Zhejiang Univ, Dept Gynecol, Hangzhou, Zhejiang, Peoples R China; [Yu, Luyang] Zhejiang Univ, Inst Genet, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Ke, Yuehai] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Cheng, HQ; Ke, YH (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, POB 59,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	hqcheng11@zju.edu.cn; yke@zju.edu.cn		Yu, Luyang/0000-0002-1301-6285	National Natural Science Foundation of China [31471258, 81530001, 81170117]; Zhejiang Provincial Natural Science Foundation of China [LZ18H020001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors thank Dr. Gen-sheng Feng (University of California San Diego, La Jolla, CA, USA) for providing the Shp2<SUP>f/f</SUP> mice. This work was supported by National Natural Science Foundation of China Grants 31471258 (to H.C.), 81530001 (to Y.K.), and 81170117 (to H.C.), and Zhejiang Provincial Natural Science Foundation of China Grant LZ18H020001 (to H.C.). The authors declare no conflicts of interest.	Barabutis N, 2016, AM J PHYSIOL-LUNG C, V311, pL832, DOI 10.1152/ajplung.00233.2016; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chichger H, 2015, AM J RESP CELL MOL, V52, P695, DOI 10.1165/rcmb.2013-0489OC; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daher Z, 2010, J BIOL CHEM, V285, P24591, DOI 10.1074/jbc.M110.115311; Daneshjou N, 2015, J CELL BIOL, V209, P181, DOI 10.1083/jcb.20140910803202015c; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Duan HF, 2006, CELL SIGNAL, V18, P2049, DOI 10.1016/j.cellsig.2006.04.002; Fraccaroli A, 2015, CIRC RES, V117, P29, DOI 10.1161/CIRCRESAHA.117.305818; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hongu T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8925; Huang MG, 2016, J CLIN INVEST, V126, P1801, DOI 10.1172/JCI84876; Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473; Jackson CL, 2014, J CELL SCI, V127, P4103, DOI 10.1242/jcs.144899; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kuppers V, 2014, CELL TISSUE RES, V355, P577, DOI 10.1007/s00441-014-1812-1; Mannell H, 2014, MINI-REV MED CHEM, V14, P471, DOI 10.2174/1389557514999140506094738; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitola S, 2006, CIRC RES, V98, P45, DOI 10.1161/01.RES.0000199355.32422.7b; MITRA P, 1991, BIOTECHNIQUES, V11, P504; Muharram G, 2014, DEV CELL, V29, P421, DOI 10.1016/j.devcel.2014.03.024; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Sun MJ, 2012, ANAL BIOCHEM, V425, P96, DOI 10.1016/j.ab.2012.03.010; Tajan M, 2015, EUR J MED GENET, V58, P509, DOI 10.1016/j.ejmg.2015.08.005; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Tien SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10420; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7; Wall N., 2008, CSH PROTOC, V2008; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; YU G, 2016, AM J RESP CRIT CARE, V193; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	48	12	12	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1124	1137		10.1096/fj.201800284R	http://dx.doi.org/10.1096/fj.201800284R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30102570	Bronze			2022-12-28	WOS:000457401500089
J	Ceccarelli, V; Valentini, V; Ronchetti, S; Cannarile, L; Billi, M; Riccardi, C; Ottini, L; Talesa, VN; Grignani, F; Vecchini, A				Ceccarelli, Veronica; Valentini, Virginia; Ronchetti, Simona; Cannarile, Lorenza; Billi, Monia; Riccardi, Carlo; Ottini, Laura; Talesa, Vincenzo Nicola; Grignani, Francesco; Vecchini, Alba			Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism	FASEB JOURNAL			English	Article						5-hydroxymethylcytosine; polyunsaturated fatty acids; PPAR; RXR	POLYUNSATURATED FATTY-ACIDS; PROSTAGLANDIN E-3; TUMOR-SUPPRESSOR; CANCER GROWTH; TET PROTEINS; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PATHOGENESIS; EPIGENETICS	In cancer cells, global genomic hypomethylation is found together with localized hypermethylation of CpG islands within the promoters and regulatory regions of silenced tumor suppressor genes. Demethylating agents may reverse hypermethylation, thus promoting gene re-expression. Unfortunately, demethylating strategies are not efficient in solid tumor cells. DNA demethylation is mediated by ten-eleven translocation (TET) enzymes. They sequentially convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), which is associated with active transcription; 5-formylcytosine; and finally, 5-carboxylcytosine. Although -linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid, the major n-3 polyunsaturated fatty acids, have anti-cancer effects, their action, as DNA-demethylating agents, has never been investigated in solid tumor cells. Here, we report that EPA demethylates DNA in hepatocarcinoma cells. EPA rapidly increases 5hmC on DNA, inducing p21(Waf1/Cip1) gene expression, which slows cancer cell-cycle progression. We show that the underlying molecular mechanism involves TET1. EPA simultaneously binds peroxisome proliferator-activated receptor (PPAR) and retinoid X receptor (RXR), thus promoting their heterodimer and inducing a PPAR-TET1 interaction. They generate a TET1-PPAR-RXR protein complex, which binds to a hypermethylated CpG island on the p21 gene, where TET1 converts 5mC to 5hmC. In an apparent shuttling motion, PPAR and RXR leave the DNA, whereas TET1 associates stably. Overall, EPA directly regulates DNA methylation levels, permitting TET1 to exert its anti-tumoral function.Ceccarelli, V., Valentini, V., Ronchetti, S., Cannarile, L., Billi, M., Riccardi, C., Ottini, L., Talesa, V. N., Grignani, F., Vecchini, A., Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism.	[Ceccarelli, Veronica; Billi, Monia; Talesa, Vincenzo Nicola; Grignani, Francesco; Vecchini, Alba] Univ Perugia, Dept Expt Med, Ple L Severi 1, I-06132 Perugia, Italy; [Ronchetti, Simona; Cannarile, Lorenza; Riccardi, Carlo] Univ Perugia, Dept Med, Perugia, Italy; [Valentini, Virginia; Ottini, Laura] Sapienza Univ, Dept Mol Med, Rome, Italy	University of Perugia; University of Perugia; Sapienza University Rome	Vecchini, A (corresponding author), Univ Perugia, Dept Expt Med, Ple L Severi 1, I-06132 Perugia, Italy.	alba.vecchini@unipg.it	Valentini, Virginia/HGB-8659-2022; Riccardi, Carlo/N-4610-2014; Grignani, Francesco/AAC-2565-2022	Riccardi, Carlo/0000-0001-9257-3997; Billi, Monia/0000-0002-5284-7380; OTTINI, LAURA/0000-0001-8030-0449	Italian Association for Cancer Research (AIRC) [IG14727, IG16933]; Fondazione Cassa di Risparmio di Perugia [2014.0063.021]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	The authors thank G. Marinacci (Department of Internal Medicine, University of Perugia) for experimental assistance and G. A. Boyd (University of Perugia) for proofreading of the manuscript. This work was supported by grants from the Italian Association for Cancer Research (AIRC; IG14727 to F.G. and IG16933 to L.O.), and from Fondazione Cassa di Risparmio di Perugia (2014.0063.021 to A.V.). The authors declare no conflicts of interest.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bansal A, 2017, PEDIATR DIABETES, V18, P167, DOI 10.1111/pedi.12521; Booth MJ, 2013, NAT PROTOC, V8, P1841, DOI 10.1038/nprot.2013.115; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Calviello G, 1998, INT J CANCER, V75, P699, DOI 10.1002/(SICI)1097-0215(19980302)75:5&lt;699::AID-IJC7&gt;3.0.CO;2-U; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Ceccarelli V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085025; Ceccarelli V, 2011, J BIOL CHEM, V286, P27092, DOI 10.1074/jbc.M111.253609; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Echeverria F, 2016, PROSTAG LEUKOTR ESS, V114, P28, DOI 10.1016/j.plefa.2016.10.001; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fernandez-Sanles A, 2017, ATHEROSCLEROSIS, V263, P325, DOI 10.1016/j.atherosclerosis.2017.05.022; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fujiki K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3262; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Gerashchenko BI, 2004, CYTOM PART A, V61A, P134, DOI 10.1002/cyto.a.20065; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Goldstein JT, 2003, ARCH BIOCHEM BIOPHYS, V420, P185, DOI 10.1016/j.abb.2003.09.034; Gu Zhennan, 2015, Curr Pharmacol Rep, V1, P283; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Isakova A, 2016, J BIOL CHEM, V291, P10293, DOI 10.1074/jbc.M115.691154; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iurlaro M, 2017, CURR OPIN GENET DEV, V43, P101, DOI 10.1016/j.gde.2017.02.003; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Li KK, 2013, SEMIN HEMATOL, V50, P48, DOI 10.1053/j.seminhematol.2013.01.005; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Linnekamp JF, 2017, CANCER TREAT REV, V54, P10, DOI 10.1016/j.ctrv.2017.01.004; Liu CY, 2013, TOUR MANAG PERSPECT, V5, P1, DOI 10.1016/j.tmp.2012.09.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madakashira BP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00076; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Nabavi SF, 2015, CANCER METAST REV, V34, P359, DOI 10.1007/s10555-015-9572-2; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Rawluszko-Wieczorek AA, 2015, CRIT REV ONCOL HEMAT, V96, P425, DOI 10.1016/j.critrevonc.2015.07.008; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Tian YP, 2016, CHINESE MED J-PEKING, V129, P2646, DOI 10.4103/0366-6999.192787; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Vaughan VC, 2013, BRIT J CANCER, V108, P486, DOI 10.1038/bjc.2012.586; Wang WC, 2014, PROSTAG OTH LIPID M, V113, P13, DOI 10.1016/j.prostaglandins.2014.07.002; Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yang PY, 2014, CANCER LETT, V348, P1, DOI 10.1016/j.canlet.2014.03.010; Yang PY, 2004, J LIPID RES, V45, P1030, DOI 10.1194/jlr.M300455-JLR200; Ye J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34034; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005	53	7	7	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5990	6001		10.1096/fj.201800245R	http://dx.doi.org/10.1096/fj.201800245R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29757674	Green Submitted, Bronze			2022-12-28	WOS:000447172000019
J	Lee, YJ; Kim, M; Lee, JY; Jung, SH; Jeon, HY; Lee, SA; Kang, S; Han, ET; Park, WS; Hong, SH; Kim, YM; Ha, KS				Lee, Yeon-Ju; Kim, Minsoo; Lee, Jee-Yeon; Jung, Se-Hui; Jeon, Hye-Yoon; Lee, Seung Ah; Kang, Seongsik; Han, Eun-Taek; Park, Won Sun; Hong, Seok-Ho; Kim, Young-Myeong; Ha, Kwon-Soo			The benzodiazepine anesthetic midazolam prevents hyperglycemia-induced microvascular leakage in the retinas of diabetic mice	FASEB JOURNAL			English	Article						diabetic retinopathy; GABA(A) receptor; VEGF	ENDOTHELIAL GROWTH-FACTOR; PROTEIN 18 KDA; C-PEPTIDE; TRANSGLUTAMINASE 2; VASCULAR LEAKAGE; RETINOPATHY; PERMEABILITY; INHIBITION; ACTIVATION; APOPTOSIS	We investigated the beneficial effects of midazolam against vascular endothelial growth factor (VEGF)-induced vascular leakage and its molecular mechanism of action in human retinal endothelial cells (HRECs) and the retinas of diabetic mice. Midazolam inhibited VEGF-induced elevation of intracellular Ca2+, generation of reactive oxygen species (ROS), and transglutaminase activation in HRECs; these effects were reversed by the GABA, type A (GABA(A)) receptor antagonist flumazenil but not by the translocator protein antagonist PK11195. Midazolam also prevented VEGF-induced disassembly of adherens junctions and in vitro permeability. Intravitreal injection of midazolam prevented hyperglycemia-induced ROS generation, transglutaminase activation, and subsequent vascular leakage in the retinas of diabetic mice, and those effects were reversed by flumazenil. The roles of flumazenil were further supported by identifying GABA(A) receptors in mouse retinas. Thus, midazolam prevents hyperglycemia-induced vascular leakage by inhibiting VEGF-induced intracellular events in the retinas of diabetic mice.Lee, Y.-J., Kim, M., Lee, J.-Y., Jung, S.-H., Jeon, H.-Y., Lee, S. A., Kang, S., Han, E.-T., Park, W. S., Hong, S.-H., Kim, Y.-M., Ha, K.-S. The benzodiazepine anesthetic midazolam prevents hyperglycemia-induced microvascular leakage in the retinas of diabetic mice.	[Lee, Yeon-Ju; Kim, Minsoo; Lee, Jee-Yeon; Jung, Se-Hui; Jeon, Hye-Yoon; Kim, Young-Myeong; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Angwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea; [Kim, Minsoo; Lee, Seung Ah; Kang, Seongsik] Kangwon Natl Univ, Sch Med, Dept Anesthesiol, Chunchon, South Korea; [Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, South Korea; [Park, Won Sun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea; [Hong, Seok-Ho] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Ha, KS (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Angwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea.	ksha@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Jung, Se-Hui/0000-0002-9323-2745; Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea [2015R1A4A1038666, 2016R1A2A1A05004975]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (Grants 2015R1A4A1038666 and 2016R1A2A1A05004975 to K.-S.H.). The authors declare no conflicts of interest.	Adamis AP, 1996, ARCH OPHTHALMOL-CHIC, V114, P66, DOI 10.1001/archopht.1996.01100130062010; BAUER TM, 1995, LANCET, V346, P145, DOI 10.1016/S0140-6736(95)91209-6; Bhatt MP, 2014, CARDIOVASC RES, V104, P234, DOI 10.1093/cvr/cvu211; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Bolinger MT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091498; Brown DM, 2015, OPHTHALMOLOGY, V122, P2044, DOI 10.1016/j.ophtha.2015.06.017; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Caldwelll RB, 2003, DIABETES-METAB RES, V19, P442, DOI 10.1002/dmrr.415; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Ghori K, 2008, EUR J ANAESTH, V25, P206, DOI 10.1017/S0265021507003018; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hasan B, 2017, CUREUS, V9, DOI 10.7759/cureus.1275; Hashim PW, 2017, CUTIS, V99, P393; Hendrickx JFA, 2008, ANESTH ANALG, V107, P494, DOI 10.1213/ane.0b013e31817b859e; Joo HK, 2015, MOL CELLS, V38, P1064, DOI 10.14348/molcells.2015.0165; Joo HK, 2009, ANESTHESIOLOGY, V110, P106, DOI 10.1097/ALN.0b013e318190bc69; Lee YJ, 2017, J ENDOCRINOL, V235, P39, DOI 10.1530/JOE-17-0109; Lee YJ, 2016, DIABETES, V65, P2414, DOI 10.2337/db15-1594; Li F, 2016, BIOCHEMISTRY-US, V55, P2821, DOI 10.1021/acs.biochem.6b00142; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Liu JY, 2017, MOL MED REP, V15, P169, DOI 10.3892/mmr.2016.6031; Liu L, 2015, CELL PHYSIOL BIOCHEM, V35, P126, DOI 10.1159/000369681; Michael IP, 2014, EMBO MOL MED, V6, P604, DOI 10.1002/emmm.201303708; Miller R. D., 2014, MILLERS AENSTHESIA, V1; Mohler H, 2002, J PHARMACOL EXP THER, V300, P2, DOI 10.1124/jpet.300.1.2; Monasterolo LA, 2002, EUR J PHARMACOL, V449, P155, DOI 10.1016/S0014-2999(02)01942-8; Olkkola K. T., 2008, V182, P335, DOI 10.1007/978-3-540-74806-9_16; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Sivilotti MLA, 2016, BRIT J CLIN PHARMACO, V81, P428, DOI 10.1111/bcp.12731; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Steinlauf AF, 1999, HEPATOLOGY, V29, P1070, DOI 10.1002/hep.510290421; Stewart MW, 2016, WORLD J DIABETES, V7, P333, DOI 10.4239/wjd.v7.i16.333; Sun GC, 2008, BRIT J ANAESTH, V101, P632, DOI 10.1093/bja/aen251; Tolentino MS, 2016, EXPERT OPIN INV DRUG, V25, P1011, DOI 10.1080/13543784.2016.1201062	38	10	10	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6089	6099		10.1096/fj.201800014RR	http://dx.doi.org/10.1096/fj.201800014RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29782207	Bronze			2022-12-28	WOS:000447172000027
J	Spinosa, M; Lu, GY; Su, G; Bontha, SV; Gehrau, R; Salmon, MD; Smith, JR; Weiss, ML; Mas, VR; Upchurch, GR; Sharma, AK				Spinosa, Michael; Lu, Guanyi; Su, Gang; Bontha, Sai Vineela; Gehrau, Ricardo; Salmon, Morgan D.; Smith, Joseph R.; Weiss, Mark L.; Mas, Valeria R.; Upchurch, Gilbert R., Jr.; Sharma, Ashish K.			Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147	FASEB JOURNAL			English	Article						inflammation; stem cells; exosomes; high mobility group box 1; IL-17	STEM-CELLS; MICROVESICLES; MECHANISM; EXOSOMES; PROTECT; GENDER; GROWTH	The formation of an abdominal aortic aneurysm (AAA) is characterized by inflammation, macrophage infiltration, and vascular remodeling. In this study, we tested the hypothesis that mesenchymal stromal cell (MSC)-derived extracellular vesicles (EVs) immunomodulate aortic inflammation, to mitigate AAA formation via modulation of microRNA-147. An elastase-treatment model of AAA was used in male C57BL/6 wild-type (WT) mice. Administration of EVs in elastase-treated WT mice caused a significant attenuation of aortic diameter and mitigated proinflammatory cytokines, inflammatory cell infiltration, an increase in smooth muscle cell -actin expression, and a decrease in elastic fiber disruption, compared with untreated mice. A 10-fold up-regulation of microRNA (miR)-147, a key mediator of macrophage inflammatory responses, was observed in murine aortic tissue in elastase-treated mice compared with controls on d 14. EVs derived from MSCs transfected with miR-147 mimic, but not with miR-147 inhibitor, attenuated aortic diameter, inflammation, and leukocyte infiltration in elastase-treated mice. In vitro studies of human aortic tissue explants and murine-derived CD11b(+) macrophages induced proinflammatory cytokines after elastase treatment, and the expression was attenuated by cocultures with EVs transfected with miR-147 mimic, but not with miR-147 inhibitor. Thus, our findings define a critical role of MSC-derived EVs in attenuation of aortic inflammation and macrophage activation via miR-147 during AAA formation.Spinosa, M., Lu, G., Su, G., Bontha, S. V., Gehrau, R., Salmon, M. D., Smith, J. R., Weiss, M. L., Mas, V. R., Upchurch, G. R., Sharma, A. K. Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147.	[Spinosa, Michael; Lu, Guanyi; Su, Gang; Bontha, Sai Vineela; Gehrau, Ricardo; Salmon, Morgan D.; Mas, Valeria R.; Upchurch, Gilbert R., Jr.; Sharma, Ashish K.] Univ Virginia, Dept Surg, POB 801359,MR-4 Bldg,409 Lane Rd, Charlottesville, VA 22908 USA; [Smith, Joseph R.; Weiss, Mark L.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	University of Virginia; Kansas State University	Sharma, AK (corresponding author), Univ Virginia, Dept Surg, POB 801359,MR-4 Bldg,409 Lane Rd, Charlottesville, VA 22908 USA.	sharma@virginia.edu	Weiss, Mark L/C-7364-2014	bontha, sai vineela/0000-0001-8914-1966; Sharma, Ashish/0000-0002-1234-6039	American Heart Association [17GRNT33370027]; U.S. National Institutes of Health, National Heart, Lung and Blood Institute [R01 HL081629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081629] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Rupande Tripathi (University of Virginia) for isolation of primary aortic smooth muscle cells; Kimberly Kelly (University of Virginia) for assistance with isolation of EVs and use of the Nanosight instrument; Joanne Lannigan (Flow Core Facility, University of Virginia) for help with the ImageStream experiments; and anonymous donors for providing umbilical cords for research and the nurses at the Via Christi Birthing Center (Wichita, KS, USA) for supplying discarded umbilical cord tissue. This study was supported by American Heart Association Grant-in-Aid 17GRNT33370027 (to A.K.S.), and U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grant R01 HL081629 (to G.R.U.). The authors declare no conflicts of interest.	Adam M, 2015, CURR VASC PHARMACOL, V13, P280, DOI 10.2174/15701611113119990015; Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; ANIDJAR S, 1992, J VASC SURG, V16, P139, DOI 10.1016/0741-5214(92)90101-D; Aziz F, 2007, ANN VASC SURG, V21, P392, DOI 10.1016/j.avsg.2006.11.001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bengtsson H, 1996, ANN NY ACAD SCI, V800, P1, DOI 10.1111/j.1749-6632.1996.tb33294.x; Bobis-Wozowicz S, 2015, STEM CELLS, V33, P2748, DOI 10.1002/stem.2078; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Cho KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131813; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Davis JP, 2015, J SURG RES, V199, P249, DOI 10.1016/j.jss.2015.04.025; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Di Rocco G, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5029619; Dimick JB, 2002, ANN SURG, V235, P579, DOI 10.1097/00000658-200204000-00017; Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041; Erdbrugger U, 2014, CYTOM PART A, V85A, P756, DOI 10.1002/cyto.a.22494; Fan CG, 2011, STEM CELL REV REP, V7, P195, DOI 10.1007/s12015-010-9168-8; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Fu XM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-175; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Hashizume R, 2011, J VASC SURG, V54, P1743, DOI 10.1016/j.jvs.2011.06.109; He Y, 2015, TRANSPLANTATION, V99, P1829, DOI 10.1097/TP.0000000000000856; Heldring N, 2015, HUM GENE THER, V26, P506, DOI 10.1089/hum.2015.072; JOHNSTON KW, 1991, J VASC SURG, V13, P452, DOI 10.1067/mva.1991.26737; Katsuda T, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0214-y; Kim CW, 2014, ARTERIOSCL THROM VAS, V34, P1412, DOI 10.1161/ATVBAHA.113.303134; Kohno T, 2012, J CARDIOL, V59, P299, DOI 10.1016/j.jjcc.2012.01.007; Laser A, 2012, J SURG RES, V178, P1038, DOI 10.1016/j.jss.2012.04.073; Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Maegdefessel L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6214; Maegdefessel L, 2012, J CLIN INVEST, V122, P497, DOI 10.1172/JCI61598; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Monsel A, 2015, AM J RESP CRIT CARE, V192, P324, DOI 10.1164/rccm.201410-1765OC; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Parvizi M, 2015, STEM CELLS DEV, V24, P1493, DOI 10.1089/scd.2014.0517; Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472; Shao LB, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4150705; Sharma AK, 2016, ARTERIOSCL THROM VAS, V36, P908, DOI 10.1161/ATVBAHA.116.307373; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Stone ML, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0704-9; Weintraub NL, 2009, NEW ENGL J MED, V361, P1114, DOI 10.1056/NEJMcibr0905244; Yamawaki-Ogata A, 2014, EUR J CARDIO-THORAC, V45, pE156, DOI 10.1093/ejcts/ezu018; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065555; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504	59	42	42	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6038	6050		10.1096/fj.201701138RR	http://dx.doi.org/10.1096/fj.201701138RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29812968	Green Published, Bronze			2022-12-28	WOS:000447172000023
J	McQueeney, KE; Salamoun, JM; Ahn, JG; Pekic, P; Blanco, IK; Struckman, HL; Sharlow, ER; Wipf, P; Lazo, JS				McQueeney, Kelley E.; Salamoun, Joseph M.; Ahn, Jennifer G.; Pekic, Paula; Blanco, Isabella K.; Struckman, Heather L.; Sharlow, Elizabeth R.; Wipf, Peter; Lazo, John S.			A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion	FASEB JOURNAL			English	Article						phosphatase; inhibitor; migration; extracellular matrix; Emilin	EXTRACELLULAR-MATRIX; COLORECTAL-CANCER; PRL-3; PHOSPHATASE; GROWTH; PROLIFERATION; METASTASIS; EXPRESSION; MIGRATION; LIVER	Dysregulation of the tightly controlled protein phosphorylation networks that govern cellular behavior causes cancer. The membrane-associated, intracellular protein tyrosine phosphatase PTP4A3 is overexpressed in human colorectal cancer and contributes to cell migration and invasion. To interrogate further the role of PTP4A3 in colorectal cancer cell migration and invasion, we deleted the Ptp4a3 gene from murine colorectal tumor cells. The resulting PTP4A3(-/-) cells exhibited impaired colony formation, spheroid formation, migration, and adherence compared with the paired PTP4A3(fl/fl) cells. We replicated these phenotypic changes using the new small-molecule, allosteric PTP4A3 inhibitor JMS-053. A related structure, JMS-038, which lacked phosphatase inhibition, displayed no cellular activity. Reduction in cell viability and colony formation by JMS-053 occurred in both mouse and human colorectal cell lines and required PTP4A3 expression. Ptp4a3 deletion increased the expression of extracellular matrix (ECM) and adhesion genes, including the tumor suppressor Emilin 1. JMS-053 also increased Emilin 1 gene expression. Moreover, The Cancer Genome Atlas genomic database revealed human colorectal tumors with high Ptp4a3 expression had low Emilin 1 expression. These chemical and biologic reagents reveal a previously unknown communication between the intracellular PTP4A3 phosphatase and the ECM and support efforts to pharmacologically target PTP4A3.McQueeney, K. E., Salamoun, J. M., Ahn J. G., Pekic, P., Blanco, I. K., Struckman, H. L., Sharlow, E. R., Wipf, P., Lazo, J. S. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.	[McQueeney, Kelley E.; Ahn, Jennifer G.; Pekic, Paula; Blanco, Isabella K.; Struckman, Heather L.; Sharlow, Elizabeth R.; Lazo, John S.] Univ Virginia, Dept Pharmacol, Fiske Drug Discovery Lab, Charlottesville, VA 22908 USA; [Salamoun, Joseph M.; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lazo, JS (corresponding author), Univ Virginia, Dept Pharmacol, POB 800735, Charlottesville, VA 22908 USA.	lazo@virginia.edu	Wipf, Peter/AAG-1771-2021	Wipf, Peter/0000-0001-7693-5863; Struckman, Heather/0000-0002-1758-0780	National Institutes of Health (NIH) National Cancer Institute [R21CA191944, F31CA196062, P30 CA44579]; NIH National Institute of General Medical Sciences [T32GM007055]; NIH Office of the Director Grant [S10OD021723]; Farrow Fellowship; Fiske Drug Discovery Fund; Owens Foundation; Ivy Foundation; Boehringer-Ingelheim Pharmaceuticals (Ridgefield, CT, USA); NATIONAL CANCER INSTITUTE [P30CA044579, F31CA196062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021723] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Office of the Director Grant; Farrow Fellowship; Fiske Drug Discovery Fund; Owens Foundation; Ivy Foundation; Boehringer-Ingelheim Pharmaceuticals (Ridgefield, CT, USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Alex Cheung (University of Virginia) for assistance in spheroid assay development, Dr. Mark Zimmerman (University of Pittsburgh) for providing tumor tissue from the colorectal tumors of Ptp4a3<SUP>fl/fl</SUP> and Ptp4a3<SUP>-/-</SUP> mice, Sophie Lewandoski (Oberlin College, Oberlin, OH, USA) for help in characterizing the JMS-053 and JMS-038 compounds, and Yongde Bao (University of Virginia Genomic Analysis and Technology Core) for assistance with RNA sequencing. This research was supported by National Institutes of Health (NIH) National Cancer Institute Grants R21CA191944 (to J.S.L.), F31CA196062 (to K.E.M.), and P30 CA44579, NIH National Institute of General Medical Sciences Grant T32GM007055, and NIH Office of the Director Grant S10OD021723 (to J.S.L.); the Farrow Fellowship (to K.E.M.); the Fiske Drug Discovery Fund (to J.S.L.); the Owens Foundation (to J.S.L.); the Ivy Foundation (to J.S.L.); and by discretionary funding from Boehringer-Ingelheim Pharmaceuticals (Ridgefield, CT, USA) (to P.W.). The authors declare no conflicts of interest.	Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Connell LC, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0463-3; Cramer JM, 2014, STEM CELL RES, V13, P164, DOI 10.1016/j.scr.2014.05.004; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Daouti S, 2008, CANCER RES, V68, P1162, DOI 10.1158/0008-5472.CAN-07-2349; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; den Hollander P, 2016, CANCER RES, V76, P1942, DOI 10.1158/0008-5472.CAN-14-0673; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Forte E, 2008, BBA-MOL CELL RES, V1783, P334, DOI 10.1016/j.bbamcr.2007.11.004; Foy M, 2017, EXP CELL RES, V353, P88, DOI 10.1016/j.yexcr.2017.03.012; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gari HH, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.50; Gari HH, 2016, CANCER LETT, V380, P505, DOI 10.1016/j.canlet.2016.07.017; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hao RT, 2010, J CANCER RES CLIN, V136, P1349, DOI 10.1007/s00432-010-0786-y; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kostantin E, 2016, J BIOL CHEM, V291, P10716, DOI 10.1074/jbc.M115.705863; Lai W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0566-z; Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Maltzman T, 1997, CARCINOGENESIS, V18, P2435, DOI 10.1093/carcin/18.12.2435; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; McQueeney K. E., 2017, ONCOTARGET, V9, P8223; National Cancer Institute, 2016, SEER CANC STAT FACTS, V2017; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Rabajdova M, 2016, J CANCER RES CLIN, V142, P2397, DOI 10.1007/s00432-016-2226-0; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; SAIGA T, 1987, IN VITRO CELL DEV B, V23, P850; Salamoun JM, 2016, ORG BIOMOL CHEM, V14, P6398, DOI 10.1039/c6ob00946h; Schwartz MA, 2001, J CELL SCI, V114, P2553; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Slordahl TS, 2016, ONCOTARGET, V7, P27295, DOI 10.18632/oncotarget.8422; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Walls CD, 2013, MOL CELL PROTEOMICS, V12, P3759, DOI 10.1074/mcp.M113.028886; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Xing C, 2016, CANCER RES, V76, P83, DOI 10.1158/0008-5472.CAN-14-3595; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; Xu ZY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000663; Yang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169665; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zhou J, 2014, EXP HEMATOL, V42; Zimmerman MW, 2014, J BIOL CHEM, V289, P5904, DOI 10.1074/jbc.M113.480038; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	59	11	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5661	5673		10.1096/fj.201701446R	http://dx.doi.org/10.1096/fj.201701446R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746167	Green Published, Bronze			2022-12-28	WOS:000447972500038
J	Rajasekaran, R; Felser, A; Nuoffer, JM; Dufour, JF; St-Pierre, MV				Rajasekaran, Raviprasadh; Felser, Andrea; Nuoffer, Jean-Marc; Dufour, Jean-Francois; St-Pierre, Marie V.			The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism	FASEB JOURNAL			English	Article						hepatic steatosis; lysine hyperacetylation; mitochondrial respiration; bioenergetics	PYRUVATE-DEHYDROGENASE COMPLEX; NONALCOHOLIC FATTY LIVER; RESPIRATORY-CHAIN; HEPATIC STEATOSIS; MITOCHONDRIAL DYSFUNCTION; PERMEABILIZED CELLS; STRESS; MECHANISM; OXYGEN; GENE	The histidine triad nucleotide-binding protein 2 (HINT-2) is a mitochondrial adenosine phosphoramidase expressed in hepatocytes. The phenotype of Hint2 knockout (Hint2(-/-)) mice includes progressive hepatic steatosis and lysine hyperacetylation of mitochondrial proteins, which are features of respiratory chain malfunctions. We postulated that the absence of HINT-2 induces a defect in mitochondria bioenergetics. Isolated Hint2(-/-) hepatocytes produced less ATP and generated a lower mitochondrial membrane potential than did Hint2(+/+) hepatocytes. In extracellular flux analyses with glucose, the basal, ATP-linked, and maximum oxygen consumption rates (OCRs) were decreased in Hint2(-/-) hepatocytes and in HepG2 cells lacking HINT-2. Conversely, in HINT-2 overexpressing SNU-449 and HepG2 cells, the basal, ATP-linked, and maximum OCRs were increased. Similarly, with palmitate, basal and maximum OCRs were decreased in Hint2(-/-) hepatocytes, but they were increased in HINT-2 overexpressing HepG2 cells. When assayed with radiolabeled substrate, palmitate oxidation was reduced by 25% in Hint2(-/-) mitochondria. In respirometry assays, complex I- and II-driven, coupled and uncoupled respirations and complex IV KCN-sensitive respiration were reduced in Hint2(-/-) mitochondria. Furthermore, HINT-2 associated with cardiolipin and glucose-regulated protein 75 kDa. Our study shows decreased electron transfer and oxidative phosphorylation capacity in the absence of HINT-2. The bioenergetics deficit accumulated over time in hepatocytes lacking HINT-2 likely leads to the secondary outcome of steatosis.Rajasekaran, R., Felser, A., Nuoffer, J.-M., Dufour, J.-F., St-Pierre, M. V. The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism.	[Rajasekaran, Raviprasadh; Dufour, Jean-Francois; St-Pierre, Marie V.] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Felser, Andrea; Nuoffer, Jean-Marc] Univ Bern, Univ Inst Clin Chem, Bern, Switzerland; [Dufour, Jean-Francois] Univ Hosp Bern, Univ Clin Visceral Surg & Med, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Dufour, JF (corresponding author), Univ Hosp Bern, Dept Visceral Surg & Med, 35 Murtenstr,Freiburgstr 4, CH-3010 Bern, Switzerland.	jean-francois.dufour@dbmr.unibe.ch	Dufour, Jean Francois Jacques/AAL-9866-2020; Nuoffer, Jean-Marc/C-8936-2009	Dufour, Jean Francois Jacques/0000-0002-8062-1346; 	Swiss National Foundation [31003A_160001]; IndoSwiss Grant from the Swiss National Foundation [IZLIZ3_156447]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); IndoSwiss Grant from the Swiss National Foundation	The authors acknowledge the services provided by Sophie Braga Lagache (Laboratory of Mass Spectrometry and Proteomics, Department for BioMedical Research, University of Bern), who processed the immunoprecipitated samples and identified the proteins subject to lysine acetylation. The authors acknowledge the technical help provided by David Belet and Philipp Kellmann (Department for Biomedical Research, University of Bern), who managed the animal breeding and care and performed hepatocyte isolation and HPLC measurements. Financial support was provided by Grant 31003A_160001 awarded by the Swiss National Foundation, and IndoSwiss Grant IZLIZ3_156447 from the Swiss National Foundation. The authors declare no conflicts of interest.	Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Bottinger L, 2013, MOL BIOL CELL, V24, P2609, DOI 10.1091/mbc.E13-02-0106; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Estan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115250; Felser A, 2014, TOXICOLOGY, V323, P1, DOI 10.1016/j.tox.2014.05.011; Fouque F, 2003, PEDIATR RES, V53, P793, DOI 10.1203/01.PDR.0000057987.46622.64; Gnaiger E., 2014, MITOCHONDRIAL PATHWA, P19; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Huebner K, 2011, ADV ENZYME REGUL, V51, P208, DOI 10.1016/j.advenzreg.2010.09.003; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Lampl T, 2015, JOVE-J VIS EXP, DOI 10.3791/52076; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Liu ZQ, 2015, BIOCHIMIE, V116, P52, DOI 10.1016/j.biochi.2015.06.023; Maize KM, 2013, FEBS J, V280, P3389, DOI 10.1111/febs.12330; Makrecka-Kuka M, 2015, BIOMOLECULES, V5, P1319, DOI 10.3390/biom5031319; Martin J, 2006, GASTROENTEROLOGY, V130, P2179, DOI 10.1053/j.gastro.2006.03.024; Martin J, 2016, AM J PHYSIOL-GASTR L, V310, pG497, DOI 10.1152/ajpgi.00178.2015; Martin J, 2013, HEPATOLOGY, V57, P2037, DOI 10.1002/hep.26060; Munnik Teun, 2013, Methods Mol Biol, V1009, P253, DOI 10.1007/978-1-62703-401-2_23; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; Rahman M, 2014, J CELL BIOL, V206, P289, DOI 10.1083/jcb.201404118; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Schroder T, 2016, MOL METAB, V5, P283, DOI 10.1016/j.molmet.2016.01.010; Schwab MA, 2005, CLIN CHEM, V51, P151, DOI 10.1373/clinchem.2004.033852; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; van Zutphen T, 2016, J HEPATOL, V65, P1198, DOI 10.1016/j.jhep.2016.05.046; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; WASSERMAN DH, 1991, AM J PHYSIOL, V260, pE811, DOI 10.1152/ajpendo.1991.260.6.E811; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Xu LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI 10.1038/jcbfm.2008.125; Zhou X, 2013, BIOCHEMISTRY-US, V52, P3588, DOI 10.1021/bi301616c	48	6	7	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5143	5161		10.1096/fj.201701429R	http://dx.doi.org/10.1096/fj.201701429R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913563	Bronze			2022-12-28	WOS:000443817700042
J	Zhao, ZH; Kudej, RK; Wen, HR; Fefelova, N; Yan, L; Vatner, DE; Vatner, SF; Xie, LH				Zhao, Zhenghang; Kudej, Raymond K.; Wen, Hairuo; Fefelova, Nadezhda; Yan, Lin; Vatner, Dorothy E.; Vatner, Stephen F.; Xie, Lai-Hua			Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck)	FASEB JOURNAL			English	Article						hibernating animals; ischemia; oxidative stress; CaMKII; triggered activity	CALMODULIN KINASE-II; REGIONAL MYOCARDIAL-ISCHEMIA; PROTEIN-KINASE; HYDROGEN-PEROXIDE; VENTRICULAR MYOCYTES; OXIDATIVE STRESS; LOW-TEMPERATURE; ADAPTIVE-MECHANISMS; ATRIAL-FIBRILLATION; GROUND-SQUIRREL	Hibernating animals show resistance to hypothermia-induced cardiac arrhythmias. However, it is not clear whether and how mammalian hibernators are resistant to ischemia-induced arrhythmias. The goal of this investigation was to determine the susceptibility of woodchucks (Marmota monax) to arrhythmias and their mechanisms after coronary artery occlusion at the same room temperature in both winter, the time for hibernation, and summer, when they do not hibernate. By monitoring telemetric electrocardiograms, we found significantly higher arrhythmia scores, calculated as the severity of arrhythmias, with incidence of ventricular tachycardia, ventricular fibrillation, and thus sudden cardiac death (SCD) in woodchucks in summer than they had in winter. The level of catalase expression in woodchuck hearts was significantly higher, whereas the level of oxidized Ca2+/calmodulin-dependent protein kinase II (CaMKII) was lower in winter than it was in summer. Ventricular myocytes isolated from woodchucks in winter were more resistant to H2O2-induced early afterdepolarizations (EADs) compared with myocytes isolated from woodchucks in summer. The EADs were eliminated by inhibiting CaMKII (with KN-93), l-type Ca current (with nifedipine), or late Na+ current (with ranolazine). In woodchucks, in the summer, the arrhythmia score was significantly reduced by overexpression of catalase (via adenoviral vectors) or the inhibition of CaMKII (with KN-93) in the heart. This study suggests that the heart of the mammalian hibernator is more resistant to ischemia-induced arrhythmias and SCD in winter. Increased antioxidative capacity and reduced CaMKII activity may confer resistance in woodchuck hearts against EADs and arrhythmias during winter. The profound protection conferred by catalase overexpression or CaMKII inhibition in this novel natural animal model may provide insights into clinical directions for therapy of arrhythmias.Zhao, Z., Kudej, R. K., Wen, H., Fefelova, N., Yan, L., Vatner, D. E., Vatner, S. F., Xie, L.-H. Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck).	[Zhao, Zhenghang] Xi An Jiao Tong Univ, Sch Med, Dept Pharmacol, Xian, Shaanxi, Peoples R China; [Zhao, Zhenghang; Kudej, Raymond K.; Wen, Hairuo; Fefelova, Nadezhda; Vatner, Dorothy E.; Vatner, Stephen F.; Xie, Lai-Hua] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 South Orange Ave,MSB G609, Newark, NJ 07103 USA; [Yan, Lin] Rutgers New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Kudej, Raymond K.] Tufts Univ, Dept Clin Sci, North Grafton, MA USA; [Wen, Hairuo] Natl Inst Food & Drug Control, Key Lab Beijing Nonclin Safety Evaluat Res Drugs, Natl Ctr Safety Evaluat Drugs, Beijing, Peoples R China	Xi'an Jiaotong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University; National Institute of Food & Drug Control - China	Xie, LH (corresponding author), Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 South Orange Ave,MSB G609, Newark, NJ 07103 USA.	xiela@njms.rutgers.edu		zhenghang, Zhao/0000-0003-0421-2046	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL97979, R01HL133294, R01HL130848]; American Heart Association [16GRNT31100022]; National Natural Science Foundation of China [81470510, 81503068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124282, R01HL097979, R01HL133294, R01HL130848, R01HL102472, R01HL106511, R01HL137368, R01HL119464, R01HL137405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG053514] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Mark Anderson (Johns Hopkins, Baltimore, MD, USA) for kindly providing oxidized CaMKII antibodies. This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grants R01HL97979 and R01HL133294 to L.-H.X and R01HL130848 to S.F.V.), the American Heart Association (Grant 16GRNT31100022 to L.-H.X.), and the National Natural Science Foundation of China (Grants 81470510 to Z.Z. and 81503068 to H.W.). The authors declare no conflicts of interest.	Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Boengler K, 2003, CARDIOVASC RES, V59, P573, DOI 10.1016/S0008-6363(03)00511-X; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; BURLINGTON RF, 1988, PHYSIOL ZOOL, V61, P387, DOI 10.1086/physzool.61.5.30161260; BUZADZIC B, 1990, FREE RADICAL BIO MED, V9, P407, DOI 10.1016/0891-5849(90)90017-D; CAPRETTE DR, 1984, AM J PHYSIOL, V247, pR722, DOI 10.1152/ajpregu.1984.247.4.R722; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Couchonnal LF, 2008, PHYSIOLOGY, V23, P151, DOI 10.1152/physiol.00043.2007; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fedorov VV, 2005, HEART RHYTHM, V2, P966, DOI 10.1016/j.hrthm.2005.06.012; Foteinou PT, 2015, BIOPHYS J, V109, P838, DOI 10.1016/j.bpj.2015.06.064; FRANZ MR, 1984, CIRCULATION, V69, P593, DOI 10.1161/01.CIR.69.3.593; Franz MR, 1999, CARDIOVASC RES, V41, P25, DOI 10.1016/S0008-6363(98)00268-5; Gao JH, 2008, J PHYSIOL SCI, V58, P389, DOI 10.2170/physiolsci.RP007108; Gbadebo TD, 2002, CIRCULATION, V105, P770, DOI 10.1161/hc0602.103724; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH823, DOI 10.1152/ajpheart.1996.271.3.H823; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hinata M, 2007, J PHARMACOL SCI, V103, P283, DOI 10.1254/jphs.FP0060015; Hool LC, 2008, CLIN EXP PHARMACOL P, V35, P229, DOI 10.1111/j.1440-1681.2007.04727.x; JOHANSSON BW, 1985, EUR HEART J, V6, P53, DOI 10.1093/eurheartj/6.suppl_D.53; Johansson BW, 1996, CARDIOVASC RES, V31, P826, DOI 10.1016/S0008-6363(95)00192-1; Kinugawa S, 2000, CIRC RES, V87, P392; Kirchhof P, 2004, J MOL CELL CARDIOL, V36, P691, DOI 10.1016/j.yjmcc.2004.03.007; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Luczak ED, 2014, J MOL CELL CARDIOL, V73, P112, DOI 10.1016/j.yjmcc.2014.02.004; Marczin N, 2003, ARCH BIOCHEM BIOPHYS, V420, P222, DOI 10.1016/j.abb.2003.08.037; Mehta D, 1997, CIRCULATION, V96, P3215, DOI 10.1161/01.CIR.96.9.3215; Morin PJ, 2007, ARCH BIOCHEM BIOPHYS, V461, P59, DOI 10.1016/j.abb.2007.01.035; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ohta H, 2006, COMP BIOCHEM PHYS C, V143, P484, DOI 10.1016/j.cbpc.2006.05.002; Rodrigo R, 2008, PHARMACOL THERAPEUT, V118, P104, DOI 10.1016/j.pharmthera.2008.01.005; ROSEN MR, 1984, ANN NY ACAD SCI, V427, P84, DOI 10.1111/j.1749-6632.1984.tb20776.x; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Said M, 2008, AM J PHYSIOL-HEART C, V295, pH1669, DOI 10.1152/ajpheart.00010.2008; Schwartz BG, 2012, AM J CARDIOL, V110, P461, DOI 10.1016/j.amjcard.2012.03.048; SLEZAK J, 1995, AM J PATHOL, V147, P772; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Tomaselli GF, 2010, NAT MED, V16, P648, DOI 10.1038/nm0610-648; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Vittone L, 2002, J MOL CELL CARDIOL, V34, P39, DOI 10.1006/jmcc.2001.1488; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang SQ, 2002, J EXP BIOL, V205, P2957; Ward CA, 1997, J PHYSIOL-LONDON, V500, P631, DOI 10.1113/jphysiol.1997.sp022048; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Wu YJ, 1999, AM J PHYSIOL-HEART C, V276, pH2168, DOI 10.1152/ajpheart.1999.276.6.H2168; XIE JT, 1990, METHOD FIND EXP CLIN, V12, P419; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; YAN L, 2015, BASIC RES CARDIOL, V110; Yang XL, 2011, BASIC RES CARDIOL, V106, P421, DOI 10.1007/s00395-011-0165-0; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003; Zhao ZH, 2015, AM J PHYSIOL-HEART C, V308, pH240, DOI 10.1152/ajpheart.00630.2014; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011; Zipes Douglas P., 1999, Journal of the American College of Cardiology, V34, P959; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zipes DP, 2000, CIRCULATION, V102, P52	60	9	9	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4229	4240		10.1096/fj.201701516R	http://dx.doi.org/10.1096/fj.201701516R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29490168	Green Published			2022-12-28	WOS:000439325400014
J	Chegeni, M; Amiri, M; Nichols, BL; Naim, HY; Hamaker, BR				Chegeni, Mohammad; Amiri, Mahdi; Nichols, Buford L.; Naim, Hassan Y.; Hamaker, Bruce R.			Dietary starch breakdown product sensing mobilizes and apically activates -glucosidases in small intestinal enterocytes	FASEB JOURNAL			English	Article						carbohydrates; gut epithelium; glycosylation; maltose	LACTASE-PHLORHIZIN HYDROLASE; SUCRASE-ISOMALTASE COMPLEX; MALTASE-GLUCOAMYLASE; DIFFERENTIAL EXPRESSION; AMINOPEPTIDASE N; TASTE RECEPTORS; CACO-2 CELLS; GLUCOSE; DIGESTION; GLYCOSYLATION	Dietary starch is finally converted to glucose for absorption by the small intestine mucosal -glucosidases (sucrase-isomaltase [SI] and maltase-glucoamylase), and control of this process has health implications. Here, the molecular mechanisms were analyzed associated with starch-triggered maturation and transport of SI. Biosynthetic pulse-chase in Caco-2 cells revealed that the high MW SI species (265 kDa) induced by maltose (an -amylase starch digestion product) had a higher rate of early trafficking and maturation compared with a glucose-induced SI (245 kDa). The maltose-induced SI was found to have higher affinity to lipid rafts, which are associated with enhanced targeting to the apical membrane and higher activity. Accordingly, in situ maltose-hydrolyzing action was enhanced in the maltose-treated cells. Thus, starch digestion products at the luminal surface of small intestinal enterocytes are sensed and accelerate the intracellular processing of SI to enhance starch digestion capacity in the intestinal lumen.Chegeni, M., Amiri, M., Nichols, B. L., Naim, H. Y., Hamaker, B. R. Dietary starch breakdown product sensing mobilizes and apically activates -glucosidases in small intestinal enterocytes.	[Chegeni, Mohammad; Hamaker, Bruce R.] Purdue Univ, Whistler Ctr Carbohydrate Res, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA; [Amiri, Mahdi; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany; [Nichols, Buford L.] ARS, Dept Pediat, USDA, Childrens Nutr Res Ctr,Baylor Coll Med, Houston, TX USA; [Amiri, Mahdi] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Veterinary Medicine Hannover, Foundation; Baylor College of Medicine; United States Department of Agriculture (USDA); Hannover Medical School	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany.; Hamaker, BR (corresponding author), Purdue Univ, Whistler Ctr Carbohydrate Res, 765 Agr Mall Dr, W Lafayette, IN 47907 USA.	hassan.naim@tiho-hannover.de; hamakerb@purdue.edu	Amiri, Mahdi/L-6934-2019	Amiri, Mahdi/0000-0003-4775-9535				Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; CHANTRET I, 1994, J CELL SCI, V107, P213; Cheng MW, 2014, J CLIN BIOCHEM NUTR, V54, P55, DOI 10.3164/jcbn.13-59; Christian MT, 2002, J PEDIATR GASTR NUTR, V34, P158, DOI 10.1097/00005176-200202000-00010; Cisse F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020124; DAHLQVIST A, 1969, BIOCHEM J, V111, P139, DOI 10.1042/bj1110139; DAHLQVIST A, 1962, J CLIN INVEST, V41, P463, DOI 10.1172/JCI104499; DANIELSEN EM, 1982, BIOCHEM J, V204, P639, DOI 10.1042/bj2040639; GRAY GM, 1979, J BIOL CHEM, V254, P6038; Hardy K, 2015, Q REV BIOL, V90, P251, DOI 10.1086/682587; HEYMANN H, 1995, BIOL CHEM H-S, V376, P249; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; Jacob R, 2000, J BIOL CHEM, V275, P10630, DOI 10.1074/jbc.275.14.10630; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Lee BH, 2014, MOL NUTR FOOD RES, V58, P1111, DOI 10.1002/mnfr.201300599; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; NAIM HY, 1988, J BIOL CHEM, V263, P7242; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; PETERSON MD, 1992, J CELL SCI, V102, P581; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Robayo-Torres CC, 2006, CLIN GASTROENTEROL H, V4, P276, DOI 10.1016/j.cgh.2005.12.023; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; STERCHI EE, 1980, CLIN CHIM ACTA, V102, P49, DOI 10.1016/0009-8981(80)90432-5; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; van Avesaat M, 2015, INT J OBESITY, V39, P235, DOI 10.1038/ijo.2014.112; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769; Wetzel G, 2009, BIOL CHEM, V390, P545, DOI 10.1515/BC.2009.077	35	8	8	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3903	3911		10.1096/fj.201701029R	http://dx.doi.org/10.1096/fj.201701029R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465310				2022-12-28	WOS:000435104500035
J	Zhang, P; Song, YR; Sun, YD; Li, XC; Chen, LF; Yang, LK; Xing, YF				Zhang, Peng; Song, Yarong; Sun, Yadong; Li, Xuechao; Chen, Lifeng; Yang, Likun; Xing, Yifei			AMPK/GSK3 beta/beta-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming	FASEB JOURNAL			English	Article						KIAA1199; apoptosis; metabolism; metastasis; prostatic carcinoma	GENE-EXPRESSION; LACTATE-DEHYDROGENASE; UP-REGULATION; TUMOR; SURVIVAL; PROTEIN; ACTIVATION; KIAA1199; KINASE; METASTASIS	Prostate cancer (PCa) represents one of the most common solid neoplasms, and metastasis is the second leading cause of death in adult males. Anoikis is a programmed cell death that is induced upon cell detachment from the extracellular matrix (ECM), which behaves as a critical protective mechanism for anchorage-independent cell growth and metastasis formation. However, in the absence of ECM attachment, shift of metabolic pattern and tolerance to anoikis facilitate the survival of aggressive cancer cells in the circulatory system as well as their metastasis to distant sites. Few molecular targets in PCa have thus far been reported to prevent anoikis resistance, metabolic reprogramming, and metastasis simultaneously. In the present study, elevated migration, invasion, pyruvate production, lactate generation, ATP level, and impaired detachment-induced apoptosis were found in anoikis-resistant PCa cells, and genome microarray analysis demonstrated that the cell migration-inducing protein (CEMIP) was a potential molecular target for the regulation of the aforementioned malignant behaviors. Additional investigation revealed that the AMPK/glycogen synthase kinase 3 (GSK3)/-catenin cascade-triggered CEMIP overexpression in anoikis-resistant PCa cells might be implicated in local progression, metabolic shift, and cellular migration and invasion, whereas knockout of CEMIP by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 in anoikis-resistant PCa cells reversed the described bioeffects by reducing expressions of matrix metalloproteinase 2 (MMP2), VEGF, pyruvate dehydrogenase kinase isoform 4 (PDK4), and lactate dehydrogenase A. In addition, inhibition of glycolysis by CEMIP-mediated PDK4 down-regulation impaired the migration and invasion of anoikis-resistant PCa cells by attenuating MMP2 and VEGF expressions. Our findings establish that AMPK/GSK3/-catenin cascade-triggered CEMIP overexpression might promote migration and invasion in anoikis-resistant PCa cells by enhancing PDK4-associated metabolic reprogramming, which may provide a novel, promising therapeutic target for the treatment of advanced PCa.Zhang, P., Song, Y., Sun, Y., Li, X., Chen, L., Yang, L., Xing, Y. AMPK/GSK3/-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.	[Zhang, Peng; Song, Yarong; Sun, Yadong; Li, Xuechao; Chen, Lifeng; Yang, Likun; Xing, Yifei] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Zhang, Peng] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Hubei, Peoples R China; [Li, Xuechao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China; [Chen, Lifeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xing, YF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	yifei_xing@163.com		Sun, Yadong/0000-0003-0384-4121; Zhang, Peng/0000-0002-9967-1597	National Natural Science Foundation of China [81272847, 81772751]; Program for New Century Excellent Talents in University [NCET-13-0239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was funded by the National Natural Science Foundation of China (Grants 81272847 and 81772751) and the Program for New Century Excellent Talents in University (NCET-13-0239; to Y.X.). The authors declare no conflicts of interest.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma M, 2006, J CLIN ONCOL, V24, p153S; Bragayrac LAN, 2017, PROSTATE, V77, P1076, DOI 10.1002/pros.23364; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Choi SH, 2010, BIOCHEM PHARMACOL, V79, P1352, DOI 10.1016/j.bcp.2009.12.011; Emami KH, 2007, CANCER LETT, V253, P170, DOI 10.1016/j.canlet.2006.12.040; Evensen NA, 2013, JNCI-J NATL CANCER I, V105, P1402, DOI 10.1093/jnci/djt224; Fossati N, 2015, EUR UROL, V67, P3, DOI 10.1016/j.eururo.2014.08.056; Freeman J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0475-1; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hasanuzzaman M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-34; Huang J, 2010, J CLIN INVEST, V120, P223, DOI 10.1172/JCI38012; Jefferies Matthew T, 2017, Biomark Cancer, V9, p1179299X17710944, DOI 10.1177/1179299X17710944; Jeon JY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1640-z; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim H, 2017, BRIT J CANCER, V116, P370, DOI 10.1038/bjc.2016.440; Kroon J, 2014, ONCOTARGET, V5, P8986, DOI 10.18632/oncotarget.1510; Kunhiraman H, 2017, J CELL BIOCHEM, V118, P252, DOI 10.1002/jcb.25629; Liu XX, 2011, PROSTATE, V71, P766, DOI 10.1002/pros.21293; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Mawji IA, 2007, J NATL CANCER I, V99, P811, DOI 10.1093/jnci/djk182; Mengual L, 2014, ACTAS UROL ESP, V38, P143, DOI 10.1016/j.acuro.2013.07.012; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Prasad S, 2011, CANCER RES, V71, P538, DOI 10.1158/0008-5472.CAN-10-3121; Rellinger EJ, 2015, PEDIATR BLOOD CANCER, V62, P581, DOI 10.1002/pbc.25348; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Shostak K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6232; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Sun AJ, 2016, PROSTATE, V76, P172, DOI 10.1002/pros.23106; Sundararaman A, 2016, J BIOL CHEM, V291, P14410, DOI 10.1074/jbc.M116.731257; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Tucci M, 2016, EUR UROL, V69, P563, DOI 10.1016/j.eururo.2015.09.013; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Weber GF, 2016, INT J CANCER, V138, P2061, DOI 10.1002/ijc.29839; Wong N, 2017, ONCOTARGET, V8, P19218, DOI 10.18632/oncotarget.15168; Xian ZY, 2015, TUMOR BIOL, V36, P8093, DOI 10.1007/s13277-015-3540-x; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Zhang P, 2016, EXP CELL RES, V347, P350, DOI 10.1016/j.yexcr.2016.08.019; Zhang P, 2016, INT J ONCOL, V48, P1417, DOI 10.3892/ijo.2016.3356; Zhang YS, 2014, ONCOL REP, V31, P1503, DOI 10.3892/or.2014.3038	54	37	38	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3924	3935		10.1096/fj.201701078R	http://dx.doi.org/10.1096/fj.201701078R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29505302				2022-12-28	WOS:000435104500037
J	Oswald, DM; Sim, ES; Baker, C; Farhan, O; Debanne, SM; Morris, NJ; Rodriguez, BG; Jones, MB; Cobb, BA				Oswald, Douglas M.; Sim, Edward S.; Baker, Courtney; Farhan, Obada; Debanne, Sara M.; Morris, Nathan J.; Rodriguez, Benigno G.; Jones, Mark B.; Cobb, Brian A.			Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infections	FASEB JOURNAL			English	Article						biomarker; glycan; glycome; lectin; CVD	MONOCYTE ACTIVATION; IMMUNE ACTIVATION; INCREASED RISK; CELL COUNT; INFLAMMATION; BIOMARKERS; PROTEIN; AIDS; ASSOCIATION; COAGULATION	Despite effective control of HIV infection with antiretroviral drugs, individuals with HIV have high incidences of secondary diseases. These sequelae, such as cardiovascular disease (CVD), are poorly understood and represent a major health burden. To date, predictive biomarkers of HIV-associated secondary disease have been elusive, making preventative clinical management essentially impossible. Here, we applied a newly developed and easy to deploy, multitarget, and high-throughput glycomic analysis to banked HIV+ human plasma samples to determine whether the glycome may include biomarkers that predict future HIV-associated cardiovascular events or CVD diagnoses. Using 324 patient samples, we identified a glycomic fingerprint that was predictive of future CVD events but independent of CD4 counts, diabetes, age, and birth sex, suggesting that the plasma glycome may serve as a biomarker for specific HIV-associated sequelae. Our findings constitute the discovery of novel glycan biomarkers that could classify patients with HIV with elevated risk for CVD and reveal the untapped prognostic potential of the plasma glycome in human disease.Oswald, D. M., Sim, E. S., Baker, C., Farhan, O., Debanne, S. M., Morris, N. J., Rodriguez, B. G., Jones, M. B., Cobb, B. A. Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infections.	[Oswald, Douglas M.; Sim, Edward S.; Jones, Mark B.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Baker, Courtney; Farhan, Obada; Debanne, Sara M.; Morris, Nathan J.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA; [Rodriguez, Benigno G.] Univ Hosp Cleveland, Dept Med, Med Ctr, Div Infect Dis & HIV Med, 2074 Abington Rd, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Cobb, BA (corresponding author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd,WRB 5132, Cleveland, OH 44106 USA.	brian.cobb@case.edu			U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM082916, GM115234]; NIH National Institute of Allergy and Infectious Diseases Training Grant [T32 AI089474]; CWRU CFAR grant [AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474, P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916, R01GM115234] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Allergy and Infectious Diseases Training Grant; CWRU CFAR grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the CFAR staff for assistance in designing the study and in selecting, gathering, and processing the samples; the members of the B.A.C. laboratory for valuable feedback and input; Dr. Michael Lederman (CFAR) for critical evaluation of this manuscript; and Dr. Jonathan Karn (CFAR) for the invitation and encouragement to work in the HIV field. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants GM082916 and GM115234 (to B.A.C.), an administrative supplement to B.A.C. through the CWRU CFAR grant AI036219 to Jonathan Karn, and NIH National Institute of Allergy and Infectious Diseases Training Grant T32 AI089474 (to D.M.O.). This work has been presented, in part, at the 2017 Society for Glycobiology Meeting. The authors declare no conflicts of interest.	Adedeji AL, 2014, EXCLI J, V13, P761; Baker JV, 2010, CURR OPIN HIV AIDS, V5, P511, DOI 10.1097/COH.0b013e32833ed7ec; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Breen EC, 2011, CANCER EPIDEM BIOMAR, V20, P1303, DOI 10.1158/1055-9965.EPI-11-0037; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Cummings R.D., 2015, ESSENTIALS GLYCOBIOL, P611; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Erlandson KM, 2017, J INFECT DIS, V215, P228, DOI 10.1093/infdis/jiw523; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Haab BB, 2012, PROTEOM CLIN APPL, V6, P346, DOI 10.1002/prca.201200014; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Jones MB, 2016, P NATL ACAD SCI USA, V113, P7207, DOI 10.1073/pnas.1523968113; Justice AC, 2018, J INFECT DIS, V217, P521, DOI 10.1093/infdis/jix586; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kreisman LSC, 2012, GLYCOBIOLOGY, V22, P1019, DOI 10.1093/glycob/cws070; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Longenecker CT, 2013, HIV MED, V14, P385, DOI 10.1111/hiv.12013; Longenecker CT, 2013, INT J CARDIOL, V168, P4039, DOI 10.1016/j.ijcard.2013.06.059; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Monforte AD, 2013, AIDS, V27, P407, DOI 10.1097/QAD.0b013e32835b2ef1; O'Connell TX, 2005, AM FAM PHYSICIAN, V71, P105; Pagan JD, 2018, CELL, V172, P564, DOI 10.1016/j.cell.2017.11.041; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Ribeiro JP, 2013, CURR OPIN CHEM BIOL, V17, P827, DOI 10.1016/j.cbpa.2013.06.009; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang YC, 2011, CELL RES, V21, P1551, DOI 10.1038/cr.2011.148; Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zanni MV, 2012, CURR HIV-AIDS REP, V9, P200, DOI 10.1007/s11904-012-0123-y	39	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1852	1859		10.1096/fj.201800923R	http://dx.doi.org/10.1096/fj.201800923R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183373	Green Published			2022-12-28	WOS:000457296600027
J	Kuefner, MS; Deng, X; Stephenson, EJ; Pham, K; Park, EA				Kuefner, Michael S.; Deng, Xiong; Stephenson, Erin J.; Pham, Kevin; Park, Edwards A.			Secretory phospholipase A(2) group IIA enhances the metabolic rate and increases glucose utilization in response to thyroid hormone	FASEB JOURNAL			English	Article						PLA2G2A; brown adipose tissue; UCP1	BROWN ADIPOSE-TISSUE; MESSENGER-RNA; UNCOUPLING PROTEIN-2; GENE-TRANSCRIPTION; ENERGY-BALANCE; FAT; EXPRESSION; OBESITY; MECHANISMS; ENZYMES	Secretory phospholipase A(2) group IIA (PLA2G2A) is a phospholipase which has a role in inflammation, atherogenesis, and host defense. Previously, we found that PLA2G2A protects mice on high-fat diets from weight gain and insulin resistance. Here, we examined the regulation of PLA2G2A and the metabolic changes that occur in response to variations in thyroid status. In particular, the impact of PLA2G2A on the brown adipose tissue (BAT) thermogenic gene expression was explored. We induced hypothyroidism in C57BL/6 and PLA2G2A-overexpressing (IIA+) mice over a 10 wk period or treated them with thyroid hormone (T-3) for 5 wk. There were no significant changes in PLA2G2A abundance in response to thyroid status. The energy expenditure of hypothyroid IIA+ mice did not increase; however, the energy expenditure, substrate utilization, insulin sensitivity, and glucose tolerance were all elevated in the IIA+ mice given T-3. Moreover, white adipocytes from IIA+ mice were much more prone to beiging, including increased expression of brown adipose thermogenic markers such as uncoupling protein 1 (UCP1), PR domain containing 16, and early B cell factor 2. Finally, the BAT of IIA+ mice had increased UCP1 and other proteins indicative of mitochondrial uncoupling and nonshivering adaptive thermogenesis. These data reveal a novel role for PLA2G2A on adipose tissue thermogenesis depending on thyroid status.Kuefner, M. S., Deng, X., Stephenson, E. J., Pham, K., Park, E. A. Secretory phospholipase A(2) group IIA enhances the metabolic rate and increases glucose utilization in response to thyroid hormone.	[Kuefner, Michael S.; Deng, Xiong; Pham, Kevin; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Coll Med, Memphis, TN USA; [Stephenson, Erin J.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pediat, Memphis, TN USA; [Kuefner, Michael S.; Deng, Xiong; Pham, Kevin; Park, Edwards A.] Dept Vet Affairs Med Ctr, Memphis, TN USA; [Stephenson, Erin J.] LeBonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Dept Vet Affairs Med Ctr, 71 S Manassas, Memphis, TN 38163 USA.	epark@uthsc.edu	Stephenson, Erin J/AHD-5759-2022	Stephenson, Erin J/0000-0001-5812-408X	U.S. Veterans Administration [1I01BX002408]; University of Tennessee Health Science Center; LeBonheur Children's Hospital; Children's Foundation Research Institute; LeBonheur Associate Board via Junior Investigator Grant [651602]; Veterans Affairs [I01BX002408] Funding Source: NIH RePORTER	U.S. Veterans Administration(US Department of Veterans Affairs); University of Tennessee Health Science Center; LeBonheur Children's Hospital; Children's Foundation Research Institute; LeBonheur Associate Board via Junior Investigator Grant; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the U.S. Veterans Administration 1I01BX002408 (to E.A.P.). M.S.K. was supported in part by the Frank Dugan Scholarship from the University of Tennessee Health Science Center. E.J.S. receives support from LeBonheur Children's Hospital, the Children's Foundation Research Institute, and the LeBonheur Associate Board via Junior Investigator Grant #651602. The authors declare no conflicts of interest.	AARSMAN AJ, 1989, J BIOL CHEM, V264, P10008; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Brent GA, 2012, WILLIAMS TXB ENDOCRI, P406; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chakraborty D, 2015, INDIAN J NUCL MED, V30, P320, DOI 10.4103/0972-3919.164147; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hones S. G., 2014, END SOC 96 ANN M  EX; Hope PJ, 1997, AM J PHYSIOL-REG I, V273, pR161, DOI 10.1152/ajpregu.1997.273.1.R161; HORIGOME K, 1987, J BIOCHEM-TOKYO, V101, P53, DOI 10.1093/oxfordjournals.jbchem.a121907; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kuefner MS, 2017, J LIPID RES, V58, P1822, DOI 10.1194/jlr.M076141; Lahesmaa M, 2014, J CLIN ENDOCR METAB, V99, pE28, DOI 10.1210/jc.2013-2312; Lanni A, 1997, FEBS LETT, V418, P171, DOI 10.1016/S0014-5793(97)01375-6; Lopez M, 2013, TRENDS MOL MED, V19, P418, DOI 10.1016/j.molmed.2013.04.004; Martinez-Sanchez N, 2017, J ENDOCRINOL, V232, P351, DOI 10.1530/JOE-16-0425; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; McAninch EA, 2014, ANN NY ACAD SCI, V1311, P77, DOI 10.1111/nyas.12374; Menschikowski M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-576; MIZUSHIMA H, 1989, J BIOCHEM-TOKYO, V105, P520, DOI 10.1093/oxfordjournals.jbchem.a122699; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Okita Y, 2016, INFECT IMMUN, V84, P573, DOI 10.1128/IAI.01000-15; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1601; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; SAKATA T, 1989, BIOCHIM BIOPHYS ACTA, V1007, P124, DOI 10.1016/0167-4781(89)90141-3; Sato H, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0012-7; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sharma P, 2014, BIOCHEM BIOPH RES CO, V444, P56, DOI 10.1016/j.bbrc.2014.01.003; Sharma P, 2013, J BIOL CHEM, V288, P16321, DOI 10.1074/jbc.M112.445569; Shimizu Y, 2002, J VET MED SCI, V64, P677, DOI 10.1292/jvms.64.677; Shore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068933; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Stine RR, 2016, MOL METAB, V5, P57, DOI 10.1016/j.molmet.2015.11.001; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Thyagarajan B, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0016; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Warner A, 2012, J MOL ENDOCRINOL, V49, pR29, DOI 10.1530/JME-12-0068; Weiner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38124; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Zhi H, 2015, OBESITY, V23, P760, DOI 10.1002/oby.21015	65	9	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					738	749		10.1096/fj.201800711R	http://dx.doi.org/10.1096/fj.201800711R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020829				2022-12-28	WOS:000457401500057
J	Vassilakos, G; Lei, HQ; Yang, Y; Puglise, J; Matheny, M; Durzynska, J; Ozery, M; Bennett, K; Spradlin, R; Bonanno, H; Park, S; Ahima, RS; Barton, ER				Vassilakos, Georgios; Lei, Hanqin; Yang, Yun; Puglise, Jason; Matheny, Michael; Durzynska, Julia; Ozery, Matan; Bennett, Katherine; Spradlin, Ray; Bonanno, Heather; Park, Soohyun; Ahima, Rexford S.; Barton, Elisabeth R.			Deletion of muscle IGF-I transiently impairs growth and progressively disrupts glucose homeostasis in male mice	FASEB JOURNAL			English	Article						exercise intolerance; diabetes; force generation	SKELETAL-MUSCLE; INSULIN-RESISTANCE; VIRAL EXPRESSION; BODY GROWTH; HYPERTROPHY; INACTIVATION; RECEPTORS; HORMONE; METABOLISM; ACTIVATION	Insulin-like growth factors (IGFs) are essential for local skeletal muscle growth and organismal physiology, but these actions are entwined with glucose homeostasis through convergence with insulin signaling. The objective of this work was to determine whether the effects of IGF-I on growth and metabolism could be separated. We generated muscle-specific IGF-I-deficient (MID) mice that afford inducible deletion of Igf1 at any age. After Igf1 deletion at birth or in young adult mice, evaluations of muscle physiology and glucose homeostasis were performed up to 16 wk of age. MID mice generated at birth had lower muscle and circulating IGF-I, decreased muscle and body mass, and impaired muscle force production. Eight-wk-old male MID had heightened insulin levels with trends of elevated fasting glucose. This phenotype progressed to impaired glucose handling and increased fat deposition without significant muscle mass loss at 16 wk of age. The same phenotype emerged in 16-wk-old MID mice induced at 12 wk of age, compounded with heightened muscle fatigability and exercise intolerance. We assert that muscle IGF-I independently modulates anabolism and metabolism in an age-dependent manner, thus positioning muscle IGF-I maintenance to be critical for both muscle growth and metabolic homeostasis.Vassilakos, G., Lei, H., Yang, Y., Puglise, J., Matheny, M., Durzynska, J., Ozery, M., Bennett, K., Spradlin, R., Bonanno, H., Park, S., Ahima, R. S., Barton, E. R. Deletion of muscle IGF-I transiently impairs growth and progressively disrupts glucose homeostasis in male mice.	[Vassilakos, Georgios; Lei, Hanqin; Puglise, Jason; Durzynska, Julia; Ozery, Matan; Bennett, Katherine; Spradlin, Ray; Barton, Elisabeth R.] Univ Florida, Coll Hlth & Human Performance, Appl Physiol & Kinesiol, Canc & Genet Res Complex,1864 Stadium Rd,124 FLG, Gainesville, FL 32611 USA; [Yang, Yun; Matheny, Michael; Barton, Elisabeth R.] Univ Florida, Coll Med, Pharmacol & Therapeut, Canc & Genetics Res Complex, Gainesville, FL USA; [Bonanno, Heather] Univ Florida, Anim Care Serv, Canc & Genetics Res Complex, Gainesville, FL USA; [Yang, Yun] Sichuan Univ, West China Hosp, West China Sch Med, Gastrointestinal Surg, Chengdu, Sichuan, Peoples R China; [Durzynska, Julia] Adam Mickiewicz Univ, Inst Expt Biol, Mol Virol, Poznan, Poland; [Park, Soohyun] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Ahima, Rexford S.] Johns Hopkins Univ, Div Endocrinol Diabet & Metab, Baltimore, MD USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sichuan University; Adam Mickiewicz University; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University	Barton, ER (corresponding author), Univ Florida, Coll Hlth & Human Performance, Appl Physiol & Kinesiol, Canc & Genet Res Complex,1864 Stadium Rd,124 FLG, Gainesville, FL 32611 USA.	erbarton@ufl.edu	Ahima, Rexford/W-1394-2019; Durzyńska, Julia/ABB-1942-2020	Durzyńska, Julia/0000-0002-8767-3755; park, soohyun/0000-0001-9847-9985	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK19525]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057363, AR052646]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Penn Mouse Phenotyping, Physiology and Metabolism (MPPM) Core (Philadelphia, PA, USA) for treadmill exercise testing and Insmed, Inc. (Monmouth Junction, NJ, USA) for providing mecasermin rinfabate (Iplex). The research was supported, in part, by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant P30-DK19525; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057363 (to E.R.B.) and AR052646 to the Physiological Assessment Core of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. The authors declare no conflicts of interest.	Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; Ashpole NM, 2017, GEROSCIENCE, V39, P129, DOI 10.1007/s11357-017-9971-0; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI 10.1139/h06-054; Barton ER, 2012, FASEB J, V26, P3691, DOI 10.1096/fj.11-203026; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; BRISMAR K, 1994, J CLIN ENDOCR METAB, V79, P872, DOI 10.1210/jc.79.3.872; Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497; Clemmons DR, 2012, ENDOCRIN METAB CLIN, V41, P425, DOI 10.1016/j.ecl.2012.04.017; Clemmons DR, 2004, HORM RES, V62, P77, DOI 10.1159/000080763; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Durzynska J, 2013, ENDOCRINOLOGY, V154, P1215, DOI 10.1210/en.2012-1992; Entingh-Pearsall A, 2016, J BIOL CHEM, V291, P22339, DOI 10.1074/jbc.A116.313201; Federici M, 1998, J CLIN ENDOCR METAB, V83, P2911, DOI 10.1210/jc.83.8.2911; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Lu YR, 2004, DIABETES, V53, P3131, DOI 10.2337/diabetes.53.12.3131; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Moorwood C, 2013, JOVE-J VIS EXP, DOI 10.3791/50036; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nakamura A, 2015, REGEN THER, V2, P49, DOI 10.1016/j.reth.2015.11.001; NIELSEN JH, 1989, MOL ENDOCRINOL, V3, P165, DOI 10.1210/mend-3-1-165; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; O'Neill BT, 2015, CELL REP, V11, P1220, DOI 10.1016/j.celrep.2015.04.037; Rao PC, 2009, DEV NEUROBIOL, V69, P401, DOI 10.1002/dneu.20714; Rehfeldt C, 2010, AM J PHYSIOL-ENDOC M, V299, pE287, DOI 10.1152/ajpendo.00492.2009; Saengsirisuwan V, 2009, METABOLISM, V58, P38, DOI 10.1016/j.metabol.2008.08.004; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Sheffield-Moore M, 2004, TRENDS ENDOCRIN MET, V15, P110, DOI 10.1016/j.tem.2004.02.009; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Sjogren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539; Slaaby R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07911; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Spangenburg EE, 2012, MED SCI SPORT EXER, V44, P1653, DOI 10.1249/MSS.0b013e31825871fa; Stevens-Lapsley JE, 2010, AM J PHYSIOL-ENDOC M, V299, pE730, DOI 10.1152/ajpendo.00230.2010; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zhao AZ, 1997, P NATL ACAD SCI USA, V94, P3223, DOI 10.1073/pnas.94.7.3223	57	19	20	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					181	194		10.1096/fj.201800459R	http://dx.doi.org/10.1096/fj.201800459R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29932867	Green Published			2022-12-28	WOS:000457401500015
J	Zhou, J; Zhu, CY; Luo, HW; Shen, L; Gong, J; Wu, YM; Magdalou, J; Chen, LB; Guo, Y; Wang, H				Zhou, Jin; Zhu, Chunyan; Luo, Hanwen; Shen, Lang; Gong, Jun; Wu, Yimeng; Magdalou, Jacques; Chen, Liaobin; Guo, Yu; Wang, Hui			Two intrauterine programming mechanisms of adult hypercholesterolemia induced by prenatal nicotine exposure in male offspring rats	FASEB JOURNAL			English	Article						glucocorticoid; hepatic cholesterol metabolism; IGF1; epigenetics	PITUITARY-ADRENAL AXIS; FATTY LIVER-DISEASE; GROWTH-RETARDATION; INCREASED SUSCEPTIBILITY; CARDIOVASCULAR-DISEASE; CHOLESTEROL TRANSPORT; HISTONE DEACETYLASE; INDUCED INHIBITION; MATERNAL SMOKING; OVER-EXPOSURE	Epidemiologic studies showed that low birth weight is associated with high cholesterol and an increased risk of cardiovascular diseases in adulthood. This study aimed to elucidate the intrauterine programming mechanisms of adult hypercholesterolemia. The results showed that prenatal nicotine exposure (PNE) caused intrauterine growth retardation and hypercholesterolemia in male adult offspring rats. Hepatic cholesterol synthesis and output were deceased in utero but increased in adults; hepatic reverse cholesterol transport (RCT) persistently deceased before and after birth. Meanwhile, PNE elevated serum corticosterone level and decreased hepatic IGF1 pathway activity in male fetuses, whereas converse changes were observed in male adults. The chronic stress model and cortisol-treated HepG2 cells verified that excessive glucocorticoid (GC)-induced GC-IGF1 axis programming enhanced hepatic cholesterol synthesis and output. In addition, PNE decreased the expression of specific protein 1 and P300 enrichment and H3K27 acetylation at the promoter region of genes responsible for RCT both in fetal and adult, male livers and reduced expression of those genes, similar alterations were also confirmed in cortisol-treated HepG2 cells, suggesting that excessive GC-related programming induced continuous RCT reduction by epigenetic modification. Taken together, the 2-programming approach discussed above may ultimately contribute to the development of hypercholesterolemia in male adult offspring.Zhou, J., Zhu, C., Luo, H., Shen, L., Gong, J., Wu, Y., Magdalou, J., Chen, L., Guo, Y., Wang, H. Two intrauterine programming mechanisms of adult hypercholesterolemia induced by prenatal nicotine exposure in male offspring rats.	[Zhou, Jin; Zhu, Chunyan; Shen, Lang; Gong, Jun; Wu, Yimeng; Guo, Yu; Wang, Hui] Wuhan Univ, Dept Pharmacol, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Luo, Hanwen; Chen, Liaobin] Wuhan Univ, Dept Orthoped Surg, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Magdalou, Jacques] Nancy Univ, CNRS, UMR 7561, Vandoeuvre Les Nancy, France; [Chen, Liaobin; Guo, Yu; Wang, Hui] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Guo, Y; Wang, H (corresponding author), Wuhan Univ, Dept Pharmacol, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	guoy@whu.edu.cn; wanghui19@whu.edu.cn			National Natural Science Foundation of China [81673524, 81220108026, 81430089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the help provided by G. H. Zhang (Zhongnan Hospital, Wuhan University) and L. T. Yu (Basic Medical School, Wuhan University) during the revision process. The authors are grateful to staff of the Center for Animal Experiment of Wuhan University. This work was supported by the National Natural Science Foundation of China (Grants 81673524, 81220108026, and 81430089). The authors declare no conflicts of interest.	Akhtar S, 2015, PAK J PHARM SCI, V28, P2273; Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Amigo H, 2010, J EPIDEMIOL COMMUN H, V64, P855, DOI 10.1136/jech.2008.078345; Baardman ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.003; Bao W, 2016, INT J EPIDEMIOL, V45, P160, DOI 10.1093/ije/dyv334; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Barouki R, 2018, ENVIRON INT, V114, P77, DOI 10.1016/j.envint.2018.02.014; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Baumann M, 2013, PLACENTA, V34, P1079, DOI 10.1016/j.placenta.2013.06.309; Busada JT, 2017, CURR TOP DEV BIOL, V125, P147, DOI 10.1016/bs.ctdb.2016.12.004; Chen CJ, 2008, EUR J PHARMACOL, V591, P36, DOI 10.1016/j.ejphar.2008.06.041; Chen LH, 2017, J CHIN MED ASSOC, V80, P44, DOI 10.1016/j.jcma.2016.08.001; Chen M, 2007, EXP TOXICOL PATHOL, V59, P245, DOI 10.1016/j.etp.2007.05.007; Cong RH, 2012, J NUTR BIOCHEM, V23, P1647, DOI 10.1016/j.jnutbio.2011.11.007; Pereira PPD, 2017, NICOTINE TOB RES, V19, P497, DOI 10.1093/ntr/ntw228; Delpisheh A, 2006, WOMENS HEALTH, V2, P389, DOI 10.2217/17455057.2.3.389; Driver PM, 2001, MOL HUM REPROD, V7, P357, DOI 10.1093/molehr/7.4.357; Engelbregt MJT, 2001, PEDIATR RES, V50, P474, DOI 10.1203/00006450-200110000-00009; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Feng JH, 2014, MOL CELL ENDOCRINOL, V394, P59, DOI 10.1016/j.mce.2014.06.016; Formisano L, 2015, J NEUROSCI, V35, P7332, DOI 10.1523/JNEUROSCI.2174-14.2015; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Grefhorst A, 2012, ATHEROSCLEROSIS, V222, P382, DOI 10.1016/j.atherosclerosis.2012.02.014; Hadidi KA, 2004, SAUDI MED J, V25, P912; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; He X, 2017, ARCH TOXICOL, V91, P3927, DOI 10.1007/s00204-017-1996-8; He Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14881-0; Hochberg Z, 2002, HORM RES, V58, P33, DOI 10.1159/000064764; Hong LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20503; Huang HG, 2015, TOXICOL APPL PHARM, V288, P84, DOI 10.1016/j.taap.2015.07.005; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jaddoe VWV, 2008, ATHEROSCLEROSIS, V196, P42, DOI 10.1016/j.atherosclerosis.2007.01.032; Knopik VS, 2016, BEHAV GENET, V46, P353, DOI 10.1007/s10519-015-9750-6; Koch S, 2012, Z GEBURTSH NEONATOL, V216, P77, DOI [10.1055/s-0032-1308958, 10.1055/s-0032-1309153]; Kuchmin A N, 2010, Voen Med Zh, V331, P25; Kumar P, 2014, J BIOL CHEM, V289, P6991, DOI 10.1074/jbc.M113.511444; Li JN, 2013, J CLIN ENDOCR METAB, V98, pE1189, DOI 10.1210/jc.2012-4291; Liang G, 2011, EXP TOXICOL PATHOL, V63, P607, DOI 10.1016/j.etp.2010.04.015; Liu L, 2012, TOXICOL LETT, V214, P307, DOI 10.1016/j.toxlet.2012.09.001; Liu MX, 2017, ACTA PHARMACOL SIN, V38, P660, DOI 10.1038/aps.2016.158; Liu XM, 2014, J CLIN BIOCHEM NUTR, V55, P40, DOI 10.3164/jcbn.13-100; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Martino F, 2016, J CARDIOVASC MED, V17, P539, DOI 10.2459/JCM.0000000000000334; Mauvais-Jarvis F, 2017, CELL METAB, V25, P1216, DOI 10.1016/j.cmet.2017.04.033; Nikkila K, 2014, AM J TRANSPLANT, V14, P2898, DOI 10.1111/ajt.12961; Ono K, 2012, J CARDIOL, V60, P339, DOI 10.1016/j.jjcc.2012.07.014; Ozkan H, 1999, BIOL NEONATE, V76, P274, DOI 10.1159/000014169; Pecks Ulrich, 2013, Pregnancy Hypertens, V3, P78, DOI 10.1016/j.preghy.2013.04.059; Pecks U, 2012, J PERINAT MED, V40, P287, DOI [10.1515/jpm.2011.135, 10.1515/JPM.2011.135]; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Restrepo MC, 2009, CAD SAUDE PUBLICA, V25, P2345, DOI 10.1590/S0102-311X2009001100005; Rosengren L, 2005, J BIOMOL SCREEN, V10, P260, DOI 10.1177/1087057104273802; Shen L, 2014, TOXICOL APPL PHARM, V274, P263, DOI 10.1016/j.taap.2013.11.009; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Succurro E, 2010, EUR J ENDOCRINOL, V163, P75, DOI 10.1530/EJE-10-0113; Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007; Tie K, 2016, REPROD TOXICOL, V60, P11, DOI 10.1016/j.reprotox.2015.12.010; Trapani L, 2012, WORLD J HEPATOL, V4, P184, DOI 10.4254/wjh.v4.i6.184; Venkatesan N, 2003, EUR J NUTR, V42, P262, DOI 10.1007/s00394-003-0420-8; Wadsack C, 2007, AM J PHYSIOL-ENDOC M, V292, pE476, DOI 10.1152/ajpendo.00547.2005; Wang LL, 2014, TOXICOL LETT, V224, P311, DOI 10.1016/j.toxlet.2013.11.006; Wang T, 2009, ENVIRON TOXICOL, V24, P33, DOI 10.1002/tox.20391; Wen YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107024; Wu JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE1087, DOI 10.1152/ajpendo.1999.277.6.E1087; Xu D, 2012, TOXICOL LETT, V209, P282, DOI 10.1016/j.toxlet.2012.01.006; Xu D, 2015, TOXICOL RES-UK, V4, P112, DOI 10.1039/c4tx00092g; Xu D, 2013, ACTA PHARMACOL SIN, V34, P1526, DOI 10.1038/aps.2013.171; Yang F, 2016, BBA-MOL CELL BIOL L, V1861, P1066, DOI 10.1016/j.bbalip.2016.06.001; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017; Zhang YL, 2018, DESTECH TRANS SOC, P60; Zhao Q, 2004, J BIOL CHEM, V279, P41477, DOI 10.1074/jbc.M405129200; Zwier MV, 2017, ACTA PHYSIOL, V220, P471, DOI 10.1111/apha.12845	76	14	14	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1110	1123		10.1096/fj.201800172R	http://dx.doi.org/10.1096/fj.201800172R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113880				2022-12-28	WOS:000457401500088
J	Keller, M; Klos, M; Rohde, K; Kruger, J; Kurze, T; Dietrich, A; Schon, MR; Gartner, D; Lohmann, T; Dressler, M; Stumvoll, M; Bluher, M; Kovacs, P; Bottcher, Y				Keller, Maria; Kloes, Matthias; Rohde, Kerstin; Krueger, Jacqueline; Kurze, Tabea; Dietrich, Arne; Schoen, Michael R.; Gaertner, Daniel; Lohmann, Tobias; Dressler, Miriam; Stumvoll, Michael; Blueher, Matthias; Kovacs, Peter; Boettcher, Yvonne			DNA methylation of SSPN is linked to adipose tissue distribution and glucose metabolism	FASEB JOURNAL			English	Article						Sarcospan; waist; waist-to-hip ratio; non-CpG methylation	PROMOTER METHYLATION; MUSCULAR-DYSTROPHY; CPG METHYLATION; SARCOSPAN; UTROPHIN; EXPRESSION; GENES; RISK	DNA methylation is a crucial epigenetic mechanism in obesity and fat distribution. We explored the Sarcospan (SSPN) gene locus by using genome-wide data sets comprising methylation and expression data, pyrosequencing analysis in the promoter region, and genetic analysis of an SNP variant rs718314, which was previously reported to associate with waist-to-hip ratio. We found that DNA methylation influences several clinical variables related to fat distribution and glucose metabolism, while SSPN mRNA levels showed directionally opposite effects on these traits. Complete DNA methylation of the SSPN promoter construct suppressed the gene expression of firefly luciferase in MCF7 cells. Moreover, rs718314 was associated with waist and with DNA methylation at CpG sites. Our data strongly support the role of the SSPN locus in body fat composition and glucose homeostasis, and suggest that this is most likely the result of changes in DNA methylation of SSPN in adipose tissue.Keller, M., Klos, M., Rohde, K., Kruger, J., Kurze, T., Dietrich, A., Schon, M. R., Gartner, D., Lohmann, T., Dre ss ler, M., Stumvoll, M., Bluher, M., Kovacs, P., Bottcher, Y. DNA methylation of SSPN is linked to adipose tissue distribution and glucose metabolism.	[Keller, Maria; Kloes, Matthias; Rohde, Kerstin; Kurze, Tabea; Kovacs, Peter; Boettcher, Yvonne] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Krueger, Jacqueline; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Dietrich, Arne] Univ Leipzig, Dept Surg, Leipzig, Germany; [Keller, Maria] Lund Univ, Ctr Diabet, Skane Univ Hosp, Genet & Mol Epidemiol Unit,Dept Clin Sci, Malmo, Sweden; [Kloes, Matthias] UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany; [Rohde, Kerstin; Boettcher, Yvonne] Univ Oslo, Akershus Univ Hosp, Inst Clin Med, Sykehusveien 25, N-1478 Lorenskog, Norway; [Schoen, Michael R.; Gaertner, Daniel] Stadt Klinikum Karlsruhe, Clin Visceral Surg, Karlsruhe, Germany; [Lohmann, Tobias; Dressler, Miriam] Municipal Clin Dresden Neustadt, Dresden, Germany	Leipzig University; Leipzig University; Leipzig University; Lund University; Skane University Hospital; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Oslo; Municipal Hospital Karlsruhe	Bottcher, Y (corresponding author), Univ Oslo, Akershus Univ Hosp, Inst Clin Med, Sykehusveien 25, N-1478 Lorenskog, Norway.; Kovacs, P (corresponding author), Univ Leipzig, IFB Adipos Dis, D-04103 Leipzig, Germany.	peter.kovacs@medizin.uni-leipzig.de; yvonne.bottcher@medisin.uio.no	Stumvoll, Michael/ABE-1121-2021; Keller, Maria/AAD-4877-2020	Stumvoll, Michael/0000-0001-6225-8240; Herold, Jacqueline/0000-0003-3059-0374; Kovacs, Peter/0000-0002-0290-5423; Klos, Matthias/0000-0002-9620-1506	Integrated Research and Treatment Center (IFB) AdiposityDiseases [ADI-K50D, K7-45, ADI-K6e-97, AD2-06E99]; Deutsche Forschungsgemeinschaft Goethe-Zentrum Hyderabad [KE 2182/1-1]; European Union (EU)-Scientia Fellowship from the University of Oslo; EU Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) [609020]; Federal Ministry of Education and Research (BMBF), Germany [FKZ 01EO1501]; Kompetenznetz Adipositas (Competence Network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank) [FKZ 01GI1128]; Deutsche Forschungsgemeinschaft [1052/2];  [ADI-K7-39];  [ADI-K6e-96]	Integrated Research and Treatment Center (IFB) AdiposityDiseases; Deutsche Forschungsgemeinschaft Goethe-Zentrum Hyderabad(German Research Foundation (DFG)); European Union (EU)-Scientia Fellowship from the University of Oslo; EU Seventh Framework Programme (FP7-PEOPLE-2013-COFUND); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Kompetenznetz Adipositas (Competence Network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	The authors thank I. Lehmann [Helmholtz-Centre for Environmental Research (UFZ)] for providing access to the PyroMark Q48 Autoprep (Qiagen, Germantown, MD, USA) to measure non-CpG methylation. The authors further thank L. Hopp and H. Binder (Interdisciplinary Centre for Bioinformatics, University of Leipzig) for preprocessing the promoter-wide methylation and mRNA expression data. This work was supported, in part, by a research grant from the Integrated Research and Treatment Center (IFB) AdiposityDiseases ADI-K50D, K7-45, ADI-K6e-97, and AD2-06E99; M.K. was funded by ADI-K7-39 (to Y.B.), and by a research fellowship from the Deutsche Forschungsgemeinschaft Goethe-Zentrum Hyderabad (GZ) (KE 2182/1-1). K.R. was funded by ADI-K6e-96 (to Y.B.), and by a European Union (EU)-Scientia Fellowship from the University of Oslo (to K.R.). The research leading to the results has received funding from the EU Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) under Agreement n609020-Scientia Fellows. IFB AdiposityDiseases is supported by the Federal Ministry of Education and Research (BMBF), Germany (FKZ 01EO1501). This work was further supported by the Kompetenznetz Adipositas (Competence Network for Obesity), funded by the Federal Ministry of Education and Research (German Obesity Biomaterial Bank; FKZ 01GI1128) to M.B. Further support was obtained from the Deutsche Forschungsgemeinschaft for a Collaborative Research Center (CRC; 1052/2): Obesity Mechanisms (B1 to M.B.; B3 to P.K.; and A1 to M.S.). The authors declare no conflicts of interest.	Alvarez-Llamas G, 2007, MOL CELL PROTEOMICS, V6, P589, DOI 10.1074/mcp.M600265-MCP200; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Crosbie RH, 1997, J BIOL CHEM, V272, P31221, DOI 10.1074/jbc.272.50.31221; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Keller M, 2017, MOL METAB, V6, P86, DOI 10.1016/j.molmet.2016.11.003; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu CT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003681; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Marshall JL, 2015, HUM MOL GENET, V24, P2011, DOI 10.1093/hmg/ddu615; Marshall JL, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-1; Marshall JL, 2012, J CELL BIOL, V197, P1009, DOI 10.1083/jcb.201110032; Peter AK, 2008, J CELL BIOL, V183, P419, DOI 10.1083/jcb.200808027; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; R Development Core Team, 2016, R LANG ENV STAT COMP; Rohde K, 2014, J MOL MED, V92, P881, DOI 10.1007/s00109-014-1154-1; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Alvarez MS, 2014, BIOCHEM BIOPH RES CO, V447, P51, DOI 10.1016/j.bbrc.2014.03.104; Voisin S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0225-4; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhou X, 2015, NAT BIOTECHNOL, V33, P345, DOI 10.1038/nbt.3158; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	28	2	3	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6898	6910		10.1096/fj.201800528R	http://dx.doi.org/10.1096/fj.201800528R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29932866	Green Submitted			2022-12-28	WOS:000449359700042
J	Sheng, LL; Jena, PK; Liu, HX; Hu, Y; Nagar, N; Bronner, DN; Settles, ML; Baumler, AJ; Wan, YJY				Sheng, Lili; Jena, Prasant Kumar; Liu, Hui-Xin; Hu, Ying; Nagar, Nidhi; Bronner, Denise N.; Settles, Matthew L.; Baumler, Andreas J.; Wan, Yu-Jui Yvonne			Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila	FASEB JOURNAL			English	Article						tea; catechin; probiotics; gut microbiota; bile acid receptor	FARNESOID X RECEPTOR; GREEN TEA POLYPHENOL; DIET-INDUCED OBESITY; FATTY LIVER-DISEASE; GUT MICROBIOME; FOOD-INTAKE; HEPATIC INFLAMMATION; TARGETED DISRUPTION; GLUCOSE-HOMEOSTASIS; NUCLEAR RECEPTOR	Dysregulated bile acid (BA) synthesis is accompanied by dysbiosis, leading to compromised metabolism. This study analyzes the effect of epigallocatechin-3-gallate (EGCG) on diet-induced obesity through regulation of BA signaling and gut microbiota. The data revealed that EGCG effectively reduced diet-increased obesity, visceral fat, and insulin resistance. Gene profiling data showed that EGCG had a significant impact on regulating genes implicated in fatty acid uptake, adipogenesis, and metabolism in the adipose tissue. In addition, metabolomics analysis revealed that EGCG altered the lipid and sugar metabolic pathways. In the intestine, EGCG reduced the FXR agonist chenodeoxycholic acid, as well as the FXR-regulated pathway, suggesting intestinal FXR deactivation. However, in the liver, EGCG increased the concentration of FXR and TGR-5 agonists and their regulated signaling. Furthermore, our data suggested that EGCG activated Takeda G protein receptor (TGR)-5 based on increased GLP-1 release and elevated serum PYY level. EGCG and antibiotics had distinct antibacterial effects. They also differentially altered body weight and BA composition. EGCG, but not antibiotics, increased Verrucomicrobiaceae, under which EGCG promoted intestinal bloom of Akkermansia muciniphila. Excitingly, A. muciniphila was as effective as EGCG in treating diet-induced obesity. Together, EGCG shifts gut microbiota and regulates BA signaling thereby having a metabolic beneficial effect.Sheng, L., Jena, P. K., Liu, H.-X., Hu, Y., Nagar, N., Bronner, D. N., Settles, M. L., Baumler, A. J., Wan, Y.-J. Y. Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila.	[Sheng, Lili; Jena, Prasant Kumar; Liu, Hui-Xin; Hu, Ying; Nagar, Nidhi; Wan, Yu-Jui Yvonne] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Bronner, Denise N.; Baumler, Andreas J.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Settles, Matthew L.] Univ Calif Davis, Bioinformat Core Facil Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Wan, YJY (corresponding author), Univ Calif Davis Hlth Syst, Dept Pathol & Lab Med, Room 3400B,Res Bldg 3,4645 2nd Ave, Sacramento, CA 95817 USA.	yjywan@ucdavis.edu	Baumler, Andreas J/H-2301-2011; Jena, Prasant Kumar/L-4339-2017	Baumler, Andreas J/0000-0001-9152-7809; Jena, Prasant Kumar/0000-0002-6729-5881; Liu, Hui-Xin/0000-0002-8981-9981	NIH National Cancer Institute [U01CA179582, R01CA222490]; NATIONAL CANCER INSTITUTE [R01CA222490, U01CA179582] Funding Source: NIH RePORTER	NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Frank J. Gonzalez [U.S. National Institutes of Health (NIH) National Cancer Institute] for providing FXR KO mice, and Dr. Mel Campbell (University of California, Davis) for editing the manuscript. This study was supported by NIH National Cancer Institute Grants U01CA179582 and R01CA222490 (to Y.-J. Y. Wan). The authors declare no conflicts of interest.	Adachi H, 2011, BIOCHEM BIOPH RES CO, V409, P177, DOI 10.1016/j.bbrc.2011.04.110; [Anonymous], MOL NUTR FOOD RES; Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; Bertaggia E, 2017, AM J PHYSIOL-ENDOC M, V313, pE121, DOI 10.1152/ajpendo.00409.2016; Bonen A, 2006, INT J OBESITY, V30, P877, DOI 10.1038/sj.ijo.0803212; Bush KT, 2017, J BIOL CHEM, V292, P15789, DOI 10.1074/jbc.M117.796516; Chen XS, 2011, EXP DIABETES RES, DOI 10.1155/2011/853501; Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016; Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534; DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259; DELZENNE NM, 1992, TOXICOL LETT, V61, P291, DOI 10.1016/0378-4274(92)90156-E; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Duboc H, 2014, DIGEST LIVER DIS, V46, P302, DOI 10.1016/j.dld.2013.10.021; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Guo C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00646; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Hayes MR, 2014, ANNU REV NUTR, V34, P237, DOI 10.1146/annurev-nutr-071812-161201; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jang HJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1444, DOI 10.1152/ajpendo.00434.2013; Jena PK, 2017, AM J PATHOL, V187, P1800, DOI 10.1016/j.ajpath.2017.04.019; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kim HM, 2013, DIABETES METAB J, V37, P173, DOI 10.4093/dmj.2013.37.3.173; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kurylowicz A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0395-2; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee MS, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1325307; Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li GD, 2012, TOXICOL APPL PHARM, V258, P268, DOI 10.1016/j.taap.2011.11.006; Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Liu HX, 2015, J HEPATOL, V63, P1502, DOI 10.1016/j.jhep.2015.08.001; Liu ZB, 2016, FOOD FUNCT, V7, P4869, DOI 10.1039/c6fo01439a; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005; Moran TH, 2005, AM J PHYSIOL-REG I, V288, pR384, DOI 10.1152/ajpregu.00535.2004; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; Pathak P, 2017, J BIOL CHEM, V292, P11055, DOI 10.1074/jbc.M117.784322; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pfalzer AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135758; Poole DP, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01487.x; Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8; Roccaro AS, 2004, ANTIMICROB AGENTS CH, V48, P1968, DOI 10.1128/AAC.48.6.1968-1973.2004; Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983; Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7; Weinreb O, 2004, J NUTR BIOCHEM, V15, P506, DOI 10.1016/j.jnutbio.2004.05.002; Williams JE, 2017, J NUTR, V147, P1739, DOI 10.3945/jn.117.248864; Wong CP, 2011, IMMUNOL LETT, V139, P7, DOI 10.1016/j.imlet.2011.04.009; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xu J, 2016, J NAT MED-TOKYO, V70, P584, DOI 10.1007/s11418-016-0980-6; Zhou H, 2015, AM J PHYSIOL-GASTR L, V308, pG863, DOI 10.1152/ajpgi.00380.2014; Zhu Y, 2011, PHARMACOL RES, V63, P259, DOI 10.1016/j.phrs.2010.12.018	79	60	65	5	111	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6371	6384		10.1096/fj.201800370R	http://dx.doi.org/10.1096/fj.201800370R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29882708	Green Published			2022-12-28	WOS:000449359700002
J	Wong, SL; Wagner, DD				Wong, Siu Ling; Wagner, Denisa D.			Peptidylarginine deiminase 4: a nuclear button triggering neutrophil extracellular traps in inflammatory diseases and aging	FASEB JOURNAL			English	Review						NETs; PAD4; thrombosis; cancer; diabetes	DEEP-VEIN THROMBOSIS; CIRCULATING TUMOR-CELLS; ACUTE LUNG INJURY; RISK-FACTORS; RHEUMATOID-ARTHRITIS; ISCHEMIC-STROKE; DNA TRAPS; CHROMATIN DECONDENSATION; VENOUS THROMBOEMBOLISM; HISTONE DEIMINATION	Peptidylarginine deiminase 4 (PAD4) is a nuclear citrullinating enzyme that is critically involved in the release of decondensed chromatin from neutrophils as neutrophil extracellular traps (NETs). NETs, together with fibrin, are implicated in host defense against pathogens; however, the formation of NETs (NETosis) has injurious effects that may outweigh their protective role. For example, PAD4 activity produces citrullinated neoantigens that promote autoimmune diseases, such as rheumatoid arthritis, to which PAD4 is genetically linked and where NETosis is prominent. NETs are also generated in basic sterile inflammatory responses that are induced by many inflammatory stimuli, including cytokines, hypoxia, and activated platelets. Mice that lack PAD4deficient in NETosisserve as an excellent tool with which to study the importance of NETs in disease models. In recent years, animal and human studies have demonstrated that NETs contribute to the etiology and propagation of many common noninfectious diseases, the focus of our review. We will discuss the role of NETs in thrombotic and cardiovascular disease, the induction of NETs by cancers and its implications for cancer progression and cancer-associated thrombosis, and elevated NETosis in diabetes and its negative impact on wound healing, and will propose a link between PAD4/NETs and age-related organ fibrosis. We identify unresolved issues and new research directions.Wong, S. L., Wagner, D. D. Peptidylarginine deiminase 4: a nuclear button triggering neutrophil extracellular traps in inflammatory diseases and aging.	[Wong, Siu Ling; Wagner, Denisa D.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Wagner, Denisa D.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Wong, Siu Ling; Wagner, Denisa D.] Harvard Med Sch, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Wagner, DD (corresponding author), Harvard Med Sch, Boston Childrens Hosp, 3 Blackfan Circle,Third Floor, Boston, MA 02115 USA.	denisa.wagner@childrens.harvard.edu	Wong, Siu Ling Christine/A-9895-2019	Wong, Siu Ling/0000-0002-2294-3187	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant [R35HL135765]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Deya Cherpokova and Elise DeRoo for critical reading of the manuscript, Caleb Staudinger and Sarah Walker (all from Boston Children's Hospital) for assistance in manuscript preparation. Some of the research described here was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R35HL135765 (to D.D.W.). The authors declare no conflicts of interest.	Acharya NK, 2012, J AUTOIMMUN, V38, P369, DOI 10.1016/j.jaut.2012.03.004; Akiyama K, 1999, NEUROSCI LETT, V274, P53, DOI 10.1016/S0304-3940(99)00678-3; Alexandraki KI, 2008, J CLIN IMMUNOL, V28, P314, DOI 10.1007/s10875-007-9164-1; Amulic B, 2017, DEV CELL, V43, P449, DOI 10.1016/j.devcel.2017.10.013; Asaga H, 2002, NEUROSCI LETT, V326, P129, DOI 10.1016/S0304-3940(02)00334-8; Asaga H, 2001, NEUROSCI LETT, V299, P5, DOI 10.1016/S0304-3940(00)01735-3; Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; Bengtsson T, 2003, INT J EPIDEMIOL, V32, P286, DOI 10.1093/ije/dyg061; Berger-Achituv S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00048; Bernimoulin M, 2009, J THROMB HAEMOST, V7, P1019, DOI 10.1111/j.1538-7836.2009.03434.x; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Cakman I, 1997, J INTERF CYTOK RES, V17, P469, DOI 10.1089/jir.1997.17.469; Carestia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168647; Carmona-Rivera C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag3358; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cedervall J, 2015, CANCER RES, V75, P2653, DOI 10.1158/0008-5472.CAN-14-3299; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Demers M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1134073; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Deng YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153567; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Diaz J A, 2013, J Vasc Surg Venous Lymphat Disord, V1, DOI 10.1016/j.jvsv.2012.12.002; Du Y, 2014, CLIN EXP RHEUMATOL, V32, P377; Ducroux C, 2018, STROKE, V49, P754, DOI 10.1161/STROKEAHA.117.019896; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Dyer MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20479-x; Erpenbeck L, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140293; Etulain J, 2015, BLOOD, V126, P242, DOI 10.1182/blood-2015-01-624023; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Falange A, 2017, CRIT REV ONCOL HEMAT, V118, P79, DOI 10.1016/j.critrevonc.2017.08.003; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gaertner F, 2016, SEMIN IMMUNOL, V28, P561, DOI 10.1016/j.smim.2016.10.010; Gavillet M, 2018, AM J HEMATOL, V93, P269, DOI 10.1002/ajh.24970; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Gong L, 2012, PATHOL ONCOL RES, V18, P989, DOI 10.1007/s12253-012-9531-y; Gourdie RG, 2016, NAT REV DRUG DISCOV, V15, P620, DOI 10.1038/nrd.2016.89; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta S, 2016, NAT REV NEPHROL, V12, P402, DOI 10.1038/nrneph.2016.71; HACBARTH E, 1986, ARTHRITIS RHEUM-US, V29, P1334, DOI 10.1002/art.1780291105; Hawes M, 2016, ANNU REV PHYTOPATHOL, V54, P143, DOI 10.1146/annurev-phyto-080615-100140; Hawes MC, 2015, CANCER RES, V75, P4260, DOI 10.1158/0008-5472.CAN-15-1546; Hell L, 2016, THROMB RES, V140, pS174, DOI 10.1016/S0049-3848(16)30133-5; Ho-Tin-Noe B, 2009, AM J PATHOL, V175, P1699, DOI 10.2353/ajpath.2009.090460; Honda M, 2018, NAT REV GASTRO HEPAT, V15, P206, DOI 10.1038/nrgastro.2017.183; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Jimenez-Alcazar M, 2015, J THROMB HAEMOST, V13, P732, DOI 10.1111/jth.12796; Jimenez-Alcazar M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191150; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; Joshi MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep36362; Kanamaru R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19091-2; Karima M, 2005, J LEUKOCYTE BIOL, V78, P862, DOI 10.1189/jlb.1004583; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/eLife.24437, 10.7554/elife.24437]; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; Lang JC, 2017, APPL MICROBIOL BIOT, V101, P7653, DOI 10.1007/s00253-017-8480-5; Laridan E, 2017, ANN NEUROL, V82, P223, DOI 10.1002/ana.24993; Leal AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06893-7; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lim MBH, 2011, J LEUKOCYTE BIOL, V90, P771, DOI 10.1189/jlb.1010549; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090042; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Oyarzun CPM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38738; Martinod K, 2016, J THROMB HAEMOST, V14, P551, DOI 10.1111/jth.13239; Martinod K, 2017, J EXP MED, V214, P439, DOI 10.1084/jem.20160530; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mastronardi FG, 2006, J NEUROSCI, V26, P11387, DOI 10.1523/JNEUROSCI.3349-06.2006; Mauracher LM, 2018, J THROMB HAEMOST, V16, P508, DOI 10.1111/jth.13951; Menegazzo L, 2015, ACTA DIABETOL, V52, P497, DOI 10.1007/s00592-014-0676-x; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Miyoshi A, 2016, PATHOBIOLOGY, V83, P243, DOI 10.1159/000444881; Mizugishi K, 2017, FASEB J, V31, P5577, DOI 10.1096/fj.201700399RR; Morel O, 2013, SEMIN THROMB HEMOST, V39, P477, DOI 10.1055/s-0033-1343888; Mulder HD, 2015, J CRIT CARE, V30, P55, DOI 10.1016/j.jcrc.2014.10.005; Najmeh S, 2017, INT J CANCER, V140, P2321, DOI 10.1002/ijc.30635; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Novotny J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190728; Okubo K, 2018, NAT MED, V24, P232, DOI 10.1038/nm.4462; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Park JH, 2016, EXP CLIN ENDOCR DIAB, V124, P557, DOI 10.1055/s-0042-101792; Park J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1711; Podaza E, 2017, CANCER IMMUNOL IMMUN, V66, P77, DOI 10.1007/s00262-016-1921-7; Razak NA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030487; Reyes-Castillo Z, 2015, CLIN EXP IMMUNOL, V182, P119, DOI 10.1111/cei.12677; Rocha BC, 2015, CELL REP, V13, P2829, DOI 10.1016/j.celrep.2015.11.055; Rosenstein MG, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.014; Rossaint J, 2014, BLOOD, V123, P2573, DOI 10.1182/blood-2013-07-516484; Savchenko AS, 2014, J THROMB HAEMOST, V12, P860, DOI 10.1111/jth.12571; Savchenko AS, 2014, BLOOD, V123, P141, DOI 10.1182/blood-2013-07-514992; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Sollberger G, 2018, DEV CELL, V44, P542, DOI 10.1016/j.devcel.2018.01.019; Sorvillo N., 2017, RES PRACT THROMB HAE, V1, P254; Spengler J, 2015, ARTHRITIS RHEUMATOL, V67, P3135, DOI 10.1002/art.39313; Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305; Stavrou EX, 2018, J CLIN INVEST, V128, P944, DOI 10.1172/JCI92880; Stephen J, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0001-5; Stoikou M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00702; Sur Chowdhury Chanchal, 2014, Arthritis Res Ther, V16, pR122, DOI 10.1186/ar4579; Tariket S, 2016, EXPERT REV HEMATOL, V9, P497, DOI 10.1586/17474086.2016.1152177; Thalin C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191231; Thalin C, 2016, THROMB RES, V139, P56, DOI 10.1016/j.thromres.2016.01.009; Thomas GM, 2015, J THROMB HAEMOST, V13, P1310, DOI 10.1111/jth.13002; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Tilvawala R, 2018, CELL CHEM BIOL, V25, P691, DOI 10.1016/j.chembiol.2018.03.002; Tohme S, 2016, CANCER RES, V76, P1367, DOI 10.1158/0008-5472.CAN-15-1591; Tran TM, 2016, ENVIRON MICROBIOL, V18, P4103, DOI 10.1111/1462-2920.13446; Ueki S, 2016, J ALLERGY CLIN IMMUN, V137, P258, DOI 10.1016/j.jaci.2015.04.041; Valles J, 2017, THROMB HAEMOSTASIS, V117, P1919, DOI 10.1160/TH17-02-0130; van Montfoort ML, 2013, ARTERIOSCL THROM VAS, V33, P147, DOI 10.1161/ATVBAHA.112.300498; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wang YD, 2014, DIABETES, V63, P4239, DOI 10.2337/db14-0480; Wen FS, 2009, PLANT PHYSIOL, V151, P820, DOI 10.1104/pp.109.142067; White PC, 2016, J DENT RES, V95, P26, DOI 10.1177/0022034515609097; Wolach O, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8292; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Yang CF, 2015, INT J CLIN EXP PATHO, V8, P14075; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zhong XY, 2001, AM J OBSTET GYNECOL, V184, P414, DOI 10.1067/mob.2001.109594	141	59	59	2	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6358	6370		10.1096/fj.201800691R	http://dx.doi.org/10.1096/fj.201800691R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29924943	Green Published, Bronze			2022-12-28	WOS:000449359700001
J	Ghavampour, S; Kleefeldt, F; Bommel, H; Volland, J; Paus, A; Horst, A; Pfeiffer, V; Hubner, S; Wagner, N; Rueckschloss, U; Ergun, S				Ghavampour, Sharang; Kleefeldt, Florian; Boemmel, Heike; Volland, Julian; Paus, Alexander; Horst, Andrea; Pfeiffer, Verena; Huebner, Stefan; Wagner, Nicole; Rueckschloss, Uwe; Erguen, Sueleyman			Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling	FASEB JOURNAL			English	Article						atherosclerosis; eNOS; adherence; endothelial dysfunction; vascular permeability	CELL-ADHESION MOLECULE-1; NITRIC-OXIDE SYNTHASE; TYROSINE PHOSPHORYLATION; TNF-ALPHA; IN-VITRO; CEACAM1; GLYCOCALYX; EXPRESSION; CADHERIN; CONTRIBUTES	Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is known to be crucial to vasculogenesis and angiogenesis. Recently, CEACAM1 deficiency was shown to result in the formation of aortic plaque-like lesions, indicating a role for CEACAM1 in adult vessels as well. The underlying mechanisms remained largely elusive. Therefore, we aimed to elucidate the role of CEACAM1 in endothelial homeostasis. Here, we show that CEACAM1 deficiency causes subcellular eNOS redistribution in endothelial cells (i.e., by eNOS depalmitoylation) and alters endothelial glycocalyx that confers antiadhesive properties to the endothelium (i.e., by repression of glycocalyx-degrading enzymes). Accordingly, our analysis revealed an increased leukocyte-endothelial interaction in CEACAM1-deficient endothelium. In addition, CEACAM1 age dependently modulated basal and TNF--mediated endothelial barrier (EB) leakiness. In younger mice, CEACAM1 was protective for EB, whereas in aged mice it promoted EB leakiness. EB function depends on interendothelial adherence junctions formed by -catenin/vascular endothelial-cadherin complexes. We show here that CEACAM1 influenced basal and TNF--mediated phosphorylation of -catenin and caveolin-1, which are essential players in EB modulation. Both increased adhesiveness to leukocytes and EB modulation due to CEACAM1 deficiency may facilitate inflammatory cell transmigration into the vascular wall and subsequent plaque formation. Collectively, these results identify a crucial role for CEACAM1 in endothelial homeostasis of adult blood vessels.Ghavampour, S., Kleefeldt, F., Bommel, H., Volland, J., Paus, A., Horst, A., Pfeiffer, V., Hubner, S., Wagner, N., Rueckschloss, U., Ergun, S. Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling.	[Ghavampour, Sharang; Kleefeldt, Florian; Boemmel, Heike; Volland, Julian; Pfeiffer, Verena; Huebner, Stefan; Wagner, Nicole; Rueckschloss, Uwe; Erguen, Sueleyman] Julius Maximilians Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany; [Paus, Alexander] Univ Hosp Essen, Inst Anat, Essen, Germany; [Horst, Andrea] Univ Hosp Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany	University of Wurzburg; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ergun, S (corresponding author), Julius Maximilians Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	sueleyman.erguen@uni-wuerzburg.de			Deutsche Forschungsgemeinschaft (DFG)/Collaborative Research Center [SFB688 TP A19]	Deutsche Forschungsgemeinschaft (DFG)/Collaborative Research Center(German Research Foundation (DFG))	The authors are grateful to Nadja Hohn and Tanja Metzger (Institute of Anatomy and Cell Biology, Julius-Maximilians-University Wurzburg) for excellent technical assistance. The authors thank Sonja Najjar (Ohio University, Athens, OH, USA) and Nicole Beauchemin (McGill University, Montreal, QC, Canada) for providing the Cc1<SUP>-/-</SUP> mice. The authors are grateful to Kathrin Holmes (University of Colorado, Denver, CO, USA) for providing the mouse monoclonal anti-CEACAM1 antibody and to Ralf Benndorf [Martin Luther University Halle-Wittenberg, Halle (Saale), Germany] for providing the monocytic cell line THP-1. This study was supported by the Deutsche Forschungsgemeinschaft (DFG)/Collaborative Research Center (SFB688 TP A19). U.R. and S.E. are senior authors. The authors declare no conflicts of interest.	Adam AP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/272858; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Biffl WL, 1996, J SURG RES, V63, P328, DOI 10.1006/jsre.1996.0270; Bommel H, 2017, HISTOCHEM CELL BIOL, V148, P117, DOI 10.1007/s00418-017-1562-8; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; BRUMMER J, 1995, ONCOGENE, V11, P1649; Chistiakov DA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00365; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Constantinescu AA, 2001, AM J PHYSIOL-HEART C, V280, pH1051, DOI 10.1152/ajpheart.2001.280.3.H1051; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Csiszar A, 2003, FASEB J, V17, P1183, DOI 10.1096/fj.02-1049fje; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Fiori V, 2012, ANN I SUPER SANITA, V48, P161, DOI [10.4415/ANN_12_02.09, 10.4415/ANN_12_02_09]; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Golenhofen N, 2002, HISTOCHEM CELL BIOL, V117, P203, DOI 10.1007/s00418-001-0378-7; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gu A, 2009, EXP CELL RES, V315, P1668, DOI 10.1016/j.yexcr.2009.02.026; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Jin L, 2008, EXP BIOL MED, V233, P849, DOI 10.3181/0712-RM-352; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kilic N, 2007, BLOOD, V110, P4223, DOI 10.1182/blood-2007-06-097592; Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Liu GQ, 2011, ARTERIOSCL THROM VAS, V31, P1342, DOI 10.1161/ATVBAHA.110.222208; Ludewig P, 2013, CIRC RES, V113, P1013, DOI 10.1161/CIRCRESAHA.113.301207; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1088, DOI 10.1160/TH14-04-0299; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; Najjar SM, 2013, AM J PHYSIOL-ENDOC M, V305, pE519, DOI 10.1152/ajpendo.00266.2013; Nouvion AL, 2010, J CELL SCI, V123, P4221, DOI 10.1242/jcs.073635; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Quillard T, 2015, EUR HEART J, V36, P1394, DOI 10.1093/eurheartj/ehv044; Ramnath R, 2014, FASEB J, V28, P4686, DOI 10.1096/fj.14-252221; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; Wang H, 2009, MOL ENDOCRINOL, V23, P1613, DOI 10.1210/me.2009-0115; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; ZABORSZKY L, 1989, NEUROANATOMICAL TRAC, V2, P49; Zhang Q, 2006, ARTERIOSCL THROM VAS, V26, P1015, DOI 10.1161/01.ATV.0000216044.49494.c4; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	51	16	16	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5612	5625		10.1096/fj.201800331R	http://dx.doi.org/10.1096/fj.201800331R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746166	Bronze			2022-12-28	WOS:000447972500034
J	Jia, XT; Min, L; Zhu, ST; Zhang, ST; Huang, XF				Jia, Xueting; Min, Li; Zhu, Shengtao; Zhang, Shutian; Huang, Xiaofeng			Loss of sonic hedgehog gene leads to muscle development disorder and megaesophagus in mice	FASEB JOURNAL			English	Article						esophagus; muscle transdifferentiation; proliferation; developmental biology	CELL; GROWTH; PROLIFERATION; MORPHOGENESIS; ESOPHAGUS; MATURATION; MYOGENESIS; TRACHEA; LUNG	Sonic hedgehog (Shh) is crucial for organogenesis in the foregut. This study investigated the function of Shh at the late-gestational stage; during which, the esophagus continues to differentiate. We established cytokeratin 14 (CK14)-Cre;Shh(fl/fl) mice in which the down-regulation of Shh in the epithelium occurred at approximately the same time as esophageal muscle conversion. Hematoxylin and eosin and immunohistochemical staining, with antibodies against keratin 14, Shh, patched 1 (Ptch1), Gli1, proliferating cell nuclear antigen (PCNA), -smooth muscle actin (SMA), high-molecular-weight caldesmon (hCD), myogenin, paired box 7 (Pax7), 3-tubulin, and protein gene product 9.5 (PGP9.5), was performed to detect specific tissue dysplasia. Organ culture was conducted in vitro, and total mRNA was extracted to determine the transcriptional dysregulation. The esophagus of CK14-Cre;Shh(fl/fl) mice developed into an independent tube with an obvious dilatation at postnatal d 0.5. The number of cell layers and the expression of PCNA were decreased in mutant mice, compared with those in wild-type mice. The expression of hCD declined progressively in the middle, distal, and lower esophageal sphincter levels of the mutant esophagus from embryonic d 17.5, compared with the expression in wild-type littermates. Pax7 accumulation and myogenin reduction in mutant mice indicated that esophageal skeletal-myoblast progression was blocked. RNA sequencing analysis revealed a significant down-regulation of genes involved in proliferation and muscular motivation in CK14-Cre;Shh(fl/fl) mice. Thus, loss of Shh at the late-gestational stage leads to megaesophagus with reduced proliferation and a muscle development disorder in mice.Jia, X., Min, L., Zhu, S., Zhang, S., Huang, X. Loss of sonic hedgehog gene leads to muscle development disorder and megaesophagus in mice.	[Jia, Xueting; Min, Li; Zhu, Shengtao; Zhang, Shutian] Capital Med Univ, Dept Gastroenterol,Beijing Digestive Dis Ctr, Beijing Key Lab Precancerous Les Digest Dis, Beijing Friendship Hosp,Natl Clin Res Ctr Dig Dis, 95 Yongan Rd, Beijing, Peoples R China; [Jia, Xueting; Huang, Xiaofeng] Capital Med Univ, Beijing Friendship Hosp, Dept Stomatol, 95 Yongan Rd, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, ST (corresponding author), Capital Med Univ, Dept Gastroenterol,Beijing Digestive Dis Ctr, Beijing Key Lab Precancerous Les Digest Dis, Beijing Friendship Hosp,Natl Clin Res Ctr Dig Dis, 95 Yongan Rd, Beijing, Peoples R China.; Huang, XF (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Stomatol, 95 Yongan Rd, Beijing, Peoples R China.	zhangshutian@ccmu.edu.cn; huangxf1998@163.com	Min, Li/AAG-2088-2021; Jia, Xueting/AAG-5054-2020; Min, Li/T-8107-2018	Min, Li/0000-0001-9595-5536; Min, Li/0000-0001-9595-5536	National Natural Science Foundation of China [81170943]; Natural Science Foundation of Beijing Municipality [7162053]; Funding Program for Excellent Talents of Beijing [2017000021469G212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Funding Program for Excellent Talents of Beijing	The authors thank Yang Chai (University of Southern California, Los Angeles, Los Angeles, CA, USA), for providing CK14-Cre and Shh<SUP>fl/fl</SUP> transgenic mice, and Dr. Guangyong Chen (Capital Medical University, Beijing, China) for technical assistance with histologic analysis. In addition, the authors thank Qiping Luo (Ant Financial Services Group, Beijing, China) for his kind support in figure preparation. This work was supported by the National Natural Science Foundation of China (81170943), the Natural Science Foundation of Beijing Municipality (7162053 to X.H.), and the Funding Program for Excellent Talents of Beijing (2017000021469G212 to L.M.). The authors declare no conflicts of interest.	Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bren-Mattison Y, 2011, DEV BIOL, V356, P486, DOI 10.1016/j.ydbio.2011.06.002; Buller NVJA, 2015, GASTROENTEROLOGY, V148, P170, DOI 10.1053/j.gastro.2014.10.006; Cao M, 2010, DIFFERENTIATION, V79, P244, DOI 10.1016/j.diff.2010.02.002; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DeSouza KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053675; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dionyssiou MG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-7; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feng R, 2012, VITAM HORM, V88, P473, DOI 10.1016/B978-0-12-394622-5.00021-3; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Huber PAJ, 1997, INT J BIOCHEM CELL B, V29, P1047, DOI 10.1016/S1357-2725(97)00004-6; Ioannides AS, 2003, J PEDIATR SURG, V38, P29, DOI 10.1053/jpsu.2003.50005; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Kahane N, 2013, DEVELOPMENT, V140, P1740, DOI 10.1242/dev.092726; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Nagy N, 2016, DEVELOPMENT, V143, P264, DOI 10.1242/dev.128132; NEUHUBER WL, 2006, ADV ANAT EMBRYOL CEL, V185, P1; Palmieri O, 2016, SCI REP-UK, V6, DOI 10.1038/srep31549; Parakati R, 2013, J BIOL CHEM, V288, P13876, DOI 10.1074/jbc.M113.457648; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rishniw M, 2009, CELLS TISSUES ORGANS, V189, P410, DOI 10.1159/000155225; Romer AI, 2013, J CELL BIOL, V201, P309, DOI 10.1083/jcb.201301005; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; van Dop WA, 2013, GUT, V62, P348, DOI 10.1136/gutjnl-2011-301141; Wang DH, 2014, J CLIN INVEST, V124, P3767, DOI 10.1172/JCI66603; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Yang CC, 2012, EMBO J, V31, P1739, DOI 10.1038/emboj.2012.24; Yu WY, 2005, DEV BIOL, V284, P157, DOI 10.1016/j.ydbio.2005.04.042; Zhao WF, 2000, DEV DYNAM, V219, P10, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1029>3.0.CO;2-2; Zizer E, 2010, GASTROENTEROLOGY, V139, P1344, DOI 10.1053/j.gastro.2010.06.041	43	3	3	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5703	5715		10.1096/fj.201701581R	http://dx.doi.org/10.1096/fj.201701581R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29768039	Bronze			2022-12-28	WOS:000447972500041
J	Kokate, SB; Dixit, P; Das, L; Rath, S; Roy, AD; Poirah, I; Chakraborty, D; Rout, N; Singh, SP; Bhattacharyya, A				Kokate, Shrikant Babanrao; Dixit, Pragyesh; Das, Lopamudra; Rath, Suvasmita; Roy, Arjama Dhar; Poirah, Indrajit; Chakraborty, Debashish; Rout, Niranjan; Singh, Shivaram Prasad; Bhattacharyya, Asima			Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells	FASEB JOURNAL			English	Article						E3 ubiquitin ligase; hypoxia-inducible factor; cancer invasiveness; post-translational modification; proteasomal degradation	HYPOXIA-INDUCIBLE FACTOR; UBIQUITIN LIGASE SIAH2; PROLYL-HYDROXYLASES; TRANSCRIPTIONAL ACTIVITY; CARCINOMA CELLS; HIF-ALPHA; HIF-1-ALPHA; ACTIVATION; EXPRESSION; PROTEIN	Gastric epithelial cells infected with Helicobacter pylori acquire highly invasive and metastatic characteristics. The seven in absentia homolog (Siah)2, an E3 ubiquitin ligase, is one of the major proteins that induces invasiveness of infected gastric epithelial cells. We find that p300-driven acetylation of Siah2 at lysine 139 residue stabilizes the molecule in infected cells, thereby substantially increasing its efficiency to degrade prolyl hydroxylase (PHD)3 in the gastric epithelium. This enhances the accumulation of an oncogenic transcription factor hypoxia-inducible factor 1 (Hif1) in H. pylori-infected gastric cancer cells in normoxic condition and promotes invasiveness of infected cells. Increased acetylation of Siah2, Hif1 accumulation, and the absence of PHD3 in the infected human gastric metastatic cancer biopsy samples and in invasive murine gastric cancer tissues further confirm that the acetylated Siah2 (ac-Siah2)-Hif1 axis is crucial in promoting gastric cancer invasiveness. This study establishes the importance of a previously unrecognized function of ac-Siah2 in regulating invasiveness of H. pylori-infected gastric epithelial cells.Kokate, S. B., Dixit, P., Das, L., Rath, S., Roy, A. D., Poirah, I., Chakraborty, D., Rout, N., Singh, S. P., Bhattacharyya, A. Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells.	[Kokate, Shrikant Babanrao; Dixit, Pragyesh; Das, Lopamudra; Rath, Suvasmita; Roy, Arjama Dhar; Poirah, Indrajit; Chakraborty, Debashish; Bhattacharyya, Asima] HBNI, Natl Inst Sci Educ & Res NISER Bhubaneswar, Sch Biol Sci, PO Bhimpur Padanpur,Via Jatni, Bhubaneswar 752050, Odisha, India; [Rout, Niranjan] Acharya Harihar Reg Canc Ctr, Dept Oncopathol, Cuttack, Odisha, India; [Singh, Shivaram Prasad] Srirama Chandra Bhanja SCB Med Coll, Dept Gastroenterol, Cuttack, Odisha, India	Homi Bhabha National Institute; National Institute of Science Education & Research (NISER); Srirama Chandra Bhanja Medical College & Hospital	Bhattacharyya, A (corresponding author), HBNI, Natl Inst Sci Educ & Res NISER Bhubaneswar, Sch Biol Sci, PO Bhimpur Padanpur,Via Jatni, Bhubaneswar 752050, Odisha, India.	asima@niser.ac.in	Singh, Shivaram Prasad/AAR-1521-2020; Rath, Suvasmita/N-7915-2017; Bhattacharyya, Asima/J-7423-2012	Singh, Shivaram Prasad/0000-0002-8197-2674; Rath, Suvasmita/0000-0001-8738-1560; Bhattacharyya, Asima/0000-0001-7292-6644; Rout, Niranjan/0000-0002-8501-5994; Dixit, Pragyesh/0000-0001-6907-3767; Kokate, Shrikant/0000-0002-6274-537X	Indian Department of Biotechnology [BT/PR15092/GBD/27/311/2011]; Indian Science and Engineering Research Board [SB/SO/BB-0015/2014]; Indian Department of Atomic Energy (DAE)	Indian Department of Biotechnology; Indian Science and Engineering Research Board; Indian Department of Atomic Energy (DAE)	This work was supported by the Indian Department of Biotechnology (BT/PR15092/GBD/27/311/2011), and by the Indian Science and Engineering Research Board (SB/SO/BB-0015/2014) (to A.B.). S.B.K., P.D., A.D.R., I.P., and D.C. are supported by fellowships from Indian Department of Atomic Energy (DAE). The authors declare no conflicts of interest.	Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Anavi S, 2014, FREE RADICAL BIO MED, V71, P61, DOI 10.1016/j.freeradbiomed.2014.03.007; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bhattacharyya A, 2010, AM J PHYSIOL-GASTR L, V299, pG1177, DOI 10.1152/ajpgi.00372.2010; Bhattacharyya A, 2009, GASTROENTEROLOGY, V136, P2258, DOI 10.1053/j.gastro.2009.02.014; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chaugule VK, 2016, BIOCHEM SOC T, V44, P212, DOI 10.1042/BST20150209; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Das L, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.26; Das L, 2016, BIOCHEM J, V473, P1629, DOI 10.1042/BCJ20160187; Deng WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep39787; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Garcia-Limones C, 2016, ONCOGENE, V35, P4289, DOI 10.1038/onc.2015.495; Gobert AP, 2017, CURR TOP MICROBIOL, V400, P27, DOI 10.1007/978-3-319-50520-6_2; Griffiths EA, 2007, BRIT J CANCER, V96, P95, DOI 10.1038/sj.bjc.6603524; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jung JH, 2013, INT J MED SCI, V10, P1217, DOI 10.7150/ijms.6054; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Knauer SK, 2015, CYTOKINE GROWTH F R, V26, P405, DOI 10.1016/j.cytogfr.2015.04.002; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang YJ, 2015, CANCER RES, V75, P3672, DOI 10.1158/0008-5472.CAN-15-0930; Liu SP, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.405; Matak P, 2015, J IMMUNOL, V194, P3259, DOI 10.4049/jimmunol.1401260; Mazzon M, 2013, P NATL ACAD SCI USA, V110, P12444, DOI 10.1073/pnas.1302140110; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Muller S, 2014, ONCOTARGET, V5, P3184; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Niecknig H, 2012, FREE RADICAL RES, V46, P705, DOI 10.3109/10715762.2012.669041; Nihira NT, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8026; Nolan KA, 2015, EXP CELL RES, V330, P371, DOI 10.1016/j.yexcr.2014.07.034; Noto J. M., 2017, GUT, V18; Park JH, 2003, CLIN CANCER RES, V9, P433; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qian JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077625; Rath S, 2017, INT J BIOCHEM CELL B, V82, P28, DOI 10.1016/j.biocel.2016.11.014; Rath S, 2015, FASEB J, V29, P796, DOI 10.1096/fj.14-257501; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rohwer N, 2009, BRIT J CANCER, V100, P772, DOI 10.1038/sj.bjc.6604919; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Schaffer K, 2015, FEBS J, V282, P2260, DOI 10.1111/febs.13270; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; Tsugawa H, 2012, CELL HOST MICROBE, V12, P764, DOI 10.1016/j.chom.2012.10.014; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Zhao CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-419; Zhao Q, 2016, ONCOL RES, V23, P129, DOI 10.3727/096504015X14500513118029; Zhao Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132746; Zhu CL, 2013, MOL BIOL REP, V40, P6055, DOI 10.1007/s11033-013-2715-z	67	7	7	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5378	5389		10.1096/fj.201701344RRR	http://dx.doi.org/10.1096/fj.201701344RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688807				2022-12-28	WOS:000447972500015
J	Pellowe, AS; Sauler, M; Hou, Y; Merola, J; Liu, R; Calderon, B; Lauridsen, HM; Harris, MR; Leng, L; Zhang, Y; Tilstam, PV; Pober, JS; Bucala, R; Lee, PJ; Gonzalez, AL				Pellowe, Amanda S.; Sauler, Maor; Hou, Yue; Merola, Jonathan; Liu, Rebecca; Calderon, Brenda; Lauridsen, Holly M.; Harris, Mariah R.; Leng, Lin; Zhang, Yi; Tilstam, Pathricia V.; Pober, Jordan S.; Bucala, Richard; Lee, Patty J.; Gonzalez, Anjelica L.			Endothelial cell-secreted MIF reduces pericyte contractility and enhances neutrophil extravasation	FASEB JOURNAL			English	Article						microvasculature; inflammation; cytokine; transmigration	MIGRATION-INHIBITORY FACTOR; LIGHT-CHAIN KINASE; VENULAR WALLS; FACTOR GENE; MECHANISMS; TRANSMIGRATION; FIBRONECTIN; CAPILLARY; MOTILITY; DRIVE	Dysregulated neutrophil extravasation contributes to the pathogenesis of many inflammatory disorders. Pericytes (PCs) have been implicated in the regulation of neutrophil transmigration, and previous work demonstrates that endothelial cell (EC)-derived signals reduce PC barrier function; however, the signaling mechanisms are unknown. Here, we demonstrate a novel role for EC-derived macrophage migration inhibitory factor (MIF) in inhibiting PC contractility and facilitating neutrophil transmigration. With the use of micro-ELISAs, RNA sequencing, quantitative PCR, and flow cytometry, we found that ECs secrete MIF, and PCs upregulate CD74 in response to TNF-. We demonstrate that EC-derived MIF decreases PC contractility on 2-dimensional silicone substrates via reduction of phosphorylated myosin light chain. With the use of an in vitro microvascular model of the human EC-PC barrier, we demonstrate that MIF decreases the PC barrier to human neutrophil transmigration by increasing intercellular PC gap formation. For the first time, an EC-specific MIF knockout mouse was used to investigate the effects of selective deletion of EC MIF. In a model of acute lung injury, selective deletion of EC MIF decreases neutrophil infiltration to the bronchoalveolar lavage and tissue and simultaneously decreases PC relaxation by increasing myosin light-chain phosphorylation. We conclude that paracrine signals from EC via MIF decrease PC contraction and enhance PC-regulated neutrophil transmigration.Pellowe, A. S., Sauler, M., Hou, Y., Merola, J., Liu, R., Calderon, B., Lauridsen, H. M., Harris, M. R., Leng, L., Zhang, Y., Tilstam, P. V., Pober, J. S., Bucala, R., Lee, P. J., Gonzalez, A. L. Endothelial cell-secreted MIF reduces pericyte contractility and enhances neutrophil extravasation.	[Pellowe, Amanda S.; Hou, Yue; Calderon, Brenda; Lauridsen, Holly M.; Harris, Mariah R.; Gonzalez, Anjelica L.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Sauler, Maor; Leng, Lin; Zhang, Yi; Tilstam, Pathricia V.; Bucala, Richard; Lee, Patty J.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Merola, Jonathan; Liu, Rebecca; Pober, Jordan S.] Yale Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Yale University; Yale University	Gonzalez, AL (corresponding author), Yale Univ, 55 Prospect St,Room 301,MEC 314, New Haven, CT 06511 USA.	anjelica.gonzalez@yale.edu		Leng, Lin/0000-0002-0605-358X; Tilstam, Pathricia/0000-0003-3620-6775	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [5R01HL051014-24]; Flight Attendant Medical Research-Young Clinical Scientist Award; Parker B. Francis Fellowship; NIH/NHLBI Grant [K08HL135402, 1R01HL130669]; Flight Attendant Medical Research-Clinical Innovator Award [R01HL138396]; DoD [PR150809]; VAORD [11858595]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138396, R01HL130669, R01HL051014, K08HL135402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007276] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003265] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); Flight Attendant Medical Research-Young Clinical Scientist Award; Parker B. Francis Fellowship; NIH/NHLBI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendant Medical Research-Clinical Innovator Award; DoD(United States Department of Defense); VAORD(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Endah Sulistijo and Kathryn Miller-Jensen for their assistance in fabricating and performing micro-ELISA assays, and Rong Fan for the use of the SpotBot personal array printer (all from Yale University). The authors also acknowledge the following funding sources: A.L.G. and J.S.P. are supported by U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) Grant 5R01HL051014-24. M.S. is supported by the Flight Attendant Medical Research-Young Clinical Scientist Award, Parker B. Francis Fellowship, and NIH/NHLBI Grant K08HL135402. P.J.L. is supported by the Flight Attendant Medical Research-Clinical Innovator Award, R01HL138396, VAORD 11858595 and DoD PR150809. R.B. is supported by NIH/NHLBI Grant 1R01HL130669. The authors declare no conflicts of interest.	Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Bhadriraju K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-43; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brown LA, 2015, CELL MOL BIOENG, V8, P349, DOI 10.1007/s12195-015-0408-5; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Guo Yubiao, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P337; Hare AA, 2010, BIOORG MED CHEM LETT, V20, P5811, DOI 10.1016/j.bmcl.2010.07.129; Hou Y, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-8; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; KELLEY C, 1987, J CELL BIOL, V104, P483, DOI 10.1083/jcb.104.3.483; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lai KN, 2003, J PATHOL, V199, P496, DOI 10.1002/path.1291; Lauridsen HM, 2014, FASEB J, V28, P1166, DOI 10.1096/fj.13-240986; Lee S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194115; Lehmann LE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-100; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Liu R, 2016, J IMMUNOL, V197, P2400, DOI 10.4049/jimmunol.1600138; Maier CL, 2010, MICROCIRCULATION, V17, P367, DOI 10.1111/j.1549-8719.2010.00038.x; Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745; MANDARINO LJ, 1993, EXP EYE RES, V57, P609, DOI 10.1006/exer.1993.1166; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Muller WA, 2015, CARDIOVASC RES, V107, P310, DOI 10.1093/cvr/cvv145; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Pellowe AS, 2016, WIRES NANOMED NANOBI, V8, P5, DOI 10.1002/wnan.1349; Pober JS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016345; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Romsey NR, 2014, CELL MOL BIOENG, V7, P122, DOI 10.1007/s12195-013-0299-2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sauler M, 2015, AM J PHYSIOL-LUNG C, V309, pL1, DOI 10.1152/ajplung.00339.2014; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sreih A, 2011, ARTHRITIS RHEUM-US, V63, P3942, DOI 10.1002/art.30624; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Taniguchi T, 1996, ONCOGENE, V12, P1357; Truong T, 2015, INTEGR BIOL-UK, V7, P1285, DOI 10.1039/c5ib00133a; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Wadgaonkar R, 2005, J CELL BIOCHEM, V95, P849, DOI 10.1002/jcb.20472; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiser JN, 2015, J INFECT DIS, V212, P1677, DOI 10.1093/infdis/jiv262; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Yoo SA, 2016, P NATL ACAD SCI USA, V113, pE7917, DOI 10.1073/pnas.1612717113	58	15	15	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2171	2186		10.1096/fj.201800480R	http://dx.doi.org/10.1096/fj.201800480R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252532	Green Published			2022-12-28	WOS:000457296600052
J	Shee, K; Jiang, A; Varn, FS; Liu, S; Traphagen, NA; Owens, P; Ma, CX; Hoog, J; Cheng, C; Golub, TR; Straussman, R; Miller, TW				Shee, Kevin; Jiang, Amanda; Varn, Frederick S.; Liu, Stephanie; Traphagen, Nicole A.; Owens, Philip; Ma, Cynthia X.; Hoog, Jeremy; Cheng, Chao; Golub, Todd R.; Straussman, Ravid; Miller, Todd W.			Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer	FASEB JOURNAL			English	Article						estrogen receptor; anti-estrogen; CDK4; CDK6	BONE MORPHOGENETIC PROTEINS; CELL-PROLIFERATION; GROWTH; INHIBITORS; PALBOCICLIB; EXPRESSION; RECEPTORS; DISCOVERY; METAANALYSIS; ACTIVATION	Despite the success of approved systemic therapies for estrogen receptor (ER)-positive breast cancer, drug resistance remains common. We hypothesized that secreted factors from the human tumor microenvironment could modulate drug resistance. We previously screened a library of 297 recombinant-secreted microenvironmental proteins for the ability to confer resistance to the anti-estrogen fulvestrant in 2 ER+ breast cancer cell lines. Herein, we considered whether factors that enhanced drug sensitivity could be repurposed as therapeutics and provide leads for drug development. Screening data revealed bone morphogenic protein (BMP)4 as a factor that inhibited cell growth and synergized with approved anti-estrogens and cyclin-dependent kinase 4/6 inhibitors (CDK4/6(i)). BMP4-mediated growth inhibition was dependent on type I receptor activin receptor-like kinase (ALK)3-dependent phosphorylation (P) of mothers against decapentaplegic homolog (SMAD/P-SMAD)1 and 5, which could be reversed by BMP receptor inhibitors and ALK3 knockdown. The primary effect of BMP4 on cell fate was cell-cycle arrest, in which RNA sequencing, immunoblot analysis, and RNA interference revealed to be dependent on p21(WAF1/Cip1) upregulation. BMP4 also enhanced sensitivity to approved inhibitors of mammalian target of rapamycin complex 1 and CDK4/6 via ALK3-mediated P-SMAD1/5 and p21 upregulation in anti-estrogen-resistant cells. Patients bearing primary ER+ breast tumors, exhibiting a transcriptomic signature of BMP4 signaling, had improved disease outcome following adjuvant treatment with anti-estrogen therapy, independently of age, tumor grade, and tumor stage. Furthermore, a transcriptomic signature of BMP4 signaling was predictive of an improved biologic response to the CDK4/6(i) palbociclib, in combination with an aromatase inhibitor in primary tumors. These findings highlight BMP4 and its downstream pathway activation as a therapeutic opportunity in ER+ breast cancer.Shee, K., Jiang, A., Varn, F. S., Liu, S., Traphagen, N. A., Owens, P., Ma, C. X., Hoog, J., Cheng, C., Golub, T. R., Straussman, R., Miller, T. W. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer.	[Shee, Kevin; Jiang, Amanda; Varn, Frederick S.; Liu, Stephanie; Traphagen, Nicole A.; Cheng, Chao; Miller, Todd W.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH USA; [Cheng, Chao] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH USA; [Miller, Todd W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Owens, Philip] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO USA; [Owens, Philip] Eastern Colorado Hlth Care Syst, Dept Vet Affairs, Res Med, Denver, CO USA; [Ma, Cynthia X.; Hoog, Jeremy] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Golub, Todd R.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Straussman, Ravid] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Weizmann Institute of Science	Miller, TW (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, One Med Ctr Dr,HB-7936, Lebanon, NH 03756 USA.	todd.w.miller@dartmouth.edu	Shee, Kevin/V-6803-2019	Shee, Kevin/0000-0001-5378-7650; Jiang, Amanda/0000-0002-0327-6980	U.S. National Institutes of Health National Cancer Institute [F30CA216966, R01CA211869]; U.S. National Institutes of Health National Cancer Institute (Norris Cotton Cancer Center Support Grant) [P30CA023108]; NATIONAL CANCER INSTITUTE [P30CA023108, F30CA216966, R01CA211869, R01CA200994] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002929] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health National Cancer Institute (Norris Cotton Cancer Center Support Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank the Genomics and Molecular Biology and Microscopy, Norris Cotton Cancer Center Shared Resources for assistance. Funding support was provided by the U.S. National Institutes of Health National Cancer Institute (Grants F30CA216966 to K.S.; R01CA211869 to T.W.M.; and Norris Cotton Cancer Center Support Grant P30CA023108). The authors declare no conflicts of interest.	ALABASTER O, 1989, CANCER RES, V49, P5638; Alarmo EL, 2013, MODERN PATHOL, V26, P10, DOI 10.1038/modpathol.2012.128; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Brama M, 2007, ENDOCR-RELAT CANCER, V14, P61, DOI 10.1677/erc.1.01307; Brubaker KD, 2004, J CELL BIOCHEM, V91, P151, DOI 10.1002/jcb.10679; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Chan N, 2010, CANCER RES, V70, P8045, DOI 10.1158/0008-5472.CAN-10-2352; Chang SF, 2009, MOL ENDOCRINOL, V23, P1827, DOI 10.1210/me.2009-0143; Cheng C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-452; Chiu CY, 2012, MOL CANCER RES, V10, P415, DOI 10.1158/1541-7786.MCR-11-0293; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; El Bialy I, 2017, PHARM RES-DORDR, V34, P1152, DOI 10.1007/s11095-017-2147-x; Engers DW, 2013, BIOORG MED CHEM LETT, V23, P3248, DOI 10.1016/j.bmcl.2013.03.113; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hart LS, 2017, CLIN CANCER RES, V23, P1785, DOI 10.1158/1078-0432.CCR-16-1131; Heilmann AM, 2014, CANCER RES, V74, P3947, DOI 10.1158/0008-5472.CAN-13-2923; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hosford SR, 2017, CLIN CANCER RES, V23, P2795, DOI 10.1158/1078-0432.CCR-15-2764; Huang PD, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.39; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Ketolainen JM, 2010, BREAST CANCER RES TR, V124, P377, DOI 10.1007/s10549-010-0808-0; Krishnakumar GS, 2017, INT ORTHOP, V41, P1073, DOI 10.1007/s00264-017-3471-9; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Ma CX, 2017, CLIN CANCER RES, V23, P4055, DOI 10.1158/1078-0432.CCR-16-3206; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mohedas AH, 2013, ACS CHEM BIOL, V8, P1291, DOI 10.1021/cb300655w; Na YR, 2009, CANCER SCI, V100, P2218, DOI 10.1111/j.1349-7006.2009.01301.x; Negri JM, 2009, BRIT J HAEMATOL, V147, P672, DOI 10.1111/j.1365-2141.2009.07891.x; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ouyang XS, 2002, CARCINOGENESIS, V23, P721, DOI 10.1093/carcin/23.5.721; Piccart M, 2014, ANN ONCOL, V25, P2357, DOI 10.1093/annonc/mdu456; Pierard GE, 2012, J ONCOL, V2012, DOI 10.1155/2012/584219; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shee K, 2018, J EXP MED, V215, P895, DOI 10.1084/jem.20171818; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Shirai Y, 2011, AM J PATHOL, V179, P2920, DOI 10.1016/j.ajpath.2011.08.022; Shon SK, 2009, BIOCHEM BIOPH RES CO, V385, P198, DOI 10.1016/j.bbrc.2009.05.038; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Varn FS, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0086-0; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; WAKELING AE, 1991, CANCER RES, V51, P3867; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xing Y, 2006, NUCLEIC ACIDS RES, V34, P3150, DOI 10.1093/nar/gkl396; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	72	11	11	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1644	1657		10.1096/fj.201801241R	http://dx.doi.org/10.1096/fj.201801241R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30161001	Green Published, Bronze			2022-12-28	WOS:000457296600012
J	Chiurchiu, V; Leuti, A; Saracini, S; Fontana, D; Finamore, P; Giua, R; Padovini, L; Incalzi, RA; Maccarrone, M				Chiurchiu, Valerio; Leuti, Alessandro; Saracini, Stefano; Fontana, Davide; Finamore, Panaiotis; Giua, Renato; Padovini, Lucia; Incalzi, Raffaele Antonelli; Maccarrone, Mauro			Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes	FASEB JOURNAL			English	Article						resolvins; chronic inflammation; adaptive immunity	NECROSIS-FACTOR-ALPHA; RESOLVIN D1; CELLS; MEDIATORS; ACTIVATION; EXPRESSION; INFECTION; CYTOKINES; IMMUNITY	Chronic heart failure (CHF) is characterized by an ongoing nonresolving inflammatory status, where T lymphocytes seem critical. It has been recently recognized that transition from acute to chronic inflammation could be caused by defects in resolving inflammation, the resolution of which is mediated by a novel family of -3-derived specialized proresolving lipid mediators such as resolvins. We analyzed 27 elderly patients with CHF and 23 healthy age-matched control subjects, and we reported significantly lower levels of D-series resolvin (RvD)1 in plasma of patients with CHF that were associated with a reduced ability of their leukocytes to produce this lipid via its biosynthetic enzyme 15-lipoxygenase and that correlated with gas exchange dysfunction. Furthermore, when pretreating ex vivo peripheral blood mononuclear cells of patients with CHF with RvD1 or RvD2, we found that neither of them was able to modulate the immune response of CD8(+) and CD4(+) T cells in terms of proinflammatory cytokine production, namely TNF-, IFN-, IL-17, and IL-2. Such impaired T-cell responsiveness in patients with CHF was associated with a significant reduction in mRNA and protein expression of RvD1 receptor GPR32, suggesting a defective signaling in the proresolving pathway. We conclude that patients with CHF show alterations in producing proresolving mediator RvD1 and a failure of adaptive immune cells in responding to the anti-inflammatory actions of RvDs that may contribute to the progression of chronic inflammation. Thus, the proresolution pathway might be a potential candidate to design better treatments for CHF aimed at reducing T cell-mediated chronic inflammation.ChiurchiU, V., Leuti, A., Saracini, S., Fontana, D., Finamore, P., Giua, R., Padovini, L., Incalzi, R. A., Maccarrone, M. Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes.	[Chiurchiu, Valerio; Leuti, Alessandro; Incalzi, Raffaele Antonelli; Maccarrone, Mauro] Univ Rome, Dept Med, Biomed Campus, Rome, Italy; [Saracini, Stefano; Fontana, Davide; Finamore, Panaiotis; Giua, Renato; Padovini, Lucia] Univ Rome, Unit Geriatr Med, Biomed Campus, Rome, Italy; [Saracini, Stefano; Fontana, Davide; Finamore, Panaiotis; Giua, Renato; Padovini, Lucia] Teaching Hosp, Rome, Italy; [Chiurchiu, Valerio; Leuti, Alessandro; Maccarrone, Mauro] Inst Res & Hlth Care IRCCS Santa Lucia Fdn, European Ctr Brain Res, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Maccarrone, M (corresponding author), Univ Rome, Dept Med, Biomed Campus, Rome, Italy.; Chiurchiu, V (corresponding author), IRCCS Sana Lucia Fdn, Via Fosso Fiorano 64, I-00143 Rome, Italy.	v.chiurchiu@hsantalucia.it; m.maccarrone@unicampus.it	Finamore, Panaiotis/ABH-2693-2021; Chiurchiu, Valerio/G-6227-2011	Finamore, Panaiotis/0000-0002-8608-9223; Leuti, Alessandro/0000-0002-5982-0682; Chiurchiu, Valerio/0000-0002-0316-7311; Fontana, Davide Onofrio/0000-0003-4262-8368				Agostoni P, 2007, PULM PHARMACOL THER, V20, P130, DOI 10.1016/j.pupt.2006.03.001; Moro-Garcia MA, 2014, INT J CARDIOL, V174, P590, DOI 10.1016/j.ijcard.2014.04.128; Ayoub KF, 2017, CARDIOVASC DRUG THER, V31, P593, DOI 10.1007/s10557-017-6752-z; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Cai YH, 2016, ASIAN PAC J TROP MED, V9, P672, DOI 10.1016/j.apjtm.2016.05.006; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Corsonello A, 2013, CURR MED CHEM, V20, P1103, DOI 10.2174/0929867311320090002; Fildes JE, 2009, J AM COLL CARDIOL, V53, P1013, DOI 10.1016/j.jacc.2008.11.046; Fredman G, 2017, MOL ASPECTS MED, V58, P65, DOI 10.1016/j.mam.2017.02.003; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fukunaga T, 2007, HEART VESSELS, V22, P178, DOI 10.1007/s00380-006-0955-8; Gilbert K, 2015, EUR J PHARMACOL, V769, P147, DOI 10.1016/j.ejphar.2015.11.010; Gilbert K, 2015, J CARDIOVASC PHARM, V66, P72, DOI 10.1097/FJC.0000000000000245; Gilbert K, 2014, MAR DRUGS, V12, P5396, DOI 10.3390/md12115396; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007; Koller L, 2013, ATHEROSCLEROSIS, V230, P414, DOI 10.1016/j.atherosclerosis.2013.08.008; Li N, 2010, CLIN CHIM ACTA, V411, P1963, DOI 10.1016/j.cca.2010.08.013; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Ogata H, 2016, EUR J PHARMACOL, V777, P26, DOI 10.1016/j.ejphar.2016.02.058; Raphael C, 2007, HEART, V93, P476, DOI 10.1136/hrt.2006.089656; Reina-Couto M, 2014, EUR J CLIN INVEST, V44, P527, DOI 10.1111/eci.12265; Sanchez-Trujillo L, 2017, ARCH MED RES, V48, P1, DOI 10.1016/j.arcmed.2016.12.008; Satoh S, 2006, INT J CARDIOL, V111, P405, DOI 10.1016/j.ijcard.2005.08.021; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Torre-Amione G, 2005, AM J CARDIOL, V95, p3C, DOI 10.1016/j.amjcard.2005.03.006; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6	33	37	39	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					909	916		10.1096/fj.201801017R	http://dx.doi.org/10.1096/fj.201801017R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052486				2022-12-28	WOS:000457401500071
J	Correa, R; Arenas, J; Montoya, G; Hoz, L; Lopez, S; Salgado, F; Arroyo, R; Salmeron, N; Romo, E; Zeichner-David, M; Arzate, H				Correa, Rodrigo; Arenas, Jesus; Montoya, Gonzalo; Hoz, Lia; Lopez, Sonia; Salgado, Fabiola; Arroyo, Rita; Salmeron, Nahum; Romo, Enrique; Zeichner-David, Margarita; Arzate, Higinio			Synthetic cementum protein 1-derived peptide regulates mineralization in vitro and promotes bone regeneration in vivo	FASEB JOURNAL			English	Article						hydroxyapatite; mineralization; osteogenesis	PERIODONTAL-LIGAMENT CELLS; OSTEOBLAST DIFFERENTIATION; CRYSTAL-FORMATION; CRITICAL-SIZE; EXPRESSION; BIOMINERALIZATION; HYDROXYAPATITE; OSTERIX; GROWTH; CEMP1	The use of recombinant proteins has revolutionized the development of biologic pharmaceuticals; however, they are not free of complications. Some have very high molecular weight, some demonstrate in vivo instability, and the high cost of producing them remains a major problem. On the other hand, it has been shown that peptides derived from active domains keep their biologic activity and can trigger events, such as osteogenesis and bone regeneration. Small peptides are advantageous because of their ease of synthesis and handling and their low immunogenic activity. The purpose of this study was to investigate the functions of a synthetic peptide, cementum protein 1-peptide1 (CEMP-1-p1), both in vitro and in vivo. Our results show that CEMP-1-p1 significantly enhanced the proliferation and differentiation of human periodontal ligament cells toward a mineralizing-like phenotype, as evidenced by increasing alkaline phosphatase (ALP)-specific activity and osterix, runt-related transcription factor (RUNX)-2, integrin binding sialoprotein, bone morphogenetic protein-2, osteocalcin, and cementum protein (CEMP)-1 expression at mRNA and protein levels. In vivo assays performed through standardized critical-size calvarial defects in rats treated with CEMP-1-p1 resulted in newly formed bone after 30 and 60 d. These data demonstrate that CEMP-1-p1 is an effective bioactive peptide for bone tissue regeneration. The application of this bioactive peptide may lead to implementing new strategies for the regeneration of bone and other mineralized tissues.Correa, R., Arenas, J., Montoya, G., Hoz, L., Lopez, S., Salgado, F., Arroyo, R., Salmeron, N., Romo, E., Zeichner-David, M., Arzate, H. Synthetic cementum protein 1-derived peptide regulates mineralization in vitro and promotes bone regeneration in vivo.	[Correa, Rodrigo; Montoya, Gonzalo; Hoz, Lia; Lopez, Sonia; Salgado, Fabiola; Arroyo, Rita; Salmeron, Nahum; Romo, Enrique; Arzate, Higinio] Univ Nacl Autonoma Mexico, Lab Biol Periodontal, Fac Odontol, Ave Univ 3000, Mexico City 04510, DF, Mexico; [Arenas, Jesus] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City, DF, Mexico; [Zeichner-David, Margarita] Univ Southern Calif, Ostrow Sch Dent, Los Angeles, CA USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Southern California	Arzate, H (corresponding author), Univ Nacl Autonoma Mexico, Lab Biol Periodontal, Fac Odontol, Ave Univ 3000, Mexico City 04510, DF, Mexico.	harzate@unam.mx	AYALA, GONZALO MONTOYA/AAT-3910-2021; Salmerón-Valdés, Elias Nahum/GQP-2349-2022; Salmerón-Valdés, Elias Nahum/AAE-9679-2020	AYALA, GONZALO MONTOYA/0000-0001-9376-7347; Salmerón-Valdés, Elias Nahum/0000-0001-6732-6388; Salmerón-Valdés, Elias Nahum/0000-0001-6732-6388	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM [IT200717, IA200917, IA203518, IA202618]	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM(Universidad Nacional Autonoma de Mexico)	The authors thank M. Aguilar, S. Tehuacanero, R. Hernandez, and J. Canetas [all from Instituto de FIsica, Universidad Nacional Autonoma de Mexico (UNAM)] for technical assistance. This work is part of the U.S. Patent Application No. US 2017/0088584 A1. This work was partially supported by Grants IT200717, IA200917, IA203518, IA202618, and postdoctoral scholarship to N.S. from Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM. The authors declare no conflicts of interest.	Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009; Amos FF, 2009, BIOMACROMOLECULES, V10, P3298, DOI 10.1021/bm900893f; Artigas N, 2014, J BIOL CHEM, V289, P27105, DOI 10.1074/jbc.M114.576793; Arzate H, 2002, J DENT RES, V81, P541, DOI 10.1177/154405910208100808; Arzate H, 2015, PERIODONTOL 2000, V67, P211, DOI 10.1111/prd.12062; Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carmona-Rodriguez B, 2007, BIOCHEM BIOPH RES CO, V358, P763, DOI 10.1016/j.bbrc.2007.04.204; Chen XF, 2016, INT J NANOMED, V11, P3145, DOI 10.2147/IJN.S104324; Chen XF, 2016, MAT SCI ENG C-MATER, V59, P384, DOI 10.1016/j.msec.2015.10.029; Choi JW, 2016, PLAST RECONSTR SURG, V138, p64E, DOI 10.1097/PRS.0000000000002290; Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200; Paula-Silva FWG, 2010, CALCIFIED TISSUE INT, V87, P144, DOI 10.1007/s00223-010-9368-x; Goncalves PF, 2008, J PERIODONTOL, V79, P323, DOI 10.1902/jop.2008.070327 ; Han PP, 2015, J BONE MINER RES, V30, P1160, DOI 10.1002/jbmr.2445; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hough TA, 2007, J BONE MINER RES, V22, P1397, DOI 10.1359/jbmr.070515; Hoz L, 2012, CELL BIOL INT, V36, P129, DOI 10.1042/CBI20110168; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Inubushi T, 2008, J PERIODONTOL, V79, P1984, DOI [10.1902/jop.2008.080081, 10.1902/jop.2008.080081 ]; Jakob F, 2013, MATURITAS, V75, P118, DOI 10.1016/j.maturitas.2013.03.004; Kemoun P, 2007, CELL TISSUE RES, V329, P283, DOI 10.1007/s00441-007-0397-3; Komaki M, 2012, J CELL PHYSIOL, V227, P649, DOI 10.1002/jcp.22770; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lowery JW, 2011, CRIT REV EUKAR GENE, V21, P177, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.60; LOWRY OH, 1954, J BIOL CHEM, V207, P19; Maria CG, 2013, INJURY, V44, P1871, DOI 10.1016/j.injury.2013.08.012; Mercado AE, 2014, J TISSUE ENG REGEN M, V8, P15, DOI 10.1002/term.1487; Montoya G, 2014, BONE, V69, P154, DOI 10.1016/j.bone.2014.09.014; Nudelman F, 2007, FARADAY DISCUSS, V136, P9, DOI 10.1039/b704418f; Nunez J, 2012, J PERIODONTAL RES, V47, P33, DOI 10.1111/j.1600-0765.2011.01402.x; Pountos I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0646-y; Pountos I, 2013, ACTA ORTHOP, V84, P65, DOI 10.3109/17453674.2013.765624; Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romo-Arevalo E, 2016, FEBS LETT, V590, P129, DOI 10.1002/1873-3468.12032; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Serrano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078807; Sugamori Y, 2016, BIOESSAYS, V38, P717, DOI 10.1002/bies.201600104; Sun S, 2008, INT J ORAL MAX SURG, V37, P350, DOI 10.1016/j.ijom.2007.11.024; Tavafoghi M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0462; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Villarreal-Ramirez E, 2009, BIOCHEM BIOPH RES CO, V384, P49, DOI 10.1016/j.bbrc.2009.04.072; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	54	11	11	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1167	1178		10.1096/fj.201800434RR	http://dx.doi.org/10.1096/fj.201800434RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113883	Bronze			2022-12-28	WOS:000457401500092
J	Klose, K; Gossen, M; Stamm, C				Klose, Kristin; Gossen, Manfred; Stamm, Christof			Turning fibroblasts into cardiomyocytes: technological review of cardiac transdifferentiation strategies	FASEB JOURNAL			English	Review						cardiac regeneration; heart disease; induced cardiomyocyte; in vivo reprogramming	PLURIPOTENT STEM-CELLS; HUMAN DERMAL FIBROBLASTS; BONE-MARROW-CELLS; MOUSE FIBROBLASTS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; GENE-TRANSFER; TRANSCRIPTION FACTORS; DIRECT CONVERSION; IN-VITRO	To date, no viable therapeutic options exist for the effective and sustained reversal of cardiac failure, other than heart transplantation and mechanical circulatory assist devices. Therefore, divergent strategies aiming at the de novo formation of contractile tissue, as a prerequisite for the restoration of cardiac pump function, are currently being pursued. Clinical trials involving the transplantation of somatic progenitor cells failed. The search for alternative cell-based strategies to combat the consequences of ischemic injury has sparked widespread interest in the genetic and pharmacologic reprogramming of fibroblasts into cardiomyocytes, harnessing the abundant in vivo pool of cardiac fibroblasts. Here, we provide a comprehensive overview of in vitro and in vivo cardiac reprogramming studies identified in an extensive literature search. We systematically review and evaluate feasibility, efficiency, and reproducibility of the different technologies currently being explored. Finally, we discuss potential safety issues deduced from preclinical studies and identify obstacles that must be overcome before clinical translation.Klose, K., Gossen, M., Stamm, C. Turning fibroblasts into cardiomyocytes: technological review of cardiac transdifferentiation strategies.	[Klose, Kristin; Gossen, Manfred; Stamm, Christof] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Klose, Kristin; Stamm, Christof] Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany; [Klose, Kristin; Stamm, Christof] Charite Univ Med Berlin, Berlin, Germany; [Gossen, Manfred] Helmholtz Zentrum Geesthacht HZG, Inst Biomat Sci, Teltow, Germany; [Stamm, Christof] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany; [Stamm, Christof] Deutsch Herzzentrum Berlin DHZB, Dept Cardiothorac & Vasc Surg, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; German Centre for Cardiovascular Research; German Heart Center Berlin	Stamm, C (corresponding author), Deutsch Herzzentrum Berlin, Augustenburger Pl 1, D-13353 Berlin, Germany.	stamm@dhzb.de	Gossen, Manfred/K-9602-2013	Gossen, Manfred/0000-0002-1761-4063	Federal Ministry of Education and Research [FKZ 13GW0098, FKZ 13GW0099]; DFG through the Berlin-Brandenburg School for Regenerative Therapies GSC 203	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG through the Berlin-Brandenburg School for Regenerative Therapies GSC 203	This work was supported by the Federal Ministry of Education and Research (Grants FKZ 13GW0098 and FKZ 13GW0099). Moreover, contributions were made possible by DFG funding through the Berlin-Brandenburg School for Regenerative Therapies GSC 203. The authors declare no conflicts of interest.	Abad M, 2017, STEM CELL REP, V8, P548, DOI 10.1016/j.stemcr.2017.01.025; Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Bai F, 2015, SCI REP-UK, V5, DOI 10.1038/srep15014; Bakker ML, 2012, CARDIOVASC RES, V94, P439, DOI 10.1093/cvr/cvs120; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bar-Nur O, 2015, NAT BIOTECHNOL, V33, P761, DOI 10.1038/nbt.3247; Bektik E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183000; Belian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125384; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Bian Q, 2016, TRENDS BIOTECHNOL, V34, P993, DOI 10.1016/j.tibtech.2016.05.010; Birket MJ, 2015, NAT BIOTECHNOL, V33, P970, DOI 10.1038/nbt.3271; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Byun JH, 2000, J GENE MED, V2, P2; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cao N, 2016, SCIENCE, V352, P1216, DOI 10.1126/science.aaf1502; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chandler RJ, 2016, MOL THER, V24, P198, DOI 10.1038/mt.2016.17; Chang YQ, 2016, CELL PHYSIOL BIOCHEM, V39, P157, DOI 10.1159/000445613; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Christoforou N, 2017, SCI REP-UK, V7, DOI 10.1038/srep40285; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898; Dal-Pra S, 2017, CIRC RES, V120, P1403, DOI 10.1161/CIRCRESAHA.116.308741; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; David R, 2009, CARDIOVASC RES, V84, P263, DOI 10.1093/cvr/cvp211; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; EGHBALI M, 1991, P NATL ACAD SCI USA, V88, P795, DOI 10.1073/pnas.88.3.795; Fernandez-Perez A, 2017, JOVE-J VIS EXP, DOI 10.3791/55456; Fisher SA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007888.pub3; Fisher SA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub4; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Fu YB, 2015, CELL RES, V25, P1013, DOI 10.1038/cr.2015.99; Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Genovese JA, 2008, BIOCHEM BIOPH RES CO, V370, P450, DOI 10.1016/j.bbrc.2008.03.115; Ghazizadeh Z, 2017, MOL BIOTECHNOL, V59, P207, DOI 10.1007/s12033-017-0007-x; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Greenberg B, 2016, LANCET, V387, P1178, DOI 10.1016/S0140-6736(16)00082-9; Guo YJ, 2017, ANIM SCI J, V88, P745, DOI 10.1111/asj.12700; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hartung S, 2013, STEM CELLS DEV, V22, P1112, DOI 10.1089/scd.2012.0351; Hirai H, 2014, CARDIOVASC RES, V102, P188, DOI 10.1093/cvr/cvu023; Hirai H, 2013, CARDIOVASC RES, V100, P105, DOI 10.1093/cvr/cvt167; Hirai H, 2011, STEM CELLS, V29, P1349, DOI 10.1002/stem.684; Hu YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008681; Huang CW, 2018, CELL RES, V28, P686, DOI 10.1038/s41422-018-0036-4; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ifkovits JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089678; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Jayawardena T, 2014, METHODS MOL BIOL, V1150, P263, DOI 10.1007/978-1-4939-0512-6_18; Jayawardena TM, 2015, CIRC RES, V116, P418, DOI 10.1161/CIRCRESAHA.116.304510; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kamaraj US, 2016, CELL CYCLE, V15, P3343, DOI 10.1080/15384101.2016.1238119; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kim H, 2017, J BIOMAT SCI-POLYM E, V28, P1070, DOI 10.1080/09205063.2017.1287537; Kim TK, 2011, P NATL ACAD SCI USA, V108, P11918, DOI 10.1073/pnas.1101223108; Kofron CM, 2017, J PHYSIOL-LONDON, V595, P3891, DOI 10.1113/JP273100; Kong P, 2013, AM J PHYSIOL-HEART C, V305, pH1363, DOI 10.1152/ajpheart.00395.2013; Kong YP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03474; Lalit PA, 2017, NAT PROTOC, V12, P1029, DOI 10.1038/nprot.2017.021; Lalit PA, 2016, CELL STEM CELL, V18, P354, DOI 10.1016/j.stem.2015.12.001; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lee K, 2015, INT J NANOMED, V10, P1841, DOI 10.2147/IJN.S75124; Lee S, 2017, CIRC RES, V120, P848, DOI 10.1161/CIRCRESAHA.116.309833; Li XH, 2015, STEM CELL TRANSL MED, V4, P1415, DOI 10.5966/sctm.2015-0136; Li YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38815; Li YX, 2010, TRENDS CARDIOVAS MED, V20, P228, DOI 10.1016/j.tcm.2011.11.006; Liu L, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.36; Liu ZQ, 2017, NATURE, V551, P100, DOI 10.1038/nature24454; Liu ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02460-2; Liu ZQ, 2016, STEM CELL RES, V16, P507, DOI 10.1016/j.scr.2016.02.037; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Lucke C, 2010, EUR RADIOL, V20, P2074, DOI 10.1007/s00330-010-1791-x; Ma H, 2017, METHODS MOL BIOL, V1521, P69, DOI 10.1007/978-1-4939-6588-5_5; Ma H, 2015, CARDIOVASC RES, V108, P217, DOI 10.1093/cvr/cvv223; Maioli M, 2013, CELL TRANSPLANT, V22, P1227, DOI 10.3727/096368912X657297; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Mathison M, 2017, J THORAC CARDIOV SUR, V154, P1601, DOI 10.1016/j.jtcvs.2017.06.035; Mathison M, 2017, J THORAC CARDIOV SUR, V153, P329, DOI 10.1016/j.jtcvs.2016.09.041; Mathison M, 2014, J THORAC CARDIOV SUR, V148, P1656, DOI 10.1016/j.jtcvs.2014.03.033; Mathison M, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005652; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; Menasche P, 2015, EUR HEART J, V36, P2011, DOI 10.1093/eurheartj/ehv189; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Miyamoto K, 2018, CELL STEM CELL, V22, P91, DOI 10.1016/j.stem.2017.11.010; Moerkamp AT, 2017, STEM CELLS DEV, V26, P1552, DOI 10.1089/scd.2017.0048; Mohamed TMA, 2017, CIRCULATION, V135, P978, DOI 10.1161/CIRCULATIONAHA.116.024692; Morez C, 2015, BIOMATERIALS, V70, P94, DOI 10.1016/j.biomaterials.2015.07.063; Muraoka N, 2014, EMBO J, V33, P1565, DOI 10.15252/embj.201387605; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nam YJ, 2014, DEVELOPMENT, V141, P4267, DOI 10.1242/dev.114025; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Nasseri BA, 2007, CELL TRANSPLANT, V16, P941, DOI 10.3727/096368907783338235; Nasseri BA, 2014, EUR HEART J, V35, P1263, DOI 10.1093/eurheartj/ehu007; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Neill BT, 2005, J CLIN INVEST, V115, P2059, DOI 10.1172/JCI25900; Palazzolo G, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4969430; Park G, 2015, BIOMATERIALS, V54, P201, DOI 10.1016/j.biomaterials.2015.02.029; Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Piras BA, 2016, GENE THER, V23, P469, DOI 10.1038/gt.2016.20; Pratico ED, 2015, STEM CELLS DEV, V24, P2622, DOI 10.1089/scd.2015.0073; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2013, NAT PROTOC, V8, P1204, DOI 10.1038/nprot.2013.067; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Raper SE, 2002, HUM GENE THER, V13, P163, DOI 10.1089/10430340152712719; Rastegar-Pouyani S, 2017, J CELL PHYSIOL, V232, P2053, DOI 10.1002/jcp.25580; Rentschler S, 2012, CIRCULATION, V126, P1058, DOI 10.1161/CIRCULATIONAHA.112.103390; Sauls K, 2018, CELL REP, V22, P1913, DOI 10.1016/j.celrep.2018.01.047; Sayed N, 2015, CIRCULATION, V131, P300, DOI 10.1161/CIRCULATIONAHA.113.007394; Schaffer DV, 2008, ANNU REV BIOMED ENG, V10, P169, DOI 10.1146/annurev.bioeng.10.061807.160514; Sia JR, 2016, BIOMATERIALS, V103, P1, DOI 10.1016/j.biomaterials.2016.06.034; Singh VP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003922; Smith AW, 2013, BIOMATERIALS, V34, P6559, DOI 10.1016/j.biomaterials.2013.05.050; Solaro R, 2010, MATERIALS, V3, P1928, DOI 10.3390/ma3031928; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2012, CIRC RES, V111, P5, DOI 10.1161/CIRCRESAHA.112.271452; Stamm C, 2004, THORAC CARDIOV SURG, V52, P152, DOI 10.1055/s-2004-817981; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stamm C, 2007, J THORAC CARDIOV SUR, V133, P717, DOI 10.1016/j.jtcvs.2006.08.077; Steinhoff G, 2017, EBIOMEDICINE, V22, P208, DOI 10.1016/j.ebiom.2017.07.022; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Talaei-Khozani T, 2014, IRAN J MED SCI, V39, P203; Talkhabi M, 2017, J CELL COMMUN SIGNAL, V11, P193, DOI 10.1007/s12079-017-0387-5; Talkhabi M, 2015, BIOCHEM BIOPH RES CO, V463, P699, DOI 10.1016/j.bbrc.2015.05.127; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Tang CC, 2010, CHINESE MED J-PEKING, V123, P2586, DOI 10.3760/cma.j.issn.0366-6999.2010.18.018; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tomaru Y, 2014, NUCLEIC ACIDS RES, V42, P8905, DOI 10.1093/nar/gku567; Treutlein B, 2016, NATURE, V534, P391, DOI 10.1038/nature18323; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Umei TC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081805; van Tuyn J, 2007, FASEB J, V21, P3369, DOI 10.1096/fj.07-8211com; Vaseghi HR, 2016, GENESIS, V54, P398, DOI 10.1002/dvg.22947; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wang HX, 2014, CELL REP, V6, P951, DOI 10.1016/j.celrep.2014.01.038; Wang L., 2015, JOVE-J VIS EXP, V105, P53426; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; Wang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23017; Wang YY, 2016, CELL REPROGRAM, V18, P1, DOI 10.1089/cell.2015.0051; Wang YS, 2012, CELL BIOCHEM FUNCT, V30, P24, DOI 10.1002/cbf.1813; Wong WT, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416628329; Xu JY, 2016, STEM CELLS, V34, P2693, DOI 10.1002/stem.2438; Yamakawa H, 2015, STEM CELL REP, V5, P1128, DOI 10.1016/j.stemcr.2015.10.019; Yoo J, 2017, J BIOMED NANOTECHNOL, V13, P269, DOI 10.1166/jbn.2017.2347; Zaglia T, 2009, J MOL CELL CARDIOL, V46, P653, DOI 10.1016/j.yjmcc.2008.12.010; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322; Zhang Y, 2016, CELL STEM CELL, V18, P368, DOI 10.1016/j.stem.2016.02.001; Zhao YB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9243; Zhou HY, 2015, P NATL ACAD SCI USA, V112, P11864, DOI 10.1073/pnas.1516237112; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048028; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Y, 2016, CELL STEM CELL, V18, P382, DOI 10.1016/j.stem.2016.02.003	164	8	9	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					49	70		10.1096/fj.201800712R	http://dx.doi.org/10.1096/fj.201800712R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30188756	Bronze			2022-12-28	WOS:000457401500005
J	Pu, QQ; Zhao, YY; Sun, YY; Huang, T; Lin, P; Zhou, CM; Qin, SG; Singh, BB; Wu, M				Pu, Qinqin; Zhao, Yuanyu; Sun, Yuyang; Huang, Ting; Lin, Ping; Zhou, Chuanmin; Qin, Shugang; Singh, Brij B.; Wu, Min			TRPC1 intensifies house dust mite-induced airway remodeling by facilitating epithelial-to-mesenchymal transition and STAT3/NF-kappa B signaling	FASEB JOURNAL			English	Article						asthma; ion channel; cell signaling; transcription factors	CA2+ ENTRY; ALLERGIC INFLAMMATION; ASTHMA; STAT3; EXPRESSION; CELLS; LUNG; PROLIFERATION; CHANNELS; CALCIUM	Airway remodeling with progressive epithelial alterations in the respiratory tract is a severe consequence of asthma. Although dysfunctional signaling transduction is attributed to airway inflammation, the exact mechanism of airway remodeling remains largely unknown. TRPC1, a member of the transient receptor potential canonical Ca2+ channel family, possesses versatile functions but its role in airway remodeling remains undefined. Here, we show that ablation of TRPC1 in mice alleviates airway remodeling following house dust mite (HDM) challenge with decreases in mucus production, cytokine secretion, and collagen deposition. HDM challenge induces Ca2+ influx via the TRPC1 channel, resulting in increased levels of signal transducer and activator of transcription 3 (STAT3) and proinflammatory cytokines. In contrast, STAT3 expression was significantly decreased in TRPC1(-/-) mouse lungs compared with wild-type controls after HDM challenge. Mechanistically, STAT3 promotes epithelial-to-mesenchymal transition and increases mucin 5AC expression. Collectively, these findings identify TRPC1 as a modulator of HDM-induced airway remodeling via STAT3-mediated increase in mucus production, which provide new insight in our understanding of the molecular basis of airway remodeling, and identify novel therapeutic targets for intervention of severe chronic asthma.Pu, Q., Zhao, Y., Sun, Y., Huang, T., Lin, P., Zhou, C., Qin, S., Singh, B. B., Wu, M. TRPC1 intensifies house dust mite-induced airway remodeling by facilitating epithelial-to-mesenchymal transition and STAT3/NF-B signaling.	[Pu, Qinqin; Zhao, Yuanyu; Sun, Yuyang; Huang, Ting; Lin, Ping; Zhou, Chuanmin; Qin, Shugang; Singh, Brij B.; Wu, Min] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA; [Pu, Qinqin; Qin, Shugang] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China; [Sun, Yuyang; Singh, Brij B.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of North Dakota Grand Forks; Sichuan University; University of Texas System; University of Texas Health San Antonio	Singh, BB (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA.; Singh, BB (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.; Wu, M (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, 1301 Columbia Rd,Room W324, Grand Forks, ND 58202 USA.	singhbb@uthscsa.edu; min.wu@med.und.edu	Huang, Ting/AAB-6002-2019	Huang, Ting/0000-0002-2943-588X; Singh, Brij/0000-0003-0535-5997; Zhou, Chuan-min/0000-0002-5975-4603; Wu, Min/0000-0003-1205-982X	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01 AI109317-01A1, AI101973-01]; NIH National Institute of Dental and Craniofacial Research Grants [R01DE017102, R01DE022765]; NIH IDeA Networks of Biomedical Research Excellence National Institute of General Medical Sciences (NIGMS) [P20GM103442]; Centers of Biomedical Research Excellence (COBRE) NIGMS [P20GM113123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022765, R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123, P20GM103442] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; NIH National Institute of Dental and Craniofacial Research Grants; NIH IDeA Networks of Biomedical Research Excellence National Institute of General Medical Sciences (NIGMS); Centers of Biomedical Research Excellence (COBRE) NIGMS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Abrahamson (University of North Dakota Imaging Core Facility) for help with confocal imaging. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants R01 AI109317-01A1 and AI101973-01, NIH National Institute of Dental and Craniofacial Research Grants R01DE017102 and R01DE022765, as well as an NIH IDeA Networks of Biomedical Research Excellence National Institute of General Medical Sciences (NIGMS) Grant P20GM103442 and Centers of Biomedical Research Excellence (COBRE) NIGMS Grant P20GM113123. The authors declare no conflicts of interest.	AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Biagtan M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0482-0; Calderon MA, 2015, J ALLERGY CLIN IMMUN, V136, P38, DOI 10.1016/j.jaci.2014.10.012; Carroll N, 1996, PATHOL RES PRACT, V192, P238, DOI 10.1016/S0344-0338(96)80227-5; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Di Valentin E, 2009, AM J PHYSIOL-LUNG C, V296, pL185, DOI 10.1152/ajplung.90367.2008; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Fischer KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149180; Frank PI, 2001, BRIT J GEN PRACT, V51, P117; Gavino AC, 2016, ALLERGY, V71, P1684, DOI 10.1111/all.12937; Gregory LG, 2010, AM J RESP CRIT CARE, V182, P143, DOI 10.1164/rccm.200905-0725OC; Guo Q, 2012, EUR J IMMUNOL, V42, P1500, DOI 10.1002/eji.201142051; He S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005743; He YH, 2001, AM J RESP CELL MOL, V25, P692, DOI 10.1165/ajrcmb.25.6.4550; Heijink IH, 2010, AM J RESP CELL MOL, V42, P69, DOI 10.1165/rcmb.2008-0449OC; Huang Q, 2016, AM J CANCER RES, V6, P440; Hung JY, 2015, J CELL PHYSIOL, V230, P1042, DOI 10.1002/jcp.24832; Ichikawa J, 2014, BRIT J PHARMACOL, V171, P5280, DOI 10.1111/bph.12840; Ito T, 2017, J EXP MED, V214, P3037, DOI 10.1084/jem.20162108; Itoigawa Y, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0207-5; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kalita M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/505864; Kannan Shibichakravarthy, 2006, Curr Stem Cell Res Ther, V1, P37, DOI 10.2174/157488806775269115; Kuang CY, 2012, STEM CELLS DEV, V21, P487, DOI 10.1089/scd.2011.0027; Kunzelmann-Marche C, 2002, J BIOL CHEM, V277, P19876, DOI 10.1074/jbc.M200324200; Lepannetier S, 2016, CELL CALCIUM, V60, P373, DOI 10.1016/j.ceca.2016.09.002; Li GP, 2005, CHINESE MED J-PEKING, V118, P534; Li GP, 2013, J IMMUNOL, V191, P5359, DOI 10.4049/jimmunol.1301596; Li Na, 2015, Nan Fang Yi Ke Da Xue Xue Bao, V35, P1374; Li RP, 2016, CELL RES, V26, P1273, DOI 10.1038/cr.2016.135; Liu X, 2004, J MEMBRANE BIOL, V200, P93, DOI 10.1007/s00232-004-0698-3; Makino S, 2010, ALLERGY ASTHMA IMMUN, V2, P172, DOI 10.4168/aair.2010.2.3.172; Pani B, 2008, J BIOL CHEM, V283, P17333, DOI 10.1074/jbc.M800107200; Pani B, 2012, FRONT BIOSCI-LANDMRK, V17, P805, DOI 10.2741/3958; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Post S, 2013, ALLERGY, V68, P1117, DOI 10.1111/all.12202; Redington AE, 1997, THORAX, V52, P310, DOI 10.1136/thx.52.4.310; ROCHE WR, 1989, LANCET, V1, P520; Saver BG, 2003, AM FAM PHYSICIAN, V67, P465; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Skopin A, 2013, BIOCHIMIE, V95, P347, DOI 10.1016/j.biochi.2012.10.004; Sohal SS, 2014, THORAX, V69, P768, DOI 10.1136/thoraxjnl-2014-205582; Stewart TA, 2015, BIOCHEM BIOPH RES CO, V458, P509, DOI 10.1016/j.bbrc.2015.01.141; Su XM, 2016, INT IMMUNOPHARMACOL, V38, P70, DOI 10.1016/j.intimp.2016.05.018; Sun YY, 2013, J BIOL CHEM, V288, P255, DOI 10.1074/jbc.M112.393918; Suzaki Y, 2008, EUR RESPIR J, V31, P783, DOI 10.1183/09031936.00111507; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Tanaka H, 2003, AM J RESP CRIT CARE, V168, P1495, DOI 10.1164/rccm.200306-727OC; Trivedi A, 2016, LANCET RESP MED, V4, P585, DOI 10.1016/S2213-2600(16)30018-2; Weber LV, 2016, BREAST CANCER-TARGET, V8, P243, DOI 10.2147/BCTT.S121610; Wu M, 2009, J NEUROCHEM, V111, P1011, DOI 10.1111/j.1471-4159.2009.06390.x; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yilmaz O, 2016, PEDIATR PULM, V51, P1422, DOI 10.1002/ppul.23488; Yin XM, 2016, INT J TUBERC LUNG D, V20, P967, DOI 10.5588/ijtld.15.0473; Yoon SY, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.35; Yuan KF, 2011, J BIOL CHEM, V286, P21814, DOI 10.1074/jbc.M111.237628; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhang D, 2003, GENE THER, V10, P2148, DOI 10.1038/sj.gt.3302121; Zhong KL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005823; Zhou XK, 2015, MOL CELL BIOL, V35, P2729, DOI 10.1128/MCB.00256-15	65	14	14	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1074	1085		10.1096/fj.201801085R	http://dx.doi.org/10.1096/fj.201801085R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30067380	Green Published			2022-12-28	WOS:000457401500085
J	Sonigo, C; Beau, I; Grynberg, M; Binart, N				Sonigo, Charlotte; Beau, Isabelle; Grynberg, Michael; Binart, Nadine			AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice	FASEB JOURNAL			English	Article						anti-Mullerian hormone; alkylating agents; burnout effect; oncofertility; autophagy	ANTI-MULLERIAN HORMONE; INHIBITS INITIATION; ACTIVATION; AUTOPHAGY; RESERVE; SUPPRESSION; PATHWAY; GROWTH; DAMAGE; PRESERVATION	The follicular ovarian reserve, constituted by primordial follicles (PMFs), is established early in life, then keeps declining regularly along reproductive life. The maintenance of a normal female reproductive function implies the presence of a vast amount of dormant PMFs. This process involves a continuous repression of PMF activation into early growing follicle through the balance between factors activating the initiation of follicular growth, mainly actors of the PI3K signaling pathway, and inhibiting factors such as anti-Mullerian hormone (AMH). Any disruption of this balance may induce follicle depletion and subsequent infertility. It has been recently proposed that cyclophosphamide (Cy), an alkylating agent commonly used for treating breast cancer, triggers PMF activation, further leading to premature ovarian insufficiency. Preventing chemotherapy-induced ovarian dysfunction might represent an interesting option for preserving optimal chances of natural or medically assisted conceptions after healing. The aim of the present study was to evaluate, in a model of Cy-treated pubertal mice, whether AMH administration might restrain PMF depletion. The counting of the total PMF number within mouse ovaries showed that recombinant AMH prevented Cy-induced PMF loss. Western blot analysis revealed activation of PI3K signaling pathway after Cy administration. After AMH injection, FOXO3A phosphorylation, a main actor of PMF activation, was significantly decreased. Taken together, these results support a protective role of AMH against Cy-induced follicular loss. We also provide evidence for a possible role of autophagy in the preservation of follicular pool reserve. Therefore, concomitant recombinant AMH administration during chemotherapy might offer a new option for preserving young patients' fertility.Sonigo, C., Beau, I., Grynberg, M., Binart, N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.	[Sonigo, Charlotte; Beau, Isabelle; Binart, Nadine] Univ Paris Saclay, Fac Med Paris Sud, INSERM, Unite 1185, Le Kremlin Bicetre, France; [Grynberg, Michael] Hop Antoine Beclere, Dept Reprod Med & Fertil Preservat, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Binart, N (corresponding author), Univ Paris Sud, INSERM, Unite 1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Beau, Isabelle/M-4423-2017; Sonigo, Charlotte/S-6438-2018; Binart, Nadine/F-2949-2013	Beau, Isabelle/0000-0002-3352-6813; Sonigo, Charlotte/0000-0002-0875-1592; Binart, Nadine/0000-0002-5606-3866	Plan Cancer 2014-2019; Canceropole Ile de France/Institut National du Cancer (INCA); Convention de Recherche [2015-1-EMERG-02-INSERM11-1]	Plan Cancer 2014-2019; Canceropole Ile de France/Institut National du Cancer (INCA); Convention de Recherche	The authors thank N. Ba and O. Trassard (Institut Biomedical de Recherche Unite Mixte de Service (UMS) 32, Plateau d'Imagerie, Histologie de Recherche, le Kremlin-Bicetre, France) for assistance in pathologic proceedings and slide scanning. Funding was received from Plan Cancer 2014-2019. This work was supported by the Canceropole Ile de France/Institut National du Cancer (INCA) and Convention de Recherche (Grant 2015-1-EMERG-02-INSERM11-1). The authors declare no conflicts of interest.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Assi J, 2018, J ASSIST REPROD GEN, V35, P601, DOI 10.1007/s10815-018-1131-7; Bedoschi G, 2016, FUTURE ONCOL, V12, P2333, DOI 10.2217/fon-2016-0176; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chang EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144245; Chen XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060836; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; Donnez J, 2017, NEW ENGL J MED, V377, P1657, DOI 10.1056/NEJMra1614676; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Fisch B, 2018, REPRODUCTION, V156, pF11, DOI 10.1530/REP-17-0483; Gannon AM, 2012, TOXICOL SCI, V125, P274, DOI 10.1093/toxsci/kfr279; Gawriluk TR, 2011, REPRODUCTION, V141, P759, DOI 10.1530/REP-10-0489; Gigli I, 2005, MOL REPROD DEV, V71, P480, DOI 10.1002/mrd.20338; Goldman KN, 2017, P NATL ACAD SCI USA, V114, P3186, DOI 10.1073/pnas.1617233114; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hayes E, 2016, MOL CELL ENDOCRINOL, V433, P56, DOI 10.1016/j.mce.2016.05.019; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Jang H, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12432; Jang H, 2016, J PINEAL RES, V60, P336, DOI 10.1111/jpi.12316; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kano M, 2017, P NATL ACAD SCI USA, V114, pE1688, DOI 10.1073/pnas.1620729114; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Meirow D, 1999, HUM REPROD, V14, P1903, DOI 10.1093/humrep/14.7.1903; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pfeifer S, 2013, FERTIL STERIL, V100, P1214, DOI 10.1016/j.fertnstert.2013.08.012; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Roness H, 2014, HUM REPROD UPDATE, V20, P759, DOI 10.1093/humupd/dmu019; Song ZH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.559; Sonigo C, 2012, J CLIN INVEST, V122, P3791, DOI 10.1172/JCI63937; Steiner AZ, 2017, JAMA-J AM MED ASSOC, V318, P1367, DOI 10.1001/jama.2017.14588; Sun YC, 2018, AGING-US, V10, P197, DOI 10.18632/aging.101376; Sun YC, 2017, INT J BIOL SCI, V13, P449, DOI 10.7150/ijbs.18836; Visser JA, 2014, MOL CELL ENDOCRINOL, V382, P460, DOI 10.1016/j.mce.2013.08.012; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Woodruff TK, 2009, NAT MED, V15, P1124, DOI 10.1038/nm1009-1124; Yang MY, 2017, MOL HUM REPROD, V23, P282, DOI 10.1093/molehr/gax010; Zhang XM, 2013, GENE, V523, P82, DOI 10.1016/j.gene.2013.03.039; Zhou LY, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0350-3	45	54	59	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1278	1287		10.1096/fj.201801089R	http://dx.doi.org/10.1096/fj.201801089R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113879				2022-12-28	WOS:000457401500101
J	Khalifeh-Soltani, A; Gupta, D; Ha, A; Podolsky, MJ; Datta, R; Atabai, K				Khalifeh-Soltani, Amin; Gupta, Deepti; Ha, Arnold; Podolsky, Michael J.; Datta, Ritwik; Atabai, Kamran			The Mfge8-alpha 81-PTEN pathway regulates airway smooth muscle contraction in allergic inflammation	FASEB JOURNAL			English	Article						integrins; airway hyperresponsiveness; cellular signaling	TUMOR-SUPPRESSOR PTEN; TISSUE DISTRIBUTION; HYPERRESPONSIVENESS; CELLS; ASTHMA; GROWTH; MFGE8; MOUSE; RHO; PHOSPHORYLATION	Asthma affects approximate to 300 million people worldwide. Despite multiple treatment options, asthma treatment remains unsatisfactory in a subset of patients. Airway obstruction is a hallmark of allergic asthma and is largely due to airway smooth muscle hypercontractility induced by airway inflammation. Identification of molecular pathways that regulate airway smooth muscle hypercontractility is of considerable therapeutic interest. We previously identified roles for milk fat globule epidermal growth factor-like 8 (Mfge8) in opposing the effects of allergic inflammation on increasing airway smooth muscle contractile force. In this study, we delineate the signaling pathway by which Mfge8 mediates these effects. By using genetic and pharmacologic approaches, we show that the 81 integrin and the phosphatase and tensin homolog (PTEN) mediate the effects of Mfge8 on preventing IL-13-induced increases in airway contractility. Tracheal rings from mice with smooth muscle-specific deletion of 81 or PTEN have enhanced contraction in response to treatment with IL-13. Enhanced IL-13-induced tracheal ring contraction in Mfge8(-/-) mice was abolished by treatment with the PI3K inhibitor. Mechanistically, IL-13 induces ubiquitination and degradation of PTEN protein. Our findings identify a role for the Mfge8-81-PTEN pathway in regulating the force of airway smooth muscle contraction in the setting of allergic inflammation.Khalifeh-Soltani, A., Gupta, D., Ha, A., Podolsky, M. J., Datta, R., Atabai, K. The Mfge8-81-PTEN pathway regulates airway smooth muscle contraction in allergic inflammation.	[Khalifeh-Soltani, Amin; Gupta, Deepti; Ha, Arnold; Podolsky, Michael J.; Datta, Ritwik; Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Podolsky, Michael J.; Atabai, Kamran] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Podolsky, Michael J.; Atabai, Kamran] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Atabai, K (corresponding author), Univ Calif San Francisco, Dept Med, Cardiovasc Res Inst, MC 3118,555 Mission Bay Blvd South,Room 252R, San Francisco, CA 94158 USA.	kamran.atabai@ucsf.edu	Gupta, Deepti/U-1777-2019; Datta, Ritwik/AFS-6077-2022	Gupta, Deepti/0000-0001-7931-0017; 				Anderson GP, 2003, TRENDS PHARMACOL SCI, V24, P71, DOI 10.1016/S0165-6147(02)00052-4; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Ceponis PJM, 2000, J BIOL CHEM, V275, P29132, DOI 10.1074/jbc.M003516200; Chan CS, 2010, GENES BRAIN BEHAV, V9, P402, DOI 10.1111/j.1601-183X.2010.00569.x; Chen C, 2012, J CLIN INVEST, V122, P2916, DOI 10.1172/JCI60387; Chiba Y, 1999, BRIT J PHARMACOL, V127, P597, DOI 10.1038/sj.bjp.0702585; Chiba Y, 2009, AM J RESP CELL MOL, V40, P159, DOI 10.1165/rcmb.2008-0162OC; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Ezeamuzie CI, 2001, AM J RESP CRIT CARE, V164, P1633, DOI 10.1164/ajrccm.164.9.2101104; Goto K, 2010, PHARMACOL RES, V61, P466, DOI 10.1016/j.phrs.2009.12.001; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huang XZ, 2000, MOL CELL BIOL, V20, P755, DOI 10.1128/MCB.20.3.755-759.2000; Janssen LJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-123; Kawabata A, 2000, LIFE SCI, V67, P2521, DOI 10.1016/S0024-3205(00)00835-3; Khalifeh-Soltani A, 2016, ELIFE, V5, DOI 10.7554/eLife.13063; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Kudo M, 2013, P NATL ACAD SCI USA, V110, P660, DOI 10.1073/pnas.1216673110; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Leslie NR, 2016, BIOCHEM SOC T, V44, P273, DOI 10.1042/BST20150224; Li N, 2015, GENE DEV, V29, P157, DOI 10.1101/gad.251785.114; Li W, 2014, NEUROSCIENCE, V274, P153, DOI 10.1016/j.neuroscience.2014.05.027; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaafsma D, 2006, EUR J PHARMACOL, V531, P145, DOI 10.1016/j.ejphar.2005.12.043; SCHNAPP LM, 1995, J CELL SCI, V108, P537; Sugimoto K, 2012, J CLIN INVEST, V122, P748, DOI 10.1172/JCI58815; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Yamada KM, 2001, J CELL SCI, V114, P2375; Zargham R, 2007, ATHEROSCLEROSIS, V195, P303, DOI 10.1016/j.atherosclerosis.2007.01.005; Zargham R, 2007, FEBS LETT, V581, P939, DOI 10.1016/j.febslet.2007.01.069; Zargham R, 2006, CARDIOVASC RES, V71, P170, DOI 10.1016/j.cardiores.2006.03.003	53	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5927	5936		10.1096/fj.201800109R	http://dx.doi.org/10.1096/fj.201800109R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29763381	Bronze			2022-12-28	WOS:000447172000014
J	Zhang, Z; Liu, J; Wang, YY; Tan, X; Zhao, WN; Xing, XX; Qiu, YL; Wang, R; Jin, MH; Fan, GW; Zhang, P; Zhong, YX; Kong, DX				Zhang, Zhe; Liu, Jie; Wang, Yingying; Tan, Xiao; Zhao, Wennan; Xing, Xiaoxue; Qiu, Yuling; Wang, Ran; Jin, Meihua; Fan, Guanwei; Zhang, Ping; Zhong, Yuxu; Kong, Dexin			Phosphatidylinositol 3-kinase and isoforms play key roles in metastasis of prostate cancer DU145 cells	FASEB JOURNAL			English	Article						PI3K isoform; inhibitor; antimetastatic; migration; invasion	PIK3CA GENE; SELECTIVE INHIBITORS; OVARIAN-CANCER; BREAST-CANCER; PI3K; PATHWAY; GROWTH; BONE; P110-ALPHA; MIGRATION	Metastasis is the main cause of the lethality of prostate cancer. Class I phosphatidylinositol 3-kinases (PI3Ks), which contain 4 isoforms, , , , and , are known to play important roles in cell growth, migration, invasion, and so on. However, the respective role of each PI3K isoform in cancer cell migration and invasion remains unknown. In a study that aimed to elucidate the respective role of the 4 PI3K isoforms, we investigated the change in migratory and invasive ability of DU145 cells after treatment with each PI3K isoform-specific inhibitor. Both migration and invasion of DU145 cells were potently blocked by each of the PI3K inhibitors (GSK2636771 and TGX221) and PI3K inhibitors (CAL101 and IC87114) while not obviously affected by PI3K inhibitor BYL719 or PI3K inhibitor AS252424. Furthermore, knocking down PI3K or PI3K isoform led to a significant decrease in migration of DU145. The results suggest that PI3K and PI3K play key roles in prostate cancer cell migration, while PI3K and PI3K might be redundant. Oral administration of GSK2636771 (100 mg/kg) and CAL101 (30 mg/kg) inhibited tumor growth in bone, an experimental model by intratibia injection of DU145 cells, with improved bone structure and bone mineral density analyzed by micro-computed tomography. Tissue staining indicated reduction of metastatic DU145 cells and osteoclasts in the bones of GSK2636771- and CAL101-treated mice compared to the untreated group. In summary, our results indicated the distinct roles of 4 PI3K isoforms in the migration of prostate cancer DU145 cells, and they demonstrated the in vitro and in vivo antimetastatic effect of PI3K-isoform specific inhibitors, most of which are in clinical trials.Zhang, Z., Liu, J., Wang, Y., Tan, X., Zhao, W., Xing, X., Qiu, Y., Wang, R., Jin, M., Fan, G., Zhang, P., Zhong, Y., Kong, D. Phosphatidylinositol 3-kinase and isoforms play key roles in metastasis of prostate cancer DU145 cells.	[Zhang, Zhe; Liu, Jie; Wang, Yingying; Tan, Xiao; Zhao, Wennan; Qiu, Yuling; Wang, Ran; Jin, Meihua; Kong, Dexin] Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Sch Pharmaceut Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Zhang, Ping] Tianjin Med Univ, Dept Anat & Histol, Sch Basic Med Sci, Tianjin, Peoples R China; [Tan, Xiao; Zhong, Yuxu] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, 27 Taiping Rd, Beijing 100850, Peoples R China; [Xing, Xiaoxue; Fan, Guanwei] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Academy of Military Medical Sciences - China; Tianjin University of Traditional Chinese Medicine	Kong, DX (corresponding author), Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Sch Pharmaceut Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.; Zhong, YX (corresponding author), Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, 27 Taiping Rd, Beijing 100850, Peoples R China.	yuxuzhong2008@aliyun.com; kongdexin@tmu.edu.cn	Kong, Dexin/AAL-8336-2020; guanwei, fan/M-8193-2019; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; wang, yi/GVT-8516-2022; FAN, GUANWEI/GWV-6480-2022		National Natural Science Foundation of China [81373441, 81673464, 81672809, 81602614]; Major Project of Tianjin for New Drug Development [17ZXXYSY00050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Tianjin for New Drug Development	The authors thank J. Li (School of Basic Medical Sciences, Tianjin Medical University) for technical assistance with the histologic analysis. This study was supported by grants from the National Natural Science Foundation of China (81373441, 81673464, 81672809, 81602614) and a grant from Major Project of Tianjin for New Drug Development (17ZXXYSY00050). The authors declare no conflicts of interest.	Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kong D, 2009, EUR J CANCER, V45, P857, DOI 10.1016/j.ejca.2008.12.007; Kretschmann KL, 2012, CANCER METAST REV, V31, P579, DOI 10.1007/s10555-012-9378-4; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Liu H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8949; Mateo J, 2017, CLIN CANCER RES, V23, P5981, DOI 10.1158/1078-0432.CCR-17-0725; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ost P, 2015, EUR UROL, V67, P852, DOI 10.1016/j.eururo.2014.09.004; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Saudemont A, 2009, P NATL ACAD SCI USA, V106, P5795, DOI 10.1073/pnas.0808594106; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shugg RPP, 2013, J BIOL CHEM, V288, P35346, DOI 10.1074/jbc.M113.507525; Simmons JK, 2015, VET PATHOL, V52, P827, DOI 10.1177/0300985815586223; Simmons JK, 2014, PROSTATE, V74, P1251, DOI 10.1002/pros.22838; Smith GC, 2013, FEBS J, V280, P5337, DOI 10.1111/febs.12428; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Tzenaki N, 2012, FASEB J, V26, P2498, DOI 10.1096/fj.11-198192; Wang X, 2015, ACTA PHARMACOL SIN, V36, P1170, DOI 10.1038/aps.2015.71; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Whyte DB, 2006, BIOCHEM BIOPH RES CO, V340, P469, DOI 10.1016/j.bbrc.2005.12.025; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao WN, 2017, ACTA PHARM SIN B, V7, P27, DOI 10.1016/j.apsb.2016.07.006; Zhao WN, 2013, INT J MOL SCI, V14, P13577, DOI 10.3390/ijms140713577; Zhou QX, 2016, INT J BIOL SCI, V12, P631, DOI 10.7150/ijbs.14878	44	20	20	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5967	5975		10.1096/fj.201800183R	http://dx.doi.org/10.1096/fj.201800183R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29792732	Bronze			2022-12-28	WOS:000447172000017
J	Samarani, M; Loberto, N; Solda, G; Straniero, L; Asselta, R; Duga, S; Lunghi, G; Zucca, FA; Mauri, L; Ciampa, MG; Schiumarini, D; Bassi, R; Giussani, P; Chiricozzi, E; Prinetti, A; Aureli, M; Sonnino, S				Samarani, Maura; Loberto, Nicoletta; Solda, Giulia; Straniero, Letizia; Asselta, Rosanna; Duga, Stefano; Lunghi, Giulia; Zucca, Fabio A.; Mauri, Laura; Ciampa, Maria Grazia; Schiumarini, Domitilla; Bassi, Rosaria; Giussani, Paola; Chiricozzi, Elena; Prinetti, Alessandro; Aureli, Massimo; Sonnino, Sandro			A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest	FASEB JOURNAL			English	Article						glycosphingolipids; glycohydrolases; cell proliferation; cell surface; catabolism	HUMAN FIBROBLASTS; SUCROSE MODEL; GANGLIOSIDE; CERAMIDE; PROTEIN; DIFFERENTIATION; IDENTIFICATION; BIOGENESIS; SURFACE; TFEB	Lysosomal accumulation of undegraded materials is a common feature of lysosomal storage diseases, neurodegenerative disorders, and the aging process. To better understand the role of lysosomal storage in the onset of cell damage, we used human fibroblasts loaded with sucrose as a model of lysosomal accumulation. Sucrose-loaded fibroblasts displayed increased lysosomal biogenesis followed by arrested cell proliferation. Notably, we found that reduced lysosomal catabolism and autophagy impairment led to an increase in sphingolipids (i.e., sphingomyelin, glucosylceramide, ceramide, and the gangliosides GM3 and GD3), at both intracellular and plasma membrane (PM) levels. In addition, we observed an increase in the lysosomal membrane protein Lamp-1 on the PM of sucrose-loaded fibroblasts and a greater release of the soluble lysosomal protein cathepsin D in their extracellular medium compared with controls. These results indicate increased fusion between lysosomes and the PM, as also suggested by the increased activity of lysosomal glycosphingolipid hydrolases on the PM of sucrose-loaded fibroblasts. The inhibition of -glucocerebrosidase and nonlysosomal glucosylceramidase, both involved in ceramide production resulting from glycosphingolipid catabolism on the PM, partially restored cell proliferation. Our findings indicate the existence of a new molecular mechanism underlying cell damage triggered by lysosomal impairment.Samarani, M., Loberto, N., Solda, G., Straniero, L., Asselta, R., Duga, S., Lunghi, G., Zucca, F. A., Mauri, L., Ciampa, M. G., Schiumarini, D., Bassi, R., Giussani, P., Chiricozzi, E., Prinetti, A., Aureli, M., Sonnino, S. A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest.	[Samarani, Maura; Loberto, Nicoletta; Lunghi, Giulia; Mauri, Laura; Ciampa, Maria Grazia; Schiumarini, Domitilla; Bassi, Rosaria; Giussani, Paola; Chiricozzi, Elena; Prinetti, Alessandro; Aureli, Massimo; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, Via Fratelli Cervi 93, I-20090 Milan, Italy; [Solda, Giulia; Straniero, Letizia; Asselta, Rosanna; Duga, Stefano] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Solda, Giulia; Straniero, Letizia; Asselta, Rosanna; Duga, Stefano] Humanitas Clin & Res Ctr, Milan, Italy; [Zucca, Fabio A.] Natl Res Council Italy, Inst Biomed Technol, Segrate, Italy	University of Milan; Humanitas University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Aureli, M; Sonnino, S (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Via Fratelli Cervi 93, I-20090 Milan, Italy.	massimo.aureli@unimi.it; sandro.sonnino@unimi.it	mauri, laura/GPS-4868-2022; Solda', Giulia/A-4053-2011; Zucca, Fabio A./O-4368-2015; Soldà, Giulia/AAG-3589-2020; Chiricozzi, Elena/AAC-2018-2019; Straniero, Letizia/HHM-4707-2022; Lunghi, Giulia/GLU-1509-2022; Asselta, Rosanna/AAC-2367-2019; STRANIERO, LETIZIA/AAB-4869-2020; MAURI, LAURA/H-5076-2017; Duga, Stefano/F-8173-2014	Solda', Giulia/0000-0003-0972-610X; Zucca, Fabio A./0000-0003-1230-1129; Soldà, Giulia/0000-0003-0972-610X; Straniero, Letizia/0000-0002-1733-7561; Asselta, Rosanna/0000-0001-5351-0619; STRANIERO, LETIZIA/0000-0002-1733-7561; MAURI, LAURA/0000-0002-4194-4804; CHIRICOZZI, ELENA/0000-0001-7431-9207; Duga, Stefano/0000-0003-3457-1410; LUNGHI, GIULIA/0000-0002-3099-3395	Fondazione Cariplo Grant 2015-1017; Italian National Research Council's flagship "InterOmics" Project [PB.P05]; National Research Program (Italian Ministry of Education, Universities and Research); National Research Council (Italian Ministry of Education, Universities and Research); Medical University of South Carolina's Lipidomics Shared Resource [Hollings Cancer Center, Medical University of South Carolina (MUSC)] [P30 CA138313]; Lipidomics Shared Resource of the South Carolina Lipidomics and Pathobiology Centers of Biomedical Research Excellence (COBRE); MUSC Department of Biochemistry [P20 RR017677]; U.S. National Institutes of Health, National Center for Research Resources [C06 RR018823]; U.S. National Institutes of Health, Office of the Director [C06 RR018823]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER	Fondazione Cariplo Grant 2015-1017(Fondazione Cariplo); Italian National Research Council's flagship "InterOmics" Project; National Research Program (Italian Ministry of Education, Universities and Research); National Research Council (Italian Ministry of Education, Universities and Research); Medical University of South Carolina's Lipidomics Shared Resource [Hollings Cancer Center, Medical University of South Carolina (MUSC)]; Lipidomics Shared Resource of the South Carolina Lipidomics and Pathobiology Centers of Biomedical Research Excellence (COBRE); MUSC Department of Biochemistry; U.S. National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. National Institutes of Health, Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Maria Carla Panzeri (Advanced Light and Electron Microscopy BioImaging Center, San Raffaele Scientific Institute, Milan, Italy) for her expert assistance in electron microscopy imaging, and Prof. J. M. F. G. Aerts (Leiden University, Leiden, The Netherlands) for providing AMP-DNM. This work was supported by Fondazione Cariplo Grant 2015-1017 to M. A., and was partially supported by the Italian National Research Council's flagship "InterOmics" Project (PB.P05), part of the 2012-2014 program on aging sponsored by the National Research Program and the National Research Council (Italian Ministry of Education, Universities and Research). Lipidomic analyses were partially supported by the Medical University of South Carolina's Lipidomics Shared Resource [Hollings Cancer Center, Medical University of South Carolina (MUSC); Grant P30 CA138313]; the Lipidomics Shared Resource of the South Carolina Lipidomics and Pathobiology Centers of Biomedical Research Excellence (COBRE); MUSC Department of Biochemistry (Grant P20 RR017677); and the U.S. National Institutes of Health, National Center for Research Resources and Office of the Director (Grant C06 RR018823) for the occupancy of space for the Lipidomics Shared Resource, 505 Children's Research Institute (CRI) Analytical Unit. The authors declare no conflicts of interest.	ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; APPELMANS F, 1955, BIOCHEM J, V59, P438, DOI 10.1042/bj0590438; Aureli M, 2014, MOL NEUROBIOL, V50, P76, DOI 10.1007/s12035-013-8592-6; Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; Aureli M, 2012, GLYCOCONJUGATE J, V29, P585, DOI 10.1007/s10719-012-9385-2; Aureli M, 2012, NEUROCHEM RES, V37, P1344, DOI 10.1007/s11064-012-0719-z; Aureli M, 2011, J NEUROCHEM, V116, P891, DOI 10.1111/j.1471-4159.2010.07019.x; Aureli M, 2009, FEBS LETT, V583, P2469, DOI 10.1016/j.febslet.2009.06.048; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009; Chigorno V, 1996, J BIOL CHEM, V271, P21738, DOI 10.1074/jbc.271.36.21738; Chigorno V, 1997, EUR J BIOCHEM, V250, P661, DOI 10.1111/j.1432-1033.1997.00661.x; Chigorno V, 1985, GLYCOCONJUGATE J, VV2, P279; COLE SR, 1987, MOL IMMUNOL, V24, P699, DOI 10.1016/0161-5890(87)90051-4; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIGLIONI A, 1990, BIOCHEM INT, V22, P85; Hamer I, 2005, EXP CELL RES, V309, P284, DOI 10.1016/j.yexcr.2005.06.006; Helip-Wooley A, 2004, EXP CELL RES, V292, P89, DOI 10.1016/j.yexcr.2003.09.003; Higuchi T, 2015, J CELL BIOCHEM, V116, P609, DOI 10.1002/jcb.25012; HUG G, 1984, NEW ENGL J MED, V310, P1018, DOI 10.1056/NEJM198404193101604; Isaac EL, 2000, EXP CELL RES, V254, P204, DOI 10.1006/excr.1999.4755; JAHRAUS A, 1994, J CELL SCI, V107, P145; Karageorgos LE, 1997, EXP CELL RES, V234, P85, DOI 10.1006/excr.1997.3581; KATO T, 1984, MOL CELL BIOCHEM, V60, P83; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mencarelli S, 2005, FEBS LETT, V579, P5501, DOI 10.1016/j.febslet.2005.08.081; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Prinetti A, 2001, J NEUROCHEM, V78, P1162, DOI 10.1046/j.1471-4159.2001.00515.x; Prinetti A, 2011, NEUROCHEM RES, V36, P1654, DOI 10.1007/s11064-010-0380-3; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Santaguida S, 2015, AUTOPHAGY, V11, P2383, DOI 10.1080/15548627.2015.1110670; Santaguida S, 2015, GENE DEV, V29, P2010, DOI 10.1101/gad.269118.115; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schiumarini D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1730245; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sciannamblo M, 2002, GLYCOCONJUGATE J, V19, P181, DOI 10.1023/A:1024249707516; Settembre C, 2015, METHOD CELL BIOL, V126, P45, DOI 10.1016/bs.mcb.2014.11.011; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sonnino S, 2000, METHOD ENZYMOL, V311, P639; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; TOYOKUNI T, 1991, J LABELLED COMPD RAD, V29, P567, DOI 10.1002/jlcr.2580290508; Valaperta R, 2007, J NEUROCHEM, V100, P708, DOI 10.1111/j.1471-4159.2006.04279.x; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VASKOVSKY VE, 1968, J LIPID RES, V9, P396; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031	68	25	25	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5685	5702		10.1096/fj.201701512RR	http://dx.doi.org/10.1096/fj.201701512RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746165	Green Published, Bronze			2022-12-28	WOS:000447972500040
J	Aidoud, N; Delplanque, B; Baudry, C; Garcia, C; Moyon, A; Balasse, L; Guillet, B; Antona, C; Darmaun, D; Fraser, K; Ndiaye, S; Leruyet, P; Martin, JC				Aidoud, Nacima; Delplanque, Bernadette; Baudry, Charlotte; Garcia, Cyrielle; Moyon, Anais; Balasse, Laure; Guillet, Benjamin; Antona, Claudine; Darmaun, Dominique; Fraser, Karl; Ndiaye, Sega; Leruyet, Pascale; Martin, Jean-Charles			A combination of lipidomics, MS imaging, and PET scan imaging reveals differences in cerebral activity in rat pups according to the lipid quality of infant formulas	FASEB JOURNAL			English	Article						omics; neonatal nutrition; lactation; artificial rearing	POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; OXIDATIVE STRESS; ARACHIDONIC-ACID; BRAIN GROWTH; HUMAN-MILK; SUPPLEMENTATION; DHA; NEUROGENESIS; METABOLISM	We evaluated the effect of adding docosahexaenoic:arachidonic acids (3:2) (DHA+ARA) to 2 representative commercial infant formulas on brain activity and brain and eye lipids in an artificially reared rat pup model. The formula lipid background was either a pure plant oil blend, or dairy fat with a plant oil blend (1:1). Results at weaning were compared to breast milk-fed pups. Brain functional activity was determined by positron emission tomography scan imaging, the brain and eye fatty acid and lipid composition by targeted and untargeted lipidomics, and DHA brain regional location by mass-spectrometry imaging. The brain functional activity was normalized to controls with DHA+ARA added to the formulas. DHA in both brain and eyes was influenced by formula intake, but more than two-thirds of tissue DHA-glycerolipids remained insensitive to the dietary challenge. However, the DHA lipidome correlated better with brain function than sole DHA content (r = 0.70 vs.r = 0.48; P < 0.05). Brain DHA regional distribution was more affected by the formula lipid background than the provision of PUFAs. Adding DHA+ARA to formulas alters the DHA content and lipidome of nervous tissue in the neonate, making it closer to dam milk-fed controls, and normalizes brain functional activity.Aidoud, N., Delplanque, B., Baudry, C., Garcia, C., Moyon, A., Balasse, L., Guillet, B., Antona, C., Darmaun, D., Fraser, K., Ndiaye, S., Leruyet, P., Martin, J.-C. A combination of lipidomics, MS imaging, and PET scan imaging reveals differences in cerebral activity in rat pups according to the lipid quality of infant formulas.	[Aidoud, Nacima; Garcia, Cyrielle; Antona, Claudine; Martin, Jean-Charles] Univ Aix Marseille, INRA, Ctr Rech Cardiovasc & Nutr C2VN, INSERM,BioMet, Marseille, France; [Moyon, Anais; Balasse, Laure; Guillet, Benjamin] Univ Aix Marseille, Ctr Europeen Rech Imagerie Med CERIMED, Marseille, France; [Delplanque, Bernadette] Ctr Neurosci Univ Paris Sud CNPS, Lab Neuroendocrinol Mol Prise Alimentaire NMPA, Orsay, France; [Baudry, Charlotte; Leruyet, Pascale] Lactalis Rech & Dev, Retiers, France; [Darmaun, Dominique; Ndiaye, Sega] Univ Nantes, INRA, Physiopathol Adaptat Nutr PHAN, Nantes, France; [Darmaun, Dominique; Ndiaye, Sega] Thermo Fisher Sci, Courtaboeuf, France; [Fraser, Karl] Massey Univ, Food Nutr & Hlth Team, Food & Biobased Prod Grp, AgRes Grasslands Res Ctr,Riddet Inst, Palmerston North, New Zealand	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Nantes Universite; Thermo Fisher Scientific; AgResearch - New Zealand; Massey University	Martin, JC (corresponding author), INRA, C2VN, Fac Med La Timone, 27 Blvd Jean Moulin, F-13385 Marseille, France.	jean-charles.martin@univ-amu.fr	Darmaun, Dominique/X-8453-2018; Fraser, Karl/V-6856-2019	Darmaun, Dominique/0000-0002-0366-3227; Fraser, Karl/0000-0002-1136-4024; Garcia, Cyrielle/0000-0001-6705-6859; martin, jean-charles/0000-0002-2870-0012	Lactalis Research and Development (Retiers, France); Aix-Marseille and Lactalis Research and Development Ph.D. Fellowship	Lactalis Research and Development (Retiers, France); Aix-Marseille and Lactalis Research and Development Ph.D. Fellowship	The authors thank Samantha Fernandez, Brigitte Nicolini, and Noelle Masotti (Universite Aix-Marseille) for animal care during rearing and PET scan imaging; and Raphael Legouffe, Florian Farcette, David Bonnel, and Alain Heron (Imabiotech, Lille, France) for MS imaging. Part of the funding was from Lactalis Research and Development (Retiers, France). Nacima Aidoud is a recipient of an Aix-Marseille and Lactalis Research and Development Ph.D. Fellowship. Pascale Leruyet and Charlotte Baudry are employees of the Lactalis company. The authors declare no other conflicts of interest.	Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3757; Alessandri JM, 2003, AM J CLIN NUTR, V78, P702, DOI 10.1093/ajcn/78.4.702; AUESTAD N, 1989, BRIT J NUTR, V61, P495, DOI 10.1079/BJN19890139; Bhinder G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45274; Bonnel D, 2017, METHODS MOL BIOL, V1641, P129, DOI 10.1007/978-1-4939-7172-5_6; Breitkopf SB, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-016-1157-8; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; Church MW, 2010, NEUROTOXICOL TERATOL, V32, P171, DOI 10.1016/j.ntt.2009.09.006; Crawford MA, 2015, PROSTAG LEUKOTR ESS, V102, P1, DOI 10.1016/j.plefa.2015.07.005; Davis-Bruno K, 2011, BIRTH DEFECTS RES B, V92, P240, DOI 10.1002/bdrb.20311; de la Presa-Owens S, 1998, J NUTR, V128, P1376, DOI 10.1093/jn/128.8.1376; Delplanque B, 2015, J PEDIATR GASTR NUTR, V61, P8, DOI 10.1097/MPG.0000000000000818; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Du Q, 2012, J NUTR BIOCHEM, V23, P1573, DOI 10.1016/j.jnutbio.2011.10.011; Friel JK, 2004, PEDIATR RES, V56, P878, DOI 10.1203/01.PDR.0000146032.98120.43; Garrigue P, 2017, J NUCL MED, V58, P1749, DOI 10.2967/jnumed.117.192674; Giacomoni F, 2015, BIOINFORMATICS, V31, P1493, DOI 10.1093/bioinformatics/btu813; Guesnet P, 2011, BIOCHIMIE, V93, P7, DOI 10.1016/j.biochi.2010.05.005; Hadley KB, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040216; HALL WG, 1975, SCIENCE, V190, P1313, DOI 10.1126/science.1198116; Hashimoto M, 2015, BBA-MOL CELL BIOL L, V1851, P203, DOI 10.1016/j.bbalip.2014.10.009; Henriksen C, 2008, PEDIATRICS, V121, P1137, DOI 10.1542/peds.2007-1511; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Kuratko CN, 2009, PROSTAG LEUKOTR ESS, V81, P111, DOI 10.1016/j.plefa.2009.05.007; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Liu WL, 2017, FREE RADICAL BIO MED, V112, P174, DOI 10.1016/j.freeradbiomed.2017.07.024; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Manev H, 2001, ANN NY ACAD SCI, V939, P45; Martin JC, 2015, METABOLOMICS, V11, P807, DOI 10.1007/s11306-014-0740-0; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; Meydani M, 1992, EXS, V62, P411; Nakajima Y, 2008, BRAIN RES, V1226, P226, DOI 10.1016/j.brainres.2008.06.026; Paxinos G., 2004, RAT BRAIN ATLAS NEW; Pifferi F, 2007, PROSTAG LEUKOTR ESS, V77, P279, DOI 10.1016/j.plefa.2007.10.011; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; Richard C, 2016, APPL PHYSIOL NUTR ME, V41, P461, DOI 10.1139/apnm-2015-0660; Russo I, 2011, CELL CYCLE, V10, P2568, DOI 10.4161/cc.10.15.15946; Sun H, 2015, J PERINATOL, V35, P867, DOI 10.1038/jp.2015.87; Tassoni D, 2008, ASIA PAC J CLIN NUTR, V17, P220; Uchida K, 2002, ZOOL SCI, V19, P1211, DOI 10.2108/zsj.19.1211; Valeille K, 2004, REPROD NUTR DEV, V44, P459, DOI 10.1051/rnd:2004048; van Goor SA, 2010, BRIT J NUTR, V103, P235, DOI 10.1017/S0007114509991528; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xiang M, 2000, ACTA PAEDIATR, V89, P142, DOI 10.1080/080352500750028735; Xiao Y, 2005, BRIT J NUTR, V94, P544, DOI 10.1079/BJN20051539; Yajima M, 2006, EXP ANIM TOKYO, V55, P391, DOI 10.1538/expanim.55.391; Yao L, 2010, J PEDIATR GASTR NUTR, V50, P670, DOI 10.1097/MPG.0b013e3181bab2d3	49	13	13	5	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4776	4790		10.1096/fj.201800034R	http://dx.doi.org/10.1096/fj.201800034R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29565735				2022-12-28	WOS:000443817700013
J	Heinemeier, KM; Schjerling, P; Ohlenschlaeger, TF; Eismark, C; Olsen, J; Kjaer, M				Heinemeier, Katja Maria; Schjerling, Peter; Ohlenschlaeger, Tommy F.; Eismark, Christian; Olsen, Jesper; Kjaer, Michael			Carbon-14 bomb pulse dating shows that tendinopathy is preceded by years of abnormally high collagen turnover	FASEB JOURNAL			English	Article						tendon; tendon disease; metabolism; collagen synthesis	ROTATOR CUFF TENDONS; ASPARTIC-ACID; ACHILLES; RACEMIZATION; RADIOCARBON; AGE; MECHANISMS; EXPRESSION; TENDINITIS; TENDINOSIS	Tendons are essential weight-bearing structures that are often affected by tendinopathy, which leads to pain and impaired mobility. In healthy Achilles tendons, no significant renewal of the weight-bearing collagen matrix seems to occur during adult life, but tendinopathy may lead to increased turnover. The carbon-14 ([C-14]) bomb pulse method was used to measure lifelong replacement rates of collagen in tendinopathic and healthy Achilles tendons (tendinopathic: n = 25, born 1937-1972. Healthy: n = 10, born 1929-1966). As expected, the healthy tendon collagen had not been replaced during adulthood, but in tendinopathic tendon, a substantial renewal had occurred. Modeling of the [C-14] data suggested that one half of the collagen in tendinopathic matrix had undergone continuous slow turnover for years before the presentation of symptoms. This finding allows for a new concept in tendon pathogenesis because it suggests that either the symptoms of tendinopathy represent a late phase of a very prolonged disease process, or an abnormally high collagen exchange could be a risk factor for tendon disorders rather than being a result of disease.Heinemeier, K. M., Schjerling, P., Ohlenschlaeger, T. F., Eismark, C., Olsen, J., Kjaer, M. Carbon-14 bomb pulse dating shows that tendinopathy is preceded by years of abnormally high collagen turnover.	[Heinemeier, Katja Maria; Schjerling, Peter; Ohlenschlaeger, Tommy F.; Eismark, Christian; Kjaer, Michael] Univ Copenhagen, Inst Sports Med Copenhagen, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark; [Heinemeier, Katja Maria; Schjerling, Peter; Ohlenschlaeger, Tommy F.; Eismark, Christian; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Olsen, Jesper] Aarhus Univ, Dept Phys & Astron, Aarhus Accelerator Mass Spectrometry AMS Ctr, Aarhus, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Aarhus University	Heinemeier, KM (corresponding author), Univ Copenhagen, Inst Sports Med, Bispebjerg Hosp, Dept Orthoped Surg M, Bldg 8,1 Floor,Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	kmh.ismc@gmail.com	Schjerling, Peter/F-6194-2011; Kjaer, Michael/W-6842-2019; Olsen, Jesper/F-1656-2013	Schjerling, Peter/0000-0001-7138-3211; Kjaer, Michael/0000-0002-4582-8755; Olsen, Jesper/0000-0002-4445-5520	Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Independent Research (Health and Disease); Nordea Foundation (Healthy Ageing Grant); Bispebjerg Hospital Research Grant	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research (Health and Disease); Nordea Foundation (Healthy Ageing Grant); Bispebjerg Hospital Research Grant	The authors thank Prof. JOrgen Tranum-Jensen (Faculty of Health and Medical Sciences, University of Copenhagen) for advice and help with tissue sampling, and to Ulla Ramer Mikkelsen (Institute of Sports Medicine, Bispebjerg Hospital) for help with tissue sampling. Financial support from the Lundbeck Foundation, Bispebjerg Hospital Research Grant, Novo Nordisk Foundation, Danish Council for Independent Research (Health and Disease), and the Nordea Foundation (Healthy Ageing Grant) is greatly appreciated. The authors declare no conflicts of interest.	Alkass K, 2010, MOL CELL PROTEOMICS, V9, P1022, DOI 10.1074/mcp.M900525-MCP200; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35; Birch HL, 2007, INT J EXP PATHOL, V88, P241, DOI 10.1111/j.1365-2613.2007.00552.x; Canoira L, 2003, INT J CHEM KINET, V35, P576, DOI 10.1002/kin.10153; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; FERRETTI A, 1986, SPORTS MED, V3, P289, DOI 10.2165/00007256-198603040-00005; Frost P, 2002, AM J IND MED, V41, P11, DOI 10.1002/ajim.10019; Heinemeier KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8335; Heinemeier KM, 2017, J APPL PHYSIOL, V123, P1397, DOI 10.1152/japplphysiol.00281.2017; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Hoemann CD, 2004, METH MOLEC MED, V101, P127; Kueppers LM, 2004, OECOLOGIA, V141, P641, DOI 10.1007/s00442-004-1689-x; Levin I, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20092; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; MAROUDAS A, 1992, CONNECT TISSUE RES, V28, P161, DOI 10.3109/03008209209015033; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Nielsen RH, 2014, MATRIX BIOL, V34, P96, DOI 10.1016/j.matbio.2013.09.005; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Olsen J, 2017, RADIOCARBON, V59, P905, DOI 10.1017/RDC.2016.85; Pingel J, 2013, EUR J APPL PHYSIOL, V113, P2101, DOI 10.1007/s00421-013-2638-3; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Stabler TV, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2639; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Sunding K, 2016, KNEE SURG SPORT TR A, V24, P1988, DOI 10.1007/s00167-014-3270-4; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Tanaka S, 2001, AM J IND MED, V39, P328, DOI 10.1002/1097-0274(200103)39:3<328::AID-AJIM1021>3.0.CO;2-I; Thomopoulos S, 2015, J ORTHOP RES, V33, P832, DOI 10.1002/jor.22806; Van Duin ACT, 1998, ORG GEOCHEM, V29, P1227, DOI 10.1016/S0146-6380(98)00098-9	35	26	26	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4763	4775		10.1096/fj.201701569R	http://dx.doi.org/10.1096/fj.201701569R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570396				2022-12-28	WOS:000443817700012
J	Henderson, AM; Tai, DC; Aleliunas, RE; Aljaadi, AM; Glier, MB; Xu, EE; Miller, JW; Verchere, CB; Green, TJ; Devlin, AM				Henderson, Amanda M.; Tai, Daven C.; Aleliunas, Rika E.; Aljaadi, Abeer M.; Glier, Melissa B.; Xu, Eric E.; Miller, Joshua W.; Verchere, C. Bruce; Green, Tim J.; Devlin, Angela M.			Maternal folic acid supplementation with vitamin B-12 deficiency during pregnancy and lactation affects the metabolic health of adult female offspring but is dependent on offspring diet	FASEB JOURNAL			English	Article						adiposity; developmental programming; folate; glucose homeostasis; maternal diet	HIGH-FAT DIET; INSULIN-RESISTANCE; DNA METHYLATION; FOLATE CONCENTRATIONS; CANADIAN WOMEN; BETA-CELLS; FORTIFICATION; MICE; POPULATION; DISEASE	Epidemiologic studies have reported relationships between maternal high folate and/or low B-12 status during pregnancy and greater adiposity and insulin resistance in children. The goal of this study was to determine the effects of maternal folic acid supplementation (10 mg/kg diet), with (50 g/kg diet) and without B-12, on adult female offspring adiposity and glucose homeostasis. Female C57BL/6J mice were fed 1 of 3 diets from weaning and throughout breeding, pregnancy, and lactation: control (2 mg/kg diet folic acid, 50 g/kg diet B-12), supplemental folic acid with no B-12 (SFA-B-12), or supplemental folic acid with adequate B-12 (SFA+B-12). Female offspring were weaned onto the control diet or a Western diet (45% energy fat, 2 mg/kg diet folic acid, 50 g/kg diet B-12) for 35 wk. After weaning, control diet-fed offspring with SFA-B-12 dams had fasting hyperglycemia, glucose intolerance, lower cell mass, and greater islet hepatocyte nuclear factor 1 homeobox and nuclear receptor subfamily 1 group H member 3 mRNA than did offspring from control dams. In Western diet-fed offspring, those with SFA-B-12 dams had lower fasting blood glucose and plasma insulin concentrations, and were smaller than control offspring. Our findings suggest that maternal folic acid supplementation with B-12 deficiency during pregnancy/lactation programs the metabolic health of adult female offspring but is dependent on offspring diet.Henderson, A. M., Tai, D. C., Aleliunas, R. E., Aljaadi, A. M., Glier, M. B., Xu, E. E., Miller, J. W., Verchere, C. B., Green, T. J., Devlin, A. M. Maternal folic acid supplementation with vitamin B-12 deficiency during pregnancy and lactation affects the metabolic health of adult female offspring but is dependent on offspring diet.	[Henderson, Amanda M.; Glier, Melissa B.; Verchere, C. Bruce; Devlin, Angela M.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Henderson, Amanda M.; Tai, Daven C.; Aleliunas, Rika E.; Aljaadi, Abeer M.; Glier, Melissa B.; Xu, Eric E.; Verchere, C. Bruce; Devlin, Angela M.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Aljaadi, Abeer M.] Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada; [Xu, Eric E.] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Henderson, Amanda M.; Tai, Daven C.; Aleliunas, Rika E.; Aljaadi, Abeer M.; Glier, Melissa B.; Xu, Eric E.; Verchere, C. Bruce; Devlin, Angela M.] British Columbia Childrens Hosp, Res Inst, Vancouver, BC, Canada; [Miller, Joshua W.] Rutgers Univ State Univ New Jersey, Dept Nutr Sci, New Brunswick, NJ USA; [Green, Tim J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; Rutgers State University New Brunswick; South Australian Health & Medical Research Institute (SAHMRI)	Devlin, AM (corresponding author), Childrens Hosp Res Inst, A4-194,950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	adevlin@bcchr.ubc.ca	Green, Tim/AAA-8601-2019	Green, Tim/0000-0002-0667-4300; Devlin, Angela/0000-0002-1390-6587	Natural Sciences and Engineering Council of Canada (NSERC); Canadian Institutes of Health Research operating grant; NSERC Canada Graduate Scholarship Master's Program award; University of British Columbia Doctoral Fellowship; British Columbia Children's Hospital Research Institute	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); NSERC Canada Graduate Scholarship Master's Program award; University of British Columbia Doctoral Fellowship; British Columbia Children's Hospital Research Institute	The authors thank Eugene Wang and Jesse Olson for assistance with animal husbandry; Nolan Chem for assistance with experiments on IGF-1; Mitsushiro Komba and Dr. Michal Simon for assistance with Seahorse experiments; and Galina Soukacheva for assistance with islet isolation (all from the British Columbia Children's Hospital Research Institute). This work was funded by a Natural Sciences and Engineering Council of Canada (NSERC) discovery grant (to A.M.D.) and a Canadian Institutes of Health Research operating grant (to A.M.D.). A.M.H. was supported by an NSERC Canada Graduate Scholarship Master's Program award. M.B.G. was supported by a University of British Columbia Doctoral Fellowship. A.M.D. and C.B.V. were supported by Investigator Grants from the British Columbia Children's Hospital Research Institute. The authors declare no conflicts of interest.	Alejandro EU, 2014, J CLIN INVEST, V124, P4395, DOI 10.1172/JCI74237; Aleliunas RE, 2016, J NUTR, V146, P688, DOI 10.3945/jn.115.227629; Atta CAM, 2016, AM J PUBLIC HEALTH, V106, pE24, DOI 10.2105/AJPH.2015.302902; Bahous RH, 2017, HUM MOL GENET, V26, P888, DOI 10.1093/hmg/ddx004; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Cho CE, 2013, EPIGENETICS-US, V8, P710, DOI 10.4161/epi.24948; Christensen KE, 2015, AM J CLIN NUTR, V101, P646, DOI 10.3945/ajcn.114.086603; Colapinto CK, 2011, CAN MED ASSOC J, V183, pE100, DOI 10.1503/cmaj.100568; Cordero P, 2014, J DEV ORIG HLTH DIS, V5, P385, DOI 10.1017/S204017441400035X; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Dumortier O, 2014, DIABETES, V63, P3416, DOI 10.2337/db13-1431; FELL D, 1985, J CHROMATOGR, V345, P150, DOI 10.1016/0378-4347(85)80146-8; Garcia-Arevalo M, 2016, ENDOCRINOLOGY, V157, P4158, DOI 10.1210/en.2016-1390; Ghosh S, 2011, J BIOL CHEM, V286, P42483, DOI 10.1074/jbc.M111.304592; Glier MB, 2014, MOL NUTR FOOD RES, V58, P172, DOI 10.1002/mnfr.201200636; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Hoile SP, 2012, BRIT J NUTR, V108, P852, DOI 10.1017/S0007114511006155; Huang YF, 2014, INT J MOL SCI, V15, P6298, DOI 10.3390/ijms15046298; Keating E, 2015, J ENDOCRINOL, V224, P245, DOI 10.1530/JOE-14-0448; Kelly KB, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100594; Krishnaveni GV, 2014, DIABETOLOGIA, V57, P110, DOI 10.1007/s00125-013-3086-7; Kumar KA, 2013, J NUTR BIOCHEM, V24, P25, DOI 10.1016/j.jnutbio.2012.01.004; Liu SL, 2016, CIRCULATION, V134, P647, DOI 10.1161/CIRCULATIONAHA.116.022126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; MacFarlane AJ, 2011, AM J CLIN NUTR, V94, P1079, DOI 10.3945/ajcn.111.020230; McKay JA, 2014, MOL NUTR FOOD RES, V58, P1087, DOI 10.1002/mnfr.201300615; Meng ZX, 2012, DIABETOLOGIA, V55, P1733, DOI 10.1007/s00125-012-2516-2; MILLER JW, 1994, AM J CLIN NUTR, V59, P1033, DOI 10.1093/ajcn/59.5.1033; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Page R, 2017, AM J CLIN NUTR, V105, P1101, DOI 10.3945/ajcn.116.137968; Paniz C, 2017, J NUTR, V147, P1684, DOI 10.3945/jn.117.247445; Pfeiffer CM, 2007, AM J CLIN NUTR, V86, P718, DOI 10.1093/ajcn/86.3.718; Pfeiffer CM, 2005, AM J CLIN NUTR, V82, P442, DOI 10.1093/ajcn/82.2.442; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Plumptre L, 2015, AM J CLIN NUTR, V102, P848, DOI 10.3945/ajcn.115.110783; Ray JG, 2008, QJM-INT J MED, V101, P475, DOI 10.1093/qjmed/hcn031; Rodriguez-Trejo A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1431, DOI 10.1152/ajpendo.00619.2011; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Sabet JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151579; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selhub J, 2016, BIOCHIMIE, V126, P71, DOI 10.1016/j.biochi.2016.04.010; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Stewart CP, 2011, J NUTR, V141, P1912, DOI 10.3945/jn.111.144717; [Subcommittee on Laboratory Animal Nutrition National Research Council (US)], 1995, NUTR REQ LAB AN, P80; Swisa A, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00021; Wilson RD, 2015, J OBSTET GYNAECOL CA, V37, P534, DOI 10.1016/S1701-2163(15)30230-9; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y	50	17	18	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5039	5050		10.1096/fj.201701503RR	http://dx.doi.org/10.1096/fj.201701503RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913560				2022-12-28	WOS:000443817700034
J	Peladeau, C; Adam, NJ; Jasmin, BJ				Peladeau, Christine; Adam, Nadine J.; Jasmin, Bernard J.			Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression	FASEB JOURNAL			English	Article						DMD; NSAID; p38 MAPK; Celebrex	DUCHENNE MUSCULAR-DYSTROPHY; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; MESSENGER-RNA; GLYCOPROTEIN COMPLEX; MOUSE MUSCLE; FIBER-TYPE; P38 MAPK; BINDING; PATHOLOGY	Duchenne muscular dystrophy (DMD) is a genetic and progressive neuromuscular disorder caused by mutations and deletions in the dystrophin gene. Although there is currently no cure, one promising treatment for DMD is aimed at increasing endogenous levels of utrophin A to compensate functionally for the lack of dystrophin. Recent studies from our laboratory revealed that heparin treatment of mdx mice activates p38 MAPK, leading to an upregulation of utrophin A expression and improvements in the dystrophic phenotype. Based on these findings, we sought to determine the effects of other potent p38 activators, including the cyclooxygenase (COX)-2 inhibitor celecoxib. In this study, we treated 6-wk-old mdx mice for 4 wk with celecoxib. Immunofluorescence analysis of celecoxib-treated mdx muscles revealed a fiber type switch from a fast to a slower phenotype along with beneficial effects on muscle fiber integrity. In agreement, celecoxib-treated mdx mice showed improved muscle strength. Celecoxib treatment also induced increases in utrophin A expression ranging from approximate to 1.5- to 2-fold in tibialis anterior diaphragm and heart muscles. Overall, these results highlight that activation of p38 in muscles can indeed lead to an attenuation of the dystrophic phenotype and reveal the potential role of celecoxib as a novel therapeutic agent for the treatment of DMD.Peladeau, C., Adam, N. J., Jasmin, B. J. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.	[Peladeau, Christine; Adam, Nadine J.; Jasmin, Bernard J.] Univ Ottawa, Fac Med, Ctr Neuromuscular Dis, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa	Jasmin, BJ (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	jasmin@uottawa.ca			Jesse's Journey; Association Francaise contre les Myopathies; Muscular Dystrophy Association; Canadian Institutes of Health Research; Centre for Neuromuscular Disease (CNMD) Scholarships in Translational Research	Jesse's Journey; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for Neuromuscular Disease (CNMD) Scholarships in Translational Research	The authors are grateful to John Lunde (University of Ottawa) for expert technical assistance. This work was supported by grants from Jesse's Journey, the Association Francaise contre les Myopathies, the Muscular Dystrophy Association and the Canadian Institutes of Health Research. C.P. benefited from Centre for Neuromuscular Disease (CNMD) Scholarships in Translational Research throughout this work. The authors declare no conflicts of interest.	Al-Rewashdy H, 2015, HUM MOL GENET, V24, P1243, DOI 10.1093/hmg/ddu535; Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Amirouche A, 2013, HUM MOL GENET, V22, P3093, DOI 10.1093/hmg/ddt165; Baby SM, 2010, BRAIN PATHOL, V20, P323, DOI 10.1111/j.1750-3639.2009.00275.x; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bogdanovich S, 2004, J MOL MED, V82, P102, DOI 10.1007/s00109-003-0484-1; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brueggemann Lioubov I, 2010, Mol Cell Pharmacol, V2, P15; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chakkalakal JV, 2005, FASEB J, V19, P880, DOI 10.1096/fj.04-1956rev; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; CLERK A, 1993, HISTOCHEM J, V25, P554; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Courdier-Fruh I, 2002, NEUROMUSCULAR DISORD, V12, pS95, DOI 10.1016/S0960-8966(02)00089-5; Daham K, 2011, CLIN EXP ALLERGY, V41, P36, DOI 10.1111/j.1365-2222.2010.03617.x; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Drmic D, 2017, WORLD J GASTROENTERO, V23, P5304, DOI 10.3748/wjg.v23.i29.5304; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dudley RWR, 2006, AM J PATHOL, V168, P1276, DOI 10.2353/ajpath.2006.050683; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Ehmsen J, 2002, J CELL SCI, V115, P2801; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Farooq F, 2013, HUM MOL GENET, V22, P3415, DOI 10.1093/hmg/ddt191; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; FENICHEL GM, 1991, NEUROLOGY, V41, P1874, DOI 10.1212/WNL.41.12.1874; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Gayraud J, 2010, PEDIATR PULM, V45, P552, DOI 10.1002/ppul.21204; Ghosh T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134809; Giordano C, 2015, HUM MOL GENET, V24, P2147, DOI 10.1093/hmg/ddu735; Gong L, 2012, PHARMACOGENET GENOM, V22, P310, DOI 10.1097/FPC.0b013e32834f94cb; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Guiraud S, 2017, CURR OPIN PHARMACOL, V34, P36, DOI 10.1016/j.coph.2017.04.002; Guiraud S, 2015, HUM MOL GENET, V24, P4212, DOI 10.1093/hmg/ddv154; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hsiao PW, 2007, TOXICOL APPL PHARM, V222, P97, DOI 10.1016/j.taap.2007.04.007; Hu F, 2005, MOL PSYCHIATR, V10, P426, DOI 10.1038/sj.mp.4001644; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Irwin AN, 2017, PHARMACOTHERAPY, V37, pE109, DOI [10.1002/phar.1966, 10.1002/phar.1996]; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Janghra N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150818; Johnson EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081521; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Ljubicic V, 2015, MUSCLE NERVE, V52, P139, DOI 10.1002/mus.24692; Ljubicic V, 2014, AM J PHYSIOL-CELL PH, V307, pC66, DOI 10.1152/ajpcell.00357.2013; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2010, HUM MOL GENET, V19, P1211, DOI 10.1093/hmg/ddp591; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Miyatake S, 2016, DRUG DES DEV THER, V10, P2745, DOI 10.2147/DDDT.S110163; Mojumdar K, 2014, EMBO MOL MED, V6, P1476, DOI 10.15252/emmm.201403967; MOKRI B, 1975, NEUROLOGY, V25, P1111, DOI 10.1212/WNL.25.12.1111; Moorwood C, 2013, J BIOMOL SCREEN, V18, P400, DOI 10.1177/1087057112465648; Moorwood C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026169; Mosqueira M, 2013, MED RES REV, V33, P1174, DOI 10.1002/med.21279; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Mukthinuthalapati PK, 2018, J CLIN GASTROENTEROL, V52, P114, DOI 10.1097/MCG.0000000000000888; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nakamura A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/184393; Niks EH, 2017, EXPERT OPIN BIOL TH, V17, P225, DOI 10.1080/14712598.2017.1271872; Nitahara-Kasahara Y, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0019-0; Novak ML, 2009, AM J PHYSIOL-REG I, V296, pR1132, DOI 10.1152/ajpregu.90874.2008; Parks TEC, 2017, HUM MOL GENET, V26, P1821, DOI 10.1093/hmg/ddx085; PASQUINI F, 1995, NEUROMUSCULAR DISORD, V5, P105, DOI 10.1016/0960-8966(94)00042-8; Paulson SK, 2000, XENOBIOTICA, V30, P731, DOI 10.1080/00498250050078039; Paulson SK, 1999, BIOPHARM DRUG DISPOS, V20, P293, DOI 10.1002/(SICI)1099-081X(199909)20:6<293::AID-BDD188>3.0.CO;2-X; Peladeau C, 2016, HUM MOL GENET, V25, P24, DOI 10.1093/hmg/ddv444; Perkins KJ, 2002, NEUROMUSCULAR DISORD, V12, pS78, DOI 10.1016/S0960-8966(02)00087-1; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Reyes NL, 2015, P NATL ACAD SCI USA, V112, P424, DOI 10.1073/pnas.1413021112; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Rodino-Klapac LR, 2013, HUM MOL GENET, V22, P4929, DOI 10.1093/hmg/ddt342; Ryan TD, 2014, ASAIO J, V60, P246, DOI 10.1097/MAT.0000000000000050; Serra F, 2012, MUSCLE NERVE, V46, P773, DOI 10.1002/mus.23432; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Slone S, 2016, CELL SIGNAL, V28, P1735, DOI 10.1016/j.cellsig.2016.08.005; Song B, 2017, ONCOL LETT, V14, P1775, DOI 10.3892/ol.2017.6316; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Steffel J, 2006, BIOCHEM BIOPH RES CO, V349, P597, DOI 10.1016/j.bbrc.2006.08.075; Strakova J, 2014, J MOL CELL CARDIOL, V76, P106, DOI 10.1016/j.yjmcc.2014.08.013; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley J, 2015, J CLIN PHARMACOL, V55, P698, DOI 10.1002/jcph.468; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; WINDER SJ, 1995, J CELL SCI, V108, P63; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; YANG B, 1995, J BIOL CHEM, V270, P4975, DOI 10.1074/jbc.270.10.4975; Zbinden-Foncea H, 2012, MED SCI SPORT EXER, V44, P1463, DOI 10.1249/MSS.0b013e31824e0d5d	111	13	13	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5090	5103		10.1096/fj.201800081R	http://dx.doi.org/10.1096/fj.201800081R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29723037	Bronze			2022-12-28	WOS:000443817700038
J	Li, J; Guo, A; Wang, QY; Li, YY; Zhao, J; Lu, J; Pei, G				Li, Juan; Guo, Ao; Wang, Qinying; Li, Yuanyuan; Zhao, Jian; Lu, Jing; Pei, Gang			NF-kappa B directly regulates -arrestin-1 expression and forms a negative feedback circuit in TNF-alpha-induced cell death	FASEB JOURNAL			English	Article						promoter; inflammation; apoptosis; cell survival	PROTEIN-KINASE-C; BETA-ARRESTIN 2; GENE-EXPRESSION; RAT-BRAIN; BETA-ARRESTIN1; DEFICIENCY; ACTIVATION; HETERODIMERS; INFLAMMATION; CONTRIBUTES	beta-Arrestins (beta-arrestin-1 and -2) are multifunctional proteins that play important roles in the regulation of inflammation and cell survival that need to be tightly controlled; however, the mechanism that underlies their gene expression is largely unclear. Here, we demonstrate that -arrestin-1 is a transcriptional target of NF-B. mRNA and protein levels of -arrestin-1 were up-regulated by NF-B inducers. Inhibition of NF-B prevented the up-regulation of -arrestin-1 mRNA, whereas activation of NF-B led to increased -arrestin-1 expression. -Arrestin-1 promoter activity was consistently enhanced upon NF-B activation as a result of the presence of a highly conserved B site. -Arrestin-1, in turn, suppressed the transcriptional activity of NF-B by interfering with the interaction between p65 and p50. -Arrestin-1-deficient mice displayed reduced TNF--induced cell death and increased expression of antiapoptotic genes. Reintroduction of -arrestin-1, but not its mutant, which is unable to interfere with the p65-p50 interaction, into -arrestin-deficient mouse embryonic fibroblasts partially restored sensitivity to TNF--induced cell death. These findings reveal NF-B and -arrestin-1 to be key components of a negative feedback circuit that is necessary to regulate cell death.Li, J., Guo, A., Wang, Q., Li, Y., Zhao, J., Lu, J., Pei, G. NF-B directly regulates beta-arrestin-1 expression and forms a negative feedback circuit in TNF-alpha-induced cell death.	[Li, Juan; Guo, Ao; Wang, Qinying; Li, Yuanyuan; Lu, Jing; Pei, Gang] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Zhao, Jian] Tongji Univ, Sch Med, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China; [Li, Juan] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tongji University; Tongji University; Rockefeller University	Lu, J; Pei, G (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	lu.jing@sibcb.ac.cn; gpei@sibs.ac.cn	Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Guo, Ao/0000-0003-2597-7558	Ministry of Science and Technology of China [2014CB964802, 2015CB964502]; International Science and Technology Cooperation Program of China [2016YFE0103500]; Shanghai Municipal Commission for Science and Technology [15JC1400202]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); International Science and Technology Cooperation Program of China; Shanghai Municipal Commission for Science and Technology	The authors thank Robert J. Lefkowitz (Duke University Medical Center, Durham, NC, USA) for A1CT Ab and Arrb1<SUP>-/-</SUP> Arrb2<SUP>-/-</SUP> MEFs; Chen Wang (Shanghai Institute of Biochemistry and Cell Biology) for plasmids encoding HA-p50, FLAG-p50, and HA-I kappa B alpha S32/36A; and Chang Liu and Jiuhong Kang (Tongji University) for helpful discussions. The authors thank all laboratory members for sharing reagents and advice. This study was supported by the Ministry of Science and Technology of China (Grants 2014CB964802 and 2015CB964502), the International Science and Technology Cooperation Program of China (Grant 2016YFE0103500), and the Shanghai Municipal Commission for Science and Technology (Grant 15JC1400202). The authors declare no conflicts of interest.	Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Chuang SE, 2002, BIOCHEM PHARMACOL, V63, P1709, DOI 10.1016/S0006-2952(02)00931-0; Cianfrocca R, 2014, LIFE SCI, V118, P179, DOI 10.1016/j.lfs.2014.01.078; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KELLEHER D, 1988, IMMUNOLOGY, V65, P351; Knuefermann P, 2002, J BIOL CHEM, V277, P23888, DOI 10.1074/jbc.M202937200; Kook S, 2014, CELL DEATH DIFFER, V21, P172, DOI 10.1038/cdd.2013.143; Lee T, 2016, J CELL PHYSIOL, V231, P992, DOI 10.1002/jcp.25216; Lee T, 2013, AM J PATHOL, V182, P1114, DOI 10.1016/j.ajpath.2012.12.025; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Li J, 2013, P NATL ACAD SCI USA, V110, P7395, DOI 10.1073/pnas.1221608110; Li PF, 2011, MOL IMMUNOL, V49, P64, DOI 10.1016/j.molimm.2011.07.021; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Ma XY, 2003, J BIOL CHEM, V278, P23008, DOI 10.1074/jbc.M302105200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Porter KJ, 2010, J CELL PHYSIOL, V225, P406, DOI 10.1002/jcp.22289; Sharma D, 2015, GENES IMMUN, V16, P499, DOI 10.1038/gene.2015.37; Sharma D, 2014, AM J PATHOL, V184, P2297, DOI 10.1016/j.ajpath.2014.05.002; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; Wang CB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26526; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042	44	1	1	3	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4096	4106		10.1096/fj.201700642RRR	http://dx.doi.org/10.1096/fj.201700642RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29485902				2022-12-28	WOS:000439325400004
J	Tang, YD; Guo, JC; Wang, TY; Zhao, K; Liu, JT; Gao, JC; Tian, ZJ; An, TQ; Cai, XH				Tang, Yan-Dong; Guo, Jin-Chao; Wang, Tong-Yun; Zhao, Kuan; Liu, Ji-Ting; Gao, Jia-Cong; Tian, Zhi-Jun; An, Tong-Qing; Cai, Xue-Hui			CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing	FASEB JOURNAL			English	Article						herpesvirus; knockout; knockin; recombination; DNA virus	HEPATITIS-B-VIRUS; EPSTEIN-BARR-VIRUS; REAL-TIME PCR; HUMAN-CELLS; GENOME; SYSTEM; MUTAGENESIS; CHINA; PIGS; RECOMBINATION	Several groups have used CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) for DNA virus editing. In most cases, one single-guide RNA (sgRNA) is used, which produces inconsistencies in gene editing. In this study, we used a swine herpesvirus, pseudorabies virus, as a model to systematically explore the application of CRISPR/Cas9 in DNA virus editing. In our current report, we demonstrated that cotransfection of 2 sgRNAs and a viral genome resulted in significantly better knockout efficiency than the transfection-infection-based approach. This method could result in 100% knockout of 3500 bp of viral nonessential large fragments. Furthermore, knockin efficiency was significantly improved by using 2 sgRNAs and was also correlated with the number of background viruses. We also demonstrated that the background viruses were all 2-sgRNA-mediated knockout mutants. Finally, this study demonstrated that the efficacy of gene knockin is determined by the replicative kinetics of background viruses. We propose that CRISPR/Cas9 coupled with 2 sgRNAs creates a powerful tool for DNA virus editing and offers great potential for future applications.Tang, Y.-D., Guo, J.-C., Wang, T.-Y., Zhao, K., Liu, J.-T., Gao, J.-C., Tian, Z.-J., An, T.-Q., Cai, X.-H. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.	[Tang, Yan-Dong; Guo, Jin-Chao; Wang, Tong-Yun; Zhao, Kuan; Liu, Ji-Ting; Gao, Jia-Cong; Tian, Zhi-Jun; An, Tong-Qing; Cai, Xue-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	An, TQ; Cai, XH (corresponding author), CAAS, Harbin Vet Res Inst, 678 HaPing Rd, Harbin 150069, Heilongjiang, Peoples R China.	antongqing@163.com; cai139@hvri.ac.cn	Tang, Yan-Dong/ABE-7678-2021	Tang, Yan-Dong/0000-0002-5690-2690	National Key Research and Development Program of China [2016YFD0500100]; National Natural Science Foundation of China [31270045]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Xing-Yu Meng (Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences) for assistance with qPCR. This study was supported by the National Key Research and Development Program of China (Grant 2016YFD0500100) and the National Natural Science Foundation of China (Grant 31270045). The authors declare no conflicts of interest.	An TQ, 2013, EMERG INFECT DIS, V19, P1749, DOI 10.3201/eid1911.130177; Balasch M, 1998, VET MICROBIOL, V60, P99, DOI 10.1016/S0378-1135(97)00156-9; Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; Bierle CJ, 2016, J VIROL, V90, P6989, DOI 10.1128/JVI.00139-16; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Guo JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02110; Hall RN, 2012, VIRUSES-BASEL, V4, P211, DOI 10.3390/v4020211; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Kanda T, 2016, J VIROL, V90, P4383, DOI 10.1128/JVI.00060-16; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Klein D, 2000, GENE THER, V7, P458, DOI 10.1038/sj.gt.3301112; Li H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00091; Liang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19176; Lin CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34531; Lin GG, 2015, INT J MOL SCI, V16, P26077, DOI 10.3390/ijms161125950; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Meng XY, 2016, ARCH VIROL, V161, P2425, DOI 10.1007/s00705-016-2925-5; Mettenleiter TC, 2000, VET RES, V31, P99, DOI 10.1051/vetres:2000059; Peng C, 2015, VIROL SIN, V30, P317, DOI 10.1007/s12250-015-3660-x; Peng ZY, 2016, VIRUS RES, V223, P197, DOI 10.1016/j.virusres.2016.08.001; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Russell TA, 2015, J VIROL METHODS, V213, P18, DOI 10.1016/j.jviromet.2014.11.009; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Sanchala DS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00270; Suenaga T, 2014, MICROBIOL IMMUNOL, V58, P513, DOI 10.1111/1348-0421.12180; Tang Y, 2017, SCI REP-UK, V7; Tang YD, 2017, ARCH VIROL, V162, P3881, DOI 10.1007/s00705-017-3553-4; Tang YD, 2016, VIRUS RES, V225, P33, DOI 10.1016/j.virusres.2016.09.004; Tang YD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040090; van Diemen FR, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12694; Xu AT, 2015, BIOTECHNOL LETT, V37, P1265, DOI 10.1007/s10529-015-1796-2; Ye C, 2016, VIROLOGY, V491, P56, DOI 10.1016/j.virol.2016.01.016; Ye C, 2015, VIROLOGY, V483, P32, DOI 10.1016/j.virol.2015.04.013; Yoon HA, 2006, J VET MED SCI, V68, P143, DOI 10.1292/jvms.68.143; Yuen KS, 2017, METHODS MOL BIOL, V1498, P23, DOI 10.1007/978-1-4939-6472-7_2; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012	38	18	19	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4293	4301		10.1096/fj.201701129R	http://dx.doi.org/10.1096/fj.201701129R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509513				2022-12-28	WOS:000439325400020
J	Xu, YJ; Sheng, H; Wu, TW; Bao, QY; Zheng, Y; Zhang, YM; Gong, YX; Lu, JQ; You, ZD; Xia, Y; Ni, X				Xu, Yong-Jun; Sheng, Hui; Wu, Tian-Wen; Bao, Qing-Yue; Zheng, You; Zhang, Yan-Min; Gong, Yu-Xiang; Lu, Jian-Qiang; You, Zhen-Dong; Xia, Yang; Ni, Xin			CRH/CRHR1 mediates prenatal synthetic glucocorticoid programming of depression-like behavior across 2 generations	FASEB JOURNAL			English	Article						hippocampus; DNA methylation; epigenetic	CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; EARLY-LIFE STRESS; DNA METHYLATION; MESSENGER-RNA; EXPOSURE; EXPRESSION; PREGNANCY; MODEL; RISK	Pregnant women at risk of preterm labor usually receive synthetic glucocorticoids (sGCs) to promote fetal lung development. Emerging evidence indicates that antenatal sGC increases the risk of affective disorders in offspring. Data from animal studies show that such disorders can be transmitted to the second generation. However, the molecular mechanisms underlying the intergenerational effects of prenatal sGC remain largely unknown. Here we show that prenatal dexamethasone (Dex) administration in late pregnancy induced depression-like behavior in first-generation (F1) offspring, which could be transmitted to second-generation (F2) offspring with maternal dependence. Moreover, corticotropin-releasing hormone (CRH) and CRH receptor type 1 (CRHR1) expression in the hippocampus was increased in F1 Dex offspring and F2 offspring from F1 Dex female rats. Administration of a CRHR1 antagonist to newborn F1 Dex offspring alleviated depression-like behavior in these rats at adult. Furthermore, we demonstrated that increased CRHR1 expression in F1 and F2 offspring was associated with hypomethylation of CpG islands in Crhr1 promoter. Our results revealed that prenatal sGC exposure could program Crh and Crhr1 gene expression in hippocampus across 2 generations, thereby leading to depression-like behavior. Our study indicates that prenatal sGC can cause epigenetic instability, which increases the risk of disease development in the offspring's later life.Xu, Y.-J., Sheng, H., Wu, T.-W., Bao, Q.-Y., Zheng, Y., Zhang, Y.-M., Gong, Y.-X., Lu, J.-Q., You, Z.-D., Xia, Y., Ni, X. CRH/CRHR1 mediates prenatal synthetic glucocorticoid programming of depression-like behavior across 2 generations.	[Xu, Yong-Jun; Sheng, Hui; Wu, Tian-Wen; Bao, Qing-Yue; Zheng, You; Zhang, Yan-Min; Xia, Yang; Ni, Xin] Second Mil Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Xu, Yong-Jun] Xiamen Univ, Sch Med, Dept Clin Genet & Expt Med, Fuzhou Gen Hosp, Fuzhou, Fujian, Peoples R China; [Gong, Yu-Xiang; Lu, Jian-Qiang] Shanghai Univ Sport, Sch Kinesiol, Key Lab Exercise & Hlth Sci, Minist Educ, Shanghai, Peoples R China; [You, Zhen-Dong] Second Mil Med Univ, Dept Neurobiol, Shanghai, Peoples R China; [Xia, Yang] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Xia, Yang; Ni, Xin] Xiangya Hosp, Inst Mol Metabol, Changsha, Hunan, Peoples R China	Naval Medical University; Xiamen University; Shanghai University of Sport; Naval Medical University; University of Texas System; University of Texas Health Science Center Houston; Central South University	Ni, X (corresponding author), Second Mil Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	knixin@smmu.edu.cn			Key State Research and Development Program of China [2017YFC1001404]; Natural Science Foundation of China [81701194, 81620108013, 81671176, 81370778, 31371197]; Technology Commission of Shanghai Municipals [13ZR1448700]	Key State Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Commission of Shanghai Municipals	This study was supported by Key State Research and Development Program of China (2017YFC1001404), the Natural Science Foundation of China (81701194, 81620108013, 81671176, 81370778, and 31371197), and the Technology Commission of Shanghai Municipals (13ZR1448700). The authors declare no conflicts of interest.	Andrews MH, 2004, DEV BRAIN RES, V149, P39, DOI 10.1016/j.devbrainres.2003.12.007; [Anonymous], 2011, Obstet Gynecol, V117, P422, DOI 10.1097/AOG.0b013e31820eee00; Bender R, 1998, EXP BRAIN RES, V120, P399, DOI 10.1007/s002210050413; Brolese G, 2014, BEHAV BRAIN RES, V269, P175, DOI 10.1016/j.bbr.2014.04.023; Buchwald U, 2012, J MED PRIMATOL, V41, P231, DOI 10.1111/j.1600-0684.2012.00551.x; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Chan J, 2007, J ENDOCRINOL, V195, P7, DOI 10.1677/JOE-07-0289; Cheng YH, 2000, J CLIN ENDOCR METAB, V85, P1937, DOI 10.1210/jc.85.5.1937; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Crudo A, 2013, ENDOCRINOLOGY, V154, P4170, DOI 10.1210/en.2013-1484; Crudo A, 2013, ENDOCRINOLOGY, V154, P1168, DOI 10.1210/en.2012-1980; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; Lopes-de-Morais AAC, 2014, BRAIN RES, V1591, P93, DOI 10.1016/j.brainres.2014.09.075; Dalton VS, 2014, J AFFECT DISORDERS, V155, P1, DOI 10.1016/j.jad.2013.10.028; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Dunn E, 2010, J PHYSIOL-LONDON, V588, P887, DOI 10.1113/jphysiol.2009.182139; Duthie L, 2013, NEUROENDOCRINOLOGY, V98, P106, DOI 10.1159/000354702; Evers MM, 2002, GERIATRICS-US, V57, P36; Fowden AL, 2009, HORM RES, V72, P257, DOI 10.1159/000245927; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hauser J, 2006, BEHAV BRAIN RES, V175, P51, DOI 10.1016/j.bbr.2006.07.026; Hauser J, 2009, HORM BEHAV, V56, P364, DOI 10.1016/j.yhbeh.2009.07.003; Hennebelle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042142; Iqbal M, 2012, ENDOCRINOLOGY, V153, P3295, DOI 10.1210/en.2012-1054; Bonfiglio JJ, 2011, NEUROENDOCRINOLOGY, V94, P12, DOI 10.1159/000328226; Kasckow JW, 2001, PEPTIDES, V22, P845, DOI 10.1016/S0196-9781(01)00399-0; Keller J, 2017, MOL PSYCHIATR, V22, P527, DOI 10.1038/mp.2016.120; Ko MC, 2014, INT J NEUROPSYCHOPH, V17, P1995, DOI 10.1017/S1461145714000868; Liao XM, 2014, HIPPOCAMPUS, V24, P528, DOI 10.1002/hipo.22254; Liu WN, 2018, J AFFECT DISORDERS, V226, P203, DOI 10.1016/j.jad.2017.09.053; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loi M, 2017, NEUROSCIENCE, V342, P101, DOI 10.1016/j.neuroscience.2015.08.024; Long NM, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.014; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Markham JA, 2011, PSYCHOPHARMACOLOGY, V214, P89, DOI 10.1007/s00213-010-2035-0; McKinlay CJD, 2012, AM J OBSTET GYNECOL, V206, P187, DOI 10.1016/j.ajog.2011.07.042; Miller DB, 2005, AGEING RES REV, V4, P123, DOI 10.1016/j.arr.2005.03.002; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Owen D, 2005, NEUROSCI BIOBEHAV R, V29, P209, DOI 10.1016/j.neubiorev.2004.10.004; Padmanabhan N, 2013, CELL, V155, P81, DOI 10.1016/j.cell.2013.09.002; Painter RC, 2012, BIRTH DEFECTS RES C, V96, P315, DOI 10.1002/bdrc.21021; Pena F, 2010, CURR MED CHEM, V17, P987, DOI 10.2174/092986710790820679; Raone A, 2007, NEUROSCIENCE, V146, P1734, DOI 10.1016/j.neuroscience.2007.03.027; Refojo D, 2009, ANN NY ACAD SCI, V1179, P106, DOI 10.1111/j.1749-6632.2009.04983.x; Richetto J, 2014, J REPROD IMMUNOL, V104, P20, DOI 10.1016/j.jri.2014.03.005; Royal College of Obstetricians and Gynaecologists, 2010, ANT CORT RED NEON MO; Savoy C, 2016, PSYCHONEUROENDOCRINO, V74, P278, DOI 10.1016/j.psyneuen.2016.09.021; Seckl JR, 2006, ANN NY ACAD SCI, V1071, P351, DOI 10.1196/annals.1364.027; Shoener JA, 2006, AM J PHYSIOL-REG I, V290, pR1366, DOI 10.1152/ajpregu.00757.2004; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tata DA, 2010, PHYSIOL BEHAV, V99, P186, DOI 10.1016/j.physbeh.2009.09.008; Varriale Annalisa, 2014, International Journal of Evolutionary Biology, P1, DOI 10.1155/2014/475981; Velayo Clarissa, 2014, ISRN Obstet Gynecol, V2014, P193816, DOI 10.1155/2014/193816; Walker CL, 2011, BIRTH DEFECTS RES A, V91, P666, DOI 10.1002/bdra.20827; Wei HY, 2017, ONCOTARGET, V8, P44351, DOI 10.18632/oncotarget.17874; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Workman JL, 2012, BEHAV NEUROSCI, V126, P54, DOI 10.1037/a0025538; Zhu Y, 2017, CHEMOSPHERE, V174, P499, DOI 10.1016/j.chemosphere.2017.01.144; Zhu Y, 2016, ENVIRON TOXICOL PHAR, V48, P197, DOI 10.1016/j.etap.2016.10.003	63	15	15	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4258	4269		10.1096/fj.201700948RR	http://dx.doi.org/10.1096/fj.201700948RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29543532				2022-12-28	WOS:000439325400017
J	Bi, GL; Wu, L; Huang, PX; Islam, S; Heruth, DP; Zhang, LQ; Li, DY; Sampath, V; Huang, WM; Simon, BA; Easley, RB; Ye, SQ				Bi, Guangliang; Wu, Lei; Huang, Peixin; Islam, Shamima; Heruth, Daniel P.; Zhang, Li Qin; Li, Ding-You; Sampath, Venkatesh; Huang, Weimin; Simon, Brett A.; Easley, Ronald Blaine; Ye, Shui Qing			Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown	FASEB JOURNAL			English	Article						surfactant proteins B; gene expression; JNK pathway; mouse model	SURFACTANT PROTEIN-B; COLONY-ENHANCING FACTOR; RESPIRATORY-DISTRESS-SYNDROME; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; DEFICIENT MICE; RISK; GENE; ARDS; POLYMORPHISMS; INHIBITOR	Although a deficiency of surfactant protein B (SFTPB) has been associated with lung injury, SFTPB expression has not yet been linked with nicotinamide phosphoribosyltransferase (NAMPT), a potential biomarker of acute lung injury (ALI). The effects of Nampt in the pulmonary epithelial cell on both SFTPB expression and lung inflammation were investigated in a LPS-induced ALI mouse model. Pulmonary epithelial cell-specific knockdown of Nampt gene expression, achieved by the crossing of Nampt gene exon 2 floxed mice with mice expressing epithelial-specific transgene Cre or by the use of epithelial-specific expression of anti-Nampt antibody cDNA, significantly attenuated LPS-induced ALI. Knockdown of Nampt expression was accompanied by lower levels of bronchoalveolar lavage (BAL) neutrophil infiltrates, total protein and TNF-alpha levels, as well as lower lung injury scores. Notably, Nampt knockdown was also associated with significantly increased BAL SFTPB levels relative to the wild-type control mice. Down-regulation of NAMPT increased the expression of SFTPB and rescued TNF-alpha-induced inhibition of SFTPB, whereas overexpression of NAMPT inhibited SFTPB expression in both H441 and A549 cells. Inhibition of NAMPT up-regulated SFTPB expression by enhancing histone acetylation to increase its transcription. Additional data indicated that these effects were mainly mediated by NAMPT nonenzymatic function via the JNK pathway. This study shows that pulmonary epithelial cell-specific knockdown of NAMPT expression attenuated ALI, in part, via up-regulation of SFTPB expression. Thus, epithelial cell-specific knockdown of Nampt may be a potential new and viable therapeutic modality to ALI.-Bi, G., Wu, L., Huang, P., Islam, S., Heruth, D. P., Zhang, L. Q., Li, D.-Y., Sampath, V., Huang, W., Simon, B. A., Easley, R. B., Ye, S. Q. Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown.	[Bi, Guangliang; Wu, Lei; Huang, Peixin; Islam, Shamima; Heruth, Daniel P.; Zhang, Li Qin; Li, Ding-You; Sampath, Venkatesh; Ye, Shui Qing] Univ Missouri, Sch Med, Dept Pediat, Childrens Mercy, 2401 Gillham Rd,PRC 4th Floor, Kansas City, MO 64108 USA; [Ye, Shui Qing] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Childrens Mercy, Kansas City, MO 64108 USA; [Bi, Guangliang; Huang, Weimin] Southern Med Univ, Dept Neonatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Lei] Changsha Cent Hosp, Dept Pediat, Changsha, Hunan, Peoples R China; [Simon, Brett A.] Cornell Univ, Mem Sloan Kettering Canc Ctr, Josie Robertson Surg Ctr, Weill Cornell Med Coll,Dept Anesthesiol, New York, NY USA; [Easley, Ronald Blaine] Baylor Coll Med, Dept Pediat Anesthesiol, Houston, TX 77030 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Southern Medical University - China; Cornell University; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine	Ye, SQ (corresponding author), Univ Missouri, Sch Med, Dept Pediat, Childrens Mercy, 2401 Gillham Rd,PRC 4th Floor, Kansas City, MO 64108 USA.	sqye@cmh.edu		Bi, Guangliang/0000-0001-8659-162X	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL080042]; Guangdong Province Science and Technology Plan Project [2013B051000049]; Southern Medical University; Children's Mercy Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128374, R01HL080042] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Guangdong Province Science and Technology Plan Project; Southern Medical University; Children's Mercy Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank our colleagues, Marianne Nsumu and Suman Chaudhary for their excellent technical assistance, and Maria Bradshaw for her able service in reagent procurements (all from Children's Mercy Hospital, University of Missouri, Kansas City, MO, USA). This work is supported, in part, by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL080042 (to S.Q.Y.); the Start-Up Fund and William R. Brown/Missouri Endowment of the Children's Mercy Hospital (to S.Q.Y.); a Guangdong Province Science and Technology Plan Project (2013B051000049 to W.H. and G.B.); and a Postdoctoral Fellowship from Southern Medical University (to G.B.). The authors declare no conflicts of interest.	Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; Baron Rebecca M, 2016, F1000Res, V5, DOI 10.12688/f1000research.7646.1; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Devaney J, 2011, CRIT CARE, V15, DOI 10.1186/cc10216; Epaud R, 2003, AM J RESP CELL MOL, V28, P373, DOI 10.1165/rcmb.2002-0071OC; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gandhi VD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00147; Ge L, 2016, BIOCHEM BIOPH RES CO, V469, P171, DOI 10.1016/j.bbrc.2015.11.089; Gill SE, 2017, CELL TISSUE RES, V367, P495, DOI 10.1007/s00441-016-2521-8; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; GREGORY TJ, 1991, J CLIN INVEST, V88, P1976, DOI 10.1172/JCI115523; Hasmann M, 2003, CANCER RES, V63, P7436; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li HL, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-15; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Matthay M A, 1993, New Horiz, V1, P613; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; Meyer NJ, 2014, CLIN CHEST MED, V35, P673, DOI 10.1016/j.ccm.2014.08.006; Ota C, 2015, EXP LUNG RES, V41, P422, DOI 10.3109/01902148.2015.1060275; Quasney MW, 2004, CRIT CARE MED, V32, P1115, DOI 10.1097/01.CCM.0000124872.55243.5A; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schmidt R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-55; Thompson BT, 2011, CRIT CARE CLIN, V27, P459, DOI 10.1016/j.ccc.2011.05.011; Tokieda K, 1999, PEDIATR RES, V46, P708, DOI 10.1203/00006450-199912000-00012; Tokieda K, 1999, AM J RESP CELL MOL, V21, P463, DOI 10.1165/ajrcmb.21.4.3436; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Yamagata K, 2018, INT REV CEL MOL BIO, V335, P143, DOI 10.1016/bs.ircmb.2017.07.009; Yanagi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/573210; Ye SQ, 2005, MICROVASC RES, V70, P142, DOI 10.1016/j.mvr.2005.08.003; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhang LQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.132; Zhang Li Qin, 2011, J Bioanal Biomed, V3, P13; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031229	39	8	8	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3583	3596		10.1096/fj.201701059R	http://dx.doi.org/10.1096/fj.201701059R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452569	Green Published			2022-12-28	WOS:000435104500009
J	Shin, Y; Kim, DY; Ko, JY; Woo, YM; Park, JH				Shin, Yubin; Kim, Do Yeon; Ko, Je Yeong; Woo, Yu Mi; Park, Jong Hoon			Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis	FASEB JOURNAL			English	Article						Pkd2; cyst; proliferation; ADPKD	POLYCYSTIC KIDNEY-DISEASE; KRUPPEL-LIKE FACTORS; PATHWAYS; PROMOTER; CANCER	Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common inherited disorders. ADPKD is caused by mutations in the gene encoding either polycystic kidney disease 1 (PKD1) or polycystic kidney disease 2 (PKD2). Patients with ADPKD show progressive growth of cystic fluid-filled renal cysts. Here, we used Pkd2(f/f) control mice and Pkd2(f/f):HoxB7-Cre experimental mice, which are bred to have a conditional deletion of Pkd2 in the collecting ducts, and analyzed the expression pattern of microRNAs (miRNAs) of kidney tissues from Pkd2(f/f) and Pkd2(f/f):HoxB7-Cre mice. Decreased expression of miR-20b-5p and miR-106a-5p in Pkd2(f/f):HoxB7-Cre mice compared to that in Pkd2(f/f) mice was observed. These miRNAs target Klf12 (Kruppel-like factor 12), which has low expression in kidney tissues of Pkd2(f/f) mice; however, its expression is enhanced in Pkd2(f/f):HoxB7-Cre mice over time. Moreover, miR-20b-5p and miR-106a-5p directly target Klf12 mRNA by binding to the 3-UTR of Klf12. In addition, human and mouse cell lines exhibit similar patterns. These findings were also consistent with the data from Pkd2 knockout mouse embryonic fibroblasts. Furthermore, direct and indirect knockdown of Klf12 slows cyst growth and cell proliferation in mouse inner medullary collecting duct cells. Taken together, we suggest that the induction of miR-20b-5p or miR-106a-5p or the down-regulation of KLF12 could be used as potential novel therapies for inhibiting cyst growth in patients with ADPKD.-Shin, Y., Kim, D. Y., Ko, J. Y., Woo, Y. M., Park, J. H. Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis.	[Shin, Yubin; Kim, Do Yeon; Ko, Je Yeong; Woo, Yu Mi; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea	Sookmyung Women's University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea.	parkjh@sook-myung.ac.kr			Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) [2015M3A9B6027555]; Bio and Medical Technology Development Program [2014M3C9A2067613]; Korean Ministry of Science and Information and Communications Technology (ICT) [2017R1C1B2002806]	Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF); Bio and Medical Technology Development Program; Korean Ministry of Science and Information and Communications Technology (ICT)	This work was supported by grants from the Bio and Medical Technology Development Program (2014M3C9A2067613), the Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) (2015M3A9B6027555), and Basic Science Program funded by the Korean Ministry of Science and Information and Communications Technology (ICT) (2017R1C1B2002806). The authors declare no conflicts of interest.	Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Fedeles SV, 2014, TRENDS MOL MED, V20, P251, DOI 10.1016/j.molmed.2014.01.004; Harris PC, 2014, J CLIN INVEST, V124, P2315, DOI 10.1172/JCI72272; Imhof A, 1999, MOL CELL BIOL, V19, P194; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Lariviere WB, 2015, TRANSL RES, V165, P488, DOI 10.1016/j.trsl.2014.11.003; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Paul BM, 2014, WIRES DEV BIOL, V3, P465, DOI 10.1002/wdev.152; Suda S, 2006, BIOCHEM BIOPH RES CO, V344, P246, DOI 10.1016/j.bbrc.2006.03.138; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Woo YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14083-8; Zitman-Gal T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-8	16	12	12	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3574	3582		10.1096/fj.201700923R	http://dx.doi.org/10.1096/fj.201700923R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475398				2022-12-28	WOS:000435104500008
J	Lin, K; Jiang, H; Zhuang, SS; Qin, YS; Qiu, GD; She, YQ; Zheng, JT; Chen, C; Fang, L; Zhang, SY				Lin, Kai; Jiang, Hong; Zhuang, Shan-Shan; Qin, Yun-Sheng; Qiu, Guo-Dong; She, Yu-Qi; Zheng, Jie-Ting; Chen, Chen; Fang, Ling; Zhang, Shu-Yao			Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer	FASEB JOURNAL			English	Article						dihydropyrimidine dehydrogenase; DNA methyltransferase; 5-Aza-dc	SUPPRESSES CELL-PROLIFERATION; DIHYDROPYRIMIDINE-DEHYDROGENASE; SENSITIVITY; RESISTANCE; CHEMOTHERAPY; INHIBITION; CISPLATIN; APOPTOSIS; SURVIVAL; INVASION	Approximately 85% of a single administered dose of 5-fluorouracil (5-FU) will be degraded by dihydropyrimidine dehydrogenase (DYPD). Studies have highlighted a link between the complete or partial loss of DYPD function and clinical responses to 5-FU; however, the underlying molecular basis of DPD deficiency remains poorly understood. Hence, the aim of the present study was to evaluate the prevailing hypothesis which suggests that overexpression of LINC00261 possesses the ability to modulate the methylation-dependent repression of DPYD, ultimately resulting in an elevation of the sensitivity of human esophageal cancer cells to 5-FU. LINC00261 levels were initially quantified, followed by analysis of DYPD methylation within the cancerous tissues collected from 75 patients diagnosed with esophageal cancer undergoing 5-FU-based adjuvant chemotherapy. In an attempt to determine the levels of LINC00261 related to the esophageal cancer cell resistance to 5-FU and to identify the interaction between the levels of LINC00261 and methylation of the DYPD promoter, esophageal cancer cells TE-1 and -5 were prepared, in which LINC00261 and the 5-FU-resistant TE-1 and -5 cells were overexpressed. The levels of LINC00261 were reduced among the cancerous tissues obtained from patients exhibiting resistance to 5-FU. Overexpression of LINC00261 was determined to dramatically inhibit proliferation and resistance to apoptosis among 5-FU-resistant TE-1 and -5 cells, whereas silencing of LINC00261 was determined to enhance proliferation and resistance to apoptosis among the TE-1 and -5 cells. DPYD, a confirmed target of LINC00261, displayed a greater incidence of DNA methylation among patient's sensitive to 5-FU. A key finding revealed that overexpressed LINC00261 could increase the methylation of the DPYD promoter through the recruitment of DNA methyltransferase (DNMT), which, in turn, acts to decrease DPYD activity in 5-FU-resistant TE-1 cells, whereas a reversible change was recorded once the demethylation reagent 5-aza-2-deoxyctidine was employed to treat the 5-FU-resistant TE-1 cells. Taken together, the results of the study provided evidence emphasizing the distinct antitumor ability of LINC00261 in cases of esophageal cancer, which was manifested by overexpression of LINC00261 detected to increase the sensitivity of human esophageal cancer cells to 5-FU by mediating methylation-dependent repression of DPYD. Our study highlighted the potential of LINC00261 as a novel target capable of improving the chemotherapeutic response and survival of patients with esophageal cancer.Lin, K., Jiang, H., Zhuang, S.-S., Qin, Y.-S., Qiu, G.-D., She, Y.-Q., Zheng, J.-T., Chen, C., Fang, L., Zhang, S.-Y. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.	[Lin, Kai] Shantou Univ, Coll Med, Affiliated Hosp 1, Family Med Ctr, Shantou, Peoples R China; [Jiang, Hong] Shantou Univ, Coll Med, Canc Hosp, Dept Radiol, Shantou, Peoples R China; [Zhuang, Shan-Shan] Shantou Univ, Coll Med, Canc Hosp, Clin Lab, Shantou, Peoples R China; [Qin, Yun-Sheng] Shantou Univ, Coll Med, Canc Hosp, Chest Surg, Shantou, Peoples R China; [Qiu, Guo-Dong; She, Yu-Qi; Zheng, Jie-Ting; Chen, Chen; Fang, Ling; Zhang, Shu-Yao] Shantou Univ, Coll Med, Canc Hosp, Dept Pharm, 7 Raoping Rd, Shantou 515031, Guangdong, Peoples R China; [Zhang, Shu-Yao] Shantou Univ, Coll Med, Clin Pharm Res Ctr, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University; Shantou University	Zhang, SY (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Dept Pharm, 7 Raoping Rd, Shantou 515031, Guangdong, Peoples R China.	zhangsy0754@163.com		Lin, Kai/0000-0003-4076-4972	Guangdong Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases	Guangdong Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases	This study was supported by the Guangdong Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases. The authors declare no conflicts of interest.	BATUMAN OA, 1990, BRAIN BEHAV IMMUN, V4, P105, DOI 10.1016/0889-1591(90)90013-G; Cai DH, 2015, INT J MOL SCI, V16, P23668, DOI 10.3390/ijms161023668; Cao W, 2017, ORAL ONCOL, V65, P94, DOI 10.1016/j.oraloncology.2016.12.017; Chen LJ, 2015, NANOSCALE, V7, P14080, DOI 10.1039/c5nr03527a; Du YM, 2012, J CANCER RES CLIN, V138, P1759, DOI 10.1007/s00432-012-1253-8; Ezzeldin HH, 2005, CLIN CANCER RES, V11, P8699, DOI 10.1158/1078-0432.CCR-05-1520; Greenwald BD, 2010, GASTROINTEST ENDOSC, V71, P686, DOI 10.1016/j.gie.2010.01.042; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Kimura M, 2011, ONCOL LETT, V2, P297, DOI 10.3892/ol.2010.227; Kristensen MH, 2010, J INT MED RES, V38, P870, DOI 10.1177/147323001003800313; Lazar A, 2008, DEUT MED WOCHENSCHR, V133, P1501, DOI 10.1055/s-2008-1081098; Li J, 2006, J SURG RES, V132, P112, DOI 10.1016/j.jss.2005.10.005; Li LH, 2013, EUR J CANCER, V49, P1752, DOI 10.1016/j.ejca.2012.12.013; Liao JQ, 2016, GENE, V578, P158, DOI 10.1016/j.gene.2015.12.032; Liu HT, 2016, CANCER MED-US, V5, P3512, DOI 10.1002/cam4.900; Lu CX, 2012, ONCOL LETT, V4, P775, DOI 10.3892/ol.2012.829; Meredith KL, 2010, ANN SURG ONCOL, V17, P1159, DOI 10.1245/s10434-009-0862-1; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Savva-Bordalo J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-470; Sharaiha RZ, 2011, ANN SURG ONCOL, V18, P3362, DOI 10.1245/s10434-011-1754-8; Shen CJ, 2017, J DRUG TARGET, V25, P637, DOI 10.1080/1061186X.2017.1307379; Suzuki M, 2007, INT J ONCOL, V31, P1449; Wang YN, 2017, ONCOL RES, V25, P733, DOI 10.3727/096504016X14772362173376; Wang ZK, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20176793, 10.1590/1414-431x20176793]; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Xiao Y, 2017, ONCOTARGET, V8, P83171, DOI 10.18632/oncotarget.20487; Yang JC, 2014, LUNG CANCER, V85, P110, DOI 10.1016/j.lungcan.2014.05.011; Yu YC, 2017, J CELL MOL MED, V21, P955, DOI 10.1111/jcmm.13035; Zhang HF, 2018, CANCER BIOMARK, V21, P575, DOI 10.3233/CBM-170471; Zhang MY, 2016, ONCOTARGET, V7, P17957, DOI 10.18632/oncotarget.7647; Zhu KP, 2017, ONCOTARGET, V8, P71881, DOI 10.18632/oncotarget.17985	32	36	40	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1972	1988		10.1096/fj.201800759R	http://dx.doi.org/10.1096/fj.201800759R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30226808				2022-12-28	WOS:000457296600036
J	Mikawa, S; Kondo, M; Kaji, N; Mihara, T; Yoshitake, R; Nakagawa, T; Takamoto, M; Nishimura, R; Shimada, S; Ozaki, H; Hori, M				Mikawa, Shoma; Kondo, Makoto; Kaji, Noriyuki; Mihara, Taiki; Yoshitake, Ryohei; Nakagawa, Takayuki; Takamoto, Masaya; Nishimura, Ryohei; Shimada, Shoichi; Ozaki, Hiroshi; Hori, Masatoshi			Serotonin 3 receptor signaling regulates 5-fluorouracil-mediated apoptosis indirectly via TNF- production by enhancing serotonin release from enterochromaffin cells	FASEB JOURNAL			English	Article						anti-apoptosis; anti-inflammatory; intestinal epithelial cells; intestinal organoids	NICOTINIC ACETYLCHOLINE-RECEPTOR; GASTROINTESTINAL TOXICITY; GUINEA-PIG; 5-HT3; TROPISETRON; 5-HYDROXYTRYPTAMINE; ANTAGONIST; EXPRESSION; INVOLVEMENT; MUCOSITIS	Antagonists of the 5-hydroxytryptamine (serotonin) 3 receptor (5-HT3R) have anti-inflammatory and anti-apoptotic activities, but the detailed, underlying mechanisms are not well understood. We focused on anti-apoptotic activities via 5-HT3R signaling to clarify the underlying mechanisms. Mice were administered 5-fluorouracil (5-FU), which induced apoptosis in intestinal epithelial cells. Coadministration with 5-HT3R antagonists or agonists tended to decrease or increase the number of apoptotic cells, respectively. In serotonin 3A receptor (5-HT3AR) null (HTR3A(-/-)) mice, the number of apoptotic cells induced by 5-FU was decreased compared with that in wild-type (WT) mice. Bone marrow (BM) transplantation was performed to determine if BM-derived immune cells regulated 5-FU-induced apoptosis, but they were found to be unrelated to this process. Data from 5-HT3AR/enhanced green fluorescent protein reporter mice revealed that 50% of enterochromaffin (EC) cells expressed 5-HT3AR, but the number of apoptotic cells induced by 5-FU in the intestinal crypt organoids of HTR3A(-/-) mice was not altered compared with WT mice. In contrast, plasma 5-HT concentrations in WT mice but not in HTR3A(-/-) mice administered 5-FU were increased significantly. In conclusion, 5-HT3R signaling may enhance 5-HT release, possibly from EC cells intravascularly, or paracrine, resulting in increases in plasma 5-HT concentration, which in turn, enhances apoptotic activities induced by 5-FU.Mikawa, S., Kondo, M., Kaji, N., Mihara, T., Yoshitake, R., Nakagawa, T., Takamoto, M., Nishimura, R., Shimada, S., Ozaki, H., Hori, M. Serotonin 3 receptor signaling regulates 5-fluorouracil-mediated apoptosis indirectly via TNF- production by enhancing serotonin release from enterochromaffin cells.	[Mikawa, Shoma; Kaji, Noriyuki; Mihara, Taiki; Ozaki, Hiroshi; Hori, Masatoshi] Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yoshitake, Ryohei; Nakagawa, Takayuki; Nishimura, Ryohei] Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kondo, Makoto; Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, Osaka, Japan; [Takamoto, Masaya] Shinshu Univ, Sch Med, Dept Infect & Host Def & Pathobiol, Nagano, Japan	University of Tokyo; University of Tokyo; Osaka University; Shinshu University	Hori, M (corresponding author), Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahori@mail.ecc.u-tokyo.ac.jp		Kaji, Noriyuki/0000-0001-7423-5679	KAKENHI [JP 16J05803]; Japan Ministry of Education [24248050, 25221205]; Smoking Research Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	The authors thank Dr. Shigeru Kakuta (Department of Biomedical Science, Graduate School of Agriculture and Life Sciences, The University of Tokyo) for receiving great support. This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Research Fellow (KAKENHI; Grant JP 16J05803 to S.M.), Grants-in-Aid for Scientific Research from the Japan Ministry of Education (24248050 to M.H.; 25221205 to H.O.), and, in part, by the Smoking Research Foundation (to M.H.). The authors declare no conflicts of interest.	Bohorquez DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089881; Boussios S, 2012, ANN GASTROENTEROL, V25, P106; Camilleri M, 2017, GUT, V66, P966, DOI 10.1136/gutjnl-2016-313425; Coates MD, 2017, ALIMENT PHARM THER, V46, P569, DOI 10.1111/apt.14226; Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P9, DOI 10.1080/03009740410006952; GEBAUER A, 1993, N-S ARCH PHARMACOL, V347, P137; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Grabinger T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.183; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Inomata A, 2002, TOXICOL LETT, V133, P231, DOI 10.1016/S0378-4274(02)00204-7; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Koyama Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42884; Lee CS, 2014, WORLD J GASTROENTERO, V20, P3751, DOI 10.3748/wjg.v20.i14.3751; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; Maehara T, 2015, BRIT J PHARMACOL, V172, P1136, DOI 10.1111/bph.13006; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Matsumoto K, 2013, DIGEST DIS SCI, V58, P3440, DOI 10.1007/s10620-013-2709-7; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mousavizadeh K, 2009, EUR J CLIN INVEST, V39, P375, DOI 10.1111/j.1365-2362.2009.02102.x; Navari RM, 2016, NEW ENGL J MED, V374, P1356, DOI 10.1056/NEJMra1515442; O'Rourke KP., 2016, BIOPROTOC, V6, pe1732, DOI DOI 10.21769/BI0PR0T0C.1732; Papke RL, 2004, BIOORG MED CHEM LETT, V14, P1849, DOI 10.1016/j.bmcl.2003.09.104; Racke K, 1996, BEHAV BRAIN RES, V73, P83; RACKE K, 1991, PHARMACOL RES, V23, P13, DOI 10.1016/S1043-6618(05)80101-X; Rahimian R, 2013, EUR J CLIN INVEST, V43, P1039, DOI 10.1111/eci.12141; Rammes G, 2004, MOL PSYCHIATR, V9, P846, DOI 10.1038/sj.mp.4001490; Rao Kamakshi V, 2012, Am Health Drug Benefits, V5, P232; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SATOH Y, 1995, GASTROENTEROLOGY, V108, P1345, DOI 10.1016/0016-5085(95)90681-9; SCHWORER H, 1991, N-S ARCH PHARMACOL, V344, P143, DOI 10.1007/BF00167211; SIBER GR, 1980, CANCER RES, V40, P3430; Spangrude G. J., 2008, CURR PROTOC IMMUNOL, V4; Spohn SN, 2017, NAT REV GASTRO HEPAT, V14, P412, DOI 10.1038/nrgastro.2017.51; Stegemann A, 2013, ARTHRITIS RHEUM-US, V65, P792, DOI 10.1002/art.37809; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Tasaka Y, 2015, J PHARMACOL SCI, V127, P275, DOI 10.1016/j.jphs.2014.12.016; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Tsukamoto A, 2017, INFLAMMATION, V40, P1409, DOI 10.1007/s10753-017-0584-7; Utsumi D, 2016, BRIT J PHARMACOL, V173, P1835, DOI 10.1111/bph.13482; Walker DP, 2006, BIOORGAN MED CHEM, V14, P8219, DOI 10.1016/j.bmc.2006.09.019; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Yasuda M, 2013, BRIT J PHARMACOL, V168, P1388, DOI 10.1111/bph.12019	44	7	7	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1669	1680		10.1096/fj.201701200RR	http://dx.doi.org/10.1096/fj.201701200RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207796				2022-12-28	WOS:000457296600014
J	Deng, JC; Chen, M; Liu, ZQ; Song, YN; Sui, TT; Lai, LX; Li, ZJ				Deng, Jichao; Chen, Mao; Liu, Zhiquan; Song, Yuning; Sui, Tingting; Lai, Liangxue; Li, Zhanjun			The disrupted balance between hair follicles and sebaceous glands in Hoxc13-ablated rabbits	FASEB JOURNAL			English	Article						ECTD-9; hypotrichosis; HFs; SGs	NAIL ECTODERMAL DYSPLASIA; UNDERLIES PURE HAIR; HOXC13; GENE; MUTATION; HYPOTRICHOSIS; KERATINS	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans. Unlike patients with ECTD-9, Hoxc13-mutated mice and pigs do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically. Here, the homozygous Hoxc13(-/-) rabbits showed complete loss of hair on the head and dorsum, whereas hypotrichosis in the limbs and tail were determined in the Hoxc13(-/-) rabbits. In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (SGs) were also found in the Hoxc13(-/-) rabbits, showing that the disrupted balance between HFs and SGs may respond to hypotrichosis of ECTD-9 in an animal model and clinically. Therefore, our findings demonstrate that Hoxc13(-/-) rabbits can be used as a model for human ECTD-9, especially to understand the pathologic mechanism of hypotrichosis. Moreover, the disrupted balance between HFs and SGs, especially in the Hoxc13(-/-) rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z. The disrupted balance between hair follicles and sebaceous glands in Hoxc13-ablated rabbits.	[Deng, Jichao; Chen, Mao; Liu, Zhiquan; Song, Yuning; Sui, Tingting; Lai, Liangxue; Li, Zhanjun] Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Inst Zoonosis, Changchun, Jilin, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cells & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Lai, LX; Li, ZJ (corresponding author), Jilin Univ, Dept Biotechnol, Room 409,5333 Xian Rd, Changchun 130062, Jilin, Peoples R China.	lai_liangxue@gibh.ac.cn; lizj_1998@jlu.edu.cn		li, zhanjun/0000-0001-6914-8589	National Key Research and Development Program of China Stem Cell and Translational Research [2017YFA0105101]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_16R32]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030501, XDA16030503]; GuangDong Province Science and Technology Plan Project [2014B020225003]	National Key Research and Development Program of China Stem Cell and Translational Research; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); GuangDong Province Science and Technology Plan Project	The authors thank Peiran Hu (Embryo Engineering Center for Technical Assistance, Chuangchun, China). This study was supported by National Key Research and Development Program of China Stem Cell and Translational Research (Grant 2017YFA0105101), The Program for Changjiang Scholars and Innovative Research Team in University (Grant IRT_16R32), The Strategic Priority Research Program of the Chinese Academy of Sciences (Grants XDA16030501 and XDA16030503), and GuangDong Province Science and Technology Plan Project (Grant 2014B020225003). The authors declare no conflicts of interest.	Ali RH, 2013, BRIT J DERMATOL, V169, P478, DOI 10.1111/bjd.12302; [Anonymous], 1942, Ann Surg, V115, P465; Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; Byrne C, 2003, J ANAT, V202, P113, DOI 10.1046/j.1469-7580.2003.00142.x; Combalia Andrea, 2017, Int J Trichology, V9, P54, DOI 10.4103/ijt.ijt_100_16; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P25211, DOI 10.1074/jbc.M114.572511; de Berker D, 1999, INT J DERMATOL, V38, P25, DOI 10.1046/j.1365-4362.1999.00005.x; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Farooq M, 2013, HUM MUTAT, V34, P578, DOI 10.1002/humu.22271; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Hall BK, 2000, METH MOL B, V135, P127; Han K, 2017, HUM MOL GENET, V26, P184, DOI 10.1093/hmg/ddw378; He YY, 2015, ANAT REC, V298, P1796, DOI 10.1002/ar.23185; Karsenty G, 1998, DEV GENET, V22, P301, DOI 10.1002/(SICI)1520-6408(1998)22:4&lt;301::AID-DVG1&gt;3.0.CO;2-A; Khan AK, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0402-y; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Lin ZM, 2012, AM J HUM GENET, V91, P906, DOI 10.1016/j.ajhg.2012.08.029; Mascaro JM, 2000, J DERMATOL TREAT, V11, pS1; Mehmood S, 2017, CLIN EXP DERMATOL, V42, P585, DOI 10.1111/ced.13115; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Neri I, 2016, J DERMATOL SCI, V81, P63, DOI 10.1016/j.jdermsci.2015.10.012; Oros J, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1545-6; Peterson RL, 2005, J INVEST DERM SYMP P, V10, P238, DOI 10.1111/j.1087-0024.2005.10114.x; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Qiu WM, 2016, CELL TISSUE RES, V364, P149, DOI 10.1007/s00441-015-2312-7; Rocha MA, 2018, ARCH DERMATOL RES, V310, P181, DOI 10.1007/s00403-017-1795-3; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Sui TT, 2016, HUM MOL GENET, V25, P2661, DOI 10.1093/hmg/ddw125; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Wang JM, 2015, INT J DERMATOL, V54, P1163, DOI 10.1111/ijd.12889; Wang Yu, 2014, Cell Regen, V3, P3, DOI 10.1186/2045-9769-3-3; Wei JCJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15830-7; Zhang J, 2015, GENE, V566, P84, DOI 10.1016/j.gene.2015.04.039	37	12	13	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1226	1234		10.1096/fj.201800928RR	http://dx.doi.org/10.1096/fj.201800928RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30125135	Bronze			2022-12-28	WOS:000457401500097
J	Keul, P; Polzin, A; Kaiser, K; Graler, M; Dannenberg, L; Daum, G; Heusch, G; Levkau, B				Keul, Petra; Polzin, Amin; Kaiser, Klaus; Graeler, Markus; Dannenberg, Lisa; Daum, Guenter; Heusch, Gerd; Levkau, Bodo			Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy	FASEB JOURNAL			English	Article						inflammation; CAD; TNF-; S1P; VSMC	HIGH-DENSITY-LIPOPROTEIN; NF-KAPPA-B; SPHINGOSINE 1-PHOSPHATE RECEPTORS; APOLIPOPROTEIN-M; BETA-RECEPTOR; P65 SUBUNIT; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; EXPRESSION; PTEN	Dysfunctional HDL is associated with coronary artery disease (CAD), but its effect on inflammation in vascular smooth muscle cells (VSMCs) in atherosclerosis is unknown. We investigated the effect of healthy human HDL and CAD-HDL on TNF--driven inflammation in VSMCs and examined whether HDL-associated sphingosine-1-phosphate (HDL-S1P) could modulate inflammation with the aim of designing novel HDL-based anti-inflammatory strategies. Healthy human HDL, human CAD-HDL, and mouse HDL were isolated by ultracentrifugation, S1P was measured by liquid chromatography-tandem mass spectrometry, and TNF--induced inflammation was characterized by gene expression and analysis of NF-B-dependent signaling. Mechanisms of S1P interference with TNF- were assessed by S1P receptor antagonists, mouse knockouts, and short interfering RNA. We observed that healthy HDL potently inhibited the induction of TNF--stimulated inflammatory genes, such as iNOS (inducible NO synthase) and MMP9 (matrix metalloproteinase 9), a process that was entirely dependent on HDL-S1P, as evidenced by loss-of-function using S1P-less HDL and mimicked by genuine S1P. Inhibition was based on suppression of TNF--activated Akt signaling resulting in reduced IkBSer32 and p65Ser534 NF-B phosphorylation based on a persistent phosphatase and tensin homolog activation by S1P through the S1P receptor 2. Intriguingly, S1P suppressed inflammation even hours after initial TNF- stimulation. The anti-inflammatory effect of healthy HDL correlated with HDL-S1P content and was superior to that of CAD-HDL featuring lower HDL-S1P. Nevertheless, therapeutic loading of HDL with S1P completely restored the anti-inflammatory capacity of CAD-HDL and greatly boosted that of both healthy and CAD-HDL. Suppression of inflammation by HDL-S1P defines a novel pathophysiologic characteristic that distinguishes functional from dysfunctional HDL. The anti-inflammatory HDL function can be boosted by S1P-loading and exploited by S1P receptor-targeting to prevent and even turn off ongoing inflammation.Keul, P., Polzin, A., Kaiser, K., Graler, M., Dannenberg, L., Daum, G., Heusch, G., Levkau, B. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.	[Keul, Petra; Kaiser, Klaus; Heusch, Gerd; Levkau, Bodo] Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Inst Pathophysiol, Essen, Germany; [Polzin, Amin; Dannenberg, Lisa] Heinrich Heine Univ, Med Ctr Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Graeler, Markus] Univ Hosp Jena, Dept Anesthesiol & Intens Care Med, Ctr Sepsis Control & Care, Jena, Germany; [Graeler, Markus] Univ Hosp Jena, Ctr Mol Biomed, Jena, Germany; [Daum, Guenter] Univ Med Ctr Hamburg Eppendorf, Clin & Polyclin Vasc Med, Univ Heart Ctr, Hamburg, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Hamburg; University Medical Center Hamburg-Eppendorf	Levkau, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Inst Pathophysiol, Essen, Germany.	bodo.levkau@uni-due.de	Heusch, Gerd/ABE-6675-2020; Gräler, Markus/ABH-1905-2021	Gräler, Markus/0000-0001-6650-7849	Deutsche Herzstiftung [F/26/17]; Deutsche Forschungsgemeinschaft [GRK 2098]	Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by Deutsche Herzstiftung to P.K. (Grant F/26/17) and by Deutsche Forschungsgemeinschaft (Grant GRK 2098, Projects 9, 10, and 11, to B.L. and P.K.). The authors declare no conflicts of interest.	Abbey-Hosch SE, 2004, HYPERTENSION, V43, P1103, DOI 10.1161/01.HYP.0000124668.80811.d3; Ahnstrom J, 2008, J LIPID RES, V49, P1912, DOI 10.1194/jlr.M700471-JLR200; Annema W, 2016, J CLIN LIPIDOL, V10, P1318, DOI 10.1016/j.jacl.2016.08.003; Ansell BJ, 2007, AM J CARDIOL, V100, p3N, DOI 10.1016/j.amjcard.2007.08.006; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Arkensteijn BWC, 2013, INT J MOL SCI, V14, P4419, DOI 10.3390/ijms14034419; Badimon JJ, 2015, J AM COLL CARDIOL, V66, P1486, DOI 10.1016/j.jacc.2015.08.008; Blaho VA, 2015, NATURE, V523, P342, DOI 10.1038/nature14462; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P976, DOI 10.1161/01.ATV.0000162171.30089.f6; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Chrisman Ted D, 2003, Cell Commun Signal, V1, P4, DOI 10.1186/1478-811X-1-4; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Christoffersen C, 2010, CIRC RES, V106, P1624, DOI 10.1161/CIRCRESAHA.109.211086; Fragoso R, 2015, METHODS, V77-78, P75, DOI 10.1016/j.ymeth.2014.10.015; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Gomaraschi M, 2013, CARDIOVASC RES, V100, P36, DOI 10.1093/cvr/cvt169; Gonzalez-Diez M, 2008, THROMB HAEMOSTASIS, V100, P119, DOI 10.1160/TH07-11-0675; Gordts SC, 2014, CURR MOL MED, V14, P481, DOI 10.2174/1566524013666131118113927; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karuna R, 2011, ATHEROSCLEROSIS, V219, P855, DOI 10.1016/j.atherosclerosis.2011.08.049; Kimura T, 2006, CELL SIGNAL, V18, P841, DOI 10.1016/j.cellsig.2005.07.011; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Levkau B, 2002, CELL DEATH DIFFER, V9, P1360, DOI 10.1038/sj.cdd.4401106; Levkau B, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00243; Moon SK, 2004, ARCH BIOCHEM BIOPHYS, V421, P267, DOI 10.1016/j.abb.2003.11.007; Muthuramu I, 2017, EXPERT OPIN BIOL TH, V17, P793, DOI 10.1080/14712598.2017.1333597; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Nussbaum C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7416; Poti F, 2014, CARDIOVASC RES, V103, P395, DOI 10.1093/cvr/cvu136; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, CIRC RES, V120, P617, DOI 10.1161/CIRCRESAHA.116.310527; Ruiz M, 2017, ARTERIOSCL THROM VAS, V37, P118, DOI 10.1161/ATVBAHA.116.308435; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sattler K, 2015, J AM COLL CARDIOL, V66, P1470, DOI 10.1016/j.jacc.2015.07.057; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Swendeman SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2722; Tamama K, 2005, ATHEROSCLEROSIS, V178, P19, DOI 10.1016/j.atherosclerosis.2004.07.032; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Tong XL, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-82; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van der Vorst EPC, 2013, FASEB J, V27, P1413, DOI 10.1096/fj.12-212753; Whetzel AM, 2006, CIRC RES, V99, P731, DOI 10.1161/01.RES.0000244088.33375.52; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zhang GQ, 2013, BLOOD, V122, P443, DOI 10.1182/blood-2012-11-467191; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	59	30	33	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1482	1495		10.1096/fj.201801245R	http://dx.doi.org/10.1096/fj.201801245R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130432				2022-12-28	WOS:000457401500116
J	Wang, Y; Wehling-Henricks, M; Welc, SS; Fisher, AL; Zuo, Q; Tidball, JG				Wang, Ying; Wehling-Henricks, Michelle; Welc, Steven S.; Fisher, Allison L.; Zuo, Qun; Tidball, James G.			Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia	FASEB JOURNAL			English	Article						skeletal muscle; macrophage; satellite cell; bone marrow transplantation; muscle fibrosis	SATELLITE CELLS; CHRONIC INFLAMMATION; SKELETAL-MUSCLES; AGE; REGENERATION; MACROPHAGES; MECHANISMS; INCREASES; MICE; REJUVENATION	Aging is associated with diminished muscle mass, reductions in muscle stem cell functions, and increased muscle fibrosis. The immune system, especially macrophages, can have important roles in modulating muscle growth and regeneration, suggesting that the immune system may also have significant influences on muscle aging. Moreover, the immune system experiences changes in function during senescence, suggesting that regulatory interaction between muscle cells and the immune system may also change during aging. In this study, we performed bone marrow transplantations between age-mismatched donor and recipient mice to test the influence of the age of the immune system on muscle aging. Transplantation of young bone marrow cells into old recipients prevented sarcopenia and prevented age-related change in muscle fiber phenotype. Transplantation of old bone marrow cells into young animals reduced satellite cell numbers and promoted satellite cells to switch toward a fibrogenic phenotype. We also demonstrated that conditioned media from young, but not old, bone marrow cells promoted myoblast proliferation in vitro, and we found that factors released by young bone marrow cells were more supportive of myotube differentiation in vitro. Together, our results demonstrate that aging of bone marrow cells promotes the age-related reduction of satellite cell number and function and contributes to sarcopenia.Wang, Y., Wehling-Henricks, M., Welc, S. S., Fisher, A. L., Zuo, Q., Tidball, J. G. Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia.	[Wang, Ying; Fisher, Allison L.; Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA; [Wehling-Henricks, Michelle; Welc, Steven S.; Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Zuo, Qun] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai University of Sport	Tidball, JG (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 1135 Terasaki Bldg, Los Angeles, CA 90095 USA.	jtidball@physci.ucla.edu		Tidball, James/0000-0003-1202-8038; Fisher, Allison/0000-0002-9393-2442; Welc, Steven/0000-0002-2353-0325	U.S. National Institutes of Health, National Institute on Aging; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR054451, RO1AG041147]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041147] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Mr. David Rangel and Ms. Katherine Wen for their expert technical assistance, and Ms. Christine Phan and Mr. Edward Garcia (all from University of California, Los Angeles) for performing fiber counts. Research reported in this publication was supported by the U.S. National Institutes of Health, National Institute on Aging and National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants R01AR054451 and RO1AG041147 to J.G.T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the U.S. National Institutes of Health. The authors declare no conflicts of interest.	Akahori H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8792; ALNAQEEB MA, 1984, J ANAT, V139, P677; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Du HQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00522-7; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fulop T, 2016, REV INVEST CLIN, V68, P84; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Haynes L, 2012, SEMIN IMMUNOL, V24, P350, DOI 10.1016/j.smim.2012.04.001; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Jo E, 2012, AGING CLIN EXP RES, V24, P412, DOI 10.3275/8464; Kung TA, 2014, J GERONTOL A-BIOL, V69, P657, DOI 10.1093/gerona/glt135; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Marty E, 2017, BONE, V105, P276, DOI 10.1016/j.bone.2017.09.008; Merly F, 1999, MUSCLE NERVE, V22, P724, DOI 10.1002/(SICI)1097-4598(199906)22:6<724::AID-MUS9>3.0.CO;2-O; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Roberts P, 1997, J ANAT, V191, P585, DOI 10.1046/j.1469-7580.1997.19140585.x; Roubenoff R, 2001, CAN J APPL PHYSIOL, V26, P78, DOI 10.1139/h01-006; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; SNOW MH, 1977, CELL TISSUE RES, V185, P399; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001; Wang Y, 2015, AGING CELL, V14, P678, DOI 10.1111/acel.12350; Wehling-Henricks M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010763; Wilson D, 2017, AGEING RES REV, V36, P1, DOI 10.1016/j.arr.2017.01.006; Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014; Zamir O, 1992, Mediators Inflamm, V1, P247, DOI 10.1155/S0962935192000371	49	35	35	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1415	1427		10.1096/fj.201800973R	http://dx.doi.org/10.1096/fj.201800973R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130434	Green Published, Bronze			2022-12-28	WOS:000457401500111
J	Zhu, BY; Cao, XY; Zhang, WQ; Pan, GP; Yi, Q; Zhong, WB; Yan, DG				Zhu, Biying; Cao, Xiuye; Zhang, Wenqiang; Pan, Guoping; Yi, Qing; Zhong, Wenbin; Yan, Daoguang			MicroRNA-31-5p enhances the Warburg effect via targeting FIH	FASEB JOURNAL			English	Article						miR-31-5p; HIF; ATP	CANCER; METABOLISM; EXPRESSION; CELLS; CARCINOMA; GLUTAMINE; UNCOVERS; PATHWAYS; HIF-1; NOTCH	The enhanced expression of miR-31 has been observed in many human malignancies including lung cancer, and this microRNA regulates several aspects of oncogenesis. However, the role of miR-31-5p in energy metabolism remains elusive. Here, we confirm that H1299 and A549 cells, 2 lung cancer cell lines, relay on aerobic glycolysis as main source of ATP. Inhibition of miR-31-5p leads to decreased glycolysis and ATP production, while miR-31-5p overexpression increases them. Hypoxia inducible factor 1 (HIF-1) up-regulates the expression of glycolytic enzymes, and the HIF-1 inhibitor (FIH) inhibits HIF-1 activity. Because FIH is a direct target of miR-31-5p, inhibition of miR-31-5p results in enhanced FIH expression and suppression of HIF-1 signaling, while overexpression of miR-31-5p has the opposite effects. Via this mechanism, miR-31-5p up-regulates aerobic glycolytic genes and maintains energy homeostasis. To further validate the mechanism of miR-31-5p in glycolysis regulation, we show that overexpression or knockdown of FIH rescued the effects of miR-31-5p or miR-31-5p inhibitor on HIF activation and its target gene expression, respectively. Finally, by means of an A549 cell xenograft mouse model, we demonstrate that the miR-31-5p promotes cell proliferation via enhancing glycolysis. In summary, this study reveals that miR-31-5p promotes the Warburg effect via direct targeting of FIH.Zhu, B., Cao, X., Zhang, W., Pan, G., Yi, Q., Zhong, W., Yan, D. MicroRNA-31-5p enhances the Warburg effect via targeting FIH.	[Zhu, Biying; Cao, Xiuye; Zhang, Wenqiang; Pan, Guoping; Zhong, Wenbin; Yan, Daoguang] Jinan Univ, Dept Biol, 601 Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China; [Yi, Qing] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA	Jinan University; Cleveland Clinic Foundation	Zhong, WB; Yan, DG (corresponding author), Jinan Univ, Dept Biol, 601 Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China.	twbzhong@jnu.edu.cn; tydg@jnu.edu.cn		Zhu, Biying/0000-0003-2358-2739	Major Research Program of Guangdong Science and Technology [2017A030308002]; National Natural Science Foundation of China [81770438, 91439122]	Major Research Program of Guangdong Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank V. Ollkonen (Minerva Foundation Institute for Medical Research, Helsinki, Finland) for his critical reading. This work was supported by grants from Major Research Program of Guangdong Science and Technology (Grant 2017A030308002 to D.Y.), and from the National Natural Science Foundation of China (Grants 81770438 and 91439122 to D.Y.). The authors declare no conflicts of interest.	Assaily W, 2006, CANCER CELL, V10, P4, DOI 10.1016/j.ccr.2006.06.014; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Cejudo-Martin P, 2005, DEV CELL, V9, P575, DOI 10.1016/j.devcel.2005.10.001; Chen XS, 2016, ACTA PHARMACOL SIN, V37, P1013, DOI 10.1038/aps.2016.47; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Dong Z, 2014, CANCER LETT, V343, P249, DOI 10.1016/j.canlet.2013.09.034; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Edmonds MD, 2016, J CLIN INVEST, V126, P349, DOI 10.1172/JCI82720; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu CH, 2013, EXP THER MED, V6, P1265, DOI 10.3892/etm.2013.1311; Igarashi H, 2015, ANN SURG ONCOL, V22, P2640, DOI 10.1245/s10434-014-4264-7; Jia D, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030021; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koumangoye RB, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0284-y; LASZLO J, 1967, BLOOD-J HEMATOL, V30, P151, DOI 10.1182/blood.V30.2.151.151; Lee MR, 2016, STEM CELL REP, V7, P1, DOI 10.1016/j.stemcr.2016.05.012; Lei SL, 2014, ONCOL LETT, V8, P1768, DOI 10.3892/ol.2014.2328; Levy P, 2016, ONCOGENE, V35, P4155, DOI 10.1038/onc.2015.479; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Mohamed A, 2014, CLIN LUNG CANCER, V15, P7, DOI 10.1016/j.cllc.2013.09.001; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Su Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.210; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	42	34	34	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					545	556		10.1096/fj.201800803R	http://dx.doi.org/10.1096/fj.201800803R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30004795				2022-12-28	WOS:000457401500043
J	Perla-Kajan, J; Borowczyk, K; Glowacki, R; Nygard, O; Jakubowski, H				Perla-Kajan, Joanna; Borowczyk, Kamila; Glowacki, Rafal; Nygard, Ottar; Jakubowski, Hieronim			Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans	FASEB JOURNAL			English	Article						PON1; BLMH; BPHL; MARS	PROTEIN N-HOMOCYSTEINYLATION; SERUM PARAOXONASE; CARDIOVASCULAR RISK; METHYLENETETRAHYDROFOLATE REDUCTASE; PATHOLOGICAL CONSEQUENCES; DENSITY-LIPOPROTEIN; POSSIBLE MECHANISM; ENDOTHELIAL-CELLS; PON1 PROTEIN; DISEASE	Genetic or nutritional deficiencies in 1 carbon and homocysteine (Hcy) metabolism elevate Hcy-thiolactone levels and are associated with cardiovascular and neurologic diseases. Hcy-thiolactone causes protein damage, cellular toxicity, and proatherogenic changes in gene expression in human cells and tissues. A polymorphic cardio-protective enzyme, paraoxonase 1 (PON1), hydrolyzes Hcy-thiolactone in vitro. However, whether Hcy-thiolactone hydrolysis is a physiologic function of the PON1 protein and whether polymorphisms in the PON1 gene affect Hcy-thiolactone levels in humans was unknown. Here we show that the PON1-192 genotype, which affects the enzymatic activity of the PON1 protein, also affected urinary Hcy-thiolactone levels, normalized to creatinine. Carriers of the PON1-192R allele had significantly lower Hcy-thiolactone/creatinine levels than individuals carrying the PON1-192Q allele. Individuals with low serum PON1 paraoxonase activity had significantly higher Hcy-thiolactone/creatinine levels compared with individuals with high paraoxonase activity. In contrast, Hcy-thiolactone/creatinine levels were unaffected by serum PON1 arylesterase activity or by PON1 protein levels. Taken together, these findings suggest that PON1 hydrolyzes Hcy-thiolactone in humans and that the interindividual variations in PON1 genotype/activity can modulate the pathology of hyperhomocysteinemia.Pera-Kajan, J., Borowczyk, K., Gowacki, R., Nygard, O., Jakubowski, H. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.	[Perla-Kajan, Joanna; Jakubowski, Hieronim] Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland; [Borowczyk, Kamila; Glowacki, Rafal] Univ Lodz, Dept Environm Chem, Fac Chem, Lodz, Poland; [Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Jakubowski, Hieronim] Rutgers New Jersey Med Sch, Int Ctr Publ Hlth, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA	Poznan University of Life Sciences; University of Lodz; University of Bergen; Haukeland University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jakubowski, H (corresponding author), Rutgers New Jersey Med Sch, Int Ctr Publ Hlth, Dept Microbiol & Mol Genet, 225 Warren St, Newark, NJ 07103 USA.	jakubows@rutgers.edu	Jakubowski, Hieronim/AAA-6834-2019; Perla-Kajan, Joanna/F-2965-2010; Jakubowski, Hieronim/A-2510-2017	Perla-Kajan, Joanna/0000-0002-0791-5057; Borowczyk, Kamila/0000-0002-8737-7913; Jakubowski, Hieronim/0000-0001-5845-4409; Glowacki, Rafal/0000-0003-0071-1470	Polish National Science Center [2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091, 2016/23/B/NZ5/00573]; American Heart Association [17GRNT32910002]	Polish National Science Center; American Heart Association(American Heart Association)	This work was supported in part by Grants 2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091, and 2016/23/B/NZ5/00573 from the Polish National Science Center, and 17GRNT32910002 from the American Heart Association. The authors declare no conflicts of interest.	Bayrak A, 2011, J CHROMATOGR B, V879, P49, DOI 10.1016/j.jchromb.2010.11.006; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Borowczyk K, 2012, J ALZHEIMERS DIS, V30, P225, DOI 10.3233/JAD-2012-111940; Brophy VH, 2001, AM J HUM GENET, V68, P1428, DOI 10.1086/320600; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2005, ANAL BIOCHEM, V337, P271, DOI 10.1016/j.ab.2004.11.035; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; Connelly PW, 2005, FREE RADICAL BIO MED, V38, P164, DOI 10.1016/j.freeradbiomed.2004.10.010; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; Domagala TB, 2006, CELL MOL BIOL, V52, P4, DOI 10.1170/T727; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Eryanni-Levin S, 2015, BBA-MOL CELL BIOL L, V1851, P1118, DOI 10.1016/j.bbalip.2015.04.008; Gamliel-Lazarovich A, 2012, ATHEROSCLEROSIS, V222, P92, DOI 10.1016/j.atherosclerosis.2012.01.047; Glowacki R, 2004, J BIOL CHEM, V279, P10864, DOI 10.1074/jbc.M313268200; Glowacki R, 2011, AMINO ACIDS, V41, P187, DOI 10.1007/s00726-010-0521-7; Gurda D, 2015, AMINO ACIDS, V47, P1319, DOI 10.1007/s00726-015-1956-7; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2001, FEBS LETT, V491, P35, DOI 10.1016/S0014-5793(01)02143-3; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H., 2016, BIOMED GENET GENOM, V1, P40, DOI DOI 10.15761/BGG.1000108; Jakubowski H., 2013, HOMOCYSTEINE PROTEIN; Jakubowski H, 2016, ANAL BIOCHEM, V508, P118, DOI 10.1016/j.ab.2016.06.002; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Kunutsor SK, 2016, ATHEROSCLEROSIS, V245, P143, DOI 10.1016/j.atherosclerosis.2015.12.021; Lacinski M, 2004, CELL MOL BIOL, V50, P885; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Mackness B, 2010, IUBMB LIFE, V62, P480, DOI 10.1002/iub.347; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; Marathe GK, 2003, J BIOL CHEM, V278, P3937, DOI 10.1074/jbc.M211126200; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Marsillach J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110054; Menini T, 2014, REDOX REP, V19, P49, DOI 10.1179/1351000213Y.0000000071; MUELLER RF, 1983, AM J HUM GENET, V35, P393; Pera-Kajan J, 2012, AMINO ACIDS, V43, P1405, DOI 10.1007/s00726-012-1321-z; Perla-Kajan J, 2007, BIOCHEMISTRY-US, V46, P6225, DOI 10.1021/bi602463m; Perla-Kajan J, 2010, FASEB J, V24, P931, DOI 10.1096/fj.09-144410; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shishehbor MH, 2008, AM J CARDIOL, V101, P1741, DOI 10.1016/j.amjcard.2008.02.060; Smith AD, 2016, ANNU REV NUTR, V36, P211, DOI 10.1146/annurev-nutr-071715-050947; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Teiber JF, 2004, J LIPID RES, V45, P2260, DOI 10.1194/jlr.M400213-JLR200; Zimny J., 2011, ACTA BIOCHIM POL S4, V58, P57; Zimny J., 2010, ACTA BIOCHIM POL S4, V57, P134; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	54	17	17	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6019	6024		10.1096/fj.201800346R	http://dx.doi.org/10.1096/fj.201800346R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29782204	Bronze			2022-12-28	WOS:000447172000021
J	Peng, XM; Gao, S; Deng, HT; Cai, HX; Zhou, ZA; Xiang, R; Zhang, QZ; Li, LY				Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan			Perturbation of epithelial apicobasal polarity by rhomboid family-1 gene overexpression	FASEB JOURNAL			English	Article						acinus; Par6; RHBDF1; protein complex	CELL-POLARITY; COMMON TARGETS; CANCER-CELLS; EXPRESSION; PROTEINS; PAR3; MORPHOGENESIS; APOPTOSIS; GTPASES	The human rhomboid family (RHBDF)1 gene is highly expressed in breast cancer under clinical conditions but not in normal mammary gland tissues. Silencing the RHBDF1 gene in breast cancer xenograft tumors leads to inhibition of tumor growth. We show in this study that artificially raising RHBDF1 protein levels in the mammary epithelial cells MCF-10A results in severe perturbations of the ability of the cells to form lumen-containing acini, either in 3-dimensional cell cultures or implanted in mouse mammary fat pads. Knocking down RHBDF1 with short hairpin (sh)RNA leads to restoration of acinus formation. Consistently, RHBDF1 overexpression gives rise to disordered distribution of polarity markers GM130 and laminin-5, which otherwise are located in apical and basal positions, respectively, in the acini. Further investigations reveal that RHBDF1 directly binds to Par6a, a component of a protein complex consisting of partitioning-defective scaffold protein (Par)6, Par3, renin-angiotensin system-related C3 botulinum toxin substrate (Rac)1, and cell-division cycle (Cdc)42, which is structurally critical to the formation of apicobasal polarity. RHBDF1 binding to Par6a results in collapse of the protein complex and thus disruption of polarity formation. Since early stages of breast cancer are characterized by the loss of mammary gland epithelial cell polarity, our findings indicate that perturbations of apicobasal polarity by high levels of RHBDF1 is a significant attribute in the development of breast neoplasia.Peng, X.-M., Gao, S., Deng, H.-T., Cai, H.-X., Zhou, Z., Xiang, R., Zhang, Q.-Z., Li, L.-Y. Perturbation of epithelial apicobasal polarity by rhomboid family-1 gene overexpression.	[Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan] Nankai Univ, Tianjin Key Lab Mol Drug Res, Coll Pharm, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin, Peoples R China; [Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Peng, Xue-Mei] Shanxi Datong Univ, Sch Med, Dept Immunol, Datong, Peoples R China	Nankai University; Nankai University; Nankai University; Shanxi Datong University	Zhang, QZ; Li, LY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol 203, 94 Weijin Rd, Tianjin 300071, Peoples R China.	zhangqiangzhe@nankai.edu.cn; liluyuan@nankai.edu.cn			National Natural Science Foundation of China (NSFC) [81672747, 31560323, 81272356, 81330029]; Tianjin Municipality Science and Technology Commission [10ZCKFSH00100, 15JCYBJC50100]; Programs for Changjiang Scholars and Innovative Teams at Nankai University [IRT13023]; Ministry of Education Science and Technology Development Center [20130031120040]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipality Science and Technology Commission; Programs for Changjiang Scholars and Innovative Teams at Nankai University; Ministry of Education Science and Technology Development Center	This work is supported, in part, by the National Natural Science Foundation of China (NSFC) Grants 81672747 and 31560323 (to Q.-Z.Z.), and 81272356 and 81330029 (to L.-Y.L.); Tianjin Municipality Science and Technology Commission Grants 10ZCKFSH00100 (to L.-Y.L.) and 15JCYBJC50100 (to Q.-Z.Z.); Programs for Changjiang Scholars and Innovative Teams at Nankai University (IRT13023); and Ministry of Education Science and Technology Development Center Grant 20130031120040 (to Q.-Z.Z.). The authors declare no conflicts of interest.	Archibald A, 2015, ONCOGENE, V34, P3199, DOI 10.1038/onc.2014.242; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Freeman M, 2016, BIOCHEM SOC T, V44, P945, DOI 10.1042/BST20160035; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Herr R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-17; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Javier RT, 2008, ONCOGENE, V27, P7031, DOI 10.1038/onc.2008.352; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Khursheed M, 2014, J BIOSCIENCES, V39, P145, DOI 10.1007/s12038-013-9410-z; Kinch LN, 2013, BBA-BIOMEMBRANES, V1828, P2937, DOI 10.1016/j.bbamem.2013.06.031; Kitaichi T, 2017, HUM PATHOL, V62, P134, DOI 10.1016/j.humpath.2017.01.009; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09701; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lin CC, 2014, J INFORM OPTIM SCI, V35, P1, DOI 10.1080/02522667.2013.867734; Lof-Ohlin ZM, 2017, NAT CELL BIOL, V19, P1313, DOI 10.1038/ncb3628; Mack Natalie Ann, 2014, Small GTPases, V5, P10, DOI 10.4161/21541248.2014.973768; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sequeira SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000615; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Ward JD, 2015, CANCER LETT, V356, P382, DOI 10.1016/j.canlet.2014.09.030; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Yang GL, 2017, FASEB J, V31, P2001, DOI 10.1096/fj.201600800R; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zhou Z, 2014, CANCER RES, V74, P2719, DOI 10.1158/0008-5472.CAN-13-1027; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	36	4	5	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5577	5586		10.1096/fj.201800016R	http://dx.doi.org/10.1096/fj.201800016R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29727209				2022-12-28	WOS:000447972500031
J	Stykel, MG; Humphries, K; Kirby, MP; Czaniecki, C; Wang, TY; Ryan, T; Bamm, V; Ryan, SD				Stykel, Morgan G.; Humphries, Kayla; Kirby, Mathew P.; Czaniecki, Chris; Wang, Tinya; Ryan, Tammy; Bamm, Vladimir; Ryan, Scott D.			Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease	FASEB JOURNAL			English	Article						neurodegeneration; isogenic hiPSCs; anterograde transport; reactive nitrogen species; tubulin nitration	PROTEIN-TYROSINE NITRATION; DOPAMINERGIC NEURON LOSS; NITRIC-OXIDE SYNTHASE; ALPHA-SYNUCLEIN GENE; NERVE GROWTH-FACTOR; COMPLEX-I; TRANSGENIC MICE; PC12 CELLS; EXPOSURE; PARAQUAT	Neuronal loss in Parkinson's disease (PD) is associated with aberrant mitochondrial function in dopaminergic (DA) neurons of the substantia nigra pars compacta. An association has been reported between PD onset and exposure to mitochondrial toxins, including the agrochemicals paraquat (PQ), maneb (MB), and rotenone (Rot). Here, with the use of a patient-derived stem cell model of PD, allowing comparison of DA neurons harboring a mutation in the -synuclein (-syn) gene (SNCA-A53T) against isogenic, mutation-corrected controls, we describe a novel mechanism whereby NO, generated from SNCA-A53T mutant neurons exposed to Rot or PQ/MB, inhibits anterograde mitochondrial transport through nitration of -tubulin (-Tub). Nitration of -Tub inhibited the association of both -syn and the mitochondrial motor protein kinesin 5B with the microtubules, arresting anterograde transport. This was, in part, a result of nitration of -Tub in the C-terminal domain. These effects were rescued by inhibiting NO synthesis with the NOS inhibitor N-nitro-L-arginine methyl ester. Collectively, our results are the first to demonstrate a gene by environment interaction in PD, whereby agrochemical exposure selectively triggers a deficit in mitochondrial transport by nitrating the microtubules in neurons harboring the SNCA-A53T mutation.Stykel, M. G., Humphries, K., Kirby, M. P., Czaniecki, C., Wang, T., Ryan, T., Bamm, V., Ryan, S. D. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.	[Stykel, Morgan G.; Humphries, Kayla; Kirby, Mathew P.; Czaniecki, Chris; Wang, Tinya; Ryan, Tammy; Bamm, Vladimir; Ryan, Scott D.] Univ Guelph, Dept Mol & Cellular Biol, Sci Complex,Room 3456,50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Ryan, Scott D.] Scintillon Inst, Neurodegenerat Dis Ctr, San Diego, CA USA	University of Guelph	Ryan, SD (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex,Room 3456,50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	sryan03@uoguelph.ca		Ryan, Tammy/0000-0002-0428-8932; Bamm, Vladimir/0000-0002-3686-1991; Ryan, Scott/0000-0001-9829-4649; Stykel, Morgan/0000-0002-4799-4220	Parkinson Society of Canada [2014-685]; Natural Sciences and Engineering Research Council of Canada [RG060805, CRDPJ490841-15]; Ontario Graduate Scholarship	Parkinson Society of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	The authors acknowledge Carla Coakley (University of Guelph) for technical assistance in the preparation of this manuscript, Michaela Struder-Kypke (Advanced Analysis Center, University of Guelph) for assistance with live-cell image acquisition, and Agata Zienowicz (University of Guelph) for tubulin purification. This work was supported, in part, by the Parkinson Society of Canada (2014-685 to S.D.R.), the Natural Sciences and Engineering Research Council of Canada (RG060805 and CRDPJ490841-15 to S.D.R.; Undergraduate Student Research Awards to M.P.K.), and an Ontario Graduate Scholarship to M.G.S. The authors declare no conflicts of interest.	Bamm VV, 2011, BIOPHYS J, V101, P1248, DOI 10.1016/j.bpj.2011.07.035; Barthwal MK, 2001, REDOX REP, V6, P297, DOI 10.1179/135100001101536436; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5; Cappelletti G, 2003, EXP CELL RES, V288, P9, DOI 10.1016/S0014-4827(03)00209-X; Cappelletti G, 2006, NEUROSCI LETT, V401, P159, DOI 10.1016/j.neulet.2006.03.009; Cartelli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33289; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chavarria C, 2013, ARCH BIOCHEM BIOPHYS, V533, P25, DOI 10.1016/j.abb.2013.02.009; Chinta SJ, 2011, FREE RADICAL RES, V45, P53, DOI 10.3109/10715762.2010.509398; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Connor BP, 1996, NEUROPHARMACOLOGY, V35, P459, DOI 10.1016/0028-3908(95)00194-8; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Dardiotis E, 2013, TOXICOLOGY, V307, P17, DOI 10.1016/j.tox.2012.12.016; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Dixit A, 2013, BBA-MOL BASIS DIS, V1832, P1227, DOI 10.1016/j.bbadis.2013.03.019; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Gatto NM, 2010, NEUROEPIDEMIOLOGY, V35, P191, DOI 10.1159/000315157; Gautier CA, 2016, HUM MOL GENET, V25, P2972, DOI 10.1093/hmg/ddw148; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Greenamyre JT, 2010, TRENDS PHARMACOL SCI, V31, P141, DOI 10.1016/j.tips.2009.12.006; Guillette EA, 1998, ENVIRON HEALTH PERSP, V106, P347, DOI 10.2307/3434041; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; LI W, 1987, TOXICOL APPL PHARM, V91, P96, DOI 10.1016/0041-008X(87)90197-9; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Markopoulou K, 2008, ACTA NEUROPATHOL, V116, P25, DOI 10.1007/s00401-008-0372-4; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; Muller CM, 2005, J NEUROPATH EXP NEUR, V64, P623; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Paul KC, 2016, ENVIRON HEALTH PERSP, V124, P570, DOI 10.1289/ehp.1408976; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Devoto VMP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05334-9; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Ryan T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03241-9; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Schwarz TL, 2013, COLD SPRING HARB PER, V5; Sheldon KL, 2015, J BIOL CHEM, V290, P26784, DOI 10.1074/jbc.M115.678854; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Shlevkov E, 2016, P NATL ACAD SCI USA, V113, pE6097, DOI 10.1073/pnas.1612283113; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; Srivastava P, 2007, FEBS J, V274, P4788, DOI 10.1111/j.1742-4658.2007.06004.x; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tapias V, 2017, CELL MOL LIFE SCI, V74, P2851, DOI 10.1007/s00018-017-2541-x; Tedeschi G, 2005, PROTEOMICS, V5, P2422, DOI 10.1002/pmic.200401208; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wecht JM, 2011, ARCH PHYS MED REHAB, V92, P1789, DOI 10.1016/j.apmr.2011.03.022; Xiong ZK, 2015, EXP THER MED, V9, P553, DOI 10.3892/etm.2014.2099; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Zhang J, 2003, J NEUROCHEM, V84, P336, DOI 10.1046/j.1471-4159.2003.01525.x; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	80	22	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5350	5364		10.1096/fj.201700759RR	http://dx.doi.org/10.1096/fj.201700759RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688812				2022-12-28	WOS:000447972500013
J	Fujita, R; Yoshioka, K; Seko, D; Suematsu, T; Mitsuhashi, S; Senoo, N; Miura, S; Nishino, I; Ono, Y				Fujita, Ryo; Yoshioka, Kiyoshi; Seko, Daiki; Suematsu, Takashi; Mitsuhashi, Satomi; Senoo, Nanami; Miura, Shinji; Nishino, Ichizo; Ono, Yusuke			Zmynd17 controls muscle mitochondrial quality and whole-body metabolism	FASEB JOURNAL			English	Article						skeletal muscle; Mss51; insulin resistance; glucose intolerance; metabolic homeostasis	HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; STEM-CELL; EXERCISE; DYSFUNCTION; HOMEOSTASIS; CHAIN; DEFICIENCY	Muscle mitochondria are crucial for systemic metabolic function, yet their regulation remains unclear. The zinc finger MYND domain-containing protein 17 (Zmynd17) was recently identified as a muscle-specific gene in mammals. Here, we investigated the role of Zmynd17 in mice. We found Zmynd17 predominantly expressed in skeletal muscle, especially in fast glycolytic muscle. Genetic Zmynd17 inactivation led to morphologic and functional abnormalities in muscle mitochondria, resulting in decreased respiratory function. Metabolic stress induced by a high-fat diet upregulated Zmynd17 expression and further exacerbated muscle mitochondrial morphology in Zmynd17-deficient mice. Strikingly, Zmynd17 deficiency significantly aggravated metabolic stress-induced hepatic steatosis, glucose intolerance, and insulin resistance. Furthermore, middle-aged mice lacking Zmynd17 exhibited impaired aerobic exercise performance, glucose intolerance, and insulin resistance. Thus, our results indicate that Zmynd17 is a metabolic stress-inducible factor that maintains muscle mitochondrial integrity, with its deficiency profoundly affecting whole-body glucose metabolism.Fujita, R., Yoshioka, K., Seko, D., Suematsu, T., Mitsuhashi, S., Senoo, N., Miura, S., Nishino, I., Ono, Y. Zmynd17 controls muscle mitochondrial quality and whole-body metabolism.	[Fujita, Ryo; Yoshioka, Kiyoshi; Seko, Daiki; Ono, Yusuke] Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Musculoskeletal Mol Biol Res Grp, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Fujita, Ryo; Yoshioka, Kiyoshi; Seko, Daiki; Ono, Yusuke] Nagasaki Univ, Grad Sch Biomed Sci, Dept Stem Cell Biol, Nagasaki, Japan; [Suematsu, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Cent Electron Microscope Lab, Nagasaki, Japan; [Mitsuhashi, Satomi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Senoo, Nanami; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Shizuoka, Japan; [Ono, Yusuke] Agcy Med Res & Dev, Tokyo, Japan; [Fujita, Ryo] McGill Univ, Montreal, PQ, Canada	Nagasaki University; Nagasaki University; Nagasaki University; National Center for Neurology & Psychiatry - Japan; University of Shizuoka; McGill University	Ono, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Musculoskeletal Mol Biol Res Grp, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	yusuke-ono@nagasaki-u.ac.jp	Miura, Shinji/K-6516-2013; Nishino, Ichizo/G-2676-2010; Fujita, Ryo/GWZ-1472-2022	Miura, Shinji/0000-0001-8806-9763; Nishino, Ichizo/0000-0001-9452-112X; Fujita, Ryo/0000-0002-8392-0122; Yoshioka, Kiyoshi/0000-0001-5472-8142; Ono, Yusuke/0000-0002-4802-7507	Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency); Japan Agency for Medical Research and Development (AMED) [16bm0704010h0001]; Japan Society for the Promotion of Science (JSPS) [16K13046, 15H05368]; Center for Clinical and Translational Research of Kyushu University; Takeda Science Foundation; ONO Medical Research Foundation; Meiji Yasuda Life Foundation of Health and Welfare;  [15J03833]	Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for Clinical and Translational Research of Kyushu University; Takeda Science Foundation(Takeda Science Foundation (TSF)); ONO Medical Research Foundation; Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); 	The authors thank Dr. K. Yamamoto (Nagasaki University School of Medicine, Nagasaki, Japan) and all lab members for technical support. The Zmynd17<SUP>Lacz/+</SUP> ES cells used in this study were obtained from the Knockout Mouse Project (KOMP) Repository (Davis, CA, USA). This work was supported by the Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency), the Japan Agency for Medical Research and Development (AMED; Project 16bm0704010h0001), a Grant-in-Aid for Challenging Exploratory Research (Project 16K13046), a Grant-in-Aid for Young Scientists A (Project 15H05368) from the Japan Society for the Promotion of Science (JSPS), the Center for Clinical and Translational Research of Kyushu University, the Takeda Science Foundation, and the ONO Medical Research Foundation. This work was also supported, in part, by a Grant-in-Aid for JSPS Research Fellows (15J03833) and the Meiji Yasuda Life Foundation of Health and Welfare. The authors declare no conflicts of interest.	Akasaki Y, 2014, AGING CELL, V13, P80, DOI 10.1111/acel.12153; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061; Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014; Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fujita R, 2015, STEM CELLS, V33, P962, DOI 10.1002/stem.1900; Fujita R, 2014, BBA-GEN SUBJECTS, V1840, P3170, DOI 10.1016/j.bbagen.2014.01.014; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Hood DA, 2011, COMPR PHYSIOL, V1, P1119, DOI 10.1002/cphy.c100074; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; Meng ZX, 2013, NAT MED, V19, P640, DOI 10.1038/nm.3144; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Moyer Adam L, 2015, J Neuromuscul Dis, V2, P371; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9; Seko D, 2016, FASEB J, V30, P1733, DOI 10.1096/fj.15-280933; Senoo N, 2015, J LIPID RES, V56, P2286, DOI 10.1194/jlr.M060533; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021; Wijngaarden MA, 2013, AM J PHYSIOL-ENDOC M, V304, pE1012, DOI 10.1152/ajpendo.00008.2013; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	56	10	10	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5012	5025		10.1096/fj.201701264R	http://dx.doi.org/10.1096/fj.201701264R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913553				2022-12-28	WOS:000443817700032
J	Johnson, CD; Barlow-Anacker, AJ; Pierre, JF; Touw, K; Erickson, CS; Furness, JB; Epstein, ML; Gosain, A				Johnson, Carl D.; Barlow-Anacker, Amanda J.; Pierre, Joseph F.; Touw, Ketrija; Erickson, Christopher S.; Furness, John B.; Epstein, Miles L.; Gosain, Ankush			Deletion of choline acetyltransferase in enteric neurons results in postnatal intestinal dysmotility and dysbiosis	FASEB JOURNAL			English	Article						acetylcholine; enteric nervous system; development; microbiome	MYENTERIC AH NEURONS; GUINEA-PIG ILEUM; SYNAPTIC-TRANSMISSION; NERVOUS-SYSTEM; PERISTALTIC REFLEX; TACHYKININS; PLEXUS; ROLES; MOUSE; NEUROTRANSMITTER	Acetylcholine (ACh)-synthesizing neurons are major components of the enteric nervous system (ENS). They release ACh and peptidergic neurotransmitters onto enteric neurons and muscle. However, pharmacological interrogation has proven inadequate to demonstrate an essential role for ACh. Our objective was to determine whether elimination of ACh synthesis during embryogenesis alters prenatal viability, intestinal function, the neurotransmitter complement, and the microbiome. Conditional deletion of choline acetyltransferase (ChAT), the ACh synthetic enzyme, in neural crest-derived neurons (ChAT-Null) was performed. Survival, ChAT activity, gut motility, and the microbiome were studied. ChAT was conditionally deleted in ENS neural crest-derived cells. Despite ChAT absence, mice were born live and survived the first 2 wk. They failed to gain significant weight in the third postnatal week, dying between postnatal d 18 and 30. Small intestinal transit of carmine red was 50% slower in ChAT-Nullsvs. WT and ChAT-Het. The colons of many neonatal ChAT-Null mice contained compacted feces, suggesting dysmotility. Microbiome analysis revealed dysbiosis in ChAT-Null mice. Developmental deletion of ChAT activity in enteric neurons results in proximal gastrointestinal tract dysmotility, critically diminished colonic transit, failure to thrive, intestinal dysbiosis, and death. ACh is necessary for sustained gut motility and survival of neonatal mice after weaning.Johnson, C. D., Barlow-Anacker, A. J., Pierre, J. F., Touw, K., Erickson, C. S., Furness, J. B., Epstein, M. L., Gosain, A. Deletion of cholineacetyltransferase in enteric neurons results in postnatal intestinal dysmotility and dysbiosis.	[Johnson, Carl D.] Univ Wisconsin, Dept Integrat Biol, Madison, WI USA; [Barlow-Anacker, Amanda J.; Erickson, Christopher S.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Epstein, Miles L.] Univ Wisconsin, Dept Neurosci, Sch Med & Publ Hlth, Madison, WI USA; [Pierre, Joseph F.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Gosain, Ankush] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Div Pediat Surg, Memphis, TN 38163 USA; [Pierre, Joseph F.; Gosain, Ankush] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA; [Touw, Ketrija] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Furness, John B.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Gosain, A (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA.	agosain@uthsc.edu	Furness, John B/B-2763-2016; Pierre, Joseph F./AAA-2469-2020; Pierre, Joseph/HCH-3993-2022	Furness, John B/0000-0002-0219-3438; Gosain, Ankush/0000-0002-0428-1503	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K08DK098271, R03DK114543, P30DK42086]; American Pediatric Surgical Association Foundation Scholars Award; American College of Surgeons George H.A. Clowes Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R03DK114543, K08DK098271] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Pediatric Surgical Association Foundation Scholars Award; American College of Surgeons George H.A. Clowes Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Brian Torres for assistance in performing assays, Dr. Timur Mavlyutov (University of Wisconsin-Madison) for assistance with confocal imaging, and Dr. June Dahl (University of Wisconsin-Madison) for suggestions on the manuscript. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants K08DK098271, R03DK114543, and P30DK42086; by an American Pediatric Surgical Association Foundation Scholars Award (to A.G.); and by an American College of Surgeons George H.A. Clowes Career Development Award (to A.G.). The authors declare no conflicts of interest.	Alex G, 2001, NEUROSCIENCE, V104, P263, DOI 10.1016/S0306-4522(01)00064-1; Bornstein JC, 2004, NEUROGASTROENT MOTIL, V16, P34, DOI 10.1111/j.1743-3150.2004.00472.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; FINK S, 1959, GASTROENTEROLOGY, V36, P661; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Galligan JJ, 2000, J AUTONOM NERV SYST, V81, P97, DOI 10.1016/S0165-1838(00)00130-2; GIULIANI S, 1993, J PHARMACOL EXP THER, V265, P1224; GRIDER JR, 1989, AM J PHYSIOL, V257, pG709, DOI 10.1152/ajpgi.1989.257.5.G709; GRIDER JR, 1989, GASTROENTEROLOGY, V97, P1414, DOI 10.1016/0016-5085(89)90384-3; HOLZER P, 1989, AM J PHYSIOL, V256, pG540, DOI 10.1152/ajpgi.1989.256.3.G540; Holzer P, 1997, PHARMACOL THERAPEUT, V73, P219, DOI 10.1016/S0163-7258(96)00196-9; HOLZER P, 1993, J PHARMACOL EXP THER, V264, P391; Huttenhower C., GALAXY; JOHNSON SM, 1981, J PHYSIOL-LONDON, V320, P175, DOI 10.1113/jphysiol.1981.sp013942; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; MCCAMAN RE, 1971, ANAL BIOCHEM, V42, P171, DOI 10.1016/0003-2697(71)90023-6; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Monro RL, 2005, NEUROSCIENCE, V134, P975, DOI 10.1016/j.neuroscience.2005.05.006; MORITA K, 1980, NATURE, V287, P151, DOI 10.1038/287151a0; NORTH RA, 1982, J PHYSIOL-LONDON, V333, P151, DOI 10.1113/jphysiol.1982.sp014445; Nurgali K, 2003, NEUROSCIENCE, V116, P335, DOI 10.1016/S0306-4522(02)00749-2; Pierre JF, 2014, J PEDIATR SURG, V49, P1242, DOI 10.1016/j.jpedsurg.2014.01.060; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; RAFFA RB, 1987, LIFE SCI, V41, P2229, DOI 10.1016/0024-3205(87)90520-0; RAND JB, 1981, ANAL BIOCHEM, V116, P361, DOI 10.1016/0003-2697(81)90372-9; Rolig AS, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000689; Sang Q, 1996, CELL TISSUE RES, V284, P39, DOI 10.1007/s004410050565; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shimizu Y, 2008, CELL MOL LIFE SCI, V65, P295, DOI 10.1007/s00018-007-7148-1; Touw K, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13182; Ward NL, 2012, NEUROGASTROENT MOTIL, V24, P874, DOI 10.1111/j.1365-2982.2012.01937.x; Wiles TJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002517	34	14	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4744	4752		10.1096/fj.201701474RR	http://dx.doi.org/10.1096/fj.201701474RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570391	Green Published			2022-12-28	WOS:000443817700010
J	Laufer, JM; Lyck, R; Legler, DF				Laufer, Julia M.; Lyck, Ruth; Legler, Daniel F.			ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins	FASEB JOURNAL			English	Article						CLL; CCR7; CXCR4; cell adhesion	BLOOD-BRAIN-BARRIER; LYMPH-NODES; ZAP-70 EXPRESSION; PERIPHERAL-BLOOD; RECEPTOR CCR7; BONE-MARROW; ENDOTHELIAL ICAM-1; SIGNALING PATHWAYS; CLL CELLS; PROLIFERATION	The -associated protein of 70 kDa (ZAP70) is expressed in the aggressive form of B-cell chronic lymphocytic leukemia (CLL). Moreover, the integrin very late antigen (VLA)-1 is highly expressed on subtypes of CLL that are associated with high proliferation rates in the lymph node context. We herein identify a critical role for ZAP70 in chemokine-mediated, inside-out signaling to integrins in trisomy 12 carrying Ohio State University-CLL cell lines derived from a patient with previously treated CLL. We found that ZAP70-positive CLL cells migrated significantly better toward ligands of the lymph node homing chemokine receptors CCR7 and CXCR4 compared with ZAP70-negative cells. In addition, ZAP70-expressing CLL cells adhered more efficiently to integrin ligands under static conditions. We discovered that ZAP70 expression controls chemokine-driven clustering of the integrins VLA-4 and lymphocyte function-associated antigen-1. More precisely, chemokine stimulation resulted in a ZAP70-dependent integrin valency regulation on CLL cells, whereas high-affinity regulation of integrins was independent of ZAP70. Consequently, ZAP70-expressing CLL cells show increased chemokine-driven arrest on immobilized integrin ligands and on chemokine-presenting endothelial cells under physiologic flow conditions. Hence, we describe a novel mechanism showing how ZAP70 controls chemokine-driven valency regulation of integrins and arrest of CLL cells on endothelial cells, a process that might contribute to CLL disease progression.Laufer, J. M., Lyck, R., Legler, D. F. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.	[Laufer, Julia M.; Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau BITg, Unterseestr 47, CH-8280 Kreuzlingen, Switzerland; [Laufer, Julia M.; Legler, Daniel F.] Univ Konstanz, Konstanz Res Sch Chem Biol KoRS CB, Constance, Germany; [Lyck, Ruth] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	University of Konstanz; University of Bern	Legler, DF (corresponding author), Univ Konstanz, Biotechnol Inst Thurgau BITg, Unterseestr 47, CH-8280 Kreuzlingen, Switzerland.	daniel.legler@bitg.ch		Lyck, Ruth/0000-0002-6479-4837; Legler, Daniel F./0000-0001-8610-4764	Swiss National Science Foundation [31003A_169936, 31003A_143841]; Thurgauische Krebsliga; Thurgauische Stiftung fur Wissenschaft und Forschung; State Secretariat for Education, Research and Innovation (Bern, Switzerland); Konstanz Research School of Chemical Biology (KoRS-CB)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Thurgauische Krebsliga; Thurgauische Stiftung fur Wissenschaft und Forschung; State Secretariat for Education, Research and Innovation (Bern, Switzerland); Konstanz Research School of Chemical Biology (KoRS-CB)	The authors thank Tanja Hartmann (Salzburg Cancer Research Institute, Salzburg, Austria) for helpful discussions and advice. This work was supported by Swiss National Science Foundation Grants 31003A_169936 and 31003A_143841, the Thurgauische Krebsliga, the Thurgauische Stiftung fur Wissenschaft und Forschung, and the State Secretariat for Education, Research and Innovation (Bern, Switzerland). J.M.L. is recipient of a stipend from the Konstanz Research School of Chemical Biology (KoRS-CB). The authors declare no conflicts of interest.	Abadier M, 2015, EUR J IMMUNOL, V45, P1043, DOI 10.1002/eji.201445125; Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; Bulian P, 2014, J CLIN ONCOL, V32, P897, DOI 10.1200/JCO.2013.50.8515; Calpe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081221; Calpe E, 2011, BLOOD, V118, P4401, DOI 10.1182/blood-2011-01-333682; Chen LG, 2005, BLOOD, V105, P2036, DOI 10.1182/blood-2004-05-1715; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Ciccone M, 2012, LEUKEMIA, V26, P499, DOI 10.1038/leu.2011.247; Coisne C, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-7; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Fiorcari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083830; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Ganghammer S, 2015, ONCOTARGET, V6, P12048, DOI 10.18632/oncotarget.3660; Ghobrial IM, 2004, MAYO CLIN PROC, V79, P318, DOI 10.4065/79.3.318; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hauser MA, 2016, J LEUKOCYTE BIOL, V99, P869, DOI 10.1189/jlb.2MR0815-380R; Hauser MA, 2016, IMMUNITY, V44, P59, DOI 10.1016/j.immuni.2015.12.010; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Hertlein E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076607; Kipps TJ, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2016.96, 10.1038/nrdp.2017.8]; Lafarge ST, 2015, BRIT J HAEMATOL, V168, P139, DOI 10.1111/bjh.13063; Legler DF, 2014, INT J BIOCHEM CELL B, V54, P78, DOI 10.1016/j.biocel.2014.07.002; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liso V, 1999, HAEMATOLOGICA, V84, P212; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Luo JX, 2014, MOL CELL BIOCHEM, V385, P287, DOI 10.1007/s11010-013-1837-x; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Otero C, 2008, J CELL SCI, V121, P2759, DOI 10.1242/jcs.029074; Packham G, 2014, HAEMATOLOGICA, V99, P1138, DOI 10.3324/haematol.2013.098384; Pasikowska M, 2016, BLOOD, V128, P563, DOI 10.1182/blood-2016-01-683128; Rai KR, 2016, AM J HEMATOL, V91, P330, DOI 10.1002/ajh.24282; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Riches JC, 2014, BLOOD, V123, P4101, DOI 10.1182/blood-2014-01-552307; Rossi D, 2013, BLOOD, V121, P4902, DOI 10.1182/blood-2013-02-486209; Schaeuble K, 2011, J IMMUNOL, V187, P5645, DOI 10.4049/jimmunol.1101850; Soma LA, 2006, HUM PATHOL, V37, P152, DOI 10.1016/j.humpath.2005.09.029; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Su'ut L, 1998, BRIT J HAEMATOL, V101, P165; Till KJ, 2002, BLOOD, V99, P2977, DOI 10.1182/blood.V99.8.2977; Tsimberidou AM, 2005, CANCER-AM CANCER SOC, V103, P216, DOI 10.1002/cncr.20773; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Zucchetto A, 2013, BLOOD, V122, P3317, DOI 10.1182/blood-2013-06-507335; Zwick C, 2013, BLOOD, V121, P4708, DOI 10.1182/blood-2012-08-447904	53	13	14	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4824	4835		10.1096/fj.201701452RR	http://dx.doi.org/10.1096/fj.201701452RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29589978				2022-12-28	WOS:000443817700018
J	Fortin, GM; Ducrot, C; Giguere, N; Kouwenhoven, WM; Bourque, MJ; Pacelli, C; Varaschin, RK; Brill, M; Singh, S; Wiseman, PW; Trudeau, LE				Fortin, Guillaume M.; Ducrot, Charles; Giguere, Nicolas; Kouwenhoven, Willemieke M.; Bourque, Marie-Josee; Pacelli, Consiglia; Varaschin, Rafael Koerich; Brill, Marion; Singh, Sherdeep; Wiseman, Paul W.; Trudeau, Louis-Eric			Segregation of dopamine and glutamate release sites in dopamine neuron axons: regulation by striatal target cells	FASEB JOURNAL			English	Article						neurobiology; neurotransmitter; plasticity; VGLUT2	TYROSINE-HYDROXYLASE; GABAERGIC PHENOTYPE; NUCLEUS-ACCUMBENS; GRANULE CELLS; MIDBRAIN; RAT; CORELEASE; DORSAL; VGLUT2; EXPRESSION	Dopamine (DA) is a key regulator of circuits controlling movement and motivation. A subset of midbrain DA neurons has been shown to express the vesicular glutamate transporter (VGLUT)2, underlying their capacity for glutamate release. Glutamate release is found mainly by DA neurons of the ventral tegmental area (VTA) and can be detected at terminals contacting ventral, but not dorsal, striatal neurons, suggesting the possibility that target-derived signals regulate the neurotransmitter phenotype of DA neurons. Whether glutamate can be released from the same terminals that release DA or from a special subset of axon terminals is unclear. Here, we provide in vitro and in vivo data supporting the hypothesis that DA and glutamate-releasing terminals in mice are mostly segregated and that striatal neurons regulate the cophenotype of midbrain DA neurons and the segregation of release sites. Our work unveils a fundamental feature of dual neurotransmission and plasticity of the DA system.Fortin, G. M., Ducrot, C., Giguere, N., Kouwenhoven, W. M., Bourque, M.-J., Pacelli, C., Varaschin, R. K., Brill, M., Singh, S., Wiseman, P. W., Trudeau, L.-E. Segregation of dopamine and glutamate release sites in dopamine neuron axons: regulation by striatal target cells.	[Fortin, Guillaume M.; Ducrot, Charles; Giguere, Nicolas; Kouwenhoven, Willemieke M.; Bourque, Marie-Josee; Pacelli, Consiglia; Varaschin, Rafael Koerich; Brill, Marion; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ, Canada; [Ducrot, Charles; Giguere, Nicolas; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada; [Trudeau, Louis-Eric] Univ Montreal, Fac Med, Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Singh, Sherdeep; Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Downtown Branch, CP 6128,Succursale Ctr Ville Montreal, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020; Core, Vector/CAF-4832-2022	Trudeau, Louis-Eric/0000-0003-4684-1377; Ducrot, Charles/0000-0002-5451-1610	Canadian Institutes of Health Research (CIHR) [MOP-106556]; Brain Canada Foundation (Krembil Foundation); Fonds de la Recherche du Quebec en Sante (FRQS); Parkinson Society of Canada; FRQS; National Council for Scientific and Technological Development (CNPq); National Sciences and Engineering Research Council (NSERC) of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Brain Canada Foundation (Krembil Foundation); Fonds de la Recherche du Quebec en Sante (FRQS); Parkinson Society of Canada; FRQS; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Dr. Kazuto Kobayashi (Fukushima University, Fukushima, Japan) for providing the TH-GFP mice. This work was funded by grants to L.-E.T. from the Canadian Institutes of Health Research (CIHR; MOP-106556) and the Brain Canada Foundation (Krembil Foundation). L.-E.T. also benefited from an infrastructure grant of the Fonds de la Recherche du Quebec en Sante (FRQS) to the Groupe de Recherche sur le Systeme Nerveux Central. G.M.F., N.G., and C.P. received partial salary support from the Parkinson Society of Canada, and R.K.V. was the recipient of a postdoctoral fellowship from FRQS and National Council for Scientific and Technological Development (CNPq). Research in the P.W.W. laboratory was supported by the National Sciences and Engineering Research Council (NSERC) of Canada. The authors declare no conflicts of interest.	Adrover MF, 2014, J NEUROSCI, V34, P3183, DOI 10.1523/JNEUROSCI.4958-13.2014; Aguilar JI, 2017, NEURON, V95, P1074, DOI 10.1016/j.neuron.2017.07.038; Alsio J, 2011, J NEUROSCI, V31, P12593, DOI 10.1523/JNEUROSCI.2397-11.2011; Avelar AJ, 2013, J NEUROCHEM, V125, P373, DOI 10.1111/jnc.12197; Berube-Carriere N, 2012, EUR J NEUROSCI, V35, P527, DOI 10.1111/j.1460-9568.2012.07992.x; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Birgner C, 2010, P NATL ACAD SCI USA, V107, P389, DOI 10.1073/pnas.0910986107; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Depuy SD, 2013, J NEUROSCI, V33, P1486, DOI 10.1523/JNEUROSCI.4269-12.2013; Descarries L, 2008, BRAIN RES REV, V58, P290, DOI 10.1016/j.brainresrev.2007.10.005; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; FAHN S, 1969, J NEUROCHEM, V16, P1293, DOI 10.1111/j.1471-4159.1969.tb05979.x; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Forlano PM, 2010, J COMP NEUROL, V518, P1330, DOI 10.1002/cne.22279; Fortin GM, 2012, J NEUROSCI, V32, P17477, DOI 10.1523/JNEUROSCI.1939-12.2012; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Gorelova N, 2012, CEREB CORTEX, V22, P327, DOI 10.1093/cercor/bhr107; Gutierrez R, 2003, PROG NEUROBIOL, V71, P337, DOI 10.1016/j.pneurobio.2003.11.004; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Hnasko TS, 2012, ANNU REV PHYSIOL, V74, P225, DOI 10.1146/annurev-physiol-020911-153315; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Mingote S, 2017, ELIFE, V6, DOI 10.7554/eLife.27566; Moss J, 2011, EUR J NEUROSCI, V33, P1205, DOI 10.1111/j.1460-9568.2011.07594.x; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Steinkellner T, 2018, J CLIN INVEST, V128, P774, DOI 10.1172/JCI95795; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tritsch NX, 2014, ELIFE, V3, DOI 10.7554/eLife.01936; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Trudeau LE, 2014, PROG BRAIN RES, V211, P141, DOI 10.1016/B978-0-444-63425-2.00006-4; Wang DV, 2017, CELL REP, V18, P2584, DOI 10.1016/j.celrep.2017.02.062; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yue M, 2015, NEUROBIOL DIS, V78, P172, DOI 10.1016/j.nbd.2015.02.031; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945; Zhang T, 2009, J NEUROSCI, V29, P4035, DOI 10.1523/JNEUROSCI.0261-09.2009; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	53	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					400	417		10.1096/fj.201800713RR	http://dx.doi.org/10.1096/fj.201800713RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30011230				2022-12-28	WOS:000457401500032
J	Guan, PP; Wang, P				Guan, Pei-Pei; Wang, Pu			Integrated communications between cyclooxygenase-2 and Alzheimer's disease	FASEB JOURNAL			English	Review						prostaglandins; neuroinflammation; apoptosis; autophagy; synaptic plasticity	AMYLOID PRECURSOR PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TUMOR-NECROSIS-FACTOR; ACTIVATED RECEPTOR-GAMMA; ACID-INDUCED NEUROTOXICITY; PROSTAGLANDIN-E SYNTHASE-1; BETA-SECRETASE EXPRESSION; MESSENGER-RNA EXPRESSION; FLUID BIOMARKER PROFILE; LONG-TERM POTENTIATION	Elevated levels of cyclooxygenase-2 (COX-2) and prostaglandins (PGs) are involved in the pathogenesis of Alzheimer's disease (AD), which is characterized by the accumulation of -amyloid protein (A) and tau hyperphosphorylation. However, the gaps in our knowledge of the roles of COX-2 and PGs in AD have not been filled. Here, we summarized the literature showing that COX-2 dysregulation obviously influences abnormal cleavage of -amyloid precursor protein, aggregation and deposition of A in -amyloid plaques and the inclusion of phosphorylated tau in neurofibrillary tangles. Neuroinflammation, oxidative stress, synaptic plasticity, neurotoxicity, autophagy, and apoptosis have been assessed to elucidate the mechanisms of COX-2 regulation of AD. Notably, an imbalance of these factors ultimately produces cognitive decline. The current review substantiates our understanding of the mechanisms of COX-2-induced AD and establishes foundations for the design of feasible therapeutic strategies to treat AD.Guan, P.-P., Wang, P. Integrated communications between cyclooxygenase-2 and Alzheimer's disease.	[Guan, Pei-Pei; Wang, Pu] Northeastern Univ, Coll Life & Hlth Sci, 3-11 Wenhua Rd, Shenyang 110819, Peoples R China	Northeastern University - China	Wang, P (corresponding author), Northeastern Univ, Coll Life & Hlth Sci, 3-11 Wenhua Rd, Shenyang 110819, Peoples R China.	wangpu@mail.neu.edu.cn			National Natural Science Foundation of China [31571064, 81771167, 81500934]; Fundamental Research Foundation of Northeastern University (Shenyang, China) [N172008008, N172004005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Foundation of Northeastern University (Shenyang, China)	This work was supported by the National Natural Science Foundation of China (Grants 31571064, 81771167, and 81500934) and the Fundamental Research Foundation of Northeastern University (Shenyang, China) (Grants N172008008 and N172004005). The authors declare no conflicts of interest.	Abdo H, 2012, J PHYSIOL-LONDON, V590, P2739, DOI 10.1113/jphysiol.2011.222935; Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmed T, 2014, NEUROBIOL AGING, V35, P2474, DOI 10.1016/j.neurobiolaging.2014.05.005; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Akarasereenont P, 1999, MEDIAT INFLAMM, V8, P287, DOI 10.1080/09629359990298; Akitake Y, 2013, J NEUROSCI RES, V91, P909, DOI 10.1002/jnr.23217; AliMohammadi Malek, 2015, Med J Islam Repub Iran, V29, P273; An Y, 2014, J NEUROSCI RES, V92, P486, DOI 10.1002/jnr.23317; An YQ, 2016, METAB BRAIN DIS, V31, P663, DOI 10.1007/s11011-016-9800-7; Anderson PJB, 2009, CLIN OPHTHALMOL, V3, P235; Andreasson KI, 2001, J NEUROSCI, V21, P8198; Ankarcrona M, 2005, INT J GERIATR PSYCH, V20, P101, DOI 10.1002/gps.1260; Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Arbo BD, 2016, BRAIN RES, V1632, P91, DOI 10.1016/j.brainres.2015.12.018; Armstrong A, 2014, NEUROMOL MED, V16, P150, DOI 10.1007/s12017-013-8269-3; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Asadbegi M, 2016, BRAIN RES BULL, V121, P178, DOI 10.1016/j.brainresbull.2016.02.005; Bacher M, 2008, J EXP MED, V205, P1593, DOI 10.1084/jem.20060467; Baldeiras I, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0362-2; Bate C, 2006, NEUROPHARMACOLOGY, V50, P229, DOI 10.1016/j.neuropharm.2005.09.008; Bazan NG, 2002, PROSTAG OTH LIPID M, V68-9, P197, DOI 10.1016/S0090-6980(02)00031-X; Bermejo P, 2008, IMMUNOL LETT, V117, P198, DOI 10.1016/j.imlet.2008.02.002; Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046/j.1460-9568.2000.00110.x; Bishnoi M, 2007, PHARMACOLOGY, V79, P34, DOI 10.1159/000097627; Bitto A, 2017, INFLAMM RES, V66, P389, DOI 10.1007/s00011-017-1022-x; Blasko I, 2001, NEUROBIOL DIS, V8, P1094, DOI 10.1006/nbdi.2001.0451; Bonet-Costa V, 2016, J ALZHEIMERS DIS, V51, P701, DOI 10.3233/JAD-151020; Boutaud O, 2002, J NEUROCHEM, V82, P1003, DOI 10.1046/j.1471-4159.2002.01064.x; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Breitner JCS, 1996, ANNU REV MED, V47, P401; Cai ZY, 2015, NEUROPSYCH DIS TREAT, V11, P2091, DOI 10.2147/NDT.S84755; Carrasco E, 2007, J NEUROSCI RES, V85, P3109, DOI 10.1002/jnr.21425; Chang CP, 2016, MOL NEUROBIOL, V53, P7329, DOI 10.1007/s12035-015-9623-2; Chang WT, 2015, 2015 INTERNATIONAL CONFERENCE ON NETWORK AND INFORMATION SYSTEMS FOR COMPUTERS (ICNISC), P5, DOI 10.1109/ICNISC.2015.134; Charidimou A, 2018, NEUROLOGY, V90, pE754, DOI 10.1212/WNL.0000000000005030; Chen C, 2005, PROSTAG OTH LIPID M, V77, P65, DOI 10.1016/j.prostaglandins.2005.07.001; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chen CY, 2010, GEN HOSP PSYCHIAT, V32, P647, DOI DOI 10.1016/J.GENH0SPPSYCH.2010.07.001; Chen H, 2015, CELL PHYSIOL BIOCHEM, V36, P24, DOI 10.1159/000374050; Chen L, 2016, J ETHNOPHARMACOL, V191, P398, DOI 10.1016/j.jep.2016.03.038; Chen ZX, 2007, INT J PARASITOL, V37, P743, DOI 10.1016/j.ijpara.2006.12.018; Cheng T, 1998, INVEST OPHTH VIS SCI, V39, P581; Cho HJ, 2007, GLIA, V55, P253, DOI 10.1002/glia.20451; Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Chung-Davidson YW, 2008, J NEUROSCI, V28, P14492, DOI 10.1523/JNEUROSCI.3589-08.2008; Coma M, 2010, NEUROBIOL DIS, V38, P482, DOI 10.1016/j.nbd.2010.01.019; Cornelius C, 2004, NEUROEPIDEMIOLOGY, V23, P135, DOI 10.1159/000075957; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Cudaback E, 2014, BIOCHEM PHARMACOL, V88, P565, DOI 10.1016/j.bcp.2013.12.014; Dean DN, 2016, BIOCHEMISTRY-US, V55, P2238, DOI 10.1021/acs.biochem.6b00161; Dong XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092864; Drew PD, 2001, J NEUROIMMUNOL, V115, P28, DOI 10.1016/S0165-5728(01)00267-3; Duan DX, 2013, J ALZHEIMERS DIS, V37, P795, DOI 10.3233/JAD-130377; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Echeverria V, 2005, EUR J NEUROSCI, V22, P2199, DOI 10.1111/j.1460-9568.2005.04427.x; El Sayed NS, 2009, DRUG DISCOV THER, V3, P307; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Falker C, 2016, J NEUROCHEM, V137, P88, DOI 10.1111/jnc.13514; Fan CD, 2017, CELL MOL NEUROBIOL, V37, P211, DOI 10.1007/s10571-016-0362-3; Fan Shengnuo, 2015, Biomed Res Int, V2015, P161020, DOI 10.1155/2015/161020; Feng L, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-017-1008-x; Ferrera P, 2005, NEUROCHEM INT, V47, P589, DOI 10.1016/j.neuint.2005.06.012; Fiebich B L, 1998, J Neural Transm Suppl, V54, P268; Francois A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-151; Frenkel-Pinter M, 2016, J ALZHEIMERS DIS, V51, P165, DOI 10.3233/JAD-150927; Fu Z, 2016, FOOD FUNCT, V7, P1014, DOI 10.1039/c5fo01124h; Garcia-Ayllon MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02841-7; Gasparini L, 2005, BRAIN RES REV, V48, P400, DOI 10.1016/j.brainresrev.2004.12.029; Gasparini L, 2004, J NEUROCHEM, V88, P337, DOI 10.1046/j.1471-4159.2003.02154.x; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Gomez-Arroyo J, 2015, EUR RESPIR J, V45, P449, DOI 10.1183/09031936.00188013; Goncalves MB, 2010, BRIT J PHARMACOL, V159, P1118, DOI 10.1111/j.1476-5381.2009.00618.x; Gorsky MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep22685; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2019, DOI 10.1002/art.11163; Grilli M, 1996, J BIOL CHEM, V271, P15002, DOI 10.1074/jbc.271.25.15002; Gu MY, 2016, NEUROCHEM RES, V41, P1458, DOI 10.1007/s11064-016-1857-5; Gupta A, 2011, PROG NEURO-PSYCHOPH, V35, P974, DOI 10.1016/j.pnpbp.2011.01.017; Hanon O, 2018, ALZHEIMERS DEMENT, V14, P858, DOI 10.1016/j.jalz.2018.01.004; Hanson AJ, 2003, J NEUROSCI RES, V74, P148, DOI 10.1002/jnr.10726; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hatanaka M, 2010, J PHARMACOL SCI, V113, P89, DOI 10.1254/jphs.10001SC; Hein AM, 2007, NEUROSCIENCE, V150, P754, DOI 10.1016/j.neuroscience.2007.10.003; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hewett SJ, 1999, J NEUROIMMUNOL, V94, P134, DOI 10.1016/S0165-5728(98)00240-9; Hoffmann NA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-82; Hong HS, 2003, BIOCHEM BIOPH RES CO, V307, P922, DOI 10.1016/S0006-291X(03)01270-1; Hoozemans JJM, 2001, EXP GERONTOL, V36, P559, DOI 10.1016/S0531-5565(00)00226-6; Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200; Hoshino T, 2012, J NEUROCHEM, V120, P795, DOI 10.1111/j.1471-4159.2011.07567.x; Hoshino T, 2009, J BIOL CHEM, V284, P18493, DOI 10.1074/jbc.M109.003269; Hsiao HY, 2007, GLIA, V55, P214, DOI 10.1002/glia.20453; Hutchinson AJ, 2009, NEUROCHEM INT, V54, P439, DOI 10.1016/j.neuint.2009.01.018; Im JY, 2004, MOL PHARMACOL, V66, P368, DOI 10.1124/mol.66.3.; Imbimbo BP, 2004, EXPERT OPIN INV DRUG, V13, P1469, DOI 10.1517/13543784.13.11.1469; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; Imbimbo BP, 2009, EXPERT OPIN INV DRUG, V18, P1147, DOI 10.1517/13543780903066780; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Irannejad H, 2015, CHEM BIOL DRUG DES, V85, P494, DOI 10.1111/cbdd.12435; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Jesky R, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1006-3; Jung KM, 2003, MOL PHARMACOL, V63, P607, DOI 10.1124/mol.63.3.607; Kadoyama K, 2001, BIOCHEM BIOPH RES CO, V281, P483, DOI 10.1006/bbrc.2001.4357; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kerr BJ, 2008, GLIA, V56, P436, DOI 10.1002/glia.20630; Kidemet-Piskac S, 2018, CNS NEUROSCI THER, V24, P734, DOI 10.1111/cns.12814; Kim Y, 2015, BIOCHEM BIOPH RES CO, V462, P112, DOI 10.1016/j.bbrc.2015.04.084; Kimura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0144; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Klegeris A, 2002, NEUROBIOL AGING, V23, P787, DOI 10.1016/S0197-4580(02)00021-0; Koch H, 2010, J NEUROSCI, V30, P11678, DOI 10.1523/JNEUROSCI.4665-09.2010; Koh SH, 2005, TOXICOLOGY, V216, P232, DOI 10.1016/j.tox.2005.08.015; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Kruger L, 2016, CURR OPIN NEUROBIOL, V36, P52, DOI 10.1016/j.conb.2015.09.004; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-54; Kumar P, 2007, FUND CLIN PHARMACOL, V21, P297, DOI 10.1111/j.1472-8206.2007.00485.x; Kumar S, 2016, ACTA NEUROPATHOL, V131, P525, DOI 10.1007/s00401-016-1546-0; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Kuroki Y, 2012, BIOCHEM BIOPH RES CO, V424, P409, DOI 10.1016/j.bbrc.2012.06.121; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Landi F, 2003, AM J GERIAT PSYCHIAT, V11, P179, DOI 10.1176/appi.ajgp.11.2.179; Landolfi C, 1998, EUR J PHARMACOL, V360, P55, DOI 10.1016/S0014-2999(98)00663-3; Lanoiselee HM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002270; Lauretti E, 2015, NEUROBIOL AGING, V36, P812, DOI 10.1016/j.neurobiolaging.2014.10.005; Le TD, 2010, P NATL ACAD SCI USA, V107, P3198, DOI 10.1073/pnas.0915020107; Leal MAS, 2017, CELL PHYSIOL BIOCHEM, V44, P1796, DOI 10.1159/000485817; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Lee JH, 2008, J IMMUNOL, V181, P8642, DOI 10.4049/jimmunol.181.12.8642; Lee RKK, 1999, J NEUROSCI, V19, P940; Lee RKK, 2000, ANN NY ACAD SCI, V920, P261; Leoutsakos JMS, 2012, INT J GERIATR PSYCH, V27, P364, DOI 10.1002/gps.2723; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; Levenga J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-34; Li L, 2016, NEURAL REGEN RES, V11, P447, DOI 10.4103/1673-5374.179057; Li WJ, 2008, NEUROCHEM RES, V33, P490, DOI 10.1007/s11064-007-9462-2; Li WJ, 2010, J NEUROCHEM, V113, P965, DOI 10.1111/j.1471-4159.2010.06674.x; Li YK, 2003, J NEUROSCI, V23, P1605; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Liang ZH, 2015, NEURAL REGEN RES, V10, P1292, DOI 10.4103/1673-5374.162762; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Liu H, 2013, NEUROTOXICOLOGY, V39, P35, DOI 10.1016/j.neuro.2013.08.001; Liu Kang-sheng, 2013, Chinese Medical Sciences Journal, V28, P178; Liu XA, 2012, APOPTOSIS, V17, P1039, DOI 10.1007/s10495-012-0744-z; Luo DJ, 2014, J NEUROCHEM, V130, P816, DOI 10.1111/jnc.12761; Ma QL, 2018, NEUROBIOL DIS, V114, P120, DOI 10.1016/j.nbd.2018.02.014; Maesaka John K, 2013, J Nephropathol, V2, P166, DOI 10.12860/JNP.2013.28; Mani V, 2017, LIFE SCI, V180, P23, DOI 10.1016/j.lfs.2017.05.013; Matsumoto Y, 2004, NEUROPHARMACOLOGY, V46, P1195, DOI 10.1016/j.neuropharm.2004.02.012; Matsumura S, 2008, AM J PHYSIOL-REG I, V294, pR266, DOI 10.1152/ajpregu.00181.2007; McFarland AJ, 2013, INT J TOXICOL, V32, P209, DOI 10.1177/1091581813482146; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Medeiros R, 2010, BEHAV BRAIN RES, V209, P165, DOI 10.1016/j.bbr.2010.01.040; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Milatovic D, 2011, NEUROTOXICOLOGY, V32, P312, DOI 10.1016/j.neuro.2011.02.004; Minghetti L, 1998, J NEUROIMMUNOL, V82, P31, DOI 10.1016/S0165-5728(97)00185-9; Mohammadi M, 2016, N-S ARCH PHARMACOL, V389, P501, DOI 10.1007/s00210-016-1222-x; Mohan S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00031; Mohri I, 2007, J NEUROPATH EXP NEUR, V66, P469, DOI 10.1097/01.jnen.0000240472.43038.27; Morihara T, 2005, NEUROPSYCHOPHARMACOL, V30, P1111, DOI 10.1038/sj.npp.1300668; Muller-Schiffmann A, 2016, BRAIN, V139, P509, DOI 10.1093/brain/awv355; Munoz O, 2005, EXP NEUROL, V195, P508, DOI 10.1016/j.expneurol.2005.06.010; Munoz U, 2008, CELL MOL LIFE SCI, V65, P3507, DOI 10.1007/s00018-008-8411-9; Ninomiya M, 2010, NEUROSCI LETT, V476, P104, DOI 10.1016/j.neulet.2010.03.082; Nishida N, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-9; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nogawa S, 2003, INT CONGR SER, V1252, P363, DOI 10.1016/S0531-5131(03)00076-1; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Ojala JO, 2008, J NEUROIMMUNOL, V205, P86, DOI 10.1016/j.jneuroim.2008.09.012; Oka A, 1999, NEUROPEDIATRICS, V30, P34, DOI 10.1055/s-2007-973454; Oshima H, 2011, CANCER SCI, V102, P713, DOI 10.1111/j.1349-7006.2011.01847.x; Oxtoby NP, 2018, BRAIN, V141, P1529, DOI 10.1093/brain/awy050; Ozcelik S, 2016, MOL PSYCHIATR, V21, P1790, DOI 10.1038/mp.2015.228; Pasinetti GM, 1998, NEUROSCIENCE, V87, P319, DOI 10.1016/S0306-4522(98)00218-8; Pelissier-Rota MA, 2015, INT J BIOCHEM CELL B, V65, P239, DOI 10.1016/j.biocel.2015.06.013; Perez-Ruiz E, 2018, ANAL CHIM ACTA, V1015, P74, DOI 10.1016/j.aca.2018.02.011; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Piedrahita D, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00498; Polydoro M, 2014, ACTA NEUROPATHOL, V127, P257, DOI 10.1007/s00401-013-1215-5; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Qian XW, 2015, INT J CLIN EXP MED, V8, P13610; Quinn J, 2003, J NEUROIMMUNOL, V137, P32, DOI 10.1016/S0165-5728(03)00037-7; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Ragolia L, 2001, NEUROREPORT, V12, P2623, DOI 10.1097/00001756-200108280-00008; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Regan P, 2015, J NEUROSCI, V35, P4804, DOI 10.1523/JNEUROSCI.2842-14.2015; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rohn TT, 2001, NEUROREPORT, V12, P839, DOI 10.1097/00001756-200103260-00043; Roychaudhuri R, 2015, ACS CHEM NEUROSCI, V6, P1941, DOI 10.1021/acschemneuro.5b00180; SAINATI SM, 2000, 6 INT STOCKH SPRINGF, P180; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Satoh J, 2000, NEUROPATHOLOGY, V20, P289, DOI 10.1046/j.1440-1789.2000.00349.x; Satoh JI, 1999, NEUROPATH APPL NEURO, V25, P492; Satoh T, 1999, BIOCHEM BIOPH RES CO, V258, P50, DOI 10.1006/bbrc.1999.0587; Savonenko A, 2009, EXP NEUROL, V217, P63, DOI 10.1016/j.expneurol.2009.01.016; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Schmitt TL, 1996, J CLIN ENDOCR METAB, V81, P1666, DOI 10.1210/jc.81.4.1666; Scott-McKean JJ, 2016, NEUROBIOL DIS, V91, P124, DOI 10.1016/j.nbd.2016.03.001; Shariatpanahi M, 2016, FUND CLIN PHARMACOL, V30, P364, DOI 10.1111/fcp.12196; Shariatpanahi M, 2015, IRAN J PHARM RES, V14, P811; Shaw KN, 2003, EUR J NEUROSCI, V17, P2438, DOI 10.1046/j.1460-9568.2003.02643.x; Sheng JG, 2001, NEUROCHEM INT, V39, P341, DOI 10.1016/S0197-0186(01)00041-9; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Shi J, 2012, ANN NEUROL, V72, P788, DOI 10.1002/ana.23677; Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220; Shie FS, 2005, BRAIN PATHOL, V15, P134; Skoumalova A, 2012, J CELL MOL MED, V16, P2291, DOI 10.1111/j.1582-4934.2012.01585.x; Small GW, 2008, AM J GERIAT PSYCHIAT, V16, P999, DOI 10.1097/JGP.0b013e31818cd3a4; Son SM, 2016, J ALZHEIMERS DIS, V51, P1197, DOI 10.3233/JAD-151200; Storer PD, 2005, J NEUROSCI RES, V80, P66, DOI 10.1002/jnr.20413; Sung S, 2004, AM J PATHOL, V165, P2197, DOI 10.1016/S0002-9440(10)63269-5; Swierkot K, 2009, J CLIN PERIODONTOL, V36, P240, DOI 10.1111/j.1600-051X.2008.01368.x; Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501; Takata K, 2003, J PHARMACOL SCI, V91, P330; Takemiya T, 2011, NEUROCHEM INT, V58, P489, DOI 10.1016/j.neuint.2011.01.003; Tanji K, 2003, NEUROREPORT, V14, P413, DOI 10.1097/01.wnr.0000059783.23521.7c; THERY C, 1994, GLIA, V11, P383, DOI 10.1002/glia.440110411; Thirumangalakudi L, 2009, NEUROSCI LETT, V452, P172, DOI 10.1016/j.neulet.2009.01.045; Thomas DM, 2005, J PHARMACOL EXP THER, V313, P870, DOI 10.1124/jpet.104.080242; Tian J, 2008, P NATL ACAD SCI USA, V105, P10537, DOI 10.1073/pnas.0804852105; Toba J, 2016, BIOCHEM BIOPH RES CO, V473, P1039, DOI 10.1016/j.bbrc.2016.04.012; Uchida K, 2002, ZOOL SCI, V19, P1211, DOI 10.2108/zsj.19.1211; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Volmar CH, 2008, CYTOKINE, V42, P336, DOI 10.1016/j.cyto.2008.03.007; Wang JZ, 2015, EXP GERONTOL, V68, P82, DOI 10.1016/j.exger.2015.03.007; Wang K, 2015, FOLIA NEUROPATHOL, V53, P226, DOI 10.5114/fn.2015.54423; Wang P, 2016, AGING CELL, V15, P861, DOI 10.1111/acel.12495; Wang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20879; Wang P, 2014, AGING CELL, V13, P605, DOI 10.1111/acel.12209; Wang P, 2012, J BIOL CHEM, V287, P31877, DOI 10.1074/jbc.M112.362731; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027630; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang X, 2017, MOL NEUROBIOL, V54, P2939, DOI 10.1007/s12035-016-9874-6; Wang Y, 2017, ONCOTARGET, V8, P99296, DOI 10.18632/oncotarget.21853; Wang ZY, 2006, J BIOL CHEM, V281, P21377, DOI 10.1074/jbc.M601201200; Wang ZY, 2005, MOL CELL NEUROSCI, V29, P222, DOI 10.1016/j.mcn.2005.02.011; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wei JCC, 2016, EUR J PHARMACOL, V770, P16, DOI 10.1016/j.ejphar.2015.11.048; Woodling NS, 2014, J NEUROSCI, V34, P5882, DOI 10.1523/JNEUROSCI.0410-14.2014; Xi YD, 2016, CELL MOL NEUROBIOL, V36, P1151, DOI 10.1007/s10571-015-0311-6; Xiang PY, 2016, NEUROBIOL AGING, V40, P98, DOI 10.1016/j.neurobiolaging.2016.01.008; Xiang ZM, 2002, GENE EXPRESSION, V10, P271, DOI 10.3727/000000002783992352; Xiang ZM, 2002, NEUROBIOL AGING, V23, P327, DOI 10.1016/S0197-4580(01)00282-2; Xu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055080; Xue ZF, 2016, NEUROSCI LETT, V618, P50, DOI 10.1016/j.neulet.2016.02.044; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029638; Yan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18668; Yan Q, 2003, J NEUROSCI, V23, P7504; Yang CC, 2013, TRANSPLANTATION, V96, P1043, DOI 10.1097/TP.0b013e3182a77e52; Yang HW, 2008, MOL CELL NEUROSCI, V37, P682, DOI 10.1016/j.mcn.2007.12.019; Yang SG, 2016, ACS CHEM NEUROSCI, V7, P505, DOI 10.1021/acschemneuro.6b00091; Yang YW, 2015, J AGR FOOD CHEM, V63, P10243, DOI 10.1021/acs.jafc.5b04156; Yang ZH, 2017, TOXICOL MECH METHOD, V27, P568, DOI 10.1080/15376516.2017.1337256; Yanni SE, 2010, EXP EYE RES, V91, P34, DOI 10.1016/j.exer.2010.03.019; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003; Yoshida Y, 2009, NEUROBIOL AGING, V30, P174, DOI 10.1016/j.neurobiolaging.2007.06.012; Yurinskaya MM, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.336; Zhang HJ, 2008, J ZHEJIANG UNIV-SC B, V9, P903, DOI 10.1631/jzus.B0820018; Zhang JB, 2012, INT J BIOL SCI, V8, P935, DOI 10.7150/ijbs.4499; Zhao XR, 2006, J CEREBR BLOOD F MET, V26, P811, DOI 10.1038/sj.jcbfm.9600233; Zheng SQ, 2017, ONCOTARGET, V8, P102801, DOI 10.18632/oncotarget.18462; Zhuang JJ, 2013, PROSTAG OTH LIPID M, V106, P45, DOI 10.1016/j.prostaglandins.2013.09.002	281	32	34	3	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					13	33		10.1096/fj.201800355RRRR	http://dx.doi.org/10.1096/fj.201800355RRRR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020833				2022-12-28	WOS:000457401500003
J	Jaggupilli, A; Singh, N; De Jesus, VC; Gounni, MS; Dhanaraj, P; Chelikani, P				Jaggupilli, Appalaraju; Singh, Nisha; De Jesus, Vivianne Cruz; Gounni, Mohamed Soussi; Dhanaraj, Premnath; Chelikani, Prashen			Chemosensory bitter taste receptors (T2Rs) are activated by multiple antibiotics	FASEB JOURNAL			English	Article						levofloxacin; tobramycin; structure-function; GPCR; cystic fibrosis	PROTEIN-COUPLED RECEPTORS; EXPRESSION; CELLS; LEVOFLOXACIN; INFECTION; FAMILY	Many medications including antibiotics taste bitter. The potency of these antibiotics on the 25 bitter taste receptors (T2Rs) in humans remains poorly understood. Here we characterize by sensory and structure-function analyses how antibiotics frequently used to treat airway infections in cystic fibrosis activate multiple human T2Rs. The potency of the broad-spectrum antibiotics, tobramycin, levofloxacin, and azithromycin on the highly expressed T2Rs in airways, T2R4, T2R14, and T2R20 was pursued. The amino acids and structural features of T2R4, T2R14, and T2R20 important for antibiotic binding were characterized by mutational analysis in heterologous cell-based assays. Strikingly, extracellular loop 2 in T2Rs performs a key function in binding to antibiotics with contribution from residues in transmembrane helices. Our results suggest that different antibiotics activate multiple T2Rs with different potencies. An understanding of the nonantibiotic and physiologic effects mediated through T2Rs on the host cells is much needed.Jaggupilli, A., Singh, N., De Jesus, V. C., Gounni, M. S., Dhanaraj, P., Chelikani, P. Chemosensory bitter taste receptors (T2Rs) are activated by multiple antibiotics.	Univ Manitoba, CHRIM, Manitoba Chemosensory Biol Res Grp, Winnipeg, MB, Canada; Univ Manitoba, CHRIM, Dept Oral Biol, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Manitoba Chemosensory Biol Res Grp, D319,780 Bannatyne Ave, Winnipeg, MB R3E 0W4, Canada.; Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, D319,780 Bannatyne Ave, Winnipeg, MB R3E 0W4, Canada.	prashen.chelikani@.umanitoba.ca	de Jesus, Vivianne Cruz/AAJ-2645-2021; dhanaraj, premnath/C-2265-2011	Chelikani, Prashen/0000-0003-1129-7957; dhanaraj, premnath/0000-0002-1969-4917; Cruz de Jesus, Vivianne/0000-0002-9755-7037; Singh, Nisha/0000-0003-0330-6411; Jaggupilli, Appalaraju/0000-0002-1718-8551	Cystic Fibrosis Canada Operating Grant [491120]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04099]; University of Manitoba Graduate Fellowship; University of Manitoba Mitacs Accelerate Fellowship	Cystic Fibrosis Canada Operating Grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Manitoba Graduate Fellowship; University of Manitoba Mitacs Accelerate Fellowship	The authors thank the following members of the P.K. laboratory at the University of Manitoba: Feroz Ahmed Shaik for providing T2R14 stable cell line, Kun Liu for assisting with flow cytometry method, and Anurag Singh Sikarwar for comments on the manuscript. This work was supported by Cystic Fibrosis Canada Operating Grant 491120, and Discovery Grant RGPIN-2014-04099 from the Natural Sciences and Engineering Research Council of Canada (to P.C.), and University of Manitoba Graduate Fellowship and Mitacs Accelerate Fellowship (to A.J.). The authors declare no conflicts of interest.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Avau B, 2016, ACTA PHYSIOL, V216, P407, DOI 10.1111/apha.12621; Babu KS, 2013, RESP MED, V107, P800, DOI 10.1016/j.rmed.2013.02.009; Badal S, 2015, J BIOL CHEM, V290, P22287, DOI 10.1074/jbc.M115.671222; Chakraborty R, 2015, METHOD ENZYMOL, V556, P267, DOI 10.1016/bs.mie.2014.12.013; Chmiel James F, 2014, Ann Am Thorac Soc, V11, P1298, DOI 10.1513/AnnalsATS.201405-203AS; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Di Pizio A, 2016, METHOD CELL BIOL, V132, P401, DOI 10.1016/bs.mcb.2015.10.005; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Gao XG, 2010, PULM PHARMACOL THER, V23, P97, DOI 10.1016/j.pupt.2009.10.010; Geller DE, 2009, RESP CARE, V54, P658, DOI 10.4187/aarc0537; Good JT, 2012, CURR OPIN PULM MED, V18, P76, DOI 10.1097/MCP.0b013e32834daff8; Hobson-Webb LD, 2006, J CHILD NEUROL, V21, P429, DOI 10.1177/08830738060210051201; Huth ME, 2015, J CLIN INVEST, V125, P583, DOI 10.1172/JCI77424; Jaggupilli A, 2018, ACS INFECT DIS, V4, P1146, DOI 10.1021/acsinfecdis.8b00094; Jaggupilli A, 2017, MOL CELL BIOCHEM, V426, P137, DOI 10.1007/s11010-016-2902-z; Jaggupilli A, 2016, INT J BIOCHEM CELL B, V77, P184, DOI 10.1016/j.biocel.2016.03.005; Jiang MY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00308; Kitazawa T, 2007, LIFE SCI, V80, P1572, DOI 10.1016/j.lfs.2007.01.025; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Liggett Stephen B, 2014, Trans Am Clin Climatol Assoc, V125, P64; Liu K, 2018, BBA-BIOMEMBRANES, V1860, P991, DOI 10.1016/j.bbamem.2018.01.014; Lu P, 2017, J GEN PHYSIOL, V149, P181, DOI 10.1085/jgp.201611637; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miravitlles M, 2013, AM J RESP CRIT CARE, V188, P1052, DOI 10.1164/rccm.201302-0289PP; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Orsmark-Pietrast C, 2013, EUR RESPIR J, V42, P65, DOI 10.1183/09031936.00077712; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pawlowski AC, 2016, CURR OPIN BIOTECH, V42, P108, DOI 10.1016/j.copbio.2016.04.006; Perry JA, 2014, BIOESSAYS, V36, P1179, DOI 10.1002/bies.201400128; Pydi SP, 2014, J BIOL CHEM, V289, P25054, DOI 10.1074/jbc.M114.576975; Pydi SP, 2016, BBA-BIOMEMBRANES, V1858, P2081, DOI 10.1016/j.bbamem.2016.06.005; Pydi SP, 2012, CURR PROTEIN PEPT SC, V13, P501; Reichling C, 2008, J NEUROCHEM, V106, P1138, DOI 10.1111/j.1471-4159.2008.05453.x; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Rollins DR, 2010, CURR ALLERGY ASTHM R, V10, P67, DOI 10.1007/s11882-009-0086-2; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Sadarangani SP, 2015, MAYO CLIN PROC, V90, P109, DOI 10.1016/j.mayocp.2014.09.006; Sengupta S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00047; Shaik FA, 2016, INT J BIOCHEM CELL B, V77, P197, DOI 10.1016/j.biocel.2016.03.011; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; Siva R, 2014, INT J CHRONIC OBSTR, V9, P179, DOI 10.2147/COPD.S55419; Stockmann C, 2013, PEDIATR PULM, V48, P211, DOI 10.1002/ppul.22667; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Uchida T, 2003, J PHARM PHARMACOL, V55, P1479, DOI 10.1211/0022357022106; Upadhyaya J, 2015, BBA-BIOMEMBRANES, V1848, P1502, DOI 10.1016/j.bbamem.2015.03.035; Upadhyaya JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156347; Upadhyaya JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110373; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yan CH, 2017, AM J RHINOL ALLERGY, V31, P85, DOI 10.2500/ajra.2017.31.4424; Zhang CL, 2018, J AGR FOOD CHEM, V66, P4902, DOI 10.1021/acs.jafc.8b00830; Zhang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11720-0	62	28	28	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					501	517		10.1096/fj.201800521RR	http://dx.doi.org/10.1096/fj.201800521RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30011231				2022-12-28	WOS:000457401500040
J	Kanugula, AK; Adapala, RK; Midha, P; Cappelli, HC; Meszaros, JG; Paruchuri, S; Chilian, WM; Thodeti, CK				Kanugula, Anantha K.; Adapala, Ravi K.; Midha, Priya; Cappelli, Holly C.; Meszaros, J. Gary; Paruchuri, Sailaja; Chilian, William M.; Thodeti, Charles K.			Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4	FASEB JOURNAL			English	Article						angiogenesis; endothelial cell; phosphorylation	ENDOTHELIAL-CELLS; ANGIOGENESIS; VEGF; TRANSDUCTION; ACTIVATION; MECHANISMS; PATHWAYS; CALCIUM	VEGF signaling via VEGF receptor-2 (VEGFR2) is a major regulator of endothelial cell (EC) functions, including angiogenesis. Although most studies of angiogenesis focus on soluble VEGF signaling, mechanical signaling also plays a critical role. Here, we examined the consequence of disruption of mechanical signaling on soluble signaling pathways. Specifically, we observed that small interfering RNA (siRNA) knockdown of a mechanosensitive ion channel, transient receptor potential vanilloid 4 (TRPV4), significantly reduced perinuclear (Golgi) VEGFR2 in human ECs with a concomitant increase in phosphorylation at Y1175 and membrane translocation. TRPV4 knockout (KO) ECs exhibited increased plasma membrane localization of phospho-VEGFR2 compared with normal ECs. The knockdown also increased phospho-VEGFR2 in whole cell lysates and membrane fractions compared with control siRNA-treated cells. siRNA knockdown of TRPV4 enhanced nuclear localization of mechanosensitive transcription factors, yes-associated protein/transcriptional coactivator with PDZ-binding motif via rho kinase, which were shown to increase VEGFR2 trafficking to the plasma membrane. Furthermore, TRPV4 deletion/knockdown enhanced VEGF-mediated migration in vitro and increased expression of VEGFR2 in vivo in the vasculature of TRPV4 KO tumors compared with wild-type tumors. Our results thus show that TRPV4 channels regulate VEGFR2 trafficking and activation to identify novel cross-talk between mechanical (TRPV4) and soluble (VEGF) signaling that controls EC migration and angiogenesis.Kanugula, A. K., Adapala, R. K., Midha, P., Cappelli, H. C., Meszaros, J. G., Paruchuri, S., Chilian, W. M., Thodeti, C. K., Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.	[Kanugula, Anantha K.; Midha, Priya; Thodeti, Charles K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Adapala, Ravi K.; Cappelli, Holly C.; Meszaros, J. Gary; Chilian, William M.; Thodeti, Charles K.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; University of Akron	Thodeti, CK (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.	cthodeti@neomed.edu	Adapala, Ravi kumar/AAD-1282-2020	Adapala, Ravi kumar/0000-0002-4082-5301	U.S. National Institutes of Health (NIH)-National Cancer Institute [R15CA202847]; National Heart, Lung, and Blood Institute [R01HL119705]; NATIONAL CANCER INSTITUTE [R15CA202847] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135024, R01HL119705, R01HL135110] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH)-National Cancer Institute (R15CA202847) and National Heart, Lung, and Blood Institute (R01HL119705). The authors declare no conflicts of interest.	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Baratchi S, 2016, CELL MOL LIFE SCI, V73, P649, DOI 10.1007/s00018-015-2018-8; Caporarello N, 2017, MOL MED REP, V16, P4393, DOI 10.3892/mmr.2017.7179; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cheng HW, 2006, ARTERIOSCL THROM VAS, V26, P1768, DOI 10.1161/01.ATV.0000231518.86795.0f; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; Domigan CK, 2015, ARTERIOSCL THROM VAS, V35, P30, DOI 10.1161/ATVBAHA.114.303215; Dragoni S, 2013, STEM CELLS DEV, V22, P2561, DOI 10.1089/scd.2013.0032; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Harry BL, 2008, ARTERIOSCL THROM VAS, V28, P2003, DOI 10.1161/ATVBAHA.108.164707; Ingber D E, 1992, Semin Cancer Biol, V3, P57; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Khan K, 2017, CURR DRUG TARGETS, V18, P56, DOI 10.2174/1389450116666150325231555; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Koehler Ralf, 2007, P377; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liedtke W., 2007, V179, P473; Lupo G, 2017, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00519; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Moccia F, 2018, J CELL PHYSIOL, V233, P3901, DOI 10.1002/jcp.26152; Morrow D, 2007, ARTERIOSCL THROM VAS, V27, P1289, DOI 10.1161/ATVBAHA.107.142778; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Tamura R, 2017, BRAIN TUMOR PATHOL, V34, P62, DOI 10.1007/s10014-017-0284-x; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thoppil RJ, 2016, ONCOTARGET, V7, P25849, DOI 10.18632/oncotarget.8405; Thoppil RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14257; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang XH, 2017, DEV CELL, V42, P462, DOI 10.1016/j.devcel.2017.08.002; Yamada KH, 2014, J CELL SCI, V127, P4518, DOI 10.1242/jcs.156109	36	23	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					195	203		10.1096/fj.201800509R	http://dx.doi.org/10.1096/fj.201800509R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957061	Green Published			2022-12-28	WOS:000457401500016
J	Jia, LF; Chopp, M; Wang, L; Lu, XR; Szalad, A; Zhang, ZG				Jia, Longfei; Chopp, Michael; Wang, Lei; Lu, Xuerong; Szalad, Alexandra; Zhang, Zheng Gang			Exosomes derived from high-glucose-stimulated Schwann cells promote development of diabetic peripheral neuropathy	FASEB JOURNAL			English	Article						microRNA; neuron; axonal growth	ROOT GANGLIA NEURONS; NERVOUS-SYSTEM; AXONAL GROWTH; PROTEIN GAP-43; IN-SITU; MICE; MICRORNAS; CULTURE; STROKE; MOUSE	Schwann cells actively interact with axons of dorsal root ganglia (DRG) neurons. Exosomes mediate intercellular communication by transferring their biomaterials, including microRNAs (miRs) into recipient cells. We hypothesized that exosomes derived from Schwann cells stimulated by high glucose (HG) exosomes accelerate development of diabetic peripheral neuropathy and that exosomal cargo miRs contribute to this process. We found that HG exosomes contained high levels of miR-28, -31a, and -130a compared to exosomes derived from non-HG-stimulated Schwann cells. In vitro, treatment of distal axons with HG exosomes resulted in reduction of axonal growth, which was associated with elevation of miR-28, -31a, and -130a and reduction of their target proteins of DNA methyltransferase-3, NUMB (an endocytic adaptor protein), synaptosome associated protein 25, and growth-associated protein-43 in axons. In vivo, administration of HG exosomes to sciatic nerves of diabetic db/db mice at 7 wk of age promoted occurrence of peripheral neuropathy characterized by impairment of nerve conduction velocity and induction of mechanic and thermal hypoesthesia, which was associated with substantial decreases in intraepidermal nerve fibers. Our findings demonstrate a functional role of exosomes derived from HG-stimulated Schwann cells in mediating development of diabetic peripheral neuropathy.Jia, L., Chopp, M., Wang, L., Lu, X., Szalad, A., Zhang, Z. G. Exosomes derived from high-glucose-stimulated Schwann cells promote development of diabetic peripheral neuropathy.	[Jia, Longfei] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Inovat Ctr Neurol Disorders, Beijing, Peoples R China; [Jia, Longfei; Chopp, Michael; Wang, Lei; Lu, Xuerong; Szalad, Alexandra; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Capital Medical University; Henry Ford Health System; Henry Ford Hospital; Oakland University	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	Jia, Longfei/0000-0003-3648-3668	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [R01 NS075084, R01 NS075156]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK097519]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156, R01NS075084] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grants R01 NS075084 (to L.W.) and R01 NS075156 (to Z.G.Z.), and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK097519 (to L.W.). The authors declare no conflicts of interest.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; BENNETT MK, 1995, CURR OPIN CELL BIOL, V7, P581, DOI 10.1016/0955-0674(95)80016-6; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Erhard F, 2014, GENOME RES, V24, P906, DOI 10.1101/gr.166702.113; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; Gonzalez S, 2014, NAT PROTOC, V9, P1160, DOI 10.1038/nprot.2014.073; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Jia LF, 2018, MOL NEUROBIOL, V55, P9089, DOI 10.1007/s12035-018-1047-3; Jia LF, 2018, MOL NEUROBIOL, V55, P851, DOI 10.1007/s12035-016-0374-5; Jia LF, 2016, NEUROSCIENCE, V329, P43, DOI 10.1016/j.neuroscience.2016.05.005; Johnson JE, 2003, TRENDS NEUROSCI, V26, P395, DOI 10.1016/S0166-2236(03)00166-8; Kaplan BB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00126; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Liu XS, 2017, MOL NEUROBIOL, V54, P227, DOI 10.1007/s12035-015-9655-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupachyk S, 2013, AM J PHYSIOL-ENDOC M, V305, pE396, DOI 10.1152/ajpendo.00186.2013; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; O'Brien PD, 2014, ILAR J, V54, P259, DOI 10.1093/ilar/ilt052; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peltier A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1799; Russell JW, 1999, NEUROBIOL DIS, V6, P347, DOI 10.1006/nbdi.1999.0254; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shi TJS, 2013, P NATL ACAD SCI USA, V110, P690, DOI 10.1073/pnas.1220794110; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Suzuki T, 2004, J NEUROCHEM, V91, P1430, DOI 10.1111/j.1471-4159.2004.02824.x; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Vienberg S, 2017, ACTA PHYSIOL, V219, P346, DOI 10.1111/apha.12681; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang L, 2014, NEUROSCIENCE, V259, P155, DOI 10.1016/j.neuroscience.2013.11.057; Wang L, 2012, NEUROBIOL DIS, V48, P546, DOI 10.1016/j.nbd.2012.08.002; Zhang L, 2016, STROKE, V47, P2112, DOI 10.1161/STROKEAHA.115.012578; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0; Zhang Y, 2015, DEV NEUROBIOL, V75, P1402, DOI 10.1002/dneu.22292; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013; Zhang ZG, 2016, J CLIN INVEST, V126, P1190, DOI 10.1172/JCI81133	47	27	28	3	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6911	6922		10.1096/fj.201800597R	http://dx.doi.org/10.1096/fj.201800597R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29932869	Green Published			2022-12-28	WOS:000449359700043
J	Widjaja-Adhi, MAK; Ramkumar, S; von Lintig, J				Widjaja-Adhi, Made Airanthi K.; Ramkumar, Srinivasagan; von Lintig, Johannes			Protective role of carotenoids in the visual cycle	FASEB JOURNAL			English	Article						retinoids; light damage; zeaxanthin	RETINAL-PIGMENT EPITHELIUM; PHOTORECEPTOR APOPTOSIS; COMPLEMENT ACTIVATION; PHOTOCHEMICAL DAMAGE; MACULAR DEGENERATION; LIGHT; ZEAXANTHIN; RHODOPSIN; LUTEIN; IDENTIFICATION	Exposure to light and accumulation of aberrant visual cycle by-products causes stress in the retina. The physical and chemical properties of carotenoids may provide protection against such scenario. These pigments exist in retinas of many vertebrates, including humans. However, the absence of carotenoids in mice, the preferred ophthalmologic animal model, hindered molecular and biochemical examination of the pigments' role in vision. We established a mouse model that accumulates significant amounts of carotenoids in the retina due to inactivating mutations in the Isx and Bco2 genes. We introduced a robust light damage protocol for the mouse retina using green (532 nm) and blue (405 nm) low-energy lasers. We observed that blue but not green laser light treatment triggered the formation of aberrant retinaldehyde isomers in the retina. The production of these visual cycle by-products was accompanied by morphologic damage in inferior parts of the mouse retina. Zeaxanthin supplementation of mice shielded retinoids from these photochemical modifications. These pigments also reduced the extent of the damage to the retina after the blue laser light insult. Thus, our study discovered a novel role of carotenoids in the visual cycle and indicated that vertebrates accumulate carotenoids to shield photoreceptors from short-wavelength light-induced damage.Widjaja-Adhi, M. A. K., Ramkumar, S., von Lintig, J. Protective role of carotenoids in the visual cycle.	[Widjaja-Adhi, Made Airanthi K.; Ramkumar, Srinivasagan; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, W341,10900 Euclid Ave, Cleveland, OH 44106 USA	Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, W341,10900 Euclid Ave, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		Widjaja-Adhi, Made Airanthi K./0000-0002-0589-2605	U.S. National Institutes of Health, National Eye Institute [EY020551]; NATIONAL EYE INSTITUTE [R01EY020551, P30EY011373] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank M. E. Kelly (Case Western Reseve University) for her expert help with quantitative image analyses and her valuable suggestions. The authors also thank Dr. Adrian Wyss (DSM Nutritional Products) for the gift of zeaxanthin. The research was supported, in part, by the U.S. National Institutes of Health, National Eye Institute (Grant EY020551 to J.V.L.). Scott Howell and Catherine Doller (Case Western Reserve University Visual Science Core Facility; P30-EY11373) provided expert help with histology, microscopy, and imaging. The authors declare no conflicts of interest.	Ablonczy Z, 2013, INVEST OPHTH VIS SCI, V54, P5535, DOI 10.1167/iovs.13-12250; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Babino D, 2015, J BIOL CHEM, V290, P24844, DOI 10.1074/jbc.M115.668822; Barker FM, 2011, INVEST OPHTH VIS SCI, V52, P3934, DOI 10.1167/iovs.10-5898; Bernstein PS, 2016, PROG RETIN EYE RES, V50, P34, DOI 10.1016/j.preteyeres.2015.10.003; Bhosale P, 2007, BIOCHEMISTRY-US, V46, P9050, DOI 10.1021/bi700558f; BONE RA, 1985, VISION RES, V25, P1531, DOI 10.1016/0042-6989(85)90123-3; BOWMAKER JK, 1978, VISION RES, V18, P1125, DOI 10.1016/0042-6989(78)90095-0; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Feng CY, 2017, MOL VIS, V23, P765; Grimm C, 2000, INVEST OPHTH VIS SCI, V41, P3984; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; Hammond BR, 2012, AM J CLIN NUTR, V96, p1207S, DOI 10.3945/ajcn.112.034876; Hartmann D, 2004, AM J CLIN NUTR, V79, P410; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Johnson EJ, 2005, INVEST OPHTH VIS SCI, V46, P692, DOI 10.1167/iovs.02-1192; Kaylor JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00018-4; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; LAND EJ, 1975, PHOTOCHEM PHOTOBIOL, V22, P286, DOI 10.1111/j.1751-1097.1975.tb06751.x; Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2012, PHOTOCHEM PHOTOBIOL, V88, P1309, DOI 10.1111/j.1751-1097.2012.01143.x; Nagao A, 2015, J LIPID RES, V56, P449, DOI 10.1194/jlr.P055459; Noell W K, 1966, Invest Ophthalmol, V5, P450; Palczewski G, 2014, FASEB J, V28, P4457, DOI 10.1096/fj.14-252411; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Rozanowska MB, 2012, PHOTOCHEM PHOTOBIOL, V88, P1303, DOI 10.1111/j.1751-1097.2012.01240.x; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; Sparrow JR, 2010, ADV EXP MED BIOL, V703, P63, DOI 10.1007/978-1-4419-5635-4_5; Toomey MB, 2016, ELIFE, V5, DOI 10.7554/eLife.15675; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; van Norren D, 2011, PHOTOCHEM PHOTOBIOL, V87, P747, DOI 10.1111/j.1751-1097.2011.00921.x; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u; Voolstra O, 2010, J BIOL CHEM, V285, P2130, DOI 10.1074/jbc.M109.056101; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Widjaja-Adhi MAK, 2015, HUM MOL GENET, V24, P3206, DOI 10.1093/hmg/ddv072; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	42	12	12	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6305	6315		10.1096/fj.201800467R	http://dx.doi.org/10.1096/fj.201800467R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29882710	Bronze, Green Published			2022-12-28	WOS:000447172000044
J	Bruno, A; Bassani, B; D'Urso, DG; Pitaku, I; Cassinotti, E; Pelosi, G; Boni, L; Dominioni, L; Noonan, DM; Mortara, L; Albini, A				Bruno, Antonino; Bassani, Barbara; D'Urso, Davide Giuseppe; Pitaku, Ilvana; Cassinotti, Elisa; Pelosi, Giuseppe; Boni, Luigi; Dominioni, Lorenzo; Noonan, Douglas M.; Mortara, Lorenzo; Albini, Adriana			Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	FASEB JOURNAL			English	Article						angiogenesis; STAT signaling; VEGF; STAT3; STAT5	NATURAL-KILLER-CELLS; MATRIX METALLOPROTEINASES; TUMOR MICROENVIRONMENT; PERIPHERAL-BLOOD; TISSUE INHIBITOR; EXPRESSION; MMP-9; INFLAMMATION; STAT5; CYTOTOXICITY	NK cells are effector lymphocytes involved in tumor immunosurveillance; however, in patients with solid malignancies, NK cells have compromised functions. We have previously reported that lung tumor-associated NK cells (TANKs; peripheral blood) and tumor-infiltrating NK cells (TINKs) show proangiogenic, decidual NK-like (dNK) phenotype. In this study, we functionally and molecularly investigated TINKs and TANKs from blood and tissue samples of patients with colorectal cancer (CRC), a neoplasm in which inflammation and angiogenesis have clinical relevance, and compared them to NK cells from controls and patients with nononcologic inflammatory bowel disease. CRC TINKs/TANKs showed decreased expression for the activatory marker NKG2D, impaired degranulation activity, a decidual-like NK polarization toward the CD56(bright)CD16(dim/-)CD9(+)CD49(+) subset. TINKs and TANKs secreted cytokines with proangiogenic activities, and induce endothelial cell proliferation, migration, adhesion, and the formation of capillary-like structures in vitro. dNK cells release specific proangiogenic factors; among which, angiogenin and invasion-associated enzymes related to the MMP9-TIMP1/2 axis. Here, we describe, for the first time, to our knowledge, the expression of angiogenin, MMP2/9, and TIMP by TANKs in patients with CRC. This phenotype could be relevant to the invasive capabilities and proangiogenic functions of CRC-NK cells and become a novel biomarker. STAT3/STAT5 activation was observed in CRC-TANKs, and treatment with pimozide, a STAT5 inhibitor, reduced endothelial cell capability to form capillary-like networks, inhibiting VEGF and angiogenin production without affecting the levels of TIMP1, TIMP2, and MMP9, indicating that STAT5 is involved in cytokine modulation but not invasion-associated molecules. Combination of Stat5 or MMP inhibitors with immunotherapy could help repolarize CRC TINKs and TANKs to anti-tumor antimetastatic ones.Bruno, A., Bassani, B., D'Urso, D. G., Pitaku, I., Cassinotti, E., Pelosi, G., Boni, L., Dominioni, L., Noonan, D. M., Mortara, L., Albini, A. Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.	[Bruno, Antonino; Bassani, Barbara; D'Urso, Davide Giuseppe; Noonan, Douglas M.; Albini, Adriana] Ist Ricovero & Cura Carattere Sci IRCCS MultiMed, Vasc Biol & Angiogenesis Lab, Sci & Technol Pole PST, Milan, Italy; [Pitaku, Ilvana; Cassinotti, Elisa; Dominioni, Lorenzo] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Noonan, Douglas M.; Mortara, Lorenzo] Univ Insubria, Dept Biotechnol & Life Sci, Via Dunant 3, I-21100 Varese, Italy; [Pelosi, Giuseppe] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Boni, Luigi] Univ Milan, Polyclin Hosp, Dept Med Surg Physiopathol & Transplantat, IRCCS, Milan, Italy; [Albini, Adriana] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy	University of Insubria; University of Insubria; University of Milan; University of Milan; University of Milano-Bicocca	Noonan, DM (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Via Dunant 3, I-21100 Varese, Italy.	douglas.noonan@uninsubria.it	Albini, Adriana/J-3701-2018; Bruno, Antonino/J-7066-2016; BONI, LUIGI/AAC-6005-2022; bassani, barbara/AAB-5832-2019; Pelosi, Giuseppe/F-5073-2012	Bruno, Antonino/0000-0002-4790-0861; BONI, LUIGI/0000-0002-5906-3810; Cassinotti, Elisa/0000-0003-3780-6561; Bassani, Barbara/0000-0002-8002-1607; Pelosi, Giuseppe/0000-0003-4725-4692	Italian Association for Cancer Research, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) [2010NECHBX_003]; University of Insubria, Fondi di Ateneo per la Ricerca; Fondazione Umberto Veronesi; PhDITalent	Italian Association for Cancer Research, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN); University of Insubria, Fondi di Ateneo per la Ricerca; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); PhDITalent	The authors are grateful to Paola Corradino for data management and Simone Libertini for manuscript assistance (both from MultiMedica, Milan, Italy). This work was supported by the Italian Association for Cancer Research, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) Grant 2010NECHBX_003 (to D.M.N.), and the University of Insubria, Fondi di Ateneo per la Ricerca (to L.M. and D.M.N.). A.B. was funded by a postdoctoral grant from Fondazione Umberto Veronesi, and is currently a permanent staff researcher awarded by the PhDITalent. B.B. was a participant in the Ph.D. Program in Biotechnology, Biosciences, and Surgical Technologies (School of Biological and Medical Sciences, University of Insubria). The authors declare no conflicts of interest.	Aghagolzadeh P, 2016, WORLD J GASTROENTERO, V22, P5678, DOI 10.3748/wjg.v22.i25.5678; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Arber N, 2008, GASTROENTEROLOGY, V134, P1224, DOI 10.1053/j.gastro.2008.02.012; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; Baeten CIM, 2006, CLIN GASTROENTEROL H, V4, P1351, DOI 10.1016/j.cgh.2006.08.005; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; Blois SM, 2011, J REPROD IMMUNOL, V88, P86, DOI 10.1016/j.jri.2010.11.002; Bruno A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju200; Bruno A, 2013, NEOPLASIA, V15, P133, DOI 10.1593/neo.121758; Burmeister K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175563; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Cantoni C, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4684268; Carpentier G., 2012, IMAGEJ NEWS, V5, P133; Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Custodio A, 2013, CANCER TREAT REV, V39, P908, DOI 10.1016/j.ctrv.2013.02.004; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Edsparr K, 2010, J IMMUNOTHER, V33, P475, DOI 10.1097/CJI.0b013e3181d372a0; Edsparr K, 2009, IMMUNOL CELL BIOL, V87, P489, DOI 10.1038/icb.2009.35; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gharagozloo M, 2015, BRATISL MED J, V116, P296, DOI 10.4149/BLL_2015_056; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Goda S, 2006, AM J PATHOL, V169, P445, DOI 10.2353/ajpath.2006.050676; Goodison S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047469; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Gotthardt D, 2014, BLOOD, V124, P2370, DOI 10.1182/blood-2014-03-564450; Gross CC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00606; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna J, 2007, TRENDS IMMUNOL, V28, P201, DOI 10.1126/scitranslmed.3006850; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Herszenyi L, 2014, WORLD J GASTROENTERO, V20, P13246, DOI 10.3748/wjg.v20.i37.13246; Herszenyi L, 2012, INT J MOL SCI, V13, P13240, DOI 10.3390/ijms131013240; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jensen SA, 2010, EUR J CANCER, V46, P3233, DOI 10.1016/j.ejca.2010.07.046; Katona TM, 2005, CLIN CANCER RES, V11, P8358, DOI 10.1158/1078-0432.CCR-05-0962; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Klintrup K, 2005, EUR J CANCER, V41, P2645, DOI 10.1016/j.ejca.2005.07.017; Krasnova Y, 2017, CLIN IMMUNOL, V177, P50, DOI 10.1016/j.clim.2015.10.001; Langers AMJ, 2012, BRIT J CANCER, V106, P1495, DOI 10.1038/bjc.2012.80; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Le Bouteiller P, 2006, NAT MED, V12, P991, DOI 10.1038/nm0906-991; Lee BK, 2008, IN VIVO, V22, P593; Lee HH, 2017, ARCH PHARM RES, V40, P1037, DOI 10.1007/s12272-017-0951-9; Levi I, 2015, ONCOTARGET, V6, P1, DOI 10.18632/oncotarget.3453; Liu QQ, 2009, J VIROL, V83, P8705, DOI 10.1128/JVI.02666-08; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Montaldo E, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00646; Mortara L, 2017, CURR OPIN PHARMACOL, V35, P66, DOI 10.1016/j.coph.2017.05.009; Naruse K, 2009, HUM REPROD, V24, P553, DOI 10.1093/humrep/den408; Nelson EA, 2011, ONCOTARGET, V2, P518; Ni J, 2016, CANCER DISCOV, V6, P347, DOI 10.1158/2159-8290.CD-16-0247; Nilsson UW, 2010, CLIN CANCER RES, V16, P3659, DOI 10.1158/1078-0432.CCR-10-0501; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Ong S, 2017, CLIN IMMUNOL, V175, P26, DOI 10.1016/j.clim.2016.11.010; Peng YP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-738; Piatkiewicz P, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0152-6; Rajaganeshan R, 2007, BRIT J CANCER, V96, P1112, DOI 10.1038/sj.bjc.6603677; Rocca YS, 2013, INNATE IMMUN-LONDON, V19, P76, DOI 10.1177/1753425912453187; Rondanin R, 2014, BIOORG MED CHEM LETT, V24, P4568, DOI 10.1016/j.bmcl.2014.07.069; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Scoville SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00360; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Shimoyama S, 1999, CLIN CANCER RES, V5, P1125; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Stetler-Stevenson WG, 2014, CONNECT TISSUE RES, V55, P13, DOI 10.3109/03008207.2013.867339; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; Sungur Can M., 2014, Critical Reviews in Oncogenesis, V19, P57; Urquidi V, 2012, CANCER EPIDEM BIOMAR, V21, P2149, DOI 10.1158/1055-9965.EPI-12-0428; Vitale M, 2014, EUR J IMMUNOL, V44, P1582, DOI 10.1002/eji.201344272; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Voron T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00070; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wallace AE, 2014, HUM REPROD, V29, P652, DOI 10.1093/humrep/deu017; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zhou Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-13; Zingoni A, 2016, CRIT REV IMMUNOL, V36, P445, DOI 10.1615/CritRevImmunol.2017020166	90	65	69	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5365	5377		10.1096/fj.201701103R	http://dx.doi.org/10.1096/fj.201701103R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29763380	Green Submitted			2022-12-28	WOS:000447972500014
J	Yang, XY; Chen, C; Tian, HL; Chi, H; Mu, ZY; Zhang, TQ; Yang, KL; Zhao, Q; Liu, XH; Wang, ZF; Ji, XY; Yang, HT				Yang, Xiaoyun; Chen, Cheng; Tian, Hongliang; Chi, Heng; Mu, Zhongyu; Zhang, Tianqing; Yang, Kailin; Zhao, Qi; Liu, Xiaohua; Wang, Zefang; Ji, Xiaoyun; Yang, Haitao			Mechanism of ATP hydrolysis by the Zika virus helicase	FASEB JOURNAL			English	Article						drug design; structure; mutagenesis	NS3 PROTEIN; INSIGHTS; DESIGN; DOMAIN	During its life cycle, Zika virus (ZIKV), an arthropod-borne flavivirus that is associated with Guillain-Barre syndrome and causes microencephaly in fetuses and newborn children, encodes a critical and indispensable helicase domain that has 5-triphosphatase activity and performs ATP hydrolysis to generate energy and thus, sustains unwinding of double-stranded RNA during ZIKV genome replication. Of these processes, ATP hydrolysis represents the most basic event; however, its dynamic mechanisms remain largely unknown, impeding the further understanding of the function of ZIKV helicase and the ongoing anti-ZIKV drug design. In this work, we determined the crystal structure of ZIKV helicase in complex with ADP-AlF3-Mn2+ and ADP-Mn2+ separately. The structural analysis indicates that these structures represent the intermediate state and posthydrolysis state, respectively, of the ATP hydrolysis process of ZIKV helicase. These findings, together with our earlier work, which identified the prehydrolysis state of ZIKV helicase, lead to a proposal of the ATP hydrolysis cycle for ZIKV helicase. On this basis, we used site-directed mutagenesis combined with an enzymatic study to identify successfully residues that are critical for the ATPase activity of ZIKV helicase; this will provide new ideas to understand the function for the key enzyme of ZIKV.Yang, X., Chen, C., Tian, H., Chi, H., Mu, Z., Zhang, T., Yang, K., Zhao, Q., Liu, X., Wang, Z., Ji, X., Yang, H. Mechanism of ATP hydrolysis by the Zika virus helicase.	[Yang, Xiaoyun; Chen, Cheng; Tian, Hongliang; Chi, Heng; Mu, Zhongyu; Zhang, Tianqing; Liu, Xiaohua; Wang, Zefang; Yang, Haitao] Tianjin Univ, 92 Weijin Rd, Tianjin 300072, Peoples R China; [Yang, Xiaoyun; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin, Peoples R China; [Yang, Kailin] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Zhao, Qi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Tianjin University; Tianjin International Joint Academy of Biomedicine; Case Western Reserve University; Cleveland Clinic Foundation; Yale University; Nanjing University	Wang, ZF; Yang, HT (corresponding author), Tianjin Univ, 92 Weijin Rd, Tianjin 300072, Peoples R China.	zefangwang@tju.edu.cn; yanght@tju.edu.cn			National Natural Science Foundation of China [31528006]; National Key Basic Research Program of China (973 Program) [2015CB859800, 2014CB542800]; National Key Research Program of China [2016YFD0500300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Research Program of China	The authors thank the staff at Beamline BL18U1 of the Shanghai Synchrotron Radiation Facility (SSRF) for data collection. Atomic coordinates and structure factors have been deposited in the Research Collaboratory for Structural Bioinformatics (RCSB) PDB IDs: 5Y6M and 5Y6N. This work was supported by the National Natural Science Foundation of China (31528006), the National Key Basic Research Program of China (973 Program) (2015CB859800 and 2014CB542800), and the National Key Research Program of China (2016YFD0500300). The authors declare no conflicts of interest.	Abdelhaleem M, 2010, METHODS MOL BIOL, V587, P1, DOI 10.1007/978-1-60327-355-8_1; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941; Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Isaguliants MG, 2003, IMMUNOL LETT, V88, P1, DOI 10.1016/S0165-2478(03)00051-8; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Roze B, 2016, EURO SURVEILL, P21; Silveira GF, 2016, CLIN EXP IMMUNOL, V183, P114, DOI 10.1111/cei.12701; Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341; Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2; Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4; Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005	27	15	16	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5250	5257		10.1096/fj.201701140R	http://dx.doi.org/10.1096/fj.201701140R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29913559				2022-12-28	WOS:000447972500005
J	Hur, J; Mateo, V; Amalric, N; Babiak, M; Bereziat, G; Kanony-Truc, C; Clerc, T; Blaise, R; Limon, I				Hur, Justine; Mateo, Veronique; Amalric, Nicolas; Babiak, Megane; Bereziat, Gilbert; Kanony-Truc, Claire; Clerc, Thierry; Blaise, Regis; Limon, Isabelle			Cerebrovascular beta-amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA-enriched diet	FASEB JOURNAL			English	Article						docosahexaenoic acid; cerebral amyloid angiopathy; vascular smooth muscle cells; 12-HETE	POLYUNSATURATED FATTY-ACID; PROTECTS CORTICAL-NEURONS; BLOOD MONONUCLEAR-CELLS; DOCOSAHEXAENOIC ACID; SPONTANEOUS HEMORRHAGE; POSSIBLE INVOLVEMENT; ANGIOPATHY; DISEASE; CHOLESTEROL; BRAIN	Cerebral amyloid angiopathy (CAA) is a major contributor to Alzheimer's disease (AD) pathogenesis. Like AD, CAA is often accompanied by marked inflammation, aggravating associated vasculopathies. No evidence-based prevention or treatment strategies are available. Here, we evaluate the possible beneficial effect of a diet enriched with docosahexaenoic acid (DHA), which is known to attenuate inflammation in CAA. Tg2576 mice, a transgenic model of AD/CAA, were fed a DHA-enriched diet starting at 2 mo of age and ending at 10, 14, or 18 mo of age. -Amyloid (A)-peptide deposition and bleeding were visualized by immunohistochemistry or histochemistry on coronal sections of the brain. DHA, arachidonic acid, and eicosanoid levels were measured by liquid chromatography/mass spectrometry or GC-MS. DHA-enriched diet throughout aging limits the accumulation of vascular A peptide deposits as well as the likelihood of microhemorrhages. There is a strong correlation between systemic 12-hydroxyeicosatetraenoic acid (HETE) levels and the size of the area affected by both vascular amyloid deposits and hemorrhages. The lowest levels of 12-HETE, a lipid-derived proinflammatory product of 12-lipoxygenase (LOX), were found in DHA-fed mice. In vitro experiments performed on amyloid vascular smooth muscle cells showed that a 12-LOX inhibitor almost completely blocked the A(1-40) peptide-induced apoptosis of these cells. This study yet again highlights the important role of inflammation in CAA pathogenesis and identifies potential new targets for preventive care.Hur, J., Mateo, V., Amalric, N., Babiak, M., Bereziat, G., Kanony-Truc, C., Clerc, T., Blaise, R., Limon, I. Cerebrovascular -amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA-enriched diet.	[Hur, Justine; Babiak, Megane; Bereziat, Gilbert; Blaise, Regis; Limon, Isabelle] Sorbonne Univ, IBPS, CNRS, Unite Mixte Rech UMR Biol Adaptat & Aging 8256, Paris, France; [Mateo, Veronique] Sorbonne Univ, Ctr Immunol & Infect Dis Immune Intervent & Bioth, INSERM, UMR Sci CR7,Unite 1135, Paris, France; [Amalric, Nicolas] Synelvia, Labege, France; [Kanony-Truc, Claire; Clerc, Thierry] Pierre Fabre Res Inst, Pierre Fabre Ctr Res & Dev, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Limon, I (corresponding author), Sorbonne Univ, IBPS, CNRS, Unite Mixte Rech UMR Biol Adaptat & Aging 8256, Paris, France.	isabelle.limon@upmc.fr	Mateo, Véronique/AAD-1379-2019; Mateo, Véronique/O-9738-2017	Mateo, Véronique/0000-0002-9327-1277; Mateo, Véronique/0000-0002-9327-1277; Blaise, Regis/0000-0001-7759-3244	Pierre Fabre Research Institute (a subsidiary of the pharmaceutical company, Pierre Fabre)	Pierre Fabre Research Institute (a subsidiary of the pharmaceutical company, Pierre Fabre)	The authors thank Stephane Fouquet and David Godefroy (Imaging Core Facility, Institut de la Vision, Paris, France) for slide scanning. The authors also thank Jean-Francois Gilles (Imaging Facility, Biological Institute of Paris-Seine) for helping to construct the macro for plaque quantification. This work was supported by the Pierre Fabre Research Institute (a subsidiary of the pharmaceutical company, Pierre Fabre). The authors declare no conflicts of interest.	Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; Blaise R, 2012, AGING CELL, V11, P384, DOI 10.1111/j.1474-9726.2012.00797.x; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fryer JD, 2003, J NEUROSCI, V23, P7889; Ghiso Jorge, 2010, Hirosaki Igaku, V61, pS111; Greenberg SM, 2002, NEUROLOGY, V58, P1587, DOI 10.1212/WNL.58.11.1587; Gupta S, 2016, J PHYS CHEM B, V120, P8346, DOI 10.1021/acs.jpcb.6b02036; Hashimoto M, 2008, J NEUROCHEM, V107, P1634, DOI 10.1111/j.1471-4159.2008.05731.x; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Jellinger KA, 2010, NEURODEGENER DIS, V7, P112, DOI 10.1159/000285518; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kim TK, 2012, EXP MOL MED, V44, P492, DOI 10.3858/emm.2012.44.8.056; Kloppenborg RP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-18; Kondreddy VKR, 2016, IMMUNOPHARM IMMUNOT, V38, P153, DOI 10.3109/08923973.2016.1147578; Lebeau A, 2004, CELL DEATH DIFFER, V11, P875, DOI 10.1038/sj.cdd.4401395; Lebeau A, 2001, NEUROREPORT, V12, P2199, DOI 10.1097/00001756-200107200-00031; Marottoli FM, 2017, ASN NEURO, V9, DOI 10.1177/1759091417719201; Mateo V, 2007, BLOOD, V110, P4285, DOI 10.1182/blood-2007-05-088286; Miguel-Alvarez M, 2015, DRUG AGING, V32, P139, DOI 10.1007/s40266-015-0239-z; Nagasawa K, 2007, NEUROSCI LETT, V429, P120, DOI 10.1016/j.neulet.2007.09.073; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Norris PC, 2012, P NATL ACAD SCI USA, V109, P8517, DOI 10.1073/pnas.1200189109; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Pratico D, 2004, AM J PATHOL, V164, P1655, DOI 10.1016/S0002-9440(10)63724-8; Reynolds MR, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0073-8; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; Serini S, 2012, CURR ALZHEIMER RES, V9, P913, DOI 10.2174/156720512803251147; Shaikh SR, 2013, PROSTAG LEUKOTR ESS, V88, P21, DOI 10.1016/j.plefa.2012.03.004; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; Simonyi A, 2010, MOL NEUROBIOL, V41, P73, DOI 10.1007/s12035-010-8107-7; Somjen D, 2016, J STEROID BIOCHEM, V163, P28, DOI 10.1016/j.jsbmb.2016.03.032; Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Vromman A, 2013, AGING CELL, V12, P358, DOI 10.1111/acel.12056; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wang XZ, 2015, J LIPID RES, V56, P674, DOI 10.1194/jlr.P055418; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001; Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114; Yamada M, 2015, J STROKE, V17, P17, DOI 10.5853/jos.2015.17.1.17; Yan P, 2015, STROKE, V46, P1633, DOI 10.1161/STROKEAHA.115.008582; Yaqoob P, 2003, EUR J MED RES, V8, P337; Yassine HN, 2016, JAMA NEUROL, V73, P1208, DOI 10.1001/jamaneurol.2016.1924	49	14	14	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4972	4983		10.1096/fj.201800200R	http://dx.doi.org/10.1096/fj.201800200R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29620941	Bronze			2022-12-28	WOS:000443817700029
J	Crespi, A; Plutino, S; Sciaccaluga, M; Righi, M; Borgese, N; Fucile, S; Gotti, C; Colombo, SF				Crespi, Arianna; Plutino, Simona; Sciaccaluga, Miriam; Righi, Marco; Borgese, Nica; Fucile, Sergio; Gotti, Cecilia; Colombo, Sara Francesca			The fifth subunit in alpha 3 beta 4 nicotinic receptor is more than an accessory subunit	FASEB JOURNAL			English	Article						nAChR trafficking; nAChR subtypes; stoichiometry; ER export signal	ACETYLCHOLINE-RECEPTORS; LUNG-CANCER; AUXILIARY SUBUNITS; GABA(A) RECEPTORS; MEMBRANE-PROTEIN; ALPHA-5 SUBUNIT; AMPA RECEPTOR; UP-REGULATION; TRAFFICKING; SUBTYPES	The alpha 3 beta 4 subtype is the predominant neuronal nicotinic acetylcholine receptor present in the sensory and autonomic ganglia and in a subpopulation of brain neurons. This subtype can form pentameric receptors with either 2 or 3 4 subunits that have different pharmacologic and functional properties. To further investigate the role of the fifth subunit, we coexpressed a dimeric construct coding for a single polypeptide containing the 4 and 3 subunit sequences, with different monomeric subunits. With this strategy, which allowed the formation of single populations of receptors with unique stoichiometry, we demonstrated with immunofluorescence and biochemical and functional assays that only the receptors with 3 4 subunits are efficiently expressed at the plasma membrane. Moreover, the LFM export motif of 4 subunit in the fifth position exerts a unique function in the regulation of the intracellular trafficking of the receptors, their exposure at the cell surface, and consequently, their function, whereas the same export motif present in the 4 subunits forming the acetylcholine binding site is dispensable.Crespi, A., Plutino, S., Sciaccaluga, M., Righi, M., Borgese, N., Fucile, S., Gotti, C., Colombo, S. F. The fifth subunit in alpha 3 beta 4 nicotinic receptor is more than an accessory subunit.	[Crespi, Arianna; Righi, Marco; Borgese, Nica; Gotti, Cecilia; Colombo, Sara Francesca] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Crespi, Arianna; Righi, Marco; Borgese, Nica; Gotti, Cecilia; Colombo, Sara Francesca] CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy; [Plutino, Simona; Fucile, Sergio] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol, Rome, Italy; [Sciaccaluga, Miriam; Fucile, Sergio] Ist Neurol Mediterraneo, Ist Ricovero & Cura Carattere Sci IRCCS Neuromed, Pozzilli, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; IRCCS Neuromed	Colombo, SF (corresponding author), CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy.	s.colombo@in.cnr.it	Sciaccaluga, Miriam/AAF-5535-2021; Righi, Marco/P-4332-2019; Fucile, Sergio/B-3934-2010; Borgese, Nica/GWZ-8895-2022; Righi, Marco Giovanni Enea/M-9003-2019	Fucile, Sergio/0000-0003-0698-1148; Borgese, Nica/0000-0002-7537-3974; Righi, Marco Giovanni Enea/0000-0003-1181-0327; Sciaccaluga, Miriam/0000-0001-7951-8045; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961; Plutino, Simona/0000-0002-6945-3134	CNR Research Project on Aging; AMANDA project from Regione Lombardia [CUP_B42F16000440005]; Fondazione Monzino (Milano)	CNR Research Project on Aging(Consiglio Nazionale delle Ricerche (CNR)); AMANDA project from Regione Lombardia; Fondazione Monzino (Milano)	The authors thank Prof. Francesco Clementi (University of Milan, Milan, Italy) for critical reading of the manuscript. The authors thank Dr. Milena Moretti (University of Milan, Milan, Italy) for performing the [<SUP>3</SUP>H] epibatidine-binding studies. This work was supported by the CNR Research Project on Aging, the AMANDA project (CUP_B42F16000440005) from Regione Lombardia, and by a grant from the Fondazione Monzino (Milano). The authors declare no conflicts of interest.	Araud T, 2010, BIOCHEM PHARMACOL, V80, P160, DOI 10.1016/j.bcp.2010.03.017; Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Boudreau Amy C, 2012, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0530s59; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; CHINI B, 1992, P NATL ACAD SCI USA, V89, P1572, DOI 10.1073/pnas.89.5.1572; Colombo SF, 2013, BIOCHEM PHARMACOL, V86, P1063, DOI 10.1016/j.bcp.2013.06.023; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Crespi A., 2017, BR J PHARM; Dallanoce C, 2011, CHEMMEDCHEM, V6, P889, DOI 10.1002/cmdc.201000514; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Fossati M, 2014, EMBO J, V33, P2080, DOI 10.15252/embj.201488367; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Gu SY, 2016, NEURON, V89, P948, DOI 10.1016/j.neuron.2016.01.018; Harlow E., 1998, ANTIBODIES LAB MANUA, P522; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Improgo MRD, 2010, ONCOGENE, V29, P4874, DOI 10.1038/onc.2010.256; Improgo MR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00251; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Matta JA, 2017, CELL REP, V19, P688, DOI 10.1016/j.celrep.2017.04.008; Mazzo F, 2013, J NEUROSCI, V33, P12316, DOI 10.1523/JNEUROSCI.2393-13.2013; Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Millar NS, 2009, BIOCHEM PHARMACOL, V78, P766, DOI 10.1016/j.bcp.2009.06.015; Molas S, 2017, TRENDS PHARMACOL SCI, V38, P169, DOI 10.1016/j.tips.2016.11.001; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mucchietto V, 2018, BRIT J PHARMACOL, V175, P1957, DOI 10.1111/bph.13954; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Pistillo F, 2015, PROG NEUROBIOL, V124, P1, DOI 10.1016/j.pneurobio.2014.10.002; Ray C, 2017, ACS CHEM BIOL, V12, P702, DOI 10.1021/acschembio.6b01117; Richards CI, 2011, J BIOL CHEM, V286, P31241, DOI 10.1074/jbc.M111.256024; Sauvageau E, 2014, TRAFFIC, V15, P383, DOI 10.1111/tra.12148; Schroeder KM, 2003, J NEUROCHEM, V85, P581, DOI 10.1046/j.1471-4159.2003.01658.x; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shanks NF, 2014, J NEUROSCI, V34, P12104, DOI 10.1523/JNEUROSCI.0595-14.2014; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; St John PA, 2009, ACTA PHARMACOL SIN, V30, P656, DOI 10.1038/aps.2009.76; Stokes C, 2015, TRENDS PHARMACOL SCI, V36, P514, DOI 10.1016/j.tips.2015.05.002; Stokes C, 2012, NEUROPHARMACOLOGY, V63, P538, DOI 10.1016/j.neuropharm.2012.04.035; STORRIE B, 1994, J CELL SCI, V107, P1309; Sumioka A, 2013, J BIOCHEM, V153, P331, DOI 10.1093/jb/mvt015; TARTAKOFF AM, 1986, EMBO J, V5, P1477, DOI 10.1002/j.1460-2075.1986.tb04385.x; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Valles AS, 2012, BBA-BIOMEMBRANES, V1818, P718, DOI 10.1016/j.bbamem.2011.10.012; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Yamasaki T, 2017, NEURON, V93, P1138, DOI 10.1016/j.neuron.2017.02.023; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003	57	5	5	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4190	4202		10.1096/fj.201701377R	http://dx.doi.org/10.1096/fj.201701377R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29505300				2022-12-28	WOS:000439325400011
J	Giacco, A; delli Paoli, G; Senese, R; Cioffi, F; Silvestri, E; Moreno, M; Ruoppolo, M; Caterino, M; Costanzo, M; Lombardi, A; Goglia, F; Lanni, A; de Lange, P				Giacco, Antonia; delli Paoli, Giuseppe; Senese, Rosalba; Cioffi, Federica; Silvestri, Elena; Moreno, Maria; Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele; Lombardi, Assunta; Goglia, Fernando; Lanni, Antonia; de Lange, Pieter			The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells	FASEB JOURNAL			English	Article						skeletal muscle; acylcarnitines; 3,5,3 '-triiodo-L-thyronine; 3,5-diiodo-L-thyronine; insulin resistance	RAT GASTROCNEMIUS; PROTEIN-KINASE; 3,5-DIIODO-L-THYRONINE; OXIDATION; HYPOTHYROIDISM; RESISTANCE; PATHWAYS; SERUM; AXIS	Using differentiated rat L6 cells, we studied the direct effect of 3,5,3-triiodo-l-thyronine (T3) and 3,5-diiodo-l-thyronine (T2) on the response to insulin in presence of fatty acids with a varying degree of saturation. We found that T3 and T2 both invert the response to insulin by modulating Akt Ser473 phosphorylation in the presence of palmitate and oleate. Both hormones prevented palmitate-induced insulin resistance, whereas increased insulin sensitivity in the presence of oleate was reduced, with normalization to (or, in the case of T3, even below) control levels. Both hormones effectively reduced intracellular acylcarnitine concentrations. Interestingly, insulin sensitization was lowered by incubation of the myotubes with relevant concentrations of palmitoylcarnitines (C16) and increased by oleylcarnitines and linoleylcarnitines (C18:1 and C18:2, respectively). The efficiency of mitochondrial respiration decreased in the order palmitate-oleate-linoleate; in the presence of palmitate, only T3 increased ATP synthesis-independent cellular respiration and mitochondrial respiratory complex activities. Both hormones modulated gene expression and enzyme activities related to insulin sensitivity, glucose metabolism, and lipid handling. Although T2 and T3 differentially regulated the expression of relevant genes involved in glucose metabolism, they equally stimulated related metabolic activities. T2 and T3 differentially modulated mitochondrial fatty acid uptake and oxidation in the presence of each fatty acid. The results show that T2 and T3 both invert the fatty acid-induced response to insulin but through different mechanisms, and that the outcome depends on the degree of saturation of the fatty acids and their derived acylcarnitines.Giacco, A., delli Paoli, G., Senese, R., Cioffi, F., Silvestri, E., Moreno, M., Ruoppolo, M., Caterino, M., Costanzo, M., Lombardi, A., Goglia, F., Lanni, A., de Lange, P. The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells.	[Giacco, Antonia; Cioffi, Federica; Silvestri, Elena; Moreno, Maria; Goglia, Fernando] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy; [delli Paoli, Giuseppe; Senese, Rosalba; Lanni, Antonia; de Lange, Pieter] Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, I-81100 Caserta, Italy; [Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Lombardi, Assunta] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele] Ceinge Biotecnol Avanzate, Naples, Italy; [Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele] Divulgaz Sci Multidisciplinare Sostenibilita Ric, Naples, Italy	University of Sannio; Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Lanni, A (corresponding author), Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, I-81100 Caserta, Italy.; de Lange, P (corresponding author), Univ Campania, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Via Vivaldi 43, I-81100 Caserta, Italy.	antonia.lanni@unicampania.it; pieter.delange@unicampania.it	de Lange, Pieter/GXA-3052-2022; Caterino, Marianna/K-4531-2016; Costanzo, Michele/AAO-5873-2020; Caterino, Marianna/AAR-3526-2020	Costanzo, Michele/0000-0002-6386-2009; Caterino, Marianna/0000-0001-6035-8213; Silvestri, Elena/0000-0002-0592-9033; CIOFFI, Federica/0000-0002-1530-8556; MORENO, Maria/0000-0002-6218-5501; SENESE, Rosalba/0000-0003-1571-0980	University of Sannio Research Grants	University of Sannio Research Grants	This work was funded by University of Sannio Research Grants. The authors declare no conflicts of interest.	Abu Bakar MH, 2017, MOL BIOSYST, V13, P1838, DOI 10.1039/c7mb00333a; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Bouchouirab FZ, 2018, CAN J DIABETES, V42, P382, DOI 10.1016/j.jcjd.2017.09.002; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cao ZM, 2009, ENDOCR RES, V34, P101, DOI 10.3109/07435800903204082; Caterino M, 2016, MOL BIOSYST, V12, P566, DOI 10.1039/c5mb00736d; Cavaliere G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149033; Cavallo A, 2016, J BIOENERG BIOMEMBR, V48, P521, DOI 10.1007/s10863-016-9686-4; Crescenzo R, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00512; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; de Lange P, 2008, ENDOCRINOLOGY, V149, P6462, DOI 10.1210/en.2008-0202; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Grasselli E, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00418; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Iossa S, 2004, DIABETES, V53, P2861, DOI 10.2337/diabetes.53.11.2861; Jonas W, 2015, ENDOCRINOLOGY, V156, P389, DOI 10.1210/en.2014-1604; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; Lombardi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116498; Lombardi A, 2012, AM J PHYSIOL-ENDOC M, V303, pE1222, DOI 10.1152/ajpendo.00037.2012; Martinez-Sanchez N, 2017, CELL METAB, V26, P212, DOI 10.1016/j.cmet.2017.06.014; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Moreno M, 2011, FASEB J, V25, P3312, DOI 10.1096/fj.11-181982; Nardi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092255; Oliveira AF, 2015, BIOTECHNIQUES, V58, P228, DOI 10.2144/000114285; OPIE LH, 1967, BIOCHEM J, V103, P391, DOI 10.1042/bj1030391; Padron AS, 2014, J ENDOCRINOL, V221, P415, DOI 10.1530/JOE-13-0502; Ruoppolo M, 2014, AM J TRANSL RES, V6, P614; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Scolamiero E, 2015, MOL BIOSYST, V11, P1525, DOI 10.1039/c4mb00729h; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Silvestri E, 2010, MOL BIOSYST, V6, P2256, DOI 10.1039/c0mb00040j; Vatner DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140837; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318	37	17	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1811	1823		10.1096/fj.201800724R	http://dx.doi.org/10.1096/fj.201800724R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204501				2022-12-28	WOS:000457296600024
J	Ji, CC; Nagaoka, K; Zou, J; Casulli, S; Lu, SL; Cao, KY; Zhang, HY; Iwagami, Y; Carlson, RI; Brooks, K; Lawrence, J; Mueller, W; Wands, JR; Huang, CK				Ji, Chengcheng; Nagaoka, Katsuya; Zou, Jing; Casulli, Sarah; Lu, Shaolei; Cao, Kevin Y.; Zhang, Hongyu; Iwagami, Yoshifumi; Carlson, Rolf I.; Brooks, Keri; Lawrence, Jonathan; Mueller, William; Wands, Jack R.; Huang, Chiung-Kuei			Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation	FASEB JOURNAL			English	Article						epigenetic modification; DNA methylation; 2-oxoglutarate; Krebs cycle; 5-azacytidine	GENOMIC DNA HYPERMETHYLATION; METHIONINE ADENOSYLTRANSFERASE; S-ADENOSYLMETHIONINE; LIVER-DISEASE; METHYLATION; REPAIR; 5-METHYLCYTOSINE; DEMETHYLATION; GAMMA-H2AX; ACTIVATION	The 5-hydroxymethylcytosine (5hmc) is a newly identified epigenetic modification thought to be regulated by the TET family of proteins. Little information is available about how ethanol consumption may modulate 5hmC formation and alcoholic liver disease (ALD) progression. A rat ALD model was used to study 5hmC in relationship to hepatocyte apoptosis. Human ALD liver samples were also used to validate these findings. It was found that chronic ethanol feeding significantly reduced 5hmC formation in a rat ALD model. There were no significant changes in TET2 and TET3 between the control- and ethanol-fed animals. In contrast, methylcytosine dioxygenase TET1 (TET1) expression was substantially reduced in the ethanol-fed rats and was accompanied by increased hepatocyte apoptosis. Similarly, knockdown of TET1 in human hepatocyte-like cells also significantly promoted apoptosis. Down-regulation of TET1 resulted in elevated expression of the DNA damage marker, suggesting a role for 5hmc in hepatocyte DNA damage as well. Mechanistic studies revealed that inhibition of TET1 promoted apoptotic gene expression. Similarly, targeting TET1 activity by removing cosubstrate promoted apoptosis and DNA damage. Furthermore, treatment with 5-azacitidine significantly mimics these effects, suggesting that chronic ethanol consumption promotes hepatocyte apoptosis and DNA damage by diminishing TET1-mediated 5hmC formation and DNA methylation. In summary, the current study provides a novel molecular insight that TET1-mediated 5hmC is involved in hepatocyte apoptosis in ALD progression.Ji, C., Nagaoka, K., Zou, J., Casulli, S., Lu, S., Cao, K. Y., Zhang, H., Iwagami, Y., Carlson, R. I., Brooks, K., Lawrence, J., Mueller, W., Wands, J. R., Huang, C.-K. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.	[Ji, Chengcheng; Nagaoka, Katsuya; Zou, Jing; Casulli, Sarah; Cao, Kevin Y.; Zhang, Hongyu; Iwagami, Yoshifumi; Carlson, Rolf I.; Brooks, Keri; Lawrence, Jonathan; Mueller, William; Wands, Jack R.; Huang, Chiung-Kuei] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Gastroenterol, Providence, RI 02903 USA; [Ji, Chengcheng; Nagaoka, Katsuya; Zou, Jing; Casulli, Sarah; Cao, Kevin Y.; Zhang, Hongyu; Iwagami, Yoshifumi; Carlson, Rolf I.; Brooks, Keri; Lawrence, Jonathan; Mueller, William; Wands, Jack R.; Huang, Chiung-Kuei] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Liver Res Ctr, 55 Claverick St, Providence, RI 02903 USA; [Lu, Shaolei] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Pathol & Lab Med, Providence, RI 02903 USA; [Ji, Chengcheng] Beijing 302 Hosp, Crit Care Ctr, Beijing, Peoples R China; [Zou, Jing] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Fifth Medical Center of Chinese PLA General Hospital; Southern Medical University - China	Huang, CK (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Liver Res Ctr, 55 Claverick St, Providence, RI 02903 USA.	chiung-kuei_huang@brown.edu	Nagaoka, Katsuya/ABU-5640-2022; NAGAOKA, Katsuya/GQZ-0492-2022; Iwagami, Yoshifumi/AAJ-3184-2021	Nagaoka, Katsuya/0000-0002-7152-6101; NAGAOKA, Katsuya/0000-0002-7152-6101; Lu, Shaolei/0000-0003-2870-5793	Common Fund of the Office of the Director of the U.S. National Institutes of Health (NIH); National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; NIH [P20GM103430-12]; Rhode Island Foundation [134279]; American Association; 302 Hospital President Foundation [YNKT 2014018]; Brown University Karen T. Romer Undergraduate Teaching and Research awards; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the U.S. National Institutes of Health (NIH); National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; American Association; 302 Hospital President Foundation; Brown University Karen T. Romer Undergraduate Teaching and Research awards; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Z. Cheng (Warren Alpert Medical School of Brown University and Rhode Island Hospital), X. Bai (Warren Alpert Medical School of Brown University and Rhode Island Hospital), and G. Zhou (Beijing 302 Hospital) for their technical support. The GTEx Project is supported by the Common Fund of the Office of the Director of the U.S. National Institutes of Health (NIH), and by the National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The data used for the analyses described here were obtained from the GTEx data set. Funding for this work was provided by NIH (P20GM103430-12), the Rhode Island Foundation (134279), American Association for the Study of Liver Diseases pinnacle research award, the 302 Hospital President Foundation (YNKT 2014018), and Brown University Karen T. Romer Undergraduate Teaching and Research awards. The authors declare no conflicts of interest.	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Breitling LP, 2013, ARTERIOSCL THROM VAS, V33, P1468, DOI 10.1161/ATVBAHA.112.300157; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Feng J, 2015, NAT NEUROSCI, V18, P536, DOI 10.1038/nn.3976; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Fukaya KI, 2001, IN VITRO CELL DEV-AN, V37, P266, DOI 10.1007/bf02577541; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Huang CK, 2015, J HEPATOL, V63, P191, DOI 10.1016/j.jhep.2015.02.030; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Inoue S, 2016, CANCER CELL, V30, P337, DOI 10.1016/j.ccell.2016.05.018; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kuo LJ, 2008, IN VIVO, V22, P305; Lang CH, 2014, ALCOHOL CLIN EXP RES, V38, P897, DOI 10.1111/acer.12343; Liu CY, 2013, TOUR MANAG PERSPECT, V5, P1, DOI 10.1016/j.tmp.2012.09.003; Liu X, 2016, NAT REV GASTRO HEPAT, V13, P126, DOI 10.1038/nrgastro.2016.16; Lu SC, 2000, AM J PHYSIOL-GASTR L, V279, pG178, DOI 10.1152/ajpgi.2000.279.1.G178; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024; Pirola CJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001480; Ratib S, 2015, AM J GASTROENTEROL, V110, P1149, DOI 10.1038/ajg.2015.191; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Shen H, 2015, EXP MOL PATHOL, V99, P326, DOI 10.1016/j.yexmp.2015.08.001; Somineni HK, 2016, J ALLERGY CLIN IMMUN, V137, P797, DOI 10.1016/j.jaci.2015.10.021; Sorensen HT, 2003, J CLIN EPIDEMIOL, V56, P88, DOI 10.1016/S0895-4356(02)00531-0; Stepanova M, 2014, JAMA INTERN MED, V174, P1407, DOI 10.1001/jamainternmed.2014.2903; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thomson JP, 2016, CANCER RES, V76, P3097, DOI 10.1158/0008-5472.CAN-15-1910; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Xin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07645; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	41	6	6	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1824	1835		10.1096/fj.201800736R	http://dx.doi.org/10.1096/fj.201800736R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30188753	Green Published			2022-12-28	WOS:000457296600025
J	Aubert, P; Oleynikova, E; Rizvi, H; Ndjim, M; Le Berre-Scoul, C; Grohard, PA; Chevalier, J; Segain, JP; Le Drean, G; Neunlist, M; Boudin, H				Aubert, Philippe; Oleynikova, Elena; Rizvi, Hina; Ndjim, Marieme; Le Berre-Scoul, Catherine; Grohard, Pierre Antoine; Chevalier, Julien; Segain, Jean-Pierre; Le Drean, Gwenola; Neunlist, Michel; Boudin, Helene			Maternal protein restriction induces gastrointestinal dysfunction and enteric nervous system remodeling in rat offspring	FASEB JOURNAL			English	Article						enteric neuron; stress; cortiscosterone; nutritional programming	INTRAUTERINE GROWTH RESTRICTION; IRRITABLE-BOWEL-SYNDROME; WATER-AVOIDANCE STRESS; EARLY-LIFE STRESS; MYENTERIC NEURONS; POSTNATAL-DEVELOPMENT; PSYCHOLOGICAL STRESS; ABDOMINAL-PAIN; PERMEABILITY; SEPARATION	Early-life adversity is a major risk factor for the development of diseases later in life. Maternal protein restriction (MPR) is associated with morbidities in offspring affecting multiple organs, but its impact on the gastrointestinal (GI) tract remains poorly studied. Using a rat model, we examined the consequences of MPR on GI function and on the enteric nervous system (ENS) in the offspring at postnatal d 35 under basal state and following a water avoidance stress (WAS). Compared with control rats, MPR rats exhibited greater colonic motility, permeability, and corticosteronemia. In contrast to controls, MPR rats presented a blunted functional and corticosteronemic response to WAS. Furthermore, MPR rats showed an increased proportion of choline acetyltransferase-immunoreactive (ChAT-IR) neurons and a reduced level of autophagy in colonic myenteric neurons. In ENS cultures, corticosterone treatment increased the proportion of ChAT-IR neurons and reduced autophagy level in enteric neurons. Inhibition of autophagy in ENS cultures resulted in a higher vulnerability of enteric neurons to a cellular stress. Altogether, this study suggests that MPR induced GI dysfunction and ENS alterations in offspring rats and that MPR-induced increased corticosteronemia might be involved in ENS remodeling and altered responsiveness of the gut to stressors later in life.Aubert, P., Oleynikova, E., Rizvi, H., Ndjim, M., Le Berre-Scoul, C., Grohard, P. A., Chevalier, J., Segain, J.-P., Le Drean, G., Neunlist, M., Boudin, H. Maternal protein restriction induces gastrointestinal dysfunction and enteric nervous system remodeling in rat offspring.	[Aubert, Philippe; Oleynikova, Elena; Rizvi, Hina; Le Berre-Scoul, Catherine; Grohard, Pierre Antoine; Chevalier, Julien; Neunlist, Michel; Boudin, Helene] Univ Nantes, INSERM, Enter Nervous Syst Gut & Brain Disorders, Nantes, France; [Ndjim, Marieme; Segain, Jean-Pierre; Le Drean, Gwenola] Inst Malad Appareil Digestif, Physiol Adaptat Nutr PhAN, INRA, Unit Mixte Rech 1280, Nantes, France; [Aubert, Philippe; Oleynikova, Elena; Rizvi, Hina; Ndjim, Marieme; Le Berre-Scoul, Catherine; Grohard, Pierre Antoine; Chevalier, Julien; Segain, Jean-Pierre; Le Drean, Gwenola; Neunlist, Michel; Boudin, Helene] Ctr Rech Nutr Humaine Grand Ouest, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; INRAE; Nantes Universite; CHU de Nantes	Neunlist, M; Boudin, H (corresponding author), Univ Nantes, INSERM, Inst Malad Appareil Digestif, Enter Nervous Syst Gut & Brain Disorders, 1 Rue Gaston Veil, F-44035 Nantes, France.	michel.neunlist@univ-nantes.fr; helene.boudin@univ-nantes.fr		Aubert, Philippe/0000-0002-3126-6202; Boudin, Helene/0000-0002-9714-2384	INSERM; Region des Pays de la Loire (Parimad); Fondation LCL; Fondation SanteDige	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region des Pays de la Loire (Parimad); Fondation LCL; Fondation SanteDige	The authors are grateful to T. Durant (Universite de Nantes) for helping with cell culture and to G. Hamery (Universite de Nantes) for assistance at the Universite de Nantes Animal Facility. This work was supported by INSERM, Region des Pays de la Loire (Parimad), Fondation LCL, and Fondation SanteDige. The authors declare no conflicts of interest.	Abdo H, 2010, FASEB J, V24, P1082, DOI 10.1096/fj.09-139519; Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Gomes OA, 2006, AUTON NEUROSCI-BASIC, V126, P277, DOI 10.1016/j.autneu.2006.03.003; Bengtson MB, 2006, GUT, V55, P1754, DOI 10.1136/gut.2006.097287; Bengtson MB, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0237-y; Bernard CE, 2009, NEUROGASTROENT MOTIL, V21, P746, DOI 10.1111/j.1365-2982.2008.01245.x; Bian ZX, 2011, STRESS, V14, P448, DOI 10.3109/10253890.2011.558604; BONAZ B, 1994, BRAIN RES, V641, P21, DOI 10.1016/0006-8993(94)91810-4; Cameron HL, 2007, NEUROGASTROENT MOTIL, V19, P47, DOI 10.1111/j.1365-2982.2006.00845.x; Castelucci P, 2002, CELL TISSUE RES, V310, P1, DOI 10.1007/s00441-002-0615-y; Chalazonitis A, 2011, J NEUROSCI, V31, P13746, DOI 10.1523/JNEUROSCI.1078-11.2011; Chevalier J, 2008, J PHYSIOL-LONDON, V586, P1963, DOI 10.1113/jphysiol.2007.149815; CHRISTENSEN MF, 1975, ARCH DIS CHILD, V50, P110, DOI 10.1136/adc.50.2.110; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; D'Inca R, 2010, J NUTR, V140, P925, DOI 10.3945/jn.109.116822; de Vries P, 2010, AM J PHYSIOL-GASTR L, V299, pG539, DOI 10.1152/ajpgi.00092.2010; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Fanca-Berthon P, 2009, PEDIATR RES, V66, P47, DOI 10.1203/PDR.0b013e3181a2047e; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Gareau MG, 2007, AM J PHYSIOL-GASTR L, V293, pG198, DOI 10.1152/ajpgi.00392.2006; Giannogonas P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23342; Hao MM, 2013, J COMP NEUROL, V521, P3358, DOI 10.1002/cne.23354; HASLER WL, 1990, AM J PHYSIOL, V258, pG404, DOI 10.1152/ajpgi.1990.258.3.G404; Hong SS, 2011, GASTROENTEROLOGY, V140, P627, DOI 10.1053/j.gastro.2010.11.003; Howell S, 2005, AM J GASTROENTEROL, V100, P2071, DOI 10.1111/j.1572-0241.2005.41753.x; Lalles JP, 2012, J NUTR BIOCHEM, V23, P1490, DOI 10.1016/j.jnutbio.2011.10.001; Larauche M, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01980.x; Le Berre-Scoul C, 2017, J PHYSIOL-LONDON, V595, P583, DOI 10.1113/JP271989; Le Drean G, 2014, FASEB J, V28, P1059, DOI 10.1096/fj.13-234203; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Long BS, 2016, J PROTEOME RES, V15, P1262, DOI 10.1021/acs.jproteome.6b00001; Lowette K, 2014, AM J PHYSIOL-GASTR L, V307, pG905, DOI 10.1152/ajpgi.00233.2014; March MI, 2015, J MATERN-FETAL NEO M, V28, P1285, DOI 10.3109/14767058.2014.951624; Matsunaga M, 2009, NEUROGASTROENT MOTIL, V21, P856, DOI 10.1111/j.1365-2982.2009.01286.x; Medland JE, 2016, NEUROGASTROENT MOTIL, V28, P1317, DOI 10.1111/nmo.12828; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Neunlist M, 2014, J PHYSIOL-LONDON, V592, P2959, DOI 10.1113/jphysiol.2014.272948; Pohl CS, 2015, AM J PHYSIOL-GASTR L, V309, pG927, DOI 10.1152/ajpgi.00206.2015; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Regev RH, 2004, CLIN PERINATOL, V31, P453, DOI 10.1016/j.clp.2004.04.017; Rincel M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.235; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; Schemann M, 2004, NEUROGASTROENT MOTIL, V16, P55, DOI 10.1111/j.1743-3150.2004.00476.x; Schneider M, 2013, CELL TISSUE RES, V354, P99, DOI 10.1007/s00441-013-1581-2; Schwetz I, 2005, AM J PHYSIOL-GASTR L, V289, pG704, DOI 10.1152/ajpgi.00498.2004; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Soret R, 2010, GASTROENTEROLOGY, V138, P1772, DOI 10.1053/j.gastro.2010.01.053; Van Landeghem L, 2011, AM J PHYSIOL-GASTR L, V300, pG976, DOI 10.1152/ajpgi.00427.2010; Walker LS, 1998, J PEDIATR-US, V132, P1010, DOI 10.1016/S0022-3476(98)70400-7; Wang W, 2016, FASEB J, V30, P863, DOI 10.1096/fj.15-274779; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273; Zheng G, 2013, NEUROGASTROENT MOTIL, V25, pE127, DOI 10.1111/nmo.12066	55	8	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					770	781		10.1096/fj.201800079R	http://dx.doi.org/10.1096/fj.201800079R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30067379	Bronze			2022-12-28	WOS:000457401500060
J	Gao, ZH; Deng, CJ; Xie, YY; Guo, XL; Wang, QQ; Liu, LZ; Lee, WH; Li, SA; Zhang, Y				Gao, Zhen-Hua; Deng, Cheng-Jie; Xie, Yue-Ying; Guo, Xiao-Long; Wang, Qi-Quan; Liu, Ling-Zhen; Lee, Wen-Hui; Li, Sheng-An; Zhang, Yun			Pore-forming toxin-like protein complex expressed by frog promotes tissue repair	FASEB JOURNAL			English	Article						aerolysin-like protein; epithelization; scarless; acute inflammatory response; -crystallin	FIBROBLAST-GROWTH-FACTOR; GRANULATION-TISSUE; APOPTOSIS; INFLAMMATION; IL-1-BETA; HOST; MODEL	Tissue repair is a highly dynamic process, and the immediate onset of acute inflammation has been considered necessary for repair. Pore-forming proteins are important, both in pathogen invasion and host immunity. However, their roles in wound healing and tissue repair are unclear. -crystallin fused aerolysin-like protein (-subunit) and trefoil factor (-subunit) complex (-CAT) is a complex of a bacterial pore-forming toxin aerolysin-like protein and trefoil factor identified in the frog Bombina maxima. In this study, we established mouse cutaneous wound models to explore the effects of -CAT on skin wound healing. -CAT accelerated the healing of full-thickness wounds by improving re-epithelialization. This complex relieved dermal edema and promoted scarless healing. -CAT treatment resulted in a rapid release of IL-1, which initiated an acute inflammation response in the early stage of healing. Meanwhile, the expression levels of TGF-1, VEGF, and bFGF and the recruitment of M2 macrophages around the wound significantly increased after -CAT treatment. -CAT protected skin wounds against methicillin-resistant Staphylococcus aureus by improving neutrophil recruitment at the site of the wound. Overall, our results suggest that -CAT can promote tissue repair and protect skin wounds against antibiotic-resistant bacterial infection by triggering the acute inflammatory response. This is the first example that aerolysin-like pore-forming proteins widely existing in plants and animals may act in wound healing and tissue repair.Gao, Z.-H., Deng, C.-J., Xie, Y.-Y., Guo, X.-L., Wang, Q.-Q., Liu, L.-Z., Lee, W.-H., Li, S.-A., Zhang, Y. Pore-forming toxin-like protein complex expressed by frog promotes tissue repair.	[Gao, Zhen-Hua; Deng, Cheng-Jie; Xie, Yue-Ying; Guo, Xiao-Long; Wang, Qi-Quan; Liu, Ling-Zhen; Lee, Wen-Hui; Li, Sheng-An; Zhang, Yun] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Gao, Zhen-Hua; Deng, Cheng-Jie; Xie, Yue-Ying; Guo, Xiao-Long; Wang, Qi-Quan; Liu, Ling-Zhen; Lee, Wen-Hui; Li, Sheng-An; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Kunming, Yunnan, Peoples R China; [Zhang, Yun] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China; [Gao, Zhen-Hua; Deng, Cheng-Jie; Wang, Qi-Quan; Liu, Ling-Zhen] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Gao, Zhen-Hua] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University	Li, SA (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming 650223, Yunnan, Peoples R China.; Zhang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, 32 East Jiaochang Rd, Kunming 650223, Yunnan, Peoples R China.	lishengan@163.com; zhangy@mail.kiz.ac.cn		Zhang, Yun/0000-0002-8636-183X; Gao, Zhenhua/0000-0002-5806-2891	National Natural Science Foundation of China [31572268, U1602225]; Yunling Scholar Program; Western Light Talents Training Program of the Chinese Academy of Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunling Scholar Program; Western Light Talents Training Program of the Chinese Academy of Science	The authors thank Dr. Ping Jiang (Kunming Medical University) and Yujie Xia (Kunming Institute of Zoology) for help with analysis of tissue section pathology. The authors also thank Prof. Yan Du (The First Affiliated Hospital of Kunming Medical University) for providing clinical MRSA strains. This study was supported by National Natural Science Foundation of China Grants 31572268 and U1602225, the Yunling Scholar Program (to Y.Z.), and the Western Light Talents Training Program of the Chinese Academy of Science (to S.-A.L). The authors declare no conflicts of interest.	Akasaka Y, 2004, J PATHOL, V203, P710, DOI 10.1002/path.1574; Behm B, 2012, J EUR ACAD DERMATOL, V26, P812, DOI 10.1111/j.1468-3083.2011.04415.x; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Brown DL, 1997, SURGERY, V121, P372, DOI 10.1016/S0039-6060(97)90306-8; Bucker R, 2011, J INFECT DIS, V204, P1283, DOI 10.1093/infdis/jir504; Cubison TCS, 2006, BURNS, V32, P992, DOI 10.1016/j.burns.2006.02.007; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Gonzalez ACD, 2016, AN BRAS DERMATOL, V91, P614, DOI 10.1590/abd1806-4841.20164741; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Eldad A, 1998, BURNS, V24, P166, DOI 10.1016/S0305-4179(97)00086-7; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fascia DTM, 2009, J BONE JOINT SURG BR, V91B, P249, DOI 10.1302/0301-620X.91B2.21339; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Garbin Stefania, 1996, Wound Repair and Regeneration, V4, P244, DOI 10.1046/j.1524-475X.1996.40213.x; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Godwin JW, 2014, DIFFERENTIATION, V87, P66, DOI 10.1016/j.diff.2014.02.002; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; Haslam IS, 2014, BIOL REV, V89, P618, DOI 10.1111/brv.12072; He JC, 2008, INVEST OPHTH VIS SCI, V49, P2936, DOI 10.1167/iovs.07-0900; Hesketh M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071545; Hoying JB, 1996, J CELL PHYSIOL, V168, P294, DOI 10.1002/(SICI)1097-4652(199608)168:2<294::AID-JCP8>3.0.CO;2-K; Jeschke MG, 2004, GENE THER, V11, P847, DOI 10.1038/sj.gt.3302229; Kathju S, 2012, BIRTH DEFECTS RES C, V96, P223, DOI 10.1002/bdrc.21015; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Larjava H, 2011, J CAN DENT ASSOC, V77; Li SA, 2017, J INFECT DIS, V215, P1753, DOI 10.1093/infdis/jix183; Li SA, 2012, ANTIMICROB AGENTS CH, V56, P3309, DOI 10.1128/AAC.06304-11; Liu H, 2014, INT J BIOCHEM CELL B, V49, P32, DOI 10.1016/j.biocel.2014.01.010; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MEENAKSHI J, 2005, INDIAN J PLAST SURG, V38, P175; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukai K, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/910605; Nedrebo T, 1999, AM J PHYSIOL-HEART C, V277, pH1857, DOI 10.1152/ajpheart.1999.277.5.H1857; Oberyszyn TM, 2007, FRONT BIOSCI-LANDMRK, V12, P2993, DOI 10.2741/2289; Raymond M, 2012, AM J PHYSIOL-GASTR L, V303, pG1270, DOI 10.1152/ajpgi.00458.2011; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; Tandara AA, 2008, J PLAST RECONSTR AES, V61, P1219, DOI 10.1016/j.bjps.2008.03.022; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang P., 2017, ACM COMPUT SURV, V1, P1; Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xiang Y, 2014, P NATL ACAD SCI USA, V111, P6702, DOI 10.1073/pnas.1321317111; Yan CX, 2016, AM J PATHOL, V186, P1466, DOI 10.1016/j.ajpath.2016.01.019; Zhang Yun, 2015, Zoological Research, V36, P183, DOI 10.13918/j.issn.2095-8137.2015.4.183	54	18	18	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					782	795		10.1096/fj.201800087R	http://dx.doi.org/10.1096/fj.201800087R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30063438	Bronze			2022-12-28	WOS:000457401500061
J	Huynh, NPT; Zhang, B; Guilak, F				Huynh, Nguyen P. T.; Zhang, Bo; Guilak, Farshid			High-depth transcriptomic profiling reveals the temporal gene signature of human mesenchymal stem cells during chondrogenesis	FASEB JOURNAL			English	Article						RNA-Seq; chondrocyte; pericyte; lncRNA; miRNA	TISSUE-ENGINEERED CARTILAGE; MICRORNA TARGET PREDICTION; IN-VITRO CULTURE; FUNCTIONAL-CHARACTERIZATION; RNA-SEQ; DIFFERENTIATION; MATRIX; SOX9; OSTEOARTHRITIS; CHONDROCYTES	Mesenchymal stem/stromal cells (MSCs) provide an attractive cell source for cartilage repair and cell therapy; however, the underlying molecular pathways that drive chondrogenesis of these populations of adult stem cells remain poorly understood. We generated a rich data set of high-throughput RNA sequencing of human MSCs throughout chondrogenesis at 6 different time points. Our data consisted of 18 libraries with 3 individual donors as biologic replicates, with each library possessing a sequencing depth of 100 million reads. Computational analyses with differential gene expression, gene ontology, and weighted gene correlation network analysis identified dynamic changes in multiple biologic pathways and, most importantly, a chondrogenic gene subset, whose functional characterization promises to further harness the potential of MSCs for cartilage tissue engineering. Furthermore, we created a graphic user interface encyclopedia built with the goal of producing an open resource of transcriptomic regulation for additional data mining and pathway analysis of the process of MSC chondrogenesis.Huynh, N. P. T., Zhang, B., Guilak, F. High-depth transcriptomic profiling reveals the temporal gene signature of human mesenchymal stem cells during chondrogenesis.	[Huynh, Nguyen P. T.; Guilak, Farshid] Washington Univ, Dept Orthoped Surg, St Louis, MO USA; [Huynh, Nguyen P. T.; Zhang, Bo; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO USA; [Huynh, Nguyen P. T.; Guilak, Farshid] Shriners Hosp Children, St Louis, MO USA; [Huynh, Nguyen P. T.] Duke Univ, Dept Cell Biol, Durham, NC USA	Washington University (WUSTL); Washington University (WUSTL); Duke University	Guilak, F (corresponding author), Washington Univ, 4515 McKinley Ave, St Louis, MO 63110 USA.	guilak@wustl.edu	Zhang, Bo/A-6874-2011	Zhang, Bo/0000-0003-2962-5314	Duke University Genomics Core Facility; Washington University in St. Louis Pathology Core Labs; Washington University Center of Regenerative Medicine; Arthritis Foundation; U.S. National Institutes of Health (NIH) [AR50245, AR48852, AG15768, AR48182, AR067467]; Nancy Taylor Foundation for Chronic Diseases; Collaborative Research Center of the AO Foundation, Davos, Switzerland; Washington University Musculoskeletal Research Center (NIH) [P30 AR057235]; NIH [DA027995]; Goldman Sachs Philanthropy Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR067467, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	Duke University Genomics Core Facility; Washington University in St. Louis Pathology Core Labs; Washington University Center of Regenerative Medicine; Arthritis Foundation; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Taylor Foundation for Chronic Diseases; Collaborative Research Center of the AO Foundation, Davos, Switzerland; Washington University Musculoskeletal Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldman Sachs Philanthropy Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Duke University Genomics Core Facility, the Washington University in St. Louis Pathology Core Labs, and the Washington University Center of Regenerative Medicine for their resources and support. The authors also wish to thank S. Oswald (Washington University in St. Louis) for assistance with technical writing. This work was supported by the Arthritis Foundation, U.S. National Institutes of Health (NIH) Grants AR50245, AR48852, AG15768, AR48182, and AR067467, the Nancy Taylor Foundation for Chronic Diseases, the Collaborative Research Center of the AO Foundation, Davos, Switzerland, and the Washington University Musculoskeletal Research Center (NIH P30 AR057235). B.Z. was supported by NIH grant DA027995 and the Goldman Sachs Philanthropy Fund. The authors declare no conflicts of interest.	Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]; Ahmed TAE, 2014, HISTOL HISTOPATHOL, V29, P669, DOI 10.14670/HH-29.669; ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B; Backesjo CM, 2009, CELLS TISSUES ORGANS, V189, P93, DOI 10.1159/000151744; Baker BM, 2010, BIOMATERIALS, V31, P6190, DOI 10.1016/j.biomaterials.2010.04.036; Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649; Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bhaskar B, 2014, CURR STEM CELL RES T, V9, P508, DOI 10.2174/1574888X09666140812112002; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110; Brunger JM, 2014, P NATL ACAD SCI USA, V111, pE798, DOI 10.1073/pnas.1321744111; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Chang W., 2017, SHINY WEB APPL FRAME; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hagmann S, 2013, CELL PROLIFERAT, V46, P396, DOI 10.1111/cpr.12046; Hall B.K., 2015, BONES AND CARTILAGE, VSecond; Hicks MR, 2018, NAT CELL BIOL, V20, P46, DOI 10.1038/s41556-017-0010-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh NPT, 2017, CONNECT TISSUE RES, V58, P116, DOI 10.1080/03008207.2016.1194406; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Ionescu A, 2012, DEV CELL, V22, P927, DOI 10.1016/j.devcel.2012.03.011; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; King BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157106; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Kwong FNK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2436; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee W, 2017, CURR TOP MEMBR, V79, P263, DOI 10.1016/bs.ctm.2016.10.003; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Mansson R, 2004, J BIOL CHEM, V279, P17905, DOI 10.1074/jbc.M400589200; Mareschi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/920581; Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021; Moutos FT, 2016, P NATL ACAD SCI USA, V113, pE4513, DOI 10.1073/pnas.1601639113; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Ng JJ, 2017, P NATL ACAD SCI USA, V114, P2556, DOI 10.1073/pnas.1611771114; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Posel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050293; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Somoza RA, 2018, TISSUE ENG PT A, V24, P335, DOI [10.1089/ten.tea.2016.0559, 10.1089/ten.TEA.2016.0559]; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5232; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	79	20	20	4	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					358	372		10.1096/fj.201800534R	http://dx.doi.org/10.1096/fj.201800534R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29985644	Green Published			2022-12-28	WOS:000457401500029
J	Shao, LL; Chen, Z; Soutto, M; Zhu, SM; Lu, H; Romero-Gallo, J; Peek, R; Zhang, ST; El-Rifai, W				Shao, Linlin; Chen, Zheng; Soutto, Mohammed; Zhu, Shoumin; Lu, Heng; Romero-Gallo, Judith; Peek, Richard; Zhang, Shutian; El-Rifai, Wael			Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer	FASEB JOURNAL			English	Article						microRNA; tff1 knockout; inflammation; KLF4; H; pylori	NF-KAPPA-B; CELL-PROLIFERATION; DOWN-REGULATION; EXPRESSION; PROTEIN; TUMORIGENESIS; MIRNAS; CHEMORESISTANCE; INFLAMMATION; ACTIVATION	Helicobacter pylori infection is a major risk factor for the development of gastric cancer. Aberrant expression of microRNAs is strongly implicated in gastric tumorigenesis; however, their contribution in response to H. pylori infection has not been fully elucidated. In this study, we evaluated the expression of miR-135b-5p and its role in gastric cancer. We describe the overexpression of miR-135b-5p in human gastric cancer tissue samples compared with normal tissue samples. Furthermore, we found that miR-135b-5p is also up-regulated in gastric tumors from the trefoil factor 1-knockout mouse model. Infection with H. pylori induced the expression of miR-135b-5p in the in vitro and in vivo models. miR-135b-5p induction was mediated by NF-B. Treatment of gastric cancer cells with TNF- induced miR-135b-5p in a NF-B-dependent manner. Mechanistically, we found that miR-135b-5p targets Kruppel-like factor 4 (KLF4) and binds to its 3 UTR, leading to reduced KLF4 expression. Functionally, high levels of miR-135b-5p suppress apoptosis and induce cisplatin resistance. Our results uncovered a mechanistic link between H. pylori infection and miR-135b-5p-KLF4, suggesting that targeting miR-135b-5p could be a potential therapeutic approach to circumvent resistance to cisplatin.Shao, L., Chen, Z., Soutto, M., Zhu, S., Lu, H., Romero-Gallo, J., Peek, R., Zhang, S., El-Rifai, W. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.	[Shao, Linlin; Zhang, Shutian] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Shao, Linlin; Chen, Zheng; Soutto, Mohammed; El-Rifai, Wael] Miami Healthcare Syst, Dept Vet Affairs, Miami, FL USA; [Chen, Zheng; Zhu, Shoumin; Lu, Heng; El-Rifai, Wael] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Surg, Miami, FL USA; [Romero-Gallo, Judith; Peek, Richard] Vanderbilt Univ, Med Ctr, Div Gastroenterol Hematol & Nutr, Nashville, TN USA	Capital Medical University; University of Miami; Vanderbilt University	Zhang, ST (corresponding author), Capital Med Univ, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 10050, Peoples R China.; El-Rifai, W (corresponding author), Univ Miami, Miller Sch Med, 1600 NW 10th Ave, Miami, FL 33136 USA.	zhangshutian@ccmu.edu.cn; wxe45@miami.edu	Shao, Linlin/AAW-4439-2021		U.S. National Institutes of Health, National Cancer Institute [R01CA93999, R01CA177372]; U.S. Department of Veterans Affairs [1IK6BX003787, I01BX001179]; Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center, University of Miami; NATIONAL CANCER INSTITUTE [P01CA116087, R01CA077955, R01CA093999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX003787, I01BX001179] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center, University of Miami; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the U.S. National Institutes of Health, National Cancer Institute (R01CA93999 and R01CA177372), a Research Career Scientist Award (1IK6BX003787), and a merit award (I01BX001179) from the U.S. Department of Veterans Affairs (to W.E.-R.). The results were also supported by the Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center, University of Miami. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Veterans Affairs, the U.S. National Institutes of Health, or the University of Miami. The authors declare no conflicts of interest.	Bagheri V, 2018, J CELL PHYSIOL, V233, P2791, DOI 10.1002/jcp.25822; BATESON MC, 1994, GUT, V35, P716, DOI 10.1136/gut.35.5.716; Chen GD, 2017, BIOCHEM BIOPH RES CO, V484, P311, DOI 10.1016/j.bbrc.2017.01.110; Chen HF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6439864; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Darnet S, 2015, BIOINFORM BIOL INSIG, V9, P1, DOI 10.4137/BBI.S23773; Dou L, 2017, CELL PHYSIOL BIOCHEM, V41, P2419, DOI 10.1159/000475912; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Floris I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140488; Gao SG, 2016, TUMOR BIOL, V37, P9411, DOI 10.1007/s13277-016-4824-5; GATELY DP, 1993, BRIT J CANCER, V67, P1171, DOI 10.1038/bjc.1993.221; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Hamajima Nobuyuki, 2002, Asian Pac J Cancer Prev, V3, P23; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto I, 2017, ONCOL LETT, V13, P819, DOI 10.3892/ol.2016.5499; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huan YW, 2015, ONCOL REP, V34, P843, DOI 10.3892/or.2015.4007; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kwon OH, 2014, INT J ONCOL, V44, P583, DOI 10.3892/ijo.2013.2211; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Lin CC, 2011, MOL CELL BIOL, V31, P2513, DOI 10.1128/MCB.01189-10; Liu B, 2017, MOL CARCINOGEN, V56, P2669, DOI 10.1002/mc.22710; Liu L, 2017, ONCOGENE, V36, P5874, DOI 10.1038/onc.2017.193; Liu SG, 2016, ONCOL RES, V24, P81, DOI 10.3727/096504016X14597766487717; Lu MD, 2018, INT J ONCOL, V52, P589, DOI 10.3892/ijo.2017.4222; Ma ZH, 2015, INT J CLIN EXP PATHO, V8, P5071; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Mo DL, 2016, CANCER RES, V76, P3057, DOI 10.1158/0008-5472.CAN-15-2361; Moss SF, 2017, CELL MOL GASTROENTER, V3, P183, DOI 10.1016/j.jcmgh.2016.12.001; Nezu Y, 2016, ONCOGENE, V35, P6177, DOI 10.1038/onc.2016.157; Noto JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00021; O'Brien DP, 2008, J BIOL CHEM, V283, P23922, DOI 10.1074/jbc.M801144200; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Rad R, 2002, J IMMUNOL, V168, P3033, DOI 10.4049/jimmunol.168.6.3033; Rinnerthaler G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020156; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Smale S. T., 2010, COLD SPRING HARB PRO, V5, P5423, DOI DOI 10.1101/PDB.PROT5423; Soutto M, 2015, CANCER-AM CANCER SOC, V121, P4348, DOI 10.1002/cncr.29644; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Su WM, 2016, BIOMED PHARMACOTHER, V84, P123, DOI 10.1016/j.biopha.2016.09.027; Tanida S., 2012, INT J SURG ONCOL, V2012, DOI [10.1155/2012/862879, DOI 10.1155/2012/862879]; Rossi AFT, 2016, CELL MICROBIOL, V18, P1444, DOI 10.1111/cmi.12587; Tse MCL, 2017, DIABETES, V66, P1858, DOI 10.2337/db16-0270; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; Xu ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12276; Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305; Yan C, 2015, BIOCHEM BIOPH RES CO, V467, P913, DOI 10.1016/j.bbrc.2015.10.044; Yang LF, 2017, TOXICOLOGY, V389, P74, DOI 10.1016/j.tox.2017.07.010; Yu YH, 2017, BIOCHEM BIOPH RES CO, V491, P478, DOI 10.1016/j.bbrc.2017.07.021; Zhao LM, 2017, FASEB J, V31, P893, DOI 10.1096/fj.201600994R; Zheng J., 2017, INT J MOL SCI, V18, pE910; Zhu SM, 2017, GUT, V66, P802, DOI 10.1136/gutjnl-2016-312141	57	45	48	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					264	274		10.1096/fj.201701456RR	http://dx.doi.org/10.1096/fj.201701456RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29985646	Green Published			2022-12-28	WOS:000457401500022
J	Xiao, L; Yang, XY; Sharma, VK; Loh, YP				Xiao, Lan; Yang, Xuyu; Sharma, Vinay Kumar; Loh, Y. Peng			Cloning, gene regulation, and neuronal proliferation functions of novel N-terminal-truncated carboxypeptidase E/neurotrophic factor-l variants in embryonic mouse brain	FASEB JOURNAL			English	Article						neurodevelopment; insulin-like growth factor binding protein 2; death associated protein-1; ephrin A1	NEUROTROPHIC FACTOR-ALPHA-1; INSULIN; PROTEIN; IDENTIFICATION; EXPRESSION; GROWTH; DIFFERENTIATION; DEGENERATION; ENDOCRINE; SEQUENCE	Carboxypeptidase E (CPE), an exopeptidase involved in proneuropeptide processing, is also a neurotrophic factor, named neurotrophic factor-1 (NF-1) and has important roles in neuroprotection, stem cell differentiation, and neurite outgrowth, independent of enzymatic activity. Additionally, an N-terminal-truncated CPE/NF-1 variant, (CPE/NF-1)-N, proposed from bioinformatic analysis of GenBank (National Center for Biotechnology Information, Bethesda, MD, USA) DNA sequences and encoding a 40-kDa protein, has been found to be exclusively expressed in embryonic neurons. To investigate the function of (CPE/NF-1)-N in neurodevelopment, we first cloned (CPE/NF-1)-N transcripts from an embryonic mouse brain. A rapid amplification of cDNA ends assay, DNA sequencing, and Northern blot revealed 1.9- and 1.73-kb transcripts, which encoded 47- and 40-kDa (CPE/NF-1)-N proteins, respectively. Those proteins were expressed in embryonic mouse brain. Expression of the 2 (CPE/NF-1)-N mRNAs surged at embryonic d 10.5, correlating with the time of neurogenesis in the developing brain and also at postnatal d 1. HT22 cells, a mouse hippocampal cell line, transduced with 40 kDa (CPE/NF-1)-N up-regulated expression of genes involved in embryonic neurodevelopment: insulin-like growth factor binding protein 2 (IGFBP2), death-associated protein 1, and ephrin A1, which regulate proliferation, programmed cell death, and neuronal migration, respectively. HT22 cells and embryonic cortical neurons overexpressing 40 kDa (CPE/NF-1)-N exhibited enhanced proliferation, which was inhibited by IGFBP2 short interfering RNA treatment. Thus, 40 kDa (CPE/NF-1)-N has an important, enzymatically independent role in the regulation of genes critical for neurodevelopment.Xiao, L., Yang, X., Sharma, V. K., Loh, Y. P. Cloning, gene regulation, and neuronal proliferation functions of novel N-terminal-truncated carboxypeptidase E/neurotrophic factor-l variants in embryonic mouse brain.	[Xiao, Lan; Yang, Xuyu; Sharma, Vinay Kumar; Loh, Y. Peng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Neurobiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Loh, YP (corresponding author), NICHD, Sect Cellular Neurobiol, NIH, 49 Convent Dr,Bldg 49,Room 6A-10, Bethesda, MD 20892 USA.	lohp@mail.nih.gov	Sharma, Vinay/AGF-1733-2022	Sharma, Vinay/0000-0002-8416-1922	Intramural Research Program of the Eunice Kennedy Shriver NICHD, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Constantine Stratakis [National Institute of Child Health and Human Development (NICHD)/U.S. National Institiutes of Health (NIH), Bethesda, MD, USA] for critical reading of the manuscript and Dr. Vincent Schram (NICHD Microscopy Core Facility) for his assistance in the confocal microscopy. This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, NIH. The authors declare no conflicts of interest.	AIZENMAN Y, 1987, BRAIN RES, V406, P32, DOI 10.1016/0006-8993(87)90766-9; Alsters SIM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131417; [Anonymous], 1995, METH NEUROSCI; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Chen YX, 2014, NEUROSCI BULL, V30, P282, DOI 10.1007/s12264-013-1408-x; Cheng Y, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.237; Cheng Y, 2015, MOL PSYCHIATR, V20, P744, DOI 10.1038/mp.2014.136; Cheng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071578; Cong L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170169; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Deng YJ, 2017, J NEURORESTORATOLOGY, V5, P143, DOI 10.2147/JN.S134363; Fan SL, 2016, ONCOTARGETS THER, V9, P2795, DOI 10.2147/OTT.S98991; FEINSTEIN E, 1995, GENOMICS, V29, P305, DOI 10.1006/geno.1995.1255; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; Jin KL, 2001, J CEREBR BLOOD F MET, V21, P1422, DOI 10.1097/00004647-200112000-00006; Koren I, 2010, CURR BIOL, V20, P1093, DOI 10.1016/j.cub.2010.04.041; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lee TK, 2011, J CLIN INVEST, V121, P880, DOI 10.1172/JCI40433; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; MANSER E, 1990, BIOCHEM J, V267, P517, DOI 10.1042/bj2670517; Mendes KN, 2010, INT J ONCOL, V37, P143, DOI 10.3892/ijo_00000662; Milanesi E., 2017, WORLD J BIOL PSYCHIA; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; OCRANT I, 1991, ADV EXP MED BIOL, V293, P471; OCRANT I, 1990, ENDOCRINOLOGY, V127, P1260, DOI 10.1210/endo-127-3-1260; Qin XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112996; RODRIGUEZ C, 1989, J BIOL CHEM, V264, P5988; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Selvaraj P, 2017, STEM CELLS, V35, P557, DOI 10.1002/stem.2511; Selvaraj P, 2015, MOL CELL NEUROSCI, V68, P222, DOI 10.1016/j.mcn.2015.08.005; Sun J, 2016, ONCOL LETT, V12, P4659, DOI 10.3892/ol.2016.5283; Thouennon E, 2015, J NEUROCHEM, V134, P463, DOI 10.1111/jnc.13152; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; van den Ameele J, 2014, TRENDS NEUROSCI, V37, P334, DOI 10.1016/j.tins.2014.03.005; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Yang X., 2017, AACR ANN M 2017 WASH; Zhou A, 2004, J CEREBR BLOOD F MET, V24, P612, DOI 10.1097/01.WCB.0000118959.03453.17; Zhu XM, 2005, J NEUROCHEM, V95, P1351, DOI 10.1111/j.1471-4159.2005.03460.x; Ziegenfuss JS, 2012, NAT NEUROSCI, V15, P979, DOI 10.1038/nn.3135	41	5	6	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					808	820		10.1096/fj.201800359R	http://dx.doi.org/10.1096/fj.201800359R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30063439	Green Published, Bronze			2022-12-28	WOS:000457401500063
J	Yang, C; Ma, X; Guan, G; Liu, H; Yang, YL; Niu, QH; Wu, ZH; Jiang, YP; Bian, C; Zang, YJ; Zhuang, LK				Yang, Chao; Ma, Xiang; Guan, Ge; Liu, Huan; Yang, Yuling; Niu, Qinghui; Wu, Zehua; Jiang, Yueping; Bian, Cheng; Zang, Yunjin; Zhuang, Likun			MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma	FASEB JOURNAL			English	Article						miR-766; HCC; -catenin; proliferation; metastasis	METASTASIS; BIOMARKER; GROWTH; CELLS; ACTS	MicroRNAs (miRNAs) have been reported to play important roles in tumor progression of various cancers. However, the clinical significance and biologic function of miR-766 in hepatocellular carcinoma (HCC) remain unknown. In this study, we investigated the roles of miR-766 in HCC progression using HCC cell lines and a xenograft mouse model. miR-766 expression in tumor tissues and adjacent nontumorous liver tissues of patients with HCC was evaluated by quantitative RT-PCR. Our results showed that miR-766 promoted proliferation and metastasis of HCC cells in vitro and in vivo and that NR3C2 was a direct target of miR-766 and involved in miR-766-mediated proliferation and metastasis of HCC cells. We also found that miR-766 affected the -catenin signaling pathway by targeting NR3C2. Furthermore, miR-766 was significantly up-regulated in HCC tissues and was correlated with the prognosis of patients with liver cancer. Taken together, our results show that miR-766 affects HCC progression by modulating NR3C2 expression and is a possible new therapeutic target for patients with HCC.Yang, C., Ma, X., Guan, G., Liu, H., Yang, Y., Niu, Q., Wu, Z., Jiang, Y., Bian, C., Zang, Y., Zhuang, L. MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma.	[Yang, Chao; Yang, Yuling; Niu, Qinghui; Jiang, Yueping; Bian, Cheng] Qingdao Univ, Affiliated Hosp, Dept Infect Dis, Qingdao, Peoples R China; [Ma, Xiang; Wu, Zehua] Qingdao Univ, Affiliated Hosp, Dept Hepatobiliary & Pancreat Surg, Qingdao, Peoples R China; [Guan, Ge; Zang, Yunjin] Qingdao Univ, Affiliated Hosp, Organ Transplantat Ctr, Qingdao, Peoples R China; [Liu, Huan; Zang, Yunjin; Zhuang, Likun] Qingdao Univ, Affiliated Hosp, Inst Transplantat Sci, 16 Jiangsu Rd, Qingdao 266003, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University	Zhuang, LK (corresponding author), Qingdao Univ, Affiliated Hosp, Inst Transplantat Sci, 16 Jiangsu Rd, Qingdao 266003, Peoples R China.	zlk0823@163.com		Zhuang, Likun/0000-0003-3002-2406	National Natural Science Foundation of China [81501812]; Natural Science Foundation of Shandong Province [BS2015SW013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China Grant 81501812 (to L.Z.), and Natural Science Foundation of Shandong Province Grant BS2015SW013 (to L.Z.).	Afgar A, 2016, CANCER BIOL THER, V17, P1126, DOI 10.1080/15384047.2016.1235657; Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Bao X, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.31; Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821; Chen C, 2017, INT J CANCER, V141, P1867, DOI 10.1002/ijc.30853; Das R, 2017, CANCER RES, V77, P1021, DOI 10.1158/0008-5472.CAN-16-2529; HORISBERGER JD, 1992, HYPERTENSION, V19, P221, DOI 10.1161/01.HYP.19.3.221; Jin XC, 2017, CLIN CANCER RES, V23, P5311, DOI 10.1158/1078-0432.CCR-17-0577; Lee HA, 2013, CIRC RES, V112, P1004, DOI 10.1161/CIRCRESAHA.113.301071; Li C, 2018, INT J ONCOL, V52, P536, DOI 10.3892/ijo.2017.4224; Li YC, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S89459; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Ma X, 2017, THER ADV MED ONCOL, V9, P665, DOI 10.1177/1758834017731052; Ma X, 2016, ANTICANCER RES, V36, P6389, DOI 10.21873/anticanres.11236; Mathiyalagan P, 2017, METHODS MOL BIOL, V1521, P139, DOI 10.1007/978-1-4939-6588-5_9; Morise Z, 2014, FRONT SURG, V1, DOI 10.3389/fsurg.2014.00021; Sethi S, 2018, CLIN LAB MED, V38, P237, DOI 10.1016/j.cll.2018.02.003; Stoica L, 2016, ANN NEUROL, V79, P687, DOI 10.1002/ana.24618; Sun MM, 2017, CANCER SCI, V108, P267, DOI 10.1111/cas.13128; Yang SH, 2016, CANCER RES, V76, P3838, DOI 10.1158/0008-5472.CAN-15-2841; Zhan MN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.440; Zhao ZJ, 2018, J CELL PHYSIOL, V233, P6825, DOI 10.1002/jcp.26550; Zhuang LK, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.100; Zhuang LK, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.216; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	25	35	35	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1456	1467		10.1096/fj.201801151R	http://dx.doi.org/10.1096/fj.201801151R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130435				2022-12-28	WOS:000457401500114
J	Coveney, CR; Collins, I; Mc Fie, M; Chanalaris, A; Yamamoto, K; Wann, AKT				Coveney, Clarissa R.; Collins, Isabella; Mc Fie, Megan; Chanalaris, Anastasios; Yamamoto, Kazuhiro; Wann, Angus K. T.			Cilia protein IFT88 regulates extracellular protease activity by optimizing LRP-1-mediated endocytosis	FASEB JOURNAL			English	Article						primary cilium; chondrocyte; cartilage; matrix; osteoarthritis	RECEPTOR-RELATED PROTEIN-1; ARTICULAR CHONDROCYTES; OSTEOARTHRITIC CARTILAGE; KIDNEY-DISEASE; ADAMTS-5; DEGRADATION; CLEARANCE; POLARIS; METALLOPROTEINASE; ORIENTATION	Matrix protease activity is fundamental to developmental tissue patterning and remains influential in adult homeostasis. In cartilage, the principal matrix proteoglycan is aggrecan, the protease-mediated catabolism of which defines arthritis; however, the pathophysiologic mechanisms that drive aberrant aggrecanolytic activity remain unclear. Human ciliopathies exhibit altered matrix, which has been proposed to be the result of dysregulated hedgehog signaling that is tuned within the primary cilium. Here, we report that disruption of intraflagellar transport protein 88 (IFT88), a core ciliary trafficking protein, increases chondrocyte aggrecanase activity in vitro. We find that the receptor for protease endocytosis in chondrocytes, LDL receptor-related protein 1 (LRP-1), is unevenly distributed over the cell membrane, often concentrated at the site of cilia assembly. Hypomorphic mutation of IFT88 disturbs this apparent hot spot for protease uptake, increases receptor shedding, and results in a reduced rate of protease clearance from the extracellular space. We propose that IFT88 and/or the cilium regulates the extracellular remodeling of matrixindependently of Hedgehog regulationby enabling rapid LRP-1-mediated endocytosis of proteases, potentially by supporting the creation of a ciliary pocket. This result highlights new roles for the cilium's machinery in matrix turnover and LRP-1 function, with potential relevance in a range of diseases.Coveney, C. R., Collins, I., Mc Fie, M., Chanalaris, A., Yamamoto, K., Wann, A. K. T. Cilia protein IFT88 regulates extracellular protease activity by optimizing LRP-1-mediated endocytosis.	[Coveney, Clarissa R.; Collins, Isabella; Mc Fie, Megan; Chanalaris, Anastasios; Yamamoto, Kazuhiro; Wann, Angus K. T.] Univ Oxford, Kennedy Inst, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Arthrit Res UK Ctr Osteoarthrit Pathogenesis, Oxford, England; [Yamamoto, Kazuhiro] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England	University of Oxford; University of Liverpool	Wann, AKT (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.	angus.wann@kennedy.ox.ac.uk	Yamamoto, Kazuhiro/AAD-9650-2019	Chanalaris, Anastasios/0000-0002-8884-6750	Arthritis Research United Kingdom (ARUK) Centre for Osteoarthritis Pathogenesis [20205]; Kennedy Trust for Rheumatology Research (KTRR) Prize Studentship; ARUK studentship [21546]; ARUK grant [20887]; ARUK Career Development Fellowship [21447]; KTRR/ARUK Career Development Fellowship	Arthritis Research United Kingdom (ARUK) Centre for Osteoarthritis Pathogenesis; Kennedy Trust for Rheumatology Research (KTRR) Prize Studentship; ARUK studentship; ARUK grant; ARUK Career Development Fellowship; KTRR/ARUK Career Development Fellowship	The authors thank the Oxford Musculoskeletal Biobank (University of Oxford) forproviding human cartilage samples; and Hideaki Nagase, Yoshi Itoh, Linda Troeberg, Heba Ismail, and Tonia Vincent (University of Oxford) for providing key reagents, Abs, and critical comments throughout the development of this manuscript. This work was supported by the Arthritis Research United Kingdom (ARUK) Centre for Osteoarthritis Pathogenesis (Grant 20205), including a small project initiative awarded to A.K.T.W. and K.Y. that supported M.M.F.; a Kennedy Trust for Rheumatology Research (KTRR) Prize Studentship supporting C.R.C.; and an ARUK studentship awarded to A.K.T.W. (Grant 21546, supporting I.C.), and ARUK grant (Grant 20887) awarded to Linda Troeberg (supporting A.C.), an ARUK Career Development Fellowship (Grant 21447, supporting K.Y.), and a KTRR/ARUK Career Development Fellowship supporting A.K.T.W. The authors declare no conflicts of interest.	Absalon S, 2008, J CELL SCI, V121, P3704, DOI 10.1242/jcs.035626; Ali SA, 2016, ARTHRITIS RHEUMATOL, V68, P127, DOI 10.1002/art.39337; Bangs F, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028175; Boehlke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140378; Borovina A, 2013, CELL REP, V5, P37, DOI 10.1016/j.celrep.2013.08.043; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Christi A, 2015, DEV CELL, V35, P36, DOI 10.1016/j.devcel.2015.09.001; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Finetti F, 2011, TRENDS IMMUNOL, V32, P139, DOI 10.1016/j.it.2011.02.001; Galgano D, 2017, J CELL SCI, V130, P1110, DOI 10.1242/jcs.200006; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Gooz MB, 2014, AM J PHYSIOL-RENAL, V307, pF551, DOI 10.1152/ajprenal.00218.2014; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Hashimoto K, 2006, INFLAMM RES, V55, P72, DOI 10.1007/s00011-005-0012-6; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Ismail HM, 2015, ARTHRITIS RHEUMATOL, V67, P1826, DOI 10.1002/art.39099; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Kanai Y, 2014, J CELL BIOL, V204, P395, DOI 10.1083/jcb.201309066; Kaushik AP, 2009, J ORTHOP RES, V27, P1093, DOI 10.1002/jor.20855; Kobayashi H, 2013, J BIOL CHEM, V288, P28620, DOI 10.1074/jbc.M113.452169; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; McGlashan SR, 2007, MATRIX BIOL, V26, P234, DOI 10.1016/j.matbio.2006.12.003; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/00041552-200309000-00006; Rattner JB, 2010, HISTOL HISTOPATHOL, V25, P865, DOI 10.14670/HH-25.865; Rich DR, 2012, OSTEOARTHR CARTILAGE, V20, P923, DOI 10.1016/j.joca.2012.04.017; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schou KB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14177; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Stinchcombe JC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0463; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Thompson CL, 2017, EUR CELLS MATER, V34, P128, DOI 10.22203/eCM.v034a09; Thompson CL, 2014, OSTEOARTHR CARTILAGE, V22, P490, DOI 10.1016/j.joca.2013.12.016; Thompson CL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0891-z; Wann AKT, 2014, CELL SIGNAL, V26, P1735, DOI 10.1016/j.cellsig.2014.04.004; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649; Wann Angus Kt, 2013, Cilia, V2, P17, DOI 10.1186/2046-2530-2-17; Yamamoto K, 2017, ARTHRITIS RHEUMATOL, V69, P1246, DOI 10.1002/art.40080; Yamamoto K, 2016, MATRIX BIOL, V56, P57, DOI 10.1016/j.matbio.2016.03.007; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yuan XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144773; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	61	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6771	6782		10.1096/fj.201800334	http://dx.doi.org/10.1096/fj.201800334			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29920219	Green Published, hybrid			2022-12-28	WOS:000449359700032
J	Tzeng, SF; Tsai, CH; Chao, TK; Chou, YC; Yang, YC; Tsai, MH; Cha, TL; Hsiao, PW				Tzeng, Sheue-Fen; Tsai, Chin-Hsien; Chao, Tai-Kuang; Chou, Yu-Ching; Yang, Yu-Chih; Tsai, Mong-Hsun; Cha, Tai-Lung; Hsiao, Pei-Wen			O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer	FASEB JOURNAL			English	Article						galectin-4; stemness; oncofetal glycan; orthotopic model	THOMSEN-FRIEDENREICH ANTIGEN; PHASE-II; C-MYC; EXPRESSION; BREAST; CELLS; COLON; ADHESION; OVEREXPRESSION; ABIRATERONE	Disseminated castration-resistant prostate cancer (CRPC) is a common disease in men that is characterized by limited survival and resistance to androgen-deprivation therapy. The increase in human epidermal growth factor receptor 2 (HER2) signaling contributes to androgen receptor activity in a subset of patients with CRPC; however, enigmatically, HER2-targeted therapies have demonstrated a lack of efficacy in patients with CRPC. Aberrant glycosylation is a hallmark of cancer and involves key processes that support cancer progression. Using transcriptomic analysis of prostate cancer data sets, histopathologic examination of clinical specimens, and in vivo experiments of xenograft models, we reveal in this study a coordinated increase in glycan-binding protein, galectin-4, specific glycosyltransferases of core 1 synthase, glycoprotein-N-acetylgalactosamine 3--galactosyltransferase 1 (C1GALT1) and ST3 -galactoside -2,3-sialyltransferase 1 (ST3GAL1), and resulting mucin-type O-glycans during the progression of CRPC. Furthermore, galectin-4 engaged with C1GALT1-dependent O-glycans to promote castration resistance and metastasis by activating receptor tyrosine kinase signaling and cancer cell stemness properties mediated by SRY-box 9 (SOX9). This galectin-glycan interaction up-regulated the MYC-dependent expression of C1GALT1 and ST3GAL1, which altered cellular mucin-type O-glycosylation to allow for galectin-4 binding. In clinical prostate cancer, high-level expression of C1GALT1 and galectin-4 together predict poor overall survival compared with low-level expression of C1GALT1 and galectin-4. In summary, MYC regulates abnormal O-glycosylation, thus priming cells for binding to galectin-4 and downstream signaling, which promotes castration resistance and metastasis.Tzeng, S.-F., Tsai, C.-H., Chao, T.-K., Chou, Y.-C., Yang, Y.-C., Tsai, M.-H., Cha, T.-L., Hsiao, P.-W. O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer.	[Tzeng, Sheue-Fen; Cha, Tai-Lung; Hsiao, Pei-Wen] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Tzeng, Sheue-Fen; Tsai, Chin-Hsien; Yang, Yu-Chih; Tsai, Mong-Hsun; Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Chao, Tai-Kuang] Triserv Gen Hosp, Dept Pathol, Natl Def Med Ctr, Taipei, Taiwan; [Cha, Tai-Lung] Triserv Gen Hosp, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Academia Sinica - Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University	Hsiao, PW (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan.	pwhsiao@gate.sinica.edu.tw			Ministry of Science and Technology (MOST) [104-2320-B-001-018, 106-2320-B-001-019]; Academia Sinica; ABRC [AS-100-CDA-L06]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Academia Sinica(Academia Sinica - Taiwan); ABRC	The authors thank the Laboratory Animal Core Facility [Agricultural Biotechnology Research Center (ABRC), Academia Sinica] for their services and Miranda Loney (editor, ABRC) for critical suggestions for editing this article. The authors thank the National RNAi Core Facility of Academia Sinica for the pLKO.1-shRNA constructions from the Taiwan Resource Center (TRC), and the Bioinformatics and Biostatistics Core, Center of Genomic Medicine, National Taiwan University, for technical support in bioinformatics analysis. This work was supported by the Ministry of Science and Technology (MOST; 104-2320-B-001-018 and 106-2320-B-001-019) and a Career Development grant from Academia Sinica and ABRC (AS-100-CDA-L06). The authors declare no conflicts of interest.	Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Anderson PD, 2012, J CLIN INVEST, V122, P1907, DOI 10.1172/JCI58540; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Broos S, 2013, NUCLEIC ACIDS RES, V41, pW531, DOI 10.1093/nar/gkt288; Buttigliero C, 2015, CANCER TREAT REV, V41, P884, DOI 10.1016/j.ctrv.2015.08.002; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen X, 2016, CLIN CANCER RES, V22, P4505, DOI 10.1158/1078-0432.CCR-15-2956; Chong YK, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv326; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; de Bono JS, 2007, J CLIN ONCOL, V25, P257, DOI 10.1200/JCO.2006.07.0888; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao S, 2016, CLIN CANCER RES, V22, P3672, DOI 10.1158/1078-0432.CCR-15-2309; Glinsky VV, 2001, CANCER RES, V61, P4851; Glinsky VV, 2003, CANCER RES, V63, P3805; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hung JS, 2014, ONCOTARGET, V5, P2096, DOI 10.18632/oncotarget.1815; Kaltz-Wittmer C, 2000, LAB INVEST, V80, P1455, DOI 10.1038/labinvest.3780152; Karsten U, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-301; Kinney AY, 1997, CANCER-AM CANCER SOC, V80, P2240, DOI 10.1002/(SICI)1097-0142(19971215)80:12<2240::AID-CNCR4>3.0.CO;2-Y; Kumamoto K, 2001, CANCER RES, V61, P4620; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Lin WM, 2011, INT J EXP PATHOL, V92, P97, DOI 10.1111/j.1365-2613.2010.00747.x; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Petrosyan A, 2014, MOL CANCER RES, V12, P1704, DOI 10.1158/1541-7786.MCR-14-0291-T; Reticker-Flynn NE, 2015, CANCER DISCOV, V5, P168, DOI 10.1158/2159-8290.CD-13-0760; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shukla S, 2017, CANCER CELL, V32, P792, DOI 10.1016/j.ccell.2017.10.008; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; Song K, 2015, J BIOL CHEM, V290, P20159, DOI 10.1074/jbc.M115.654483; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsai CH, 2016, CANCER RES, V76, P5756, DOI 10.1158/0008-5472.CAN-16-0641; Ulloa F, 2000, J BIOL CHEM, V275, P18785, DOI 10.1074/jbc.M000510200; Very N, 2018, ONCOTARGET, V9, P1380, DOI 10.18632/oncotarget.22377; Vidal SJ, 2015, CANCER CELL, V27, P223, DOI 10.1016/j.ccell.2014.11.013; Whang YE, 2013, UROL ONCOL-SEMIN ORI, V31, P82, DOI 10.1016/j.urolonc.2010.09.018; Yazawa EM, 2015, J INVEST DERMATOL, V135, P1849, DOI 10.1038/jid.2015.95; Yi B, 2013, ONCOL REP, V30, P1841, DOI 10.3892/or.2013.2639; Zhang SL, 1997, INT J CANCER, V73, P50, DOI 10.1002/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.3.CO;2-O; Ziada A, 2004, PROSTATE, V60, P332, DOI 10.1002/pros.20065	46	29	30	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6869	6882		10.1096/fj.201800687	http://dx.doi.org/10.1096/fj.201800687			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906246	Bronze			2022-12-28	WOS:000449359700040
J	Xu, X; Huang, EP; Luo, BY; Cai, DP; Zhao, X; Luo, Q; Jin, YL; Chen, L; Wang, Q; Liu, C; Lin, ZM; Xie, WB; Wang, HJ				Xu, Xiang; Huang, Enping; Luo, Baoying; Cai, Dunpeng; Zhao, Xu; Luo, Qin; Jin, Yili; Chen, Ling; Wang, Qi; Liu, Chao; Lin, Zhoumeng; Xie, Wei-Bing; Wang, Huijun			Methamphetamine exposure triggers apoptosis and autophagy in neuronal cells by activating the C/EBP-related signaling pathway	FASEB JOURNAL			English	Article						neurotoxicity; ER Stress; C; EBP; IGFBP5 signaling axis; C; EBP; Trib3 signaling axis	CCAAT/ENHANCER-BINDING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; DOPAMINERGIC-NEURONS; MEDIATED REGULATION; EPITHELIAL-CELLS; GLIOMA-CELLS; DEATH; BETA; INSULIN	Methamphetamine (Meth) is a widely abused psychoactive drug that primarily damages the nervous system, notably causing dopaminergic neuronal apoptosis. CCAAT-enhancer binding protein (C/EBP) is a transcription factor and an important regulator of cell apoptosis and autophagy. Insulin-like growth factor binding protein (IGFBP5) is a proapoptotic factor that mediates Meth-induced neuronal apoptosis, and Trib3 (tribbles pseudokinase 3) is an endoplasmic reticulum (ER) stress-inducible gene involved in autophagic cell death through the mammalian target of rapamycin (mTOR) signaling pathway. To test the hypothesis that C/EBP is involved in Meth-induced IGFBP5-mediated neuronal apoptosis and Trib3-mediated neuronal autophagy, we measured the protein expression of C/EBP after Meth exposure and evaluated the effects of silencing C/EBP, IGFBP5, or Trib3 on Meth-induced apoptosis and autophagy in neuronal cells and in the rat striatum after intrastriatal Meth injection. We found that, at relatively high doses, Meth exposure increased C/EBP protein expression, which was accompanied by increased neuronal apoptosis and autophagy; triggered the IGFBP5-mediated, p53-up-regulated modulator of apoptosis (PUMA)-related mitochondrial apoptotic signaling pathway; and stimulated the Trib3-mediated ER stress signaling pathway through the Akt-mTOR signaling axis. We also found that autophagy is an early response to Meth-induced stress upstream of apoptosis and plays a detrimental role in Meth-induced neuronal cell death. These results suggest that Meth exposure induces C/EBP expression, which plays an essential role in the neuronal apoptosis and autophagy induced by relatively high doses of Meth; however, relatively low concentrations of Meth did not change the expression of C/EBP in vitro. Further studies are needed to elucidate the role of C/EBP in low-dose Meth-induced neurotoxicity.Xu, X., Huang, E., Luo, B., Cai, D., Zhao, X., Luo, Q., Jin, Y., Chen, L., Wang, Q., Liu, C., Lin, Z., Xie, W.-B., Wang, H. Methamphetamine exposure triggers apoptosis and autophagy in neuronal cells by activating the C/EBP-related signaling pathway.	[Xu, Xiang; Huang, Enping; Luo, Baoying; Cai, Dunpeng; Zhao, Xu; Luo, Qin; Jin, Yili; Chen, Ling; Wang, Qi; Xie, Wei-Bing; Wang, Huijun] Southern Med Univ, Sch Forens Med, 1023 South Shaitai Rd, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Xiang] Wannan Med Coll, Sch Forens Med, Wuhu, Peoples R China; [Liu, Chao] Guangzhou Forens Sci Inst, Guangzhou, Guangdong, Peoples R China; [Lin, Zhoumeng] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Inst Computat Comparat Med, Manhattan, KS 66506 USA	Southern Medical University - China; Wannan Medical College; Kansas State University	Xie, WB; Wang, HJ (corresponding author), Southern Med Univ, Sch Forens Med, 1023 South Shaitai Rd, Guangzhou 510515, Guangdong, Peoples R China.	xieweib@126.com; hjwang711@yahoo.cn	Zhao, Xiaoshan/GPF-7929-2022; Lin, Zhoumeng/U-8450-2019; wang, hui/GRS-4730-2022	Lin, Zhoumeng/0000-0002-8731-8366; 	Natural Science Foundation of China [81430045, 81370227]; Medical Science and Technology Research Foundation of Guangdong Province [A2015043]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Research Foundation of Guangdong Province	This work was supported by the Natural Science Foundation of China (Grants 81430045 and 81370227), and the Medical Science and Technology Research Foundation of Guangdong Province (A2015043). The authors declare no conflicts of interest.	Abreu MM, 2010, EXP CELL RES, V316, P3227, DOI 10.1016/j.yexcr.2010.07.021; Barakat DJ, 2016, CANCER LETT, V375, P152, DOI 10.1016/j.canlet.2016.03.005; Barbosa DJ, 2015, ARCH TOXICOL, V89, P1695, DOI 10.1007/s00204-015-1478-9; Beauvais G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028946; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Brifault C, 2015, STROKE, V46, P520, DOI 10.1161/STROKEAHA.114.006864; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Button RW, 2017, J BIOL CHEM, V292, P13599, DOI 10.1074/jbc.M117.782276; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Cai D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.67; Carvalho M, 2012, ARCH TOXICOL, V86, P1167, DOI 10.1007/s00204-012-0815-5; Castino R, 2008, J NEUROCHEM, V106, P1426, DOI 10.1111/j.1471-4159.2008.05488.x; Chen CX, 2016, TOXICOL LETT, V240, P149, DOI 10.1016/j.toxlet.2015.10.020; Chen PW, 2014, AUTOPHAGY, V10, P192, DOI 10.4161/auto.26927; Chen QZ, 2016, NEUROCHEM RES, V41, P1483, DOI 10.1007/s11064-016-1862-8; Chen YT, 2017, BIOCHEM BIOPH RES CO, V486, P423, DOI 10.1016/j.bbrc.2017.03.057; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Chou J, 2008, NEUROSCIENCE, V151, P92, DOI 10.1016/j.neuroscience.2007.10.044; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Colitti M, 2009, TISSUE CELL, V41, P326, DOI 10.1016/j.tice.2009.02.004; Du SH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00409; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Erazo T, 2016, CLIN CANCER RES, V22, P2508, DOI 10.1158/1078-0432.CCR-15-1808; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fujikawa DG, 2016, NEUROTOXICOLOGY, V52, P84, DOI 10.1016/j.neuro.2015.11.001; Funakoshi-Hirose I, 2013, TOXICOLOGY, V312, P74, DOI 10.1016/j.tox.2013.07.016; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gullu G, 2012, CHIN J CANCER, V31, P266, DOI 10.5732/cjc.011.10405; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Huang GD, 2016, AUTOPHAGY, V12, P1292, DOI 10.1080/15548627.2016.1183843; Huang WY, 2015, TOXICOL SCI, V145, P68, DOI 10.1093/toxsci/kfv014; Irie Y, 2011, CELL TISSUE RES, V345, P231, DOI 10.1007/s00441-011-1207-5; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Karch J, 2015, CIRC RES, V116, P1800, DOI 10.1161/CIRCRESAHA.116.305421; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kobeissy FH, 2008, J PROTEOME RES, V7, P1971, DOI 10.1021/pr800029h; Kobeissy FH, 2008, ADDICT BIOL, V13, P15, DOI 10.1111/j.1369-1600.2007.00083.x; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Larsen KE, 2002, J NEUROSCI, V22, P8951; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li B, 2017, MOL NEUROBIOL, V54, P1642, DOI 10.1007/s12035-015-9637-9; Liang X, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-10; Liang XY, 2012, CANCER RES, V72, P2791, DOI 10.1158/0008-5472.CAN-12-0320; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Y, 2009, FUTURE MICROBIOL, V4, P299, DOI 10.2217/FMB.09.4; Luna-Vargas MPA, 2016, FEBS J, V283, P2676, DOI 10.1111/febs.13624; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maxwell JC, 2011, ADDICT BEHAV, V36, P1168, DOI 10.1016/j.addbeh.2011.07.017; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moratalla R, 2017, PROG NEUROBIOL, V155, P149, DOI 10.1016/j.pneurobio.2015.09.011; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Nara A, 2010, BRAIN RES, V1352, P1, DOI 10.1016/j.brainres.2010.07.043; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pan HC, 2013, EUR J IMMUNOL, V43, P2854, DOI 10.1002/eji.201343301; Pena-Altamira E, 2014, EUR J NEUROSCI, V39, P176, DOI 10.1111/ejn.12407; Peruzzi B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1651; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Purnell PR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-86; Qiao DF, 2014, TOXICOL LETT, V230, P444, DOI 10.1016/j.toxlet.2014.08.010; Rininger A, 2012, CELL DEATH DIFFER, V19, P1634, DOI 10.1038/cdd.2012.41; Roberts GG, 2007, ANTIOXID REDOX SIGN, V9, P2265, DOI 10.1089/ars.2007.1786; Rubiolo JA, 2014, CELL SIGNAL, V26, P419, DOI 10.1016/j.cellsig.2013.10.004; Saez AJG, 2016, GENE DEV, V30, P878, DOI 10.1101/gad.281519.116; Salazar M, 2015, BIOCHEM SOC T, V43, P1122, DOI 10.1042/BST20150124; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Samuel W, 2010, J CELL PHYSIOL, V224, P827, DOI 10.1002/jcp.22191; SCHMIDT CJ, 1985, J PHARMACOL EXP THER, V233, P539; Shukla RK, 2012, INT J DRUG POLICY, V23, P426, DOI 10.1016/j.drugpo.2012.07.004; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Tamura A, 2015, BIOCHEM BIOPH RES CO, V464, P654, DOI 10.1016/j.bbrc.2015.07.045; Tang B, 2015, AUTOPHAGY, V11, P344, DOI 10.1080/15548627.2015.1023682; Tang YT, 2015, MOL CELL BIOCHEM, V401, P209, DOI 10.1007/s11010-014-2308-8; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Tungkum W, 2017, J TOXICOL SCI, V42, P63, DOI 10.2131/jts.42.63; Um HD, 2016, ONCOTARGET, V7, P5193, DOI 10.18632/oncotarget.6405; van der Krieken SE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/324815; Vearrier D, 2012, DM-DIS MON, V58, P38, DOI 10.1016/j.disamonth.2011.09.004; Wang JinLiang, 2014, Climate Change Research Letters, V3, P1, DOI 10.12677/CCRL.2014.31001; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Winek CL, 2001, FORENSIC SCI INT, V122, P107, DOI 10.1016/S0379-0738(01)00483-2; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wongprayoon P, 2017, NEUROTOX RES, V31, P1, DOI 10.1007/s12640-016-9647-z; Xu X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00203; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033; Zhao LJ, 2016, PHYTOMEDICINE, V23, P114, DOI 10.1016/j.phymed.2015.12.019; Zheng JH, 2016, FEBS J, V283, P2690, DOI 10.1111/febs.13527	103	29	32	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6737	6759		10.1096/fj.201701460RRR	http://dx.doi.org/10.1096/fj.201701460RRR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29939784				2022-12-28	WOS:000449359700030
J	Xu, HM; Liu, XD; Xia, JJ; Yu, TS; Qu, YA; Jiang, H; Xie, JX				Xu, Huamin; Liu, Xiaodong; Xia, Jianjian; Yu, Tianshu; Qu, Yanan; Jiang, Hong; Xie, Junxia			Activation of NMDA receptors mediated iron accumulation via modulating iron transporters in Parkinson's disease	FASEB JOURNAL			English	Article						DMT1; ferropotin 1; iron regulatory protein	NITRIC-OXIDE; NERVOUS-SYSTEM; RAT MODEL; NEURONS; PROTEINS; CELLS; EXCITOTOXICITY; TRANSMISSION; CONTRIBUTES; HOMEOSTASIS	Increasing evidence has confirmed that nigral iron accumulation and activation of NMDA receptors (NRs) contribute to the neurodegeneration of dopamine (DA) neurons in Parkinson's disease (PD). Earlier work indicated that activation of NRs participated in iron metabolism in the hippocampus. However, the relationship between activation of NRs and iron accumulation in DA neurons of the substantia nigra in PD was unknown. In this study, our results showed that NRs inhibitors MK-801 and AP5 protected nigrostriatal projection system and reduced nigral iron levels of 6-hydroxydopamine (6-OHDA)-induced PD rats. In vitro studies demonstrated that NMDA treatment increased the expression of iron importer divalent metal transporter 1 (DMT1) and decreased the expression of iron exporter ferropotin 1 (Fpn1), which were dependent on iron regulatory protein 1 (IRP1). This led to increased intracellular iron levels and intensified the decrease in mitochondrial transmembrane potential in MES23.5 dopaminergic neurons. In addition, we reported that MK801 and neuronal nitric oxide synthase inhibitor could antagonize 6-OHDA-induced up-regulation of IRP1 and DMT1 and down-regulation of Fpn1, thus attenuating 6-OHDA-induced iron accumulation in MES23.5 cells. This suggested that 6-OHDA-induced activation of NRs might modulate the expression of DMT1 and Fpn1 via the neuronal nitric oxide synthase-IRP1 pathway.Xu, H., Liu, X., Xia, J., Yu, T., Qu, Y., Jiang, H., Xie, J., Activation of NMDA receptors mediated iron accumulation via modulating iron transporters in Parkinson's disease.	Qingdao Univ, Dept Physiol, Shandong Prov Collaborat Innovat Ctr Neurodegener, Key Lab Pathogenesis & Prevent Neurol Disorders, Qingdao, Peoples R China; Qingdao Univ, Med Coll, State Key Disciplines Physiol, Qingdao, Peoples R China; Qingdao Univ, Inst Brain Sci & Dis, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Xu, HM; Xie, JX (corresponding author), Qingdao Univ, Med Coll, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Dept Physiol, 308 Ningxia Rd, Qingdao, Peoples R China.; Xu, HM; Xie, JX (corresponding author), Qingdao Univ, Med Coll, State Key Disciplines Physiol, 308 Ningxia Rd, Qingdao, Peoples R China.	huamin102@163.com; jxiaxie@public.qd.sd.cn			National Natural Science Foundation of China [31371081, 81430024, 31771124]; Department of Science and Technology of Shandong Province [ZR2015JL011]; Bureau of Science and Technology of Qingdao [15-9-1-20-jch]; Excellent Innovative Team of Shandong Province; Taishan Scholars Construction Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shandong Province; Bureau of Science and Technology of Qingdao; Excellent Innovative Team of Shandong Province; Taishan Scholars Construction Project	This work was supported by grants from National Natural Science Foundation of China (31371081, 81430024 and 31771124), the Department of Science and Technology of Shandong Province (ZR2015JL011) (to J.X.), and the Bureau of Science and Technology of Qingdao (15-9-1-20-jch), Excellent Innovative Team of Shandong Province and Taishan Scholars Construction Project. The authors declare no conflicts of interest.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Ayton S, 2015, J NEUROSCI, V35, P3591, DOI 10.1523/JNEUROSCI.3439-14.2015; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Chen Y, 2013, J NEUROSCI, V33, P3582, DOI 10.1523/JNEUROSCI.1497-12.2013; Cheng FR, 2011, J NEUROCHEM, V119, P815, DOI 10.1111/j.1471-4159.2011.07460.x; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Flores-Soto ME, 2013, CURR PHARM DESIGN, V19, P6709; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Genoud S, 2017, METALLOMICS, V9, P1447, DOI [10.1039/c7mt00244k, 10.1039/C7MT00244K]; Gonzalez J, 2015, INT J NEUROSCI, V125, P315, DOI 10.3109/00207454.2014.940941; Guan XJ, 2017, NEUROSCI BULL, V33, P561, DOI 10.1007/s12264-017-0138-x; Hansen KB, 2017, METHODS MOL BIOL, V1677, P1, DOI 10.1007/978-1-4939-7321-7_1; Ishii H, 2006, J NEUROCHEM, V96, P1531, DOI 10.1111/j.1471-4159.2006.03656.x; Jia WT, 2015, NEUROBIOL AGING, V36, P1183, DOI 10.1016/j.neurobiolaging.2014.10.021; Jiang H, 2017, MOL NEUROBIOL, V54, P3078, DOI 10.1007/s12035-016-9879-1; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Li S, 2017, NEUROSCI BULL, V33, P598, DOI 10.1007/s12264-017-0178-2; Li S, 2017, NEUROSCI BULL, V33, P481, DOI 10.1007/s12264-017-0184-4; Majlath Z, 2014, NEURODEGENER DIS MAN, V4, P23, DOI [10.2217/nmt.13.77, 10.2217/NMT.13.77]; Mastrangelo L, 2017, ADV GENET, V98, P43, DOI 10.1016/bs.adgen.2017.08.001; Miyamoto T, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0176-x; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Przedborski S, 2017, NAT REV NEUROSCI, V18, P251, DOI 10.1038/nrn.2017.25; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Schiemann J, 2012, NAT NEUROSCI, V15, P1272, DOI 10.1038/nn.3185; Song N, 2010, FREE RADICAL BIO MED, V48, P332, DOI 10.1016/j.freeradbiomed.2009.11.004; Suarez F, 2010, EUR J NEUROSCI, V32, P359, DOI 10.1111/j.1460-9568.2010.07298.x; Tian Y, 2017, ACTA BIOCH BIOPH SIN, V49, P827, DOI 10.1093/abbs/gmx082; Tsutsui M, 2015, J PHARMACOL SCI, V127, P42, DOI 10.1016/j.jphs.2014.10.002; Wang HT, 2010, MOL CELL BIOCHEM, V342, P87, DOI 10.1007/s11010-010-0471-0; Wang J, 2013, BBA-MOL BASIS DIS, V1832, P618, DOI 10.1016/j.bbadis.2013.01.021; Wang JY, 2012, J MOL NEUROSCI, V47, P113, DOI 10.1007/s12031-011-9693-1; Wang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10729; Wang J, 2009, NEUROCHEM INT, V54, P43, DOI 10.1016/j.neuint.2008.10.003; Xu HM, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00071; Yan JQ, 2014, INT J CLIN EXP MED, V7, P3313; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025; Zhong CB, 2017, NEUROSCI BULL, V33, P483, DOI 10.1007/s12264-017-0179-1; Zhu YQ, 2017, PARKINSONISM RELAT D, V36, P76, DOI 10.1016/j.parkreldis.2017.01.003	48	13	14	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6100	6111		10.1096/fj.201800060RR	http://dx.doi.org/10.1096/fj.201800060RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29897813	Bronze			2022-12-28	WOS:000447172000028
J	Asen, AK; Goebel, L; Rey-Rico, A; Sohier, J; Zurakowski, D; Cucchiarini, M; Madry, H				Asen, Ann-Kathrin; Goebel, Lars; Rey-Rico, Ana; Sohier, Jerome; Zurakowski, David; Cucchiarini, Magali; Madry, Henning			Sustained spatiotemporal release of TGF-1 confers enhanced very early chondrogenic differentiation during osteochondral repair in specific topographic patterns	FASEB JOURNAL			English	Article						cartilage defect; large animal model; cartilage repair; scaffold	ARTICULAR-CARTILAGE REPAIR; TRANSFORMING GROWTH FACTOR-BETA(1); MESENCHYMAL STEM-CELLS; FULL-THICKNESS DEFECTS; IN-VIVO; SUBCHONDRAL BONE; ENCAPSULATED CHONDROCYTES; PROGENITOR CELLS; MODEL; TISSUE	The continuous presence of TGF- is critically important to induce effective chondrogenesis. To investigate chondrogenesis in a cartilage defect, we tested the hypothesis that the implantation of TGF-1-releasing scaffolds improves very early cartilage repair in vivo. Spatiotemporal controlled release of TGF-1 was achieved from multiblock scaffolds that were implanted in osteochondral defects in the medial femoral condyles of adult minipigs. We observed a sustained presence of TGF-1 at 4 wk in vivo, which significantly promoted structural aspects of early overall cartilage repair, especially cellularity, cellular morphology, and safranin O staining intensity. Furthermore, early aggrecan and type II collagen production were both increased in specific topographic patterns in cartilaginous repair tissue. Sustained release of TGF-1 also increased cell numbers and proliferation, staining intensities for the stem cell surface marker, CD105, and number of stromal cell-derived factor-1 (SDF-1) -positive cells within cartilaginous repair tissue. These data identify a mechanism by which TGF-1 modulates early chondrogenesis by primarily increasing the number of progenitor cells arising from the subchondral bone marrow compartment via the SDF-1/chemokine (CXC motif) receptor 4 pathway, their proliferation, differentiation, and extracellular matrix deposition in specific topographic patterns, highlighting the pivotal role played by TGF-1 during this crucial phase.Asen, A.-K., Goebel, L., Rey-Rico, A., Sohier, J., Zurakowski, D., Cucchiarini, M., Madry, H. Sustained spatiotemporal release of TGF-1 confers enhanced very early chondrogenic differentiation during osteochondral repair in specific topographic patterns.	[Asen, Ann-Kathrin; Goebel, Lars; Rey-Rico, Ana; Cucchiarini, Magali; Madry, Henning] Saarland Univ, Med Ctr, Ctr Expt Orthopaed, Homburg, Germany; [Goebel, Lars; Madry, Henning] Saarland Univ, Med Ctr, Dept Orthopaed Surg, Homburg, Germany; [Sohier, Jerome] CNRS, Inst Biol & Chem Prot, Lyon, France; [Zurakowski, David] Harvard Med Sch, Childrens Hosp Boston, Dept Anesthesia, Boston, MA USA; [Zurakowski, David] Harvard Med Sch, Childrens Hosp Boston, Dept Surg, Boston, MA USA	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Centre National de la Recherche Scientifique (CNRS); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Madry, H (corresponding author), Univ Saarland, Gebaude 37,Kirrberger Str 1,Bldg 37-38, D-66421 Homburg, Germany.	henning.madry@uks.eu	Goebel, Lars/AAF-3497-2020; Rico, Ana Rey/K-5951-2014; sohier, jerome/O-1923-2017; Rey-Rico, Ana/AAK-9298-2021; Madry, Henning/AAP-7115-2020	Goebel, Lars/0000-0002-9907-264X; Rico, Ana Rey/0000-0003-1682-498X; sohier, jerome/0000-0002-2696-5754; Rey-Rico, Ana/0000-0003-1682-498X; 	Center of Experimental Orthopaedics, Saarland University Medical Center	Center of Experimental Orthopaedics, Saarland University Medical Center	The authors thank Dr. Lorenzo Moroni (Maastricht University, Maastricht, The Netherlands) for helpful discussions. This research was funded by the Center of Experimental Orthopaedics, Saarland University Medical Center. The study sponsor was not involved in the study design, data collection, or analysis or in the writing of the manuscript. Furthermore, receiving funding did not affect the decision to submit the manuscript for publication. The data sets generated and/or analyzed during the current study are available from the corresponding researcher on reasonable request. The authors declare no conflicts of interest.	Alegre-Aguaron E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088053; Alliston T, 2014, CURR OSTEOPOROS REP, V12, P366, DOI 10.1007/s11914-014-0213-4; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Barron V, 2015, ANN BIOMED ENG, V43, P2069, DOI 10.1007/s10439-015-1246-2; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bartha Lajos, 2013, Eur J Orthop Surg Traumatol, V23, P81, DOI 10.1007/s00590-011-0907-6; Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chen MJ, 2018, J THEOR BIOL, V439, P1, DOI 10.1016/j.jtbi.2017.11.024; Chen PF, 2015, BIOMATERIALS, V39, P114, DOI 10.1016/j.biomaterials.2014.10.049; CRITCHLOW MA, 1995, BONE, V16, P521, DOI 10.1016/8756-3282(95)00085-R; Cucchiarini M, 2014, GENE THER, V21, P811, DOI 10.1038/gt.2014.58; Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899; Ferguson CM, 2004, J ORTHOP RES, V22, P687, DOI 10.1016/j.orthres.2003.10.023; Fisher MB, 2016, CARTILAGE, V7, P174, DOI 10.1177/1947603515623030; Gao L, 2019, AM J SPORT MED, V47, P222, DOI 10.1177/0363546517740575; Gao L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45189; Goebel L, 2012, OSTEOARTHR CARTILAGE, V20, P1046, DOI 10.1016/j.joca.2012.05.010; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Guermazi A, 2017, ARTHRITIS RHEUMATOL, V69, P560, DOI 10.1002/art.39970; HAYAMIZU TF, 1991, DEV BIOL, V145, P164, DOI 10.1016/0012-1606(91)90222-O; Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171; Kaul G, 2006, J GENE MED, V8, P100, DOI 10.1002/jgm.819; Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8; Lee CH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009696; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Madry H, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1609685; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Madry H, 2012, KNEE SURG SPORT TR A, V20, P407, DOI 10.1007/s00167-011-1705-8; Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Maruki H, 2017, J BIOMED MATER RES B, V105, P2592, DOI 10.1002/jbm.b.33792; MEACHIM G, 1971, J ANAT, V109, P317; Mello MA, 2006, J ORTHOP RES, V24, P2095, DOI 10.1002/jor.20233; Mendelson A, 2011, FASEB J, V25, P3496, DOI 10.1096/fj.10-176305; Nakamura N, 2009, ARTHROSCOPY, V25, P531, DOI 10.1016/j.arthro.2009.02.007; Orth P, 2013, OSTEOARTHR CARTILAGE, V21, P614, DOI 10.1016/j.joca.2013.01.008; Orth P, 2015, PROG HISTOCHEM CYTO, V50, P19, DOI 10.1016/j.proghi.2015.10.001; Orth P, 2013, TISSUE ENG PART C-ME, V19, P885, DOI [10.1089/ten.tec.2012.0699, 10.1089/ten.TEC.2012.0699]; Orth P, 2012, AM J SPORT MED, V40, P828, DOI 10.1177/0363546511430376; Rey-Rico A, 2015, J BIOMED MATER RES A, V103, P371, DOI 10.1002/jbm.a.35181; Ripamonti U, 1996, J BONE MINER RES, V11, P938; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Sohier J, 2007, INT J PHARMACEUT, V332, P80, DOI 10.1016/j.ijpharm.2006.09.037; Sohier J, 2003, EUR J PHARM BIOPHARM, V55, P221, DOI 10.1016/S0939-6411(02)00161-3; Sridhar BV, 2014, J BIOMED MATER RES A, V102, P4464, DOI 10.1002/jbm.a.35115; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tuan RS, 2013, J AM ACAD ORTHOP SUR, V21, P303, DOI 10.5435/JAAOS-21-05-303; Ulrich-Vinther M, 2005, Eur Cell Mater, V10, P40; Vagima Y, 2011, METHODS MOL BIOL, V750, P277, DOI 10.1007/978-1-61779-145-1_19; Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018; Wang WG, 2014, BIRTH DEFECTS RES C, V102, P37, DOI 10.1002/bdrc.21058; Ying BB, 2013, BRIT J ORAL MAX SURG, V51, P241, DOI 10.1016/j.bjoms.2012.05.014; Yu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1274, DOI 10.1002/art.39049; Zhou TF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11322-w; Zhu YH, 2015, MOL MED REP, V12, P5573, DOI 10.3892/mmr.2015.4068	61	15	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5298	5311		10.1096/fj.201800105R	http://dx.doi.org/10.1096/fj.201800105R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688810	Bronze			2022-12-28	WOS:000447972500009
J	Li, XZ; Mazaleuskaya, LL; Ballantyne, LL; Meng, H; FitzGerald, GA; Funk, CD				Li, Xinzhi; Mazaleuskaya, Liudmila L.; Ballantyne, Laurel L.; Meng, Hu; FitzGerald, Garret A.; Funk, Colin D.			Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions	FASEB JOURNAL			English	Article						eicosanoid; gene targeting; kidney development; kidney function	MEDULLARY INTERSTITIAL-CELLS; ANGIOTENSIN-II; BLOOD-PRESSURE; MACULA DENSA; PHYSIOLOGICAL REGULATION; ANTIINFLAMMATORY DRUGS; GENE DISRUPTION; RAT-KIDNEY; EXPRESSION; INHIBITION	The distinct functions of each cyclooxygenase (COX) isoform in renal homeostasis have been the subject of intense investigation for many years. We took the novel approach of using 3 characterized mouse lines, where the prostaglandin (PG)-endoperoxide synthase genes 1 and 2 (Ptgs1 and Ptgs2) substitute for one another to delineate distinct roles and the potential for COX isoform substitution. Flipped Ptgs genes generate a reversed COX-expression pattern in the kidney, where the knockin COX-2 is highly expressed. Normal nephrogenesis was sustained in all 3 strains at the postnatal stage d 8 (P8). Knockin COX-1 can temporally restore renal function and delay but not prevent renal pathology consequent to COX-2 deletion. Loss of COX-2 in adult COX-1 > COX-2 mice results in severe nephropathy, which leads to impaired renal function. These defects are partially rescued by the knockin COX-2 in Reversa mice, whereas COX-2 can compensate for the loss of COX-1 in COX-2 > COX-1 mice. Intriguingly, the highly expressed knockin COX-2 enzyme barely makes any PGs or thromboxane in neonatal P8 or adult mice, demonstrating that prostanoid biosynthesis requires native COX-1 and cannot be rescued by the knockin COX-2. In summary, the 2 COX isoforms can preferentially compensate for some renal functions, which appears to be independent of the PG-synthetic capacity.Li, X., Mazaleuskaya, L. L., Ballantyne, L. L., Meng, H., FitzGerald, G. A., Funk, C. D. Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.	[Li, Xinzhi; Ballantyne, Laurel L.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada; [Mazaleuskaya, Liudmila L.; Meng, Hu; FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA	Queens University - Canada; University of Pennsylvania; Pennsylvania Medicine	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca	Li, Xinzhi/X-2650-2019	Funk, Colin/0000-0001-7029-4233	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [U54 HL117798]; Canadian Institutes of Health Research [MOP142476]; NIH [T32 HL07971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007971, U54HL117798] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant U54 HL117798. C.D.F. holds a Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine, and is supported by the Canadian Institutes of Health Research Grant MOP142476. G.A.F. is the McNeil Professor in Translational Medicine and Therapeutics. L.L.M. was supported by NIH Training Grant T32 HL07971. The authors declare no conflicts of interest.	Ahmetaj-Shala B, 2015, CIRCULATION, V131, P633, DOI 10.1161/CIRCULATIONAHA.114.011591; Athirakul K, 2001, KIDNEY INT, V60, P2324, DOI 10.1046/j.1523-1755.2001.00072.x; Campean V, 2003, AM J PHYSIOL-RENAL, V285, pF19, DOI 10.1152/ajprenal.00443.2002; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cheng HF, 1999, J CLIN INVEST, V103, P953, DOI 10.1172/JCI5505; DIBONA GF, 1986, AM J MED, V80, P12, DOI 10.1016/0002-9343(86)90928-9; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; DUNN MJ, 1980, KIDNEY INT, V18, P609, DOI 10.1038/ki.1980.179; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Frolich S, 2017, KIDNEY INT, V91, P818, DOI 10.1016/j.kint.2016.11.003; Gonzalez JD, 2000, J CARDIOVASC PHARM, V36, P236, DOI 10.1097/00005344-200008000-00014; Grosser T, 2006, THROMB HAEMOSTASIS, V96, P393, DOI 10.1160/TH06-08-0444; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF18, DOI 10.1152/ajprenal.1997.273.1.F18; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Harris Raymond C, 2013, Trans Am Clin Climatol Assoc, V124, P139; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Harris RC, 2001, AM J PHYSIOL-RENAL, V281, pF1, DOI 10.1152/ajprenal.2001.281.1.F1; Khan KNM, 2002, KIDNEY INT, V61, P1210, DOI 10.1046/j.1523-1755.2002.00263.x; Komhoff M, 2000, KIDNEY INT, V57, P414; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; LARSSON C, 1973, EUR J PHARMACOL, V21, P30, DOI 10.1016/0014-2999(73)90202-1; Li XZ, 2018, J LIPID RES, V59, P102, DOI 10.1194/jlr.M080028; Li XZ, 2018, J LIPID RES, V59, P89, DOI 10.1194/jlr.M079996; Liu Y, 2014, AM J PHYSIOL-RENAL, V307, pF388, DOI 10.1152/ajprenal.00512.2013; Mann B, 2001, KIDNEY INT, V59, P62, DOI 10.1046/j.1523-1755.2001.00466.x; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; Qi ZH, 2006, HYPERTENSION, V48, P323, DOI 10.1161/01.HYP.0000231934.67549.b7; Rodriguez F, 2000, HYPERTENSION, V36, P276, DOI 10.1161/01.HYP.36.2.276; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; Slattery P, 2016, AM J PHYSIOL-RENAL, V310, pF1113, DOI 10.1152/ajprenal.00430.2015; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang JL, 1999, HYPERTENSION, V34, P96, DOI 10.1161/01.HYP.34.1.96; Wolf K, 1999, HYPERTENSION, V34, P503, DOI 10.1161/01.HYP.34.3.503; Yang TX, 2017, FRONT BIOSCI-LANDMRK, V22, P128, DOI 10.2741/4476; Yang TX, 2000, AM J PHYSIOL-RENAL, V279, pF819, DOI 10.1152/ajprenal.2000.279.5.F819; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF1, DOI 10.1152/ajprenal.1999.277.1.F1; Yang TX, 1998, AM J PHYSIOL-RENAL, V274, pF481, DOI 10.1152/ajprenal.1998.274.3.F481; Ye WL, 2006, AM J PHYSIOL-RENAL, V290, pF542, DOI 10.1152/ajprenal.00232.2005; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787; Yu Y, 2010, CIRC RES, V106, P337, DOI 10.1161/CIRCRESAHA.109.204529; Zhang JY, 2002, PROSTAG OTH LIPID M, V67, P121, DOI 10.1016/S0090-6980(01)00177-0	49	3	3	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5326	5337		10.1096/fj.201800252R	http://dx.doi.org/10.1096/fj.201800252R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29676940	Green Published			2022-12-28	WOS:000447972500011
J	Chatterjee, K; Jana, S; DasMahapatra, P; Swarnakar, S				Chatterjee, Kasturi; Jana, Sayantan; DasMahapatra, Pramathes; Swarnakar, Snehasikta			EGFR-mediated matrix metalloproteinase-7 up-regulation promotes epithelial-mesenchymal transition via ERK1-AP1 axis during ovarian endometriosis progression	FASEB JOURNAL			English	Article						MMP-7; EMT; endometrioma	E-CADHERIN; COLORECTAL-CANCER; CELLS; EXPRESSION; PATHOGENESIS; RECEPTOR; MMP-7; RISK; ACTIVATION; STIFFNESS	Endometriosis, characterized by extrauterine development of endometrial glands and stroma, is associated with increased risk of ovarian cancer development. In the present study, we investigated the role of matrix metalloproteinase-7 (MMP-7) on epithelial-mesenchymal transition (EMT) during ovarian endometriosis (N = 40) progression. We found that the expressions of EMT markers such as vimentin, slug, and N-cadherin were significantly elevated in late stages of ovarian endometriosis compared with those found in early stages. In addition, the activity and expression of ectopic MMP-7 were significantly higher in the late stages of endometriosis. In vitro studies revealed that increased expression of MMP-7 as well as epidermal growth factor (EGF), which was significantly elevated in severe stages of ovarian endometriosis, induced EMT in endocervical epithelial cells (End1/E6E7). Silencing the MMP-7 transcripts using small interfering RNA attenuated EMT responses, whereas treatment with recombinant active MMP-7 promoted EMT by cleaving E-cadherin. In addition, EGF receptor (EGFR) inhibitor treatments regressed endometriotic lesions and decreased MMP-7 activities in a mouse model of endometriosis. Chromatin immunoprecipitation assay identified EGFR-mediated ERK1 and activator protein 1 signaling for the transcriptional activation of MMP-7 in End1/E6E7 epithelial cells.Chatterjee, K., Jana, S., DasMahapatra, P., Swarnakar, S. EGFR-mediated matrix metalloproteinase-7 up-regulation promotes epithelial-mesenchymal transition via ERK1-AP1 axis during ovarian endometriosis progression.	[Chatterjee, Kasturi; Jana, Sayantan; Swarnakar, Snehasikta] CSIR, Canc Biol & Inflammatory Disorder Div, Indian Inst Chem Biol, Kolkata 700032, W Bengal, India; [Jana, Sayantan] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [DasMahapatra, Pramathes] Spectrum Clin & Endoscopy Res Inst, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Alberta	Swarnakar, S (corresponding author), CSIR, Canc Biol & Inflammatory Disorder Div, Indian Inst Chem Biol, Kolkata 700032, W Bengal, India.	snehasiktas@hotmail.com		JANA, SAYANTAN/0000-0003-2855-1560; Swarnakar, Snehasikta/0000-0002-7139-9683	Council of Scientific and Industrial Research (CSIR)-Network Project [BSC0119, BSC0111]; Indian Council of Scientific and Industrial Research [BSC0111-INDEPTH]	Council of Scientific and Industrial Research (CSIR)-Network Project; Indian Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The authors gratefully acknowledge Prof. Samit Chattopadhyay, Director, CSIR-IICB for his support. The authors acknowledge fellowships from the Council of Scientific and Industrial Research (CSIR)-Network Project (BSC0119 to K.C.; BSC0111 to S.J. This work was supported by the Indian Council of Scientific and Industrial Research (Grant BSC0111-INDEPTH). The authors declare no conflicts of interest.	Bruner-Tran KL, 2006, J CLIN ENDOCR METAB, V91, P1554, DOI 10.1210/jc.2005-2024; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Gaetje R, 1997, AM J PATHOL, V150, P461; Gorodeski GI, 2007, ENDOCRINOLOGY, V148, P218, DOI 10.1210/en.2006-1120; Jana S, 2016, MED J OBSTET GYNECOL, V4, P1085; Jana S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163540; Jana S, 2012, BIOCHEM PHARMACOL, V83, P797, DOI 10.1016/j.bcp.2011.12.030; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kesh K, 2015, J BIOL CHEM, V290, P14391, DOI 10.1074/jbc.M114.630129; Kheradmand F, 2002, J CELL SCI, V115, P839; Kim HS, 2014, BRIT J CANCER, V110, P1878, DOI 10.1038/bjc.2014.29; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu H, 2008, CANCER SCI, V99, P2185, DOI 10.1111/j.1349-7006.2008.00922.x; Lynch CC, 2010, J ONCOL, V2010, DOI 10.1155/2010/530745; Matsuzaki S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44616; Matsuzaki S, 2012, HUM REPROD, V27, P712, DOI 10.1093/humrep/der442; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; Melin A, 2006, HUM REPROD, V21, P1237, DOI 10.1093/humrep/dei462; Mimori K, 2004, CLIN CANCER RES, V10, P8243, DOI 10.1158/1078-0432.CCR-04-0849; Mitsiades N, 2001, CANCER RES, V61, P577; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paul S, 2008, J PINEAL RES, V44, P439, DOI 10.1111/j.1600-079X.2007.00547.x; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Salamonsen LA, 2000, HUM REPROD, V15, P112, DOI 10.1093/humrep/15.suppl_3.112; Samani Elham N, 2019, Oncotarget, V10, P2282, DOI 10.18632/oncotarget.16889; SHI M, 2010, MOL CANCER, V9; Sizemore ST, 2012, J BIOL CHEM, V287, P24631, DOI 10.1074/jbc.M112.375865; Varma R, 2004, REPRODUCTION, V127, P293, DOI 10.1530/rep.1.00020; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Xiong Y, 2016, HUM REPROD, V31, P1327, DOI 10.1093/humrep/dew081; Zeitvogel A, 2001, AM J PATHOL, V159, P1839, DOI 10.1016/S0002-9440(10)63030-1; Zeng ZS, 2002, CLIN CANCER RES, V8, P144; Zhang Q, 2017, ONCOGENE, V36, P687, DOI 10.1038/onc.2016.240; Zhang Q, 2016, REPROD SCI, V23, P1409, DOI 10.1177/1933719116641763; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983	38	36	37	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4560	4572		10.1096/fj.201701382RR	http://dx.doi.org/10.1096/fj.201701382RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29558202				2022-12-28	WOS:000439325400041
J	Ishii, T; Ruiz-Torruella, M; Ikeda, A; Shindo, S; Movila, A; Mawardi, H; Albassam, A; Kayal, RA; Al-Dharrab, AA; Egashira, K; Wisitrasameewong, W; Yamamoto, K; Mira, AI; Sueishi, K; Han, XZ; Taubman, MA; Miyamoto, T; Kawai, T				Ishii, Takenobu; Ruiz-Torruella, Montserrat; Ikeda, Atsushi; Shindo, Satoru; Movila, Alexandru; Mawardi, Hani; Albassam, Abdullah; Kayal, Rayyan A.; Al-Dharrab, Ayman A.; Egashira, Kenji; Wisitrasameewong, Wichaya; Yamamoto, Kenta; Mira, Abdulghani I.; Sueishi, Kenji; Han, Xiaozhe; Taubman, Martin A.; Miyamoto, Takeshi; Kawai, Toshihisa			OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9	FASEB JOURNAL			English	Article						osteoclastogenesis; periodontal bone loss; mouse model; DC-STAMP; RANKL	STIMULATORY TRANSMEMBRANE PROTEIN; CELL-CELL FUSION; TETRASPANIN CD9; DC-STAMP; IN-VITRO; RANKL; EXPRESSION; PRECURSORS; ALPHA; DIFFERENTIATION	Cell fusion-mediated formation of multinuclear osteoclasts (OCs) plays a key role in bone resorption. It is reported that 2 unique OC-specific fusogens [i.e., OC-stimulatory transmembrane protein (OC-STAMP) and dendritic cell-specific transmembrane protein (DC-STAMP)], and permissive fusogen CD9, are involved in OC fusion. In contrast to DC-STAMP-knockout (KO) mice, which show the osteopetrotic phenotype, OC-STAMP-KO mice show no difference in systemic bone mineral density. Nonetheless, according to the ligature-induced periodontitis model, significantly lower level of bone resorption was found in OC-STAMP-KO mice compared to WT mice. Anti-OC-STAMP-neutralizing mAb down-modulated in vitro: 1) the emergence of large multinuclear tartrate-resistant acid phosphatase-positive cells, 2) pit formation, and 3) mRNA and protein expression of CD9, but not DC-STAMP, in receptor activator of NF-B ligand (RANKL)-stimulated OC precursor cells (OCps). While anti-DC-STAMP-mAb also down-regulated RANKL-induced osteoclastogenesis in vitro, it had no effect on CD9 expression. In our mouse model, systemic administration of anti-OC-STAMP-mAb suppressed the expression of CD9 mRNA, but not DC-STAMP mRNA, in periodontal tissue, along with diminished alveolar bone loss and reduced emergence of CD9(+) OCps and tartrate-resistant acid phosphatase-positive multinuclear OCs. The present study demonstrated that OC-STAMP partners CD9 to promote periodontal bone destruction by up-regulation of fusion during osteoclastogenesis, suggesting that anti-OC-STAMP-mAb may lead to the development of a novel therapeutic regimen for periodontitis.Ishii, T., Ruiz-Torruella, M., Ikeda, A., Shindo, S., Movila, A., Mawardi, H., Albassam, A., Kayal, R. A., Al-Dharrab, A. A., Egashira, K., Wisitrasameewong, W., Yamamoto, K., Mira, A. I., Sueishi, K., Han, X., Taubman, M. A., Miyamoto, T., Kawai, T. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.	[Ishii, Takenobu; Ruiz-Torruella, Montserrat; Ikeda, Atsushi; Shindo, Satoru; Movila, Alexandru; Egashira, Kenji; Han, Xiaozhe; Taubman, Martin A.] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Ishii, Takenobu; Sueishi, Kenji] Tokyo Dent Coll, Orthodont, Tokyo, Japan; [Mawardi, Hani; Albassam, Abdullah; Kayal, Rayyan A.; Al-Dharrab, Ayman A.; Mira, Abdulghani I.] King Abdulaziz Univ, Fac Dent, Jeddah, Saudi Arabia; [Egashira, Kenji] Lion Corp, Res & Dev Headquarters, Odawara, Kanagawa, Japan; [Wisitrasameewong, Wichaya] Chulalongkorn Univ, Periodontol, Bangkok, Thailand; [Yamamoto, Kenta] Nova Southeastern Univ, Dept Periodontol, Coll Dent Med, Ft Lauderdale, FL USA; [Han, Xiaozhe] Harvard Sch Dent Med, Oral Med Infect & Immun, Boston, MA USA; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Taubman, Martin A.] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA	Harvard University; Forsyth Institute; Tokyo Dental College; King Abdulaziz University; Lion Corporation; Chulalongkorn University; Nova Southeastern University; Harvard University; Harvard School of Dental Medicine; Keio University; Harvard University; Harvard School of Dental Medicine	Kawai, T (corresponding author), Nova Southeastern Univ, Dept Periodontol, Cell Therapy Inst, Ctr Collaborat Res,Coll Dent Med, 3200 South Univ Dr, Ft Lauderdale, FL 33328 USA.	tkawai@nova.edu	Mawardi, Hani/AAD-3987-2019; Han, Xiaozhe/I-7532-2019; Kayal, Rayyan/GQP-6538-2022; Kayal, Rayyan/CAG-4371-2022; Kayal, Rayyan/AAI-1333-2019	Mawardi, Hani/0000-0002-4768-1523; Han, Xiaozhe/0000-0001-8357-1471; Kayal, Rayyan/0000-0003-3887-7775; Kayal, Rayyan/0000-0003-3887-7775; 	U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research [DE-018499, DE-019917, T32 DE 007327-12]; NIH National Institute on Aging [AG-053615]; King Abdulaziz University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007327, R01DE025255, R01DE019917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG053615] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); King Abdulaziz University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in part, by U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grants DE-018499, DE-019917, and T32 DE 007327-12, NIH National Institute on Aging Grant AG-053615, and a research grant from King Abdulaziz University. The authors declare no conflicts of interest.	Abe E, 1999, CALCIFIED TISSUE INT, V64, P508, DOI 10.1007/s002239900641; Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Aimetti M, 2014, INT J ESTHET DENT, V9, P251; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bin Zaman S, 2017, CUREUS, V9, DOI 10.7759/cureus.1403; Bisson-Boutelliez C, 2001, J CLIN PERIODONTOL, V28, P650, DOI 10.1034/j.1600-051x.2001.028007650.x; Cobb CM, 2017, PERIODONTOL 2000, V75, P205, DOI 10.1111/prd.12137; Dietrich T, 2005, J PERIODONTOL, V76, P2175, DOI 10.1902/jop.2005.76.11-S.2175; Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922; Fiorino C, 2016, BONE, V86, P106, DOI 10.1016/j.bone.2016.03.004; Hobolt-Pedersen AS, 2014, CALCIFIED TISSUE INT, V95, P73, DOI 10.1007/s00223-014-9864-5; Hu Y, 2017, BBA-MOL BASIS DIS, V1863, P2149, DOI 10.1016/j.bbadis.2017.06.001; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Iwai K, 2008, RHEUMATOL INT, V28, P225, DOI 10.1007/s00296-007-0424-4; Jin QM, 2007, J PERIODONTOL, V78, P1300, DOI 10.1902/jop.2007.070073; Kaji K, 2004, REPRODUCTION, V127, P423, DOI 10.1530/rep.1.00163; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kaji K, 2002, DEV BIOL, V247, P327, DOI 10.1006/dbio.2002.0694; Kawai T, 2007, ORAL MICROBIOL IMMUN, V22, P208, DOI 10.1111/j.1399-302X.2007.00348.x; Kawai T, 1998, CLIN DIAGN LAB IMMUN, V5, P11, DOI 10.1128/CDLI.5.1.11-17.1998; Kawai T, 2000, J IMMUNOL, V164, P2102, DOI 10.4049/jimmunol.164.4.2102; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim MH, 2011, AMINO ACIDS, V40, P1447, DOI 10.1007/s00726-010-0755-4; Komatsuzawa H, 1999, INFECT IMMUN, V67, P942, DOI 10.1128/IAI.67.2.942-945.1999; Koskinen C, 2013, J BIOL CHEM, V288, P29333, DOI 10.1074/jbc.M113.494591; Leavy O, 2010, NAT REV IMMUNOL, V10, P297, DOI 10.1038/nri2763; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lin XP, 2011, INFECT IMMUN, V79, P911, DOI 10.1128/IAI.00944-10; Liu JKH, 2014, ANN MED SURG, V3, P113, DOI 10.1016/j.amsu.2014.09.001; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Matsuda S, 2016, J IMMUNOL METHODS, V438, P21, DOI 10.1016/j.jim.2016.08.008; Mayer Y, 2009, J PERIODONTOL, V80, P1414, DOI 10.1902/jop.2009.090015; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Moller AMJ, 2017, J CELL PHYSIOL, V232, P1396, DOI 10.1002/jcp.25633; Movila A, 2016, J BONE MINER RES, V31, P1688, DOI 10.1002/jbmr.2854; Oz HS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/754857; Ren C, 2017, J PERIODONTAL RES, V52, P8, DOI 10.1111/jre.12361; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; RUSSELL WC, 1947, J MAMMAL, V28, P284, DOI 10.2307/1375178; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Wara-aswapati N, 2007, J PERIODONTOL, V78, P1062, DOI 10.1902/jop.2007.060398; Wisitrasameewong W, 2017, J DENT RES, V96, P685, DOI 10.1177/0022034517690490; Witwicka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128275; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xing LP, 2012, WORLD J ORTHOP, V3, P212, DOI 10.5312/wjo.v3.i12.212; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yi TG, 2006, BIOCHEM BIOPH RES CO, V347, P178, DOI 10.1016/j.bbrc.2006.06.061; Yu P, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00645-16; Yu X, 2018, J PERIODONTAL RES, V53, P98, DOI 10.1111/jre.12492; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zhu M, 2013, FASEB J, V27, P3344, DOI 10.1096/fj.12-220228	57	23	24	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4016	4030		10.1096/fj.201701424R	http://dx.doi.org/10.1096/fj.201701424R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29533736	Green Published, Bronze			2022-12-28	WOS:000435104500045
J	Du, JJ; Zhang, PW; Zhao, X; He, J; Xu, Y; Zou, Q; Luo, J; Shen, LY; Gu, H; Tang, QZ; Li, MZ; Jiang, YZ; Tang, GQ; Bai, L; Li, XW; Wang, JY; Zhang, SH; Zhu, L				Du, Jingjing; Zhang, Peiwen; Zhao, Xue; He, Jin; Xu, Yan; Zou, Qin; Luo, Jia; Shen, Linyuan; Gu, Hao; Tang, Qianzi; Li, Mingzhou; Jiang, Yanzhi; Tang, Guoqing; Bai, Lin; Li, Xuewei; Wang, Jinyong; Zhang, Shunhua; Zhu, Li			MicroRNA-351-5p mediates skeletal myogenesis by directly targeting lactamase- and is regulated by lnc-mg	FASEB JOURNAL			English	Article						ceRNA; C2C12 cells; proliferation; differentiation	LONG NONCODING RNA; MUSCLE-FIBER-TYPE; CYCLIN-DEPENDENT KINASES; CELL PROLIFERATION; GENE-EXPRESSION; SATELLITE CELLS; STEM-CELLS; DIFFERENTIATION; MYOD; METABOLISM	Skeletal muscle is an important and complex organ with a variety of functions in humans and animals. Skeletal myogenesis is a multistep and complex process, and increasing evidence suggests that microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) play critical roles in skeletal myogenesis. In this study the expression of miR-351-5p is dynamically regulated during skeletal myogenesis in vitro and in vivo. Cell-counting kit-8, qRT-PCR, and EdU immunofluorescence analysis showed that miR-351-5p overexpression promoted the proliferation and inhibited the differentiation of C2C12 myoblast, whereas inhibition of miR-351-5p had the opposite effect. In addition, miR-351-5p mediated the regulation of muscle fiber type transition in vivo. In vitro, loss of miR-351-5p in muscle tissues promoted muscle hypertrophy and increased slow-twitch fibers in the gastrocnemius muscles of mice. Luciferase reporter assay and functional analyses demonstrated that lactamase (LACTB) is a direct target of miR-351-5p involved in the regulation of skeletal myogenesis. Expression levels of a myogenesis-associated lncRNA (lnc-mg) correlated negatively with miR-351-5p and positively with LACTB during C2C12 myoblast proliferation and differentiation. Further analyses showed that lnc-mg acted as a molecular sponge for miR-351-5p, demonstrating its involvement in the negative regulation of LACTB by miR-351-5p during skeletal myogenesis. These findings indicate that miRNA-351-5p functions in skeletal myogenesis by targeting LACTB and is regulated by lnc-mg, supporting the role of the competing endogenous RNA network in skeletal myogenesis.Du, J., Zhang, P., Zhao, X., He, J., Xu, Y., Zou, Q., Luo, J., Shen, L., Gu, H., Tang, Q., Li, M., Jiang, Y., Tang, G., Bai, L., Li, X., Wang, J., Zhang, S., Zhu, L. MicroRNA-351-5p mediates skeletal myogenesis by directly targeting lactamase and is regulated by lnc-mg.	[Du, Jingjing; Zhang, Peiwen; Zhao, Xue; He, Jin; Xu, Yan; Luo, Jia; Shen, Linyuan; Gu, Hao; Tang, Qianzi; Li, Mingzhou; Tang, Guoqing; Bai, Lin; Li, Xuewei; Zhang, Shunhua; Zhu, Li] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Sichuan, Peoples R China; [Zou, Qin; Jiang, Yanzhi] Sichuan Agr Univ, Coll Life & Sci, Chengdu, Sichuan, Peoples R China; [Wang, Jinyong] Chongqing Acad Anim Sci, Rongchang, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zhang, SH; Zhu, L (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Sichuan, Peoples R China.	zhangsh1919@163.com; zhuli7508@163.com	Zou, Qin/GVU-2237-2022	Shen, Linyuan/0000-0001-6072-3268; Li, Mingzhou/0000-0001-8681-7684	National Key Research and Development Program of China [2018YFD0501004]; Sichuan Sci and Tech Support Program [6ZC2838, 2016NZ0089]; National Natural Science Foundation of China [31530073]; Earmarked Fund for China Agriculture Research System [CARS-36-05B]	National Key Research and Development Program of China; Sichuan Sci and Tech Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for China Agriculture Research System	This study was supported by the National Key Research and Development Program of China (Grant 2018YFD0501004 to L.Z.), the Sichuan Sci and Tech Support Program (Grants 6ZC2838 and 2016NZ0089 to L.Z.), National Natural Science Foundation of China (Grant 31530073 to L.Z.), and the Earmarked Fund for China Agriculture Research System (Grant CARS-36-05B to L.Z.). The authors declare no conflicts of interest.	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Beylkin DH, 2006, DEV BIOL, V294, P541, DOI 10.1016/j.ydbio.2006.02.049; Boonstra K, 2018, BBA-MOL CELL RES, V1865, P95, DOI 10.1016/j.bbamcr.2017.07.016; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; Cheng X, 2018, BIOMED PHARMACOTHER, V101, P528, DOI 10.1016/j.biopha.2018.02.096; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; GERDES J, 1984, J IMMUNOL, V133, P1710; Gong CG, 2015, DEV CELL, V34, P181, DOI 10.1016/j.devcel.2015.05.009; GRANA X, 1995, ONCOGENE, V11, P211; Hanke N, 2011, BBA-MOL CELL RES, V1813, P377, DOI 10.1016/j.bbamcr.2010.12.021; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ijuin T, 2015, BBA-MOL CELL RES, V1853, P3192, DOI 10.1016/j.bbamcr.2015.09.009; Jia L, 2014, INT J MOL SCI, V15, P296, DOI 10.3390/ijms15010296; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Keckesova Z, 2017, NATURE, V543, P681, DOI 10.1038/nature21408; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9054; Li L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/s00335-009-9241-2; Li ZZ, 2013, DEV CELL, V24, P112, DOI 10.1016/j.devcel.2012.12.007; Lindholm ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006294; Liu J, 2016, EMBO MOL MED, V8, P1212, DOI 10.15252/emmm.201606372; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Velasco E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/391306; Lv MX, 2017, BBA-MOL CELL RES, V1864, P1887, DOI 10.1016/j.bbamcr.2017.08.001; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Polianskyte Z, 2009, P NATL ACAD SCI USA, V106, P18960, DOI 10.1073/pnas.0906734106; Qaisar R, 2016, FREE RADICAL BIO MED, V98, P56, DOI 10.1016/j.freeradbiomed.2016.03.025; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salmon M, 2009, BBA-MOL CELL RES, V1793, P1144, DOI 10.1016/j.bbamcr.2009.01.019; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; Shen LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148532; Shu MF, 2012, MOL PHARMACOL, V81, P292, DOI 10.1124/mol.111.076166; Song CC, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv006; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Sun XM, 2016, BBA-MOL CELL RES, V1863, P2835, DOI 10.1016/j.bbamcr.2016.08.014; Sun ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P4765, DOI 10.2741/3038; Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607; Umemoto T, 2011, BBA-GEN SUBJECTS, V1810, P1127, DOI 10.1016/j.bbagen.2011.09.008; Valdez MR, 2000, DEV BIOL, V219, P287, DOI 10.1006/dbio.2000.9621; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Waldemer-Streyer R. J., 2017, NPJ REGEN MED, V2, P16017; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7779; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu XC, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0040-6; Yan M, 2016, GENE DEV, V30, P1034, DOI 10.1101/gad.281410.116; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang D, 2014, J CELL BIOL, V207, P753, DOI 10.1083/jcb.201406068; Zhang Y, 2015, BIOCHEM BIOPH RES CO, V468, P300, DOI 10.1016/j.bbrc.2015.10.108; Zhu M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14718	66	31	34	2	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1911	1926		10.1096/fj.201701394RRR	http://dx.doi.org/10.1096/fj.201701394RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30216112	Bronze			2022-12-28	WOS:000457296600032
J	Seyed-Razavi, Y; Lopez, MJ; Mantopoulos, D; Zheng, LX; Massberg, S; Sendra, VG; Harris, DL; Hamrah, P				Seyed-Razavi, Yashar; Lopez, Maria J.; Mantopoulos, Dimosthenis; Zheng, Lixin; Massberg, Steffen; Sendra, Victor G.; Harris, Deshea L.; Hamrah, Pedram			Kinetics of corneal leukocytes by intravital multiphoton microscopy	FASEB JOURNAL			English	Article						antigen-presenting cells; dendritic cells; MHC-II; keratitis; cell morphology	MHC CLASS-II; OCULAR IMMUNE PRIVILEGE; MARROW-DERIVED CELLS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; IN-VIVO; 2ND-HARMONIC GENERATION; T-CELLS; BEHAVIORAL-RESPONSES; TISSUE MACROPHAGES	Corneal immune privilege is integral in maintaining the clear avascular window to the foreign world. The presence of distinct populations of corneal leukocytes (CLs) in the normal cornea has been firmly established. However, their precise function and kinetics remain, as of yet, unclear. Through intravital multiphoton microscopy (IV-MPM), allowing the means to accumulate critical spatial and temporal cellular information, we provide details for long-term investigation of CL morphology and kinetics under steady state and following inflammation. Significant alterations in size and morphology of corneal CD11c(+) dendritic cells (DCs) were noted following acute sterile inflammation, including cell volume (4364.4 +/- 489.6 vs. 1787.6 +/- 111.0 m(3), P < 0.001) and sphericity (0.82 +/- 0.01 vs. 0.42 +/- 0.02, P < 0.001) compared with steady state. Furthermore, IV-MPM analyses revealed alterations in both the CD11c(+) DC and major histocompatibility complex class II (MHC)-II+ mature antigen-presenting cell population kinetics during inflammation, including track displacement length (CD11c: 16.57 +/- 1.41 vs. 4.64 +/- 0.56 m, P < 0.001; MHC-II: 9.03 +/- 0.37 vs. 4.09 +/- 0.39, P < 0.001) and velocity (CD11c: 1.91 +/- 0.07 m/min vs. 1.73 +/- 0.1302 m/min; MHC-II: 2.97 +/- 0.07 vs. 1.62 +/- 0.08, P < 0.001) compared with steady state. Our results reveal in vivo evidence of sessile CL populations exhibiting dendritic morphology under steady state and increased velocity of spherical leukocytes following inflammation. IV-MPM represents a powerful tool to study leukocytes in corneal diseases in context.Seyed-Razavi, Y., Lopez, M. J., Mantopoulos, D., Zheng, L., Massberg, S., Sendra, V. G., Harris, D. L., Hamrah, P. Kinetics of corneal leukocytes by intravital multiphoton microscopy.	[Seyed-Razavi, Yashar; Lopez, Maria J.; Sendra, Victor G.; Harris, Deshea L.; Hamrah, Pedram] Tufts Univ, Sch Med, Ctr Translat Ocular Immunol, Boston, MA 02111 USA; [Seyed-Razavi, Yashar; Lopez, Maria J.; Sendra, Victor G.; Harris, Deshea L.; Hamrah, Pedram] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Ophthalmol, 800 Washington St,Box 312, Boston, MA 02111 USA; [Hamrah, Pedram] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Seyed-Razavi, Yashar; Lopez, Maria J.; Mantopoulos, Dimosthenis; Zheng, Lixin; Sendra, Victor G.; Harris, Deshea L.; Hamrah, Pedram] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA; [Hamrah, Pedram] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Cornea Serv, Boston, MA 02114 USA; [Mantopoulos, Dimosthenis; Zheng, Lixin; Massberg, Steffen; Hamrah, Pedram] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA USA; [Massberg, Steffen] Ludwig Maximilians Univ Munchen, Dept Cardiol, Munich, Germany; [Hamrah, Pedram] Tufts New England Eye Ctr, Cornea Serv, Boston, MA USA	Tufts University; Tufts Medical Center; Tufts University; Tufts University; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; University of Munich	Hamrah, P (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Dept Ophthalmol, 800 Washington St,Box 312, Boston, MA 02111 USA.	pedram.hamrah@tufts.edu	Massberg, Steffen/AAN-6054-2021	Seyed Razavi, Yashar/0000-0003-4657-2074	U.S. National Institutes of Health, National Eye Institute [R01-EY022695, K08-EY020575, K12-EY016335]; Research to Prevent Blindness Career Development Award; Fight for Sight; NATIONAL EYE INSTITUTE [K12EY016335, R01EY022695] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial support was provided by U.S. National Institutes of Health, National Eye Institute Grants R01-EY022695, K08-EY020575, and K12-EY016335 (to P.H.); Research to Prevent Blindness Career Development Award (to P.H.); and Fight for Sight Grant-in-Aid (to P.H.). The authors are grateful to Dr. Ulrich H. von Andrian (Harvard Medical School) for his critical consultations and suggestions in experimental design, and to the Harvard Medical School Center for Immune Imaging. The authors declare no conflicts of interest.	Acosta MC, 2001, J PHYSIOL-LONDON, V534, P511, DOI 10.1111/j.1469-7793.2001.t01-1-00511.x; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Hoang ATN, 2014, J LEUKOCYTE BIOL, V96, P481, DOI 10.1189/jlb.3TA0513-303R; Benhar I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00296; Benninger R.K.P., 2013, CURR PROTOC CELL BIO, P1; Blomster LV, 2011, MOL CELL NEUROSCI, V48, P236, DOI 10.1016/j.mcn.2011.08.004; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Bueno JM, 2011, INVEST OPHTH VIS SCI, V52, P5325, DOI 10.1167/iovs.11-7184; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Carlson EC, 2006, INVEST OPHTH VIS SCI, V47, P241, DOI 10.1167/iovs.04-0741; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chinnery HR, 2007, INVEST OPHTH VIS SCI, V48, P1568, DOI 10.1167/iovs.06-0746; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Cook WJ, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-5; Coppieters K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015732; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EFRON N, 1989, CURR EYE RES, V8, P901; Forrester JV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00338; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gao N, 2016, SCI REP-UK, V6, DOI 10.1038/srep36414; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hammarfjord O, 2010, J LEUKOCYTE BIOL, V88, P747, DOI 10.1189/jlb.0310155; Hamrah P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1132, DOI 10.1001/archopht.121.8.1132; Hamrah P, 2003, INVEST OPHTH VIS SCI, V44, P581, DOI 10.1167/iovs.02-0838; Hamrah P, 2002, INVEST OPHTH VIS SCI, V43, P639; Hamrah P, 2010, ENCY EYE, P120; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; Han M, 2004, J BIOMED OPT, V9, P760, DOI 10.1117/1.1756919; Hashimoto M, 2015, J IMMUNOL, V195, P1182, DOI 10.4049/jimmunol.1500348; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Knickelbein JE, 2014, INVEST OPHTH VIS SCI, V55, P1118, DOI 10.1167/iovs.13-13523; Knickelbein JE, 2009, OPHTHALMOL EYE DIS, V1, P45; Kojima S, 2016, INVEST OPHTH VIS SCI, V57, P1207, DOI 10.1167/iovs.15-18507; Kolesnikov M, 2015, J IMMUNOL METHODS, V421, P73, DOI 10.1016/j.jim.2015.03.008; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Lee EJ, 2010, INVEST OPHTH VIS SCI, V51, P2101, DOI 10.1167/iovs.08-2213; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Lo W, 2006, MICROSC RES TECHNIQ, V69, P973, DOI 10.1002/jemt.20373; Lyubovitsky JG, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2163254; Mantopoulos D, 2010, SEMIN OPHTHALMOL, V25, P178, DOI 10.3109/08820538.2010.518542; MEDAWAR PB, 1961, NATURE, V189, P14, DOI 10.1038/189014a0; Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mori A, 1997, AM J OPHTHALMOL, V124, P729, DOI 10.1016/S0002-9394(14)71689-7; Morishige N, 2007, INVEST OPHTH VIS SCI, V48, P1087, DOI 10.1167/iovs.06-1177; Nakamura T, 2005, INVEST OPHTH VIS SCI, V46, P497, DOI 10.1167/iovs.04-1154; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Niederkorn JY, 2003, J LEUKOCYTE BIOL, V74, P167, DOI 10.1189/jlb.1102543; Nishibu A, 2006, J INVEST DERMATOL, V126, P787, DOI 10.1038/sj.jid.5700107; Park CY, 2015, INVEST OPHTH VIS SCI, V56, P5622, DOI 10.1167/iovs.15-17129; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; Piston DW, 1999, TRENDS CELL BIOL, V9, P66, DOI 10.1016/S0962-8924(98)01432-9; Roediger B, 2008, HISTOCHEM CELL BIOL, V130, P1131, DOI 10.1007/s00418-008-0531-7; Seyed-Razavi Y, 2014, INVEST OPHTH VIS SCI, V55, P1313, DOI 10.1167/iovs.13-12995; Sharaf R, 2016, METHODS MOL BIOL, V1354, P189, DOI 10.1007/978-1-4939-3046-3_13; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sosnova M, 2005, STEM CELLS, V23, P507, DOI 10.1634/stemcells.2004-0291; Steven P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026253; Streilein J W, 1999, Chem Immunol, V73, P11; Streilein JW, 2003, J LEUKOCYTE BIOL, V74, P179, DOI 10.1189/jlb.1102574; Streilein JW, 2003, EYE, V17, P943, DOI 10.1038/sj.eye.6700615; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Streilein JW, 2002, DNA CELL BIOL, V21, P453, DOI 10.1089/10445490260099746; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Tan HY, 2006, INVEST OPHTH VIS SCI, V47, P5251, DOI 10.1167/iovs.06-0386; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Turcotte R, 2014, BIOMED OPT EXPRESS, V5, P3578, DOI 10.1364/BOE.5.003578; Ueta M, 2016, BRIT J OPHTHALMOL, V100, P432, DOI 10.1136/bjophthalmol-2015-307024; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Ward BR, 2007, IMMUNOLOGY, V120, P556, DOI 10.1111/j.1365-2567.2006.02533.x; Yamagami S, 2006, ARCH OPHTHALMOL-CHIC, V124, P62, DOI 10.1001/archopht.124.1.62; Yamagami S, 2005, CORNEA, V24, pS71, DOI 10.1097/01.ico.0000178732.42921.05; Yamagami S, 2005, INVEST OPHTH VIS SCI, V46, P4489, DOI 10.1167/iovs.05-0054; Yamagami S, 1999, INVEST OPHTH VIS SCI, V40, P2892; Zgair AK, 2012, CELL IMMUNOL, V275, P55, DOI 10.1016/j.cellimm.2012.03.001; Zhang HM, 2013, INVEST OPHTH VIS SCI, V54, P6526, DOI 10.1167/iovs.13-12214; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	86	20	21	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2199	2211		10.1096/fj.201800684RR	http://dx.doi.org/10.1096/fj.201800684RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30226811	Green Published			2022-12-28	WOS:000457296600054
J	Godoy, JC; Niesman, IR; Busija, AR; Kassan, A; Schilling, JM; Schwarz, A; Alvarez, EA; Dalton, ND; Drummond, JC; Roth, DM; Kararigas, G; Patel, HH; Zemljic-Harpf, AE				Godoy, Joseph C.; Niesman, Ingrid R.; Busija, Anna R.; Kassan, Adam; Schilling, Jan M.; Schwarz, Anna; Alvarez, Erika A.; Dalton, Nancy D.; Drummond, John C.; Roth, David M.; Kararigas, Georgios; Patel, Hemal H.; Zemljic-Harpf, Alice E.			Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes	FASEB JOURNAL			English	Article						Statins; statin-induced myopathy; cardiomyocytes; oxygen consumption rate; heart failure	COA REDUCTASE INHIBITION; SERUM TOTAL CHOLESTEROL; COENZYME-A REDUCTASE; HEART-FAILURE; LDL CHOLESTEROL; STATIN THERAPY; RAT; SIMVASTATIN; GLUCOSE; CERIVASTATIN	Statins, which reduce LDL-cholesterol by inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are among the most widely prescribed drugs. Skeletal myopathy is a known statin-induced adverse effect associated with mitochondrial changes. We hypothesized that similar effects would occur in cardiac myocytes in a lipophilicity-dependent manner between 2 common statins: atorvastatin (lipophilic) and pravastatin (hydrophilic). Neonatal cardiac ventricular myocytes were treated with atorvastatin and pravastatin for 48 h. Both statins induced endoplasmic reticular (ER) stress, but only atorvastatin inhibited ERK1/2(T202/Y204), Akt(Ser473), and mammalian target of rapamycin signaling; reduced protein abundance of caveolin-1, dystrophin, epidermal growth factor receptor, and insulin receptor-; decreased Ras homolog gene family member A activation; and induced apoptosis. In cardiomyocyte-equivalent HL-1 cells, atorvastatin, but not pravastatin, reduced mitochondrial oxygen consumption. When male mice underwent atorvastatin and pravastatin administration per os for up to 7 mo, only long-term atorvastatin, but not pravastatin, induced elevated serum creatine kinase; swollen, misaligned, size-variable, and disconnected cardiac mitochondria; alteration of ER structure; repression of mitochondria- and endoplasmic reticulum-related genes; and a 21% increase in mortality in cardiac-specific vinculin-knockout mice during the first 2 months of administration. To our knowledge, we are the first to demonstrate in vivo that long-term atorvastatin administration alters cardiac ultrastructure, a finding with important clinical implications.Godoy, J. C., Niesman, I. R., Busija, A. R., Kassan, A., Schilling, J. M., Schwarz, A., Alvarez, E. A., Dalton, N. D., Drummond, J. C., Roth, D. M., Kararigas, G., Patel, H. H., Zemljic-Harpf, A. E. Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes.	[Godoy, Joseph C.; Kassan, Adam; Schilling, Jan M.; Schwarz, Anna; Drummond, John C.; Roth, David M.; Patel, Hemal H.; Zemljic-Harpf, Alice E.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Niesman, Ingrid R.; Busija, Anna R.; Kassan, Adam; Schilling, Jan M.; Drummond, John C.; Roth, David M.; Patel, Hemal H.; Zemljic-Harpf, Alice E.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Alvarez, Erika A.; Dalton, Nancy D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kassan, Adam] West Coast Univ, Dept Pharmaceut Sci, Sch Pharm, North Hollywood, CA USA; [Kararigas, Georgios] Charite Univ Med Berlin, Berlin, Germany; [Kararigas, Georgios] German Ctr Cardiovasc Res DZHK, Berlin, Germany	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Zemljic-Harpf, AE (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	azemljicharpf@ucsd.edu	Stefanadis, Christodoulos/ABH-2232-2020; Patel, Hemal/C-7325-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; Niesman, Ingrid/0000-0001-9767-6629; Patel, Hemal/0000-0001-6722-9625; Kararigas, Georgios/0000-0002-8187-0176	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [HL107200, HL091071]; U.S. National Institutes of Health (National Institute on Aging) [AG052722]; American Heart Association Beginning Grant-in-Aid (BGIA) [2260359]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG052722] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association Beginning Grant-in-Aid (BGIA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. Marilyn Farquhar (University of California, San Diego), Velia Fowler, and Malcom Wood (both from Scripps Research, La Jolla, CA, USA) for helpful discussions regarding the TEM analysis; Ying Jones (University of California, San Diego) for excellent technical assistance in preparation of tissues for electron microscopic analysis; Drs. Joan Heller Brown and Sunny Y. Xiang (both from the University of California, San Diego) for providing the GST plasmid; the Veterans Affairs/Veterans Medical Research Foundation (VA/VMRF) Microarray and Next Generation Sequencing (NGS) Core (San Diego, CA, USA) for microarray profiling; and Dr. Benedict Lucchesi (University of Michigan, Ann Arbor, MI, USA) for valuable scientific discussions and encouragement to pursue this project. The authors declare no conflicts of interest. This work was funded by the U.S. National Institutes of Health HL107200, HL091071 (National Heart, Lung, and Blood Institute), and AG052722 (National Institute on Aging) (to H.H.P.), and by American Heart Association Beginning Grant-in-Aid (BGIA) 2260359 (to A.E.Z.-H.).	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Allard NAE, 2018, J CLIN ENDOCR METAB, V103, P75, DOI 10.1210/jc.2017-01561; Apostolopoulou M, 2015, EUR J CLIN INVEST, V45, P745, DOI 10.1111/eci.12461; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bakakos A, 2017, CURR PHARM DESIGN, V23, P7128, DOI 10.2174/1381612823666170926125754; Baker SK, 2001, CLIN INVEST MED, V24, P258; Bergt Stefan, 2017, JACC Basic Transl Sci, V2, P149, DOI 10.1016/j.jacbts.2017.01.009; Brault M, 2014, METABOLISM, V63, P735, DOI 10.1016/j.metabol.2014.02.014; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen YH, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1828071; Chung HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168065; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crane FL, 2007, MITOCHONDRION, V7, pS2, DOI 10.1016/j.mito.2007.02.011; Crespo MJ, 2014, PHARMACOLOGY, V93, P84, DOI 10.1159/000358256; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Demeulder B, 2013, BBA-MOL BASIS DIS, V1832, P780, DOI 10.1016/j.bbadis.2013.02.015; Dong QT, 2011, INT J CARDIOL, V153, P311, DOI 10.1016/j.ijcard.2010.08.047; ENDO A, 1992, J LIPID RES, V33, P1569; FOLKERS K, 1990, P NATL ACAD SCI USA, V87, P8931, DOI 10.1073/pnas.87.22.8931; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Gambelli S., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P85; Ghavami S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.61; Giordano N, 1997, LANCET, V349, P1600, DOI 10.1016/S0140-6736(05)61628-5; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Gray DF, 2000, CARDIOVASC RES, V47, P329, DOI 10.1016/S0008-6363(00)00106-1; Greene SJ, 2013, AM J CARDIOL, V111, P574, DOI 10.1016/j.amjcard.2012.10.042; Guder G, 2009, CIRC-HEART FAIL, V2, P563, DOI 10.1161/CIRCHEARTFAILURE.108.825059; Hasegawa H, 2003, J MOL CELL CARDIOL, V35, P953, DOI 10.1016/S0022-2828(03)00180-9; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Horwich TB, 2008, AM HEART J, V156, P1170, DOI 10.1016/j.ahj.2008.07.004; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Inoue R, 2003, J PHARMACOL SCI, V93, P279, DOI 10.1254/jphs.93.279; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jarcho JA, 2015, NEW ENGL J MED, V372, P2448, DOI 10.1056/NEJMe1507041; Jiang ZH, 2016, MED SCI MONITOR, V22, P2825, DOI 10.12659/MSM.897047; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Kadota S, 2008, J CARDIOL, V51, P171, DOI 10.1016/j.jjcc.2008.02.003; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kobayashi M, 2008, LIFE SCI, V82, P969, DOI 10.1016/j.lfs.2008.02.019; Krols M, 2016, J CELL BIOL, V214, P367, DOI 10.1083/jcb.201607124; Kumazaki M, 2013, EUR J PHARMACOL, V707, P71, DOI 10.1016/j.ejphar.2013.03.022; Ky B, 2008, J AM COLL CARDIOL, V51, P1653, DOI 10.1016/j.jacc.2008.01.026; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Liantonio A, 2007, J PHARMACOL EXP THER, V321, P626, DOI 10.1124/jpet.106.118331; Liao Y, 2008, HYPERTENS RES, V31, P335, DOI 10.1291/hypres.31.335; Liao Y, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00307; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Martinet W, 2014, ATHEROSCLEROSIS, V233, P601, DOI 10.1016/j.atherosclerosis.2014.01.040; Marz W, 2000, J Cardiovasc Pharmacol Ther, V5, P275, DOI 10.1054/JCPT.2000.16695; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Mita T, 2007, ENDOCR J, V54, P441, DOI 10.1507/endocrj.K06-198; Mullen PJ, 2011, BBA-MOL CELL RES, V1813, P2079, DOI 10.1016/j.bbamcr.2011.07.019; NAKAHARA K, 1994, BIOCHEM BIOPH RES CO, V202, P1579, DOI 10.1006/bbrc.1994.2112; Nakao T, 2007, J PHARMACOL SCI, V105, P334, DOI 10.1254/jphs.FP0070682; Nochioka K, 2015, CIRC J, V79, P574, DOI 10.1253/circj.CJ-14-0865; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Omar MA, 2001, ANN PHARMACOTHER, V35, P1096, DOI 10.1345/aph.10228; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sarr FS, 2008, J CHROMATOGR B, V868, P20, DOI 10.1016/j.jchromb.2008.03.034; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Teshima Y, 2009, J CARDIOL, V53, P58, DOI 10.1016/j.jjcc.2008.08.008; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071; Tousoulis D, 2014, PHARMACOL THERAPEUT, V141, P79, DOI 10.1016/j.pharmthera.2013.09.001; Trapani L, 2011, FASEB J, V25, P4037, DOI 10.1096/fj.11-184218; Vaduganathan M, 2014, HEART FAIL REV, V19, P695, DOI 10.1007/s10741-014-9423-1; Vallejo-Vaz AJ, 2015, ATHEROSCLEROSIS, V241, P409, DOI 10.1016/j.atherosclerosis.2015.06.001; Wagner RJ, 2010, AM J PHYSIOL-CELL PH, V299, pC119, DOI 10.1152/ajpcell.00429.2009; Wang JC, 2018, CANCER SCI, V109, P1627, DOI 10.1111/cas.13570; Wiggins BS, 2016, CIRCULATION, V134, pE468, DOI 10.1161/CIR.0000000000000456; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zemljic-Harpf AE, 2014, J CELL SCI, V127, P1104, DOI 10.1242/jcs.143743; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977; Zheng G, 2015, J INTERV CARDIOL, V28, P514, DOI 10.1111/joic.12245; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110; Zhu YQ, 2016, J MOL CELL CARDIOL, V97, P204, DOI 10.1016/j.yjmcc.2016.05.013	89	18	19	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1209	1225		10.1096/fj.201800876R	http://dx.doi.org/10.1096/fj.201800876R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30169110	Green Published, Bronze			2022-12-28	WOS:000457401500096
J	Inoue, M; Matsuoka, H; Lesage, F; Harada, K				Inoue, Masumi; Matsuoka, Hidetada; Lesage, Florian; Harada, Keita			Lack of p11 expression facilitates acidity-sensing function of TASK1 channels in mouse adrenal medullary cells	FASEB JOURNAL			English	Article						chromaffin cell; trafficking; ER exit; K channel; pH	RECTIFYING K+ CHANNELS; POTASSIUM CHANNELS; CHROMAFFIN CELLS; CATECHOLAMINE SECRETION; MUSCARINIC RECEPTOR; BK CHANNELS; STIMULATION; INHIBITION; APAMIN; TASK-1/TASK-3	External acidity induces catecholamine secretion by inhibiting TASK1-like channels in rat adrenal medullary (AM) cells. TASK channels can function as a heteromer or homomer in the TASK subfamily. In this study, we elucidate the molecular identity of TASK1-like channels in mouse AM cells using gene knockout. Genetic deletion of TASK1, but not TASK3, abolished the depolarizing inward current and catecholamine secretion in response to acidity, whereas it did not affect the resting current level. Immunocytochemistry revealed that AM cells exhibited predominantly TASK1-like and little TASK3-like immunoreactivity. A proximity ligation assay showed that TASK1/3 heteromeric channels were not formed in AM cells or PC12 cells. However, the exogenous expression of p11 in PC12 cells resulted in the heteromeric formation of TASK isoforms, which were mainly located in the cytoplasm, and p11 was not expressed in rat adrenal medullae or PC12 cells. In AM cells, genetic deletion of TASK1 resulted in enhancement of the immunoreactivity of the TALK2 channel, but not TASK3. The results indicate that TASK1 homomeric channels function as acidity sensors in AM cells, and that function is facilitated by the lack of p11 expression.Inoue, M., Matsuoka, H., Lesage, F., Harada, K. Lack of p11 expression facilitates acidity-sensing function of TASK1 channels in mouse adrenal medullary cells.	[Inoue, Masumi; Matsuoka, Hidetada; Harada, Keita] Univ Occupat & Environm Hlth, Sch Med, Dept Cell & Syst Physiol, Kitakyushu, Fukuoka, Japan; [Lesage, Florian] Univ Cote Azur, Lab Excellence Ion Channel Sci & Therapeut LabEx, Inst Pharmacol Mol & Cellulaire, CNRS,INSERM, Valbonne, France	University of Occupational & Environmental Health - Japan; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Inoue, M (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Cell & Syst Physiol, Yahatanishi Ku, 1-1 Isseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	minoue@med.uoeh-u.ac.jp	Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106	Salt Science Foundation; Japan Society for the Promotion of Science [17K08555, 26460306]	Salt Science Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by a grant from the Salt Science Foundation (to M.I.), and the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI; 17K08555 to M.I. and 26460306 to H.M.). The authors are grateful to Dr. W. Wisden for the generous gift of TASK1-KO and TASK3-KO mice, and to Dr. D. A. Bayliss (University of Virginia, Charlottesville, VA, USA) for that of GFP-TASK1 and GFP-TASK3 constructs. Thanks are also due to Dr. J. H. Steinbach (Washington University, St. Louis, MO, USA) for critically reading an early version of the manuscript. The authors declare no conflicts of interest.	Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; Bournaud R, 2007, PFLUG ARCH EUR J PHY, V454, P83, DOI 10.1007/s00424-006-0185-z; BRANDT BL, 1976, J PHYSIOL-LONDON, V263, P417, DOI 10.1113/jphysiol.1976.sp011638; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CLAUSEN T, 1993, J PHYSIOL-LONDON, V472, P521, DOI 10.1113/jphysiol.1993.sp019960; CRYER PE, 1980, NEW ENGL J MED, V303, P436; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; Feliciangeli S, 2015, J PHYSIOL-LONDON, V593, P2587, DOI 10.1113/jphysiol.2014.287268; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Guarina L, 2017, J PHYSIOL-LONDON, V595, P2587, DOI 10.1113/JP273735; Harada K, 2018, CELL TISSUE RES, V372, P457, DOI 10.1007/s00441-018-2809-y; Harada K, 2015, BRIT J PHARMACOL, V172, P1348, DOI 10.1111/bph.13011; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Inoue M, 2000, J PHYSIOL-LONDON, V528, P473, DOI 10.1111/j.1469-7793.2000.00473.x; INOUE M, 1995, BRIT J PHARMACOL, V114, P419, DOI 10.1111/j.1476-5381.1995.tb13243.x; Inoue M, 1997, AM J PHYSIOL-CELL PH, V273, pC137, DOI 10.1152/ajpcell.1997.273.1.C137; INOUE M, 1993, AM J PHYSIOL, V265, pC946, DOI 10.1152/ajpcell.1993.265.4.C946; Inoue M, 2018, PFLUG ARCH EUR J PHY, V470, P29, DOI 10.1007/s00424-017-2047-2; Inoue M, 2012, AM J PHYSIOL-CELL PH, V303, pC635, DOI 10.1152/ajpcell.00147.2012; Inoue M, 2008, J NEUROCHEM, V106, P1804, DOI 10.1111/j.1471-4159.2008.05521.x; Inoue S, 2017, FASEB J, V31; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kilisch M, 2015, PFLUG ARCH EUR J PHY, V467, P1105, DOI 10.1007/s00424-014-1672-2; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Lee J, 2000, PFLUG ARCH EUR J PHY, V439, P700, DOI 10.1007/s004240050995; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; MASIAKOWSKI P, 1988, P NATL ACAD SCI USA, V85, P1277, DOI 10.1073/pnas.85.4.1277; Matsuoka H, 2017, J PHYSIOL-LONDON, V595, P6851, DOI 10.1113/JP275039; Matsuoka H, 2013, PFLUG ARCH EUR J PHY, V465, P1051, DOI 10.1007/s00424-013-1222-3; MEDBO JI, 1990, J PHYSIOL-LONDON, V421, P105, DOI 10.1113/jphysiol.1990.sp017935; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MONTIEL C, 1995, J PHYSIOL-LONDON, V486, P427, DOI 10.1113/jphysiol.1995.sp020823; Nagayama T, 2000, AM J PHYSIOL-REG I, V279, pR448, DOI 10.1152/ajpregu.2000.279.2.R448; NEELY A, 1992, J PHYSIOL-LONDON, V453, P97, DOI 10.1113/jphysiol.1992.sp019220; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Rinne S, 2015, J MOL CELL CARDIOL, V81, P71, DOI 10.1016/j.yjmcc.2015.01.017; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOLARO CR, 1995, J NEUROSCI, V15, P6110; Streit AK, 2011, J BIOL CHEM, V286, P13977, DOI 10.1074/jbc.M111.227884; Suzuki Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186252; Thompson RJ, 1998, J PHYSIOL-LONDON, V512, P421, DOI 10.1111/j.1469-7793.1998.421be.x	51	7	8	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					455	468		10.1096/fj.201800407RR	http://dx.doi.org/10.1096/fj.201800407RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30001168	Bronze			2022-12-28	WOS:000457401500036
J	Li, N; Kong, M; Zeng, S; Hao, CZ; Li, M; Li, LY; Xu, Z; Zhu, M; Xu, Y				Li, Nan; Kong, Ming; Zeng, Sheng; Hao, Chenzhi; Li, Min; Li, Luyang; Xu, Zheng; Zhu, Min; Xu, Yong			Brahma related gene 1 (Brg1) contributes to liver regeneration by epigenetically activating the Wnt/-catenin pathway in mice	FASEB JOURNAL			English	Article						transcriptional regulation; epigenetics; Wnt signaling; chromatin remodeling protein; histone demethylase	TRANSCRIPTION FACTOR; BETA-CATENIN; C-MYC; SWI/SNF; CELLS; BRM; COMPLEXES; FIBROSIS; REQUIRES; PLAYS	Liver regeneration is a complicated pathophysiologic process that is regulated by a myriad of signaling pathways and transcription factors. The interaction among these pathways and factors, either cooperatively or antagonistically, may ultimately lead to recovery and restoration of liver function or permanent loss of liver function and liver failure. In the present study, we investigated the mechanism whereby the chromatin remodeling protein brahma related gene 1 (Brg1) regulates liver regeneration in mice. The Smarca4-Flox strain of mice was crossbred with the Alb-Cre strain to generate hepatocyte-specific Brg1 knockout mice. Liver injury was induced by partial hepatectomy (PHx). We report that Brg1 deletion in hepatocyte compromised liver regeneration and dampened survival after PHx in mice. Brg1 interacted with -catenin to potentiate Wnt signaling and promote hepatocyte proliferation. Mechanistically, Brg1 recruited lysine demethylase 4 (KDM4) to activate -catenin target genes. Our data suggest that Brg1 might play an essential role maintaining hepatic homeostasis and contributing to liver repair.Li, N., Kong, M., Zeng, S., Hao, C., Li, M., Li, L., Xu, Z., Zhu, M., Xu, Y. Brahma related gene 1 (Brg1) contributes to liver regeneration by epigenetically activating the Wnt/-catenin pathway in mice.	[Li, Nan; Kong, Ming; Zeng, Sheng; Hao, Chenzhi; Li, Min; Li, Luyang; Xu, Zheng; Xu, Yong] Nanjing Med Univ, Dept Pathophysiol, Key Lab Targeted Intervent Cardiovasc Dis, Collaborat Ctr Cardiovasc Translat Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Min] Nanjing Med Univ, Dept Anat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhu, M; Xu, Y (corresponding author), Nanjing Med Univ, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	zhumin@njmu.edu.cn; yjxu@njmu.edu.cn			Natural Science Foundation of China [81725001, 81670223, 81401864]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grants 81725001, 81670223, and 81401864). The authors declare no conflicts of interest.	Berry WL, 2014, INT J ONCOL, V44, P1341, DOI 10.3892/ijo.2014.2279; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Endo M, 2013, LIVER INT, V33, P105, DOI 10.1111/liv.12005; Fan ZW, 2017, HEPATOLOGY, V65, P1904, DOI 10.1002/hep.29127; Fan ZW, 2015, BBA-GENE REGUL MECH, V1849, P1219, DOI 10.1016/j.bbagrm.2015.07.013; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Griffin CT, 2011, P NATL ACAD SCI USA, V108, P2282, DOI 10.1073/pnas.1013751108; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Itoh T, 2016, HEPATOLOGY, V64, P663, DOI 10.1002/hep.28661; Kaufmann B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180225; Kleger A, 2012, GASTROENTEROLOGY, V142, P907, DOI 10.1053/j.gastro.2012.01.004; Malouf GG, 2015, EPIGENETICS-US, V10, P872, DOI 10.1080/15592294.2015.1076955; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Oike T, 2013, JPN J CLIN ONCOL, V43, P849, DOI 10.1093/jjco/hyt101; Pedersen MT, 2016, EMBO J, V35, P1550, DOI 10.15252/embj.201593317; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sinha S, 2016, DNA CELL BIOL, V35, P373, DOI 10.1089/dna.2015.3155; Soeda J, 2014, HEPATOLOGY, V60, P1023, DOI 10.1002/hep.27266; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stravitz RT, 2009, NAT REV GASTRO HEPAT, V6, P542, DOI 10.1038/nrgastro.2009.127; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tian WF, 2016, INT J BIOCHEM CELL B, V71, P35, DOI 10.1016/j.biocel.2015.12.005; Tian WF, 2013, HEPATOLOGY, V58, P576, DOI 10.1002/hep.26207; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Weng XY, 2015, J MOL CELL CARDIOL, V82, P48, DOI 10.1016/j.yjmcc.2015.02.010; Wiley MM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001972; Willis MS, 2017, J MOL CELL CARDIOL, V105, P99, DOI 10.1016/j.yjmcc.2017.02.003; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Xu Yong, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P141; Yamamoto S, 2013, CARCINOGENESIS, V34, P2380, DOI 10.1093/carcin/bgt174; Yang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14941; ZHONG R, 2014, SCI REP UK, V4; Zhou BS, 2016, BBA-MOL BASIS DIS, V1862, P1203, DOI 10.1016/j.bbadis.2016.02.002	36	40	39	4	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					327	338		10.1096/fj.201800197R	http://dx.doi.org/10.1096/fj.201800197R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30001167				2022-12-28	WOS:000457401500027
J	Lin, CM; Cheng, CJ; Yang, SS; Tseng, MH; Yen, MT; Sung, CC; Lin, SH				Lin, Chien-Ming; Cheng, Chih-Jen; Yang, Sung-Sen; Tseng, Min-Hua; Yen, Ming-Tso; Sung, Chih-Chien; Lin, Shih-Hua			Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain	FASEB JOURNAL			English	Article						Cullin 3; Kelch-like 3; PHAII; with-no-lysine kinases	DISEASE-CAUSING MUTATIONS; FAMILIAL HYPERKALEMIC HYPERTENSION; NA-CL COTRANSPORTER; KELCH-LIKE 3; BLOOD-PRESSURE; KNOCKIN MOUSE; ION-TRANSPORT; WNK4; KINASE; UBIQUITINATION	The Kelch-like 3 (KLHL3) mutations contributed to the most common causative genes in patients with pseudohypoaldosteronism type II (PHAII); however, the molecular mechanisms of PHAII-causing mutations in BTB domain of KLHL3in vivo have not been investigated. We generated and analyzed Klhl3 knock-in (KI) mice carrying a missense M131V mutation in the BTB domain (corresponding to human KLHL3 M78V mutation). Klhl3(M131V/+) KI mice exhibited typical PHAII phenotype with an exaggerated diuretic response to hydrochlorothiazide. Their kidney tissues showed an unchanged KLHL3, decreased cullin 3 (Cul3), and increased with-no-lysine kinases (WNKs) WNK1 and WNK4 along with an enhanced downstream ste20-related proline/alanine-rich kinase/oxidative stress response kinase 1-N(K)CC phosphorylation. Their Cul3 protein in the cytosol of distal convoluted tubule cells was also significantly attenuated on immunogold-labeling electron microscopy. In microdissected renal tubules, Klhl3(M131V/+) KI mice expressed high levels of Wnk4 mRNA in the distal nephron. In vitro coimmunoprecipitation showed the KLHL3 BTB domain mutation retained intact interaction with WNKs but reduced binding to Cul3, thus leading to the increased abundance of total WNKs. In summary, Klhl3(M131V/+) KI mice feature typical PHAII with a simultaneous increase of WNK1 and WNK4 through the impaired KLHL3 BTB domain binding to Cul3.Lin, C.-M., Cheng, C.-J., Yang, S.-S., Tseng, M.-H., Yen, M.-T., Sung, C.-C., Lin, S.-H. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.	[Lin, Chien-Ming; Yang, Sung-Sen; Tseng, Min-Hua; Yen, Ming-Tso; Sung, Chih-Chien; Lin, Shih-Hua] Triserv Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Chien-Ming] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pediat, Taipei, Taiwan; [Cheng, Chih-Jen; Yang, Sung-Sen; Sung, Chih-Chien; Lin, Shih-Hua] Triserv Gen Hosp, Natl Def Med Ctr, Div Nephrol, Dept Med, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan; [Tseng, Min-Hua] Chang Gung Mem Hosp, Div Pediat Nephrol, Dept Pediat, Taoyuan, Taiwan; [Yen, Ming-Tso] Cathay Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Cathay General Hospital	Lin, SH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Div Nephrol, Dept Med, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan.	l521116@ndmctsgh.edu.tw	Cheng, Chih-Jen/AAM-3305-2021		Ministry of Science and Technology (MOST) [103-2314-B-016-010-MY3, 104-2314-B-016-023-MY3, 107-2314-B-016-064-MY3]; Research Fund of Tri-Service General Hospital (TSGH) [C105-110, C106-091, C106-007-S03, C107-015]; Teh-Tzer Study Group for Human Medical Research Foundation	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Research Fund of Tri-Service General Hospital (TSGH); Teh-Tzer Study Group for Human Medical Research Foundation	The authors thank the technical services provided by the Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, and the Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine. The authors thank T.-H. Chang, C.-C. Huang, W.-S. Lee, and M.-H. Chen (Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center) for their technical assistance. This work was supported in part by a grant from the Ministry of Science and Technology (MOST; 103-2314-B-016-010-MY3, 104-2314-B-016-023-MY3, and 107-2314-B-016-064-MY3), the Research Fund of Tri-Service General Hospital (TSGH; C105-110, C106-091, C106-007-S03, and C107-015), and the Teh-Tzer Study Group for Human Medical Research Foundation. The authors declare no conflicts of interest.	Ahlstrom R, 2009, AM J PHYSIOL-RENAL, V297, pF685, DOI 10.1152/ajprenal.00358.2009; Bergaya S, 2011, HYPERTENSION, V58, P439, DOI 10.1161/HYPERTENSIONAHA.111.172429; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Cheng CJ, 2015, AM J PHYSIOL-RENAL, V308, pF437, DOI 10.1152/ajprenal.00493.2013; Chiga M, 2011, J CELL SCI, V124, P1391, DOI 10.1242/jcs.084111; Ellison D. H., 2011, GENEREVIEWS, P1993; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Hadchouel J, 2006, J AM SOC NEPHROL, V17, P208, DOI 10.1681/ASN.2005030314; Huang CL, 2008, CURR OPIN NEPHROL HY, V17, P519, DOI 10.1097/MNH.0b013e32830dd580; Huang CL, 2015, PFLUG ARCH EUR J PHY, V467, P2235, DOI 10.1007/s00424-015-1708-2; Ishizawa K, 2016, BIOCHEM BIOPH RES CO, V480, P745, DOI 10.1016/j.bbrc.2016.10.127; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Lee YR, 2010, EMBO J, V29, P1748, DOI 10.1038/emboj.2010.62; Lin MY, 2011, J CELL BIOL, V193, P985, DOI 10.1083/jcb.201103015; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; McCormick JA, 2014, J CLIN INVEST, V124, P4723, DOI 10.1172/JCI76126; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Mori Y, 2015, BIOCHEM J, V472, P33, DOI 10.1042/BJ20150500; Mori Y, 2013, BIOCHEM BIOPH RES CO, V439, P30, DOI 10.1016/j.bbrc.2013.08.035; Murthy M, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12850; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Pathare G, 2013, AM J PHYSIOL-RENAL, V305, pF1513, DOI 10.1152/ajprenal.00440.2013; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Sasaki E, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00508-16; Schumacher FR, 2015, EMBO MOL MED, V7, P1285, DOI 10.15252/emmm.201505444; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Sohara E, 2016, NEPHROL DIAL TRANSPL, V31, P1417, DOI 10.1093/ndt/gfv259; Susa K, 2017, BIOCHEM BIOPH RES CO, V491, P727, DOI 10.1016/j.bbrc.2017.07.121; Susa K, 2014, HUM MOL GENET, V23, P5052, DOI 10.1093/hmg/ddu217; Susa K, 2012, CLIN EXP NEPHROL, V16, P530, DOI 10.1007/s10157-012-0590-x; Takahashi D, 2014, BIOSCIENCE REP, V34, P195, DOI 10.1042/BSR20140047; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Uchida S, 2014, BIOL CELL, V106, P45, DOI 10.1111/boc.201300069; Vidal-Petiot E, 2013, P NATL ACAD SCI USA, V110, P14366, DOI 10.1073/pnas.1304230110; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu GJ, 2013, FEBS LETT, V587, P1717, DOI 10.1016/j.febslet.2013.04.032; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Yang SS, 2013, J AM SOC NEPHROL, V24, P1587, DOI 10.1681/ASN.2012070742; Yang SS, 2010, HUM MUTAT, V31, P1304, DOI 10.1002/humu.21364; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Yang SS, 2010, ENDOCRINOLOGY, V151, P1829, DOI 10.1210/en.2009-0951	48	8	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1051	1061		10.1096/fj.201801023R	http://dx.doi.org/10.1096/fj.201801023R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148674				2022-12-28	WOS:000457401500083
J	Schweitzer, GG; Collier, SL; Chen, ZJ; McCommis, KS; Pittman, SK; Yoshino, J; Matkovich, SJ; Hsu, FF; Chrast, R; Eaton, JM; Harris, TE; Weihl, CC; Finck, BN				Schweitzer, George G.; Collier, Sara L.; Chen, Zhouji; McCommis, Kyle S.; Pittman, Sara K.; Yoshino, Jun; Matkovich, Scot J.; Hsu, Fong-Fu; Chrast, Roman; Eaton, James M.; Harris, Thurl E.; Weihl, Conrad C.; Finck, Brian N.			Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice	FASEB JOURNAL			English	Article						LPIN1; rhabdomyolysis; diacylglycerol; triacylglycerol; autophagy	PYRUVATE CARRIER 2; LPIN1; RHABDOMYOLYSIS; CLEARANCE; MUTATIONS; AUTOPHAGY; CONTRIBUTES; DEFICIENCY; RESISTANCE; LYSOSOMES	Lipin 1 regulates glycerolipid homeostasis by acting as a phosphatidic acid phosphohydrolase (PAP) enzyme in the triglyceride-synthesis pathway and by regulating transcription factor activity. Mutations in human lipin 1 are a common cause of recurrent rhabdomyolysis in children. Mice with constitutive whole-body lipin 1 deficiency have been used to examine mechanisms connecting lipin 1 deficiency to myocyte injury. However, that mouse model is confounded by lipodystrophy not phenocopied in people. Herein, 2 muscle-specific mouse models were studied: 1) Lpin1 exon 3 and 4 deletion, resulting in a hypomorphic protein without PAP activity, but which preserved transcriptional coregulatory function; and 2) Lpin1 exon 7 deletion, resulting in total protein loss. In both models, skeletal muscles exhibited a chronic myopathy with ongoing muscle fiber necrosis and regeneration and accumulation of phosphatidic acid and, paradoxically, diacylglycerol. Additionally, lipin 1-deficient mice had abundant, but abnormal, mitochondria likely because of impaired autophagy. Finally, these mice exhibited increased plasma creatine kinase following exhaustive exercise when unfed. These data suggest that mice lacking lipin 1-mediated PAP activity in skeletal muscle may serve as a model for determining the mechanisms by which lipin 1 deficiency leads to myocyte injury and for testing potential therapeutic approaches.Schweitzer, G. G., Collier, S. L., Chen, Z., McCommis, K. S., Pittman, S. K., Yoshino, J., Matkovich, S. J., Hsu, F.-F., Chrast, R., Eaton, J. M., Harris, T. E., Weihl, C. C., Finck, B. N. Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice.	[Schweitzer, George G.; Collier, Sara L.; Chen, Zhouji; McCommis, Kyle S.; Yoshino, Jun; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; [Pittman, Sara K.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Matkovich, Scot J.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA; [Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Chrast, Roman] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Chrast, Roman] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Eaton, James M.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Karolinska Institutet; Karolinska Institutet; University of Virginia	Finck, BN (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	bfinck@wustl.edu	Matkovich, Scot J/B-9077-2009; Matkovich, Scot J/AFP-0908-2022	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Yoshino, Jun/0000-0001-9833-4356; Finck, Brian/0000-0001-5411-3674; McCommis, Kyle/0000-0003-2381-1589; Hsu, Fong-Fu/0000-0001-5368-0183; Chrast, Roman/0000-0003-4189-3514	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK078187]; NIH National Heart, Lung, and Blood Institute [R01 HL119225, T32 HL007275, T32 HL007081]; Washington University Institute of Clinical and Translational Sciences NIH from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000448, KL2 TR000450]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [T32-DK007120, R01 DK101946]; Washington University Institute of Clinical and Translational Sciences NIH Grant [UL1 TR000448, KL2 TR000450]; NIH National Institute on Aging [R01 AG031867]; Washington University Nutrition Obesity Research Center [P30 DK56341]; Diabetes Research Center (DRC) [P30 DK020579]; Metabolomics Facility at Washington University [P30 DK056341]; Washington University NIH National Institute of General Medical Sciences Biomedical Mass Spectrometry Resource [P41 GM103422]; Washington University Genome Technology Access Center in the Department of Genetics [P30 CA91842]; Department of Pathology DRC Electron Microscopy Facility [P60 DK020579]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR002346, KL2TR000450, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119225, T32HL007081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068797, K24AR073317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104995, P30DK056341, R01DK101946, P30DK020579, T32DK007120, R01DK078187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422, T32GM007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031867] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington University Institute of Clinical and Translational Sciences NIH from the National Center for Advancing Translational Sciences (NCATS); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Washington University Institute of Clinical and Translational Sciences NIH Grant; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Washington University Nutrition Obesity Research Center; Diabetes Research Center (DRC); Metabolomics Facility at Washington University; Washington University NIH National Institute of General Medical Sciences Biomedical Mass Spectrometry Resource; Washington University Genome Technology Access Center in the Department of Genetics; Department of Pathology DRC Electron Microscopy Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Alan Pestronk and Dr. Abhinav Diwan for technical assistance in interpreting histology, and Dennis J. Dietzen for determining plasma creatine kinase (all from Washington University). This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK078187 and NIH National Heart, Lung, and Blood Institute Grant R01 HL119225 (to B.N.F.). G.G.S. was supported by NIH National Heart, Lung, and Blood Institute Grants T32 HL007275, T32 HL007081, and the Washington University Institute of Clinical and Translational Sciences NIH Grant UL1 TR000448, Subaward KL2 TR000450, from the National Center for Advancing Translational Sciences (NCATS). K.S.M. was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant T32-DK007120. J.Y. was supported by Washington University Institute of Clinical and Translational Sciences NIH Grant UL1 TR000448, Subaward KL2 TR000450. T.E.H. and J.M.E. were supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK101946. C.C.W. and S.K.P were supported by NIH National Institute on Aging Grant R01 AG031867. This work was also supported by the cores of the Washington University Nutrition Obesity Research Center (Grant P30 DK56341), Diabetes Research Center (DRC) (Grant P30 DK020579), the Metabolomics Facility at Washington University (Grant P30 DK056341), and the Washington University NIH National Institute of General Medical Sciences Biomedical Mass Spectrometry Resource (Grant P41 GM103422) to F.-F.H.; the Washington University Genome Technology Access Center in the Department of Genetics (Grant P30 CA91842); and the Department of Pathology DRC Electron Microscopy Facility (Grant P60 DK020579). The authors declare no conflicts of interest.	Alshudukhi AA, 2018, FASEB J, V32, P6796, DOI 10.1096/fj.201800374; Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364; Bergounioux J, 2012, J PEDIATR-US, V160, P1052, DOI 10.1016/j.jpeds.2012.02.033; Chen ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051320; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; De Palma C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00188; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Frazier EP, 2011, MATRIX BIOL, V30, P154, DOI 10.1016/j.matbio.2010.12.004; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hu JS, 2007, J MEMBRANE BIOL, V215, P27, DOI 10.1007/s00232-007-9002-7; Jaradat SA, 2016, META GENE, V7, P90, DOI 10.1016/j.mgene.2015.12.003; Jiang WH, 2015, J BIOL CHEM, V290, P23646, DOI 10.1074/jbc.M115.686519; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; Legendre A, 2018, MOL GENET METAB, V123, P375, DOI 10.1016/j.ymgme.2017.12.429; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; MARTIN A, 1987, BIOCHEM J, V245, P347, DOI 10.1042/bj2450347; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Meijer IA, 2015, MOLEC GENET METAB RE, V5, P85, DOI 10.1016/j.ymgmr.2015.10.010; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Michot C, 2012, J INHERIT METAB DIS, V35, P1119, DOI 10.1007/s10545-012-9461-6; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Mitra MS, 2013, P NATL ACAD SCI USA, V110, P642, DOI 10.1073/pnas.1213493110; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pichler K, 2015, MUSCLE NERVE, V52, P437, DOI 10.1002/mus.24749; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Reue K, 2000, J LIPID RES, V41, P1067; Ryan TE, 2014, J PHYSIOL-LONDON, V592, P3231, DOI 10.1113/jphysiol.2014.274456; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Schweitzer GG, 2015, JIMD REP, V23, P113, DOI 10.1007/8904_2015_440; Schweitzer GG, 2015, J LIPID RES, V56, P848, DOI 10.1194/jlr.M055962; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Soufi N, 2014, J BIOL CHEM, V289, P30177, DOI 10.1074/jbc.M114.595850; Timmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014503; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Yi YP, 2006, GEN PHYSIOL BIOPHYS, V25, P149; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhao K, 2012, J LIPID RES, V53, P2102, DOI 10.1194/jlr.M027557	49	13	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					652	667		10.1096/fj.201800361R	http://dx.doi.org/10.1096/fj.201800361R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30028636	Green Published			2022-12-28	WOS:000457401500051
J	Gautier, Y; Luneau, I; Coquery, N; Meurice, P; Malbert, CH; Guerin, S; Kemp, B; Bolhuis, JE; Clouard, C; Le Huerou-Luron, I; Blat, S; Val-Laillet, D				Gautier, Yentl; Luneau, Isabelle; Coquery, Nicolas; Meurice, Paul; Malbert, Charles-Henri; Guerin, Sylvie; Kemp, Bas; Bolhuis, J. Elizabeth; Clouard, Caroline; Le Huerou-Luron, Isabelle; Blat, Sophie; Val-Laillet, David			Maternal Western diet during gestation and lactation modifies adult offspring's cognitive and hedonic brain processes, behavior, and metabolism in Yucatan minipigs	FASEB JOURNAL			English	Article						perinatal programming; nutrition; neuroethology; physiology	HIGH-FAT DIET; BLOOD LIPID-LEVELS; PIGS SUS-SCROFA; NUCLEUS-ACCUMBENS; DOPAMINE TRANSPORTER; INDUCED OBESITY; ENVIRONMENTAL ENRICHMENT; DISCRIMINATION TASK; INSULIN SENSITIVITY; GLUCOSE-METABOLISM	This study explores the long-term effects of exposure to a maternal Western diet (WD) vs. standard diet (SD) in the Yucatan minipig, on the adult progeny at lean status (n = 32), and then overweight status. We investigated eating behavior, cognitive abilities, brain basal glucose metabolism, dopamine transporter availability, microbiota activity, blood lipids, and glucose tolerance. Although both groups demonstrated similar cognitive abilities in a holeboard test, WD pigs expressed a higher stress level than did SD pigs (immobility, P < 0.05) and lower performance in an alley maze (P = 0.06). WD pigs demonstrated lower dopamine transporter binding potential in the hippocampus and parahippocampal cortex (P < 0.05 for both), as well as a trend in putamen (P = 0.07), associated with lower basal brain activity in the prefrontal cortex and nucleus accumbens (P < 0.05) compared with lean SD pigs. Lean WD pigs demonstrated a lower glucose tolerance than did SD animals (higher glucose peak, P < 0.05) and a tendency to a higher incremental area under the curve of insulin from 0 to 30 minutes after intravenous glucose injection (P < 0.1). Both groups developed glucose intolerance with overweight, but WD animals were less impacted than SD animals. These results demonstrate that maternal diet shaped the offspring's brain functions and cognitive responses long term, even after being fed a balanced diet from weaning, but behavioral effects were only revealed in WD pigs under anxiogenic situation; however, WD animals seemed to cope better with the obesogenic diet from a metabolic standpoint.Gautier, Y., Luneau, I., Coquery, N., Meurice, P., Malbert, C.-H., Guerin, S., Kemp, B., Bolhuis, J. E., Clouard, C., Le Huerou-Luron, I., Blat, S., Val-Laillet, D. Maternal Western diet during gestation and lactation modifies adult offspring's cognitive and hedonic brain processes, behavior, and metabolism in Yucatan minipigs.	[Gautier, Yentl; Luneau, Isabelle; Coquery, Nicolas; Meurice, Paul; Guerin, Sylvie; Le Huerou-Luron, Isabelle; Blat, Sophie; Val-Laillet, David] Univ Rennes, INRA, Nutr Metab & Canc NuMeCan, INSERM, Rennes St Gilles, France; [Malbert, Charles-Henri] INRA, AniScan US1395, St Gilles, France; [Kemp, Bas; Bolhuis, J. Elizabeth; Clouard, Caroline] Wageningen Univ & Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Wageningen University & Research	Val-Laillet, D (corresponding author), Inst Natl Rech, NuMeCan UMR1341, 16 Le Clos, F-35590 St Gilles, France.	david.val-laillet@inra.fr	Gautier-Luneau, Isabelle/ABF-7007-2020; Clouard, Caroline/K-1255-2014; coquery, nicolas/N-9206-2019; VAL-LAILLET, David/AAH-6454-2021; coquery, nicolas/GQP-5662-2022	Gautier-Luneau, Isabelle/0000-0003-1800-0167; Clouard, Caroline/0000-0002-5562-6057; coquery, nicolas/0000-0002-4687-5924; coquery, nicolas/0000-0002-4687-5924; Malbert, Charles-Henri/0000-0002-0665-4545; Luron, Isabelle/0000-0002-1769-5246	INRA Diet Impact and Determinants: Interactions and Transitions Metaprogramme; INRA; Region Bretagne	INRA Diet Impact and Determinants: Interactions and Transitions Metaprogramme; INRA; Region Bretagne(Region Bretagne)	The authors thank Walter Gerrits (Animal Nutrition Group, Wageningen University and Research) and Franz Josef van der Staay (Department of Farm Animal Health, Utrecht University) for insight into methodologic questions. The authors gratefully acknowledge the efforts and cooperation of the technical staff at Institut National de la Recherche Agronomique (INRA) St. Gilles, and especially Isabelle Nogret, Veronique Rome, Thibaud Le Mouel, Eric Bobillier, Armel Delalande, Mickael Genissel, Julien Georges, Regis Janvier, Alain Chauvin, Francis Le Gouevec, and Vincent Piedvache (all from INRA), for participating in laboratory analyses or taking care of the animals. This work was funded by the INRA Diet Impact and Determinants: Interactions and Transitions Metaprogramme in the context of the SweetLip-Kid project coordinated by Sophie Nicklaus. Y.G. received a Ph.D. grant from INRA and Region Bretagne. The authors declare no conflicts of interest.	Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Asher A, 2012, INT J NEUROPSYCHOPH, V15, P1287, DOI 10.1017/S146114571100143X; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; BARKER DJP, 1989, LANCET, V2, P577; Bateson P, 2014, J PHYSIOL-LONDON, V592, P2357, DOI 10.1113/jphysiol.2014.271460; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; BECKER JT, 1980, BRAIN RES, V200, P307, DOI 10.1016/0006-8993(80)90922-1; Bellisle F, 2004, BRIT J NUTR, V92, pS227, DOI 10.1079/BJN20041171; Benton D, 2008, EUR J NUTR, V47, P38, DOI 10.1007/s00394-008-3004-9; BERENDSE HW, 1992, J NEUROSCI, V12, P2079; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Blat S, 2015, OBESITY, V23, P415, DOI 10.1002/oby.20990; Bohbot VD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00431; Bolhuis JE, 2013, ANIM COGN, V16, P845, DOI 10.1007/s10071-013-0646-7; Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Chen XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032511; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Clouard C, 2016, FASEB J, V30, P2466, DOI 10.1096/fj.201500208R; Clouard C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00861; Clouard C, 2012, APPL ANIM BEHAV SCI, V136, P26, DOI 10.1016/j.applanim.2011.11.007; Cone JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058251; Couvreur O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018043; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Francis H, 2013, APPETITE, V63, P119, DOI 10.1016/j.appet.2012.12.018; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140; Gibson PR, 2007, ALIMENT PHARM THER, V25, P349, DOI 10.1111/j.1365-2036.2006.03186.x; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Grayson BE, 2010, ENDOCRINOLOGY, V151, P1622, DOI 10.1210/en.2009-1019; Grimberg-Henrici CGE, 2016, ANIM COGN, V19, P271, DOI 10.1007/s10071-015-0932-7; Haber SN, 1999, ANN NY ACAD SCI, V877, P33, DOI 10.1111/j.1749-6632.1999.tb09259.x; HOUPT KA, 1979, YALE J BIOL MED, V52, P307; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Huang XF, 2006, BEHAV BRAIN RES, V175, P415, DOI 10.1016/j.bbr.2006.08.034; Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035; Ikemoto S, 1996, BEHAV NEUROSCI, V110, P331, DOI 10.1037/0735-7044.110.2.331; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Isaacs EB, 2008, PEDIATR RES, V63, P308, DOI 10.1203/PDR.0b013e318163a271; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kereliuk SM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071451; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Le Bourgot C, 2017, BRIT J NUTR, V117, P83, DOI 10.1017/S0007114516004268; Le DSNT, 2007, AM J CLIN NUTR, V86, P573, DOI 10.1093/ajcn/86.3.573; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; MARTINOT JL, 1990, AM J PSYCHIAT, V147, P1313; MIDTVEDT AC, 1992, J PEDIATR GASTR NUTR, V15, P395, DOI 10.1097/00005176-199211000-00005; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Minuzzi L, 2006, SYNAPSE, V59, P211, DOI 10.1002/syn.20234; Morris MJ, 2009, INT J OBESITY, V33, P115, DOI 10.1038/ijo.2008.213; Naef L, 2011, NEUROSCIENCE, V176, P225, DOI 10.1016/j.neuroscience.2010.12.037; Naef L, 2008, PSYCHOPHARMACOLOGY, V197, P83, DOI 10.1007/s00213-007-1008-4; Narayanaswami V., 2005, INT J OBESITY, V37, P1095; Ochoa M, 2014, APPL ANIM BEHAV SCI, V157, P61, DOI 10.1016/j.applanim.2014.05.010; Petry CJ, 2001, MOL CELL ENDOCRINOL, V185, P81, DOI 10.1016/S0303-7207(01)00627-X; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Roelofs S, 2017, APPL ANIM BEHAV SCI, V191, P5, DOI 10.1016/j.applanim.2017.01.016; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; South T, 2008, NEUROCHEM RES, V33, P598, DOI 10.1007/s11064-007-9483-x; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Val-Laillet D, 2010, BRIT J NUTR, V104, P1719, DOI 10.1017/S0007114510002667; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; Val-Laillet D, 2011, OBESITY, V19, P749, DOI 10.1038/oby.2010.292; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Walker CD, 2008, ANN NY ACAD SCI, V1144, P189, DOI 10.1196/annals.1418.023; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; WOLRAICH ML, 1994, NEW ENGL J MED, V330, P301, DOI 10.1056/NEJM199402033300501	90	11	11	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6478	6494		10.1096/fj.201701541	http://dx.doi.org/10.1096/fj.201701541			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29897815	Bronze, Green Submitted			2022-12-28	WOS:000449359700011
J	Seegobin, M; Kisiala, A; Noble, A; Kaplan, D; Brunetti, C; Emery, RJN				Seegobin, Mark; Kisiala, Anna; Noble, Adam; Kaplan, David; Brunetti, Craig; Emery, R. J. Neil			Canis familiaris tissues are characterized by different profiles of cytokinins typical of the tRNA degradation pathway	FASEB JOURNAL			English	Article						phytohormones; methylthiols; mass spectrometry; mammalian tissue	ISOPRENOID END-PRODUCT; CANCER CELL-LINE; ISOPENTENYL TRANSFERASE; SALMONELLA-TYPHIMURIUM; TUMOR-SUPPRESSOR; CIS-ZEATIN; NK CELLS; IN-VITRO; BIOSYNTHESIS; APOPTOSIS	Cytokinins (CKs) are a group of phytohormones essential to plant growth and development. The presence of these N-6-modified adenine derivatives has also been documented in other groups of organisms, including bacteria, fungi, and insects. Thus far, however, only a single CK, N-6-((2)-isopentenyl) adenine-9-riboside (iPR), has been identified in mammals. In plants, the nucleotide form of isopentenyladenine [iPR (mono/di/tri)phosphate (iPRP)] is the first form of CK synthesized, and it is further modified to produce other CK types. To determine whether a similar biosynthesis pathway exists in mammals, we tested for the presence of 27 CKs in a wide selection of canine organs using HPLC electrospray ionization-tandem mass spectrometry. Seven forms of CK were detected in the majority of the analyzed samples, including iPR, iPRP, cis-zeatin-9-riboside, cis-zeatin-9-riboside-5 (mono/di/tri)phosphate, 2-methylthio-N-6-isopentenyladenine, 2-methylthio-N-6-isopentenyladenosine, and 2-methylthiozeatin. Total CK concentrations ranged from 1.96 pmol/g fresh weight (adrenal glands) to 1.40 x 10(3) pmol/g fresh weight (thyroid). The results of this study provide evidence that mammalian cells, like plant cells, can synthesize and process a diverse set of CKs including cis- and methylthiol-type CKs.Seegobin, M., Kisiala, A., Noble, A., Kaplan, D., Brunetti, C., Emery, R. J. N. Canis familiaris tissues are characterized by different profiles of cytokinins typical of tRNA degradation pathway.	[Seegobin, Mark; Kisiala, Anna; Brunetti, Craig; Emery, R. J. Neil] Trent Univ, Dept Biol, 1600 West Bank Dr, Peterborough, ON K9J 0G2, Canada; [Noble, Adam] Noblegen, Peterborough, ON, Canada; [Kaplan, David] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	Trent University; University of Toronto	Seegobin, M (corresponding author), Trent Univ, Dept Biol, 1600 West Bank Dr, Peterborough, ON K9J 0G2, Canada.	markseegobin@trentu.ca	Kisiala, Anna/O-8218-2019; Kisiala, Anna/V-1224-2019; Kisiala, Anna/C-4598-2019	Kisiala, Anna/0000-0002-4918-7836; Kisiala, Anna/0000-0002-4918-7836; Emery, Neil/0000-0003-1304-6430	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-05436]; Champlain Animal Hospital (Peterborough, ON, Canada)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Champlain Animal Hospital (Peterborough, ON, Canada)	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-05436 (to R.J.N.E.). The authors thank Champlain Animal Hospital (Peterborough, ON, Canada) for support and assistance in acquiring canine tissue donation. The authors declare no conflicts of interest.	Becker NP, 2014, METALLOMICS, V6, P1079, DOI 10.1039/c4mt00004h; Bifulco M, 2008, ANTI-CANCER AGENT ME, V8, P200, DOI 10.2174/187152008783497028; Chen CM, 1997, PHYSIOL PLANTARUM, V101, P665, DOI 10.1111/j.1399-3054.1997.tb01051.x; Ciaglia E, 2014, PHARMACOL RES, V89, P1, DOI 10.1016/j.phrs.2014.07.003; Ciaglia E, 2013, J LEUKOCYTE BIOL, V94, P1207, DOI 10.1189/jlb.0413190; Emery RJN, 1998, PLANT PHYSIOL, V117, P1515, DOI 10.1104/pp.117.4.1515; Farrow SC, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-42; Fradejas N, 2013, BIOCHEM J, V450, P427, DOI 10.1042/BJ20121713; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Globisch D, 2011, ANGEW CHEM INT EDIT, V50, P9739, DOI 10.1002/anie.201103229; Golovko A, 2002, PLANT MOL BIOL, V49, P161, DOI 10.1023/A:1014958816241; Golovko A, 2000, GENE, V258, P85, DOI 10.1016/S0378-1119(00)00421-2; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Horvath R, 2015, CELL METAB, V21, P351, DOI 10.1016/j.cmet.2015.02.012; Huyet J., 2018, CELL CHEM BIOL, P1; Hwang I., 2010, PLANT HORMONES BIOSY, V126, P95; Ishii Y, 2002, CELL GROWTH DIFFER, V13, P19; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Kasahara H, 2004, J BIOL CHEM, V279, P14049, DOI 10.1074/jbc.M314195200; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; Laezza C, 2006, FASEB J, V20, P412, DOI 10.1096/fj.05-4044lsf; Laezza C, 2010, MOL CARCINOGEN, V49, P892, DOI 10.1002/mc.20666; Laezza C, 2009, INT J CANCER, V124, P1322, DOI 10.1002/ijc.24056; Lamichhane TN, 2013, MOL CELL BIOL, V33, P4900, DOI 10.1128/MCB.01041-13; Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611; Mathevon C, 2007, P NATL ACAD SCI USA, V104, P13295, DOI 10.1073/pnas.0704338104; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mlejnek P, 2005, TOXICOL IN VITRO, V19, P985, DOI 10.1016/j.tiv.2005.06.023; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; Morrison EN, 2017, PLANT PATHOL, V66, P726, DOI 10.1111/ppa.12629; Morrison EN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130945; Morrison EN, 2015, MYCOLOGIA, V107, P245, DOI 10.3852/14-157; Naseem M, 2014, TRENDS PLANT SCI, V19, P481, DOI 10.1016/j.tplants.2014.04.001; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Othman EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168386; PERSSON BC, 1994, BIOCHIMIE, V76, P1152, DOI 10.1016/0300-9084(94)90044-2; PERSSON BC, 1993, J BACTERIOL, V175, P7776, DOI 10.1128/JB.175.24.7776-7785.1993; Pisanti S, 2014, FASEB J, V28, P1132, DOI 10.1096/fj.13-238238; Quesnelle PE, 2007, CAN J BOT, V85, P91, DOI 10.1139/B06-149; Reiter V, 2012, NUCLEIC ACIDS RES, V40, P6235, DOI 10.1093/nar/gks240; ROBINS MJ, 1967, BIOCHEMISTRY-US, V6, P1837, DOI 10.1021/bi00858a035; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; Schmidt Ulrike, 2008, Genome Inform, V20, P243; Schweizer U, 2017, RNA BIOL, V14, P1197, DOI 10.1080/15476286.2017.1294309; Smaldino PJ, 2015, GENE, V556, P13, DOI 10.1016/j.gene.2014.09.049; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Spinola M, 2005, ONCOGENE, V24, P5502, DOI 10.1038/sj.onc.1208687; Stirk WA, 2010, PLANT GROWTH REGUL, V62, P101, DOI 10.1007/s10725-010-9481-x; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Urlacher VB, 2012, TRENDS BIOTECHNOL, V30, P26, DOI 10.1016/j.tibtech.2011.06.012; Voller J, 2010, PHYTOCHEMISTRY, V71, P1350, DOI 10.1016/j.phytochem.2010.04.018; Waller TJ, 2017, GENE, V612, P19, DOI 10.1016/j.gene.2016.10.041; Wang HB, 2015, ONCOL REP, V33, P1089, DOI 10.3892/or.2015.3736; Wei FY, 2015, CELL METAB, V21, P428, DOI 10.1016/j.cmet.2015.01.019	59	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6575	6581		10.1096/fj.201800347	http://dx.doi.org/10.1096/fj.201800347			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29894666				2022-12-28	WOS:000449359700018
J	Kim, EY; Sudini, K; Singh, AK; Haque, M; Leaman, D; Khuder, S; Ahmed, S				Kim, Eugene Y.; Sudini, Kuladeep; Singh, Anil K.; Haque, Mahamudul; Leaman, Douglas; Khuder, Sadik; Ahmed, Salahuddin			Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1	FASEB JOURNAL			English	Article						ursolic acid; synovial hyperplasia; BH3-only protein; ubiquitination	CHRONIC LYMPHOCYTIC-LEUKEMIA; TRANSCRIPTION FACTOR; DOWN-REGULATION; CANCER CELLS; C-MYC; SUPPRESSION; EPIGALLOCATECHIN-3-GALLATE; ACTIVATION; PROTEIN; KINASE	Rheumatoid arthritis (RA) is characterized by hyperplastic pannus formation mediated by activated synovial fibroblasts that cause joint destruction. We have shown earlier that RA synovial fibroblasts (RASFs) exhibit resistance to apoptosis, primarily as a result of enhanced expression of myeloid cell leukemia-1 (Mcl-1). In this study, we discovered that ursolic acid (UA), a plant-derived pentacyclic triterpenoid, selectively induces B-cell lymphoma 2 homology 3-only protein Noxa in human RASFs. We observed that UA-induced Noxa expression was followed by a consequent decrease in Mcl-1 expression in a dose-dependent manner. Subsequent evaluation of the signaling pathways showed that UA-induced Noxa is primarily mediated by the JNK pathway in human RASFs. Chromatin immunoprecipitation (IP) studies into the promoter region of Noxa indicated the role of transcription factor specificity protein 1 in JNK-mediated Noxa expression. Furthermore, the results from IP studies and proximity ligation assays indicated that UA-induced Noxa colocalizes and associates with Mcl-1 to prime it for proteasomal degradation through K-48-linked ubiquitination by the selective recruitment of Mcl-1 ubiquitin ligase E3, a homologous to E6-associated protein C terminus domain-containing E3 ubiquitin ligase. These findings unveil a novel mechanism of inducing apoptosis in RASFs and a potential adjunct therapeutic strategy of regulating synovial hyperplasia in RA.Kim, E. Y., Sudini, K., Singh, A. K., Haque, M., Leaman, D., Khuder, S., Ahmed, S. Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1.	[Kim, Eugene Y.; Singh, Anil K.; Haque, Mahamudul; Ahmed, Salahuddin] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, 412 E Spokane Falls Blvd, Spokane, WA 99202 USA; [Sudini, Kuladeep; Leaman, Douglas] Univ Toledo, Dept Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Khuder, Sadik] Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [Khuder, Sadik] Univ Toledo, Dept Publ Hlth, 2801 W Bancroft St, Toledo, OH 43606 USA; [Ahmed, Salahuddin] Univ Washington, Sch Med, Div Rheumatol, Seattle, WA USA	Washington State University; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Washington; University of Washington Seattle	Ahmed, S (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, 412 E Spokane Falls Blvd, Spokane, WA 99202 USA.	salah.ahmed@wsu.edu	Singh, Anil K/H-6225-2019; Haque, Mahamudul/ABE-7240-2020	Singh, Anil K/0000-0002-4102-2420; 	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [AR-068517]; Start-Up Funds from Washington State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR068517] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; Start-Up Funds from Washington State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the Cooperative Human Tissue Network (CHTN) and National Disease Research Interchange (NDRI) for providing RA synovial tissues. The authors thank Carolyn Zielinski and Maria Beamer (University of Toledo) for their technical help. This study was funded by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR-068517 (to S.A.) and Start-Up Funds from Washington State University (to S.A.). The authors declare no conflicts of interest.	Ahmed S, 2006, ARTHRITIS RHEUM-US, V54, P2393, DOI 10.1002/art.22023; Ahmed S, 2009, ARTHRITIS RHEUM-US, V60, P1282, DOI 10.1002/art.24488; Baek SY, 2014, ACTA PHARMACOL SIN, V35, P1177, DOI 10.1038/aps.2014.58; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bates D, 2016, CANCER BIOL THER, V17, P291, DOI 10.1080/15384047.2016.1139245; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Bin Hafeez B, 2006, TOXICOL APPL PHARM, V216, P11, DOI 10.1016/j.taap.2006.03.013; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chuang WL, 2016, MOLECULES, V21, DOI 10.3390/molecules21040460; Cottier KE, 2014, RHEUMATOLOGY, V53, P1539, DOI 10.1093/rheumatology/ket408; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dai Y, 2007, CANCER RES, V67, P2908, DOI 10.1158/0008-5472.CAN-07-0082; Davis LS, 2003, AM J PATHOL, V162, P1399, DOI 10.1016/S0002-9440(10)64272-1; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Escobar D, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.165; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; FIRESTEIN GS, 1995, J CLIN INVEST, V96, P1631, DOI 10.1172/JCI118202; Gao N, 2012, BRIT J PHARMACOL, V165, P1813, DOI 10.1111/j.1476-5381.2011.01684.x; Gentile M, 2017, EXPERT OPIN INV DRUG, V26, P1307, DOI 10.1080/13543784.2017.1386173; Grodzicky T, 2000, AM J MED, V108, P73, DOI 10.1016/S0002-9343(99)00332-0; Gu HC, 2011, BBA-GENE REGUL MECH, V1809, P276, DOI 10.1016/j.bbagrm.2011.02.002; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Jeong JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080050; Kang SY, 2008, J PHARM PHARMACOL, V60, P1347, DOI 10.1211/jpp/60.10.0011; Kashyap D, 2016, LIFE SCI, V146, P201, DOI 10.1016/j.lfs.2016.01.017; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Leal AS, 2012, BIOORGAN MED CHEM, V20, P5774, DOI 10.1016/j.bmc.2012.08.010; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Lin Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep33358; Lipsky PE, 2007, NEW ENGL J MED, V356, P2419, DOI 10.1056/NEJMcibr070846; Liu HT, 2006, ARTHRITIS RHEUM-US, V54, P3174, DOI 10.1002/art.22132; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Liu HT, 2004, RHEUM DIS CLIN N AM, V30, P603, DOI 10.1016/j.rdc.2004.04.010; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Mandelin AM, 2007, EXPERT OPIN THER TAR, V11, P363, DOI 10.1517/14728222.11.3.363; Meinecke I, 2005, CURR PHARM DESIGN, V11, P563, DOI 10.2174/1381612053381945; Migita K, 1997, CLIN EXP IMMUNOL, V108, P199, DOI 10.1046/j.1365-2249.1997.d01-1002.x; Mojsa B, 2014, CELLS-BASEL, V3, P418, DOI 10.3390/cells3020418; Murakami S, 2004, FEBS LETT, V566, P55, DOI 10.1016/j.febslet.2004.04.036; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Park JH, 2013, PHARMACOL REP, V65, P1366, DOI 10.1016/S1734-1140(13)71495-6; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Perlman H, 2010, ARTHRITIS RHEUM-US, V62, P643, DOI 10.1002/art.27297; Pietkiewicz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061438; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Pope RM, 2002, NAT REV IMMUNOL, V2, P527, DOI 10.1038/nri846; Qiang ZY, 2011, J ETHNOPHARMACOL, V137, P1107, DOI 10.1016/j.jep.2011.07.037; Rosebeck S, 2011, VIROLOGY, V417, P293, DOI 10.1016/j.virol.2011.06.010; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Singh AK, 2016, ARTHRITIS RHEUMATOL, V68, P347, DOI 10.1002/art.39447; Valis K, 2011, CANCER RES, V71, P946, DOI 10.1158/0008-5472.CAN-10-2203; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Zhang HG, 2001, ARTHRITIS RHEUM-US, V44, P1555, DOI 10.1002/1529-0131(200107)44:7<1555::AID-ART279>3.0.CO;2-M; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	60	18	19	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6174	6185		10.1096/fj.201800425R	http://dx.doi.org/10.1096/fj.201800425R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29799788	Green Published			2022-12-28	WOS:000447172000034
J	Shukla, PK; Meena, AS; Manda, B; Gomes-Solecki, M; Dietrich, P; Dragatsis, I; Rao, R				Shukla, Pradeep K.; Meena, Avtar S.; Manda, Bhargavi; Gomes-Solecki, Maria; Dietrich, Paula; Dragatsis, Ioannis; Rao, RadhaKrishna			Lactobacillus plantarum prevents and mitigates alcohol-induced disruption of colonic epithelial tight junctions, endotoxemia, and liver damage by an EGF receptor-dependent mechanism	FASEB JOURNAL			English	Article						probiotics; barrier function; colon; alcoholic hepatitis; cytokines	GUT BARRIER DYSFUNCTION; CACO-2 CELL MONOLAYER; IN-VIVO; DISEASE; PERMEABILITY; ACETALDEHYDE; EXPRESSION; ETHANOL; MUCOSA; PROBIOTICS	Pathogenesis of alcohol-related diseases such as alcoholic hepatitis involves gut barrier dysfunction, endotoxemia, and toxin-mediated cellular injury. Here we show that Lactobacillus plantarum not only blocks but also mitigates ethanol (EtOH)-induced gut and liver damage in mice. L. plantarum blocks EtOH-induced protein thiol oxidation, and down-regulation of antioxidant gene expression in colon L. plantarum also blocks EtOH-induced expression of TNF-, IL-1, IL-6, monocyte chemotactic protein 1 (MCP1), C-X-C motif chemokine ligand (CXCL)1, and CXCL2 genes in colon. Epidermal growth factor receptor (EGFR) signaling mediates the L. plantarum-mediated protection of tight junctions (TJs) and barrier function from acetaldehyde, the EtOH metabolite, in Caco-2 cell monolayers. In mice, doxycycline-mediated expression of dominant negative EGFR blocks L. plantarum-mediated prevention of EtOH-induced TJ disruption, mucosal barrier dysfunction, oxidative stress, and inflammatory response in colon. L. plantarum blocks EtOH-induced endotoxemia as well as EtOH-induced pathologic lesions, triglyceride deposition, oxidative stress, and inflammatory responses in the liver by an EGFR-dependent mechanism. L. plantarum treatment after injury accelerated recovery from EtOH-induced TJ, barrier dysfunction, oxidative stress, and inflammatory response in colon, endotoxemia, and liver damage. Results demonstrate that L. plantarum has both preventive and therapeutic values in treatment of alcohol-induced tissue injury, particularly in alcoholic hepatitis.Shukla, P. K., Meena, A. S., Manda, B., Gomes-Solecki, M., Dietrich, P., Dragatsis, I., Rao, R. Lactobacillus plantarum prevents and mitigates alcohol-induced disruption of colonic epithelial tight junctions, endotoxemia, and liver damage by an EGF receptor-dependent mechanism.	[Shukla, Pradeep K.; Meena, Avtar S.; Manda, Bhargavi; Dietrich, Paula; Dragatsis, Ioannis; Rao, RadhaKrishna] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 3 North Dunlap St,Suite S303, Memphis, TN 38103 USA; [Gomes-Solecki, Maria] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Rao, R (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 3 North Dunlap St,Suite S303, Memphis, TN 38103 USA.	rrao2@uthsc.edu	Meena, Avtar Singh/AAG-4419-2021; Meena, Avtar S/AAZ-8213-2020	shukla, pradeep/0000-0003-2515-9766	U.S. National Institutes of Health [AA12307, DK55532]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK055532, R01DK055532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012307] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by U.S. National Institutes of Health Grants AA12307 (National Institute on Alcohol Abuse and Alcoholism) and DK55532 (National Institute of Diabetes and Digestive and Kidney Diseases) to R.R. The authors declare no conflicts of interest.	Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; Al-Sadi R, 2012, J INTERF CYTOK RES, V32, P474, DOI 10.1089/jir.2012.0031; Balda MS, 2016, CURR OPIN CELL BIOL, V42, P94, DOI 10.1016/j.ceb.2016.05.006; Basuroy S, 2005, AM J PHYSIOL-GASTR L, V289, pG367, DOI 10.1152/ajpgi.00464.2004; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Chaudhry KK, 2016, J NUTR BIOCHEM, V27, P16, DOI 10.1016/j.jnutbio.2015.08.012; de Timary P, 2017, NEUROPHARMACOLOGY, V122, P148, DOI 10.1016/j.neuropharm.2017.04.013; del Rio B, 2008, CLIN VACCINE IMMUNOL, V15, P1429, DOI 10.1128/CVI.00169-08; Fleming S, 2001, ALCOHOL CLIN EXP RES, V25, P579, DOI 10.1111/j.1530-0277.2001.tb02253.x; Fu YH, 2013, VET IMMUNOL IMMUNOP, V151, P20, DOI 10.1016/j.vetimm.2012.09.039; Hernandez JA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1543809; Huang XY, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0199-7; Kane CJM, 2016, J LEUKOCYTE BIOL, V100, P951, DOI 10.1189/jlb.3MR0416-171R; Kirpich IA, 2012, ALCOHOL CLIN EXP RES, V36, P835, DOI 10.1111/j.1530-0277.2011.01673.x; Kirpich IA, 2008, ALCOHOL, V42, P675, DOI 10.1016/j.alcohol.2008.08.006; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Magdaleno F, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010009; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Potula HH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005870; Quiros M, 2014, SEMIN CELL DEV BIOL, V36, P194, DOI 10.1016/j.semcdb.2014.09.003; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; Salaspuro M, 1997, ADDICT BIOL, V2, P35, DOI 10.1080/13556219772840; Samak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38899; Shaw DM, 2000, IMMUNOLOGY, V100, P510, DOI 10.1046/j.1365-2567.2000.00069.x; Sheth P, 2004, ALCOHOL CLIN EXP RES, V28, P797, DOI 10.1097/01.ALC.0000125358.92335.90; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tilg H, 2016, HEPATOLOGY, V64, P955, DOI 10.1002/hep.28456; Visapaa JP, 2002, ALCOHOL ALCOHOLISM, V37, P322, DOI 10.1093/alcalc/37.4.322; Wilkins T, 2017, AM FAM PHYSICIAN, V96, P170	32	23	24	3	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6274	6292		10.1096/fj.201800351R	http://dx.doi.org/10.1096/fj.201800351R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29912589	Green Published, Bronze			2022-12-28	WOS:000447172000042
J	Mirrasekhian, E; Nilsson, JLA; Shionoya, K; Blomgren, A; Zygmunt, PM; Engblom, D; Hogestatt, ED; Blomqvist, A				Mirrasekhian, Elahe; Nilsson, Johan L. A.; Shionoya, Kiseko; Blomgren, Anders; Zygmunt, Peter M.; Engblom, David; Hoegestaett, Edward D.; Blomqvist, Anders			The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain	FASEB JOURNAL			English	Article						fever; TRPA1; N-acetyl cysteine; NAPQI; acetaminophen	ACETAMINOPHEN-INDUCED HYPOTHERMIA; LIPOPOLYSACCHARIDE-INDUCED FEVER; GENE-DERIVED PROTEIN; ENDOTHELIAL-CELLS; E SYNTHASE-1; N-ACETYLCYSTEINE; MICE; TRPA1; RESPONSES; AM404	The mode of action of paracetamol (acetaminophen), which is widely used for treating pain and fever, has remained obscure, but may involve several distinct mechanisms, including cyclooxygenase inhibition and transient receptor potential ankyrin 1 (TRPA1) channel activation, the latter being recently associated with paracetamol's propensity to elicit hypothermia at higher doses. Here, we examined whether the antipyretic effect of paracetamol was due to TRPA1 activation or cyclooxygenase inhibition. Treatment of wild-type and TRPA1 knockout mice rendered febrile by immune challenge with LPS with a dose of paracetamol that did not produce hypothermia (150 mg/kg) but is known to be analgetic, abolished fever in both genotypes. Paracetamol completely suppressed the LPS-induced elevation of prostaglandin E-2 in the brain and also reduced the levels of several other prostanoids. The hypothermia induced by paracetamol was abolished in mice treated with the electrophile-scavenger N-acetyl cysteine. We conclude that paracetamol's antipyretic effect in mice is dependent on inhibition of cyclooxygenase activity, including the formation of pyrogenic prostaglandin E-2, whereas paracetamol-induced hypothermia likely is mediated by the activation of TRPA1 by electrophilic metabolites of paracetamol, similar to its analgesic effect in some experimental paradigms.Mirrasekhian, E., Nilsson, J. L. angstrom., Shionoya, K., Blomgren, A., Zygmunt, P. M., Engblom, D., Hogestatt, E. D., Blomqvist, A. The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain.	[Mirrasekhian, Elahe; Shionoya, Kiseko; Engblom, David; Blomqvist, Anders] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Nilsson, Johan L. A.; Blomgren, Anders; Zygmunt, Peter M.; Hoegestaett, Edward D.] Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, S-22185 Lund, Sweden	Linkoping University; Lund University	Zygmunt, PM (corresponding author), Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, S-22185 Lund, Sweden.; Blomqvist, A (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Neurobiol, S-58185 Linkoping, Sweden.	peter.zygmunt@med.lu.se; anders.blomqvist@liu.se		Zygmunt, Peter/0000-0002-5102-8199; Blomqvist, Anders/0000-0002-6928-4473	Swedish Medical Research Council [20725, 07879, 2014-3801]; European Research Council (ERC) Starting Grant; Knut and Alice Wallenberg Foundation; Swedish Brain Foundation; Swedish Cancer Foundation [16/0572]; County Council of Ostergotland; Medical Faculty of Lund University (ALF); AFA Insurance	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Research Council (ERC) Starting Grant(European Research Council (ERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Brain Foundation; Swedish Cancer Foundation; County Council of Ostergotland; Medical Faculty of Lund University (ALF); AFA Insurance	The authors thank Anna Eskilsson (Linkoping University, Linkoping, Sweden) for help with the illustrations. This study was supported by the Swedish Medical Research Council (20725 to D.E., 07879 to A.B., and 2014-3801 to P.M.Z. and E.D.H.), the European Research Council (ERC) Starting Grant (to D.E.), the Knut and Alice Wallenberg Foundation (to D.E.), the Swedish Brain Foundation (to D.E. and A.B.), the Swedish Cancer Foundation (16/0572 to A.B.), the County Council of Ostergotland (to D.E. and A.B.),the Medical Faculty of Lund University (ALF; to E.D.H. and P.M.Z.) and AFA Insurance (to E.D.H. and P.M.Z.). The authors declare no conflicts of interest.	Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Ayoub SS, 2006, EUR J PHARMACOL, V538, P57, DOI 10.1016/j.ejphar.2006.03.061; Ayoub SS, 2004, P NATL ACAD SCI USA, V101, P11165, DOI 10.1073/pnas.0404185101; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; DOHERTY NS, 1990, BRIT J PHARMACOL, V101, P869, DOI 10.1111/j.1476-5381.1990.tb14173.x; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Engstrom L, 2012, ENDOCRINOLOGY, V153, P4849, DOI 10.1210/en.2012-1375; Eskilsson A, 2014, J NEUROSCI, V34, P15957, DOI 10.1523/JNEUROSCI.3520-14.2014; FELDBERG W, 1973, J PHYSIOL-LONDON, V228, P41, DOI 10.1113/jphysiol.1973.sp010071; FLOWER R, 1972, NATURE-NEW BIOL, V238, P104, DOI 10.1038/newbio238104a0; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Gentry C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12771; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Li SX, 2008, PROSTAG OTH LIPID M, V85, P89, DOI 10.1016/j.prostaglandins.2007.10.007; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Moparthi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28763; Nilsberth C, 2009, J NEUROENDOCRINOL, V21, P715, DOI 10.1111/j.1365-2826.2009.01888.x; Ouellet M, 2001, ARCH BIOCHEM BIOPHYS, V387, P273, DOI 10.1006/abbi.2000.2232; Raskovic A, 2014, MOLECULES, V19, P3869, DOI 10.3390/molecules19043869; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Ruud LE, 2013, NEUROPHARMACOLOGY, V71, P124, DOI 10.1016/j.neuropharm.2013.03.012; Saha S, 2005, AM J PHYSIOL-REG I, V288, pR1100, DOI 10.1152/ajpregu.00872.2004; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Steiner AA, 2006, BLOOD, V107, P4000, DOI 10.1182/blood-2005-11-4743; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Tateishi T, 1998, ACTA ANAESTH SCAND, V42, P1028, DOI 10.1111/j.1399-6576.1998.tb05371.x; WALKER RM, 1981, TOXICOL APPL PHARM, V59, P500, DOI 10.1016/0041-008X(81)90303-3; Wilhelms DB, 2014, J NEUROSCI, V34, P11684, DOI 10.1523/JNEUROSCI.1838-14.2014; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	37	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5751	5759		10.1096/fj.201800272R	http://dx.doi.org/10.1096/fj.201800272R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29738273	Bronze, Green Submitted			2022-12-28	WOS:000447972500045
J	Zhong, XC; Lee, HN; Kim, SH; Park, SA; Kim, W; Cha, YN; Surh, YJ				Zhong, Xiancai; Lee, Ha-Na; Kim, Seung Hyeon; Park, Sin-Aye; Kim, Wonki; Cha, Young-Nam; Surh, Young-Joon			Myc-nick promotes efferocytosis through M2 macrophage polarization during resolution of inflammation	FASEB JOURNAL			English	Article						c-Myc; phagocytosis; peritonitis; tubulin acetylation	APOPTOTIC CELLS; TUBULIN ACETYLATION; C-MYC; ENGULFMENT; RECEPTOR; CLEARANCE; PHAGOCYTOSIS; MECHANISMS; ALPHA; MICROTUBULES	A key event required for effective resolution of inflammation is efferocytosis, which is defined as phagocytic removal of apoptotic cells mostly by macrophages acquiring an alternatively activated phenotype (M2). c-Myc has been reported to play a role in alternative activation of human macrophages and is proposed as one of the M2 macrophage markers. We found that M2-like peritoneal macrophages from zymosan A-treated mice exhibited a marked accumulation of Myc-nick, a truncated protein generated by a Calpain-mediated proteolytic cleavage of full-length c-Myc. Further, ectopic expression of Myc-nick in murine bone marrow-derived macrophages promoted the M2 polarization and, consequently, enhanced their efferocytic capability. Notably, Myc-nick-induced efferocytosis was found to be tightly associated with -tubulin acetylation by K acetyltransferase 2a (Kat2a/Gcn5) activity. These findings suggest Myc-nick as a novel proresolving mediator that has a fundamental function in maintaining homeostasis under inflammatory conditions.Zhong, X., Lee, H.-N., Kim, S. H., Park, S.-A., Kim, W., Cha, Y.-N., Surh, Y.-J. Myc-nick promotes efferocytosis through M2 macrophage polarization during resolution of inflammation.	[Zhong, Xiancai; Lee, Ha-Na; Kim, Seung Hyeon; Park, Sin-Aye; Kim, Wonki; Surh, Young-Joon] Seoul Natl Univ, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Zhong, Xiancai; Lee, Ha-Na; Kim, Seung Hyeon; Park, Sin-Aye; Kim, Wonki; Surh, Young-Joon] Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Kim, Seung Hyeon; Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Cha, Young-Nam] Inha Univ, Coll Med, Dept Pharmacol & Toxicol, Incheon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inha University	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea.	surh@snu.ac.kr	Zhong, Xiancai/AAV-2761-2020; Zhong, Xiancai/AAM-3069-2020; Park, Sin-Aye/E-2303-2019	Zhong, Xiancai/0000-0001-8312-4057; Zhong, Xiancai/0000-0001-8312-4057; Park, Sin-Aye/0000-0003-2456-3572; Kim, Seung Hyeon/0000-0001-9197-5978	Global Core Research Center from the National Research Foundation of Korea [2011-0030001]	Global Core Research Center from the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Global Core Research Center Grant 2011-0030001 from the National Research Foundation of Korea. The authors declare no conflicts of interest.	Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006; Anderson S, 2016, P NATL ACAD SCI USA, V113, pE5481, DOI 10.1073/pnas.1610994113; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Conacci-Sorrell M, 2014, GENE DEV, V28, P689, DOI 10.1101/gad.231894.113; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Dayam RM, 2015, TRAFFIC, V16, P1010, DOI 10.1111/tra.12303; Donaldson JG., 2015, CURRENT PROTOCOLS, V69, p4.3.1; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Flannagan RS, 2014, MOL BIOL CELL, V25, P1511, DOI 10.1091/mbc.E13-04-0212; Gilberti RM, 2015, MOL BIOL CELL, V26, P518, DOI 10.1091/mbc.E14-08-1301; Ginhoux F, 2017, TRENDS IMMUNOL, V38, P693, DOI 10.1016/j.it.2017.05.009; Grabiec AM, 2012, ANN RHEUM DIS, V71, P424, DOI 10.1136/ard.2011.154211; Grimaldi A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.73; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Harvey SR, 2012, J AM CHEM SOC, V134, P19384, DOI 10.1021/ja306519h; Hermetet F, 2016, BIOL CELL, V108, P189, DOI 10.1111/boc.201500090; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Holmes K, 2001, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0503s44; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Khalil M, 2016, MUCOSAL IMMUNOL, V9, P1500, DOI 10.1038/mi.2016.16; Lavin B, 2014, ARTERIOSCL THROM VAS, V34, P1739, DOI 10.1161/ATVBAHA.114.303866; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Pello OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045399; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Portran D, 2017, NAT CELL BIOL, V19, P391, DOI 10.1038/ncb3481; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Wang B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4479; Wang JD, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0226-x; Weavers H, 2016, CELL, V165, P1658, DOI 10.1016/j.cell.2016.04.049; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110718; Ying W., 2013, JOVE-J VIS EXP, V76	56	27	27	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5312	5325		10.1096/fj.201800223R	http://dx.doi.org/10.1096/fj.201800223R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718706	Bronze			2022-12-28	WOS:000447972500010
J	Sharma, H; Chinnappan, M; Agarwal, S; Dalvi, P; Gunewardena, S; O'Brien-Ladner, A; Dhillon, NK				Sharma, Himanshu; Chinnappan, Mahendran; Agarwal, Stuti; Dalvi, Pranjali; Gunewardena, Sumedha; O'Brien-Ladner, Amy; Dhillon, Navneet K.			Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse	FASEB JOURNAL			English	Article						HIV-PAH; pulmonary vascular remodelling; miR-130a; cocaine	PULMONARY ARTERIAL-HYPERTENSION; ANTIRETROVIRAL THERAPY; EXOSOMES INDUCE; CELL PROLIFERATION; ENDOTHELIAL-CELLS; UP-REGULATION; KAPPA-B; COCAINE; PTEN; MICRORNA	Our previous studies consistently demonstrate enhanced pulmonary vascular remodeling in HIV-infected intravenous drug users, and in simian immunodeficiency virus-infected macaques or HIV-transgenic rats exposed to opioids or cocaine. Although we reported an associated increase in perivascular inflammation, the exact role of inflammatory cells in the development of pulmonary vascular remodeling remains unknown. In this study, HIV-infected and cocaine (H+C)-treated human monocyte derived macrophages released a higher number of extracellular vesicles (EVs), compared to HIV-infected or uninfected cocaine-treated macrophages, with a significant increase in the particle size range to 100-150 nm. Treatment of primary human pulmonary arterial smooth muscle cells (HPASMCs) with these EVs resulted in a significant increase in smooth muscle proliferation. We also observed a significant increase in the miRNA-130a level in the EVs derived from H+C-treated macrophages that corresponded with the decrease in the expression of phosphatase and tensin homolog and tuberous sclerosis 1 and 2 and activation of PI3K/protein kinase B signaling in HPASMCs on addition of these EVs. Transfection of HPASMCs with antagomir-130a-ameliorated the EV-induced effect. Thus, we conclude that EVs derived from H+C-treated macrophages promote pulmonary smooth muscle proliferation by delivery of its prosurvival miRNA cargo, which may play a crucial role in the development of PAH.Sharma, H., Chinnappan, M., Agarwal, S., Dalvi, P., Gunewardena, S., O'Brien-Ladner, A., Dhillon, N. K. Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse.	[Sharma, Himanshu; Chinnappan, Mahendran; Agarwal, Stuti; Dalvi, Pranjali; O'Brien-Ladner, Amy; Dhillon, Navneet K.] Univ Kansas, Med Ctr, Dept Med, Div Pulm & Crit Care Med, 3901 Rainbow Blvd,Mail Stop 3007, Kansas City, KS 66160 USA; [Gunewardena, Sumedha; Dhillon, Navneet K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Dhillon, NK (corresponding author), Univ Kansas, Med Ctr, Dept Med, Div Pulm & Crit Care Med, 3901 Rainbow Blvd,Mail Stop 3007, Kansas City, KS 66160 USA.	ndhillon@kumc.edu	Chinnappan, Mahendran/AAH-4930-2021; Dalvi, Pranjali/GRF-1132-2022	Dalvi, Pranjali/0000-0002-5247-9645; Agarwal, Stuti/0000-0002-4436-942X	Kansas Intellectual and Developmental Disabilities Research Center, U. S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [U54 HD 090216]; Molecular Regulation of Cell Development and Differentiation Centers of Biomedical Research Excellence (COBRE) Grant (University of Kansas Medical Center for RNA Sequencing and Bioinformatics Services) [5P20GM104936-10]; NIH National Institute on Drug Abuse [R01DA034542, R01DA042715]; NIH National Heart, Blood, and Lung Institute [R01HL129875]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042715, R01DA034542] Funding Source: NIH RePORTER	Kansas Intellectual and Developmental Disabilities Research Center, U. S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; Molecular Regulation of Cell Development and Differentiation Centers of Biomedical Research Excellence (COBRE) Grant (University of Kansas Medical Center for RNA Sequencing and Bioinformatics Services); NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Electron Microscopy Research Laboratory (EMRL) facility and Barbara Fegley for assistance with electron microscopy of isolate extracellular vesicles; Dr. Lane Christenson for providing access to NanoSight-LM10; the Kansas Intellectual and Developmental Disabilities Research Center, U. S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant U54 HD 090216; and the Molecular Regulation of Cell Development and Differentiation Centers of Biomedical Research Excellence (COBRE) Grant 5P20GM104936-10 (University of Kansas Medical Center for RNA Sequencing and Bioinformatics Services). This work was supported by NIH National Institute on Drug Abuse Grants R01DA034542 and R01DA042715, and NIH National Heart, Blood, and Lung Institute R01HL129875 (to N.K.D.). The authors declare no conflicts of interest.	Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Aliotta JM, 2016, CARDIOVASC RES, V110, P319, DOI 10.1093/cvr/cvw054; Almodovar Sharilyn, 2011, Proc Am Thorac Soc, V8, P308, DOI 10.1513/pats.201006-046WR; Almodovar S, 2010, CHEST, V137, p6S, DOI 10.1378/chest.09-3065; Arenaccio C, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0216-y; Barclay RA, 2017, J BIOL CHEM, V292, P11682, DOI 10.1074/jbc.M117.793521; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouhlal H, 2005, J IMMUNOL, V174, P7202, DOI 10.4049/jimmunol.174.11.7202; Brock M, 2015, INT J BIOCHEM CELL B, V61, P129, DOI 10.1016/j.biocel.2015.02.002; Chen JS, 2016, ONCOL REP, V35, P3285, DOI 10.3892/or.2016.4719; Colvin KL, 2013, AM J RESP CRIT CARE, V188, P1126, DOI 10.1164/rccm.201302-0403OC; Dalvi PN, 2015, AM J RESP CRIT CARE, V191; Dalvi P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10449-0; Dalvi P, 2016, AM J RESP CELL MOL, V55, P201, DOI 10.1165/rcmb.2015-0264OC; Dalvi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085246; Dalvi P, 2013, ARTERIOSCL THROM VAS, V33, P2585, DOI 10.1161/ATVBAHA.113.302054; Dalvi PN, 2015, AM J RESP CELL MOL, V53, P336, DOI 10.1165/rcmb.2014-0369OC; Deng L, 2015, CIRC RES, V117, P870, DOI 10.1161/CIRCRESAHA.115.306806; Denzer K, 2000, J CELL SCI, V113, P3365; Dhillon NK, 2007, J NEUROVIROL, V13, P483, DOI 10.1080/13550280701528684; Dhillon NK, 2011, AM J RESP CELL MOL, V45, P40, DOI 10.1165/rcmb.2010-0097OC; Feng YQ, 2016, ARCH BIOCHEM BIOPHYS, V598, P57, DOI 10.1016/j.abb.2016.03.019; Fitzpatrick M, 2013, CLIN CHEST MED, V34, P325, DOI 10.1016/j.ccm.2013.01.010; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao YS, 2016, AM J RESP CELL MOL, V54, P451, DOI 10.1165/rcmb.2015-0323TR; Garat CV, 2013, J CARDIOVASC PHARM, V62, P539, DOI 10.1097/FJC.0000000000000014; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; HE LH, 1991, J APPL PHYSIOL, V70, P1861, DOI 10.1152/jappl.1991.70.4.1861; Horita H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10830; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Isasti G, 2013, AIDS RES HUM RETROV, V29, P231, DOI [10.1089/aid.2012.0166, 10.1089/AID.2012.0166]; Kang BY, 2017, AM J RESP CELL MOL, V56, P131, DOI 10.1165/rcmb.2016-0166OC; Konadu KA, 2015, J INFECT DIS, V211, P1712, DOI 10.1093/infdis/jiu676; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; L'Huillier AG, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00025; Lane TE, 1996, MOL MED, V2, P27, DOI 10.1007/BF03402200; Langkilde A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051698; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810; Marecki J, 2005, CHEST, V128, p621S, DOI 10.1378/chest.128.6_suppl.621S-a; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; McDonald RA, 2012, CARDIOVASC RES, V93, P594, DOI 10.1093/cvr/cvr299; Mermis J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-103; Miao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41942; Morris A, 2012, AIDS, V26, P731, DOI 10.1097/QAD.0b013e32835099ae; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Niu F, 2014, J NEUROSCI, V34, P11812, DOI 10.1523/JNEUROSCI.1139-14.2014; Osada-Oka M, 2017, HYPERTENS RES, V40, P353, DOI 10.1038/hr.2016.163; Porter KM, 2013, PULM CIRC, V3, P58, DOI 10.4103/2045-8932.109915; Rasoulinejad Mehrnaz, 2014, Acta Med Iran, V52, P827; Reinsch N, 2008, HIV MED, V9, P550, DOI 10.1111/j.1468-1293.2008.00602.x; Roberts TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089237; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth WW, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010032; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Selvendiran K, 2009, J PHARMACOL EXP THER, V329, P959, DOI 10.1124/jpet.108.150367; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Song CL, 2016, ONCOTARGET, V7, P71922, DOI 10.18632/oncotarget.12431; Spikes L, 2012, AM J RESP CRIT CARE, V185, P1235, DOI 10.1164/rccm.201110-1909OC; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR; Teow SY, 2016, ADV VIROL, V2016, DOI 10.1155/2016/9852494; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang YQ, 2017, CELL DEATH DIFFER, V24, P2089, DOI 10.1038/cdd.2017.129; Wei HJ, 2017, CANCER RES, V77, P6168, DOI 10.1158/0008-5472.CAN-17-0530; Willis GR, 2018, AM J RESP CRIT CARE, V197, P104, DOI 10.1164/rccm.201705-0925OC; Wu J, 2014, INT J MOL SCI, V15, P13738, DOI 10.3390/ijms150813738; Wu YT, 2015, ANALYST, V140, P6631, DOI 10.1039/c5an00688k; Xia XD, 2016, DNA CELL BIOL, V35, P599, DOI 10.1089/dna.2016.3342; Yu X, 2012, J MOL CELL CARDIOL, V53, P848, DOI 10.1016/j.yjmcc.2012.10.002; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhao L, 2017, CARDIOLOGY, V137, P43, DOI 10.1159/000453544; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR; Zuber JP, 2004, CLIN INFECT DIS, V38, P1178, DOI 10.1086/383037	80	37	39	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5174	5185		10.1096/fj.201701558R	http://dx.doi.org/10.1096/fj.201701558R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29672222	Green Published, hybrid			2022-12-28	WOS:000443817700044
J	Theurl, M; Lener, D; Albrecht-Schgoer, K; Beer, A; Schgoer, W; Liu, Y; Stanzl, U; Fischer-Colbrie, R; Kirchmair, R				Theurl, Markus; Lener, Daniela; Albrecht-Schgoer, Karin; Beer, Arno; Schgoer, Wilfried; Liu, Yu; Stanzl, Ursula; Fischer-Colbrie, Reiner; Kirchmair, Rudolf			Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy	FASEB JOURNAL			English	Article						signaling; Schwann cell; nerve conduction velocity	ACUTE MYOCARDIAL-INFARCTION; REPAIR-AMI TRIAL; PERIPHERAL NEUROPATHY; BLOOD-FLOW; SECRETOGRANIN-II; PROGENITOR CELLS; VASA NERVORUM; BASIC FGF; IN-VITRO; ISCHEMIA	The pathogenesis of diabetic neuropathy remains enigmatic. Damage to the vasa nervorum may be responsible for this disorder. Recently, we showed that secretoneurin (SN) induces angiogenesis in hindlimb and myocardial ischemia. Moreover, beneficial effects were observed in wound healing. We therefore hypothesized that SN therapy may ameliorate diabetic neuropathy. We used db/db mice as animal model for neuropathy. Gene therapy was accomplished by intramuscular injection of SN plasmid along the sciatic nerve. Sciatic nerve motor and sensory conduction velocities were then measured for 9 wk. Nerve conduction velocities showed normal values in heterozygous mice for the observational period, but were severely reduced in homozygous mice in which velocities were significantly improved by SN, but not by control plasmid gene therapy. The reaction time in the tail-flick test improved significantly in SN-treated animals. The induction of growth of vasa nervorum seems to be part of the underlying mechanism. In addition, SN positively affected Schwann cell function in vitro and induced activation of important signaling pathways. Our observations suggest that SN exerts beneficial effects on nerve function in vivo and on Schwann cells in vitro. It therefore may be a promising treatment option for diabetic neuropathy.Theurl, M., Lener, D., Albrecht-Schgoer, K., Beer, A., Schgoer, W., Liu, Y., Stanzl, U., Fischer-Colbrie, R., Kirchmair, R. Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy.	[Theurl, Markus; Lener, Daniela; Albrecht-Schgoer, Karin; Beer, Arno; Schgoer, Wilfried; Stanzl, Ursula; Kirchmair, Rudolf] Med Univ Innsbruck, Univ Hosp Internal Med 3, Dept Cardiol & Angiol, Innsbruck, Austria; [Albrecht-Schgoer, Karin] Med Univ Innsbruck, Div Translat Cell Genet, Innsbruck, Austria; [Fischer-Colbrie, Reiner] Med Univ Innsbruck, Inst Pharmacol, Innsbruck, Austria; [Liu, Yu] Capital Med Univ, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Capital Medical University	Theurl, M; Kirchmair, R (corresponding author), Med Univ Innsbruck, Univ Hosp Internal Med Cardiol & Angiol, Anichstr 35, A-6020 Innsbruck, Austria.	markus.theurl@i-med.ac.at; rudolf.kirchmair@i-med.ac.at	Albrecht-Schgoer, Karin/AAG-4463-2020	Albrecht-Schgoer, Karin/0000-0001-8551-4067; Theurl, Markus/0000-0002-3609-9730	Austrian Diabetes Association (oDG); Ernst-Mach fellowship awarded by the Eurasia-Pacific-Uninet; Austrian Science Fund (FWF) [L500-B05]	Austrian Diabetes Association (oDG); Ernst-Mach fellowship awarded by the Eurasia-Pacific-Uninet; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank Sylvia Berger (Department of Infectious Diseases, Immunology, Rheumatology, Pneumology, University Hospital of Internal Medicine II, Medical University Innsbruck) for excellent technical assistance. The current study was supported by a grant of the Austrian Science Fund (FWF; translational research grant L500-B05) and a 2007 research grant of the Austrian Diabetes Association (oDG) (to R.K.). Y.L. is the recipient of an Ernst-Mach fellowship awarded by the Eurasia-Pacific-Uninet. The authors declare no conflicts of interest.	Albrecht-Schgoer K, 2014, ANGIOGENESIS, V17, P27, DOI 10.1007/s10456-013-9375-4; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; APFEL SC, 1994, BRAIN RES, V634, P7, DOI 10.1016/0006-8993(94)90252-6; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; CAMERON NE, 1991, AM J PHYSIOL, V261, pE1, DOI 10.1152/ajpendo.1991.261.1.E1; CAMERON NE, 1994, DIABETES METAB REV, V10, P189, DOI 10.1002/dmr.5610100302; Cho YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083204; Cohen JA, 1998, MUSCLE NERVE, V21, P72, DOI 10.1002/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2; CULLUM NA, 1991, DIABETOLOGIA, V34, P387, DOI 10.1007/BF00403175; DYCK PJ, 1989, NEUROLOGY, V39, P111, DOI 10.1212/WNL.39.1.111; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; GREENE DA, 1987, NEW ENGL J MED, V316, P599; He B, 2011, EUR J PHARMACOL, V667, P195, DOI 10.1016/j.ejphar.2011.06.001; Jeong JO, 2009, CIRCULATION, V119, P699, DOI 10.1161/CIRCULATIONAHA.108.789297; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Kirchmair R, 2007, MOL THER, V15, P69, DOI 10.1038/sj.mt.6300019; Kusano KF, 2004, ARTERIOSCL THROM VAS, V24, P2102, DOI 10.1161/01.ATV.0000144813.44650.75; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Norrmen C, 2013, BIOCHEM SOC T, V41, P944, DOI 10.1042/BST20130046; Pang ZD, 2017, FASEB J, V31, P4053, DOI 10.1096/fj.201700110R; PARKHOUSE N, 1988, NEW ENGL J MED, V318, P1306, DOI 10.1056/NEJM198805193182005; Pittenger Gary, 2003, Exp Diabesity Res, V4, P271, DOI 10.1155/EDR.2003.271; Posod A, 2017, NEUROSCIENCE, V352, P88, DOI 10.1016/j.neuroscience.2017.03.055; Ropper AH, 2009, ANN NEUROL, V65, P386, DOI 10.1002/ana.21675; Rosjo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037401; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2009, EUR J HEART FAIL, V11, P973, DOI 10.1093/eurjhf/hfp113; Schgoer W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074029; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; SCHMID KW, 1995, HISTOCHEM J, V27, P473; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Stavniichuk Roman, 2013, J Diabetes Mellitus, V3, DOI 10.4236/jdm.2013.33015; STEVENS EJ, 1994, DIABETOLOGIA, V37, P43, DOI 10.1007/BF00428776; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; TESFAYE S, 1993, DIABETOLOGIA, V36, P1266, DOI 10.1007/BF00400804; Theurl M, 2015, CARDIOVASC RES, V105, P96, DOI 10.1093/cvr/cvu237; TUCK RR, 1984, BRAIN, V107, P935, DOI 10.1093/brain/107.3.935; Veves A, 1998, DIABETES, V47, P457, DOI 10.2337/diabetes.47.3.457; Walter DH, 2011, CIRC-CARDIOVASC INTE, V4, P26, DOI 10.1161/CIRCINTERVENTIONS.110.958348	42	4	4	3	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4815	4823		10.1096/fj.201701391R	http://dx.doi.org/10.1096/fj.201701391R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913555				2022-12-28	WOS:000443817700017
J	Zhang, J; Yin, JM; Wang, YJ; Li, B; Zeng, XJ				Zhang, Jia; Yin, Jiming; Wang, Yangjia; Li, Bin; Zeng, Xiangjun			Apelin impairs myogenic response to induce diabetic nephropathy in mice	FASEB JOURNAL			English	Article						smooth muscle cell; renal blood flow; endothelial cell; APJ; kidney	VASCULAR SMOOTH-MUSCLE; RENAL BLOOD-FLOW; PEPTIDE APELIN; PHOSPHORYLATION; MECHANISMS; RECEPTORS; TONE; AUTOREGULATION; PROMOTES; APJ	The cause of the invalid reaction of smooth muscle cells to mechanical stimulation that results in a dysfunctional myogenic response that mediates the disruption of renal blood flow (RBF) in patients with diabetes is debatable. The present study revealed that increased apelin concentration in serum of diabetic mice neutralized the myogenic response mediated by apelin receptor (APJ) and resulted in increased RBF, which promoted the progression of diabetic nephropathy. The results showed that apelin concentration, RBF, and albuminuria:creatinine ratio were all increased in kkAy mice, and increased RBF correlated positively with serum apelin both in C57 and diabetic mice. The increased RBF was accompanied by decreased phosphorylation of myosin light chain (MLC), -arrestin, and increased endothelial NOS in glomeruli. Meanwhile, calcium, phosphorylation of MLC, and -arrestin were decreased by high glucose and apelin treatment in cultured smooth muscle cells, as well. eNOS was increased by high glucose and increased by apelin in cultured endothelial cells (ECs). Knockdown of -arrestin expression in smooth muscle cells cancelled phosphorylation of MLC induced by apelin. Therefore, apelin may induce the progression of diabetic nephropathy by counteracting the myogenic response in smooth muscle cells.Zhang, J., Yin, J., Wang, Y., Li, B., Zeng, X. Apelin impairs myogenic response to induce diabetic nephropathy in mice.	[Zhang, Jia; Wang, Yangjia; Li, Bin; Zeng, Xiangjun] Capital Med Univ, Dept Pathophysiol, Beijing You An Hosp, Beijing, Peoples R China; [Yin, Jiming] Capital Med Univ, Beijing Inst Hepatol, Beijing You An Hosp, Beijing, Peoples R China; [Zhang, Jia; Wang, Yangjia; Li, Bin; Zeng, Xiangjun] Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zeng, XJ (corresponding author), Capital Med Univ, You Anmen Wai 10, Beijing 100069, Peoples R China.	megan_zeng@163.com			Natural Science Foundation of China [81270815]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Wei Wang, Haixia Huang, and Sitao Zhang (Capital Medical University) for assistance with the ex vivo study. The work was supported by the Natural Science Foundation of China Grant 81270815. The authors declare no conflicts of interest.	Carlstrom M, 2015, PHYSIOL REV, V95, P405, DOI 10.1152/physrev.00042.2012; Czogalla J, 2016, JOVE-J VIS EXP, DOI 10.3791/54712; Dautzenberg M, 2011, J PHYSIOL-LONDON, V589, P4731, DOI 10.1113/jphysiol.2011.215897; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Guo CX, 2015, J CELL MOL MED, V19, P2273, DOI 10.1111/jcmm.12619; Habchi M, 2014, CLIN ENDOCRINOL, V81, P696, DOI 10.1111/cen.12404; Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Jensen EP, 2015, AM J PHYSIOL-RENAL, V308, pF867, DOI 10.1152/ajprenal.00527.2014; Kauffenstein G, 2012, CARDIOVASC RES, V95, P223, DOI 10.1093/cvr/cvs152; Khavandi K, 2009, NEPHROL DIAL TRANSPL, V24, P361, DOI 10.1093/ndt/gfn583; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Loutzenhiser R, 2002, CIRC RES, V90, P1316, DOI 10.1161/01.RES.0000024262.11534.18; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Murphy TV, 2002, CLIN EXP PHARMACOL P, V29, P612, DOI 10.1046/j.1440-1681.2002.03698.x; O'Brien SP, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/498925; O'Harte FPM, 2017, BIOCHEM PHARMACOL, V146, P165, DOI 10.1016/j.bcp.2017.10.002; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pihl L, 2012, AM J PHYSIOL-REG I, V303, pR39, DOI 10.1152/ajpregu.00582.2011; Schofield I, 2002, CIRCULATION, V106, P3037, DOI 10.1161/01.CIR.0000041432.80615.A5; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Seo KW, 2015, J MOL CELL CARDIOL, V85, P13, DOI 10.1016/j.yjmcc.2015.05.006; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tomino Yasuhiko, 2012, Nephrourol Mon, V4, P524, DOI 10.5812/numonthly.1954; Wang L, 2016, CIRCULATION, V134, P1353, DOI 10.1161/CIRCULATIONAHA.115.020754; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; ZHANG W, 2013, PLOS ONE, V8; Zhong JC, 2007, REGUL PEPTIDES, V144, P109, DOI 10.1016/j.regpep.2007.06.010; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002	31	6	7	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4315	4327		10.1096/fj.201701257R	http://dx.doi.org/10.1096/fj.201701257R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29522374				2022-12-28	WOS:000439325400022
J	Carli, JFM; LeDuc, CA; Zhang, YY; Stratigopoulos, G; Leibel, RL				Carli, Jayne F. Martin; LeDuc, Charles A.; Zhang, Yiying; Stratigopoulos, George; Leibel, Rudolph L.			The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function	FASEB JOURNAL			English	Article						Fto; adipogenesis; obesity	BASAL BODY PROTEIN; ADIPOSE-TISSUE; FTO GENE; 3T3-L1 PREADIPOCYTES; JOUBERT-SYNDROME; TRANSITION-ZONE; ADIPOGENIC DIFFERENTIATION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; CRE RECOMBINASE	Genetic variants within the FTO (-ketoglutarate-dependent dioxygenase) gene have been strongly associated with a modest increase in adiposity as a result of increased food intake. These risk alleles are associated with decreased expression of both FTO and neighboring RPGRIP1L (retinitis pigmentosa GTPase regulator-interacting protein 1 like). RPGRIP1L encodes a protein that is critical to the function of the primary cilium, which conveys extracellular information to the cell. Rpgrip1l(+/-) mice exhibit increased adiposity, in part, as a result of hyperphagia. Here, we describe the effects of Rpgrip1l in adipocytes that may contribute to the adiposity phenotype observed in these animals and possibly in humans who segregate for FTO risk alleles. Loss of Rpgrip1l in 3T3-L1 preadipocytes increased the number of cells that are capable of differentiating into mature adipocytes. Knockout of Rpgrip1l in mature adipocytes using Adipoq-Cre did not increase adiposity in mice that were fed chow or a high-fat diet. We also did not observe any effects of Rpgrip1l knockdown in mature 3T3-L1 adipocytes. Thus, to the extent that Rpgrip1l affects cell-autonomous adipose tissue function, it may do so as a result of the effects conveyed in preadipocytes in which the primary cilium is functionally important. We propose that decreased RPGRIP1L expression in preadipocytes in humans who segregate for FTO obesity risk alleles may increase the storage capacity of adipose tissue.Martin Carli, J. F., LeDuc, C. A., Zhang, Y., Stratigopoulos, G., Leibel, R. L. The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function.	[Carli, Jayne F. Martin] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, 1150 St Nicholas Ave,Room 620, New York, NY 10032 USA; [Carli, Jayne F. Martin; LeDuc, Charles A.; Zhang, Yiying; Stratigopoulos, George; Leibel, Rudolph L.] Columbia Univ, Med Ctr, Naomi Berrie Diabet Ctr, New York, NY USA; [Carli, Jayne F. Martin; LeDuc, Charles A.; Zhang, Yiying; Stratigopoulos, George; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Carli, JFM (corresponding author), Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, 1150 St Nicholas Ave,Room 620, New York, NY 10032 USA.	jfm2170@cumc.columbia.edu	Stratigopoulos, George/D-4159-2015	Stratigopoulos, George/0000-0003-4752-9123; LeDuc, Charles/0000-0002-2073-5050	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK097399, DK-P30026687-36, S10-RR027050, 5P30-DK063608]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097399, R01DK052431, P30DK063608, P30DK026687] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK097399, DK-P30026687-36 (New York Obesity Nutrition Research Center), S10-RR027050 (Columbia Center for Translational Immunology Flow Cytometry Core), and 5P30-DK063608 (Diabetes Education and Research Center). The authors declare no conflicts of interest.	Aksanov O, 2014, CELL MOL LIFE SCI, V71, P3381, DOI 10.1007/s00018-014-1571-x; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Christensen ST, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028167; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cousin W, 2006, BIOCHEM BIOPH RES CO, V349, P799, DOI 10.1016/j.bbrc.2006.08.112; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Forcioli-Conti N, 2016, BIOCHIMIE, V124, P112, DOI 10.1016/j.biochi.2015.09.011; Forcioli-Conti N, 2015, BIOCHEM BIOPH RES CO, V458, P117, DOI 10.1016/j.bbrc.2015.01.078; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerdes JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6308; Gerhardt C, 2015, J CELL BIOL, V210, P115, DOI 10.1083/jcb.201408060; Gerhardt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057545; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Huang-Doran I, 2010, INT J OBESITY, V34, P1554, DOI 10.1038/ijo.2010.92; James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Li CM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002416; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; LIEBELT RA, 1963, ANN NY ACAD SCI, V110, P723, DOI 10.1111/j.1749-6632.1963.tb15794.x; Lin YW, 2009, EUR J CANCER, V45, P2041, DOI 10.1016/j.ejca.2009.04.012; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mahuzier A, 2012, J CELL BIOL, V198, P927, DOI 10.1083/jcb.201111009; Mariman ECM, 2016, BRIT J NUTR, V116, P576, DOI 10.1017/S0007114516002282; Marion V, 2012, CELL METAB, V16, P363, DOI 10.1016/j.cmet.2012.08.005; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Oh EC, 2015, CELL METAB, V21, P21, DOI 10.1016/j.cmet.2014.11.019; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Ravussin Y, 2014, CELL METAB, V20, P565, DOI 10.1016/j.cmet.2014.09.002; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Russell CD, 1998, AM J PHYSIOL-ENDOC M, V275, pE507, DOI 10.1152/ajpendo.1998.275.3.E507; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sherafat-Kazemzadeh R, 2013, PEDIATR OBES, V8, pE64, DOI 10.1111/j.2047-6310.2013.00182.x; Shi XY, 2017, NAT CELL BIOL, V19, P1178, DOI 10.1038/ncb3599; Slieker LJ, 1998, BIOCHEM BIOPH RES CO, V251, P225, DOI 10.1006/bbrc.1998.9433; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SMYTH MJ, 1992, EXP CELL RES, V199, P29, DOI 10.1016/0014-4827(92)90458-K; Soriano P, 1997, DEVELOPMENT, V124, P2691; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Stratigopoulos G, 2016, J CLIN INVEST, V126, P1897, DOI 10.1172/JCI85526; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Sun CY, 2017, DEVELOPMENT, V144, P83, DOI 10.1242/dev.135962; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Vaisse C, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028217; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Zhang Y., 2017, EATING DISORDERS OBE; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	82	8	8	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3946	3956		10.1096/fj.201701216R	http://dx.doi.org/10.1096/fj.201701216R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29466054	Green Published			2022-12-28	WOS:000435104500039
J	Chevre, R; Trigueros-Motos, L; Castano, D; Chua, T; Corliano, M; Patankar, JV; Sng, L; Sim, L; Juin, TL; Carissimo, G; Ng, LFP; Yi, CNJ; Eliathamby, CC; Groen, AK; Hayden, MR; Singaraja, RR				Chevre, Raphael; Trigueros-Motos, Laia; Castano, David; Chua, Tricia; Corliano, Maria; Patankar, Jay V.; Sng, Lareina; Sim, Lauren; Juin, Tan Liang; Carissimo, Guillaume; Ng, Lisa F. P.; Yi, Cheryl Neo Jia; Eliathamby, Chelsea Chandani; Groen, Albert K.; Hayden, Michael R.; Singaraja, Roshni R.			Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice	FASEB JOURNAL			English	Article						NAFLD therapeutics; steatosis; liver targeting; siRNA delivery; intestinal cholesterol absorption	STEROL 12-ALPHA-HYDROXYLASE; NUCLEAR RECEPTOR; CHOLESTEROL; FXR; IDENTIFICATION; HOMEOSTASIS; METABOLISM; LIGANDS; TGR5; RNA	Bile acids (BAs) are surfactant molecules that regulate the intestinal absorption of lipids. Thus, the modulation of BAs represents a potential therapy for nonalcoholic fatty liver disease (NAFLD), which is characterized by hepatic accumulation of fat and is a major cause of liver disease worldwide. Cyp8b1 is a critical modulator of the hydrophobicity index of the BA pool. As a therapeutic proof of concept, we aimed to determine the impact of Cyp8b1 inhibition in vivo on BA pool composition and as protection against NAFLD. Inhibition of Cyp8b1 expression in mice led to a remodeling of the BA pool, which altered its signaling properties and decreased intestinal fat absorption. In a model of cholesterol-induced NAFLD, Cyp8b1 knockdown significantly decreased steatosis and hepatic lipid content, which has been associated with an increase in fecal lipid and BA excretion. Moreover, inhibition of Cyp8b1 not only decreased hepatic lipid accumulation, but also resulted in the clearance of previously accumulated hepatic cholesterol, which led to a regression in hepatic steatosis. Taken together, our data demonstrate that Cyp8b1 inhibition is a viable therapeutic target of crucial interest for metabolic diseases, such as NAFLD.Chevre, R., Trigueros-Motos, L., Castano, D., Chua, T., Corlian, M., Patankar, J. V., Sng, L., Sim, L., Juin, T. L., Carissimo, G., Ng, L. F. P., Yi, C. N. J., Eliathamby, C. C., Groen, A. K., Hayden, M. R., Singaraja, R. R. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice.	[Chevre, Raphael; Trigueros-Motos, Laia; Castano, David; Chua, Tricia; Corliano, Maria; Sng, Lareina; Sim, Lauren; Juin, Tan Liang; Yi, Cheryl Neo Jia; Eliathamby, Chelsea Chandani; Hayden, Michael R.; Singaraja, Roshni R.] ASTAR, Translat Lab Genet Med, Singapore, Singapore; [Carissimo, Guillaume; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Patankar, Jay V.; Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC, Canada; [Ng, Lisa F. P.; Singaraja, Roshni R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Groen, Albert K.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Patankar, Jay V.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Erlangen, Germany	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Child & Family Research Institute; University of British Columbia; National University of Singapore; University of Liverpool; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Erlangen Nuremberg	Singaraja, RR (corresponding author), Natl Univ Singapore, Agcy Sci Technol & Res, 8A Biomed Grove,Immunos L5, Singapore 138648, Singapore.	rsingaraja@tlgm.a-star.edu.sg	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867; Patankar, Jay/0000-0002-1884-7424; Carissimo, Guillaume/0000-0002-9703-9096	A*STAR; National University of Singapore	A*STAR(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	Microscopy images were acquired at the Image Microscopy Unit [Institute of Medical Biology, Agency for Science, Technology, and Research (A*STAR)]. Funding was provided by A*STAR and the National University of Singapore. The authors declare no conflicts of interest.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Bajor A, 2010, SCAND J GASTROENTERO, V45, P645, DOI 10.3109/00365521003702734; Barteau B, 2008, CURR GENE THER, V8, P313, DOI 10.2174/156652308786070961; Bertaggia E, 2017, AM J PHYSIOL-ENDOC M, V313, pE121, DOI 10.1152/ajpendo.00409.2016; Bonde Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147772; Eguchi A, 2016, J HEPATOL, V64, P699, DOI 10.1016/j.jhep.2015.11.002; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kim EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097841; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pathak P, 2013, J BIOL CHEM, V288, P37154, DOI 10.1074/jbc.M113.485987; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Puri P, 2018, HEPATOLOGY, V67, P534, DOI 10.1002/hep.29359; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2008, THYROID, V18, P167, DOI 10.1089/thy.2007.0255; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wierzbicki AS, 2012, CURR OPIN LIPIDOL, V23, P345, DOI 10.1097/MOL.0b013e3283541cfc; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Yamada M, 2000, BIOL CHEM, V381, P1149, DOI 10.1515/BC.2000.142; Yuan LY, 2015, WORLD J HEPATOL, V7, P2811, DOI 10.4254/wjh.v7.i28.2811; Zezos P, 2014, WORLD J GASTROENTERO, V20, P15532, DOI 10.3748/wjg.v20.i42.15532	49	24	24	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3792	3802		10.1096/fj.201701084RR	http://dx.doi.org/10.1096/fj.201701084RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481310				2022-12-28	WOS:000435104500026
J	Lin, WS; Yeh, SR; Fan, SZ; Chen, LY; Yen, JH; Fu, TF; Wu, MS; Wang, PY				Lin, Wei-Sheng; Yeh, Sheng-Rong; Fan, Shou-Zen; Chen, Liang-Yu; Yen, Jui-Hung; Fu, Tsai-Feng; Wu, Ming-Shiang; Wang, Pei-Yu			Insulin signaling in female Drosophila links diet and sexual attractiveness	FASEB JOURNAL			English	Article						courtship preference; oenocytes; cuticular hydrocarbons	INSECT CUTICULAR HYDROCARBONS; MALE COURTSHIP BEHAVIOR; LIFE-SPAN; MATE CHOICE; MELANOGASTER; RESTRICTION; PREFERENCE; RECEPTOR; NEURONS	Appropriate sexual selection or individual sexual attractiveness is closely associated with the reproductive success of a species. Here, we report that young male flies exhibit innate courtship preference for female flies that are raised on higher-yeast diets and that have greater body weight and fecundity, but reduced locomotor activity and shortened lifespan. Male flies discriminate among females that have been fed diets that contain 3 different yeast concentrations1, 5, and 20% yeastvia gustatory, but not visual or olfactory, perception. Female flies that are raised on higher-yeast diets exhibit elevated expression levels of Drosophila insulin-like peptides (dilps), and we demonstrate that hypomorphic mutations of dilp2, 3, 5 or foxo, as well as oenocyte-specific gene disruption of the insulin receptor, all abolish this male courtship preference for high yeast-fed females. Moreover, our data demonstrate that disrupted dilp signaling can alter the expression profile of some cuticular hydrocarbons (CHCs) in female flies, and that genetic inhibition of an enzyme involved in the biosynthesis of CHCs in oenocytes, elongase F, also eliminates the male courtship preference. Together, our findings provide mechanistic insights that link female reproductive potential to sexual attractiveness, thereby encouraging adaptive mating and optimal reproductive success.Lin, W.-S., Yeh, S.-R., Fan, S.-Z., Chen, L.-Y., Yen, J.-H., Fu, T.-F., Wu, M.-S., Wang, P.-Y. Insulin signaling in female Drosophila links diet and sexual attractiveness.	[Lin, Wei-Sheng; Yeh, Sheng-Rong; Wang, Pei-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Wang, Pei-Yu] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei, Taiwan; [Wang, Pei-Yu] Natl Taiwan Univ, Ctr Syst Biol, Taipei, Taiwan; [Lin, Wei-Sheng] Natl Taiwan Univ Hosp Yunlin, Dept Pediat, Yunlin, Taiwan; [Fan, Shou-Zen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Chen, Liang-Yu] Mingchuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Yen, Jui-Hung] Indiana Univ Sch Med, Dept Microbiol & Immunol, Ft Wayne, IN USA; [Fu, Tsai-Feng] Natl Chinan Univ, Dept Appl Chem, Nantou, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Purdue University System; Indiana University Purdue University Fort Wayne; National Chi Nan University	Wang, PY (corresponding author), Natl Taiwan Univ, 1,Sect 1,Renai Rd, Taipei 10051, Taiwan.	wangpeiyu@ntu.edu.tw	Yen, Jui-Hung/AAV-3455-2020; Lin, Wei-Sheng/AAV-9949-2020	Lin, Wei-Sheng/0000-0002-9016-2067; Fan, Shou-Zen/0000-0002-6849-8453; Chen, Liang-Yu/0000-0002-2981-1945; WANG, PEI-YU/0000-0002-1792-8935; Yen, Jui-Hung Jimmy/0000-0002-7325-9756	Ministry of Science and Technology, Taiwan [MOST 105-2321-B-002-009-, MOST 105-2410-H-002-050-MY2]; National Taiwan University Hospital [UN103-055]; National Taiwan University Hospital Yunlin [NTUHYL107.X017]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); National Taiwan University Hospital Yunlin	The authors thank Frederick Chien (Graduate Institute of Brain and Mind Sciences, National Taiwan University) for technical assistance and the Fly Core in Taiwan for fly stocks and reagents. P.-Y.W., M.-S.W., and W.-S.L. are supported by grants from the Ministry of Science and Technology, Taiwan (MOST 105-2321-B-002-009- and MOST 105-2410-H-002-050-MY2), National Taiwan University Hospital (UN103-055), and National Taiwan University Hospital Yunlin (NTUHYL107.X017). The authors declare no conflicts of interest.	ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Arbuthnott D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13953; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Chertemps T, 2007, P NATL ACAD SCI USA, V104, P4273, DOI 10.1073/pnas.0608142104; Chou HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058441; Chung H, 2015, BIOESSAYS, V37, P822, DOI 10.1002/bies.201500014; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799; Gorter JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19441; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Hu YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07777; Huang CW, 2015, J GERONTOL A-BIOL, V70, P1461, DOI 10.1093/gerona/glv094; Ingleby FC, 2015, INSECTS, V6, P732, DOI 10.3390/insects6030732; Kallman BR, 2015, ELIFE, V4, DOI 10.7554/eLife.11188; Khan I, 2013, J INSECT PHYSIOL, V59, P1017, DOI 10.1016/j.jinsphys.2013.07.010; Kuo SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8490; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Lin WS, 2014, AGE, V36, P689, DOI 10.1007/s11357-013-9606-z; Makki R, 2014, ANNU REV ENTOMOL, V59, P405, DOI 10.1146/annurev-ento-011613-162056; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Nandy B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00447; Rajpurohit S, 2017, J EVOLUTION BIOL, V30, P66, DOI 10.1111/jeb.12988; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Vijayan V, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004238; Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106; Yamamoto D, 2014, J COMP PHYSIOL A, V200, P251, DOI 10.1007/s00359-014-0891-5; Zajitschek F, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0914; Zhuang LM, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160086	37	11	11	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3870	3877		10.1096/fj.201800067R	http://dx.doi.org/10.1096/fj.201800067R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475396				2022-12-28	WOS:000435104500032
J	Liu, T; Liu, LM; Liu, MN; Du, R; Dang, YJ; Bai, M; Zhang, L; Ma, F; Yang, XX; Ning, XX; Sun, SR				Liu, Ting; Liu, Limin; Liu, Minna; Du, Rui; Dang, Yangjie; Bai, Ming; Zhang, Lei; Ma, Feng; Yang, Xiaoxia; Ning, Xiaoxuan; Sun, Shiren			MicroRNA-493 targets STMN-1 and promotes hypoxia-induced epithelial cell cycle arrest in G(2)/M and renal fibrosis	FASEB JOURNAL			English	Article						hypoxia; chronic kidney injury; tubular cell; HIF-1 alpha	TO-MESENCHYMAL TRANSITION; DOWN-REGULATION; GROWTH ARREST; CANCER-CELLS; STATHMIN; EXPRESSION; MYOFIBROBLASTS; IDENTIFICATION; PROLIFERATION; PROGRESSION	Hypoxia plays an important role in the development of renal fibrosis. G(2)/M arrest in renal tubular cells is an important pathway in the development of chronic kidney disease. It is unknown whether hypoxia leads to renal fibrosis via the regulation of G(2)/M arrest in renal tubular epithelial cells. For the first time, to our knowledge, we showed that hypoxia induces G(2)/M arrest in renal tubular cells leading to renal fibrosis, and microRNAs are involved in this regulation. We compared microRNA expression between hypoxia and normoxia in HK2 cells and found microRNA (miR)-493 to be highly expressed at 24 and 48 h after hypoxia. The overexpression of miR-493 reduced the expression of the cell cycle regulator, Stathmin (STMN)-1, and increased the percentage of G(2)/M phase cells and profibrotic factors in HK2 cells. Targeting STMN-1 with short hairpin RNA produced an effect similar to that of miR-493 overexpression. On contrast, the miR-493 inhibitor reversed these effects in vitro. Consistent with these results, miR-493 sponge adeno-associated virus reduced the expression of profibrotic factors and increased STMN-1 in vivo. In summary, these results suggest that the miR-493-STMN-1 pathway contributes to hypoxia-induced tubular epithelial cell G(2)/M arrest and renal fibrosis. Abrogating G(2)/M arrest and blocking the miR-493-STMN-1 pathway will provide further insight for the development of antifibrosis therapy.Liu, T., Liu, L., Liu, M., Du, R., Dang, Y., Bai, M., Zhang, L., Ma, F., Yang, X., Ning, X., Sun, S. MicroRNA-493 targets STMN-1 and promotes hypoxia-induced epithelial cell cycle arrest In G(2)/M and renal fibrosis.	[Liu, Ting; Liu, Limin; Liu, Minna; Bai, Ming; Zhang, Lei; Ma, Feng; Yang, Xiaoxia; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian, Shaanxi, Peoples R China; [Liu, Ting; Liu, Limin; Liu, Minna; Bai, Ming; Zhang, Lei; Ning, Xiaoxuan; Sun, Shiren] Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Ning, Xiaoxuan] Fourth Mil Med Univ, Dept Geriatr, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Liu, Ting] Xi An Jiao Tong Univ, Dept Nephrol, Guangren Hosp, Xian, Shaanxi, Peoples R China; [Du, Rui] Navy Gen Hosp, Dept Radiat Oncol, Beijing, Peoples R China; [Dang, Yangjie] Children Hosp Xian, Dept Anesthesiol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Sixth Medical Center of Chinese PLA General Hospital	Ning, XX (corresponding author), Fourth Mil Med Univ, Dept Geriatr, State Key Lab Canc Biol, Xijing Hosp, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China.; Sun, SR (corresponding author), Fourth Mil Med Univ, Dept Nephrol, State Key Lab Canc Biol, Xijing Hosp, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China.	ningxx01@fmmu.edu.cn; sunshiren@medmail.com.cn	Liu, Minna/AAV-1609-2020; liu, li/HGC-0900-2022	liu, limin/0000-0003-2527-7201	National Natural Science Foundation of China [81370789, 81670655, 81400699]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Gang Wang and Dr. Di Wang from the Department of Nephrology, Xijing Hospital, who provided kidney biopsies and pathological technical support. This work was supported by The National Natural Science Foundation of China (81370789, 81670655, and 81400699). The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030771; Eddy AA, 2014, KIDNEY INT SUPPL, V4, P2, DOI 10.1038/kisup.2014.2; Fine LG, 2000, KIDNEY INT, V57, pS22, DOI 10.1046/j.1523-1755.2000.07512.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102602; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Jayle C, 2007, AM J PHYSIOL-RENAL, V292, pP1082, DOI 10.1152/ajprenal.00338.2006; Jenkins RH, 2014, AM J PATHOL, V184, P996, DOI 10.1016/j.ajpath.2013.12.028; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu XL, 2015, INT J CLIN EXP MED, V8, P6502; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Pichiorri F, 2016, CANCER CELL, V30, P349, DOI 10.1016/j.ccell.2016.07.007; Polager S, 2003, J BIOL CHEM, V278, P1443, DOI 10.1074/jbc.M210327200; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Sole C, 2015, NEPHROL DIAL TRANSPL, V30, P1488, DOI 10.1093/ndt/gfv128; Sonneville F, 2015, AM J PATHOL, V185, P897, DOI 10.1016/j.ajpath.2014.12.022; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tambe M, 2016, ONCOTARGET, V7, P12267, DOI 10.18632/oncotarget.7860; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tian FJ, 2015, AM J PATHOL, V185, P2709, DOI 10.1016/j.ajpath.2015.06.010; Wang G, 2012, AM J NEPHROL, V36, P412, DOI 10.1159/000343452; Whitehouse A, 2015, ONCOTARGET, V6, P32289, DOI 10.18632/oncotarget.5961; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zahedi K, 2006, AM J PHYSIOL-RENAL, V290, pF1559, DOI 10.1152/ajprenal.00424.2005; Zahedi K, 2004, AM J PHYSIOL-CELL PH, V286, pC1203, DOI 10.1152/ajpcell.00432.2003; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	47	18	22	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1565	1577		10.1096/fj.201701355RR	http://dx.doi.org/10.1096/fj.201701355RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183377	Bronze			2022-12-28	WOS:000457296600006
J	Parisi, G; Montemiglio, LC; Giuffre, A; Macone, A; Scaglione, A; Cerutti, G; Exertier, C; Savino, C; Vallone, B				Parisi, Giacomo; Montemiglio, Linda Celeste; Giuffre, Alessandro; Macone, Alberto; Scaglione, Antonella; Cerutti, Gabriele; Exertier, Cecile; Savino, Carmelinda; Vallone, Beatrice			Substrate-induced conformational change in cytochrome P450 OleP	FASEB JOURNAL			English	Article						X-ray crystallography; multistep binding kinetics; 6DEB; structural transition; spectroscopic intermediate	STREPTOMYCES-ANTIBIOTICUS; 2-DIMENSIONAL NMR; STRUCTURAL BASIS; BIOSYNTHESIS; OLEANDOMYCIN; BINDING; DYNAMICS; KINETICS; OXIDATION; ENZYMES	The regulation of cytochrome P450 activity is often achieved by structural transitions induced by substrate binding. We describe the conformational transition experienced upon binding by the P450 OleP, an epoxygenase involved in oleandomycin biosynthesis. OleP bound to the substrate analog 6DEB crystallized in 2 forms: one with an ensemble of open and closed conformations in the asymmetric unit and another with only the closed conformation. Characterization of OleP-6DEB binding kinetics, also using the P450 inhibitor clotrimazole, unveiled a complex binding mechanism that involves slow conformational rearrangement with the accumulation of a spectroscopically detectable intermediate where 6DEB is bound to open OleP. Data reported herein provide structural snapshots of key precatalytic steps in the OleP reaction and explain how structural rearrangements induced by substrate binding regulate activity.Parisi, G., Montemiglio, L. C., Giuffre, A., Macone, A., Scaglione, A., Cerutti, G., Exertier, C., Savino, C., Vallone, B. Substrate-induced conformational change in cytochrome P450 OleP.	[Parisi, Giacomo; Montemiglio, Linda Celeste; Scaglione, Antonella; Vallone, Beatrice] Sapienza Univ Roma, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Parisi, Giacomo; Montemiglio, Linda Celeste; Macone, Alberto; Scaglione, Antonella; Cerutti, Gabriele; Exertier, Cecile; Vallone, Beatrice] Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ple A Moro 5, I-00185 Rome, Italy; [Montemiglio, Linda Celeste; Giuffre, Alessandro; Savino, Carmelinda; Vallone, Beatrice] CNR, Inst Mol Biol & Pathol, Ple A Moro 5, I-00185 Rome, Italy; [Parisi, Giacomo] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Scaglione, Antonella] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Columbia University; City University of New York (CUNY) System	Vallone, B (corresponding author), Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ple A Moro 5, I-00185 Rome, Italy.; Savino, C (corresponding author), CNR, Inst Mol Biol & Pathol, Ple A Moro 5, I-00185 Rome, Italy.	linda.savino@uniroma1.it; beatrice.vallone@uniroma1.it	Macone, Alberto/AAB-2570-2019; Scaglione, Antonella/W-4691-2019; Giuffrè, Alessandro/K-4341-2015	Macone, Alberto/0000-0003-0455-1400; Giuffrè, Alessandro/0000-0001-5301-0681; Cerutti, Gabriele/0000-0002-9081-7561; PARISI, GIACOMO/0000-0002-3064-0928	Sapienza Awards Grant [C26H154L5A]; Sapienza Avvio alla Ricerca 2016 grant; Progetto Premiale 2012: Avanzati Sistemi Biosensoristici per la Diagnosi e il Follow-Up della Malattia Celiaca (Advanced Biosensor Systems for the Diagnosis and Follow-Up of Celiac Disease) from the National Research Council; H2CU-Honors Center of Italian Universities; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant [637295]	Sapienza Awards Grant; Sapienza Avvio alla Ricerca 2016 grant; Progetto Premiale 2012: Avanzati Sistemi Biosensoristici per la Diagnosi e il Follow-Up della Malattia Celiaca (Advanced Biosensor Systems for the Diagnosis and Follow-Up of Celiac Disease) from the National Research Council; H2CU-Honors Center of Italian Universities; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant	The authors thank Barrie Wilkinson and Rachel Lill (Biotica Technology, Cambridge, United Kingdom) for the kind gift of 6DEB; Ida Freda (University of Rome Sapienza, Rome, Italy) for assistance during protein purification; Prof. Stefano Gianni (University of Rome Sapienza) for carefully reading the manuscript and for insightful comments; and the staff at the European Synchrotron Radiation Facility (Beamlines ID14-01; Grenoble, France) and the synchrotron, Berlin Electron Storage Ring Society for Synchrotron Radiation (BESSY, Hemholtz-Zentrum Berlin, Berlin Germany; Beamline ID-14-02). This work was supported by Sapienza Awards Grant C26H154L5A (to B.V.), Sapienza Avvio alla Ricerca 2016 grant (to L.C.M.), the Progetto Premiale 2012: Avanzati Sistemi Biosensoristici per la Diagnosi e il Follow-Up della Malattia Celiaca (Advanced Biosensor Systems for the Diagnosis and Follow-Up of Celiac Disease) from the National Research Council (to C.S), and H2CU-Honors Center of Italian Universities (to B.V.). This project has received funding from the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant Agreement 637295. The atomic coordinates and the structure factors were deposited under Codes 5MNV (structural and functional characterization of OleP in complex with 6DEB in PEG) and 5MNS (structural and functional characterization of OleP in complex with 6DEB in sodium formate) in the Protein Data Bank Research Collaboratory for Structural Bioinformatics at Rutgers University (New Brunswick, NJ, USA; http://www.rcsb.org).The authors declare no conflicts of interest.	Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balding PR, 2008, J PHYS CHEM A, V112, P12911, DOI 10.1021/jp802087w; Basudhar D, 2015, J BIOL CHEM, V290, P10000, DOI 10.1074/jbc.M114.627935; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Colthart AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22035; Correia M. A., 2015, CYTOCHROME P450 STRU, V4th, P177, DOI [10.1007/978-3-319-12108-6_5, DOI 10.1007/978-3-319-12108-6_5]; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; CUPPVICKERY JR, 1994, PROTEINS, V20, P197, DOI 10.1002/prot.340200210; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaisser S, 2002, MOL MICROBIOL, V44, P771, DOI 10.1046/j.1365-2958.2002.02910.x; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; HANIU M, 1982, BIOCHEM BIOPH RES CO, V105, P889, DOI 10.1016/0006-291X(82)91053-1; Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Montemiglio LC, 2016, BBA-GEN SUBJECTS, V1860, P465, DOI 10.1016/j.bbagen.2015.10.009; Montemiglio LC, 2013, BIOCHEMISTRY-US, V52, P3678, DOI 10.1021/bi400223j; Montemiglio LC, 2010, BIOCHEMISTRY-US, V49, P9199, DOI 10.1021/bi101062v; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Podust LM, 2012, NAT PROD REP, V29, P1251, DOI 10.1039/c2np20020a; Poulos T. L., 2015, CYTOCHROME P450 STRU, V4th, P3, DOI DOI 10.1007/978-3-319-12108-6_1; QUIROS LM, 1995, J BIOL CHEM, V270, P18234, DOI 10.1074/jbc.270.31.18234; RODRIGUEZ AM, 1995, FEMS MICROBIOL LETT, V127, P117; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Shah S, 2000, J ANTIBIOT, V53, P502, DOI 10.7164/antibiotics.53.502; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; TATSUTA K, 1990, J ANTIBIOT, V43, P909, DOI 10.7164/antibiotics.43.909; Tietz DR, 2017, BIOCHEMISTRY-US, V56, P2701, DOI 10.1021/acs.biochem.7b00291; Vagin A, 1998, ACTA CRYSTALLOGR D, V54, P400, DOI 10.1107/S0907444997014923	47	9	9	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1787	1800		10.1096/fj.201800450RR	http://dx.doi.org/10.1096/fj.201800450RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207799	Green Submitted, Bronze			2022-12-28	WOS:000457296600022
J	Goetzl, EJ; Nogueras-Ortiz, C; Mustapic, M; Mullins, RJ; Abner, EL; Schwartz, JB; Kapogiannis, D				Goetzl, Edward J.; Nogueras-Ortiz, Carlos; Mustapic, Maja; Mullins, Roger J.; Abner, Erin L.; Schwartz, Janice B.; Kapogiannis, Dimitrios			Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease	FASEB JOURNAL			English	Article						neurodegeneration; dementia; growth factors	HEPATOCYTE GROWTH-FACTOR; NEURONAL DIFFERENTIATION; CEREBROSPINAL-FLUID; SYNAPTIC PROTEINS; STEM-CELLS; FGF; PROLIFERATION; SURVIVAL; INSULIN; ROLES	Exosomes derived from chondroitin sulfate proteoglycan (CSPG) 4 type neural precursor cells (CSPG4Es) were purified from human plasma by sequential immunoabsorption with anti-CSPG4 and anti-platelet growth factor receptor mAb to characterize the potential in vivo roles of CSPG4 cells in neuronal repair. Hepatocyte growth factor, fibroblast growth factors (FGFs)-2 and -13, and type 1 insulin-like growth factor (IGF-1), which enhance neuronal survival and functions, were quantified in CSPG4E extracts. For CSPG4Es of 24 healthy control subjects, mean levels of hepatocyte growth factor, FGF-13, and IGF-1, but not FGF-2, were significantly higher by up to 7-fold than in their neuronal-derived exosomes, and mean levels of all 4 growth factors were significantly higher by up to 8-fold than in their astrocyte-derived exosomes. Mean CSPG4E levels of all growth factors were significantly lower in patients with mild Alzheimer disease (AD) (n = 24) than in age- and sex-matched cognitively normal control subjects (n = 24). Mean CSPG4E levels of all growth factors were also significantly lower in 15 patients at the stage of moderate dementia from AD (AD(2)) and at their preclinical stage 3 to 8 yr earlier (AD(1)), with no differences between values at stages AD(1) and AD(2). Current findings suggest that CSPG4 cells export in exosomes higher levels of neurotrophic factors than neurons or astrocytes and that CSPG4E neurotrophic factors are diminished early in AD, with no significant progression of decreases later in the course.Goetzl, E. J., Nogueras-Ortiz, C., Mustapic, M., Mullins, R. J., Abner, E. L., Schwartz, J. B., Kapogiannis, D. Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease.	[Goetzl, Edward J.; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, San Francisco, CA USA; [Nogueras-Ortiz, Carlos; Mustapic, Maja; Mullins, Roger J.; Kapogiannis, Dimitrios] NIA, Lab Neurosci, Baltimore, MD 21224 USA; [Abner, Erin L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Kentucky	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Schwartz, Janice/K-6354-2019; Kapogiannis, Dimitrios/AAW-4934-2020; Mustapic, Maja/AAV-3212-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Mullins, Roger/0000-0002-0561-4402; Mustapic, Maja/0000-0003-0511-2047	Intramural Research Program of the U.S. National Institutes of Health/National Institute on Aging; NIA [P30 AG028383]; NATIONAL INSTITUTE ON AGING [ZIAAG000966, P30AG028383, ZIAAG000975] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health/National Institute on Aging; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank J. H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. D.K., C.N.-O., and M.M. were supported by the Intramural Research Program of the U.S. National Institutes of Health/National Institute on Aging. E.L.A. was supported by NIA Grant P30 AG028383. E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report. All other authors declare no conflicts of interest.	Aron L, 2016, NATURE, V540, P207, DOI 10.1038/540207a; Bianchi VE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112441; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Carro E, 2004, EUR J PHARMACOL, V490, P127, DOI 10.1016/j.ejphar.2004.02.050; del Corral RD, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00058; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eugenin-von Bernhardi J, 2016, ADV EXP MED BIOL, V949, P27, DOI 10.1007/978-3-319-40764-7_2; Fenton H, 1998, BRAIN RES, V779, P262, DOI 10.1016/S0006-8993(97)00958-X; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2018, FASEB J, V32, P888, DOI 10.1096/fj.201700731R; Goetzl EJ, 2017, FASEB J, V31, P1792, DOI 10.1096/fj.201601221R; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Guan J, 1996, ENDOCRINOLOGY, V137, P893, DOI 10.1210/en.137.3.893; Kelly CM, 2003, CELL TRANSPLANT, V12, P215, DOI 10.3727/000000003108746777; Kokuzawa J, 2003, MOL CELL NEUROSCI, V24, P190, DOI 10.1016/S1044-7431(03)00160-X; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Mashayekhi F, 2010, J CLIN NEUROSCI, V17, P357, DOI 10.1016/j.jocn.2009.05.037; Matsumoto K, 2014, BIOMEDICINES, V2, P275, DOI 10.3390/biomedicines2040275; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; NAKANO M, 2017, SCI REP UK, V7; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Nishiyama A, 2001, Hum Cell, V14, P77; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pitt J, 2017, MOL BIOL CELL, V28, P2623, DOI 10.1091/mbc.E17-06-0416; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; Sun WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.16262; Thorns V, 2001, NEUROPATHOLOGY, V21, P203, DOI 10.1046/j.1440-1789.2001.00399.x; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; Vinters HV, 2015, ANNU REV PATHOL-MECH, V10, P291, DOI 10.1146/annurev-pathol-020712-163927; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046; Zhang X, 2012, SCI CHINA LIFE SCI, V55, P1038, DOI 10.1007/s11427-012-4412-x	41	29	28	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					231	238		10.1096/fj.201801001	http://dx.doi.org/10.1096/fj.201801001			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29924942	Green Published			2022-12-28	WOS:000457401500019
J	Le Bourgot, C; Ferret-Bernard, S; Apper, E; Taminiau, B; Cahu, A; Le Normand, L; Respondek, F; Le Huerou-Luron, I; Blat, S				Le Bourgot, Cindy; Ferret-Bernard, Stephanie; Apper, Emmanuelle; Taminiau, Bernard; Cahu, Armelle; Le Normand, Laurence; Respondek, Frederique; Le Huerou-Luron, Isabelle; Blat, Sophie			Perinatal short-chain fructooligosaccharides program intestinal microbiota and improve enteroinsular axis function and inflammatory status in high-fat diet-fed adult pigs	FASEB JOURNAL			English	Article						nutritional programming; prebiotic; GLP-1; Prevotella	GLUCAGON-LIKE PEPTIDE-1; MATERNAL HIGH-PROTEIN; GUT MICROBIOTA; INSULIN SENSITIVITY; GENE-EXPRESSION; DELIVERY MODE; GLUCOSE; OBESE; CONSEQUENCES; SECRETION	Perinatal nutrition programs physiologic and metabolic functions, with consequences on the susceptibility to develop metabolic diseases in adulthood. The microbiota represents a key factor of such programming. We investigated whether perinatal prebiotic [short-chain fructooligosaccharides (scFOS)] supplementation improved adult metabolic health in association with microbiota changes in pigs used as human model. Sows were supplemented with scFOS or not during the end of gestation and the entire lactation, and offspring received scFOS accordingly during 1 mo after weaning. Pigs were then fed a standard diet for 5 mo, followed by a high-fat diet for 3 mo once adults. Perinatal scFOS supplementation induced a persistent modulation of the composition of the fecal microbiota in adulthood, notably by increasing the Prevotella genus. Meanwhile, scFOS animals displayed improved capacity to secrete glucagon-like peptide-1 and improved pancreas sensitivity to glucose without any changes in peripheral insulin sensitivity. Perinatal scFOS supplementation also increased ileal secretory IgA secretion and alkaline phosphatase activity and decreased TNF- expression in adipose tissue. In conclusion, perinatal scFOS supplementation induced long-lasting modulation of intestinal microbiota and had beneficial consequences on the host physiology in adulthood. Our results highlight the key role of perinatal nutrition on later microbiota and host metabolic adaptation to an unbalanced diet.Le Bourgot, C., Ferret-Bernard, S., Apper, E., Taminiau, B., Cahu, A., Le Normand, L., Respondek, F., Le Huerou-Luron, I., Blat, S. Perinatal short-chain fructooligosaccharides program intestinal microbiota and improve enteroinsular axis function and inflammatory status in high-fat diet-fed adult pigs.	[Le Bourgot, Cindy; Apper, Emmanuelle; Respondek, Frederique] Tereos, Marckolsheim, France; [Le Bourgot, Cindy; Ferret-Bernard, Stephanie; Cahu, Armelle; Le Normand, Laurence; Le Huerou-Luron, Isabelle; Blat, Sophie] Univ Rennes, INSERM, INRA, Nutr Metab & Canc,NuMeCan, Rennes, France; [Taminiau, Bernard] Univ Liege, Liege, Belgium	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Liege	Blat, S (corresponding author), Univ Rennes, INSERM, INRA, NuMeCan, 16 Le Clos, F-35590 St Gilles, France.	sophie.blat@inra.fr	Ferret-Bernard, Stéphanie/AAD-4465-2019	Ferret-Bernard, Stéphanie/0000-0002-1439-9206; Luron, Isabelle/0000-0002-1769-5246	Tereos, a company producing scFOS	Tereos, a company producing scFOS	The authors thank the technical staff of Nutrition Metabolisms and Cancer (NuMeCan) for its expert assistance during the course of this project. They also acknowledge all of the staff of Rennes Porcine Experimental Facilities (UEPR) for animal care and feeding. This study received funding from Tereos, a company producing scFOS. F.R. and E.A. are employed by Tereos. A French patent application has been filed (FR 17/0035). C.L.B., S.F.B., B.T., A.C., L.L.N., I.L.H.L., and S.B. declare no conflict of interest.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; Bindels LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131009; Blat S, 2012, BRIT J NUTR, V108, P102, DOI 10.1017/S0007114511005253; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Chan HM, 2011, AM J PHYSIOL-REG I, V300, pR1126, DOI 10.1152/ajpregu.00687.2010; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; CHEN TT, 2017, SCI REP UK, V0007; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delamaire E, 2012, CLIN NUTR, V31, P741, DOI 10.1016/j.clnu.2012.02.005; Delmee E, 2006, LIFE SCI, V79, P1007, DOI 10.1016/j.lfs.2006.05.013; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fujiwara R, 2008, BRIT J NUTR, V99, P1174, DOI 10.1017/S0007114507862349; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Hallam MC, 2014, OBESITY, V22, P2344, DOI 10.1002/oby.20849; Hallam MC, 2013, BRIT J NUTR, V110, P1732, DOI 10.1017/S0007114513000998; JOUANY JP, 1981, REPROD NUTR DEV, V21, P871, DOI 10.1051/rnd:19810701; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Le Bourgot C, 2017, BRIT J NUTR, V117, P83, DOI 10.1017/S0007114516004268; Le Bourgot C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107508; Liu TW, 2016, J NUTR, V146, P949, DOI 10.3945/jn.115.227504; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; Maurer AD, 2011, BRIT J NUTR, V105, P329, DOI 10.1017/S0007114510003533; Mosnier E, 2010, J ANIM SCI, V88, P612, DOI 10.2527/jas.2008-1768; Mourot J, 2004, B ACAD VET FR, V157, P29; Ohland CL, 2015, CELL MOL GASTROENTER, V1, P28, DOI 10.1016/j.jcmgh.2014.11.004; Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Respondek F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071026; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schokker D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116523; Swanson KS, 2002, J NUTR, V132, P3721, DOI 10.1093/jn/132.12.3721; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132	58	19	19	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					301	313		10.1096/fj.201800108R	http://dx.doi.org/10.1096/fj.201800108R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29975568	Green Submitted			2022-12-28	WOS:000457401500025
J	Liu, XJ; Zhang, N; Liu, Y; Liu, L; Zeng, QX; Yin, MX; Wang, YX; Song, DQ; Deng, HB				Liu, Xiaojia; Zhang, Na; Liu, Yang; Liu, Lu; Zeng, Qingxuan; Yin, Mingxiao; Wang, Yanxiang; Song, Danqing; Deng, Hongbin			MPB, a novel berberine derivative, enhances lysosomal and bactericidal properties via TGF--activated kinase 1-dependent activation of the transcription factor EB	FASEB JOURNAL			English	Article						lysosome; bacterial eradication; c-Jun N-terminal protein kinase; AMP-activated protein kinase	UBIQUITIN-DEPENDENT KINASE; CELLULAR CLEARANCE; AUTOPHAGY; TAK1; TFEB; INNATE; BIOGENESIS; PHOSPHORYLATION; ANTIBIOTICS; INFECTIONS	Lysosome has a crucial role in clearance of endocytosed pathogens from the cell. Small molecules that can boost lysosome function and bactericidal ability to cope with subsequent infection are urgently needed. Here, we report that MPB, a novel berberine derivative, induced lysosome-based degradation and clearance of methicillin-resistant Staphylococcus aureus and enteroinvasive Escherichia coli in macrophages. MPB caused nuclear translocation of transcription factor EB (TFEB), which boosted expression of lysosome genes. TFEB silencing repressed the MPB-mediated enhancements in degradation and bacterial eradication. MPB switched on TFEB nuclear translocation by coupling 2 parallel signaling pathways. MPB-triggered JNK activation led to 14-3-3 being released from TFEB, which, in turn, caused TFEB nuclear translocation. In addition, MPB induced AMPK activation and subsequent inhibition of mechanistic target of rapamycin activity, which also contributed to TFEB nuclear translocation. Importantly, genetical or pharmaceutical inhibition of TGF--activated kinase 1 (TAK1) reduced MPB action remarkably. MPB acted through TAK1 at lysine 158 to activate JNK and AMPK and, thus, induced TFEB-dependent bactericidal activity in macrophages. Therefore, our study reveals a novel mechanism by which MPB controls JNK and AMPK phosphorylation cascades to activate lysosomal function and bactericidal activity via TAK1 K158-dependent manner, which may offer insight into novel therapeutic strategies to control bacterial infection.Liu, X., Zhang, N., Liu, Y., Liu, L., Zeng, Q., Yin, M., Wang, Y., Song, D., Deng, H. MPB, a novel berberine derivative, enhances lysosomal and bactericidal properties via TGF--activated kinase 1-dependent activation of the transcription factor EB.	[Liu, Xiaojia; Zhang, Na; Liu, Yang; Liu, Lu; Zeng, Qingxuan; Yin, Mingxiao; Wang, Yanxiang; Song, Danqing; Deng, Hongbin] Chinese Acad Med Sci, Inst Med Biotechnol, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China; [Liu, Xiaojia; Zhang, Na; Liu, Yang; Liu, Lu; Zeng, Qingxuan; Yin, Mingxiao; Wang, Yanxiang; Song, Danqing; Deng, Hongbin] Peking Union Med Coll, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Song, DQ; Deng, HB (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China.; Song, DQ; Deng, HB (corresponding author), Peking Union Med Coll, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China.	songdanqingsdq@hotmail.com; hdeng@imb.pumc.edu.cn	Deng, Hongbin/AAN-3603-2020	Deng, Hongbin/0000-0002-4398-8819	National Natural Science Foundation of China [81773782, 81473248]; Chinese Academy of Medical Sciences Major Collaborative Innovation Project [2016-12M-1-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences Major Collaborative Innovation Project	The authors thank Dr. Jianhua Yang (Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA) for kindly providing TAK1 (WT, K34R, K72R, and K209R) plasmids. This work was supported by grants from National Natural Science Foundation of China (Grants 81773782 and 81473248), and the Chinese Academy of Medical Sciences Major Collaborative Innovation Project (Grant 2016-12M-1-011). The authors declare no conflicts of interest.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bewley MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001262; Carroll B, 2017, BIOCHEM J, V474, P1453, DOI 10.1042/BCJ20160780; Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078; Deng HB, 2011, INT J BIOCHEM CELL B, V43, P409, DOI 10.1016/j.biocel.2010.11.011; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Fan YH, 2011, CELL SIGNAL, V23, P660, DOI 10.1016/j.cellsig.2010.11.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Fisher RA, 2017, NAT REV MICROBIOL, V15, P453, DOI 10.1038/nrmicro.2017.42; Heathcote HR, 2016, BIOCHEM J, V473, P4681, DOI 10.1042/BCJ20160211; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Inokuchi-Shimizu S, 2014, J CLIN INVEST, V124, P3566, DOI 10.1172/JCI74068; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim SH, 2017, AUTOPHAGY, V13, P1767, DOI 10.1080/15548627.2017.1356977; Kim W, 2018, NATURE, V556, P103, DOI 10.1038/nature26157; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Larrosa M, 2012, MOL CELL PROBE, V26, P121, DOI 10.1016/j.mcp.2012.03.001; Levin R, 2016, IMMUNOL REV, V273, P156, DOI 10.1111/imr.12439; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Liu L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41862; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Ploper D, 2015, PHARMACOL RES, V99, P36, DOI 10.1016/j.phrs.2015.04.006; Powers JH, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k587; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Saberi B, 2014, HEPATOLOGY, V59, P1543, DOI 10.1002/hep.26625; Samie M, 2015, NAT IMMUNOL, V16, P729, DOI 10.1038/ni.3196; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Uribe-Querol E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01368; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Vega-Rubin-de-Celis S, 2017, AUTOPHAGY, V13, P464, DOI 10.1080/15548627.2016.1271514; Visvikis O, 2014, IMMUNITY, V40, P896, DOI 10.1016/j.immuni.2014.05.002; Vural A, 2016, J IMMUNOL, V196, P846, DOI 10.4049/jimmunol.1501595; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YX, 2018, EUR J MED CHEM, V143, P1858, DOI 10.1016/j.ejmech.2017.10.078; Wang YX, 2017, MOLECULES, V22, DOI 10.3390/molecules22081257; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8; Zhang N, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0309-3; Zhong KL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005823; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	59	11	11	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1468	1481		10.1096/fj.201801198R	http://dx.doi.org/10.1096/fj.201801198R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30161000				2022-12-28	WOS:000457401500115
J	Paschen, M; Moede, T; Valladolid-Acebes, I; Leibiger, B; Moruzzi, N; Jacob, S; Garcia-Prieto, CF; Brismar, K; Leibiger, IB; Berggren, PO				Paschen, Meike; Moede, Tilo; Valladolid-Acebes, Ismael; Leibiger, Barbara; Moruzzi, Noah; Jacob, Stefan; Garcia-Prieto, Concha F.; Brismar, Kerstin; Leibiger, Ingo B.; Berggren, Per-Olof			Diet-induced -cell insulin resistance results in reversible loss of functional -cell mass	FASEB JOURNAL			English	Article						in vivo imaging; diabetes mellitus; fluorescence microscopy; biosensor; diet intervention	BETA-CELL; CA2+ CHANNELS; GLUCOSE-HOMEOSTASIS; GENE-TRANSCRIPTION; HIGH-RESOLUTION; MOUSE MODELS; RECEPTOR; SECRETION; MICE; DISSOCIATION	Although convincing in genetic models, the relevance of -cell insulin resistance in diet-induced type 2 diabetes (T2DM) remains unclear. Exemplified by diabetes-prone, male, C57B1/6J mice being fed different combinations of Western-style diet, we show that -cell insulin resistance occurs early during T2DM progression and is due to a combination of lipotoxicity and increased -cell workload. Within 8 wk of being fed a high-fat, high-sucrose diet, mice became obese, developed impaired insulin and glucose tolerances, and displayed noncompensatory insulin release, due, at least in part, to reduced expression of syntaxin-1A. Through reporter islets transplanted to the anterior chamber of the eye, we demonstrated a concomitant loss of functional -cell mass. When mice were changed from diabetogenic diet to normal chow diet, the diabetes phenotype was reversed, suggesting a remarkable plasticity of functional -cell mass in the early phase of T2DM development. Our data reinforce the relevance of diet composition as an environmental factor determining different routes of diabetes progression in a given genetic background. Employing the in vivo reporter islet-monitoring approach will allow researchers to define key times in the dynamics of reversible loss of functional -cell mass and, thus, to investigate the underlying, molecular mechanisms involved in the progression toward T2DM manifestation.Paschen, M., Moede, T., Valladolid-Acebes, I., Leibiger, B., Moruzzi, N., Jacob, S., Garcia-Prieto, C. F., Brismar, K., Leibiger, I. B., Berggren, P.-O. Diet-induced -cell insulin resistance results in reversible loss of functional -cell mass.	[Paschen, Meike; Moede, Tilo; Valladolid-Acebes, Ismael; Leibiger, Barbara; Moruzzi, Noah; Jacob, Stefan; Garcia-Prieto, Concha F.; Brismar, Kerstin; Leibiger, Ingo B.; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, L1 03, SE-17176 Stockholm, Sweden	Karolinska Institutet	Leibiger, IB; Berggren, PO (corresponding author), Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, L1 03, SE-17176 Stockholm, Sweden.	ingo.leibiger@ki.se; per-olof.berggren@ki.se	Moruzzi, Noah/AAC-8875-2019	Moede, Tilo/0000-0002-2045-9244; Berggren, Per-Olof/0000-0001-8991-413X; Moruzzi, Noah/0000-0001-6868-1488; Jacob, Stefan/0000-0001-8456-3924; Valladolid-Acebes, Ismael/0000-0002-7699-9207	Karolinska Institutet (KID programme); Swedish Research Council; Family Erling-Persson Foundation; Novo Nordisk Foundation; Novo Nordisk A/S; Stichting af Jochnick Foundation; Swedish Diabetes Association; Scandia Insurance Company Limited; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; ERC-2013 [AdG 338936 BetaImage]; ERC-2017 [PoC 727306 BETASCREEN]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Novo Nordisk; Karolinska Institutet	Karolinska Institutet (KID programme); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk A/S(Novo Nordisk); Stichting af Jochnick Foundation; Swedish Diabetes Association; Scandia Insurance Company Limited; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; ERC-2013; ERC-2017; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk(Novo Nordisk); Karolinska Institutet(Karolinska Institutet)	This work was supported by funds from the Karolinska Institutet (KID programme), the Swedish Research Council, the Family Erling-Persson Foundation, the Novo Nordisk Foundation, Novo Nordisk A/S, the Stichting af Jochnick Foundation, the Swedish Diabetes Association, Scandia Insurance Company Limited, the Diabetes Research and Wellness Foundation, the Berth von Kantzow's Foundation, the Strategic Research Program in Diabetes at Karolinska Institutet, the ERC-2013-AdG 338936 BetaImage, the ERC-2017-PoC 727306 BETASCREEN, the Swedish Foundation for Strategic Research, and the Knut and Alice Wallenberg Foundation. N.M. was supported by a Novo Nordisk postdoctoral fellowship run in partnership with the Karolinska Institutet. P.-O.B. is cofounder of Biocrine AB, I.B.L. and B.L. are consultants for Biocrine AB, and S.J. is employed by Biocrine AB.	Abdulreda MH, 2011, P NATL ACAD SCI USA, V108, P12863, DOI 10.1073/pnas.1105002108; Alquier T, 2018, DIABETOLOGIA, V61, P526, DOI 10.1007/s00125-017-4495-9; Avall K, 2015, P NATL ACAD SCI USA, V112, pE2611, DOI 10.1073/pnas.1423849112; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Chen CG, 2016, DIABETES, V65, P2676, DOI 10.2337/db15-1718; Chmelova H, 2015, DIABETES, V64, P2148, DOI 10.2337/db14-1055; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; de Monvel JB, 2001, BIOPHYS J, V80, P2455, DOI 10.1016/S0006-3495(01)76214-5; Diez JA, 2017, CELL REP, V20, P1490, DOI 10.1016/j.celrep.2017.07.039; Drewnowski A, 1998, NUTR REV, V56, P347, DOI 10.1111/j.1753-4887.1998.tb01677.x; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Gerdes JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6308; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Hughey CC, 2014, MAMM GENOME, V25, P522, DOI 10.1007/s00335-014-9533-z; Ilegems E, 2015, SCI REP-UK, V5, DOI 10.1038/srep10740; Ilegems E, 2013, P NATL ACAD SCI USA, V110, P20581, DOI 10.1073/pnas.1313696110; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Kaneto H, 2015, INT J MOL SCI, V16, P6281, DOI 10.3390/ijms16036281; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kroon D.-J., 2011, SEGMENTATION MANDIBU; Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Laurent D, 2016, DIABETES OBES METAB, V18, P6, DOI 10.1111/dom.12544; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Leibiger B, 2004, FRONT DIABETES, V16, P249; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leibiger B., 1994, INSULIN SECRETION PA, P15; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Leibiger IB, 2017, MOL METAB, V6, P1002, DOI 10.1016/j.molmet.2017.03.014; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li L, 2013, CLIN EXP PHARMACOL P, V40, P841, DOI 10.1111/1440-1681.12160; Lindqvist A, 2005, REGUL PEPTIDES, V130, P123, DOI 10.1016/j.regpep.2005.05.002; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Moede T, 2001, DIABETES, V50, pS15, DOI 10.2337/diabetes.50.2007.S15; Mosser RE, 2015, AM J PHYSIOL-ENDOC M, V308, pE573, DOI 10.1152/ajpendo.00460.2014; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Paschen M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21448; Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sellmann C, 2015, J NUTR BIOCHEM, V26, P1183, DOI 10.1016/j.jnutbio.2015.05.011; Softic S, 2017, J CLIN INVEST, V127, P4059, DOI 10.1172/JCI94585; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; van Krieken PP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12124-w; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yoo T, 2018, DIABETES, V67, P360, DOI 10.2337/db17-0499; Zanella R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02523; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	64	17	17	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					204	218		10.1096/fj.201800826R	http://dx.doi.org/10.1096/fj.201800826R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957055	Green Published, hybrid			2022-12-28	WOS:000457401500017
J	Wang, L; Fan, Y; Zhang, LA; Li, LL; Kuang, GY; Luo, C; Li, C; Xiang, TX; Tao, Q; Zhang, Q; Ying, JM				Wang, Lu; Fan, Yu; Zhang, Lian; Li, Lili; Kuang, Guanyu; Luo, Cheng; Li, Chen; Xiang, Tingxiu; Tao, Qian; Zhang, Qian; Ying, Jianming			Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma	FASEB JOURNAL			English	Article						SRY-related high mobility group; promoter; CpG methylation; epithelial to mesenchymal transition; renal cancer	PROMOTER METHYLATION; TRANSCRIPTION FACTOR; DNA METHYLATION; EXPRESSION; CANCER; PROGENITORS; SEQUENCE	SOX7 (SRY-related high mobility group box 7), a high mobility group protein, is reported to be down-regulated in several cancer types, which indicates an important role in tumorigenesis; however, its biologic role in renal cell carcinoma (RCC) pathogenesis remains unknown. We studied the alterations and functions of SOX7 in RCC. We detected its broad expression in multiple human normal tissues, including kidney, but frequent down-regulation in RCC cell lines and primary tumors. Promoter CpG methylation seems to directly mediate SOX7 silencing in RCC cells, which could be reversed by demethylation treatment. SOX7 methylation was detected in primary RCC tumors, but rarely in normal kidney tissues. Restoration of SOX7 in silenced 786-O and A498 RCC cell lines inhibited their cell growth by inducing G(0)/G(1) arrest, whereas SOX7 knockdown promoted RCC cell proliferation. We also found that SOX7 silencing resulted in the activation of WNT signaling and the induction of epithelial to mesenchymal transition. In conclusion, the current study demonstrates that SOX7 is frequently inactivated by promoter CpG methylation in RCC and functions as a tumor suppressor by regulating WNT signaling.Wang, L., Fan, Y., Zhang, L., Li, L., Kuang, G., Luo, C., Li, C., Xiang, T., Tao, Q., Zhang, Q., Ying, J. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.	[Wang, Lu; Fan, Yu; Zhang, Lian; Kuang, Guanyu; Luo, Cheng; Zhang, Qian] Peking Univ, Hosp 1, Natl Res Ctr Genitourinary Oncol, Dept Urol, Beijing, Peoples R China; [Wang, Lu; Fan, Yu; Zhang, Lian; Kuang, Guanyu; Luo, Cheng; Zhang, Qian] Inst Urol, Beijing, Peoples R China; [Li, Lili; Li, Chen; Tao, Qian] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, Canc Epigenet Lab,State Key Lab Oncol South China, Hong Kong, Peoples R China; [Li, Lili; Li, Chen; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Li, Lili; Li, Chen; Tao, Qian] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Peoples R China; [Xiang, Tingxiu] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Mol Oncol & Epigenet, Chongqing, Peoples R China; [Ying, Jianming] Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr,Dept Pathol, Beijing, Peoples R China; [Ying, Jianming] Peking Union Med Coll, Beijing, Peoples R China	Peking University; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chongqing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, Q (corresponding author), Inst Urol, Beijing, Peoples R China.; Zhang, Q (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing, Peoples R China.; Ying, JM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing, Peoples R China.	zhangqianbmu@vip.sina.com; jmying@hotmail.com	Tao, Qian/T-4743-2018; Li, Lili/Q-5750-2018	Tao, Qian/0000-0001-5383-4808; Li, Lili/0000-0002-0292-5889	National Natural Science Foundation [81272290, 81572510, 81772869]; National Key Research and Development Program of China [2017YFE0191700]; Vice-Chancellor special research fund from The Chinese University of Hong Kong	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Vice-Chancellor special research fund from The Chinese University of Hong Kong	This work was supported by the National Natural Science Foundation (Grants 81272290, 81572510, and 81772869), the National Key Research and Development Program of China (Grant 2017YFE0191700), and the Vice-Chancellor special research fund from The Chinese University of Hong Kong. The authors declare no conflicts of interest.	Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Du ZF, 2016, ONCOTARGET, V7, P21618, DOI 10.18632/oncotarget.7822; Fenner A, 2017, NAT REV UROL, V14, P8, DOI 10.1038/nrurol.2016.226; Fisel P, 2013, CLIN CANCER RES, V19, P5170, DOI 10.1158/1078-0432.CCR-13-1180; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Han KR, 2003, J UROLOGY, V169, P899, DOI 10.1097/01.ju.0000051480.62175.35; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; LIU H, 2016, SCI REP UK, V6; Liu HD, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0087-1; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Nelson TJ, 2009, DIFFERENTIATION, V77, P248, DOI 10.1016/j.diff.2008.10.012; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Shiozawa M, 1996, BBA-GENE STRUCT EXPR, V1309, P73, DOI 10.1016/S0167-4781(96)00145-5; Slater AA, 2013, EPIGENETICS-US, V8, P252, DOI 10.4161/epi.23817; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Taniguchi K, 1999, BBA-GENE STRUCT EXPR, V1445, P225, DOI 10.1016/S0167-4781(99)00047-0; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Zhang Q, 2014, CANCER LETT, V354, P227, DOI 10.1016/j.canlet.2014.07.040; Zhang QA, 2010, J UROLOGY, V184, P731, DOI 10.1016/j.juro.2010.03.108; Zhang Q, 2007, CANCER LETT, V249, P220, DOI 10.1016/j.canlet.2006.08.019; Zhang Y, 2009, CANCER LETT, V277, P29, DOI 10.1016/j.canlet.2008.11.014; Zhao TS, 2016, CANCER LETT, V375, P100, DOI 10.1016/j.canlet.2016.02.044; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	40	16	17	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					254	263		10.1096/fj.201701453RR	http://dx.doi.org/10.1096/fj.201701453RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957056				2022-12-28	WOS:000457401500021
J	Ramos, A; Miow, QH; Liang, X; Lin, QS; Putti, TC; Lim, YP				Ramos, Alisha; Miow, Qing Hao; Liang, Xu; Lin, Qing Song; Putti, Thomas Choudary; Lim, Yoon Pin			Phosphorylation of E-box binding USF-1 by PI3K/AKT enhances its transcriptional activation of the WBP2 oncogene in breast cancer cells	FASEB JOURNAL			English	Article						transcription factor; promoter; cell signaling	PHOSPHATIDYLINOSITOL 3-KINASE PATHWAY; YES-ASSOCIATED PROTEIN; WW-DOMAIN; GENE; KINASE; COACTIVATOR; EXPRESSION; ESTROGEN; PROMOTER; RECEPTOR	WW domain binding protein 2 (WBP2), a transcriptional coactivator, plays a vital role in breast tumorigenesis. It positively regulates estrogen receptor, Hippo, and Wnt pathways, which subsequently enhance the transcription of downstream target genes contributing to cancer. Understanding the regulation of the expression and activity of WBP2 oncoprotein has implication in cancer therapy. We have previously reported that WBP2 is regulated at the post-translational and post-transcriptional levels. However, its regulation at the transcriptional level is not known. In this study, the minimal promoter region of WBP2 that is critical for its transcription was identified. The E-box motif in the WBP2 promoter was demonstrated to be essential for its transcription. The E-box binding protein upstream stimulatory factor 1 (USF-1) was discovered to be a key transcription factor for WBP2 by yeast one-hybrid analysis and was validated through reporter and chromatin immunoprecipitation assays and tandem mass spectrometry, which also suggested that USF-1 acts by regulating a network of genes, in addition to WBP2, associated with cell movement, proliferation, cell-cycle, and survival cellular processes. USF-1 is overexpressed in majority of the breast cancer cell lines and tissues tested, and has profound effects on cancer cell proliferation. USF-1-mediated transcription of WBP2 was demonstrated to be inducible by insulin, which led to AKT-mediated phosphorylation of USF-1 that modulated its ability to bind to the WBP2 promoter and activate its transcription. This study sheds new light onto the regulation of the WBP2 oncogene at the transcriptional level by a novel oncogenic transcription factor, USF-1. USF-1 is a potential drug target for treatment of WBP2-positive breast cancer.Ramos, A., Miow, Q. H., Liang, X., Lin, Q. S., Putti, T. C., Lim, Y. P. Phosphorylation of E-box binding USF-1 by PI3K/AKT enhances its transcriptional activation of the WBP2 oncogene in breast cancer cells.	[Ramos, Alisha; Miow, Qing Hao; Liang, Xu; Lim, Yoon Pin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Lin, Qing Song] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, Natl Univ Canc Inst, Singapore, Singapore; [Putti, Thomas Choudary] Natl Univ Singapore Hosp, Dept Pathol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lim, YP (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore, Singapore.	bchlyp@nus.edu.sg		Miow, Qing Hao/0000-0001-8029-8238	Ministry of Education [MOE2016-T2-2-007]	Ministry of Education	This study was supported by funding from a Ministry of Education Tier 2 grant (MOE2016-T2-2-007). The authors declare no conflicts of interest.	Bartel P. L., 1993, CELLULAR INTERACTION, P153; Belfiore A, 1996, ANN NY ACAD SCI, V784, P173, DOI 10.1111/j.1749-6632.1996.tb16235.x; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Buffa L, 2013, IUBMB LIFE, V65, P76, DOI 10.1002/iub.1105; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Cheung E, 1999, BIOCHEM J, V344, P145, DOI 10.1042/0264-6021:3440145; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Day DA, 1998, J ENDOCRINOL, V157, P361, DOI 10.1677/joe.0.1570361; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Gonda TJ, 2015, NAT REV CANCER, V15, P686, DOI 10.1038/nrc4018; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Ismail PM, 1999, ONCOGENE, V18, P5582, DOI 10.1038/sj.onc.1202932; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lim SK, 2016, CANCER RES, V76, P6278, DOI 10.1158/0008-5472.CAN-15-3537; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Lim YP, 2003, MOL CANCER THER, V2, P1369; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; McDonald CB, 2011, BIOCHEMISTRY-US, V50, P9616, DOI 10.1021/bi201286p; Nitsch R, 2004, BIOCHEM J, V377, P553, DOI 10.1042/BJ20031233; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; PAPA V, 1993, ENDOCRINOLOGY, V133, P1369, DOI 10.1210/en.133.3.1369; Qi L, 2006, J CELL BIOCHEM, V99, P495, DOI 10.1002/jcb.20885; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ren YQ, 2017, CANCER CHEMOTH PHARM, V79, P1003, DOI 10.1007/s00280-017-3302-0; STOTZ A, 1990, GENE, V95, P91, DOI 10.1016/0378-1119(90)90418-Q; Terragni J, 2011, J BIOL CHEM, V286, P36215, DOI 10.1074/jbc.M111.246116; Travers MT, 2001, BIOCHEM J, V359, P273, DOI 10.1042/0264-6021:3590273; Vernieri C, 2016, CANCER DISCOV, V6, P1315, DOI 10.1158/2159-8290.CD-16-0615; Walko G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14744; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; Wong RHF, 2009, CELL CYCLE, V8, P1977; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhang XH, 2007, CURR CANCER DRUG TAR, V7, P305, DOI 10.2174/156800907780809741	47	10	10	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6982	7001		10.1096/fj.201801167RR	http://dx.doi.org/10.1096/fj.201801167RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30183375				2022-12-28	WOS:000449359700048
J	Margolis, LM; Carbone, JW; Berryman, CE; Carrigan, CT; Murphy, NE; Ferrando, AA; Young, AJ; Pasiakos, SM				Margolis, Lee M.; Carbone, John W.; Berryman, Claire E.; Carrigan, Christopher T.; Murphy, Nancy E.; Ferrando, Arny A.; Young, Andrew J.; Pasiakos, Stefan M.			Severe energy deficit at high altitude inhibits skeletal muscle mTORC1-mediated anabolic signaling without increased ubiquitin proteasome activity	FASEB JOURNAL			English	Article						hypoxia; rpS6; proteolysis; REDD1; weight loss	MYOFIBRILLAR PROTEIN-SYNTHESIS; RANDOMIZED CONTROLLED-TRIAL; ACUTE ENVIRONMENTAL HYPOXIA; LABELED WATER MEASUREMENT; FAT-FREE MASS; SHORT-TERM; RESISTANCE EXERCISE; CALORIC RESTRICTION; HYPOBARIC HYPOXIA; OPERATION EVEREST	Muscle loss at high altitude (HA) is attributable to energy deficit and a potential dysregulation of anabolic signaling. Exercise and protein ingestion can attenuate the effects of energy deficit on muscle at sea level (SL). Whether these effects are observed when energy deficit occurs at HA is unknown. To address this, muscle obtained from lowlanders (n = 8 males) at SL, acute HA (3 h, 4300 m), and chronic HA (21 d, -1766 kcal/d energy balance) before [baseline (Base)] and after 80 min of aerobic exercise followed by a 2-mile time trial [postexercise (Post)] and 3 h into recovery (Rec) after ingesting whey protein (25 g) were analyzed using standard molecular techniques. At SL, Post, and REC, p-mechanistic target of rapamycin (mTOR)(Ser2448), p-p70 ribosomal protein S6 kinase (p70S6K)(Ser424/421), and p-ribosomal protein S6 (rpS6)(Ser235/236) were similar and higher (P < 0.05) than Base. At acute HA, Post p-mTOR(Ser2448) and Post and REC p-p70S6K(Ser424/421) were not different from Base and lower than SL (P < 0.05). At chronic HA, Post and Rec p-mTOR(Ser2448) and p-p70S6K(Ser424/421) were not different from Base and lower than SL, and, independent of time, p-rpS6(Ser235/236) was lower than SL (P < 0.05). Post proteasome activity was lower (P < 0.05) than Base and Rec, independent of phase. Our findings suggest that HA exposure induces muscle anabolic resistance that is exacerbated by energy deficit during acclimatization, with no change in proteolysis.Margolis, L. M., Carbone, J. W., Berryman, C. E., Carrigan, C. T., Murphy, N. E., Ferrando, A. A., Young, A. J., Pasiakos, S. M. Severe energy deficit at high altitude inhibits skeletal muscle mTORC1-mediated anabolic signaling without increased ubiquitin proteasome activity.	[Margolis, Lee M.; Berryman, Claire E.; Carrigan, Christopher T.; Murphy, Nancy E.; Young, Andrew J.; Pasiakos, Stefan M.] US Army Res Inst Environm Med, Mil Nutr Div, Natick, MA USA; [Margolis, Lee M.; Carbone, John W.; Berryman, Claire E.; Young, Andrew J.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Carbone, John W.] Eastern Michigan Univ, Sch Hlth Sci, Ypsilanti, MI 48197 USA; [Ferrando, Arny A.] Univ Arkansas Med Sci, Ctr Translat Res Aging & Longev, Donald W Reynolds Inst Aging, Dept Geriatr, Little Rock, AR 72205 USA	United States Department of Defense; United States Army; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Eastern Michigan University; University of Arkansas System; University of Arkansas Medical Sciences	Pasiakos, SM (corresponding author), US Army Res Inst Environm Med, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA.	stefan.m.pasiakos.civ@mail.mil	Pasiakos, Stefan M/E-6295-2014	Pasiakos, Stefan M/0000-0002-5378-5820	U.S. Army Medical Research and Materiel Command	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The authors thank the volunteers who participated in this research experiment. The authors acknowledge the medical oversight team and Dr. Stephen Muza (U.S. Army Research Institute of Environmental Medicine) for support of this study. Most importantly, the authors sincerely thank Patrick Radcliffe, Adam Luippold, Bradley Anderson, Grant Holmes, Anthony Karis, Matthew Kominsky, Katelyn Guerriere, Karleigh Bradbury, Adrienne Hatch, Laura Lutz, and Drs. Stephen R. Hennigar, Robert W. Kenefick, Taylor Roth, J. Philip Karl, Scott J. Montain, and LTC Renee Cole (U.S. Army Research Institute of Environmental Medicine) for significant contributions to the project. This work was supported, in part, by the U.S. Army Medical Research and Materiel Command and appointment to the U.S. Army Research Institute of Environmental Medicine administered by the Oak Ridge Institute for Science and Education (to L.M.M., J.W.C., C.E.B., and A.J.Y.) through an interagency agreement between the U.S. Department of Energy and the U.S. Army Medical Research and Materiel Command. The investigators adhered to the policies for protection of human subjects as prescribed in Army Regulation 70-25, and the research was conducted in adherence with the provisions of 32 CFR Part 219. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Army or the Department of Defense. Any citations of commercial organizations and trade names in this report do not constitute an official Department of the Army endorsement of approval of the products or services of these organizations. The authors declare no conflicts of interest.	Areta JL, 2014, AM J PHYSIOL-ENDOC M, V306, pE989, DOI 10.1152/ajpendo.00590.2013; Barnholt KE, 2006, AM J PHYSIOL-ENDOC M, V290, pE1078, DOI 10.1152/ajpendo.00449.2005; Berryman CE, 2018, FASEB J, V32, P894, DOI 10.1096/fj.201700915R; Boutellier U, 1983, Prog Clin Biol Res, V136, P273; BUTTERFIELD GE, 1992, J APPL PHYSIOL, V72, P1741, DOI 10.1152/jappl.1992.72.5.1741; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Carbone JW, 2014, APPL PHYSIOL NUTR ME, V39, P960, DOI 10.1139/apnm-2013-0433; Carbone JW, 2013, FASEB J, V27, P5104, DOI 10.1096/fj.13-239228; Chaudhary P, 2012, MOL CELL BIOCHEM, V364, P101, DOI 10.1007/s11010-011-1210-x; D'Hulst G, 2013, ACTA PHYSIOL, V208, P251, DOI 10.1111/apha.12086; D'Hulst G, 2016, HYPOXIA, V4, P1, DOI 10.2147/HP.S101133; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Etheridge T, 2011, AM J PHYSIOL-ENDOC M, V301, pE697, DOI 10.1152/ajpendo.00276.2011; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; Gorissen SHM, 2017, AM J CLIN NUTR, V105, P332, DOI 10.3945/ajcn.115.129924; Hector AJ, 2018, FASEB J, V32, P265, DOI 10.1096/fj.201700158RR; Hector AJ, 2015, J NUTR, V145, P246, DOI 10.3945/jn.114.200832; Hoppeler H, 2001, J EXP BIOL, V204, P3133; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; Hoyt RW, 2006, AM J CLIN NUTR, V83, P1068, DOI 10.1093/ajcn/83.5.1068; HOYT RW, 1991, J APPL PHYSIOL, V71, P16, DOI 10.1152/jappl.1991.71.1.16; HOYT RW, 1994, AM J PHYSIOL, V266, pR966, DOI 10.1152/ajpregu.1994.266.3.R966; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; Margolis LM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00182; Margolis LM, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00445; Margolis LM, 2016, MED SCI SPORT EXER, V48, P1604, DOI 10.1249/MSS.0000000000000944; Margolis LM, 2014, APPL PHYSIOL NUTR ME, V39, P1395, DOI 10.1139/apnm-2014-0212; Margolis LM, 2013, APPL PHYSIOL NUTR ME, V38, P396, DOI 10.1139/apnm-2012-0323; Masschelein E, 2014, FASEB J, V28, P1022, DOI 10.1096/fj.13-239863; Mawson JT, 2000, J APPL PHYSIOL, V88, P272, DOI 10.1152/jappl.2000.88.1.272; Miller BF, 2013, J GERONTOL A-BIOL, V68, P530, DOI 10.1093/gerona/gls219; Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; Murphy CH, 2015, AM J PHYSIOL-ENDOC M, V308, pE734, DOI 10.1152/ajpendo.00550.2014; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Pasiakos SM, 2017, MED SCI SPORT EXER, V49, P1336, DOI 10.1249/MSS.0000000000001228; Pasiakos SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140863; Pasiakos SM, 2015, FASEB J, V29, P1136, DOI 10.1096/fj.14-266890; Pasiakos SM, 2014, IUBMB LIFE, V66, P478, DOI 10.1002/iub.1291; Pasiakos SM, 2013, FASEB J, V27, P3837, DOI 10.1096/fj.13-230227; Pasiakos SM, 2011, AM J CLIN NUTR, V94, P809, DOI 10.3945/ajcn.111.017061; Pasiakos SM, 2010, INT J SPORT NUTR EXE, V20, P282, DOI 10.1123/ijsnem.20.4.282; Pasiakos SM, 2010, J NUTR, V140, P745, DOI 10.3945/jn.109.118372; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIMENTAL NA, 1979, ERGONOMICS, V22, P963, DOI 10.1080/00140137908924670; ROSE MS, 1988, J APPL PHYSIOL, V65, P2545, DOI 10.1152/jappl.1988.65.6.2545; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Smiles WJ, 2015, AM J PHYSIOL-REG I, V309, pR603, DOI 10.1152/ajpregu.00413.2014; Thomson DM, 2006, J PHYSIOL-LONDON, V574, P291, DOI 10.1113/jphysiol.2006.107490; Thomson DM, 2005, J APPL PHYSIOL, V98, P557, DOI 10.1152/japplphysiol.00811.2004; Vigano A, 2008, PROTEOMICS, V8, P4668, DOI 10.1002/pmic.200800232	52	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5955	5966		10.1096/fj.201800163RR	http://dx.doi.org/10.1096/fj.201800163RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29878853	Bronze			2022-12-28	WOS:000447172000016
J	Park, SH; Kim, JH; Ko, E; Kim, JY; Park, MJ; Kim, MJ; Seo, H; Li, SB; Lee, JY				Park, Seong-Hee; Kim, Jae Hwan; Ko, Eunsun; Kim, Jeong-Yub; Park, Myung-Jin; Kim, Min Jung; Seo, Hyemin; Li, Shibo; Lee, Ji-Yun			Resistance to gefitinib and cross-resistance to irreversible EGFR-TKIs mediated by disruption of the Keap1-Nrf2 pathway in human lung cancer cells	FASEB JOURNAL			English	Article						NSCLC; NFE2L2; ARE; Osimertinib	ALDO-KETO REDUCTASES; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; OPEN-LABEL; CHEMOTHERAPY; MUTATIONS; NRF2; AMPLIFICATION; ACTIVATION; MECHANISMS	The development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) occurs by various mechanisms and appears to be almost inevitable, even in patients with lung cancer who initially respond well to EGFR-TKIs. Consequently, considerable efforts have been made to develop more effective EGFR-TKIs. Therefore, an understanding of the mechanisms behind TKI resistance is essential for improving EGFR-TKI therapeutic efficacy in patients with non-small cell lung cancer (NSCLC). In this study, we discovered that overexpression of antioxidant-responsive element (ARE)-containing Nrf2 target genes by increased transactivation of Nrf2 occurred because of an acquired Keap1 mutation in the gefitinib-resistant (GR) NSCLC cell line we established. These GR cells also acquired cross-resistance to the irreversible EGFR-TKIs, afatinib and osimertinib, and showed increased viability, invasiveness, proliferation, and tumorigenicity both in vitro and in vivo. These results were confirmed by the fact that inhibition of Nrf2 activity, either by treatment with brusatol or by inducing expression of exogenously introduced wild-type Keap1, suppressed tumor cell proliferation and tumorigenicity in vitro and in vivo. Our data suggest that disruption of the Keap1-Nrf2 pathway is one of the mechanisms by which EGFR-TKI resistance occurs, a fact that must be considered when treating patients with EGFR-TKI.Park, S.-H., Kim, J. H., Ko, E., Kim, J.-Y., Park, M.-J., Kim, M. J., Seo, H., Li, S., Lee, J.-Y. Resistance to gefitinib and cross-resistance to irreversible EGFR-TKIs mediated by disruption of the Keap1-Nrf2 pathway in human lung cancer cells.	[Park, Seong-Hee; Kim, Jae Hwan; Ko, Eunsun; Kim, Jeong-Yub; Lee, Ji-Yun] Korea Univ, Coll Med, Dept Pathol, 73 Inchon Ro, Seoul 02841, South Korea; [Park, Seong-Hee; Kim, Jae Hwan; Ko, Eunsun] Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Kim, Jeong-Yub; Park, Myung-Jin] Korea Inst Radiol & Med Sci KIRAMS, Div Radiat Canc Res, Res Ctr Radiosenescence, Seoul, South Korea; [Kim, Min Jung; Seo, Hyemin] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea; [Li, Shibo] Univ Oklahoma Hlth Sci Ctr OUHSC, Dept Pediat, Coll Med, Oklahoma City, OK USA	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Sookmyung Women's University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lee, JY (corresponding author), Korea Univ, Coll Med, Dept Pathol, 73 Inchon Ro, Seoul 02841, South Korea.	jiyun-lee@korea.ac.kr			Basic Science Research Program from the National Research Foundation of Korea [NRF-2014R1A2A2A01003566, NRF-2017R1A2B4003233]; Ministry of Education, Science and Technology, South Korea	Basic Science Research Program from the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was funded by the Basic Science Research Program Grants (NRF-2014R1A2A2A01003566 and NRF-2017R1A2B4003233) from the National Research Foundation of Korea, which is funded by the Ministry of Education, Science and Technology, South Korea. The authors declare no conflicts of interest.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bersanelli M, 2016, J THORAC ONCOL, V11, pE121, DOI 10.1016/j.jtho.2016.05.019; Chaib I, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx014; Chou TC, 2005, COMPUSYN DRUG COMBIN; Coco S, 2015, TARGET ONCOL, V10, P393, DOI 10.1007/s11523-014-0344-7; Deshmukh Prashant, 2017, Biophys Rev, V9, P41, DOI 10.1007/s12551-016-0244-4; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Ichihara E, 2017, CANCER RES, V77, P2990, DOI 10.1158/0008-5472.CAN-16-2300; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jacobsen K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00450-6; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jung KA, 2013, TOXICOL LETT, V218, P39, DOI 10.1016/j.toxlet.2012.12.026; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Krail EB, 2017, ELIFE, V6, DOI [10.7554/eLife.18970, 10.7554/eLife.33173]; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Lou H, 2006, MOL PHARMACOL, V69, P1662, DOI 10.1124/mol.105.019794; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacLeod AK, 2016, BRIT J CANCER, V115, P1530, DOI 10.1038/bjc.2016.363; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Murakami Y, 2017, ONCOTARGET, V8, P70736, DOI 10.18632/oncotarget.19982; Nishinaka T, 2011, CHEM-BIOL INTERACT, V191, P185, DOI 10.1016/j.cbi.2011.01.026; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; No Jae Hong, 2014, J Cancer Prev, V19, P111, DOI 10.15430/JCP.2014.19.2.111; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park JH, 2016, ONCOTARGET, V7, P22005, DOI 10.18632/oncotarget.8013; Reddy NM, 2007, PHYSIOL GENOMICS, V32, P74, DOI 10.1152/physiolgenomics.00126.2007; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tian YJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0246-5; Uchibori K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14768; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zheng D, 2017, ONCOTARGET, V8, P49671, DOI 10.18632/oncotarget.17913; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	45	25	25	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5862	5873		10.1096/fj.201800011R	http://dx.doi.org/10.1096/fj.201800011R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29812969	Bronze			2022-12-28	WOS:000447172000009
J	Chiurchiu, V; Leuti, A; Smoum, R; Mechoulam, R; Maccarrone, M				Chiurchiu, Valerio; Leuti, Alessandro; Smoum, Reem; Mechoulam, Raphael; Maccarrone, Mauro			Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes	FASEB JOURNAL			English	Article						adaptive immunity; cytokines; N-acyl ethanolamines; T cells	ACID AMIDASE INHIBITOR; N-ACYLETHANOLAMINE; PPAR-ALPHA; IN-VITRO; PALMITOYLETHANOLAMIDE; ANANDAMIDE; OLEOYLETHANOLAMIDE; RECEPTOR; DISCOVERY; REVEALS	Autacoid local injury antagonist amides (ALIAmides) are a family of endogenous bioactive acyl ethanolamides that include the renowned palmitoyl ethanolamide (PEA), oleoyl ethanolamide (OEA), and stearoyl ethanolamide (SEA), and that are involved in several biologic processes such as nociception, lipid metabolism, and inflammation. The role of ALIAmides in the control of inflammatory processes has recently gained much attention and prompted the use of these molecules or their analogs, and the pharmacologic manipulation of their endogenous levels, as plausible therapeutic strategies in the treatment of several chronic inflammatory conditions. Since chronic inflammation is mainly driven by cells of adaptive immunity, particularly T lymphocytes, we aimed at investigating whether such bioactive lipids could directly modulate T-cell responses. We found that OEA, PEA, and eicosatrienoyl ethanolamide (ETEA) could directly inhibit both T-cell responses by reducing their production of TNF- and IFN- from CD8 T cells and TNF-, IFN- and IL-17 from CD4 T cells. Furthermore, neither SEA nor docosatrienoyl ethanolamide (DTEA) could affect cytokine production from both T cell subsets. Interestingly, unlike OEA and ETEA, PEA was also able to enhance de novo generation of forkhead box P3 (FoxP3)-expressing regulatory T cells from CD4-naive T cells. Our findings show for the first time that specific ALIAmides can directly affect different T-cell subsets, and provide proof of their anti-inflammatory role in chronic inflammation, ultimately suggesting that these bioactive lipids could offer novel tools for the management of T-cell dependent chronic inflammatory diseases.ChiurchiU, V., Leuti, A., Smoum, R., Mechoulam, R., Maccarrone, M. Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes.	[Chiurchiu, Valerio; Leuti, Alessandro; Maccarrone, Mauro] Campus Biomed Univ Rome, Dept Med, Via Alvaro Portillo 21, I-00128 Rome, Italy; [Chiurchiu, Valerio; Leuti, Alessandro; Maccarrone, Mauro] Santa Lucia Fdn, IRCCS, Neurochem Lipids, European Ctr Brain Res CERC, Rome, Italy; [Smoum, Reem; Mechoulam, Raphael] Hebrew Univ Jerusalem, Med Fac, Inst Cannabinoid Res, Jerusalem, Israel	University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia; Hebrew University of Jerusalem	Maccarrone, M (corresponding author), Campus Biomed Univ Rome, Dept Med, Via Alvaro Portillo 21, I-00128 Rome, Italy.; Chiurchiu, V (corresponding author), Santa Lucia Fdn, IRCCS, Neurochem Lipids, Via Fosso Fiorano 64, I-00143 Rome, Italy.	v.chiurchiu@hsantalucia.it; m.maccarrone@unicampus.it	Chiurchiu, Valerio/G-6227-2011	Chiurchiu, Valerio/0000-0002-0316-7311; Leuti, Alessandro/0000-0002-5982-0682	Italian Ministry of Education, Universities, and Research (MIUR); Research Projects of National Interest competitive grant [PRIN2015-KMMKBN]	Italian Ministry of Education, Universities, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Research Projects of National Interest competitive grant	This work was supported by the Italian Ministry of Education, Universities, and Research (MIUR). The authors gratefully acknowledge a Research Projects of National Interest (PRIN2015-KMMKBN) competitive grant (to M.M.). The authors declare no conflicts of interest.	Alhouayek M, 2015, FASEB J, V29, P650, DOI 10.1096/fj.14-255208; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; ALOE L, 1993, AGENTS ACTIONS, V39, pC145, DOI 10.1007/BF01972748; Bandiera T, 2014, PHARMACOL RES, V86, P11, DOI 10.1016/j.phrs.2014.04.011; Brown JD, 2017, PHYSIOL BEHAV, V176, P50, DOI 10.1016/j.physbeh.2017.02.034; Carbonare MD, 2008, J NEUROENDOCRINOL, V20, P26, DOI 10.1111/j.1365-2826.2008.01689.x; Chen L, 2015, ONCOTARGET, V6, P42530, DOI 10.18632/oncotarget.6466; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Chiurchiu V, 2016, J IMMUNOL, V197, P3545, DOI 10.4049/jimmunol.1500546; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Chiurchiu V, 2016, CURR OPIN PHARMACOL, V29, P54, DOI 10.1016/j.coph.2016.06.005; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Chiurchiu V, 2015, INT IMMUNOL, V27, P153, DOI 10.1093/intimm/dxu097; Cope AP, 2002, ARTHRITIS RES THER, V4, pS197, DOI 10.1186/ar557; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Impellizzeri D, 2016, BIOCHEM PHARMACOL, V119, P27, DOI 10.1016/j.bcp.2016.09.001; Impellizzeri D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0136-0; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Lanuti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126839; Lissoni P, 2008, ANTICANCER RES, V28, P3743; Luo GH, 2016, SCI REP-UK, V6, P1, DOI [10.1038/srep35231, 10.1038/s41598-016-0027-y]; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Onopchenko OV, 2015, LIPIDS, V50, P13, DOI 10.1007/s11745-014-3960-1; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Pontis S, 2016, CRIT REV BIOCHEM MOL, V51, P7, DOI 10.3109/10409238.2015.1092944; PRILLER J, 1995, MOL PHARMACOL, V48, P288; Rahman IAS, 2014, PHARMACOL RES, V86, P1, DOI 10.1016/j.phrs.2014.04.001; Ribeiro A, 2015, ACS CHEM BIOL, V10, P1838, DOI 10.1021/acschembio.5b00114; Sarnelli G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156198; Sasso O, 2013, PAIN, V154, P350, DOI 10.1016/j.pain.2012.10.018; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Skaper SD, 2015, MOL NEUROBIOL, V52, P1034, DOI 10.1007/s12035-015-9253-8; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019	35	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5716	5723		10.1096/fj.201800107R	http://dx.doi.org/10.1096/fj.201800107R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29879374	Bronze			2022-12-28	WOS:000447972500042
J	Frolinger, T; Smith, C; Cobo, CF; Sims, S; Brathwaite, J; de Boer, S; Huang, J; Pasinetti, GM				Frolinger, Tal; Smith, Chad; Cobo, Carmen Freire; Sims, Steven; Brathwaite, Justin; de Boer, Sterre; Huang, Jing; Pasinetti, Giulio M.			Dietary polyphenols promote resilience against sleep deprivation-induced cognitive impairment by activating protein translation	FASEB JOURNAL			English	Article						memory consolidation; mTORC1; BDPP	CAP-DEPENDENT TRANSLATION; LONG-TERM POTENTIATION; OBJECT RECOGNITION; MEMORY CONSOLIDATION; GENE-EXPRESSION; SYNAPTIC PLASTICITY; MAMMALIAN TARGET; MESSENGER-RNA; MOUSE MODEL; MOLECULAR-MECHANISMS	Previous evidence has suggested that dietary supplementation with a bioactive dietary polyphenol preparation (BDPP) rescues impairment of hippocampus-dependent memory in a mouse model of sleep deprivation (SD). In the current study, we extend our previous evidence and demonstrate that a mechanism by which dietary BDPP protects against SD-mediated cognitive impairment is via mechanisms that involve phosphorylation of the mammalian target of rapamycin complex 1 and its direct downstream targets, including the eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) and the ribosomal protein S6 kinase -1 (p70S6K). In additional mechanistic studies in vitro, we identified the brain bioavailable phenolic metabolites derived from the metabolism of dietary BDPP that are responsible for the attenuation of SD-mediated memory impairments. On the basis of high-throughput bioavailability studies of brain bioavailable metabolites after dietary BDPP treatment, we found that select polyphenol metabolites [e.g., cyanidin-3-O-glucoside and 3-(3-hydroxyphenyl) propionic acid] were able to rescue mTOR and p70S6K phosphorylation in primary cortico-hippocampal neuronal cultures, as well as rescue 4E-BP1 phosphorylation in response to treatment with 4EGI-1, a specific inhibitor of eIF4E-eIF4G interaction. Our findings reveal a previously unknown role for dietary polyphenols in the rescue of SD-mediated memory impairments via mechanisms involving the promotion of protein translation.Frolinger, T., Smith, C., Cobo, C. F., Sims, S., Brathwaite, J., de Boer, S., Huang, J., Pasinetti, G. M. Dietary polyphenols promote resilience against sleep deprivation-induced cognitive impairment by activating protein translation.	[Frolinger, Tal; Smith, Chad; Cobo, Carmen Freire; Sims, Steven; Brathwaite, Justin; de Boer, Sterre; Huang, Jing; Pasinetti, Giulio M.] Icahn Sch Med Mt Sinai, Dept Neurol, 1 Gustave L Levy Pl,Box 1137, New York, NY 10029 USA; [de Boer, Sterre] Vrije Univ Amsterdam, VUMC Sch Med Sci, Amsterdam, Netherlands; [Huang, Jing] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; Vrije Universiteit Amsterdam; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, 1 Gustave L Levy Pl,Box 1137, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu		Pasinetti, Giulio/0000-0002-1524-5196	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH) [P50-AT008661-01]; Office of Dietary Supplements (ODS); National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Grant P50-AT008661-01 from the U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH), and the Office of Dietary Supplements (ODS). G.M.P. holds a Senior Veterans Affairs Career Scientist Award. The contents of this study do not represent the views of the NCCIH, the ODS, the NIH, the U.S. Department of Veterans Affairs, or the U.S. Government. The authors declare no conflicts of interest.	Abbott SM, 2016, NAT SCI SLEEP, V8, P55, DOI 10.2147/NSS.S78947; Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Anderson KN, 2013, NAT SCI SLEEP, V5, P61, DOI 10.2147/NSS.S34842; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Banko JL, 2008, PROG BRAIN RES, V169, P59, DOI 10.1016/S0079-6123(07)00004-0; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bermudez-Rattoni F, 2005, LEARN MEMORY, V12, P447, DOI 10.1101/lm.97605; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blount JW, 2012, BIOCHEM BIOPH RES CO, V417, P457, DOI 10.1016/j.bbrc.2011.11.139; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Cirelli C, 2000, SLEEP, V23, P453; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dias GP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/541971; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flowers A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0395-4; Foukas LC, 2004, BIOCHEM BIOPH RES CO, V319, P541, DOI 10.1016/j.bbrc.2004.04.191; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gal-Ben-Ari S, 2012, LEARN MEMORY, V19, P410, DOI 10.1101/lm.026849.112; Gold PE, 2008, NEUROBIOL LEARN MEM, V89, P201, DOI 10.1016/j.nlm.2007.10.006; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Gronli J, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00224; Groppo R, 2009, CURR OPIN CELL BIOL, V21, P444, DOI 10.1016/j.ceb.2009.01.011; Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Havekes R, 2016, ELIFE, V5, DOI 10.7554/eLife.13424; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez PJ, 2008, NEUROBIOL LEARN MEM, V89, P293, DOI 10.1016/j.nlm.2007.09.010; Hines DJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.136; Ho L, 2013, FASEB J, V27, P769, DOI 10.1096/fj.12-212118; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hsieh T. C., 2012, ISRN UROL, V2012, DOI DOI 10.5402/2012/272697.; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Igaz LM, 2002, J NEUROSCI, V22, P6781; Igaz LM, 2004, NEUROTOX RES, V6, P189, DOI 10.1007/BF03033221; Ishikawa A, 2006, EUR J NEUROSCI, V24, P243, DOI 10.1111/j.1460-9568.2006.04874.x; Janus A, 2005, CELL MOL BIOL LETT, V10, P479; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364; Kumar T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047042; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Le Tourneau C, 2008, BRIT J CANCER, V99, P1197, DOI 10.1038/sj.bjc.6604636; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maas S, 2010, DISCOV MED, V10, P379; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Palchykova S, 2006, NEUROBIOL LEARN MEM, V85, P263, DOI 10.1016/j.nlm.2005.11.005; Pasinetti Giulio Maria, 2012, Planta Med, V78, pE24, DOI 10.1055/s-0035-1545846; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Seibt Julie, 2012, Commun Integr Biol, V5, P491, DOI 10.4161/cib.21010; Seibt J, 2012, CURR BIOL, V22, P676, DOI 10.1016/j.cub.2012.02.016; Somarajan BI, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00025; Souza AD, 2015, CURR TOP BEHAV NEURO, V25, P65, DOI 10.1007/7854_2014_360; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tudor JC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4949; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Vecsey CG, 2012, PHYSIOL GENOMICS, V44, P981, DOI 10.1152/physiolgenomics.00084.2012; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Wang DJ, 2015, MOL NUTR FOOD RES, V59, P1025, DOI 10.1002/mnfr.201400544; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wang J, 2012, J NEUROSCI, V32, P5144, DOI 10.1523/JNEUROSCI.6437-11.2012; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Wang JJ, 2014, CHIN HERB MED, V6, P42, DOI 10.1016/S1674-6384(14)60005-8; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Wisor JP, 2013, PHYSIOL GENOMICS, V45, P26, DOI 10.1152/physiolgenomics.00156.2012; Yaghouby F, 2014, IEEE ENG MED BIO, P3771, DOI 10.1109/EMBC.2014.6944444; Zagaar MA, 2016, MOL NEUROBIOL, V53, P2900, DOI 10.1007/s12035-015-9176-4; Zhao W, 2015, NEUROCHEM INT, V89, P191, DOI 10.1016/j.neuint.2015.07.023; Zhong LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032195	96	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5390	5404		10.1096/fj.201800030R	http://dx.doi.org/10.1096/fj.201800030R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29702026	Bronze, Green Published			2022-12-28	WOS:000447972500016
J	Lonati, C; Bassani, GA; Brambilla, D; Leonardi, P; Carlin, A; Faversani, A; Gatti, S; Valenza, F				Lonati, Caterina; Bassani, Giulia A.; Brambilla, Daniela; Leonardi, Patrizia; Carlin, Andrea; Faversani, Alice; Gatti, Stefano; Valenza, Franco			Influence of ex vivo perfusion on the biomolecular profile of rat lungs	FASEB JOURNAL			English	Article						lung gene expression; hyaluronan; rat model; ischemic preconditioning; DCD	INJURY SALVAGE KINASE; REPERFUSION INJURY; DONOR LUNGS; TRANSPLANTATION; HYALURONAN; FRAGMENTATION; ISCHEMIA; IMPROVES; OUTCOMES; REMOVAL	Despite increasing clinical adoption, biologic influences of ex vivo lung perfusion (EVLP) remain insufficiently elucidated. The aim of the current study was to investigate biomolecular changes induced by EVLP in rat lungs. EVLP was maintained for 180 min. Hyaluronan, mediators, and cells were assessed in the perfusate. Gene expression, signaling pathways, and ATP content were investigated in lung tissue. EVLP induced the release of medium-high molecular weight hyaluronan and transcription of hyaluronan synthases (P < 0.001). Increasing concentrations of inflammatory mediators were detected in the perfusate (P < 0.001). Perfused lungs exhibited a distinctive transcriptional signature compared with organs examined before or after surgery/procurement (P = 0.003). Up-regulated genes were involved in inflammation and its regulation, apoptosis/survival, heat shock, and oxidative stress response (q = 0). Down-regulated genes were related to lymphocyte function (q = 0). The NF-B, signal transducer and activator of transcription 3, ERK1/2, p38, Akt, and stress-activated protein kinase/JNK signaling pathways were modulated by EVLP (P < 0.05). Most of these biomolecular changes were examined and confirmed in additional experiments that were performed in lungs procured from donation after cardiocirculatory death after 180 min of warm ischemia. The current study demonstrates that EVLP broadly affects the lung biomolecular phenotype. These findings improve our comprehension of the effects exerted by the procedure and encourage additional research in preclinical models to implement therapeutic interventions.Lonati, C., Bassani, G. A., Brambilla, D., Leonardi, P., Carlin, A., Faversani, A., Gatti, S., Valenza, F. Influence of ex vivo perfusion on the biomolecular profile of rat lungs.	[Lonati, Caterina; Bassani, Giulia A.; Brambilla, Daniela; Gatti, Stefano] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Ctr Surg Res, Milan, Italy; [Lonati, Caterina; Bassani, Giulia A.; Leonardi, Patrizia; Carlin, Andrea] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Ctr Preclin Invest, Dipartimento Anestesia Rianimaz Emergenza Urgenza, Milan, Italy; [Faversani, Alice] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Div Pathol, Milan, Italy; [Leonardi, Patrizia; Carlin, Andrea] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Faversani, Alice] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy	University of Milan; University of Milan	Lonati, C (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Surg Res, 9 Pace St, I-20122 Milan, Italy.	caterina.lonati@gmail.com	Gatti, Stefano/AAE-3281-2022; lonati, caterina/GVT-5843-2022; lonati, caterina/ABI-1503-2020; Bassani, Giulia A./AAC-3634-2022; lonati, caterina/M-3748-2015	Gatti, Stefano/0000-0003-2209-4338; Bassani, Giulia A./0000-0001-9196-6975; lonati, caterina/0000-0001-7855-7851; Brambilla, Daniela/0000-0002-9669-278X	Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant 5x1000-2014; Centro Nazionale Trapianti (Rome, Italy); Milano Liver Transplant Association (MILTA); Lega Italiana Fibrosi Cistica Onlus (Lombardia, Italy)	Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant 5x1000-2014; Centro Nazionale Trapianti (Rome, Italy); Milano Liver Transplant Association (MILTA); Lega Italiana Fibrosi Cistica Onlus (Lombardia, Italy)	The authors acknowledge their colleagues at Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico; Dr. Maurizio Marchini (Referral Center for Systemic Autoimmune Diseases, University of Milan) for facilitating the logistics for the Luminex platform utilization; Dr. Emanuela Pappalardo (Department of Pathophysiology and Transplantation, University of Milan) for providing the Nanodrop spectrophotometer; and Drs. Mauro Pomati and Manuela Zappa (Laboratorio Oncoematologia Diagnostica, Milan, Italy) for allowing access to the 7900HT platform. The authors also thank Dr. Vincenzo Carbonelli (Referral Center for Systemic Autoimmune Diseases, University of Milan) for technical assistance in leukocyte characterization. This work was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant 5x1000-2014 "Ottimizzazione della procedura di perfusione di organi isolati a scopo di trapianto mediante modulazione del liquido di perfusione (Improvement of the procedure to perfuse isolated organs before transplantation through perfusion fluid optimization)," Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico 5x1000-2014 "Il benessere animale nella ricerca preclinica: strategie di implememntazione (strategies for improvement of animal healthcare in preclinical research)", by Centro Nazionale Trapianti (Rome, Italy), by Milano Liver Transplant Association (MILTA), and by Lega Italiana Fibrosi Cistica Onlus (Lombardia, Italy). The authors declare no conflicts of interest.	Bassani GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167898; Boffini M, 2014, EUR J CARDIO-THORAC, V46, P789, DOI 10.1093/ejcts/ezu239; Cypel M, 2012, J THORAC CARDIOV SUR, V144, P1200, DOI 10.1016/j.jtcvs.2012.08.009; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Eldridge L, 2011, AM J PHYSIOL-LUNG C, V301, pL782, DOI 10.1152/ajplung.00079.2011; Fildes JE, 2015, TRANSPLANTATION, V99, P1078, DOI 10.1097/TP.0000000000000462; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Harada M, 2015, GEN THORAC CARDIOVAS, V63, P645, DOI 10.1007/s11748-015-0585-0; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Inokawa H, 2006, ANN THORAC SURG, V82, P1219, DOI 10.1016/j.athoracsur.2006.05.004; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kakishita T, 2010, ANN THORAC SURG, V89, P1773, DOI 10.1016/j.athoracsur.2010.02.077; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Koike T, 2011, J HEART LUNG TRANSPL, V30, P1312, DOI 10.1016/j.healun.2011.07.014; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Liang JR, 2016, ADV DRUG DELIVER REV, V97, P186, DOI 10.1016/j.addr.2015.10.017; Lindstedt S, 2011, INTERACT CARDIOV TH, V12, P162, DOI 10.1510/icvts.2010.244830; Machuca TN, 2015, ANN SURG, V261, P591, DOI 10.1097/SLA.0000000000000974; Mehaffey JH, 2017, ANN THORAC SURG, V103, P1723, DOI 10.1016/j.athoracsur.2017.01.018; Moriondo A, 2007, J APPL PHYSIOL, V103, P747, DOI 10.1152/japplphysiol.00056.2007; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Noda K, 2014, TRANSPLANTATION, V98, P499, DOI 10.1097/TP.0000000000000254; Reeb J, 2016, CLIN TRANSPLANT, V30, P183, DOI 10.1111/ctr.12680; Sadaria MR, 2011, ANN THORAC SURG, V92, P478, DOI 10.1016/j.athoracsur.2011.04.027; Sanchez PG, 2016, CURR OPIN ORGAN TRAN, V21, P258, DOI 10.1097/MOT.0000000000000310; Selzner N, 2012, TRANSPLANT REV-ORLAN, V26, P115, DOI 10.1016/j.trre.2011.07.003; Slama A, 2017, J HEART LUNG TRANSPL, V36, P744, DOI 10.1016/j.healun.2017.02.011; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033; Stone JP, 2016, AM J TRANSPLANT, V16, P33, DOI 10.1111/ajt.13446; Stone JP, 2014, J HEART LUNG TRANSPL, V33, P864, DOI 10.1016/j.healun.2014.03.005; Tanaka Y, 2015, AM J TRANSPLANT, V15, P1219, DOI 10.1111/ajt.13109; Todd JL, 2014, AM J RESP CRIT CARE, V189, P556, DOI 10.1164/rccm.201308-1481OC; Valenza F, 2014, TRANSPL INT, V27, P553, DOI 10.1111/tri.12295; Vogel T, 2012, TRANSPLANT REV-ORLAN, V26, P156, DOI 10.1016/j.trre.2011.02.004; Wagner FM, 2016, J THORAC CARDIOV SUR, V151, P547, DOI 10.1016/j.jtcvs.2015.10.052; Wallinder A, 2016, J HEART LUNG TRANSPL, V35, P1303, DOI 10.1016/j.healun.2016.05.021; Yeung JC, 2018, AM J TRANSPLANT, V18, P1518, DOI 10.1111/ajt.14700; Yuan H, 2015, ANAL BIOCHEM, V474, P78, DOI 10.1016/j.ab.2014.12.020; Zych B, 2012, J HEART LUNG TRANSPL, V31, P274, DOI 10.1016/j.healun.2011.10.008	44	21	21	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5532	5549		10.1096/fj.201701255R	http://dx.doi.org/10.1096/fj.201701255R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718705	Bronze			2022-12-28	WOS:000447972500028
J	Bageghni, SA; Hemmings, KE; Zava, N; Denton, CP; Porter, KE; Ainscough, JFX; Drinkhill, MJ; Turner, NA				Bageghni, Sumia A.; Hemmings, Karen E.; Zava, Ngonidzashe; Denton, Christopher P.; Porter, Karen E.; Ainscough, Justin F. X.; Drinkhill, Mark J.; Turner, Neil A.			Cardiac fibroblast-specific p38 alpha MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism	FASEB JOURNAL			English	Article						heart; cardiomyocyte; microRNA; isoproterenol; mouse	ACTIVATED PROTEIN-KINASE; II TYPE-1 RECEPTOR; PRESSURE-OVERLOAD; HEART-FAILURE; P38 MAPK; MYOCARDIAL-INFARCTION; CYTOKINE EXPRESSION; GENE-EXPRESSION; REGULATORY ROLE; UP-REGULATION	Recent studies suggest that cardiac fibroblast-specific p38 MAPK contributes to the development of cardiac hypertrophy, but the underlying mechanism is unknown. Our study used a novel fibroblast-specific, tamoxifen-inducible p38 knockout (KO) mouse line to characterize the role of fibroblast p38 in modulating cardiac hypertrophy, and we elucidated the mechanism. Myocardial injury was induced in tamoxifen-treated Cre-positive p38 KO mice or control littermates via chronic infusion of the -adrenergic receptor agonist isoproterenol. Cardiac function was assessed by pressure-volume conductance catheter analysis and was evaluated for cardiac hypertrophy at tissue, cellular, and molecular levels. Isoproterenol infusion in control mice promoted overt cardiac hypertrophy and dysfunction (reduced ejection fraction, increased end systolic volume, increased cardiac weight index, increased cardiomyocyte area, increased fibrosis, and up-regulation of myocyte fetal genes and hypertrophy-associated microRNAs). Fibroblast-specific p38 KO mice exhibited marked protection against myocardial injury, with isoproterenol-induced alterations in cardiac function, histology, and molecular markers all being attenuated. In vitro mechanistic studies determined that cardiac fibroblasts responded to damaged myocardium by secreting several paracrine factors known to induce cardiomyocyte hypertrophy, including IL-6, whose secretion was dependent upon p38 activity. In conclusion, cardiac fibroblast p38 contributes to cardiomyocyte hypertrophy and cardiac dysfunction, potentially via a mechanism involving paracrine fibroblast-to-myocyte IL-6 signaling.Bageghni, S. A., Hemmings, K. E., Zava, N., Denton, C. P., Porter, K. E., Ainscough, J. F. X., Drinkhill, M. J., Turner, N. A. Cardiac fibroblast-specific p38 MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism.	[Bageghni, Sumia A.; Hemmings, Karen E.; Zava, Ngonidzashe; Porter, Karen E.; Ainscough, Justin F. X.; Drinkhill, Mark J.; Turner, Neil A.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Sch Med, Leeds, W Yorkshire, England; [Denton, Christopher P.] UCL, Div Med, Ctr Rheumatol, London, England	University of Leeds; University of London; University College London	Turner, NA (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, LIGHT Labs, Discovery & Translat Sci Dept, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	n.a.turner@leeds.ac.uk		Hemmings, Karen/0000-0002-4967-6314; Turner, Neil/0000-0002-4957-5433; Bageghni, Sumia Abdulaziz/0000-0001-9640-3717; Ainscough, Justin/0000-0003-0231-433X	British Heart Foundation [PG/11/110/29248, PG/11/80/29135]	British Heart Foundation(British Heart Foundation)	The authors thank Drs. Juan-Jose Ventura [Katholieke Universiteit (KU) Leuven, Leuven, Belgium] and Manolis Pasparakis (University of Cologne, Cologne, Germany), for the provision of floxed Mapk14 mice, and Emmanuel Pinteaux (University of Manchester, Manchester, United Kingdom) for the provision of floxed Il1r1 mice. This work was supported by funding from the British Heart Foundation (Grants PG/11/110/29248 and PG/11/80/29135) awarded to N.A.T. (principal investigator), J.F.X.A., M.J.D., and K.E.P. The authors declare no conflicts of interest.	Abdulaal WH, 2016, EUR J IMMUNOL, V46, P912, DOI 10.1002/eji.201546075; Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Ancey C, 2003, CARDIOVASC RES, V59, P78, DOI 10.1016/S0008-6363(03)00346-8; Arabacilar P, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00102; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Cha HN, 2010, KOREAN J PHYSIOL PHA, V14, P377, DOI 10.4196/kjpp.2010.14.6.377; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Coles B, 2007, AM J PATHOL, V171, P315, DOI 10.2353/ajpath.2007.061078; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Diao XH, 2011, MOL MED REP, V4, P633, DOI 10.3892/mmr.2011.489; Dingar D, 2010, CELL SIGNAL, V22, P1634, DOI 10.1016/j.cellsig.2010.06.002; Dostal D, 2015, COMPR PHYSIOL, V5, P887, DOI 10.1002/cphy.c140053; Du WJ, 2016, CELL PHYSIOL BIOCHEM, V39, P827, DOI 10.1159/000447793; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Emde B, 2014, EUR J HISTOCHEM, V58, P315, DOI 10.4081/ejh.2014.2448; Frentzou GA, 2015, DIS MODEL MECH, V8, P783, DOI 10.1242/dmm.019174; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Goldsmith Steven R, 2004, Curr Heart Fail Rep, V1, P45, DOI 10.1007/s11897-004-0024-5; Grisanti LA, 2015, AM J PHYSIOL-HEART C, V308, pH316, DOI 10.1152/ajpheart.00635.2014; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hou YL, 2012, MED SCI MONITOR, V18, pBR309, DOI 10.12659/MSM.883263; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kamo T, 2015, CIRC RES, V117, P89, DOI 10.1161/CIRCRESAHA.117.305349; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; Lal H, 2014, CIRCULATION, V130, P419, DOI 10.1161/CIRCULATIONAHA.113.008364; Lal H, 2008, J MOL CELL CARDIOL, V45, P770, DOI 10.1016/j.yjmcc.2008.09.121; Lemke LE, 2001, J MOL CELL CARDIOL, V33, P1527, DOI 10.1006/jmcc.2001.1415; Li YL, 2017, CIRCULATION, V135, P2041, DOI 10.1161/CIRCULATIONAHA.116.024599; Li ZH, 2004, J CARDIOVASC PHARM, V44, P486, DOI 10.1097/01.fjc.0000141474.06383.6f; Lugrin J, 2015, J IMMUNOL, V194, P499, DOI 10.4049/jimmunol.1401948; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021; Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901; Meier H, 2009, CELL PHYSIOL BIOCHEM, V23, P327, DOI 10.1159/000218180; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Mylonas KJ, 2017, J ENDOCRINOL, V233, P315, DOI 10.1530/JOE-16-0501; Nawaito SA, 2017, AM J PHYSIOL-HEART C, V313, pH46, DOI 10.1152/ajpheart.00597.2016; Ning QL, 2013, BIOMED REP, V1, P776, DOI 10.3892/br.2013.144; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Ohkura S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182329; Perez DM, 2009, MOL PHARMACOL, V76, P144, DOI 10.1124/mol.108.054320; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Ramanujam D, 2016, MOL THER, V24, P1939, DOI 10.1038/mt.2016.166; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sari FR, 2011, CELL PHYSIOL BIOCHEM, V27, P487, DOI 10.1159/000329970; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sinfield JK, 2013, BIOCHEM BIOPH RES CO, V430, P419, DOI 10.1016/j.bbrc.2012.11.071; Singh VP, 2008, AM J PHYSIOL-HEART C, V294, pH1675, DOI 10.1152/ajpheart.91493.2007; Stratton MS, 2017, CIRCULATION, V136, P562, DOI 10.1161/CIRCULATIONAHA.117.028957; Sun C, 2017, BIOCHEM BIOPH RES CO, V490, P1106, DOI 10.1016/j.bbrc.2017.06.182; Sun M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18351; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Turner NA, 2001, CELL SIGNAL, V13, P269, DOI 10.1016/S0898-6568(01)00135-8; Turner NA, 2016, J MOL CELL CARDIOL, V94, P189, DOI 10.1016/j.yjmcc.2015.11.002; Turner NA, 2011, FUTUR CARDIOL, V7, P673, DOI [10.2217/fca.11.41, 10.2217/FCA.11.41]; Turner NA, 2010, MATRIX BIOL, V29, P613, DOI 10.1016/j.matbio.2010.06.007; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Xiao H, 2018, EUR HEART J, V39, P60, DOI 10.1093/eurheartj/ehx261; Yang SF, 2015, ONCOTARGET, V6, P2736, DOI 10.18632/oncotarget.3088; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290; Zhao L, 2015, CELL SIGNAL, V27, P2026, DOI 10.1016/j.cellsig.2015.07.007; Zhao L, 2016, CIRC RES, V118, P1918, DOI 10.1161/CIRCRESAHA.116.308688; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X; Zhu JY, 2012, CYTOKINE, V58, P368, DOI 10.1016/j.cyto.2012.02.008	73	42	45	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4941	4954		10.1096/fj.201701455RR	http://dx.doi.org/10.1096/fj.201701455RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29601781	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000443817700027
J	Chen, EM; Liu, GY; Zhou, XP; Zhang, W; Wang, C; Hu, DC; Xue, DT; Pan, ZJ				Chen, Erman; Liu, Guanyi; Zhou, Xiaopeng; Zhang, Wei; Wang, Cong; Hu, Dongcai; Xue, Deting; Pan, Zhijun			Concentration-dependent, dual roles of IL-10 in the osteogenesis of human BMSCs via P38/MAPK and NF-B signaling pathways	FASEB JOURNAL			English	Article						interleukin; osteogenic differentiation; stem cells	MESENCHYMAL STEM-CELLS; ALVEOLAR BONE LOSS; FRACTURE HEMATOMA; STROMAL CELLS; IMMUNE CELLS; TNF-ALPHA; INTERLEUKIN-10; MICROENVIRONMENT; DIFFERENTIATION; OSTEOBLAST	Microenvironmental conditions can influence the differentiation and functional roles of mesenchymal stem cells (MSCs). Recent studies have suggested that an inflammatory microenvironment can significantly affect the osteogenic differentiation of MSCs. Here, we show, for the first time, that IL-10 has concentration-dependent, dual roles in the osteogenesis of human bone marrow mesenchymal stem cells (hBMSCs). Low physiologic concentrations of IL-10 (0.01-1.0 ng/ml) activate the p38/MAPK signaling pathway to promote the osteogenesis of hBMSCs, but higher pathologic doses of IL-10 (10-100 ng/ml) inhibit p38/MAPK signaling by activating NF-B, inhibiting osteogenesis. These results demonstrate that p38/MAPK and NF-B signaling mediates the double-edged sword effect of IL-10 on hBMSCs. The osteogenic impairment was reversed at higher doses of IL-10 when cells were supplemented with the NF-B inhibitor BAY11-7082. These data provide important insights into the regulatory effects of IL-10 on the biologic behavior of hBMSCs.Chen, E., Liu, G., Zhou, X., Zhang, W., Wang, C., Hu, D., Xue, D., Pan, Z. Concentration-dependent, dual roles of IL-10 in the osteogenesis of human BMSCs via P38/MAPK and NF-B signaling pathways.	[Chen, Erman; Liu, Guanyi; Zhou, Xiaopeng; Zhang, Wei; Wang, Cong; Hu, Dongcai; Xue, Deting; Pan, Zhijun] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China; [Chen, Erman; Liu, Guanyi; Zhou, Xiaopeng; Zhang, Wei; Xue, Deting; Pan, Zhijun] Zhejiang Univ, Orthoped Res Inst, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xue, DT; Pan, ZJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	blueskine@zju.edu.cn; zrpzj@zju.edu.cn		Xue, deting/0000-0001-6388-2862	National Natural Science Foundation of China [81672147, 81201397]; Zhejiang Provincial Natural Science Foundation of China [LQ17H060002, LY15H060001, LY15H060002, LY16H060003]; Education Department of Zhejiang Province [Y201328201]; Public welfare projects of Zhejiang Science and Technology Department [2012C23079]; Zhejiang medical and health science and technology plan project [2015KYB182, 2017KY382, 2014KYA092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Education Department of Zhejiang Province; Public welfare projects of Zhejiang Science and Technology Department; Zhejiang medical and health science and technology plan project	This work was supported by grants from the National Natural Science Foundation of China (Grants 81672147 and 81201397), Zhejiang Provincial Natural Science Foundation of China (Grants LQ17H060002, LY15H060001, LY15H060002, and LY16H060003), the Education Department of Zhejiang Province (Grant Y201328201), Public welfare projects of Zhejiang Science and Technology Department (Grant 2012C23079), and Zhejiang medical and health science and technology plan project (Grants 2015KYB182, 2017KY382, and 2014KYA092). The authors declare no conflicts of interest.	Abu-Amer Y, 2013, OSTEOPOROSIS INT, V24, P2377, DOI 10.1007/s00198-013-2313-x; Al-Rasheed A, 2003, J DENT RES, V82, P632, DOI 10.1177/154405910308200812; Bai WJ, 2014, CELL SIGNAL, V26, P942, DOI 10.1016/j.cellsig.2014.01.015; Barrachina L, 2017, STEM CELLS DEV, V26, P15, DOI 10.1089/scd.2016.0209; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Camorani S, 2017, THERANOSTICS, V7, P3595, DOI 10.7150/thno.18974; Campana L, 2018, J IMMUNOL, V200, P1169, DOI 10.4049/jimmunol.1701247; Chen EEM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.429; Claudino M, 2010, EUR J ORAL SCI, V118, P19, DOI 10.1111/j.1600-0722.2009.00706.x; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Deng MY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0693-0; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; El-Jawhari JJ, 2016, INJURY, V47, P2399, DOI 10.1016/j.injury.2016.10.008; Feng L, 2016, EXP THER MED, V12, P3941, DOI 10.3892/etm.2016.3857; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fu WY, 2017, FASEB J, V31, P1354, DOI 10.1096/fj.201601134R; Giannoudis PV, 2008, INJURY, V39, pS5, DOI 10.1016/S0020-1383(08)70010-X; Giannoudis PV, 2011, INJURY, V42, P549, DOI 10.1016/j.injury.2011.03.037; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Haller JM, 2015, J BONE JOINT SURG AM, V97A, P478, DOI 10.2106/JBJS.N.00200; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; Hauser CJ, 1996, SHOCK, V6, P3, DOI 10.1097/00024382-199607000-00002; Hoff P, 2013, CELL MOL IMMUNOL, V10, P151, DOI 10.1038/cmi.2012.56; Holgersen K, 2015, INFLAMM BOWEL DIS, V21, P257, DOI 10.1097/MIB.0000000000000269; Horst K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/126060; Huh JE, 2013, BBA-MOL CELL RES, V1833, P2608, DOI 10.1016/j.bbamcr.2013.06.025; Jung YK, 2013, ARTHRITIS RHEUM-US, V65, P3153, DOI 10.1002/art.38181; Katagiri W, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12333; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kong XW, 2013, BBA-GEN SUBJECTS, V1830, P5119, DOI 10.1016/j.bbagen.2013.07.027; Kovach TK, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/752510; Lastrucci C, 2015, CELL RES, V25, P1333, DOI 10.1038/cr.2015.123; Mao CY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.204; Marinou I, 2007, ARTHRITIS RHEUM, V56, P2549, DOI 10.1002/art.22814; MIZUNO K, 1990, J BONE JOINT SURG BR, V72, P822, DOI 10.1302/0301-620X.72B5.2211764; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Park SH, 2002, J ORTHOP RES, V20, P1197, DOI 10.1016/S0736-0266(02)00072-4; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Sharma N, 2017, CYTOKINE, V90, P169, DOI 10.1016/j.cyto.2016.11.010; Sidney LE, 2014, STEM CELLS DEV, V23, P605, DOI 10.1089/scd.2013.0336; Singh R, 2016, INJURY, V47, pS33, DOI 10.1016/S0020-1383(16)30837-3; Sullivan CB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt492; Tabrez S, 2017, IUBMB LIFE, V69, P522, DOI 10.1002/iub.1637; van de Vyver M, 2016, SCAND J MED SCI SPOR, V26, P638, DOI 10.1111/sms.12497; VANVLASSELAER P, 1994, J CELL BIOL, V124, P569, DOI 10.1083/jcb.124.4.569; VANVLASSELAER P, 1993, BLOOD, V82, P2361; VANVLASSELAER P, 1995, CLIN ORTHOP RELAT R, P103; Walters G, 2018, J TISSUE ENG REGEN M, V12, pE1662, DOI 10.1002/term.2593; Wang BS, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0744-6; Xie GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074126; Xue DT, 2017, ONCOTARGET, V8, P42098, DOI 10.18632/oncotarget.16887; Yamada PM, 2007, J APPL PHYSIOL, V103, P1196, DOI 10.1152/japplphysiol.00242.2007; Zhang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep29359; Zheng YJ, 2013, CELL MOL IMMUNOL, V10, P330, DOI 10.1038/cmi.2013.3; Zong C, 2010, EUR CELLS MATER, V20, P109	59	36	38	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4917	4929		10.1096/fj.201701256RRR	http://dx.doi.org/10.1096/fj.201701256RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29630408				2022-12-28	WOS:000443817700025
J	Sinha, D; Kalimutho, M; Bowles, J; Chan, AL; Merriner, DJ; Bain, AL; Simmons, JL; Freire, R; Lopez, JA; Hobbs, RM; O'Bryan, MK; Khanna, KK				Sinha, Debottam; Kalimutho, Murugan; Bowles, Josephine; Chan, Ai-Leen; Merriner, D. Jo; Bain, Amanda L.; Simmons, Jacinta L.; Freire, Raimundo; Lopez, J. Alejandro; Hobbs, Robin M.; O'Bryan, Moira K.; Khanna, Kum Kum			Cep55 overexpression causes male-specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling	FASEB JOURNAL			English	Article						spermatogenesis; mouse model; azoospermia; male infertility	SPERMATOGONIAL STEM-CELLS; MALE GERM-CELLS; INTERCELLULAR BRIDGES; SELF-RENEWAL; MALE-INFERTILITY; UNDIFFERENTIATED SPERMATOGONIA; ESCRT MACHINERY; MOUSE TESTES; CYTOKINESIS; SPERMATOGENESIS	Spermatogenesis is a dynamic process involving self-renewal and differentiation of spermatogonial stem cells, meiosis, and ultimately, the differentiation of haploid spermatids into sperm. Centrosomal protein 55 kDa (CEP55) is necessary for somatic cell abscission during cytokinesis. It facilitates equal segregation of cytoplasmic contents between daughter cells by recruiting endosomal sorting complex required for transport machinery (ESCRT) at the midbody. In germ cells, CEP55, in partnership with testes expressed-14 (TEX14) protein, has also been shown to be an integral component of intercellular bridge before meiosis. Various in vitro studies have demonstrated a role for CEP55 in multiple cancers and other diseases. However, its oncogenic potential in vivo remains elusive. To investigate, we generated ubiquitously overexpressing Cep55 transgenic (Cep55(Tg/Tg)) mice aiming to characterize its oncogenic role in cancer. Unexpectedly, we found that Cep55(Tg/Tg) male mice were sterile and had severe and progressive defects in spermatogenesis related to spermatogenic arrest and lack of spermatids in the testes. In this study, we characterized this male-specific phenotype and showed that excessively high levels of Cep55 results in hyperactivation of PI3K/protein kinase B (Akt) signaling in testis. In line with this finding, we observed increased phosphorylation of forkhead box protein O1 (FoxO1), and suppression of its nuclear retention, along with the relative enrichment of promyelocytic leukemia zinc finger (PLZF) -positive cells. Independently, we observed that Cep55 amplification favored upregulation of ret (Ret) proto-oncogene and glial-derived neurotrophic factor family receptor -1 (Gfra1). Consistent with these data, we observed selective down-regulation of genes associated with germ cell differentiation in Cep55-overexpressing testes at postnatal day 10, including early growth response-4 (Egr4) and spermatogenesis and oogenesis specific basic helix-loop-helix-1 (Sohlh1). Thus, Cep55 amplification leads to a shift toward the initial maintenance of undifferentiated spermatogonia and ultimately results in progressive germ cell loss. Collectively, our findings demonstrate that Cep55 overexpression causes change in germ cell proportions and manifests as a Sertoli cell only tubule phenotype, similar to that seen in many azoospermic men.Sinha, D., Kalimutho, M., Bowles, J., Chan, A.-L., Merriner, D. J., Bain, A. L., Simmons, J. L., Freire, R., Lopez, J. A., Hobbs, R. M., O'Bryan, M. K., Khanna, K. K. Cep55 overexpression causes male-specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling.	[Sinha, Debottam; Kalimutho, Murugan; Bain, Amanda L.; Simmons, Jacinta L.; Lopez, J. Alejandro; Khanna, Kum Kum] Queensland Inst Med Res QIMR Berghofer Med Res In, Herston, Qld, Australia; [Sinha, Debottam; Kalimutho, Murugan; Lopez, J. Alejandro] Griffith Univ, Sch Nat Sci, Nathan, Qld, Australia; [Bowles, Josephine] Univ Queensland, Sch Biomed Sci, Inst Mol Biosci, St Lucia, Qld, Australia; [Chan, Ai-Leen; Hobbs, Robin M.] Monash Univ, Germline Stem Cell Lab, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Chan, Ai-Leen; Hobbs, Robin M.] Monash Univ, Dept Anat & Dev Biol, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Merriner, D. Jo; O'Bryan, Moira K.] Monash Univ, Sch Biol Sci, Male Infertil & Germ Cell Biol Lab, 25 Rainforest Walk, Clayton, Vic 3800, Australia; [Freire, Raimundo] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Tenerife, Spain	Griffith University; University of Queensland; Australian Regenerative Medicine Institute; Monash University; Monash University; Monash University; Universidad de la Laguna	O'Bryan, MK (corresponding author), Monash Univ, Sch Biol Sci, Male Infertil & Germ Cell Biol Lab, 25 Rainforest Walk, Clayton, Vic 3800, Australia.; Khanna, KK (corresponding author), QIMR Berghofer Med Res Inst, 300 Herston Rd, Brisbane, Qld 4006, Australia.	moira.obryan@monash.edu; kumkum.khanna@qimrberghofer.edu.au	Simmons, Jacinta/GLT-7261-2022; Lopez, J. Alejandro/B-9290-2008; Simmons, Jacinta L/S-2373-2018; Bowles, Josephine/AAG-4903-2020; Lopez, J. Alejandro/P-4129-2019; Kalimutho, Murugan/AAD-1441-2019; Sinha, Debottam/J-5521-2019; Freire, Raimundo/Q-7660-2019; O'Bryan, Moira K/F-8256-2012; Hobbs, Robin/I-2577-2014	Simmons, Jacinta/0000-0002-9311-1046; Lopez, J. Alejandro/0000-0001-9370-1516; Simmons, Jacinta L/0000-0002-9311-1046; Bowles, Josephine/0000-0003-2867-7438; Lopez, J. Alejandro/0000-0001-9370-1516; Sinha, Debottam/0000-0001-7153-856X; Freire, Raimundo/0000-0003-4473-8894; O'Bryan, Moira K/0000-0001-7298-4940; Kalimutho, Murugan/0000-0002-0772-8673; Chan, Ai-Leen/0000-0003-3553-7249; Khanna, Kum Kum/0000-0001-8650-5381; Hobbs, Robin/0000-0002-3853-2614	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS); Cancer Council Queensland (CCQ) [1087363]; Spanish Ministry of Economy (MINECO) [SAF2016-80626-R]; National Health and Medical Research Council (NHMRC) [APP1058356]; Australian Research Council (ARC) Future Fellowship [FT140101029]; NH&MRC Program Grant [1017028]	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS); Cancer Council Queensland (CCQ)(Cancer Council Queensland); Spanish Ministry of Economy (MINECO)(Spanish Government); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Future Fellowship(Australian Research Council); NH&MRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the members of the K.K.K. laboratory for helpful discussions and technical assistance and the QIMR Berghofer Animal facility staff and Nigel Waterhouse and Tam Hong Nguyen for microscopy assistance. D.S. is supported by a Griffith University International Postgraduate Research Scholarship (GUIPRS) and Griffith University Postgraduate Research Scholarship (GUPRS). M.K. is supported by Cancer Council Queensland (CCQ) Project Grant 1087363. R.F. is supported by Spanish Ministry of Economy (MINECO) Grant SAF2016-80626-R. M.K.O. is supported by a fellowship from the National Health and Medical Research Council (NH & MRC; APP1058356). R.M.H. is supported by an Australian Research Council (ARC) Future Fellowship FT140101029. The K.K.K. laboratory is supported by NH&MRC Program Grant 1017028. The authors declare no conflicts of interest.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Aponte PM, 2005, APMIS, V113, P727, DOI 10.1111/j.1600-0463.2005.apm_302.x; Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Bhasin S, 1997, ANN MED, V29, P261, DOI 10.3109/07853899708999344; Bondeson ML, 2017, CLIN GENET, V92, P510, DOI 10.1111/cge.13012; Boucher D, 2015, FASEB J, V29, P3326, DOI 10.1096/fj.14-269944; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang YC, 2010, J CELL BIOCHEM, V109, P1274, DOI 10.1002/jcb.22517; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; De Rooij DG, 2000, J ANDROL, V21, P776; Ding XB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28218; Durcova-Hills G, 2008, CURR TOP DEV BIOL, V83, P185, DOI [10.1016/S0070-2153(08)00406-7, 10.1016/S0070-2153(09)00406-7]; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Flannigan R, 2017, BEST PRACT RES CL OB, V44, P26, DOI 10.1016/j.bpobgyn.2017.05.002; Frosk P, 2017, J MED GENET, V54, P490, DOI 10.1136/jmedgenet-2016-104296; Geister KA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005569; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Gonzalez-Merino E, 2007, FERTIL STERIL, V88, P600, DOI 10.1016/j.fertnstert.2006.12.020; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Guo GQ, 2004, J THEOR BIOL, V229, P139, DOI 10.1016/j.jtbi.2004.03.010; Haglund Kaisa, 2011, Communicative & Integrative Biology, V4, P1, DOI 10.4161/cib.4.1.13550; Handel MA, 1999, J EXP ZOOL, V285, P243, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;243::AID-JEZ7&gt;3.0.CO;2-#; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Hart RJ, 2015, HUM REPROD, V30, P2713, DOI 10.1093/humrep/dev244; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; He ZP, 2009, MICROSC RES TECHNIQ, V72, P586, DOI 10.1002/jemt.20698; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; HUCKINS C, 1978, ANAT REC, V192, P529, DOI 10.1002/ar.1091920407; Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Jain S, 2004, DEVELOPMENT, V131, P5503, DOI 10.1242/dev.01421; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Jeffery J, 2016, ONCOGENE, V35, P683, DOI 10.1038/onc.2015.128; Jeffery J, 2015, FASEB J, V29, P1999, DOI 10.1096/fj.14-265090; Jijiwa M, 2008, GENES CELLS, V13, P365, DOI 10.1111/j.1365-2443.2008.01171.x; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Hamra FK, 2007, J BIOL CHEM, V282, P721, DOI 10.1074/jbc.M608398200; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim HJ, 2015, P NATL ACAD SCI USA, V112, P12372, DOI 10.1073/pnas.1418606112; KLUIN PM, 1981, INT J ANDROL, V4, P475, DOI 10.1111/j.1365-2605.1981.tb00732.x; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Maatouk DM, 2008, CURR TOP DEV BIOL, V83, P151, DOI 10.1016/S0070-2153(08)00405-5; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Mittal D, 2016, CANCER RES, V76, P4372, DOI 10.1158/0008-5472.CAN-16-0544; Moreno SG, 2010, DEV BIOL, V342, P74, DOI 10.1016/j.ydbio.2010.03.007; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nagano R, 2000, ANAT REC, V258, P210; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Saitou M, 2009, FRONT BIOSCI-LANDMRK, V14, P1068, DOI 10.2741/3294; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Seshagiri PB, 2001, J BIOSCIENCES, V26, P429, DOI 10.1007/BF02704745; SILBER SJ, 1995, HUM REPROD, V10, P1031, DOI 10.1093/oxfordjournals.humrep.a136085; Tanaka SS, 2010, DEV DYNAM, V239, P2851, DOI 10.1002/dvdy.22417; Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	84	29	32	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4984	4999		10.1096/fj.201701096RR	http://dx.doi.org/10.1096/fj.201701096RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29683733	Bronze			2022-12-28	WOS:000443817700030
J	Moorthi, S; Burns, TA; Yu, GQ; Luberto, C				Moorthi, Sitapriya; Burns, Tara Ann; Yu, Gui-Qin; Luberto, Chiara			Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation	FASEB JOURNAL			English	Article						transcription; alternative TSS; cancer; translation; translation efficiency	CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; HETEROGENEOUS NUCLEAR-RNA; DNA-BINDING ACTIVITY; ALDOLASE-A GENE; WILD-TYPE P53; NF-KAPPA-B; MESSENGER-RNA; ALTERNATIVE PROMOTER; INDUCED APOPTOSIS	Bcr-Abl (break-point cluster region-abelson), the oncogenic trigger of chronic myelogenous leukemia (CML), has previously been shown to up-regulate the expression and activity of sphingomyelin synthase 1 (SMS1), which contributes to the proliferation of CML cells; however, the mechanism by which this increased expression of SMS1 is mediated remains unknown. In the current study, we show that Bcr-Abl enhances the expression of SMS1via a 30-fold up-regulation of its transcription. Of most interest, the Bcr-Abl-regulated transcription of SMS1 is initiated from a novel transcription start site (TSS) that is just upstream of the open reading frame. This shift in TSS utilization generates an SMS1 mRNA with a substantially shorter 5 UTR compared with its canonical mRNA. This shorter 5 UTR imparts a 20-fold greater translational efficiency to SMS1 mRNA, which further contributes to the increase of its expression in CML cells. Therefore, our study demonstrates that Bcr-Abl increases SMS1 protein levels via 2 concerted mechanisms: up-regulation of transcription and enhanced translation as a result of the shift in TSS utilization. Remarkably, this is the first time that an oncogeneBcr-Ablhas been demonstrated to drive such a mechanism that up-regulates the expression of a functionally important target gene, SMS1.Moorthi, S., Burns, T. A., Yu, G.-Q., Luberto, C. Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation.	[Moorthi, Sitapriya] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Yu, Gui-Qin; Luberto, Chiara] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Burns, Tara Ann] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina	Luberto, C (corresponding author), SUNY Stony Brook, 100 Nicolls Rd,HSC 15-023, Stony Brook, NY 11794 USA.	chiara.luberto@stonybrook.edu		Moorthi, Sitapriya/0000-0001-6372-5170	U.S. National Institutes of Health, National Cancer Institute [P01-CA097132, 4]; Stony Brook Scholars in Biomedical Sciences Award; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stony Brook Scholars in Biomedical Sciences Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Paola Signorelli (Department of Health Sciences, University of Milan, Milan, Italy) and Dr. Daniella Ishimaru (Medical University of South Carolina) for expert advice. The authors also thank Dr. Can Senkal and Dr. Yusuf Hannun (both of the Department of Medicine and Cancer Center at Stony Brook University) for critical input when writing the manuscript. The authors thank the Stony Brook DNA Sequencing facility for timely assistance. This work was supported by U.S. National Institutes of Health, National Cancer Institute Grant P01-CA097132 (to C. L. for Project #4) and the Stony Brook Scholars in Biomedical Sciences Award (to S. M.). The authors declare no conflicts of interest.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Atchison Michael, 2011, Critical Reviews in Oncogenesis, V16, P143; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Berger Angelika, 2014, Oncotarget, V5, P9564; BERNERT JT, 1981, BIOCHIM BIOPHYS ACTA, V666, P99, DOI 10.1016/0005-2760(81)90095-3; Bourteele S, 1998, J BIOL CHEM, V273, P31245, DOI 10.1074/jbc.273.47.31245; Bujko M, 2016, J NEURO-ONCOL, V130, P473, DOI 10.1007/s11060-016-2261-3; Burns TA, 2013, J LIPID RES, V54, P794, DOI 10.1194/jlr.M033985; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Carter BZ, 2010, SEMIN HEMATOL, V47, P362, DOI 10.1053/j.seminhematol.2010.06.006; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; COSTANZO P, 1993, BIOCHEM BIOPH RES CO, V195, P935, DOI 10.1006/bbrc.1993.2134; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; Dergunova LV, 2013, MOL BIOL REP, V40, P6685, DOI 10.1007/s11033-013-2783-0; Dieudonne FX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2179-8; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; DIRINGER H, 1972, BIOCHEM BIOPH RES CO, V47, P1345, DOI 10.1016/0006-291X(72)90220-3; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; GOLDBERG S, 1977, P NATL ACAD SCI USA, V74, P4520, DOI 10.1073/pnas.74.10.4520; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HATCH GM, 1992, J BIOL CHEM, V267, P12443; Hughes TA, 2006, CANCER LETT, V233, P338, DOI 10.1016/j.canlet.2005.03.026; Hughes TA, 2005, J BIOL CHEM, V280, P8581, DOI 10.1074/jbc.M410806200; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Itoh M, 2003, CLIN CANCER RES, V9, P415; Jin ZX, 2008, INT IMMUNOL, V20, P1427, DOI 10.1093/intimm/dxn100; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Ko FCF, 2010, LIVER INT, V30, P139, DOI 10.1111/j.1478-3231.2009.02133.x; Lafont E, 2010, CELL DEATH DIFFER, V17, P642, DOI 10.1038/cdd.2009.130; Landers JE, 1997, CANCER RES, V57, P3562; Lavieu G, 2007, AUTOPHAGY, V3, P45, DOI 10.4161/auto.3416; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Luberto C, 2000, J BIOL CHEM, V275, P14760, DOI 10.1074/jbc.275.19.14760; LUPO A, 1995, BIOCHEM BIOPH RES CO, V216, P69, DOI 10.1006/bbrc.1995.2593; MAIRE P, 1987, J MOL BIOL, V197, P425, DOI 10.1016/0022-2836(87)90556-0; MARGGRAF WD, 1982, BIOCHIM BIOPHYS ACTA, V710, P314, DOI 10.1016/0005-2760(82)90114-X; MARGGRAF WD, 1981, BIOCHIM BIOPHYS ACTA, V664, P61, DOI 10.1016/0005-2760(81)90028-X; Maru Y, 2012, CANCER SCI, V103, P1601, DOI 10.1111/j.1349-7006.2012.02346.x; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; MIROOBRADORS MJ, 1993, CARCINOGENESIS, V14, P941, DOI 10.1093/carcin/14.5.941; Moorthi S., 2015, BIOACTIVE SPHINGOLIP, P53; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; NOWELL PC, 1960, SCIENCE, V132, P1497; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Perrotti D, 2017, CURR DRUG TARGETS, V18, P377, DOI 10.2174/1389450117666160615074120; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Polakova KM, 2013, CURR HEMATOL MALIG R, V8, P28, DOI 10.1007/s11899-012-0152-z; Riboni L, 2001, J BIOL CHEM, V276, P12797, DOI 10.1074/jbc.M011570200; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rozhkova AV, 2011, GENE, V481, P65, DOI 10.1016/j.gene.2011.04.010; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Saba JD, 1996, PHILOS T ROY SOC B, V351, P233, DOI 10.1098/rstb.1996.0021; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Separovic D, 2007, BIOCHEM BIOPH RES CO, V358, P196, DOI 10.1016/j.bbrc.2007.04.095; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shuai K, 1996, ONCOGENE, V13, P247; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Sudarkina OY, 2015, MOL CELL BIOCHEM, V406, P91, DOI 10.1007/s11010-015-2427-x; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tu RR, 2016, NEUROREPORT, V27, P967, DOI 10.1097/WNR.0000000000000639; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Vladychenskaya IP, 2004, GENE, V338, P257, DOI 10.1016/j.gene.2004.06.003; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Watanabe M, 2004, CANCER RES, V64, P1000, DOI 10.1158/0008-5472.CAN-03-1383; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wertheim JA, 2002, BLOOD, V99, P4122, DOI 10.1182/blood.V99.11.4122; Wesley UV, 2015, MOL NEUROBIOL, V51, P1530, DOI 10.1007/s12035-014-8829-z; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yang Z, 2005, GENE, V363, P123, DOI 10.1016/j.gene.2005.07.036; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang Y, 2009, BBA-BIOMEMBRANES, V1788, P178, DOI 10.1016/j.bbamem.2008.07.030	91	10	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4270	4283		10.1096/fj.201701016R	http://dx.doi.org/10.1096/fj.201701016R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29533737	Green Published			2022-12-28	WOS:000439325400018
J	Chen, JM; Hamers, AJP; Finsterbusch, M; Massimo, G; Zafar, M; Corder, R; Colas, RA; Dalli, J; Thiemermann, C; Ahluwalia, A				Chen, Jianmin; Hamers, Alexander J. P.; Finsterbusch, Michaela; Massimo, Gianmichele; Zafar, Maleeha; Corder, Roger; Colas, Romain A.; Dalli, Jesmond; Thiemermann, Christoph; Ahluwalia, Amrita			Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis	FASEB JOURNAL			English	Article						heart; CGRP; 20-HETE; endotoxemia; shock	GENE-RELATED PEPTIDE; CAPSAICIN RECEPTOR VR1; INFLAMMATORY RESPONSES; POSTISCHEMIC RECOVERY; VANILLOID RECEPTOR; LIPID MEDIATORS; UNITED-STATES; SEPTIC SHOCK; ACID; ACTIVATION	The severity of cardiac dysfunction predicts mortality in sepsis. Activation of transient receptor potential vanilloid receptor type (TRPV)-1, a predominantly neuronal nonselective cation channel, has been shown to improve outcome in sepsis and endotoxemia. However, the role of TRPV1 and the identity of its endogenous ligands in the cardiac dysfunction caused by sepsis and endotoxemia are unknown. Using TRPV1(-/-) and TRPV1(+/+) mice, we showed that endogenous activation of cardiac TRPV1 during sepsis is key to limiting the ensuing cardiac dysfunction. Use of liquid chromatography-tandem mass spectrometry lipid analysis and selective inhibitors of arachidonic metabolism suggest that the arachidonate-derived TRPV1 activator, 20-hydroxyeicosateraenoic acid (20-HETE), underlies a substantial component of TRPV1-mediated cardioprotection in sepsis. Moreover, using selective antagonists for neuropeptide receptors, we show that this effect of TRPV1 relates to the activity of neuronally released cardiac calcitonin gene-related peptide (CGRP) and that, accordingly, administration of CGRP can rescue cardiac dysfunction in severe endotoxemia. In sum activation of TRPV1 by 20-HETE leads to the release of CGRP, which protects the heart against the cardiac dysfunction in endotoxemia and identifies both TRPV1 and CGRP receptors as potential therapeutic targets in endotoxemia.Chen, J., Hamers, A. J. P., Finsterbusch, M., Massimo, G., Zafar, M., Corder, R., Colas, R. A., Dalli, J., Thiemermann, C., Ahluwalia, A. Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis.	[Chen, Jianmin; Hamers, Alexander J. P.; Finsterbusch, Michaela; Massimo, Gianmichele; Zafar, Maleeha; Corder, Roger; Colas, Romain A.; Dalli, Jesmond; Thiemermann, Christoph; Ahluwalia, Amrita] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England	University of London; Queen Mary University London	Ahluwalia, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	a.ahluwalia@qmul.ac.uk	Corder, Roger/H-2588-2012	Corder, Roger/0000-0003-1712-6841; Dalli, Jesmond/0000-0001-6328-3640; AHLUWALIA, Amrita/0000-0001-7626-6399; Finsterbusch, Michaela/0000-0001-9470-4313; Thiemermann, Christoph/0000-0003-4228-9722	China Scholarship Council; Derek Willoughby Trust Ph.D. Studentship; Wellcome Trust Dale Fellowship; European Research Council under the European Union's Horizon 2020 Research and Innovation Program [677542]; Barts and The London Charity [753/1722]; Wellcome Trust [107613/Z/15/Z]; Royal Society [107613/Z/15/Z]	China Scholarship Council(China Scholarship Council); Derek Willoughby Trust Ph.D. Studentship; Wellcome Trust Dale Fellowship(Wellcome Trust); European Research Council under the European Union's Horizon 2020 Research and Innovation Program; Barts and The London Charity; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was funded by the China Scholarship Council (to J.C.); a Derek Willoughby Trust Ph.D. Studentship (to A.J.P.H.), and a Wellcome Trust Dale Fellowship and funding from the European Research Council under the European Union's Horizon 2020 Research and Innovation Program Grant Agreement 677542 (to J.D.). This work contributes to the Organ Protection Research Theme of the Barts Centre for Trauma Sciences, supported by the Barts and The London Charity (Award 753/1722). The Sir Henry Dale Fellowship is jointly funded by the Wellcome Trust and the Royal Society Grant 107613/Z/15/Z. The authors declare no conflicts of interest.	Ammann P, 2003, J AM COLL CARDIOL, V41, P2004, DOI 10.1016/S0735-1097(03)00421-2; Ang SF, 2010, CRIT CARE MED, V38, P619, DOI 10.1097/CCM.0b013e3181c0df00; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bhowmick R, 2013, J IMMUNOL, V191, P5115, DOI 10.4049/jimmunol.1300522; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Bryant P, 2003, J SURG RES, V112, P152, DOI 10.1016/S0022-4804(03)00154-9; Bubb KJ, 2013, HYPERTENSION, V62, P426, DOI 10.1161/HYPERTENSIONAHA.111.00942; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chen JM, 2017, J AM SOC NEPHROL, V28, P94, DOI 10.1681/ASN.2015060670; Chen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100631; Chen M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003718; Chen W, 1999, AM J PHYSIOL-HEART C, V276, pH2094, DOI 10.1152/ajpheart.1999.276.6.H2094; Chiang N, 1998, J PHARMACOL EXP THER, V287, P779; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Clark N, 2007, FASEB J, V21, P3747, DOI 10.1096/fj.06-7460com; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; De Winter BY, 2009, EUR J PHARMACOL, V615, P177, DOI 10.1016/j.ejphar.2009.04.055; Demirbilek S, 2004, ANESTH ANALG, V99, P1501, DOI 10.1213/01.ANE.0000132975.02854.65; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Enyeart JA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1154, DOI 10.1152/ajpendo.00223.2004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandes CJ, 1999, INTENS CARE MED, V25, P1165, DOI 10.1007/s001340051030; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; Fusi C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6736; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gong YZ, 2008, EUR J PHARMACOL, V600, P18, DOI 10.1016/j.ejphar.2008.10.010; Harada N, 2006, THROMB HAEMOSTASIS, V95, P788, DOI 10.1160/TH05-09-0636; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Helyes Z, 2007, AM J PHYSIOL-LUNG C, V292, pL1173, DOI 10.1152/ajplung.00406.2006; HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kaplan BB, 2004, ANN NY ACAD SCI, V1018, P244, DOI 10.1196/annals.1296.029; Kark T, 2008, MOL PHARMACOL, V73, P1405, DOI 10.1124/mol.107.043323; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Lang HM, 2015, BRIT J PHARMACOL, V172, P5548, DOI 10.1111/bph.12987; LECHLEITNER P, 1992, AM HEART J, V124, P1433, DOI 10.1016/0002-8703(92)90054-Y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; MUERHOFF AS, 1989, J BIOL CHEM, V264, P749; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Munt B, 1998, CRIT CARE MED, V26, P1829, DOI 10.1097/00003246-199811000-00023; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Patel HH, 2003, CIRC RES, V92, P676, DOI 10.1161/01.RES.0000065167.52922.F6; PERRETTI M, 1993, IMMUNOLOGY, V80, P73; Prescott HC, 2018, JAMA-J AM MED ASSOC, V319, P62, DOI 10.1001/jama.2017.17687; Puneet P, 2006, J IMMUNOL, V176, P3813, DOI 10.4049/jimmunol.176.6.3813; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2012, MINERVA ANESTESIOL, V78, P712; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Sand CA, 2015, J HISTOCHEM CYTOCHEM, V63, P449, DOI 10.1369/0022155415581014; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sexton A, 2007, FASEB J, V21, P2695, DOI 10.1096/fj.06-7828com; Shieh DB, 2005, J DENT RES, V84, P468, DOI 10.1177/154405910508400513; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Sun T, 2016, INT J CARDIOL, V220, P226, DOI 10.1016/j.ijcard.2016.06.092; Suto B, 2014, PEPTIDES, V54, P49, DOI 10.1016/j.peptides.2014.01.006; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Wang DH, 2005, ACTA PHARMACOL SIN, V26, P286, DOI 10.1111/j.1745-7254.2005.00057.x; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Wang LH, 2005, CIRCULATION, V112, P3617, DOI 10.1161/CIRCULATIONAHA.105.556274; Wang YP, 2008, AM J PHYSIOL-REG I, V294, pR1517, DOI 10.1152/ajpregu.00005.2008; Wang YP, 2013, CLIN VACCINE IMMUNOL, V20, P1008, DOI 10.1128/CVI.00674-12; Wei ZH, 2009, CIRC J, V73, P1127, DOI 10.1253/circj.CJ-08-0945; Wen HR, 2012, J BIOL CHEM, V287, P13868, DOI 10.1074/jbc.M111.334896; Yang DC, 2010, CELL METAB, V12, P130, DOI 10.1016/j.cmet.2010.05.015; Zaky A, 2014, SHOCK, V41, P12, DOI 10.1097/SHK.0000000000000065	81	11	11	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3816	3831		10.1096/fj.201701303R	http://dx.doi.org/10.1096/fj.201701303R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465314				2022-12-28	WOS:000435104500028
J	Michalski, MN; Seydel, AL; Siismets, EM; Zweifler, LE; Koh, AJ; Sinder, BP; Aguirre, JI; Atabai, K; Roca, H; McCauley, LK				Michalski, Megan N.; Seydel, Anna L.; Siismets, Erica M.; Zweifler, Laura E.; Koh, Amy J.; Sinder, Benjamin P.; Aguirre, J. Ignacio; Atabai, Kamran; Roca, Hernan; McCauley, Laurie K.			Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide	FASEB JOURNAL			English	Article						osteoporosis; osteoclasts; PTH; immune cells	GROWTH-FACTOR 8; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PARATHYROID-HORMONE; RHEUMATOID-ARTHRITIS; APOPTOTIC CELLS; MACROPHAGE EFFEROCYTOSIS; INTESTINAL INFLAMMATION; MINERAL DENSITY; BOWEL-DISEASE; OSTEOPOROSIS	A prolonged increase in proinflammatory cytokines is associated with osteoporotic and autoimmune bone loss and, conversely, anti-inflammatory pathways are associated with protection against bone loss. Milk fat globule-epidermal growth factor (MFG-E)-8 is a glycoprotein that is proresolving, regulates apoptotic cell clearance, and has been linked to autoimmune disease and skeletal homeostasis. The role of MFG-E8 in the young vs. adult skeleton was determined in mice deficient in MFG-E8 (KO). In vivo, trabecular bone was similar in MFG-E8KO and wild-type (WT) mice at 6 and 16 wk, whereas 22 wk adult MFG-E8KO mice displayed significantly reduced trabecular BV/TV. The number of osteoclasts per bone surface was increased in 22-wk MFG-E8 KO vs. WT mice, and recombinant murine MFG-E8 decreased the number and size of osteoclasts in vitro. Adult MFG-E8KO spleen weight:body weight was increased compared with WT, and flow cytometric analysis showed significantly increased myeloid-derived suppressor cells (CD11b(hi)GR-1(+)) and neutrophils (CD11b(hi)Ly6G(+)) in MFG-E8KO bone marrow, suggesting an inflammatory phenotype. PTH-treated MFG-E8KO mice showed a greater anabolic response (+124% BV/TV) than observed in PTH-treated WT mice (+64% BV/TV). These data give insight into the role of MFG-E8 in the adult skeleton and suggest that anabolic PTH may be a valuable therapeutic approach for autoimmune-associated skeletal disease.Michalski, M. N., Seydel, A. L., Siismets, E. M., Zweifler, L. E., Koh, A. J., Sinder, B. P., Aguirre, J. I., Atabai, K., Roca, H., McCauley, L. K. Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide.	[Michalski, Megan N.; Seydel, Anna L.; Siismets, Erica M.; Zweifler, Laura E.; Koh, Amy J.; Sinder, Benjamin P.; Roca, Hernan; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Aguirre, J. Ignacio] Univ Michigan, Sch Dent, Dept Pathol, Ann Arbor, MI 48109 USA; [Atabai, Kamran] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [McCauley, Laurie K.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; University of California System; University of California San Francisco	McCauley, LK (corresponding author), Univ Michigan, Sch Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	mccauley@umich.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes, Digestive, and Kidney Disease [R01DK053904]; NIH National Institute of Dental and Craniofacial Research [F30DE025154]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022327, F30DE025154, T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053904, R01DK110098] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes, Digestive, and Kidney Disease; NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Michelle Lynch for mCT technical support and Chris Strayhorn and Theresa Cody for histology sectioning (all from the University of Michigan). Funding was provided by U.S. National Institutes of Health (NIH) National Institute of Diabetes, Digestive, and Kidney Disease Grant R01DK053904 (to L.K.M.), and NIH National Institute of Dental and Craniofacial Research Grant F30DE025154 (to M.N.M.). The authors declare no conflicts of interest.	Abe T, 2014, J IMMUNOL, V193, P1383, DOI 10.4049/jimmunol.1400970; Albus E, 2016, J BONE MINER RES, V31, P596, DOI 10.1002/jbmr.2721; Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Bashutski JD, 2010, NEW ENGL J MED, V363, P2396, DOI 10.1056/NEJMoa1005361; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111; Cho SW, 2013, J BIOL CHEM, V288, P6814, DOI 10.1074/jbc.M112.393363; Das A, 2016, J IMMUNOL, V196, P5089, DOI 10.4049/jimmunol.1502270; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ebina K, 2014, OSTEOPOROSIS INT, V25, P2755, DOI 10.1007/s00198-014-2819-x; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Garcia-Carrasco M, 2009, ISR MED ASSOC J, V11, P486; Gordan G S, 1985, Clin Geriatr Med, V1, P95; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Gravallese EM, 1998, AM J PATHOL, V152, P943; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hu CY, 2009, LUPUS, V18, P676, DOI 10.1177/0961203309103027; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Kudo M, 2013, P NATL ACAD SCI USA, V110, P660, DOI 10.1073/pnas.1216673110; Kuroshima S, 2014, J PERIODONTOL, V85, P24, DOI 10.1902/jop.2013.130094; Kusunoki R, 2012, DIGESTION, V85, P103, DOI 10.1159/000334679; Matsuda A, 2011, MOL MED, V17, P126, DOI 10.2119/molmed.2010.00135; McCauley LK, 2014, J IMMUNOL, V193, P26, DOI 10.4049/jimmunol.1301945; Michalski MN, 2017, PHARMACOL THERAPEUT, V174, P43, DOI 10.1016/j.pharmthera.2017.02.017; Miksa M, 2009, J IMMUNOL, V183, P5983, DOI 10.4049/jimmunol.0802994; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Novince CM, 2012, J BONE MINER RES, V27, P11, DOI 10.1002/jbmr.508; ODELL WD, 1993, DM-DIS MON, V39, P794; Paganelli M, 2007, INFLAMM BOWEL DIS, V13, P416, DOI 10.1002/ibd.20039; Panopalis Pantelis, 2009, Curr Rheumatol Rep, V11, P177; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Roldan JF, 2006, J RHEUMATOL, V33, P508; Romas E, 2006, RHEUM DIS CLIN N AM, V32, P759, DOI 10.1016/j.rdc.2006.07.004; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; Shirley M, 2017, DRUGS, V77, P1363, DOI 10.1007/s40265-017-0780-7; Sinder BP, 2017, J BONE MINER RES, V32, P2116, DOI 10.1002/jbmr.3196; Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735; Sinningen K, 2015, BONE, V76, P107, DOI 10.1016/j.bone.2015.04.003; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Syed Farhan A, 2010, Curr Osteoporos Rep, V8, P235, DOI 10.1007/s11914-010-0035-y; Uchiyama A, 2014, AM J PATHOL, V184, P1981, DOI 10.1016/j.ajpath.2014.03.017; Yoshihara A, 2004, J CLIN PERIODONTOL, V31, P680, DOI 10.1111/j.1600-051X.2004.00548.x	54	10	11	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3730	3741		10.1096/fj.201701238R	http://dx.doi.org/10.1096/fj.201701238R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475373	Green Submitted, Green Published			2022-12-28	WOS:000435104500021
J	Sambataro, M; Sambado, L; Trevisiol, E; Cacciatore, M; Furlan, A; Stefani, PM; Seganfreddo, E; Durante, E; Conte, S; Della Bella, S; Paccagnella, A; dei Tos, AP				Sambataro, Maria; Sambado, Luisa; Trevisiol, Enrica; Cacciatore, Matilde; Furlan, Anna; Stefani, Piero Maria; Seganfreddo, Elena; Durante, Elisabetta; Conte, Stefania; Della Bella, Silvia; Paccagnella, Agostino; dei Tos, Angelo Paolo			Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesions	FASEB JOURNAL			English	Article						type 2 diabetes; peripheral neurovascular; diabetic foot	NECROSIS-FACTOR-ALPHA; PERIPHERAL NEUROPATHY; FLOW-CYTOMETRY; GLUCOSE-TOLERANCE; T-CELLS; HYPERGLYCEMIA; DISEASE; MICE; INFLAMMATION; MANAGEMENT	Diabetic neuropathy is the most common complication of diabetes and is frequently associated with foot ischemia and infection, but its pathogenesis is controversial. We hypothesized that proinsulin expression in peripheral blood mononuclear cells is a process relevant to this condition and could represent a link among hyperglycemia, nerve susceptibility, and diabetic foot lesions. We assessed proinsulin expression by using flow cytometry in dendritic cells from control participants and patients with type 2 diabetes with or without peripheral neuropathy or accompanied by diabetic foot. Among 32 non-neuropathic and 120 neuropathic patients with type 2 diabetes, we performed leg electromyography and found average sensory sural nerve conduction velocities of 48 +/- 4 and 30 +/- 4 m/s, respectively (P < 0.03). Of those with neuropathy, 42 were without lesions, 39 had foot lesions, and 39 had neuroischemic foot lesions (allux oximetry <30 mmHg). In this well-defined diabetic population, but not in nondiabetic participants, a progressively increasing level of peripheral blood dendritic cell proinsulin expression was detected, which directly correlated with circulating TNF- levels (P < 0.002) and multiple conduction velocities of leg nerves (P < 0.05). These results are consistent with the hypothesis that, in type 2 diabetes, proinsulin-expressing blood cells, possibly via their involvement in innate immunity, may play a role in diabetic peripheral neuropathy and foot lesions.Sambataro, M., Sambado, L., Trevisiol, E., Cacciatore, M., Furlan, A., Stefani, P. M., Seganfreddo, E., Durante, E., Conte, S., Della Bella, S., Paccagnella, A., dei Tos, A. P. Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesions.	[Sambataro, Maria; Sambado, Luisa; Paccagnella, Agostino] Santa Maria di Ca Foncello Hosp, Endocrine Metab & Nutr Dis Unit, Treviso, Italy; [Cacciatore, Matilde; dei Tos, Angelo Paolo] Santa Maria di Ca Foncello Hosp, Dept Pathol, Treviso, Italy; [Furlan, Anna; Stefani, Piero Maria] Santa Maria di Ca Foncello Hosp, Hematol Unit, Treviso, Italy; [Seganfreddo, Elena; Durante, Elisabetta] Santa Maria di Ca Foncello Hosp, Immunohematol & Transfus Med Serv, Treviso, Italy; [Conte, Stefania] Santa Maria di Ca Foncello Hosp, Neurol Unit, Treviso, Italy; [Trevisiol, Enrica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Della Bella, Silvia] Univ Milan, Dept Biomed Technol & Translat Med, Milan, Italy; [Della Bella, Silvia] Humanitas Clin & Res Ctr, Lab Clin & Expt Immunol, Milan, Italy	ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; University of Padua; University of Milan	Sambataro, M (corresponding author), Osped Santa Maria di Ca Foncello, UOC Malattie Endocrine Metab & Nutr Clin, Piazza Osped 1, I-31100 Treviso, Italy.	maria.sambataro@aulss2.veneto.it	Dei Tos, Angelo/AAN-3244-2020; Sambado, Luisa/ABG-8001-2020; Furlan, Anna/AAV-2794-2021; Bella, Silvia Della/AAB-7904-2019; Furlan, Anna/AAV-6184-2021	Dei Tos, Angelo/0000-0002-1228-8940; Della Bella, Silvia/0000-0003-0818-5049; Sambataro, Maria/0000-0002-9259-8366	Italian Leukemia-Lymphoma-Myeloma Organizzazione non Lucrativa di Utilita' Sociale (ONLUS) Association, section of Treviso	Italian Leukemia-Lymphoma-Myeloma Organizzazione non Lucrativa di Utilita' Sociale (ONLUS) Association, section of Treviso	The authors thank Teresa Mariotto Pelos, former head of Associazione Italiana Leucemie-Linfomi e Mieloma (AIL) Treviso section (Santa Maria di Ca' Foncello Hospital, Treviso, Italy), for contributions to the project. This research was supported by the Italian Leukemia-Lymphoma-Myeloma Organizzazione non Lucrativa di Utilita' Sociale (ONLUS) Association, section of Treviso. The authors declare no conflicts of interest.	[Anonymous], 1991, Ophthalmology, V98, P786; Apelqvist J, 2008, DIABETES-METAB RES, V24, pS181, DOI 10.1002/dmrr.848; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Buras ED, 2015, FASEB J, V29, P3537, DOI 10.1096/fj.15-271452; Delisa J. A., 1994, MANUAL NERVE CONDUCT, P110; Della Bella S, 2008, J IMMUNOL METHODS, V339, P153, DOI 10.1016/j.jim.2008.09.009; Dopheide JF, 2012, THROMB HAEMOSTASIS, V108, P1198, DOI 10.1160/TH12-05-0327; DYCK PJ, 1986, ANN NEUROL, V19, P440, DOI 10.1002/ana.410190504; Elia AR, 2008, J LEUKOCYTE BIOL, V84, P1472, DOI 10.1189/jlb.0208082; Erbel C, 2011, EUR J MED RES, V16, P367, DOI 10.1186/2047-783X-16-8-367; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Hamid HS, 2014, ANN CLIN TRANSL NEUR, V1, P799, DOI 10.1002/acn3.119; Katagi M, 2014, FEBS LETT, V588, P1080, DOI 10.1016/j.febslet.2014.02.030; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lee CC, 2015, DIABETES CARE, V38, P793, DOI 10.2337/dc14-2585; Lu H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-80; Melzer S, 2015, CYTOM PART B-CLIN CY, V88, P270, DOI 10.1002/cyto.b.21234; Ogrin R, 2011, INT WOUND J, V8, P437, DOI 10.1111/j.1742-481X.2011.00784.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papanas N, 2011, NAT REV ENDOCRINOL, V7, P682, DOI 10.1038/nrendo.2011.113; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Portou MJ, 2015, VASC PHARMACOL, V71, P31, DOI 10.1016/j.vph.2015.02.007; Rao XQ, 2014, LIFE SCI, V116, P59, DOI 10.1016/j.lfs.2014.09.015; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sambataro M, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/589412; Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987; Santegoets SJAM, 2015, CANCER IMMUNOL IMMUN, V64, P1271, DOI 10.1007/s00262-015-1729-x; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Thrainsdottir S, 2003, DIABETES, V52, P2615, DOI 10.2337/diabetes.52.10.2615; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Urabe H, 2016, AM J PHYSIOL-ENDOC M, V310, pE269, DOI 10.1152/ajpendo.00381.2015; Urabe H, 2015, DIABETOLOGIA, V58, P402, DOI 10.1007/s00125-014-3440-4; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Zhu T, 2015, NEUROSCI LETT, V585, P28, DOI 10.1016/j.neulet.2014.11.020	41	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3742	3751		10.1096/fj.201701279RR	http://dx.doi.org/10.1096/fj.201701279RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29436863				2022-12-28	WOS:000435104500022
J	Huang, ZQ; Liang, N; Damdimopoulos, A; Fan, RR; Treuter, E				Huang, Zhiqiang; Liang, Ning; Damdimopoulos, Anastasius; Fan, Rongrong; Treuter, Eckardt			G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide-induced ATP-binding cassette transporter A1 expression in macrophages	FASEB JOURNAL			English	Article						nuclear receptor corepressor complex; LXR; RAW264; 7; THP1	HISTONE DEACETYLASE 3; NF-KAPPA-B; TRANSCRIPTIONAL REPRESSION; ABCA1; ATHEROSCLEROSIS; ACTIVATION; ABCG1; LXR; BACTERIAL; OBESITY	Macrophages play important roles in linking alterations of cholesterol metabolism and inflammation to the development of atherosclerosis. Previous studies have identified several positive and negative crosstalk mechanisms that connect cholesterol efflux and inflammation at the transcriptional level. Of particular relevance is that the expression of ATP-binding cassette transporter A1 (Abca1), a main regulator of cholesterol efflux, can be induced by oxysterol receptor LXR agonists but also by bacterial endotoxins, such as LPS, that activate TLR4 signaling. However, the extent to which these pathways influence each other has remained incompletely understood. We investigated the possible role of the transcriptional coregulator G protein pathway suppressor 2 (GPS2) in LPS-induced Abca1 expression and cholesterol efflux in mouse and human macrophages. To activate Abca1, GPS2 cooperates with the LPS-inducible NF-B subunit p65, but not with LXRs nor with corepressor complex subunits that otherwise cooperate with GPS2 to repress proinflammatory gene expression. Overall, our work identifies a regulatory chromatin component of crosstalk mechanisms between cholesterol efflux and inflammation that specifically affects ABCA1. Because GPS2 expression is down-regulated in some humans with obese and type 2 diabetes, the macrophage GPS-2/ABC-A1 pathway could be altered and contribute to atherogenesis.Huang, Z., Liang, N., Damdimopoulos, A., Fan, R., Treuter, E. G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide-induced ATP-binding cassette transporter A1 expression in macrophages.	[Huang, Zhiqiang; Liang, Ning; Damdimopoulos, Anastasius; Fan, Rongrong; Treuter, Eckardt] Karolinska Inst, Dept Biosci & Nutr, Ctr Innovat Med CIMED, Huddinge, Sweden	Karolinska Institutet	Fan, RR; Treuter, E (corresponding author), Karolinska Inst, Dept Biosci & Nutr, NEO, S-14183 Huddinge, Sweden.	rongrong.fan@ki.se; eckardt.treuter@ki.se	Fan, Rongrong/N-3446-2017	Fan, Rongrong/0000-0002-5707-1497; Liang, Ning/0000-0002-7848-2893; Treuter, Eckardt/0000-0002-4147-8989; Huang, Zhiqiang/0000-0001-5208-008X	Center for Innovative Medicine (CIMED) at the Karolinska Institutet; Swedish Research Council; Swedish Cancer Society; Swedish Diabetes Foundation; Novo Nordisk Foundation; European Foundation for the Study of Diabetes (EFSD)/Lilly research fellowship; CSC [201206170053]	Center for Innovative Medicine (CIMED) at the Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Diabetes Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes (EFSD)/Lilly research fellowship; CSC	The authors thank all members of the laboratory for scientific discussions and materials. The study was supported by grants from the Center for Innovative Medicine (CIMED) at the Karolinska Institutet, the Swedish Research Council, the Swedish Cancer Society, the Swedish Diabetes Foundation, and the Novo Nordisk Foundation (to E.T.); a European Foundation for the Study of Diabetes (EFSD)/Lilly research fellowship (to R.F.); and CSC doctoral scholarship File 201206170053 (to Z.H.). The authors declare no conflicts of interest.	Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Cederquist CT, 2017, MOL METAB, V6, P125, DOI 10.1016/j.molmet.2016.10.007; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Emmett MJ, 2017, NATURE, V546, P544, DOI 10.1038/nature22819; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; Gerbod-Giannone MC, 2006, P NATL ACAD SCI USA, V103, P3112, DOI 10.1073/pnas.0510345103; Gillespie MA, 2015, EMBO J, V34, P1244, DOI 10.15252/embj.201489819; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kaplan R, 2002, J LIPID RES, V43, P952; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Libby P, 2016, CIRC RES, V118, P531, DOI 10.1161/CIRCRESAHA.116.308334; Mauerer R, 2009, EXP MOL MED, V41, P126, DOI 10.3858/emm.2009.41.2.015; Maurya MR, 2013, J LIPID RES, V54, P2525, DOI 10.1194/jlr.M040212; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Park SH, 2012, ARTERIOSCL THROM VAS, V32, P2869, DOI 10.1161/ATVBAHA.112.254573; Phillips MC, 2018, J LIPID RES, V59, P749, DOI 10.1194/jlr.R082313; Pollack RM, 2016, DIABETES CARE, V39, pS244, DOI 10.2337/dcS15-3015; Pothineni NVK, 2017, EUR HEART J, V38, P3195, DOI 10.1093/eurheartj/ehx362; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Sallam T, 2018, NAT MED, V24, P304, DOI 10.1038/nm.4479; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Thompson PA, 2010, J LIPID RES, V51, P2672, DOI 10.1194/jlr.M007435; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Treuter E, 2017, FEBS LETT, V591, P2959, DOI 10.1002/1873-3468.12850; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Westerterp M, 2018, CIRCULATION, V138, P898, DOI 10.1161/CIRCULATIONAHA.117.032636; Wojcik AJ, 2008, J IMMUNOL, V180, P4273, DOI 10.4049/jimmunol.180.6.4273; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	48	9	9	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1631	1643		10.1096/fj.201801123R	http://dx.doi.org/10.1096/fj.201801123R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30153049	hybrid			2022-12-28	WOS:000457296600011
J	Guo, W; Wu, ZX; Yang, LB; Cai, ZK; Zhao, LF; Zhou, ST				Guo, Wei; Wu, Zhongxia; Yang, Libin; Cai, Zhaokui; Zhao, Lianfeng; Zhou, Shutang			Juvenile hormone-dependent Kazal-type serine protease inhibitor Greglin safeguards insect vitellogenesis and egg production	FASEB JOURNAL			English	Article						insect hormone; vitellogenin; proteolysis; reproduction; gene knockdown	KRUPPEL-HOMOLOG 1; AEDES-AEGYPTI; SIGNALING PATHWAY; MOLECULAR ACTIONS; FAT-BODY; GENES; METAMORPHOSIS; REPRODUCTION; ROLES; TRANSCRIPTION	In addition to preventing insect metamorphosis, juvenile hormone (JH) is known to stimulate aspects of insect reproduction. However, the molecular mechanisms of JH action in insect reproduction remain largely unknown. By reanalyzing the transcriptomic data from adults and other developmental stages of the migratory locust Locusta migratoria, we identified a gene coding for Kazal-type protease inhibitor, previously named Greglin. Greglin is specifically expressed in adult females and most abundant in the fat body and ovaries. Interestingly, Greglin is among the top 3 of highly expressed genes in adult female locusts, after 2 vitellogenin (Vg) genes. Greglin is induced by JH and expressed at remarkably high levels in the vitellogenic stage. Knockdown of Greglin in adult female locusts results in accelerated degradation of serine protease substrate and significantly reduced levels of Greglin protein in hemolymph and ovaries. The consequent phenotypes include blocked oocyte maturation, arrested ovarian growth and shrunken follicular epithelium, as well as declines in egg number and hatchability. The data provide the first evidence, to our knowledge, that JH-dependent Greglin is involved in locust vitellogenesis and oocyte maturation likely by protecting vitellogenesis and other forms of yolk precursors from proteolysis. The result offers new insights into the regulation of JH and function of protease inhibitors in insect vitellogenesis, oocyte maturation and fecundity.Guo, W., Wu, Z., Yang, L., Cai, Z., Zhao, L., Zhou, S. Juvenile hormone-dependent Kazal-type serine protease inhibitor Greglin safeguards insect vitellogenesis and egg production.	[Guo, Wei; Cai, Zhaokui; Zhao, Lianfeng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Wu, Zhongxia; Yang, Libin; Zhou, Shutang] Henan Univ, Sch Life Sci, Key Lab Plant Stress Biol, State Key Lab Cotton Biol, Jinming Rd, Kaifeng 475004, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Henan University	Zhou, ST (corresponding author), Henan Univ, Sch Life Sci, Key Lab Plant Stress Biol, State Key Lab Cotton Biol, Jinming Rd, Kaifeng 475004, Peoples R China.	szhou@henu.edu.cn			National Natural Science Foundation of China [31201748, 31630070]; Youth Innovation Promotion Association, Chinese Academy of Sciences [2016080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association, Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China Grants 31201748 and 31630070. It was also partially supported by the Youth Innovation Promotion Association, Chinese Academy of Sciences (to W.G.) (Grant 2016080). The authors declare no conflicts of interest.	Belles X, 2005, REPRO BIOL, V12, P157; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; Brillard-Bourdet M, 2006, BIOCHEM J, V400, P467, DOI 10.1042/BJ20060437; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; DALE JF, 1986, J INSECT PHYSIOL, V32, P763, DOI 10.1016/0022-1910(86)90079-X; Derache C, 2012, FEBS J, V279, P4466, DOI 10.1111/febs.12033; DHADIALLA TS, 1987, DEV BIOL, V123, P108, DOI 10.1016/0012-1606(87)90432-5; FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216; GLINKA AV, 1995, INSECT BIOCHEM MOLEC, V25, P775, DOI 10.1016/0965-1748(94)00098-3; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; GUJAR H, 2016, SCI REP UK, V6; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kayukawa T, 2017, P NATL ACAD SCI USA, V114, P1057, DOI 10.1073/pnas.1615423114; Kayukawa T, 2016, J BIOL CHEM, V291, P1751, DOI 10.1074/jbc.M115.686121; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kim BY, 2013, TOXICON, V76, P110, DOI 10.1016/j.toxicon.2013.09.017; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Li Y, 2009, MAR BIOTECHNOL, V11, P252, DOI 10.1007/s10126-008-9140-7; Li Y, 2008, MOL REPROD DEV, V75, P1327, DOI 10.1002/mrd.20872; Li YS, 2016, INSECT SCI, V23, P835, DOI 10.1111/1744-7917.12241; Liu X, 2015, J BIOL CHEM, V290, P27370, DOI 10.1074/jbc.M115.687293; LOCKE J, 1987, DNA-J MOLEC CELL BIO, V6, P331, DOI 10.1089/dna.1987.6.331; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Luo MW, 2017, J BIOL CHEM, V292, P8823, DOI 10.1074/jbc.M117.780957; Meekins DA, 2017, SEMIN CELL DEV BIOL, V62, P105, DOI 10.1016/j.semcdb.2016.09.001; Ojani R, 2018, INSECT MOL BIOL, V27, P268, DOI 10.1111/imb.12370; Otlewski J, 1999, ACTA BIOCHIM POL, V46, P531, DOI 10.18388/abp.1999_4128; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Qian C, 2015, TOXINS, V7, P2888, DOI 10.3390/toxins7082888; Raikhel A.S., 2005, P433; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Richard DS, 2001, J INSECT PHYSIOL, V47, P905, DOI 10.1016/S0022-1910(01)00063-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258; Sheng ZT, 2011, J BIOL CHEM, V286, P41924, DOI 10.1074/jbc.M111.269845; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Spit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32460; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Urena E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006020; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; van Hoef V, 2013, PEPTIDES, V41, P59, DOI 10.1016/j.peptides.2012.10.015; Wang ZM, 2017, INSECT BIOCHEM MOLEC, V82, P31, DOI 10.1016/j.ibmb.2017.01.009; Watanabe RMO, 2010, BIOCHIMIE, V92, P933, DOI 10.1016/j.biochi.2010.03.024; Wu ZX, 2016, J BIOL CHEM, V291, P5418, DOI 10.1074/jbc.M115.698936; Wurm Y, 2010, CURR BIOL, V20, pR242, DOI 10.1016/j.cub.2010.01.027; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zhao B, 2016, INSECT BIOCHEM MOLEC, V77, P69, DOI 10.1016/j.ibmb.2016.08.003	58	25	27	2	64	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					917	927		10.1096/fj.201801068R	http://dx.doi.org/10.1096/fj.201801068R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30063437				2022-12-28	WOS:000457401500072
J	Kanetake, T; Sassa, T; Nojiri, K; Sawai, M; Hattori, S; Miyakawa, T; Kitamura, T; Kihara, A				Kanetake, Tsukasa; Sassa, Takayuki; Nojiri, Koki; Sawai, Megumi; Hattori, Satoko; Miyakawa, Tsuyoshi; Kitamura, Takuya; Kihara, Akio			Neural symptoms in a gene knockout mouse model of Sjogren-Larsson syndrome are associated with a decrease in 2-hydroxygalactosylceramide	FASEB JOURNAL			English	Article						aldehyde; ALDH3A2; myelin; sphingolipid; fatty acid 2-hydroxylase	FATTY ALDEHYDE DEHYDROGENASE; SPHINGOSINE 1-PHOSPHATE; ENDOPLASMIC-RETICULUM; PERMEABILITY BARRIER; LOCALIZATION; SPHINGOLIPIDS; MUTATIONS; MICE; METABOLISM; ENCODES	Insulation by myelin lipids is essential to fast action potential conductivity: changes in their quality or amount can cause several neurologic disorders. Sjogren-Larsson syndrome (SLS) is one such disorder, which is caused by mutations in the fatty aldehyde dehydrogenase ALDH3A2. To date, the molecular mechanism underlying SLS pathology has remained unknown. In this study, we found that Aldh3a2 is expressed in oligodendrocytes and neurons in the mouse brain, and neurons of Aldh3a2 knockout (KO) mice exhibited impaired metabolism of the long-chain base, a component of sphingolipids. Aldh3a2 KO mice showed several abnormalities corresponding to SLS symptoms in behavioral tests, including increased paw slips on a balance beam and light-induced anxiety. In their brain tissue, 2-hydroxygalactosylceramide, an important lipid for myelin function and maintenance, was reduced by the inactivation of fatty acid 2-hydroxylase. Our findings provide important new insights into the molecular mechanisms responsible for neural pathogenesis caused by lipid metabolism abnormalities.Kanetake, T., Sassa, T., Nojiri, K., Sawai, M., Hattori, S., Miyakawa, T., Kitamura, T., Kihara, A. Neural symptoms in a gene knockout mouse model of Sjogren-Larsson syndrome are associated with a decrease in 2-hydroxygalactosylceramide.	[Kanetake, Tsukasa; Sassa, Takayuki; Nojiri, Koki; Sawai, Megumi; Kitamura, Takuya; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido, Japan; [Hattori, Satoko; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan	Hokkaido University; Fujita Health University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012; Hattori, Satoko/AAE-6873-2022; SASSA, Takayuki/B-2519-2012	KIHARA, AKIO/0000-0001-5889-0788; Hattori, Satoko/0000-0002-1047-6454; SASSA, Takayuki/0000-0003-3145-9829; Sawai-Ogawa, Megumi/0000-0002-7406-802X	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the "Support Program for Implementation of a New Equipment Sharing System"; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED); Ono Medical Research Foundation; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) [JP18gm0910002]; MEXT; Japan Society for the Promotion of Science [JP18H03976, JP18H04664, JP16K08220]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the "Support Program for Implementation of a New Equipment Sharing System"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ono Medical Research Foundation; Advanced Research and Development Programs for Medical Innovation (AMED-CREST); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Dr. T. Naganuma and S. Takagi (both from Hokkaido University) for breeding the mice, preparing the eye samples, and helpful discussion; Dr. R. A. Zoeller (Boston University School of Medicine, Boston MA, USA) for providing FAA-K1A cells. The authors owe thanks for the use of the mass spectrometer received from Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU), which is funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the "Support Program for Implementation of a New Equipment Sharing System," and from the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT and the Japan Agency for Medical Research and Development (AMED). This work was supported by funding from the Ono Medical Research Foundation, by the Advanced Research and Development Programs for Medical Innovation (AMED-CREST) Grant JP18gm0910002 (AMED), by a Grant-in-Aid for Scientific Research on Innovative Areas "Platform of Advanced Animal Model Support" from MEXT, and by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (JSPS KAKENHI) Grants JP18H03976 and JP18H04664 (to A.K.) and JP16K08220 (to T.S.). Behavioral analyses were performed at the Institute for Comprehensive Medical Science, Fujita Health University (Joint Usage/Research Center for Genes, Brain and Behavior, accredited by MEXT). The authors declare no conflicts of interest.	Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; DeLaurenzi V, 1996, NAT GENET, V12, P52; Dick KJ, 2010, HUM MUTAT, V31, pE1251, DOI 10.1002/humu.21205; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; Edvardson S, 2008, AM J HUM GENET, V83, P643, DOI 10.1016/j.ajhg.2008.10.010; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fuijkschot J, 2012, J INHERIT METAB DIS, V35, P955, DOI 10.1007/s10545-012-9518-6; Ganemo A, 2009, ACTA DERM-VENEREOL, V89, P68, DOI 10.2340/00015555-0561; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Jackson Brian, 2011, Human Genomics, V5, P283; James PF, 1997, J BIOL CHEM, V272, P23532, DOI 10.1074/jbc.272.38.23532; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kitamura T, 2013, BBA-MOL CELL BIOL L, V1831, P1395, DOI 10.1016/j.bbalip.2013.05.007; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Naganuma T, 2016, J BIOL CHEM, V291, P11676, DOI 10.1074/jbc.M116.714030; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Nakao A, 2015, FRONT BEHAV NEUROSCI, V9, P1, DOI 10.3389/fnbeh.2015.00141; Norton WT., 1984, MYELIN, P147, DOI DOI 10.1007/978-1-4757-1830-0_5; Ohkuni A, 2013, BIOCHEM BIOPH RES CO, V442, P195, DOI 10.1016/j.bbrc.2013.11.036; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Potter KA, 2011, GLIA, V59, P1009, DOI 10.1002/glia.21172; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; Rizzo WB, 2007, MOL GENET METAB, V90, P1, DOI 10.1016/j.ymgme.2006.08.006; Rizzo WB, 2014, BBA-MOL CELL BIOL L, V1841, P377, DOI 10.1016/j.bbalip.2013.09.001; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Schumacher F, 2017, J LIPID RES, V58, P1648, DOI 10.1194/jlr.M076562; Shibutani M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091872; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; SJOGREN T, 1957, Acta Psychiatr Neurol Scand Suppl, V113, P1; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Willemsen MAAP, 2004, AM J NEURORADIOL, V25, P649; Willemsen MAAP, 2001, BRAIN, V124, P1426, DOI 10.1093/brain/124.7.1426; Willemsen MAAP, 2000, AM J OPHTHALMOL, V130, P782, DOI 10.1016/S0002-9394(00)00576-6; Zhu GY, 2015, J BIOL CHEM, V290, P29820, DOI 10.1074/jbc.M115.680124; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	46	12	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					928	941		10.1096/fj.201800291R	http://dx.doi.org/10.1096/fj.201800291R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30085884	Bronze			2022-12-28	WOS:000457401500073
J	Schutte-Nutgen, K; Edeling, M; Mendl, G; Krahn, MP; Edemir, B; Weide, T; Kremerskothen, J; Michgehl, U; Pavenstadt, H				Schuette-Nuetgen, Katharina; Edeling, Maria; Mendl, Gudrun; Krahn, Michael P.; Edemir, Bayram; Weide, Thomas; Kremerskothen, Joachim; Michgehl, Ulf; Pavenstaedt, Hermann			Getting a Notch closer to renal dysfunction: activated Notch suppresses expression of the adaptor protein Disabled-2 in tubular epithelial cells	FASEB JOURNAL			English	Article						NICD1; Dab2; endocytosis; kidney function	MESENCHYMAL TRANSITION EMT; FUNCTIONAL-ANALYSIS; SIGNALING PATHWAY; KIDNEY FIBROSIS; GENE; ENDOCYTOSIS; DAB2; ROLES; MICE	Reactivation of Notch signaling in kidneys of animal models and patients with chronic kidney disease (CKD) has been shown to contribute to epithelial injury and fibrosis development. Here, we investigated the mechanisms of Notch-induced injury in renal epithelial cells. We performed genome-wide transcriptome analysis to identify Notch target genes using an in vitro system of cultured tubular epithelial cells expressing the intracellular domain of Notch1. One of the top downregulated genes was Disabled-2 (Dab2). With the use of Drosophila nephrocytes as a model system, we found that Dab (the Drosophila homolog of Dab2) knockdown resulted in a significant filtration defect, indicating that loss of Dab2 plays a functional role in kidney disease development. We showed that Dab2 expression in cultured tubular epithelial cells is involved in endocytic regulation and that it also protects cells from TGF--induced epithelial-to-mesenchymal transition. In vivo correlation studies indicated its additional role in renal ischemia-induced injury. Together, these data suggest that Dab2 plays a versatile role in the kidney and may impact on acute and CKDs.Schutte-Nutgen, K., Edeling, M., Mendl, G., Krahn, M. P., Edemir, B., Weide, T., Kremerskothen, J., Michgehl, U., Pavenstadt, H. Getting a Notch closer to renal dysfunction: activated Notch suppresses expression of the adaptor protein Disabled-2 in tubular epithelial cells.	[Schuette-Nuetgen, Katharina; Edeling, Maria; Mendl, Gudrun; Krahn, Michael P.; Edemir, Bayram; Weide, Thomas; Kremerskothen, Joachim; Michgehl, Ulf; Pavenstaedt, Hermann] Univ Hosp Muenster, Internal Med D, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany; [Edemir, Bayram] Univ Hosp Halle Saale, Internal Med 4, Dept Hematol & Oncol, Halle, Saale, Germany	University of Munster; Martin Luther University Halle Wittenberg	Pavenstadt, H (corresponding author), Univ Hosp Muenster, Internal Med D, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany.	hermann.pavenstaedt@ukmuenster.de	Edemir, Bayram/AAF-6845-2020; Krahn, Michael/AAD-4476-2022	Krahn, Michael/0000-0001-7718-9890	Innovative Medizinische Forschung and Jackstadt Stiftung; German Research Foundation (DFG) [SFB699]	Innovative Medizinische Forschung and Jackstadt Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank Ralf Adams (Max-Planck-Institute Muenster, Germany) for providing the human Dab2 construct. The authors also thank Katalin Susztak (University of Pennsylvania, Philadelphia, PA, USA) for providing the full-length Notch cDNA. The authors are also immensely grateful to Dominik Kentrup and Stefan Reuter for performing the animal studies. The authors thank Rita Schroter for excellent technical support. This work was supported by the Innovative Medizinische Forschung and Jackstadt Stiftung (to M.E. and H.P.), and the German Research Foundation (DFG) SFB699 (University of Regensburg, Regensburg, Germany) (A13; to M.P.K.). Parts of this article have been published in the Ph.D. thesis of M.E. The authors declare no conflicts of interest.	Adamson SE, 2016, J CLIN INVEST, V126, P1311, DOI 10.1172/JCI79590; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bonegio R, 2012, EXP CELL RES, V318, P986, DOI 10.1016/j.yexcr.2012.02.036; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Finkielstein CV, 2016, BIOESSAYS, V38, pS45, DOI 10.1002/bies.201670907; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Gerlach GF, 2013, WIRES DEV BIOL, V2, P559, DOI 10.1002/wdev.92; Hesketh EE, 2014, JOVE-J VIS EXP, DOI 10.3791/51816; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hochapfel F., 2018, J CELL BIOCH; Hochapfel F, 2017, CELL MOL LIFE SCI, V74, P4573, DOI 10.1007/s00018-017-2593-y; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kawasaki F, 2011, P NATL ACAD SCI USA, V108, pE222, DOI 10.1073/pnas.1102231108; Kentrup D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026419; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Koral K, 2014, AM J PHYSIOL-RENAL, V307, pF1380, DOI 10.1152/ajprenal.00454.2014; Koral K, 2012, AM J PHYSIOL-RENAL, V302, pF1013, DOI 10.1152/ajprenal.00289.2011; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kur E, 2011, DEV DYNAM, V240, P1567, DOI 10.1002/dvdy.22624; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin JC, 2010, BRIT J CANCER, V103, P1716, DOI 10.1038/sj.bjc.6605975; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mok SC, 1998, ONCOGENE, V16, P2381, DOI 10.1038/sj.onc.1201769; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Schnaper HW, 2003, FRONT BIOSCI-LANDMRK, V8, pE68, DOI 10.2741/925; Schnockel U, 2008, EUR J NUCL MED MOL I, V35, P2267, DOI 10.1007/s00259-008-0878-y; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Schwahn DJ, 1998, ONCOGENE, V17, P1173, DOI 10.1038/sj.onc.1202038; Sharma S, 2011, CURR OPIN NEPHROL HY, V20, P56, DOI 10.1097/MNH.0b013e3283414c88; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Sorensen-Zender I, 2014, AM J PHYSIOL-RENAL, V306, pF907, DOI 10.1152/ajprenal.00030.2014; Song JK, 2010, DEVELOPMENT, V137, P3719, DOI 10.1242/dev.050948; Sweetwyne MT, 2014, KIDNEY INT SUPPL, V4, P91, DOI 10.1038/kisup.2014.17; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Weide T, 2017, J AM SOC NEPHROL, V28, P2093, DOI 10.1681/ASN.2016040474; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Xiao ZC, 2014, INT J BIOCHEM CELL B, V55, P65, DOI 10.1016/j.biocel.2014.08.009; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P209, DOI 10.1681/ASN.2012080795; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P191, DOI 10.1681/ASN.2012080769; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	56	6	6	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					821	832		10.1096/fj.201800392RR	http://dx.doi.org/10.1096/fj.201800392RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052485				2022-12-28	WOS:000457401500064
J	Tripathi, JK; Sharma, A; Sukumaran, P; Sun, YY; Mishra, BB; Singh, BB; Sharma, J				Tripathi, Jitendra Kumar; Sharma, Atul; Sukumaran, Pramod; Sun, Yuyang; Mishra, Bibhuti Bhusan; Singh, Brij Bhan; Sharma, Jyotika			Oxidant sensor cation channel TRPM2 regulates neutrophil extracellular trap formation and protects against pneumoseptic bacterial infection	FASEB JOURNAL			English	Article						reactive oxygen species; cell signaling; pneumonic sepsis	OXIDATIVE STRESS; DOPAMINERGIC-NEURONS; HYDROGEN-PEROXIDE; INFLAMMATION; INHIBITION; AUTOPHAGY; IMMUNITY; DISEASES; RELEASE; LUNG	Neutrophil extracellular trap (NET) formation constitutes an important extracellular antimicrobial function of neutrophils that plays a protective role in bacterial pneumonia. Formation of reactive oxygen species (ROS) such as highly diffusible hydrogen peroxide (H2O2) is a hallmark of oxidative stress during inflammatory lung conditions including pneumonia. However, the impact of exogenous ROS on NET formation and the signaling pathway involved in the process is not completely understood. Here we demonstrate that the ROS-sensing, nonselective, calcium-permeable channel transient receptor potential melastatin 2 (TRPM2) is required for NET formation in response to exogenous H2O2. This TRPM2-dependent H2O2-mediated NET formation involved components of autophagy and activation of AMPK and p38 MAPK, but not PI3K and AKT. Primary neutrophils from Trpm2(-/-) mice fail to activate this pathway with a block in NET release and a concomitant decrease in their antimicrobial capacity. Consequently, Trpm2(-/-) mice were highly susceptible to pneumonic infection with Klebsiella pneumoniae owing to an impaired NET formation and high bacterial burden despite increased neutrophil infiltration in their lungs. These results identify a key role of TRPM2 in regulating NET formation by exogenous ROS via AMPK/p38 activation and autophagy machinery, as well as a protective antimicrobial role of TRPM2 in pneumonic bacterial infection.Tripathi, J. K., Sharma, A., Sukumaran, P., Sun, Y., Mishra, B. B., Singh, B. B., Sharma, J. Oxidant sensor cation channel TRPM2 regulates neutrophil extracellular trap formation and protects against pneumoseptic bacterial infection.	[Tripathi, Jitendra Kumar; Sharma, Atul; Sukumaran, Pramod; Sun, Yuyang; Mishra, Bibhuti Bhusan; Singh, Brij Bhan; Sharma, Jyotika] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, 1301 N Columbia Rd, Grand Forks, ND 58202 USA; [Sukumaran, Pramod; Sun, Yuyang; Singh, Brij Bhan] Univ Texas San Antonio, Hlth Sci Ctr, San Antonio, TX USA	University of North Dakota Grand Forks; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio	Sharma, J (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, 1301 N Columbia Rd, Grand Forks, ND 58202 USA.	jyotika.sharma@med.und.edu	Tripathi, Jitendra Kumar/N-2631-2013	Tripathi, Jitendra Kumar/0000-0001-9246-8388; Singh, Brij/0000-0003-0535-5997	IDeA Networks of Biomedical Research Excellence [P20GM103442]; Centers of Biomedical Research Excellence (COBRE) [P20GM113123]; U.S. National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) [P20GM113123]; NIH/National Institute of Allergy and Infectious Diseases [R21AI107457, R01AI121804]; NIH National Institute of Dental and Craniofacial Research Grant [R21DE024300, R01DE017102]; NIH/NIGMS [P20GM113123]; Office of the Vice President of Research, University of North Dakota; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121804, R21AI136472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022765, R21DE024300, R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123, P20GM103442] Funding Source: NIH RePORTER	IDeA Networks of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Institute of Dental and Craniofacial Research Grant; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of the Vice President of Research, University of North Dakota; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Sarah Abrahamson (Research Specialist, Imaging Core Facility, Biomedical Sciences) for the technical support for the microscopy. The Flow Cytometry Core Facility at the University of North Dakota is supported by grants from IDeA Networks of Biomedical Research Excellence (P20GM103442) and the Centers of Biomedical Research Excellence (COBRE; P20GM113123). The Imaging Core Facility is supported by COBRE Grant P20GM113123 from the U.S. National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS). This work was supported by NIH/National Institute of Allergy and Infectious Diseases Grants R21AI107457 and R01AI121804 (to J.S.), NIH National Institute of Dental and Craniofacial Research Grant R21DE024300 (to B.B.S. and B.B.M.) and R01DE017102 (to B.B.S), and NIH/NIGMS Grant P20GM113123 (to J.S. and B.B.M.). A.S. is partially supported by a postdoctoral award from the Office of the Vice President of Research, University of North Dakota. The authors declare no conflicts of interest.	Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Bonaventura A, 2018, THROMB HAEMOSTASIS, V118, P6, DOI 10.1160/TH17-09-0630; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Di A, 2017, J CELL SCI, V130, P735, DOI 10.1242/jcs.196014; Eddens T, 2012, CURR OPIN IMMUNOL, V24, P424, DOI 10.1016/j.coi.2012.07.005; Forman HJ, 2016, ARCH BIOCHEM BIOPHYS, V603, P48, DOI 10.1016/j.abb.2016.05.005; Gonzalez-Gonzalez FJ, 2017, TRANSL RES, V190, P61, DOI 10.1016/j.trsl.2017.09.005; Grayson PC, 2016, J LEUKOCYTE BIOL, V99, P253, DOI 10.1189/jlb.5BT0615-247R; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Hecquet CM, 2009, THROMB HAEMOSTASIS, V101, P619, DOI 10.1160/TH08-10-0641; Hong CW, 2010, J IMMUNOL, V184, P4401, DOI 10.4049/jimmunol.0902814; Jin LL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006637; Jondle CN, 2016, J IMMUNOL, V196, P3088, DOI 10.4049/jimmunol.1501790; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Juneau RA, 2015, J INFECT DIS, V212, P316, DOI 10.1093/infdis/jiv031; Kenno S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00879; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kovach MA, 2012, CURR OPIN INFECT DIS, V25, P321, DOI 10.1097/QCO.0b013e3283528c9b; Lightfoot YL, 2017, CURR OPIN RHEUMATOL, V29, P65, DOI 10.1097/BOR.0000000000000357; Liu XB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2526; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; Metan G, 2016, CURR OPIN INFECT DIS, V29, P555, DOI 10.1097/QCO.0000000000000313; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Miyake T, 2014, BIOCHEM BIOPH RES CO, V444, P212, DOI 10.1016/j.bbrc.2014.01.022; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Mortadza SAS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00407; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nguyen GT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00373; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Ogawa N, 2016, CELL CALCIUM, V60, P115, DOI 10.1016/j.ceca.2016.02.009; Ohbuchi Ayako, 2017, Biochem Biophys Rep, V11, P147, DOI 10.1016/j.bbrep.2017.07.009; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Roy J, 2017, FASEB J, V31, P3729, DOI 10.1096/fj.201700170R; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Shakerley NL, 2016, J BIOL CHEM, V291, P3871, DOI 10.1074/jbc.M115.706879; Sharma A, 2017, J INFECT DIS, V215, P1040, DOI 10.1093/infdis/jix072; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035; Sollberger G, 2018, DEV CELL, V44, P542, DOI 10.1016/j.devcel.2018.01.019; Steichen AL, 2013, J LEUKOCYTE BIOL, V94, P393, DOI 10.1189/jlb.1212622; Sukumaran P, 2018, FASEB J, V32, P1640, DOI 10.1096/fj.201700662RR; Sun YY, 2018, MOL NEUROBIOL, V55, P409, DOI 10.1007/s12035-016-0338-9; Sun YY, 2017, J NEUROSCI, V37, P3364, DOI 10.1523/JNEUROSCI.3010-16.2017; Sun YY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0210-7; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Wang G, 2016, DEV CELL, V38, P453, DOI 10.1016/j.devcel.2016.07.014; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yonezawa R, 2016, FREE RADICAL BIO MED, V90, P101, DOI 10.1016/j.freeradbiomed.2015.11.021	56	23	23	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6848	6859		10.1096/fj.201800605	http://dx.doi.org/10.1096/fj.201800605			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906250	Green Published			2022-12-28	WOS:000449359700038
J	Li, H; Ye, FF; Ren, JY; Wang, PY; Du, LL; Liu, JL				Li, Hui; Ye, Fangfu; Ren, Jing-Yi; Wang, Peng-Ye; Du, Li-Lin; Liu, Ji-Long			Active transport of cytoophidia in Schizosaccharomyces pombe	FASEB JOURNAL			English	Article						cytoophidium; actin filaments; motor proteins; microtubules	FISSION YEAST; SACCHAROMYCES-CEREVISIAE; CTP SYNTHASE; METABOLIC ENZYMES; DROSOPHILA-MELANOGASTER; V MYOSINS; BODIES; CELL; MECHANISM; PROTEINS	The metabolic enzyme cytidine triphosphate synthase has recently been found to form micrometer-sized filamentous structures termed cytoophidia, which are evolutionarily conserved across prokaryotes and eukaryotes. The cytoophidium represents a novel type of membraneless organelle and behaves dynamically inside the cell. The question of how cytoophidia transport is mediated, however, remains unanswered. For the first time, we detected in this study the active transport of cytoophidia, taking advantage of the fission yeast Schizosaccharomyces pombe as an excellent model for studying membraneless organelles. We demonstrated that actin filaments, not microtubules, are responsible for this transport. Furthermore, we determined that Myo52, a type of myosin V, is required for the active transport of cytoophidia. These results reveal the major players critical to the dynamics of cytoophidia and extend our understanding of intracellular transport of membraneless organelles.Li, H., Ye, F., Ren, J.-Y., Wang, P.-Y., Du, L.-L., Liu, J.-L. Active transport of cytoophidia in Schizosaccharomyces pombe.	[Li, Hui; Liu, Ji-Long] Univ Oxford, Dept Physiol Anat & Genet, Med Res Council Funct Genom Unit, Oxford, England; [Li, Hui; Ye, Fangfu; Wang, Peng-Ye] Chinese Acad Sci, Key Lab Soft Matter Phys, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing, Peoples R China; [Ye, Fangfu] Univ Chinese Acad Sci, Sch Phys Sci, Beijing, Peoples R China; [Ren, Jing-Yi; Du, Li-Lin] Natl Inst Biol Sci, Beijing, Peoples R China; [Liu, Ji-Long] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	University of Oxford; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Institute of Biological Sciences, Beijing; ShanghaiTech University	Liu, JL (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, South Parks Rd, Oxford OX1 3PT, England.	liujl3@shanghaitech.edu.cn	Li, Hui/C-7251-2019; Li, Hui/L-2704-2019	Li, Hui/0000-0003-0551-9912; Du, Li-Lin/0000-0002-1028-7397; Wang, Peng-Ye/0000-0002-9765-0610	UK Medical Research Council; National Natural Science Foundation of China [11674383]; MRC [MC_UU_12021/3, MC_U137788471] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank members of the J.-L.L. group, especially S. Ghosh, for discussion and comments. The authors are grateful to M. Balasubramanian (University of Warwick, Coventry, United Kingdom), T. Burke (University of Chicago, Chicago, IL, USA), T. Pollard (Yale University, New Haven, CT, USA), and the fission yeast community for reagents and discussions. This work was supported by the UK Medical Research Council and a grant from the National Natural Science Foundation of China (11674383). The authors declare no conflicts of interest.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Aughey GN, 2014, BIOL OPEN, V3, P1045, DOI 10.1242/bio.201410165; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Bond LM, 2013, FUTURE MED CHEM, V5, P41, DOI 10.4155/fmc.12.185; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; Chang CC, 2015, J CELL SCI, V128, P3550, DOI 10.1242/jcs.175265; Chen KN, 2011, J GENET GENOMICS, V38, P391, DOI 10.1016/j.jgg.2011.08.004; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; East DA, 2011, J CELL SCI, V124, P1383, DOI 10.1242/jcs.078527; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fedorov R, 2009, NAT STRUCT MOL BIOL, V16, P80, DOI 10.1038/nsmb.1542; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; HAIMO LT, 1994, BIOESSAYS, V16, P727, DOI 10.1002/bies.950161007; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Keppeke GD, 2015, J GENET GENOMICS, V42, P287, DOI 10.1016/j.jgg.2015.04.002; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Li H, 2016, DATA BRIEF, V8, P40, DOI 10.1016/j.dib.2016.05.015; Li H, 2015, J AM CHEM SOC, V137, P436, DOI 10.1021/ja511273c; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045465; Liu JL, 2007, P NATL ACAD SCI USA, V104, P11655, DOI 10.1073/pnas.0704977104; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Lo Presti L, 2012, MOL BIOL CELL, V23, P4579, DOI 10.1091/mbc.E12-07-0499; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Nover L., 1980, CELL COMPARTMENTATIO; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Strochlic TI, 2014, EMBO REP, V15, P1184, DOI 10.15252/embr.201438688; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; van Bergeijk P, 2016, TRENDS CELL BIOL, V26, P121, DOI 10.1016/j.tcb.2015.10.001; Wang B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.208102; Win TZ, 2001, J CELL SCI, V114, P69; Zhang J, 2014, BIOL OPEN, V3, P1092, DOI 10.1242/bio.20149613	52	16	17	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5891	5898		10.1096/fj.201800045RR	http://dx.doi.org/10.1096/fj.201800045RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29782206	Green Published, hybrid			2022-12-28	WOS:000447172000011
J	Nho, B; Lee, J; Lee, J; Ko, KR; Lee, SJ; Kim, S				Nho, Boram; Lee, Junghun; Lee, Junsub; Ko, Kyeong Ryang; Lee, Sung Joong; Kim, Sunyoung			Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model	FASEB JOURNAL			English	Article						VM202; plasmid DNA; gene therapy; DRG; microglia	CRITICAL LIMB ISCHEMIA; FACTOR SCATTER FACTOR; DIABETIC PERIPHERAL NEUROPATHY; SCIATIC-NERVE INJURY; FACTOR GENE-THERAPY; 2 ISOFORMS; NAKED DNA; INTRAMYOCARDIAL TRANSFER; PLASMID DNA; PHASE-I	Hepatocyte growth factor (HGF) is a multifunctional protein that contains angiogenic and neurotrophic properties. In the current study, we investigated the analgesic effects of HGF by using a plasmid DNA that was designed to express 2 isoforms of human HGFpCK-HGF-X7 (or VM202)in a chronic constriction injury (CCI) -induced mouse neuropathic pain model. Intramuscular injection of pCK-HGF-X7 into proximal thigh muscle induced the expression of HGF in the muscle, sciatic nerve, and dorsal root ganglia (DRG). This gene transfer procedure significantly attenuated mechanical allodynia and thermal hyperalgesia after CCI. Injury-induced expression of activating transcription factor 3, calcium channel subunit 21, and CSF1 in the ipsilateral DRG neurons was markedly down-regulated in the pCK-HGF-X7-treated group, which suggested that HGF might exert its analgesic effects by inhibiting pain-mediating genes in the sensory neurons. In addition, suppressed CSF1 expression in DRG neurons by pCK-HGF-X7 treatment was accompanied by a noticeable suppression of the nerve injury-induced glial cell activation in the spinal cord dorsal horn. Taken together, our data show that pCK-HGF-X7 attenuates nerve injury-induced neuropathic pain by inhibiting pain-related factors in DRG neurons and subsequent spinal cord glial activation, which suggests its therapeutic efficacy in the treatment of neuropathic pain.Nho, B., Lee, J., Lee, J., Ko, K. R., Lee, S. J., Kim, S. Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model.	[Nho, Boram; Lee, Junghun; Lee, Junsub; Ko, Kyeong Ryang; Kim, Sunyoung] Seoul Natl Univ, Sch Biol Sci, Bldg 504,1 Gwanak Ro,Gwanak Gu 151-742, Seoul 08826, South Korea; [Lee, Sung Joong] Seoul Natl Univ, Dept Neurosci & Physiol, Seoul, South Korea; [Lee, Junghun; Ko, Kyeong Ryang; Kim, Sunyoung] ViroMed, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504,1 Gwanak Ro,Gwanak Gu 151-742, Seoul 08826, South Korea.	sunyoung@snu.ac.kr		Lee, Junghun/0000-0003-4524-0625	ViroMed	ViroMed	The authors thank Subin Kim (ViroMed) for providing the pCK-HGF-X7 plasmid and Hyoungsub Lim (School of Dentistry, Seoul National University) for technical support. This work was supported by grants from ViroMed. B.N. and S.J.L. declare no conflicts of interest.	Ajroud-Driss S, 2013, MOL THER, V21, P1279, DOI 10.1038/mt.2013.69; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bell A, 1999, ONCOGENE, V18, P887, DOI 10.1038/sj.onc.1202379; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boroujerdi A, 2011, PAIN, V152, P649, DOI 10.1016/j.pain.2010.12.014; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Carlsson M, 2008, AM J PHYSIOL-HEART C, V295, pH522, DOI 10.1152/ajpheart.00280.2008; Cho KR, 2008, EUR J CARDIO-THORAC, V34, P857, DOI 10.1016/j.ejcts.2008.05.045; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Gascon E, 2010, J NEUROSCI, V30, P12414, DOI 10.1523/JNEUROSCI.3135-10.2010; Gille J, 1998, J INVEST DERMATOL, V111, P1160, DOI 10.1046/j.1523-1747.1998.00418.x; Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009; Gu YQ, 2011, J GENE MED, V13, P602, DOI 10.1002/jgm.1614; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Hahn W, 2011, J GENE MED, V13, P549, DOI 10.1002/jgm.1603; Hashimoto N, 2001, NEUROREPORT, V12, P1403, DOI 10.1097/00001756-200105250-00022; Henry TD, 2011, GENE THER, V18, P788, DOI 10.1038/gt.2011.21; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Kagawa T, 2006, NEPHRON PHYSIOL, V102, P92, DOI 10.1159/000090071; Kessler JA, 2015, ANN CLIN TRANSL NEUR, V2, P465, DOI 10.1002/acn3.186; Kibbe MR, 2016, GENE THER, V23, P306, DOI 10.1038/gt.2015.110; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kim JS, 2013, GENE THER, V20, P717, DOI 10.1038/gt.2012.87; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lee Y, 2000, BIOCHEM BIOPH RES CO, V272, P230, DOI 10.1006/bbrc.2000.2758; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Lutz BM, 2014, ANESTHESIOLOGY, V121, P409, DOI 10.1097/ALN.0000000000000265; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; Morishita R, 2002, ENDOCR J, V49, P273, DOI 10.1507/endocrj.49.273; Nakagami H, 2005, EXPERT REV CARDIOVAS, V3, P513, DOI 10.1586/14779072.3.3.513; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Okubo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153375; Old EA, 2015, HANDB EXP PHARMACOL, V227, P145, DOI 10.1007/978-3-662-46450-2_8; Pyun WB, 2010, GENE THER, V17, P1442, DOI 10.1038/gt.2010.101; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Saeed M, 2008, RADIOLOGY, V249, P107, DOI 10.1148/radiol.2483071579; Saeed M, 2011, CARDIOVASC REVASCULA, V12, P111, DOI 10.1016/j.carrev.2010.05.003; SEKI T, 1991, GENE, V102, P213; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Sufit RL, 2017, AMYOTROPH LAT SCL FR, V18, P269, DOI 10.1080/21678421.2016.1259334; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Tsuchihara T, 2009, MOL THER, V17, P42, DOI 10.1038/mt.2008.214; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Yang XM, 1998, J NEUROSCI, V18, P8369; Zhou HJ, 1998, STRUCTURE, V6, P109, DOI 10.1016/S0969-2126(98)00012-4	61	19	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5119	5131		10.1096/fj.201800476R	http://dx.doi.org/10.1096/fj.201800476R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913557	Green Published, hybrid			2022-12-28	WOS:000443817700040
J	Lu, YN; Rafiq, A; Zhang, ZG; Aslani, F; Fijak, M; Lei, T; Wang, M; Kumar, S; Klug, J; Bergmann, M; Chakraborty, T; Meinhardt, A; Bhushan, S				Lu, Yongning; Rafiq, Amir; Zhang, Zhengguo; Aslani, Ferial; Fijak, Monika; Lei, Tao; Wang, Ming; Kumar, Sanjeev; Klug, Joerg; Bergmann, Martin; Chakraborty, Trinad; Meinhardt, Andreas; Bhushan, Sudhanshu			Uropathogenic Escherichia coli virulence factor hemolysin A causes programmed cell necrosis by altering mitochondrial dynamics	FASEB JOURNAL			English	Article						apoptosis; caspase; HMGB1; histone 3; ATP	HOST-PATHOGEN INTERACTIONS; TOXIN ALPHA-HEMOLYSIN; DEATH; INFECTION; TESTIS; CONVERGENCE; APOPTOSIS; PATHWAYS; TARGET; MEN	Uropathogenic Escherichia coli (UPEC) is the most common cause of urinary tract infections. In this study, UPEC strains harboring hemolysin A (HlyA) did not induce programmed cell death pathways by the activation of caspases. Instead, the UPEC pore-forming toxin HlyA triggered an increase in mitochondrial Ca2+ levels and manipulated mitochondrial dynamics by causing fragmentation of the mitochondrial network. Alterations in mitochondrial dynamics resulted in severe impairment of mitochondrial functions by loss of membrane potential, increase in reactive oxygen species production, and ATP depletion. Moreover, HlyA caused disruption of plasma membrane integrity that was accompanied by extracellular release of the danger-associated molecules high-mobility group box 1 (HMGB1) and histone 3 (H3). Our results indicate that UPEC induced programmed cell necrosis by irreversibly impairing mitochondrial function. This finding suggests a strategy devised by UPEC at the onset of infection to escape early innate immune response and silently propagate inside host cells.Lu, Y., Rafiq, A., Zhang, Z., Aslani, F., Fijak, M., Lei, T., Wang, M., Kumar, S., Klug, J., Bergmann, M., Chakraborty, T., Meinhardt, A., Bhushan, S. Uropathogenic Escherichia coli virulence factor hemolysin A causes programmed cell necrosis by altering mitochondrial dynamics.	[Lu, Yongning; Rafiq, Amir; Zhang, Zhengguo; Aslani, Ferial; Fijak, Monika; Lei, Tao; Wang, Ming; Klug, Joerg; Meinhardt, Andreas; Bhushan, Sudhanshu] Justus Liebig Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Giessen, Germany; [Kumar, Sanjeev; Chakraborty, Trinad] Justus Liebig Univ Giessen, Dept Med Microbiol, Giessen, Germany; [Bergmann, Martin] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Bhushan, S (corresponding author), Justus Liebig Univ Giessen, Dept Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany.	sudhanshu.bhushan@anatomie.med.uni-giessen.de	; kumar, Sanjeev/P-8547-2014	Fijak, Monika/0000-0002-7384-3872; kumar, Sanjeev/0000-0003-0562-2645	Deutsche Forschungsgemeinschaft (DFG) [BH 93/1-1]; China Scholarship Council; Justus-Liebig-University of Giessen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Justus-Liebig-University of Giessen	The authors thank Vanesa Herlaxi (National University of La Plata, Buenos Aires, Argentina) for generously providing the purified hemolysin A, Suada Frohlich (Justus-Liebig-University Giessen), for technical assistance with Western blot analysis, and Matthew Jones (a native English speaker; University of Giessen) for proofreading the manuscript for grammatical and typographical errors. This study was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, BH 93/1-1). The fellowship support of the China Scholarship Council (to L.Y., Z.Z., T.L., and M.W.) and Justus-Liebig-University of Giessen (to Z.Z.) are gratefully acknowledged. The authors declare no conflicts of interest.	Arck P, 2014, MOL CELL ENDOCRINOL, V382, P509, DOI 10.1016/j.mce.2013.09.022; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Bhushan S, 2016, JOVE-J VIS EXP, DOI 10.3791/53389; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Bhushan S, 2009, J REPROD IMMUNOL, V83, P164, DOI 10.1016/j.jri.2009.07.007; Bohme L, 2009, MICROBES INFECT, V11, P1063, DOI 10.1016/j.micinf.2009.08.014; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Dhakal BK, 2012, CELL HOST MICROBE, V11, P58, DOI 10.1016/j.chom.2011.12.003; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Eguchi Y, 1997, CANCER RES, V57, P1835; El Kebir D, 2006, CELL SIGNAL, V18, P2302, DOI 10.1016/j.cellsig.2006.05.013; Emody L, 2003, INT J ANTIMICROB AG, V22, pS29, DOI 10.1016/S0924-8579(03)00236-X; Escoll P, 2016, NAT REV MICROBIOL, V14, P5, DOI 10.1038/nrmicro.2015.1; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Gonzalez-Juarbe N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005337; Green D.R., 2015, COLD SPRING HARB PER, V7; Jiang JH, 2012, IUBMB LIFE, V64, P397, DOI 10.1002/iub.1021; Johnson JR, 2005, CLIN INFECT DIS, V40, P813, DOI 10.1086/428048; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Karch J, 2015, CIRC RES, V116, P1800, DOI 10.1161/CIRCRESAHA.116.305421; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; LEE SJ, 2015, CELL DEATH DIS, V6; Lipsky BA, 1999, AM J MED, V106, P327, DOI 10.1016/S0002-9343(99)00017-0; Lobet E, 2015, BIOCHEM PHARMACOL, V94, P173, DOI 10.1016/j.bcp.2015.02.007; Lu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052919; MERINO G, 1995, ARCH ANDROLOGY, V35, P43, DOI 10.3109/01485019508987852; Michel V, 2015, ASIAN J ANDROL, V17, P756, DOI 10.4103/1008-682X.155770; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Parham NJ, 2005, J CLIN MICROBIOL, V43, P4076, DOI 10.1128/JCM.43.8.4076-4082.2005; Rudel T, 2010, NAT REV MICROBIOL, V8, P693, DOI 10.1038/nrmicro2421; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Wang M, 2017, J IMMUNOL, V198, P4327, DOI 10.4049/jimmunol.1700162; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wiles TJ, 2013, FUTURE MICROBIOL, V8, P73, DOI [10.2217/fmb.12.131, 10.2217/FMB.12.131]; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343; Zhang ZG, 2016, J INFECT DIS, V213, P1198, DOI 10.1093/infdis/jiv569	42	14	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4107	4120		10.1096/fj.201700768R	http://dx.doi.org/10.1096/fj.201700768R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29490169				2022-12-28	WOS:000439325400005
J	Mata-Balaguer, T; Cuchillo-Ibanez, I; Calero, M; Ferrer, I; Saez-Valero, J				Mata-Balaguer, Trinidad; Cuchillo-Ibanez, Inmaculada; Calero, Miguel; Ferrer, Isidro; Saez-Valero, Javier			Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease	FASEB JOURNAL			English	Article						brain; ApoE; DNMT1; methylation	MESSENGER-RNA EXPRESSION; APOLIPOPROTEIN-E; DNA METHYLATION; SYNAPTIC PLASTICITY; RECEPTOR; BRAIN; PROMOTER; LIGAND; BINDING; PROTEIN	Increasing evidence indicates that altered reelin signaling could contribute to synaptic dysfunction in Alzheimer's disease (AD). We found that reelin protein and mRNA levels were increased in the AD brain (particularly at advanced Braak stages in apolipoprotein E4 noncarriers), compared with that of control subjects. The beta-amyloid (A) protein impairs reelin activity and increases reelin expression through a mechanism that is not yet understood. To explore that mechanism, we examined the effect of A beta aa 1-42 (A beta(42)) on DNA methylation of the RELN promoter and the processing of reelin receptor apolipoprotein E receptor 2 (ApoER2) in differentiated SH-SY5Y cells because ApoER2 C-terminal fragments (CTFs), generated after reelin binding, regulate reelin expression. We found that A beta(42) decreased nuclear levels of DNA-methyltransferase 1. However, RELN promoter methylation did not change in A beta(42)-treated cells or in AD brain extracts. Instead, the levels of ApoER2-CTF appeared significantly lower in A beta(42)-treated cells and in AD extracts from advanced Braak stages of apolipoprotein E4 noncarriers. Our data show that ApoER2-CTF levels are decreased, whereas reelin expression is increased in AD brain at advanced Braak stages and after A treatment, supporting the view that ApoER2-CTF exerts a modulatory role on reelin expression. -Mata-Balaguer, T., Cuchillo-Ibanez, I., Calero, M., Ferrer, I., Saez-Valero, J. Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.	[Mata-Balaguer, Trinidad; Cuchillo-Ibanez, Inmaculada; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Crta Alicante Valencia Km 87, Alicante 03550, Spain; [Mata-Balaguer, Trinidad; Cuchillo-Ibanez, Inmaculada; Calero, Miguel; Ferrer, Isidro; Saez-Valero, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Calero, Miguel] Queen Sofia Fdn, Alzheimer Ctr, Ctr Nacl Invest Enfermedades Neurol CIEN Fdn, Alzheimer Dis Res Unit, Madrid, Spain; [Calero, Miguel] Carlos III Inst Hlth, Chron Dis Programme, Madrid, Spain; [Ferrer, Isidro] Univ Barcelona, Inst Neuropatol, Hosp Univ Bellvitge, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); CIBERNED; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Cuchillo-Ibanez, I; Saez-Valero, J (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Crta Alicante Valencia Km 87, Alicante 03550, Spain.	icuchillo@umh.es; j.saez@umh.es	Calero, Miguel/H-5691-2015; cuchillo, inmaculada/P-2975-2019	Calero, Miguel/0000-0001-5366-3324; /0000-0002-3689-5518	Fundacion Ramon Areces, Fondo de Investigaciones Sanitarias [PI15/00665]; Fondo Europeo de Desarrollo Regional (FEDER) "Investing in your future"; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in RD [SEV- 2013-0317]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (Instituto de Salud Carlos III, Madrid, Spain)	Fundacion Ramon Areces, Fondo de Investigaciones Sanitarias; Fondo Europeo de Desarrollo Regional (FEDER) "Investing in your future"; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in RD; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (Instituto de Salud Carlos III, Madrid, Spain)	The authors thank Prof. T. Curran (Eppley Institute, University of Nebraska Medical Center, Omaha, NE, USA), J. Nimpf (Max F. Perutz Laboratories, Department of Medical Biochemistry, Medical University of Vienna, Vienna, Austria), and W. Rebeck (Georgetown University Medical Center, Washington, D.C., USA) for generously providing cDNAs and antibodies. The authors also thank E. Llorens (Universidad Miguel Hernandez-CSIC, Sant Joan d'Alacant, Spain) for technical assistance. This work was supported by grants from the Fundacion Ramon Areces, Fondo de Investigaciones Sanitarias [PI15/00665, cofunded by the Fondo Europeo de Desarrollo Regional (FEDER) "Investing in your future"], and through Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED; Instituto de Salud Carlos III, Madrid, Spain). The authors also acknowledge financial support from the Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in R&D (SEV- 2013-0317). The authors declare no conflicts of interest.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Abraham H, 2003, HIPPOCAMPUS, V13, P715, DOI 10.1002/hipo.10125; Alcantara S, 1998, J NEUROSCI, V18, P7779; Bachmeier C, 2014, NEUROMOL MED, V16, P686, DOI 10.1007/s12017-014-8318-6; Balmaceda V, 2014, FASEB J, V28, P1543, DOI 10.1096/fj.13-239350; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Botella-Lopez A, 2010, NEUROBIOL DIS, V37, P682, DOI 10.1016/j.nbd.2009.12.006; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Calero O, 2009, J NEUROSCI METH, V183, P238, DOI 10.1016/j.jneumeth.2009.06.033; Carvajal AE, 2017, BBA-MOL BASIS DIS, V1863, P462, DOI 10.1016/j.bbadis.2016.11.028; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Cuchillo-Ibanez I, 2016, SCI REP-UK, V6, DOI 10.1038/srep31646; Cuchillo-Ibanez I, 2016, J ALZHEIMERS DIS, V52, P403, DOI 10.3233/JAD-151193; Cuchillo-Ibanez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072297; D'Aiuto L, 2011, DIFFERENTIATION, V82, P9, DOI 10.1016/j.diff.2011.03.003; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Day JJ, 2015, ANNU REV PHARMACOL, V55, P591, DOI 10.1146/annurev-pharmtox-010814-124527; Divekar SD, 2014, J BIOL CHEM, V289, P15894, DOI 10.1074/jbc.M113.537548; Dong E, 2015, SCHIZOPHR RES, V167, P35, DOI 10.1016/j.schres.2014.10.030; Eid Aseel, 2016, Alzheimers Dement (Amst), V2, P123, DOI 10.1016/j.dadm.2016.02.002; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Guidotti A, 2007, NEUROREPORT, V18, P57, DOI 10.1097/WNR.0b013e32800fefd7; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hinrich AJ, 2016, EMBO MOL MED, V8, P328, DOI 10.15252/emmm.201505846; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, BRAIN RES, V1112, P70, DOI 10.1016/j.brainres.2006.07.035; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hussain A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-49; Klein HU, 2016, ACTA NEUROPATHOL, V132, P503, DOI 10.1007/s00401-016-1612-7; Kobow K, 2009, J NEUROPATH EXP NEUR, V68, P356, DOI 10.1097/NEN.0b013e31819ba737; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kundakovic M, 2009, MOL PHARMACOL, V75, P342, DOI 10.1124/mol.108.051763; Lane-Donovan C, 2017, TRENDS ENDOCRIN MET, V28, P273, DOI 10.1016/j.tem.2016.12.001; Lane-Donovan C, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6674; Lee GH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00122; Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271; Lin L, 2017, HEMATOL ONCOL, V35, P685, DOI 10.1002/hon.2311; Lintas C, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9151-z; Liu DS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0002-2; Lu HY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00085; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martinez-Cerdeno V, 2002, CEREB CORTEX, V12, P1298, DOI 10.1093/cercor/12.12.1298; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Noh JS, 2005, P NATL ACAD SCI USA, V102, P1749, DOI 10.1073/pnas.0409648102; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pujadas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4443; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Saiz-Sanchez D, 2016, EXP NEUROL, V276, P13, DOI 10.1016/j.expneurol.2015.11.009; Sanchez-Mut JV, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.214; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Silveyra M. X., 2012, NEUROBIOL AGING, V33; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Sui L, 2010, STEROIDS, V75, P988, DOI 10.1016/j.steroids.2010.06.005; Tochigi M, 2008, BIOL PSYCHIAT, V63, P530, DOI 10.1016/j.biopsych.2007.07.003; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Yu JT, 2012, MOL NEUROBIOL, V45, P314, DOI 10.1007/s12035-012-8237-1	68	18	19	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3536	3546		10.1096/fj.201700736RR	http://dx.doi.org/10.1096/fj.201700736RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29442527				2022-12-28	WOS:000435104500005
J	Baker, JR; Vuppusetty, C; Colley, T; Hassibi, S; Fenwick, PS; Donnelly, LE; Ito, K; Barnes, PJ				Baker, Jonathan R.; Vuppusetty, Chaitanya; Colley, Thomas; Hassibi, Shyreen; Fenwick, Peter S.; Donnelly, Louise E.; Ito, Kazuhiro; Barnes, Peter J.			MicroRNA-570 is a novel regulator of cellular senescence and inflammaging	FASEB JOURNAL			English	Article						COPD; miRNA; cell cycle; epithelial cells; inflammation	OXIDATIVE STRESS; MOLECULAR-MECHANISMS; PREMATURE SENESCENCE; DNA-DAMAGE; P38 MAPK; DISEASE; SIRT1; INHIBITOR; PROTEIN; COPD	Diseases of accelerated aging often occur together (multimorbidity), and their prevalence is increasing, with high societal and health care costs. Chronic obstructive pulmonary disease (COPD) is one such condition, in which one half of patients exhibit 4 age-related diseases. Diseases of accelerated aging share common molecular pathways, which lead to the detrimental accumulation of senescent cells. These senescent cells no longer divide but release multiple inflammatory proteins, known as the senescence-associated secretory phenotype, which may perpetuate and speed disease. Here, we show that inhibiting miR-570-3p, which is increased in COPD cells, reverses cellular senescence by restoring the antiaging molecule sirtuin-1. MiR-570-3p is induced by oxidative stress in airway epithelial cells through p38 MAP kinase-c-Jun signaling and drives senescence by inhibiting sirtuin-1. Inhibition of elevated miR-570-3p in COPD small airway epithelial cells, using an antagomir, restores sirtuin-1 and suppresses markers of cellular senescence (p16(INK4a), p21(Waf1), and p27(Kip1)), thereby restoring cellular growth by allowing progression through the cell cycle. MiR-570-3p inhibition also suppresses the senescence-associated secretory phenotype (matrix metalloproteinases-2/9, C-X-C motif chemokine ligand 8, IL-1, and IL-6). Collectively, these data suggest that inhibiting miR-570-3p rejuvenates cells via restoration of sirtuin-1, reducing many of the abnormalities associated with cellular senescence.Baker, J. R., Vuppusetty, C., Colley, T., Hassibi, S., Fenwick, P. S., Donnelly, L. E., Ito, K., Barnes, P. J. MicroRNA-570 is a novel regulator of cellular senescence and inflammaging.	[Baker, Jonathan R.; Vuppusetty, Chaitanya; Colley, Thomas; Hassibi, Shyreen; Fenwick, Peter S.; Donnelly, Louise E.; Ito, Kazuhiro; Barnes, Peter J.] Imperial Coll London, Airway Dis Sect, Natl Heart & Lung Inst, London, England	Imperial College London	Barnes, PJ (corresponding author), Imperial Coll London, NHLI, Dovehouse St, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk	Ito, Kazuhiro/AAF-5994-2019	Barnes, Peter/0000-0002-5122-4018	British Lung Foundation [JFRG17-7]; Wellcome Trust Programme Grant [093080/Z/10/Z]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London	British Lung Foundation; Wellcome Trust Programme Grant(Wellcome Trust); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London	The authors thank Prof. Jim Hogg (University of British Columbia, Vancouver, BC, Canada) for kindly providing peripheral lung tissue samples and Dr. Andriana I. Papaioannou (Sismanogleio Hospital, Athens, Greece) for providing the sputum samples. This work was funded by the British Lung Foundation Grant (JFRG17-7), Wellcome Trust Programme Grant (093080/Z/10/Z), and supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The authors declare no conflicts of interest.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aoshiba K, 2012, EUR RESPIR J, V39, P1368, DOI 10.1183/09031936.00050211; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Baker JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep35871; Baraldo S, 2007, CHEST, V132, P1733, DOI 10.1378/chest.06-2819; Barnes PJ, 2017, ANNU REV PHYSIOL, V79, P517, DOI 10.1146/annurev-physiol-022516-034314; Barnes PJ, 2015, EUR RESPIR J, V45, P790, DOI 10.1183/09031936.00229714; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Barnes PJ, 2011, AM J RESP CRIT CARE, V184, P866, DOI 10.1164/rccm.201108-1436ED; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Booton R, 2014, CHEST, V146, P193, DOI 10.1378/chest.13-2736; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao L, 2013, BRAZ J MED BIOL RES, V46, P659, DOI 10.1590/1414-431X20132903; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Choi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115787; Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Ding Lily, 2004, COPD, V1, P191, DOI 10.1081/COPD-120039810; Donohue JF, 2006, THORAX, V61, P461, DOI 10.1136/thx.2005.053058; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Guo W, 2015, TUMOR BIOL, V36, P9049, DOI 10.1007/s13277-015-3644-3; Hayakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116480; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hesselbach K, 2017, EPIGENETICS-US, V12, P779, DOI 10.1080/15592294.2017.1356555; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jenkins NC, 2011, ONCOGENE, V30, P265, DOI 10.1038/onc.2010.419; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Renda T, 2008, EUR RESPIR J, V31, P62, DOI 10.1183/09031936.00036707; Roff AN, 2014, AM J CLIN EXP IMMUNO, V3, P68; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090022; Siganaki M, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-46; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Thorley Andrew J, 2007, Int J Chron Obstruct Pulmon Dis, V2, P409; To M, 2011, CHEST, V140, P76, DOI 10.1378/chest.10-1608; Tong XD, 2015, INT J CLIN EXP PATHO, V8, P2829; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zhang R, 2014, J NEUROL SCI, V338, P57, DOI 10.1016/j.jns.2013.12.017; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	58	42	44	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1605	1616		10.1096/fj.201800965R	http://dx.doi.org/10.1096/fj.201800965R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30156909	Green Published, hybrid			2022-12-28	WOS:000457296600009
J	Shi, CH; Ulke-Lemee, A; Deng, JT; Batulan, Z; O'Brien, ER				Shi, Chunhua; Ulke-Lemee, Annegret; Deng, Jingti; Batulan, Zarah; O'Brien, Edward R.			Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-inflammatory therapy	FASEB JOURNAL			English	Article						exosomes; HSP27; inflammation; mass spectrometry; TEM	CELL-DERIVED EXOSOMES; PROTEOMIC APPROACH; HEAT-SHOCK-PROTEIN-27; EXPRESSION; BIOMARKER; PLAQUES; ATHEROSCLEROSIS	Previously, we reported that elevated serum levels of heat shock protein 27 (HSP27) are predictive of a lower risk of having a heart attack, stroke, or death from cardiovascular disease. Moreover, augmenting HSP27 (or the murine ortholog, HSP25) attenuated experimental atherogenesis, reduced inflammation, and lowered cholesterol levels. Recently, we noted that HSP27 activates NF-B via TLR-4, resulting in attenuation of plaque inflammation; however, the precise anti-atherosclerosis mechanisms mediated by extracellular HSP27 are incompletely understood. Our purpose in this study was to investigate the existence of HSP27 in extracellular vesicles (EVs) and whether HSP27 elicited atheroprotective effects on target cells. Here, we provide evidence that HSP27 localizes to EVs derived from THP-1 cells using transmission electron microscopy (TEM) and immunogold labeling, Western blotting, ELISA, and fluorescence-activated cell sorting. TEM imaging indicated that HSP27 is found at the exosomal membrane. Multiple reactor monitor-mass spectrometric analysis of large vesicles, which included microparticles and exosomes, isolated from human plasma, also led to detection of HSP27 using the unique signature peptide, R.LFDQAFGLPR.L. Studies using THP-1 and human embryonic kidney cells show that HSP27-laden exosomes significantly stimulated NF-B activation (P < 0.001) and release of IL-10 (P < 0.0001), suggesting that HSP27 may be important exosomal cargo with beneficial anti-inflammatory effects.Shi, C., Ulke-Lemee, A., Deng, J., Batulan, Z., O'Brien, E. R. Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-inflammatory therapy.	[Shi, Chunhua; Ulke-Lemee, Annegret; Deng, Jingti; Batulan, Zarah; O'Brien, Edward R.] Univ Calgary, Dept Cardiac Sci, Libin Cardiovasc Inst Alberta, Cumming Sch Med, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	O'Brien, ER (corresponding author), Univ Calgary, Dept Cardiac Sci, Libin Cardiovasc Inst Alberta, Hlth Res & Innovat Ctr,Cumming Sch Med, Room GAA16,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	ermobrie@ucalgary.ca			Canadian Vascular Network; Canadian Institutes of Health Research Project [PJT-149015]; Heart and Stroke Foundation of Canada [G-13-0001599]	Canadian Vascular Network; Canadian Institutes of Health Research Project(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors gratefully acknowledge the contributions of Dr. Wei-Xiang Dong (Microscopy and Imaging Facility, University of Calgary, Calgary, AB, Canada) for his technical expertise and assistance involving transmission electron microscopy, Dr. Adijiang Ayinuer (currently at University of Alberta, Edmonton, AB, Canada) for her technical expertise in generating the HSP27 knockdown THP-1 cell line, Dr. Justin McDonald (Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada) for his support and advice related to the MRM-MS method, and Dr. Yong Xiang Chen (Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada) for helpful discussions. This manuscript was supported by research grants to E.R.O. from the Canadian Vascular Network, a Canadian Institutes of Health Research Project grant (PJT-149015) and a Heart and Stroke Foundation of Canada grant (G-13-0001599). The authors declare no conflicts of interest.	Arrigo AP, 2017, CELL STRESS CHAPERON, V22, P517, DOI 10.1007/s12192-017-0765-1; Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Bavisotto CC, 2017, EXPERT REV MOL DIAGN, V17, P815, DOI 10.1080/14737159.2017.1356230; Boulanger CM, 2017, NAT REV CARDIOL, V14, P259, DOI 10.1038/nrcardio.2017.7; Braga-Lagache S, 2016, MOL CELL PROTEOMICS, V15, P3640, DOI 10.1074/mcp.M116.060491; Charmpilas N, 2017, CELL STRESS CHAPERON, V22, P481, DOI 10.1007/s12192-016-0761-x; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Cruz L, 2018, STEM CELL REV REP, V14, P262, DOI 10.1007/s12015-017-9776-7; Cuerrier CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055867; DENG JT, 1988, CLIN CHIM ACTA, V176, P291; Deng JT, 1996, HEPATOLOGY, V23, P445; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Lepedda AJ, 2009, ATHEROSCLEROSIS, V203, P112, DOI 10.1016/j.atherosclerosis.2008.07.001; Liang WZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26231; Lou NJ, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/3918681; Ma XL, 2014, FASEB J, V28, P594, DOI 10.1096/fj.13-230417; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Merchant ML, 2017, NAT REV NEPHROL, V13, P731, DOI 10.1038/nrneph.2017.148; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Nguyen MA, 2018, ARTERIOSCL THROM VAS, V38, P49, DOI 10.1161/ATVBAHA.117.309795; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Phuyal S, 2014, FEBS J, V281, P2214, DOI 10.1111/febs.12775; Raizman JE, 2013, BBA-MOL CELL BIOL L, V1831, P1721, DOI 10.1016/j.bbalip.2013.07.015; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sun AL, 2012, DIABETES VASC DIS RE, V9, P301, DOI 10.1177/1479164111434318; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Venu VKP, 2017, FASEB J, V31, P2364, DOI 10.1096/fj.201601188R; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Waldenstrom A, 2014, CIRC RES, V114, P315, DOI 10.1161/CIRCRESAHA.114.300584; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	36	30	30	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1617	1630		10.1096/fj.201800987R	http://dx.doi.org/10.1096/fj.201800987R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30188755				2022-12-28	WOS:000457296600010
J	Agrawal, M; Yeo, CR; Shabbir, A; Chhay, V; Silver, DL; Magkos, F; Vidal-Puig, A; Toh, SA				Agrawal, Madhur; Yeo, Chia Rou; Shabbir, Asim; Chhay, Vanna; Silver, David L.; Magkos, Faidon; Vidal-Puig, Antonio; Toh, Sue-Anne			Fat storage-inducing transmembrane protein 2 (FIT2) is less abundant in type 2 diabetes, and regulates triglyceride accumulation and insulin sensitivity in adipocytes	FASEB JOURNAL			English	Article						adipose function; lipid droplets; glucose uptake; ER stress	ENDOPLASMIC-RETICULUM STRESS; ADIPOSE-TISSUE EXPANDABILITY; PPAR-GAMMA; BETA-CELLS; TNF-ALPHA; PALMITATE; RESISTANCE; APOPTOSIS; OBESITY; PHOSPHORYLATION	Fat storage-inducing transmembrane protein 2 (FIT2) aids in partitioning of cellular triacylglycerol into lipid droplets. A genome-wide association study reported FITM2-R3H domain containing like-HNF4A locus to be associated with type 2 diabetes (T2DM) in East Asian populations. Mice with adipose tissue (AT)-specific FIT2 knockout exhibited lipodystrophic features, with reduced AT mass, insulin resistance, and greater inflammation in AT when fed a high-fat diet. The role of FIT2 in regulating human adipocyte function is not known. Here, we found FIT2 protein abundance is lower in subcutaneous and omental AT obtained from patients with T2DM compared with nondiabetic control subjects. Partial loss of FIT2 protein in primary human adipocytes attenuated their lipid storage capacity and induced insulin resistance. After palmitate treatment, triacylglycerol accumulation, insulin-induced Akt (Ser-473) phosphorylation, and insulin-stimulated glucose uptake were significantly reduced in FIT2 knockdown adipocytes compared with control cells. Gene expression of proinflammatory cytokines IL-18 and IL-6 and phosphorylation of the endoplasmic reticulum stress marker inositol-requiring enzyme 1 were greater in FIT2 knockdown adipocytes than in control cells. Our results show for the first time that FIT2 is associated with T2DM in humans and plays an integral role in maintaining metabolically healthy AT function.Agrawal, M., Yeo, C. R., Shabbir, A., Chhay, V., Silver, D. L., Magkos, F., Vidal-Puig, A., Toh, S.-A. Fat storage-inducing transmembrane protein 2 (FIT2) is less abundant in type 2 diabetes, and regulates triglyceride accumulation and insulin sensitivity in adipocytes.	[Agrawal, Madhur] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Yeo, Chia Rou; Chhay, Vanna; Toh, Sue-Anne] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, 14 Med Dr, S-117599 Singapore, Singapore; [Magkos, Faidon] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Shabbir, Asim] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore; [Silver, David L.] Duke Natl Univ Singapore, Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore, Singapore; [Magkos, Faidon] ASTAR, SICS, Singapore, Singapore; [Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Toh, Sue-Anne] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	University of Kentucky; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; National University of Singapore	Toh, SA (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, 14 Med Dr, S-117599 Singapore, Singapore.	mdcsates@nus.edu.sg	Shabbir, Asim/W-3259-2017; Magkos, Faidon/B-4384-2010; Magkos, Faidon/CAA-9939-2022	Magkos, Faidon/0000-0002-1312-7364; Magkos, Faidon/0000-0002-1312-7364; Chhay, Vanna/0000-0003-1352-8384; Agrawal, Madhur/0000-0002-0966-8571; Vidal-Puig, Antonio/0000-0003-4220-9577	Singapore Ministry of Health's National Medical Research Council [NMRC/CSA/034/2012, NMRC/CIRG/1377/2013]; MRC [G0400192, MC_UU_12012/2, G0802051, MC_UU_00014/2, G0600717] Funding Source: UKRI	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.L.S. is thankfully acknowledged for providing the FIT2 antibody. Part of this work has been presented at the American Diabetes Association's 74th Scientific Sessions in 2014 as a guided audio poster (2014-A-4177-Diabetes). S.-A.T. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. This research is funded by the Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award Grant (NMRC/CSA/034/2012) and Individual Research Grant (NMRC/CIRG/1377/2013). The authors declare no conflicts of interest.	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Barneda D, 2017, CURR OPIN CELL BIOL, V47, P9, DOI 10.1016/j.ceb.2017.02.002; Boden G, 2014, DIABETES, V63, P912, DOI 10.2337/db13-0906; Boden G, 2011, METHOD ENZYMOL, V489, P67, DOI 10.1016/B978-0-12-385116-1.00004-2; Capel F, 2016, BBA-MOL CELL BIOL L, V1861, P2000, DOI 10.1016/j.bbalip.2016.10.002; Carobbio S, 2011, CURR OPIN CLIN NUTR, V14, P520, DOI 10.1097/MCO.0b013e32834ad966; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Gil-Campos M, 2004, INT J OBESITY, V28, pS75, DOI 10.1038/sj.ijo.0802806; Goh VJ, 2015, J BIOL CHEM, V290, P25686, DOI 10.1074/jbc.M115.676700; Gray SL, 2007, NUTR REV, V65, pS7, DOI [10.1111/j.1753-4887.2007.tb00331.x, 10.1301/nr.2007.jun.S7-S12]; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; Gu XM, 2010, LIFE SCI, V87, P724, DOI 10.1016/j.lfs.2010.10.012; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Jung S, 2015, J CRANIO MAXILL SURG, V43, P2144, DOI 10.1016/j.jcms.2015.10.002; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kien CL, 2005, AM J CLIN NUTR, V82, P320, DOI 10.1093/ajcn/82.2.320; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170728; McCall KD, 2010, J ENDOCRINOL, V207, P343, DOI 10.1677/JOE-09-0370; Miranda DA, 2014, J BIOL CHEM, V289, P9560, DOI 10.1074/jbc.M114.547687; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Russo V, 2014, STEM CELL TRANSL MED, V3, P206, DOI 10.5966/sctm.2013-0125; Sabin MA, 2007, J CELL PHYSIOL, V211, P244, DOI 10.1002/jcp.20922; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Sovik O, 1996, ACTA PAEDIATR, V85, P29, DOI 10.1111/j.1651-2227.1996.tb14263.x; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Talbot NA, 2014, MOL CELL ENDOCRINOL, V393, P129, DOI 10.1016/j.mce.2014.06.010; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wood IS, 2005, BIOCHEM BIOPH RES CO, V337, P422, DOI 10.1016/j.bbrc.2005.09.068; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010	49	5	5	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					430	440		10.1096/fj.201701321RR	http://dx.doi.org/10.1096/fj.201701321RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020828				2022-12-28	WOS:000457401500034
J	Ashton, NN; Stewart, RJ				Ashton, Nicholas N.; Stewart, Russell J.			Aquatic caddisworm silk is solidified by environmental metal ions during the natural fiber-spinning process	FASEB JOURNAL			English	Article						bioadhesive; metallofibers; caddisfly; Trichoptera; Ca2+-phosphoserine complexes	AMINO-ACID-COMPOSITION; BOMBYX-MORI FIBROIN; SPIDER SILK; C-13 NMR; PH; PROTEIN; STATE; TRICHOPTERA; MECHANISM; CONSERVATION	Aquatic caddisfly larvae (caddisworms) wet-spin fibers to construct composite cases of silk and stone. The silk emerges from labial ducts as a nanofibrous fluid gel, flowing over the stone substrate and making intimate interfacial adhesive contacts before being drawn into tough fibers that rapidly solidify underwater to span gaps in the construction. Divalent metal ions are responsible for the unique mechanical properties of naturally spun silk fibers; however, when and where divalent metal ions are incorporated into the metallofibers and other aspects of the fiber solidification mechanism are poorly understood. To investigate, the elemental composition and secondary structure of silk precursors stored in the silk gland lumen were compared with naturally spun fibers by inductively coupled plasma optical emission spectroscopy and attenuated total reflection Fourier transform infrared spectroscopy. Naturally spun fibers contained near equimolar ratios of Ca2+ to P. In contrast, silk precursors stored in the silk gland lumen contained only traces of Ca2+ and other multivalent metal ions. Ca2+ was also undetectable in anterior lumenal silk using the histochemical Ca2+ indicator, alizarin S red. Addition of Ca2+ to isolated lumenal silk resulted in Ca2+ complexation by H-fibroin phosphoserines (pSs) and a shift in secondary structure from random coils to -structures, creating infrared spectra in the phosphate and amide I regions nearly equivalent to those found in naturally spun Ca2+-containing silk fibers. Light and electron microscopy within distinct regions of the silk gland suggested that posterior gland silk colloidal complexes transition into a nanofibrous morphology as they pass into the chitin-lined anterior lumen. Altogether, the results suggest that environmental Ca2+ absorbed from natural water triggers silk fiber solidification postdraw by complexing H-fibroin pSs, creating Ca2+-stabilized crystalline -nanodomains that cross-link and toughen the freshly drawn silk fibers.Ashton, N. N., Stewart, R. J. Aquatic caddisworm silk is solidified by environmental metal ions during the natural fiber-spinning process.	[Ashton, Nicholas N.; Stewart, Russell J.] Univ Utah, Dept Bioengn, 20 S 2030 East,Room 506C, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Stewart, RJ (corresponding author), Univ Utah, Dept Bioengn, 20 S 2030 East,Room 506C, Salt Lake City, UT 84112 USA.	russell.stewart@utah.edu			U.S. Army Research Office, Life Sciences Division [W911NF1310319]	U.S. Army Research Office, Life Sciences Division	The authors thank Daniel Taggert (University of Utah) for confocal images of the caddisworm silk glands. This work was funded by the U.S. Army Research Office, Life Sciences Division (W911NF1310319). The authors declare no conflicts of interest.	Addison JB, 2014, BIOMACROMOLECULES, V15, P1269, DOI 10.1021/bm401822p; Addison JB, 2013, BIOMACROMOLECULES, V14, P1140, DOI 10.1021/bm400019d; AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158; Andersson M, 2017, NAT CHEM BIOL, V13, P262, DOI [10.1038/NCHEMBIO.2269, 10.1038/nchembio.2269]; Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921; Asakura T, 2001, BIOPOLYMERS, V58, P521, DOI 10.1002/1097-0282(20010415)58:5&lt;521::AID-BIP1027&gt;3.0.CO;2-T; Ashton NN, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160067; Ashton NN, 2015, SOFT MATTER, V11, P1667, DOI 10.1039/c4sm02435d; Ashton NN, 2013, BIOMACROMOLECULES, V14, P3668, DOI 10.1021/bm401036z; Ashton NN, 2012, BIOPOLYMERS, V97, P432, DOI 10.1002/bip.21720; Chawla K, 1998, FIBROUS MAT; Collin MA, 2018, INT J BIOL MACROMOL, V113, P829, DOI 10.1016/j.ijbiomac.2018.02.032; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Deng H, 1998, J PHYS CHEM B, V102, P3617, DOI 10.1021/jp973314q; Domigan LJ, 2015, INSECT BIOCHEM MOLEC, V65, P100, DOI 10.1016/j.ibmb.2015.09.001; Eisoldt L, 2012, BIOPOLYMERS, V97, P355, DOI 10.1002/bip.22006; ENGSTER MS, 1976, CELL TISSUE RES, V169, P77; Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7; He YX, 2012, J MOL BIOL, V418, P197, DOI 10.1016/j.jmb.2012.02.040; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109; Jenkins JE, 2010, BIOMACROMOLECULES, V11, P192, DOI 10.1021/bm9010672; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; LAROCHE G, 1991, BIOCHEMISTRY-US, V30, P3105, DOI 10.1021/bi00226a018; LUCAS F, 1960, J MOL BIOL, V2, P339, DOI 10.1016/S0022-2836(60)80045-9; Naskar D, 2014, WOODH PUBL SER BIOM, V74, P3, DOI 10.1533/9780857097064.1.3; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; Ochi A, 2002, BIOMACROMOLECULES, V3, P1187, DOI 10.1021/bm020056g; Ohkawa K, 2012, J FIBER BIOENG INF, V5, P125; Ohkawa K, 2013, BIOFOULING, V29, P357, DOI 10.1080/08927014.2013.774376; PARKER CR, 1985, CAN J ZOOL, V63, P2443, DOI 10.1139/z85-361; RUDALL KM, 1971, ANNU REV ENTOMOL, V16, P73, DOI 10.1146/annurev.en.16.010171.000445; SAITO H, 1984, MACROMOLECULES, V17, P1405, DOI 10.1021/ma00137a018; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P3338, DOI 10.1021/bi00409a033; Sandrin V, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-104; Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256; Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d; Strickland M, 2018, HEREDITY, V120, P574, DOI 10.1038/s41437-018-0050-9; Strzelecki JW, 2011, CENT EUR J PHYS, V9, P482, DOI 10.2478/s11534-010-0105-x; Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147; VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wallace JA, 2012, J PHYS CHEM LETT, V3, P658, DOI 10.1021/jz2016846; Wang CS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0710; Wang CS, 2014, INSECT BIOCHEM MOLEC, V54, P69, DOI 10.1016/j.ibmb.2014.08.009; WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0; Wiggens G. B., 2004, CADDISFLIES UNDERWAT; Wilding M. A., 1995, CHEM TEXTILES IND, P1; Woodings C., 2001, REGENERATED CELLULOS, V18; Yonemura N, 2009, J MOL EVOL, V68, P641, DOI 10.1007/s00239-009-9234-5; Yonemura N, 2006, BIOMACROMOLECULES, V7, P3370, DOI 10.1021/bm060663u; Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078; Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i	56	10	10	2	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					572	583		10.1096/fj.201801029R	http://dx.doi.org/10.1096/fj.201801029R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29985645				2022-12-28	WOS:000457401500045
J	Brew, K				Brew, Keith			Reflections on the evolution of the vertebrate tissue inhibitors of metalloproteinases	FASEB JOURNAL			English	Review						angiogenesis; cell growth; matrix structure; enzyme inhibition; zymogen activation	DEPTH PROTEOMIC ANALYSIS; GROWTH-PROMOTING ACTIVITY; BREAST EPITHELIAL-CELLS; TIMP-FREE MMP-9; GENOME DUPLICATION; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; X-CHROMOSOME; MATRIX; GENE	Jawed vertebrates (Gnathostomes) have 4 tissue inhibitors of metalloproteinases (TIMPs), multifunctional proteins that all inhibit members of the large matrix metalloproteinase (MMP) family but differ in their other roles, including the regulation of pro-MMP activation, cell growth, apoptosis and angiogenesis, and the structure of extracellular matrices (ECMs). Molecular phylogeny analyses indicate that vertebrate TIMP genes arose from an invertebrate ancestor through 3 successive duplications, possibly including 2 whole genome duplications, during early vertebrate phylogeny. TIMPs from invertebrates also inhibit metalloproteinases, bind to pro-MMPs, and contribute to ECM structures but are not orthologs of any particular vertebrate TIMP. The most ancient vertebrate superclass, the Agnatha (jawless fish), seems to provide a snapshot of a stage in TIMP evolution preceding the third gene duplication. This review examines the structures of TIMPs from different vertebrate orders using information relating to the structural basis of their various functions. Provisional conclusions are that during their evolutionary divergence, various TIMPs lost inhibitory activity toward some metalloproteinases, specialized in effects on different pro-MMPs, and developed new interactions with discrete targets (including integrins and receptors), while recapitulating a role in ECM structure. The analysis is limited by the sparse information available regarding the functional properties of nonmammalian TIMPs.Brew, K. Reflections on the evolution of the vertebrate tissue inhibitors of metalloproteinases.	[Brew, Keith] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Brew, K (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd, Boca Raton, FL 33431 USA.	kbrew@health.fau.edu	Brew, Keith/W-1643-2019		U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR40994]	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The author thanks the collaborators and colleagues for their helpful comments on this review. The author's research was previously funded by Grant AR40994 from the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases. The author declares no conflict of interest.	Aguilera F, 2017, MOL BIOL EVOL, V34, P779, DOI 10.1093/molbev/msw294; Akahane T, 2004, BIOCHEM BIOPH RES CO, V324, P440, DOI 10.1016/j.bbrc.2004.09.063; ANDERSSON L, 1992, J CHROMATOGR, V604, P13, DOI 10.1016/0021-9673(92)85523-V; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BERTAUX B, 1991, J INVEST DERMATOL, V97, P679, DOI 10.1111/1523-1747.ep12483956; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bigg HF, 2001, CANCER RES, V61, P3610; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Candiani S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-32; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; de Mateo S, 2011, PROTEOMICS, V11, P2714, DOI 10.1002/pmic.201000799; Dobzhansky T, 2013, AM BIOL TEACH, V75, P87, DOI 10.2307/4444260; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; Doherty CM, 2016, J BIOL CHEM, V291, P22160, DOI 10.1074/jbc.M116.733261; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Greenstein JP, 1939, J BIOL CHEM, V129, P681; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hernandez-Barrantes S, 2001, BIOCHEM BIOPH RES CO, V281, P126, DOI 10.1006/bbrc.2001.4323; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Jackson DJ, 2015, GENOME BIOL EVOL, V7, P1349, DOI 10.1093/gbe/evv074; Jackson HW, 2017, NAT REV CANCER, V17, P38, DOI 10.1038/nrc.2016.115; Jaworski DM, 2007, PHYSIOL GENOMICS, V28, P168, DOI 10.1152/physiolgenomics.00160.2006; Johanns M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04648-y; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Kubota K, 2017, J STRUCT BIOL, V199, P216, DOI 10.1016/j.jsb.2017.07.010; Kubota S, 2003, BBA-GENE STRUCT EXPR, V1629, P102, DOI 10.1016/j.bbaexp.2003.08.007; Kumar A, 2009, EUKARYOT CELL, V8, P1321, DOI 10.1128/EC.00143-09; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2004, J BIOL CHEM, V279, P45121, DOI 10.1074/jbc.M406611200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lee YCG, 2013, GENOME BIOL EVOL, V5, P1978, DOI 10.1093/gbe/evt149; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Li Y., 2017, NAT COMMUN, V8; Liao Z, 2015, J PROTEOMICS, V122, P26, DOI 10.1016/j.jprot.2015.03.027; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17269; Liu XW, 2005, CANCER RES, V65, P898; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Meunier I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32544; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nicosia A, 2016, GENOME BIOL EVOL, V8, P1056, DOI 10.1093/gbe/evw052; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Ohno S., 1970, EVOLUTION GENE DUPLI; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohar N, 1999, GENOMICS, V57, P293, DOI 10.1006/geno.1999.5776; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qi JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055667; Qin CL, 2016, J PROTEOMICS, V144, P87, DOI 10.1016/j.jprot.2016.06.014; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Seo DW, 2011, PEPTIDES, V32, P1840, DOI 10.1016/j.peptides.2011.08.010; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Singh N. D., 2007, V3, P101, DOI 10.1159/000107606; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STETLERSTEVENSON WG, 1992, FEBS LETT, V296, P231, DOI 10.1016/0014-5793(92)80386-U; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Takechi M, 2011, J EXP ZOOL PART B, V316B, P526, DOI 10.1002/jez.b.21427; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Tsukamoto H, 2007, COMP BIOCHEM PHYS B, V148, P225, DOI 10.1016/j.cbpb.2007.02.016; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Waters PD, 2005, CHROMOSOME RES, V13, P401, DOI 10.1007/s10577-005-0978-5; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Worley JR, 2003, BIOCHEM J, V372, P799, DOI 10.1042/BJ20021573; Xu XY, 2011, COMP BIOCHEM PHYS B, V159, P115, DOI 10.1016/j.cbpb.2011.02.008; Yamamoto K, 2015, MATRIX BIOL, V44-46, P255, DOI 10.1016/j.matbio.2015.02.007; Yan F, 2014, BIOCHEM BIOPH RES CO, V450, P300, DOI 10.1016/j.bbrc.2014.05.118; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Yu WP, 2003, TRENDS GENET, V19, P180, DOI 10.1016/S0168-9525(03)00048-9; Zayas-Santiago A, 2017, INVEST OPHTH VIS SCI, V58, P3046, DOI 10.1167/iovs.17-21720; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang JX, 2017, ONCOTARGET, V8, P6496, DOI 10.18632/oncotarget.14133	108	5	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					71	87		10.1096/fj.201801262R	http://dx.doi.org/10.1096/fj.201801262R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30125136	Green Published			2022-12-28	WOS:000457401500006
J	Cai, C; Sang, CJ; Du, J; Jia, HB; Tu, JY; Wan, Q; Bao, BH; Xie, SL; Huang, Y; Li, A; Li, JY; Yang, K; Wang, S; Lu, QW				Cai, Chen; Sang, Caijun; Du, Juan; Jia, Haibo; Tu, Jiayi; Wan, Qing; Bao, Binghao; Xie, Shanglun; Huang, Ying; Li, Ao; Li, Jiayu; Yang, Kun; Wang, Song; Lu, Qunwei			Knockout of tnni1b in zebrafish causes defects in atrioventricular valve development via the inhibition of the myocardial wnt signaling pathway	FASEB JOURNAL			English	Article						CRISPR; Cas9; cardiac troponin I; heart valve; lef1; tcf3	CARDIAC TROPONIN-I; EPITHELIAL-MESENCHYMAL TRANSITION; DEVELOPING HEART; MOUSE MODEL; EXPRESSION; CUSHION; CARDIOMYOPATHY; SKELETAL; ISOFORM; RISK	The proper development of atrioventricular (AV) valves is critical for heart morphogenesis and for the formation of the cardiac conduction system. Defects in AV valve development are the most common type of congenital heart defect. Cardiac troponin I (ctnni), a structural and regulatory protein involved in cardiac muscle contraction, is a subunit of the troponin complex, but the functions and molecular mechanisms of ctnni during early heart development remain unclear. We created a knockout zebrafish model in which troponin I type 1b (tnni1b) (Tnni-HC, heart and craniofacial) was deleted using the clustered regularly interspaced short palindromic repeat/clustered regularly interspaced short palindromic repeat-associated protein system. In the homozygous mutant, the embryos showed severe pericardial edema, malformation of the heart tube, reduction of heart rate without contraction and with almost no blood flow, heart cavity congestion, and lack of an endocardial ring or valve leaflet, resulting in 88.8 +/- 6.0% lethality at 7 d postfertilization. Deletion of tnni1b caused the abnormal expression of several markers involved in AV valve development, including bmp4, cspg2, has2, notch1b, spp1, and Alcam. Myocardial re-expression of tnni1b in mutants partially rescued the pericardial edema phenotype and AV canal (AVC) developmental defects. We further showed that tnni1b knockout in zebrafish and ctnni knockdown in rat h9c2 myocardial cells inhibited cardiac wnt signaling and that myocardial reactivation of wnt signaling partially rescued the abnormal expression of AVC markers caused by the tnni1b deletion. Taken together, our data suggest that tnni1b plays a vital role in zebrafish AV valve development by regulating the myocardial wnt signaling pathway.Cai, C., Sang, C., Du, J., Jia, H., Tu, J., Wan, Q., Bao, B., Xie, S., Huang, Y., Li, A., Li, J., Yang, K., Wang, S., Lu, Q. Knockout of tnni1b in zebrafish causes defects in atrioventricular valve development via the inhibition of myocardial wnt signaling pathway.	[Cai, Chen; Sang, Caijun; Jia, Haibo; Tu, Jiayi; Wan, Qing; Bao, Binghao; Xie, Shanglun; Huang, Ying; Li, Ao; Li, Jiayu; Lu, Qunwei] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China; [Du, Juan] Huazhong Univ Sci & Technol, Sch Hosp, Wuhan, Hubei, Peoples R China; [Yang, Kun; Wang, Song] Wuhan Sports Univ, Exercise Immunol Ctr, Wuhan 430079, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan Sports University	Lu, QW (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.; Wang, S (corresponding author), Wuhan Sports Univ, Exercise Immunol Ctr, Wuhan 430079, Hubei, Peoples R China.	wangsong@whsu.edu.cn; luqw@hust.edu.cn		shanglun, xie/0000-0002-8947-1399	Ministry of Science and Technology of China [2013CB945300]; National Natural Science Foundation of China [81770102]; Natural Science Foundation of Hubei Province [2016CKB707]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The authors thank Prof. Jianfeng Zhou (Tongji Hospital, Wuhan, China) for providing the plasmids of the CRISPR/Cas9 system, Prof. Yun Deng (Hunan Normal University Changsha City, China) for the kind gift of pTol2-myl7-IRES-EGFP plasmid, and the laboratories of Prof. Qing Wang and Prof. Mugen Liu (Huazhong University of Science and Technology) for help with feeding zebrafish and for the cell culture. This study was supported by the Ministry of Science and Technology of China (2013CB945300), the National Natural Science Foundation of China (81770102), and the Natural Science Foundation of Hubei Province (2016CKB707). The authors declare no conflicts of interest.	Ahmad F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002642; Ahuja S, 2016, DEV BIOL, V412, P71, DOI 10.1016/j.ydbio.2016.02.003; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; AUSONI S, 1991, DEVELOPMENT, V112, P1041; Bai Y, 2013, J MOL CELL CARDIOL, V57, P82, DOI 10.1016/j.yjmcc.2013.01.008; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Burns CG, 2006, BIOTECHNIQUES, V40, P274, DOI 10.2141/000112135; Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127; Chen Tingfang, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P230; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; England J, 2017, J MOL CELL CARDIOL, V106, P1, DOI 10.1016/j.yjmcc.2017.03.006; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fu CY, 2009, GENE EXPR PATTERNS, V9, P348, DOI 10.1016/j.gep.2009.02.001; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Gillers BS, 2015, CIRC RES, V116, P398, DOI 10.1161/CIRCRESAHA.116.304731; Goddard LM, 2017, DEV CELL, V43, P274, DOI 10.1016/j.devcel.2017.09.023; Gomez-Stallons MV, 2016, ARTERIOSCL THROM VAS, V36, P1398, DOI 10.1161/ATVBAHA.116.307526; Houk AR, 2016, METHOD CELL BIOL, V134, P335, DOI 10.1016/bs.mcb.2016.03.002; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang XP, 1999, CIRC RES, V84, P1; Huang XP, 2000, J MOL CELL CARDIOL, V32, P2221, DOI 10.1006/jmcc.2000.1249; Hulin A, 2017, CARDIOVASC RES, V113, P40, DOI 10.1093/cvr/cvw229; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Hwang JJ, 2002, PHYSIOL GENOMICS, V10, P31, DOI 10.1152/physiolgenomics.00122.2001; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Katrukha IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1447, DOI 10.1134/S0006297913130063; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim JD, 2014, MOL CELLS, V37, P406, DOI 10.14348/molcells.2014.0072; Lagendijk AK, 2013, TRENDS CARDIOVAS MED, V23, P135, DOI 10.1016/j.tcm.2012.10.002; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Liu Lian, 2017, Shengli Xuebao, V69, P267, DOI 10.13294/j.aps.2017.0026; Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E; Lu QW, 2013, J GERIATR CARDIOL, V10, P91, DOI [10.3724/SP.J.1263.2012.07131, 10.3969/j.issn.1671-5411.2013.01.014]; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; MARTIN AF, 1991, J MOL CELL CARDIOL, V23, P583, DOI 10.1016/0022-2828(91)90050-V; Maytum R, 2003, J BIOL CHEM, V278, P6696, DOI 10.1074/jbc.M210690200; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Oliveira SM, 2012, CIRC RES, V110, P1192, DOI 10.1161/CIRCRESAHA.111.259952; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pang KL, 2017, J MOL CELL CARDIOL, V108, P114, DOI 10.1016/j.yjmcc.2017.05.012; PARMACEK MS, 1991, CIRCULATION, V84, P991, DOI 10.1161/01.CIR.84.3.991; Patra C, 2011, DEVELOPMENT, V138, P4499, DOI 10.1242/dev.067454; Peal DS, 2009, DEV DYNAM, V238, P3103, DOI 10.1002/dvdy.22154; Qiu SL, 2015, J PATHOL, V237, P330, DOI 10.1002/path.4579; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Saxon JG, 2017, DEV BIOL, V430, P113, DOI 10.1016/j.ydbio.2017.08.008; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Sogah VM, 2010, DEV DYNAM, V239, P3115, DOI 10.1002/dvdy.22445; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Solaro RJ, 1996, J MOL CELL CARDIOL, V28, P217; Solis RS, 2011, PROTEIN SCI, V20, P894, DOI 10.1002/pro.623; Tang M, 2017, J CANCER RES CLIN, V143, P793, DOI 10.1007/s00432-016-2333-y; Tauc HM, 2012, GENESIS, V50, P466, DOI 10.1002/dvg.22021; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tiwari RP, 2012, MOL DIAGN THER, V16, P371, DOI 10.1007/s40291-012-0011-6; Verhoeven MC, 2011, BIRTH DEFECTS RES A, V91, P435, DOI 10.1002/bdra.20804; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060244; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Zhang HY, 1997, DEV GENES EVOL, V207, P340, DOI 10.1007/s004270050121	82	8	8	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					696	710		10.1096/fj.201800481RR	http://dx.doi.org/10.1096/fj.201800481RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30044923				2022-12-28	WOS:000457401500054
J	Leitao, L; Alves, CJ; Alencastre, IS; Sousa, DM; Neto, E; Conceicao, F; Leitao, C; Aguiar, P; Almeida-Porada, G; Lamghari, M				Leitao, Luis; Alves, Cecilia J.; Alencastre, Ines S.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Leitao, Catarina; Aguiar, Paulo; Almeida-Porada, Graca; Lamghari, Meriem			Bone marrow cell response after injury and during early stage of regeneration is independent of the tissue-of-injury in 2 injury models	FASEB JOURNAL			English	Article						bone injury; muscle injury; mesenchymal stromal cells; endothelial cells	MESENCHYMAL STEM-CELLS; HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; PROGENITOR CELLS; SELF-RENEWAL; WOUND REPAIR; B-CELLS; G-CSF; DIFFERENTIATION; MOBILIZATION	Selectively recruiting bone marrow (BM)-derived stem and progenitor cells to injury sites is a promising therapeutic approach. The coordinated action of soluble factors is thought to trigger the mobilization of stem cells from the BM and recruit them to lesions to contribute to tissue regeneration. Nevertheless, the temporal response profile of the major cellular players and soluble factors involved in priming the BM and recruiting BM-derived cells to promote regeneration is unknown. We show that injury alters the BM cellular composition, introducing population-specific fluctuations during tissue regeneration. We demonstrate that injury causes an immediate, transient response of mesenchymal stromal cells and endothelial cells followed by a nonoverlapping increase in hematopoietic stem and progenitor cells. Moreover, BM reaction is identical whether the injury is inflicted on skin and muscle or also involves a bone defect, but these 2 injury paradigms trigger distinct systemic cytokine responses. Together, our results indicate that the BM response to injury in the early stages of regeneration is independent of the tissue-of-injury based on the 2 models used, but the injured tissue dictates the systemic cytokine response.LeitAo, L., Alves, C. J., Alencastre, I. S., Sousa, D. M., Neto, E., ConceicAo, F., LeitAo, C., Aguiar, P., Almeida-Porada, G., Lamghari, M. Bone marrow cell response after injury and during early stage of regeneration is independent of the tissue-of-injury in 2 injury models.	[Leitao, Luis; Alves, Cecilia J.; Alencastre, Ines S.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Leitao, Catarina; Aguiar, Paulo; Lamghari, Meriem] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal; [Leitao, Luis; Alves, Cecilia J.; Alencastre, Ines S.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Aguiar, Paulo; Lamghari, Meriem] Univ Porto, Inst Engn Biomed INEB, Porto, Portugal; [Leitao, Luis; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, ICBAS, Porto, Portugal; [Leitao, Catarina] Univ Porto, IBMC, Porto, Portugal; [Neto, Estrela] FMUP, Porto, Portugal; [Almeida-Porada, Graca] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Wake Forest University	Lamghari, M (corresponding author), Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal.	lamghari@ineb.up.pt	Sousa, Daniela/C-1485-2014; Aguiar, Paulo/AAD-2462-2020; Conceição, Francisco/HCI-8740-2022; Neto, Estrela C/M-2561-2013; Lamghari, Meriem/K-2159-2013	Sousa, Daniela/0000-0001-8498-0664; Aguiar, Paulo/0000-0003-4164-5713; Neto, Estrela C/0000-0003-2334-2292; Lamghari, Meriem/0000-0002-2500-4548; Alves, Cecilia Juliana/0000-0002-0719-574X; Alencastre, Ines/0000-0002-5591-5596; Conceicao, Francisco/0000-0003-4587-2470; Almeida-Porada, Maria da Graca/0000-0002-6715-865X	Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation, Portugal 2020; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274];  [PTDC/BIMMED/4041/2014];  [SFRH/BD/109686/2015];  [SFRH/BD/128771/2017];  [SFRH/BPD/75285/2010];  [SFRH/BPD/115341/2016]	Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation, Portugal 2020; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; ; ; ; ; 	The authors thank Ana Geros (Instituto de Investigacao e Inovacao em Saude) for helping with MatLab software. This study was financed by Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation, Portugal 2020, and by Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the Institute for Research and Innovation in Health Sciences Project (POCI-01-0145-FEDER-007274), as well as the framework of the financed Project PTDC/BIMMED/4041/2014. L.L. and F.C. are recipients of Ph.D. fellowships (SFRH/BD/109686/2015 and SFRH/BD/128771/2017, respectively). I.S.A. and D.M.S. are recipients of post-doctoral fellowships (SFRH/BPD/75285/2010 and SFRH/BPD/115341/2016, respectively). The authors declare no conflicts of interest.	Alves CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165465; Ammirante M, 2013, GENE DEV, V27, P1435, DOI 10.1101/gad.220202.113; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bonig Halvard, 2012, Methods Mol Biol, V904, P1, DOI 10.1007/978-1-61779-943-3_1; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen WK, 2018, J CELL PHYSIOL, V233, P1095, DOI 10.1002/jcp.25967; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Cheng M, 2012, PROG MOL BIOL TRANSL, V111, P243, DOI 10.1016/B978-0-12-398459-3.00011-3; Chung L, 2017, ADV DRUG DELIVER REV, V114, P184, DOI 10.1016/j.addr.2017.07.006; Colmone A, 2008, TRANSL RES, V151, P1, DOI 10.1016/j.trsl.2007.09.003; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; De Silva K, 2001, WOUND REPAIR REGEN, V9, P495, DOI 10.1046/j.1524-475x.2001.00495.x; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Ding YC, 2010, TRANSPLANTATION, V89, P270, DOI 10.1097/TP.0b013e3181c6ffbe; Drukala J, 2012, STEM CELL REV REP, V8, P184, DOI 10.1007/s12015-011-9272-4; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Fisher JN, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9352598; Gehling UM, 2010, WORLD J GASTROENTERO, V16, P217, DOI 10.3748/wjg.v16.i2.217; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Hasselblatt M, 2007, ACTA NEUROPATHOL, V113, P45, DOI 10.1007/s00401-006-0152-y; He NN, 2014, BONE MARROW RES, DOI 10.1155/2014/128436; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim Hee Jung, 2017, Dev Reprod, V21, P1, DOI 10.12717/DR.2017.21.1.001; Kim N, 2015, INT J STEM CELLS, V8, P54, DOI 10.15283/ijsc.2015.8.1.54; Kirby GTS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/285869; Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kovtun A, 2016, EUR CELLS MATER, V32, P152, DOI 10.22203/eCM.v032a10; Kumar S, 2012, BONE, V50, P1012, DOI 10.1016/j.bone.2012.01.027; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lapid K., 2008, STEMBOOK; Lee SW, 2009, J ORTHOP RES, V27, P295, DOI 10.1002/jor.20736; Li B, 2010, STEM CELL RES, V4, P17, DOI 10.1016/j.scr.2009.08.001; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nitzsche F, 2017, STEM CELLS, V35, P1446, DOI 10.1002/stem.2614; Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Perlin JR, 2017, J MOL MED, V95, P809, DOI 10.1007/s00109-017-1559-8; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponte AL, 2012, STEM CELLS DEV, V21, P3162, DOI 10.1089/scd.2012.0048; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; REBAR AH, 1993, TOXICOL PATHOL, V21, P118, DOI 10.1177/019262339302100202; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754; Rennert RC, 2012, REGEN MED, V7, P833, DOI [10.2217/RME.12.82, 10.2217/rme.12.82]; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shah S, 2009, J TRAUMA, V67, P315, DOI 10.1097/TA.0b013e3181a5c9c7; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Silva AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091406; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Wirsdorfer F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155870; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yang C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0804-1; Yu HK, 2013, CLIN CANCER RES, V19, P5340, DOI 10.1158/1078-0432.CCR-12-3685; Yu VWC, 2016, CURR OPIN HEMATOL, V23, P331, DOI 10.1097/MOH.0000000000000265	72	4	4	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					857	872		10.1096/fj.201800610RR	http://dx.doi.org/10.1096/fj.201800610RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30044924				2022-12-28	WOS:000457401500067
J	Nash, AJ; Mandaviya, PR; Dib, MJ; Uitterlinden, AG; van Meurs, J; Heil, SG; Andrew, T; Ahmadi, KR				Nash, Alexander J.; Mandaviya, Pooja R.; Dib, Marie-Joe; Uitterlinden, Andre G.; van Meurs, Joyce; Heil, Sandra G.; Andrew, Toby; Ahmadi, Kourosh R.			Interaction between plasma homocysteine and the MTHFR c.677C > T polymorphism is associated with site-specific changes in DNA methylation in humans	FASEB JOURNAL			English	Article						1-carbon metabolism; methylenetetrahydrofolate reductase; methylome-wide association study; epigenetics; vascular disease	METHYLENETETRAHYDROFOLATE-REDUCTASE; FOLATE INTAKE; RISK-FACTOR; HYPOMETHYLATION; HYPERHOMOCYSTEINEMIA; DETERMINANTS; NEPHROPATHY; METABOLISM; EXPRESSION; DEMENTIA	One-carbon metabolism provides a direct link among dietary folate/vitamin B-12 exposure, the activity of the enzyme methylenetetrahydrofolate reductase (MTHFR), and epigenetic regulation of the genome via DNA methylation. Previously, it has been shown that the common c.677C > T polymorphism in MTHFR influences global DNA methylation status through a direct interaction with folate status and (indirectly) with total homocysteine (tHcy) levels. To build on that and other more recent observations that have further highlighted associations among MTHFR c.677C > T, tHcy, and aberrations in DNA methylation, we investigated whether the interaction between mildly elevated plasma tHcy and the c.677C > T polymorphism is associated with site-specific changes in DNA methylation in humans. We used data on plasma tHcy levels, c.677C > T polymorphism, and site-specific DNA methylation levels for a total of 915 white women and 335 men from the TwinsUK registry (n = 610) and the Rotterdam study (n = 670). We performed methylome-wide association analyses in each cohort to model the interaction between levels of tHcy and c.677C > T genotypes on DNA methylation values. Our meta-analysis identified 13 probes significantly associated with rs1801133 x tHcy levels [false-discovery rate (FDR) < 0.05]. The most significant associations were with a cluster of probes at the AGTRAP-MTHFR-NPPA/B gene locus on chromosome 1 (FDR = 1.3E-04), with additional probes on chromosomes 2, 3, 4, 7, 12, 16, and 19. Our top 2 hits on chromosome 1 were functionally associated with variability in expression of the TNF receptor superfamily member 8 (TNFRSF8) gene/locus on that chromosome. This is the first study, to our knowledge, to provide a direct link between perturbations in 1-carbon metabolism, through an interaction of tHcy and the activity of MTHFR enzyme on epigenetic regulation of the genome via DNA methylation.Nash, A. J., Mandaviya, P. R., Dib, M.-J., Uitterlinden, A. G., van Meurs, J., Heil, S. G., Andrew, T., Ahmadi, K. R. Interaction between plasma homocysteine and the MTHFR c.677C>T polymorphism is associated with site-specific changes in DNA methylation in humans.	[Nash, Alexander J.] Imperial Coll, Inst Clin Sci, London, England; [Nash, Alexander J.] Imperial Coll, MRC, London Inst Med Sci, London, England; [Dib, Marie-Joe; Andrew, Toby] Imperial Coll, Dept Genom Common Dis, London, England; [Mandaviya, Pooja R.; Heil, Sandra G.] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands; [Mandaviya, Pooja R.; Uitterlinden, Andre G.; van Meurs, Joyce] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Ahmadi, Kourosh R.] Univ Surrey, Sch Biosci & Med, Dept Nutr Sci, Guildford GU2 7XH, Surrey, England	Imperial College London; Imperial College London; Imperial College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Surrey	Ahmadi, KR (corresponding author), Univ Surrey, Sch Biosci & Med, Dept Nutr Sci, Guildford GU2 7XH, Surrey, England.	k.ahmadi@surrey.ac.uk	Heil, Sandra/AAM-8104-2020	Nash, Alexander/0000-0002-0956-4326; van Meurs, Joyce/0000-0001-6245-2123; Dib, Marie-Joe/0000-0001-7591-5684	Wellcome Trust; European Community; Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; Netherlands Organization for Scientific Research (NWO) [184021007]; Erasmus MC and Erasmus University Organization for Health Research and Development (ZonMw); Research Institute of Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus MC and Erasmus University Organization for Health Research and Development (ZonMw); Research Institute of Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London	For the TwinsUK study, the authors thank all the participants as well as the staff. The TwinsUK National Institute for Health Research Biomedical Research Centre BioResource is funded by the Wellcome Trust, the European Community's Seventh Framework Programme (Grant FP7/2007-2013), and the National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. For the Rotterdam study, the authors thank Michael Verbiest, Mila Jhamai, Sarah Higgins, and Marijn Verkerk [Erasmus University Medical Center (Erasmus MC)] for their help in creating the methylation database. The authors are grateful to the study participants, the staff from the Rotterdam study, and the participating general practitioners and pharmacists. The generation and management of the Illumina 450,000 methylation array data [epigenome-wide association study (EWAS) data] for the Rotterdam study were executed by the Human Genotyping Facility of the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC. The EWAS data were funded by the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, and by The Netherlands Organization for Scientific Research (NWO; Project 184021007), and made available as a Rainbow Project [RP3; Biobank-Based Integrative Omics Study (BIOS)] of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL). The Rotterdam study is funded by Erasmus MC and Erasmus University Organization for Health Research and Development (ZonMw), the Research Institute of Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors declare no conflicts of interest.	Amarasekera M, 2014, FASEB J, V28, P4068, DOI 10.1096/fj.13-249029; Axume J, 2007, NUTR RES, V27, P13, DOI 10.1016/j.nutres.2006.12.006; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; Buysschaert M, 2000, DIABETES CARE, V23, P1816, DOI 10.2337/diacare.23.12.1816; Carmel R., 2001, HOMOCYSTEINE HLTH DI; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Fryer Anthony A, 2009, Epigenetics, V4, P394; Greene CN, 2008, HUM GENET, V124, P255, DOI 10.1007/s00439-008-0548-y; Haertle L, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0329-3; Hatanaka M, 2009, BIOL PHARM BULL, V32, P1166, DOI 10.1248/bpb.32.1166; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Hoogeveen EK, 2000, CIRCULATION, V101, P1506, DOI 10.1161/01.CIR.101.13.1506; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Jin HF, 2018, AM J CLIN NUTR, V107, P817, DOI 10.1093/ajcn/nqy035; Kok DEG, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0154-5; Kumar Jitender, 2015, Front Cardiovasc Med, V2, P11, DOI 10.3389/fcvm.2015.00011; Madjd Z, 2016, INT J BIOL MARKER, V31, pE118, DOI 10.5301/jbm.5000209; Main AM, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0258-6; Mandaviya PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182472; Mandaviya PR, 2017, EPIGENOMICS-UK, V9, P1403, DOI 10.2217/epi-2017-0038; Mandaviya PR, 2014, MOL GENET METAB, V113, P243, DOI 10.1016/j.ymgme.2014.10.006; Mederle K, 2016, CARDIOVASC RES, V110, P359, DOI 10.1093/cvr/cvw064; Meigs JB, 2001, DIABETES CARE, V24, P1403, DOI 10.2337/diacare.24.8.1403; Mok A, 2016, LUPUS SCI MED, V3, DOI 10.1136/lupus-2016-000183; Muta H, 2013, IMMUNOL RES, V57, P151, DOI 10.1007/s12026-013-8464-1; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Nygard O, 1998, AM J CLIN NUTR, V67, P263, DOI 10.1093/ajcn/67.2.263; Parle-McDermott A, 2011, ADV NUTR, V2, P463, DOI 10.3945/an.111.001008; Patterson S, 2006, J ENDOCRINOL, V189, P301, DOI 10.1677/joe.1.06537; Pfeiffer S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27969; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Salbaum JM, 2012, PROG MOL BIOL TRANSL, V108, P129, DOI 10.1016/B978-0-12-398397-8.00006-X; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; Sheng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083269; Shinoda K, 2015, J AUTOIMMUN, V57, P14, DOI 10.1016/j.jaut.2014.11.005; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Sun BL, 2016, ONCOL REP, V36, P1062, DOI 10.3892/or.2016.4880; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Verhoef P, 1997, ATHEROSCLEROSIS, V132, P105, DOI 10.1016/S0021-9150(97)00084-1; Wald DS, 2011, ALZHEIMERS DEMENT, V7, P412, DOI 10.1016/j.jalz.2010.08.234; Wang TJ, 2017, MOL MED REP, V15, P839, DOI 10.3892/mmr.2016.6040; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wilhelm-Benartzi CS, 2013, BRIT J CANCER, V109, P1394, DOI 10.1038/bjc.2013.496; Yin L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.88; Zeisel SH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050445; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074521	56	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					833	843		10.1096/fj.201800400R	http://dx.doi.org/10.1096/fj.201800400R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30080444	Bronze, Green Submitted			2022-12-28	WOS:000457401500065
J	Singh, A; Ruiz, C; Bhalla, K; Haley, JA; Li, QK; Acquaah-Mensah, G; Montal, E; Sudini, KR; Skoulidis, F; Wistuba, II; Papadimitrakopoulou, V; Heymach, JV; Boros, LG; Gabrielson, E; Carretero, J; Wong, KK; Haley, JD; Biswal, S; Girnun, GD				Singh, Anju; Ruiz, Christian; Bhalla, Kavita; Haley, John A.; Li, Qing Kay; Acquaah-Mensah, George; Montal, Emily; Sudini, Kuladeep R.; Skoulidis, Ferdinandos; Wistuba, Ignacio I.; Papadimitrakopoulou, Vassiliki; Heymach, John V.; Boros, Laszlo G.; Gabrielson, Edward; Carretero, Julian; Wong, Kwok-Kin; Haley, John D.; Biswal, Shyam; Girnun, Geoffrey D.			De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer	FASEB JOURNAL			English	Article						cancer metabolism; NSCLC; Warburg Effect	FATTY-ACID SYNTHASE; ATP CITRATE LYASE; COA-CARBOXYLASE-ALPHA; RAS ONCOGENE; GROWTH; METABOLISM; INHIBITION; COMBINATION; EXPRESSION; MUTATIONS	Oncogenic Kras mutations are one of the most common alterations in non-small cell lung cancer and are associated with poor response to treatment and reduced survival. Driver oncogenes, such as Kras are now appreciated for their ability to promote tumor growth via up-regulation of anabolic pathways. Therefore, we wanted to identify metabolic vulnerabilities in Kras-mutant lung cancer. Using the Kras(LSL-G12D) lung cancer model, we show that mutant Kras drives a lipogenic gene-expression program. Stable-isotope analysis reveals that mutant Kras promotes de novo fatty acid synthesis in vitro and in vivo. The importance of fatty acid synthesis in Kras-induced tumorigenesis was evident by decreased tumor formation in Kras(LSL-G12D) mice after treatment with a fatty acid synthesis inhibitor. Importantly, with gain and loss of function models of mutant Kras, we demonstrate that mutant Kras potentiates the growth inhibitory effects of several fatty acid synthesis inhibitors. These studies highlight the potential to target mutant Kras tumors by taking advantage of the lipogenic phenotype induced by mutant Kras.Singh, A., Ruiz, C., Bhalla, K., Haley, J. A., Li, Q. K., Acquaah-Mensah, G., Montal, E., Sudini, K. R., Skoulidis, F., Wistuba, I. I., Papadimitrakopoulou, V., Heymach, J. V., Boros, L. G., Gabrielson, E., Carretero, J., Wong, K.-K., Haley, J. D., Biswal, S., Girnun, G. D. De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer.	[Singh, Anju; Sudini, Kuladeep R.; Biswal, Shyam] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Li, Qing Kay; Gabrielson, Edward] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Acquaah-Mensah, George; Biswal, Shyam] Johns Hopkins Univ, Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Ruiz, Christian; Haley, John A.; Montal, Emily; Haley, John D.; Girnun, Geoffrey D.] Stony Brook Sch Med, Dept Pathol, Stony Brook, NY USA; [Bhalla, Kavita; Girnun, Geoffrey D.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Acquaah-Mensah, George; Biswal, Shyam] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Worcester, MA USA; [Skoulidis, Ferdinandos; Wistuba, Ignacio I.; Papadimitrakopoulou, Vassiliki; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Boros, Laszlo G.] Stable Isotope Based Dynam Metab Profiling SiDMAP, Los Angeles, CA USA; [Carretero, Julian] Univ Valencia, Dept Physiol, Valencia, Spain; [Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University of Texas System; UTMD Anderson Cancer Center; University of Valencia; Harvard University; Dana-Farber Cancer Institute	Singh, A; Biswal, S (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Environm Hlth Sci,Bloomberg Sch Publ Hlth, 615 North St, Baltimore, MD 21205 USA.; Girnun, GD (corresponding author), SUNY Stony Brook, Stony Brook Sch Med, Dept Pathol, 101 Nicolls Rd, Stony Brook, NY 11794 USA.	sbiswal1@jhu.edu; sbiswal1@jhu.edu; geoffrey.girnun@stonybrookmedicine.edu	Acquaah-Mensah, George/H-3124-2019; Carretero, Julian/N-5214-2014; Heymach, John/AAG-2361-2019	Acquaah-Mensah, George/0000-0003-3984-8327; Carretero, Julian/0000-0001-7269-8506; Heymach, John/0000-0001-9068-8942; Haley, John A./0000-0003-2652-4841	U.S. National Institutes of Health, National Cancer Institute [CA169919, R01CA206155]; Maryland Cigarette Restitution Fund; Young Clinical Innovator Award from the Flight Attendant Medical Research Institute	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Cigarette Restitution Fund; Young Clinical Innovator Award from the Flight Attendant Medical Research Institute	The authors thank Prabhanshu Tripathi (Bloomberg School of Public Health, Johns Hopkins University) for help with the mouse studies and Ellen Tully (Johns Hopkins University) for assistance with the immunohistochemical studies. This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants CA169919 (to G.D.G.) and R01CA206155 (to S.B.); a research grant from the Maryland Cigarette Restitution Fund (to S.B., G.G., and A.S.); and a Young Clinical Innovator Award (to A.S.) from the Flight Attendant Medical Research Institute. We apologize to those laboratories that we were not able to reference. The authors declare no conflicts of interest.	Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Blumenschein GR, 2013, CLIN CANCER RES, V19, P6967, DOI 10.1158/1078-0432.CCR-12-1818; Boren J, 2003, J BIOL CHEM, V278, P28395, DOI 10.1074/jbc.M302932200; BOS JL, 1989, CANCER RES, V49, P4682; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Girnun GD, 2008, CLIN CANCER RES, V14, P6478, DOI 10.1158/1078-0432.CCR-08-1128; Gouw AM, 2017, P NATL ACAD SCI USA, V114, P4300, DOI 10.1073/pnas.1617709114; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Huncharek M, 1999, CARCINOGENESIS, V20, P1507, DOI 10.1093/carcin/20.8.1507; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Jiang L, 2015, ONCOGENE, V34, P3908, DOI 10.1038/onc.2014.321; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; KANNAN R, 1980, CANCER RES, V40, P4606; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; LEE WNP, 1992, BIOL MASS SPECTROM, V21, P114, DOI 10.1002/bms.1200210210; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Matikas A, 2017, CRIT REV ONCOL HEMAT, V110, P1, DOI 10.1016/j.critrevonc.2016.12.005; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Pizer ES, 1996, CANCER RES, V56, P745; RACKER E, 1985, P NATL ACAD SCI USA, V82, P3535, DOI 10.1073/pnas.82.11.3535; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Ricoult SJH, 2016, ONCOGENE, V35, P1250, DOI 10.1038/onc.2015.179; Rivkin A, 2006, BIOORG MED CHEM LETT, V16, P4620, DOI 10.1016/j.bmcl.2006.06.014; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	50	25	25	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					7018	7027		10.1096/fj.201800204	http://dx.doi.org/10.1096/fj.201800204			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906244	Green Published, Bronze			2022-12-28	WOS:000449359700050
J	Cross, M; Biberacher, S; Park, SY; Rajan, S; Korhonen, P; Gasser, RB; Kim, JS; Coster, MJ; Hofmann, A				Cross, Megan; Biberacher, Sonja; Park, Suk-Youl; Rajan, Siji; Korhonen, Pasi; Gasser, Robin B.; Kim, Jeong-Sun; Coster, Mark J.; Hofmann, Andreas			Trehalose 6-phosphate phosphatases of Pseudomonas aeruginosa	FASEB JOURNAL			English	Article						drug discovery; enzyme activity; halo-acid dehydrogenase; multidrug resistance; protein structure-function	HORIZONTAL GENE-TRANSFER; CRYSTAL-STRUCTURE; BURKHOLDERIA-PSEUDOMALLEI; GENOMIC ISLANDS; ACTIVE-SITE; ENZYME; TREHALOSE-6-PHOSPHATE; VIRULENCE; COMPLEX; PATHOGENICITY	The opportunistic bacterium Pseudomonas aeruginosa has been recognized as an important pathogen of clinical relevance and is a leading cause of hospital-acquired infections. The presence of a glycolytic enzyme in Pseudomonas, which is known to be inhibited by trehalose 6-phosphate (T6P) in other organisms, suggests that these bacteria may be vulnerable to the detrimental effects of intracellular T6P accumulation. In the present study, we explored the structural and functional properties of trehalose 6-phosphate phosphatase (TPP) in P. aeruginosa in support of future target-based drug discovery. A survey of genomes revealed the existence of 2 TPP genes with either chromosomal or extrachromosomal location. Both TPPs were produced as recombinant proteins, and characterization of their enzymatic properties confirmed specific, magnesium-dependent catalytic hydrolysis of T6P. The 3-dimensional crystal structure of the chromosomal TPP revealed a protein dimer arising through -sheet expansion of the individual monomers, which possess the overall fold of halo-acid dehydrogenases.Cross, M., Biberacher, S., Park, S.-Y., Rajan, S., Korhonen, P., Gasser, R. B., Kim, J.-S., Coster, M. J., Hofmann, A. Trehalose 6-phosphate phosphatases of Pseudomonas aeruginosa.	[Cross, Megan; Biberacher, Sonja; Rajan, Siji; Coster, Mark J.; Hofmann, Andreas] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Biberacher, Sonja] Friedrich Alexander Univ, Dept Biol, Erlangen, Germany; [Park, Suk-Youl] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, Gyeongbuk, South Korea; [Korhonen, Pasi; Gasser, Robin B.; Hofmann, Andreas] Univ Melbourne, Melbourne Vet Sch, Dept Vet Biosci, Parkville, Vic, Australia; [Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Gwangju, South Korea; [Hofmann, Andreas] Queensland Trop Hlth Alliance, Smithfield, RI, Australia	Griffith University; University of Erlangen Nuremberg; Pohang University of Science & Technology (POSTECH); University of Melbourne; Chonnam National University	Hofmann, A (corresponding author), Griffith Univ, N75 Don Young Rd, Nathan, Qld 4111, Australia.	a.hofmann@griffith.edu.au	Hofmann, Andreas/M-9870-2019; Gasser, Robin/ABH-6185-2020	Hofmann, Andreas/0000-0003-4408-5467; Gasser, Robin/0000-0002-4423-1690; Cross, Megan/0000-0001-7512-7223; Korhonen, Pasi/0000-0002-9957-4674; Rajan, Siji/0000-0002-2142-0042	Australian Research Council; Rebecca L. Cooper Medical Research Foundation; Chonnam National University [2015-0597]; German Academic Exchange Service through DAAD RISE scholarship; German Academic Exchange Service through DAAD PROMOS scholarship	Australian Research Council(Australian Research Council); Rebecca L. Cooper Medical Research Foundation; Chonnam National University; German Academic Exchange Service through DAAD RISE scholarship; German Academic Exchange Service through DAAD PROMOS scholarship	Research in the investigators' laboratories was funded by the Australian Research Council (to A.H. and R.B.G.), the Rebecca L. Cooper Medical Research Foundation (to A.H.), and the Chonnam National University (2015-0597, to J.-S.K.). The Equity Trustees Ph.D. Scholarship and the Australian Government Research Training Program Scholarship (to M.C.), as well as support by the German Academic Exchange Service through DAAD RISE and PROMOS scholarships (to S.B.) are gratefully acknowledged. Mass spectrometric analysis was undertaken at the Australian Proteome Analysis Facility, and the infrastructure was provided by the Australian Government through the National Collaborative Research Infrastructure Strategy. The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CAMPBELL JJ, 1962, J BACTERIOL, V83, P1155, DOI 10.1128/JB.83.5.1155-1160.1962; Claridge C. A., 1953, THESIS; Cross M, 2017, EMERG TOP LIFE SCI, V1, P675, DOI 10.1042/ETLS20170106; Cross M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02220-2; Cross M, 2017, FASEB J, V31, P920, DOI 10.1096/fj.201601149R; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deroover S, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow036; Di Nardo G, 2015, J BIOL CHEM, V290, P1186, DOI 10.1074/jbc.M114.595108; Djonovic S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003217; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farelli JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004245; Gaballa A, 1997, APPL ENVIRON MICROB, V63, P4340, DOI 10.1128/AEM.63.11.4340-4345.1997; Guo FB, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0986-6; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller P., 1982, MINERALOGICAL RECORD, V13, P155; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Korte J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006043; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Kuser P, 2008, PROTEINS, V72, P731, DOI 10.1002/prot.21956; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; LAPP D, 1971, J BIOL CHEM, V246, P4567; Leitner G, 2007, VET IMMUNOL IMMUNOP, V119, P198, DOI 10.1016/j.vetimm.2007.05.007; Liu CL, 2017, EUR J MED CHEM, V128, P274, DOI 10.1016/j.ejmech.2017.02.001; Matthijs S, 2000, RES MICROBIOL, V151, P845, DOI 10.1016/S0923-2508(00)01151-7; MATULA M, 1971, J BACTERIOL, V107, P217, DOI 10.1128/JB.107.1.217-222.1971; MCDOUGALL J, 1993, FEMS MICROBIOL LETT, V107, P25, DOI 10.1111/j.1574-6968.1993.tb05998.x; Moore Nicholas M, 2011, Clin Lab Sci, V24, P47; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Nunes C, 2013, PLANT PHYSIOL BIOCH, V63, P89, DOI 10.1016/j.plaphy.2012.11.011; Nzula S, 2000, FEMS IMMUNOL MED MIC, V28, P307, DOI 10.1111/j.1574-695X.2000.tb01491.x; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pannu NS, 2003, ACTA CRYSTALLOGR D, V59, P1801, DOI 10.1107/S090744490301936X; Park HC, 2007, LETT APPL MICROBIOL, V44, P50, DOI 10.1111/j.1472-765X.2006.02036.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Puttikamonkul S, 2010, MOL MICROBIOL, V77, P891, DOI 10.1111/j.1365-2958.2010.07254.x; Qiu X, 2009, GENOME DYNAM, V6, P126, DOI 10.1159/000235767; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; Roder A, 2005, FEMS MICROBIOL LETT, V243, P219, DOI 10.1016/j.femsle.2004.12.005; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarz S, 2017, VIRULENCE, V8, P5, DOI 10.1080/21505594.2016.1216295; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SIMOPOULOS TT, 1994, BIOCHEMISTRY-US, V33, P10375, DOI 10.1021/bi00200a018; Stratton JR, 2001, BIOCHEMISTRY-US, V40, P10411, DOI 10.1021/bi015542n; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TARDIF G, 1982, ANTIMICROB AGENTS CH, V22, P142, DOI 10.1128/AAC.22.1.142; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanaporn M, 2017, VIRULENCE, V8, P30, DOI 10.1080/21505594.2016.1199316; Wang CK, 2012, BIOINFORMATICS, V28, P1026, DOI 10.1093/bioinformatics/bts035; Weaver VB, 2004, J BACTERIOL, V186, P2376, DOI 10.1128/JB.186.8.2376-2384.2004; Weeratunga S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-201; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Zeidler S, 2017, ENVIRON MICROBIOL, V19, P5088, DOI 10.1111/1462-2920.13987; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	84	9	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5470	5482		10.1096/fj.201800500R	http://dx.doi.org/10.1096/fj.201800500R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688811	Green Submitted, Bronze			2022-12-28	WOS:000447972500023
J	Kim, G; Kim, JY; Lim, SC; Lee, KY; Kim, O; Choi, HS				Kim, Garam; Kim, Jin-Young; Lim, Sung-Chul; Lee, Kwang Youl; Kim, Okyun; Choi, Hong Seok			SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development	FASEB JOURNAL			English	Article						prolyl isomerase; E2F1; CpG methylation; histone methylation	CELL-CYCLE PROGRESSION; PROLYL ISOMERASE PIN1; DNA METHYLATION; HISTONE H3; MALIGNANT-TRANSFORMATION; EPIDERMAL-CELLS; BREAST-CANCER; METHYLTRANSFERASE; MUTATIONS; GENE	Melanoma is among the most aggressive and treatment-resistant human cancers. Aberrant histone H3 methylation at Lys 9 (H3K9) correlates with carcinogenic gene silencing, but the significance of suppressor of variegation 3-9 homolog 1 (SUV39H1), an H3K9-specific methyltransferase, in melanoma initiation and progression remains unclear. Here, we show that SUV39H1-mediated H3K9 trimethylation facilitates retinoblastoma (RB)1 promoter CpG island methylation by interacting with DNA methyltransferase 3A and decreasing RB mRNA and protein in melanoma cells. Reduced RB abundance, in turn, impairs E2F1 transcriptional inhibition, leading to increased peptidyl-prolyl cis-trans isomerase never-in-mitosis A (NIMA)-interacting 1 (PIN1) levels, human keratinocyte neoplastic cell transformation, and melanoma tumorigenesis via enhanced rapidly accelerated fibrosarcoma 1(RAF1)-MEK-ERK signaling pathway activation. In a synergistic model with B16-F1 murine melanoma cells, SUV39H1 and PIN1 overexpression increased melanoma growth, which was abrogated by their inhibition in SUV39H1-overexpressing B16-F1 mice. SUV39H1 also positively correlated with PIN1 expression in human melanoma. Our studies establish SUV39H1 as an oncogene in melanoma and underscore the role of chromatin factors in regulating tumorigenesis.Kim, G., Kim, J.-Y., Lim, S.-C., Lee, K. Y., Kim, O., Choi, H. S. SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.	[Kim, Garam; Kim, Jin-Young; Kim, Okyun; Choi, Hong Seok] Chosun Univ, Coll Pharm, Room 1101,Bldg 2,309 Philmundaero, Gwangju 61452, South Korea; [Lim, Sung-Chul] Chosun Univ, Sch Med, Dept Pathol, Gwangju, South Korea; [Lee, Kwang Youl] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea	Chosun University; Chosun University; Chonnam National University	Choi, HS (corresponding author), Chosun Univ, Coll Pharm, Room 1101,Bldg 2,309 Philmundaero, Gwangju 61452, South Korea.	chs@chosun.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2016R1A2B4010536]; Ministry of Science, Information and Communications Technology (ICT), and Future Planning [NRF-2015R1A5A2009070]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Ministry of Science, Information and Communications Technology (ICT), and Future Planning	This work was supported by the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP; NRF-2016R1A2B4010536) and the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (NRF-2015R1A5A2009070). The authors declare no conflicts of interest.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bird AP, 1996, CANCER SURV, V28, P87; Brose MS, 2002, CANCER RES, V62, P6997; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chen BF, 2014, EPIGENETICS-US, V9, P669, DOI 10.4161/epi.28324; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Cherblanc F, 2012, FUTURE MED CHEM, V4, P425, DOI [10.4155/fmc.12.7, 10.4155/FMC.12.7]; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cho YS, 2012, MOL CELL BIOCHEM, V367, P85, DOI 10.1007/s11010-012-1322-y; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Han CY, 2011, BIOCHEM BIOPH RES CO, V410, P68, DOI 10.1016/j.bbrc.2011.05.106; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hunter T, 1998, CELL, V92, P141, DOI 10.1016/S0092-8674(00)80906-X; Ikegami K, 2007, GENES CELLS, V12, P1, DOI 10.1111/j.1365-2443.2006.01029.x; Indra AK, 2007, J INVEST DERMATOL, V127, P1250, DOI 10.1038/sj.jid.5700672; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Khanal P, 2013, FASEB J, V27, P4606, DOI 10.1096/fj.13-236851; Khanal P, 2010, MOL CANCER THER, V9, P606, DOI 10.1158/1535-7163.MCT-09-0560; Kruiswijk F, 2016, ONCOGENE, V35, P2166, DOI 10.1038/onc.2015.282; Li W, 2013, J HUAZHONG U SCI-MED, V33, P798, DOI 10.1007/s11596-013-1201-0; Liu HP, 2004, CURR OPIN GENET DEV, V14, P55, DOI 10.1016/j.gde.2003.11.005; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Rastetter M, 2007, HISTOL HISTOPATHOL, V22, P1005, DOI 10.14670/HH-22.1005; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Riverso M, 2017, ONCOGENE, V36, P3322, DOI 10.1038/onc.2016.481; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Yang Y, 2015, ONCOGENE, V34, P104, DOI 10.1038/onc.2013.522; Zhang JC, 2014, TUMOR BIOL, V35, P2795, DOI 10.1007/s13277-013-1372-0	51	16	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5647	5660		10.1096/fj.201700645RRRRR	http://dx.doi.org/10.1096/fj.201700645RRRRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29750576	Bronze			2022-12-28	WOS:000447972500037
J	Liu, AD; Dong, W; Peng, J; Dirsch, O; Dahmen, U; Fang, HS; Zhang, CT; Sun, J				Liu, Anding; Dong, Wei; Peng, Jing; Dirsch, Olaf; Dahmen, Uta; Fang, Haoshu; Zhang, Cuntai; Sun, Jian			Growth differentiation factor 11 worsens hepatocellular injury and liver regeneration after liver ischemia reperfusion injury	FASEB JOURNAL			English	Article						aging; hepatocyte; cell cycle	CELL-CYCLE CONTROL; ISCHEMIA/REPERFUSION INJURY; PARTIAL-HEPATECTOMY; PROLIFERATIVE RESPONSE; SKELETAL-MUSCLE; GDF11; AGE; DISEASE; RATS; NEUROGENESIS	Growth differentiation factor 11 (GDF11) has been implicated in a variety of aging conditions and the regulation of organ regeneration after injury; however, the role of GDF11 in liver ischemia reperfusion injury (IRI) is unknown. The aim of the current study was to investigate the possible role of GDF11 in liver IRI. We investigated the effects of GDF11 in liver IRI in both young (3 mo) and old (22 mo) mice in vivo, and in primary young and old mouse hepatocytes in vitro. Both serum and hepatic GDF11 protein expression levels increased with age and after IRI. Treatment with recombinant GDF11 significantly increased IRI-induced elevations of serum aminotransferase levels, worsened the histologic status of livers, and impaired liver regeneration. In contrast, inhibition of GDF11 activity with neutralizing Abs significantly decreased liver injury and improved liver regeneration after IRI. In vitro, treatment with recombinant GDF11 significantly delayed cell proliferation in cultured hepatocytes that were subjected to hypoxia/reoxygenation insult. Moreover, suppression of cell-cycle progression may be a key mechanism by which GDF11 inhibited hepatocyte regeneration. Collectively, rather than acting as a rejuvenating agent, GDF11 worsens hepatocellular injury and impairs liver regeneration after IRI.Liu, A., Dong, W., Peng, J., Dirsch, O., Dahmen, U., Fang, H., Zhang, C., Sun, J. Growth differentiation factor 11 worsens hepatocellular injury and liver regeneration after liver ischemia reperfusion injury.	[Liu, Anding] Huazhong Univ Sci & Technol, Ctr Med Expt, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Dong, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Hubei, Peoples R China; [Peng, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Clin Lab, Wuhan, Hubei, Peoples R China; [Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China; [Dirsch, Olaf] Klinikum Chemnitz, Inst Pathol, Chemnitz, Germany; [Dahmen, Uta] Friedrich Schiller Univ Jena, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany; [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yanjiang, Guangzhou, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chemnitz Clinic; Friedrich Schiller University of Jena; Anhui Medical University; Sun Yat Sen University; Sun Yat Sen University	Sun, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yanjiang, Guangzhou, Guangdong, Peoples R China.	sjmed02@outlook.com	Liu, Anding/AAU-2477-2020		National Natural Science Fund of China [81300343, 81770680]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Fund of China Grants 81300343 and 81770680. The authors declare no conflicts of interest.	Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Brun CE, 2015, CELL METAB, V22, P54, DOI 10.1016/j.cmet.2015.05.009; Chen L, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-18; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Deneme MA, 2006, J SURG RES, V136, P280, DOI 10.1016/j.jss.2006.08.020; Do N, 2012, AM J PHYSIOL-GASTR L, V303, pG1220, DOI 10.1152/ajpgi.00105.2012; Du GQ, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-016-0593-y; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Elliott BT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13343; Glass DJ, 2016, CELL METAB, V24, P7, DOI 10.1016/j.cmet.2016.06.017; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Harper SC, 2016, CIRC RES, V118, P1143, DOI 10.1161/CIRCRESAHA.116.306206; Hinken AC, 2016, AGING CELL, V15, P582, DOI 10.1111/acel.12475; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Karkampouna S, 2016, ARCH TOXICOL, V90, P347, DOI 10.1007/s00204-014-1436-y; Karkampouna S, 2012, CURR PHARM DESIGN, V18, P4103, DOI 10.2174/138161212802430521; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708; Liu AD, 2016, ONCOTARGET, V7, P78372, DOI 10.18632/oncotarget.13281; Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042; Liu AD, 2015, INT IMMUNOPHARMACOL, V24, P72, DOI 10.1016/j.intimp.2014.11.014; Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659; Liu WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12794; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Nakamura T, 2004, J HEPATOL, V41, P974, DOI 10.1016/j.jhep.2004.08.015; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Olson KA, 2015, EUR HEART J, V36, P3426, DOI 10.1093/eurheartj/ehv385; Onodera K, 2017, THORAX, V72, P893, DOI 10.1136/thoraxjnl-2016-209352; Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363; Rodgers BD, 2015, ENDOCRINOLOGY, V156, P3885, DOI 10.1210/en.2015-1628; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Schafer MJ, 2016, CELL METAB, V23, P1207, DOI 10.1016/j.cmet.2016.05.023; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Shi YT, 2011, J NEUROSCI, V31, P883, DOI 10.1523/JNEUROSCI.2394-10.2011; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527; Stein GS, 2006, J CELL PHYSIOL, V209, P706, DOI 10.1002/jcp.20843; Sun J, 2017, LIVER TRANSPLANT, V23, P510, DOI 10.1002/lt.24733; Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391; Williams G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078478; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34624; Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9	48	14	14	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5186	5198		10.1096/fj.201800195R	http://dx.doi.org/10.1096/fj.201800195R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913561	Bronze			2022-12-28	WOS:000443817700045
J	Wang, L; Wang, Y; Meng, Y; Zhang, C; Di, LJ				Wang, Li; Wang, Yuan; Meng, Yuan; Zhang, Chao; Di, Lijun			GSK3-activated STAT5 regulates expression of SFRPs to modulate adipogenesis	FASEB JOURNAL			English	Article						adipocyte differentiation; GSK3; Wnt pathway	GLYCOGEN-SYNTHASE KINASE-3; FRIZZLED-RELATED PROTEIN-1; ACTIVATED-RECEPTOR-GAMMA; SIGNALING PATHWAY; ADIPOCYTE DIFFERENTIATION; SKELETAL-MUSCLE; INSULIN ACTION; INHIBIT ADIPOGENESIS; GLUCOSE-TRANSPORT; METABOLISM	Adipogenesis is a tightly regulated cellular process and is closely associated with obesity and its associated metabolic disorders, such as diabetes. Multiple transcription factors and signaling pathways are involved in the regulation of adipogenesis. Here, we report that glycogen synthase kinase (GSK3), which was reported to play an important role in many cellular processes, is essential to adipocyte differentiation at early and terminal differentiation phases. Mechanistically, GSK3 modulates adipogenesis through regulation of both canonical Wnt pathways, which involve Wnt/-catenin signaling, and noncanonical Wnt pathways, which include JNK and Ras-related C3 botulinum toxin substrate signaling. GSK3-regulated adipogenesis is also mediated by secreted frizzled-related proteins (SFRPs), especially SFRP1, the canonical Wnt antagonist. The obesity-induced increase of Sfrp1 expression can be reversed by the GSK3 inhibitor. GSK3-regulated expression of Sfrp is mediated by signal transducer and activator of transcription 5 (STAT5). We demonstrated that GSK3 activates STAT5 through regulation of its phosphorylation to bind to the promoter of Sfrp genes and the peroxisome proliferator-activated receptor gene to stimulate their expression, which could ultimately lead to a modulated adipogenic process. Our findings identify a GSK3/STAT5/SFRP/Wnt regulatory axis of adipogenesis and shed light on the molecular mechanism of adipogenesis by suggesting that different pathways and adipogenic regulators coordinately modulate adipocyte differentiation.Wang L., Wang, Y., Meng, Y., Zhang, C., Di, L. GSK3-activated STAT5 regulates expression of SFRPs to modulate adipogenesis.	[Wang, Li; Wang, Yuan; Meng, Yuan; Zhang, Chao; Di, Lijun] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	University of Macau	Wang, L; Di, LJ (corresponding author), Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China.	liwang@umac.mo; lijundi@umac.mo			Science and Technology Development Fund (FDCT) of Macao [025/2014/A1, 088/2014/A2]; Multi-Year Research Grants from the University of Macau [MYRG2015-00037-FHS, MYRG2015-00167-FHS, MYRG2016-00251-FHS]	Science and Technology Development Fund (FDCT) of Macao; Multi-Year Research Grants from the University of Macau	This work was supported by the Science and Technology Development Fund (FDCT) of Macao (Grants 025/2014/A1 and 088/2014/A2; to L.D.), and by Multi-Year Research Grants MYRG2015-00037-FHS and MYRG2015-00167-FHS (to L.D.) and MYRG2016-00251-FHS (to L.W.) from the University of Macau. The authors declare no conflicts of interest.	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Keats EC, 2014, STEM CELLS, V32, P1649, DOI 10.1002/stem.1659; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moreno-Navarrete J.M., 2017, ADIPOSE TISSUE BIOL, P69, DOI DOI 10.1007/978-3-319-52031-5_3; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Nanbu-Wakao R, 2002, MOL ENDOCRINOL, V16, P1565, DOI 10.1210/me.16.7.1565; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Okada Y., 2009, J MED SCI, V54, pE241; Okamoto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04493; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schmidt C, 2007, DEV DYNAM, V236, P2502, DOI 10.1002/dvdy.21260; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; TABATA I, 1994, DIABETES, V43, P903, DOI 10.2337/diabetes.43.7.903; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; Wakao Hiroshi, 2011, Environmental Health and Preventive Medicine, V16, P247, DOI 10.1007/s12199-010-0193-7; Wang L, 2015, J BIOL CHEM, V290, P19458, DOI 10.1074/jbc.M115.641332; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11	53	18	19	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4714	4726		10.1096/fj.201701314R	http://dx.doi.org/10.1096/fj.201701314R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29579399				2022-12-28	WOS:000443817700008
J	Munson, P; Lam, YW; Dragon, J; MacPherson, M; Shukla, A				Munson, Phillip; Lam, Ying-Wai; Dragon, Julie; MacPherson, Maximilian; Shukla, Arti			Exosomes from asbestos-exposed cells modulate gene expression in mesothelial cells	FASEB JOURNAL			English	Article						extracellular vesicles; mesothelioma; biomarkers; proteomics; tumorigenesis	MANGANESE SUPEROXIDE-DISMUTASE; ENDOPLASMIC-RETICULUM STRESS; MESENCHYMAL TRANSITION; LUNG-CANCER; MECHANISMS; INFLAMMASOME; ACTIVATION; SPREAD	Asbestos exposure is a determinate cause of many diseases, such as mesothelioma, fibrosis, and lung cancer, and poses a major human health hazard. At this time, there are no identified biomarkers to demarcate asbestos exposure before the presentation of disease and symptoms, and there is only limited understanding of the underlying biology that governs asbestos-induced disease. In our study, we used exosomes, 30-140 nm extracellular vesicles, to gain insight into these knowledge gaps. As inhaled asbestos is first encountered by lung epithelial cells and macrophages, we hypothesize that asbestos-exposed cells secrete exosomes with signature proteomic cargo that can alter the gene expression of mesothelial cells, contributing to disease outcomes like mesothelioma. In the present study using lung epithelial cells (BEAS2B) and macrophages (THP-1), we first show that asbestos exposure causes changes in abundance of some proteins in the exosomes secreted from these cells. Furthermore, exposure of human mesothelial cells (HPM3) to these exosomes resulted in gene expression changes related to epithelial-to-mesenchymal transition and other cancer-related genes. This is the first report to indicate that asbestos-exposed cells secrete exosomes with differentially abundant proteins and that those exosomes have a gene-altering effect on mesothelial cells.Munson, P., Lam, Y.-W., Dragon, J. MacPherson, M., Shukla, A. Exosomes from asbestos-exposed cells modulate gene expression in mesothelial cells.	[Munson, Phillip; MacPherson, Maximilian; Shukla, Arti] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA; [Lam, Ying-Wai] Univ Vermont, Dept Biol, Burlington, VT USA; [Lam, Ying-Wai] Univ Vermont, Vermont Genet Network Prote Facil, Burlington, VT USA; [Dragon, Julie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont	Shukla, A (corresponding author), Univ Vermont, Larner Coll Med, Dept Pathol & Lab Med, 89 Beaumont Ave, Burlington, VT 05405 USA.	arti.shukla@uvm.edu			U.S. Department of Defense [W81XWH-13-PRCRP-IA]; U.S. National Institutes of Health (NIH), National Institute of Environmental Health Sciences [R01ES021110]; UVM Department of Pathology and Laboratory Medicine; IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NIH National Institute of General Medical Sciences [P20GM103449]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health (NIH), National Institute of Environmental Health Sciences; UVM Department of Pathology and Laboratory Medicine; IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NIH National Institute of General Medical Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Joyce Thompson (University of Michigan, Ann Arbor, MI, USA) for assistance with initial experiments; the Proteomic Facility, Advanced Genomic Technology Core and Microscopy Imaging Center at the University of Vermont (UVM), for proteomic profiling, microarray analysis, quantitative RT-PCR services and imaging services; and Raju Badireddy, PhD, (UVM Bioengineering Department) for the use of DLS. Financial support was provided by the U.S. Department of Defense (W81XWH-13-PRCRP-IA) and U.S. National Institutes of Health (NIH), National Institute of Environmental Health Sciences Grant R01ES021110 (to A.S.), and fellowship support from the UVM Department of Pathology and Laboratory Medicine (to P.M.). The Vermont Genetics Network Proteomics Facility is supported through Grant P20GM103449 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NIH National Institute of General Medical Sciences. The authors declare no conflicts of interest.	Berman DW, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802276167; Bruno R, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.e20028; Casarsa C, 2011, CANCER LETT, V302, P136, DOI 10.1016/j.canlet.2011.01.009; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dragon J, 2015, J CELL BIOCHEM, V116, P1540, DOI 10.1002/jcb.25095; Dutta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097580; Eitan E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01386-z; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fassina A, 2012, MODERN PATHOL, V25, P86, DOI 10.1038/modpathol.2011.144; Frank AL, 2014, ANN GLOB HEALTH, V80, P257, DOI 10.1016/j.aogh.2014.09.016; Franko A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/493083; GREENING DW, 2016, SCI REP UK, V6; Guo LX, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/520590; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hillegass JM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-39; Hirvonen A, 2002, CANCER LETT, V178, P71, DOI 10.1016/S0304-3835(01)00819-9; Hristova M, 2014, REDOX BIOL, V2, P436, DOI 10.1016/j.redox.2013.12.030; Kahlos K, 2000, BRIT J CANCER, V82, P1022, DOI 10.1054/bjoc.1999.1037; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamp DW, 2013, AM J RESP CELL MOL, V49, P892, DOI 10.1165/rcmb.2013-0053OC; Kim MC, 2013, ASIAN PAC J CANCER P, V14, P3625, DOI 10.7314/APJCP.2013.14.6.3625; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li MY, 2012, CYTOKINE, V60, P718, DOI 10.1016/j.cyto.2012.08.025; Lu HZ, 2017, CANCER MED-US, V6, P1181, DOI 10.1002/cam4.1064; Markowitz SB, 2013, AM J RESP CRIT CARE, V188, P90, DOI 10.1164/rccm.201302-0257OC; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; MOSSMAN BT, 1986, LAB INVEST, V54, P204; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Nabavi Noushin, 2016, Genes Cancer, V7, P340, DOI 10.18632/genesandcancer.124; Ohta Y, 1999, CANCER, V85, P2570, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2570::AID-CNCR12>3.3.CO;2-6; Perkins TN, 2015, HUM MOL GENET, V24, P1374, DOI 10.1093/hmg/ddu551; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Roe OD, 2010, LUNG CANCER, V67, P57, DOI 10.1016/j.lungcan.2009.03.016; Ryan AJ, 2014, J BIOL CHEM, V289, P33391, DOI 10.1074/jbc.M114.579870; Sarafan-Vasseur N, 2002, ONCOGENE, V21, P2051, DOI 10.1038/sj.onc.1205257; Schramm A, 2010, EUR J CARDIO-THORAC, V37, P566, DOI 10.1016/j.ejcts.2009.08.027; Sen D, 2015, OCCUP MED-OXFORD, V65, P6, DOI 10.1093/occmed/kqu175; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Shukla A, 2009, AM J RESP CELL MOL, V41, P114, DOI 10.1165/rcmb.2008-0146OC; Tamminen JA, 2012, J CELL BIOCHEM, V113, P2234, DOI 10.1002/jcb.24094; Thompson JK, 2017, AM J PATHOL, V187, P665, DOI 10.1016/j.ajpath.2016.11.008; Thompson JK, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-24; W.H.O. IARC, 2012, IARC MONOGRAPHS EVAL, P219	48	12	13	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4328	4342		10.1096/fj.201701291RR	http://dx.doi.org/10.1096/fj.201701291RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29553831	Green Published			2022-12-28	WOS:000439325400023
J	Fuller-Jackson, JP; Clarke, IJ; Rao, A; Henry, BA				Fuller-Jackson, John-Paul; Clarke, Iain J.; Rao, Alexandra; Henry, Belinda A.			Exercise counteracts the homeostatic decrease in thermogenesis caused by caloric restriction in sheep	FASEB JOURNAL			English	Article						brown adipose tissue; diet; physical activity; hypothalamic appetite-regulating peptides	BROWN ADIPOSE-TISSUE; REDUCED BODY-WEIGHT; ENERGY-EXPENDITURE; ADAPTIVE THERMOGENESIS; SKELETAL-MUSCLE; MELANOCORTIN-4 RECEPTOR; UNCOUPLING PROTEIN-3; OVARIECTOMIZED EWES; PHYSICAL-ACTIVITY; OREXIN-A	Caloric restriction causes a homeostatic reduction in thermogenesis. We aimed to determine whether exercise could counteract this. We studied four groups of normal-weight ewes (n = 5), including control sedentary fed ad libitum, exercise fed ad libitum (30 min/d, 5 d/wk), diet-restricted (70% of ad libitum food intake), and combined diet and exercise. Temperature probes implanted in sternal and retroperitoneal adipose tissue and skeletal muscle measured thermogenesis. After the 4-wk intervention, hypothalami were collected for in situ hybridization, and fat and muscle biopsies were collected for real-time PCR and Western blotting. Combined diet and exercise reduced adiposity (P < 0.05). Caloric restriction alone reduced overnight temperatures in sternal and retroperitoneal fat (P < 0.05), which was counteracted by exercise (P < 0.05). Exercise did not induce expression of cellular markers of browning in adipose tissue. There was no effect of diet or exercise on skeletal muscle thermogenesis. Combined diet and exercise increased the expression of neuropeptide Y and agouti-related protein in the hypothalamic arcuate nucleus (P < 0.05), consistent with reduced adiposity. Gene expressions of key hypothalamic appetite-regulating peptides were not associated with altered thermogenesis. We demonstrate that exercise counteracts the inhibitory effect of caloric restriction to restore thermogenesis in adipose tissue of sheep.Fuller-Jackson, J.-P., Clarke, I. J., Rao, A., Henry, B. A. Exercise counteracts the homeostatic decrease in thermogenesis caused by caloric restriction in sheep.	[Fuller-Jackson, John-Paul; Clarke, Iain J.; Rao, Alexandra; Henry, Belinda A.] Monash Univ, Dept Physiol, Monash Biomed Discovery Inst, Clayton, Vic, Australia	Monash University	Henry, BA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Metab Diabet & Obes Program, Dept Physiol, 26 Innovat Walk,Bldg 13 F,Wellington Rd, Clayton, Vic 3800, Australia.	belinda.henry@monash.edu		Clarke, Iain/0000-0002-6613-2757; Fuller-Jackson, John-Paul/0000-0002-2997-1340				Anderson EJP, 2016, J MOL ENDOCRINOL, V56, pT157, DOI 10.1530/JME-16-0014; Arruda AP, 2007, BBA-BIOMEMBRANES, V1768, P1498, DOI 10.1016/j.bbamem.2007.03.016; Backholer K, 2010, NEUROENDOCRINOLOGY, V91, P27, DOI 10.1159/000260060; BALLOR DL, 1988, AM J CLIN NUTR, V47, P19, DOI 10.1093/ajcn/47.1.19; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; BOCKING AD, 1986, J DEV PHYSIOL, V8, P237; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Calbet JAL, 2015, SCAND J MED SCI SPOR, V25, P223, DOI 10.1111/sms.12194; Camps SGJA, 2015, METABOLISM, V64, P1284, DOI 10.1016/j.metabol.2015.06.016; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Germano CMR, 2008, HORM METAB RES, V40, P842, DOI 10.1055/s-0028-1086024; Goele K, 2009, OBESITY FACTS, V2, P105, DOI 10.1159/000210369; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harper ME, 2002, DIABETES, V51, P2459, DOI 10.2337/diabetes.51.8.2459; Henry BA, 2015, J ANIM SCI, V93, P2083, DOI 10.2527/jas.2014-8764; Henry BA, 2001, BRAIN RES, V918, P40, DOI 10.1016/S0006-8993(01)02918-3; Henry BA, 2000, ENDOCRINOLOGY, V141, P1506, DOI 10.1210/en.141.4.1506; Henry BA, 2017, ENDOCRINOLOGY, V158, P2212, DOI 10.1210/en.2017-00081; Henry BA, 2011, ENDOCRINOLOGY, V152, P2609, DOI 10.1210/en.2011-0143; Hewagalamulage SD, 2015, J NEUROENDOCRINOL, V27, P44, DOI 10.1111/jne.12233; Hewagalamulage SD, 2016, ENDOCRINOLOGY, V157, P3540, DOI 10.1210/en.2016-1287; HIRATA K, 1981, JPN J PHYSIOL, V31, P657; Johns DJ, 2014, J ACAD NUTR DIET, V114, P1557, DOI 10.1016/j.jand.2014.07.005; KAHN CR, 1976, J CELL BIOL, V70, P261, DOI 10.1083/jcb.70.2.261; KEKOW J, 1988, DIABETES, V37, P321, DOI 10.2337/diabetes.37.3.321; Kissileff HR, 2012, AM J CLIN NUTR, V95, P309, DOI 10.3945/ajcn.111.012385; Kiwaki K, 2004, AM J PHYSIOL-ENDOC M, V286, pE551, DOI 10.1152/ajpendo.00126.2003; Kotz CM, 2006, NEUROSCIENCE, V142, P29, DOI 10.1016/j.neuroscience.2006.05.028; Kotz CM, 2002, REGUL PEPTIDES, V104, P27, DOI 10.1016/S0167-0115(01)00346-9; LEHMAN MN, 1986, J COMP NEUROL, V244, P19, DOI 10.1002/cne.902440103; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEWIS DE, 1993, AM J PHYSIOL, V264, pE279, DOI 10.1152/ajpendo.1993.264.2.E279; Loh K, 2015, TRENDS ENDOCRIN MET, V26, P125, DOI 10.1016/j.tem.2015.01.003; MacLean PS, 2009, AM J PHYSIOL-REG I, V297, pR793, DOI 10.1152/ajpregu.00192.2009; Motiani P, 2017, DIABETES OBES METAB, V19, P1379, DOI 10.1111/dom.12947; Muller MJ, 2015, AM J CLIN NUTR, V102, P807, DOI 10.3945/ajcn.115.109173; Nixon Joshua P, 2012, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-642-24716-3_4; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Novak CM, 2006, AM J PHYSIOL-ENDOC M, V290, pE396, DOI 10.1152/ajpendo.00293.2005; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Rogers NH, 2016, ENDOCRINOLOGY, V157, P1430, DOI 10.1210/en.2015-1745; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Rosenbaum M, 2016, OBESITY, V24, P1620, DOI 10.1002/oby.21559; ROTHWELL NJ, 1984, BIOSCIENCE REP, V4, P351, DOI 10.1007/BF01140499; Scharhag-Rosenberger F, 2014, MED SCI SPORT EXER, V46, P1736, DOI 10.1249/MSS.0000000000000286; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; THOMAS GB, 1991, ENDOCRINOLOGY, V128, P1151, DOI 10.1210/endo-128-2-1151; Trexler E. T., 2017, J NAT SCI, V3, pe335; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004; Verty ANA, 2010, ENDOCRINOLOGY, V151, P4236, DOI 10.1210/en.2009-1235; Vosselman MJ, 2015, INT J OBESITY, V39, P1696, DOI 10.1038/ijo.2015.130; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu MV, 2014, J BIOL CHEM, V289, P34129, DOI 10.1074/jbc.M114.591008; YOSHIOKA K, 1989, ENDOCRINOL JAPON, V36, P403; Yu YH, 2009, BEHAV BRAIN RES, V205, P50, DOI 10.1016/j.bbr.2009.07.003	61	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3859	3869		10.1096/fj.201701504R	http://dx.doi.org/10.1096/fj.201701504R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29455575				2022-12-28	WOS:000435104500031
J	Hempel, C; Sporring, J; Kurtzhals, JAL				Hempel, Casper; Sporring, Jon; Kurtzhals, Jorgen Anders Lindholm			Experimental cerebral malaria is associated with profound loss of both glycan and protein components of the endothelial glycocalyx	FASEB JOURNAL			English	Article						image analyses; adjunctive treatment; pathogenesis; Plasmodium berghei ANKA; Plasmodium chabaudi AS	HEPARAN-SULFATE PROTEOGLYCANS; PLASMODIUM-FALCIPARUM; MATRIX METALLOPROTEINASES; BLOOD-COAGULATION; TISSUE INHIBITORS; GROWTH-FACTOR; CELLS; BRAIN; ANTITHROMBIN; INFLAMMATION	Vascular pathology is central to malaria pathogenesis and associated with severity of disease. We have previously documented shedding of the cerebral endothelial glycocalyx in experimental malaria and hypothesized that this action is implicated in the pathogenesis of cerebral malaria (CM). Quantification and characterization of the intraluminal vascular glycocalyx are technically challenging. Here, we used ferritin labeling, computerized image analysis, and biochemical characterization by using in vivo biotinylation and pull down. Image analysis divided mice with CM and uncomplicated malaria and uninfected control mice into 3 non-overlapping groups. Biochemical assessment of the luminal surface revealed malaria-induced alterations in all components of the glycocalyx in CM. This loss was mirrored in increases of the same components in peripheral blood samples. Corticosteroid treatment protected against CM, reduced inflammation, and prevented glycocalyx loss. Adjunctive antithrombin-3 also prevented glycocalyx loss and significantly reduced CM-associated mortality, as well as reduced local inflammation and prevented blood-brain barrier leakage. In contrast, inhibition of matrix metalloproteases with batimastat had limited effects on the glycocalyx and disease progression. Thus, glycocalyx loss may be associated with malaria pathogenesis and could be targeted by adjunctive treatment.Hempel, C., Sporring, J., Kurtzhals, J. A. L. Experimental cerebral malaria is associated with profound loss of both glycan and protein components of the endothelial glycocalyx.	[Hempel, Casper; Kurtzhals, Jorgen Anders Lindholm] Copenhagen Univ Hosp, Dept Clin Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Hempel, Casper; Kurtzhals, Jorgen Anders Lindholm] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Sporring, Jon] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Hempel, Casper] Tech Univ Denmark, Dept Micro & Nanotechnol, Bldg 423, DK-2800 Lyngby, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Hempel, C (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Bldg 423, DK-2800 Lyngby, Denmark.	casperhempel@gmail.com	Kurtzhals, Jorgen/Y-3799-2019; Hempel, Casper/ABE-7065-2020; Sporring, Jon/L-4499-2016	Kurtzhals, Jorgen/0000-0003-2760-8713; Hempel, Casper/0000-0002-9816-4673; Sporring, Jon/0000-0003-1261-6702	Research Council at Copenhagen University Hospital; Danish Research Council (FSS) Grant [6110-00554]	Research Council at Copenhagen University Hospital; Danish Research Council (FSS) Grant	The Core Facility for Integrated Microscopy (CFIM; University of Copenhagen) is highly acknowledged. The authors give special thanks to Ramon Liebrechts for help with electron tomography. The authors greatly appreciate the technical staff at the department for Experimental Medicine (University of Copenhagen) for taking care of the mice and for assistance with animal experiments. The use of the charge-coupled device camera for detecting luminescence at the Centre of Inflammation and Metabolism (Bente Klarlund, University of Copenhagen) is highly appreciated. The authors thank Anna Kildemoes (University of Copenhagen) for help with initial ELISAs, and Michele Kreutzer (previously from the University of Copenhagen) for helping with tissue homogenates, Lars Christoffersen (Copenhagen University Hospital) for helping with Luminex assays, and Brian DellaValle and Trine StaalsO (University of Copenhagen) for fruitful discussions. This work was supported by the Research Council at Copenhagen University Hospital and Danish Research Council (FSS) Grant 6110-00554 (to C.H.). The authors declare no conflicts of interest.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Albeiroti S, 2015, BLOOD, V125, P1460, DOI 10.1182/blood-2014-07-590513; BALDWIN AL, 1985, ATHEROSCLEROSIS, V55, P233, DOI 10.1016/0021-9150(85)90102-9; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Becker BF, 2015, BRIT J CLIN PHARMACO, V80, P389, DOI 10.1111/bcp.12629; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Chappell D, 2009, CARDIOVASC RES, V83, P388, DOI 10.1093/cvr/cvp097; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Dellavalle B., 2014, PARASITOLOGY; Dietmann A, 2008, J INFECT DIS, V197, P1614, DOI 10.1086/587943; Egorov SA, 2015, SOFT MATTER, V11, P2604, DOI 10.1039/c4sm02862g; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Gilbert-Kawai E, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-015-0078-8; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Hein-Kristensen L, 2009, EXP PARASITOL, V123, P152, DOI 10.1016/j.exppara.2009.06.010; Hempel C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1844-6; Hempel C, 2016, TRENDS MOL MED, V22, P453, DOI 10.1016/j.molmed.2016.04.004; Hempel C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00291; Hempel C, 2014, J CEREBR BLOOD F MET, V34, P1107, DOI 10.1038/jcbfm.2014.79; Hempel C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-216; Hempel C, 2011, AM J PATHOL, V179, P1939, DOI 10.1016/j.ajpath.2011.06.027; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; ISHAIMICHAELI R, 1990, CELL REGUL, V1, P833, DOI 10.1091/mbc.1.11.833; JORDAN RE, 1980, J BIOL CHEM, V255, P81; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Levy JH, 2016, THROMB HAEMOSTASIS, V115, P712, DOI 10.1160/TH15-08-0687; Liuhanen S, 2013, COMPUT METH PROG BIO, V110, P38, DOI 10.1016/j.cmpb.2012.10.019; LOSSINSKY AS, 1989, ACTA NEUROPATHOL, V77, P480, DOI 10.1007/BF00687249; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Medana IM, 2000, AM J PATHOL, V156, P1055, DOI 10.1016/S0002-9440(10)64973-5; Mohanty D, 1997, AM J HEMATOL, V54, P23, DOI 10.1002/(SICI)1096-8652(199701)54:1&lt;23::AID-AJH4&gt;3.0.CO;2-6; Mota MM, 2000, INFECT IMMUN, V68, P4135, DOI 10.1128/IAI.68.7.4135-4144.2000; Moxon CA, 2014, J INFECT DIS, V209, P610, DOI 10.1093/infdis/jit419; Mulivor AW, 2009, MICROCIRCULATION, V16, P657, DOI 10.3109/10739680903133714; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; O'Sullivan JM, 2016, BLOOD, V127, P2281, DOI 10.1182/blood-2015-11-636464; Piguet PF, 2000, INFECT IMMUN, V68, P3822, DOI 10.1128/IAI.68.7.3822-3829.2000; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P657, DOI 10.1097/00001721-200212000-00001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; SEWELL RF, 1989, BIOCHEM J, V264, P777, DOI 10.1042/bj2640777; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; SIMIONESCU M, 1982, ANN NY ACAD SCI, V401, P9, DOI 10.1111/j.1749-6632.1982.tb25703.x; Storm J, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00100; Szatmari T, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00310; Tatour M, 2017, THROMB HAEMOSTASIS, V117, P1391, DOI 10.1160/TH16-10-0766; Team RC., 2022, LANG ENV STAT COMP; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; van den Biggelaar M, 2014, BLOOD, V123, pE22, DOI 10.1182/blood-2013-12-546036; Van den Steen PE, 2006, LAB INVEST, V86, P873, DOI 10.1038/labinvest.3700454; Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; Wassmer SC, 2011, CELL MICROBIOL, V13, P198, DOI 10.1111/j.1462-5822.2010.01528.x; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; Wiesinger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080905; Winkler CW, 2012, J BIOL CHEM, V287, P33237, DOI 10.1074/jbc.M112.356287	68	17	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2058	2071		10.1096/fj.201800657R	http://dx.doi.org/10.1096/fj.201800657R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30226810				2022-12-28	WOS:000457296600043
J	Petrosino, JM; Leask, A; Accornero, F				Petrosino, Jennifer M.; Leask, Andrew; Accornero, Federica			Genetic manipulation of CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle	FASEB JOURNAL			English	Article						fibrosis; muscular dystrophy; muscle regeneration	TISSUE GROWTH-FACTOR; TGF-BETA; FACTOR CTGF/CCN2; SATELLITE CELLS; COLLAGEN; MATRIX; REGENERATION; FIBROSIS; HYPERTROPHY; FIBROBLASTS	In skeletal muscle, extracellular matrix (ECM) remodeling can either support the complete regeneration of injured muscle or facilitate pathologic fibrosis and muscle degeneration. Muscular dystrophy (MD) is a group of genetic disorders that results in a progressive decline in muscle function and is characterized by the abundant deposition of fibrotic tissue. Unlike acute injury, where ECM remodeling is acute and transient, in MD, remodeling persists until fibrosis obstructs the regenerative efforts of diseased muscles. Thus, understanding how ECM is deposited and organized is critical in the context of muscle repair. Connective tissue growth factor (CTGF or CCN2) is a matricellular protein expressed by multiple cell types in response to tissue injury. Although used as a general marker of fibrosis, the cell type-dependent role of CTGF in dystrophic muscle has not been elucidated. To address this question, a conditional Ctgf myofiber and fibroblast-knockout mouse lines were generated and crossed to a dystrophic background. Only myofiber-selective inhibition of CTGF protected -sarcoglycan-null (Sgcd(-/-)) mice from the dystrophic phenotype, and it did so by affecting collagen organization in a way that allowed for improvements in dystrophic muscle regeneration and function. To confirm that muscle-specific CTGF functions to mediate collagen organization, we generated mice with transgenic muscle-specific overexpression of CTGF. Again, genetic modulation of CTGF in muscle was not sufficient to drive fibrosis, but altered collagen content and organization after injury. Our results show that the myofibers are critical mediators of the deleterious effects associated with CTGF in MD and acutely injured skeletal muscle.Petrosino, J. M., Leask, A., Accornero, F. Genetic manipulation of CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle.	[Petrosino, Jennifer M.; Accornero, Federica] Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA; [Leask, Andrew] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada	University System of Ohio; Ohio State University; Western University (University of Western Ontario)	Accornero, F (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA.	federica.accornero@osumc.edu	Leask, Andrew/G-5217-2015; Leask, Andy/ABH-9433-2020	Petrosino, Jennifer M/0000-0002-5951-8942; Accornero, Federica/0000-0003-1209-7228	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R00HL121284, R01HL136951]; NIH National Institute of General Medical Sciences [T32GM068412]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [F31AR073638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL121284, R01HL136951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR073638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (Grants R00HL121284 and R01HL136951 to F.A.), NIH National Institute of General Medical Sciences (Grant T32GM068412), and NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant F31AR073638 to J.M.P.). The authors declare no conflicts of interest.	Accornero F, 2015, MOL CELL BIOL, V35, P2154, DOI 10.1128/MCB.00199-15; Accornero F, 2014, HUM MOL GENET, V23, P6903, DOI 10.1093/hmg/ddu413; Accornero F, 2011, CIRC RES, V109, P272, DOI 10.1161/CIRCRESAHA.111.240820; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008; Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Carmignac V, 2012, J PATHOL, V226, P200, DOI 10.1002/path.3020; Chapman MA, 2016, DIFFERENTIATION, V92, P108, DOI 10.1016/j.diff.2016.05.007; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Cordova G, 2015, J CELL BIOCHEM, V116, P1880, DOI 10.1002/jcb.25143; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Fallon JR, 2018, MATRIX BIOL, V68-69, P616, DOI 10.1016/j.matbio.2018.02.016; Fontes MSC, 2015, J MOL CELL CARDIOL, V88, P82, DOI 10.1016/j.yjmcc.2015.09.015; Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010; Morales MG, 2018, J CELL COMMUN SIGNAL, V12, P413, DOI 10.1007/s12079-017-0409-3; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Goldstein JA, 2014, HUM MOL GENET, V23, P6722, DOI 10.1093/hmg/ddu390; Gonzalez MN, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0138-6; Gravning J, 2013, INT J CARDIOL, V168, P2049, DOI 10.1016/j.ijcard.2013.01.165; Hack AA, 2000, J CELL SCI, V113, P2535; IANNACCONE S, 1995, J NEUROL SCI, V128, P36, DOI 10.1016/0022-510X(94)00219-E; Ivey MJ, 2016, CIRC J, V80, P2269, DOI 10.1253/circj.CJ-16-1003; Acuna MJ, 2017, METHODS MOL BIOL, V1489, P513, DOI 10.1007/978-1-4939-6430-7_43; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Kutchuk L, 2015, DEVELOPMENT, V142, P983, DOI 10.1242/dev.113449; Lamar KM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006019; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Leask A, 2013, EXPERT OPIN THER TAR, V17, P1067, DOI 10.1517/14728222.2013.812074; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Merly F, 1999, MUSCLE NERVE, V22, P724, DOI 10.1002/(SICI)1097-4598(199906)22:6<724::AID-MUS9>3.0.CO;2-O; Mezzano V, 2007, J CELL COMMUN SIGNAL, V1, P205, DOI 10.1007/s12079-008-0018-2; Murakami N, 1999, MUSCLE NERVE, V22, P889, DOI 10.1002/(SICI)1097-4598(199907)22:7<889::AID-MUS12>3.0.CO;2-B; Petrosino JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148010; Quattrocelli M, 2017, BBA-MOL CELL RES, V1864, P572, DOI 10.1016/j.bbamcr.2016.12.020; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; RICARDBLUM S, 1989, INT J BIOCHEM, V21, P1185, DOI 10.1016/0020-711X(89)90001-3; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Smith LR, 2018, MATRIX BIOL, V68-69, P602, DOI 10.1016/j.matbio.2018.01.014; Smith LR, 2016, MUSCLE NERVE, V54, P71, DOI 10.1002/mus.24998; Smith LR, 2014, AM J PHYSIOL-CELL PH, V306, pC889, DOI 10.1152/ajpcell.00383.2013; Song YM, 2017, EXP THER MED, V13, P1209, DOI 10.3892/etm.2017.4105; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; Sun GL, 2009, J NEUROL SCI, V280, P40, DOI 10.1016/j.jns.2009.01.020; Takagi R, 2016, PFLUG ARCH EUR J PHY, V468, P1565, DOI 10.1007/s00424-016-1860-3; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Tierney MT, 2016, CELL REP, V14, P1940, DOI 10.1016/j.celrep.2016.01.072; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278	57	22	22	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2047	2057		10.1096/fj.201800622RR	http://dx.doi.org/10.1096/fj.201800622RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30216109	Green Published			2022-12-28	WOS:000457296600042
J	Feldman, A; Saleh, A; Pnueli, L; Qiao, S; Shlomi, T; Boehm, U; Melamed, P				Feldman, Alona; Saleh, Ayah; Pnueli, Lilach; Qiao, Sen; Shlomi, Tomer; Boehm, Ulrich; Melamed, Philippa			Sensitivity of pituitary gonadotropes to hyperglycemia leads to epigenetic aberrations and reduced follicle-stimulating hormone levels	FASEB JOURNAL			English	Article						fertility; gonadotropin; histone acetylation; histone methylation; DNA methylation	METABOLIC-CONTROL; HISTONE DEACETYLASES; GENE-TRANSCRIPTION; PUBERTY ONSET; INSULIN; EXPRESSION; MEMORY; MICE; ACTIVATION; MECHANISMS	The connection between metabolism and reproductive function is well recognized, and we hypothesized that the pituitary gonadotropes, which produce luteinizing hormone and follicle-stimulating hormone (FSH), mediate some of the effects directly via insulin-independent glucose transporters, which allow continued glucose metabolism during hyperglycemia. We found that glucose transporter 1 is the predominant glucose transporter in primary gonadotropes and a gonadotrope precursor-derived cell line, and both are responsive to culture in high glucose; moreover, metabolite levels were altered in the cell line. Several of the affected metabolites are cofactors for chromatin-modifying enzymes, and in the gonadotrope precursor-derived cell line, we recorded global changes in histone acetylation and methylation, decreased DNA methylation, and increased hydroxymethylation, some of which did not revert to basal levels after cells were returned to normal glucose. Despite this weakening of epigenetic-mediated repression seen in the model cell line, FSH -subunit (Fshb) mRNA levels in primary gonadotropes were significantly reduced, apparently due in part to increased autocrine/paracrine effects of inhibin. However, unlike thioredoxin interacting protein and inhibin subunit , Fshb mRNA levels did not recover after the return of cells to normal glucose. The effect on Fshb expression was also seen in 2 hyperglycemic mouse models, and levels of circulating FSH, required for follicle growth and development, were reduced. Thus, hyperglycemia seems to target the pituitary gonadotropes directly, and the likely extensive epigenetic changes are sensed acutely by Fshb. This scenario would explain clinical findings in which, even after restoration of optimal blood glucose levels, fertility often remains adversely affected. However, the relative accessibility of the pituitary provides a possible target for treatment, particularly crucial in the young in which hyperglycemia is increasingly common and fertility most relevant.Feldman, A., Saleh, A., Pnueli, L., Qiao, S., Shlomi, T., Boehm, U., Melamed, P. Sensitivity of pituitary gonadotropes to hyperglycemia leads to epigenetic aberrations and reduced follicle-stimulating hormone levels.	[Feldman, Alona; Saleh, Ayah; Pnueli, Lilach; Shlomi, Tomer; Melamed, Philippa] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel; [Qiao, Sen; Boehm, Ulrich] Saarland Univ, Ctr Mol Signaling PZMS, Expt Pharmacol, Sch Med, Homburg, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Universitatsklinikum des Saarlandes	Melamed, P (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	philippa@tx.technion.ac.il			German Research Foundation (Deutsche Forschungsgemeinschaft) [BO 1743/7-1, SFB 894]; Israel Science Foundation [840/12]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	This research was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grants BO 1743/7-1 (to U.B. and P.M.) and SFB 894 (to U.B.), and Israel Science Foundation Grant 840/12 (to P.M.). The authors acknowledge the gift from Pamela Mellon (University of California-San Diego, La Jolla, CA, USA) of the gonadotrope cell line and Derek LeRoith (Technion-Israel Institute of Technology) for the MKR mice. The authors declare no conflicts of interest.	Aguilar-Arnal L, 2015, NAT STRUCT MOL BIOL, V22, P312, DOI 10.1038/nsmb.2990; ANDERS S, 2010, GENOME BIOL, V11; Arrais RF, 2006, HUM REPROD, V21, P327, DOI 10.1093/humrep/dei353; Berger S. L., 2016, COLD SPRING HARB PER, V8; Brewer CJ, 2010, REPRODUCTION, V140, P347, DOI 10.1530/REP-09-0568; Chandel A, 2008, DIABETES CARE, V31, P2013, DOI 10.2337/dc08-0851; Chen Z, 2016, P NATL ACAD SCI USA, V113, pE3002, DOI 10.1073/pnas.1603712113; Chisolm DA, 2018, CURR OPIN IMMUNOL, V51, P62, DOI 10.1016/j.coi.2018.01.005; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Codner E, 2012, HUM REPROD UPDATE, V18, P568, DOI 10.1093/humupd/dms024; Codner E, 2009, HORM RES, V71, P12, DOI 10.1159/000173737; Cosentino C, 2013, CELL MOL LIFE SCI, V70, P1525, DOI 10.1007/s00018-013-1295-3; Donato J, 2011, NEUROENDOCRINOLOGY, V93, P9, DOI 10.1159/000322472; Egan OK, 2017, J NEUROSCI, V37, P3875, DOI 10.1523/JNEUROSCI.3138-16.2017; Feng J, 2008, BIOL REPROD, V79, P546, DOI 10.1095/biolreprod.108.068106; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Haj M, 2017, J BIOL CHEM, V292, P20720, DOI 10.1074/jbc.M117.797845; Harris VM, 2012, J ENDOCRINOL, V212, P139, DOI 10.1530/JOE-11-0359; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hwang ES, 2017, CELL MOL LIFE SCI, V74, P3347, DOI 10.1007/s00018-017-2527-8; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kelsey MM, 2018, J CLIN ENDOCR METAB, V103, P2309, DOI 10.1210/jc.2018-00132; Kim CH, 2006, AM J PHYSIOL-ENDOC M, V291, pE298, DOI 10.1152/ajpendo.00319.2005; Kolthur-Seetharam U, 2009, BIOL REPROD, V80, P384, DOI 10.1095/biolreprod.108.070193; Lannes J, 2015, MOL ENDOCRINOL, V29, P364, DOI 10.1210/me.2014-1390; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Luo ZJ, 2010, MOL CELL BIOL, V30, P745, DOI 10.1128/MCB.00807-09; Manfredi-Lozano M, 2018, FRONT NEUROENDOCRIN, V48, P37, DOI 10.1016/j.yfrne.2017.07.008; Maresch CC, 2018, HUM REPROD UPDATE, V24, P86, DOI 10.1093/humupd/dmx033; Martinez D, 2016, DIABETIC MED, V33, P1366, DOI 10.1111/dme.13078; Melamed P, 2008, TRENDS ENDOCRIN MET, V19, P25, DOI 10.1016/j.tem.2007.10.008; Melamed P, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00022; Melamed P, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00058; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Navarro VM, 2013, CURR OPIN ENDOCRINOL, V20, P335, DOI 10.1097/MED.0b013e32836318ce; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Olsen AS, 2012, DIABETES, V61, P485, DOI 10.2337/db11-0588; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Pnueli L, 2015, P NATL ACAD SCI USA, V112, P4369, DOI 10.1073/pnas.1414841112; Qiao S, 2016, ENDOCRINOLOGY, V157, P1082, DOI 10.1210/en.2015-1836; Raffel S, 2017, NATURE, V551, P384, DOI 10.1038/nature24294; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Roa J, 2010, MOL CELL ENDOCRINOL, V324, P87, DOI 10.1016/j.mce.2009.12.018; Rudnizky S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12958; Sanchez-Garrido MA, 2013, ENDOCRINOLOGY, V154, P3387, DOI 10.1210/en.2012-2157; Sanchez-Garrido MA, 2013, HORM BEHAV, V64, P187, DOI 10.1016/j.yhbeh.2013.01.014; Savulescu D, 2013, MOL ENDOCRINOL, V27, P1856, DOI 10.1210/me.2013-1210; Schoeller EL, 2012, DIABETES, V61, P1869, DOI 10.2337/db11-1527; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; STEGER RW, 1993, NEUROENDOCRINOLOGY, V57, P525, DOI 10.1159/000126401; van der Knaap JA, 2016, GENE DEV, V30, P2345, DOI 10.1101/gad.289140.116; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Volpi R, 1998, EUR J CLIN INVEST, V28, P819; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; Wijeweera A, 2015, BBA-GENE REGUL MECH, V1849, P328, DOI 10.1016/j.bbagrm.2015.01.001; Wolfe A, 2014, FRONT NEUROENDOCRIN, V35, P558, DOI 10.1016/j.yfrne.2014.05.007; Wu XY, 2016, DNA CELL BIOL, V35, P542, DOI 10.1089/dna.2016.3280; Yosefzon Y, 2017, P NATL ACAD SCI USA, V114, P10131, DOI 10.1073/pnas.1704393114; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022	68	4	4	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1020	1032		10.1096/fj.201800943R	http://dx.doi.org/10.1096/fj.201800943R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30074825				2022-12-28	WOS:000457401500080
J	Whitcomb, EA; Tsai, YC; Basappa, J; Liu, K; Le Feuvre, AK; Weissman, AM; Taylor, A				Whitcomb, Elizabeth A.; Tsai, Yien Che; Basappa, Johnvesly; Liu, Ke; Le Feuvre, Aurelie K.; Weissman, Allan M.; Taylor, Allen			Stabilization of p27(Kip1)/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control	FASEB JOURNAL			English	Article						cell division; proteasome; ubiquitin-conjugating enzyme; CDKI	LENS EPITHELIAL-CELLS; CONJUGATING ENZYMES E2S; S-PHASE; PROTEASOME PATHWAY; ACTIVATING ENZYME; DAMAGED PROTEINS; NUCLEAR EXPORT; BREAST-CANCER; DEGRADATION; EXPRESSION	Ubiquitinylation drives many cellular processes by targeting proteins for proteasomal degradation. Ubiquitin conjugation enzymes promote ubiquitinylation and, thus, degradation of protein substrates. Ubiquitinylation is a well-known posttranslational modification controlling cell-cycle transitions and levels or/and activation levels of ubiquitin-conjugating enzymes change during development and cell cycle. Progression through the cell cycle is tightly controlled by CDK inhibitors such as p27(Kip1). Here we show that, in contrast to promoting its degradation, the ubiquitin-conjugating enzyme UBCH7/UBE2L3 specifically protects p27(Kip1) from degradation. Overexpression of UBCH7/UBE2L3 stabilizes p27(Kip1) and delays the G(1)-to-S transition, while depletion of UBCH7/UBE2L3 increases turnover of p27(Kip1). Levels of p21(Cip1/Waf1), p57(Kip2), cyclin A and cyclin E, all of which are also involved in regulating the G(1)/S transition are not affected by UBCH7/UBE2L3 depletion. The effect of UBCH7/UBE2L3 on p27(Kip1) is not due to alteration of the levels of any of the ubiquitin ligases known to ubiquitinylate p27(Kip1). Rather, UBCH7/UBE2L3 catalyzes the conjugation of heterotypic ubiquitin chains on p27(Kip1) that are proteolytically incompetent. These data reveal new controls and concepts about the ubiquitin proteasome system in which a ubiquitin-conjugating enzyme selectively inhibits and may even protect, rather than promote degradation of a crucial cell-cycle regulatory molecule.Whitcomb, E. A., Tsai, Y. C., Basappa, J., Liu, K., Le Feuvre, A. K., Weissman, A. M., Taylor, A. Stabilization of p27(Kip1)/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control.	[Whitcomb, Elizabeth A.; Basappa, Johnvesly; Liu, Ke; Le Feuvre, Aurelie K.; Taylor, Allen] Tufts Univ, Lab Nutr & Vis Res, JM USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, Frederick, MD 21701 USA; [Basappa, Johnvesly] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Liu, Ke] Sichuan Univ, Key Lab Bioresource & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Le Feuvre, Aurelie K.] Mission Therapeut, Cambridge, England	Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fox Chase Cancer Center; Sichuan University	Whitcomb, EA; Taylor, A (corresponding author), Tufts Univ, JM USDA, Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	elizabeth.whitcomb@tufts.edu; allen.taylor@tufts.edu	Liu, Ke/D-3380-2015	Liu, Ke/0000-0002-4683-9325; Tsai, Yien Che/0000-0001-9624-1092	U.S. National Institutes of Health (NIH) National Eye Institute [RO1 EY 13250, RO1 EY21212, RO1 EY26979]; U.S. Department of Agriculture [1950-510000-060-03A]; NIH Center for Cancer Research-National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC010292] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY026979] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NIH Center for Cancer Research-National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was provided by U.S. National Institutes of Health (NIH) National Eye Institute Grants RO1 EY 13250, RO1 EY21212, and RO1 EY26979, U.S. Department of Agriculture contract 1950-510000-060-03A (to A.T.), and the NIH Center for Cancer Research-National Cancer Institute Intramural Research Program (to Y.C.T. and A.M.W.). The authors thank E. Bejarano-Fernandez (Tufts University) for critical review and W. Yang (Brandeis University, Waltham, MA, USA) for expert technical assistance. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Borel F, 2002, J CELL SCI, V115, P2829; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chiaroni-Clarke RC, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-53; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Craney A, 2013, CURR OPIN CELL BIOL, V25, P704, DOI 10.1016/j.ceb.2013.07.004; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; Eliseeva E, 2001, CELL GROWTH DIFFER, V12, P427; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Grice GL, 2015, CELL REP, V12, P545, DOI 10.1016/j.celrep.2015.06.061; Guan XX, 2010, J CELL MOL MED, V14, P944, DOI 10.1111/j.1582-4934.2009.00730.x; Guo WM, 2004, INVEST OPHTH VIS SCI, V45, P1194, DOI 10.1167/iovs.03-0830; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iovine B, 2011, BIOCHIMIE, V93, P867, DOI 10.1016/j.biochi.2010.12.017; JAHNGEN JH, 1986, J BIOL CHEM, V261, P3760; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kullmann MK, 2013, CELL CYCLE, V12, P2625, DOI 10.4161/cc.25622; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Liu K, 2015, P NATL ACAD SCI USA, V112, P1071, DOI 10.1073/pnas.1404059112; Liu Q, 2004, EXP EYE RES, V78, P197, DOI 10.1016/j.exer.2003.11.009; Liu Q, 2006, INVEST OPHTH VIS SCI, V47, P1302, DOI 10.1167/iovs.05-0935; Liu Q, 2006, MOL VIS, V12, P931; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Lyu L, 2016, FASEB J, V30, P1087, DOI 10.1096/fj.15-278036; Ma XJ, 2017, ONCOTARGET, V8, P84193, DOI 10.18632/oncotarget.20449; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Oh KJ, 2004, J VIROL, V78, P5338, DOI 10.1128/JVI.78.10.5338-5346.2004; Ohtake F, 2018, P NATL ACAD SCI USA, V115, pE1401, DOI 10.1073/pnas.1716673115; Orozco G, 2011, ANN RHEUM DIS, V70, P463, DOI 10.1136/ard.2010.137174; Park SH, 2011, CANCER LETT, V310, P232, DOI 10.1016/j.canlet.2011.07.009; Patel D, 2010, J VIROL, V84, P10956, DOI 10.1128/JVI.00259-10; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Plafker KS, 2010, J BIOL CHEM, V285, P23062, DOI 10.1074/jbc.M110.121913; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reichard EL, 2016, J BIOL CHEM, V291, P18547, DOI 10.1074/jbc.M116.720151; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shang F, 2001, EXP EYE RES, V73, P827, DOI 10.1006/exer.2001.1091; Shi Q, 2015, DEV CELL, V35, P483, DOI 10.1016/j.devcel.2015.10.014; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Thomas JJ, 2016, CELL REP, V16, P3388, DOI 10.1016/j.celrep.2016.08.024; Topper LM, 2001, J CELL BIOL, V154, P707, DOI 10.1083/jcb.200104130; Tsuruta F, 2016, MOL CELL BIOL, V36, P2182, DOI 10.1128/MCB.00174-16; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Wagner M, 2001, EXP GERONTOL, V37, P41, DOI 10.1016/S0531-5565(01)00165-6; Wang Y, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0098-6; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Whitcomb EA, 2009, MOL BIOL CELL, V20, P1, DOI 10.1091/mbc.E08-01-0036; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162	84	12	14	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1235	1247		10.1096/fj.201800960R	http://dx.doi.org/10.1096/fj.201800960R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113882	Green Published			2022-12-28	WOS:000457401500098
J	Bseikri, M; McCann, JC; Lal, A; Fong, E; Graves, K; Goldrich, A; Block, D; Gildengoren, GL; Mietus-Snyder, M; Shigenaga, M; Suh, J; Hardy, K; Ames, BN				Bseikri, Mustafa; McCann, Joyce C.; Lal, Ashutosh; Fong, Edward; Graves, Kirsten; Goldrich, Alisa; Block, Devan; Gildengoren, Ginny L.; Mietus-Snyder, Michele; Shigenaga, Mark; Suh, Jung; Hardy, Karen; Ames, Bruce N.			A novel nutritional intervention improves lung function in overweight/obese adolescents with poorly controlled asthma: the Supplemental Nutrition in Asthma Control (SNAC) pilot study	FASEB JOURNAL			English	Article						CHORI-bar; chronic inflammation; noneosinophilic asthma	EXHALED NITRIC-OXIDE; EXERCISE-INDUCED BRONCHOCONSTRICTION; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; WEIGHT-LOSS; METABOLIC SYNDROME; SYSTEMIC INFLAMMATION; AIRWAY INFLAMMATION; RESPIRATORY HEALTH; PHYSICAL-ACTIVITY	Asthma in the obese is often severe, difficult to treat, and characterized by less eosinophilic inflammation than asthma in the nonobese. Obesity-associated metabolic dysregulation may be a causal factor. We previously reported that a nutrient- and fiber-dense bar [Children's Hospital Oakland Research Institute (CHORI)-bar], which was designed to fill gaps in poor diets, improved metabolism in healthy overweight/obese (OW/OB) adults. In this pilot trial, OW/OB adolescents with poorly controlled asthma were randomized to weekly nutrition/exercise classes with or without twice-daily CHORI-bar consumption. Intent-to-treat analysis did not indicate CHORI-bar-specific effects. However, restricting the analysis to participants with acceptable compliance and a relatively low fraction of exhaled nitric oxide (FENO; <50/ ppb, a surrogate for noneosinophilic asthma; study participants: CHORI-bar, n = 16; controls, n = 15) indicated that CHORI-bar-specific, significant improvements in lung function (forced vital capacity, percent-predicted forced expiratory volume in 1 s, and percent-predicted forced expiratory flow between 25 and 75% of forced vital capacity), primarily in participants with low chronic inflammation (high-sensitivity C-reactive protein <1.5 mg/L). (We previously observed that chronic inflammation blunted CHORI-bar-induced metabolic improvements in healthy OW/OB adults.) Lung function improvement occurred without weight loss and was independent of improvements in metabolic and anthropometric end points and questionnaire-based measures of asthma control and quality of life. This study suggests that a nutritional intervention can improve lung function in OW/OB adolescents with asthma and relatively low FENO without requiring major changes in dietary habits, lifestyle, or weight loss and that this effect is blunted by chronic inflammation.Bseikri, M., McCann, J. C., Lal, A., Fong, E., Graves, K., Goldrich, A., Block, D., Gildengoren, G. L., Mietus-Snyder, M., Shigenaga, M., Suh, J., Hardy, K., Ames, B. N. A novel nutritional intervention improves lung function in overweight/obese adolescents with poorly controlled asthma: the Supplemental Nutrition in Asthma Control (SNAC) pilot study.	[Bseikri, Mustafa; Lal, Ashutosh; Fong, Edward; Gildengoren, Ginny L.; Mietus-Snyder, Michele; Hardy, Karen] Univ Calif San Francisco UCSF Benioff Childrens H, 747 52nd St, Oakland, CA 94609 USA; [McCann, Joyce C.; Graves, Kirsten; Goldrich, Alisa; Block, Devan; Gildengoren, Ginny L.; Shigenaga, Mark; Suh, Jung; Ames, Bruce N.] CHORI, Ctr Nutr & Metab, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA; [Mietus-Snyder, Michele] Childrens Natl Med Ctr, Washington, DC 20010 USA	Children's Hospital Oakland Research Institute; Children's National Health System	Lal, A (corresponding author), Univ Calif San Francisco UCSF Benioff Childrens H, 747 52nd St, Oakland, CA 94609 USA.; Ames, BN (corresponding author), CHORI, Ctr Nutr & Metab, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	alal@mail.cho.org; bames@chori.org		Mietus-Snyder, Michele/0000-0003-2791-9896	Children's Hospital Oakland Research Institute-Ames Foundation; University of California, San Francisco, Clinical and Translational Science Institute (CTSI)-Strategic Opportunities Support (SOS) Program	Children's Hospital Oakland Research Institute-Ames Foundation; University of California, San Francisco, Clinical and Translational Science Institute (CTSI)-Strategic Opportunities Support (SOS) Program(University of California System)	The authors thank Chia-Wei Lu [Children's Hospital Oakland Research Institute (CHORI), Oakland, CA, USA] for technical assistance with the database; Tara McHugh and her colleagues, Donald Olson and Rachelle Woods (Processed Foods Research Unit, U.S. Department of Agriculture, Agricultural Research Service-Western Regional Research Center (Albany, CA, USA), for a long and productive collaboration, and for CHORI-bar production for this trial; the staff at the Pediatric Clinical Research Center at Children's Hospital Oakland; Teresa Klask and Kim Younger (CHORI) for administrative assistance; and the many volunteers who assisted with recruitment and conduct of classes. The authors are grateful to several organizations for their generous donations of bar ingredients: Pharmachem Laboratories (Kearny, NJ, USA) for a vitamin and mineral blend; the U.S. Highbush Blueberry Council (Folsom, CA, USA) for blueberry powder; and Dow Chemical (Midland, MI, USA) for hydroxypropyl methylcellulose. This work was supported by the Children's Hospital Oakland Research Institute-Ames Foundation and a grant from the University of California, San Francisco, Clinical and Translational Science Institute (CTSI)-Strategic Opportunities Support (SOS) Program. The authors declare no conflicts of interest.	Aaron SD, 2004, CHEST, V125, P2046, DOI 10.1378/chest.125.6.2046; Agarwal S, 2015, J AM COLL NUTR, V34, P126, DOI 10.1080/07315724.2014.901196; Agrawal A, 2011, AM J RESP CELL MOL, V44, P270, DOI 10.1165/rcmb.2010-0141TR; Al-Shawwa BA, 2007, J ASTHMA, V44, P469, DOI 10.1080/02770900701423597; Ames B., 2009, [U. S. Patent Application, International Patent Application PCT/US], Patent No. [61/388,890, 2011/054433, 61388890]; Arvaniti F, 2011, PEDIAT ALLERG IMM-UK, V22, P283, DOI 10.1111/j.1399-3038.2010.01113.x; Baek HS, 2011, ANN ALLERG ASTHMA IM, V107, P14, DOI 10.1016/j.anai.2011.03.013; Berg CM, 2011, CHEST, V139, P1109, DOI 10.1378/chest.10-1299; Berthon BS, 2015, NUTRIENTS, V7, P1618, DOI 10.3390/nu7031618; Boulay ME, 2013, RESP MED, V107, P511, DOI 10.1016/j.rmed.2012.12.015; Brigham EP, 2015, ANN ALLERG ASTHMA IM, V114, P273, DOI 10.1016/j.anai.2014.11.003; Burns JS, 2007, CHEST, V132, P238, DOI 10.1378/chest.07-0038; Carrera-Bastos P, 2011, RES REP CLIN CARDIOL, V2, P15, DOI 10.2147/RRCC.S16919; Carson KV, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001116.pub4; Centers for Disease Control and Prevention, ASTHM AND OB; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Crosbie A, 2012, PEDIATR EXERC SCI, V24, P472, DOI 10.1123/pes.24.3.472; de Andrade LB, 2014, RESP MED, V108, P1438, DOI 10.1016/j.rmed.2014.07.009; Deraz TE, 2012, PEDIATR PULM, V47, P220, DOI 10.1002/ppul.21539; Dias SA, 2014, EUR RESPIR J, V43, P1368, DOI 10.1183/09031936.00053413; Diaz J, 2014, IMMUNOL ALLERGY CLIN, V34, P739, DOI 10.1016/j.iac.2014.07.008; Dixon AE, 2016, AM J RESP CELL MOL, V54, P601, DOI 10.1165/rcmb.2016-0017PS; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Farres MN, 2011, INTERNAL MED, V50, P205, DOI 10.2169/internalmedicine.50.4424; Forno E, 2017, CURR OPIN ALLERGY CL, V17, P123, DOI 10.1097/ACI.0000000000000339; Freitas PD, 2017, AM J RESP CRIT CARE, V195, P32, DOI [10.1164/rccm.201603-0446OC, 10.1164/rccm.201603-0446oc]; Garcia OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x; Garmendia JV, 2014, RECENT PATENTS ENDOC, V8, P60, DOI 10.2174/1872214807666140107151023; Gauthier M, 2015, AM J RESP CRIT CARE, V192, P660, DOI 10.1164/rccm.201504-0763PP; Gold W. M., 2016, MURRAY NADELS TXB RE; Green RJ, 2013, CHEST, V143, P117, DOI 10.1378/chest.12-1070; Han YY, 2014, AM J RESP CRIT CARE, V190, P32, DOI 10.1164/rccm.201403-0565OC; Heaney RP, 2006, AM J CLIN NUTR, V84, P471, DOI 10.1093/ajcn/84.3.471; Heikkinen SAM, 2012, EUR J EPIDEMIOL, V27, P397, DOI 10.1007/s10654-012-9684-8; Holguin F, 2011, J ASTHMA, V48, P217, DOI 10.3109/02770903.2011.555033; Jensen ME, 2011, PAEDIATR RESPIR REV, V12, P152, DOI 10.1016/j.prrv.2011.01.009; Jensen ME, 2013, EUR RESPIR J, V42, P1012, DOI 10.1183/09031936.00124912; Kishida K, 2014, BEST PRACT RES CL EN, V28, P119, DOI 10.1016/j.beem.2013.08.006; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Komakula S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-32; Kony S, 2004, THORAX, V59, P892, DOI 10.1136/thx.2003.015768; Korn S, 2011, ANN ALLERG ASTHMA IM, V107, P474, DOI 10.1016/j.anai.2011.09.001; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Lang JE, 2013, CONTEMP CLIN TRIALS, V34, P326, DOI 10.1016/j.cct.2012.12.009; Litonjua AA, 2012, CURR OPIN ALLERGY CL, V12, P179, DOI 10.1097/ACI.0b013e3283507927; Lugogo NL, 2011, BBA-GEN SUBJECTS, V1810, P1120, DOI 10.1016/j.bbagen.2011.09.004; Lugogo NL, 2010, J APPL PHYSIOL, V108, P729, DOI 10.1152/japplphysiol.00845.2009; Lv N, 2014, J ASTHMA ALLERGY, V7, P105, DOI 10.2147/JAA.S49960; Ma J, 2010, ALLERGY, V65, P1455, DOI 10.1111/j.1398-9995.2010.02402.x; Ma J, 2016, EUR RESPIR J, V47, P122, DOI 10.1183/13993003.00591-2015; Ma J, 2015, ANN AM THORAC SOC, V12, P1, DOI 10.1513/AnnalsATS.201406-271OC; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCann JC, 2015, FASEB J, V29, P3287, DOI 10.1096/fj.15-271833; McCloud E, 2011, J AM DIET ASSOC, V111, P1052, DOI 10.1016/j.jada.2011.04.005; Melosini L, 2012, J ASTHMA, V49, P317, DOI 10.3109/02770903.2012.661008; Mietus-Snyder ML, 2012, FASEB J, V26, P3515, DOI 10.1096/fj.11-201558; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program Third Expert Panel on the Diagnosis and Management of Asthma, 2007, 3 NAT HEART LUNG BLO; Paul G, 2012, AM J RESP CRIT CARE, V185, P124, DOI 10.1164/rccm.201108-1502CI; Periyalil HA, 2013, NUTRIENTS, V5, P3506, DOI 10.3390/nu5093506; Qi L, 2006, DIABETES CARE, V29, P207, DOI 10.2337/diacare.29.02.06.dc05-1903; Ricciardiello L, 2011, NAT REV GASTRO HEPAT, V8, P592, DOI 10.1038/nrgastro.2011.149; Ricciardolo FLM, 2014, CURR OPIN PULM MED, V20, P53, DOI 10.1097/MCP.0000000000000006; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Schleich FN, 2010, THORAX, V65, P1039, DOI 10.1136/thx.2009.124925; Scott HA, 2013, CLIN EXP ALLERGY, V43, P36, DOI 10.1111/cea.12004; Scott HA, 2011, EUR RESPIR J, V38, P594, DOI 10.1183/09031936.00139810; Silverman RA, 2003, ANN EMERG MED, V42, P577, DOI 10.1067/S0196-0644(03)00410-4; Singh Y, 2013, J CLIN RES PEDIATR E, V5, P245, DOI 10.4274/Jcrpe.1127; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; Thomas Mike, 2009, Prim Care Respir J, V18, P41, DOI 10.4104/pcrj.2009.00010; Thuesen BH, 2010, ALLERGY, V65, P1446, DOI 10.1111/j.1398-9995.2010.02378.x; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Troesch B, 2015, NUTRIENTS, V7, P6016, DOI 10.3390/nu7075266; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Umetsu DT, 2017, THORAX, V72, P174, DOI 10.1136/thoraxjnl-2016-209130; US Department of Agriculture National Agricultural Library, 2007, USDA DAT FLAV CONT S; van Leeuwen JC, 2014, PEDIATR PULM, V49, P1155, DOI 10.1002/ppul.22932; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wenzel SE, 2016, AM J RESP CELL MOL, V55, P1, DOI 10.1165/rcmb.2016-0141PS	85	7	7	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6643	6654		10.1096/fj.201700338	http://dx.doi.org/10.1096/fj.201700338			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30024788				2022-12-28	WOS:000449359700023
J	Gamage, AM; Liao, CS; Cheah, IK; Chen, YH; Lim, DRX; Ku, JWK; Chee, RSL; Gengenbacher, M; Seebeck, FP; Halliwell, B; Gan, YH				Gamage, Akshamal M.; Liao, Cangsong; Cheah, Irwin K.; Chen, Yahua; Lim, Daniel R. X.; Ku, Joanne W. K.; Chee, Rhonda Sin Ling; Gengenbacher, Martin; Seebeck, Florian P.; Halliwell, Barry; Gan, Yunn-Hwen			The proteobacterial species Burkholderia pseudomallei produces ergothioneine, which enhances virulence in mammalian infection	FASEB JOURNAL			English	Article						microbial antioxidant; oxidative stress; glutathione; Burkholderia thailandensis	BIOSYNTHETIC-PATHWAY; SULFOXIDE SYNTHASE; ANTIOXIDANT; GLUTATHIONE; GENES; BACTERIA; SYSTEM; PCR	Bacteria use various endogenous antioxidants for protection against oxidative stress associated with environmental survival or host infection. Although glutathione (GSH) is the most abundant and widely used antioxidant in Proteobacteria, ergothioneine (EGT) is another microbial antioxidant, mainly produced by fungi and Actinobacteria. The Burkholderia genus is found in diverse environmental niches. We observed that gene homologs required for the synthesis of EGT are widely distributed throughout the genus. By generating gene-deletion mutants and monitoring production with isotope-labeled substrates, we show that pathogenic Burkholderia pseudomallei and environmental B. thailandensis are able to synthesize EGT de novo. Unlike most other bacterial EGT synthesis pathways described, Burkholderia spp. use cysteine rather than -glutamyl cysteine as the thiol donor. Analysis of recombinant EgtB indicated that it is a proficient sulfoxide synthase, despite divergence in the active site architecture from that of mycobacteria. The absence of GSH, but not EGT, increased bacterial susceptibility to oxidative stresses in vitro. However, deletion of EGT synthesis conferred a reduced fitness to B. pseudomallei, with a delay in organ colonization and time to death during mouse infection. Therefore, despite the lack of an apparent antioxidant role in vitro, EGT is important for optimal bacterial pathogenesis in the mammalian host.Gamage, A. M., Liao, C., Cheah, I. K., Chen, Y., Lim, D. R. X., Ku, J. W. K., Chee, R. S. L., Gengenbacher, M., Seebeck, F. P., Halliwell, B., Gan, Y.-H. The proteobacterial species Burkholderia pseudomallei produces ergothioneine, which enhances virulence in mammalian infection.	[Gamage, Akshamal M.; Cheah, Irwin K.; Chen, Yahua; Lim, Daniel R. X.; Ku, Joanne W. K.; Chee, Rhonda Sin Ling; Halliwell, Barry; Gan, Yunn-Hwen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Liao, Cangsong; Seebeck, Florian P.] Univ Basel, Dept Chem, Basel, Switzerland; [Gengenbacher, Martin] Rutgers State Univ, Publ Hlth Res Inst, New Jersey Med Sch, Newark, NJ USA; [Gamage, Akshamal M.] Duke Natl Univ Singapore Med Sch, Program Emerging Infect Dis, Singapore, Singapore	National University of Singapore; University of Basel; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gan, YH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, MD7,05-10,8 Med Dr, SI-117597 Singapore, Singapore.	bchganyh@nus.edu.sg	Halliwell, Barry/C-8318-2009; Gan, Yunn-Hwen/AAH-8515-2021	Halliwell, Barry/0000-0002-3560-7123; Lim, Daniel Rui Xiang/0000-0003-0563-7740; Cheah, Irwin/0000-0001-9817-468X; Ku, Joanne/0000-0002-0421-5741	National Medical Research Council Center, Singapore Ministry of Health Grant "MINE" Core [4 BSL-3 NMRC/CG/013/2013]; National University of Singapore Yong Loo Lin School of Medicine BSL-3 Core Facility; Sino-Swiss Science and Technology Cooperation; Professur fur Molekulare Bionik; European Research Council [ERC-2013-StG 336559]; Tan Chin Tuan Foundation; China Scholarship Council	National Medical Research Council Center, Singapore Ministry of Health Grant "MINE" Core(National Medical Research Council, Singapore); National University of Singapore Yong Loo Lin School of Medicine BSL-3 Core Facility(National University of Singapore); Sino-Swiss Science and Technology Cooperation; Professur fur Molekulare Bionik; European Research Council(European Research Council (ERC)European Commission); Tan Chin Tuan Foundation; China Scholarship Council(China Scholarship Council)	The authors thank Tetrahedron (Paris, France) for providing L-ergothioneine, L-ergothioneine-d9, hercynine, and hercynine-d9 analytical standards used in this study. This work was supported by the National Medical Research Council Center, Singapore Ministry of Health Grant "MINE" Core 4 BSL-3 NMRC/CG/013/2013, and the National University of Singapore Yong Loo Lin School of Medicine BSL-3 Core Facility (to Y.-H.G). L.C. is a recipient of a Sino-Swiss Science and Technology Cooperation and China Scholarship Council Postdoctoral Fellowship; F.P.S. was supported by the "Professur fur Molekulare Bionik." This work was also supported by the European Research Council (ERC-2013-StG 336559). B.H. thanks the Tan Chin Tuan Foundation for support of his Centennial Professorship. The authors declare no conflicts of interest.	AKANMU D, 1991, ARCH BIOCHEM BIOPHYS, V288, P10, DOI 10.1016/0003-9861(91)90158-F; ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; Burn R, 2017, ANGEW CHEM INT EDIT, V56, P12508, DOI 10.1002/anie.201705932; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Chen L, 2018, J AM CHEM SOC, V140, P4604, DOI 10.1021/jacs.7b13628; Cumming BM, 2018, ANTIOXID REDOX SIGN, V28, P431, DOI 10.1089/ars.2017.7300; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emani CS, 2013, ANTIMICROB AGENTS CH, V57, P3202, DOI 10.1128/AAC.02572-12; Faponle AS, 2017, J AM CHEM SOC, V139, P9259, DOI 10.1021/jacs.7b04251; Goncharenko KV, 2016, CHEM COMMUN, V52, P1945, DOI 10.1039/c5cc07772a; Goncharenko KV, 2015, ANGEW CHEM INT EDIT, V54, P2821, DOI 10.1002/anie.201410045; Halliwell B., 2015, FREE RADICALS BIOL M; Han SK, 2016, ONCOTARGET, V7, P56147, DOI 10.18632/oncotarget.11269; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hu W, 2014, ORG LETT, V16, P5382, DOI 10.1021/ol502596z; Jones GW, 2014, GENE, V549, P161, DOI 10.1016/j.gene.2014.07.065; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054961; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Liao CS, 2017, CHEMBIOCHEM, V18, P2115, DOI 10.1002/cbic.201700354; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moore T, 2013, J CHROMATOGR B, V929, P51, DOI 10.1016/j.jchromb.2013.04.004; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Saini V, 2016, CELL REP, V14, P572, DOI 10.1016/j.celrep.2015.12.056; Seebeck FP, 2010, J AM CHEM SOC, V132, P6632, DOI 10.1021/ja101721e; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh Arishma Rajkarnikar, 2016, Biochem Biophys Rep, V8, P100, DOI 10.1016/j.bbrep.2016.08.006; Song H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11870; Tan KS, 2012, J CLIN INVEST, V122, P2289, DOI 10.1172/JCI57817; Wong J, 2015, CELL HOST MICROBE, V18, P38, DOI 10.1016/j.chom.2015.06.002	34	12	12	0	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6395	6409		10.1096/fj.201800716	http://dx.doi.org/10.1096/fj.201800716			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29890088				2022-12-28	WOS:000449359700004
J	Geist, J; Ward, CW; Kontrogianni-Konstantopoulos, A				Geist, Janelle; Ward, Christopher W.; Kontrogianni-Konstantopoulos, Aikaterini			Structure before function: myosin binding protein-C slow is a structural protein with regulatory properties	FASEB JOURNAL			English	Article						in vivo gene-transfer; thick filament; contractility kinetics; force production; CRISPR	RABBIT SKELETAL-MUSCLE; THICK FILAMENT; ARTHROGRYPOSIS MYOPATHY; CMYBP-C; PHOSPHORYLATION; MUTATION; DISEASE; MICE; ACTIVATION; ISOFORM	Myosin binding protein-C slow (sMyBP-C) comprises a family of accessory proteins in skeletal muscles that bind both myosin and actin filaments. Herein, we examined the role of sMyBP-C in adult skeletal muscles using in vivo gene transfer and clustered regularly interspaced short palindromic repeats technology to knock down all known sMyBP-C variants. Our findings, confirmed in two different skeletal muscles, demonstrated efficient knockdown (KD) of sMyBP-C (>70%) resulting in notably decreased levels of thick, but not thin, filament proteins ranging from approximate to 50% for slow and fast myosin to approximate to 20% for myomesin. Consistent with this, A bands were selectively distorted, and sarcomere length was significantly reduced. Contrary to earlier in vitro studies showing that addition of recombinant sMyBP-C slows down the formation of actomyosin crossbridges, our work demonstrates that KD of sMyBP-C in intact myofibers results in decreased contraction and relaxation kinetics under no-load conditions. Similarly, KD muscles develop markedly reduced twitch and tetanic force and contraction velocity. Taken together, our results show that sMyBP-C is essential for the regular organization and maintenance of myosin filaments into A bands and that its structural role precedes its ability to regulate actomyosin crossbridges.Geist, J., Ward, C. W., Kontrogianni-Konstantopoulos, A. Structure before function: myosin binding protein-C slow is a structural protein with regulatory properties.	[Geist, Janelle; Kontrogianni-Konstantopoulos, Aikaterini] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Ward, Christopher W.] Univ Maryland, Sch Med, Dept Orthoped, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kontrogianni-Konstantopoulos, A (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	akontrogianni@som.umaryland.edu			Training Program in Muscle Biology Grant [T32 AR007592-17]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR071618]; Muscular Dystrophy Association Research Grant [313579]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592, R01AR071614, R01AR071618] Funding Source: NIH RePORTER	Training Program in Muscle Biology Grant; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association Research Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Training Program in Muscle Biology Grant T32 AR007592-17 (to J.G.); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01 AR071618 (to C.W.W.); and Muscular Dystrophy Association Research Grant 313579 (to A.K.-K). The authors thank Dr. Ramzi Khairallah (Myologica LLC, Baltimore, MD, USA) for collaborative assistance with the development of the in vivo FDB assay. The authors declare no conflicts of interest.	Ackermann MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13235; Ackermann MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12637; Ackermann MA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00391; Ackermann MA, 2013, FASEB J, V27, P3217, DOI 10.1096/fj.13-228882; Ackermann MA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/636403; Ackermann MA, 2011, J PROTEOME RES, V10, P4547, DOI 10.1021/pr200355w; Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Carrier L, 2004, CARDIOVASC RES, V63, P293, DOI 10.1016/j.cardiores.2004.04.009; Carrier L, 2015, GENE, V573, P188, DOI 10.1016/j.gene.2015.09.008; CRAIG R, 1976, PROC R SOC SER B-BIO, V192, P451, DOI 10.1098/rspb.1976.0023; DAVIS JS, 1988, J MUSCLE RES CELL M, V9, P174, DOI 10.1007/BF01773739; Ehler E, 2008, ADV EXP MED BIOL, V642, P1; Ekhilevitch N, 2016, CLIN GENET, V90, P84, DOI 10.1111/cge.12707; Gautel M, 1998, CIRC RES, V82, P124; Geist J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00410; Gupta MK, 2014, PFLUG ARCH EUR J PHY, V466, P231, DOI 10.1007/s00424-013-1377-y; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; Hu LYR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/714197; Kontrogianni-Konstantopoulos A, 2006, AM J PHYSIOL-CELL PH, V290, pC626, DOI 10.1152/ajpcell.00442.2005; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kuster DWD, 2014, PFLUG ARCH EUR J PHY, V466, P207, DOI 10.1007/s00424-013-1417-7; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li M, 2016, J GEN PHYSIOL, V147, P309, DOI 10.1085/jgp.201511452; Li XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117158; Lin BL, 2016, BIOPHYS J, V110, p14A, DOI 10.1016/j.bpj.2015.11.132; Lin BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21053-1; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Lynch TL, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/424751; Markus B, 2012, HUM MUTAT, V33, P1435, DOI 10.1002/humu.22122; McNamara J. W., 2018, MYOFILAMENT C, V35, P122; Moss RL, 2016, P NATL ACAD SCI USA, V113, P3133, DOI 10.1073/pnas.1602568113; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Previs MJ, 2016, P NATL ACAD SCI USA, V113, P3239, DOI 10.1073/pnas.1522236113; Previs MJ, 2014, PFLUG ARCH EUR J PHY, V466, P439, DOI 10.1007/s00424-013-1433-7; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Wang L, 2018, COMPR PHYSIOL, V8, P631, DOI 10.1002/cphy.c170023	46	6	6	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6385	6394		10.1096/fj.201800624R	http://dx.doi.org/10.1096/fj.201800624R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29874125	Green Published, Bronze			2022-12-28	WOS:000449359700003
J	Ruiz-Rosado, JD; Lee, YU; Mahler, N; Yi, T; Robledo-Avila, F; Martinez-Saucedo, D; Lee, AY; Shoji, T; Heuer, E; Yates, AR; Pober, JS; Shinoka, T; Partida-Sanchez, S; Breuer, CK				Ruiz-Rosado, Juan de Dios; Lee, Yong-Ung; Mahler, Nathan; Yi, Tai; Robledo-Avila, Frank; Martinez-Saucedo, Diana; Lee, Avione Y.; Shoji, Toshihiro; Heuer, Eric; Yates, Andrew R.; Pober, Jordan S.; Shinoka, Toshiharu; Partida-Sanchez, Santiago; Breuer, Christopher K.			Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts	FASEB JOURNAL			English	Article						losartan; monocytes; macrophages	ACUTE MYOCARDIAL-INFARCTION; AORTIC-ANEURYSM; MOUSE MODEL; BONE-MARROW; CLINICAL-APPLICATION; INHIBITION PREVENTS; INFLAMMATORY SITES; SPLENIC RESERVOIR; MARFAN-SYNDROME; LOSARTAN	We previously developed a tissue-engineered vascular graft (TEVG) made by seeding autologous cells onto a biodegradable tubular scaffold, in an attempt to create a living vascular graft with growth potential for use in children undergoing congenital heart surgery. Results of our clinical trial showed that the TEVG possesses growth capacity but that its widespread clinical use is not yet advisable due to the high incidence of TEVG stenosis. In animal models, TEVG stenosis is caused by increased monocytic cell recruitment and its classic (M1) activation. Here, we report on the source and regulation of these monocytes. TEVGs were implanted in wild-type, CCR2 knockout (Ccr2(-/-)), splenectomized, and spleen graft recipient mice. We found that bone marrow-derived Ly6C(+hi) monocytes released from sequestration by the spleen are the source of mononuclear cells infiltrating the TEVG during the acute phase of neovessel formation. Furthermore, short-term administration of losartan (0.6 g/L, 2 wk), an angiotensin II type 1 receptor antagonist, significantly reduced the macrophage populations (Ly6C(+/-)/F480(+)) in the scaffolds and improved long-term patency in TEVGs. Notably, the combined effect of bone marrow-derived mononuclear cell seeding with short-term losartan treatment completely prevented the development of TEVG stenosis. Our results provide support for pharmacologic treatment with losartan as a strategy to modulate monocyte infiltration into the grafts and thus prevent TEVG stenosis.Ruiz-Rosado, J. D. D., Lee, Y.-U., Mahler, N., Yi, T., Robledo-Avila, F., Martinez-Saucedo, D., Lee, A. Y., Shoji, T., Heuer, E., Yates, A. R., Pober, J. S., Shinoka, T., Partida-Sanchez, S., Breuer, C. K. Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.	[Ruiz-Rosado, Juan de Dios; Lee, Yong-Ung; Mahler, Nathan; Yi, Tai; Lee, Avione Y.; Shoji, Toshihiro; Heuer, Eric; Shinoka, Toshiharu; Breuer, Christopher K.] Nationwide Childrens Hosp, Tissue Engn Ctr, Columbus, OH USA; [Ruiz-Rosado, Juan de Dios; Robledo-Avila, Frank; Martinez-Saucedo, Diana; Partida-Sanchez, Santiago] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH USA; [Shinoka, Toshiharu] Nationwide Childrens Hosp, Ctr Heart, Dept Cardiothorac Surg, Columbus, OH USA; [Yates, Andrew R.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Cardiol Sect, Columbus, OH 43210 USA; [Yates, Andrew R.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Sect Crit Care, Columbus, OH 43210 USA; [Pober, Jordan S.] Yale Univ, Dept Immunobiol, New Haven, CT USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Yale University	Partida-Sanchez, S (corresponding author), Nationwide Childrens Hosp, Res Inst, Tissue Engn Ctr, 700 Childrens Dr,WB4151, Columbus, OH 43205 USA.; Breuer, CK (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, 700 Childrens Dr, Columbus, OH 43205 USA.	santiago.partida-sanchez@nationwidechildrens.org; christopher.breuer@nationwidechildrens.org	Partida-Sanchez, Santiago/B-7523-2008; Robledo-Avila, Frank/L-6013-2016	Partida-Sanchez, Santiago/0000-0003-2996-9440; Robledo-Avila, Frank/0000-0001-5583-9194; RUIZ-ROSADO, JUAN DE DIOS/0000-0002-6429-9086; Yates, Andrew/0000-0003-2860-6808	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01-HL098228, R01-HL128847]; NIH National Institute of Allergy and Infectious Diseases [R01AI092117, R21AI120013]; Consejo Nacional de Ciencia y Tecnologia (CONACYT); Pall Corp.; Gunze Ltd.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128847, R01HL098228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120013] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Pall Corp.; Gunze Ltd.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge Brendan Radel, Mellissa Mauntel, and Ekene Onwuka (all from the Tissue Engineering Center, Nationwide Children's Hospital) for their contributions on weight change, blood pressure, plasma level of losartan measurements, and preparation of the histologic samples and surgical procedures. This research was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (Grants R01-HL098228 and R01-HL128847 to C.K.B.). S.P.-S. was supported by NIH National Institute of Allergy and Infectious Diseases Grants R01AI092117 and R21AI120013. J.D.D.R.-R. and D.M.-S. received support from Consejo Nacional de Ciencia y Tecnologia (CONACYT). C.K.B. and T.S. have received grant support from the Pall Corp. and Gunze Ltd. None of the work presented was funded by Gunze Ltd. or Pall Corp. The authors declare no conflicts of interest.	[Anonymous], 2015, COZ PACK INS; Baan J, 1996, CARDIOVASC RES, V32, P973; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Buscemi S, 2017, TRANSPL P, V49, P716, DOI 10.1016/j.transproceed.2017.02.017; Chu KY, 2006, DIABETES, V55, P367, DOI 10.2337/diabetes.55.02.06.db05-1022; Daugherty A, 2009, JOVE-J VIS EXP, V27, P1, DOI [10.3791/1291, DOI 10.3791/1291]; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; GOTTLIEB SS, 1993, CIRCULATION, V88, P1602, DOI 10.1161/01.CIR.88.4.1602; Guo YS, 2015, MOL MED REP, V11, P1587, DOI 10.3892/mmr.2014.2952; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hibino N, 2011, FASEB J, V25, P2731, DOI 10.1096/fj.11-182246; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Ju HS, 1997, CARDIOVASC RES, V35, P223, DOI 10.1016/S0008-6363(97)00130-2; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; Lee Y. U., 2014, JOVE-J VIS EXP, V86, P1; Lee YU, 2016, FASEB J, V30, P2627, DOI 10.1096/fj.201500179R; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Naito Y, 2003, J THORAC CARDIOV SUR, V125, P419, DOI 10.1067/mtc.2003.134; Nataatmadja M, 2013, OCHSNER J, V13, P42; Palumbo VD, 2014, INT J ARTIF ORGANS, V37, P503, DOI 10.5301/ijao.5000343; Potteaux S, 2015, CURR OPIN LIPIDOL, V26, P457, DOI 10.1097/MOL.0000000000000223; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Sayeski PP, 2001, J RENIN-ANGIO-ALDO S, V2, P4, DOI 10.3317/jraas.2001.007; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shand FHW, 2014, P NATL ACAD SCI USA, V111, P7771, DOI 10.1073/pnas.1402914111; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Varo N, 1999, J HYPERTENS, V17, P107, DOI 10.1097/00004872-199917010-00016; Webb NJA, 2014, CLIN J AM SOC NEPHRO, V9, P1441, DOI 10.2215/CJN.11111113; Xu FC, 2009, CURR MED CHEM, V16, P3841, DOI 10.2174/092986709789178046	40	8	8	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6822	6832		10.1096/fj.201800458	http://dx.doi.org/10.1096/fj.201800458			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29906242	Bronze, Green Published			2022-12-28	WOS:000449359700036
J	He, WY; Ye, SJ; Zeng, C; Xue, S; Hu, XY; Zhang, XJ; Gao, SQ; Xiong, Y; He, XY; Vivalda, S; Li, L; Wang, YF; Ye, QF				He, Weiyang; Ye, Shaojun; Zeng, Cheng; Xue, Shuai; Hu, Xiaoyan; Zhang, Xingjian; Gao, Siqi; Xiong, Yan; He, Xueyu; Vivalda, Soatina; Li, Ling; Wang, Yanfeng; Ye, Qifa			Hypothermic oxygenated perfusion (HOPE) attenuates ischemia/reperfusion injury in the liver through inhibition of the TXNIP/NLRP3 inflammasome pathway in a rat model of donation after cardiac death	FASEB JOURNAL			English	Article						liver transplantation; organ preservation; sterile inflammation; flow stimulation	THIOREDOXIN-INTERACTING PROTEIN; HEPATIC ISCHEMIA-REPERFUSION; MACHINE PERFUSION; COLD-STORAGE; SHEAR-STRESS; CELL-DEATH; PRESERVATION; TRANSPLANTATION; EXPRESSION; GRAFT	Hypothermic oxygenated perfusion (HOPE) is a relatively new dynamic preservation procedure that has not been widely implemented in liver transplantation despite its advantages. Improved graft protection is one such advantage offered by HOPE and has been attributed to multiple mechanisms, one of which may be the modulation of the thioredoxin-interacting protein (TXNIP)/NOD-like receptor protein 3 (NLRP3) inflammasome pathway. The TXNIP/NLRP3 inflammasome pathway plays a critical role in sterile inflammation under oxidative stress as a result of ischemia/reperfusion injury (IRI). In the current study, we aimed to investigate the graft protection offered by HOPE and its impact on the TXNIP/NLRP3 inflammasome pathway. To simulate conditions of donation after cardiac death (DCD) liver transplantation, rat livers were exposed to 30 min of warm ischemia after cardiac arrest. Livers were then preserved under cold storage (CS) or with HOPE for 3 h. Livers were then subjected to 1 h of isolated reperfusion. Liver injuries were assessed on the isolated perfusion rat liver model system before and after reperfusion. Compared with the CS group, the HOPE group had a significant reduction in liver injury and improvement in liver function. Our findings also revealed that reperfusion injury induced liver damage and activated the TXNIP/NLRP3 inflammasome pathway in DCD rat livers. Pretreatment of DCD rat livers with HOPE inhibited the TXNIP/NLRP3 inflammasome pathway and attenuated liver IRI. Attenuation of oxidative stress as a result of HOPE led to the down-regulation of the TXNIP/NLRP3 inflammasome pathway and thus offered superior protection compared with the traditional CS method of organ preservation.He, W., Ye, S., Zeng, C., Xue, S., Hu, X., Zhang, X., Gao, S., Xiong, Y., He, X., Vivalda, S., Li, L., Wang, Y., Ye, Q. Hypothermic oxygenated perfusion (HOPE) attenuates ischemia/reperfusion injury in the liver through inhibition of the TXNIP/NLRP3 inflammasome pathway in a rat model of donation after cardiac death.	[He, Weiyang; Ye, Shaojun; Zeng, Cheng; Xue, Shuai; Hu, Xiaoyan; Zhang, Xingjian; Gao, Siqi; Xiong, Yan; He, Xueyu; Vivalda, Soatina; Li, Ling; Wang, Yanfeng; Ye, Qifa] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Med Technol Transplantat, Inst Hepatobiliary Dis,Transplant Ctr, Wuhan 430071, Hubei, Peoples R China; [Ye, Qifa] Cent South Univ, Xiangya Hosp 3, Natl Hlth Commiss, Transplantat Med Engn & Technol Res Ctr, Changsha, Hunan, Peoples R China	Wuhan University; Central South University	Wang, YF; Ye, QF (corresponding author), Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Med Technol Transplantat, Inst Hepatobiliary Dis,Transplant Ctr, Wuhan 430071, Hubei, Peoples R China.	yanfengwang@whu.edu.cn; yqf_china@163.com			National Natural Science Foundation of China [U1403222, 81570079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the professors and students from Zhongnan Hospital of Wuhan University and the Institute of Hepatobiliary Diseases of Wuhan University who participated in this study. The authors also thank LetPub (http://www.letpub.com) for providing linguistic assistance during the preparation of this manuscript. This study was supported by Grants U1403222 and 81570079 from the National Natural Science Foundation of China (to Q.Y. and Y.W.). W.H. and S.Y. share first authorship. The authors declare no conflicts of interest.	Arthur PG, 2013, WORLD J GASTROENTERO, V19, P673, DOI 10.3748/wjg.v19.i5.673; Balaban CL, 2011, ARTIF ORGANS, V35, P508, DOI 10.1111/j.1525-1594.2011.01256.x; Ben Mosbah I, 2006, LIVER TRANSPLANT, V12, P1215, DOI 10.1002/lt.20788; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Bunegin L, 2013, ASAIO J, V59, P427, DOI 10.1097/MAT.0b013e318292e865; Cao GS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091418; Carnevale ME, 2013, ARTIF ORGANS, V37, P985, DOI 10.1111/aor.12235; Chatauret N, 2014, AM J TRANSPLANT, V14, P2500, DOI 10.1111/ajt.12904; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; de Rougemont O, 2009, ANN SURG, V250, P674, DOI 10.1097/SLA.0b013e3181bcb1ee; Debbaut C, 2011, IEEE T BIO-MED ENG, V58, P25, DOI 10.1109/TBME.2010.2065229; Dutkowski P, 1998, CRYOBIOLOGY, V36, P61, DOI 10.1006/cryo.1997.2066; Dutkowski P, 2006, ANN SURG, V244, P968, DOI 10.1097/01.sla.0000247056.85590.6b; Dutkowski P, 2014, J HEPATOL, V60, P765, DOI 10.1016/j.jhep.2013.11.023; Dutkowski R, 2006, AM J TRANSPLANT, V6, P903, DOI 10.1111/j.1600-6143.2006.01264.x; Eppensteiner J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00190; Gallinat A, 2014, TRANSPL INT, V27, P1214, DOI 10.1111/tri.12393; Gehrke N, 2018, J HEPATOL, V68, P986, DOI 10.1016/j.jhep.2018.01.008; Graham JA, 2014, J HEPATOL, V61, P418, DOI 10.1016/j.jhep.2014.04.019; Guarrera JV, 2010, AM J TRANSPLANT, V10, P372, DOI 10.1111/j.1600-6143.2009.02932.x; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Henry SD, 2012, AM J TRANSPLANT, V12, P2477, DOI 10.1111/j.1600-6143.2012.04086.x; Dinh HL, 2012, WORLD J GASTROENTERO, V18, P4491, DOI 10.3748/wjg.v18.i33.4491; Khandoga A, 2002, TRANSPLANTATION, V74, P681, DOI 10.1097/00007890-200209150-00016; Lee DD, 2014, LIVER TRANSPLANT, V20, P1447, DOI 10.1002/lt.23985; Li P, 2015, CLIN TRANSPLANT, V29, P820, DOI 10.1111/ctr.12586; Liu Y, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0415-z; Liu ZZ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3861914; Liu ZZ, 2017, ARTIF ORGANS, V41, P82, DOI 10.1111/aor.12701; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Meijer D K, 1981, Methods Enzymol, V77, P81; Merion RM, 2006, ANN SURG, V244, P555, DOI 10.1097/01.sla.0000239006.33633.39; Minor T, 2007, CRYOBIOLOGY, V54, P188, DOI 10.1016/j.cryobiol.2007.01.002; Minutoli L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2183026; Monbaliu D, 2007, TRANSPL P, V39, P2652, DOI 10.1016/j.transproceed.2007.08.009; O'Leary JG, 2008, GASTROENTEROLOGY, V134, P1764, DOI 10.1053/j.gastro.2008.02.028; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Pizarro MD, 2009, CRYOBIOLOGY, V58, P248, DOI 10.1016/j.cryobiol.2009.01.002; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Quillin RC, 2018, LIVER TRANSPLANT, V24, P276, DOI 10.1002/lt.25004; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schlegel A, 2015, Curr Transplant Rep, V2, P52; Schlegel A, 2016, CURR OPIN ORGAN TRAN, V21, P308, DOI 10.1097/MOT.0000000000000303; Schlegel A, 2014, J HEPATOL, V61, P1267, DOI 10.1016/j.jhep.2014.07.023; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Spindel ON, 2014, CIRC RES, V114, P1125, DOI 10.1161/CIRCRESAHA.114.301315; Spindel ON, 2012, ARTERIOSCL THROM VAS, V32, P1264, DOI 10.1161/ATVBAHA.111.244681; Strowitzki MJ, 2015, ANN TRANSPL, V20, P36, DOI 10.12659/AOT.892302; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; 't Hart NA, 2004, AM J TRANSPLANT, V4, P1836, DOI 10.1111/j.1600-6143.2004.00580.x; van Golen RF, 2012, CYTOKINE GROWTH F R, V23, P69, DOI 10.1016/j.cytogfr.2012.04.006; Vekemans K, 2007, TRANSPL P, V39, P2647, DOI 10.1016/j.transproceed.2007.08.007; Wang XX, 2015, NEUROSCI LETT, V600, P182, DOI 10.1016/j.neulet.2015.06.016; Wang XQ, 2012, CIRC RES, V110, P560, DOI 10.1161/CIRCRESAHA.111.256362; Westerkamp AC, 2016, TRANSPLANTATION, V100, P825, DOI 10.1097/TP.0000000000001081; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zaouali MA, 2010, WORLD J GASTROENTERO, V16, P3499, DOI 10.3748/wjg.v16.i28.3499; Zeng C, 2017, MOL MED REP, V16, P8649, DOI 10.3892/mmr.2017.7738; Zhang X, 2015, ANTIOXID REDOX SIGN, V22, P848, DOI 10.1089/ars.2014.5868; Zhang XJ, 2018, ARTIF ORGANS, V42, P280, DOI 10.1111/aor.13005; Zhong ZB, 2016, ARTIF ORGANS, V40, P596, DOI 10.1111/aor.12607; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	67	14	14	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6212	6227		10.1096/fj.201800028RR	http://dx.doi.org/10.1096/fj.201800028RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29870680				2022-12-28	WOS:000447172000037
J	Perrot, CY; Sawada, J; Komatsu, M				Perrot, Carole Y.; Sawada, Junko; Komatsu, Masanobu			Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS	FASEB JOURNAL			English	Article						CREB; endothelial permeability; vascular leakage; prostaglandin E2	SOLUBLE ADENYLYL-CYCLASE; CELL GAP FORMATION; R-RAS; TUMOR MICROENVIRONMENT; VASCULAR-PERMEABILITY; PROSTAGLANDIN E-2; MICROVASCULAR PERMEABILITY; EP4 RECEPTORS; BREAST-CANCER; ANGIOGENESIS	The increase in cAMP levels in endothelial cells triggers cellular signaling to alter vascular permeability. It is generally considered that cAMP signaling stabilizes the endothelial barrier function and reduces permeability. However, previous studies have only examined the permeability shortly after cAMP elevation and thus have only investigated acute responses. Because cAMP is a key regulator of gene expression, elevated cAMP may have a delayed but profound impact on the endothelial permeability by altering the expression of the genes that are vital for the vessel wall stability. The small guanosine triphosphate hydrolase Ras-related protein (R-Ras) stabilizes VE-cadherin clustering and enhances endothelial barrier function, thereby stabilizing the integrity of blood vessel wall. Here we show that cAMP controls endothelial permeability through RRAS gene regulation. The prolonged cAMP elevation transcriptionally repressed RRAS in endothelial cells via a cAMP response element-binding 3 (CREB3)-dependent mechanism and significantly disrupted the adherens junction. These effects resulted in a marked increase of endothelial permeability that was reversed by R-Ras transduction. Furthermore, cAMP elevation in the endothelium by prostaglandin E-2 or phosphodiesterase type 4 inhibition caused plasma leakage from intact microvessels in mouse skin. Our study demonstrated that, contrary to the widely accepted notion, cAMP elevation in endothelial cells ultimately increases vascular permeability, and the cAMP-dependent RRAS repression critically contributes to this effect.Perrot, C. Y., Sawada, J., Komatsu, M. Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS.	Sanford Burnham Prebys Med Discovery Inst Lake No, Ctr Canc, Orlando, FL USA; Sanford Burnham Prebys Med Discovery Inst Lake No, Ctr Metab Origins Dis, Orlando, FL USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Komatsu, M (corresponding author), Sanford Burnham Prebys Med Discovery Inst Lake No, 6400 Sanger Rd, Orlando, FL 32827 USA.	mkomatsu@sbpdiscovery.org	Komatsu, Masanobu/AAV-3013-2020		U.S. National Institutes of Health, National Cancer Institute [CA125255]; Florida Breast Cancer Foundation; Florida Department of Health Bankhead-Coley Cancer Research Program [4BB17, 5BC08]; National Science Foundation [CBET-1403535]; American Heart Association [16POST27080004]; NATIONAL CANCER INSTITUTE [R01CA125255] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Breast Cancer Foundation; Florida Department of Health Bankhead-Coley Cancer Research Program; National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Histologic preparations and imaging were performed at the Histology and Imaging core facilities of Sanford Burnham Prebys Medical Discovery Institute at Lake Nona. Breast cancer tissue samples were obtained from the Florida Hospital Cancer Institute. This work was supported by the U.S. National Institutes of Health, National Cancer Institute (Grant CA125255), the Florida Breast Cancer Foundation, the Florida Department of Health Bankhead-Coley Cancer Research Program (4BB17 and 5BC08), the National Science Foundation (CBET-1403535), and the American Heart Association (16POST27080004). The authors declare no conflicts of interest.	Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Adamson RH, 1998, AM J PHYSIOL-HEART C, V274, pH1885, DOI 10.1152/ajpheart.1998.274.6.H1885; Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; ANTONOV AS, 1986, P NATL ACAD SCI USA, V83, P9704, DOI 10.1073/pnas.83.24.9704; Bindewald K, 2004, AM J PHYSIOL-CELL PH, V287, pC1246, DOI 10.1152/ajpcell.00132.2004; Braadland PR, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00375; Bundey Richard A, 2004, Sci STKE, V2004, ppe19, DOI 10.1126/stke.2312004pe19; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Cole AL, 2003, ARTERIOSCL THROM VAS, V23, P1384, DOI 10.1161/01.ATV.0000081215.45714.71; Cole SW, 2015, NAT REV CANCER, V15, P563, DOI 10.1038/nrc3978; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Creighton J, 2008, J CELL SCI, V121, P110, DOI 10.1242/jcs.011692; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dalvi S, 2015, J NEUROCHEM, V135, P867, DOI 10.1111/jnc.13117; Feldman RD, 2007, LIFE SCI, V81, P267, DOI 10.1016/j.lfs.2007.05.015; Fischmeister R, 2006, CIRC RES, V98, P582, DOI 10.1161/01.RES.0000215564.22445.7e; Fu BM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15697; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hanoun M, 2015, NEURON, V86, P360, DOI 10.1016/j.neuron.2015.01.026; Hassan S, 2014, INT UROL NEPHROL, V46, P505, DOI 10.1007/s11255-013-0513-0; HEWLETT EL, 1976, P NATL ACAD SCI USA, V73, P1926, DOI 10.1073/pnas.73.6.1926; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Jones VC, 2016, BRIT J PHARMACOL, V173, P992, DOI 10.1111/bph.13400; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Kochel TJ, 2017, ONCOTARGET, V8, P6540, DOI 10.18632/oncotarget.14145; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Leone RD, 2015, CANCER CELL, V27, P435, DOI 10.1016/j.ccell.2015.03.014; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Li FF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01865-x; Li XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11017; Ma XJ, 2015, CANCER RES, V75, P2822, DOI 10.1158/0008-5472.CAN-15-0125; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Markovic T, 2017, DRUG DISCOV TODAY, V22, P57, DOI 10.1016/j.drudis.2016.08.003; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Namkoong S, 2009, CELL SIGNAL, V21, P906, DOI 10.1016/j.cellsig.2009.01.038; Nickols J, 2015, AM J PHYSIOL-LUNG C, V309, pL1430, DOI 10.1152/ajplung.00067.2015; Obiako B, 2013, AM J PHYSIOL-LUNG C, V305, pL185, DOI 10.1152/ajplung.00392.2012; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; Parnell E, 2012, BRIT J PHARMACOL, V166, P434, DOI 10.1111/j.1476-5381.2011.01808.x; Sawada J, 2015, J VASC RES, V52, P347, DOI 10.1159/000444526; Sawada J, 2015, J BIOL CHEM, V290, P8133, DOI 10.1074/jbc.M114.591511; Sawada J, 2012, CANCER CELL, V22, P235, DOI 10.1016/j.ccr.2012.06.013; Sayner S, 2006, BIOCHEM SOC T, V34, P492, DOI 10.1042/BST0340492; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y; Spindler V, 2011, AM J PATHOL, V178, P2424, DOI 10.1016/j.ajpath.2011.01.014; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; Suzuki J, 1997, ONCOGENE, V15, P1689, DOI 10.1038/sj.onc.1201333; Vahatupa M, 2016, INVEST OPHTH VIS SCI, V57, P4898, DOI 10.1167/iovs.16-19212; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/NCHEMBIO.1611, 10.1038/nchembio.1611]; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; WATANABE H, 1992, AM J PHYSIOL, V262, pH1174; Xu LS, 2009, J BIOL CHEM, V284, P2706, DOI 10.1074/jbc.M808184200; Zhang YS, 2011, BLOOD, V118, P5355, DOI 10.1182/blood-2011-04-350587; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	62	12	12	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5793	5812		10.1096/fj.201700818RRR	http://dx.doi.org/10.1096/fj.201700818RRR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29775418	hybrid, Green Published			2022-12-28	WOS:000447172000004
J	Yang, F; Ma, HW; Butler, MR; Ding, XQ				Yang, Fan; Ma, Hongwei; Butler, Michael R.; Ding, Xi-Qin			Deficiency of type 2 iodothyronine deiodinase reduces necroptosis activity and oxidative stress responses in retinas of Leber congenital amaurosis model mice	FASEB JOURNAL			English	Article						thyroid hormone; cone photoreceptor; retinal degeneration; RPE65 deficiency	CONE PHOTORECEPTOR DEGENERATION; RECEPTOR-INTERACTING PROTEIN; THYROID-HORMONE RECEPTOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; ENDOPLASMIC-RETICULUM STRESS; KINASE-MEDIATED NECROSIS; CELL-DEATH; OPSIN EXPRESSION; MOUSE MODEL; CROSS-TALK	Thyroid hormone (TH) signaling has been shown to regulate cone photoreceptor viability. Suppression of TH signaling with antithyroid drug treatment or by targeting iodothyronine deiodinases and TH receptors preserves cones in mouse models of retinal degeneration, including the Leber congenital amaurosis Rpe65-deficient mice. This work investigates the cellular mechanisms underlying how suppressing TH signaling preserves cones in Rpe65-deficient mice, using mice deficient in type 2 iodothyronine deiodinase (Dio2), the enzyme that converts the prohormone thyroxine to the active hormone triiodothyronine (T3). Deficiency of Dio2 improved cone survival and function in Rpe65(-/-) and Rpe65 deficiency on a cone dominant background (Rpe65(-/-)/Nrl(-/-)) mice. Analysis of cell death pathways revealed that receptor-interacting serine/threonine-protein kinase (RIPK)/necroptosis activity was increased in Rpe65(-/-)/Nrl(-/-) retinas, and Dio2 deficiency reversed the alterations. Cell-stress analysis showed that the cellular oxidative stress responses were increased in Rpe65(-/-)/Nrl(-/-) retinas, and Dio2 deficiency abolished the elevations. Similarly, antithyroid drug treatment resulted in reduced RIPK/necroptosis activity and oxidative stress responses in Rpe65(-/-)/Nrl(-/-) retinas. Moreover, treatment with T3 significantly induced RIPK/necroptosis activity and oxidative stress responses in the retina. This work shows that suppression of TH signaling reduces cellular RIPK/necroptosis activity and oxidative stress responses in degenerating retinas, suggesting a mechanism underlying the observed cone preservation.Yang, F., Ma, H., Butler, M. R., Ding, X.-Q. Deficiency of type 2 iodothyronine deiodinase reduces necroptosis activity and oxidative stress responses in retinas of Leber congenital amaurosis model mice.	[Yang, Fan; Ma, Hongwei; Butler, Michael R.; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Yang, Fan/I-5735-2019		NEI [P30EY021725, R21EY024583, R01EY027754]; Foundation Fighting Blindness; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R21EY024583, P30EY021725, R01EY027754] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Anand Swaroop [U.S. National Institutes of Health/National Eye Institute (NIH/NEI)] for the Nrl<SUP>-/-</SUP> mouse line. The authors thank Dr. T. Michael Redmond (NIH/NEI) for the Rpe65<SUP>-/-</SUP> mouse line. The authors thank Dr. Cheryl Craft (University of South California, Los Angeles, CA, USA) for the anti-M-opsin and anti-CAR antibodies, and Dr. Muna Naash (University of Houston, Houston, TX, USA) for the anti-S-opsin antibody. The authors thank the Imaging Core Facility of the Department of Cell Biology at the University of Oklahoma Health Sciences Center for technical assistance. This work was supported by grants from the NEI (P30EY021725, R21EY024583, and R01EY027754), the Foundation Fighting Blindness, and the Knights Templar Eye Foundation. The authors declare no conflicts of interest.	ASAYAMA K, 1987, ENDOCRINOLOGY, V121, P2112, DOI 10.1210/endo-121-6-2112; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bernardi S, 2017, CLIN BIOCHEM, V50, P972, DOI 10.1016/j.clinbiochem.2017.05.011; Bessant DAR, 2001, CURR OPIN GENET DEV, V11, P307, DOI 10.1016/S0959-437X(00)00195-7; Bhumika S, 2015, MOL CELL NEUROSCI, V68, P92, DOI 10.1016/j.mcn.2015.04.002; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bomer N, 2016, ANN RHEUM DIS, V75, P571, DOI 10.1136/annrheumdis-2014-206608; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Chaker L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0329-0; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chatziralli Irini, 2017, Biomed Hub, V2, P1, DOI 10.1159/000454706; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Croniger CM, 2002, BIOCHEM MOL BIOL EDU, V30, P14, DOI 10.1002/bmb.2002.494030010018; Croniger CM, 2002, BIOCHEM MOL BIOL EDU, V30, P353, DOI 10.1002/bmb.2002.494030060151; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; Cruz-Guilloty F, 2011, NATURE, V478, P42, DOI 10.1038/478042a; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Dong K, 2012, AM J PATHOL, V181, P1634, DOI 10.1016/j.ajpath.2012.07.029; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Elnakish MT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/854265; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Gao S, 2014, MOL VIS, V20, P1374; Genini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085408; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; Gopinath B, 2016, INVEST OPHTH VIS SCI, V57, P5273, DOI 10.1167/iovs.16-19735; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hasebe T, 2017, STEM CELLS, V35, P2175, DOI 10.1002/stem.2671; Houbrechts AM, 2016, MOL CELL ENDOCRINOL, V424, P81, DOI 10.1016/j.mce.2016.01.018; Huang SA, 2008, NAT CLIN PRACT ENDOC, V4, P148, DOI 10.1038/ncpendmet0727; IP YT, 1989, MOL CELL BIOL, V9, P1289, DOI 10.1128/MCB.9.3.1289; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kimura A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2817252; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Komeima K, 2008, FREE RADICAL BIO MED, V45, P905, DOI 10.1016/j.freeradbiomed.2008.06.020; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Leveillard T, 2017, CELL MOL LIFE SCI, V74, P3649, DOI 10.1007/s00018-016-2318-7; Li J, 2001, EXP MOL PATHOL, V71, P79, DOI 10.1006/exmp.2001.2381; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Lu LL, 2009, ANTIOXID REDOX SIGN, V11, P715, DOI [10.1089/ars.2008.2171, 10.1089/ARS.2008.2171]; Ma HW, 2017, FASEB J, V31, P3425, DOI 10.1096/fj.201601166RR; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Mancini A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6757154; Masuda T, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9208489; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mendez-Lucas A, 2014, J BIOL CHEM, V289, P22090, DOI 10.1074/jbc.M114.566927; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Moriwaki K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.16; Mrowicka M, 2017, ACTA OPHTHALMOL, V95, P530, DOI 10.1111/aos.13289; Murakami Y, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.58; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Murakami Y, 2011, ONCOTARGET, V2, P497; Nakazawa T, 2011, INVEST OPHTH VIS SCI, V52, P1384, DOI 10.1167/iovs.10-6509; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2017, ENDOCRINOLOGY, V158, P1999, DOI 10.1210/en.2017-00055; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Sahel JA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017111; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sano Y, 2006, AM J PATHOL, V169, P132, DOI 10.2353/ajpath.2006.060085; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Sawant OB, 2017, CELL REP, V21, P692, DOI 10.1016/j.celrep.2017.09.069; Schenk B, 2015, ONCOGENE, V34, P5796, DOI 10.1038/onc.2015.35; SCHMIDT EDL, 1993, BIOCHIM BIOPHYS ACTA, V1172, P82, DOI 10.1016/0167-4781(93)90272-F; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Shindo R, 2013, BIOCHEM BIOPH RES CO, V436, P212, DOI 10.1016/j.bbrc.2013.05.075; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Tapia G, 2006, FREE RADICAL BIO MED, V40, P1628, DOI 10.1016/j.freeradbiomed.2005.12.033; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Tischner D, 2012, APOPTOSIS, V17, P1197, DOI 10.1007/s10495-012-0756-8; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Venditti P, 2006, J EXP BIOL, V209, P817, DOI 10.1242/jeb.02045; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; Viringipurampeer IA, 2014, CELL DEATH DIFFER, V21, P665, DOI 10.1038/cdd.2013.191; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yamada-Okabe T, 2003, EUR J BIOCHEM, V270, P3064, DOI 10.1046/j.1432-1033.2003.03686.x; Yang F, 2016, FASEB J, V30, P4313, DOI 10.1096/fj.201600715R; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108	104	4	4	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6316	6329		10.1096/fj.201800484RR	http://dx.doi.org/10.1096/fj.201800484RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29874126	Green Published, Bronze			2022-12-28	WOS:000447172000045
J	Zhou, XX; Xiong, CX; Tolbert, E; Zhao, TC; Bayliss, G; Zhuang, SG				Zhou, Xiaoxu; Xiong, Chongxiang; Tolbert, Evelyn; Zhao, Ting C.; Bayliss, George; Zhuang, Shougang			Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis	FASEB JOURNAL			English	Article						Snail; Twist; PTEN; AKT; EMT	UNILATERAL URETERAL OBSTRUCTION; CHRONIC KIDNEY-DISEASE; CELL-CYCLE ARREST; FIBROBLAST ACTIVATION; INTERSTITIAL FIBROSIS; AKT ACTIVATION; MECHANISMS; EXPRESSION; EPIGENETICS; PROGRESSION	Enhancer of zeste homolog-2 (EZH2) is a methyltransferase that induces histone H3 lysine 27 trimethylation (H3K27me3) and functions as an oncogenic factor in many cancer types. Its role in renal epithelial-mesenchymal transition (EMT) remains unknown. In this study, we found that EZH2 and H3K27me3 were highly expressed in mouse kidney with unilateral ureteral obstruction and cultured mouse kidney proximal tubular (TKPT) cells undergoing EMT. Inhibition of EZH2 with 3-deazaneplanocin A (3-DZNeP) attenuated renal fibrosis, which was associated with preserving E-cadherin expression and inhibiting Vimentin up-regulation in the obstructed kidney. Treatment with 3-DZNeP or transfection of EZH2 siRNA also inhibited TGF-1-induced EMT of TKPT cells. Injury to the kidney or cultured TKPT cells resulted in up-regulation of Snail family transcriptional repressor 1 (Snail-1) and Twist family basic helix-loop-helix (BHLH) transcription factor 1 (Twist-1), which are 2 transcription factors, and down-regulation of phosphatase and tensin homolog, a protein tyrosine phosphatase associated with inhibition of PI3K-protein kinase B (AKT) signaling; EZH2 inhibition or silencing reversed all those responses. 3-DZNeP was also effective in suppressing epithelial arrest at the G(2)/M phase and dephosphorylating AKT and -catenin in vivo and in vitro. These data indicate that EZH2 activation contributes to renal EMT and fibrosis through activation of multiple signaling pathways and suggest that EZH2 has potential as a therapeutic target for treatment of renal fibrosis.Zhou, X., Xiong, C., Tolbert, E., Zhao, T. C., Bayliss, G., Zhuang, S. Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.	[Zhou, Xiaoxu; Xiong, Chongxiang; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Zhou, Xiaoxu; Xiong, Chongxiang; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Zhou, Xiaoxu] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Zhao, Ting C.] Roger Williams Med Ctr, Dept Surg, Providence, RI USA; [Zhuang, Shougang] Tongji Univ, Sch Med, Dept Nephrol, Shanghai East Hosp, Shanghai, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Harbin Medical University; Roger Williams Medical Center; Tongji University	Zhuang, SG (corresponding author), Tongji Univ, Sch Med, Dept Nephrol, 150 Jimo Rd, Shanghai 200120, Peoples R China.	szhuang@lifespan.org			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK085065, 1R01DK113256-01A1]; National Nature Science Foundation of China [81270778, 81470920]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065, R01DK113256] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Yingjie Guan (Warren Alpert Medical School, Brown University) for critically reading and editing the article. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants 5R01DK085065 and 1R01DK113256-01A1 (to S.Z.), and National Nature Science Foundation of China Grants 81270778 and 81470920 (to S.Z.). The authors declare no conflicts of interest.	Atta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112384; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chowdhury MKH, 2015, ARCH PHYSIOL BIOCHEM, V121, P88, DOI 10.3109/13813455.2015.1048693; Coward WR, 2014, FASEB J, V28, P3183, DOI 10.1096/fj.13-241760; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Deb G, 2014, MOL CANCER RES, V12, P639, DOI 10.1158/1541-7786.MCR-13-0546; Francois H., 2017, MATRIX BIOL, DOI [10. 1016/j. matbio. 2017. 12. 013, DOI 10.1016/J.MATBI0.2017.12.013]; Galichon P, 2013, CANCER LETT, V341, P24, DOI 10.1016/j.canlet.2013.04.018; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Hewitson TD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00520; Hibino S, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.17; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Kramer M, 2013, ANN RHEUM DIS, V72, P614, DOI 10.1136/annrheumdis-2012-201615; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan AP, 2015, NEPHROL DIAL TRANSPL, V30, P385, DOI 10.1093/ndt/gfu196; Le Hir M, 2005, HISTOCHEM CELL BIOL, V123, P335, DOI 10.1007/s00418-005-0788-z; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lin XL, 2018, INT J MOL MED, V41, P129, DOI 10.3892/ijmm.2017.3228; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu SS, 2017, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00520; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Poesen R, 2013, CLIN J AM SOC NEPHRO, V8, P1508, DOI 10.2215/CJN.00300113; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Rosivatz E, 2007, BIOCHEM SOC T, V35, P257, DOI 10.1042/BST0350257; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tampe B, 2014, NEPHROL DIAL TRANSPL, V29, pI1, DOI 10.1093/ndt/gft361; Tan RJ, 2014, KIDNEY INT SUPPL, V4, P84, DOI 10.1038/kisup.2014.16; Tang HF, 2016, ONCOTARGET, V7, P62767, DOI 10.18632/oncotarget.11232; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; Vu T, 2017, CANCERS, V9, DOI 10.3390/cancers9120171; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wanner N, 2017, CELL TISSUE RES, V369, P75, DOI 10.1007/s00441-017-2588-x; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yao Y, 2011, J HUAZHONG U SCI-MED, V31, P469, DOI 10.1007/s11596-011-0475-3; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zhu MQ, 1996, EXP NEPHROL, V4, P172	60	27	29	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5976	5989		10.1096/fj.201800237R	http://dx.doi.org/10.1096/fj.201800237R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29775417	Bronze, Green Published			2022-12-28	WOS:000447172000018
J	Hannibal, L; Bolisetty, K; Axhemi, A; DiBello, PM; Quadros, EV; Fedosov, S; Jacobsen, DW				Hannibal, Luciana; Bolisetty, Keerthana; Axhemi, Armend; DiBello, Patricia M.; Quadros, Edward V.; Fedosov, Sergey; Jacobsen, Donald W.			Transcellular transport of cobalamin in aortic endothelial cells	FASEB JOURNAL			English	Article						vitamin B-12; transcobalamin; vascular endothelium; MMACHC processing; exocytosis	SOLUBLE TRANSCOBALAMIN RECEPTOR; RESISTANCE-ASSOCIATED PROTEIN-1; INTRINSIC FACTOR-COBALAMIN; CELLULAR UPTAKE; HOLO-TRANSCOBALAMIN; VITAMIN-B-12 DEFICIENCY; METHYLMALONIC ACIDURIA; FUNCTIONAL EXPRESSION; CULTURED FIBROBLASTS; PROMOTER REGION	Cobalamin [Cbl (or B-12)] deficiency causes megaloblastic anemia and a variety of neuropathies. However, homeostatic mechanisms of cyanocobalamin (CNCbl) and other Cbls by vascular endothelial cells are poorly understood. Herein, we describe our investigation into whether cultured bovine aortic endothelial cells (BAECs) perform transcytosis of B-12, namely, the complex formed between serum transcobalamin and B-12, designated as holo-transcobalamin (holo-TC). We show that cultured BAECs endocytose [Co-57]-CNCbl-TC (source material) via the CD320 receptor. The bound Cbl is transported across the cell both via exocytosis in its free form, [Co-57]-CNCbl, and via transcytosis as [Co-57]-CNCbl-TC. Transcellular mobilization of Cbl occurred in a bidirectional manner. A portion of the endocytosed [Co-57]-CNCbl was enzymatically processed by methylmalonic aciduria combined with homocystinuria type C (cblC) with subsequent formation of hydroxocobalamin, methylcobalamin, and adenosylcobalamin, which were also transported across the cell in a bidirectional manner. This demonstrates that transport mechanisms for Cbl in vascular endothelial cells do not discriminate between various -axial ligands of the vitamin. Competition studies with apoprotein- and holo-TC and holo-intrinsic factor showed that only holo-TC was effective at inhibiting transcellular transport of Cbl. Incubation of BAECs with a blocking antibody against the extracellular domain of the CD320 receptor inhibited uptake and transcytosis by approximate to 40%. This study reveals that endothelial cells recycle uncommitted intracellular Cbl for downstream usage by other cell types and suggests that the endothelium is self-sufficient for the specific acquisition and subsequent distribution of circulating B(12)via the CD320 receptor. We posit that the endothelial lining of the vasculature is an essential component for the maintenance of serum-tissue homeostasis of B-12.Hannibal, L., Bolisetty, K., Axhemi, A., DiBello, P. M., Quadros, E. V., Fedosov, S., Jacobsen, D. W. Transcellular transport of cobalamin in aortic endothelial cells.	[Hannibal, Luciana] Univ Freiburg, Med Ctr, Dept Pediat, Lab Clin Biochem & Metab, Freiburg, Germany; [Hannibal, Luciana; Bolisetty, Keerthana; Axhemi, Armend; DiBello, Patricia M.; Jacobsen, Donald W.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Fedosov, Sergey] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	University of Freiburg; Cleveland Clinic Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Aarhus University	Hannibal, L (corresponding author), Univ Freiburg, Med Ctr, Mathildenstr 1, D-79106 Freiburg, Germany.	luciana.hannibal@uniklinik-freiburg.de	Fedosov, Sergey N./J-2340-2019; Hannibal, Luciana/AAY-7689-2021	Fedosov, Sergey N./0000-0002-7016-2959; Hannibal, Luciana/0000-0002-0911-5758; Axhemi, Armend/0000-0001-5747-9380	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL71907]; Department of Pediatrics, University of Freiburg Medical Center	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Pediatrics, University of Freiburg Medical Center	This work was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL71907 (to D.W.J.). L.H. acknowledges intramural funding support from the Department of Pediatrics, University of Freiburg Medical Center. The authors declare no conflicts of interest.	Abuyaman O, 2016, SCAND J CLIN LAB INV, V76, P641, DOI 10.1080/00365513.2016.1230885; Abuyaman O, 2015, SCAND J CLIN LAB INV, V75, P514, DOI 10.3109/00365513.2015.1057761; Abuyaman O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073110; Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; Arendt JFB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045979; Arendt JFB, 2012, CLIN CHEM LAB MED, V50, P515, DOI 10.1515/CCLM.2011.810; Arora K, 2017, FASEB J, V31, P3098, DOI 10.1096/fj.201700025R; Arora K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177156; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; BEGLEY JA, 1994, J NEUROL SCI, V122, P57, DOI 10.1016/0022-510X(94)90051-5; Bor MV, 2004, CLIN CHEM, V50, P1043, DOI 10.1373/clinchem.2003.027458; Bose S, 1997, J BIOL CHEM, V272, P3538, DOI 10.1074/jbc.272.6.3538; Bose S, 2007, J PHYSIOL-LONDON, V581, P457, DOI 10.1113/jphysiol.2007.129171; Brokner M, 2017, SCAND J CLIN LAB INV, V77, P433, DOI 10.1080/00365513.2017.1335881; CARMEL R, 1990, BLOOD, V75, P251; Carmel R, 2000, ANNU REV MED, V51, P357, DOI 10.1146/annurev.med.51.1.357; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; DAN N, 1994, J BIOL CHEM, V269, P18849; Devalia V, 2014, BRIT J HAEMATOL, V166, P496, DOI 10.1111/bjh.12959; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Fedosov SN, 1999, J BIOL CHEM, V274, P26015, DOI 10.1074/jbc.274.37.26015; FERNANDESCOSTA F, 1979, BRIT J HAEMATOL, V43, P625, DOI 10.1111/j.1365-2141.1979.tb03795.x; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; FRATERSCHRODER M, 1985, BIOCHIM BIOPHYS ACTA, V845, P421, DOI 10.1016/0167-4889(85)90207-1; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; Gailus S, 2010, J INHERIT METAB DIS, V33, P17, DOI 10.1007/s10545-009-9032-7; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; Green R, 2017, BLOOD, V129, P2603, DOI 10.1182/blood-2016-10-569186; GUEANT JL, 1988, GUT, V29, P1370, DOI 10.1136/gut.29.10.1370; Hannibal L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00027; Hannibal L, 2013, CLIN CHEM LAB MED, V51, P477, DOI 10.1515/cclm-2012-0568; Hannibal L, 2011, MOL GENET METAB, V103, P226, DOI 10.1016/j.ymgme.2011.03.008; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; HERBERT V, 1994, AM J CLIN NUTR, V59, p1213S, DOI 10.1093/ajcn/59.5.1213S; Hoffmann-Lucke E, 2013, CLIN CHEM LAB MED, V51, P677, DOI 10.1515/cclm-2012-0554; HOM BL, 1969, SCAND J CLIN LAB INV, V23, P201, DOI 10.3109/00365516909077650; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Jehle J, 2017, ARCH MED SCI, V13, P930, DOI 10.5114/aoms.2017.68239; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; Jiang WX, 2010, GENE, V466, P49, DOI 10.1016/j.gene.2010.07.004; Kim JC, 2012, MOL GENET METAB, V107, P664, DOI 10.1016/j.ymgme.2012.10.005; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Kornerup LS, 2018, EUR J NUTR, V57, P1459, DOI 10.1007/s00394-017-1424-0; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Lai SC, 2011, EXP CELL RES, V317, P1603, DOI 10.1016/j.yexcr.2011.02.016; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LI N, 1994, BIOCHEM J, V301, P585, DOI 10.1042/bj3010585; Lysne V, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010026; Malinovskaya NA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00599; Markel SF, 2017, J NEUROCHEM, V140, P216, DOI 10.1111/jnc.13861; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; Neuser J, 2016, J DIABETES COMPLICAT, V30, P623, DOI 10.1016/j.jdiacomp.2016.02.002; Nexo E, 2002, CLIN CHEM, V48, P1768; Nexo E, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013458; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Pangilinan F, 2010, J MED GENET, V47, P677, DOI 10.1136/jmg.2009.073775; Perez-D'Gregorio RE, 1998, J PEDIATR-US, V132, pS35, DOI 10.1016/S0022-3476(98)70526-8; Plesa M, 2011, MOL GENET METAB, V102, P139, DOI 10.1016/j.ymgme.2010.10.011; Pons L, 2000, CELL PHYSIOL BIOCHEM, V10, P135, DOI 10.1159/000016344; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; QUADROS EV, 1995, BBA-GEN SUBJECTS, V1244, P395, DOI 10.1016/0304-4165(95)00037-C; Quadros EV, 2005, BIOCHEM BIOPH RES CO, V327, P1006, DOI 10.1016/j.bbrc.2004.12.103; QUADROS EV, 1986, J BIOL CHEM, V261, P5455; Quadros EV, 1999, AM J PHYSIOL-GASTR L, V277, pG161, DOI 10.1152/ajpgi.1999.277.1.G161; QUADROS EV, 1989, AM J PHYSIOL, V256, pC296, DOI 10.1152/ajpcell.1989.256.2.C296; QUADROS EV, 1994, ARCH BIOCHEM BIOPHYS, V308, P192, DOI 10.1006/abbi.1994.1027; RAMANUJAM KS, 1991, J BIOL CHEM, V266, P13135; RAMANUJAM KS, 1991, AM J PHYSIOL, V260, pG416, DOI 10.1152/ajpgi.1991.260.3.G416; RAMANUJAM KS, 1991, BIOCHEM BIOPH RES CO, V179, P543, DOI 10.1016/0006-291X(91)91405-2; RAMANUJAM KS, 1994, ARCH BIOCHEM BIOPHYS, V315, P8, DOI 10.1006/abbi.1994.1464; RAMANUJAM KS, 1992, BIOCHEM BIOPH RES CO, V182, P439, DOI 10.1016/0006-291X(92)91751-B; Regec AL, 2002, ARCH BIOCHEM BIOPHYS, V407, P202, DOI 10.1016/S0003-9861(02)00495-2; Rutsch F, 2011, J INHERIT METAB DIS, V34, P121, DOI 10.1007/s10545-010-9083-9; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Schneider H, 2010, INT J DEV BIOL, V54, P367, DOI 10.1387/ijdb.082773hs; SCHOHN H, 1991, BIOCHEM J, V280, P427, DOI 10.1042/bj2800427; SODA R, 1985, BLOOD, V65, P795; Solomon LR, 2005, BLOOD, V105, P978, DOI 10.1182/blood-2004-04-1641; Takahashi K, 2012, BIOL PHARM BULL, V35, P1269, DOI 10.1248/bpb.b12-00069; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; United States Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1998, DIET REF INT THIAM R; von Castel-Roberts KM, 2007, AM J CLIN NUTR, V85, P1057, DOI 10.1093/ajcn/85.4.1057; Watkins D, 2013, BIOCHIMIE, V95, P1019, DOI 10.1016/j.biochi.2013.01.013; Weber-Adrian D, 2017, J NEUROCHEM, V140, P192, DOI 10.1111/jnc.13898; Yamani L, 2008, MOL GENET METAB, V95, P104, DOI 10.1016/j.ymgme.2008.05.007; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje; Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167044	98	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5506	5519		10.1096/fj.201701141RR	http://dx.doi.org/10.1096/fj.201701141RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29741927	Green Published, Bronze			2022-12-28	WOS:000447972500026
J	Zhu, DD; Lyu, L; Shen, P; Wang, JX; Chen, JL; Sun, XL; Chen, LT; Zhang, L; Zhou, Q; Duan, YN				Zhu, Dandan; Lyu, Lei; Shen, Pei; Wang, Jianxin; Chen, Jinling; Sun, Xiaolei; Chen, Liuting; Zhang, Li; Zhou, Qi; Duan, Yinong			rSjP40 protein promotes PPAR gamma expression in LX-2 cells through microRNA-27b	FASEB JOURNAL			English	Article						Schistosoma japonicum; miR-27b; hepatic stellate cell; methylation	HEPATIC STELLATE CELLS; LIVER FIBROSIS; ACTIVATION; MIR-27B; METHYLATION; GROWTH	miR-27b is reported to participate in the proliferation and differentiation of hepatic stellate cells (HSCs) and to regulate fat metabolism of rat HSCs by targeting retinoid X receptor . Our previous study also indicated that the recombinant P40 protein from Schistosoma japonicum (rSjP40) inhibited the activation of HSCs. In this study, we observed the expression of miR-27b in rSjP40-treated LX-2 cells and explored its potential mechanisms. Quantitative real-time PCR showed that rSjP40 inhibits the expression of miR-27b in LX-2 cells. Further results obtained by Western blot and dual-luciferase reporter assay confirmed that miR-27b regulates peroxisome proliferator-activated receptor (PPAR) expression in rSjP40-treated LX-2 cells by targeting the 3-UTR of PPAR. 5-AZA-2-deoxycytidine (5-AZA-dC), which inhibits methylation of HSCs, partially reversed rSjP40-induced down-regulation expression of miR-27b in LX-2 cells. 5-AZA-dC also partially reversed rSjP40-induced up-regulation expression of PPAR in LX-2 cells. The increased expression of PPAR in rSjP40-treated LX-2 cells may be partially due to miR-27b methylation. Therefore, our study provides further insight into the mechanism by which rSjP40 inhibits HSC activation and provides a basis for future study of the blocking effect of rSjP40 in liver fibrosis.Zhu, D., Lyu, L., Shen, P., Wang, J., Chen, J., Sun, X., Chen, L., Zhang, L., Zhou, Q., Duan, Y. rSjP40 protein promotes PPAR expression in LX-2 cells through microRNA-27b.	[Zhu, Dandan; Lyu, Lei; Chen, Jinling; Sun, Xiaolei; Chen, Liuting; Zhang, Li; Zhou, Qi; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China; [Lyu, Lei] Nanjing Red Cross Blood Ctr, Nanjing, Jiangsu, Peoples R China; [Shen, Pei; Wang, Jianxin] Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong, Peoples R China	Nantong University; Nantong University	Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	yinongduan@aliyun.com	Duan, yinong/GSD-9438-2022	Chen, Jinling/0000-0003-2992-6571	National Natural Science Foundation of China [81501763, 81471975, 81171589]; Jiangsu Provincial Natural Science Foundation [BK20140435]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The authors thank Dr. Zhaolian Bian (Nantong Institute of Liver Disease, Nantong Third People's Hospital, Nantong, China) for providing the LX-2 cells. This work was supported by National Natural Science Foundation of China Grants 81501763, 81471975, and 81171589; by Jiangsu Provincial Natural Science Foundation Grant BK20140435; and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare no conflicts of interest.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cao Q, 2014, ENDOCRINOLOGY, V155, P4925, DOI 10.1210/en.2014-1595; Chan LS, 2012, HORM METAB RES, V44, P819, DOI 10.1055/s-0032-1321909; Dharap A, 2015, J NEUROCHEM, V135, P139, DOI 10.1111/jnc.13220; Du JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16163; Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003; Ge JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22141; Halasz T, 2015, WORLD J GASTROENTERO, V21, P7814, DOI 10.3748/wjg.v21.i25.7814; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kwiecinski M, 2012, LAB INVEST, V92, P978, DOI 10.1038/labinvest.2012.70; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Li XN, 2016, BIOCHEM BIOPH RES CO, V477, P768, DOI 10.1016/j.bbrc.2016.06.133; Lu L, 2015, BIOCHEM BIOPH RES CO, V465, P387, DOI 10.1016/j.bbrc.2015.08.012; Mann J, 2009, ADV DRUG DELIVER REV, V61, P497, DOI 10.1016/j.addr.2009.03.011; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Pan SF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0193-4; Rapp J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2943-4; Sun XL, 2015, PARASITOL RES, V114, P4251, DOI 10.1007/s00436-015-4663-0; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tsukamoto H, 2006, J GASTROEN HEPATOL, V21, pS102, DOI 10.1111/j.1440-1746.2006.04573.x; Tu KS, 2014, INT J MOL SCI, V15, P20486, DOI 10.3390/ijms151120486; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Zeng XM, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-016-0123-7; Zhang Z, 2013, ONKOLOGIE, V36, P598, DOI 10.1159/000355328; Zhu DD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-148	28	12	12	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4798	4803		10.1096/fj.201700520RR	http://dx.doi.org/10.1096/fj.201700520RR			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29608331				2022-12-28	WOS:000443817700015
J	Mauro, L; Naimo, GD; Gelsomino, L; Malivindi, R; Bruno, L; Pellegrino, M; Tarallo, R; Memoli, D; Weisz, A; Panno, ML; Ando, S				Mauro, Loredana; Naimo, Giuseppina Daniela; Gelsomino, Luca; Malivindi, Rocco; Bruno, Leonardo; Pellegrino, Michele; Tarallo, Roberta; Memoli, Domenico; Weisz, Alessandro; Panno, Maria Luisa; Ando, Sebastiano			Uncoupling effects of estrogen receptor on LKB1/AMPK interaction upon adiponectin exposure in breast cancer	FASEB JOURNAL			English	Article						breast cancer cells; ER; adiponectin levels; LKB1; AMPK signaling; cell metabolism	IN-VITRO; TUMOR-GROWTH; PPAR-GAMMA; ALPHA; EXPRESSION; PATHWAY; COMPLEX; PROTEIN; OBESITY; ACTIVATION	Adipose tissue is a metabolic and endocrine organ that secretes bioactive molecules called adipocytokines. Among these, adiponectin has a crucial role in obesity-associated breast cancer. The key molecule of adiponectin signaling is AMPK, which is mainly activated by liver kinase B1 (LKB1). Here, we demonstrated that estrogen receptor- (ER)/LKB1 interaction may negatively interfere with the LKB1 capability to phosphorylate AMPK and inhibit its downstream signaling TSC2/mTOR/p70S6k. In adiponectin-treated MCF-7 cells, AMPK signaling was not working, resulting in its downstream target acetyl-CoA carboxylase (ACC) being still active. In contrast, in MDA-MB-231 cells, AMPK and ACC phosphorylation was enhanced by adiponectin, inhibiting lipogenesis and cell growth. Upon adiponectin, ER signaling switched the energy balance of breast cancer cells toward a lipogenic phenotype. Therefore, adiponectin played an inhibitory role on ER-negative cell growth and progression in vitro and in vivo. In contrast, low adiponectin levels, similar to those circulating in obese patients, acted on ER-positive cells as a growth factor, stimulating proliferation. The latter effect was blunted in vivo by high adiponectin concentration. All this may have translational relevance, addressing how the handling of adiponectin, as a therapeutic tool in breast cancer treatment, needs to be carefully considered in ER-positive obese patients, where circulating levels of this adipocytokine are relatively low. In other words, in ER-positive breast cancer obese patients, higher adiponectin doses should be administered with respect to ER-negative breast cancer, also opportunely combined with antiestrogen therapy. Mauro, L., Naimo, G. D., Gelsomino, L., Malivindi, R., Bruno, L., Pellegrino, M., Tarallo, R., Memoli, D., Weisz, A., Panno, M. L., And, S. Uncoupling effects of estrogen receptor on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.	[Mauro, Loredana; Naimo, Giuseppina Daniela; Gelsomino, Luca; Malivindi, Rocco; Pellegrino, Michele; Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy; [Bruno, Leonardo] Univ Calabria, Dept Biol Ecol & Earth Sci, Arcavacata Di Rende, Italy; [Tarallo, Roberta; Memoli, Domenico; Weisz, Alessandro] Scuola Med Salernitana, Lab Mol Med & Genom, Dept Med Surg & Dent, Baronissi, Italy	University of Calabria; University of Calabria	Mauro, L; Ando, S (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, Via P Bucci, I-87036 Cosenza, Italy.	loredana.mauro@unical.it; sebastiano.ando@unical.it	Malivindi, Rocco/ABB-8562-2021; Memoli, Domenico/AAA-7500-2019; Weisz, Alessandro/A-1317-2014	Memoli, Domenico/0000-0001-5290-2709; Weisz, Alessandro/0000-0003-0455-2083; Naimo, Giuseppina Daniela/0000-0002-7300-0111; MALIVINDI, Rocco/0000-0002-8313-2492; Bruno, Leonardo/0000-0001-8260-4729; Gelsomino, Luca/0000-0003-3076-3482	Associazione Italiana Ricerca sul Cancro (AIRC) [IG-18602, IG-17426]; Fondazione Italiana per la Ricerca sul Cancro (FIRC) [16487]; Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca [2015B7M39T_001]; Lilli Funaro foundation	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Lilli Funaro foundation	The authors thank Dr. S. A. W. Fuqua (Baylor College of Medicine, Houston, TX, USA) for providing wild-type YFP-ER alpha plasmid, Dr. D. Picard (University of Geneva, Geneva, Switzerland) for the XETL plasmid, and Dr. A. Cossari (Department of Economics, Statistics, and Finance, University of Calabria, Italy) for performing in vivo statistical analysis. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) Grants IG-18602 (to S.A., M.L.P., L.M.) and IG-17426 (to A.W.); by Fondazione Italiana per la Ricerca sul Cancro (FIRC) Grant 16487 (to L.G.), by Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca Grant 2015B7M39T_001, and by funds from the Lilli Funaro foundation (to G.D.N.). The authors declare no conflicts of interest.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Catalano S, 2013, INT J CANCER, V132, P2237, DOI 10.1002/ijc.27915; Catalano S, 2011, AM J PATHOL, V179, P1030, DOI 10.1016/j.ajpath.2011.04.026; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; De Amicis F, 2009, MOL ENDOCRINOL, V23, P454, DOI 10.1210/me.2008-0267; De Amicis F, 2013, MOL NUTR FOOD RES, V57, P840, DOI 10.1002/mnfr.201200560; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Du Q, 2009, ONCOL REP, V22, P659, DOI 10.3892/or_00000486; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Guan DY, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0051-9; Hong KU, 2009, CELL CYCLE, V8, P314, DOI 10.4161/cc.8.2.7597; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043362; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Katira A, 2016, CANCER BIOL MED, V13, P101, DOI 10.28092/j.issn.2095-3941.2015.0092; Kim SH, 2014, CANCER LETT, V346, P249, DOI 10.1016/j.canlet.2013.12.031; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Korsse SE, 2013, BBA-REV CANCER, V1835, P194, DOI 10.1016/j.bbcan.2012.12.006; Lam JBB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004968; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li SF, 2018, ANTI-CANCER AGENT ME, V18, P314, DOI 10.2174/1871520617666170327120747; Li TG, 2009, PPAR RES, V2009, DOI 10.1155/2009/501739; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Maccio A, 2011, THESCIENTIFICWORLDJO, V11, P2020, DOI 10.1100/2011/806787; Mancuso MR, 2016, CURR PROB CANCER, V40, P95, DOI 10.1016/j.currproblcancer.2016.09.001; Mauro L, 2007, CANCER RES, V67, P3412, DOI 10.1158/0008-5472.CAN-06-2890; Mauro L, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00157; Mauro L, 2015, FASEB J, V29, P2150, DOI 10.1096/fj.14-262808; Mauro L, 2014, CELL CYCLE, V13, P553, DOI 10.4161/cc.27455; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; Medina-Gomez G, 2007, PUBLIC HEALTH NUTR, V10, P1132, DOI 10.1017/S1368980007000614; Nardone A, 2015, BREAST, V24, pS60, DOI 10.1016/j.breast.2015.07.015; Nath-Sain S, 2009, MOL BIOL CELL, V20, P2785, DOI 10.1091/mbc.E08-11-1138; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Panno ML, 2016, CURR OPIN PHARMACOL, V31, P1, DOI 10.1016/j.coph.2016.08.001; Panno ML, 2006, J MOL ENDOCRINOL, V36, P91, DOI 10.1677/jme.1.01848; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Raimondo A, 2015, CURR OPIN LIPIDOL, V26, P88, DOI 10.1097/MOL.0000000000000155; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sisci D, 2013, CELL CYCLE, V12, P3405, DOI 10.4161/cc.26421; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Takahata C, 2007, CANCER LETT, V250, P229, DOI 10.1016/j.canlet.2006.10.006; Tarallo R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1321-0; Vrieling A, 2010, BREAST CANCER RES TR, V123, P641, DOI 10.1007/s10549-010-1116-4; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87	62	19	20	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4343	4355		10.1096/fj.201701315R	http://dx.doi.org/10.1096/fj.201701315R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29513571				2022-12-28	WOS:000439325400024
J	Mukai, S; Ogawa, Y; Kawakami, Y; Mashima, Y; Tsubota, K				Mukai, Shin; Ogawa, Yoko; Kawakami, Yutaka; Mashima, Yukihiko; Tsubota, Kazuo			Inhibition of Vascular Adhesion Protein-1 for Treatment of Graft-Versus-Host Disease in Mice	FASEB JOURNAL			English	Article						age-associated disease; refractory disease; inhibitor; inflammation; fibrosis	TISSUE GROWTH-FACTOR; CHOROIDAL NEOVASCULARIZATION; T-CELLS; VAP-1; EXPRESSION; BLOCKADE; GVHD; TRANSPLANTATION; INFLAMMATION; MECHANISM	Graft-versus-host disease (GVHD) is a potentially lethal complication of hematopoietic stem cell transplantation (HSCT). GVHD comprises acute and chronic forms. To date, several approaches to treat acute GVHD or chronic GVHD have been reported. However, there is no literature precedent regarding all-in-one methods to address the 2 GVHD types. Severe inflammation in organs affected by GVHD is highly problematic, and vascular adhesion protein-1 (VAP-1) is known to be detrimentally involved in various inflammatory diseases. Based on the previous reports, we envisaged that there would be a link between GVHD and VAP-1, and we strived to create effective therapies for the 2 types of GVHD using a mouse model of GVHD. Our investigation indicated that expression of VAP-1 was elevated in organs disordered by GVHD. Hence, we subsequently attempted to block VAP-1 by using a novel inhibitor. Our results indicate that systemic injection of the inhibitor prevented aberrant influx of inflammatory cells into tissues and thereby mitigate GVHD-elicited inflammation and fibrosis. Collectively, our study suggests that the increased expression of VAP-1 is detrimentally associated with the development of GVHD and that the blockade of VAP-1 could be a promising medical modality to combat the acute and chronic variants.Mukai, S., Ogawa, Y., Kawakami, Y., Mashima, Y., Tsubota, K. Inhibition of vascular adhesion protein-1 for treatment of graft-versus-host disease in mice.	[Mukai, Shin; Ogawa, Yoko; Mashima, Yukihiko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Mukai, Shin; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Mashima, Yukihiko] Sucampo Pharmaceut Inc, Tokyo, Japan	Keio University; Keio University	Ogawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoko@z7.keio.jp	Ogawa, Yoko/AAV-1932-2021; Tsubota, Kazuo/M-1915-2013	Ogawa, Yoko/0000-0002-2906-9621; Tsubota, Kazuo/0000-0002-8874-7111	Japanese Ministry of Education, Science, Sports and Culture [26462668]; Sucampo Pharmaceuticals	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sucampo Pharmaceuticals	This research was subsidized by the Japanese Ministry of Education, Science, Sports and Culture (#26462668). The assistance of Dr. Toshihiro Nagai and Dr. Tetsuya Yano at the Keio University School of Medicine is also gratefully appreciated. Financial and non-financial support from Sucampo Pharmaceuticals was given to K.T. and Y.O. Y.M. is a special adviser for Sucampo Pharmaceuticals. The authors declare no other conflicts of interest.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Akin E, 2001, INFECT IMMUN, V69, P1774, DOI 10.1128/IAI.69.3.1774-1780.2001; Anderson Graeme, 1996, P47; Aronni S, 2006, EUR J OPHTHALMOL, V16, P17, DOI 10.1177/112067210601600104; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bligt-Linden E, 2013, J MED CHEM, V56, P9837, DOI 10.1021/jm401372d; Ceredig R, 2012, IMMUNOL CELL BIOL, V90, P253, DOI 10.1038/icb.2011.62; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Dziadzio M, 2005, QJM-INT J MED, V98, P485, DOI 10.1093/qjmed/hci078; Flowers MED, 2015, BLOOD, V125, P606, DOI 10.1182/blood-2014-08-551994; Foot JS, 2013, J PHARMACOL EXP THER, V347, P365, DOI 10.1124/jpet.113.207613; He J., 2018, CORNEA, DOI [10. 1097/ICO. 0000000000001487, DOI 10.1097/IC0.0000000000001487]; Hopwood D, 1996, THEORY PRACTICE HIST, P23; Jaakkola K, 2000, J AM COLL CARDIOL, V36, P122, DOI 10.1016/S0735-1097(00)00706-3; Kawai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02455; Kim SW, 2016, EXP HEMATOL, V44, P332, DOI 10.1016/j.exphem.2016.02.002; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Kitko CL, 2012, BIOL BLOOD MARROW TR, V18, pS46, DOI 10.1016/j.bbmt.2011.10.021; Krupski MC, 2016, BIOL BLOOD MARROW TR, V22, pS404, DOI 10.1016/j.bbmt.2015.11.932; McGeough MD, 2012, J IMMUNOL, V189, P2707, DOI 10.4049/jimmunol.1101737; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Noda K, 2009, EXP EYE RES, V89, P774, DOI 10.1016/j.exer.2009.07.010; Noonan T, 2013, AM J CLIN EXP IMMUNO, V2, P172; Ogawa Y, 2016, ELIFE, V5, DOI 10.7554/eLife.09394; Pillai AB, 2007, J IMMUNOL, V178, P6242, DOI 10.4049/jimmunol.178.10.6242; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Sampson MJ, 2006, DIABETOLOGIA, V49, P1726, DOI 10.1007/s00125-006-0322-4; Sato S, 2000, J RHEUMATOL, V27, P149; Schilter HC, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0200-z; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Singh B, 2003, VIRCHOWS ARCH, V442, P491, DOI 10.1007/s00428-003-0802-6; Socie G, 2014, BLOOD, V124, P374, DOI 10.1182/blood-2014-01-514752; Solomon SR, 2003, BONE MARROW TRANSPL, V31, P783, DOI 10.1038/sj.bmt.1703928; Toubai T, 2008, BEST PRACT RES CL HA, V21, P101, DOI 10.1016/j.beha.2008.02.005; Vigorito AC, 2009, BLOOD, V114, P702, DOI 10.1182/blood-2009-03-208983; Vogelsang GB, 2001, BLOOD, V97, P1196, DOI 10.1182/blood.V97.5.1196; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058397; Wu T, 2013, J IMMUNOL, V191, P488, DOI 10.4049/jimmunol.1300657; Yaguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064724; Yoon HK, 2010, TRANSPLANTATION, V90, P853, DOI 10.1097/TP.0b013e3181f2c92b; Yoshikawa N, 2012, MOL VIS, V18, P593	44	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4085	4095		10.1096/fj.201700176R	http://dx.doi.org/10.1096/fj.201700176R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29490166				2022-12-28	WOS:000439325400003
J	Miyazaki, T; Haraguchi, S; Kim-Kaneyama, JR; Miyazaki, A				Miyazaki, Takuro; Haraguchi, Shogo; Kim-Kaneyama, Joo-Ri; Miyazaki, Akira			Endothelial calpain systems orchestrate myofibroblast differentiation during wound healing	FASEB JOURNAL			English	Article						PDGFR-beta fibroblasts; angiogenesis; calpastatin; extracellular matrix	KAPPA-B-ALPHA; PROTEOLYTIC SYSTEMS; CA2+ TRANSIENTS; CELL; ANGIOGENESIS; BETA; PROLIFERATION; DYSFUNCTION; INHIBITION; MODULATION	The transformation of fibroblasts to myofibroblasts plays a major role in fibrogenic responses during dermal wound healing. We show a contribution of calpain systems (intracellular regulatory protease systems) in vascular endothelial cells (ECs) to myofibroblast differentiation in wound sites. Dermal wound healing experiments in mice found that calpastatin (an endogenous inhibitor of calpains) is enriched in preexisting vessels but not in newly formed capillaries. Transgenic overexpression of calpastatin in ECs delayed wound healing in mice as well as reducing the keratinocyte layer, extracellular matrix deposition, and myofibroblast accumulation in wound sites. EC and leukocyte markers, however, remain unchanged. Calpastatin overexpression reduced the expression of genes encoding platelet-derived growth factor-B and PDGF receptor- (PDGFR-). Topical application of platelet-derived growth factor-BB-containing ointment to wounds accelerated healing in control mice, but calpastatin overexpression prevented this acceleration. In cultured human dermal fibroblasts, -smooth muscle actin and PDGFR- were up-regulated by coculturing with ECs, but this action was inhibited by suppression of EC calpain activity. EC-driven transformation of mouse dermal fibroblasts was also suppressed by calpastatin overexpression in ECs. These results suggest that endothelial calpain systems influence PDGFR- signaling in fibroblasts, EC-driven myofibroblast differentiation, and subsequent fibrogenic responses in wounds.Miyazaki, T., Haraguchi, S., Kim-Kaneyama, J.-R., Miyazaki, A. Endothelial calpain systems orchestrate myofibroblast differentiation during wound healing.	[Miyazaki, Takuro; Haraguchi, Shogo; Kim-Kaneyama, Joo-Ri; Miyazaki, Akira] Showa Univ, Sch Med, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan	Showa University	Miyazaki, T (corresponding author), Showa Univ, Sch Med, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	taku@pharm.showa-u.ac.jp		Miyazaki, Takuro/0000-0003-3354-0292; Haraguchi, Shogo/0000-0002-8731-3311	Japan Society for the Promotion of Science (KAKENHI) [17K09869, 15K09418]; Takeda Science Foundation; Senshin Medical Research Foundation; Kanae Foundation for the Promotion of Medical Science	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Kanae Foundation for the Promotion of Medical Science	The authors thank Nicholas Rufaut (Edanz Group, Fukuoka, Japan; https://www.edanzediting.com/ac), for editing a draft of the manuscript. This work was supported, in part, by Japan Society for the Promotion of Science (KAKENHI; Grant 17K09869 to A.M. and 15K09418 to T.M.), and research grants from Takeda Science Foundation, Senshin Medical Research Foundation, and The Kanae Foundation for the Promotion of Medical Science (all to T.M.). The authors declare no conflicts of interest.	Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; DiPietro LA, 2016, J LEUKOCYTE BIOL, V100, P979, DOI 10.1189/jlb.4MR0316-102R; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Gao ZY, 2005, J BIOL CHEM, V280, P9375, DOI 10.1074/jbc.M413081200; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hoang MV, 2011, BBA-MOL BASIS DIS, V1812, P549, DOI 10.1016/j.bbadis.2010.08.008; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kwon YB, 2006, J VET SCI, V7, P105, DOI 10.4142/jvs.2006.7.2.105; Lambers C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19294-1; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; Milligan SA, 1996, ARCH BIOCHEM BIOPHYS, V335, P388, DOI 10.1006/abbi.1996.9998; Miyazaki T, 2001, BIOCHEM BIOPH RES CO, V281, P172, DOI 10.1006/bbrc.2001.4331; Miyazaki T, 2007, LIFE SCI, V81, P1421, DOI 10.1016/j.lfs.2007.08.041; Miyazaki T, 2018, J ATHEROSCLER THROMB, V25, P1, DOI 10.5551/jat.RV17008; Miyazaki T, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00079; Miyazaki T, 2017, CELL MOL LIFE SCI, V74, P3011, DOI 10.1007/s00018-017-2528-7; Miyazaki T, 2016, J CLIN INVEST, V126, P3417, DOI 10.1172/JCI85880; Miyazaki T, 2015, CIRC RES, V116, P1170, DOI 10.1161/CIRCRESAHA.116.305363; Miyazaki T, 2013, J ATHEROSCLER THROMB, V20, P228, DOI 10.5551/jat.14787; Miyazaki T, 2010, CARDIOVASC RES, V85, P530, DOI 10.1093/cvr/cvp311; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Nissen NN, 1998, AM J PATHOL, V152, P1445; Oberringer M, 2008, J MOL HISTOL, V39, P37, DOI 10.1007/s10735-007-9124-3; Oberringer M, 2007, BIOL CELL, V99, P197, DOI 10.1042/BC20060116; Roman CD, 2002, J SURG RES, V105, P43, DOI 10.1006/jsre.2002.6444; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Scalia R, 2007, DIABETES, V56, P1842, DOI 10.2337/db06-1198; Singh V, 2014, EXP EYE RES, V120, P152, DOI 10.1016/j.exer.2014.01.003; Stalker TJ, 2003, FASEB J, V17, P1511, DOI 10.1096/fj.02-1213fje; Zhang YX, 2017, BBA-MOL BASIS DIS, V1863, P1326, DOI 10.1016/j.bbadis.2017.03.021	35	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2037	2046		10.1096/fj.201800588RR	http://dx.doi.org/10.1096/fj.201800588RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199285	Bronze			2022-12-28	WOS:000457296600041
J	Formaggio, F; Saracino, E; Mola, MG; Rao, SB; Amiry-Moghaddam, M; Muccini, M; Zamboni, R; Nicchia, GP; Caprini, M; Benfenati, V				Formaggio, Francesco; Saracino, Emanuela; Mola, Maria Grazia; Rao, Shreyas Balachandra; Amiry-Moghaddam, Mahmood; Muccini, Michele; Zamboni, Roberto; Nicchia, Grazia Paola; Caprini, Marco; Benfenati, Valentina			LRRC8A is essential for swelling-activated chloride current and for regulatory volume decrease in astrocytes	FASEB JOURNAL			English	Article						edema; ion channels; VRAC; central nervous system; volume regulation	EXCITATORY AMINO-ACIDS; ANION CHANNEL; BRAIN EDEMA; PHARMACOLOGICAL CHARACTERIZATION; ESSENTIAL COMPONENT; WATER TRANSPORT; TAURINE RELEASE; AQUAPORIN-4; POTASSIUM; ATP	Consolidated evidence indicates that astroglial cells are critical in the homeostatic regulation of cellular volume by means of ion channels and aquaporin-4. Volume-regulated anion channel (VRAC) is the chloride channel that is activated upon cell swelling and critically contributes to cell volume regulation in astrocytes. The molecular identity of VRAC has been recently defined, revealing that it belongs to the leucine-rich repeat-containing 8 (LRRC8) protein family. However, there is a lack of evidence demonstrating that LRRC8A underpins VRAC currents in astrocyte. Nonetheless, direct evidence of the role of LRRC8A in astrocytic regulatory volume decrease remains to be proved. Here, we aim to bridge this gap in knowledge by combining RNA interference specific for LRRC8A with patch-clamp analyses and a water-permeability assay. We demonstrated that LRRC8A molecular expression is essential for swelling-activated chloride current via VRAC in primary-cultured cortical astrocytes. The knockdown of LRRC8A with a specific short interference RNA abolished the recovery of the cell volume after swelling induced by hypotonic challenge. In addition, immunoblotting, immunofluorescence, confocal imaging, and immunogold electron microscopy demonstrated that LRRC8A is expressed in the plasma membrane of primary cortical astrocytes and in situ in astrocytes at the perivascular interface with endothelial cells. Collectively, our results suggest that LRRC8A is an essential subunit of VRAC and a key factor for astroglial volume homeostasis.Formaggio, F., Saracino, E., Mola, M. G., Rao, S. B., Amiry-Moghaddam, M., Muccini, M., Zamboni, R., Nicchia, G. P., Caprini, M., Benfenati, V. LRRC8A is essential for swelling-activated chloride current and for regulatory volume decrease in astrocytes.	[Formaggio, Francesco; Caprini, Marco] Univ Bologna, Dept Pharm & Biotechnol, Lab Human & Gen Physiol, Bologna, Italy; [Formaggio, Francesco; Muccini, Michele; Caprini, Marco; Benfenati, Valentina] Natl Res Council Italy, Inst Study Nanostruct Mat, Bologna, Italy; [Saracino, Emanuela; Zamboni, Roberto; Benfenati, Valentina] Natl Res Council Italy, Inst Organ Synth & Photoreact, Bologna, Italy; [Mola, Maria Grazia; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Ctr Excellence Comparat Gen, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Rao, Shreyas Balachandra; Amiry-Moghaddam, Mahmood] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Nicchia, Grazia Paola] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, Bronx, NY USA	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Universita degli Studi di Bari Aldo Moro; University of Oslo; Yeshiva University; Albert Einstein College of Medicine	Caprini, M (corresponding author), Univ Bologna, Lab Human & Gen Physiol, Dept Pharm & Biotechnol FaBiT, Via S Donato 19-2, I-40127 Bologna, Italy.; Benfenati, V (corresponding author), Natl Res Council Italy CNR ISOF, Inst Organ Synth & Photoreact, Via P Gobetti 101, I-40129 Bologna, Italy.	m.caprini@unibo.it; valentina.benfenati@isof.cnr.it	Muccini, Michele/D-6935-2018; Benfenati, Valentina/AAD-1821-2019; Formaggio, Francesco/AAH-3521-2020; Mola, Maria Grazia/I-3507-2019; Saracino, Emanuela/Q-4385-2018	Muccini, Michele/0000-0003-0489-8316; Benfenati, Valentina/0000-0002-2858-8497; Mola, Maria Grazia/0000-0002-4421-9237; Formaggio, Francesco/0000-0002-7504-6607; Rao, Shreyas/0000-0001-6029-3018	Fondazione Del Monte di Bologna e Ravenna; Fund for Investment in Basic Research (FIRB)-Futuro in Ricerca [RBFR12SJA8_001, RBFR12SJA8_002]; University of Bologna [RFO2016/17]; FIRB-Futuro in Ricerca; U.S. Air Force Office of Scientific Research [FA9550 16 1 0502, FA9550-17-1-0502]	Fondazione Del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); Fund for Investment in Basic Research (FIRB)-Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); University of Bologna; FIRB-Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	The authors thank Alessia Minardi (University of Bologna) for assistance in astrocyte preparation; Bjorg Riber, Karen Marie Gujord and Nadia Skauli (University of Oslo) for technical assistance; and Wilson R. Adams (Vanderbilt University, Nashville, TN, USA) for the English proofreading of the manuscript. Special thanks are given to Prof. Stefano Ferroni (University of Bologna) for technical assistance in patch-clamp experiments, and Prof. Thomas Jentsch (Max Delbruck Center for Molecular Medicine, Berlin, Germany) for kindly providing the LRRC8A/pCMV6 clone and the HCT 116 LRRC8A-KO cell line. The authors thank the Fondazione Del Monte di Bologna e Ravenna and the Italian Minister for Education, University, and Research within the Fund for Investment in Basic Research (FIRB)-Futuro in Ricerca (RBFR12SJA8_001; RBFR12SJA8_002) for providing F.F. and E.S. a Ph.D. fellowship. This work was supported by grants from the University of Bologna (RFO2016/17; to M.C.) and the Italian Minister for Education, University, and Research within the FIRB-Futuro in Ricerca (to V.B. and G.P.N.). The U.S. Air Force Office of Scientific Research, Research Projects Advanced Nano-Structured Material Interfaces and Devices for In Vivo-like-In Vitro Monitoring of Astrocytes Physiology and Brain Toxicology (ASTROMAT; FA9550 16 1 0502) and Shedding Light on Glial Function (ASTRONIR; FA9550-17-1-0502) (both to V.B.) are acknowledged. The authors declare no conflicts of interest.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Akita T, 2014, NEUROSCIENCE, V275, P211, DOI 10.1016/j.neuroscience.2014.06.015; Akita T, 2011, CELL PHYSIOL BIOCHEM, V28, P1181, DOI 10.1159/000335867; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2015, HOMEOSTATIC CONTROL, V1st, P3, DOI DOI 10.1093/MED/9780199322299.003.0001; Benfenati V, 2007, J NEUROCHEM, V100, P87, DOI 10.1111/j.1471-4159.2006.04164.x; Benfenati V, 2006, J NEUROCHEM, V98, P430, DOI 10.1111/j.1471-4159.2006.03877.x; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cardin V, 2003, GLIA, V44, P119, DOI 10.1002/glia.10271; Cardin V, 1999, J NEUROSCI RES, V56, P659; Crepel V, 1998, J NEUROSCI, V18, P1196; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Fabene PF, 2006, NEUROBIOL DIS, V21, P80, DOI 10.1016/j.nbd.2005.06.013; FERRONI S, 1995, FEBS LETT, V367, P319, DOI 10.1016/0014-5793(95)00588-Z; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; Fisher SK, 2010, J PHYSIOL-LONDON, V588, P3355, DOI 10.1113/jphysiol.2010.190777; Gaitan-Penas H, 2016, BIOPHYS J, V111, P1429, DOI 10.1016/j.bpj.2016.08.030; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haskew-Layton RE, 2005, J BIOL CHEM, V280, P3548, DOI 10.1074/jbc.M409803200; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hyzinski-Garcia MC, 2014, J PHYSIOL-LONDON, V592, P4855, DOI 10.1113/jphysiol.2014.278887; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Kimelberg HK, 1998, CONTRIB NEPHROL, V123, P240, DOI 10.1159/000059916; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Minieri L, 2013, BRIT J PHARMACOL, V168, P1240, DOI 10.1111/bph.12011; Mola MG, 2016, GLIA, V64, P139, DOI 10.1002/glia.22921; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Mongin AA, 2005, AM J PHYSIOL-CELL PH, V288, pC204, DOI 10.1152/ajpcell.00330.2004; Mongin AA, 2002, AM J PHYSIOL-CELL PH, V283, pC569, DOI 10.1152/ajpcell.00438.2001; Mongin AA, 2016, PFLUG ARCH EUR J PHY, V468, P421, DOI 10.1007/s00424-015-1765-6; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nielsen S, 1997, J NEUROSCI, V17, P171; Nilius B, 2004, NEUROCHEM RES, V29, P3, DOI 10.1023/B:NERE.0000010430.23137.be; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; OKADA Y, 1994, JPN J PHYSIOL, V44, P403, DOI 10.2170/jjphysiol.44.403; Olson JE, 1997, GLIA, V20, P254, DOI 10.1002/(SICI)1098-1136(199707)20:3<254::AID-GLIA9>3.0.CO;2-7; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Parkerson KA, 2004, GLIA, V46, P419, DOI 10.1002/glia.10361; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; PASANTESMORALES H, 1990, GLIA, V3, P427, DOI 10.1002/glia.440030514; Phillis JW, 1998, BRAIN RES, V780, P352, DOI 10.1016/S0006-8993(97)01352-8; Phillis JW, 1997, BRAIN RES, V758, P9, DOI 10.1016/S0006-8993(97)00155-8; Prydz A, 2017, NEUROSCIENCE, V359, P258, DOI 10.1016/j.neuroscience.2017.07.029; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Rutledge EM, 1998, AM J PHYSIOL-CELL PH, V274, pC1511, DOI 10.1152/ajpcell.1998.274.6.C1511; Schober AL, 2017, J PHYSIOL-LONDON, V595, P6939, DOI 10.1113/JP275053; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sirianant L, 2016, PFLUG ARCH EUR J PHY, V468, P805, DOI 10.1007/s00424-016-1789-6; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; VITARELLA D, 1994, J NEUROCHEM, V63, P1143; Voets T, 1997, J GEN PHYSIOL, V110, P313, DOI 10.1085/jgp.110.3.313; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Walz W, 2002, GLIA, V40, P1, DOI 10.1002/glia.10125; Wang RP, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90632; Yamada T, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12940; Zhang YH, 2017, NAT CELL BIOL, V19, P504, DOI 10.1038/ncb3514	83	25	26	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					101	113		10.1096/fj.201701397RR	http://dx.doi.org/10.1096/fj.201701397RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957062	Green Submitted			2022-12-28	WOS:000457401500008
J	Lee, MS; Wang, J; Yuan, HH; Jiao, HL; Tsai, TL; Squire, MW; Li, WJ				Lee, Ming-Song; Wang, Jesse; Yuan, Huihua; Jiao, Hongli; Tsai, Tsung-Lin; Squire, Matthew W.; Li, Wan-Ju			Endothelin-1 differentially directs lineage specification of adipose- and bone marrow-derived mesenchymal stem cells	FASEB JOURNAL			English	Article						endothelin receptor; adipogenesis; osteogenesis; regenerative medicine	B RECEPTOR; STROMAL CELLS; EXPRESSION; TISSUE; ACTIVATION; LIPOLYSIS; BIOLOGY; CLONING; RESIDE	Blood vessels composed of endothelial cells (ECs) contact with mesenchymal stem cells (MSCs) in different tissues, suggesting possible interaction between these 2 types of cells. We hypothesized that endothelin-1 (ET1), a secreted paracrine factor of ECs, can differentially direct the lineages of adipose-derived stem cells (ASCs) and bone marrow-derived MSCs (BMSCs). Predifferentiated ASCs and BMSCs were treated with ET1 for 2 cell passages and then induced for multilineage differentiation. Our results showed that adipogenesis of ET1-pretreated ASCs and osteogenesis of ET1-pretreated BMSCs were increased compared to those of control cells. The effect of ET1 on enhancing adipogenesis of ASCs and osteogenesis of BMSCs was attenuated by blocking endothelin receptor type A (ETAR) and/or endothelin receptor type B (ETBR). Western blot analysis indicated that regulation by ET1 was mediated through activation of the protein kinase B and ERK1/2 signaling pathways. We analyzed subpopulations of ASCs and BMSCs with or without ETAR and/or ETBR, and we found that ETAR(+)/ETBR- and ETAR(-)/ETBR+ subpopulations of ASCs and those of BMSCs pretreated with ET1 were prone to turning into adipocytes and osteoblasts, respectively, after differentiation induction. Our findings provide insight into the differential regulation of MSC specification by ET1, which may help develop viable approaches for tissue regeneration.Lee, M.-S., Wang, J., Yuan, H., Jiao, H., Tsai, T.-L., Squire, M. W., Li, W.-J. Endothelin-1 differentially directs lineage specification of adipose- and bone marrow-derived mesenchymal stem cells.	[Lee, Ming-Song; Wang, Jesse; Yuan, Huihua; Jiao, Hongli; Tsai, Tsung-Lin; Squire, Matthew W.; Li, Wan-Ju] Univ Wisconsin, Dept Orthoped & Rehabil, Lab Musculoskeletal Biol & Regenerat Med, Madison, WI USA; [Lee, Ming-Song; Wang, Jesse; Tsai, Tsung-Lin; Li, Wan-Ju] Univ Wisconsin, Dept Biomed Engn, 1111 Highland Ave,WIMR 5051, Madison, WI 53705 USA; [Yuan, Huihua] Donghua Univ, Coll Chem, Chem Engn & Biotechnol, Shanghai, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Donghua University	Li, WJ (corresponding author), Univ Wisconsin, Dept Biomed Engn, 1111 Highland Ave,WIMR 5051, Madison, WI 53705 USA.	li@ortho.wisc.edu	Li, Wan-Ju/B-4911-2011; Yuan, Huihua/G-8590-2012	Li, Wan-Ju/0000-0002-6579-8063; Yuan, Huihua/0000-0001-8657-984X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR064803]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064803] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank E.-L. Hsieh (Shih Chien University, Taipei, Taiwan), J. L. Michel (University of Wisconsin-La Crosse, WI, USA), and C. Ma (Wellesley College, MA, USA) for their help in this study. Research reported in this publication was partially supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR064803). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Brown PT, 2014, CELL TISSUE RES, V358, P149, DOI 10.1007/s00441-014-1926-5; Caplan AI, 2017, J ORTHOP RES, V35, P1151, DOI 10.1002/jor.23560; Chen S, 2015, GENES DIS, V2, P76, DOI 10.1016/j.gendis.2014.12.003; Cianfrocca R, 2010, CAN J PHYSIOL PHARM, V88, P796, DOI 10.1139/Y10-052; CLERK A, 1994, J BIOL CHEM, V269, P32848; Clines GA, 2011, J BONE MINER RES, V26, P2523, DOI 10.1002/jbmr.450; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dawson LA, 2004, BRIT J CANCER, V90, P1577, DOI 10.1038/sj.bjc.6601717; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dibra D, 2016, HEPATOLOGY, V63, P1000, DOI 10.1002/hep.28379; Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI 10.1089/ten.TEA.2009.0398; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Eriksson AKS, 2009, INT J OBESITY, V33, P67, DOI 10.1038/ijo.2008.212; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hiruma Y, 1998, AM J PHYSIOL-REG I, V275, pR1099, DOI 10.1152/ajpregu.1998.275.4.R1099; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Juan CC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1146, DOI 10.1152/ajpendo.00481.2004; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kwon A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23544; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Liao Han-Tsung, 2014, World J Stem Cells, V6, P288, DOI 10.4252/wjsc.v6.i3.288; Lin RZ, 2014, P NATL ACAD SCI USA, V111, P10137, DOI 10.1073/pnas.1405388111; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mundy AL, 2007, CARDIOVASC RES, V73, P368, DOI 10.1016/j.cardiores.2006.11.019; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Nadiminty N, 2006, CLIN CANCER RES, V12, P1420, DOI 10.1158/1078-0432.CCR-05-1849; Nassiri SM, 2014, STEM CELLS DEV, V23, P319, DOI 10.1089/scd.2013.0419; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Nelson JB, 1999, UROLOGY, V53, P1063, DOI 10.1016/S0090-4295(98)00658-X; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Robertson JA, 2001, NAT REV GENET, V2, P74, DOI 10.1038/35047594; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Tanaka S, 2017, J ORAL MAX SURG MED, V29, P85, DOI 10.1016/j.ajoms.2016.09.002; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tsai TL, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0065-6; van Harmelen V, 2008, DIABETES, V57, P378, DOI 10.2337/db07-0893; Winter A, 2003, ARTHRITIS RHEUM-US, V48, P418, DOI 10.1002/art.10767; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yamaguchi T, 2003, EUR J BIOCHEM, V270, P1816, DOI 10.1046/j.1432-1033.2003.03544.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang JL, 2014, AM J PATHOL, V184, P1706, DOI 10.1016/j.ajpath.2014.02.027; Zhong Q, 2002, BIOCHEM BIOPH RES CO, V296, P383, DOI 10.1016/S0006-291X(02)00882-3	55	15	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					996	1007		10.1096/fj.201800614R	http://dx.doi.org/10.1096/fj.201800614R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30096039	Green Published			2022-12-28	WOS:000457401500078
J	Schoenauer, R; Larpin, Y; Babiychuk, EB; Drucker, P; Babiychuk, VS; Avota, E; Schneider-Schaulies, S; Schumacher, F; Kleuser, B; Koffel, R; Draeger, A				Schoenauer, Roman; Larpin, Yu; Babiychuk, Eduard B.; Drucker, Patrick; Babiychuk, Viktoriia S.; Avota, Elita; Schneider-Schaulies, Sibylle; Schumacher, Fabian; Kleuser, Burkhard; Koffel, Rene; Draeger, Annette			Down-regulation of acid sphingomyelinase and neutral sphingomyelinase-2 inversely determines the cellular resistance to plasmalemmal injury by pore-forming toxins	FASEB JOURNAL			English	Article						membrane repair; blebbing; calcium; bacterial toxins; annexins	ACTIVATED PROTEIN-KINASE; EPITHELIAL-CELLS; P38 MAPK; MEMBRANE; REPAIR; CERAMIDE; CHOLESTEROL; ENDOCYTOSIS; EXPRESSION; RECOVERY	Bacterial pore-forming toxins compromise plasmalemmal integrity, leading to Ca2+ influx, leakage of the cytoplasm, and cell death. Such lesions can be repaired by microvesicular shedding or by the endocytic uptake of the injured membrane sites. Cells have at their disposal an entire toolbox of repair proteins for the identification and elimination of membrane lesions. Sphingomyelinases catalyze the breakdown of sphingomyelin into ceramide and phosphocholine. Sphingomyelin is predominantly localized in the outer leaflet, where it is hydrolyzed by acid sphingomyelinase (ASM) after lysosomal fusion with the plasma membrane. The magnesium-dependent neutral sphingomyelinase (NSM)-2 is found at the inner leaflet of the plasmalemma. Because either sphingomyelinase has been ascribed a role in the cellular stress response, we investigated their role in plasma membrane repair and cellular survival after treatment with the pore-forming toxins listeriolysin O (LLO) or pneumolysin (PLY). Jurkat T cells, in which ASM or NSM-2 was down-regulated [ASM knockdown (KD) or NSM-2 KD cells], showed inverse reactions to toxin-induced membrane damage: ASM KD cells displayed reduced toxin resistance, decreased viability, and defects in membrane repair. In contrast, the down-regulation of NSM-2 led to an increase in viability and enhanced plasmalemmal repair. Yet, in addition to the increased plasmalemmal repair, the enhanced toxin resistance of NSM-2 KD cells also appeared to be dependent on the activation of p38/MAPK, which was constitutively activated, whereas in ASM KD cells, the p38/MAPK activation was constitutively blunted.Schoenauer, R., Larpin, Y., Babiychuk, E. B., Drucker, P., Babiychuk, V. S., Avota, E., Schneider-Schaulies, S., Schumacher, F., Kleuser, B., Koffel, R., Draeger, A. Down-regulation of acid sphingomyelinase and neutral sphingomyelinase-2 inversely determines the cellular resistance to plasmalemmal injury by pore-forming toxins.	[Schoenauer, Roman; Larpin, Yu; Babiychuk, Eduard B.; Drucker, Patrick; Babiychuk, Viktoriia S.; Koffel, Rene; Draeger, Annette] Univ Bern, Inst Anat, Dept Cell Biol, Bern, Switzerland; [Avota, Elita; Schneider-Schaulies, Sibylle] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Schumacher, Fabian; Kleuser, Burkhard] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany	University of Bern; University of Wurzburg; University of Potsdam	Koffel, R; Draeger, A (corresponding author), Univ Bern, Inst Anat, Baltzerstr 2, CH-3000 Bern 9, Switzerland.	rene.koeffel@ana.unibe.ch; draeger@ana.unibe.ch	Köffel, René/ABI-2028-2020; Babiychuk, Eduard/AAV-7223-2021; Schumacher, Fabian/ABC-1750-2020	Köffel, René/0000-0001-9477-4282; Schumacher, Fabian/0000-0001-8703-3275; Babiychuk, Eduard/0000-0003-1786-0085; Drucker, Patrick/0000-0003-3353-5880; Kleuser, Burkhard/0000-0002-1888-9595; Larpin, Yu/0000-0002-4313-5509	Swiss National Science Foundation [SNF 601 31003A_159414]; Gebert-Ruf Foundation [GRS-073/14]; Novartis [16B100]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert-Ruf Foundation; Novartis(Novartis)	The authors thank Andrea Hostettler and Adolfo Odriozola for technical assistance and Dr. Ioan Iacovache (all from Institute of Anatomy, University of Bern) for providing the pET29-LLO construct. Images were acquired on equipment supported by the Microscopy Imaging Center of the University of Bern. Funding was provided by the Swiss National Science Foundation (SNF 601 31003A_159414), the Gebert-Ruf Foundation (GRS-073/14) (to A.D.), and Novartis (16B100) (to E.B.B). The authors declare no conflicts of interest.	Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Atanassoff AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089743; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Babiychuk EB, 2015, SEMIN CELL DEV BIOL, V45, P39, DOI 10.1016/j.semcdb.2015.10.016; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Barth BM, 2012, J NEUROSCI RES, V90, P229, DOI 10.1002/jnr.22748; Bienias K, 2016, PHARMACOL REP, V68, P570, DOI 10.1016/j.pharep.2015.12.008; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Cassidy SKB, 2013, TOXINS, V5, P618, DOI 10.3390/toxins5040618; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clement AB, 2009, J NEUROCHEM, V111, P669, DOI 10.1111/j.1471-4159.2009.06360.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Draeger A, 2014, BIOCHIMIE, V107, P66, DOI 10.1016/j.biochi.2014.08.008; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Dreschers S, 2007, CELL PHYSIOL BIOCHEM, V20, P241, DOI 10.1159/000104170; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Goni FM, 2012, PROG LIPID RES, V51, P238, DOI 10.1016/j.plipres.2012.03.002; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2002, BBA-MOL CELL BIOL L, V1585, P139, DOI 10.1016/S1388-1981(02)00334-7; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Henry BD, 2015, NAT BIOTECHNOL, V33, P81, DOI 10.1038/nbt.3037; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Husmann M, 2006, BIOCHEM BIOPH RES CO, V344, P1128, DOI 10.1016/j.bbrc.2006.03.241; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; LOIKE JD, 1983, J IMMUNOL METHODS, V57, P373, DOI 10.1016/0022-1759(83)90097-2; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; MORGAN BP, 1987, J IMMUNOL, V138, P246; Mueller N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004574; Niaudet C, 2017, CELL SIGNAL, V33, P10, DOI 10.1016/j.cellsig.2017.02.001; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ohanian J, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12015; Ohanian J, 2012, J VASC RES, V49, P353, DOI 10.1159/000336649; Perry DM, 2014, J BIOL CHEM, V289, P22401, DOI 10.1074/jbc.M114.589648; Podobnik M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09623; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Schoenauer R, 2014, BBA-MOL CELL RES, V1843, P915, DOI 10.1016/j.bbamcr.2014.01.024; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Valencia-Nunez DM, 2017, HEART VESSELS, V32, P1390, DOI 10.1007/s00380-017-1006-3; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Wolfmeier H, 2016, BBA-GEN SUBJECTS, V1860, P2498, DOI 10.1016/j.bbagen.2016.07.022; Wolfmeier H, 2015, BBA-MOL CELL RES, V1853, P2045, DOI 10.1016/j.bbamcr.2014.09.005	56	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					275	285		10.1096/fj.201800033R	http://dx.doi.org/10.1096/fj.201800033R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979630				2022-12-28	WOS:000457401500023
J	Wei, CC; Luo, Z; Hogstrand, C; Xu, YH; Wu, LX; Chen, GH; Pan, YX; Song, YF				Wei, Chuan-Chuan; Luo, Zhi; Hogstrand, Christer; Xu, Yi-Huan; Wu, Li-Xiang; Chen, Guang-Hui; Pan, Ya-Xiong; Song, Yu-Feng			Zinc reduces hepatic lipid deposition and activates lipophagy via Zn2+/MTF-1/PPAR and Ca2+/CaMKK/AMPK pathways	FASEB JOURNAL			English	Article						fish; mineral elements; lipid metabolism; regulatory pathways; autophagy	CATFISH PELTEOBAGRUS-FULVIDRACO; WATERBORNE ZN EXPOSURE; RECEPTOR-ALPHA; PPAR-ALPHA; MONITORING AUTOPHAGY; KINASE-BETA; ER STRESS; METABOLISM; AMPK; LIVER	Zinc (Zn) deficiency is the most consistently discovered nutritional manifestations of fatty liver disease. Although Zn is known to stimulate hepatic lipid oxidation, little is known about its underlying mechanism of action in lipolysis. Given the potential role of lipophagy in lipid metabolism, the purpose of this study was to test the hypothesis that Zn attenuates hepatic lipid accumulation by modulating lipophagy. The present study indicated that Zn is a potent promoter of lipophagy. Zn administration significantly alleviated hepatocellular lipid accumulation and increased the release of free fatty acids in association with enhanced fatty acid oxidation and inhibited lipogenesis, which was accompanied by activation of autophagy. Moreover, Zn reduced lipid accumulation and stimulated lipolysis by autophagy-mediated lipophagy. Zn-induced up-regulation of autophagy and lipid depletion is free Zn2+-dependent in the cytosols. Zn-induced autophagy and lipid turnover involved up-regulation of the calcium/calmodulin-dependent protein kinase kinase- (Ca2+/CaMKK)/AMPK pathway. Meanwhile, Zn2+-activated autophagy and lipid depletion were via enhancing metal response element-binding transcription factor (MTF)-1 DNA binding at PPAR promoter region, which in turn induced transcriptional activation of the key genes related to autophagy and lipolysis. Zn activated the pathways of Zn2+/MTF-1/ Peroxisome proliferator-activated receptor (PPAR) and Ca2+/CaMKK/AMPK, resulting in the up-regulation of lipophagy and accordingly reduced hepatic lipid accumulation. Our study, for the first time, provided innovative evidence of the direct relationship between metal elements (Zn) and lipid metabolism. The present study also indicated the novel mechanism for Zn-induced lipolysis by the activation of Zn2+/MTF-1/PPAR and Ca2+/CaMKK/AMPK pathways, which induced the occurrence of lipophagy. These results provide new insight into Zn nutrition and its potential beneficial effects on the prevention of fatty liver disease in vertebrates.Wei, C.-C., Luo, Z., Hogstrand, C., Xu, Y.-H., Wu, L.-X., Chen, G.-H., Pan, Y.-X., Song, Y.-F. Zinc reduces hepatic lipid deposition and activates lipophagy via Zn2+/MTF-1/PPAR and Ca2+/CaMKK/AMPK pathways.	[Wei, Chuan-Chuan; Luo, Zhi; Xu, Yi-Huan; Wu, Li-Xiang; Chen, Guang-Hui; Pan, Ya-Xiong; Song, Yu-Feng] Huazhong Agr Univ, Fishery Coll, Key Lab Freshwater Anim Breeding, Minist Agr, Wuhan, Hubei, Peoples R China; [Luo, Zhi] Collaborat Innovat Ctr Efficient & Hlth Prod Fish, Changde, Peoples R China; [Hogstrand, Christer] Kings Coll London, Sch Med, Diabet & Nutr Sci Div, London, England	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; University of London; King's College London	Luo, Z (corresponding author), Huazhong Agr Univ, Fishery Coll, Key Lab Freshwater Anim Breeding, Minist Agr, Wuhan, Hubei, Peoples R China.	luozhi99@mail.hzau.edu.cn		Hogstrand, Christer/0000-0001-7545-6975	National Natural Science Foundation of China [31422056, 31372547]; Fundamental Research Funds for the Central Universities, China [2662018PY089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31422056 and 31372547 (to Z.L.), and Fundamental Research Funds for the Central Universities, China Grant 2662018PY089 (to Z.L.). The authors declare no conflicts of interest.	BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Dieck HT, 2005, J NUTR, V135, P199, DOI 10.1093/jn/135.2.199; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; King JC, 2016, J NUTR, V146, p858S, DOI 10.3945/jn.115.220079; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liuzzi JP, 2014, BIOMETALS, V27, P1087, DOI 10.1007/s10534-014-9773-0; Luo Z, 2011, AQUACULTURE, V319, P150, DOI 10.1016/j.aquaculture.2011.06.047; Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336; Prasad AS, 1993, BIOCH ZINC, P219; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Ranasinghe P, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0023-4; Reiterer G, 2004, J NUTR, V134, P1711, DOI 10.1093/jn/134.7.1711; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Song YF, 2017, ENVIRON POLLUT, V228, P256, DOI 10.1016/j.envpol.2017.05.046; Suzuki H, 2017, CURR OPIN STRUC BIOL, V43, P10, DOI 10.1016/j.sbi.2016.09.010; Vucicevic L, 2011, AUTOPHAGY, V7, P40, DOI 10.4161/auto.7.1.13883; Wei CC, 2017, J NUTR, V147, P1070, DOI 10.3945/jn.116.245852; Wei CC, 2017, CHEMOSPHERE, V175, P228, DOI 10.1016/j.chemosphere.2017.02.042; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wu K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38716; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; You WJ, 2017, GENE, V627, P106, DOI 10.1016/j.gene.2017.06.022; Zhang JJ, 2017, J LIPID RES, V58, P1845, DOI 10.1194/jlr.M077198; Zheng JL, 2015, AQUAT TOXICOL, V159, P90, DOI 10.1016/j.aquatox.2014.12.003; Zheng JL, 2013, AQUAT TOXICOL, V132, P173, DOI 10.1016/j.aquatox.2013.02.002	39	74	84	9	66	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6666	6680		10.1096/fj.201800463	http://dx.doi.org/10.1096/fj.201800463			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29912588				2022-12-28	WOS:000449359700025
J	Kang, JY; Kim, JY; Kim, KB; Park, JW; Cho, H; Hahm, JY; Chae, YC; Kim, D; Kook, H; Rhee, S; Ha, NC; Seo, SB				Kang, Joo-Young; Kim, Ji-Young; Kim, Kee-Beom; Park, Jin Woo; Cho, Hana; Hahm, Ja Young; Chae, Yun-Cheol; Kim, Daehwan; Kook, Hyun; Rhee, Sangmyeong; Ha, Nam-Chul; Seo, Sang-Beom			KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing	FASEB JOURNAL			English	Article						histone demethylase; H3K79 methylation; SIRT1; transcription	METHYL-LYSINE ANALOGS; PRC1 COMPLEX; CPG ISLANDS; EMBRYONIC FIBROBLASTS; DIVERSE FUNCTIONS; H3; DOMAIN; GENE; PROTEIN; LANGUAGE	The methylation of histone H3 lysine 79 (H3K79) is an active chromatin marker and is prominent in actively transcribed regions of the genome; however, demethylase of H3K79 remains unknown despite intensive research. Here, we show that KDM2B, also known as FBXL10 and a member of the Jumonji C family of proteins known for its histone H3K36 demethylase activity, is a di- and trimethyl H3K79 demethylase. We demonstrate that KDM2B induces transcriptional repression of HOXA7 and MEIS1via occupancy of promoters and demethylation of H3K79. Furthermore, genome-wide analysis suggests that H3K79 methylation levels increase when KDM2B is depleted, which indicates that KDM2B functions as an H3K79 demethylase in vivo. Finally, stable KDM2B-knockdown cell lines exhibit displacement of NAD(+)-dependent deacetylase sirtuin-1 (SIRT1) from chromatin, with concomitant increases in H3K79 methylation and H4K16 acetylation. Our findings identify KDM2B as an H3K79 demethylase and link its function to transcriptional repression via SIRT1-mediated chromatin silencing.Kang, J.-Y., Kim, J.-Y., Kim, K.-B., Park, J. W., Cho, H., Hahm, J. Y., Chae, Y.-C., Kim, D., Kook, H., Rhee, S., Ha, N.-C., Seo, S.-B. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.	[Kang, Joo-Young; Kim, Ji-Young; Kim, Kee-Beom; Park, Jin Woo; Cho, Hana; Hahm, Ja Young; Chae, Yun-Cheol; Kim, Daehwan; Rhee, Sangmyeong; Seo, Sang-Beom] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, 221 Heukseok Dong, Seoul 156756, South Korea; [Kook, Hyun] Chonnam Natl Univ, Med Res Ctr Gene Regulat, Dept Pharmacol, Gwangju, South Korea; [Ha, Nam-Chul] Seoul Natl Univ, Dept Food & Anim Biotechnol, Seoul, South Korea; [Kook, Hyun] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Chung Ang University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU)	Seo, SB (corresponding author), Chung Ang Univ, Coll Nat Sci, Dept Life Sci, 221 Heukseok Dong, Seoul 156756, South Korea.	sangbs@cau.ac.kr	Kim, Kee-Beom/AAG-9225-2022; Kook, Hyun/AAR-5405-2021; Kim, Kee-Beom/AFL-8804-2022	Kim, Kee-Beom/0000-0003-0132-8924; Kook, Hyun/0000-0002-0740-1806; Kim, Kee-Beom/0000-0003-0132-8924	Chung-Ang University Excellent Student Scholarship in 2013; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology (ICT), and Future Planning [NRF-2016R1A4A1008035]; Ministry of Science and Technology, Basic Science Research Program [NRF-2017R1A2B4004407]	Chung-Ang University Excellent Student Scholarship in 2013; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology (ICT), and Future Planning; Ministry of Science and Technology, Basic Science Research Program	The authors thank Dr. Jin Young Kim and Dr. Ju Yeon Lee (Korea Basic Science Institute, Ochang Headquarters, Division of Bioconvergence Analysis) for nano-liquid chromatography LTQ-Orbitrap analysis. ChIP-seq data are available from the Gene Expression Omnibus under Accession No. GSE89052. The authors thank Dr. Vivian Bardwell (University of Minnesota, Minneapolis, MN, USA) for providing EFplink2-FLAG-KDM2B. This work was supported by the Chung-Ang University Excellent Student Scholarship in 2013 (to J.-Y.K.); Grant NRF-2016R1A4A1008035 (to J.-Y.K., J.W.P., H.C., J.Y.H., and Y.-C.C.) from the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Communication Technology (ICT), and Future Planning; and Grant NRF-2017R1A2B4004407 (to J.-Y.K. and J.Y.H.) funded by the Ministry of Science and Technology, Basic Science Research Program. The authors declare no conflicts of interest.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Beguelin W, 2016, CANCER CELL, V30, P197, DOI 10.1016/j.ccell.2016.07.006; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Cheng ZJ, 2014, GENE DEV, V28, P1758, DOI 10.1101/gad.246561.114; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Gilan O, 2016, NAT STRUCT MOL BIOL, V23, P673, DOI 10.1038/nsmb.3249; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Im H, 2003, J BIOL CHEM, V278, P18346, DOI 10.1074/jbc.M300890200; Jia GS, 2009, CELL RES, V19, P1217, DOI 10.1038/cr.2009.110; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee SH, 2013, CANCER LETT, V335, P397, DOI 10.1016/j.canlet.2013.02.051; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Millar CB, 2004, COLD SPRING HARB SYM, V69, P193, DOI 10.1101/sqb.2004.69.193; Morishita M, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0025-x; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Park JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12485; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Singer MS, 1998, GENETICS, V150, P613; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan JY, 2011, CANCER CELL, V20, P563, DOI 10.1016/j.ccr.2011.09.008; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Wysocka J, 2005, CELL, V122, P654, DOI 10.1016/j.cell.2005.08.022; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	69	39	40	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5737	5750		10.1096/fj.201800242R	http://dx.doi.org/10.1096/fj.201800242R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29763382	Green Submitted			2022-12-28	WOS:000447972500044
J	Le Billan, F; Amazit, L; Bleakley, K; Xue, QY; Pussard, E; Lhadj, C; Kolkhof, P; Viengchareun, S; Fagart, J; Lombes, M				Le Billan, Florian; Amazit, Larbi; Bleakley, Kevin; Xue, Qiong-Yao; Pussard, Eric; Lhadj, Christophe; Kolkhof, Peter; Viengchareun, Say; Fagart, Jerome; Lombes, Marc			Corticosteroid receptors adopt distinct cyclical transcriptional signatures	FASEB JOURNAL			English	Article						<bold>c</bold>hromatin immunoprecipitation; kinetics; nuclear receptors; aldosterone signaling; cortisol	HUMAN MINERALOCORTICOID RECEPTOR; RNA-POLYMERASE-II; GLUCOCORTICOID-RECEPTOR; CIRCADIAN CLOCK; STEROID-RECEPTORS; ER-ALPHA; BINDING; ALDOSTERONE; SPECIFICITY; MECHANISMS	Mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) are two closely related hormone-activated transcription factors that regulate major pathophysiologic functions. High homology between these receptors accounts for the crossbinding of their corresponding ligands, MR being activated by both aldosterone and cortisol and GR essentially activated by cortisol. Their coexpression and ability to bind similar DNA motifs highlight the need to investigate their respective contributions to overall corticosteroid signaling. Here, we decipher the transcriptional regulatory mechanisms that underlie selective effects of MRs and GRs on shared genomic targets in a human renal cellular model. Kinetic, serial, and sequential chromatin immunoprecipitation approaches were performed on the period circadian protein 1 (PER1) target gene, providing evidence that both receptors dynamically and cyclically interact at the same target promoter in a specific and distinct transcriptional signature. During this process, both receptors regulate PER1 gene by binding as homo- or heterodimers to the same promoter region. Our results suggest a novel level of MR-GR target gene regulation, which should be considered for a better and integrated understanding of corticosteroid-related pathophysiology.Le Billan, F., Amazit, L., Bleakley, K., Xue, Q.-Y., Pussard, E., Lhadj, C., Kolkhof, P., Viengchareun, S., Fagart, J., Lombes, M. Corticosteroid receptors adopt distinct cyclical transcriptional signatures.	[Le Billan, Florian; Amazit, Larbi; Xue, Qiong-Yao; Pussard, Eric; Lhadj, Christophe; Viengchareun, Say; Fagart, Jerome; Lombes, Marc] INSERM, U1185, Le Kremlin Bicetre, France; [Le Billan, Florian; Amazit, Larbi; Lhadj, Christophe; Viengchareun, Say; Fagart, Jerome; Lombes, Marc] Univ Paris Saclay, Univ Paris Sud, Fac Med Paris Sud, Unite Mixte Rech S1185, Le Kremlin Bicetre, France; [Amazit, Larbi] Inst Biomed Bicetre, Unite Mixte Serv 32, Le Kremlin Bicetre, France; [Bleakley, Kevin] Inst Natl Rech Informat & Automat Saclay, Palaiseau, France; [Bleakley, Kevin] Dept Math Orsay, Orsay, France; [Xue, Qiong-Yao; Pussard, Eric] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogen & Hormonol, Le Kremlin Bicetre, France; [Kolkhof, Peter] Bayer AG, Global Drug Discovery, Dept Cardiol Res, Wuppertal, Germany; [Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Fagart, J; Lombes, M (corresponding author), Univ Paris Sud, Fac Med Paris Sud, INERM, U1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	jerome.fagart@inserm.fr; marc.lombes@u-psud.fr	Lombes, Marc/L-5933-2018; PUSSARD, Eric/S-6059-2018; Viengchareun, Say/M-6612-2017; Fagart, Jerome/S-4581-2018; Viengchareun, Say/GOV-6812-2022	Lombes, Marc/0000-0003-3189-023X; Fagart, Jerome/0000-0002-7965-0553; Le Billan, Florian/0000-0002-3400-9295; viengchareun, say/0000-0003-4280-3250	Bayer AG [P1155.0]; HAC Pharma [P1156.0]; Ministere de l'Enseignement Superieur et de la Recherche; INSERM; Universite Paris-Sud; Agence Nationale de la Recherche (ANR Calsignaldo) [ANR-15-CE14-0005]	Bayer AG(Bayer AG); HAC Pharma; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Sud; Agence Nationale de la Recherche (ANR Calsignaldo)(French National Research Agency (ANR))	The authors acknowledge funding from Bayer AG (P1155.0) and HAC Pharma (P1156.0). F.L.B. is the recipient of a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by INSERM, Universite Paris-Sud, and the Agence Nationale de la Recherche (ANR Calsignaldo; ANR-15-CE14-0005). P.K. is a full-time employee of Bayer AG. The authors declare no conflicts of interest.	Amazit L, 2015, J BIOL CHEM, V290, P21876, DOI 10.1074/jbc.M115.657957; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Auwerx J, 1999, CELL, V97, P161; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheon S, 2013, NUCLEIC ACIDS RES, V41, P6161, DOI 10.1093/nar/gkt307; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Conway-Campbell BL, 2012, MOL CELL ENDOCRINOL, V348, P383, DOI 10.1016/j.mce.2011.08.014; Denker A, 2015, CELL, V162, P942, DOI 10.1016/j.cell.2015.08.022; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Fagart J, 2005, MOL PHARMACOL, V67, P1714, DOI 10.1124/mol.104.010710; Fujihara Y, 2014, BONE, V61, P1, DOI 10.1016/j.bone.2013.12.026; Fuller PJ, 2000, KIDNEY INT, V57, P1256, DOI 10.1046/j.1523-1755.2000.00959.x; Funder J, 1996, ENDOCRINOLOGY, V137, P5264, DOI 10.1210/en.137.12.5264; Funder JW, 2007, HYPERTENSION, V50, P840, DOI 10.1161/HYPERTENSIONAHA.107.098012; Funder JW, 2017, J ENDOCRINOL, V234, pT17, DOI 10.1530/JOE-17-0119; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Grossmann C, 2012, CHEM BIOL, V19, P742, DOI 10.1016/j.chembiol.2012.04.014; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Jaisser F, 2016, PHARMACOL REV, V68, P49, DOI 10.1124/pr.115.011106; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; LOMBES M, 1994, BIOCHEM J, V302, P191, DOI 10.1042/bj3020191; LOMBES M, 1994, ENDOCRINOLOGY, V135, P834, DOI 10.1210/en.135.3.834; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mifsud KR, 2016, P NATL ACAD SCI USA, V113, P11336, DOI 10.1073/pnas.1605246113; Morris DJ, 2009, STEROIDS, V74, P1, DOI 10.1016/j.steroids.2008.10.005; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Odermatt A, 2009, STEROIDS, V74, P163, DOI 10.1016/j.steroids.2008.10.010; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Petit-Topin I, 2014, J STEROID BIOCHEM, V144, P427, DOI 10.1016/j.jsbmb.2014.08.008; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; PRIE D, 1995, KIDNEY INT, V47, P1310, DOI 10.1038/ki.1995.186; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Richards J, 2014, J BIOL CHEM, V289, P11791, DOI 10.1074/jbc.M113.531095; Richards J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00253; Rowley MJ, 2016, CURR OPIN CELL BIOL, V40, P8, DOI 10.1016/j.ceb.2016.01.009; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; SCHREIBER JR, 1983, CONTRACEPTION, V28, P77, DOI 10.1016/S0010-7824(83)80008-0; Stortz M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06676-0; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Terker AS, 2015, AM J PHYSIOL-REG I, V309, pR1068, DOI 10.1152/ajpregu.00135.2015; Travers S, 2017, J STEROID BIOCHEM, V165, P202, DOI 10.1016/j.jsbmb.2016.06.005; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Viengchareun S, 2014, J AM SOC NEPHROL, V25, P2213, DOI 10.1681/ASN.2013091023; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012	60	13	13	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5626	5639		10.1096/fj.201800391RR	http://dx.doi.org/10.1096/fj.201800391RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29733691	Green Submitted, Bronze			2022-12-28	WOS:000447972500035
J	Mijwel, S; Cardinale, DA; Norrbom, J; Chapman, M; Ivarsson, N; Wengstrom, Y; Sundberg, CJ; Rundqvist, H				Mijwel, Sara; Cardinale, Daniele A.; Norrbom, Jessica; Chapman, Mark; Ivarsson, Niklas; Wengstrom, Yvonne; Sundberg, Carl Johan; Rundqvist, Helene			Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer	FASEB JOURNAL			English	Article						concurrent training; high-intensity interval training; oxidative phosphorylation; exercise training adaptation	AUTOPHAGY; ASSOCIATION; SPECIFICITY; DYSFUNCTION; ADAPTATION; GUIDELINES; PROTECTS; ATROPHY; QUALITY; CELLS	Exercise has been suggested to ameliorate the detrimental effects of chemotherapy on skeletal muscle. The aim of this study was to compare the effects of different exercise regimens with usual care on skeletal muscle morphology and mitochondrial markers in patients being treated with chemotherapy for breast cancer. Specifically, we compared moderate-intensity aerobic training combined with high-intensity interval training (AT-HIIT) and resistance training combined with high-intensity interval training (RT-HIIT) with usual care (UC). Resting skeletal muscle biopsies were obtained pre- and postintervention from 23 randomly selected women from the OptiTrain breast cancer trial who underwent RT-HIIT, AT-HIIT, or UC for 16 wk. Over the intervention, citrate synthase activity, muscle fiber cross-sectional area, capillaries per fiber, and myosin heavy chain isoform type I were reduced in UC, whereas RT-HIIT and AT-HIIT were able to counteract these declines. AT-HIIT promoted up-regulation of the electron transport chain protein levels vs. UC. RT-HIIT favored satellite cell count vs. UC and AT-HIIT. There was a significant association between change in citrate synthase activity and self-reported fatigue. AT-HIIT and RT-HIIT maintained or improved markers of skeletal muscle function compared with the declines found in the UC group, indicating a sustained trainability in addition to the preservation of skeletal muscle structural and metabolic characteristics during chemotherapy. These findings highlight the importance of supervised exercise programs for patients with breast cancer during chemotherapy.Mijwel, S., Cardinale, D. A., Norrbom, J., Chapman, M., Ivarsson, N., Wengstrom, Y., Sundberg, C. J., Rundqvist, H. Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer.	[Mijwel, Sara; Norrbom, Jessica; Chapman, Mark; Ivarsson, Niklas; Sundberg, Carl Johan] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Mijwel, Sara; Wengstrom, Yvonne] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Sundberg, Carl Johan] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Rundqvist, Helene] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Cardinale, Daniele A.] Swedish Sch Sport & Hlth Sci, Astrand Lab, Stockholm, Sweden; [Wengstrom, Yvonne] Karolinska Univ Hosp, Canc Theme, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Swedish School of Sport & Health Sciences; Karolinska Institutet; Karolinska University Hospital	Mijwel, S (corresponding author), Karolinska Inst, von Eulers Vag 8, S-17176 Stockholm, Sweden.	sara.mijwel@ki.se	Sundberg, Carl Johan/B-9356-2013; Rundqvist, Helene/AAE-7334-2020	Rundqvist, Helene/0000-0002-5617-9076; Chapman, Mark/0000-0001-9905-4022; Cardinale, Daniele/0000-0002-8607-550X; Mijwel, Sara/0000-0002-6718-5797	Swedish Cancer Society [130452]; Cancer Society of Stockholm Grant [131242]; Swedish Cancer and Traffic Accident Foundation Grant [F-C-001225]; Swedish Society for Medical Research Grants [SLS 505141, 692641]	Swedish Cancer Society(Swedish Cancer Society); Cancer Society of Stockholm Grant; Swedish Cancer and Traffic Accident Foundation Grant; Swedish Society for Medical Research Grants	The authors thank the participants in the OptiTrain trial, Malin Backman (Karolinska Institute) for assistance during muscle biopsy collection and supervision of exercise sessions, Marcus Moberg (Swedish School of Health and Sports Sciences) for Western blot technical support, Rocio Paublete (Karolinska Institutet) for microscopy technical support, and Eric Emanuelsson (Orebro University) for the MHC immunohistochemitry protocol. This work was supported by Swedish Cancer Society Grant 130452 (to Y.W.), Cancer Society of Stockholm Grant 131242 (to Y.W.), Swedish Cancer and Traffic Accident Foundation Grant F-C-001225 (to Y.W.), and Swedish Society for Medical Research Grants SLS 505141 and 692641 (to H.R.). S.M. and D.A.C. are shared first authors. C.J.S. and H.R. are shared last authors. The authors declare no conflicts of interest.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ansenberger-Fricano K, 2013, FREE RADICAL BIO MED, V54, P116, DOI 10.1016/j.freeradbiomed.2012.08.573; Antharavally BS, 2004, ANAL BIOCHEM, V329, P276, DOI 10.1016/j.ab.2004.02.049; Batchelor TT, 1997, NEUROLOGY, V48, P1234, DOI 10.1212/WNL.48.5.1234; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BIANCHI C, 1987, EXP MOL PATHOL, V46, P123, DOI 10.1016/0014-4800(87)90036-0; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Borjesson M, 2011, EUR J CARDIOV PREV R, V18, P446, DOI 10.1097/HJR.0b013e32833bo969; Bozzetti F, 2017, ANN ONCOL, V28, P2107, DOI 10.1093/annonc/mdx271; Brooks NE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00099; Chaillou T, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13261; Christensen JF, 2016, ACTA ONCOL, V55, P1246, DOI 10.3109/0284186X.2016.1170200; Christensen JF, 2014, BRIT J CANCER, V111, P8, DOI 10.1038/bjc.2014.273; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Crouch ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181086; Dirks-Naylor AJ, 2013, J CACHEXIA SARCOPENI, V4, P239, DOI 10.1007/s13539-013-0104-z; Filler K, 2014, BBA CLIN, V1, P12, DOI 10.1016/j.bbacli.2014.04.001; Furmaniak AC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005001.pub3; Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965; Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009; Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717; Green N., 2017, J STRENGTH COND RES, DOI [10. 1519/JSC. 0000000000002154, DOI 10.1519/JSC.0000000000002154]; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; Hikida RS, 2000, J GERONTOL A-BIOL, V55, pB347, DOI 10.1093/gerona/55.7.B347; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; McLoon LK, 1998, MUSCLE NERVE, V21, P1457, DOI 10.1002/(SICI)1097-4598(199811)21:11<1457::AID-MUS14>3.3.CO;2-U; Mijwel S, 2018, BREAST CANCER RES TR, V169, P93, DOI 10.1007/s10549-018-4663-8; Mijwel S, 2018, BREAST CANCER RES TR, V168, P79, DOI 10.1007/s10549-017-4571-3; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Moriscot AS, 2010, J STRUCT BIOL, V170, P344, DOI 10.1016/j.jsb.2010.02.001; Mustian KM, 2017, JAMA ONCOL, V3, P961, DOI 10.1001/jamaoncol.2016.6914; Nilsen TS, 2016, SCAND J MED SCI SPOR, V26, P1026, DOI 10.1111/sms.12543; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; Scheede-Bergdahl C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00049; Schmitt J, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12693; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Siebrands CC, 2004, CELL MOTIL CYTOSKEL, V58, P39, DOI 10.1002/cm.10177; Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; Sorensen JC, 2016, CANCER CHEMOTH PHARM, V78, P673, DOI 10.1007/s00280-016-3045-3; TESCH PA, 1988, MED SCI SPORT EXER, V20, pS132, DOI 10.1249/00005768-198810001-00008; Toth MJ, 2016, CLIN NUTR, V35, P1359, DOI 10.1016/j.clnu.2016.02.016; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Wengstrom Y, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3079-x; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599	51	55	56	10	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5495	5505		10.1096/fj.201700968R	http://dx.doi.org/10.1096/fj.201700968R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29750574	hybrid			2022-12-28	WOS:000447972500025
J	Torre, OM; Das, R; Berenblum, RE; Huang, AH; Iatridis, JC				Torre, Olivia M.; Das, Rohit; Berenblum, Ramy E.; Huang, Alice H.; Iatridis, James C.			Neonatal mouse intervertebral discs heal with restored function following herniation injury	FASEB JOURNAL			English	Article						annulus fibrosus; puncture model; healing	NEEDLE PUNCTURE INJURY; HUMAN LUMBAR DISC; DIGIT TIP REGENERATION; ANNULUS FIBROSUS; ANULUS FIBROSUS; IN-VIVO; PROGENITOR CELLS; GENE-EXPRESSION; ANIMAL-MODEL; RAT DISC	Adult intervertebral discs (IVDs) have poor endogenous healing capacity, because of their challenging microenvironment and complex mechanical demands, which can result in painful IVD herniation. There are no regenerative strategies available to improve IVD healing and restore its function. Neonatal mice are excellent models of mammalian regeneration, but there are no studies of the regenerative capacity of neonatal IVDs. In this study, we developed a neonatal model of improved IVD healing to inform repair strategies after herniation. In vivo puncture injuries were performed to simulate herniation with complete annulus fibrosus (AF) tears in caudal IVDs of neonatal (postnatal d 5) and adult (4-6 mo) Scleraxis green fluorescent protein (ScxGFP) mice. Acute and long-term healing responses were assessed with histologic, radiologic, and biomechanical measurements. Neonates underwent accelerated IVD healing compared to adults with functional restoration and enhanced structural repair after herniation. A population of ScxGFP(-) cells identified in the neonatal repair site may be associated with this improved healing and warrants future investigation. In summary, function of neonatal IVDs was restored after herniation injury, whereas that of adult discs was not. This improved healing response is likely driven by multiple mechanisms that may include differences in mechanical loading and available repair cells during growth.Torre, O. M., Das, R., Berenblum, R. E., Huang, A. H., Iatridis, J. C. Neonatal mouse intervertebral discs heal with restored function following herniation injury.	[Torre, Olivia M.; Das, Rohit; Berenblum, Ramy E.; Huang, Alice H.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, 1 Gustave Levy Pl,Box 1188, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Huang, AH; Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, 1 Gustave Levy Pl,Box 1188, New York, NY 10029 USA.	alice.huang@mssm.edu; james.iatridis@mssm.edu	Huang, Alice H/L-2256-2015	Huang, Alice H/0000-0002-5037-6829; Iatridis, James/0000-0002-2186-0590; Torre, Olivia M/0000-0003-3405-6259	U. S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR064157, R01 AR064157-04S1, R01 AR069537]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069537, R01AR064157, R01AR057397] Funding Source: NIH RePORTER	U. S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Ronen Schweitzer (Shriners Children Hospital, Portland, OR, USA) for the ScxGFP mice, Dr. Meredith Bartelstein (Icahn School of Medicine at Mount Sinai) for biomechanical testing assistance, and Dr. Peter J. Taub (Icahn School of Medicine at Mount Sinai) for animal surgery training. This work was supported by U. S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01 AR064157 and R01 AR064157-04S1 (to J.C.I.), and R01 AR069537 (to A.H.H.). The authors declare no conflicts of interest.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Bassat E, 2017, NATURE, V547, P179, DOI 10.1038/nature22978; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Brisby H, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0179; Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Carragee EJ, 2006, SPINE, V31, P653, DOI 10.1097/01.brs.0000203714.76250.68; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905; CHELBERG MK, 1995, J ANAT, V186, P43; Cortes D.H., 2014, INTERVERTEBRAL DISC, P17; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Daneyemez M, 1999, MINIM INVAS NEUROSUR, V42, P63, DOI 10.1055/s-2008-1053372; Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA; Fan Y, 2017, J CELL BIOCHEM, V118, P2828, DOI 10.1002/jcb.25933; Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010; Fujita Y, 2000, MED ENG PHYS, V22, P349, DOI 10.1016/S1350-4533(00)00053-9; Guerin HAL, 2006, J BIOMECH, V39, P1410, DOI 10.1016/j.jbiomech.2005.04.007; Guterl CC, 2013, EUR CELLS MATER, V25, P1; HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009; Henriksen L, 1996, BRIT J NEUROSURG, V10, P289, DOI 10.1080/02688699650040160; Henriksson HB, 2012, SPINE, V37, P722, DOI 10.1097/BRS.0b013e318231c2f7; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; KEY JA, 1948, J BONE JOINT SURG AM, V30-A, P621, DOI 10.2106/00004623-194830030-00009; Korecki CL, 2008, SPINE, V33, P235, DOI 10.1097/BRS.0b013e3181624504; Lai A, 2013, J ORTHOP RES, V31, P621, DOI 10.1002/jor.22281; Lebow RL, 2011, SPINE, V36, P2147, DOI 10.1097/BRS.0b013e3182054595; Lee JW, 2013, DEV BIOL, V382, P98, DOI 10.1016/j.ydbio.2013.07.020; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lequin Michiel B, 2012, Korean J Spine, V9, P340, DOI 10.14245/kjs.2012.9.4.340; Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184; MacLean JJ, 2005, J ORTHOP RES, V23, P1120, DOI 10.1016/j.orthres.2005.01.020; MacLean JJ, 2003, SPINE, V28, P973, DOI 10.1097/00007632-200305150-00004; MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011; Martin JT, 2013, J ORTHOP RES, V31, P1276, DOI 10.1002/jor.22355; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Meakin JR, 2000, J BIOMECH, V33, P575, DOI 10.1016/S0021-9290(99)00215-8; Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z; Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5; Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001; Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z; Nakazawa KR, 2018, SPINE J, V18, P343, DOI 10.1016/j.spinee.2017.09.018; Nerlich AG, 2007, EUR SPINE J, V16, P547, DOI 10.1007/s00586-006-0213-x; Orias AAE, 2009, SPINE J, V9, P204, DOI 10.1016/j.spinee.2008.01.014; OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008010-00005; PANJABI MM, 1992, J SPINAL DISORD, V5, P390, DOI 10.1097/00002517-199212000-00002; Parker SL, 2016, CLIN SPINE SURG, V29, P454, DOI 10.1097/BSD.0b013e3182956ec5; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Rousseau MAA, 2007, SPINE, V32, P17, DOI 10.1097/01.brs.0000251013.07656.45; Sarver JJ, 2005, J ORTHOP RES, V23, P150, DOI 10.1016/j.orthres.2004.04.010; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shinohara Harumichi, 1999, Okajimas Folia Anatomica Japonica, V76, P17; Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c; SKAGGS DL, 1994, SPINE, V19, P1310, DOI 10.1097/00007632-199406000-00002; SMITH JW, 1951, J BONE JOINT SURG BR, V33, P612, DOI 10.1302/0301-620X.33B4.612; Sobajima S, 2005, SPINE, V30, P15, DOI 10.1097/01.brs.0000148048.15348.9b; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Taghiyar L, 2018, CELL J, V19, P585, DOI 10.22074/cellj.2018.4710; Torre OM, 2017, BIOL APPROACHES SPIN; URBAN JPG, 1995, MOL MED TODAY, V1, P329, DOI 10.1016/S1357-4310(95)80032-8; van den Akker GGH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144497; Walter BA, 2015, J ANAT, V227, P707, DOI 10.1111/joa.12258; Walters BJ, 2014, J NEUROSCI, V34, P15751, DOI 10.1523/JNEUROSCI.3200-14.2014; Wilke H.-J., 2011, SPINE J, V11, pS148, DOI DOI 10.1016/J.SPINEE.2011.08.358; Yasen M, 2013, ACTA BIOCH BIOPH SIN, V45, P368, DOI 10.1093/abbs/gmt019; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhang HN, 2009, J NEUROSURG-SPINE, V10, P522, DOI 10.3171/2009.2.SPINE08925	78	23	23	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4753	4762		10.1096/fj.201701492R	http://dx.doi.org/10.1096/fj.201701492R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570392	Green Published			2022-12-28	WOS:000443817700011
J	Schmitz, C; Noels, H; El Bounkari, O; Straussfeld, E; Megens, RTA; Sternkopf, M; Alampour-Rajabi, S; Krammer, C; Tilstam, PV; Gerdes, N; Burger, C; Kapurniotu, A; Bucala, R; Jankowski, J; Weber, C; Bernhagen, J				Schmitz, Corinna; Noels, Heidi; El Bounkari, Omar; Straussfeld, Eva; Megens, Remco T. A.; Sternkopf, Marieke; Alampour-Rajabi, Setareh; Krammer, Christine; Tilstam, Pathricia V.; Gerdes, Norbert; Buerger, Christina; Kapurniotu, Aphrodite; Bucala, Richard; Jankowski, Joachim; Weber, Christian; Bernhagen, Juergen			Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis	FASEB JOURNAL			English	Article						lymphocyte; chemokine; immunology; antibody	MIGRATION INHIBITORY FACTOR; B-CELL SURVIVAL; REDUCES ATHEROSCLEROSIS; IMMUNE-COMPLEXES; OXIDIZED LDL; T-CELLS; MICE; BAFF; ANTIBODIES; RECEPTORS	The inflammatory cytokine macrophage migration-inhibitory factor (MIF) promotes atherosclerosis via lesional monocyte and T-cell recruitment. B cells have emerged as important components in atherogenesis, but the interaction between MIF and B cells in atherogenesis is unknown. Here, we investigated the atherosclerotic phenotype of Mif-gene deletion in Apoe(-/-) mice. Apoe(-/-)Mif(-/-) mice fed a Western diet exhibited strongly reduced atherosclerotic lesions in brachiocephalic artery (BC) and abdominal aorta compared with controls. This phenotype was accompanied by reduced circulating B cells. Flow cytometry revealed a B-cell developmental defect with increased premature and immature B-cell counts in bone marrow (BM) of Apoe(-/-)Mif(-/-) mice and diminished B-cell numbers in spleen. This finding was linked with a decreased expression of Baff-R and differentiation-driving transcription factors at the immature B-cell stage, whereas peritoneal B cells exhibited unchanged CD80 and CD86 expression but vastly decreased CD9 and elevated CD23 levels, indicating that the developmental block favors the generation of immature, egressing, and reactive B cells. Mif deficiency did not affect absolute B-cell numbers in the vessel wall but favored a relative increase of B cells in the atheroprone BC region and the appearance of periadventitial B-cell-rich clusters. Of note, Mif(-/-) mice exhibited a significant increase in oxidized low-density lipoprotein (oxLDL)-specific antibodies after the injection of oxLDL, indicating that Mif deficiency is associated with higher sensitivity of B cells against natural-occurring antigens such as oxLDL. Importantly, Apoe(-/-) mice adoptively transplanted with Apoe(-/-)Mif(-/-) BM showed reduced peripheral B cells compared with Apoe(-/-) BM transplantation but no atheroprotection in the BC; also, whereas there was a selective increase in atheroprotective IgM-anti-oxLDL-antibodies in global Mif deficiency, BM-specific Mif deficiency also led to elevated proatherogenic anti-oxLDL-IgG. Together, these findings reveal a novel link between MIF and B cells in atherogenesis. Protection from atherosclerosis by Mif deficiency is associated with enhanced B-cell hypersensitivity, which in global but not BM-restricted Mif deficiency favors an atheroprotective autoantibody profile in atherosclerotic mice. Targeting MIF may induce protective B-cell responses in atherosclerosis.Schmitz, C., Noels, H., El Bounkari, O., Straussfeld, E., Megens, R. T. A., Sternkopf, M., Alampour-Rajabi, S., Krammer, C., Tilstam, P. V., Gerdes, N., Burger, C., Kapurniotu, A., Bucala, R., Jankowski, J., Weber, C., Bernhagen, J. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.	[Schmitz, Corinna; El Bounkari, Omar; Straussfeld, Eva; Krammer, Christine; Bernhagen, Juergen] Ludwig Maximilians Univ LMU Munich, Inst Stroke & Dementia Res ISD, Vasc Biol, Munich, Germany; [Megens, Remco T. A.; Gerdes, Norbert; Buerger, Christina; Weber, Christian] Ludwig Maximilians Univ LMU Munich, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Schmitz, Corinna; Noels, Heidi; Straussfeld, Eva; Sternkopf, Marieke; Alampour-Rajabi, Setareh; Tilstam, Pathricia V.; Jankowski, Joachim] Rheinish Westphalian Tech Univ RWTH Aachen Univ, Univ Hosp Aachen, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany; [Tilstam, Pathricia V.; Bucala, Richard] Yale Univ, Yale Sch Med, New Haven, CT USA; [Gerdes, Norbert] Univ Hosp Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Kapurniotu, Aphrodite] Tech Univ Munich, Div Peptide Biochem, Freising Weihenstephan, Germany; [Jankowski, Joachim; Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Weber, Christian; Bernhagen, Juergen] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany; [Bernhagen, Juergen] SyNergy Excellence Cluster, Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; RWTH Aachen University Hospital; Yale University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Technical University of Munich; Maastricht University; German Centre for Cardiovascular Research; Munich Heart Alliance	Noels, H (corresponding author), Rhein Westfal TH Aachen, Univ Clin Aachen, Inst Mol Cardiovasc Res IMCAR, Pauwelsstr 30, D-52074 Aachen, Germany.; Bernhagen, J (corresponding author), Ludwig Maximilians Univ LMU Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Feodor Lynen Str 17, D-81377 Munich, Germany.	hnoels@ukaachen.de; juergen.bernhagen@med.uni-muenchen.de	Noels, Heidi/AAQ-2622-2020; Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714; megens, remco/0000-0001-9871-6696; Tilstam, Pathricia/0000-0003-3620-6775	Deutsche Forschungsgemeinschaft (DFG) [SFB1123]; DFG-Munich Cluster for Systems Neurology [EXC 1010 SyNergy]; Interdisciplinary Centre for Clinical Research at the RWTH Aachen University [IZKF K7-1]; U.S. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1AR049610, R01AR049610]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG-Munich Cluster for Systems Neurology; Interdisciplinary Centre for Clinical Research at the RWTH Aachen University; U.S. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Nadine Persigehl, Roya Soltan, Yuan Kong (IMCAR), Michael Lacy, Marlies Tursch (ISD), Melanie Garbe, Stephanie Elbin (IMCAR), and Birgitt Lennartz (Biochemistry, University Hospital RWTH), for excellent technical assistance and Saroj Mohanta, Changjun Yin, and Andreas Habenicht (IPEK), for discussions on atherosclerosis-related B-cell phenotypes. This research was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB1123 to J.B. (A03), A.K. (A03), C.W. (A01), R.T.A.M. (Z01), and N.G. (A05); by DFG-Munich Cluster for Systems Neurology (EXC 1010 SyNergy) to J.B.; and a grant from the Interdisciplinary Centre for Clinical Research at the RWTH Aachen University (IZKF K7-1) to J.B. and H.N.R.B. was supported by the U.S. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants RO1AR049610 and R01AR049610. J.B. and R.B. are co-inventors on anti-MIF patents. The other authors declare no conflicts of interest.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Alampour-Rajabi S, 2015, FASEB J, V29, P4497, DOI 10.1096/fj.15-273904; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Burger-Kentischer A, 2006, ATHEROSCLEROSIS, V184, P28, DOI 10.1016/j.atherosclerosis.2005.03.028; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen DX, 2015, CIRCULATION, V131, P1350, DOI 10.1161/CIRCULATIONAHA.114.013423; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hastings WD, 2006, EUR J IMMUNOL, V36, P1114, DOI 10.1002/eji.200535142; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; Jackson SW, 2016, J IMMUNOL, V197, P4529, DOI 10.4049/jimmunol.1601198; Ketelhuth DFJ, 2016, CIRC RES, V118, P668, DOI 10.1161/CIRCRESAHA.115.306427; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313; Mohanta SK, 2014, CIRC RES, V114, P1772, DOI 10.1161/CIRCRESAHA.114.301137; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Muller II, 2014, ATHEROSCLEROSIS, V237, P426, DOI 10.1016/j.atherosclerosis.2014.09.010; Nus M, 2017, NAT MED, V23, P601, DOI 10.1038/nm.4315; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Pelanda R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007146; Radomir L, 2017, J IMMUNOL, V199, P2745, DOI 10.4049/jimmunol.1700557; Rajasekaran D, 2016, J BIOL CHEM, V291, P15881, DOI 10.1074/jbc.M116.717751; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Rowland SL, 2010, J IMMUNOL, V185, P4570, DOI 10.4049/jimmunol.1001708; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Strussmann T, 2013, THROMB HAEMOSTASIS, V110, P1004, DOI 10.1160/TH13-01-0049; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Sun JS, 2010, CIRCULATION, V122, P808, DOI 10.1161/CIRCULATIONAHA.109.891887; Tillmann S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00115; Tsiantoulas D, 2015, ARTERIOSCL THROM VAS, V35, P296, DOI 10.1161/ATVBAHA.114.303569; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Wang LD, 2003, IMMUNOLOGY, V110, P411, DOI 10.1111/j.1365-2567.2003.01756.x; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Weih F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00226; Xu H, 2015, SCAND J IMMUNOL, V81, P39, DOI 10.1111/sji.12248; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	53	16	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4428	4443		10.1096/fj.201800058R	http://dx.doi.org/10.1096/fj.201800058R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29543531	Green Published			2022-12-28	WOS:000439325400031
J	Zhang, C; Li, L; Jiang, YD; Wang, CC; Geng, BM; Wang, YQ; Chen, JL; Liu, F; Qiu, P; Zhai, GJ; Chen, P; Quan, RF; Wang, JF				Zhang, Cui; Li, Liang; Jiang, Yuanda; Wang, Cuicui; Geng, Baoming; Wang, Yanqiu; Chen, Jianling; Liu, Fei; Qiu, Peng; Zhai, Guangjie; Chen, Ping; Quan, Renfu; Wang, Jinfu			Space microgravity drives transdifferentiation of human bone marrow-derived mesenchymal stem cells from osteogenesis to adipogenesis	FASEB JOURNAL			English	Article						hMSCs; signaling pathway; SJ-10 satellite; RNA-SEQ	FOCAL ADHESION KINASE; ACTIVATED-RECEPTOR-GAMMA; SKELETAL-MUSCLE ATROPHY; BINDING-PROTEIN-ALPHA; GENE-EXPRESSION; MODELED MICROGRAVITY; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; STROMAL CELLS; OSTEOBLASTIC DIFFERENTIATION	Bone formation is linked with osteogenic differentiation of mesenchymal stem cells (MSCs) in the bone marrow. Microgravity in spaceflight is known to reduce bone formation. In this study, we used a real microgravity environment of the SJ-10 Recoverable Scientific Satellite to examine the effects of space microgravity on the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hMSCs). hMSCs were induced toward osteogenic differentiation for 2 and 7 d in a cell culture device mounted on the SJ-10 satellite. The satellite returned to Earth after going through space experiments in orbit for 12 d, and cell samples were harvested and analyzed for differentiation potentials. The results showed that space microgravity inhibited osteogenic differentiation and resulted in adipogenic differentiation, even under osteogenic induction conditions. Under space microgravity, the expression of 10 genes specific for osteogenesis decreased, including collagen family members, alkaline phosphatase (ALP), and runt-related transcription factor 2 (RUNX2), whereas the expression of 4 genes specific for adipogenesis increased, including adipsin (CFD), leptin (LEP), CCAAT/enhancer binding protein (CEBPB), and peroxisome proliferator-activated receptor- (PPARG). In the analysis of signaling pathways specific for osteogenesis, we found that the expression and activity of RUNX2 was inhibited, expression of bone morphogenetic protein-2 (BMP2) and activity of SMAD1/5/9 were decreased, and activity of focal adhesion kinase (FAK) and ERK-1/2 declined significantly under space microgravity. These data indicate that space microgravity plays a dual role by decreasing RUNX2 expression and activity through the BMP2/SMAD and integrin/FAK/ERK pathways. In addition, we found that space microgravity increased p38 MAPK and protein kinase B (AKT) activities, which are important for the promotion of adipogenic differentiation of hMSCs. Space microgravity significantly decreased the expression of Tribbles homolog 3 (TRIB3), a repressor of adipogenic differentiation. Y15, a specific inhibitor of FAK activity, was used to inhibit the activity of FAK under normal gravity; Y15 decreased protein expression of TRIB3. Therefore, it appears that space microgravity decreased FAK activity and thereby reduced TRIB3 expression and derepressed AKT activity. Under space microgravity, the increase in p38 MAPK activity and the derepression of AKT activity seem to synchronously lead to the activation of the signaling pathway specifically promoting adipogenesis.Zhang, C., Li, L., Jiang, Y., Wang, C., Geng, B., Wang, Y., Chen, J., Liu, F., Qiu, P., Zhai, G., Chen, P., Quan, R., Wang, J. Space microgravity drives transdifferentiation of human bone marrow-derived mesenchymal stem cells from osteogenesis to adipogenesis.	[Zhang, Cui; Li, Liang; Wang, Cuicui; Chen, Jianling; Wang, Jinfu] Zhejiang Univ, Coll Life Sci, Inst Cell & Dev Biol, Zijingang Campus, Hangzhou, Zhejiang, Peoples R China; [Jiang, Yuanda; Geng, Baoming; Wang, Yanqiu; Qiu, Peng; Zhai, Guangjie] Chinese Acad Sci, Natl Ctr Space Sci, Beijing, Peoples R China; [Liu, Fei; Quan, Renfu] Xiaoshan Tradit Chinese Med Hosp, Inst Orthoped, Hangzhou, Zhejiang, Peoples R China; [Chen, Ping] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Chen, Ping] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA USA	Zhejiang University; Chinese Academy of Sciences; Emory University; Emory University	Quan, RF (corresponding author), Xiaoshan Tradit Chinese Med Hosp, Inst Orthoped, Hangzhou 311201, Zhejiang, Peoples R China.; Wang, JF (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus,866 Yuhangtang Rd, Hangzhou, Zhejiang, Peoples R China.	quanrenfu@126.com; wjfu@zju.edu.cn	Wang, Yin/HCI-9352-2022; Wang, Yuan/HHC-1520-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022; jiang, anyi/GPT-0379-2022; wangwangwang, yuanyaun/HHN-6432-2022		Chinese Academy of Sciences [XDA04020202-23]; Chinese National Nature Science Foundation [U1738102, 81570932]; TZ-1 Application Program [KYTZ01-0901-FB-003]; National Development Program of Important Scientific Instruments [2013YQ030595]; Opening Foundation of the State Key Laboratory of Space Medicine Fundamentals and Application [SMFA12K02]; National Basic Research Program of China [2014CB541705]	Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); TZ-1 Application Program; National Development Program of Important Scientific Instruments; Opening Foundation of the State Key Laboratory of Space Medicine Fundamentals and Application; National Basic Research Program of China(National Basic Research Program of China)	The authors thank those involved with the SJ-10 Recoverable Scientific Satellite for providing the opportunity to conduct the experiment. The project was supported by grants from the Strategically Guiding Scientific Special Project from Chinese Academy of Sciences (XDA04020202-23), Chinese National Nature Science Foundation (U1738102, 81570932), TZ-1 Application Program (KYTZ01-0901-FB-003), National Development Program of Important Scientific Instruments (2013YQ030595), Opening Foundation of the State Key Laboratory of Space Medicine Fundamentals and Application (SMFA12K02), and National Basic Research Program of China (2014CB541705). The authors declare no conflicts of interest.	Aksanov O, 2014, CELL MOL LIFE SCI, V71, P3381, DOI 10.1007/s00018-014-1571-x; Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Avery J, 2010, CIRC RES, V106, P1516, DOI 10.1161/CIRCRESAHA.109.211920; Ayuso M, 2015, J ANIM SCI, V93, P2730, DOI 10.2527/jas.2014-8573; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Barlier-Mur AM, 2003, AM J RESP CELL MOL, V29, P620, DOI 10.1165/rcmb.4912; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Berg-Johansen B, 2016, J ORTHOP RES, V34, P48, DOI 10.1002/jor.23029; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Booth FW, 1997, INT J SPORTS MED, V18, pS265, DOI 10.1055/s-2007-972723; Chen J, 2013, TISSUE ENG PART B-RE, V19, P516, DOI [10.1089/ten.teb.2012.0672, 10.1089/ten.TEB.2012.0672]; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; Date T, 2004, J ORTHOP SCI, V9, P503, DOI 10.1007/s00776-004-0815-2; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Fu R, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0132-6; Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018; Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hu ZM, 2005, J CRANIOFAC SURG, V16, P1006, DOI 10.1097/01.scs.0000170449.72040.ee; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Izu Y, 2016, CELL TISSUE RES, V364, P623, DOI 10.1007/s00441-015-2345-y; KEILA S, 1994, J BONE MINER RES, V9, P321; Kim S, 2013, J ORTHOP RES, V31, P1920, DOI 10.1002/jor.22453; Klaus D M, 2001, Gravit Space Biol Bull, V14, P55; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Kuznetsov SA, 2013, J TISSUE ENG REGEN M, V7, P226, DOI 10.1002/term.515; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480; Liebergall M, 2013, MOL THER, V21, P1631, DOI 10.1038/mt.2013.109; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Luo Y, 2015, ACS APPL MATER INTER, V7, P6331, DOI 10.1021/acsami.5b00862; Mankani MH, 2007, EXP HEMATOL, V35, P995, DOI 10.1016/j.exphem.2007.01.051; Marfy-Smith SJ, 2017, STEM CELL TRANSL MED, V6, P3, DOI 10.5966/sctm.2016-0026; Martin I, 2015, TISSUE ENG PT A, V21, P1, DOI [10.1089/ten.TEA.2014.0515, 10.1089/ten.tea.2014.0515]; Matsuzaki H, 1996, FEBS LETT, V396, P305, DOI 10.1016/0014-5793(96)01120-9; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Michurina T V, 1996, Adv Space Res, V17, P295, DOI 10.1016/0273-1177(95)00650-4; Nakamura Hiroshi, 2003, Journal of Medical and Dental Sciences, V50, P167; Ontiveros C, 2003, J CELL BIOCHEM, V88, P427, DOI 10.1002/jcb.10410; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qi Meng, 2015, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V31, P787; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Shekkeris AS, 2012, CURR STEM CELL RES T, V7, P127; Shi DY, 2010, STEM CELL REV REP, V6, P567, DOI 10.1007/s12015-010-9182-x; Sonnenfeld G, 1999, ADV SPACE RES, V23, P1945, DOI 10.1016/S0273-1177(99)00455-X; Tadokoro M, 2009, J PEDIATR-US, V154, P924, DOI 10.1016/j.jpeds.2008.12.021; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Volk SW, 2014, CALCIFIED TISSUE INT, V94, P621, DOI 10.1007/s00223-014-9843-x; Wu M, 2003, J BIOL CHEM, V278, P27072, DOI 10.1074/jbc.M209814200; Xiang Y, 2007, CELL BIOL INT, V31, P444, DOI 10.1016/j.cellbi.2006.11.012; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xu BY, 2014, J BIOSCI BIOENG, V117, P624, DOI 10.1016/j.jbiosc.2013.10.018; Yue R, 2016, CELL STEM CELL, V18, P782, DOI 10.1016/j.stem.2016.02.015; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156; Zayzafoon M, 2002, J BIOL CHEM, V277, P37212, DOI 10.1074/jbc.M200129200; Zhang H, 2012, ENDOCRINOLOGY, V153, P2665, DOI 10.1210/en.2011-2008; Zheng Q, 2007, BIOL CHEM, V388, P755, DOI 10.1515/BC.2007.082; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633; Zong C, 2010, EUR CELLS MATER, V20, P109	83	33	34	6	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4444	4458		10.1096/fj.201700208RR	http://dx.doi.org/10.1096/fj.201700208RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29533735				2022-12-28	WOS:000439325400032
J	Zhong, L; Simard, MJ; Huot, J				Zhong, Liang; Simard, Martin J.; Huot, Jacques			Endothelial microRNAs regulating the NF-kappa B pathway and cell adhesion molecules during inflammation	FASEB JOURNAL			English	Review						p38 MAPK; E-selectin; extravasation	FLOW-DEPENDENT REGULATION; ACUTE CORONARY SYNDROMES; HUMAN BRAIN ENDOTHELIUM; KRUPPEL-LIKE FACTOR-2; VASCULAR INFLAMMATION; LEUKOCYTE ADHESION; ICAM-1 EXPRESSION; SELECTIN LIGANDS; GENE-EXPRESSION; ARTERY-DISEASE	The surface of endothelial cells is covered with cell adhesion molecules, including E-selectin, intercellular adhesion molecule 1 (ICAM-1), and vascular cell adhesion molecule 1 (VCAM- 1) , that mediate the adhesion and extravasation of leukocytes and play pivotal roles in inflammatory response. microRNAs (miRNAs) regulate the expression of these important cell adhesion molecules through two distinct major mechanisms, namely via modulating the proinflammatory NF-B pathway, which controls their transcription, and via directly targeting them. The present review highlights the role of various miRNAs in controlling the expression of E-selectin, ICAM-1, and VCAM-1: a type of regulation that can be harnessed for therapeutic prevention of inflammation-associated diseases such as atherosclerosis and sepsis. The roles of secreted miRNAs as paracrine regulators, and cell adhesion molecule-based miRNA delivery are also addressed.Zhong, L., Simard, M. J., Huot, J. Endothelial microRNAs regulating the NF-B pathway and cell adhesion molecules during inflammation.	[Zhong, Liang; Simard, Martin J.; Huot, Jacques] Laval Univ, Canc Res Ctr, St Patrick Res Grp Basic Oncol,Hotel Dieu Quebec, Ctr Hosp Univ CHU Quebec,Univ Laval,Res Ctr, Quebec City, PQ, Canada	Laval University	Simard, MJ; Huot, J (corresponding author), Laval Univ, Canc Res Ctr, 9 Rue McMahon, Quebec City, PQ G1R 3S3, Canada.	martin.simard@crchudequebec.ulaval.ca; jacques.huot@fmed.ulaval.ca		Zhong, Liang/0000-0002-4514-9074	Canadian Institutes of Health Research; Laval University Cancer Research Center	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Laval University Cancer Research Center	The authors thank members of their laboratories for comments on the manuscript. This work has been funded by Canadian Institutes of Health Research (to M.J.S.). M.J.S. is a Research Chair of Fonds de Recherche du Quebec-Sante. L.Z. holds a studentship from the Laval University Cancer Research Center. The authors declare no conflicts of interest.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asgeirsdottir SA, 2012, AM J PHYSIOL-RENAL, V302, pF1630, DOI 10.1152/ajprenal.00400.2011; Bao H, 2014, KIDNEY INT, V85, P624, DOI 10.1038/ki.2013.469; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Bayraktar R, 2017, MOL ONCOL, V11, P1673, DOI 10.1002/1878-0261.12144; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Bulut D, 2009, EUR J CLIN INVEST, V39, P17, DOI 10.1111/j.1365-2362.2008.02058.x; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cerutti C, 2017, SCI REP-UK, V7, DOI 10.1038/srep45284; Cerutti C, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0032-3; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Cheng HS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00422; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Chu MP, 2016, CRIT CARE MED, V44, pE639, DOI 10.1097/CCM.0000000000001629; Codagnone M, 2017, FASEB J, V31, P1856, DOI 10.1096/fj.201600952R; Cowan C, 2014, INVEST OPHTH VIS SCI, V55, P4944, DOI 10.1167/iovs.13-13631; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]; Demolli S, 2015, J MOL CELL CARDIOL, V88, P111, DOI 10.1016/j.yjmcc.2015.10.009; Deng HY, 2017, CELL PHYSIOL BIOCHEM, V41, P2183, DOI 10.1159/000475576; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; dos Santos AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/497280; Duan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060170; Duan Q, 2016, BBA-GENE REGUL MECH, V1859, P564, DOI 10.1016/j.bbagrm.2016.02.004; Echavarria R, 2015, CARDIOVASC RES, V106, P465, DOI 10.1093/cvr/cvv120; Fan WD, 2015, J CELL SCI, V128, P70, DOI 10.1242/jcs.154252; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gidlof O, 2015, J VASC RES, V52, P71, DOI 10.1159/000431367; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Harris TA, 2010, ARTERIOSCL THROM VAS, V30, P1990, DOI 10.1161/ATVBAHA.110.211706; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hu JZ, 2015, BRAIN RES, V1608, P191, DOI 10.1016/j.brainres.2015.02.036; Hu RZ, 2012, NAT MED, V18, P1009, DOI 10.1038/nm.2849; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; IADEMARCO MF, 1993, P NATL ACAD SCI USA, V90, P3943, DOI 10.1073/pnas.90.9.3943; Jansen F, 2015, J CELL MOL MED, V19, P2202, DOI 10.1111/jcmm.12607; Kheirolomoom A, 2015, ACS NANO, V9, P8885, DOI 10.1021/acsnano.5b02611; Kuo CH, 2014, J MATER CHEM B, V2, P8142, DOI 10.1039/c4tb00977k; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee DY, 2017, P NATL ACAD SCI USA, V114, P2072, DOI 10.1073/pnas.1621425114; Leonov G, 2015, INT J BIOCHEM CELL B, V69, P75, DOI 10.1016/j.biocel.2015.10.006; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Li JN, 2017, THROMB RES, V154, P96, DOI 10.1016/j.thromres.2017.04.016; Li P, 2017, J CLIN ENDOCR METAB, V102, P594, DOI 10.1210/jc.2016-2974; Lin JB, 2016, FASEB J, V30, P3216, DOI 10.1096/fj.201500163R; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Liu DZ, 2016, J CEREBR BLOOD F MET, V36, P1374, DOI 10.1177/0271678X15610786; Liu RR, 2015, AM J PHYSIOL-HEART C, V309, pH303, DOI 10.1152/ajpheart.00290.2015; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Ma H, 2016, J INFECT DIS, V214, P1773, DOI 10.1093/infdis/jiw449; Ma ST, 2016, SCI REP-UK, V6, DOI 10.1038/srep22910; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Nozaki T, 2009, J AM COLL CARDIOL, V54, P601, DOI 10.1016/j.jacc.2009.05.022; Pan QW, 2017, AM J PHYSIOL-CELL PH, V312, pC119, DOI 10.1152/ajpcell.00296.2016; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Pourhoseini S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116780; Rau CS, 2014, TOXICOL SCI, V140, P315, DOI 10.1093/toxsci/kfu097; Rohde JH, 2015, NUCLEIC ACID THER, V25, P141, DOI 10.1089/nat.2014.0501; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; St Hill CA, 2011, FRONT BIOSCI-LANDMRK, V16, P3233, DOI 10.2741/3909; Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Suzuki HI, 2017, CELL, V168, P1000, DOI 10.1016/j.cell.2017.02.015; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Walzog B, 2000, NEWS PHYSIOL SCI, V15, P107; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Witkowski M, 2016, ARTERIOSCL THROM VAS, V36, P1263, DOI 10.1161/ATVBAHA.115.306094; Wu M, 2015, EXP THER MED, V9, P1125, DOI 10.3892/etm.2015.2224; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Wu XY, 2014, J CELL BIOCHEM, V115, P1928, DOI 10.1002/jcb.24864; Yin YQ, 2016, CELL PHYSIOL BIOCHEM, V40, P486, DOI 10.1159/000452563; Yoshizaki K, 2008, BIOCHEM BIOPH RES CO, V371, P747, DOI 10.1016/j.bbrc.2008.04.160; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang LW, 2014, CARDIOVASC DRUG THER, V28, P303, DOI 10.1007/s10557-014-6533-x; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690; Zhong L, 2017, ONCOTARGET, V8, P1678, DOI 10.18632/oncotarget.13779; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108; Zhu HQ, 2014, INT J CARDIOL, V176, P764, DOI 10.1016/j.ijcard.2014.07.095; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	103	98	105	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4070	4084		10.1096/fj.201701536R	http://dx.doi.org/10.1096/fj.201701536R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29565737				2022-12-28	WOS:000439325400002
J	Fu, WY; Liu, Y; Sun, C; Yin, H				Fu, Wenyan; Liu, Yang; Sun, Christina; Yin, Hang			Transient p53 inhibition sensitizes aged white adipose tissue for beige adipocyte recruitment by blocking mitophagy	FASEB JOURNAL			English	Article						mitochondria; autophagy; aging; insulin sensitivity; diabetes	BROWN ADIPOCYTES; TUMOR-SUPPRESSOR; COLD-EXPOSURE; AUTOPHAGY; FAT; CELL; ACTIVATION; STRESS; MOUSE; MICE	Aging of white adipose tissue (WAT) is associated with reduced insulin sensitivity, which contributes to whole-body glucose intolerance. WAT aging in mice impairs cold-induced beige adipocyte recruitment (beiging), which has been attributed to the senescence of adipose progenitor cells. Tumor suppressor p53 has also been implicated in WAT aging. However, whether p53-related cellular aging in mature white adipocytes is causative of age-impaired WAT beiging remains unknown. It is also unclear whether transient p53 inhibition can rescue WAT beiging. Herein, we report that p53 increased in adipose tissues of 28-wk-old (aged) mice with impaired beiging capability. Cold exposure decreased p53 in beiging WAT of young mice but not in aged mice. In aged mice, inducible p53 ablation in differentiated adipocytes restored cold-induced WAT beiging and augmented whole-body energy expenditure and insulin sensitivity. Transient pharmacological inhibition of p53 led to the same beneficial effects. Mechanistically, cold exposure repressed autophagy in beiging WAT of young mice yet increased autophagy in aged WAT. p53-ablation reduced microtubule-associated protein light chain 3-mediated mitochondria clearance (mitophagy) and hence facilitated the increase of mitochondria during beiging. These findings suggest that p53-induced mitophagy in aged white adipocytes impedes WAT beiging and may be therapeutically targeted to improve insulin sensitivity in aged WAT.Fu, W., Liu, Y., Sun, C., Yin, H. Transient p53 inhibition sensitizes aged white adipose tissue for beige adipocyte recruitment by blocking mitophagy.	[Fu, Wenyan; Liu, Yang; Yin, Hang] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Fu, Wenyan; Liu, Yang; Yin, Hang] Univ Georgia, Ctr Mol Med, Athens, GA 30602 USA; [Sun, Christina] Augusta Univ, Dept Biol Sci, Augusta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Yin, H (corresponding author), Univ Georgia, 325 Riverbend Rd,Ctr Mol Med 2228, Athens, GA 30602 USA.	hyin@uga.edu	Yin, Hang/J-3613-2019; Liu, Yang/GSN-4444-2022	Yin, Hang/0000-0002-9621-0138; Liu, Yang/0000-0001-8364-1476	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR070178]; American Heart Association [17GRNT33700260]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070178] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Jarrod Call (The University of Georgia) for constructive discussion of the project. Research reported in this publication was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 1R01AR070178, and American Heart Association Grant-in-Aid 17GRNT33700260 (to H.Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or American Heart Association. The authors declare no conflicts of interest.	Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023; Berry DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10184; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Chen CY, 2012, J BIOL CHEM, V287, P44498, DOI 10.1074/jbc.M112.399790; Cinti S, 2002, J ENDOCRINOL INVEST, V25, P823, DOI 10.1007/BF03344046; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Goldman SJ, 2011, ANTIOXID REDOX SIGN, V14, P1971, DOI 10.1089/ars.2010.3777; Hall BM, 2017, AGING-US, V9, P1867, DOI 10.18632/aging.101268; Hallenborg P, 2016, AM J PHYSIOL-ENDOC M, V310, pE116, DOI 10.1152/ajpendo.00119.2015; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HEATON JM, 1972, J ANAT, V112, P35; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Itahana Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030776; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kung CP, 2016, J ENDOCRINOL, V231, pR61, DOI 10.1530/JOE-16-0324; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lu XD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aap8526; Lusk G, 1928, ELEMENTS SCI NUTR; Ma Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12709; Martinez-Lopez N, 2013, EMBO REP, V14, P795, DOI 10.1038/embor.2013.111; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Narita M, 2009, AUTOPHAGY, V5, P1046, DOI 10.4161/auto.5.7.9444; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Soro-Arnaiz I, 2016, CELL REP, V16, P2991, DOI 10.1016/j.celrep.2016.08.041; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tran CM, 2016, DIABETES, V65, P927, DOI 10.2337/db15-0502; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wang EY, 2013, HYPERTENSION, V62, P70, DOI 10.1161/HYPERTENSIONAHA.113.01028; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	59	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					844	856		10.1096/fj.201800577R	http://dx.doi.org/10.1096/fj.201800577R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30052487	Green Published			2022-12-28	WOS:000457401500066
J	Lipina, C; Walsh, SK; Mitchell, SE; Speakman, JR; Wainwright, CL; Hundal, HS				Lipina, Christopher; Walsh, Sarah K.; Mitchell, Sharon E.; Speakman, John R.; Wainwright, Cherry L.; Hundal, Harinder S.			GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues	FASEB JOURNAL			English	Article						endocannabinoid; cannabinoid receptor; skeletal muscle; liver; adipogenesis	CARDIOMETABOLIC RISK-FACTORS; CANNABINOID RECEPTOR GPR55; ENDOCANNABINOID LEVELS; GLUCOSE-UPTAKE; POTENTIAL ROLE; MUSCLE; OBESITY; IDENTIFICATION; STIMULATION; ACTIVATION	Emerging evidence indicates that G-protein coupled receptor 55 (GPR55), a nonclassic receptor of the endocannabinoid system that is activated by L--lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function and energy metabolism. We examined how GPR55 deficiency and modulation affects insulin signaling in skeletal muscle, adipose tissue, and liver alongside expression analysis of proteins implicated in insulin action and energy metabolism. We show that GPR55-null mice display decreased insulin sensitivity in these tissues, as evidenced by reduced phosphorylation of PKB/Akt and its downstream targets, concomitant with increased adiposity and reduced physical activity relative to wild-type counterparts. Impaired tissue insulin sensitivity coincided with reduced insulin receptor substrate-1 abundance in skeletal muscle, whereas in liver and epididymal fat it was associated with increased expression of the 3-phosphoinoistide lipid phosphatase, phosphatase and tensin homolog. In contrast, GPR55 activation enhanced insulin signaling in cultured skeletal muscle cells, adipocytes, and hepatocytes; this response was negated by receptor antagonists and GPR55 gene silencing in L6 myotubes. Sustained GPR55 antagonism in 3T3-L1 adipocytes enhanced expression of proteins implicated in lipogenesis and promoted triglyceride accumulation. Our findings identify GPR55 as a positive regulator of insulin action and adipogenesis and as a potential therapeutic target for countering obesity-induced metabolic dysfunction and insulin resistance.Lipina, C., Walsh, S. K., Mitchell, S. E., Speakman, J. R., Wainwright, C. L., Hundal, H. S. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.	[Lipina, Christopher; Hundal, Harinder S.] Univ Dundee, Sch Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland; [Walsh, Sarah K.; Wainwright, Cherry L.] Robert Gordon Univ, Ctr Cardiometab Hlth Res, Aberdeen, Scotland; [Mitchell, Sharon E.; Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	University of Dundee; Robert Gordon University; University of Aberdeen; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Hundal, HS (corresponding author), Univ Dundee, Sch Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	Walsh, Sarah/ABF-2490-2020	Walsh, Sarah K/0000-0002-9936-5303	Biotechnology and Biological Sciences Research Council (BBSRC); Diabetes UK; BBSRC [BB/S00033X/1, BB/N003500/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and Diabetes UK. The authors declare no conflicts of interest.	Abdulla H, 2016, DIABETOLOGIA, V59, P44, DOI 10.1007/s00125-015-3751-0; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Arifin SA, 2016, METABOLITES, V6, DOI 10.3390/metabo6010006; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; Bjursell M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167965; Caldwell MD, 2013, BRIT J PHARMACOL, V169, P834, DOI 10.1111/bph.12136; Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Despres JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Diaz-Arteaga A, 2012, DIABETES OBES METAB, V14, P234, DOI 10.1111/j.1463-1326.2011.01515.x; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Gupta A, 2016, J BIOL CHEM, V291, P18465, DOI 10.1074/jbc.M116.727750; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Kargl J, 2013, J PHARMACOL EXP THER, V346, P54, DOI 10.1124/jpet.113.204180; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kotsikorou E, 2013, BIOCHEMISTRY-US, V52, P9456, DOI 10.1021/bi4008885; Lanuti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126839; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lee Mak-Soon, 2016, Prev Nutr Food Sci, V21, P62, DOI [10.3746/pnf.2016.21.1.62, 10.3746/pnf.2016.21.1.57]; Lingerfelt MA, 2017, BIOCHEMISTRY-US, V56, P473, DOI 10.1021/acs.biochem.6b01013; Lipina C, 2016, AGING CELL, V15, P325, DOI 10.1111/acel.12438; Lipina C, 2010, DIABETES, V59, P375, DOI 10.2337/db09-0979; Liu B, 2016, DIABETES OBES METAB, V18, P1263, DOI 10.1111/dom.12780; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McKillop AM, 2013, BRIT J PHARMACOL, V170, P978, DOI 10.1111/bph.12356; Meadows A, 2016, INT J OBESITY, V40, P417, DOI 10.1038/ijo.2015.209; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Petitet F, 2006, CHEM BIOL DRUG DES, V67, P252, DOI 10.1111/j.1747-0285.2006.00370.x; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tuduri E, 2017, J MOL ENDOCRINOL, V58, pR191, DOI 10.1530/JME-16-0253; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Walsh SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108999; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Yang Hyewon, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P297, DOI 10.1515/jbcpp-2015-0080; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Zhang P, 2012, BIOMED PHARMACOTHER, V66, P485, DOI 10.1016/j.biopha.2012.04.004	53	37	37	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1299	1312		10.1096/fj.201800171R	http://dx.doi.org/10.1096/fj.201800171R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148676	Green Published, hybrid			2022-12-28	WOS:000457401500103
J	Login, FH; Jensen, HH; Pedersen, GA; Amieva, MR; Nejsum, LN				Login, Frederic H.; Jensen, Helene H.; Pedersen, Gitte A.; Amieva, Manuel R.; Nejsum, Lene N.			The soluble extracellular domain of E-cadherin interferes with EPEC adherence via interaction with the Tir:intimin complex	FASEB JOURNAL			English	Article						enteropathogenic E; coli; polarity; intimin	ENTEROPATHOGENIC ESCHERICHIA-COLI; CELL POLARITY; EAE GENE; MEMBRANE; INTIMIN; EXPRESSION; PROTEINS; RECEPTOR; ADHESION; DISRUPTION	Enteropathogenic Escherichia coli (EPEC) causes watery diarrhea when colonizing the surface of enterocytes. The translocated intimin receptor (Tir):intimin receptor complex facilitates tight adherence to epithelial cells and formation of actin pedestals beneath EPEC. We found that the host cell adherens junction protein E-cadherin (Ecad) was recruited to EPEC microcolonies. Live-cell and confocal imaging revealed that Ecad recruitment depends on, and occurs after, formation of the Tir:intimin complex. Combinatorial binding experiments using wild-type EPEC, isogenic mutants lacking Tir or intimin, and E. coli expressing intimin showed that the extracellular domain of Ecad binds the bacterial surface in a Tir:intimin-dependent manner. Finally, addition of the soluble extracellular domain of Ecad to the infection medium or depletion of Ecad extracellular domain from the cell surface reduced EPEC adhesion to host cells. Thus, the soluble extracellular domain of Ecad may be used in the design of intervention strategies targeting EPEC adherence to host cells.Login, F. H., Jensen, H. H., Pedersen, G. A., Amieva, M. R., Nejsum, L. N. The soluble extracellular domain of E-cadherin interferes with EPEC adherence via interaction with the Tir:intimin complex.	[Login, Frederic H.; Jensen, Helene H.; Pedersen, Gitte A.; Nejsum, Lene N.] Aarhus Univ, Dept Clin Med, Bartholins Alle 6, DK-8000 Aarhus C, Denmark; [Jensen, Helene H.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Amieva, Manuel R.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Amieva, Manuel R.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Aarhus University; Aarhus University; Stanford University; Stanford University	Nejsum, LN (corresponding author), Aarhus Univ, Dept Clin Med, Bartholins Alle 6, DK-8000 Aarhus C, Denmark.	nejsum@clin.au.dk	Jensen, Helene/GZK-5914-2022; Jensen, Helene H/V-5038-2018; Amieva, Manuel/U-2581-2017	Jensen, Helene H/0000-0002-8426-9802; Nejsum, Lene Niemann/0000-0003-4368-8821; Amieva, Manuel/0000-0002-5601-4490	Lundbeck Foundation; Graduate School of Science and Technology, Aarhus University; Carlsberg Foundation; MEMBRANES (Aarhus University)	Lundbeck Foundation(Lundbeckfonden); Graduate School of Science and Technology, Aarhus University; Carlsberg Foundation(Carlsberg Foundation); MEMBRANES (Aarhus University)	The authors thank Dr. W. James Nelson (Stanford University) for MDCK cells, cells secreting the Ecad:Fc domain, and for the T151 cells. The authors thank Dr. Gad Frankel (Imperial College London, UK) for EPEC strains and Dr. John M. Leong (Tufts University School of Medicine, Boston, MA, USA) for the TirMC construct. This work was supported by a Lundbeck Junior Group Leader Fellowship (to L.N.N.) from the Lundbeck Foundation, and a fellowship from the Graduate School of Science and Technology, Aarhus University (to H.H.J.). The Nikon microscope was funded by the Lundbeck Foundation, the Carlsberg Foundation, and MEMBRANES (Aarhus University). The authors declare no conflicts of interest.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Arnspang EC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111804; Arnspang EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073977; Bai L, 2008, INFECT IMMUN, V76, P361, DOI 10.1128/IAI.01199-07; BALCAROVASTANDER J, 1984, EMBO J, V3, P2687, DOI 10.1002/j.1460-2075.1984.tb02194.x; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x; Drees Frauke, 2004, V294, P303; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; Frankel G, 1996, J BIOL CHEM, V271, P20359, DOI 10.1074/jbc.271.34.20359; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Goosney DL, 2001, INFECT IMMUN, V69, P3315, DOI 10.1128/IAI.69.5.3315-3322.2001; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Guttman JA, 2007, CELL MICROBIOL, V9, P131, DOI 10.1111/j.1462-5822.2006.00773.x; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; Hecht G, 2004, AM J PHYSIOL-GASTR L, V287, pG370, DOI 10.1152/ajpgi.00432.2003; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Jensen HH, 2018, AM J PHYSIOL-CELL PH, V314, pC654, DOI 10.1152/ajpcell.00186.2017; Jensen HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141871; Kenny B, 1997, INFECT IMMUN, V65, P2528, DOI 10.1128/IAI.65.7.2528-2536.1997; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kierbel A, 2007, J CELL BIOL, V177, P21, DOI 10.1083/jcb.200605142; Koffman JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133324; Kristensen SH, 2013, J PHYS CHEM B, V117, P10376, DOI 10.1021/jp4038528; Kristensen SH, 2013, ACTA BIOMATER, V9, P6158, DOI 10.1016/j.actbio.2013.01.011; Kristensen SH, 2012, NANO LETT, V12, P2129, DOI 10.1021/nl300514v; LEVINE MM, 1978, LANCET, V1, P1119; Liu H, 1999, INFECT IMMUN, V67, P2045; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Marlar S, 2014, AM J PHYSIOL-CELL PH, V306, pC598, DOI 10.1152/ajpcell.00132.2013; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Muza-Moons MM, 2004, CELL MICROBIOL, V6, P783, DOI 10.1111/j.1462-5822.2004.00404.x; Muza-Moons MM, 2003, INFECT IMMUN, V71, P7069, DOI 10.1128/IAI.71.12.7069-7078.2003; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Pedersen GA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179122; Perez TD, 2008, J BIOL CHEM, V283, P5014, DOI 10.1074/jbc.M705209200; Plotkowski MC, 1999, AM J RESP CELL MOL, V20, P880, DOI 10.1165/ajrcmb.20.5.3408; SCHAUER DB, 1993, INFECT IMMUN, V61, P4654, DOI 10.1128/IAI.61.11.4654-4661.1993; Simonovic I, 2000, CELL MICROBIOL, V2, P305, DOI 10.1046/j.1462-5822.2000.00055.x; Sinclair JF, 2004, J BIOL CHEM, V279, P33751, DOI 10.1074/jbc.M401616200; SPITZ J, 1995, AM J PHYSIOL-GASTR L, V268, pG374, DOI 10.1152/ajpgi.1995.268.2.G374; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tapia R, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12757; Troxell ML, 2000, J CELL SCI, V113, P985; Troxell ML, 1999, AM J PHYSIOL-CELL PH, V276, pC404, DOI 10.1152/ajpcell.1999.276.2.C404; Velle KB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006501; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; YU J, 1992, MOL MICROBIOL, V6, P411, DOI 10.1111/j.1365-2958.1992.tb01484.x; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618	54	3	3	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6860	6868		10.1096/fj.201800651	http://dx.doi.org/10.1096/fj.201800651			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29920220				2022-12-28	WOS:000449359700039
J	Rancourt, A; Dufresne, SS; St-Pierre, G; Levesque, JC; Nakamura, H; Kikuchi, Y; Satoh, MS; Frenette, J; Sato, S				Rancourt, Ann; Dufresne, Sebastien S.; St-Pierre, Guillaume; Levesque, Julie-Christine; Nakamura, Haruka; Kikuchi, Yodai; Satoh, Masahiko S.; Frenette, Jerome; Sato, Sachiko			Galectin-3 and N-acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						glycobiology; lectins; monosaccharide	GALACTOSIDE-BINDING LECTINS; F344 RATS; IN-VITRO; MACROPHAGES; NEUTROPHILS; MECHANISMS; GLYCANS; DISEASE; SURFACE; CELLS	The muscle membrane, sarcolemma, must be firmly attached to the basal lamina. The failure of proper attachment results in muscle injury, which is the underlying cause of Duchenne muscular dystrophy (DMD), in which mutations in the dystrophin gene disrupts the firm adhesion. In patients with DMD, even moderate contraction causes damage, leading to progressive muscle degeneration. The damaged muscles are repaired through myogenesis. Consequently, myogenesis is highly active in patients with DMD, and the repeated activation of myogenesis leads to the exhaustion of the myogenic stem cells. Therefore, approaches to reducing the risk of the exhaustion are to develop a treatment that strengthens the interaction between the sarcolemma and the basal lamina and increases the efficiency of the myogenesis. Galectin-3 is an oligosaccharide-binding protein and is known to be involved in cell-cell interactions and cell-matrix interactions. Galectin-3 is expressed in myoblasts and skeletal muscle, although its function in muscle remains elusive. In this study, we found evidence that galectin-3 and the monosaccharide N-acetylglucosamine, which increases the synthesis of binding partners (oligosaccharides) of galectin-3, promote myogenesis in vitro. Moreover, in the mdx mouse model of DMD, treatment with N-acetylglucosamine increased muscle-force production. The results suggest that treatment with N-acetylglucosamine might mitigate the burden of DMD.Rancourt, A., Dufresne, S. S., St-Pierre, G., Levesque, J.-C., Nakamura, H., Kikuchi, Y., Satoh, M. S., Frenette, J., Sato, S. Galectin-3 and N-acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy.	[Rancourt, Ann; St-Pierre, Guillaume; Nakamura, Haruka; Kikuchi, Yodai; Sato, Sachiko] Laval Univ, Fac Med, CHU Quebec, Glycobiol & Bioimaging Lab,Res Ctr Infect Dis,Res, Quebec City, PQ, Canada; [Rancourt, Ann; Satoh, Masahiko S.] Laval Univ, Fac Med, CHU Quebec, Lab DNA Damage Responses & Bioimaging,Res Ctr, Quebec City, PQ, Canada; [Dufresne, Sebastien S.; Frenette, Jerome] Laval Univ, Fac Med, CHU Quebec, Dept Rehabil,Res Ctr, Quebec City, PQ, Canada; [Levesque, Julie-Christine; Sato, Sachiko] CHU Quebec, Bioimaging Platform, Res Ctr, Quebec City, PQ, Canada; [Dufresne, Sebastien S.] Univ Quebec Chicoutimi, Unite Enseignement Physiotherapie, Chicoutimi, PQ, Canada	Laval University; Laval University; Laval University; Laval University; University of Quebec; University of Quebec Chicoutimi	Sato, S (corresponding author), CHU Quebec, Fac Med, Res Ctr Infect Dis, Glycobiol & Bioimaging Lab,CRI CHUL CHU Quebec Re, RC 709,2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	sachiko.sato@crchul.ulaval.ca	Dufresne, Sebastien S./AAL-7005-2021	Dufresne, Sebastien S./0000-0001-5924-7962; Frenette, Jerome/0000-0002-4308-9418				Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Brzoska E, 2006, DIFFERENTIATION, V74, P105, DOI 10.1111/j.1432-0436.2005.00059.x; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cheung P, 2007, GLYCOBIOLOGY, V17, P828, DOI 10.1093/glycob/cwm048; Cummings R. D., 2017, ESSENTIALS GLYCOBIOL; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Duddy W, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0041-y; Dufresne SS, 2015, AM J PATHOL, V185, P920, DOI 10.1016/j.ajpath.2015.01.006; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Gatheridge MA, 2016, JAMA NEUROL, V73, P111, DOI 10.1001/jamaneurol.2015.3537; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee KY, 2004, FOOD CHEM TOXICOL, V42, P687, DOI 10.1016/j.fct.2003.12.005; Leung DG, 2013, ANN NEUROL, V74, P404, DOI 10.1002/ana.23989; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Manning J, 2015, J MUSCLE RES CELL M, V36, P155, DOI 10.1007/s10974-015-9406-4; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Nieminen J, 2005, J LEUKOCYTE BIOL, V78, P1127; Nieminen J, 2008, J IMMUNOL, V180, P2466, DOI 10.4049/jimmunol.180.4.2466; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Novak R, 2012, BBA-GEN SUBJECTS, V1820, P1383, DOI 10.1016/j.bbagen.2011.11.014; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SATO S, 1992, J BIOL CHEM, V267, P6983; SATO S, 1994, J BIOL CHEM, V269, P4424; Sato S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23328; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Simon RR, 2011, DIABETES-METAB RES, V27, P14, DOI 10.1002/dmrr.1150; St-Pierre C, 2010, METHOD ENZYMOL, V480, P267, DOI 10.1016/S0076-6879(10)80013-8; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Takahashi M, 2009, FOOD CHEM TOXICOL, V47, P462, DOI 10.1016/j.fct.2008.12.002; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910	51	12	12	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6445	6455		10.1096/fj.201701151RRR	http://dx.doi.org/10.1096/fj.201701151RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29894670	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000449359700008
J	Zhang, LN; Tian, H; Zhou, XL; Tian, SC; Zhang, XH; Wu, TJ				Zhang, Li-Na; Tian, Hui; Zhou, Xiu-Li; Tian, Suo-Chen; Zhang, Xi-Hong; Wu, Tie-Jun			Upregulation of microRNA-351 exerts protective effects during sepsis by ameliorating skeletal muscle wasting through the Tead-4-mediated blockade of the Hippo signaling pathway	FASEB JOURNAL			English	Article						protein degradation; atrophy; apoptosis; C57BL; 6J mice; lipopolysaccharide	CELL-PROLIFERATION; PROTEIN-SYNTHESIS; EXPRESSION; TEAD4; TROPHECTODERM; APOPTOSIS; SURVIVAL; DENSITY; CANCER; MODEL	Sepsis-induced skeletal muscle wasting may lead to various severe clinical consequences. Understanding molecular mechanisms of the regulation of the loss of skeletal muscle mass in septic patients remains a significant clinical challenge. The current study was conducted to establish septic mouse models to explore the relationship between microRNA (miR)-351 and the transcription element apical (TEA) domain transcription factor (Tead)-4 gene and to investigate its effects on the skeletal muscle through mediating the Hippo signaling pathway in mice with acute sepsis. A total of 60 mice were collected to establish mouse models of acute sepsis. The positive expression rate of Tead-4 and the apoptotic index (AI) were measured. A dual-luciferase reporter gene assay was conducted to verify the targeting relationship between miR-351 and Tead-4. Furthermore, the muscle fiber diameter (MFD) and area (MFA) and the content of 3-methylhistidine (3-MH) and tyrosine (Tyr) were assessed. The expression levels of miR-351, p38-MAPK, Yes-associated protein, Tead-4, B-cell lymphoma X protein (Bax), and Caspase-3 were determined with quantitative RT-PCR and Western blot analysis. Finally, cell viability, apoptosis, and levels of inflammatory factors, including IL-1, IL-6, IGF-1, TNF-, and monocyte chemoattractant protein-1 were detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, flow cytometry, and ELISA. Initially, Tead-4 protein expression was higher in skeletal muscle tissues of mice with acute sepsis. Tead-4 was identified to negatively regulate miR-351. Upregulation of miR-351 increased MFA and MFD, muscle weight water content, Bcl-2 expression levels, and cell viability. Up-regulation of miR-351 reduced AI; 3-MH and Tyr content; positive expression of Tead-4 protein; the expression levels of p38-MAPK, Yap, Tead-4, Bax, and Caspase-3; apoptosis; and inflammatory responses. The current study demonstrated that up-regulation of miR-351 inhibits the degradation of skeletal muscle protein and the atrophy of skeletal muscle in mice with acute sepsis by targeting Tead-4 through suppression of the Hippo signaling pathway. Thus, miR-351 overexpression may be a future therapeutic strategy for acute sepsis.Zhang, L.-N., Tian, H., Zhou, X.-L., Tian, S.-C., Zhang, X.-H., Wu, T.-J. Upregulation of microRNA-351 exerts protective effects during sepsis by ameliorating skeletal muscle wasting through the Tead-4-mediated blockade of the Hippo signaling pathway.	[Wu, Tie-Jun] Liaocheng Peoples Hosp, Intens Care Unit, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China; [Wu, Tie-Jun] Taishan Med Univ, Sch Clin, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences	Wu, TJ (corresponding author), Liaocheng Peoples Hosp, Intens Care Unit, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China.; Wu, TJ (corresponding author), Taishan Med Univ, Sch Clin, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China.	drwutiejun2017@126.com						Banerjee A, 2006, TOXICOL PATHOL, V34, P373, DOI 10.1080/01926230600806543; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Chen MY, 2015, ONCOTARGET, V6, P44466, DOI 10.18632/oncotarget.6298; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Fischer M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00041; Ge C, 2018, SHOCK, V50, P112, DOI 10.1097/SHK.0000000000000978; He L, 2014, MOL MED REP, V9, P1869, DOI 10.3892/mmr.2014.1991; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang QK, 2016, MED SCI MONITOR, V22, P1161, DOI 10.12659/MSM.897909; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Li G, 2016, NEURAL REGEN RES, V11, P1293, DOI 10.4103/1673-5374.189195; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li Q, 2010, AM J PHYSIOL-HEART C, V298, pH1340, DOI 10.1152/ajpheart.00592.2009; Li TX, 2013, MOL MED REP, V7, P1889, DOI 10.3892/mmr.2013.1444; Li X, 2012, RNA BIOL, V9, P292, DOI 10.4161/rna.19100; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Parrish WR, 2008, ANN NY ACAD SCI, V1144, P210, DOI 10.1196/annals.1418.011; Sato A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153130; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Sharron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041549; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Vary TC, 2007, J NUTR, V137, P2074, DOI 10.1093/jn/137.9.2074; Wang LN, 2013, EXP THER MED, V5, P1101, DOI 10.3892/etm.2013.937; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zhao XJ, 2016, ONCOL LETT, V11, P4245, DOI 10.3892/ol.2016.4527; Zheng G, 2017, INT IMMUNOPHARMACOL, V45, P6, DOI 10.1016/j.intimp.2017.01.029; Zhou JH, 2015, CYTOKINE, V71, P89, DOI 10.1016/j.cyto.2014.09.003; Zhou Y, 2017, ELECTROMAGN BIOL MED, V36, P1, DOI 10.3109/15368378.2016.1140058	36	7	7	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6934	6947		10.1096/fj.201800151RR	http://dx.doi.org/10.1096/fj.201800151RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30040486				2022-12-28	WOS:000449359700045
J	Cheon, Y; Lee, S				Cheon, Yeongmi; Lee, Soojin			CENP-W inhibits CDC25A degradation by destabilizing the SCF beta(-TrCP-1) complex at G(2)/M	FASEB JOURNAL			English	Article						CRL; CUL1; -TrCP1; kinetochore; mitosis	BETA-TRCP; COP9 SIGNALOSOME; UBIQUITIN LIGASES; PROTEIN; SCF; INTERACTS; NEDD8; ACTIVATION; COMPONENT; FORMS	Skp, Cullin, F-box (SCF)(-TrCP-1) ubiquitin ligases play a central role in cell cycle regulation and tumorigenesis via proteolytic cleavage of many essential cell cycle regulators. In this study, we propose that centromere protein (CENP)-W, a newly identified kinetochore component, is a novel negative regulator of the SCF-TrCP-1 complex. CENP-W interacts with Cullin (CUL)-1 and -Transducin repeat-containing protein (-TrCP)-1 through highly overlapped binding sites with S-phase kinase-associated protein (SKP)-1. CENP-W is incorporated into the SCF-TrCP-1 complex to promote complex disassembly. Unlike other known regulators that increase SCF-TrCP-1 ubiquitin ligase activity by promoting complex reassociation, CENP-W-mediated complex disorganization induced -TrCP1 degradation and consequently decreased its activity. The association between CENP-W and the SCF-TrCP-1 complex was prominent during the G(2)/M transition in the nucleus. Especially, CENP-W knockdown decreased the cell division cycle-25A protein level, leading to a delay in mitotic progression. We propose that CENP-W participates in cell cycle regulation by modulating SCF-TrCP-1 ubiquitin ligase activity.Cheon, Y., Lee, S. CENP-W inhibits CDC25A degradation by destabilizing the SCF-TrCP-1 complex at G(2)/M.	[Cheon, Yeongmi; Lee, Soojin] Chungnam Natl Univ, Dept Microbiol & Mol Biol, 99 Daehak Ro, Daejeon 34134, South Korea	Chungnam National University	Lee, S (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, 99 Daehak Ro, Daejeon 34134, South Korea.	leesoojin@cnu.ac.kr		Lee, Soojin/0000-0002-0383-5025	Basic Science Research Program of the Korean Ministry of Education, Science, and Technology [NRF-2016R1A2B4009244]	Basic Science Research Program of the Korean Ministry of Education, Science, and Technology	This research was supported by Basic Science Research Program of the Korean Ministry of Education, Science, and Technology (NRF-2016R1A2B4009244; to S.L.). The authors declare no conflicts of interest.	Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cheon Y, 2016, FEBS LETT, V590, P4441, DOI 10.1002/1873-3468.12483; Choo YY, 2011, MOL BIOL CELL, V22, P4706, DOI 10.1091/mbc.E11-03-0251; Chun Y, 2013, J BIOL CHEM, V288, P27208, DOI 10.1074/jbc.M113.469221; Chun Y, 2011, J BIOL CHEM, V286, P42758, DOI 10.1074/jbc.M111.228411; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kim H, 2009, MOL CELLS, V27, P697, DOI 10.1007/s10059-009-0083-2; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mathur R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005727; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; Mosadeghi R, 2016, ELIFE, V5, DOI 10.7554/eLife.12102; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Putters J, 2011, CELL SIGNAL, V23, P641, DOI 10.1016/j.cellsig.2010.11.015; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Seo E, 2009, CELL SIGNAL, V21, P43, DOI 10.1016/j.cellsig.2008.09.009; Wang C, 2013, BIOCHEM BIOPH RES CO, V434, P728, DOI 10.1016/j.bbrc.2013.03.096; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	31	6	6	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6051	6065		10.1096/fj.201701358RRR	http://dx.doi.org/10.1096/fj.201701358RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29863914				2022-12-28	WOS:000447172000024
J	Huang, YJ; Shao, Q; Luo, XR; Yang, DJ; Zeng, BL; Xiang, TX; Ren, GS; Cheng, Q				Huang, Yujing; Shao, Qing; Luo, Xinrong; Yang, Dejuan; Zeng, Beilei; Xiang, Tingxiu; Ren, Guosheng; Cheng, Qiao			Poly(ADP-ribose) polymerase-1 promotes recruitment of meiotic recombination-11 to chromatin and DNA double-strand break repair in Ku70-deficient breast cancer cells	FASEB JOURNAL			English	Article						Alt-EJ; NHEJ; PARP inhibition; MRN complex	HOMOLOGOUS RECOMBINATION; DAMAGE; KU; CLEAVAGE; RELAXATION; DEFICIENT; PARP-1; BACKUP; GENES; ROLES	Poly(ADP-ribose) polymerase (PARP)-1 may act in an error-prone pathway called alternative end joining (Alt-EJ) for DNA double-strand break (DSB) repair when nonhomologous end joining is defective. We examined the recruitment of PARP-1 to chromatin in response to radiomimetic agents and the effects of PARP-1 inhibition on DSB repair and recruitment of the meiotic recombination (MRE)-11-double-strand break repair (RAD50) protein-Nijmegen breakage syndrome (NSB)-1 (MRN) complex to the chromatin in Ku70-deficient breast cancer cells. The chromatin-binding affinity of PARP-1 was enhanced in response to neocarzinostatin (NCS) or calicheamicin treatment in the absence of Ku70. PARP-1 inhibition impaired the repair of both NCS-induced DSBs and intron-encoded endonuclease from Physarum polycephalum-induced site-specific DSB. Both fractionation and chromatin immunoprecipitation assays demonstrated that chromatin recruitment of MRN was PARP-1 dependent. These data suggest that PARP-1 is vital for DSB repair in breast cancer cells when Alt-EJ is activated.Huang, Y., Shao, Q., Luo, X., Yang, D., Zeng, B., Xiang, T., Ren, G., Cheng, Q. Poly(ADP-ribose) polymerase-1 promotes recruitment of meiotic recombination-11 to chromatin and DNA double-strand break repair in Ku70-deficient breast cancer cells.	[Huang, Yujing; Shao, Qing; Luo, Xinrong; Yang, Dejuan; Zeng, Beilei; Xiang, Tingxiu; Ren, Guosheng; Cheng, Qiao] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Mol Oncol & Epigenet, Chongqing, Peoples R China; [Luo, Xinrong; Ren, Guosheng; Cheng, Qiao] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Cheng, Q (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China.	c914chengqiao@hotmail.com			National Natural Science Foundation of China [81101653]; Natural Science Foundation Project of Chongqing Science Technology Commission [cstc2011jjA10037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science Technology Commission	This work was supported by the National Natural Science Foundation of China Grant 81101653 (to Q.C.) and Natural Science Foundation Project of Chongqing Science Technology Commission Grant cstc2011jjA10037 (to Q.C.). The authors declare no conflicts of interest.	Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Balestrini A, 2013, CELL REP, V3, P2033, DOI 10.1016/j.celrep.2013.05.026; Benitez-Bribiesca L, 1999, ANN NY ACAD SCI, V887, P133, DOI 10.1111/j.1749-6632.1999.tb07928.x; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Davidson JM, 2000, BRIT J CANCER, V83, P1309, DOI 10.1054/bjoc.2000.1458; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Decottignies A, 2007, GENETICS, V176, P1403, DOI 10.1534/genetics.107.071621; DEDON PC, 1990, J BIOL CHEM, V265, P14713; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Deniz M, 2016, FASEB J, V30, P3786, DOI 10.1096/fj.201600453R; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Ferguson LR, 2015, SEMIN CANCER BIOL, V35, pS5, DOI 10.1016/j.semcancer.2015.03.005; FERRO AM, 1982, J BIOL CHEM, V257, P7808; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Iliakis G, 2015, MUTAT RES-GEN TOX EN, V793, P166, DOI 10.1016/j.mrgentox.2015.07.001; Jia Q, 2013, PLANT MOL BIOL, V82, P339, DOI 10.1007/s11103-013-0065-9; Kent T, 2016, ELIFE, V5, DOI 10.7554/eLife.13740; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Luke AM, 2010, MUTAT RES-FUND MOL M, V694, P65, DOI 10.1016/j.mrfmmm.2010.08.008; Mansour WY, 2013, DNA REPAIR, V12, P1134, DOI 10.1016/j.dnarep.2013.10.005; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Robert I, 2009, J EXP MED, V206, P1047, DOI 10.1084/jem.20082468; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Sellou H, 2016, MOL BIOL CELL, V27, P3791, DOI 10.1091/mbc.E16-05-0269; Wang HC, 2001, ONCOGENE, V20, P2212, DOI 10.1038/sj.onc.1204350; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; Yuan Y, 2015, NUCLEIC ACIDS RES, V43, P10264, DOI 10.1093/nar/gkv894	39	6	7	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6112	6122		10.1096/fj.201800092R	http://dx.doi.org/10.1096/fj.201800092R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29874127	Bronze			2022-12-28	WOS:000447172000029
J	Novoselova, TV; Hussain, M; King, PJ; Guasti, L; Metherell, LA; Charalambous, M; Clark, AJL; Chan, LF				Novoselova, Tatiana V.; Hussain, Mashal; King, Peter J.; Guasti, Leonardo; Metherell, Louise A.; Charalambous, Marika; Clark, Adrian J. L.; Chan, Li F.			MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation	FASEB JOURNAL			English	Article						ACTH; accessory protein; melanocortin; cell fate; familial glucocorticoid deficiency	FAMILIAL GLUCOCORTICOID DEFICIENCY; MELANOCORTIN 2 RECEPTOR; BETA-CATENIN; ACTH RECEPTOR; X-ZONE; CAPSULE; CORTEX; MICE; STEROIDOGENESIS; ACTIVATION	Melanocortin 2 receptor accessory protein (MRAP) is a single transmembrane domain accessory protein and a critical component of the hypothamo-pituitary-adrenal axis. MRAP is highly expressed in the adrenal gland and is essential for adrenocorticotropin hormone (ACTH) receptor expression and function. Human loss-of-function mutations in MRAP cause familial glucocorticoid (GC) deficiency (FGD) type 2 (FGD2), whereby the adrenal gland fails to respond to ACTH and to produce cortisol. In this study, we generated Mrap-null mice to study the function of MRAP in vivo. We found that the vast majority of Mrap(-/-) mice died at birth but could be rescued by administration of corticosterone to pregnant dams. Surviving Mrap(-/-) mice developed isolated GC deficiency with normal mineralocorticoid and catecholamine production, recapitulating FGD2. The adrenal glands of adult Mrap(-/-) mice were small, with grossly impaired adrenal capsular morphology and cortex zonation. Progenitor cell differentiation was significantly impaired, with dysregulation of WNT4/-catenin and sonic hedgehog pathways. These data demonstrate the roles of MRAP in both steroidogenesis and the regulation of adrenal cortex zonation. This is the first mouse model of isolated GC deficiency and reveals the role of MRAP in adrenal progenitor cell regulation and cortex zonation.Novoselova, T. V., Hussain, M., King, P. J., Guasti, L., Metherell, L. A., Charalambous, M., Clark, A. J. L., Chan, L. F. MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation.	[Novoselova, Tatiana V.; Hussain, Mashal; King, Peter J.; Guasti, Leonardo; Metherell, Louise A.; Clark, Adrian J. L.; Chan, Li F.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Ctr Endocrinol, Charterhouse Sq, London EC1M 6BQ, England; [Charalambous, Marika] Kings Coll London, Med & Mol Genet, London, England	University of London; Queen Mary University London; University of London; King's College London	Chan, LF (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Ctr Endocrinol, Charterhouse Sq, London EC1M 6BQ, England.	l.chan@qmul.ac.uk	Metherell, Louise A/E-8695-2012	Metherell, Louise A/0000-0002-0530-3524; Chan, Li/0000-0001-5146-8242; Charalambous, Marika/0000-0002-1684-5783	Medical Research Council (MRC) UK/Academy of Medical Sciences Clinician Scientist Fellowship Grant [G0802796]; Society for Endocrinology Early Career award; MRC Collaborative Awards in Science and Engineering (CASE) Studentship Grant [MR/J006394/1]; Biotechnology and Biological Sciences Research Council [BB/L00267/1]; Rosetrees Trust; MRC Grant [UK MR/K020455/1, MR/L002345/1]; MRC [MR/L002345/2, MR/K020455/1, MR/L002345/1, G0802796, G0801265, MR/R022836/1] Funding Source: UKRI	Medical Research Council (MRC) UK/Academy of Medical Sciences Clinician Scientist Fellowship Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Society for Endocrinology Early Career award; MRC Collaborative Awards in Science and Engineering (CASE) Studentship Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rosetrees Trust(Rosetrees Trust); MRC Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Medical Research Council (MRC) UK/Academy of Medical Sciences Clinician Scientist Fellowship Grant G0802796 (to L.F.C., supporting T.V.N.), a Society for Endocrinology Early Career award (to T.V.N.), MRC Collaborative Awards in Science and Engineering (CASE) Studentship Grant MR/J006394/1 (to A.J.L.C. and L.F.C. supporting M.H.), Biotechnology and Biological Sciences Research Council Award BB/L00267/1 and funds from the Rosetrees Trust (to L.G.), MRC Grant UK MR/K020455/1 (to L.M.), and MRC Grant MR/L002345/1 (to M.C.). The authors thank Dr. C. E. Gomez-Sanches (University of Mississippi, Jackson, MI, USA) for the kind gift of CYP11B1 and CYP11B2 antibody, Dr. Ed Laufer (Columbia University, NY, USA) for technical advice, Prof. Yacob Weinstein (Ben-Gurion University of the Negev, Israel) for the 20-alpha HSD antibody, Anthony Price and the staff at the Biological Services Unit at Queen Mary University of London for technical assistance, Dr. Anthony Coll and Sir/Prof. Steven O'Rahilly (Institute of Metabolic Sciences, Cambridge, Uninted Kingdom) for help with conceptualization and support of the project, Keith Burling and Peter Barker [Cambridge University Hospitals National Health Service (NHS) Foundation Trust] for the provision of laboratory services, and David Jackson (QMUL) for the critical reading of the manuscript. The authors declare no conflicts of interest.	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Berthon A, 2014, HUM MOL GENET, V23, P889, DOI 10.1093/hmg/ddt484; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Bornstein SR, 1999, FASEB J, V13, P1185, DOI 10.1096/fasebj.13.10.1185; Chaly AL, 2016, ELIFE, V5, DOI 10.7554/eLife.12397; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Chida D, 2009, MOL CELL ENDOCRINOL, V300, P32, DOI 10.1016/j.mce.2008.10.027; Chung TTLL, 2010, CLIN ENDOCRINOL, V72, P589, DOI 10.1111/j.1365-2265.2009.03663.x; Clark AJL, 2017, J MOL ENDOCRINOL, V58, pF1, DOI 10.1530/JME-17-0002; CLARK AJL, 1993, LANCET, V341, P461, DOI 10.1016/0140-6736(93)90208-X; Cooray SN, 2008, ENDOCRINOLOGY, V149, P1935, DOI 10.1210/en.2007-1463; Drelon C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12751; Drelon C, 2015, MOL CELL ENDOCRINOL, V408, P156, DOI 10.1016/j.mce.2014.12.014; Freedman BD, 2013, DEV CELL, V26, P666, DOI 10.1016/j.devcel.2013.07.016; Gorrigan RJ, 2011, J MOL ENDOCRINOL, V46, P227, DOI 10.1530/JME-11-0011; Guasti L, 2013, ENDOCRINOLOGY, V154, P4675, DOI 10.1210/en.2013-1211; Guasti L, 2013, MOL CELL ENDOCRINOL, V371, P182, DOI 10.1016/j.mce.2013.01.014; Hershkovitz L, 2007, ENDOCRINOLOGY, V148, P976, DOI 10.1210/en.2006-1100; HOLMES PV, 1971, J REPROD FERTIL, V25, P111; Jeong KH, 2000, ENDOCRINOLOGY, V141, P1142, DOI 10.1210/en.141.3.1142; Kim AC, 2008, DEVELOPMENT, V135, P2593, DOI 10.1242/dev.021493; King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106; Lerario AM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00052; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Novoselova TV, 2016, J ENDOCRINOL, V230, P13, DOI 10.1530/JOE-16-0057; Novoselova TV, 2013, J ENDOCRINOL, V217, pR1, DOI 10.1530/JOE-12-0501; Penny MK, 2017, MOL CELL ENDOCRINOL, V445, P42, DOI 10.1016/j.mce.2016.12.005; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Vidal V, 2016, GENE DEV, V30, P1389, DOI 10.1101/gad.277756.116; Walczak EM, 2014, MOL ENDOCRINOL, V28, P1471, DOI 10.1210/me.2014-1060; Webb TR, 2009, ENDOCRINOLOGY, V150, P720, DOI 10.1210/en.2008-0941; WEBER A, 1994, HUM MOL GENET, V3, P585, DOI 10.1093/hmg/3.4.585	34	16	17	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6186	6196		10.1096/fj.201701274RR	http://dx.doi.org/10.1096/fj.201701274RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29879378	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000447172000035
J	Abdullah, CS; Jin, ZQ				Abdullah, Chowdhury S.; Jin, Zhu-Qiu			Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice	FASEB JOURNAL			English	Article						CD4(+) T lymphocytes; regulatory T cells; diabetic cardiomyopathy; myocardial fibrosis	MYOCARDIAL-INFARCTION; SPHINGOSINE 1-PHOSPHATE; HEART-FAILURE; CARDIOMYOPATHY; LYMPHOCYTES; MECHANISMS; ACTIVATION; SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; INFLAMMATION	Infiltration of T cells is associated with patients who have diabetes at an increased risk of heart attack. T-cell sphingosine 1-phosphate receptor 1 (S1P(1))-mediated signaling directs T-lymphocyte trafficking. Effects of T-cell S1P(1) activation on cardiac fibrosis in a murine diabetic model remain to be explored. For this purpose, conditional T-cell S1P(1) knockout (TS1P(1)KO) mice generated by crossing S1pr(1)(loxP/loxP) mice with Lck-Cre mice were used in a model of streptozotocin-induced diabetic cardiomyopathy. The TS1P(1)KO mice exhibited sustained deficiency of both CD4(+) and CD8(+) T cells in the blood. The TS1P(1)KO vehicle control mouse hearts featured an altered phenotype characterized by increased myocardial fibrosis and reduced cardiac contractility under normal levels of glucose. Compared with littermate diabetic mice, TS1P(1)KO diabetic mice had improved cardiac function and alleviated cardiac fibrosis detected after 11 wk of diabetic induction. Our results indicate that T-cell S1P(1) signaling activation plays a dual role in the pathogenesis of cardiac fibrosis with respect to the levels of glucose: T-cell S1P(1) activation exerts antifibrotic effects in normoglycemia but exacerbates fibrosis under hyperglycemia.Abdullah, C. S., Jin, Z.-Q. Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice.	[Abdullah, Chowdhury S.] South Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Brookings, SD 57007 USA; [Jin, Zhu-Qiu] Calif Northstate Univ, Dept Pharmaceut & Biomed Sci, Coll Pharm, 9700 West Taron Dr, Elk Grove, CA 95757 USA; [Abdullah, Chowdhury S.] Louisiana State Univ, Dept Pathol, Hlth Sci Ctr, Shreveport, LA 71105 USA	South Dakota State University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jin, ZQ (corresponding author), Calif Northstate Univ, Dept Pharmaceut & Biomed Sci, Coll Pharm, 9700 West Taron Dr, Elk Grove, CA 95757 USA.	zhuqiu.jin@cnsu.edu	Abdullah, Chowdhury S/AAJ-9373-2020; Jin, Zhuqiu/ABB-1444-2020	Abdullah, Chowdhury S/0000-0001-5771-220X; Jin, Zhuqiu/0000-0001-9856-7790	Rollins Juhnke Research Fund (College of Pharmacy, South Dakota State University); Faculty Development Fund (College of Pharmacy, California Northstate University)	Rollins Juhnke Research Fund (College of Pharmacy, South Dakota State University); Faculty Development Fund (College of Pharmacy, California Northstate University)	This research was supported by the Rollins Juhnke Research Fund (College of Pharmacy, South Dakota State University) and the Faculty Development Fund (College of Pharmacy, California Northstate University) to Z.-Q.J. The authors declare no conflicts of interest.	Abdullah CS, 2016, INT IMMUNOPHARMACOL, V39, P251, DOI 10.1016/j.intimp.2016.07.027; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bansal SS, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003688; Becher PM, 2013, INT J MOL MED, V32, P158, DOI 10.3892/ijmm.2013.1368; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Boveda-Ruiz D, 2013, IMMUNOBIOLOGY, V218, P245, DOI 10.1016/j.imbio.2012.05.020; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Camm J, 2014, AM HEART J, V168, P632, DOI 10.1016/j.ahj.2014.06.028; Dong C, 2010, CELL MOL IMMUNOL, V7, P163, DOI 10.1038/cmi.2010.23; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Huwiler A, 2008, BIOCHEM PHARMACOL, V75, P1893, DOI 10.1016/j.bcp.2007.12.018; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Jin ZQ, 2004, CIRCULATION, V110, P1980, DOI 10.1161/01.CIR.0000143632.06471.93; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Laroumanie F, 2014, CIRCULATION, V129, P2111, DOI 10.1161/CIRCULATIONAHA.113.007101; Li Z, 2014, BRIT J PHARMACOL, V171, P2913, DOI 10.1111/bph.12621; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Lu J, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-105; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Russo I, 2016, J MOL CELL CARDIOL, V90, P84, DOI 10.1016/j.yjmcc.2015.12.011; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Wang WG, 2004, FASEB J, V18, P1043, DOI 10.1096/fj.04-1555fje; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Westermann D, 2007, BASIC RES CARDIOL, V102, P500, DOI 10.1007/s00395-007-0673-0; Zhen Y, 2012, CELL MOL IMMUNOL, V9, P75, DOI 10.1038/cmi.2011.37; Zouggari Y, 2013, NAT MED, V19, P1273, DOI 10.1038/nm.3284	39	14	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5426	5435		10.1096/fj.201800231R	http://dx.doi.org/10.1096/fj.201800231R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29698062	Bronze			2022-12-28	WOS:000447972500019
J	Li, W; Ji, ML; Lin, YD; Miao, Y; Chen, SM; Li, H				Li, Wenli; Ji, Meiling; Lin, Yandie; Miao, Yi; Chen, Simin; Li, Hao			DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21	FASEB JOURNAL			English	Article						decidualization; liver; reactive oxygen species; insulin	GROWTH-FACTOR 21; PHOSPHOENOLPYRUVATE CARBOXYKINASE; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; ADIPOSE-TISSUE; GENES; IDENTIFICATION; PROGESTERONE; SENSITIVITY	Decidual protein induced by progesterone (DEPP/DEPP1/C10ORF10) is induced by denying access to food and reduced by refeeding in insulin-sensitive organs in vivo. The negative regulation of DEPP by insulin is also proven in several cell lines. However, the functions of DEPP in insulin-sensitive organs remain unknown. In the present study, we investigated the impact of DEPP on hepatic energy metabolism and addressed the underlying mechanisms. The metabolic effects of DEPP were investigated in mice with adenovirus-mediated hepatic overexpression. Liver triglyceride (TG), glycogen, and serum metabolites were detected by biochemical assays. Energy homeostasis was measured by indirect calorimetry. Quantitative PCR was used to examine expression of genes involved in fatty acid oxidation, ketogenesis, lipogenesis, and gluconeogenesis. To evaluate the role of fibroblast growth factor 21 (FGF21) mediating the metabolic effects of DEPP, FGF21 antibody was administrated intraperitoneally to mice at 24 h after the delivery of adenovirus, and the metabolic alterations were examined. Reactive oxygen species (ROS) levels were measured by catalase activity assay, live cell fluorescence, or quantitative PCR. Effects of DEPP on the phenotype of db/db mice were also assessed. Acute hepatic overexpression of DEPP significantly reduced serum glucose and TG levels, dramatically elevated -hydroxybutyrate levels, and improved glucose clearance. Compared with controls, DEPP overexpression reduced food intake, the energy expenditure rate, and the respiratory quotient. DEPP overexpression significantly increased fatty acid oxidation and ketogenesis but suppressed lipid synthesis and gluconeogenesis. Investigations of the underlying mechanisms revealed that DEPP regulates energy metabolism by inducing oxidative stress. With the impairment of the ROS scavenging system and promotion of ROS formation, DEPP overexpression leads to ROS accumulation. FGF21 is upregulated in response to oxidative stress and mediates the effects of DEPP on fatty acid oxidation, ketogenesis, and lipid synthesis but not gluconeogenesis, as evidenced by the fact that the FGF21 antibody dramatically suppressed a DEPP-induced increase of fatty acid oxidation and ketogenesis, reversed the reduction of lipid synthesis, but did not change the suppression of gluconeogenesis. Moreover, overexpression of DEPP in db/db mice led to a marked reduction in body weight and serum glucose levels and significantly improved insulin sensitivity. Hepatic overexpression of DEPP in mice promotes fatty acid oxidation and ketogenesis and suppresses lipogenesis and gluconeogenesis, which is partly mediated by FGF21 induced by elevated cellular ROS levels.Li, W., Ji, M., Lin, Y., Miao, Y., Chen, S., Li, H. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.	[Li, Wenli; Ji, Meiling; Lin, Yandie; Miao, Yi; Chen, Simin; Li, Hao] Nanjing Med Univ, Key Lab Targeted Intervent Cardiovasc Dis, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Dept Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Li, Wenli] Binzhou Peoples Hosp, Binzhou, Peoples R China	Nanjing Medical University	Li, H (corresponding author), Nanjing Med Univ, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	haoli@njmu.edu.cn	Miao, Yi/AAE-9123-2020		National Natural Science Foundation of China [81270944, 81070678]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81270944 and 81070678; to H.L.). H.L. is an associate fellow at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. The authors declare no conflicts of interest.	Gomez-Samano MA, 2017, REDOX BIOL, V11, P335, DOI 10.1016/j.redox.2016.12.024; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen SM, 2011, FEBS LETT, V585, P1796, DOI 10.1016/j.febslet.2011.04.024; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Kim HT, 2006, CANCER RES, V66, P12009, DOI 10.1158/0008-5472.CAN-05-2515; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Kuroda Y, 2010, HORM METAB RES, V42, P173, DOI 10.1055/s-0029-1241841; Lu Y, 2010, CHINESE MED J-PEKING, V123, P3417, DOI 10.3760/cma.j.issn.0366-6999.2010.23.008; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Salcher S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-224; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Stepp MW, 2014, BBA-MOL CELL RES, V1843, P1076, DOI 10.1016/j.bbamcr.2014.02.003; Viollet B, 2011, HANDB EXP PHARMACOL, V203, P303, DOI 10.1007/978-3-642-17214-4_13; WANG K, 1995, SHOCK, V3, P204, DOI 10.1097/00024382-199503000-00008; Watanabe H, 2005, MOL HUM REPROD, V11, P471, DOI 10.1093/molehr/gah186; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Yabuta N, 2006, NUCLEIC ACIDS RES, V34, P4878, DOI 10.1093/nar/gkl651	24	7	7	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5459	5469		10.1096/fj.201800357R	http://dx.doi.org/10.1096/fj.201800357R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29702025	Bronze			2022-12-28	WOS:000447972500022
J	Liu, GZ; Gong, YJ; Zhang, R; Piao, LJ; Li, XZ; Liu, Q; Yan, S; Shen, YJ; Guo, SM; Zhu, MJ; Yin, HY; Funk, CD; Zhang, J; Yu, Y				Liu, Guizhu; Gong, Yanjun; Zhang, Rui; Piao, Lingjuan; Li, Xinzhi; Liu, Qian; Yan, Shuai; Shen, Yujun; Guo, Shumin; Zhu, Mingjiang; Yin, Huiyong; Funk, Colin D.; Zhang, Jian; Yu, Ying			Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration	FASEB JOURNAL			English	Article						neointimal hyperplasia; inflammation; VSMC	LOW-DOSE ASPIRIN; NF-KAPPA-B; ARTERIAL INJURY; DEFICIENT MICE; P-SELECTIN; MACROPHAGE POLARIZATION; INDUCED ATHEROGENESIS; MONOCYTE RECRUITMENT; INTIMAL HYPERPLASIA; BIOACTIVE PRODUCTS	Mechanical insults, such as stent implantation, can induce endothelial injury, vascular inflammation, and ultimately lead to vascular neointimal hyperplasia. Resolvin E1 (RvE1), derived from the 3 fatty acid eicosapentaenoic acid, can facilitate the resolution of inflammation in many settings. We therefore aimed to determine if there was a role for RvE1 in preventing neointimal formation after arterial injury and to understand the underlying mechanisms. Vascular inflammation and neointimal hyperplasia were induced by wire injury in the femoral arteries of mice. Administration of exogenous RvE1 and endogenously generated RvE1 via dietary supplementation with eicosapentaenoic acid and aspirin markedly reduced vascular neointima formation in this model. Mechanistically, RvE1 was found to inhibit vascular neutrophil infiltration, promote macrophage polarization toward an M2-like phenotype, suppress T-cell trafficking by reducing RANTES secretion from vascular smooth muscle cells, and inhibit vascular smooth muscle cell migration. In summary, RvE1 demonstrated a protective role against vascular inflammation and remodeling in response to mechanical injury, suggesting that it may serve as an adjuvant therapeutic agent for percutaneous coronary interventions, such as stent implantation.Liu, G., Gong, Y., Zhang, R., Piao, L., Li, X., Liu, Q., Yan, S., Shen, Y., Guo, S., Zhu, M., Yin, H., Funk, C. D., Zhang, J., Yu, Y. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration.	[Liu, Guizhu; Gong, Yanjun; Yan, Shuai; Guo, Shumin; Zhu, Mingjiang; Yin, Huiyong; Yu, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci,CAS Key Lab Nutr Metab & F, Beijing, Peoples R China; [Liu, Guizhu; Zhang, Rui; Liu, Qian; Shen, Yujun; Zhang, Jian; Yu, Ying] Tianjin Med Univ, Dept Pharmacol, Coll Basic Med Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Piao, Lingjuan] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Li, Xinzhi; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tianjin Medical University; Ewha Womans University; Queens University - Canada	Zhang, J; Yu, Y (corresponding author), Tianjin Med Univ, Dept Pharmacol, Coll Basic Med Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	zhangjian_tina@163.com; yuying@tmu.edu.cn	Li, Xinzhi/X-2650-2019	yin, hui yong/0000-0001-7049-1560; Yan, Shuai/0000-0003-0650-1837	Ministry of Science and Technology of China [2017YFC1307402]; National Natural Science Foundation of China [91439204, 81525004, 81790623, 91639302, 81771513, 81400239, 31771269, 31200860]; Tianjin Committee of Science and Technology [17JCYBJC26800]; Canadian Institutes of Health Research (CIHR) [MOP142476]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Committee of Science and Technology; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Ministry of Science and Technology of China (2017YFC1307402), the National Natural Science Foundation of China (91439204, 81525004, 81790623, 91639302, 81771513, 81400239, 31771269, 31200860), and the Tianjin Committee of Science and Technology (17JCYBJC26800). Y.Y. is a fellow at the Jiangsu Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. C.D.F. holds a Canada Research Chair position and is supported by the Canadian Institutes of Health Research (CIHR; MOP142476). The authors declare no conflicts of interest.	Aizik G., 2017, DRUG DELIV TRANSL RE; An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Asztalos IB, 2016, METABOLISM, V65, P1636, DOI 10.1016/j.metabol.2016.07.010; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Bai L, 2017, ARTERIOSCL THROM VAS, V37, P1470, DOI 10.1161/ATVBAHA.117.309672; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Block RC, 2012, PROSTAG LEUKOTR ESS, V87, P143, DOI 10.1016/j.plefa.2012.08.007; Boehm M, 2004, J CLIN INVEST, V114, P419, DOI 10.1172/jci200420176; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Chen JH, 2011, CIRCULATION, V123, P584, DOI 10.1161/CIRCULATIONAHA.110.971853; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Faggin E, 2000, ARTERIOSCL THROM VAS, V20, P152, DOI 10.1161/01.ATV.20.1.152; Flesher RP, 2014, CLIN SCI, V126, P805, DOI 10.1042/CS20130623; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Fu CH, 2012, ARTERIOSCL THROM VAS, V32, P2418, DOI 10.1161/ATVBAHA.112.255786; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Gong YJ, 2015, BRIT J PHARMACOL, V172, P5647, DOI 10.1111/bph.12986; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Hayashi S, 2000, CIRCULATION, V102, P1710, DOI 10.1161/01.CIR.102.14.1710; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Herova M, 2015, J IMMUNOL, V194, P2330, DOI 10.4049/jimmunol.1402166; Hiram R, 2015, AM J PHYSIOL-LUNG C, V309, pL776, DOI 10.1152/ajplung.00177.2015; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Hong S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00013; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Keyes KT, 2010, AM J PHYSIOL-HEART C, V299, pH153, DOI 10.1152/ajpheart.01057.2009; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Lavin B, 2014, ARTERIOSCL THROM VAS, V34, P1739, DOI 10.1161/ATVBAHA.114.303866; Li CC, 2014, J NUTR BIOCHEM, V25, P19, DOI 10.1016/j.jnutbio.2013.08.010; Li RC, 2011, AM J RESP CRIT CARE, V184, P124, DOI 10.1164/rccm.201012-2039OC; Liu GZ, 2018, BRIT J PHARMACOL, V175, P1205, DOI 10.1111/bph.14041; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; Manka DR, 1999, J VASC RES, V36, P372, DOI 10.1159/000025676; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Roy J, 2016, J PHARMACOL EXP THER, V359, P134, DOI 10.1124/jpet.116.234781; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shen YJ, 2016, CIRC RES, V118, P1194, DOI 10.1161/CIRCRESAHA.115.307853; Skarke C, 2015, J LIPID RES, V56, P1808, DOI 10.1194/jlr.M060392; Smirnova NF, 2014, J EXP MED, V211, P1779, DOI 10.1084/jem.20131276; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Suna G, 2018, CIRCULATION, V137, P166, DOI 10.1161/CIRCULATIONAHA.116.023381; Waksman R, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004150; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoneda S, 2013, CORONARY ARTERY DIS, V24, P368, DOI 10.1097/MCA.0b013e32836222ec; Yun JJ, 2001, TRANSPLANTATION, V71, P1649, DOI 10.1097/00007890-200106150-00026; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033	74	30	31	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5413	5425		10.1096/fj.201800173R	http://dx.doi.org/10.1096/fj.201800173R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29723062				2022-12-28	WOS:000447972500018
J	Bernard, V; Lamothe, S; Beau, I; Guillou, A; Martin, A; Le Tissier, P; Grattan, D; Young, J; Binart, N				Bernard, Valerie; Lamothe, Sophie; Beau, Isabelle; Guillou, Anne; Martin, Agnes; Le Tissier, Paul; Grattan, David; Young, Jacques; Binart, Nadine			Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo	FASEB JOURNAL			English	Article						pituitary; autocrine effect; mouse model	RECEPTOR-DEFICIENT MICE; TRANSCRIPTION FACTOR; ANTERIOR-PITUITARY; SIGNAL TRANSDUCER; PRL SECRETION; DOPAMINE; HYPERPROLACTINEMIA; HYPOTHALAMUS; HYPERPLASIA; EXPRESSION	Prolactin (PRL), whose principal role is regulation of lactation, is mainly synthesized and secreted by lactotroph anterior pituitary cells. Its signaling is exerted via a transmembrane PRL receptor (PRLR) expressed in a wide variety of tissues, including the anterior pituitary. Dopamine, which is secreted by tuberoinfundibular hypothalamic neurons, is the major inhibitory regulator of prolactin secretion. Although PRL is well established to stimulate hypothalamic dopamine secretion, thereby exerting a negative feedback regulation on its own release, autocrine or paracrine actions of PRL on lactotroph cells have also been suggested. Within the pituitary, PRL may inhibit both lactotroph proliferation and secretion, but in vivo evaluation of these putative functions is limited. To determine whether the autocrine actions of prolactin have a significant role in the physiologic function of lactotrophs in vivo, we examined the consequences of conditional deletion of Prlr in lactotroph cells using a novel mouse line with loxP sites flanking the Prlr gene (Prlr(lox/lox)) and Cre-recombinase (Cre) expressed under the control of the pituitary-specific Prl promoter. Prlr(lox/lox)/Prl-Cre mice have normal PRL levels and did not develop any pituitary lactotroph adenoma, even at 20 mo of age. Nevertheless, Prlr(lox/lox)/Prl-Cre mice displayed an increased dopaminergic inhibitory tone compared with control Prlr(lox/lox) mice. These results elegantly confirm an autocrine/paracrine feedback of PRL on lactotroph cells in vivo, which can be fully compensated by an intact hypothalamic feedback system.Bernard, V., Lamothe, S., Beau, I., Guillou, A., Martin, A., Le Tissier, P., Grattan, D., Young, J., Binart, N. Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo.	[Bernard, Valerie; Lamothe, Sophie; Beau, Isabelle; Young, Jacques; Binart, Nadine] Univ Paris Saclay, Fac Med Paris Sud, U1185, INSERM, Le Kremlin Bicetre, France; [Guillou, Anne; Martin, Agnes] Inst Genom Fonct, CNRS, U1191, INSERM, Montpellier, France; [Le Tissier, Paul] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Grattan, David] Univ Otago, Dept Anat, Ctr Neuroendocrinol, Dunedin, New Zealand; [Young, Jacques] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Edinburgh; University of Otago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Binart, N (corresponding author), Univ Paris Sud, U1185, INSERM, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Binart, Nadine/F-2949-2013; Beau, Isabelle/M-4423-2017; Young, Jacques/N-5251-2019; Grattan, David/M-4307-2019; Young, Jacques/T-2976-2018	Binart, Nadine/0000-0002-5606-3866; Beau, Isabelle/0000-0002-3352-6813; Young, Jacques/0000-0001-9286-5631; Grattan, David/0000-0001-5606-2559; Young, Jacques/0000-0001-9286-5631; Martin, Agnes/0000-0001-6680-7139	Agence Nationale de la Recherche [12 BSV1 0032-01]; Health Research Council of New Zealand	Agence Nationale de la Recherche(French National Research Agency (ANR)); Health Research Council of New Zealand(Health Research Council of New Zealand)	The authors thank Dr. Gwennhael Autret [INSERM Unite Mixte de Recherche (UMR) 970, Paris-Centre de Recherche Cardiovasculaire-Hopital Europeen Georges-Pompidou (PARCC-HEGP), Paris, France, and Plateforme Imageries du Vivant, Universite Paris Descartes, Sorbonne Paris Cite, Paris, France] for MRI performance, Virginie Tolle and Axelle Simon (INSERM UMR 894, Paris, France) for help in immunofluorescence experiments, Valerie Nicolas [Institut Paris Saclay d'Innovation Therapeutique (IPSIT), Chatenay-Malabry, France] for assistance in confocal microscopic analysis, Francoise Magnin (Unite INSERM 1185, Le Kremlin-Bicetre, France) for help in genotyping, Nathalie Ba (Institut Biomedical de Recherche Unite Mixte de Service (UMS) 32, Le Kremlin-Bicetre, France) for assistance in pathologic proceedings and Chiara Villa (Service d'Anatomie et Cytologie Pathologiques, Hopital Foch, Suresnes France) for help in pathologic analysis. Funding was from Poste d'Accueil Inserm/Plan Cancer 2014-2019, and la Societe Francaise d'Endocrinologie et Diabetologie Pediatrique. This research was supported by grants from Agence Nationale de la Recherche (12 BSV1 0032-01) and a grant from the Health Research Council of New Zealand (D.G.). V.B. and S.L. are cofirst authors. The authors declare no conflicts of interest.	Asa SL, 1999, ENDOCRINOLOGY, V140, P5348, DOI 10.1210/en.140.11.5348; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; Bang Soyoung, 2016, Clin Exp Reprod Med, V43, P9, DOI 10.5653/cerm.2016.43.1.9; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Bernard V, 2016, NEUROENDOCRINOLOGY, V103, P738, DOI 10.1159/000442981; Bernard V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152872; Bernard V, 2015, NAT REV ENDOCRINOL, V11, P265, DOI 10.1038/nrendo.2015.36; Brown RSE, 2016, J NEUROSCI, V36, P9173, DOI 10.1523/JNEUROSCI.1471-16.2016; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Castrique E, 2010, J ENDOCRINOL, V205, P49, DOI 10.1677/JOE-09-0414; Chanson P, 2017, PITUITARY, 4TH EDITION, P467, DOI 10.1016/B978-0-12-804169-7.00016-7; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Ding KS, 2017, ENDOCRINOLOGY, V158, P1595, DOI 10.1210/en.2016-1903; Ferraris J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097383; Ferraris J, 2012, AM J PHYSIOL-ENDOC M, V302, pE356, DOI 10.1152/ajpendo.00333.2011; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Grattan DR, 2015, J ENDOCRINOL, V226, pT101, DOI 10.1530/JOE-15-0213; Grattan DR, 2001, ENDOCRINOLOGY, V142, P3935, DOI 10.1210/en.142.9.3935; Guillou A, 2015, ENDOCRINOLOGY, V156, P1924, DOI 10.1210/en.2014-1571; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Jin L, 1997, J CLIN ENDOCR METAB, V82, P963, DOI 10.1210/jc.82.3.963; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Le Tissier P, 2017, NAT REV ENDOCRINOL, V13, P257, DOI 10.1038/nrendo.2016.193; MohanKumar PS, 2001, J NEUROENDOCRINOL, V13, P261, DOI 10.1046/j.1365-2826.2001.00621.x; Molitch ME, 2017, JAMA-J AM MED ASSOC, V317, P516, DOI 10.1001/jama.2016.19699; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; Nevalainen MT, 1997, J CLIN INVEST, V99, P618, DOI 10.1172/JCI119204; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Sonigo C, 2012, J CLIN INVEST, V122, P3791, DOI 10.1172/JCI63937; Yip SH, 2012, J NEUROENDOCRINOL, V24, P1484, DOI 10.1111/j.1365-2826.2012.02357.x	32	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4791	4797		10.1096/fj.201701111RR	http://dx.doi.org/10.1096/fj.201701111RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29596024				2022-12-28	WOS:000443817700014
J	Wu, J; Tao, WW; Chong, DY; Lai, SS; Wang, C; Liu, Q; Zhang, TY; Xue, B; Li, CJ				Wu, Jing; Tao, Wei-Wei; Chong, Dan-Yang; Lai, Shan-Shan; Wang, Chuang; Liu, Qi; Zhang, Tong-Yu; Xue, Bin; Li, Chao-Jun			Early growth response-1 negative feedback regulates skeletal muscle postprandial insulin sensitivity via activating Ptp1b transcription	FASEB JOURNAL			English	Article						insulin signaling; EGR-1; skeletal muscle; PTP1B; postprandial	TYROSINE-PHOSPHATASE 1B; RECEPTOR NUMBER; GLUCOSE-HOMEOSTASIS; EXERCISE; PROTEIN; EGR-1; GENE; CELLS; MICE; RAT	Postprandial insulin desensitization plays a critical role in maintaining whole-body glucose homeostasis by avoiding the excessive absorption of blood glucose; however, the detailed mechanisms that underlie how the major player, skeletal muscle, desensitizes insulin action remain to be elucidated. Herein, we report that early growth response gene-1 (Egr-1) is activated by insulin in skeletal muscle and provides feedback inhibition that regulates insulin sensitivity after a meal. The inhibition of the transcriptional activity of Egr-1 enhanced the phosphorylation of the insulin receptor (InsR) and Akt, thus increasing glucose uptake in L6 myotubes after insulin stimulation, whereas overexpression of Egr-1 decreased insulin sensitivity. Furthermore, deletion of Egr-1 in the skeletal muscle improved systemic insulin sensitivity and glucose tolerance, which resulted in lower blood glucose levels after refeeding. Mechanistic analysis demonstrated that EGR-1 inhibited InsR phosphorylation and glucose uptake in skeletal muscle by binding to the proximal promoter region of protein tyrosine phosphatase-1B (PTP1B) and directly activating transcription. PTP1B knockdown largely restored insulin sensitivity and enhanced glucose uptake, even under conditions of EGR-1 overexpression. Our results indicate that EGR-1/PTP1B signaling negatively regulates postprandial insulin sensitivity and suggest a potential therapeutic target for the prevention and treatment of excessive glucose absorption.Wu, J., Tao, W.-W., Chong, D.-Y., Lai, S.-S., Wang, C., Liu, Q., Zhang, T.-Y., Xue, B., Li, C.-J. Early growth response-1 negative feedback regulates skeletal muscle postprandial insulin sensitivity via activating Ptp1b transcription.	[Wu, Jing; Wang, Chuang; Liu, Qi; Xue, Bin; Li, Chao-Jun] Nanjing Univ, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China; [Tao, Wei-Wei; Chong, Dan-Yang; Lai, Shan-Shan; Zhang, Tong-Yu; Xue, Bin; Li, Chao-Jun] Nanjing Univ, Model Anim Res Ctr, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Xue, B; Li, CJ (corresponding author), Nanjing Univ, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.; Xue, B; Li, CJ (corresponding author), Nanjing Univ, Model Anim Res Ctr, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	xuebin@nju.edu.cn; licj@nju.edu.cn	tao, wei/GXN-4445-2022	Li, Chaojun/0000-0001-9474-7321; Tao, Weiwei/0000-0003-2933-9262	Nature Science Foundation of China [530046]; Nanjing University Innovation and Creative Program for PhD Candidate [2016028]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing University Innovation and Creative Program for PhD Candidate	The authors thank Dr. Amira Klip (Hospital for Sick Children, Toronto, ON, Canada) for providing L6 cells overexpressing c-MYC-GLUT4. The authors also thank Dr. Chen Shuai (Model Animal Research Center) for providing technical help with glucose uptake. This work was supported by Nature Science Foundation of China (530046) and Nanjing University Innovation and Creative Program for PhD Candidate (2016028). The authors declare no conflicts of interest.	Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CRETTAZ M, 1984, DIABETES, V33, P477, DOI 10.2337/diabetes.33.5.477; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21; Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; HUANG RP, 1995, CANCER RES, V55, P5054; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; KAHN CR, 1978, ENDOCRINOLOGY, V103, P1054; Kahn R, 2001, DIABETES CARE, V24, P775; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; MUGGEO M, 1977, J CLIN ENDOCR METAB, V44, P1206, DOI 10.1210/jcem-44-6-1206; OSTEROP APRM, 1992, J BIOL CHEM, V267, P14647; Prato S. D., 2003, DIABETOLOGIA S41, V46, pM42; RICHTER EA, 1982, J CLIN INVEST, V69, P785, DOI 10.1172/JCI110517; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Shen N, 2015, AM J PATHOL, V185, P513, DOI 10.1016/j.ajpath.2014.10.016; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Shen N, 2011, AM J PATHOL, V178, P110, DOI 10.1016/j.ajpath.2010.11.016; Shin SY, 2013, BMB REP, V46, P92, DOI 10.5483/BMBRep.2013.46.2.202; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tao WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15212; TAOUIS M, 1994, J ENDOCRINOL, V140, P119, DOI 10.1677/joe.0.1400119; TELL GP, 1978, METABOLISM, V27, P1566, DOI 10.1016/S0026-0495(78)80029-8; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wojtaszewski JFP, 2000, DIABETES, V49, P325, DOI 10.2337/diabetes.49.3.325; Wojtaszewski JFP, 1997, DIABETES, V46, P1775, DOI 10.2337/diabetes.46.11.1775; Xie BX, 2016, DIABETES, V65, P3327, DOI 10.2337/db16-0416; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Yu X, 2011, EMBO J, V30, P3754, DOI 10.1038/emboj.2011.277	44	5	5	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4370	4379		10.1096/fj.201701340R	http://dx.doi.org/10.1096/fj.201701340R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29543533				2022-12-28	WOS:000439325400026
J	Zhao, LX; Ge, YH; Xiong, CH; Tang, L; Yan, YH; Law, PY; Qiu, Y; Chen, HZ				Zhao, Lan-Xue; Ge, Yan-Hui; Xiong, Cai-Hong; Tang, Ling; Yan, Ying-Hui; Law, Ping-Yee; Qiu, Yu; Chen, Hong-Zhuan			M1 muscarinic receptor facilitates cognitive function by interplay with AMPA receptor GluA1 subunit	FASEB JOURNAL			English	Article						learning and memory; GluA1 phosphorylation at Ser845; postsynaptic densities	LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTORS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; M-1 RECEPTORS; SK CHANNELS; MEMORY; PHOSPHORYLATION; HIPPOCAMPUS; ACTIVATION	M1 muscarinic acetylcholine receptors (M1 mAChRs) are the most abundant muscarinic receptors in the hippocampus and have been shown to have procognitive effects. AMPA receptors (AMPARs), an important subtype of ionotropic glutamate receptors, are key components in neurocognitive networks. However, the role of AMPARs in procognitive effects of M1 mAChRs and how M1 mAChRs affect the function of AMPARs remain poorly understood. Here, we found that basal expression of GluA1, a subunit of AMPARs, and its phosphorylation at Ser845 were maintained by M1 mAChR activity. Activation of M1 mAChRs promoted membrane insertion of GluA1, especially to postsynaptic densities. Impairment of hippocampus-dependent learning and memory by antagonism of M1 mAChRs paralleled the reduction of GluA1 expression, and improvement of learning and memory by activation of M1 mAChRs was accompanied by the synaptic insertion of GluA1 and its increased phosphorylation at Ser845. Furthermore, abrogation of phosphorylation of Ser845 residue of GluA1 ablated M1 mAChR-mediated improvement of learning and memory. Taken together, these results show a functional correlation of M1 mAChRs and GluA1 and the essential role of GluA1 in M1 mAChR-mediated cognitive improvement.Zhao, L.-X., Ge, Y.-H., Xiong, C.-H., Tang, L., Yan, Y.-H., Law, P.-Y., Qiu, Y., Chen, H.-Z. M1 muscarinic receptor facilitates cognitive function by interplay with AMPA receptor GluA1 subunit.	[Zhao, Lan-Xue; Ge, Yan-Hui; Xiong, Cai-Hong; Tang, Ling; Yan, Ying-Hui; Qiu, Yu; Chen, Hong-Zhuan] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA	Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities	Qiu, Y; Chen, HZ (corresponding author), Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	qiuy@shsmu.edu.cn; yaoli@shsmu.edu.cn			National Natural Science Foundation of China [81473217, 81573415]; International Science and Technology Cooperation Program of China [2011DFA33180]; General Financial Grant from the China Postdoctoral Science Foundation [2016M601619]; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine [BXJ201403]; Shanghai Jiao Tong University Medical-Science Cross Fund [YG2017ZD14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China; General Financial Grant from the China Postdoctoral Science Foundation; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University Medical-Science Cross Fund	The authors thank Dr. Dezhi Liao (University of Minnesota) for technical help. This work was supported by the National Natural Science Foundation of China (81473217, 81573415), International Science and Technology Cooperation Program of China (2011DFA33180), General Financial Grant from the China Postdoctoral Science Foundation (2016M601619), Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ201403), and Shanghai Jiao Tong University Medical-Science Cross Fund (YG2017ZD14). The authors declare no conflicts of interest.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Aronica E, 1998, NEUROSCIENCE, V82, P979; Ballinger EC, 2016, NEURON, V91, P1199, DOI 10.1016/j.neuron.2016.09.006; Bradley SJ, 2017, J CLIN INVEST, V127, P487, DOI 10.1172/JCI87526; Bradley SR, 2010, NEUROPHARMACOLOGY, V58, P365, DOI 10.1016/j.neuropharm.2009.10.003; Bubser M., 2012, HDB EXP PHARM, V208, P121; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carruthers SP, 2015, NEUROSCI BIOBEHAV R, V55, P393, DOI 10.1016/j.neubiorev.2015.05.011; Caulfield MP, 1998, PHARMACOL REV, V50, P279; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Crombag HS, 2008, EUR J NEUROSCI, V27, P3284, DOI 10.1111/j.1460-9568.2008.06299.x; Crook JM, 2000, BIOL PSYCHIAT, V48, P381, DOI 10.1016/S0006-3223(00)00918-5; Davis AA, 2010, J NEUROSCI, V30, P4190, DOI 10.1523/JNEUROSCI.6393-09.2010; Dennis SH, 2016, CEREB CORTEX, V26, P414, DOI 10.1093/cercor/bhv227; Dickinson BA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-18; Douchamps V, 2017, BEHAV PHARMACOL, V28, P112, DOI 10.1097/FBP.0000000000000300; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Hagena H, 2016, CEREB CORTEX, V26, P1349, DOI 10.1093/cercor/bhv330; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Jo J, 2010, NAT NEUROSCI, V13, P1216, DOI 10.1038/nn.2636; Kam AYF, 2010, J NEUROSCI, V30, P15304, DOI 10.1523/JNEUROSCI.4255-10.2010; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kibaly C, 2016, BIOL PSYCHIAT, V79, P906, DOI 10.1016/j.biopsych.2015.04.019; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Maltese M, 2014, MOVEMENT DISORD, V29, P1655, DOI 10.1002/mds.26009; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Nathan PJ, 2013, INT J NEUROPSYCHOPH, V16, P721, DOI 10.1017/S1461145712000752; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Partin KM, 2015, CURR OPIN PHARMACOL, V20, P46, DOI 10.1016/j.coph.2014.11.002; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Potter PE, 2011, ACTA NEUROPATHOL, V122, P49, DOI 10.1007/s00401-011-0831-1; Puri V, 2015, BEHAV BRAIN RES, V287, P96, DOI 10.1016/j.bbr.2015.03.029; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sarter M, 2014, EUR J NEUROSCI, V39, P1912, DOI 10.1111/ejn.12515; Sheffler DJ, 2009, MOL PHARMACOL, V76, P356, DOI 10.1124/mol.109.056531; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Spires TL, 2004, REV NEUROSCIENCE, V15, P267, DOI 10.1515/REVNEURO.2004.15.4.267; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wakabayashi K, 1999, NEUROBIOL AGING, V20, P287, DOI 10.1016/S0197-4580(99)00035-4; Watt ML, 2011, J PHARMACOL EXP THER, V338, P622, DOI 10.1124/jpet.111.182063; Williams MR, 2013, EUR ARCH PSY CLIN N, V263, P485, DOI 10.1007/s00406-012-0387-7	55	14	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4247	4257		10.1096/fj.201800029R	http://dx.doi.org/10.1096/fj.201800029R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509512				2022-12-28	WOS:000439325400016
J	Korovina, I; Neuwirth, A; Sprott, D; Weber, S; Pasha, SPBS; Gercken, B; Breier, G; El-Armouche, A; Deussen, A; Karl, MO; Wielockx, B; Chavakis, T; Klotzsche-von Ameln, A				Korovina, Irina; Neuwirth, Ales; Sprott, David; Weber, Silvio; Pasha, Sheik Pran Babu Sardar; Gercken, Bettina; Breier, Georg; El-Armouche, Ali; Deussen, Andreas; Karl, Mike O.; Wielockx, Ben; Chavakis, Triantafyllos; Klotzsche-von Ameln, Anne			Hematopoietic hypoxia-inducible factor 2 deficiency ameliorates pathological retinal neovascularization via modulation of endothelial cell apoptosis	FASEB JOURNAL			English	Article						microglia; retinopathy; angiogenesis; FasL; Adam17	OXYGEN-INDUCED RETINOPATHY; FAS LIGAND; INFLAMMATION; MICROGLIA; ANGIOGENESIS; PATHOGENESIS; ACTIVATION; INHIBITION; CLEAVAGE; ADAM17	A hallmark of proliferative retinopathies, such as retinopathy of prematurity (ROP), is a pathological neovascularization orchestrated by hypoxia and the resulting hypoxia-inducible factor (HIF)-dependent response. We studied the role of Hif2 in hematopoietic cells for pathological retina neovascularization in the murine model of ROP, the oxygen-induced retinopathy (OIR) model. Hematopoietic-specific deficiency of Hif2 ameliorated pathological neovascularization in the OIR model, which was accompanied by enhanced endothelial cell apoptosis. That latter finding was associated with up-regulation of the apoptosis-inducer FasL in Hif2-deficient microglia. Consistently, pharmacological inhibition of the FasL reversed the reduced pathological neovascularization from hematopoietic-specific Hif2 deficiency. Our study found that the hematopoietic cell Hif2 contributes to pathological retina angiogenesis. Our findings not only provide novel insights regarding the complex interplay between immune cells and endothelial cells in hypoxia-driven retina neovascularization but also may have therapeutic implications for proliferative retinopathies.Korovina, I., Neuwirth, A., Sprott, D., Weber, S., Sardar Pasha, S. P. B., Gercken, B., Breier, G., El-Armouche, A., Deussen, A., Karl, M. O., Wielockx, B., Chavakis, T., Klotzsche-von Ameln, A. Hematopoietic hypoxia-inducible factor 2 deficiency ameliorates pathological retinal neovascularization via modulation of endothelial cell apoptosis.	[Korovina, Irina; Neuwirth, Ales; Sprott, David; Gercken, Bettina; Wielockx, Ben; Chavakis, Triantafyllos; Klotzsche-von Ameln, Anne] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Dresden, Germany; [Weber, Silvio; El-Armouche, Ali] Tech Univ Dresden, Inst Pharmacol & Toxicol, Fac Med, Dresden, Germany; [Pasha, Sheik Pran Babu Sardar; Karl, Mike O.; Wielockx, Ben] Tech Univ Dresden, DFG, Ctr Regenerat Therapies, CMCB, Dresden, Germany; [Breier, Georg] Tech Univ Dresden, Med Biol, Dept Psychiat, Fac Med, Dresden, Germany; [Deussen, Andreas; Klotzsche-von Ameln, Anne] Tech Univ Dresden, Inst Physiol, Fac Med, Dresden, Germany; [Karl, Mike O.] German Ctr Neurodegenerat Dis DZNE Dresden, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; German Research Foundation (DFG); Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Klotzsche-von Ameln, A (corresponding author), Tech Univ Dresden, Inst Physiol, Fetscherstr 74, D-01307 Dresden, Germany.	anne.klotzsche-von_ameln@tu-dresden.de	Pasha, Pran Babu Sardar/AAH-8388-2019; Chavakis, Triantafyllos/ABE-8845-2020; Wielockx, Ben/AAC-6854-2020; PASHA, PRAN BABU SARDAR/AAS-7266-2020; Karl, Mike O./E-7246-2010	Wielockx, Ben/0000-0002-4923-2596; PASHA, PRAN BABU SARDAR/0000-0001-8974-7562; Karl, Mike O./0000-0002-0926-6556	Medical Theoretical Center (MTZ) Imaging Facility of the Technische Universitat Dresden; European Research Council (ENDHOMRET) Grant [281296]; Excellence Initiative from the German Federal and State Governments of Technische Universitat Dresden	Medical Theoretical Center (MTZ) Imaging Facility of the Technische Universitat Dresden; European Research Council (ENDHOMRET) Grant; Excellence Initiative from the German Federal and State Governments of Technische Universitat Dresden	The authors thank Sylvia Grossklaus, Janine Gebler, Christine Mund, Bianca Muller, and Carmen Friebel (Technische Universitat Dresden) for technical assistance and the Medical Theoretical Center (MTZ) Imaging Facility of the Technische Universitat Dresden for their support. The authors thank Dr. Matina Economopoulou (Technische Universitat Dresden) for helpful discussions. This work was supported by the European Research Council (ENDHOMRET) Grant 281296, and by "Support-the Best" funding from the Excellence Initiative from the German Federal and State Governments of Technische Universitat Dresden. The authors declare no conflicts of interest.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Alexaki VI, 2018, MOL PSYCHIATR, V23, P1410, DOI 10.1038/mp.2017.167; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Barreiro R, 2003, INVEST OPHTH VIS SCI, V44, P1282, DOI 10.1167/iovs.02-0478; Barsoum IB, 2011, CANCER RES, V71, P7433, DOI 10.1158/0008-5472.CAN-11-2104; Caprara C, 2012, PROG RETIN EYE RES, V31, P89, DOI 10.1016/j.preteyeres.2011.11.003; Charbonneau M, 2007, J BIOL CHEM, V282, P33714, DOI 10.1074/jbc.M704041200; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Davies MH, 2003, INVEST OPHTH VIS SCI, V44, P3202, DOI 10.1167/iovs.03-0050; Davies M, 2006, MOL VIS, V12, P467; Dejda A, 2014, J CLIN INVEST, V124, P4807, DOI 10.1172/JCI76492; Ebsen H, 2015, MOL IMMUNOL, V65, P416, DOI 10.1016/j.molimm.2015.02.008; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; Economopoulou M, 2015, THROMB HAEMOSTASIS, V114, P1241, DOI 10.1160/TH15-01-0051; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fischer F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-120; Fleck D, 2013, J NEUROSCI, V33, P7856, DOI 10.1523/JNEUROSCI.3372-12.2013; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hewing NJ, 2013, INVEST OPHTH VIS SCI, V54, P864, DOI 10.1167/iovs.12-10954; Horton SM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00365; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kaplan HJ, 1999, NAT MED, V5, P292, DOI 10.1038/6509; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Klotzsche-von Ameln A, 2017, THROMB HAEMOSTASIS, V117, P1150, DOI 10.1160/TH16-05-0354; Klotzsche-von Ameln A, 2013, MOL CANCER RES, V11, P1337, DOI 10.1158/1541-7786.MCR-13-0201; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Linkermann A, 2005, EXPERT OPIN THER TAR, V9, P119, DOI 10.1517/14728222.9.1.119; Liyanage SE, 2016, ARTERIOSCL THROM VAS, V36, P19, DOI 10.1161/ATVBAHA.115.306681; Matsuno H, 2001, J RHEUMATOL, V28, P22; Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571; Mitsiades N, 2001, CANCER RES, V61, P577; Mogi M, 2001, LAB INVEST, V81, P177, DOI 10.1038/labinvest.3780225; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Moussaud S, 2010, J NEUROSCI METH, V187, P243, DOI 10.1016/j.jneumeth.2010.01.017; Nagamine Y, 2016, AM J RESP CELL MOL, V55, P878, DOI 10.1165/rcmb.2015-0266OC; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Roychoudhury J, 2010, INVEST OPHTH VIS SCI, V51, P3560, DOI 10.1167/iovs.09-3890; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Semkova I, 2006, FASEB J, V20, P1689, DOI 10.1096/fj.05-5653fje; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Voss Matthias, 2008, Cell Commun Signal, V6, P11, DOI 10.1186/1478-811X-6-11; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Wigginton JM, 2001, J CLIN INVEST, V108, P51; Wong K, 2017, NAT IMMUNOL, V18, P633, DOI 10.1038/ni.3743; Zhao H, 2013, INVEST OPHTH VIS SCI, V54, P5321, DOI 10.1167/iovs.13-12122; Zheng XG, 2007, CANCER SCI, V98, P674, DOI 10.1111/j.1349-7006.2007.00440.x	68	11	10	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1758	1770		10.1096/fj.201800430R	http://dx.doi.org/10.1096/fj.201800430R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30156910				2022-12-28	WOS:000457296600020
J	Al-Obaidi, N; Mohan, S; Liang, ST; Zhao, ZZ; Nayak, BK; Li, BJ; Sriramarao, P; Habib, SL				Al-Obaidi, Noor; Mohan, Sumathy; Liang, Sitai; Zhao, Zhenze; Nayak, Bijaya K.; Li, Boajie; Sriramarao, P.; Habib, Samy L.			Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes	FASEB JOURNAL			English	Article						renal fibrosis; IDDM; NIDDM; Gal-1	TUBULAR EPITHELIAL-CELLS; OXIDATIVE DNA-DAMAGE; BINDING PROTEIN; MATRIX PROTEIN; MECHANISM; GLUCOSE; FIBRONECTIN	Chronic exposure of tubular renal cells to high glucose contributes to tubulointerstitial changes in diabetic nephropathy. In the present study, we identified a new fibrosis gene called galectin-1 (Gal-1), which is highly expressed in tubular cells of kidneys of type 1 and type 2 diabetic mouse models. Gal-1 protein and mRNA expression showed significant increase in kidney cortex of heterozygous Akita(+/-) and db/db mice compared with wild-type mice. Mouse proximal tubular cells exposed to high glucose showed significant increase in phosphorylation of Akt and Gal-1. We cloned Gal-1 promoter and identified the transcription factor AP4 as binding to the Gal-1 promoter to up-regulate its function. Transfection of cells with plasmid carrying mutations in the binding sites of AP4 to Gal-1 promoter resulted in decreased protein function of Gal-1. In addition, inhibition of Gal-1 by OTX-008 showed significant decrease in p-Akt/AP4 and protein-promoter activity of Gal-1 and fibronectin. Moreover, down-regulation of AP4 by small interfering RNA resulted in a significant decrease in protein expression and promoter activity of Gal-1. We found that kidney of Gal-1(-/-) mice express very low levels of fibronectin protein. In summary, Gal-1 is highly expressed in kidneys of type 1 and 2 diabetic mice, and AP4 is a major transcription factor that activates Gal-1 under hyperglycemia. Inhibition of Gal-1 by OTX-008 blocks activation of Akt and prevents accumulation of Gal-1, suggesting a novel role of Gal-1 inhibitor as a possible therapeutic target to treat renal fibrosis in diabetes.Al-Obaidi, N., Mohan, S., Liang, S., Zhao, Z., Nayak, B. K., Li, B., Sriramarao, P., Habib, S. L. Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.	[Al-Obaidi, Noor; Liang, Sitai; Zhao, Zhenze; Nayak, Bijaya K.; Habib, Samy L.] Univ Texas Hlth, Dept Cell Syst & Anat, San Antonio, TX USA; [Mohan, Sumathy] Univ Texas Hlth, Dept Pathol, San Antonio, TX USA; [Li, Boajie] Shanghai Jiao Tong Univ, Bio X Inst, Shanghai, Peoples R China; [Sriramarao, P.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Habib, Samy L.] Vet Healthcare Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center	Habib, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	habib@uthscsa.edu	Zhao, Zhenze/AAW-5870-2020	Rao, Srirama/0000-0001-9082-1029	American Heart Association; South Texas Veterans Healthcare System; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [5RO1 DK096119]	American Heart Association(American Heart Association); South Texas Veterans Healthcare System; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the American Heart Association, a Merit Review Award from the South Texas Veterans Healthcare System (to S.L.H.), and a U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant 5RO1 DK096119 (to S.M.). The authors declare no conflicts of interest.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Fioretto P, 2006, J AM SOC NEPHROL, V17, pS86, DOI 10.1681/ASN.2005121343; Fryk E, 2016, METABOLISM, V65, P998, DOI 10.1016/j.metabol.2016.04.003; Ge XN, 2016, P NATL ACAD SCI USA, V113, pE4837, DOI 10.1073/pnas.1601958113; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Habib SL, 2008, AM J PHYSIOL-RENAL, V294, pF281, DOI 10.1152/ajprenal.00370.2007; Habib SL, 2016, CELL CYCLE, V15, P3048, DOI 10.1080/15384101.2016.1231259; Habib SL, 2015, CELL CYCLE, V14, P2598, DOI 10.1080/15384101.2015.1064204; Habib SL, 2014, ONCOTARGET, V5, P2542, DOI 10.18632/oncotarget.1833; Habib SL, 2013, J NEPHROL, V26, P865, DOI 10.5301/jn.5000287; Habib SL, 2012, J AM SOC NEPHROL, V23, P1652, DOI 10.1681/ASN.2012030285; Habib SL, 2010, EUR J CANCER, V46, P2806, DOI 10.1016/j.ejca.2010.06.117; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; Lim MJ, 2014, EXP CELL RES, V326, P125, DOI 10.1016/j.yexcr.2014.06.001; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2015, CELL BIOL INT, V39, P217, DOI 10.1002/cbin.10363; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Martinez-Martinez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166272; Morrisey K, 1999, KIDNEY INT, V55, P160, DOI 10.1046/j.1523-1755.1999.00248.x; Okamura DM, 2011, AM J PHYSIOL-RENAL, V300, pF245, DOI 10.1152/ajprenal.00326.2010; Okano K, 2010, EXP CELL RES, V316, P3282, DOI 10.1016/j.yexcr.2010.08.015; Pattabiraman DR, 2016, COLD SH Q B, V81, P11, DOI 10.1101/sqb.2016.81.030957; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Rao SP, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00068; Rebholz CM, 2018, KIDNEY INT, V93, P252, DOI 10.1016/j.kint.2017.06.028; Simone S, 2008, DIABETES, V57, P2626, DOI 10.2337/db07-1579; Tan KCB, 2018, DIABETOLOGIA, V61, P1212, DOI 10.1007/s00125-018-4552-z; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; WELLS V, 1991, CELL, V64, P91, DOI 10.1016/0092-8674(91)90211-G; ZIYADEH FN, 1990, AM J PHYSIOL, V259, pF704, DOI 10.1152/ajprenal.1990.259.4.F704	37	24	24	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					373	387		10.1096/fj.201800555RR	http://dx.doi.org/10.1096/fj.201800555RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29975570	Green Published			2022-12-28	WOS:000457401500030
J	Chang, JM; Bhasin, SS; Bielenberg, DR; Sukhatme, VP; Bhasin, M; Huang, S; Kieran, MW; Panigrahy, D				Chang, Jaimie; Bhasin, Swati S.; Bielenberg, Diane R.; Sukhatme, Vikas P.; Bhasin, Manoj; Huang, Sui; Kieran, Mark W.; Panigrahy, Dipak			Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin	FASEB JOURNAL			English	Article						cancer; macrophage; angiogenesis	APOPTOTIC CELLS; CANCER-CELLS; CASPASE 3; MACROPHAGES; METASTASIS; EXPRESSION; PROMOTES; PROLIFERATION; MICROENVIRONMENT; TUMORIGENICITY	Colon cancer recurrence after therapy, such as 5-fluorouracil (5-FU), remains a challenge in the clinical setting. Chemotherapy reduces tumor burden by inducing cell death; however, the resulting dead tumor cells, or debris, may paradoxically stimulate angiogenesis, inflammation, and tumor growth. Here, we demonstrate that 5-FU-generated colon carcinoma debris stimulates the growth of a subthreshold inoculum of living tumor cells in subcutaneous and orthotopic models. Debris triggered the release of osteopontin (OPN) by tumor cells and host macrophages. Both coinjection of debris and systemic treatment with 5-FU increased plasma OPN levels in tumor-bearing mice. RNA expression levels of secreted phosphoprotein 1, the gene that encodes OPN, correlate with poor prognosis in patients with colorectal cancer and are elevated in chemotherapy-treated patients who experience tumor recurrence vs. no recurrence. Pharmacologic and genetic ablation of OPN inhibited debris-stimulated tumor growth. Systemic treatment with a combination of a neutralizing OPN antibody and 5-FU dramatically inhibited tumor growth. These results demonstrate a novel mechanism of tumor progression mediated by OPN released in response to chemotherapy-generated tumor cell debris. Neutralization of debris-stimulated OPN represents a potential therapeutic strategy to overcome the inherent limitation of cytotoxic therapies as a result of the generation of cell debris.Chang, J., Bhasin, S. S., Bielenberg, D. R., Sukhatme, V. P., Bhasin, M., Huang, S., Kieran, M. W., Panigrahy, D. Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin.	[Chang, Jaimie; Panigrahy, Dipak] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA USA; [Chang, Jaimie; Panigrahy, Dipak] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA; [Chang, Jaimie; Sukhatme, Vikas P.; Panigrahy, Dipak] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA USA; [Bhasin, Swati S.; Bhasin, Manoj] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Interdisciplinary Med & Biol, Boston, MA USA; [Sukhatme, Vikas P.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; [Bielenberg, Diane R.] Harvard Med Sch, Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Kieran, Mark W.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat Hematol Oncol, Boston, MA USA; [Bielenberg, Diane R.] Harvard Med Sch, Dept Surg, Boston, MA USA; [Huang, Sui] Inst Syst Biol, Seattle, WA USA; [Kieran, Mark W.] Harvard Med Sch, Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Institute for Systems Biology (ISB); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chang, JM; Panigrahy, D (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, 99 Brookline Ave, Boston, MA 02115 USA.	jchang10@rush.edu; dpanigra@bidmc.harvard.edu	Sukhatme, Vikas/W-2776-2019	Bhasin, Swati/0000-0001-8661-1459	U.S. National Institutes of Health, National Cancer Institute [R01-01CA170549-02, R01-CA148633-01A4]; Stop and Shop Pediatric Brain Tumor Fund; C. J. Buckley Pediatric Brain Tumor Fund; Alex Lemonade Stand; Molly's Magic Wand for Pediatric Brain Tumors; Markoff Foundation Art-In-Giving Foundation; Kamen Foundation; Jared Branfman Sunflowers for Life; Joe Andruzzi Foundation; Credit Unions Kids at Heart Team	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stop and Shop Pediatric Brain Tumor Fund; C. J. Buckley Pediatric Brain Tumor Fund; Alex Lemonade Stand; Molly's Magic Wand for Pediatric Brain Tumors; Markoff Foundation Art-In-Giving Foundation; Kamen Foundation; Jared Branfman Sunflowers for Life; Joe Andruzzi Foundation; Credit Unions Kids at Heart Team	The authors thank Steve Moskowitz (Advanced Medical Graphics, Boston, MA, USA) for preparation of the figures; Dr. David Zurakowski (Boston Children's Hospital, Boston, MA, USA) for guidance in statistical analyses; Ricasan Rowley Histology Consultants (Cambridge, MA, USA) for tissue sectioning services; and Drs. Allison Gartung (Beth Israel Deaconess Medical Center, Boston, MA, USA), Bruce Hammock (University of California Davis, Davis, CA, USA), Bruce Zetter, and Randy Watnick (both from Boston Children's Hospital, Boston, MA, USA) for their advice and discussion. This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants R01-01CA170549-02 (to D.P.) and R01-CA148633-01A4 (to D.P.), the Stop and Shop Pediatric Brain Tumor Fund (to M.W.K.), the C. J. Buckley Pediatric Brain Tumor Fund (to M.W.K.), the Alex Lemonade Stand (to M.W.K.), Molly's Magic Wand for Pediatric Brain Tumors (to M.W.K.), the Markoff Foundation Art-In-Giving Foundation (to M.W.K.), the Kamen Foundation (to M.W.K.), Jared Branfman Sunflowers for Life (to M.W.K.), the Joe Andruzzi Foundation (to M.W.K.), and the Credit Unions Kids at Heart Team (to M.W.K.). D.P. has served as an unpaid scientific advisor for Tempest Therapeutics (formerly known as Inception 2, Inc.; San Francisco, CA, USA) since 2011, and owned stock options in the company from 2011 until August 8, 2018. The other authors declare no conflicts of interest.	Abubaker K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-24; Albertsson P, 2009, ACTA ONCOL, V48, P418, DOI 10.1080/02841860802409512; Alcaide J, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-24; Bandopadhyay M, 2014, EXPERT OPIN THER TAR, V18, P883, DOI 10.1517/14728222.2014.925447; Cao K, 2018, INT REV CEL MOL BIO, V337, P135, DOI 10.1016/bs.ircmb.2017.12.003; Cao L, 2015, ONCOTARGET, V6, P6627, DOI 10.18632/oncotarget.3113; Chang YS, 2017, P NATL ACAD SCI USA, V114, pE7159, DOI 10.1073/pnas.1700455114; Chaurio R, 2013, AUTOIMMUNITY, V46, P317, DOI 10.3109/08916934.2012.754433; Correa M, 2005, INT J CANCER, V114, P356, DOI 10.1002/ijc.20673; da Silva IA, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2016.90; Daenen LGM, 2011, CANCER RES, V71, P6976, DOI 10.1158/0008-5472.CAN-11-0627; de Jong JS, 2000, BRIT J CANCER, V82, P368; de Ruiter J, 1979, Eur J Cancer, V15, P1139, DOI 10.1016/0014-2964(79)90130-0; Feng X, 2017, CANCER LETT, V385, P12, DOI 10.1016/j.canlet.2016.10.042; Feng X, 2015, ONCOTARGET, V6, P32353, DOI 10.18632/oncotarget.5898; Flanagan L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.7; Ford CA, 2015, CURR BIOL, V25, P577, DOI 10.1016/j.cub.2014.12.059; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Gunjal PM, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0141-7; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Himuro T, 2016, ANN SURG ONCOL, V23, P2235, DOI 10.1245/s10434-016-5164-9; Hsu HP, 2010, CANCER BIOL THER, V10, P144, DOI 10.4161/cbt.10.2.12160; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58; Imano M, 2011, AM SURGEON, V77, P1515; Imano M, 2010, WORLD J SURG, V34, P1930, DOI 10.1007/s00268-010-0582-5; Jalalinadoushan Mohammadreza, 2004, Urol J, V1, P177; Kale S, 2014, ONCOGENE, V33, P2295, DOI 10.1038/onc.2013.184; Karagiannis GS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0026; Kindy MS, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0757-9; Korbelik M, 2007, BRIT J CANCER, V97, P1381, DOI 10.1038/sj.bjc.6604059; LEOPOLD WR, 1981, CANCER RES, V41, P4368; Lin CN, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1114-3; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin HH, 2017, ONCOTARGET, V8, P13805, DOI 10.18632/oncotarget.14638; Liu J, 2014, INT J ONCOL, V45, P282, DOI 10.3892/ijo.2014.2393; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; MURRY CE, 1994, AM J PATHOL, V145, P1450; Naresh KN, 2001, CANCER, V91, P578, DOI 10.1002/1097-0142(20010201)91:3<578::AID-CNCR1037>3.3.CO;2-N; O'Connell MJ, 2008, J CLIN ONCOL, V26, P2336, DOI 10.1200/JCO.2007.15.8261; ORMEROD EJ, 1986, CANCER RES, V46, P884; ORR FW, 1986, CANCER RES, V46, P891; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Pisco AO, 2015, BRIT J CANCER, V112, P1725, DOI 10.1038/bjc.2015.146; Ramchandani D, 2015, BBA-REV CANCER, V1855, P202, DOI 10.1016/j.bbcan.2015.02.003; Rao GH, 2013, CLIN CANCER RES, V19, P785, DOI 10.1158/1078-0432.CCR-12-2788; REVESZ L, 1956, NATURE, V178, P1391, DOI 10.1038/1781391a0; Rittling SR, 1998, BIOCHEM BIOPH RES CO, V250, P287, DOI 10.1006/bbrc.1998.9306; Roca H, 2018, J CLIN INVEST, V128, P248, DOI 10.1172/JCI92466; Sahu RP, 2014, CANCER RES, V74, P7069, DOI 10.1158/0008-5472.CAN-14-2043; Shan CC, 2015, ONCOL LETT, V9, P1549, DOI 10.3892/ol.2015.2977; Sharp JA, 1999, LAB INVEST, V79, P869; Sinicrope FA, 1996, CLIN CANCER RES, V2, P1999; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Sun BC, 2006, EUR J CANCER PREV, V15, P258, DOI 10.1097/01.cej.0000198896.02185.68; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Weigert A, 2016, ADV EXP MED BIOL, V930, P205, DOI 10.1007/978-3-319-39406-0_9; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xu ST, 2015, MOL MED REP, V11, P3701, DOI 10.3892/mmr.2015.3202; Yang L, 2012, MOL MED REP, V5, P373, DOI 10.3892/mmr.2011.679; Zhang H, 2014, CELL PHYSIOL BIOCHEM, V33, P991, DOI 10.1159/000358670	66	23	23	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					114	125		10.1096/fj.201800019RR	http://dx.doi.org/10.1096/fj.201800019RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957058	Green Published, hybrid			2022-12-28	WOS:000457401500009
J	Adak, M; Das, D; Niyogi, S; Nagalakshmi, C; Ray, D; Chakrabarti, P				Adak, Moumita; Das, Debajyoti; Niyogi, Sougata; Nagalakshmi, Challa; Ray, Dipika; Chakrabarti, Partha			Inflammasome activation in Kupffer cells confers a protective response in nonalcoholic steatohepatitis through pigment epithelium-derived factor expression	FASEB JOURNAL			English	Article						apoptosis; IL-1; NASH; TNF-; liver	NF-KAPPA-B; HEPATOCYTE APOPTOSIS; FACTOR PEDF; LIVER INFLAMMATION; TNF-ALPHA; INSULIN-RESISTANCE; HEPATIC STEATOSIS; GENE-EXPRESSION; FIBROSIS; MACROPHAGES	Hepatocellular death or ballooning distinguishes the transition of simple steatosis to irreversible nonalcoholic steatohepatitis (NASH). However, the molecular mechanism of hepatocellular apoptosis in NASH is largely unclear, and discovery of endogenous mediators that could prevent or inhibit cell death is thereby critical in intercepting NASH progression. Here, we identified pigment epithelium-derived factor (PEDF), a secreted, moonlighting hepatokine as 1 hepatoprotective agent in mice with diet-induced NASH. Hepatic PEDF expression is induced by IL-1, which is derived from inflammasome activation in liver-resident Kupffer cells, an effect that is negatively regulated by TNF- and predominantly secreted by monocyte-derived, recruited, hepatic macrophages. Mechanistically, reciprocal and opposing roles for IL-1 and TNF- in PEDF expression are mediated by differential activation of NF-B. Although augmented TNF- production leads to temporal reduction of PEDF expression in NASH, PEDF conversely abrogates TNF--mediated hepatocyte death by modulating the extrinsic apoptosis pathway. Thus, our study highlights PEDF as a functionally important hepatokine in NASH progression by linking inflammasome activation and hepatocellular death.Adak, M., Das, D., Niyogi, S., Nagalakshmi, C., Ray, D., Chakrabarti, P. Inflammasome activation in Kupffer cells confers a protective response in nonalcoholic steatohepatitis through pigment epithelium-derived factor expression.	[Adak, Moumita; Das, Debajyoti; Niyogi, Sougata; Ray, Dipika; Chakrabarti, Partha] Indian Inst Chem Biol, CSIR, Div Cell Biol & Physiol, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Nagalakshmi, Challa] Natl Inst Pharmaceut Educ & Res, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); National Institute of Pharmaceutical Education & Research (NIPER)	Chakrabarti, P (corresponding author), Indian Inst Chem Biol, CSIR, Div Cell Biol & Physiol, 4 Raja SC Mullick Rd, Kolkata 700032, India.	pchakrabarti@iicb.res.in		, NIPERKolkata/0000-0003-4906-3988	Indian Council of Medical Research (ICMR) [5/4/5-9/Diab.-16-NCD-II]; Council of Scientific and Industrial Research (CSIR) [BSC 0206]; Indian University Grants Commission (UGC); Department of Science and Technology-Innovation in Science Pursuit for Inspired Research (DST-INSPIRE)	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian University Grants Commission (UGC); Department of Science and Technology-Innovation in Science Pursuit for Inspired Research (DST-INSPIRE)	The authors thank Debrup Sen (Vidyasagar College, Kolkata, India) and Binayak Pal (Council of Scientific and Industrial Research, Indian Institute of Chemical Biology) for help with flow cytometry and confocal microscopy experiments, respectively. This work was supported by grants to P.C. by the Indian Council of Medical Research (ICMR); 5/4/5-9/Diab.-16-NCD-II), and the Council of Scientific and Industrial Research (CSIR; BSC 0206). M.A. and D.D. received research fellowships from the Indian University Grants Commission (UGC). S.N. received research fellowships from the Department of Science and Technology-Innovation in Science Pursuit for Inspired Research (DST-INSPIRE). P.C. is the guarantor of this work, has full access to all the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors declare no conflicts of interest.	Albiero M, 2015, DIABETES, V64, P2957, DOI 10.2337/db14-1473; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005; Carlos AR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3697; Chen Z, 2012, DIABETES, V61, P566, DOI 10.2337/db11-0474; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Duarte N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/984578; Enomoto N, 1999, HEPATOLOGY, V29, P1680, DOI 10.1002/hep.510290633; Famulla S, 2011, INT J OBESITY, V35, P762, DOI 10.1038/ijo.2010.212; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gao X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05637; Ghosh M, 2016, DIABETES, V65, P3561, DOI 10.2337/db16-0506; GREEN DR, 2015, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A006080; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Hatting M, 2013, HEPATOLOGY, V57, P2189, DOI 10.1002/hep.26271; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Ho TC, 2010, AM J PATHOL, V177, P1798, DOI 10.2353/ajpath.2010.091085; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Ishibashi Y, 2013, MICROVASC RES, V85, P54, DOI 10.1016/j.mvr.2012.10.007; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; KAMIMURA S, 1995, HEPATOLOGY, V22, P1304, DOI 10.1002/hep.1840220441; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; LEIST M, 1994, J IMMUNOL, V153, P1778; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Mejias M, 2015, GUT, V64, P657, DOI 10.1136/gutjnl-2014-307138; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moreno-Navarrete JM, 2013, INT J OBESITY, V37, P1230, DOI 10.1038/ijo.2012.223; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022; Osuka A, 2012, SHOCK, V37, P47, DOI 10.1097/SHK.0b013e318234f7ff; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Szabo G, 2015, CLIN RES HEPATOL GAS, V39, pS18, DOI 10.1016/j.clinre.2015.06.012; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Tian SW, 2017, INT J OPHTHALMOL-CHI, V10, P1046, DOI 10.18240/ijo.2017.07.05; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131664; Yoshida T, 2017, DIGEST DIS SCI, V62, P1527, DOI 10.1007/s10620-017-4550-x; Zeng T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00538; Zhang C, 2015, TRANSPL P, V47, P553, DOI 10.1016/j.transproceed.2015.01.018; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje	53	4	4	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6510	6524		10.1096/fj.201800190	http://dx.doi.org/10.1096/fj.201800190			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29897812	Bronze			2022-12-28	WOS:000449359700013
J	Alshudukhi, AA; Zhu, J; Huang, DT; Jama, A; Smith, JD; Wang, QJ; Esser, KA; Ren, HM				Alshudukhi, Abdullah A.; Zhu, Jing; Huang, Dengtong; Jama, Abdulrahman; Smith, Jeffrey D.; Wang, Qing Jun; Esser, Karyn A.; Ren, Hongmei			Lipin-1 regulates Bnip3-mediated mitophagy in glycolytic muscle	FASEB JOURNAL			English	Article						fld; mitochondrial autophagy; contractile force; rhabdomyolysis; LC3	SKELETAL-MUSCLE; SELECTIVE AUTOPHAGY; POMPE DISEASE; MITOCHONDRIAL; MECHANISMS; METABOLISM; LC3; DEGRADATION; MUTATIONS; APOPTOSIS	Autophagy of mitochondria (mitophagy) is essential for maintaining muscle mass and healthy skeletal muscle. Patients with heritable phosphatidic acid phosphatase lipin-1-null mutations present with severe rhabdomyolysis and muscle atrophy in glycolytic muscle fibers, which are accompanied with mitochondrial aggregates and reduced mitochondrial cytochrome c oxidase activity. However, the underlying mechanisms leading to muscle atrophy as a result of lipin-1 deficiency are still not clear. In this study, we found that lipin-1 deficiency in mice is associated with a marked accumulation of abnormal mitochondria and autophagic vacuoles in glycolytic muscle fibers. Our studies using lipin-1-deficient myoblasts suggest that lipin-1 participates in B-cell leukemia (BCL)-2 adenovirus E1B 19 kDa protein-interacting protein 3 (Bnip3)-regulated mitophagy by interacting with microtubule-associated protein 1A/1B-light chain (LC)3, which is an important step in the recruitment of mitochondria to nascent autophagosomes. The requirement of lipin-1 for Bnip3-mediated mitophagy was further verified in vivo in lipin-1-deficient green fluorescent protein-LC3 transgenic mice (lipin-1(-/-)-GFP-LC3). Finally, we showed that lipin-1 deficiency in mice resulted in defective mitochondrial adaptation to starvation-induced metabolic stress and impaired contractile muscle force in glycolytic muscle fibers. In summary, our study suggests that deregulated mitophagy arising from lipin-1 deficiency is associated with impaired muscle function and may contribute to muscle rhabdomyolysis in humans.Alshudukhi, A. A., Zhu, J., Huang, D., Jama, A., Smith, J. D., Wang, Q. J., Esser, K. A., Ren, H. Lipin-1 regulates Bnip3-mediated mitophagy in glycolytic muscle.	[Alshudukhi, Abdullah A.; Huang, Dengtong; Jama, Abdulrahman; Ren, Hongmei] Wright State Univ, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA; [Zhu, Jing] Univ Kentucky, Cardiovasc Res Ctr, Lexington, KY USA; [Smith, Jeffrey D.] Univ Kentucky, Dept Biosyst & Agr Engn, Lexington, KY USA; [Wang, Qing Jun] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY USA; [Esser, Karyn A.] Univ Florida, Coll Med, Myol Inst, Gainesville, FL USA	University System of Ohio; Wright State University Dayton; University of Kentucky; University of Kentucky; University of Kentucky; State University System of Florida; University of Florida	Ren, HM (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	hongmei.ren@wright.edu		Wang, Qingjun/0000-0002-1959-4107; Smith, Jeffrey/0000-0002-6094-0585	Wright State University; U.S. National Institutes of Health Center of Biomedical Research Excellence on Obesity and Cardiovascular Diseases Grant [P20 GM103527-06]; American Heart Association [11BGIA7710059, 12SDG12050697]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	Wright State University; U.S. National Institutes of Health Center of Biomedical Research Excellence on Obesity and Cardiovascular Diseases Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Noboro Mizushima (University of Tokyo, Tokyo, Japan) for the GFP-LC3 mice, Dr. Wen-Xing Ding (University of Kansas Medical School, Kansas City, KS, USA) for the GFP-Bnip3 plasmid, and Dr. Feng Zhang (McGovern Institute for Brian Research, Massachusetts Institute of Technology, Cambridge, MA, USA) for pSpCas9 (BB)-2A-Puro (PX495) v.2.0 (plasmid 62988; Addgene, Cambridge, MA, USA). This work was supported by startup funds from Wright State University (to H.R.), U.S. National Institutes of Health Center of Biomedical Research Excellence on Obesity and Cardiovascular Diseases Grant P20 GM103527-06, and Beginning Grant-in-Aid 11BGIA7710059 and Scientist Development Grant 12SDG12050697 from the American Heart Association (to H.R.). The authors declare no conflicts of interest.	Bergounioux J, 2012, J PEDIATR-US, V160, P1052, DOI 10.1016/j.jpeds.2012.02.033; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Eskelinen EL, 2011, AUTOPHAGY, V7, P931, DOI 10.4161/auto.7.9.16679; Garcia-Cazarin M. L., 2011, JOVE-J VIS EXP, V49; Goodman CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037890; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Jiang WH, 2015, J BIOL CHEM, V290, P23646, DOI 10.1074/jbc.M115.686519; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kuma A, 2008, AUTOPHAGY, V4, P61, DOI 10.4161/auto.4846; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Michot C, 2012, J INHERIT METAB DIS, V35, P1119, DOI 10.1007/s10545-012-9461-6; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P219625, DOI 10.1155/2012/219625; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Shi RY, 2014, CNS NEUROSCI THER, V20, P1045, DOI 10.1111/cns.12325; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamada E, 2012, CELL REP, V1, P557, DOI 10.1016/j.celrep.2012.03.014; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang JH, 2013, REDOX BIOL, V1, P19, DOI 10.1016/j.redox.2012.11.008; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	57	9	9	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6796	6807		10.1096/fj.201800374	http://dx.doi.org/10.1096/fj.201800374			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29939786	Green Published			2022-12-28	WOS:000449359700034
J	Lin, ZC; Hsieh, PW; Hwang, TL; Chen, CY; Sung, CT; Fang, JY				Lin, Zih-Chan; Hsieh, Pei-Wen; Hwang, Tsong-Long; Chen, Chi-Yuan; Sung, Calvin T.; Fang, Jia-You			Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte-derived chemokine expression and neutrophil infiltration	FASEB JOURNAL			English	Article						psoriasis; imiquimod; anthranlic acid; skin disease; phosphodiesterase-4 inhibitor	IMIQUIMOD-INDUCED PSORIASIS; GENERALIZED PUSTULAR PSORIASIS; NF-KAPPA-B; SKIN INFLAMMATION; MICROABSCESS FORMATION; ATOPIC-DERMATITIS; PATHOGENESIS; CYTOKINES; DISEASES; IMMUNOPATHOGENESIS	Psoriasis is an inflammatory autoimmune skin disorder possessing a complex etiology related to genetic and environmental triggers. Keratinocytes show a potential role for the origin of psoriasis. In this study, we estimated the efficiency of 2 anthranilate derivatives(E)-4-(N-{2-[1-(hydroxyimino)ethyl]phenyl}sulfamoyl)phenyl pivalate (HFP031) and butyl 2-[2-(2-fluorophenyl)acetamido]benzoate (HFP034)on psoriasis amelioration in a mouse model. The results showed that topical treatment with both compounds could attenuate epidermal thickness and scaling in an imiquimod (IMQ)-induced psoriasis mouse model via decreased expression of cytokines and chemokines [C-X-C chemokine ligand (CXCL)1 and CXCL2], leading to the reduction of neutrophilic abscess in the skin. The in vivo cutaneous absorption of HFP034 was 7.6-fold greater than that of HFP031. Both compounds caused negligible irritation on healthy mouse skin. In addition, we examined the effect of the anthranilate derivatives on chemokine expression in IMQ-treated HaCaT keratinocytes. Our results elucidated a mechanism for anti-inflammatory activity of HFP034 that involved the elevation of intracellular cAMP concentration, suppression of NF-B activity, and attenuation of neutrophil chemoattractant expression. These results suggest that HFP034 could increase the cutaneous concentration of cAMP to suppress neutrophil infiltration into the skin. Topically applied HFP034 may demonstrate a potential for future clinical application as a novel therapy for psoriasis treatment.Lin, Z.-C., Hsieh, P.-W., Hwang, T.-L., Chen, C.-Y., Sung, C. T., Fang, J.-Y. Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte-derived chemokine expression and neutrophil infiltration.	[Lin, Zih-Chan] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Hsieh, Pei-Wen; Hwang, Tsong-Long; Fang, Jia-You] Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan; [Hwang, Tsong-Long; Fang, Jia-You] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Hsieh, Pei-Wen; Hwang, Tsong-Long; Chen, Chi-Yuan; Fang, Jia-You] Chang Gung Univ Sci & Technol, Res Ctr Food & Cosmet Safety, Taoyuan, Taiwan; [Hsieh, Pei-Wen; Hwang, Tsong-Long; Chen, Chi-Yuan; Fang, Jia-You] Chang Gung Univ Sci & Technol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan; [Chen, Chi-Yuan] Chang Gung Univ Sci & Technol, Grad Inst Hlth Ind Technol, Taoyuan, Taiwan; [Hsieh, Pei-Wen; Hwang, Tsong-Long; Fang, Jia-You] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Chen, Chi-Yuan] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan; [Sung, Calvin T.] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of California System; University of California Riverside	Fang, JY (corresponding author), Chang Gung Univ, Pharmaceut Lab, Grad Inst Nat Prod, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan.	fajy@mail.cgu.edu.tw	Hwang, Tsong-Long/AAE-6944-2020	Hwang, Tsong-Long/0000-0002-5780-3977	Ministry of Science and Technology of Taiwan [MOST-105-2320-B-182-010-MY3]; Chang Gung Memorial Hospital [CMRPD1G0411]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors are grateful to the financial support from the Ministry of Science and Technology of Taiwan (MOST-105-2320-B-182-010-MY3) and Chang Gung Memorial Hospital (CMRPD1G0411). The authors declare no conflicts of interest.	Amaro-Ortiz A, 2014, MOLECULES, V19, P6202, DOI 10.3390/molecules19056202; Andoh T, 2014, J DERMATOL SCI, V76, P206, DOI 10.1016/j.jdermsci.2014.10.005; Asahina R, 2017, VET DERMATOL, V28, P16, DOI 10.1111/vde.12351; Asif M., 2014, AM J MED SCI, V2, P24; Bernard Francois-Xavier, 2012, J Allergy (Cairo), V2012, P718725, DOI 10.1155/2012/718725; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Cheng YD, 2011, ORG BIOMOL CHEM, V9, P7113, DOI 10.1039/c1ob05714f; Chuang SY, 2018, EXPERT OPIN DRUG DIS, V13, P551, DOI 10.1080/17460441.2018.1463214; Croxford AL, 2014, J INVEST DERMATOL, V134, P728, DOI 10.1038/jid.2013.404; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Feldman SR, 2008, J AM ACAD DERMATOL, V59, P1009, DOI 10.1016/j.jaad.2008.08.028; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Greb JE, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.82; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072; Hwang TL, 2015, BIOORGAN MED CHEM, V23, P1123, DOI 10.1016/j.bmc.2014.12.056; Ikeda S, 2013, J AM ACAD DERMATOL, V68, P609, DOI 10.1016/j.jaad.2012.09.037; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Kim J, 2015, DERMATOL CLIN, V33, P13, DOI 10.1016/j.det.2014.09.002; Lima XT, 2015, AUTOIMMUNITY, V48, P57, DOI 10.3109/08916934.2014.947476; Lin CF, 2016, PHARM RES-DORDR, V33, P2152, DOI 10.1007/s11095-016-1953-x; Lin YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137890; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Mabuchi T, 2012, J DERMATOL SCI, V65, P4, DOI 10.1016/j.jdermsci.2011.11.007; Mahil SK, 2016, SEMIN IMMUNOPATHOL, V38, P11, DOI 10.1007/s00281-015-0539-8; Murphy G, 2011, J EUR ACAD DERMATOL, V25, P3, DOI 10.1111/j.1468-3083.2011.04059.x; Nedoszytko B, 2014, POSTEP DERM ALERGOL, V31, P84, DOI 10.5114/pdia.2014.40920; Pohl David, 2009, Acta Medica (Hradec Kralove), V52, P9; Qi XF, 2009, MOL IMMUNOL, V46, P1925, DOI 10.1016/j.molimm.2009.03.018; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; Richmond JM, 2017, J INVEST DERMATOL, V137, P350, DOI 10.1016/j.jid.2016.09.016; Rio GF, 2015, AN ACAD BRAS CIENC, V87, P1525, DOI 10.1590/0001-3765201520140289; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Sah SK, 2016, ANTIOXID REDOX SIGN, V24, P233, DOI 10.1089/ars.2015.6368; Sawamura R, 2015, BIOPHARM DRUG DISPOS, V36, P352, DOI 10.1002/bdd.1945; Schett G, 2010, THER ADV MUSCULOSKEL, V2, P271, DOI 10.1177/1759720X10381432; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Schon MP, 2017, EXP DERMATOL, V26, P305, DOI 10.1111/exd.13067; Shi LQ, 2012, EUR J MED CHEM, V54, P549, DOI 10.1016/j.ejmech.2012.06.001; Shou QY, 2014, FITOTERAPIA, V93, P62, DOI 10.1016/j.fitote.2013.12.008; Singh TP, 2013, EXPERT OPIN THER TAR, V17, P1405, DOI 10.1517/14728222.2013.838220; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Suzuki O, 2015, ACTA PHARMACEUT, V65, P191, DOI 10.1515/acph-2015-0016; Tsai YF, 2015, FREE RADICAL BIO MED, V89, P387, DOI 10.1016/j.freeradbiomed.2015.08.008; Tschachler E, 2007, CLIN DERMATOL, V25, P589, DOI 10.1016/j.clindermatol.2007.09.021; Uribe-Herranz M, 2013, J INVEST DERMATOL, V133, P1541, DOI 10.1038/jid.2012.512; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wu PR, 2017, CLIN IMMUNOL, V174, P53, DOI 10.1016/j.clim.2016.11.003; Zippin JH, 2010, J INVEST DERMATOL, V130, P1279, DOI 10.1038/jid.2009.440; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	50	15	15	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6783	6795		10.1096/fj.201800354	http://dx.doi.org/10.1096/fj.201800354			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29920221				2022-12-28	WOS:000449359700033
J	Nikaj, S; Roychowdhury, D; Lund, PK; Matthews, M; Pearson, K				Nikaj, Silda; Roychowdhury, Deepshikha; Lund, P. Kay; Matthews, Marguerite; Pearson, Katrina			Examining trends in the diversity of the US National Institutes of Health participating and funded workforce	FASEB JOURNAL			English	Article						career stage; demographics; independent researcher; nationally underrepresented groups; women	BIOMEDICAL-RESEARCH; RESEARCH AWARDS; NIH RESEARCH; RACE/ETHNICITY; GENERATION; SUCCESS; SCIENCE; FUTURE; SEX	Here, we use recent U.S. National Institutes of Health (NIH) data to document trends in the NIH-funded workforce over time. Consistent with previous studies that were initiated by NIH, we find that the number of scientists funded on competing R01-equivalent (R01 Eq.) and research project grants (RPGs) increased 2-5% per year between 2009 and 2016. Primary beneficiaries of this growth were experienced investigators (Exps), whereas the share of funding awarded to early-stage investigators (ESIs) and new investigators (NIs) declined. The decline occurred even after NIH instituted the New and Early-Stage Investigator policy in 2009. When we evaluate the investigator pool, we find that women and racial and ethnic minorities represent a higher percentage of NIs and ESIs relative to Exps. Thus, trends of diminishing support for NIs and ESIs may negatively impact the diversity of the current and future biomedical research workforce. We find some recent gains among women and Hispanics as part of the applicant and awardee pool for both R01 Eq. and RPGs, but significant, large gaps persist among nationally underrepresented racial minorities. Our findings suggest a need to prioritize investments and support of ESIs and NIs, groups in which women and racial and ethnic minorities represent a larger proportion of the applicant pool, to enhance diversity in the NIH-funded workforce.Nikaj, S., Roychowdhury, D., Lund, P. K., Matthews, M., Pearson, K. Examining trends in the diversity of the U.S. National Institutes of Health participating and funded workforce.	[Nikaj, Silda; Roychowdhury, Deepshikha; Lund, P. Kay; Matthews, Marguerite; Pearson, Katrina] NIH, Off Extramural Res, Off Director, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Nikaj, S (corresponding author), NIH, Div Biomed Res Workforce, Off Extramural Res, 6705 Rockledge Dr,Suite 350, Bethesda, MD 20892 USA.	silda.nikaj@nih.gov		Matthews, Marguerite/0000-0001-5911-4537				Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Alexander H, 2009, AAMC ANAL BRIEF, V9, P1; Andriole DA, 2012, ACAD MED, V87, P1722, DOI 10.1097/ACM.0b013e318271e57b; [Anonymous], 2016, STAT WOM AC MED PIP; Bhattacharjee Y, 2012, SCIENCE, V336, P969, DOI 10.1126/science.336.6084.969; Blau DM, 2017, P NATL ACAD SCI USA, V114, P3879, DOI 10.1073/pnas.1611748114; Burtraw D., 2020, 2021 ANN REPORT INDE; Charette MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168511; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Eblen MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155060; Flores A., 2017, FACTS US LATINOS 201; FR Collins, 2017, LAUNCHING NEXT GENER; Gibbs KD, 2016, ELIFE, V5, DOI 10.7554/eLife.21393; Ginther DK, 2016, ACAD MED, V91, P1098, DOI 10.1097/ACM.0000000000001278; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Heggeness ML, 2016, ACAD MED, V91, P1164, DOI 10.1097/ACM.0000000000001209; Kaatz A, 2016, ACAD MED, V91, P1080, DOI 10.1097/ACM.0000000000001272; Kaiser J, 2008, SCIENCE, V322, P848, DOI 10.1126/science.322.5903.848; Kaplan SE, 2018, ACAD MED, V93, P616, DOI 10.1097/ACM.0000000000001968; Lauer M., 2017, DATA TRENDS ACCORDIN; Lauer M, 2017, P NATL ACAD SCI USA, V114, P11801, DOI 10.1073/pnas.1716941114; Levitt M, 2017, P NATL ACAD SCI USA, V114, P6498, DOI 10.1073/pnas.1609996114; Matthews KRW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029738; Myers SL, 2004, AM ECON REV, V94, P296, DOI 10.1257/0002828041301614; National Academies of Sciences Engineering and Medicine, 2017, NEXT GEN RES IN; National Institutes of Health, 2014, PHYS SCI WORKF WORK; National Institutes of Health, 2017, NEXT GEN RES IN WORK; National Institutes of Health, 2016, NEW EARL STAG INV PO; National Institutes of Health, 2012, BIOM RES WORKF WORK; National Institutes of Health, 2016, PROGR REP ADV COMM D; National Institutes of Health, 2012, AG DISTR NIH PRINC I; National Institutes of Health, 2017, POL SUPP NEXT GEN RE; National Science Foundation, 2017, WOM MIN PERS DIS SCI; Pohlhaus JR, 2011, ACAD MED, V86, P759, DOI 10.1097/ACM.0b013e31821836ff; Sinatra R, 2016, SCIENCE, V354, DOI 10.1126/science.aaf5239; Tabak L., 2017, ENHANCING STEWARDSHI; United States Census Bureau, 2016, POP EST JUL 1 2016	37	37	37	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6410	6422		10.1096/fj.201800639	http://dx.doi.org/10.1096/fj.201800639			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29920223				2022-12-28	WOS:000449359700005
J	Soroush, F; Tang, Y; Zaidi, HM; Sheffield, JB; Kilpatrick, LE; Kiani, MF				Soroush, Fariborz; Tang, Yuan; Zaidi, Hasan M.; Sheffield, Joel B.; Kilpatrick, Laurie E.; Kiani, Mohammad F.			PKC inhibition as a novel medical countermeasure for radiation-induced vascular damage	FASEB JOURNAL			English	Article						adhesion; microfluidics; leukocytes; transmigration; acute radiation syndrome	PROTEIN-KINASE-C; ENDOTHELIAL-CELL-ADHESION; INDUCED UP-REGULATION; MICROVASCULAR NETWORKS; IONIZING-RADIATION; LEUKOCYTE ADHESION; DELTA-PKC; NEUTROPHIL MIGRATION; MICROFLUIDIC ASSAY; PARTICLE ADHESION	In the event of a radiologic catastrophe, endothelial cell and neutrophil dysfunction play important roles in tissue injury. Clinically available therapeutics for radiation-induced vascular injury are largely supportive. PKC was identified as a critical regulator of the inflammatory response, and its inhibition was shown to protect critical organs during sepsis. We used a novel biomimetic microfluidic assay (bMFA) to interrogate the role of PKC in radiation-induced neutrophil-endothelial cell interaction and endothelial cell function. HUVECs formed a complete lumen in bMFA and were treated with 0.5, 2, or 5 Gy ionizing radiation (IR). At 24 h post-IR, the cells were treated with a PKC inhibitor for an additional 24 h. Under physiologic shear flow, the role of PKC on endothelium function and neutrophil adherence/migration was determined. PKC inhibition dramatically attenuated IR-induced endothelium permeability increase and significantly decreased neutrophil migration across IR-treated endothelial cells. Moreover, neutrophil adhesion to irradiated endothelial cells was significantly decreased after PKC inhibition in a flow-dependent manner. PKC inhibition downregulated IR-induced P-selectin, intercellular adhesion molecule 1, and VCAM-1 but not E-selectin overexpression. PKC is an important regulator of neutrophil-endothelial cell interaction post-IR, and its inhibition can serve as a potential radiation medical countermeasure.Soroush, F., Tang, Y., Zaidi, H. M., Sheffield, J. B., Kilpatrick, L. E., Kiani, M. F. PKC inhibition as a novel medical countermeasure for radiation-induced vascular damage.	[Soroush, Fariborz; Tang, Yuan; Kiani, Mohammad F.] Temple Univ, Coll Engn, Dept Mech Engn, 1947 N 12th St, Philadelphia, PA 19122 USA; [Zaidi, Hasan M.] Temple Univ, Coll Engn, Dept Bioengn, Philadelphia, PA 19122 USA; [Sheffield, Joel B.] Temple Univ, Dept Biol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Kilpatrick, Laurie E.] Temple Univ, Lewis Katz Sch Med, Ctr Inflammat Clin & Translat Lung Res, Philadelphia, PA 19122 USA; [Kiani, Mohammad F.] Temple Univ, Lewis Katz Sch Med, Dept Radiat Oncol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kiani, MF (corresponding author), Temple Univ, Coll Engn, Dept Mech Engn, 1947 N 12th St, Philadelphia, PA 19122 USA.	mkiani@temple.edu	Soroush, Fariborz/K-7873-2019; Tang, Yuan/ABG-7928-2020; Soroush, Fariborz/O-1778-2019	Tang, Yuan/0000-0003-0450-3222; Soroush, Fariborz/0000-0003-2742-1684	American Heart Association [16GRNT29980001]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM114359]; NIH National Heart, Lung, and Blood Institute [HL111552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114359] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	F.S. is a Predoctoral Fellow of the American Heart Association (Grant 16PRE29860006). This work was supported by the American Heart Association (Grant 16GRNT29980001) and U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (Grant GM114359) and NIH National Heart, Lung, and Blood Institute (Grant HL111552). L.E.K. is listed as an inventor on U.S. Patent No. 8,470,766, entitled "Novel Protein Kinase C Therapy for the Treatment of Acute Lung Injury," which is assigned to the Children's Hospital of Philadelphia and the University of Pennsylvania (Philadelphia, PA, USA). M.F.K., L.E.K., Y.T., and F.S. are listed as inventors on U.S. Provisional Patent Application No. 62/518058, entitled " Protein Kinase C-delta Targeted Therapy for Treating Radiation Injury," which is assigned to Temple University.	Ansari R, 2007, RADIAT RES, V167, P80, DOI 10.1667/RR0616.1; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45, DOI 10.1080/095530097143527; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Deosarkar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142725; Farese AM, 2015, DRUG TODAY, V51, P537, DOI 10.1358/dot.2015.51.9.2386730; Flanders KC, 2008, AM J PATHOL, V173, P68, DOI 10.2353/ajpath.2008.070937; Francois A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/123241; Hofer M, 2014, MOLECULES, V19, P4770, DOI 10.3390/molecules19044770; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kiani MF, 2002, PHARM RES-DORDR, V19, P1317, DOI 10.1023/A:1020350708672; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Korpela E, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0266-7; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; Lamberti G, 2013, MICROVASC RES, V89, P107, DOI 10.1016/j.mvr.2013.03.007; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee YJ, 2002, CELL GROWTH DIFFER, V13, P237; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; MAXWELL C, 1982, AM J PUBLIC HEALTH, V72, P275, DOI 10.2105/AJPH.72.3.275; Micke O, 2005, STRAHLENTHER ONKOL, V181, P313, DOI 10.1007/s00066-005-1346-2; Mitsutake N, 2001, ONCOGENE, V20, P989, DOI 10.1038/sj.onc.1204179; Molla M, 1999, INT J RADIAT ONCOL, V45, P1011, DOI 10.1016/S0360-3016(99)00286-2; Mondrinos MJ, 2015, J PHARMACOL EXP THER, V355, P86, DOI 10.1124/jpet.115.224832; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Mondrinos MJ, 2013, SHOCK, V39, P467, DOI 10.1097/SHK.0b013e318294f85a; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; PANES J, 1995, GASTROENTEROLOGY, V108, P1761, DOI 10.1016/0016-5085(95)90138-8; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; Prabhakarpandian B, 2001, MICROCIRCULATION, V8, P355, DOI 10.1038/sj.mn.7800105; Prabhakarpandian B, 2008, BIOMED MICRODEVICES, V10, P585, DOI 10.1007/s10544-008-9170-y; Prabhakarpandian B, 2011, MICROVASC RES, V82, P210, DOI 10.1016/j.mvr.2011.06.013; Prabhakarpandian B, 2011, MICROCIRCULATION, V18, P380, DOI 10.1111/j.1549-8719.2011.00099.x; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Reyland ME, 2016, PHARMACOL THERAPEUT, V165, P1, DOI 10.1016/j.pharmthera.2016.05.001; Rosano JM, 2009, BIOMED MICRODEVICES, V11, P1051, DOI 10.1007/s10544-009-9322-8; Satyamitra MM, 2016, RADIAT RES, V186, P99, DOI 10.1667/RR14436.1; Schaue D, 2015, SEMIN RADIAT ONCOL, V25, P4, DOI 10.1016/j.semradonc.2014.07.007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Singh VK, 2017, INT J RADIAT BIOL, V93, P851, DOI 10.1080/09553002.2017.1332438; Singh VK, 2015, CYTOKINE, V71, P22, DOI 10.1016/j.cyto.2014.08.003; Soroush F, 2016, J LEUKOCYTE BIOL, V100, P1027, DOI 10.1189/jlb.3MA0216-087R; Springer T A, 1990, Scand J Immunol, V32, P211, DOI 10.1111/j.1365-3083.1990.tb02912.x; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Tang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09815-9; Tousi N, 2010, MICROVASC RES, V80, P384, DOI 10.1016/j.mvr.2010.07.001; Vary TC, 2005, AM J PHYSIOL-ENDOC M, V289, pE684, DOI 10.1152/ajpendo.00613.2004; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Wie SM, 2014, J BIOL CHEM, V289, P10900, DOI 10.1074/jbc.M114.551366; Williams JP, 2011, INT J RADIAT BIOL, V87, P851, DOI 10.3109/09553002.2011.560996; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Wood K, 2005, NEUROSURGERY, V57, P1282, DOI 10.1227/01.NEU.0000187318.17832.55; Yuan H, 2005, RADIAT RES, V163, P544, DOI 10.1667/RR3361; Yuan H, 2003, BRAIN RES, V969, P59, DOI 10.1016/S0006-8993(03)02278-9; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698	58	6	7	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6436	6444		10.1096/fj.201701099	http://dx.doi.org/10.1096/fj.201701099			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	29897816	Bronze			2022-12-28	WOS:000449359700007
J	Wang, WK; Wang, LF; Ruan, LH; Oh, JY; Dong, XW; Zhuge, QC; Su, DM				Wang, Weikan; Wang, Liefeng; Ruan, Linhui; Oh, Jiyoung; Dong, Xiaowei; Zhuge, Qichuan; Su, Dong-Ming			Extracellular vesicles extracted from young donor serum attenuate inflammaging via partially rejuvenating aged T-cell immunotolerance	FASEB JOURNAL			English	Article						young serum; exosomes; rejuvenation; age-related thymic involution; chronic inflammation	CENTRAL-NERVOUS-SYSTEM; NEGATIVE SELECTION; THYMIC INVOLUTION; COGNITIVE FUNCTION; IMMUNE-RESPONSES; SKELETAL-MUSCLE; MICRORNAS; SENESCENCE; BRAIN; MOUSE	Biologic aging results in a chronic inflammatory condition, termed inflammaging, which establishes a risk for such age-related diseases as neurocardiovascular diseases; therefore, it is of great importance to develop rejuvenation strategies that are able to attenuate inflammaging as a means of intervention for age-related diseases. A promising rejuvenation factor that is present in young blood has been found that can make aged neurons younger; however, the component in the young blood and its mechanism of action are poorly elucidated. We assessed rejuvenation in naturally aged mice with extracellular vesicles (EVs) or exosomes extracted from young murine serum on the basis of different spectrums of microRNAs in these vesicles from young and old sera. We found that EVs extracted from young donor mouse serum, rather than EVs extracted from old donor mouse serum or non-EV supernatant extracted from young donor mouse serum, were able to attenuate inflammaging in old mice. Inflammaging is attributed to multiple factors, one of which is thymic aging-released self-reactive T cell-induced pathology. We found that the attenuation of inflammaging after treatment with EVs from young serum partially contributed to the rejuvenation of thymic aging, which is characterized by partially reversed thymic involution, enhancement of negative selection signals, and reduced autoreactions in the periphery. Our results provide evidence for understanding of the potential rejuvenation factor in the young donor serum, which holds great promise for the development of novel therapeutics to reduce morbidity and mortality caused by age-related inflammatory diseases.Wang, W., Wang, L., Ruan, L., Oh, J., Dong, X., Zhuge, Q., Su, D.-M. Extracellular vesicles extracted from young donor serum attenuate inflammaging via partially rejuvenating aged T-cell immunotolerance.	[Wang, Weikan; Wang, Liefeng; Ruan, Linhui; Oh, Jiyoung; Su, Dong-Ming] Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA; [Dong, Xiaowei] Univ North Texas, Hlth Sci Ctr, Dept Pharmaceut Sci, Ft Worth, TX USA; [Wang, Weikan; Ruan, Linhui; Zhuge, Qichuan] Wenzhou Med Univ, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Affiliated Hosp 1, Wenzhou, Peoples R China; [Wang, Liefeng] Gannan Med Univ, Dept Biotechnol, Ganzhou, Peoples R China	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center; University of North Texas System; University of North Texas Denton; Wenzhou Medical University; Gannan Medical University	Su, DM (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	dongming.su@unthsc.edu			U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases [R01-AI121147]; National Natural Science Foundation of China [31660256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121147] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases Grant R01-AI121147 (to D.-M.S.), and by the National Natural Science Foundation of China (31660256; to L.W.). The authors declare no conflicts of interest.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgarth N, 2000, IMMUNOL REV, V176, P171; Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Brun CE, 2015, CELL METAB, V22, P54, DOI 10.1016/j.cmet.2015.05.009; Brunner S, 2011, AGEING RES REV, V10, P362, DOI 10.1016/j.arr.2010.08.003; Burnley P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.460; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Coder B, 2017, ONCOTARGET, V8, P7116, DOI 10.18632/oncotarget.12572; Coder B, 2015, ONCOTARGET, V6, P21777, DOI 10.18632/oncotarget.4970; Coder BD, 2015, J IMMUNOL, V194, P5825, DOI 10.4049/jimmunol.1500082; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; de Candia P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00043; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Fraga MF, 2009, CURR OPIN IMMUNOL, V21, P446, DOI 10.1016/j.coi.2009.04.003; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Giunta Sergio, 2006, Immun Ageing, V3, P12, DOI 10.1186/1742-4933-3-12; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; High KP, 2012, SEMIN IMMUNOL, V24, P373, DOI 10.1016/j.smim.2012.04.007; Iorio MV, 2010, BBA-GENE REGUL MECH, V1799, P694, DOI 10.1016/j.bbagrm.2010.05.005; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Kim MJ, 2015, J IMMUNOL, V194, P4784, DOI 10.4049/jimmunol.1403158; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Legroux L, 2015, J NEUROSCI METH, V247, P23, DOI 10.1016/j.jneumeth.2015.03.021; Li T, 2017, BRAIN RES, V1657, P120, DOI 10.1016/j.brainres.2016.12.006; Licastro Federico, 2005, Immun Ageing, V2, P8; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nakken B, 2003, SCAND J IMMUNOL, V58, P478, DOI 10.1046/j.1365-3083.2003.01323.x; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nusser A, 2014, EUR J IMMUNOL, V44, P2893, DOI 10.1002/eji.201344408; Oh J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003352; Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001; Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8; Olivieri Fabiola, 2013, Frontiers in Genetics, V4, P121, DOI 10.3389/fgene.2013.00121; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Pishel I, 2012, REJUV RES, V15, P239, DOI 10.1089/rej.2012.1331; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2013, AUTOIMMUN REV, V12, P674, DOI 10.1016/j.autrev.2012.10.014; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; WILLIAMS KA, 1980, TRANSPLANTATION, V29, P274, DOI 10.1097/00007890-198004000-00002; Wilson AG, 2008, J PERIODONTOL, V79, P1514, DOI 10.1902/jop.2008.080172; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xia JY, 2012, AGING DIS, V3, P248; Zook EC, 2011, BLOOD, V118, P5723, DOI 10.1182/blood-2011-03-342097	69	32	32	4	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5899	5912		10.1096/fj.201800059R	http://dx.doi.org/10.1096/fj.201800059R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29782203	Bronze, Green Published			2022-12-28	WOS:000447172000012
J	Zheng, C; Chen, DX; Zhang, Y; Bai, Y; Huang, SY; Zheng, DF; Liang, WW; She, SP; Peng, XJ; Wang, PZ; Mo, XN; Song, QS; Lv, P; Huang, J; Ye, RD; Wang, Y				Zheng, Can; Chen, Dixin; Zhang, Yan; Bai, Yun; Huang, Shiyang; Zheng, Danfeng; Liang, Weiwei; She, Shaoping; Peng, Xinjian; Wang, Pingzhang; Mo, Xiaoning; Song, Quansheng; Lv, Ping; Huang, Jing; Ye, Richard D.; Wang, Ying			FAM19A1 is a new ligand for GPR1 that modulates neural stem-cell proliferation and differentiation	FASEB JOURNAL			English	Article						neural stem cell; GPCR; cytokines	CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN FOREBRAIN; OLFACTORY-BULB CIRCUITS; SUBVENTRICULAR ZONE; ALZHEIMERS-DISEASE; NEURONS; BRAIN; RECEPTOR; PROTEINS; CHEMERIN	FAM19A1 is a member of the family with sequence similarity 19 with unknown function. FAM19A1 mRNA expression is restricted to the CNS. Here, we report that FAM19A1 is a classic secretory protein, and expression levels correlate with brain development, increasing from embryonic d 12.5, peaking between postnatal d (P)1 and P7 and decreasing at wk 8. The adult hippocampus is a region of FAM19A1 high expression. Recombinant FAM19A1 suppressed the proliferation and self-renewal of neural stem cells (NSCs) and altered the lineage progression of NSCs with promoted neuron differentiation and suppressed astrocyte differentiation. Although GPCR 1 (GPR1) has been reported to be expressed in the CNS, its functions in the brain remain unclear. We identified GPR1 to be a functional receptor for FAM19A1. FAM19A1 interacted with GPR1 via the N-terminal domain (GPR1-ND), and its NSC modulatory functions required the Rho-associated protein kinase (ROCK) /ERK1/2 and ROCK/signal transducer and activator of transcription 3 signaling pathways. GPR1-ND that selectively bound to FAM19A1 neutralized the effects of FAM19A1 on NSC functions. Taken together, our results show, for the first time to our knowledge, that FAM19A1 is a novel regulatory factor of the proliferation and differentiation of NSCs, and identified a novel mechanism by which GPCR mediates the effects of FAM19A1 on NSC functions that may be important for brain development and neurogenesis. Additional exploration of the functions of FAM19A1 and GPR1 in the CNS may broaden the range of therapeutic options available for major brain disorders.Zheng, C., Chen, D., Zhang, Y., Bai, Y., Huang, S., Zheng, D., Liang, W., She, S., Peng, X., Wang, P., Mo, X., Song, Q., Lv, P., Huang, J., Ye, R. D., Wang, Y. FAM19A1 is a new ligand for GPR1 that modulates neural stem-cell proliferation and differentiation.	[Zheng, Can; Chen, Dixin; Zhang, Yan; Huang, Shiyang; Zheng, Danfeng; Liang, Weiwei; She, Shaoping; Peng, Xinjian; Wang, Pingzhang; Song, Quansheng; Lv, Ping; Huang, Jing; Wang, Ying] Peking Univ, Dept Immunol, Sch Basic Med Sci, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Zheng, Can; Chen, Dixin; Zhang, Yan; Huang, Shiyang; Zheng, Danfeng; Liang, Weiwei; She, Shaoping; Peng, Xinjian; Wang, Pingzhang; Song, Quansheng; Lv, Ping; Huang, Jing; Wang, Ying] Peking Univ, Key Lab Med Immunol, Minist Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Bai, Yun] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Sch Basic Med Sci, Beijing, Peoples R China; [Wang, Pingzhang; Mo, Xiaoning; Song, Quansheng; Lv, Ping; Huang, Jing; Wang, Ying] Peking Univ, Ctr Human Dis Genom, Beijing, Peoples R China; [Ye, Richard D.] Univ Macau, Inst Chinese Med Sci, Taipa 999078, Macau, Peoples R China	Peking University; Peking University; Peking University; Peking University; University of Macau	Wang, Y (corresponding author), Peking Univ, Dept Immunol, Sch Basic Med Sci, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.; Ye, RD (corresponding author), Univ Macau, Inst Chinese Med Sci, Taipa 999078, Macau, Peoples R China.	richardye@umac.mo; yw@bjmu.edu.cn	Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620	National Natural Science Foundation of China [31470842, 31770940, 31470865]; University of Macau [MYRG2016-00152-ICMS-QRCM, CPG2015-00018-ICMS]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Macau	This work was supported by the National Natural Science Foundation of China (Grants 31470842, 31770940, and 31470865) and the University of Macau (Grants MYRG2016-00152-ICMS-QRCM and CPG2015-00018-ICMS). The authors declare no conflicts of interest.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Amin E, 2013, BIOL CHEM, V394, P1399, DOI 10.1515/hsz-2013-0181; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Chaudhry M, 2015, J ALZHEIMERS DIS, V44, P989, DOI 10.3233/JAD-142106; Chen JH, 2015, CELL TRANSPLANT, V24, P779, DOI 10.3727/096368913X676925; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Gonzalez R, 2016, CNS NEUROL DISORD-DR, V15, P881, DOI 10.2174/1871527315666160815164247; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Hsu YC, 2007, CELL TRANSPLANT, V16, P133; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Lepousez G, 2013, ANNU REV PHYSIOL, V75, P339, DOI 10.1146/annurev-physiol-030212-183731; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x; Park D, 2012, CELL TRANSPLANT, V21, P365, DOI 10.3727/096368911X586765; Pei XL, 2014, J IMMUNOL, V192, P1878, DOI 10.4049/jimmunol.1300758; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROSSNITZ ER, 1991, BIOCHEM BIOPH RES CO, V179, P471, DOI 10.1016/0006-291X(91)91394-R; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rourke JL, 2015, MOL CELL ENDOCRINOL, V417, P36, DOI 10.1016/j.mce.2015.09.002; Rourke JL, 2014, J ENDOCRINOL, V222, P201, DOI 10.1530/JOE-14-0069; Rushing Gabrielle, 2016, Front Biol (Beijing), V11, P261, DOI 10.1007/s11515-016-1407-1; Sakamoto M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00121; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shimizu Y, 2017, BIOCHEM PHARMACOL, V140, P105, DOI 10.1016/j.bcp.2017.06.115; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Tang YT, 2004, GENOMICS, V83, P727, DOI 10.1016/j.ygeno.2003.10.006; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396; Wang YB, 2018, CIRCULATION, V138, P48, DOI 10.1161/CIRCULATIONAHA.117.032398; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Zhang W, 2014, J NEUROSCI RES, V92, P185, DOI 10.1002/jnr.23299; Ziegler AN, 2015, NAT REV ENDOCRINOL, V11, P161, DOI 10.1038/nrendo.2014.208	49	16	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5874	5890		10.1096/fj.201800020RRR	http://dx.doi.org/10.1096/fj.201800020RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29799787	Bronze			2022-12-28	WOS:000447172000010
J	Fiamoncini, J; Rundle, M; Gibbons, H; Thomas, EL; Geillinger-Kastle, K; Bunzel, D; Trezzi, JP; Kiselova-Kaneva, Y; Wopereis, S; Wahrheit, J; Kulling, SE; Hiller, K; Sonntag, D; Ivanova, D; van Ommen, B; Frost, G; Brennan, L; Bell, J; Daniel, H				Fiamoncini, Jarlei; Rundle, Milena; Gibbons, Helena; Thomas, E. Louise; Geillinger-Kaestle, Kerstin; Bunzel, Diana; Trezzi, Jean-Pierre; Kiselova-Kaneva, Yoana; Wopereis, Suzan; Wahrheit, Judith; Kulling, Sabine E.; Hiller, Karsten; Sonntag, Denise; Ivanova, Diana; van Ommen, Ben; Frost, Gary; Brennan, Lorraine; Bell, Jimmy; Daniel, Hannelore			Plasma metabolome analysis identifies distinct human metabotypes in the postprandial state with different susceptibility to weight loss-mediated metabolic improvements	FASEB JOURNAL			English	Article						dietary challenges; phenotypic flexibility; metabolomics; acylcarnitines	FREE FATTY-ACIDS; GLUCOSE-TOLERANCE TEST; INSULIN-RESISTANCE; MINIMAL MODEL; CHALLENGE; KINETICS; OBESITY; ADIPOSITY; MARKERS; HEALTH	Health has been defined as the capability of the organism to adapt to challenges. In this study, we tested to what extent comprehensively phenotyped individuals reveal differences in metabolic responses to a standardized mixed meal tolerance test (MMTT) and how these responses change when individuals experience moderate weight loss. Metabolome analysis was used in 70 healthy individuals. with profiling of approximate to 300 plasma metabolites during an MMTT over 8 h. Multivariate analysis of plasma markers of fatty acid catabolism identified 2 distinct metabotype clusters (A and B). Individuals from metabotype B showed slower glucose clearance, had increased intra-abdominal adipose tissue mass and higher hepatic lipid levels when compared with individuals from metabotype A. An NMR-based urine analysis revealed that these individuals also to have a less healthy dietary pattern. After a weight loss of approximate to 5.6 kg over 12 wk, only the subjects from metabotype B showed positive changes in the glycemic response during the MMTT and in markers of metabolic diseases. Our study in healthy individuals demonstrates that more comprehensive phenotyping can reveal discrete metabotypes with different outcomes in a dietary intervention and that markers of lipid catabolism in plasma could allow early detection of the metabolic syndrome.Fiamoncini, J., Rundle, M., Gibbons, H., Thomas, E. L., Geillinger-Kastle, K., Bunzel, D., Trezzi, J.-P., Kiselova-Kaneva, Y., Wopereis, S., Wahrheit, J., Kulling, S. E., Hiller, K., Sonntag, D., Ivanova, D., van Ommen, B., Frost, G., Brennan, L., Bell, J. Daniel, H. Plasma metabolome analysis identifies distinct human metabotypes in the postprandial state with different susceptibility to weight loss-mediated metabolic improvements.	[Fiamoncini, Jarlei; Geillinger-Kaestle, Kerstin; Daniel, Hannelore] Tech Univ Munich, Dept Food & Nutr, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany; [Rundle, Milena; Frost, Gary] Imperial Coll London, Dept Med, Div Diabet Endocrinol & Metab, London, England; [Gibbons, Helena; Brennan, Lorraine] Univ Coll Dublin, Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland; [Thomas, E. Louise; Bell, Jimmy] Univ Westminster, Dept Life Sci, Res Ctr Optimal Hlth, London, England; [Bunzel, Diana; Kulling, Sabine E.] Max Rubner Inst, Dept Safety & Qual Fruit & Vegetables, Karlsruhe, Germany; [Trezzi, Jean-Pierre] Integrated Biobank Luxembourg, Dudelange, Luxembourg; [Trezzi, Jean-Pierre] Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Kiselova-Kaneva, Yoana; Ivanova, Diana] Med Univ Varna, Dept Biochem Mol Med & Nutrigen, Varna, Bulgaria; [Wopereis, Suzan; Sonntag, Denise; van Ommen, Ben] Netherlands Inst Appl Sci Res TNO, Dept Microbiol & Syst Biol, Zeist, Netherlands; [Wahrheit, Judith] Biocrates Life Sci, Innsbruck, Austria; [Hiller, Karsten] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol, Braunschweig, Germany; [Hiller, Karsten] Helmholtz Ctr Infect Res, Dept Computat Biol Infect Res, Braunschweig, Germany	Technical University of Munich; Imperial College London; University College Dublin; University of Westminster; Luxembourg Institute of Health; Medical University Varna; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Fiamoncini, J (corresponding author), Tech Univ Munich, Dept Food & Nutr, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany.	jarleifiamoncini@gmail.com	Fiamoncini, Jarlei/L-5497-2017; Thomas, Elizabeth Louise/AIF-0055-2022	Fiamoncini, Jarlei/0000-0002-8456-983X; Trezzi, Jean-Pierre/0000-0001-7418-754X; Bell, Jimmy/0000-0003-3804-1281; Ivanova, Diana/0000-0002-4502-081X; Hiller, Karsten/0000-0001-9322-5820; Thomas, Elizabeth/0000-0003-4235-4694; Frost, Gary/0000-0003-0529-6325; Brennan, Lorraine/0000-0002-7711-7499; Rundle, Milena/0000-0001-9908-5195	FP7 Project NutriTech; European Commission [289511]	FP7 Project NutriTech; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank Alexander Haag, Ronny Scheundel, Barbara Gelhaus, Christa Lachermeier, and Helene Prunkl (Technical University of Munich, Freising, Germany), and Rita Bauerle, and Claudia Hoffmann (Max-Rubner Institute, Karlsruhe, Germany) for excellent technical work. This work was funded by the FP7 Project NutriTech. NutriTech is financed by the European Commission in the 7th Framework Programme FP7, Grant Agreement 289511. The authors declare no conflicts of interest.	Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boston RC, 2008, AM J PHYSIOL-REG I, V295, pR395, DOI 10.1152/ajpregu.90317.2008; Boston RC, 2008, AM J PHYSIOL-REG I, V294, pR1140, DOI 10.1152/ajpregu.00749.2007; Boston RC, 2008, J DAIRY RES, V75, P13, DOI 10.1017/S0022029907002853; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Elliott R, 2007, BRIT J NUTR, V98, P1095, DOI 10.1017/S0007114507803400; Fiamoncini J, 2017, AM J PHYSIOL-GASTR L, V313, pG300, DOI 10.1152/ajpgi.00157.2017; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; FRAYN KN, 1995, ADV ENZYME REGUL, V35, P163, DOI 10.1016/0065-2571(94)00011-Q; Gibbons H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601050; Giesbertz P, 2016, CURR OPIN CLIN NUTR, V19, P48, DOI 10.1097/MCO.0000000000000235; Giesbertz P, 2015, J LIPID RES, V56, P2029, DOI 10.1194/jlr.D061721; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Hirabara SM, 2006, BBA-BIOENERGETICS, V1757, P57, DOI 10.1016/j.bbabio.2005.11.007; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Jelic K, 2009, ANN BIOMED ENG, V37, P1897, DOI 10.1007/s10439-009-9738-6; Kardinaal AFM, 2015, FASEB J, V29, P4600, DOI 10.1096/fj.14-269852; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Morris C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072890; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pellis L, 2012, METABOLOMICS, V8, P347, DOI 10.1007/s11306-011-0320-5; Ramos-Roman MA, 2012, METABOLISM, V61, P202, DOI 10.1016/j.metabol.2011.06.008; RANDLE PJ, 1963, LANCET, V1, P785; Rauschert S, 2016, J CLIN ENDOCR METAB, V101, P871, DOI 10.1210/jc.2015-3525; Rico-Sanz J, 1999, J APPL PHYSIOL, V87, P2068, DOI 10.1152/jappl.1999.87.6.2068; Stroeve JHM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0459-1; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; Thomas EL, 2012, OBESITY, V20, P76, DOI 10.1038/oby.2011.142; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; van den Broek TJ, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0589-8; van Ommen B, 2008, GENES NUTR, V3, P51, DOI 10.1007/s12263-008-0084-3; van Ommen B, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0423-5; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wopereis S, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0570-6; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	40	39	40	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5447	5458		10.1096/fj.201800330R	http://dx.doi.org/10.1096/fj.201800330R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718708	Bronze			2022-12-28	WOS:000447972500021
J	Luo, BB; Xiang, D; Wu, D; Liu, CC; Fang, YQ; Chen, PJ; Hu, YP				Luo, Beibei; Xiang, Dao; Wu, Die; Liu, Changcheng; Fang, Yiqun; Chen, Peijie; Hu, Yi-Ping			Hepatic PHD2/HIF-1 axis is involved in postexercise systemic energy homeostasis	FASEB JOURNAL			English	Article						liver; swimming; metabolic chamber; hypoxia; energy metabolism	FATTY LIVER-DISEASE; PHYSICAL-ACTIVITY; ACID HOMEOSTASIS; SHORT-TERM; EXERCISE; HYPOXIA; MICE; HIF-1-ALPHA; GLUCOSE; BINDING	Exercise plays an important role in the prevention and treatment of chronic liver disease and associated metabolic disorders. A single bout of exercise induces tissue blood flow redistribution, which decreases splanchnic circulation and leads to physiologic hypoxia in the gastrointestinal system and liver. The transcription factor, hypoxia inducible factor-1 (HIF-1), and its regulator, prolylhydroxylase 2 (PHD2), play pivotal roles in the response to oxygen flux by regulating downstream gene expression levels in the liver. We hypothesized that exercise increases the HIF-1 levels in the liver, and that the hepatic PHD2/HIF-1 axis is involved in postexercise restoration of systemic energy homeostasis. Through constant O-2 consumption, CO2 production, food and water intake, and physical activity detection with metabolic chambers, we observed that one 30-min session of swimming exercise enhances systemic energy metabolism in mice. By using the noninvasive bioluminescence imaging ROSA26 oxygen-dependent domain Luc mouse model, we reveal that exercise increases in vivo HIF levels in the liver. Intraperitoneal injections of the PHD inhibitor, dimethyloxalylglycine, mimicked exercise-induced HIF increase, whereas the HIF-1 inhibitor, PX-478, blocked this effect. We next constructed liver-specific knockout (LKO) mouse models with albumin-Cre-mediated, hepatocyte-specific Hif1a and Phd2 deletion. Compared with their controls, Hif1a-LKO and Phd2-LKO mice exhibited distinct patterns of hepatic metabolism-related gene expression profiles. Moreover, Hif1a-LKO mice failed to restore systemic energy homeostasis after exercise. In conclusion, the current study demonstrates that a single bout of exercise disrupts systemic energy homeostasis, increasing the HIF-1 levels in the liver. These findings also provide evidence that the hepatic PHD2/HIF-1 axis is involved in postexercise systemic metabolic homeostasis.Luo, B., Xiang, D., Wu, D., Liu, C., Fang, Y., Chen, P., Hu, Y.-P. Hepatic PHD2/HIF-1 axis is involved in postexercise systemic energy homeostasis.	[Luo, Beibei; Wu, Die; Chen, Peijie; Hu, Yi-Ping] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Luo, Beibei; Liu, Changcheng; Hu, Yi-Ping] Second Mil Med Univ, Dept Cell Biol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Xiang, Dao; Fang, Yiqun] Second Mil Med Univ, Naval Med Res Inst, Dept Div Med, Shanghai, Peoples R China	Shanghai University of Sport; Naval Medical University; Naval Medical University	Hu, YP (corresponding author), Second Mil Med Univ, Dept Cell Biol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	yphu@smmu.edu.cn			National Natural Science Foundation of China [31471135, 31701040]; China Postdoctoral Science Foundation [2015M572679]; Shanghai Sailing Program [17YF1418000]; Chenguang Program [16CG57]; Major Logistics Projects of the People's Liberation Army (PLA) [AWS16J033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Sailing Program; Chenguang Program; Major Logistics Projects of the People's Liberation Army (PLA)	The authors thank Shennian Ge and Prof. Yexiong Tan [Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (SMMU)] for bioluminescent imaging; Prof. Haiying Zhu, Prof. Wenlin Li, and Prof. Xiaoyuan Zi (Department of Cell Biology, SMMU) for useful discussions; Qin Yang and Prof. Xin Xu (School of Kinesiology, Shanghai University of Sport) for animal studies and proofreading; Yongchao Cai and Prof. Zhiying He (Shanghai East Hospital, Tongji University, Shanghai, China) for technical help and animal studies. P.C. was supported by the National Natural Science Foundation of China (31471135). B.L. was supported by the National Natural Science Foundation of China (31701040), China Postdoctoral Science Foundation (2015M572679), Shanghai Sailing Program (17YF1418000), and Chenguang Program (16CG57). Y.F. was supported by Major Logistics Projects of the People's Liberation Army (PLA) (AWS16J033). The authors declare no conflicts of interest.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; BISHOP JM, 1957, J PHYSIOL-LONDON, V137, P309, DOI 10.1113/jphysiol.1957.sp005814; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Emhoff CAW, 2013, J APPL PHYSIOL, V114, P297, DOI 10.1152/japplphysiol.01202.2012; Flannigan KL, 2015, FASEB J, V29, P1591, DOI 10.1096/fj.14-266015; George AS, 2009, HEPATOLOGY, V50, P68, DOI 10.1002/hep.22940; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Haus JM, 2013, J CLIN ENDOCR METAB, V98, pE1181, DOI 10.1210/jc.2013-1229; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Herbst EAF, 2014, AM J PHYSIOL-REG I, V306, pR102, DOI 10.1152/ajpregu.00150.2013; Hodson EJ, 2016, J PHYSIOL-LONDON, V594, P1179, DOI 10.1113/JP271050; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kim KH, 2017, HEPATOLOGY, V66, P498, DOI 10.1002/hep.29199; Knab AM, 2011, MED SCI SPORT EXER, V43, P1643, DOI 10.1249/MSS.0b013e3182118891; Kregel K. C., 2006, RESOURCE BOOK DESIGN, P53; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Luo BB, 2014, BRAIN BEHAV IMMUN, V39, P99, DOI 10.1016/j.bbi.2013.11.013; Melanson EL, 2007, J APPL PHYSIOL, V103, P1576, DOI 10.1152/japplphysiol.01455.2006; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Nishiyama Y, 2012, J HEPATOL, V56, P441, DOI 10.1016/j.jhep.2011.07.024; Olenchock BA, 2016, CELL, V164, P884, DOI 10.1016/j.cell.2016.02.006; Otte JA, 2001, J APPL PHYSIOL, V91, P866, DOI 10.1152/jappl.2001.91.2.866; Perko MJ, 1998, J PHYSIOL-LONDON, V513, P907, DOI 10.1111/j.1469-7793.1998.907ba.x; Powers SK, 2016, J PHYSIOL-LONDON, V594, P5081, DOI 10.1113/JP270646; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shibue K, 2015, AM J PHYSIOL-ENDOC M, V308, pE583, DOI 10.1152/ajpendo.00543.2014; Suhara T, 2015, P NATL ACAD SCI USA, V112, P11642, DOI 10.1073/pnas.1515872112; Sullivan S, 2012, HEPATOLOGY, V55, P1738, DOI 10.1002/hep.25548; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; van Wijck K, 2012, AM J PHYSIOL-GASTR L, V303, pG155, DOI 10.1152/ajpgi.00066.2012; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang QO, 2010, J LIPID RES, V51, P2516, DOI 10.1194/jlr.M003335; Wu D, 2017, ELIFE, V6, DOI 10.7554/eLife.25217; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Zelber-Sagi S, 2008, HEPATOLOGY, V48, P1791, DOI 10.1002/hep.22525; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001	45	8	9	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4670	4680		10.1096/fj.201701139R	http://dx.doi.org/10.1096/fj.201701139R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29601782				2022-12-28	WOS:000443817700005
J	Grames, MS; Dayton, RD; Jackson, KL; Richard, AD; Lu, XH; Klein, RL				Grames, Mychal S.; Dayton, Robert D.; Jackson, Kasey L.; Richard, Adam D.; Lu, Xiaohong; Klein, Ronald L.			Cre-dependent AAV vectors for highly targeted expression of disease-related proteins and neurodegeneration in the substantia nigra	FASEB JOURNAL			English	Article						adeno-associated virus; alpha-synuclein; tau; TDP-43; pathological protein spreading	AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA-SYNUCLEIN; GENE-TRANSFER; TAU; DEGENERATION; MUTATION; TDP-43; PATHOLOGY; PROMOTER	Recombinant adeno-associated virus (AAV) vectors are a popular genetic approach in neuroscience because they confer such efficient transgene expression in the brain and spinal cord. A number of studies have used AAV to express pathological disease-related proteins in the dopaminergic neurons of the substantia nigra in situ (e.g., -synuclein to model aspects of Parkinson's disease). The neuropathology and neurodegeneration of Parkinson's disease occur in a circumscribed pattern in the brain, and one of the most important goals of any gene transfer study is accurate, pinpoint targeting. By combining Cre recombinase-dependent AAVs in Cre-driver rats in which Cre is expressed only in the tyrosine hydroxylase neurons, we have achieved more highly targeted expression of several disease-relevant neuropathological proteins in the substantia nigra pars compacta than using constitutive expression AAV vectors. Alpha-synuclein, tau, transactive response DNA-binding protein of 43 kDa, or the control fluorescent protein yellow fluorescent protein was individually expressed to induce highly targeted, dopaminergic neuron-specific neurodegeneration models. The refined targeting foreshadows a next-generation disease modeling system for expressing neurodegenerative disease-related proteins in a disease-relevant manner. We foresee specific utilities of this in vivo AAV vector targeting of pathological proteins to a well-defined and well-demarcated cell population.Grames, M. S., Dayton, R. D., Jackson, K. L., Richard, A. D., Lu, X., Klein, R. L. Cre-dependent AAV vectors for highly targeted expression of disease-related proteins and neurodegeneration in the substantia nigra.	[Grames, Mychal S.; Dayton, Robert D.; Jackson, Kasey L.; Richard, Adam D.; Lu, Xiaohong; Klein, Ronald L.] Louisiana State Univ LSU Hlth Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Klein, RL (corresponding author), LSU Hlth Shreveport, Dept Pharmacol Toxicol & Neurosci, 1501 Kings Highway, Shreveport, LA 71130 USA.	klein@lsuhsc.edu			Amyotrophic Lateral Sclerosis (ALS) Association [15-TALS-296]; Meira GTx	Amyotrophic Lateral Sclerosis (ALS) Association; Meira GTx	The authors thank Thomas Lawson for his charitable donation for neurodegenerative disease research, and Jean-Charles Paterna (Neuroscience Center Zurich, University of Zurich, Zurich, Switzerland) for critiquing the manuscript. This work was supported by the Amyotrophic Lateral Sclerosis (ALS) Association (Grant 15-TALS-296) and Meira GTx. Meira GTx had no involvement in the design or execution of the experiments, or in the decision to publish this research. The authors are collaborating with Meira GTx on a preclinical gene therapy project for ALS involving TDP-43. The authors declare no conflicts of interest.	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Jackson KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169291; Kim C, 2016, EXP NEUROBIOL, V25, P113, DOI 10.5607/en.2016.25.3.113; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Klein RL, 2005, NEUROBIOL DIS, V20, P64, DOI 10.1016/j.nbd.2005.02.001; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Klein RL, 1998, EXP NEUROL, V150, P183, DOI 10.1006/exnr.1997.6736; Klein RL, 2008, EUR J NEUROSCI, V27, P1615, DOI 10.1111/j.1460-9568.2008.06161.x; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kumaran R, 2015, HUM MOL GENET, V24, pR32, DOI 10.1093/hmg/ddv236; Leverenz JB, 2007, BRAIN, V130, P1360, DOI 10.1093/brain/awm069; Ling H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.011; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Miki Y, 2010, NEUROPATHOLOGY, V30, P149, DOI 10.1111/j.1440-1789.2009.01046.x; Mirra SS, 1999, J NEUROPATH EXP NEUR, V58, P335, DOI 10.1097/00005072-199904000-00004; Mishima T, 2017, J NEUROPATH EXP NEUR, V76, P676, DOI 10.1093/jnen/nlx049; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Peel AL, 2000, J NEUROSCI METH, V98, P95, DOI 10.1016/S0165-0270(00)00183-7; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 2002, ANN NEUROL, V52, P511, DOI 10.1002/ana.10340; Rolland AS, 2017, NEUROSCIENCE, V346, P126, DOI 10.1016/j.neuroscience.2017.01.014; Schneider JA, 2002, J HISTOCHEM CYTOCHEM, V50, P99, DOI 10.1177/002215540205000111; Smedemark-Margulies N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00018; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3; WAKABAYASHI K, 1994, ACTA NEUROPATHOL, V87, P545; Wider C, 2009, PARKINSONISM RELAT D, V15, P281, DOI 10.1016/j.parkreldis.2008.07.005; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang H, 2008, ACTA NEUROPATHOL, V115, P115, DOI 10.1007/s00401-007-0285-7; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	43	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4420	4427		10.1096/fj.201701529RR	http://dx.doi.org/10.1096/fj.201701529RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29513569				2022-12-28	WOS:000439325400030
J	Lv, ZP; Fan, H; Zhang, BB; Ning, C; Xing, K; Guo, YM				Lv, Zengpeng; Fan, Hao; Zhang, Beibei; Ning, Chao; Xing, Kun; Guo, Yuming			Dietary genistein supplementation in laying broiler breeder hens alters the development and metabolism of offspring embryos as revealed by hepatic transcriptome analysis	FASEB JOURNAL			English	Article						genistein; embryo; transcriptome; metabolism; development	CHICKEN GALLUS-DOMESTICUS; LIPID-METABOLISM; SKELETAL-MUSCLE; POSTMENOPAUSAL WOMEN; SOY ISOFLAVONE; EGG-YOLK; LIVER; ACTIVATION; QUALITY; GROWTH	Genistein (GEN) is a type of isoflavone mainly derived from soy products. In this experiment, we added 40 and 400 mg/kg GEN to the diet of laying broiler breeder hens to clarify the maternal effects of GEN on the development and metabolism of chick embryos. GEN treatment at 40 mg/kg increased embryonic length, weight, and liver index, as well as the width of the proliferative zone in the tibial growth plate of chick embryos. Gene ontology (GO) cluster analysis of the hepatic transcriptome showed that GEN treatment promoted embryonic development and cell proliferation. Low-dose GEN treatment increased insulin growth factor-binding protein (IGFBP)3 mRNA expression in the embryonic liver, whereas high-dose GEN treatment increased IGFBP5 expression and activated the apoptosis and protein tyrosine kinase signaling pathways. Furthermore, adding supplemental GEN to the diet of hens promoted the glycolysis process in the embryonic liver through the insulin-signaling pathway, upregulated target genes (phosphoglucomutase-2, hexokinase 1, dihydroxyacetone phosphate by aldolase, phosphofructokinase, platelet, and enolase 2), and enhanced the transport of carboxylic acids and cholesterol and the synthesis of unsaturated fatty acid (arachidonic acid) in the embryonic liver through upregulation of liver X receptor, sterol regulatory element-binding protein 1, and patatin-like phospholipase A. Additionally, GEN treatment increased fatty acid -oxidation and Na+/K+-ATPase activity in the embryonic liver through activation of peroxisome proliferator-activated receptors (PPARs; PPAR and PPAR) and the AMPK signaling pathway, which could provide energy for embryonic development. In addition, GEN treatment in hens increased superoxide dismutase activity and metallothionein expression in the chick embryonic liver and promoted lymphocyte proliferation through upregulation of mRNA expression of CDKN1A, IL12RB1, Sox11, PRKAR1A, PRKCQ, and TCF3. The improved immunity and antioxidant capacity, as a result of maternal GEN effects, was conducive to embryonic development. In summary, the addition of GEN to the diet of laying broiler breeder hens significantly promoted the development and metabolism of chick embryos.Lv, Z., Fan, H., Zhang, B., Ning, C., Xing, K., Guo, Y. Dietary genistein supplementation in laying broiler breeder hens alters the development and metabolism of offspring embryos as revealed by hepatic transcriptome analysis.	[Lv, Zengpeng; Fan, Hao; Zhang, Beibei; Ning, Chao; Xing, Kun; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	China Agricultural University	Guo, YM (corresponding author), China Agr Univ, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	guoyum@cau.edu.cn	Fan, Hao/AAY-7810-2020	Fan, Hao/0000-0001-5245-9698; Ning, Chao/0000-0001-8247-1700	China Agricultural Research System program [CARS-41]; Chinese Universities Scientific Fund	China Agricultural Research System program; Chinese Universities Scientific Fund	The authors thank the Animal Quantitative Inheritance Lab (College of Animal Science and Technology, China Agricultural University, Beijing, China) for providing the server for RNA-Seq analysis. This work was financially supported by the China Agricultural Research System program (CARS-41) and the Chinese Universities Scientific Fund. The authors declare no conflicts of interest.	Akdemir F, 2009, POULTRY SCI, V88, P2125, DOI 10.3382/ps.2009-00004; Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloedon LT, 2002, AM J CLIN NUTR, V76, P1126, DOI 10.1093/ajcn/76.5.1126; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; BURKE WH, 1989, POULTRY SCI, V68, P805, DOI 10.3382/ps.0680805; Clapper J., 2015, Open Journal of Animal Sciences, V5, P163, DOI 10.4236/ojas.2015.52019; Cooke P. S., 2003, PROG OBES RES, V9, P98; DANESCH U, 1994, J BIOL CHEM, V269, P27258; Das B, 2004, PARASITOL INT, V53, P345, DOI 10.1016/j.parint.2004.06.002; Doerge DR, 2001, REPROD TOXICOL, V15, P105, DOI 10.1016/S0890-6238(01)00108-3; Feast M, 1998, J ANAT, V193, P383, DOI 10.1046/j.1469-7580.1998.19330383.x; Flynn KM, 2000, TOXICOL SCI, V55, P311, DOI 10.1093/toxsci/55.2.311; Fu Z, 2012, APPL PHYSIOL NUTR ME, V37, P480, DOI [10.1139/H2012-005, 10.1139/h2012-005]; 박옥진, 2007, Preventive Nutrition and Food Science, V12, P197; Jiang SQ, 2007, FOOD CHEM, V105, P1086, DOI 10.1016/j.foodchem.2007.05.010; Jones S, 2016, TOXICOLOGY, V355, P21, DOI 10.1016/j.tox.2016.05.008; Jungbauer A, 2014, J STEROID BIOCHEM, V139, P277, DOI 10.1016/j.jsbmb.2012.12.009; Kamboh AA, 2013, POULTRY SCI, V92, P2411, DOI 10.3382/ps.2012-02960; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; KOUBA M, 1995, COMP BIOCHEM PHYS B, V110, P47, DOI 10.1016/0305-0491(94)00147-M; Lee YM, 2006, NUTRITION, V22, P956, DOI 10.1016/j.nut.2005.12.014; Ley D, 2013, PEDIATR RES, V73, P68, DOI 10.1038/pr.2012.146; [马海田 Ma Haitian], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P297; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Minutoli L, 2009, J UROLOGY, V181, P1913, DOI 10.1016/j.juro.2008.11.095; Morabito N, 2002, OSTEOPOROSIS INT, V13, pS22; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; NOBLE RC, 1985, LIPIDS, V20, P278, DOI 10.1007/BF02534260; NOBLE RC, 1990, PROG LIPID RES, V29, P107, DOI 10.1016/0163-7827(90)90014-C; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Palanisamy N, 2008, RENAL FAILURE, V30, P645, DOI 10.1080/08860220802134532; Paulson C. N, 2010, THESIS; Pitt BR, 1997, AM J PHYSIOL-LUNG C, V273, pL856, DOI 10.1152/ajplung.1997.273.4.L856; Rasouli E, 2015, ANIMAL, V9, P1473, DOI 10.1017/S1751731115000853; Rehfeldt C, 2007, MEAT SCI, V75, P103, DOI 10.1016/j.meatsci.2006.06.028; Retana-Marquez S, 2016, PHYSIOL BEHAV, V164, P1, DOI 10.1016/j.physbeh.2016.05.004; Saitoh S, 2001, BIOSCI BIOTECH BIOCH, V65, P2220, DOI 10.1271/bbb.65.2220; Sakai J, 2004, SEIKAGAKU, V76, P517; Sassi-Messai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004935; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Shin JH, 2012, KOREAN J FOOD SCI AN, V32, P404, DOI 10.5851/kosfa.2012.32.4.404; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Steinshamn H, 2010, ANIM SCI PAP REP, V28, P195; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van der Kaay DCM, 2009, GROWTH HORM IGF RES, V19, P198, DOI 10.1016/j.ghir.2008.08.010; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wu Q, 2017, CELL SIGNAL, V37, P62, DOI 10.1016/j.cellsig.2017.06.001; Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199; Yon JM, 2012, J EMB T, V27, P101; Yoo NY, 2015, J AGR FOOD CHEM, V63, P4305, DOI 10.1021/acs.jafc.5b00398; Zanella I, 2015, EUR J NUTR, V54, P1095, DOI 10.1007/s00394-014-0786-9; Zhao L, 2016, J AGR FOOD CHEM, V64, P7291, DOI 10.1021/acs.jafc.6b02907; Zhi-Ping H. U., 2011, CHINESE J EXP TRADIT, V41, P121	57	11	12	1	56	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4214	4228		10.1096/fj.201701457R	http://dx.doi.org/10.1096/fj.201701457R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29518347				2022-12-28	WOS:000439325400013
J	Escate, R; Mata, P; Cepeda, JM; Padro, T; Badimon, L				Escate, Rafael; Mata, Pedro; Cepeda, Jose Maria; Padro, Teresa; Badimon, Lina			miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia	FASEB JOURNAL			English	Article						LDL cholesterol; microRNAs; innate immunity; inflammatory markers; age	MICRORNAS; ATHEROSCLEROSIS; INFLAMMATION; LDL; LIPOPROTEINS; CELLS; CHOLESTEROL; PROTEIN; ACTIVATION; MECHANISMS	Familial hypercholesterolemia (FH) conveys a high risk of premature atherosclerosis as a result of lifelong exposure to high LDL cholesterol levels that are not fully reduced by standard-of-care lipid-lowering treatment. Inflammatory mediators have played a role in the progression of atherosclerotic lesions. Here, we investigated whether innate immunity cells in patients with FH have a specific proinflammatory phenotype that is distinct from that of cells in normal participants. To this end, miR-505-3p-a microRNA related to chronic inflammation-and its target genes were investigated in monocyte-derived macrophages (MACs) of patients with FH(FH-MACs) and non-FH controls (co-MACs). On the basis of the profiler PCR array analysis of agomiR-505-3p-transfected MACs, we identified the chemokine receptors, CCR3, CCR4, and CXCR1, as genes that are regulated by miR-505-3p via the transcription factor, RUNX1. miR-505-3p was significantly down-regulated, whereas CCR3, CCR4, CXCR, and RUNX1 were increased in FH-MAC compared with co-MAC, with the increase being more evident in the proinflammatory M1-like FH-MAC. Chemokine receptor levels were unrelated to LDL plasma levels at entry, but correlated with age in patients with FH, not in controls. In summary, we demonstrate for first time to our knowledge that MACs from FH-MACs have an inflammatory phenotype that is characterized by the up-regulation of CCR3, CCR4, and CXCR1 under the control of miR-505-3p. These results suggest a chronic inflammatory condition in FH innate immunity cells that is not reverted by standard lipid-lowering treatment.	[Escate, Rafael; Padro, Teresa; Badimon, Lina] Hosp Santa Creu & Sant Pau, Catalan Inst Cardiovasc Sci ICCC, St Pau Biomed Res Inst IIB St Pau, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Barcelona, Spain; [Mata, Pedro] Fdn Hipercolesterolemia Familiar, Madrid, Spain; [Cepeda, Jose Maria] Hosp Vega Baja, Dept Internal Med, Orihuela, Spain; [Badimon, Lina] Univ Autonoma Barcelona, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Padro, T (corresponding author), Cardiovasc Sci Inst ICCC, Cardiovasc Res Ctr, St Antoni Maria Claret 167, Barcelona 08025, Spain.	tpadro@csic-iccc.org	Escate, Rafael/D-3271-2016; BADIMON, LINA/S-2950-2019; Badimon, Lina/O-4711-2014	Escate, Rafael/0000-0002-8448-7244; Badimon, Lina/0000-0002-9162-2459	Fundacion Jesus Serra; Fundacion de Investigacion Cardiovascular, Barcelona; Institute of Health Carlos III (ISCIII) [FIS PI16/01915, TerCel-RD/12/0019/0026]; Institute of Health Carlos III (ISCIII) [Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV)] [CB16/11/00411]; Spanish Ministry of Economy and Competitiveness [SAF2016-76819-R]; European Regional Development Fund (FEDER) "Una Manera de Hacer Europa"; Department of Economy and Knowledge of the Government of Catalonia [2014SGR1303]; Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya	Fundacion Jesus Serra; Fundacion de Investigacion Cardiovascular, Barcelona; Institute of Health Carlos III (ISCIII); Institute of Health Carlos III (ISCIII) [Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV)]; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER) "Una Manera de Hacer Europa"; Department of Economy and Knowledge of the Government of Catalonia; Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya	The authors acknowledge Dr. Esther Pena for help in confocal microscopy analysis, and Montse Gomez-Pardo (both from Catalan Institute of Cardiovascular Sciences) for technical assistance during the study. The authors are indebted to the patients for their valuable contribution and willingness to participate. The authors also thank Fundacion Jesus Serra and Fundacion de Investigacion Cardiovascular, Barcelona, for their continuous support. This work was supported by the Institute of Health Carlos III (ISCIII) [FIS PI16/01915 (to T.P.); TerCel-RD/12/0019/0026 and Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) CB16/11/00411 (to L.B.)], the Spanish Ministry of Economy and Competitiveness [SAF2016-76819-R (to L.B.)], the European Regional Development Fund (FEDER) "Una Manera de Hacer Europa," the Secretary of University and Research, Department of Economy and Knowledge of the Government of Catalonia (2014SGR1303), and Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya. The authors declare no conflicts of interest.	Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Andreou L, 2015, TRENDS MOL MED, V21, P307, DOI 10.1016/j.molmed.2015.02.003; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Badimon L, 2006, CURR MOL MED, V6, P439, DOI 10.2174/156652406778018725; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bekkering S, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0645-3; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Buttari B, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/257543; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; El Messal M, 2006, CLIN CHIM ACTA, V366, P185, DOI 10.1016/j.cca.2005.09.027; Escate R, 2016, ATHEROSCLEROSIS, V246, P177, DOI 10.1016/j.atherosclerosis.2016.01.002; Escate R, 2017, J CELL MOL MED, V21, P487, DOI 10.1111/jcmm.12993; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Greaves DR, 2001, ARTERIOSCL THROM VAS, V21, P923, DOI 10.1161/01.ATV.21.6.923; GUYTON JR, 1991, J LIPID RES, V32, P953; Haley KJ, 2000, CIRCULATION, V102, P2185; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartmann P, 2015, CELL MOL LIFE SCI, V72, P3253, DOI 10.1007/s00018-015-1925-z; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holven KB, 2003, EUR HEART J, V24, P1756, DOI 10.1016/S0195-668X(03)00467-6; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Leonard DA, 2011, CORONARY ARTERY DIS, V22, P491, DOI 10.1097/MCA.0b013e32834b67e2; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu Y, 1997, ARTERIOSCL THROM VAS, V17, P317, DOI 10.1161/01.ATV.17.2.317; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Mata N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-94; Mozas Pilar, 2004, Hum Mutat, V24, P187, DOI 10.1002/humu.9264; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ninomiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066086; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Raghuwanshi SK, 2012, J IMMUNOL, V189, P2824, DOI 10.4049/jimmunol.1201114; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2014, LANCET, V384, P607, DOI 10.1016/S0140-6736(14)61009-6; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Suades R, 2014, THROMB HAEMOSTASIS, V111, P111, DOI 10.1160/TH13-07-0612; van Wijk DF, 2014, J AM COLL CARDIOL, V64, P1418, DOI 10.1016/j.jacc.2014.01.088; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Vogt A, 2015, APPL CLIN GENET, V8, P27, DOI 10.2147/TACG.S44315; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Wierzbicki Anthony S, 2008, BMJ, V337, pa1095, DOI 10.1136/bmj.a1095; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Yang Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1371, DOI 10.1159/000430303; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603	51	24	25	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					601	612		10.1096/fj.201700476RR	http://dx.doi.org/10.1096/fj.201700476RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	32172543				2022-12-28	WOS:000425146900007
